Structure Search

List Search MOL Search Structure Search

 EN

English - EN Chinese - ZH

 Cart 0
Chemistry
Life Science
Catalysts Ligands
Materials Science
Catalysts Ligands
Achiral Nitrogen Ligands
Pyridine and Phenanthroline Ligands (162)
Other Achiral Nitrogen Ligands (53)
Achiral Oxygen Ligands
Achiral Oxygen Ligand (54)
Achiral Phosphine Ligands
Alkyl-phosphine Ligands (17)
Aryl-phosphine Ligands (86)
2-(Diphenylphosphaneyl)Benzaldehyde (5)[1,1'-Biphenyl]-2-Yldi-Tert-Butylphosphane (4)Triphenylphosphine Oxide (7)
Bis-phosphine Ligands (90)
Monophosphine Ligands (256)
Multi-phosphine Ligands (5)
Chiral Nitrogen Ligands
Chiral Bis-nitrogen Ligands (133)
Salen Ligands (7)
Other Chiral Nitrogen Ligands (64)
Chiral Oxazoline Ligands
BOX Ligands (510)
Chiral Mono Oxazoline Ligands (363)
Ferrocenyl-oxazoline Ligands (10)
PHOX Ligands (218)
SOX Ligands (34)
TOX Ligands (6)
Other Oxazoline Ligands (14)
Chiral Oxygen Ligands
BINOLs (46)
BIPHENs (2)
Chiral Diphenols (112)
Other Chiral Oxygen Ligands (24)
Chiral Phosphine Ligands
Atropisomeric Bisphosphine Ligands (137)
BIDIME and BIBOP Ligands (78)
BIDIME-BIBOP (7)
2,2',3,3'-Tetrahydro-4,4'-Bibenzo[D][1,3]Oxaphosphole (7)
Chiral Aminophosphine Ligands (50)
Chiral Ferrocenyl Phosphine Ligands (96)
Chiral Phosphoramidite Ligands (98)
Duphos and BPE Ligands (28)
PHOX Ligands (218)
Sadphos Ligands (110)
Other C-Chiral Ligands (76)
Other P-Chiral Ligands (10)
Main-Group Metals
Aluminum (11)
Tin (3)
Metalloids
Metalloid (5)
Photoredox Catalysts
Organic-dye Photoredox Catalysts (88)
Photoredox Acridinium Catalysts (22)
Photoredox Carbazole Catalysts (10)
Photoredox Iridiums Catalysts (100)
Photoredox Rutheniums Catalysts (36)
Other Photoredox Catalysts (13)
Transition Metals
Cadmium (1)
Cobalt (93)
Copper (108)
Gold (70)
Iridium (60)
Iron (101)
Manganese (45)
Molybdenum (11)
Nickel (95)
Osmium (2)
Palladium (240)
Platinum (75)
Rhenium (6)
Rhodium (165)
Ruthenium (199)
Silver (33)
Tantalum (1)
Titanium (10)
Tungsten (6)
Vanadium (6)
Zinc (48)
Other Cheap Metals (6)
Chemistry
Asymmetric Synthesis
Chiral Building Blocks (18769)
Boronic Acids/Esters
1,3,2-Dioxaborinane (394)
Boronic Acids (13203)
MIDA Boronates (363)
Pinacol Boronates (16139)
Pinanediol Boronates (96)
Potassium Organotrifluoroborate Salts (1077)
Other Boronates (132)
Fluorine Chemistry
Aliphatic Fluorinated Building Blocks (660)
Aromatic Fluorinated Building Blocks (9087)
Bis(trifluoromethane)sulfonimides (49)
Difluoromethoxylated Building Blocks (238)
Difluoromethylated Building Blocks (334)
Hexafluorophosphates (62)
Monofluoromethylated Building Blocks (65)
Polyfluoroalkanes (84)
SF5-Containing Building Blocks (72)
Sulfonyl Fluorides (67)
Tetrafluoroborates (139)
Triflates (85)
Trifluoroborates (212)
Trifluoromethoxylated Building Blocks (567)
Trifluoromethylated Building Blocks (4366)
Trifluoromethylthiolated Building Blocks (49)
Heterocyclic Building Blocks
Acridines (641)
1,2,3,4-Tetrahydroacridine (9)9,10-Diphenylacridin-10-Ium (6)Acridine (19)
Aliphatic Heterocycles (104)
(1R,5S)-3-Azabicyclo[3.1.0]Hexane (11)1,2-Dithiolane (6)1,4-Diazepan-2-One (5)1,4-Diazepan-5-One (9)1,4-Dioxane (17)1,4-Oxazepane (8)10,11-Dihydro-5H-Dibenzo[B,F]Azepine (9)11,12-Didehydro-5,6-Dihydrodibenz[B,F]Azocine (14)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Glycyl)-2,2-Dimethyloxazolidine-4-Carboxylic Acid (9)3H-Diazirine (11)4-Benzyl-1,4-Oxazepane (5)Tetrahydro-2H-Thiopyran 1,1-Dioxide (8)
Aromatic Heterocycles (30)
1,2,4,5-Tetrazine (7)3,4-Dihydronaphthalen-2(1H)-One (23)
Azetidines (2929)
1-(Azetidin-1-Yl)-2-Bromoethan-1-One (3)1-(Azetidin-3-Yl)-1H-Pyrazole (7)1-(Phenylsulfonyl)Azetidine (7)1-Benzhydrylazetidine (13)1-Benzylazetidine (6)1-Methylazetidine (6)1-Phenylazetidine (8)2,7-Diazaspiro[3.5]Nonane (7)2-Azaspiro[3.3]Heptane (11)2-Imino-N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-(Thiazol-4-Yl)Acetamide (3)3-Bromoazetidine (3)3-Methylazetidin-3-Ol (3)3-Methyleneazetidine (8)3-Phenylazetidine (3)4-(Azetidin-1-Yl)Piperidine (6)Azetidin-2-One (11)Azetidin-2-Ylmethanol (7)Azetidin-3-Amine (4)Azetidin-3-Ol (11)Azetidin-3-Yl Acetate (3)Azetidin-3-Ylmethanamine (3)Azetidine-2-Carboxylic Acid (6)Azetidine-3-Carboxylic Acid (5)Benzyl Azetidine-1-Carboxylate (9)Methyl Azetidine-2-Carboxylate (3)N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-Phenylacetamide (5)Tert-Butyl Azetidine-1-Carboxylate (64)
Benzimidazoles (4387)
(1H-Benzo[D]Imidazol-2-Yl)Methanamine (7)(1H-Benzo[D]Imidazol-2-Yl)Methanol (14)1,2-Diphenyl-1H-Benzo[D]Imidazole (7)1-Benzyl-1H-Benzo[D]Imidazole (6)1-Ethyl-1H-Benzo[D]Imidazole (4)1-Methyl-1H-Benzo[D]Imidazole (47)1-Phenyl-1H-Benzo[D]Imidazole (4)1H-Benzo[D]Imidazol-2-Amine (7)1H-Benzo[D]Imidazol-5-Amine (4)1H-Benzo[D]Imidazol-6-Amine (6)1H-Benzo[D]Imidazole-2-Carbaldehyde (5)1H-Benzo[D]Imidazole-2-Carboxylic Acid (7)1H-Benzo[D]Imidazole-2-Thiol (10)1H-Benzo[D]Imidazole-4-Carboxylic Acid (6)1H-Benzo[D]Imidazole-5-Carboxylic Acid (4)2-((Pyridin-2-Ylmethyl)Thio)-1H-Benzo[D]Imidazole (7)2-(1H-Benzo[D]Imidazol-2-Yl)Ethan-1-Amine (6)2-(Chloromethyl)-1H-Benzo[D]Imidazole (9)2-Benzyl-1H-Benzo[D]Imidazole (7)2-Bromo-1H-Benzo[D]Imidazole (4)2-Chloro-1H-Benzo[D]Imidazole (17)2-Methyl-1H-Benzo[D]Imidazole (20)4-Bromo-1H-Benzo[D]Imidazole (14)4-Methyl-1H-Benzo[D]Imidazole (7)5,6-Dichloro-1H-Benzo[D]Imidazole (4)5-Bromo-1H-Benzo[D]Imidazole (13)5-Chloro-1H-Benzo[D]Imidazole (14)5-Methoxy-1H-Benzo[D]Imidazole (2)5-Methyl-1H-Benzo[D]Imidazole (10)6-Chloro-1H-Benzo[D]Imidazole (25)Methyl (1H-Benzo[D]Imidazol-2-Yl)Carbamate (5)Methyl 1H-Benzo[D]Imidazole-2-Carboxylate (3)Tert-Butyl 1H-Benzo[D]Imidazole-1-Carboxylate (3)Benzimidazole-Carboxylic Acid (43)
Benzisoxazoles (508)
3-Chlorobenzo[D]Isoxazole (7)3-Methylbenzo[D]Isoxazole (8)6-Bromobenzo[D]Isoxazole (5)Benzo[C]Isoxazole (5)Benzo[D]Isoxazol-3-Amine (8)
Benzodioxans (694)
(2,3-Dihydrobenzo[B][1,4]Dioxin-2-Yl)Methanamine (3)2,3-Dihydrobenzo[B][1,4]Dioxine-2-Carboxylic Acid (3)2,3-Dihydrobenzo[B][1,4]Dioxine-6-Carboxylic Acid (3)6-Bromo-2,3-Dihydrobenzo[B][1,4]Dioxine (6)
Benzofurans (3708)
1-(Benzofuran-2-Yl)Ethan-1-One (3)2,2-Dimethyl-2,3-Dihydrobenzofuran (7)2,3-Dihydrobenzofuran-3-Amine (11)2,3-Dihydrobenzofuran-5-Amine (3)2,3-Dihydrobenzofuran-7-Amine (5)2-(Benzofuran-3-Yl)Acetic Acid (3)2-Bromodibenzo[B,D]Furan (6)2-Ethylbenzofuran (3)2-Methylbenzofuran (5)3-Methylbenzofuran (4)4-Bromobenzofuran (3)4-Phenyldibenzo[B,D]Furan (8)5,7,8-Trimethylchromane (3)5-Bromo-2,3-Dihydrobenzofuran (6)5-Chloro-2,3-Dihydrobenzofuran (5)5-Fluoro-2,3-Dihydrobenzofuran (5)5-Methoxyisobenzofuran-1(3H)-One (5)6-Bromo-2,3-Dihydrobenzofuran (7)6-Fluoro-2,3-Dihydrobenzofuran (6)6-Methoxybenzofuran (4)7-Bromo-2,3-Dihydrobenzofuran (6)7-Bromobenzofuran (6)7-Fluoro-2,3-Dihydrobenzofuran (6)Benzofuran-2(3H)-One (7)Benzofuran-2-Carbaldehyde (5)Benzofuran-2-Carboxylic Acid (21)Benzofuran-2-Ylboronic Acid (8)Benzofuran-3(2H)-One (15)Benzofuran-3-Carboxylic Acid (6)Benzofuran-3-Yl(Phenyl)Methanone (11)Methyl Benzofuran-2-Carboxylate (6)Benzofuran-Carboxylic Acid (67)Dimethoxyisobenzofuran (4)Epoxyisobenzofuran (1)Fluorobenzofuran (19)Fluoroisobenzofuran (5)Methoxyisobenzofuran (4)Methylbenzofuran (25)
Benzothiazoles (2424)
2-(Methylthio)Benzo[D]Thiazole (6)2-Bromobenzo[D]Thiazole (28)2-Chlorobenzo[D]Thiazole (21)2-Methylbenzo[D]Thiazole (26)4-Bromobenzo[D]Thiazole (9)4-Chlorobenzo[D]Thiazole (7)4-Fluorobenzo[D]Thiazole (6)4-Methylbenzo[D]Thiazole (10)5-Chlorobenzo[D]Thiazole (5)5-Nitrobenzo[D]Thiazole (3)6-Bromobenzo[D]Thiazole (7)6-Chlorobenzo[D]Thiazole (6)6-Fluorobenzo[D]Thiazole (5)6-Methoxybenzo[D]Thiazole (6)6-Methylbenzo[D]Thiazole (6)6-Nitrobenzo[D]Thiazole (3)7-Bromobenzo[D]Thiazole (8)7-Chlorobenzo[D]Thiazole (6)7-Fluorobenzo[D]Thiazole (9)Benzo[D]Thiazol-2-Amine (30)Benzo[D]Thiazol-5-Amine (3)Benzo[D]Thiazol-6-Amine (3)Benzo[D]Thiazol-6-Ol (2)Benzo[D]Thiazole-2-Carbonitrile (11)Benzo[D]Thiazole-2-Thiol (11)Benzo[D]Thiazole-6-Carboxylic Acid (5)Methyl Benzo[D]Thiazole-6-Carboxylate (5)Benzothiazole-Carboxylic Acid (27)Bromobenzothiazole (7)Dichlorobenzothiazole (10)Methoxybenzothiazole (4)Methylbenzothiazole (7)
Benzothiophenes (1117)
2-(Benzo[B]Thiophen-2-Yl)-4,5-Dihydrooxazole (10)2-Methylbenzo[B]Thiophene (4)3-Bromobenzo[B]Thiophene (5)3-Chlorobenzo[B]Thiophene (6)3-Methylbenzo[B]Thiophene (4)4,5,6,7-Tetrahydrobenzo[B]Thiophene (21)5-Bromobenzo[B]Thiophene (3)5-Chlorobenzo[B]Thiophene (4)6-Bromobenzo[B]Thiophene (4)7-Bromobenzo[B]Thiophene (5)Benzo[B]Thiophen-2-Amine (5)Benzo[B]Thiophen-2-Ylboronic Acid (5)Benzo[B]Thiophene-2-Carbaldehyde (7)Benzo[B]Thiophene-2-Carbonitrile (3)Benzo[B]Thiophene-2-Carboxylic Acid (32)Benzo[B]Thiophene-3-Carbaldehyde (6)Ethyl Benzo[B]Thiophene-2-Carboxylate (9)Methyl Benzo[B]Thiophene-2-Carboxylate (27)Benzothiophene-Carboxylic Acid (58)
Benzoxazoles (2805)
2-Chlorobenzo[D]Oxazole (11)2-Methylbenzo[D]Oxazole (26)2-Phenylbenzo[D]Oxazole (22)3-Phenylbenzo[D]Oxazol-3-Ium (8)5-Bromobenzo[D]Oxazole (3)5-Chlorobenzo[D]Oxazole (5)5-Methylbenzo[D]Oxazole (3)6-Chlorobenzo[D]Oxazole (4)Benzo[D]Oxazol-2-Amine (16)Benzo[D]Oxazole-2-Thiol (6)Methyl Benzo[D]Oxazole-2-Carboxylate (3)Benzoxazole-Carboxylic Acid (25)
Carbazole Series (482)
1-Methyl-9H-Carbazole (7)2,3,4,9-Tetrahydro-1H-Carbazol-1-One (7)2-Bromo-9H-Carbazole (4)3,9-Diphenyl-9H-Carbazole (7)3-(Tert-Butyl)-9H-Carbazole (3)3-Bromo-9-Phenyl-9H-Carbazole (16)3-Bromo-9H-Carbazole (4)3-Chloro-9H-Carbazole (3)3-Methyl-9H-Carbazole (3)7H-Benzo[C]Carbazole (5)9-([1,1'-Biphenyl]-4-Yl)-9H-Carbazole (9)9-(P-Tolyl)-9H-Carbazole (5)9-Benzyl-9H-Carbazole (7)9-Ethyl-9H-Carbazole (10)Carbazolyl-Phenyl-Boronic Acid/Ester (14)
Cinnolines (355)
Cinnoline (11)
Dioxolanes (1580)
(3As,6As)-Tetrahydrofuro[3,4-D][1,3]Dioxole (6)1,3-Dioxolan-2-One (11)2,2-Difluorobenzo[D][1,3]Dioxole (24)2,2-Dimethyl-1,3-Dioxolane (29)2,2-Dimethylbenzo[D][1,3]Dioxole (7)2-Phenyl-1,3-Dioxolane (18)4-Bromobenzo[D][1,3]Dioxole (6)4-Methyl-1,3-Dioxolane (5)5,6-Dihydro-[1,3]Dioxolo[4,5-G]Isoquinolino[3,2-A]Isoquinolin-7-Ium (4)5-Bromobenzo[D][1,3]Dioxole (12)5-Chlorobenzo[D][1,3]Dioxole (5)5-Nitrobenzo[D][1,3]Dioxole (4)9-((3As,4R,6Ar)-Tetrahydrofuro[3,4-D][1,3]Dioxol-4-Yl)-9H-Purine (7)Benzo[D][1,3]Dioxol-5-Amine (3)
Dioxoles (13)
Epoxides (407)
7-Oxabicyclo[4.1.0]Heptane (7)Ethyl Oxirane-2-Carboxylate (4)Oxiran-2-Ylmethanol (3)Epoxy (7)Oxirane (64)
Furans (6963)
2,3-Dihydrofuran-3-One (9)2-(Bromomethyl)Furan (3)2-(Chloromethyl)Furan (3)2-(Furan-2-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (6)2-Bromofuran (21)2-Chlorofuran (3)2-Methylfuran (38)2-Nitrofuran (9)3-Bromofuran (13)4-Methylisobenzofuran-1(3H)-One (3)5-Nitro-2,3-Dihydrobenzofuran (3)5-Phenylfuran-2-Carbaldehyde (9)5-Phenylfuran-2-Carboxylic Acid (6)6-Chloro-2,3-Dihydrobenzofuran (3)6-Fluoroisobenzofuran-1(3H)-One (3)7-Chloro-2,3-Dihydrobenzofuran (3)Ethyl Furan-2-Carboxylate (6)Furan-2,5-Dione (8)Furan-2-Carbaldehyde (22)Furan-2-Carbonitrile (8)Furan-2-Carboxylic Acid (32)Furan-2-Ylmethanol (8)Furan-3-Carboxylic Acid (11)Furo[3,2-B]Pyridine (7)Furo[3,2-C]Pyridine (7)Methyl Furan-2-Carboxylate (20)N-(Furan-2-Ylmethyl)Aniline (5)Aminodihydrofuran (7)Bromofuran (32)Chlorofuran (2)Chlorofuro (11)Cyanofuran (53)Dibromofuran (5)Dihydrofuran (31)Dihydrofuro (15)Dihydroxydihydrofuran (8)Dimethylfuran (10)Formylfuran (10)Hexahydrofuro (6)Hydroxydihydrofuran (31)Methyldihydrofuran (11)Methylfuran (58)Nitrofuran (10)
Imidazoles (834)
Biimidazole (5)Bromoimidazo (102)Dibromoimidazo (8)Dichloroimidazo (9)Dihydroimidazo (25)Imidazol-Amine (1)Methoxyimidazo (13)Methylimidazo (121)Tetrahydroimidazo (40)1,1'-Diphenyl-4,4',5,5'-Tetrahydro-1H,1'H-2,2'-Biimidazole (11)1,2-Dimethyl-1H-Imidazole (6)1,3-Diphenyl-1H-Imidazol-3-Ium (14)1,3-Diphenyl-4,5-Dihydro-1H-Imidazol-3-Ium (5)1-(Imidazo[1,2-A]Pyridin-3-Yl)Ethan-1-One (3)1-(Phenylsulfonyl)-1H-Imidazole (5)1-Benzyl-1H-Imidazole (20)1-Decyl-3-Methyl-1H-Imidazol-3-Ium (14)1-Ethyl-1H-Imidazole (3)1-Isopropyl-1H-Imidazole (5)1-Phenyl-1H-Imidazole-4-Carboxylic Acid (5)1-Trityl-1H-Imidazole (15)1H-Imidazo[4,5-B]Pyridine (14)1H-Imidazo[4,5-C]Pyridine (12)1H-Imidazol-2-Amine (6)1H-Imidazole-2-Carboxylic Acid (7)1H-Imidazole-4-Carbonitrile (2)1H-Imidazole-4-Carboxylic Acid (4)2-(Pyridin-2-Yl)-1H-Benzo[D]Imidazole (5)2-Bromo-1H-Imidazole (13)2-Bromoimidazo[1,2-A]Pyridine (5)2-Ethyl-1H-Imidazole (3)2-Methyl-1-Phenyl-1H-Imidazole (11)2-Methylimidazo[1,2-A]Pyridine (8)2-Phenyl-1H-Benzo[D]Imidazole (26)2-Phenyl-1H-Imidazole (26)2-Phenylimidazo[1,2-A]Pyridine (12)2-Propyl-1H-Imidazole (5)3-Bromoimidazo[1,2-A]Pyrazine (6)3-Bromoimidazo[1,2-A]Pyridine (26)3-Bromoimidazo[1,2-A]Pyrimidine (6)3-Iodoimidazo[1,2-A]Pyridine (10)3-Methylimidazo[1,2-A]Pyridine (3)4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine (5)4-(1H-Imidazol-1-Yl)Benzaldehyde (7)4-Bromo-1-Phenyl-1H-Imidazole (9)4-Methyl-1-Phenyl-1H-Imidazole (7)4-Methyl-1H-Imidazole (6)4-Phenyl-1H-Imidazole (8)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine (15)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyridine (12)5,6,7,8-Tetrahydroimidazo[1,5-A]Pyrazine (11)5-Benzyl-1H-Imidazole (1)5-Bromoimidazo[1,2-A]Pyridine (6)5-Chloro-1H-Imidazole (2)5-Fluoro-1H-Benzo[D]Imidazole (12)5-Iodo-1H-Imidazole (4)5-Methylimidazo[1,2-A]Pyridine (4)5-Phenyl-1H-Imidazole (6)6,7-Dihydro-5H-Pyrrolo[1,2-A]Imidazole (9)6-Bromoimidazo[1,2-A]Pyrazine (11)6-Bromoimidazo[1,2-A]Pyridine (14)6-Bromoimidazo[1,2-A]Pyrimidine (5)6-Chloroimidazo[1,2-A]Pyridine (4)6-Chloroimidazo[1,2-B]Pyridazine (30)7-Methylimidazo[1,2-A]Pyridine (3)8-Bromoimidazo[1,2-A]Pyrazine (7)8-Bromoimidazo[1,2-A]Pyridine (15)8-Chloroimidazo[1,2-A]Pyrazine (8)8-Chloroimidazo[1,2-A]Pyridine (7)8-Fluoroimidazo[1,2-A]Pyridine (3)8-Methylimidazo[1,2-A]Pyridine (9)Ethyl 1H-Imidazole-2-Carboxylate (6)Ethyl 2-(Imidazo[1,2-A]Pyridin-3-Yl)Acetate (3)Ethyl Imidazo[1,2-A]Pyridine-2-Carboxylate (25)Ethyl Imidazo[1,2-A]Pyridine-3-Carboxylate (13)Imidazo[1,2-A]Pyridin-3-Amine (7)Imidazo[1,2-A]Pyridin-8-Amine (7)Imidazo[1,2-A]Pyridin-8-Ol (3)Imidazo[1,2-A]Pyridine-2-Carbaldehyde (8)Imidazo[1,2-A]Pyridine-2-Carboxylic Acid (21)Imidazo[1,2-A]Pyridine-3-Carbaldehyde (9)Imidazo[1,2-A]Pyridine-3-Carboxylic Acid (14)Imidazo[1,2-A]Pyridine-7-Carboxylic Acid (5)Imidazo[1,2-A]Pyridine-8-Carboxylic Acid (6)Imidazo[1,2-A]Pyrimidine-3-Carboxylic Acid (5)Imidazo[1,2-C]Pyrimidine (6)Imidazo[1,5-A]Pyrazine (9)Imidazo[2,1-B]Thiazole (14)Methyl 1H-Imidazole-2-Carboxylate (4)Methyl 1H-Imidazole-5-Carboxylate (8)Methyl Imidazo[1,2-A]Pyridine-8-Carboxylate (3)Tert-Butyl 1H-Imidazole-1-Carboxylate (6)
Imidazolidines (1145)
Methylimidazolidine (3)Oxoimidazolidine (8)Thioxoimidazolidin (9)(3Ar,6As)-Tetrahydro-1H-Thieno[3,4-D]Imidazol-2(3H)-One (18)1-Phenylimidazolidin-2-One (8)3-Phenyl-2-Thioxoimidazolidin-4-One (6)3-Phenylimidazolidine-2,4-Dione (4)Imidazolidin-2-One (16)Imidazolidine-2,4-Dione (17)
Imidazolines (695)
Indazoles (3060)
(1H-Indazol-4-Yl)Boronic Acid (3)(1H-Indazol-6-Yl)Boronic Acid (4)1-(1H-Indazol-1-Yl)Ethan-1-One (7)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Indazole (17)1-Benzyl-1H-Indazole (5)1-Ethyl-1H-Indazole (6)1H-Indazol-3-Amine (23)1H-Indazol-3-Ol (10)1H-Indazol-4-Amine (12)1H-Indazol-4-Ol (4)1H-Indazol-5-Amine (3)1H-Indazol-6-Amine (5)1H-Indazol-6-Ol (6)1H-Indazol-7-Amine (6)1H-Indazole-3-Carbaldehyde (19)1H-Indazole-3-Carbonitrile (9)1H-Indazole-3-Carboxylic Acid (23)1H-Indazole-4-Carboxylic Acid (9)1H-Indazole-5-Carboxylic Acid (4)1H-Indazole-7-Carboxylic Acid (6)2,3-Dimethyl-2H-Indazole (4)2-Methyl-2H-Indazole (34)3-(Piperidin-4-Yl)-1H-Indazole (5)3-Chloro-1H-Indazole (13)4,5,6,7-Tetrahydro-1H-Indazole (12)4-Chloro-1H-Indazole (18)4-Fluoro-1H-Indazole (22)4-Methoxy-1H-Indazole (7)4-Methyl-1H-Indazole (12)4-Nitro-1H-Indazole (10)5-Bromo-1H-Indazole (14)5-Chloro-1H-Indazole (9)5-Methoxy-1H-Indazole (5)5-Nitro-1H-Indazole (5)6-(Trifluoromethyl)-1H-Indazole (6)6-Bromo-1H-Indazole (23)6-Chloro-1H-Indazole (14)6-Fluoro-1H-Indazole (15)6-Methoxy-1H-Indazole (14)6-Methyl-1H-Indazole (9)6-Nitro-1H-Indazole (9)7-Bromo-1H-Indazole (18)7-Chloro-1H-Indazole (7)7-Fluoro-1H-Indazole (12)7-Methoxy-1H-Indazole (5)7-Nitro-1H-Indazole (11)Methyl 1H-Indazole-3-Carboxylate (23)Methyl 1H-Indazole-4-Carboxylate (10)Methyl 1H-Indazole-5-Carboxylate (3)Methyl 1H-Indazole-6-Carboxylate (9)Methyl 1H-Indazole-7-Carboxylate (8)Methyl 2-Methyl-2H-Indazole-3-Carboxylate (3)Tert-Butyl 1H-Indazole-1-Carboxylate (29)Indazol-Amide (3)
Indoles (7643)
(1-(Tert-Butoxycarbonyl)-1H-Indol-2-Yl)Boronic Acid (17)(1H-Indol-2-Yl)Boronic Acid (3)(1H-Indol-2-Yl)Methanol (8)(3As,7As)-Octahydro-1H-Indole (5)(9H-Fluoren-9-Yl)Methyl (2-(1H-Indol-3-Yl)Ethyl)Carbamate (12)1,2,3,4-Tetrahydrocyclopenta[B]Indole (5)1,2-Dimethyl-1H-Indole (3)1-(1H-Indol-1-Yl)Ethan-1-One (9)1-(1H-Indol-3-Yl)Ethan-1-One (6)1-(Phenylsulfonyl)-1H-Indole (26)1-(Triisopropylsilyl)-1H-Pyrrolo[2,3-B]Pyridine (8)1-Benzyl-1H-Indole (9)1-Ethyl-1H-Indole (7)1-Methyl-1H-Indole (82)1-Methyl-1H-Indole-2-Carboxylic Acid (8)1-Methyl-1H-Indole-3-Carbaldehyde (9)1-Methyl-1H-Pyrrolo[2,3-B]Pyridine (14)1-Phenyl-1H-Indole (5)1H-Indol-3-Ol (5)1H-Indol-3-Yl Acetate (4)1H-Indol-4-Amine (10)1H-Indol-4-Ol (7)1H-Indol-5-Ol (4)1H-Indol-6-Amine (21)1H-Indol-6-Ol (6)1H-Indol-7-Amine (10)1H-Indole-2-Carbaldehyde (20)1H-Indole-2-Carbonitrile (9)1H-Indole-3-Carbonitrile (17)1H-Indole-3-Carboxylic Acid (28)1H-Indole-4-Carboxylic Acid (10)1H-Indole-5-Carbonitrile (5)1H-Indole-5-Carboxylic Acid (4)1H-Indole-6-Carbonitrile (4)1H-Indole-6-Carboxylic Acid (5)1H-Indole-7-Carbonitrile (6)1H-Indole-7-Carboxylic Acid (7)1H-Pyrrolo[2,3-B]Pyridine-3-Carbaldehyde (14)1H-Pyrrolo[2,3-B]Pyridine-5-Carbaldehyde (5)2,3,4,5-Tetrahydro-1H-Pyrido[4,3-B]Indole (12)2,3,4,9-Tetrahydro-1H-Pyrido[3,4-B]Indole (13)2,3-Dimethyl-1H-Indole (9)2-(1,3,2-Dioxaborolan-2-Yl)-1-Methyl-1H-Indole (6)2-(1H-Indol-1-Yl)Acetic Acid (5)2-(1H-Indol-3-Yl)Acetic Acid (28)2-(1H-Indol-3-Yl)Ethan-1-Amine (4)2-(1H-Indol-3-Yl)Ethan-1-Ol (10)2-(2-Methyl-1H-Indol-3-Yl)Acetic Acid (5)2-(4-Fluorophenyl)-1H-Indole (4)2-Methyl-1H-Indole-3-Carbaldehyde (3)2-Methyl-1H-Pyrrolo[2,3-B]Pyridine (12)3-(1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione (21)3-(1H-Indol-3-Yl)Propanoic Acid (4)3-(Piperidin-4-Yl)-1H-Indole (8)3-Iodo-1H-Pyrrolo[2,3-B]Pyridine (11)3-Methyl-1H-Indole (41)3H-Indole (8)4-Bromo-1H-Indole (25)4-Chloro-1H-Indole (21)4-Fluoro-1H-Indole (24)4-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (6)4-Fluoroindoline-2,3-Dione (3)4-Methoxy-1H-Indole (11)4-Methyl-1H-Indole (23)4-Nitro-1H-Indole (6)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Indole (5)5-(Benzyloxy)-1H-Indole (8)5-Bromo-1-Methyl-1H-Indole (3)5-Chloro-1H-Indole (64)5-Chloro-1H-Indole-2-Carboxylic Acid (6)5-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)5-Fluoro-1H-Indole (50)5-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (9)5-Fluoroindolin-2-One (4)5-Methoxy-1H-Indole (11)5-Methoxy-2-Methyl-1H-Indole (5)5-Methyl-1H-Indole (33)5-Nitro-1H-Indole (6)6-(Trifluoromethyl)-1H-Indole (5)6-Bromo-1-Methyl-1H-Indole (3)6-Bromo-1H-Indole (15)6-Bromo-1H-Pyrrolo[2,3-B]Pyridine (6)6-Chloro-1H-Indole (19)6-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)6-Fluoro-1H-Indole (17)6-Methoxy-1H-Indole (12)6-Methyl-1H-Indole (29)6-Methyl-1H-Pyrrolo[2,3-B]Pyridine (8)6-Nitro-1H-Indole (8)7-Bromo-1H-Indole (28)7-Bromoindoline-2,3-Dione (3)7-Chloro-1H-Indole (29)7-Fluoro-1H-Indole (24)7-Fluoro-1H-Indole-2-Carboxylic Acid (5)7-Methoxy-1H-Indole (8)7-Methyl-1H-Indole (34)7-Nitro-1H-Indole (11)9H-Pyrido[3,4-B]Indole (5)Benzo[Cd]Indol-2(1H)-One (5)Ethyl 1H-Indole-3-Carboxylate (6)Ethyl 5-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 5-Fluoro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 7-Chloro-1H-Indole-2-Carboxylate (5)Methyl 1H-Indole-3-Carboxylate (21)Methyl 1H-Indole-4-Carboxylate (9)Methyl 1H-Indole-5-Carboxylate (7)Methyl 1H-Indole-6-Carboxylate (9)Methyl 1H-Indole-7-Carboxylate (7)Methyl 2-(1H-Indol-3-Yl)Acetate (3)N-(2-(1H-Indol-3-Yl)Ethyl)Acetamide (5)Spiro[Indoline-3,4'-Piperidin]-2-One (18)Tert-Butyl 1H-Indole-1-Carboxylate (18)Tert-Butyl 1H-Pyrrolo[2,3-B]Pyridine-1-Carboxylate (9)Tert-Butyl 2-(1,3,2-Dioxaborolan-2-Yl)-1H-Indole-1-Carboxylate (6)Tert-Butyl 3-(Hydroxymethyl)-1H-Indole-1-Carboxylate (10)Tert-Butyl 3-Bromo-1H-Indole-1-Carboxylate (9)Tert-Butyl 3-Iodo-1H-Indole-1-Carboxylate (7)Tert-Butyl 5-Methoxy-1H-Indole-1-Carboxylate (6)Tryptophan (22)Azaindole (44)Benzyloxyindole (1)Biindolinylidene (1)Bromo-Indole-Carboxylic Acid (25)Cyanoindole (5)Dihydroindolo (14)Fluoroindole (5)Formylindole (44)Hydroxyindole (7)Hydroxyisoindoline (2)Indolecarboxylic (2)Isoindole (26)Methoxyindole (9)Nitroindole (6)
Indolines (4489)
(E)-[3,3'-Biindolinylidene]-2,2'-Dione (5)(Z)-3-((1H-Pyrrol-2-Yl)Methylene)Indolin-2-One (8)(Z)-3-(Phenyl(Phenylamino)Methylene)Indolin-2-One (5)(Z)-3-Benzylideneindolin-2-One (7)1-(Indolin-1-Yl)Ethan-1-One (9)1-Benzylindoline-2,3-Dione (5)1-Methylindolin-2-One (14)1-Methylindoline (3)1-Methylindoline-2,3-Dione (8)2-(1,3-Dioxoisoindolin-2-Yl)Propanoic Acid (3)2-Methylindoline (7)2-Methylisoindolin-1-One (7)3,3-Dimethylindolin-2-One (5)3,3-Dimethylindoline (7)4-Bromoindoline (4)4-Chloroindoline-2,3-Dione (6)4-Methylindoline (3)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Indoline (5)5-Bromoindolin-2-One (5)5-Bromoindoline (8)5-Bromoisoindoline-1,3-Dione (3)5-Chloroindolin-2-One (3)5-Fluoroindoline (3)5-Methoxyindoline (4)5-Methylindolin-2-One (3)5-Methylindoline (3)6-Bromoindolin-2-One (8)6-Bromoindoline-2,3-Dione (4)6-Chloroindolin-2-One (5)6-Chloroindoline (3)6-Chloroindoline-2,3-Dione (5)6-Fluoroindolin-2-One (5)6-Fluoroindoline-2,3-Dione (3)7-Bromoindoline (3)7-Fluoroindolin-2-One (3)7-Fluoroindoline-2,3-Dione (6)7-Methylindoline-2,3-Dione (7)Indoline-2-Carboxylic Acid (3)Methyl Indoline-6-Carboxylate (3)Spiro[Cyclopropane-1,3'-Indolin]-2'-One (6)Tert-Butyl Indoline-1-Carboxylate (24)Aminoindoline (10)Bromoindoline (17)Bromoisoindolin (5)Bromoisoindoline (6)Chloroindolin (4)Chloroisoindoline (3)Dibromoindoline (12)Dichloroindoline (16)Difluoroindoline (1)Dimethylindoline (21)Dioxoindoline (8)Dioxoisoindolin (72)Fluoroindolin (9)Fluoroindoline (9)Fluoroisoindoline (10)Hydroxyindolin (5)Indoline-Carboxylate (1)Isoindoline (20)Methoxyindoline (12)Methoxyisoindoline (9)Methylindoline (46)Methylisoindoline (18)Nitroindolin (6)Nitroindoline (11)Nitroisoindoline (8)Oxoindoline (32)Oxoisoindoline (16)Spiro-Indoline-Piperidine (34)
Isoquinolines (2730)
1,3-Dichloroisoquinoline (14)1-Bromoisoquinoline (20)1-Chloroisoquinoline (20)1-Methylisoquinoline (9)1H-Benzo[De]Isoquinoline-1,3(2H)-Dione (14)2-Methyl-3,4-Dihydroisoquinolin-1(2H)-One (6)3-Bromoisoquinoline (10)3-Chloroisoquinoline (20)3-Methylisoquinoline (8)4-Bromoisoquinolin-1(2H)-One (3)4-Bromoisoquinoline (33)4-Chloroisoquinoline (11)4-Fluoroisoquinoline (6)5,6-Dihydro-[1,3]Dioxolo[4,5-G]Isoquinolino[3,2-A]Isoquinolin-7-Ium (4)5-Bromoisoquinoline (17)5-Chloroisoquinoline (6)5-Methoxyisoquinoline (6)5-Nitroisoquinoline (7)6-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)6-Bromoisoquinoline (9)6-Methoxy-3,4-Dihydroisoquinolin-1(2H)-One (3)7-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)7-Bromoisoquinoline (6)7-Chloroisoquinoline (6)7-Fluoroisoquinoline (3)7-Methoxyisoquinoline (5)8-Bromoisoquinoline (17)8-Chloroisoquinoline (7)8-Fluoroisoquinolin-1(2H)-One (3)8-Fluoroisoquinoline (10)8-Methoxyisoquinoline (7)Isoquinolin-1-Amine (18)Isoquinolin-1-Ol (9)Isoquinolin-3-Amine (13)Isoquinolin-3-Ol (6)Isoquinolin-4-Amine (16)Isoquinolin-4-Ol (9)Isoquinolin-4-Ylboronic Acid (3)Isoquinolin-5-Amine (9)Isoquinolin-5-Ol (7)Isoquinolin-8-Amine (6)Isoquinoline-1-Carbonitrile (7)Isoquinoline-1-Carboxylic Acid (10)Isoquinoline-3-Carboxylic Acid (7)Isoquinoline-4-Carboxylic Acid (12)Isoquinoline-5-Carboxylic Acid (5)Isoquinoline-5-Sulfonyl Chloride (3)Isoquinoline-6-Carboxylic Acid (3)Methyl Isoquinoline-3-Carboxylate (3)Methyl Isoquinoline-4-Carboxylate (6)Tert-Butyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (19)Bromoisoquinoline (69)Chloroisoquinoline (101)Dibromoisoquinoline (9)Dichloroisoquinoline (14)Dihydroisoquinoline (107)Fluoroisoquinoline (78)Methoxyisoquinoline (59)Methylisoquinoline (59)Nitroisoquinoline (23)
Isothiazoles (343)
Benzo[D]Isothiazol-3(2H)-One 1,1-Dioxide (10)Benzo[D]Isothiazole (12)Isothiazole (24)Methylisothiazole (5)
Isoxazoles (3403)
(3-Phenylisoxazol-5-Yl)Methanol (7)3-Bromoisoxazole (7)3-Methyl-5-Phenylisoxazole (6)3-Methylisoxazole (30)3-Phenylisoxazol-5-Amine (8)5-(Thiophen-2-Yl)Isoxazole (5)5-Cyclopropylisoxazole (5)5-Methyl-3-Phenylisoxazole (4)5-Methylisoxazole (16)5-Phenylisoxazole-3-Carboxylic Acid (15)Ethyl Isoxazole-3-Carboxylate (8)Ethyl Isoxazole-4-Carboxylate (5)Isoxazol-3-Amine (7)Isoxazol-3-Ylmethanol (3)Isoxazol-5-Amine (15)Isoxazol-5-Ylmethanol (5)Isoxazole-3-Carboxylic Acid (8)Isoxazole-5-Carboxylic Acid (7)Methyl 5-Phenylisoxazole-3-Carboxylate (6)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-3-Phenylisoxazole-4-Carboxamide (1)Aminoisoxazole (7)Bromoisoxazole (5)Dihydroisoxazol (2)Dimethylisoxazole (17)Phenylisoxazole (28)
Morpholines (4990)
(R)-3-Phenylmorpholine (7)(S)-3-Phenylmorpholine (10)2,2-Dimethylmorpholine (5)2,6-Dimethylmorpholine (5)2-(Methoxymethyl)Morpholine (4)2-(Morpholin-2-Yl)Acetic Acid (5)2-Ethylmorpholine (3)2-Isopropylmorpholine (4)2-Methylmorpholine (7)2-Phenylmorpholine (8)3-(4-Morpholinophenyl)Oxazolidin-2-One (5)3-(Methoxymethyl)Morpholine (4)3-Ethylmorpholine (4)3-Isopropylmorpholine (5)3-Methylmorpholine (13)3-Phenylmorpholine (8)4-(2-Fluorophenyl)Morpholine (8)4-(3-Phenoxypropyl)Morpholine (7)4-(O-Tolyl)Morpholine (6)4-(Pyrazin-2-Yl)Morpholine (5)4-(Pyridin-4-Yl)Morpholine (5)4-(Pyrimidin-2-Yl)Morpholine (9)4-Benzylmorpholin-3-One (6)4-Morpholinoaniline (4)4-Morpholinobenzaldehyde (8)4-Morpholinobenzoic Acid (5)4-Phenylmorpholin-3-One (6)6,6-Dimethylmorpholine-3-Carboxylic Acid (5)Benzyl Morpholine-4-Carboxylate (5)Ethyl Morpholine-2-Carboxylate (4)Methyl 2-(Morpholin-3-Yl)Acetate (3)Methyl Morpholine-2-Carboxylate (4)Methyl Morpholine-3-Carboxylate (10)Morpholin-2-Ylmethanamine (8)Morpholin-2-Ylmethanol (12)Morpholin-3-Ylmethanol (14)Morpholine-2-Carbonitrile (4)Morpholine-2-Carboxylic Acid (12)Morpholine-3-Carboxylic Acid (10)Morpholino(Phenyl)Methanone (11)Tert-Butyl (Morpholin-2-Ylmethyl)Carbamate (3)Tert-Butyl 2-(Bromomethyl)Morpholine-4-Carboxylate (3)Tert-Butyl Morpholine-4-Carboxylate (23)Benzylmorpholine (25)Cyanomorpholine (6)Dimorpholine (3)Ethylmorpholine (9)Isopropylmorpholine (9)Methylmorpholine (68)Morpholinobenzaldehyde (11)Morpholinobenzo (13)Morpholinobenzoic (8)Morpholinoethanone (5)Morpholinoethoxy (1)Morpholinoethyl (5)Morpholinomethyl (16)Morpholinophenyl (14)Morpholinopropoxy (6)Morpholinopyrimidin (6)Morpholinosulfonyl (7)Oxomorpholine (6)
Naphthyridines (940)
1,5-Naphthyridine-3-Carboxylic Acid (6)1,6-Naphthyridine (22)1,7-Naphthyridine (23)2,7-Naphthyridine (5)3-Bromo-1,5-Naphthyridine (8)4-Bromo-1,5-Naphthyridine (5)4-Chloro-1,5-Naphthyridine (6)5,6,7,8-Tetrahydro-1,6-Naphthyridine (22)5,6,7,8-Tetrahydro-1,7-Naphthyridine (6)
Oxadiazoles (3552)
1,2,4-Oxadiazole (19)1,2,5-Oxadiazole (12)1,3,4-Oxadiazole (25)2,5-Diphenyl-1,3,4-Oxadiazole (6)2-Phenyl-1,3,4-Oxadiazole (26)3-Phenyl-1,2,4-Oxadiazole (23)Benzo[C][1,2,5]Oxadiazole (17)
Oxazines (235)
2,2-Dimethyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2-Methyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2H-Pyrido[3,2-B][1,4]Oxazin-3(4H)-One (8)3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine (5)6-Amino-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)6-Bromo-2H-Benzo[B][1,4]Oxazin-3(4H)-One (7)6-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Chloro-2H-Benzo[B][1,4]Oxazin-3(4H)-One (8)6-Chloro-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)7-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (7)Spiro[Benzo[D][1,3]Oxazine-4,4'-Piperidin]-2(1H)-One (5)
Oxazoles (2026)
Bioxazole (12)2-Bromooxazole (7)2-Chlorooxazole (7)2-Methyloxazole (19)2-Phenyloxazole (16)3,4-Diphenylisoxazole (8)4,5-Diphenyloxazole (7)4-(Oxazol-5-Yl)Aniline (3)4-Methyloxazole (9)5-(4-Nitrophenyl)Oxazole (3)5-Methyloxazole (5)6-Bromobenzo[D]Oxazole (3)Ethyl Oxazole-4-Carboxylate (8)Ethyl Oxazole-5-Carboxylate (3)Methyl Oxazole-4-Carboxylate (9)Oxazol-2-Amine (8)Oxazole-4-Carboxylic Acid (4)Oxazolo[4,5-B]Pyridine (7)Oxazolo[5,4-B]Pyridine (5)
Oxazolidines (1299)
(R)-4-Benzyloxazolidin-2-One (5)(S)-4-Benzyloxazolidin-2-One (11)3-(4-Morpholinophenyl)Oxazolidin-2-One (5)3-Phenyloxazolidin-2-One (4)4-Isopropyloxazolidine (6)Oxazolidine (21)Oxazolidine-2,5-Dione (9)Dimethyloxazolidin (6)Dioxooxazolidin (2)Oxazolidinone (5)Phenyloxazolidin (9)Propionyloxazolidin (5)
Oxazolines (1577)
(3Ar,8As)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (6)(3As,8Ar)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (7)(4R,5S)-4,5-Diphenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (5)(R)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(R)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(S)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (8)(S)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (6)1,3-Bis(4,5-Dihydrooxazol-2-Yl)Benzene (8)2,2'-(1,3-Diphenylpropane-2,2-Diyl)Bis(4,5-Dihydrooxazole) (5)2,2'-(2-Phenylethane-1,1-Diyl)Bis(4,5-Dihydrooxazole) (5)2,3-Dihydropyrazolo[5,1-B]Oxazole (7)2,6-Bis(4,5-Dihydrooxazol-2-Yl)Pyridine (12)2-(6-Benzhydrylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(6-Cyclopropylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(Benzo[B]Thiophen-2-Yl)-4,5-Dihydrooxazole (10)2-(Pyridin-2-Ylmethyl)-4,5-Dihydrooxazole (14)2-(Quinolin-2-Yl)-4,5-Dihydrooxazole (7)2-Phenyl-4,5-Dihydrooxazole (18)4,4',5,5'-Tetrahydro-2,2'-Bioxazole (10)4-(Tert-Butyl)-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-Isopropyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)Bis((3Ar,8As)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazol-2-Yl)Methane (5)Bis((3As,8Ar)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazol-2-Yl)Methane (5)Bis(4,5-Dihydrooxazol-2-Yl)Methane (22)
Oxetanes (772)
Methyloxetane (11)
Phthalazines (423)
Phthalazine (16)Dihydrophthalazine (15)
Piperazines (7430)
(9H-Fluoren-9-Yl)Methyl Piperazine-1-Carboxylate (7)(R)-2-Benzylpiperazine (5)1,4-Diphenylpiperazine (7)1-(2-Chlorophenyl)Piperazine (4)1-(2-Fluorophenyl)Piperazine (8)1-(3-Methoxyphenyl)Piperazine (4)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Piperazine (10)1-(5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Yl)Piperazine (6)1-(Methylsulfonyl)Piperazine (5)1-(Phenylsulfonyl)Piperazine (17)1-(Piperidin-4-Yl)Piperazine (6)1-(Pyridin-3-Yl)Piperazine (13)1-(Pyridin-3-Ylmethyl)Piperazine (6)1-Benzhydryl-4-Benzylpiperazine (1)1-Benzhydrylpiperazine (9)1-Benzyl 4-(Tert-Butyl) Piperazine-1,4-Dicarboxylate (10)1-Benzyl-4-Methylpiperazine (10)1-Ethyl-4-Phenylpiperazine (4)1-Ethylpiperazine (6)1-Isopropylpiperazine (4)1-Methyl-4-(Pyridin-2-Yl)Piperazine (5)1-Methyl-4-Phenylpiperazine (22)1-Methylpiperazin-2-One (6)1-Methylpiperazine (21)10-(3-(Piperazin-1-Yl)Propyl)-10H-Phenothiazine (2)2-(4-(Benzyloxy)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(Piperazin-1-Yl)Benzonitrile (6)2-(Piperazin-1-Yl)Ethan-1-Amine (8)2-(Piperazin-1-Yl)Ethan-1-Ol (10)2-(Piperazin-1-Yl)Pyrazine (9)2-(Piperazin-1-Yl)Pyrimidine (11)2-Phenylpiperazine (17)3-(Piperazin-1-Yl)Aniline (3)3-(Piperazin-1-Yl)Benzoic Acid (3)3-(Piperazin-1-Yl)Pyridazine (7)3-Methylpiperazin-2-One (7)4-(Piperazin-1-Yl)Benzaldehyde (5)4-(Piperazin-1-Yl)Pyrimidine (13)Benzyl 2-Methylpiperazine-1-Carboxylate (7)Benzyl 3-(Hydroxymethyl)Piperazine-1-Carboxylate (6)Benzyl 3-Methylpiperazine-1-Carboxylate (5)Phenyl(Piperazin-1-Yl)Methanone (20)Piperazine-2,5-Dione (9)Tert-Butyl 3-Oxopiperazine-1-Carboxylate (7)Tert-Butyl 4-(Pyridin-2-Yl)Piperazine-1-Carboxylate (12)Tert-Butyl 4-Benzylpiperazine-1-Carboxylate (13)Tert-Butyl 4-Phenylpiperazine-1-Carboxylate (23)Tert-Butyl Piperazine-1-Carboxylate (30)Isobutylpiperazine (6)Propylpiperazine (10)
Piperidines (21787)
Bipiperidine (12)Chloropiperidine (6)Dimethylpiperidine (46)Ethynylpiperidine (5)Fluoropiperidine (33)Formylpiperidine (9)Isopropylpiperidine (11)Piperidine-Carboxylate (3)Piperidineacetic (5)Piperidinecarboxylic (6)Piperidinyl-Phenyl-Boronic Acid/Ester (32)Propylpiperidine (8)(9H-Fluoren-9-Yl)Methyl Piperidine-1-Carboxylate (16)(E)-N-(3-Oxo-1-Phenyl-3-(Piperidin-1-Yl)Prop-1-En-2-Yl)Benzamide (6)(R)-2-Phenylpiperidine (10)(R)-3-Aminopiperidin-2-One (3)(R)-N-(Piperidin-3-Yl)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (5)(S)-2-Phenylpiperidine (11)(S)-N-Phenylpiperidine-2-Carboxamide (1)1,3-Dihydrospiro[Indene-2,4'-Piperidine] (5)1,4'-Bipiperidine (8)1-((Benzyloxy)Carbonyl)Piperidine-2-Carboxylic Acid (5)1-((Benzyloxy)Carbonyl)Piperidine-3-Carboxylic Acid (3)1-(Methylsulfonyl)Piperidine (6)1-(Phenylsulfonyl)Piperidine (23)1-(Piperidin-1-Yl)Ethan-1-One (13)1-(Piperidin-4-Yl)Piperazine (6)1-Benzyl 3-Methyl Piperidine-1,3-Dicarboxylate (3)1-Benzyl-N-Methylpiperidin-3-Amine (6)1-Benzylpiperidin-3-One (5)1-Benzylpiperidin-4-Amine (8)1-Benzylpiperidin-4-One (8)1-Isopropylpiperidine (5)1-Methyl-4-Phenylpiperidine (4)1-Methylpiperidin-2-One (3)1-Oxa-8-Azaspiro[4.5]Decane (5)1-Phenylpiperidin-2-One (8)2,2-Dimethylpiperidin-4-One (6)2,2-Dimethylpiperidine (21)2,7-Diazaspiro[3.5]Nonane (7)2,8-Diazaspiro[4.5]Decan-3-One (6)2,8-Diazaspiro[4.5]Decane (5)2-(Piperidin-1-Yl)Ethan-1-Amine (8)2-(Piperidin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-1-Yl)Pyridine (11)2-(Piperidin-1-Yl)Pyrimidine (16)2-(Piperidin-2-Yl)Ethan-1-Ol (8)2-(Piperidin-4-Yl)Ethan-1-Ol (5)2-(Piperidin-4-Yl)Pyridine (5)2-Methylpiperidin-4-One (6)2-Methylpiperidine (14)2-Phenylpiperidine (14)3,3-Difluoropiperidin-4-One (3)3,3-Difluoropiperidine (29)3,3-Dimethylpiperidin-4-One (3)3,3-Dimethylpiperidine (5)3-(1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione (21)3-(Piperidin-1-Yl)Pyridine (5)3-(Piperidin-4-Yl)-1H-Indazole (5)3-(Piperidin-4-Yl)-1H-Indole (8)3-(Piperidin-4-Yl)Pyridine (5)3-Fluoropiperidin-4-One (3)3-Fluoropiperidine (26)3-Methoxypiperidine (7)3-Methylpiperidin-4-One (3)3-Methylpiperidine (10)3-Phenylpiperidine (2)4,4-Difluoropiperidine (5)4-(1H-Pyrazol-1-Yl)Piperidine (11)4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1,2,3,6-Tetrahydropyridine (11)4-(Azetidin-1-Yl)Piperidine (6)4-(Piperidin-1-Yl)Pyrimidine (9)4-(Pyrrolidin-1-Yl)Piperidine (6)4-Benzylpiperidine (18)4-Hydrazineylpiperidine (5)4-Hydroxypiperidin-2-One (3)4-Methyl-1-Phenylpiperidine (6)4-Methylenepiperidine (14)4-Oxopiperidine-2-Carboxylic Acid (3)4-Phenylpiperidin-4-Ol (10)5-Hydroxypiperidin-2-One (3)6-Azaspiro[2.5]Octane (10)6-Oxopiperidine-2-Carboxylic Acid (3)7-Azaspiro[3.5]Nonane (7)Azepane (25)Benzyl 3-Hydroxypiperidine-1-Carboxylate (7)Benzyl 4-Oxopiperidine-1-Carboxylate (12)Benzyl Piperidin-4-Ylcarbamate (7)Benzyl Piperidine-1-Carboxylate (50)Benzyl-3-Aminopiperidine-1-Carboxylate (6)Ethyl Piperidine-1-Carboxylate (5)Ethyl Piperidine-2-Carboxylate (9)Ethyl Piperidine-3-Carboxylate (14)Ethyl Piperidine-4-Carboxylate (10)Methyl 4-Oxopiperidine-2-Carboxylate (3)Methyl Piperidine-2-Carboxylate (12)Methyl Piperidine-3-Carboxylate (19)N-Benzylpiperidin-4-Amine (3)N-Methylpiperidin-3-Amine (5)N-Phenylpiperidine-2-Carboxamide (2)Phenyl(Piperidin-1-Yl)Methanone (21)Phenyl(Piperidin-4-Yl)Methanone (21)Piperidin-2-Ylmethanamine (6)Piperidin-2-Ylmethanol (11)Piperidin-3-Amine (17)Piperidin-3-Ol (27)Piperidin-3-One (13)Piperidin-3-Ylmethanamine (5)Piperidin-3-Ylmethanol (15)Piperidin-4-Amine (14)Piperidin-4-Ol (44)Piperidin-4-Ylmethanamine (7)Piperidin-4-Ylmethanol (11)Piperidine-2,4-Dione (5)Piperidine-2,6-Dione (13)Piperidine-2-Carboxylic Acid (26)Piperidine-3-Carboxamide (5)Piperidine-3-Carboxylic Acid (14)Piperidine-4-Carboxylic Acid (12)Quinuclidine (5)Spiro[Benzo[D][1,3]Oxazine-4,4'-Piperidin]-2(1H)-One (5)Spiro[Chromane-2,4'-Piperidin]-4-One (6)Spiro[Indene-2,4'-Piperidin]-1(3H)-One (5)Spiro[Indoline-3,4'-Piperidin]-2-One (18)Spiro[Indoline-3,4'-Piperidine] (5)Tert-Butyl (2-Oxopiperidin-3-Yl)Carbamate (4)Tert-Butyl (6-Oxopiperidin-3-Yl)Carbamate (3)Tert-Butyl (Piperidin-3-Ylmethyl)Carbamate (5)Tert-Butyl 2-Oxopiperidine-1-Carboxylate (3)Tert-Butyl 3-Bromopiperidine-1-Carboxylate (4)Tert-Butyl 4-Oxopiperidine-1-Carboxylate (16)Tert-Butyl 4-Phenoxypiperidine-1-Carboxylate (12)Tert-Butyl 4-Phenylpiperidine-1-Carboxylate (16)Tert-Butyl Piperidin-3-Ylcarbamate (9)
Purines (2026)
(R)-N-(9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)2-(Acetoxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diyl Diacetate (6)2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diol (28)2-Chloro-7H-Purine (3)2-Chloro-9H-Purine (5)7H-Purin-2-Amine (6)7H-Purin-6-Amine (9)9-((3As,4R,6Ar)-Tetrahydrofuro[3,4-D][1,3]Dioxol-4-Yl)-9H-Purine (7)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Amine (30)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Ol (6)9-(Tetrahydrofuran-2-Yl)-9H-Purine (2)9H-Purin-6-Amine (3)
Pyrans (1098)
(S)-2-Phenylchroman-4-One (17)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Indazole (17)2,2-Dimethylchromane (5)2-(2-Oxo-2H-Chromen-4-Yl)Acetic Acid (4)2-Oxo-2H-Chromene-3-Carbonitrile (4)2-Oxo-2H-Chromene-3-Carboxylic Acid (14)2H-Chromene (16)3,4-Dihydro-2H-Pyran (11)3,6-Dihydro-2H-Pyran (8)3-Acetyl-2H-Chromen-2-One (3)3-Hydroxy-2-Phenyl-4H-Chromen-4-One (22)4-(Trifluoromethyl)-2H-Chromen-2-One (6)4-Hydroxy-2H-Chromen-2-One (10)4-Methyl-2H-Chromen-2-One (27)5-Fluorochroman-4-One (3)5-Fluorochromane (6)5-Hydroxy-2-Phenyl-4H-Chromen-4-One (36)5-Methoxy-2-Phenyl-4H-Chromen-4-One (10)6-Bromochroman-4-One (6)6-Chlorochroman-4-One (6)6-Chlorochromane (6)6-Fluorochroman-4-One (5)6-Fluorochromane (6)6-Methoxychromane (5)7-(Diethylamino)-2H-Chromen-2-One (9)7-Bromochroman-4-One (4)7-Bromochromane (7)7-Chlorochromane (5)7-Fluorochroman-4-One (5)7-Hydroxy-2H-Chromen-2-One (23)7-Methoxy-2H-Chromen-2-One (12)7-Methoxychroman-4-One (3)8-Bromochroman-4-One (4)8-Bromochromane (6)8-Chlorochromane (5)8-Fluorochromane (5)8-Methylchroman-4-One (4)8-Methylchromane (11)Chroman-2-One (5)Chroman-2-Ylmethanamine (3)Chroman-3-Amine (3)Chroman-4-Amine (20)Chroman-4-Ol (4)Chromane-2-Carboxylic Acid (6)Chromane-3-Carboxylic Acid (4)Dihydro-2H-Pyran-2,6(3H)-Dione (5)Ethyl 2-Oxo-2H-Chromene-3-Carboxylate (5)Isochromane (11)Spiro[Chromane-2,4'-Piperidin]-4-One (6)Tetrahydro-2H-Pyran-2-One (15)Tetrahydro-2H-Thiopyran (10)Tetrahydro-4H-Pyran-4-One (12)Thiochroman-4-One (10)Chromene-Carboxylic Acid (1)Thioglucopyranoside (4)
Pyrazines (3359)
Dibromopyrazine (7)Dichloropyrazine (21)Dihydropyrazine (6)Dimethylpyrazine (30)Ethoxypyrazine (5)Ethylpyrazine (7)Fluoropyrazine (6)Hydroxypyrazine (4)Iodopyrazine (17)Methoxypyrazine (36)Phenylpyrazin (5)Pyrazino (5)Pyrazino-Nitrile (50)1,2,3,4-Tetrahydropyrido[2,3-B]Pyrazine (5)1-(Pyrazin-2-Yl)Ethan-1-One (5)1H-Pyrazolo[3,4-B]Pyrazine (5)2,3-Diphenylpyrazine (5)2,5-Dibromopyrazine (4)2,5-Dichloropyrazine (4)2,6-Dibromopyrazine (9)2,6-Dichloropyrazine (14)2-(Piperazin-1-Yl)Pyrazine (9)2-(Trifluoromethyl)Pyrazine (6)2-Bromo-3-Methoxypyrazine (5)2-Bromo-3-Methylpyrazine (5)2-Bromo-5-Chloropyrazine (6)2-Bromo-6-Chloropyrazine (5)2-Bromo-6-Methylpyrazine (5)2-Bromopyrazine (15)2-Chloro-3-Methylpyrazine (7)2-Chloro-6-Methylpyrazine (12)2-Chloropyrazine (24)2-Ethoxypyrazine (3)2-Ethylpyrazine (9)2-Fluoropyrazine (7)2-Iodopyrazine (25)2-Methoxypyrazine (45)2-Methylpyrazine (16)2-Phenylpyrazine (12)3-Chloropyrazin-2-Amine (6)3-Chloropyrazine-2-Carbonitrile (6)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine (7)4-(Pyrazin-2-Yl)Morpholine (5)5,6,7,8-Tetrahydro-[1,2,4]Triazolo[4,3-A]Pyrazine (11)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine (15)5,6,7,8-Tetrahydroimidazo[1,5-A]Pyrazine (11)5-Bromopyrazin-2-Amine (13)5-Bromopyrazin-2-Ol (5)5-Chloropyrazin-2-Amine (9)5H-Pyrrolo[2,3-B]Pyrazine (14)6-Bromopyrazin-2-Amine (5)6-Chloropyrazin-2-Amine (11)[1,2,4]Triazolo[1,5-A]Pyrazine (9)[1,2,4]Triazolo[4,3-A]Pyrazine (11)Ethyl Pyrazine-2-Carboxylate (10)Imidazo[1,5-A]Pyrazine (9)Methyl 3-Bromopyrazine-2-Carboxylate (5)Methyl 6-Bromopyrazine-2-Carboxylate (7)Methyl 6-Chloropyrazine-2-Carboxylate (5)Methyl Pyrazine-2-Carboxylate (19)Pyrazin-2-Amine (22)Pyrazin-2-Ol (7)Pyrazin-2-Ylmethanamine (12)Pyrazine-2-Carbaldehyde (17)Pyrazine-2-Carbohydrazide (3)Pyrazine-2-Carbonitrile (15)Pyrazine-2-Carboxamide (10)Pyrazine-2-Carboxylic Acid (34)Pyrazolo[1,5-A]Pyrazine (5)Pyrido[2,3-B]Pyrazine (12)Pyrido[3,4-B]Pyrazine (11)Tert-Butyl Pyrazin-2-Ylcarbamate (8)
Pyrazoles (16151)
(1-Methyl-1H-Pyrazol-3-Yl)Methanol (7)(1-Phenyl-1H-Pyrazol-4-Yl)Boronic Acid (4)1,3-Dimethyl-1H-Pyrazole (28)1,3-Diphenyl-1H-Pyrazole (6)1,4,5,6-Tetrahydropyrrolo[3,4-C]Pyrazole (6)1,5-Diphenyl-1H-Pyrazole (13)1-(2-Chlorophenyl)-1H-Pyrazole (3)1-(3-Chlorophenyl)-1H-Pyrazole (3)1-(4-Methoxybenzyl)-1H-Pyrazole (5)1-(Azetidin-3-Yl)-1H-Pyrazole (7)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Pyrazole (9)1-(Tetrahydro-2H-Pyran-4-Yl)-1H-Pyrazole (6)1-Benzyl-1H-Pyrazolo[3,4-B]Pyridine (9)1-Benzyl-4-Bromo-1H-Pyrazole (5)1-Benzyl-4-Iodo-1H-Pyrazole (5)1-Cyclopentyl-1H-Pyrazole (5)1-Cyclopropyl-1H-Pyrazole (9)1-Methyl-1H-Pyrazol-3-Amine (14)1-Methyl-3-Phenyl-1H-Pyrazole (21)1-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole (6)1-Methyl-5-Phenyl-1H-Pyrazole (7)1-Phenyl-1H-Pyrazol-3-Amine (3)1-Phenyl-1H-Pyrazol-3-Ol (3)1-Phenyl-1H-Pyrazol-5-Amine (4)1-Phenyl-1H-Pyrazole-3-Carboxylic Acid (10)1-Phenyl-1H-Pyrazole-4-Carbaldehyde (8)1-Phenyl-1H-Pyrazole-4-Carbonitrile (17)1-Phenyl-1H-Pyrazole-4-Carboxylic Acid (19)1-Phenyl-1H-Pyrazole-5-Carboxylic Acid (3)1-Phenyl-3-(Trifluoromethyl)-1H-Pyrazole (5)1-Trityl-1H-Pyrazole (5)1H-Pyrazol-4-Amine (6)1H-Pyrazol-4-Ol (3)1H-Pyrazol-5-Amine (19)1H-Pyrazole-4-Carbaldehyde (30)1H-Pyrazole-4-Carbonitrile (5)1H-Pyrazole-4-Carboxylic Acid (9)1H-Pyrazole-4-Sulfonyl Chloride (8)1H-Pyrazole-5-Carboxamide (3)1H-Pyrazole-5-Carboxylic Acid (10)1H-Pyrazolo[3,4-B]Pyrazine (5)1H-Pyrazolo[3,4-B]Pyridin-5-Amine (3)1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (5)1H-Pyrazolo[4,3-D]Pyrimidine (5)2,3-Dihydropyrazolo[5,1-B]Oxazole (7)2,4-Dihydro-3H-Pyrazol-3-One (10)2,6-Di(1H-Pyrazol-1-Yl)Pyridine (5)2-(1H-Pyrazol-1-Yl)Pyridine (16)2-(1H-Pyrazol-1-Yl)Pyrimidine (6)2-(1H-Pyrazol-3-Yl)Pyridine (5)2-Phenyl-2,4-Dihydro-3H-Pyrazol-3-One (24)3-(Tert-Butyl)-1-Phenyl-1H-Pyrazole (4)3-Bromo-1-Methyl-1H-Pyrazole (16)3-Bromopyrazolo[1,5-A]Pyridine (6)3-Bromopyrazolo[1,5-A]Pyrimidine (11)3-Chloro-1-Methyl-1H-Pyrazole (7)3-Cyclopropyl-1H-Pyrazole (5)3-Iodo-1-Methyl-1H-Pyrazole (6)3-Iodo-1H-Pyrazolo[3,4-B]Pyridine (4)3-Methyl-1-Phenyl-1H-Pyrazole (23)3-Phenyl-1H-Pyrazol-5-Amine (11)4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine (7)4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridine (14)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine (7)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyridine (6)4-(1H-Pyrazol-1-Yl)Benzoic Acid (3)4-(1H-Pyrazol-1-Yl)Piperidine (11)4-Bromo-1-Methyl-1H-Pyrazole (14)4-Bromo-1-Phenyl-1H-Pyrazole (11)4-Bromo-1H-Pyrazolo[3,4-B]Pyridine (4)4-Bromopyrazolo[1,5-A]Pyridine (8)4-Chloro-1H-Pyrazole (10)4-Chloro-1H-Pyrazolo[3,4-B]Pyridine (5)4-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (5)4-Iodo-1H-Pyrazole (9)4-Methyl-1-Phenyl-1H-Pyrazole (6)4-Methyl-1H-Pyrazole (11)4-Nitro-1H-Pyrazole (8)4-Phenyl-1H-Pyrazole (18)5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole (8)5-(Difluoromethyl)-1H-Pyrazole (6)5-Bromo-1H-Pyrazole (11)5-Bromo-1H-Pyrazolo[3,4-B]Pyridine (11)5-Bromo-1H-Pyrazolo[3,4-C]Pyridine (5)5-Chloro-1H-Pyrazole (8)5-Chloro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Chloropyrazolo[1,5-A]Pyrimidine (24)5-Cyclopropyl-1H-Pyrazole (6)5-Iodo-1H-Pyrazole (4)5-Nitro-1H-Pyrazole (9)5-Nitro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Phenyl-1H-Pyrazole-3-Carboxylic Acid (15)6,7-Dihydro-5H-Pyrazolo[5,1-B][1,3]Oxazine (13)6-Bromopyrazolo[1,5-A]Pyridine (8)6-Bromopyrazolo[1,5-A]Pyrimidine (7)6-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (12)7-Chloropyrazolo[1,5-A]Pyrimidine (8)Ethyl 1-Phenyl-1H-Pyrazole-3-Carboxylate (4)Ethyl 1-Phenyl-1H-Pyrazole-4-Carboxylate (13)Ethyl 1H-Pyrazole-4-Carboxylate (11)Ethyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (11)Ethyl Pyrazolo[1,5-A]Pyrimidine-3-Carboxylate (6)Methyl 1H-Pyrazole-4-Carboxylate (10)Methyl 1H-Pyrazolo[3,4-B]Pyridine-5-Carboxylate (3)Methyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (16)Pyrazolo[1,5-A]Pyrazine (5)Pyrazolo[1,5-A]Pyridine-2-Carboxylic Acid (5)Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acid (13)Pyrazolo[1,5-A]Pyrimidine-3-Carboxylic Acid (7)Tert-Butyl 1H-Pyrazolo[3,4-B]Pyridine-1-Carboxylate (7)Tert-Butyl 4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole-1-Carboxylate (3)Bipyrazole (5)Chloropyrazolo (33)Dichloropyrazolo (11)Dihydropyrazolo (28)Dimethylpyrazolo (6)Ethylpyrazole (7)Fluoropyrazolo (9)Hydroxypyrazolo (10)Methoxypyrazolo (16)Methyl-Pyrazole-Carboxylic Acid (147)Methyl-Pyrazolone (87)Methylpyrazolo (32)Pyrazolopyridine-Carboxylic Acid (48)Tetrahydropyrazolo (23)
Pyridazines (2753)
2-Methylpyridazin-3(2H)-One (7)3,6-Dichloropyridazine (20)3-(Piperazin-1-Yl)Pyridazine (7)3-(Trifluoromethyl)Pyridazine (3)3-Bromopyridazine (25)3-Chloro-4-Methylpyridazine (7)3-Chloropyridazine (44)3-Iodopyridazine (5)3-Methoxypyridazine (17)3-Methylpyridazine (6)3-Phenylpyridazine (8)4-Aminopyridazin-3(2H)-One (4)4-Bromopyridazin-3(2H)-One (3)4-Bromopyridazine (5)4-Chloropyridazin-3(2H)-One (4)4-Chloropyridazine (16)4-Methoxypyridazine (8)4-Methylpyridazine (3)6-Chloropyridazin-3(2H)-One (5)6-Chloropyridazin-3-Amine (5)[1,2,4]Triazolo[4,3-B]Pyridazine (10)Ethyl Pyridazine-3-Carboxylate (6)Methyl Pyridazine-3-Carboxylate (7)Pyridazin-3-Amine (18)Pyridazin-3-Ol (3)Pyridazin-4-Amine (10)Pyridazine-3-Carboxylic Acid (7)Aminopyridazine (12)Dihydropyridazine (26)Dimethylpyridazine (9)Hexahydropyridazines (10)Pyridazinecarboxylic (1)
Pyridines (70358)
Acetylpyridin (5)Aminopicolinate (8)Benzyloxypyridine (36)Bipyridine (202)Bromopicolinate (19)Bromopicolinic (4)Bromopicolinic Acid (5)Bromopicolinonitrile (6)Bromopyrido (13)Butylpyridine (5)Chloroisonicotinic Acid (5)Chloronicotinaldehyde (23)Chloronicotinamide (11)Chloronicotinate (45)Chloronicotinic (41)Cyanopicolinate (7)Cyanopicolinic (6)Cyanopyridine (34)Cyclopropoxypyridine (6)Cyclopropylpyridine (30)Dibromopicolinate (4)Dibromopicolinic Acid (3)Dibromopyridine (36)Dichloropicolinate (9)Dichloropicolinonitrile (4)Dichloropyridine (120)Difluoropicolinic Acid (3)Difluoropyridine (58)Dihydropyrido (27)Diiodopyridine (13)Dimethoxypicolinic Acid (5)Dimethoxypyridine (33)Dimethylpyridine (143)Diphenylpyridine (6)Dipyridine (28)Ethoxypicolinic Acid (3)Ethoxypyridine (35)Ethylpyridine (36)Ethynylpicolinate (3)Fluoro-Pyridine--Boronate (79)Fluoropicolinaldehyde (8)Fluoropicolinamide (8)Fluoropicolinate (22)Fluoropyridine (287)Fluoropyrido (3)Formylpyridine (23)Hexahydropyrido (7)Hydrazinylpyridine (22)Hydroxymethylpyridine (27)Hydroxypicolinate (13)Hydroxypicolinic (9)Hydroxypicolinonitrile (7)Iodopicolinate (5)Iodopicolinic Acid (4)Iodopyridine (167)Isopropoxypyridine (20)Isopropylpyridine (32)Methoxyisonicotinaldehyde (10)Methoxynicotinaldehyde (18)Methoxypicolinaldehyde (13)Methoxypicolinamide (13)Methoxypicolinate (21)Methoxypicolinic (18)Methoxypicolinic Acid (16)Methoxypicolinimidamide (5)Methoxypicolinonitrile (13)Methoxypyridine (341)Methylisonicotinamide (8)Methylnicotinaldehyde (30)Methylnicotinamide (13)Methylpicolinaldehyde (16)Methylpicolinamide (15)Methylpicolinate (27)Methylpicolinic (23)Methylpicolinonitrile (28)Methylpyrido (13)Nitropyridine (393)Oxopyridin (2)Phenoxypyridin (1)Picolinate (42)Pyridinecarbonitrile (50)Pyridyl-Benzene-Boronic Acid/Ester (16)Pyridyl-Phenyl-Boronate (2)Pyridylmethyl (6)Terpyridine (32)Tetrachloropyridine (5)Tetrafluoropyridine (21)Tetrahydropyridine (49)Tetrahydropyrido (32)Tribromopyridine (9)Trichloropyridine (17)Trifluoropyridine (8)Trimethylpyridine (5)(2-Chloropyridin-4-Yl)Boronic Acid (6)(3-Bromopyridin-2-Yl)Methanol (7)(3-Chloropyridin-2-Yl)Methanamine (6)(3-Fluoropyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanol (10)(3Ar,8As)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (6)(3As,8Ar)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (7)(4R,5S)-4,5-Diphenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (5)(5-(Trifluoromethyl)Pyridin-3-Yl)Boronic Acid (4)(5-Bromopyridin-2-Yl)Methanamine (5)(5-Bromopyridin-2-Yl)Methanol (5)(5-Chloropyridin-2-Yl)Methanamine (5)(6-Methylpyridin-2-Yl)Methanamine (6)(6-Methylpyridin-2-Yl)Methanol (5)(6-Phenoxypyridin-3-Yl)Boronic Acid (5)(R)-3-(Pyrrolidin-2-Yl)Pyridine (9)(R)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(R)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(S)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (8)(S)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (6)1,1'-Diphenyl-[4,4'-Bipyridine]-1,1'-Diium (7)1,10-Phenanthrolin-4-Ol (3)1,2,3,4-Tetrahydropyrido[2,3-B]Pyrazine (5)1,2,3,6-Tetrahydropyridine (22)1,3-Dihydro-2H-Pyrrolo[2,3-B]Pyridin-2-One (19)1,3-Dihydro-2H-Pyrrolo[2,3-C]Pyridin-2-One (5)1,3-Dihydro-2H-Pyrrolo[3,2-B]Pyridin-2-One (11)1,4-Di(Pyridin-4-Yl)Benzene (5)1-(5-Bromopyridin-2-Yl)Piperazine (6)1-(Phenylsulfonyl)-1H-Pyrrolo[2,3-B]Pyridine (30)1-(Pyridin-2-Yl)Ethan-1-Amine (15)1-(Pyridin-2-Yl)Ethan-1-One (36)1-(Pyridin-2-Yl-L2-Azaneyl)Ethan-1-One (12)1-(Pyridin-3-Yl)Ethan-1-Amine (17)1-(Pyridin-3-Yl)Ethan-1-One (29)1-(Pyridin-3-Yl)Piperazine (13)1-(Pyridin-3-Ylmethyl)Piperazine (6)1-(Pyridin-4-Yl)Ethan-1-Amine (23)1-(Pyridin-4-Yl)Ethan-1-One (14)1-Benzyl-1,2,3,6-Tetrahydropyridine (9)1-Benzyl-1H-Pyrazolo[3,4-B]Pyridine (9)1-Methyl-4-(Pyridin-2-Yl)Piperazine (5)1-Methylpyridin-1-Ium Iodide (5)1-Phenyl-3-(4-(Pyridin-4-Yloxy)Phenyl)Urea (8)1H-Imidazo[4,5-B]Pyridine (14)1H-Imidazo[4,5-C]Pyridine (12)1H-Pyrazolo[3,4-B]Pyridin-5-Amine (3)1H-Pyrrolo[2,3-C]Pyridin-7-Ol (3)1H-Pyrrolo[2,3-C]Pyridine-2-Carboxylic Acid (4)1H-Pyrrolo[3,2-B]Pyridine-3-Carboxylic Acid (6)2,2':6',2''-Terpyridine (15)2,2-Dimethyl-1-(Pyridin-2-Yl-L2-Azaneyl)Propan-1-One (7)2,3'-Bipyridine (11)2,3,4,5-Tetrahydro-1H-Pyrido[4,3-B]Indole (12)2,3,4,9-Tetrahydro-1H-Pyrido[3,4-B]Indole (13)2,3,5-Trichloropyridine (13)2,3,6-Trichloropyridine (16)2,3-Dibromopyridine (21)2,3-Dichloropyridine (38)2,3-Difluoropyridine (13)2,3-Dihydro-1H-Pyrrolo[2,3-B]Pyridine (10)2,3-Dihydro-1H-Pyrrolo[2,3-C]Pyridine (5)2,3-Dihydro-1H-Pyrrolo[3,2-C]Pyridine (7)2,3-Dihydro-1H-Pyrrolo[3,4-C]Pyridine (6)2,3-Dihydro-[1,4]Dioxino[2,3-B]Pyridine (5)2,3-Dihydropyridin-2-One (5)2,3-Dimethoxypyridine (7)2,3-Dimethylpyridine (8)2,4,6-Trichloropyridine (5)2,4,6-Triphenylpyridine (7)2,4-Dibromopyridine (5)2,4-Dichloro-6-Methylpyridine (8)2,4-Dichloropyridine (50)2,4-Dimethylpyridine (5)2,5-Dibromopyridine (26)2,5-Dichloropyridine (32)2,5-Difluoropyridine (8)2,6-Bis(4,5-Dihydrooxazol-2-Yl)Pyridine (12)2,6-Di(1H-Pyrazol-1-Yl)Pyridine (5)2,6-Dibromo-3-Fluoropyridine (3)2,6-Dibromopyridin-4-Amine (3)2,6-Dibromopyridine (28)2,6-Dichloro-3-Fluoropyridine (10)2,6-Dichloro-3-Methylpyridine (5)2,6-Dichloro-3-Nitropyridine (6)2,6-Dichloro-4-Iodopyridine (4)2,6-Dichloro-4-Methylpyridine (5)2,6-Dichloronicotinonitrile (8)2,6-Dichloropyridin-3-Amine (11)2,6-Dichloropyridine (49)2,6-Difluoropyridine (29)2,6-Dimethoxypyridine (11)2,6-Dimethylpyridin-4-Ol (4)2,6-Dimethylpyridine (26)2-(1H-Pyrazol-1-Yl)Pyridine (16)2-(1H-Pyrazol-3-Yl)Pyridine (5)2-(2,2,2-Trifluoroethoxy)Pyridine (8)2-(2-Chlorophenyl)Pyridine (3)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-(4-Fluorophenyl)Pyridine (11)2-(6-Benzhydrylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(6-Cyclopropylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(Benzyloxy)Pyridine (18)2-(Bromomethyl)Pyridine (27)2-(Chloromethyl)-3-Methylpyridine (12)2-(Chloromethyl)Pyridine (12)2-(Chloromethyl)Pyridine 1-Oxide (4)2-(Difluoromethyl)Pyridine (21)2-(Methylsulfonyl)Pyridine (11)2-(Methylthio)Pyridine (5)2-(P-Tolyl)Pyridine (6)2-(Phenoxymethyl)Pyridine (5)2-(Piperidin-1-Yl)Pyridine (11)2-(Piperidin-4-Yl)Pyridine (5)2-(Pyridin-2-Yl)-1H-Benzo[D]Imidazole (5)2-(Pyridin-2-Yl)Acetonitrile (8)2-(Pyridin-2-Yl)Pyrimidine (8)2-(Pyridin-2-Ylmethyl)-4,5-Dihydrooxazole (14)2-(Pyridin-3-Yl)Acetic Acid (14)2-(Pyridin-3-Yl)Acetonitrile (6)2-(Pyrrolidin-2-Yl)Pyridine (5)2-(Thiophen-2-Yl)Pyridine (5)2-(Trifluoromethoxy)Pyridine (6)2-(Trifluoromethyl)Pyridine (6)2-Aminonicotinonitrile (6)2-Benzylpyridine (12)2-Bromo-3-(Trifluoromethyl)Pyridine (4)2-Bromo-3-Chloropyridine (25)2-Bromo-3-Fluoropyridine (26)2-Bromo-3-Iodopyridine (6)2-Bromo-3-Methoxypyridine (7)2-Bromo-3-Methylpyridine (25)2-Bromo-3-Nitropyridine (5)2-Bromo-4-Chloropyridine (7)2-Bromo-4-Methylpyridine (6)2-Bromo-5-(Trifluoromethyl)Pyridine (6)2-Bromo-5-Chloropyridine (22)2-Bromo-5-Fluoropyridine (33)2-Bromo-5-Methoxypyridine (11)2-Bromo-5-Methylpyridine (19)2-Bromo-5-Nitropyridine (11)2-Bromo-6-(Trifluoromethyl)Pyridine (6)2-Bromo-6-Chloropyridine (23)2-Bromo-6-Fluoropyridine (21)2-Bromo-6-Iodopyridine (5)2-Bromo-6-Methoxypyridine (15)2-Bromo-6-Methylpyridine (17)2-Bromo-6-Phenylpyridine (4)2-Bromonicotinic Acid (5)2-Bromopyridin-3-Amine (10)2-Bromopyridin-3-Ol (7)2-Bromopyridine (10)2-Bromopyridine 1-Oxide (6)2-Chloro-3,6-Dimethylpyridine (4)2-Chloro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (4)2-Chloro-3-(Trifluoromethyl)Pyridine (12)2-Chloro-3-Fluoropyridin-4-Amine (3)2-Chloro-3-Fluoropyridine (20)2-Chloro-3-Iodopyridin-4-Amine (3)2-Chloro-3-Iodopyridine (13)2-Chloro-3-Methoxypyridine (12)2-Chloro-3-Methylpyridine (17)2-Chloro-3-Nitropyridine (10)2-Chloro-4,6-Dimethylpyridine (7)2-Chloro-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (14)2-Chloro-4-(Trifluoromethyl)Pyridine (9)2-Chloro-4-Ethoxypyridine (5)2-Chloro-4-Fluoropyridine (10)2-Chloro-4-Iodopyridine (19)2-Chloro-4-Methoxypyridine (22)2-Chloro-4-Methylpyridine (31)2-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-Chloro-5-(Trifluoromethyl)Pyridine (4)2-Chloro-5-Fluoropyridin-4-Amine (3)2-Chloro-5-Fluoropyridine (16)2-Chloro-5-Iodopyridine (18)2-Chloro-5-Methylpyridine (11)2-Chloro-5-Nitropyridine (8)2-Chloro-6-(Trifluoromethyl)Pyridine (16)2-Chloro-6-Fluoropyridine (14)2-Chloro-6-Iodopyridine (9)2-Chloro-6-Methoxypyridine (24)2-Chloro-6-Methyl-3-Nitropyridine (4)2-Chloro-6-Methylnicotinonitrile (10)2-Chloro-6-Methylpyridine (49)2-Chloroisonicotinaldehyde (19)2-Chloroisonicotinic Acid (17)2-Chloroisonicotinonitrile (7)2-Chloronicotinic Acid (7)2-Chloronicotinonitrile (9)2-Chloropyridin-3-Amine (11)2-Chloropyridin-3-Ol (9)2-Chloropyridin-4-Amine (28)2-Chloropyridine 1-Oxide (10)2-Cyclopropyl-4-Phenylquinoline (12)2-Cyclopropylpyridine (20)2-Ethoxypyridine (20)2-Ethylpyridine (9)2-Ethynylpyridine (31)2-Fluoro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Fluoro-3-Iodopyridine (8)2-Fluoro-3-Methylpyridine (14)2-Fluoro-4-Methylpyridine (6)2-Fluoro-5-Methoxypyridine (4)2-Fluoro-5-Methylpyridine (6)2-Fluoro-6-Methoxypyridine (6)2-Fluoro-6-Methylpyridine (20)2-Fluoropyridine (15)2-Hydrazineylpyridine (32)2-Iodo-6-Methylpyridine (5)2-Iodopyridine (27)2-Isopropoxypyridine (16)2-Isopropylpyridine (14)2-Methoxy-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-3-(Trifluoromethyl)Pyridine (6)2-Methoxy-4-Methylpyridine (5)2-Methoxy-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methoxy-5-(Trifluoromethyl)Pyridine (4)2-Methoxy-5-Methylpyridine (5)2-Methoxy-5-Nitropyridine (8)2-Methoxy-6-Methylpyridine (14)2-Methoxyisonicotinic Acid (13)2-Methoxypyridin-3-Amine (6)2-Methoxypyridine (435)2-Methyl-1,10-Phenanthroline (3)2-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-3-Nitropyridine (9)2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (3)2-Methylimidazo[1,2-A]Pyridine (8)2-Methylpyridin-3-Ol (9)2-Methylpyridin-4-Amine (7)2-Methylpyridine 1-Oxide (9)2-Nitropyridine (40)2-Phenoxy-5-(Trifluoromethyl)Pyridine (7)2-Phenylimidazo[1,2-A]Pyridine (12)2-Propoxypyridine (9)2H-Pyrido[3,2-B][1,4]Oxazin-3(4H)-One (8)3,3'-Bipyridine (7)3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine (5)3,5-Dibromopyridine (12)3,5-Dichloropyridine (16)3,5-Difluoropyridine (12)3,5-Dimethoxypyridine (4)3,5-Dimethylpyridine (8)3,5-Diphenylpyridine (5)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-5-(Trifluoromethyl)Pyridine (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (74)3-(Benzyloxy)Pyridine (19)3-(Bromomethyl)Pyridine (18)3-(Chloromethyl)Pyridine (22)3-(Cyclopropylmethyl)Pyridine (6)3-(Difluoromethyl)Pyridine (5)3-(Methylsulfonyl)Pyridine (5)3-(Piperidin-1-Yl)Pyridine (5)3-(Piperidin-4-Yl)Pyridine (5)3-(Pyrrolidin-2-Yl)Pyridine (6)3-(Tert-Butyl)Pyridine (5)3-(Trifluoromethyl)-1H-Pyrrolo[2,3-B]Pyridine (3)3-(Trifluoromethyl)Pyridin-2-Ol (5)3-(Trifluoromethyl)Pyridine (51)3-Bromo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Bromo-2-Chloropyridin-4-Amine (3)3-Bromo-2-Chloropyridine (20)3-Bromo-2-Fluoropyridine (21)3-Bromo-2-Methoxypyridine (20)3-Bromo-2-Methylpyridine (27)3-Bromo-4-Methylpyridine (13)3-Bromo-5-Chloropyridine (14)3-Bromo-5-Fluoropyridine (18)3-Bromo-5-Methylpyridine (14)3-Bromo-5-Nitropyridine (10)3-Bromopicolinic Acid (9)3-Bromopicolinonitrile (13)3-Bromopyrazolo[1,5-A]Pyridine (6)3-Bromopyridin-2-Amine (30)3-Bromopyridin-2-Ol (17)3-Bromopyridine 1-Oxide (8)3-Chloro-2-Fluoropyridine (13)3-Chloro-2-Methoxypyridine (16)3-Chloro-2-Methylpyridine (4)3-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)3-Chloro-5-Fluoropyridine (10)3-Chloro-5-Methylpyridine (7)3-Chloro-5-Nitropyridine (5)3-Chloroimidazo[1,2-A]Pyridine (3)3-Chloropicolinic Acid (9)3-Chloropicolinonitrile (6)3-Chloropyridin-2-Amine (17)3-Chloropyridin-2-Ol (10)3-Cyclopropylpyridine (28)3-Ethoxypyridine (12)3-Ethylpyridine (11)3-Ethynylpyridine (22)3-Fluoro-2-Methoxypyridine (14)3-Fluoro-2-Methylpyridine (15)3-Fluoro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)3-Fluoropicolinic Acid (6)3-Fluoropicolinonitrile (5)3-Fluoropyridin-2-Amine (12)3-Fluoropyridin-4-Amine (4)3-Hydrazineylpyridine (8)3-Iodo-1H-Pyrazolo[3,4-B]Pyridine (4)3-Iodo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Iodo-1H-Pyrrolo[3,2-C]Pyridine (4)3-Iodopyridin-2-Amine (12)3-Iodopyridin-2-Ol (4)3-Iodopyridin-4-Amine (6)3-Iodopyridin-4-Ol (4)3-Iodopyridine (37)3-Methoxypyridin-2-Amine (5)3-Methoxypyridine (51)3-Methyl-1H-Pyrrolo[2,3-B]Pyridine (5)3-Methyl-2-Phenylpyridine (3)3-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)3-Methyl-5-Nitropyridine (4)3-Methylimidazo[1,2-A]Pyridine (3)3-Methylpicolinic Acid (13)3-Methylpyridin-2-Amine (7)3-Methylpyridine (49)3-Methylpyridine 1-Oxide (7)3-Nitropyridin-2-Ol (11)3-Nitropyridin-4-Amine (5)3-Nitropyridine (54)3-Phenoxypyridine (12)4'-Phenyl-2,2':6',2''-Terpyridine (13)4,4'-Bipyridine (10)4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine (7)4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridine (14)4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine (5)4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (9)4,6-Dichloropyridin-2-Amine (6)4,6-Dichloropyridin-3-Amine (4)4,7-Diphenyl-1,10-Phenanthroline (4)4-(2,4-Diphenyl-1H-Imidazol-5-Yl)Pyridine (5)4-(Benzyloxy)Pyridine (8)4-(Bromomethyl)Pyridine (8)4-(Pyridin-2-Yl)Morpholine (21)4-(Pyridin-3-Yl)Pyrimidine (5)4-(Pyridin-4-Yl)Morpholine (5)4-(Tert-Butyl)-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-(Tert-Butyl)Pyridine (5)4-(Trifluoromethyl)Nicotinic Acid (3)4-(Trifluoromethyl)Pyridine (14)4-Bromo-2-Chloropyridine (29)4-Bromo-2-Fluoropyridine (4)4-Bromo-2-Methoxypyridine (4)4-Bromo-3-Methylpyridine (5)4-Bromopyrazolo[1,5-A]Pyridine (8)4-Bromopyridine (31)4-Chloro-1H-Pyrazolo[4,3-C]Pyridine (7)4-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)4-Chloro-1H-Pyrrolo[3,2-C]Pyridine (10)4-Chloro-2,6-Dimethylpyridine (4)4-Chloro-2-Methoxypyridine (6)4-Chloro-3-Methylpyridine (7)4-Chloronicotinic Acid (4)4-Chloropyridin-2-Amine (6)4-Chloropyridine (31)4-Cyclopropylpyridine (7)4-Ethoxypyridine (7)4-Ethynylpyridine (10)4-Iodopyridine (17)4-Isopropyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-Methoxypyridine (136)4-Methyl-2,2'-Bipyridine (8)4-Methyl-2-Phenylpyridine (3)4-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)4-Methyl-3-Nitropyridine (8)4-Methylnicotinic Acid (5)4-Methylpyridine (24)4-Nitropyridine (11)4-Phenoxypyridine (7)4-Phenyl-1,2,3,6-Tetrahydropyridine (7)4-Phenyl-1,4-Dihydropyridine (10)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyridine (12)5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidine (7)5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidine (17)5,6-Dichloropyridin-2-Amine (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinonitrile (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Amine (9)5-(Trifluoromethyl)Pyridin-2-Amine (5)5-(Trifluoromethyl)Pyridin-2-Ol (8)5-Benzyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (7)5-Bromo-2-Chloro-4-Methylpyridine (5)5-Bromo-2-Chloropyridine (40)5-Bromo-2-Fluoropyridine (22)5-Bromo-2-Iodopyridine (5)5-Bromo-2-Methoxypyridine (29)5-Bromo-2-Methylpyridine (23)5-Bromo-2-Phenylpyridine (3)5-Bromo-4-Methylpyridin-2-Amine (5)5-Bromo-6-Chloropyridin-2-Amine (3)5-Bromonicotinaldehyde (12)5-Bromonicotinic Acid (6)5-Bromonicotinonitrile (6)5-Bromopicolinic Acid (11)5-Bromopicolinonitrile (13)5-Bromopyridin-2-Amine (35)5-Bromopyridin-2-Ol (18)5-Bromopyridin-3-Amine (10)5-Bromopyridin-3-Ol (6)5-Chloro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Chloro-1H-Pyrazolo[4,3-B]Pyridine (6)5-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)5-Chloro-1H-Pyrrolo[3,2-B]Pyridine (6)5-Chloro-2-Fluoropyridine (13)5-Chloro-2-Methoxypyridine (10)5-Chloro-2-Methylpyridine (10)5-Chloroimidazo[1,2-A]Pyridine (3)5-Chloropicolinic Acid (7)5-Chloropicolinonitrile (6)5-Chloropyridin-2-Amine (26)5-Chloropyridin-2-Ol (15)5-Chloropyridin-3-Amine (7)5-Fluoro-2-Methoxypyridine (15)5-Fluoro-2-Methylpyridine (8)5-Fluoropicolinonitrile (5)5-Fluoropyridin-2-Amine (15)5-Iodopyridin-2-Amine (17)5-Iodopyridin-2-Ol (8)5-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (4)5-Methoxypyridin-3-Amine (4)5-Methylimidazo[1,2-A]Pyridine (4)5-Methylpyridin-2-Amine (7)5-Methylpyridin-3-Amine (4)5-Nitronicotinic Acid (5)5-Nitropyridin-2-Amine (6)5-Phenylpicolinic Acid (4)6,7-Dihydro-5H-Cyclopenta[B]Pyridine (18)6,7-Dihydro-5H-Cyclopenta[C]Pyridine (7)6,7-Dihydro-5H-Pyrrolo[3,4-B]Pyridine (5)6-(Trifluoromethyl)Pyridin-2-Amine (11)6-(Trifluoromethyl)Pyridin-3-Amine (5)6-Bromo-1H-Pyrazolo[4,3-B]Pyridine (4)6-Bromo-1H-Pyrrolo[3,2-B]Pyridine (7)6-Bromo-1H-Pyrrolo[3,2-C]Pyridine (5)6-Bromoimidazo[1,2-A]Pyridine (14)6-Bromonicotinaldehyde (10)6-Bromonicotinic Acid (9)6-Bromonicotinonitrile (7)6-Bromopicolinic Acid (5)6-Bromopyrazolo[1,5-A]Pyridine (8)6-Bromopyridin-2-Amine (8)6-Bromopyridin-3-Amine (12)6-Bromopyridin-3-Ol (13)6-Chloro-1H-Pyrazolo[4,3-C]Pyridine (8)6-Chloro-1H-Pyrrolo[3,2-C]Pyridine (13)6-Chloro-3-Nitropyridin-2-Amine (4)6-Chloro-5-(Trifluoromethyl)Pyridin-2-Amine (3)6-Chloro-5-Iodopyridin-2-Amine (3)6-Chloroimidazo[1,2-A]Pyridine (4)6-Chloronicotinaldehyde (24)6-Chloronicotinic Acid (4)6-Chloropicolinic Acid (12)6-Chloropicolinonitrile (9)6-Chloropyridin-2-Amine (21)6-Chloropyridin-2-Ol (9)6-Chloropyridin-3-Amine (4)6-Chloropyridine-3-Sulfonyl Chloride (5)6-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (3)6-Fluoropyridin-2-Amine (8)6-Fluoropyridin-3-Amine (4)6-Methoxy-1H-Pyrrolo[2,3-B]Pyridine (3)6-Methoxynicotinaldehyde (4)6-Methoxypicolinic Acid (9)6-Methoxypyridin-2-Amine (14)6-Methoxypyridin-3-Amine (8)6-Methylnicotinic Acid (6)6-Methylnicotinonitrile (7)6-Methylpicolinic Acid (12)6-Methylpicolinonitrile (10)6-Methylpyridin-2-Amine (46)6-Methylpyridin-2-Ol (23)6-Methylpyridin-3-Amine (5)6-Methylpyridin-3-Ol (7)6-Phenoxypyridin-3-Amine (5)6-Phenylnicotinic Acid (8)6-Phenylpicolinic Acid (3)7-Bromo-1H-Pyrrolo[2,3-C]Pyridine (4)7-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)7-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (5)7-Methylimidazo[1,2-A]Pyridine (3)9H-Pyrido[3,4-B]Indole (5)Bis(Pyridin-2-Ylmethyl)Amine (6)Dimethyl Pyridine-2,6-Dicarboxylate (7)Dimethyl(Pyridin-2-Yl)Phosphine Oxide (8)Dimethyl(Pyridin-3-Yl)Phosphine Oxide (7)Ethyl 2-(Pyridin-2-Yl)Acetate (15)Ethyl 2-Methylnicotinate (6)Ethyl 4,6-Dichloronicotinate (4)Ethyl 6-Chloropicolinate (7)Ethyl Isonicotinate (12)Ethyl Nicotinate (25)Ethyl Picolinate (41)Ethyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (11)Furo[3,2-B]Pyridine (7)Furo[3,2-C]Pyridine (7)Imidazo[1,2-A]Pyridin-2-Ylmethanol (4)Imidazo[1,2-A]Pyridine-5-Carboxylic Acid (3)Imidazo[1,2-A]Pyridine-6-Carbonitrile (3)Isonicotinaldehyde (68)Isonicotinamide (12)Isonicotinic Acid (23)Isonicotinohydrazide (6)Isonicotinonitrile (16)Methyl 1H-Pyrazolo[3,4-B]Pyridine-5-Carboxylate (3)Methyl 1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate (3)Methyl 2-(Pyridin-2-Yl)Acetate (9)Methyl 2-Chloroisonicotinate (11)Methyl 2-Chloronicotinate (6)Methyl 3-Bromopicolinate (9)Methyl 3-Chloropicolinate (9)Methyl 5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinate (4)Methyl 5-Hydroxypicolinate (5)Methyl 6-Bromonicotinate (6)Methyl 6-Chloropicolinate (11)Methyl 6-Fluoronicotinate (4)Methyl 6-Methoxynicotinate (4)Methyl Isonicotinate (16)Methyl Nicotinate (52)Methyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (16)N,N-Dimethylpyridin-2-Amine (10)N,N-Dimethylpyridin-4-Amine (6)N-(Pyridin-2-Yl)Benzamide (9)N-Benzylpyridin-2-Amine (9)N-Methylpicolinamide (10)N-Methylpyridin-2-Amine (47)N-Methylpyridin-3-Amine (15)N-Phenyl-4-(Pyridin-3-Yl)Pyrimidin-2-Amine (5)N-Phenylpicolinamide (8)N-Phenylpyridin-2-Amine (9)Nicotinaldehyde (152)Nicotinamide (64)Nicotinic Acid (53)Nicotinonitrile (82)Oxazolo[4,5-B]Pyridine (7)Oxazolo[5,4-B]Pyridine (5)Phenyl(Pyridin-2-Yl)Methanone (10)Phenyl(Pyridin-3-Yl)Methanone (9)Picolinaldehyde (98)Picolinamide (26)Picolinic Acid (22)Picolinimidamide (11)Picolinohydrazide (5)Pyrazolo[1,5-A]Pyridine-2-Carboxylic Acid (5)Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acid (13)Pyridin-2-Amine (29)Pyridin-2-Ol (170)Pyridin-2-Ylboronic Acid (9)Pyridin-2-Ylmethanamine (38)Pyridin-2-Ylmethanol (65)Pyridin-3-Amine (21)Pyridin-3-Ol (13)Pyridin-3-Ylboronic Acid (49)Pyridin-3-Ylmethanamine (29)Pyridin-3-Ylmethanol (39)Pyridin-4-Amine (22)Pyridin-4-Ol (16)Pyridin-4-Ylboronic Acid (21)Pyridin-4-Ylmethanamine (12)Pyridin-4-Ylmethanol (16)Pyridine 1-Oxide (33)Pyridine-2,3-Diamine (5)Pyridine-2,6-Diamine (12)Pyridine-2,6-Dicarboxylic Acid (9)Pyridine-2,6-Diol (6)Pyridine-2-Sulfonamide (6)Pyridine-2-Sulfonyl Chloride (9)Pyridine-2-Thiol (8)Pyridine-3-Sulfonic Acid (6)Pyridine-3-Sulfonyl Chloride (25)Pyrido[2,3-B]Pyrazine (12)Pyrido[2,3-D]Pyrimidine (8)Pyrido[3,2-D]Pyrimidine (14)Pyrido[3,4-B]Pyrazine (11)Pyrido[3,4-D]Pyrimidine (10)Tert-Butyl (2-Chloropyridin-4-Yl)Carbamate (4)Tert-Butyl 1H-Pyrazolo[3,4-B]Pyridine-1-Carboxylate (7)Tert-Butyl 4-(Pyridin-2-Yl)Piperazine-1-Carboxylate (12)Tert-Butyl Pyridin-2-Ylcarbamate (37)Tert-Butyl Pyridin-3-Ylcarbamate (16)Tert-Butyl Pyridin-4-Ylcarbamate (6)Thiazolo[4,5-B]Pyridine (12)Thiazolo[5,4-B]Pyridine (13)Thiazolo[5,4-C]Pyridine (5)Thieno[2,3-B]Pyridine (22)Thieno[2,3-C]Pyridine (14)Thieno[3,2-B]Pyridine (18)Thieno[3,2-C]Pyridine (13)
Pyrimidines (14569)
Bipyrimidine (4)Dibromopyrimidine (15)Methoxypyrimidine (107)Pyrimidinone (3)Tetraoxatetradecan (10)Trichloropyrimidine (11)(R)-7-(Tetrahydrofuran-2-Yl)-7H-Pyrrolo[2,3-D]Pyrimidine (8)(R)-N-(Piperidin-3-Yl)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (5)1,4,5,6-Tetrahydropyrimidine (4)1-(3-Fluorotetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (10)1-(5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (31)1-(Pyrimidin-2-Yl)Ethan-1-One (5)1-(Pyrimidin-4-Yl)Ethan-1-One (6)1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (50)1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (5)1H-Pyrazolo[4,3-D]Pyrimidine (5)2,4,5-Trichloropyrimidine (6)2,4,6-Trichloropyrimidine (14)2,4,6-Triphenylpyrimidine (9)2,4-Dichloro-6-Methylpyrimidine (7)2,4-Dichloropyrimidin-5-Amine (6)2,4-Dimethoxypyrimidine (13)2,4-Dimethylpyrimidine (7)2-(1H-Pyrazol-1-Yl)Pyrimidine (6)2-(Chloromethyl)Pyrimidine (5)2-(Methylsulfonyl)Pyrimidine (25)2-(Methylthio)Pyrimidin-4-Amine (10)2-(Methylthio)Pyrimidine (19)2-(Piperazin-1-Yl)Pyrimidine (11)2-(Piperidin-1-Yl)Pyrimidine (16)2-(Propylthio)Pyrimidine (5)2-(Pyridin-2-Yl)Pyrimidine (8)2-(Pyrrolidin-1-Yl)Pyrimidine (8)2-(Trifluoromethyl)Pyrimidine (27)2-Aminopyrimidin-4(3H)-One (11)2-Bromopyrimidine (22)2-Chloro-4-(Trifluoromethyl)Pyrimidine (6)2-Chloro-4-Methoxypyrimidine (14)2-Chloro-4-Methylpyrimidine (16)2-Chloro-4-Phenylpyrimidine (7)2-Chloro-5-Fluoropyrimidine (6)2-Chloro-5-Methylpyrimidine (5)2-Chloro-5-Nitropyrimidine (5)2-Chloro-7H-Pyrrolo[2,3-D]Pyrimidine (13)2-Chloropyrimidin-4-Amine (22)2-Cyclopropylpyrimidine (10)2-Ethoxypyrimidine (7)2-Ethylpyrimidine (6)2-Fluoropyrimidine (9)2-Hydrazineylpyrimidine (6)2-Iodopyrimidine (8)2-Methoxypyrimidin-4-Amine (6)2-Methoxypyrimidine (59)2-Methylpyrimidin-4-Amine (22)2-Methylpyrimidin-4-Ol (11)2-Phenoxypyrimidine (8)2-Phenylpyrimidin-5-Amine (5)3-Methylpyrimidin-4(3H)-One (6)4,5-Dichloropyrimidine (7)4,6-Dichloro-2-(Methylthio)Pyrimidine (9)4,6-Dichloro-2-Methylpyrimidine (7)4,6-Dichloropyrimidin-2-Amine (9)4,6-Dichloropyrimidine (14)4,6-Diphenylpyrimidine (7)4-(Dimethoxymethyl)Pyrimidine (5)4-(Piperazin-1-Yl)Pyrimidine (13)4-(Piperidin-1-Yl)Pyrimidine (9)4-(Pyridin-3-Yl)Pyrimidine (5)4-(Pyrimidin-2-Yl)Morpholine (9)4-(Pyrimidin-4-Yl)Morpholine (13)4-(Trifluoromethyl)Pyrimidin-2-Amine (6)4-(Trifluoromethyl)Pyrimidine (12)4-Amino-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (22)4-Bromopyrimidine (24)4-Chloro-2-(Methylthio)Pyrimidine (29)4-Chloro-2-Methoxypyrimidine (12)4-Chloro-2-Phenylpyrimidine (5)4-Chloro-5-Fluoro-2-Methylpyrimidine (5)4-Chloro-5-Iodopyrimidine (6)4-Chloro-5-Methoxypyrimidine (7)4-Chloro-5-Methylpyrimidine (8)4-Chloro-6-Methoxypyrimidine (5)4-Chloropyrimidin-2-Amine (23)4-Chloropyrimidin-5-Amine (7)4-Chloropyrimidine-5-Carbonitrile (6)4-Ethoxypyrimidine (6)4-Fluoropyrimidine (8)4-Iodopyrimidine (9)4-Methoxy-2-Methylpyrimidine (8)4-Methoxypyrimidin-2-Amine (6)4-Methoxypyrimidine (102)4-Methyl-2-(Methylthio)Pyrimidine (7)4-Methylpyrimidin-2-Amine (9)4-Methylpyrimidine (22)4-Phenoxypyrimidine (5)4-Phenylpyrimidin-2-Amine (15)5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidine (7)5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidine (17)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyrimidine (27)5-(Benzyloxy)Pyrimidine (5)5-Benzylpyrimidine (7)5-Bromo-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (4)5-Bromo-2-(Methylthio)Pyrimidine (6)5-Bromo-2-Chloropyrimidine (6)5-Bromo-2-Methylpyrimidine (5)5-Bromo-4-Chloropyrimidine (4)5-Bromo-7H-Pyrrolo[2,3-D]Pyrimidine (3)5-Bromopyrimidin-4(3H)-One (3)5-Chloropyrimidin-4(3H)-One (4)5-Chloropyrimidine (8)5-Chloropyrimidine-2,4(1H,3H)-Dione (3)5-Ethylpyrimidine (5)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (7)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (3)5-Fluoropyrimidin-4(3H)-One (3)5-Fluoropyrimidine (11)5-Fluoropyrimidine-2,4(1H,3H)-Dione (3)5-Iodo-7H-Pyrrolo[2,3-D]Pyrimidine (4)5-Iodopyrimidine (5)5-Methylpyrimidine (3)5-Phenylpyrimidine (16)5H-Pyrrolo[3,2-D]Pyrimidine (16)6,7-Dihydro-5H-Cyclopenta[D]Pyrimidine (5)6,7-Dihydro-5H-Pyrrolo[3,4-D]Pyrimidine (8)6-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (12)6-Chloropyrimidin-4-Amine (8)7-(Phenylsulfonyl)-7H-Pyrrolo[2,3-D]Pyrimidine (7)7H-Pyrrolo[2,3-D]Pyrimidin-2-Amine (5)7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (3)[1,2,4]Triazolo[1,5-A]Pyrimidine (14)Ethyl 4-Chloropyrimidine-5-Carboxylate (5)Ethyl Pyrazolo[1,5-A]Pyrimidine-3-Carboxylate (6)Ethyl Pyrimidine-4-Carboxylate (7)Ethyl Pyrimidine-5-Carboxylate (5)Imidazo[1,2-C]Pyrimidine (6)Methyl Pyrimidine-2-Carboxylate (10)Methyl Pyrimidine-4-Carboxylate (11)Methyl Pyrimidine-5-Carboxylate (5)N,N-Dimethylpyrimidin-2-Amine (10)N-(9-((2R,5S)-5-((Trityloxy)Methyl)Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)N-Benzyl-9H-Purin-6-Amine (6)N-Cyclopropylpyrimidin-2-Amine (5)N-Methyl-N-(4-Phenylpyrimidin-2-Yl)Methanesulfonamide (7)N-Methylpyrimidin-2-Amine (10)N-Methylpyrimidin-4-Amine (10)N-Phenyl-4-(Pyridin-3-Yl)Pyrimidin-2-Amine (5)N-Phenylpyrimidin-2-Amine (5)N-Phenylpyrimidin-4-Amine (7)N2,N4-Diphenylpyrimidine-2,4-Diamine (5)Pyrido[2,3-D]Pyrimidine (8)Pyrido[3,2-D]Pyrimidine (14)Pyrido[3,4-D]Pyrimidine (10)Pyrimidin-2-Ol (21)Pyrimidin-2-Ylmethanamine (7)Pyrimidin-2-Ylmethanol (5)Pyrimidin-4-Amine (29)Pyrimidin-4-Ol (25)Pyrimidin-5-Amine (6)Pyrimidin-5-Ol (5)Pyrimidin-5-Ylboronic Acid (9)Pyrimidine-2,4-Diamine (14)Pyrimidine-2-Carbonitrile (14)Pyrimidine-2-Carboxylic Acid (11)Pyrimidine-2-Thiol (6)Pyrimidine-4,6(1H,5H)-Dione (3)Pyrimidine-4-Carbonitrile (9)Pyrimidine-4-Carboxylic Acid (17)Pyrimidine-5-Carbaldehyde (38)Pyrimidine-5-Carbonitrile (6)Pyrimidine-5-Carboxylic Acid (7)Tetrahydropyrimidin-2(1H)-One (6)Thiazolo[5,4-D]Pyrimidine (5)Thieno[2,3-D]Pyrimidine (30)Thieno[3,2-D]Pyrimidine (24)
Pyrroles (4904)
(9H-Fluoren-9-Yl)Methyl Pyrrolidine-1-Carboxylate (26)(Z)-3-((1H-Pyrrol-2-Yl)Methylene)Indolin-2-One (8)1,3-Dihydro-2H-Pyrrolo[2,3-B]Pyridin-2-One (19)1,3-Dihydro-2H-Pyrrolo[3,2-B]Pyridin-2-One (11)1,4,5,6-Tetrahydropyrrolo[3,4-C]Pyrazole (6)1-(1H-Pyrrolo[2,3-B]Pyridin-3-Yl)Ethan-1-One (4)1-(Phenylsulfonyl)-1H-Pyrrole (24)1-(Phenylsulfonyl)-1H-Pyrrolo[2,3-B]Pyridine (30)1-Benzylpyrrolidin-2-One (18)1-Methyl-1H-Pyrrole (43)1H-Pyrrol-1-Amine (7)1H-Pyrrole-2-Carbaldehyde (21)1H-Pyrrole-2-Carbonitrile (7)1H-Pyrrole-2-Carboxylic Acid (30)1H-Pyrrole-3-Carbaldehyde (9)1H-Pyrrole-3-Carbonitrile (9)1H-Pyrrolo[2,3-B]Pyridin-6-Amine (4)1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid (5)1H-Pyrrolo[2,3-C]Pyridin-7-Ol (3)2,3-Dihydro-1H-Pyrrolo[2,3-B]Pyridine (10)2,3-Dihydro-1H-Pyrrolo[3,4-C]Pyridine (6)2-Bromo-1H-Pyrrole (11)2-Methyl-1H-Pyrrole (49)2-Nitro-1H-Pyrrole (5)2-Phenyl-1H-Pyrrole (24)3,6-Di(Thiophen-2-Yl)-2,5-Dihydropyrrolo[3,4-C]Pyrrole-1,4-Dione (17)3-Bromo-1H-Pyrrole (16)3-Bromo-1H-Pyrrolo[2,3-B]Pyridine (7)3-Iodo-1H-Pyrrolo[3,2-C]Pyridine (4)3-Methyl-1H-Pyrrolo[2,3-B]Pyridine (5)3-Phenyl-1H-Pyrrole (5)3-Phenylpyrrolidine (7)4-Bromo-1H-Pyrrolo[2,3-B]Pyridine (9)4-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)4H-Thieno[3,2-B]Pyrrole (6)5-Bromo-1H-Pyrrolo[2,3-B]Pyridine (13)5-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)5-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (4)5H-Pyrrolo[2,3-B]Pyrazine (14)5H-Pyrrolo[3,2-D]Pyrimidine (16)7-(Phenylsulfonyl)-7H-Pyrrolo[2,3-D]Pyrimidine (7)7-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (5)Ethyl 1H-Pyrrole-2-Carboxylate (24)Ethyl 1H-Pyrrole-3-Carboxylate (8)Methyl 1H-Pyrrole-2-Carboxylate (30)Methyl 1H-Pyrrole-3-Carboxylate (5)Methyl 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylate (4)Methyl 1H-Pyrrolo[2,3-B]Pyridine-6-Carboxylate (3)Pyrrolo[2,1-F][1,2,4]Triazine (14)Tert-Butyl 1H-Pyrrole-1-Carboxylate (8)Tert-Butyl 1H-Pyrrole-2-Carboxylate (3)Bromopyrrolo (8)Chloropyrrolo (10)Dihydropyrrolo (15)Octahydropyrrolo (6)Pyrrol-Amine (1)Pyrrolopyridine-Methylamine (6)
Pyrrolidines (14604)
(3Ar,6As)-Octahydrocyclopenta[C]Pyrrole (5)(9H-Fluoren-9-Yl)Methyl Pyrrolidine-1-Carboxylate (26)(R)-3-(Pyrrolidin-2-Yl)Pyridine (9)(R)-3-Benzylpyrrolidine (6)(R)-3-Phenylpyrrolidine (4)(S)-3-Phenylpyrrolidine (4)(S)-N-(((S)-Tetrahydro-2H-Pyran-2-Yl)Methyl)Pyrrolidine-2-Carboxamide (4)(S)-N-(4-(Thiazol-5-Yl)Benzyl)Pyrrolidine-2-Carboxamide (7)(S)-N-Phenethyl-3-(Pyrrolidin-2-Yl)Propanamide (5)1-((Benzyloxy)Carbonyl)Pyrrolidine-3-Carboxylic Acid (6)1-(3-Chlorophenyl)Pyrrolidine (3)1-(Phenylsulfonyl)Pyrrolidine (15)1-(Pyrrolidin-1-Yl)Ethan-1-One (9)1-Benzyl 2-Methyl Pyrrolidine-1,2-Dicarboxylate (7)1-Benzylpyrrolidin-2-One (18)1-Benzylpyrrolidine (26)1-Methylpyrrolidin-2-One (13)1-Phenylpyrrolidin-2-One (18)2,2-Dimethylpyrrolidine (4)2,5-Dioxopyrrolidin-1-Yl ((Benzyloxy)Carbonyl)Glycinate (8)2,5-Dioxopyrrolidin-1-Yl Benzoate (8)2,8-Diazaspiro[4.5]Decan-3-One (6)2-((3-Phenylpropyl)Amino)-1-(Pyrrolidin-1-Yl)Ethan-1-One (2)2-(2-Chlorophenyl)Pyrrolidine (17)2-(2-Fluorophenyl)Pyrrolidine (16)2-(3-Fluorophenyl)Pyrrolidine (5)2-(Methoxymethyl)Pyrrolidine (6)2-(Pyrrolidin-1-Yl)Benzoic Acid (3)2-(Pyrrolidin-1-Yl)Pyridine (11)2-(Pyrrolidin-1-Yl)Pyrimidine (8)2-(Pyrrolidin-2-Yl)Acetic Acid (8)2-(Pyrrolidin-2-Yl)Pyridine (5)2-(Pyrrolidin-3-Yl)Acetic Acid (6)2-Amino-1-(Pyrrolidin-1-Yl)Ethan-1-One (5)2-Azabicyclo[2.2.1]Heptane (6)2-Methyl-1-Phenyl-1H-Pyrrole (8)2-Methylpyrrolidine (21)3,3-Difluoropyrrolidine (29)3-(Pyrrolidin-2-Yl)Pyridine (6)3-Aminopyrrolidin-2-One (5)3-Bromopyrrolidine (6)3-Hydroxypyrrolidin-2-One (4)3-Phenoxypyrrolidine (5)3-Phenyl-1-(Pyrrolidin-1-Yl)Propan-1-One (5)3-Phenylpyrrolidine (7)4-(Hydroxymethyl)Pyrrolidin-2-One (4)4-(Pyrrolidin-1-Yl)Aniline (3)4-(Pyrrolidin-1-Yl)Piperidine (6)4-Hydroxypyrrolidin-2-One (7)4-Phenylpyrrolidin-2-One (7)4H-Thieno[3,4-C]Pyrrole-4,6(5H)-Dione (7)5-(Aminomethyl)Pyrrolidin-2-One (3)5-(Hydroxymethyl)Pyrrolidin-2-One (7)5-Azaspiro[2.4]Heptane (13)5-Oxopyrrolidine-2-Carboxylic Acid (4)6-Azaspiro[3.4]Octane (4)Benzyl (S)-Pyrrolidin-3-Ylcarbamate (7)Benzyl 3-Hydroxypyrrolidine-1-Carboxylate (5)Benzyl-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate (9)Benzyl-3-Aminopyrrolidine-1-Carboxylate (7)Ethyl 5-Oxopyrrolidine-2-Carboxylate (3)Hexahydro-1H-Pyrrolizine (12)Methyl 5-Oxopyrrolidine-2-Carboxylate (3)Methyl Prolinate (43)Methyl Pyrrolidine-3-Carboxylate (9)N,N-Dimethylpyrrolidin-3-Amine (7)N-Methylpyrrolidin-3-Amine (6)Octahydrocyclopenta[C]Pyrrole (6)Phenyl(Pyrrolidin-1-Yl)Methanone (12)Proline (13)Pyrrolidin-2-Ylmethanamine (12)Pyrrolidin-2-Ylmethanol (26)Pyrrolidin-3-Ol (59)Pyrrolidin-3-Ylmethanamine (6)Pyrrolidin-3-Ylmethanol (13)Pyrrolidine-2-Carbonitrile (9)Pyrrolidine-2-Carboxamide (12)Pyrrolidine-3-Carbonitrile (6)Pyrrolidine-3-Carboxylic Acid (14)Tert-Butyl (2-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (5-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl 2-Oxopyrrolidine-1-Carboxylate (15)Tert-Butyl 3-((Methylsulfonyl)Oxy)Pyrrolidine-1-Carboxylate (5)Tert-Butyl 3-Hydroxypyrrolidine-1-Carboxylate (20)Tert-Butyl 3-Methoxypyrrolidine-1-Carboxylate (6)Tert-Butyl Pyrrolidin-3-Ylcarbamate (12)Tert-Butyl Pyrrolidine-1-Carboxylate (21)Acetylpyrrolidine (9)Benzylpyrrolidine (31)Bipyrrolidine (9)Bromopyrrolidine (7)Carbamoylpyrrolidine (5)Difluoropyrrolidine (16)Dimethylpyrrolidine (31)Dioxopyrrolidin (131)Ethylpyrrolidine (9)Fluoropyrrolidine (26)Formylpyrrolidine (10)Mercaptopyrrolidine (4)Methoxypyrrolidine (19)Methylenepyrrolidine (2)Methylpyrrolidine (128)Phenoxypyrrolidine (3)Pyrrolidine-Benzene-Boronic Acid/Ester (20)
Pyrrolines (1763)
1,3-Dihydro-2H-Pyrrolo[2,3-C]Pyridin-2-One (5)1-Phenyl-1H-Pyrrole-2,5-Dione (12)2,3-Dihydro-1H-Pyrrolo[2,3-C]Pyridine (5)2,3-Dihydro-1H-Pyrrolo[3,2-C]Pyridine (7)2,5-Dihydro-1H-Pyrrol-2-One (5)2,5-Dihydro-1H-Pyrrole (13)2-Phenyl-2,5,6,7-Tetrahydropyrrolo[2,1-C][1,2,4]Triazol-4-Ium (6)3,4-Dihydro-2H-Pyrrole (5)3-Bromo-1H-Pyrrole-2,5-Dione (3)5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole (8)6,7-Dihydro-5H-Pyrrolo[1,2-A]Imidazole (9)6,7-Dihydro-5H-Pyrrolo[3,4-B]Pyridine (5)6,7-Dihydro-5H-Pyrrolo[3,4-D]Pyrimidine (8)
Quinazolines (3145)
2,4-Dichloroquinazoline (19)2-(Trifluoromethyl)Quinazoline (4)2-Bromoquinazoline (4)2-Chloroquinazolin-4(3H)-One (4)2-Cyclopropylquinazoline (5)2-Mercaptoquinazolin-4(3H)-One (3)2-Methylquinazoline (20)4-Chloroquinazoline (39)4-Methylquinazoline (4)5,6,7,8-Tetrahydroquinazoline (8)5-Chloroquinazoline (4)6-Bromoquinazoline (7)7-Bromoquinazolin-4(3H)-One (4)7-Fluoroquinazolin-4(3H)-One (4)7-Methoxy-N-Phenylquinazolin-4-Amine (12)8-Bromoquinazoline (8)8-Chloroquinazoline (5)8-Fluoroquinazoline (4)8-Methoxyquinazoline (3)8-Methylquinazoline (3)Ethyl Quinazoline-2-Carboxylate (4)N-(3-Chlorophenyl)Quinazolin-4-Amine (10)Quinazolin-2-Amine (13)Quinazolin-2-Ol (7)Quinazolin-4-Amine (8)Quinazolin-4-Ol (10)Dichloroquinazoline (14)Iodoquinazoline (10)Methylquinazoline (46)Nitroquinazoline (20)Trichloroquinazoline (5)
Quinolines (11911)
Iodoquinoline (32)1,2-Dihydroquinoline (5)1-Cyclopropyl-3-(4-(Quinolin-4-Yloxy)Phenyl)Urea (6)2,2'-Biquinoline (3)2,3,6,7-Tetrahydro-1H,5H-Pyrido[3,2,1-Ij]Quinoline (7)2-(Quinolin-2-Yl)-4,5-Dihydrooxazole (7)2-Hydroxyquinolin-4(1H)-One (3)2-Phenylquinoline (19)3,4-Dihydroisoquinoline (11)4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid (3)4-Phenoxyquinoline (5)4-Phenylquinoline (9)6-Bromo-3,4-Dihydroquinolin-2(1H)-One (4)7,8-Dihydroquinolin-5(6H)-One (5)7-(Benzyloxy)Quinoline (6)7-Methoxy-3,4-Dihydroquinolin-2(1H)-One (3)N-Phenyl-N-(4-(Quinolin-4-Yloxy)Phenyl)Cyclopropane-1,1-Dicarboxamide (5)N-Phenylquinolin-4-Amine (11)
Quinoxalines (1412)
1,2,3,4-Tetrahydroquinoxaline (6)2-Chloroquinoxaline (39)2-Methylquinoxaline (5)2-Phenylquinoxaline (5)3,4-Dihydroquinoxalin-2(1H)-One (7)5-Bromoquinoxaline (6)6-Bromoquinoxaline (9)6-Chloroquinoxaline (3)6-Methoxyquinoxaline (6)Quinoxalin-2-Amine (3)Quinoxalin-2-Ol (4)Dichloroquinoxaline (8)Dihydroquinoxalin (7)
Quinuclidines (202)
Spiroes (4766)
1,3-Dihydrospiro[Indene-2,4'-Piperidine] (5)1,4-Dioxaspiro[4.5]Decane (17)2,8-Diazaspiro[4.5]Decane (5)2-Oxa-8-Azaspiro[4.5]Decane (5)3-Phenyloxetane (11)6-Azaspiro[3.4]Octane (4)7-Azaspiro[3.5]Nonane (7)9,9'-Spirobi[Fluorene] (19)Spiro[Cyclopropane-1,3'-Indolin]-2'-One (6)Spiro[Indene-2,4'-Piperidin]-1(3H)-One (5)Spiro[Indoline-3,4'-Piperidine] (5)Aminospiro (4)Azaspiro (246)Bromospiro (11)Diazaspiro (182)Dihydrospiro (18)Dioxaspiro (39)Fluorospiro (4)Oxospiro (22)Triazaspiro (13)
Tetrahydrofurans (2275)
(2R,3S)-2-((Benzoyloxy)Methyl)Tetrahydrofuran-3-Yl Benzoate (8)(3Ar,6Ar)-Hexahydrofuro[3,2-B]Furan (5)(3As,6As)-Tetrahydrofuro[3,4-D][1,3]Dioxole (6)(R)-7-(Tetrahydrofuran-2-Yl)-7H-Pyrrolo[2,3-D]Pyrimidine (8)(R)-N-(9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)(Tetrahydrofuran-2-Yl)Methanamine (4)(Tetrahydrofuran-2-Yl)Methanol (6)(Tetrahydrofuran-3-Yl)Methanamine (3)1,3-Dihydrobenzo[C][1,2]Oxaborole (20)1-(3-Fluorotetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (10)1-(5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (31)1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (50)1-Oxa-8-Azaspiro[4.5]Decane (5)2-(Acetoxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diyl Diacetate (6)2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diol (28)2-Oxa-8-Azaspiro[4.5]Decane (5)2-Oxabicyclo[2.1.1]Hexane (6)3-Aminodihydrofuran-2(3H)-One (4)3-Iodotetrahydrofuran (3)4-Amino-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (22)4-Fluoro-2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3-Ol (4)4-Hydroxydihydrofuran-2(3H)-One (14)5-(Hydroxymethyl)Dihydrofuran-2(3H)-One (7)5-Bromo-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (4)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (7)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (3)5-Oxotetrahydrofuran-2-Carboxylic Acid (4)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Amine (30)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Ol (6)9-(Tetrahydrofuran-2-Yl)-9H-Purine (2)Dihydrofuran-3(2H)-One (8)Tert-Butyl (Tetrahydrofuran-3-Yl)Carbamate (4)Tetrahydrofuran-2-Carboxylic Acid (4)Tetrahydrofuran-3-Amine (6)Tetrahydrofuran-3-Carboxylic Acid (4)Tetrahydrofuran-3-Ol (6)Hydroxytetrahydrofuran (16)Iodotetrahydrofuran (3)Methoxytetrahydrofuran (11)Oxotetrahydrofuran (26)
Tetrahydroisoquinolines (1291)
(9H-Fluoren-9-Yl)Methyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (7)1,2,3,4-Tetrahydroisoquinolin-5-Amine (4)1,2,3,4-Tetrahydroisoquinolin-5-Ol (3)1,2,3,4-Tetrahydroisoquinolin-6-Amine (3)1,2,3,4-Tetrahydroisoquinolin-6-Ol (6)1,2,3,4-Tetrahydroisoquinolin-7-Amine (3)1,2,3,4-Tetrahydroisoquinoline-1-Carboxylic Acid (19)1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (12)1,4-Dihydroisoquinolin-3(2H)-One (5)1-Methyl-1,2,3,4-Tetrahydroisoquinoline (4)2-Methyl-1,2,3,4-Tetrahydroisoquinoline (13)4,4-Dimethyl-1,2,3,4-Tetrahydroisoquinoline (3)5,6,7,8-Tetrahydroisoquinoline (5)5-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)5-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)5-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)5-Methyl-1,2,3,4-Tetrahydroisoquinoline (4)6-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)6-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)6-Methoxy-1,2,3,4-Tetrahydroisoquinoline (3)6-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)7-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)7-Chloro-1,2,3,4-Tetrahydroisoquinoline (5)7-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)7-Methoxy-1,2,3,4-Tetrahydroisoquinoline (6)7-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)Isoquinoline-1,3(2H,4H)-Dione (7)Tetrahydroisoquinoline-Carboxylic Acid (48)
Tetrahydropyrans (3363)
(1S,4Ar,7Ar)-1-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-1,4A,5,7A-Tetrahydrocyclopenta[C]Pyran (4)(6-Phenoxytetrahydro-2H-Pyran-2-Yl)Methanol (17)(R)-2-Phenoxytetrahydro-2H-Pyran (7)(S)-2-(Phenylthio)Tetrahydro-2H-Pyran (5)(S)-7-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-7,8,9,10-Tetrahydrotetracene-5,12-Dione (5)(S)-N-(((S)-Tetrahydro-2H-Pyran-2-Yl)Methyl)Pyrrolidine-2-Carboxamide (4)1-(Tetrahydro-2H-Pyran-4-Yl)-1H-Pyrazole (6)2-(Phenoxymethyl)Tetrahydro-2H-Pyran (5)2-Phenoxytetrahydro-2H-Pyran (6)2-Phenoxytetrahydro-2H-Pyran-4-Yl Acetate (6)4-Phenoxytetrahydro-2H-Pyran (5)9-Bromoanthracene (5)Chroman-Amine (1)Difluorochroman (16)
Tetrahydroquinolines (1464)
1-Ethyl-1,2,3,4-Tetrahydroquinoline (6)1-Methyl-1,2,3,4-Tetrahydroquinoline (6)2,3-Dihydroquinolin-4(1H)-One (19)2-Methyl-1,2,3,4-Tetrahydroquinoline (3)4,4-Dimethyl-1,2,3,4-Tetrahydroquinoline (3)4-Methyl-1,2,3,4-Tetrahydroquinoline (2)5,6,7,8-Tetrahydroquinoline (17)6-Bromo-1,2,3,4-Tetrahydroquinoline (6)6-Chloro-1,2,3,4-Tetrahydroquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroquinoline (3)7-Fluoro-1,2,3,4-Tetrahydroquinoline (3)Tert-Butyl 3,4-Dihydroquinoline-1(2H)-Carboxylate (11)Tetrahydroquinoline-Carboxylic Acid (18)
Tetrazoles (83)
1-Phenyl-1H-Tetrazole (6)5-Phenyl-1H-Tetrazole (23)5-Phenyl-2H-Tetrazole (9)
Thiadiazoles (2122)
1,2,3-Thiadiazole (8)1,2,4-Thiadiazole (16)1,2,5-Thiadiazole (6)1,3,4-Thiadiazol-2-Amine (9)2-Bromo-1,3,4-Thiadiazole (11)2-Methyl-1,3,4-Thiadiazole (12)2-Phenyl-1,3,4-Thiadiazole (19)4,7-Diphenylbenzo[C][1,2,5]Thiadiazole (6)4-Bromobenzo[C][1,2,5]Thiadiazole (14)Benzo[D][1,2,3]Thiadiazole (7)
Thiazines (62)
Thiazoles (6688)
1-(Thiazol-2-Yl)Ethan-1-One (9)2,4-Dibromothiazole (5)2,4-Dichlorothiazole (4)2,4-Dimethylthiazole (7)2,5-Dibromothiazole (5)2,5-Dimethylthiazole (4)2-(Chloromethyl)Thiazole (5)2-(Methylthio)Thiazole (5)2-(Thiazol-4-Yl)Acetic Acid (9)2-(Trifluoromethyl)Thiazole (11)2-Bromo-4-Methylthiazole (7)2-Bromo-5-Methylthiazole (7)2-Chloro-4-Methylthiazole (5)2-Chloro-5-Methylthiazole (5)2-Chlorothiazole (32)2-Imino-N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-(Thiazol-4-Yl)Acetamide (3)2-Isopropylthiazole (11)2-Methyl-4-Phenylthiazole (6)2-Phenoxythiazole (5)2-Phenylbenzo[D]Thiazole (16)2-Phenylthiazole-4-Carbaldehyde (9)4,5,6,7-Tetrahydrobenzo[D]Thiazole (14)4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine (10)4,5-Dihydrothiazole (8)4-(4-Fluorophenyl)Thiazole (9)4-(Trifluoromethyl)Thiazole (7)4-Bromothiazole (10)4-Cyclopropylthiazole (6)4-Methyl-2-Phenylthiazole (6)4-Methylthiazol-2-Amine (7)4-Methylthiazole (5)4-Phenylthiazol-2-Amine (37)5,6-Dihydrobenzo[D]Thiazol-7(4H)-One (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Thiazole (7)5-Bromothiazol-2-Amine (6)5-Bromothiazole (8)5-Methyl-4-Phenylthiazole (5)5-Methylthiazol-2-Amine (6)5-Phenylthiazole (20)Ethyl 2-Aminothiazole-4-Carboxylate (6)Ethyl 2-Aminothiazole-5-Carboxylate (5)Ethyl 2-Phenylthiazole-4-Carboxylate (12)Ethyl 2-Phenylthiazole-5-Carboxylate (9)Ethyl Thiazole-2-Carboxylate (7)Ethyl Thiazole-4-Carboxylate (7)Ethyl Thiazole-5-Carboxylate (7)Methyl 2-Aminothiazole-4-Carboxylate (6)Methyl Thiazole-2-Carboxylate (6)Methyl Thiazole-4-Carboxylate (6)N-(Thiazol-2-Yl)Acetamide (9)N-(Thiazol-2-Yl)Benzamide (9)N-Phenylthiazol-2-Amine (9)Tert-Butyl Thiazol-2-Ylcarbamate (22)Thiazol-2-Ylmethanamine (5)Thiazol-2-Ylmethanol (9)Thiazol-5-Amine (6)Thiazole-2-Carbaldehyde (9)Thiazole-2-Carboxylic Acid (9)Thiazole-4-Carboxylic Acid (5)Thiazole-5-Carbaldehyde (19)Thiazole-5-Carbonitrile (7)Thiazole-5-Carboxylic Acid (10)Thiazolo[4,5-B]Pyridine (12)Thiazolo[5,4-B]Pyridine (13)Thiazolo[5,4-C]Pyridine (5)Thiazolo[5,4-D]Pyrimidine (5)Acetylthiazole (7)Bromothiazolo (9)Chlorothiazole (32)Chlorothiazolo (18)Cyanothiazole (7)Cyclopropylthiazole (11)Dibromothiazole (7)Dichlorothiazole (8)Dihydrothiazole (16)Dihydrothiazolo (14)Dimethylthiazole (22)Ethylthiazole (8)Formylthiazole (7)Methylthiazole (109)Nitrothiazol (8)Tetrahydrothiazolo (8)
Thiazolidines (1260)
(E)-5-Benzylidenethiazolidine-2,4-Dione (6)1,2,3-Oxathiazolidine 2,2-Dioxide (14)2-Thioxothiazolidin-4-One (6)Thiazolidine (16)Thioxothiazolidin (23)
Thiomorpholines (453)
Thiomorpholine (10)Thiomorpholine 1,1-Dioxide (6)
Thiophenes (956)
(9H-Fluoren-9-Yl)Methyl (2-(Thiophen-2-Yl)Ethyl)Carbamate (5)1-(Thiophen-2-Yl)Ethan-1-One (17)2,2'-Bithiophene (25)2,2':5',2''-Terthiophene (9)2,3-Dihydrothieno[3,4-B][1,4]Dioxine (9)2,5-Dibromothiophene (18)2,5-Diphenylthiophene (5)2-(Thiophen-2-Yl)Pyridine (5)2-(Trifluoromethyl)Thiophene (10)2-Chlorothiophene (20)2-Ethynylthiophene (8)2-Iodothiophene (14)2-Methoxythiophene (7)2-Nitrothiophene (20)3-Bromothiophene (6)3-Chlorothiophene (17)3-Fluorothiophene (6)3-Methoxythiophene (9)3-Methylthiophene (14)3-Nitrothiophene (6)3-Phenylthiophene (13)4,4,5,5-Tetramethyl-2-(Thiophen-2-Yl)-1,3,2-Dioxaborolane (23)4,4,5,5-Tetramethyl-2-(Thiophen-3-Yl)-1,3,2-Dioxaborolane (10)4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (9)4,7-Di(Thiophen-2-Yl)Benzo[C][1,2,5]Thiadiazole (9)4,8-Di(Thiophen-2-Yl)Benzo[1,2-B:4,5-B']Dithiophene (8)4-Phenyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepine (5)4H-Cyclopenta[2,1-B:3,4-B']Dithiophene (9)4H-Thieno[3,2-B]Pyrrole (6)4H-Thieno[3,4-C]Pyrrole-4,6(5H)-Dione (7)5,6-Dihydro-4H-Cyclopenta[B]Thiophene (7)5-(Thiophen-2-Yl)Isoxazole (5)5-Benzyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (7)5-Phenylthiophen-2-Amine (5)Benzo[1,2-B:4,5-B']Dithiophene (7)Dibenzo[B,D]Thiophene (22)Dihydrothiophen-3(2H)-One (4)Dithieno[3,2-B:2',3'-D]Thiophene (5)Ethyl Thiophene-2-Carboxylate (19)Ethyl Thiophene-3-Carboxylate (11)Methyl Thiophene-3-Carboxylate (34)N,N-Diphenyl-4-(Thiophen-2-Yl)Aniline (5)Phenyl(Thiophen-2-Yl)Methanone (6)Thieno[2,3-B]Pyridine (22)Thieno[2,3-C]Pyridine (14)Thieno[2,3-D]Pyrimidine (30)Thieno[3,2-B]Pyridine (18)Thieno[3,2-B]Thiophene (19)Thieno[3,2-C]Pyridine (13)Thieno[3,2-D]Pyrimidine (24)Thieno[3,4-B]Thiophene (5)Thiophen-2-Ylboronic Acid (20)Thiophen-2-Ylmethanol (11)Thiophen-3-Amine (18)Thiophen-3-Ol (6)Thiophene-2-Carbaldehyde (43)Thiophene-2-Carbonitrile (23)Thiophene-3-Carbaldehyde (17)Thiophene-3-Carbonitrile (13)Thiophene-3-Carboxamide (5)Thiophene-3-Carboxylic Acid (8)Acetylthiophene (5)Aminothiophene (23)Bromothieno (29)Chlorothieno (41)Chlorothiophene (61)Cyanothiophene (5)Dibromothieno (5)Dibromothiophene (17)Dichlorothieno (10)Dichlorothiophene (13)Dihydrothieno (24)Dihydrothiophene (1)Dihydroxythiophene (7)Dimethylthieno (10)Dimethylthiophene (21)Dithiophene (40)Fluorothiophene (18)Formylthiophene (16)Hydroxythiophene (7)Iodothieno (6)Iodothiophene (13)Methylthieno (27)Nitrothiophene (27)Terthiophene (10)Tetrahydrothieno (17)Thiophenecarboxaldehyde (10)Thiphen-Amine-Hydrochloride (54)Trithiophene (5)
Triazines (1388)
1,2,4-Triazine (10)1,3,5-Triazin-2-Amine (3)2,4,6-Triphenoxy-1,3,5-Triazine (4)2,4,6-Triphenyl-1,3,5-Triazine (24)2,4-Diphenyl-1,3,5-Triazine (6)2-Chloro-1,3,5-Triazine (10)2-Methoxy-1,3,5-Triazine (10)2-Phenyl-1,3,5-Triazine (6)N2,N4,N6-Triphenyl-1,3,5-Triazine-2,4,6-Triamine (4)Pyrrolo[2,1-F][1,2,4]Triazine (14)
Triazoles (7751)
(5As,10Br)-2-Phenyl-2,5A,6,10B-Tetrahydro-4H-Indeno[2,1-B][1,2,4]Triazolo[4,3-D][1,4]Oxazin-11-Ium (6)1-(Phenylsulfonyl)-1H-1,2,4-Triazole (6)1-Benzyl-1H-1,2,3-Triazole (8)1-Benzyl-1H-1,2,4-Triazole (6)1-Methyl-1H-1,2,3-Triazole (9)1-Methyl-1H-1,2,4-Triazole (17)1-Methyl-1H-Benzo[D][1,2,3]Triazole (10)1-Phenethyl-1H-1,2,4-Triazole (6)1-Phenyl-1H-1,2,3-Triazole (7)1-Phenyl-1H-1,2,4-Triazole (20)1H-1,2,4-Triazol-3-Amine (7)1H-1,2,4-Triazol-5-Amine (6)2-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)2-Phenyl-2,5,6,7-Tetrahydropyrrolo[2,1-C][1,2,4]Triazol-4-Ium (6)2-Phenyl-2H-1,2,3-Triazole (7)2-Phenyl-2H-Benzo[D][1,2,3]Triazole (8)2H-1,2,3-Triazole (7)4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazole (7)4-Phenyl-4H-1,2,4-Triazole (6)4-Phenyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepine (5)4H-1,2,4-Triazole (13)5-Bromo-1H-1,2,4-Triazole (6)5-Bromo-1H-Benzo[D][1,2,3]Triazole (5)5-Fluoro-1H-Benzo[D][1,2,3]Triazole (4)6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (12)6-Bromo-[1,2,4]Triazolo[4,3-A]Pyridine (8)8-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)[1,2,4]Triazolo[1,5-A]Pyrazine (9)[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine (17)[1,2,4]Triazolo[4,3-A]Pyridin-3-Ylmethanamine (5)Ethyl 1H-1,2,4-Triazole-3-Carboxylate (3)
Other Aliphatic Heterocycles (6209)
1,3-Dioxane (20)1,4-Diazepane (12)3-Azabicyclo[3.1.0]Hexane (14)
Other Aromatic Heterocycles (37758)
Indolizine (15)Phenazine (8)
NHCs
Achiral NHCs Catalysts (35)
Achiral NHCs Ligands (110)
Chiral NHCs Catalysts (138)
Chiral NHCs Ligands (84)
Organic Building Blocks
Acyl Chlorides (3021)
2-Chlorobenzoyl Chloride (13)2-Phenoxyacetyl Chloride (3)2-Phenylacetyl Chloride (9)
Alcohols (45626)
(1-Methyl-1H-Pyrazol-3-Yl)Methanol (7)(1-Phenylcyclopropyl)Methanol (3)(1H-Benzo[D]Imidazol-2-Yl)Methanol (14)(1H-Indol-2-Yl)Methanol (8)(2-(Trifluoromethyl)Phenyl)Methanol (10)(2-Bromo-6-Fluorophenyl)Methanol (4)(2-Bromophenyl)Methanol (39)(2-Chlorophenyl)Methanol (40)(2-Fluorophenyl)Methanol (60)(2-Iodophenyl)Methanol (12)(2-Nitrophenyl)Methanol (29)(3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Methanol (7)(3-(Trifluoromethoxy)Phenyl)Methanol (4)(3-(Trifluoromethyl)Phenyl)Methanol (22)(3-Chlorophenyl)Methanol (38)(3-Fluorophenyl)Methanol (58)(3-Iodophenyl)Methanol (13)(3-Methylpyridin-2-Yl)Methanol (10)(3-Nitrophenyl)Methanol (31)(3-Phenoxyphenyl)Methanol (3)(3-Phenylisoxazol-5-Yl)Methanol (7)(4-Fluorophenyl)Methanol (29)(4-Nitrophenyl)Methanol (17)(6-Methylpyridin-2-Yl)Methanol (5)(Tetrahydrofuran-2-Yl)Methanol (6)1,2-Diphenylethan-1-Ol (8)1-Phenyl-1H-Pyrazol-3-Ol (3)1-Phenylethan-1-Ol (103)2,2,2-Trifluoro-1-Phenylethan-1-Ol (27)2-(1H-Indol-3-Yl)Ethan-1-Ol (10)2-(2-Chlorophenyl)Ethan-1-Ol (8)2-(Piperazin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-2-Yl)Ethan-1-Ol (8)2-(Piperidin-4-Yl)Ethan-1-Ol (5)2-Amino-2-(2-Fluorophenyl)Ethan-1-Ol (7)2-Amino-2-(Anthracen-9-Yl)Ethan-1-Ol (4)2-Amino-2-Phenylethan-1-Ol (196)2-Hydroxy-1,2-Diphenylethan-1-One (3)2-Hydroxy-1-Phenylethan-1-One (8)2-Hydroxyethyl Benzoate (3)2-Phenoxyethan-1-Ol (14)2-Phenylethan-1-Ol (78)2-Phenylpropan-2-Ol (21)3-Phenylpropan-1-Ol (24)4-Fluoro-2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3-Ol (4)4-Phenylpiperidin-4-Ol (10)Azetidin-2-Ylmethanol (7)Azetidin-3-Ol (11)Benzyl 3-(Hydroxymethyl)Piperazine-1-Carboxylate (6)Benzyl-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate (9)Bicyclo[1.1.1]Pentan-1-Ylmethanol (3)Cyclobutanol (46)Cyclobutylmethanol (15)Cyclohexanol (72)Cyclohexylmethanol (31)Cyclopentanol (51)Diphenylmethanol (20)Isoxazol-3-Ylmethanol (3)Isoxazol-5-Ylmethanol (5)M-Tolylmethanol (34)Morpholin-2-Ylmethanol (12)Morpholin-3-Ylmethanol (14)Naphthalen-1-Ylmethanol (8)O-Tolylmethanol (35)Oxiran-2-Ylmethanol (3)Piperidin-2-Ylmethanol (11)Piperidin-3-Ol (27)Piperidin-3-Ylmethanol (15)Piperidin-4-Ylmethanol (11)Pyridin-2-Ylmethanol (65)Pyridin-3-Ylmethanol (39)Pyridin-4-Ylmethanol (16)Pyrimidin-2-Ylmethanol (5)Pyrrolidin-2-Ylmethanol (26)Pyrrolidin-3-Ylmethanol (13)Quinazolin-2-Ol (7)Tert-Butyl 3-(Hydroxymethyl)-1H-Indole-1-Carboxylate (10)Thiazol-2-Ylmethanol (9)Thiophen-2-Ylmethanol (11)Triphenylmethanol (13)Amino-Propanol (6)Cyclopropylethanol (6)Diethanol (23)Diethanol (23)Dihydroxybenzylidene (4)Dihydroxynaphthalene (7)Dihydroxypropanoate (7)Dihydroxyterephthalic Acid (3)Hydroxyacetamide (1)Hydroxyacetimidamide (3)Hydroxyadamantan (4)Hydroxyadamantan (4)Hydroxyazetidine (7)Hydroxybenzyl (18)Hydroxybenzylidene (5)Hydroxybicyclo (7)Hydroxybutan (4)Hydroxybutan (4)Hydroxybutanoate (36)Hydroxybutanoic (33)Hydroxycarbamimidoyl (2)Hydroxycinnamic Acid (2)Hydroxycyclobutyl (3)Hydroxycyclohexyl (7)Hydroxycyclopentyl (1)Hydroxydiphenylmethyl (2)Hydroxyethoxy (22)Hydroxyethoxy (22)Hydroxyhexanoate (8)Hydroxyhexanoic (6)Hydroxyimino (11)Hydroxyisonicotinaldehyde (7)Hydroxyisonicotinate (5)Hydroxyisonicotinic (5)Hydroxyisonicotinic (5)Hydroxyisonicotinic Acid (4)Hydroxymethyl-Phenyl-Boronic-Acid (32)Hydroxynaphthalene (29)Hydroxynicotinaldehyde (7)Hydroxynicotinate (13)Hydroxynicotinonitrile (6)Hydroxyoctadec (1)Hydroxyoctadec (1)Hydroxyoctadecanoic (7)Hydroxypentanoate (6)Hydroxypropanoic (35)Pentahydroxyhexanal (9)Phenyl-Methanol (3)Propanediol (9)Propanediol (9)Tetrahydroxy (25)Tetrahydroxy (25)Tetrahydroxyhexanal (9)Tetrahydroxypentanal (5)Trihydroxy (246)Trihydroxy (246)
Aldehydes (18915)
1-Methyl-1H-Indole-3-Carbaldehyde (9)1-Naphthaldehyde (23)1-Phenyl-1H-Pyrazole-4-Carbaldehyde (8)1H-Benzo[D]Imidazole-2-Carbaldehyde (5)1H-Indazole-3-Carbaldehyde (19)1H-Indole-2-Carbaldehyde (20)1H-Pyrazole-4-Carbaldehyde (30)1H-Pyrrole-2-Carbaldehyde (21)1H-Pyrrole-3-Carbaldehyde (9)1H-Pyrrolo[2,3-B]Pyridine-3-Carbaldehyde (14)1H-Pyrrolo[2,3-B]Pyridine-5-Carbaldehyde (5)2,3-Dichlorobenzaldehyde (7)2,3-Difluorobenzaldehyde (18)2,4-Dichlorobenzaldehyde (8)2,4-Difluorobenzaldehyde (19)2,6-Dibromobenzaldehyde (4)2,6-Difluorobenzaldehyde (25)2-(Benzyloxy)Benzaldehyde (13)2-(Phenylethynyl)Benzaldehyde (9)2-(Trifluoromethoxy)Benzaldehyde (7)2-(Trifluoromethyl)Benzaldehyde (27)2-Bromo-3-Hydroxybenzaldehyde (4)2-Bromo-3-Methoxybenzaldehyde (4)2-Bromo-6-Fluorobenzaldehyde (15)2-Chloro-3-Hydroxybenzaldehyde (4)2-Chloro-3-Methoxybenzaldehyde (7)2-Chloro-4-Fluorobenzaldehyde (10)2-Fluoro-3-Methylbenzaldehyde (8)2-Fluorobenzaldehyde (175)2-Hydroxy-3-Iodobenzaldehyde (3)2-Iodobenzaldehyde (17)2-Methyl-1H-Indole-3-Carbaldehyde (3)2-Naphthaldehyde (12)2-Nitrobenzaldehyde (53)2-Oxo-2-Phenylacetaldehyde (12)2-Phenylacetaldehyde (20)3-(Benzyloxy)Benzaldehyde (13)3-(Trifluoromethoxy)Benzaldehyde (10)3-(Trifluoromethyl)Benzaldehyde (31)3-Bromo-2-Chlorobenzaldehyde (4)3-Bromo-2-Fluorobenzaldehyde (9)3-Bromo-2-Hydroxybenzaldehyde (10)3-Bromo-4-Fluorobenzaldehyde (7)3-Bromo-4-Hydroxybenzaldehyde (9)3-Bromo-4-Methoxybenzaldehyde (9)3-Chloro-2-Fluorobenzaldehyde (9)3-Chloro-2-Hydroxybenzaldehyde (5)3-Chloro-4-Methoxybenzaldehyde (7)3-Chlorobenzaldehyde (106)3-Fluorobenzaldehyde (137)3-Iodobenzaldehyde (28)3-Methoxy-2-Nitrobenzaldehyde (3)3-Nitrobenzaldehyde (49)3-Phenoxybenzaldehyde (7)4-(1H-Imidazol-1-Yl)Benzaldehyde (7)4-(Benzyloxy)Benzaldehyde (23)4-(Piperazin-1-Yl)Benzaldehyde (5)4-Fluorobenzaldehyde (78)4-Hydroxy-3-Nitrobenzaldehyde (5)4-Morpholinobenzaldehyde (8)4-Nitrobenzaldehyde (18)4-Phenoxybenzaldehyde (12)5-Phenylfuran-2-Carbaldehyde (9)6-Methoxynicotinaldehyde (4)[1,1'-Biphenyl]-3-Carbaldehyde (20)[1,1'-Biphenyl]-4-Carbaldehyde (31)Benzo[B]Thiophene-2-Carbaldehyde (7)Benzo[B]Thiophene-3-Carbaldehyde (6)Benzo[D][1,3]Dioxole-5-Carbaldehyde (6)Benzofuran-2-Carbaldehyde (5)Furan-2-Carbaldehyde (22)Imidazo[1,2-A]Pyridine-2-Carbaldehyde (8)Imidazo[1,2-A]Pyridine-3-Carbaldehyde (9)Isonicotinaldehyde (68)Methyl 3-Formylbenzoate (23)Nicotinaldehyde (152)Picolinaldehyde (98)Pyrazine-2-Carbaldehyde (17)Pyrimidine-5-Carbaldehyde (38)Thiazole-2-Carbaldehyde (9)Thiazole-5-Carbaldehyde (19)Thiophene-2-Carbaldehyde (43)Thiophene-3-Carbaldehyde (17)Aminonicotinaldehyde (5)Aminonicotinaldehyde (5)Carboxyaldehyde (1094)Dicarbaldehyde (37)Dicarbaldehyde (37)Formylisonicotinate (7)Tetracarbaldehyde (8)Tetracarbaldehyde (8)Tricarbaldehyde (10)
Aliphatic Chain Hydrocarbons (12590)
Acetylthio (7)Acetylthio (7)Azanonadecan (7)Azanylylidene (1)Azapentadecan (10)Azapentadecan (10)Azatridecan (4)Butyloctyl (4)Butyloctyl (4)Carbonylbis (2)Carbonylbis (2)Diazirine (13)Diazirine (13)Didodecyl (7)Didodecyl (7)Diethyl (73)Diethyl (73)Dihydroxypropan (6)Diisobutyl (2)Diisopropyl (27)Diisopropyl (27)Dimethoxy (306)Dimethyladamantane (14)Dimethyladamantane (14)Dimethylalkanes (7)Dinonyl (1)Dinonyl (1)Dioctyl (1)Dioxide (451)Dioxide (451)Ethoxy (711)Ethoxyethoxy (5)Ethoxyethoxy (5)Ethoxyethyl (16)Ethoxyethyl (16)Ethoxymethyl (11)Ethoxymethylene (1)Ethoxymethylene (1)Isopropylidenebis (2)Isopropylsulfonyl (10)Isopropylsulfonyl (10)Methoxybut (2)Methoxybut (2)Methoxyethoxy (67)Methoxyethoxy (67)Methoxyethyl (68)Methoxyisonicotinic (11)Methoxyisonicotinic (11)Methoxymethoxy (23)Methoxymethoxy (23)Methoxymethyl (117)Methoxynicotinic (26)Methoxynicotinic (26)Methoxynicotinic Acid (20)Methoxypropan (24)Methoxypropan (24)Methoxypropoxy (8)Methoxypropoxy (8)Methoxypropyl (10)Methoxytetrahydro (14)Methoxytetrahydro (14)Methyladamantan (4)Methylisonicotinic (13)Oxoethoxy (1)Oxopropane (10)Oxopropyl (32)Oxopropyl (32)Pentyloxy (7)Tetramethoxy (6)Trimethoxy (15)Trimethoxy (15)Yldisulfanyl (7)
Aliphatic Cyclic Hydrocarbons (11026)
(1-Phenylcyclobutyl)Methanamine (9)(1-Phenylcyclopropyl)Methanamine (12)(1-Phenylcyclopropyl)Methanol (3)(3Ar,E)-4-((Z)-2-(2-Methylenecyclohexylidene)Ethylidene)Octahydro-1H-Indene (7)(4-Cyclohexylphenyl)Boronic Acid (7)(4-Pentylcyclohexyl)Benzene (5)(4-Propylcyclohexyl)Benzene (5)(9H-Fluoren-2-Yl)Boronic Acid (6)(9H-Fluoren-9-Yl)Methyl (4-Methoxybenzyl)Carbamate (7)(Cyclopropylmethoxy)Benzene (18)1,1-Difluorocyclobutane (14)1,1-Difluorocyclohexane (18)1,1-Difluorocyclopentane (5)1-Bromo-2-Cyclopropylbenzene (3)1-Bromo-3-Cyclopropylbenzene (6)1-Chloro-2-Cyclopropylbenzene (7)1-Cyclohexyl-2-Fluorobenzene (4)1-Cyclopropyl-3-Methylbenzene (3)1-Methylcyclohex-1-Ene (26)1-Phenylcyclobutan-1-Amine (5)1-Phenylcyclobutane-1-Carbonitrile (7)1-Phenylcyclobutane-1-Carboxylic Acid (16)1-Phenylcyclohexane-1-Carboxylic Acid (6)1-Phenylcyclopropan-1-Amine (26)1-Phenylcyclopropane-1-Carbonitrile (19)1-Phenylcyclopropane-1-Carboxylic Acid (23)2-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-2-Phenylacetic Acid (5)2-Bromo-9,9-Diphenyl-9H-Fluorene (5)2-Bromo-9H-Fluorene (15)2-Cyclohexylacetic Acid (14)2-Cyclopropyl-4-Phenylquinoline (12)2-Cyclopropylpyridine (20)2-Cyclopropylpyrimidine (10)2-Iodo-9H-Fluorene (8)2-Methylcyclohexan-1-One (3)2-Phenylcyclopropan-1-Amine (20)3,3-Dimethylcyclohexan-1-One (4)3-Cyclopropylpyridine (28)3-Methylcyclohexan-1-One (9)4-Cyclohexylbenzoic Acid (6)4-Cyclohexylbenzonitrile (10)4-Cyclohexylphenol (7)5-Azaspiro[2.4]Heptane (13)6-Azaspiro[2.5]Octane (10)9,9-Dimethyl-9H-Fluorene (16)Bicyclo[1.1.1]Pentan-1-Ylmethanol (3)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid (6)Bicyclo[2.2.1]Hept-2-Ene (18)Bicyclo[2.2.1]Heptane (15)Bromocyclohexane (7)Cyclobutanamine (90)Cyclobutanecarboxylic Acid (23)Cyclobutanol (46)Cyclobutylmethanol (15)Cycloheptane (12)Cyclohex-3-Ene-1-Carboxylic Acid (7)Cyclohexanamine (59)Cyclohexanecarboxylic Acid (83)Cyclohexanol (72)Cyclohexylmethanol (31)Cyclopentanamine (5)Cyclopentanecarboxylic Acid (26)Cyclopentanol (51)Cyclopropoxybenzene (13)Ethyl 1-Phenylcyclopropane-1-Carboxylate (4)Ethyl 2-Phenylcyclopropane-1-Carboxylate (5)Ethyl Cyclohexanecarboxylate (33)Isopropylcyclohexane (19)Methoxycyclohexane (7)Methyl 1-Phenylcyclopropane-1-Carboxylate (10)Methyl 4-Oxocyclohexane-1-Carboxylate (5)Methyl Bicyclo[1.1.1]Pentane-1-Carboxylate (10)Methyl Cyclobutanecarboxylate (24)Methyl Cyclohexanecarboxylate (45)Methyl Cyclopentanecarboxylate (18)N-Methylcyclohexanamine (7)Naphthalene-1,4-Dione (23)Spiro[3.3]Heptane (11)Tert-Butyl (1-Phenylcyclopropyl)Carbamate (6)Tert-Butyl (2-Phenylcyclopropyl)Carbamate (3)Tert-Butyl Bicyclo[1.1.1]Pentan-1-Ylcarbamate (5)Tert-Butyl Cyclobutylcarbamate (17)Tert-Butyl Cyclohexylcarbamate (9)Tert-Butyl Cyclopentylcarbamate (28)Aminobicyclo (24)Aminocyclobutanol (5)Aminocyclobutyl (5)Aminocyclohexane (55)Aminocyclohexanol (21)Aminocyclopentanol (17)Aminocyclopentyl (6)Aminocyclopropyl (4)Azabicyclo (292)Azabicyclo (292)Azatricyclo (5)Azatricyclo (5)Azetidine (179)Azetidine (179)Benzylazetidin (9)Bicyclo (61)Bicyclohexyl (6)Bromobicyclo (9)Butylcyclohexyl (9)Butylsulfonyl (6)Chlorocyclopropyl (2)Cyanoazetidine (5)Cyanocyclopropyl (4)Cyclobutanecarbonitrile (2)Cyclobutylacetic (4)Cyclobutylmethyl (4)Cyclobutylmethyl (4)Cyclodextrin (1)Cyclodextrin (1)Cyclohexa (173)Cyclohexa (173)Cyclohexane (127)Cyclohexane (127)Cyclohexanecarboxylic (19)Cyclohexanediamine (8)Cyclohexanone (92)Cyclohexylacetic (2)Cyclohexylamino (9)Cyclohexylbutanoic (4)Cyclohexylcarbamoyl (5)Cyclohexylethanamine (11)Cyclohexylmethoxy (4)Cyclohexylmethoxy (4)Cyclohexylmethyl (7)Cyclohexylmethyl (7)Cyclohexyloxy (10)Cyclohexylpropan (92)Cyclohexylpropanoic (9)Cyclopentadienyl (2)Cyclopentane (169)Cyclopentane (169)Cyclopentanecarboxylic (7)Cyclopentyl (56)Cyclopentyl (56)Cyclopentylacetic (3)Cyclopentylamino (1)Cyclopentylmethyl (4)Cyclopentyloxy (16)Cyclopentyloxy (16)Cyclopentylpropanoic (1)Cyclopropanamine (32)Cyclopropanamine (32)Cyclopropanecarbonitrile (14)Cyclopropanecarbonyl (6)Cyclopropanecarbonyl (6)Cyclopropanecarboxamide (14)Cyclopropanol (4)Cyclopropoxyphenyl (7)Cyclopropyl (356)Cyclopropyl (356)Cyclopropylacetate (6)Cyclopropylacetic (3)Cyclopropylamino (24)Cyclopropylcarbamoyl (5)Cyclopropylethan (5)Cyclopropylethan (5)Cyclopropylethynyl (1)Cyclopropylmethoxy (32)Cyclopropylmethoxy (32)Cyclopropylmethyl (22)Cyclopropylmethyl (22)Cyclopropylpropanoic (5)Cyclopropylsulfonyl (6)Cyclopropylsulfonyl (6)Diazabicyclo (77)Diazabicyclo (77)Dicyclohexyl (6)Dicyclohexyl (6)Dicyclohexylphosphino (18)Dicyclohexylphosphino (18)Difluorocyclobutyl (6)Difluorocyclohexyl (6)Dihydroinden (8)Dihydroindeno (5)Dihydroindeno (5)Dihydropteridin (6)Dimethylbicyclo (5)Dimethylbicyclo (5)Dimethylcyclohex (5)Dimethylcyclohexane (16)Dimethylcyclohexanone (7)Dioxathiolane (1)Dioxathiolane (1)Dioxol (174)Dithiolan (1)Dithiolan (1)Ethylcyclohexyl (4)Ethylcyclohexyl (4)Ethylsulfonyl (42)Fluoroazetidine (1)Fluorobicyclo (4)Hexahydrocyclohepta (6)Hexahydrocyclohepta (6)Hexahydrocyclopenta (4)Hydroxycyclobutanecarboxylic (4)Hydroxycyclohexanecarboxylic (6)Methanesulfonyl (314)Methanesulfonyl (314)Methoxycyclohexanamine (6)Methylazetidine (30)Methylbicyclo (6)Methylbicyclo (6)Methylcyclobutanamine (5)Methylcyclobutanecarboxylic (5)Methylcyclohexanamine (11)Methylcyclohexane (8)Methylcyclohexane (8)Methylcyclohexanecarboxylic (5)Methylcyclohexanecarboxylic Acid (4)Methylcyclohexanol (21)Methylcyclohexanone (5)Methylcyclohexyl (33)Methylcyclopentane (2)Methylcyclopropanamine (4)Methylcyclopropanamine (4)Methylcyclopropane (16)Methylsulfinyl (24)Methylsulfonimidoyl (6)Methylsulfonimidoyl (6)Methylsulphonyl (10)Octahydrocyclopenta (14)Oxabicyclo (40)Oxabicyclo (40)Oxazepane (13)Oxetanes (228)Oxoazetidine (8)Oxoazetidine (8)Oxobicyclo (11)Oxobicyclo (11)Oxocyclobutyl (2)Oxocyclohex (3)Oxocyclohexane (4)Oxocyclohexane (4)Oxocyclohexanecarboxylic (6)Oxocyclohexyl (3)Oxocyclohexyl (3)Oxocyclopentane (2)Oxocyclopentyl (5)Pentamethylcyclopentadienyl (11)Pentylcyclohexyl (10)Pentylcyclohexyl (10)Phenylcyclopropanamine (8)Propylcyclohexyl (15)Propylcyclohexyl (15)Tetraazacyclododecane (13)Tetraazacyclododecane (13)Tetraazacyclotetradecane (7)Tetraazacyclotetradecane (7)Tetramethylcyclohexane (4)Tetraoxatridecan (3)Tetraoxatridecan (3)Thiazepine (2)Tricyclohexylphosphine (9)Trimethylbicyclo (21)Trimethylcyclohex (20)Trimethylcyclohexane (1)Trimethylcyclohexane (1)
Alkenyls (16089)
(1E,4E)-1,5-Diphenylpenta-1,4-Dien-3-One (7)(1E,6E)-1,7-Diphenylhepta-1,6-Diene-3,5-Dione (7)(2,2-Dibromovinyl)Benzene (6)(2-(4-Bromophenyl)Ethene-1,1,2-Triyl)Tribenzene (11)(2-Nitrovinyl)Benzene (28)(Allyloxy)Benzene (19)(E)-5-Benzylidenethiazolidine-2,4-Dione (6)(E)-[3,3'-Biindolinylidene]-2,2'-Dione (5)(E)-N-(3-Oxo-1-Phenyl-3-(Piperidin-1-Yl)Prop-1-En-2-Yl)Benzamide (6)(Z)-3-(Phenyl(Phenylamino)Methylene)Indolin-2-One (5)(Z)-3-Benzylideneindolin-2-One (7)1,2-Diphenylethene (5)1,3,3-Trimethylcyclohex-1-Ene (12)1-Bromo-4-Styrylbenzene (5)1-Methylcyclohex-1-Ene (26)2-Benzalacetophenone (36)2-Methoxycyclohexa-2,5-Diene-1,4-Dione (7)2-Methylcyclohexa-2,5-Diene-1,4-Dione (5)3-(2-Fluorophenyl)Acrylic Acid (17)3-(3-Chlorophenyl)Acrylic Acid (10)3-Methylene-2,3-Dihydro-1H-Inden-1-One (5)3-Methyleneazetidine (8)3-Phenylacrylaldehyde (29)3-Styrylphenol (11)4-(1,2,2-Triphenylvinyl)Benzaldehyde (5)4-(Prop-1-En-2-Yl)Cyclohex-1-Ene (5)5H-Dibenzo[B,F]Azepine (5)Allyl Benzoate (5)Cyclohex-1-En-1-Yl Trifluoromethanesulfonate (3)Cyclohex-1-En-1-Ylboronic Acid (4)Cyclohex-1-Ene-1-Carboxylic Acid (4)Cyclohexa-1,3-Diene (5)Cyclopent-2-En-1-Amine (4)Ethyl Cyclohex-1-Ene-1-Carboxylate (5)Methyl Cinnamate (37)Methyl Cyclohex-3-Ene-1-Carboxylate (3)Methylenecyclobutane (8)Methylenecyclohexane (8)N-Phenylacrylamide (7)Styrene (81)Tert-Butyl-Cyclopent-2-En-1-Ylcarbamate (6)Vinylcyclopropane (8)Acrylaldehyde (11)Acryloyl (9)Acryloyl (9)Annulene (2)Cyclohexene (88)Cyclooctene (9)Cyclopentene (3)Diacrylamide (6)Diallyl (5)Diazene (21)Divinyl (1)Divinyl (1)Enamide (6)Enamide (6)Enecarbaldehyde (2)Enoyl (9)Methacrylamide (3)Methacrylamide (3)Methoxycinnamaldehyde (3)Nitroethylene (37)Tetrahydrocyclopenta (19)
Alkyls (194)
Isopropyl-Phenyl-Boronic Acid/Ester (26)Methylpentan (11)
Alkynyls (2695)
(Bromoethynyl)Benzene (5)(Prop-2-Yn-1-Yloxy)Benzene (13)1,3,5-Tris(Phenylethynyl)Benzene (6)1,4-Bis(Phenylethynyl)Benzene (7)1,4-Diphenylbuta-1,3-Diyne (9)1-Ethynyl-2-Fluorobenzene (10)1-Methyl-4-(Phenylethynyl)Benzene (7)2-(Phenylethynyl)Benzaldehyde (9)2-Ethynylpyridine (31)2-Ethynylthiophene (8)3-Ethynylpyridine (22)4-(Phenylethynyl)-1,1'-Biphenyl (5)4-(Phenylethynyl)Phenol (7)4-Ethynylpyridine (10)9,10-Bis(Phenylethynyl)Anthracene (5)Ethynylbenzene (145)Trimethyl(Phenylethynyl)Silane (23)
Amides (90268)
Acetamide (649)Acetamide (649)Acetamido (154)Carboxamide (929)Carboxamide (929)Diacetamide (3)Dicarboxamide (19)Diethylacetamide (4)Diethylacetamide (4)Dimethylacetamide (9)Dimethylnicotinamide (7)Dimethylnicotinamide (7)Formamidophenylboronic Acid/Ester (11)Isobutyramide (7)Oxobutanamide (10)Oxobutanamide (10)Pentanamide (18)Pentanamide (18)Propanamide (2)Propanamido (5)Propanamido (5)(3-(Phenylcarbamoyl)Phenyl)Boronic Acid (3)(4-(Phenylcarbamoyl)Phenyl)Boronic Acid (11)(9H-Fluoren-9-Yl)Methyl (3-Phenylpropyl)Carbamate (24)(S)-N-Phenethyl-3-(Pyrrolidin-2-Yl)Propanamide (5)(S)-N-Phenylpiperidine-2-Carboxamide (1)1-(Pyridin-2-Yl-L2-Azaneyl)Ethan-1-One (12)1-Methylindoline-2,3-Dione (8)1-Phenylurea (11)1H-Pyrazole-5-Carboxamide (3)2,2-Dimethyl-1-(Pyridin-2-Yl-L2-Azaneyl)Propan-1-One (7)2-((Tert-Butoxycarbonyl)Amino)Benzoic Acid (11)2-(Trifluoromethyl)Benzamide (6)2-Amino-3-Phenylpropanamide (8)2-Amino-N-Phenylbenzamide (21)2-Aminobenzamide (30)2-Bromo-N-Phenylacetamide (5)2-Chloro-N-Phenylacetamide (26)2-Chloro-N-Phenylbenzamide (4)2-Chlorobenzamide (16)2-Fluoro-N-Methylbenzamide (12)2-Fluorobenzamide (32)2-Hydroxy-N-Phenylbenzamide (3)2-Hydroxybenzamide (14)2-Iodobenzamide (4)2-Methoxybenzamide (9)3-Benzamidopropanoic Acid (3)3-Bromo-4-Fluorobenzamide (3)3-Fluorobenzamide (26)3-Nitrobenzamide (17)3-Oxo-N-Phenylbutanamide (10)4-Amino-N-Phenylbenzamide (7)4-Benzamidobenzoic Acid (3)4-Fluorobenzamide (19)4-Oxo-4-(Phenylamino)Butanoic Acid (7)Benzoylglycine (15)Benzyl Benzylcarbamate (16)Benzyl Cyclohexylcarbamate (9)Benzyl Phenylcarbamate (15)Ethyl 2-Oxo-2-(Phenylamino)Acetate (8)Isonicotinamide (12)N,N-Diethylbenzamide (17)N,N-Dimethylbenzamide (34)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-3-Phenylisoxazole-4-Carboxamide (1)N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-Phenylacetamide (5)N-(2-(1H-Indol-3-Yl)Ethyl)Acetamide (5)N-(2-Benzoylphenyl)-2-Bromoacetamide (3)N-(2-Chlorophenyl)Acetamide (16)N-(2-Iodophenyl)Acetamide (8)N-(2-Nitrophenyl)Acetamide (11)N-(3-Fluorophenyl)Acetamide (14)N-(4-Aminophenyl)Benzamide (2)N-(4-Chlorophenyl)Acetamide (9)N-(4-Chlorophenyl)Benzamide (6)N-(4-Fluorophenyl)Benzamide (3)N-(4-Phenoxyphenyl)Acetamide (4)N-(O-Tolyl)Benzamide (9)N-(P-Tolyl)Benzamide (6)N-(Thiazol-2-Yl)Acetamide (9)N-Isopropylbenzamide (16)N-Methoxy-N-Methylbenzamide (24)N-Methylbenzamide (58)N-Methylpicolinamide (10)N-Phenylacrylamide (7)N-Phenylpivalamide (11)Nicotinamide (64)Phenyl Dimethylcarbamate (5)Phenyl Ethyl(Methyl)Carbamate (5)Picolinamide (26)Piperidine-3-Carboxamide (5)Pyrazine-2-Carboxamide (10)Pyrrolidine-2-Carboxamide (12)Tert-Butyl (1-Phenylethyl)Carbamate (19)Tert-Butyl (4-Fluorophenyl)Carbamate (9)Tert-Butyl Benzylcarbamate (52)Tert-Butyl Methyl(Phenyl)Carbamate (9)Tert-Butyl O-Tolylcarbamate (11)Tert-Butyl Phenethylcarbamate (12)Tert-Butyl-Cyclopent-2-En-1-Ylcarbamate (6)Thiophene-3-Carboxamide (5)
Amidines (1563)
Benzimidamide (50)N'-Hydroxybenzimidamide (13)Picolinimidamide (11)Carbamimidoyl (16)
Amines (139431)
Amino-Carboxylate (2)Amino-Propanol (6)Aminoacetamido (4)Aminoacetyl (2)Aminoadamantan (5)Aminoadamantan (5)Aminoazepane (10)Aminobutane (23)Aminobutane (23)Aminobutyl (15)Aminobutyl (15)Aminoethoxy (18)Aminoethoxy (18)Aminoethyl (157)Aminoethyl (157)Aminohexan (6)Aminohexyl (3)Aminohexyl (3)Aminoisonicotinic Acid (12)Aminomethyl (403)Aminomethyl (403)Aminooxy (6)Aminopentyl (10)Aminopentyl (10)Aminopropanamido (1)Aminopropane (20)Aminopropane (20)Aminopropoxy (2)Aminopropoxy (2)Aminotetrahydro (12)Aminotetrahydro (12)Benzylazetidine (4)Bromobenzylamine (6)Bromobenzylcarbamate (28)Butoxycarbonylamino (8)Butylcarbamoyl (5)Carbamothioyl (2)Carbamoyl (114)Chlorobenzylamine (4)Chroman-Amine (1)Diamino (90)Diamino (90)Diaminopteridin (3)Diaminopteridin (3)Dibutylamino (6)Dibutylamino (6)Dichlorobenzylamine (5)Diethylamino (91)Diethylamino (91)Diisopropylamino (1)Dimethyl-Ethylamine (2)Dimethylamino (489)Dimethylamino (489)Dimethylcarbamoyl (14)Dimethylmethanamine (16)Dipropylamino (1)Dipropylamino (1)Ethylamino (37)Ethylamino (37)Fluindamine (32)Hydroxyamino (3)Hydroxyamino (3)Imidazol-Amine (1)Methoxyethanamine (1)Methoxyethanamine (1)Methoxyimino (2)Methylamino (239)Methylamino (239)Methylcarbamoyl (19)Methylcarbamoyl (19)Propanediamine (6)Propylamino (5)Propylamino (5)Pyrrol-Amine (1)Pyrrolopyridine-Methylamine (6)Silanamine (3)Triamine (25)Triamine (25)(1-Phenylcyclobutyl)Methanamine (9)(1-Phenylcyclopropyl)Methanamine (12)(1H-Benzo[D]Imidazol-2-Yl)Methanamine (7)(2,3-Dihydrobenzo[B][1,4]Dioxin-2-Yl)Methanamine (3)(2-Aminophenyl)(Phenyl)Methanone (30)(2-Bromophenyl)Methanamine (12)(2-Chlorophenyl)Methanamine (28)(2-Fluorophenyl)Methanamine (49)(3-Chlorophenyl)Methanamine (19)(3-Fluoropyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanamine (5)(4-Aminophenyl)(Phenyl)Methanone (4)(4-Fluorophenyl)Methanamine (27)(6-Methylpyridin-2-Yl)Methanamine (6)(Tetrahydrofuran-2-Yl)Methanamine (4)(Tetrahydrofuran-3-Yl)Methanamine (3)1,2,3,4-Tetrahydroisoquinolin-5-Amine (4)1,2,3,4-Tetrahydroisoquinolin-6-Amine (3)1,2,3,4-Tetrahydroisoquinolin-7-Amine (3)1,2-Diphenylethan-1-Amine (13)1,3,4-Thiadiazol-2-Amine (9)1,3,5-Triazin-2-Amine (3)1-(2,3-Dihydro-1H-Inden-5-Yl)Ethan-1-Amine (3)1-(2-Aminophenyl)Ethan-1-One (29)1-(2-Bromophenyl)Ethan-1-Amine (10)1-(2-Chlorophenyl)-1H-Pyrazole (3)1-(2-Fluorophenyl)Ethan-1-Amine (80)1-(2-Fluorophenyl)Propan-1-Amine (8)1-(3-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(3-(Trifluoromethyl)Phenyl)Ethan-1-Amine (25)1-(3-Aminophenyl)Ethan-1-One (18)1-(3-Chlorophenyl)-N-Methylmethanamine (8)1-(4-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(Anthracen-9-Yl)Ethan-1-Amine (3)1-(Pyridin-2-Yl)Ethan-1-Amine (15)1-(Pyridin-3-Yl)Ethan-1-Amine (17)1-(Pyridin-4-Yl)Ethan-1-Amine (23)1-Aminoanthracene-9,10-Dione (8)1-Benzyl-N-Methylpiperidin-3-Amine (6)1-Benzylpiperidin-4-Amine (8)1-Methyl-1H-Pyrazol-3-Amine (14)1-Phenyl-1H-Pyrazol-3-Amine (3)1-Phenyl-1H-Pyrazol-5-Amine (4)1-Phenylcyclobutan-1-Amine (5)1-Phenylcyclopropan-1-Amine (26)1-Phenylethan-1-Amine (436)1H-1,2,4-Triazol-3-Amine (7)1H-1,2,4-Triazol-5-Amine (6)1H-Benzo[D]Imidazol-2-Amine (7)1H-Benzo[D]Imidazol-5-Amine (4)1H-Benzo[D]Imidazol-6-Amine (6)1H-Imidazol-2-Amine (6)1H-Indazol-3-Amine (23)1H-Indazol-4-Amine (12)1H-Indazol-5-Amine (3)1H-Indazol-6-Amine (5)1H-Indazol-7-Amine (6)1H-Indol-4-Amine (10)1H-Indol-6-Amine (21)1H-Indol-7-Amine (10)1H-Pyrazol-4-Amine (6)1H-Pyrazol-5-Amine (19)1H-Pyrrol-1-Amine (7)1H-Pyrrolo[2,3-B]Pyridin-6-Amine (4)2,2,2-Trifluoro-1-Phenylethan-1-Amine (48)2,3-Dichloroaniline (18)2,3-Difluoroaniline (34)2,3-Dihydrobenzofuran-3-Amine (11)2,3-Dihydrobenzofuran-5-Amine (3)2,4-Dibromoaniline (18)2,4-Dichloropyrimidin-5-Amine (6)2,4-Difluoroaniline (44)2,5-Difluoroaniline (34)2,6-Dibromoaniline (17)2,6-Dichloroaniline (27)2,6-Difluoroaniline (23)2,6-Diiodoaniline (8)2-((2-Nitrophenyl)Amino)Ethan-1-Ol (5)2-((3-Phenylpropyl)Amino)-1-(Pyrrolidin-1-Yl)Ethan-1-One (2)2-(1H-Benzo[D]Imidazol-2-Yl)Ethan-1-Amine (6)2-(1H-Indol-3-Yl)Ethan-1-Amine (4)2-(Diethylamino)Ethyl Benzoate (3)2-(Methylsulfonyl)Aniline (3)2-(Phenylamino)Benzoic Acid (11)2-(Piperazin-1-Yl)Ethan-1-Amine (8)2-(Piperidin-1-Yl)Ethan-1-Amine (8)2-(Trifluoromethoxy)Aniline (18)2-(Trifluoromethyl)Aniline (58)2-Amino-2-(2-Fluorophenyl)Ethan-1-Ol (7)2-Amino-2-Phenylethan-1-Ol (196)2-Amino-3,3-Diphenylpropanoic Acid (4)2-Amino-3-Chlorophenol (4)2-Amino-3-Fluorobenzoic Acid (11)2-Amino-6-Bromophenol (3)2-Amino-6-Chlorobenzoic Acid (5)2-Amino-6-Chlorobenzonitrile (3)2-Amino-6-Chlorophenol (5)2-Aminobenzamide (30)2-Aminobenzenesulfonic Acid (9)2-Aminophenol (107)2-Aminopyrimidin-4(3H)-One (11)2-Bromo-3-Chloroaniline (4)2-Bromo-3-Fluoroaniline (13)2-Bromo-3-Methylaniline (6)2-Bromo-4-Methylaniline (14)2-Bromo-6-Methylaniline (11)2-Bromo-N,N-Dimethylaniline (5)2-Bromo-N-Methylaniline (8)2-Chloro-3-Methylaniline (4)2-Chloro-4-Methylaniline (7)2-Chloro-6-Methylaniline (11)2-Chloro-N-Methylaniline (4)2-Chloro-N-Phenylaniline (8)2-Chloroaniline (214)2-Chlorobenzene-1,3-Diamine (3)2-Chlorobenzene-1,4-Diamine (6)2-Chloropyrimidin-4-Amine (22)2-Fluoro-6-Iodoaniline (7)2-Fluoro-N-Phenylaniline (4)2-Fluoroaniline (262)2-Iodo-4-Methylaniline (5)2-Iodo-N,N-Dimethylaniline (3)2-Iodoaniline (87)2-Methoxypyridin-3-Amine (6)2-Methyl-6-Nitroaniline (10)2-Methyl-N-Phenylaniline (7)2-Methylpyridin-4-Amine (7)2-Methylpyrimidin-4-Amine (22)2-Nitro-N-Phenylaniline (3)2-Phenoxyaniline (4)2-Phenylcyclopropan-1-Amine (20)2-Phenylpyrimidin-5-Amine (5)3,4-Dibromoaniline (4)3,4-Dichloroaniline (21)3,4-Difluoroaniline (44)3-(1,3,2-Dioxaborinan-2-Yl)Aniline (3)3-(Benzyloxy)Aniline (12)3-(Methylsulfonyl)Aniline (7)3-(Piperazin-1-Yl)Aniline (3)3-(Trifluoromethoxy)Aniline (22)3-(Trifluoromethyl)Aniline (102)3-Aminobenzenesulfonic Acid (6)3-Aminodihydrofuran-2(3H)-One (4)3-Bromo-2-Fluoroaniline (15)3-Bromo-4-Chloroaniline (13)3-Bromo-4-Fluoroaniline (22)3-Bromo-4-Methoxyaniline (7)3-Bromo-4-Methylaniline (14)3-Bromoaniline (187)3-Bromobenzene-1,2-Diamine (11)3-Chloro-2-Iodoaniline (3)3-Chloro-2-Methylaniline (11)3-Chloro-4-Fluoroaniline (18)3-Chloro-4-Iodoaniline (3)3-Chloro-4-Methoxyaniline (6)3-Chloro-4-Methylaniline (12)3-Chlorobenzene-1,2-Diamine (6)3-Chloropyrazin-2-Amine (6)3-Fluoro-2-Methylaniline (9)3-Fluoroaniline (289)3-Iodo-2-Methylaniline (4)3-Iodoaniline (32)3-Methoxypyridin-2-Amine (5)3-Methyl-N-Phenylaniline (4)3-Methylpyridin-2-Amine (7)3-Nitroaniline (98)3-Phenoxyaniline (2)3-Phenyl-1H-Pyrazol-5-Amine (11)3-Phenylisoxazol-5-Amine (8)4,6-Dichloropyrimidin-2-Amine (9)4-(Benzyloxy)Aniline (8)4-(Oxazol-5-Yl)Aniline (3)4-(Pyrrolidin-1-Yl)Aniline (3)4-(Trifluoromethoxy)Aniline (26)4-Amino-2-Chlorobenzonitrile (8)4-Amino-2-Fluorophenol (9)4-Amino-3-Chlorobenzoic Acid (6)4-Amino-3-Chlorophenol (5)4-Amino-N-Phenylbenzenesulfonamide (3)4-Aminopyridazin-3(2H)-One (4)4-Benzylaniline (7)4-Bromo-3-Chloroaniline (21)4-Bromo-3-Fluoroaniline (29)4-Bromo-3-Methylaniline (19)4-Bromo-3-Nitroaniline (8)4-Bromo-N,N-Diphenylaniline (10)4-Bromo-N-Phenylaniline (6)4-Chloro-2-Iodoaniline (9)4-Chloro-3-Fluoroaniline (17)4-Chloro-3-Iodoaniline (3)4-Chloro-3-Methylaniline (11)4-Chloro-N-Phenylaniline (6)4-Chloropyrimidin-2-Amine (23)4-Chloropyrimidin-5-Amine (7)4-Fluoro-N-Phenylaniline (4)4-Fluoroaniline (225)4-Iodo-N,N-Diphenylaniline (3)4-Methoxy-N-Phenylaniline (5)4-Methyl-3-Nitroaniline (8)4-Methylpyrimidin-2-Amine (9)4-Methylthiazol-2-Amine (7)4-Morpholinoaniline (4)4-Nitroaniline (65)4-Phenoxyaniline (6)4-Phenylpyrimidin-2-Amine (15)4-Phenylthiazol-2-Amine (37)5-Bromopyrazin-2-Amine (13)5-Bromothiazol-2-Amine (6)5-Chloropyrazin-2-Amine (9)5-Methoxypyridin-3-Amine (4)5-Methyl-2-Nitroaniline (6)5-Methylpyridin-2-Amine (7)5-Methylpyridin-3-Amine (4)5-Methylthiazol-2-Amine (6)5-Phenylthiophen-2-Amine (5)5H-Dibenzo[B,F]Azepine (5)6-Amino-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)6-Bromopyrazin-2-Amine (5)6-Chloropyrazin-2-Amine (11)6-Chloropyridazin-3-Amine (5)6-Chloropyrimidin-4-Amine (8)6-Methoxypyridin-2-Amine (14)6-Methoxypyridin-3-Amine (8)6-Methylpyridin-2-Amine (46)6-Methylpyridin-3-Amine (5)6-Phenoxypyridin-3-Amine (5)7-Methoxy-N-Phenylquinazolin-4-Amine (12)7H-Purin-2-Amine (6)7H-Purin-6-Amine (9)7H-Pyrrolo[2,3-D]Pyrimidin-2-Amine (5)7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (3)9H-Purin-6-Amine (3)[1,1'-Biphenyl]-2-Amine (8)[1,1'-Biphenyl]-3-Amine (11)[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine (17)[1,2,4]Triazolo[4,3-A]Pyridin-3-Ylmethanamine (5)Azetidin-3-Amine (4)Azetidin-3-Ylmethanamine (3)Aziridine (9)Benzo[B]Thiophen-2-Amine (5)Benzo[D]Oxazol-2-Amine (16)Benzo[D]Thiazol-2-Amine (30)Benzo[D]Thiazol-5-Amine (3)Benzo[D]Thiazol-6-Amine (3)Benzyl-3-Aminopiperidine-1-Carboxylate (6)Benzyl-3-Aminopyrrolidine-1-Carboxylate (7)Bis(Pyridin-2-Ylmethyl)Amine (6)Chroman-2-Ylmethanamine (3)Chroman-3-Amine (3)Chroman-4-Amine (20)Cyclobutanamine (90)Cyclohexanamine (59)Cyclopent-2-En-1-Amine (4)Cyclopentanamine (5)Cyclopropyl(Phenyl)Methanamine (22)Diphenylmethanamine (26)Ethyl 2-Aminobenzoate (23)Ethyl 3-Aminobenzoate (19)Ethyl 4-Aminobenzoate (23)Imidazo[1,2-A]Pyridin-3-Amine (7)Imidazo[1,2-A]Pyridin-8-Amine (7)Isoquinolin-1-Amine (18)Isoquinolin-3-Amine (13)Isoquinolin-4-Amine (16)Isoquinolin-5-Amine (9)Isoquinolin-8-Amine (6)Isoxazol-5-Amine (15)Methyl 2-Amino-2-Phenylacetate (38)Methyl 2-Aminobenzoate (95)Methyl 3-Amino-3-Phenylpropanoate (27)Methyl 3-Aminobenzoate (88)Methyl 4-Aminobenzoate (71)Methyl L-Phenylalaninate (7)Morpholin-2-Ylmethanamine (8)N,N-Diethylaniline (18)N,N-Dimethyl-2-Phenoxyethan-1-Amine (17)N,N-Dimethylaniline (117)N,N-Dimethylnaphthalen-1-Amine (4)N,N-Dimethylpyridin-2-Amine (10)N,N-Dimethylpyridin-4-Amine (6)N,N-Dimethylpyrimidin-2-Amine (10)N,N-Dimethylpyrrolidin-3-Amine (7)N,N-Diphenyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (6)N,N-Diphenyl-[1,1'-Biphenyl]-4-Amine (8)N-(4-Aminophenyl)Benzamide (2)N-(Furan-2-Ylmethyl)Aniline (5)N-(Prop-2-Yn-1-Yl)-2,3-Dihydro-1H-Inden-1-Amine (3)N-Benzyl-1-Phenylethan-1-Amine (7)N-Benzylpiperidin-4-Amine (3)N-Cyclopropylpyrimidin-2-Amine (5)N-Methyl-1,2-Diphenylethan-1-Amine (7)N-Methyl-1-Phenylmethanamine (65)N-Methyl-2-Nitroaniline (20)N-Methyl-4-Nitroaniline (6)N-Methylaniline (140)N-Methylcyclohexanamine (7)N-Methylpiperidin-3-Amine (5)N-Methylpyridin-2-Amine (47)N-Methylpyridin-3-Amine (15)N-Methylpyrimidin-2-Amine (10)N-Methylpyrimidin-4-Amine (10)N-Methylpyrrolidin-3-Amine (6)N-Phenyl-3-(Trifluoromethyl)Aniline (3)N-Phenyl-4-(Trifluoromethyl)Aniline (3)N-Phenylnaphthalen-1-Amine (5)N-Phenylpyridin-2-Amine (9)N-Phenylpyrimidin-2-Amine (5)N-Phenylpyrimidin-4-Amine (7)N1,N1-Diphenylbenzene-1,4-Diamine (2)N1-Phenylbenzene-1,4-Diamine (3)N2,N4,N6-Triphenyl-1,3,5-Triazine-2,4,6-Triamine (4)N2,N4-Diphenylpyrimidine-2,4-Diamine (5)Naphthalen-2-Amine (12)O-Benzylhydroxylamine (16)Oxazol-2-Amine (8)Phenylmethanamine (316)Piperidin-2-Ylmethanamine (6)Piperidin-3-Amine (17)Piperidin-3-Ylmethanamine (5)Piperidin-4-Amine (14)Piperidin-4-Ylmethanamine (7)Pyrazin-2-Amine (22)Pyrazin-2-Ylmethanamine (12)Pyridazin-3-Amine (18)Pyridazin-4-Amine (10)Pyridin-2-Amine (29)Pyridin-2-Ylmethanamine (38)Pyridin-3-Amine (21)Pyridin-3-Ylmethanamine (29)Pyridin-4-Amine (22)Pyridin-4-Ylmethanamine (12)Pyridine-2,3-Diamine (5)Pyridine-2,6-Diamine (12)Pyrimidin-2-Ylmethanamine (7)Pyrimidin-4-Amine (29)Pyrimidin-5-Amine (6)Pyrimidine-2,4-Diamine (14)Pyrrolidin-2-Ylmethanamine (12)Pyrrolidin-3-Ylmethanamine (6)Quinazolin-2-Amine (13)Quinazolin-4-Amine (8)Quinoxalin-2-Amine (3)Tetrahydrofuran-3-Amine (6)Thiazol-2-Ylmethanamine (5)Thiazol-5-Amine (6)Thiophen-3-Amine (18)Tri([1,1'-Biphenyl]-4-Yl)Amine (9)
Anhydrides (659)
1H,3H-Benzo[De]Isochromene-1,3-Dione (8)Furan-2,5-Dione (8)Dianhydride (3)
Aryls (187143)
(6-Phenoxytetrahydro-2H-Pyran-2-Yl)Methanol (17)(8S,9S,14R)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-Tetradecahydro-3H-Cyclopenta[A]Phenanthren-3-One (1)(9H-Fluoren-9-Yl)Methyl (2-(Tritylthio)Ethyl)Carbamate (10)(9H-Fluoren-9-Yl)Methyl Cyclohexylcarbamate (8)(Benzylsulfonyl)Benzene (11)(Cyclopentyloxy)Benzene (12)1,1-Dimethylcyclopropane (5)1,3,4,5-Tetrahydro-2H-Benzo[B]Azepin-2-One (15)1,3-Diphenylurea (24)1-(2-Hydroxyphenyl)-2-Phenylethan-1-One (6)1-(2-Hydroxyphenyl)-3-Phenylprop-2-En-1-One (11)1-([1,1'-Biphenyl]-4-Yl)Ethan-1-One (5)1-(Naphthalen-2-Yl)Ethan-1-One (3)1-Benzyl-4-Chlorobenzene (6)1-Benzyl-4-Fluorobenzene (2)1-Bromonaphthalene (4)1-Chloronaphthalene (24)1-Fluoronaphthalene (23)1-Methoxynaphthalene (18)1-Methyl-4-(Phenylethynyl)Benzene (7)1-Methylnaphthalene (10)1-Naphthaldehyde (23)1-Naphthoic Acid (23)1-Nitronaphthalene (3)10H-Phenothiazine (20)2,2',3,3',5,5',6,6'-Octafluoro-1,1'-Biphenyl (4)2,5-Diphenylthiophene (5)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (7)2-(Trifluoromethyl)-1,1'-Biphenyl (8)2-Benzylaniline (5)2-Bromo-1,1'-Biphenyl (12)2-Bromonaphthalene (4)2-Chloro-1,1'-Biphenyl (8)2-Chloronaphthalene (6)2-Ethoxynaphthalene (4)2-Fluorocyclopropane-1-Carboxylic Acid (7)2-Hydroxycyclohexa-2,5-Diene-1,4-Dione (3)2-Iodonaphthalene (5)2-Methoxy-1,1'-Biphenyl (7)2-Methoxynaphthalene (22)2-Methoxytetrahydro-2H-Pyran (9)2-Methyl-1,1'-Biphenyl (26)2-Methylnaphthalene (13)2-Naphthaldehyde (12)2-Naphthoic Acid (14)2-Naphthonitrile (15)2-Nitronaphthalene (4)2-Phenoxytetrahydro-2H-Pyran-4-Yl Acetate (6)2-Phenylnaphthalene (12)3,3'-Diphenyl-5,5',6,6',7,7',8,8'-Octahydro-1,1'-Binaphthalene (13)3,3-Diphenyl-3H-Benzo[C][1,2]Oxathiole 1,1-Dioxide (19)3-Bromo-1,1'-Biphenyl (12)3-Chloro-1,1'-Biphenyl (12)3-Fluoro-1,1'-Biphenyl (16)3-Methyl-1,1'-Biphenyl (10)3-Methyl-1,1':4',1''-Terphenyl (3)3-Phenethylphenol (5)3-Phenyl-1,2,4,5-Tetrazine (9)3-Styrylphenol (11)4-(Bromomethyl)-1,1'-Biphenyl (13)4-(Phenyldiazenyl)Benzoic Acid (4)4-(Phenylsulfonyl)Morpholine (14)4-(Tert-Butyl)-1,1'-Biphenyl (5)4-Cyclohexylphenol (7)4-Iodo-1,1'-Biphenyl (9)4-Methoxy-1,1'-Biphenyl (4)9H-Xanthene (7)[1,1'-Biphenyl]-2-Amine (8)[1,1'-Biphenyl]-2-Carbonitrile (12)[1,1'-Biphenyl]-2-Carboxylic Acid (24)[1,1'-Biphenyl]-2-Ol (16)[1,1'-Biphenyl]-3-Amine (11)[1,1'-Biphenyl]-3-Carbaldehyde (20)[1,1'-Biphenyl]-3-Carboxylic Acid (40)[1,1'-Biphenyl]-3-Ol (9)[1,1'-Biphenyl]-4-Carbaldehyde (31)[1,1'-Biphenyl]-4-Carbonitrile (27)[1,1'-Biphenyl]-4-Ol (29)[1,1'-Biphenyl]-4-Ylboronic Acid (29)Benzyltriphenylphosphonium (14)Cyclopentylbenzene (28)Cyclopropanecarboxylic Acid (11)Cyclopropyl(Phenyl)Methanamine (22)Cyclopropyl(Phenyl)Methanone (13)Diphenyl Phosphonate (11)Diphenylphosphane (25)Diphenylphosphine Oxide (27)Ethane-1,1-Diyldibenzene (3)Ethene-1,1,2-Triyltribenzene (13)Ethyl Cyclopropanecarboxylate (8)Methyl 1-Naphthoate (7)Methyl 2-Naphthoate (11)Methyl [1,1'-Biphenyl]-4-Carboxylate (8)Methyl Cyclopropanecarboxylate (8)N,1-Diphenylmethanimine (15)N,N-Dimethylnaphthalen-1-Amine (4)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-2-Phenylacetamide (5)N-Benzylbenzamide (21)N-Benzylbenzenesulfonamide (18)N-Cyclopropylbenzamide (14)N-Cyclopropylbenzenesulfonamide (10)N-Phenethylbenzamide (9)N-Phenyl-2-Naphthamide (11)Naphthalen-1-Ol (28)Naphthalen-1-Ylboronic Acid (4)Naphthalen-1-Ylmethanol (8)Naphthalen-2-Amine (12)Naphthalen-2-Ol (25)Naphthalen-2-Ylboronic Acid (8)Naphthalene-1,4-Diol (3)Naphthalene-2-Sulfonic Acid (4)Propane-2,2-Diyldibenzene (17)Tert-Butyl Cyclopropylcarbamate (7)Tetrahydro-2H-Pyran-2-Ol (12)Tetrahydro-2H-Pyran-2-Yl Acetate (12)Tetraphenylmethane (16)Triphenylene (12)Vinylcyclopropane (8)Acetylbenzonitrile (3)Aminobenzyl (7)Benzylamine (21)Benzylamino (47)Benzylhydroxylamine (25)Benzylidene (16)Benzylidene (16)Benzyloxy (1061)Benzylthio (16)Benzylthio (16)Cyanobenzyl (12)Dibenzyl (15)Dibenzylamino (7)Dichlorobenzylidene (8)Difluorobenzyl (17)Dimethoxybenzyl (20)Dimethoxybenzyl (20)Dimethylbenzonitrile (25)Dimethylbenzyl (6)Dimethylbenzyl (6)Dimethylbenzylamine (6)Ethoxybenzyl (8)Ethoxybenzyl (8)Fluorobenzyl (131)Fluorobenzylidene (2)Formylbenzonitrile (35)Iodobenzyl (9)Isopropylbenzonitrile (4)Methoxybenzyl (175)Methoxybenzylamine (7)Methoxybenzylidene (6)Methylbenzonitrile (104)Methylbenzyl (73)Methylbenzyl (73)Methylbenzylamine (8)Methylbenzylidene (1)Methylbenzylidene (1)Nitrobenzyl (33)Nitrobenzylidene (2)Phenoxybenzonitrile (5)Trifluorobenzyl (2)
Azides (42)
Azoes (113)
(E)-1-(Naphthalen-1-Yl)-2-Phenyldiazene (7)1,2-Diphenyldiazene (7)3-(Phenyldiazenyl)Benzoic Acid (7)
Benzene Compounds (18901)
(((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Fluorophenyl)Propanoic Acid (3)(10Ar)-1,2,3,4,4A,9,10,10A-Octahydrophenanthrene (3)(1E,1'E)-N,N'-(Ethane-1,2-Diyl)Bis(1-Phenylmethanimine) (5)(1R,4R)-4-Phenyl-1,1'-Bi(Cyclohexane) (24)(9H-Fluoren-9-Yl)Methyl Benzylcarbamate (22)(9H-Fluoren-9-Yl)Methyl Piperazine-1-Carboxylate (7)(Cyclopentylmethyl)Benzene (5)(R)-3-Benzylpyrrolidine (6)(R)-3-Phenylmorpholine (7)(R)-4-Benzyloxazolidin-2-One (5)(R)-N-(1,2-Diphenylethyl)Benzenesulfonamide (7)(S)-N-(1,2-Diphenylethyl)Benzenesulfonamide (7)1,1':2',1''-Terphenyl (4)1,1':3',1''-Terphenyl (28)1,1':4',1'':4'',1'''-Quaterphenyl (7)1,1,2,2-Tetra([1,1'-Biphenyl]-4-Yl)Ethene (10)1,1-Dimethyl-1,2,3,4-Tetrahydronaphthalene (10)1,2,3,4-Tetrahydronaphthalen-1-Amine (36)1,2,3,4-Tetrahydronaphthalen-1-Ol (5)1,2,3,4-Tetrahydronaphthalene-1-Carboxylic Acid (3)1,2,3,5,6,7-Hexahydro-S-Indacene (23)1,2,4-Trimethylbenzene (41)1,2-Dihydroacenaphthylene (6)1,2-Dinitrobenzene (6)1,3,5-Tris(Phenylethynyl)Benzene (6)1,3,6,8-Tetraphenylpyrene (10)1,3-Bis(Benzyloxy)Benzene (8)1,3-Dihydro-2H-Inden-2-One (6)1,3-Diphenoxypropane (6)1,3-Diphenyl-1H-Pyrazole (6)1,3-Diphenylpropane (6)1,3-Diphenylpropane-1,3-Dione (4)1,4-Bis(Phenylethynyl)Benzene (7)1,4-Diphenylbuta-1,3-Diyne (9)1-(2,3-Dihydro-1H-Inden-5-Yl)Ethan-1-Amine (3)1-(Anthracen-9-Yl)Ethan-1-Amine (3)1-Benzylazetidine (6)1-Bromopyrene (4)1-Cyclohexyl-4-(Phenylethynyl)Benzene (10)1-Cyclopropylnaphthalene (6)1-Phenyl-1H-Tetrazole (6)1-Phenylnaphthalene (12)1-Trityl-1H-Pyrazole (5)1H-Indene (18)1H-Indene-1,3(2H)-Dione (5)2,2 ', 3,3' - Tetrahydro-1,1 '- Spiro [Indene] (5)2,3,4,5-Tetrahydro-1H-Benzo[C]Azepine (7)2,3-Dihydro-1H-Inden-1-Amine (52)2,3-Dihydro-1H-Inden-1-Ol (13)2,3-Dihydro-1H-Inden-4-Amine (6)2,3-Dihydro-1H-Inden-4-Ol (6)2,3-Dihydro-1H-Indene-1-Carboxylic Acid (5)2,3-Dihydro-1H-Indene-4-Carbonitrile (4)2,4-Diphenyl-1,3,5-Triazine (6)2,5-Diphenyl-1,3,4-Oxadiazole (6)2,7-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-9H-Fluorene (7)2-(2-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (24)2-(2-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (21)2-(2-Methoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (29)2-(3-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (14)2-(3-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (19)2-(3-Methoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (30)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (17)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzaldehyde (20)2-(4-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (15)2-(4-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (16)2-Amino-2-(Anthracen-9-Yl)Ethan-1-Ol (4)2-Methyl-2,3-Dihydro-1H-Inden-1-One (9)2-Phenyl-1,3,5-Triazine (6)2-Phenyl-1,3-Dioxane (7)2-Phenyl-2H-1,2,3-Triazole (7)2-Phenylisoindoline-1,3-Dione (7)2H-Benzo[B][1,4]Thiazin-3(4H)-One (6)3,3-Dimethyl-2,3-Dihydro-1H-Inden-1-One (5)3,4-Dihydro-2H-Benzo[B][1,4]Dioxepine (7)3,5,6,7-Tetrahydro-S-Indacen-1(2H)-One (5)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(2-Bromophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(2-Chlorophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-(Trifluoromethyl)Phenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Fluorophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Methoxyphenyl)Propanoic Acid (4)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Nitrophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Bromophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Nitrophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(O-Tolyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(P-Tolyl)Propanoic Acid (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (25)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzaldehyde (19)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoic Acid (12)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (13)3-Methyl-2,3-Dihydro-1H-Inden-1-One (4)3-Phenyl-1H-Pyrrole (5)3-Phenylazetidine (3)3-Phenyloxazolidin-2-One (4)3-Phenylpiperidine (2)4',5'-Diphenyl-1,1':2',1''-Terphenyl (7)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (19)4,4,5,5-Tetramethyl-2-(3-Nitrophenyl)-1,3,2-Dioxaborolane (24)4,4,5,5-Tetramethyl-2-(M-Tolyl)-1,3,2-Dioxaborolane (21)4,4,5,5-Tetramethyl-2-(O-Tolyl)-1,3,2-Dioxaborolane (24)4,5-Diphenyloxazole (7)4,7-Diphenylbenzo[C][1,2,5]Thiadiazole (6)4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazole (7)4-(Phenylethynyl)-1,1'-Biphenyl (5)4-Bromo-2,3-Dihydro-1H-Inden-1-One (5)4-Bromo-2,3-Dihydro-1H-Indene (10)4-Chloro-2,3-Dihydro-1H-Inden-1-One (8)4-Chloro-2,3-Dihydro-1H-Indene (5)4-Cyclohexyl-1,1'-Biphenyl (18)4-Fluoro-2,3-Dihydro-1H-Inden-1-One (6)4-Fluoro-2,3-Dihydro-1H-Indene (14)4-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)4-Methyl-2,3-Dihydro-1H-Inden-1-One (8)4-Methyl-2,3-Dihydro-1H-Indene (3)4-Phenyl-1,1'-Bi(Cyclohexane) (8)4-Phenyl-4H-1,2,4-Triazole (6)5''-([1,1'-Biphenyl]-4-Yl)-1,1':4',1'':3'',1''':4''',1''''-Quinquephenyl (5)5',5''-Diphenyl-1,1':3',1'':3'',1'''-Quaterphenyl (8)5,5',6,6',7,7',8,8'-Octahydro-1,1'-Binaphthalene (6)5,6,7,8-Tetrahydronaphthalen-2-Ol (5)5-Bromo-1,2,3,4-Tetrahydronaphthalene (6)5-Bromo-2,3-Dihydro-1H-Indene (8)5-Fluoro-2,3-Dihydro-1H-Indene (3)5-Methoxy-1,2,3,4-Tetrahydronaphthalene (3)5-Methoxy-2,3-Dihydro-1H-Indene (2)5-Methyl-3,4-Dihydronaphthalen-1(2H)-One (6)5-Phenyl-1H-Imidazole (6)5-Phenylcyclohexane-1,3-Dione (6)6,7,8,9-Tetrahydro-5H-Benzo[7]Annulen-5-One (6)6-Bromo-1,2,3,4-Tetrahydronaphthalene (9)6-Bromo-2,3-Dihydro-1H-Inden-1-One (8)6-Bromo-3,4-Dihydronaphthalen-1(2H)-One (3)6-Chloro-1,2,3,4-Tetrahydronaphthalene (3)6-Chloro-2,3-Dihydro-1H-Inden-1-One (5)6-Fluoro-1,2,3,4-Tetrahydronaphthalene (6)6-Fluoro-2,3-Dihydro-1H-Inden-1-One (4)6-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)6-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (5)6-Methyl-1,2,3,4-Tetrahydronaphthalene (5)6-Methyl-2,3-Dihydro-1H-Inden-1-One (3)6-Methyl-3,4-Dihydronaphthalen-1(2H)-One (2)7-Bromo-2,3-Dihydro-1H-Inden-1-One (13)7-Chloro-2,3-Dihydro-1H-Inden-1-One (9)7-Fluoro-2,3-Dihydro-1H-Inden-1-One (8)7-Hydroxy-2,3-Dihydro-1H-Inden-1-One (6)7-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)7-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (6)7-Methyl-2,3-Dihydro-1H-Inden-1-One (7)9,10-Bis(Phenylethynyl)Anthracene (5)9,10-Diphenylanthracene (16)9-Methylanthracene (4)9-Phenylxanthylium (7)9H-Fluoren-9-One (17)[1,1'-Binaphthalen]-2-Amine (3)[1,1':4',1''-Terphenyl]-4,4''-Dicarbaldehyde (9)Benzenesulfinic Acid (6)Benzil (17)Benzo-18-Crown-6 (7)Benzo[Lmn][3,8]Phenanthroline-1,3,6,8(2H,7H)-Tetraone (10)Benzyl ((Benzyloxy)Carbonyl)Glycinate (8)Benzyl (4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Carbamate (5)Benzyl (S)-Pyrrolidin-3-Ylcarbamate (7)Benzyl 3-Phenylpropanoate (8)Benzyl Piperidin-4-Ylcarbamate (7)Bicyclo[4.2.0]Octa-1,3,5-Triene (13)Cumene (182)Dibenzyl Phosphonate (6)Diphenylmethanimine (9)Ethane-1,1,2-Triyltribenzene (4)Ethylbenzene (198)Mesitylene (71)Methyl 2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (14)Methyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (11)N,2-Diphenylacetamide (7)N,N,N-Trimethyl-1-Phenylmethanaminium (6)N,N-Diphenyl-[1,1'-Biphenyl]-4-Amine (8)N-Benzylcyclopropanamine (6)N-Phenylcinnamamide (16)N1,N1,N4,N4-Tetraphenylbenzene-1,4-Diamine (6)N4,N4,N4',N4'-Tetraphenyl-[1,1'-Biphenyl]-4,4'-Diamine (7)Phenanthrene (23)Phenanthrene-9,10-Dione (8)Phenethyldiphenylphosphane (6)Phenothiazin-5-Ium (6)Phenyl (1R,4R)-[1,1'-Bi(Cyclohexane)]-4-Carboxylate (6)Phenyl 4-Cyclohexylbenzoate (8)Tert-Butyl (2,3-Dihydro-1H-Inden-1-Yl)Carbamate (3)Tert-Butylbenzene (252)Triphenyl Phosphate (6)Acetamidophenoxy (1)Acetamidophenyl (5)Acetylbenzoate (7)Acetylphenyl (13)Acetylphenyl (13)Acetylphenylboronic (3)Aminobenzoyl (4)Aminobiphenyl (4)Aminonaphthalene (14)Aminophenoxy (19)Aminophenyl (239)Anisole (4)Anthracenes (143)Benzaldehyde (1603)Benzamidophenyl (1)Benzenedimethanol (4)Benzenethiol (8)Benzhydrylazetidine (10)Benzhydrylazetidine (10)Benzhydryloxy (4)Benzhydryloxy (4)Benziodoxol (2)Benzodioxole (5)Benzoquinone (6)Benzoquinone (6)Benzoylbenzoate (4)Benzoylphenyl (4)Binaphthalene (123)Binaphthalene (123)Biphenyl (1393)Boronophenyl (1)Boronophenyl (1)Bromobenzo (104)Bromobenzoyl (6)Bromodibenzo (9)Bromophenoxy (34)Bromophenyl (975)Butoxyphenyl (8)Butylaniline (7)Butylbenzene (16)Butyldiphenylsilyl (7)Butylphenol (20)Butylphenyl (32)Butylphenyl (32)Carbamoylphenoxy (12)Carbamoylphenyl (8)Carboxyphenyl (17)Carboxyphenyl (17)Chlorobenzenesulfonyl (23)Chlorobenzoyl (9)Chlorodibenzo (18)Chloronaphthalene (36)Chlorophenethyl (7)Chlorophenoxy (44)Chlorophenylacetate (4)Chlorophenylacetate Acid (9)Chlorophenylboronic (5)Cyclopropylaniline (6)Cyclopropylbenzoate (5)Cyclopropylnaphthalen (10)Cyclopropylnaphthalen (10)Cyclopropylphenyl (12)Cyclopropylphenyl (12)Diaminobenzene (7)Dibenzaldehyde (19)Dibenzene (7)Dibenzimidamide (5)Dibenzo (108)Dibenzo (108)Dibenzoate (9)Dibenzonitrile (11)Dibromobenzene (45)Dibromobenzo (14)Dibromodibenzo (8)Dibromonaphthalene (15)Dibromophenanthrene (3)Dibromophenoxy (2)Dibromophenylboronic (3)Dichlorobenzene (38)Dichlorobenzoyl (4)Dichlorophenoxy (16)Dichlorophenyl (338)Dichlorophenylboronic (5)Didehydrodibenz (2)Didehydrodibenz (2)Diethoxyphenyl (10)Diethylaniline (6)Diethylbenzamide (7)Diethylbenzene (6)Diethylbenzene (6)Difluorobenzene (57)Difluorobenzo (12)Difluorobenzoyl (9)Difluorophenoxy (9)Difluorophenyl (399)Difluorophenylboronic (11)Dihydroanthracene (1)Dihydroanthracene (1)Dihydrobenzo (189)Dihydrobenzo (189)Dihydrodibenzo (7)Dihydronaphthalene (104)Dihydronaphthalene (104)Diiodobenzene (12)Diisopropylaniline (5)Diisopropylbenzamide (8)Diisopropylphenyl (40)Diisopropylphenyl (40)Dimesityl (12)Dimesityl (12)Dimethoxyacetophenone (5)Dimethoxyaniline (20)Dimethoxybenzaldehyde (40)Dimethoxybenzamide (6)Dimethoxybenzene (47)Dimethoxybenzo (4)Dimethoxybenzo (4)Dimethoxybenzoate (20)Dimethoxybenzohydrazide (3)Dimethoxybenzonitrile (11)Dimethoxybenzoyl (4)Dimethoxybiphenyl (3)Dimethoxybiphenyl (3)Dimethoxynaphthalene (10)Dimethoxynaphthalene (10)Dimethoxyphenol (22)Dimethoxyphenyl (255)Dimethoxyphenylboronic (17)Dimethoxyphenylboronic (17)Dimethoxystyryl (4)Dimethylaminophenyl (4)Dimethylanthracene (4)Dimethylbenzaldehyde (27)Dimethylbenzamide (37)Dimethylbenzene (334)Dimethylbenzene (334)Dimethylbenzenesulfonamide (16)Dimethylbenzo (21)Dimethylbenzo (21)Dimethylbenzoate (27)Dimethylbenzoyl (3)Dimethylbenzoyl (3)Dimethylnaphthalene (6)Dimethylphenol (36)Dimethylphenoxy (13)Dimethylphenoxy (13)Dimethylphenylboronic (6)Dimethylphenylboronic (6)Dimethylphenylhydrazine (3)Dimethylphenylisothiocyanate (4)Dinaphtho (5)Dinitrobenzene (20)Diphenol (32)Diphenylamino (27)Diphenylaniline (9)Diphenylethane (19)Diphenylethanone (5)Diphenylethene (6)Diphenylethyl (7)Diphenylethyl (7)Diphenylmethyl (8)Diphenylmethyl (8)Diphenylmethylene (6)Diphenylphosphine (204)Diphenylphosphine (204)Diphenylpropane (18)Diphenylsilane (2)Diphenylurea (4)Diphenylurea (4)Ethoxyaniline (10)Ethoxybenzaldehyde (9)Ethoxybenzoate (12)Ethoxybenzonitrile (6)Ethoxyphenoxy (7)Ethoxyphenoxy (7)Ethoxyphenyl (45)Ethoxyphenyl (45)Ethoxyphenylboronic (7)Ethylaniline (8)Ethylaniline (8)Ethylbenzenesulfonamide (337)Ethylbenzo (7)Ethylbenzo (7)Ethylbenzoate (9)Ethylphenol (12)Ethylphenyl (39)Ethylphenyl (39)Ethynylaniline (7)Ethynylbenzaldehyde (17)Ethynylphenyl (35)Fluorobenzeneboronic (24)Fluoronaphthalene (34)Fluorophenoxy (46)Formylbenzoate (39)Formylphenoxy (4)Formylphenoxy (4)Formylphenyl (43)Formylphenyl (43)Formylphenylboronic (9)Formylphenylboronic (9)Hexahydrobenzo (3)Hexahydrobenzo (3)Hexylphenyl (3)Hexylphenyl (3)Homophenylalanine (18)Hydroxybenzenesulfonate (5)Hydroxybenzimidamide (11)Hydroxyisophthalaldehyde (6)Hydroxyphenethyl (2)Hydroxyphenethyl (2)Hydroxyphenyl (461)Hydroxyphenyl (461)Iodobenzo (15)Iodobenzoic (54)Iodobenzoyl (7)Iodobiphenyl (24)Iododibenzo (7)Iodonaphthalene (9)Iodophenoxy (6)Isobutoxyphenyl (15)Isobutoxyphenyl (15)Isobutylbenzene (5)Isobutylbenzene (5)Isobutylphenyl (9)Isophthalate (8)Isophthalonitrile (4)Isopropoxyaniline (10)Isopropoxyaniline (10)Isopropoxybenzaldehyde (7)Isopropoxybenzoate (7)Isopropoxyphenyl (41)Isopropoxyphenyl (41)Isopropylaniline (18)Isopropylbenzaldehyde (6)Isopropylbenzamide (9)Isopropylbenzenesulfonamide (19)Isopropylbenzoate (8)Isopropylphenyl (58)Mercaptobenzo (21)Methanobenzo (15)Methanobenzo (15)Methoxyacetophenone (12)Methoxyaniline (74)Methoxybenzaldehyde (104)Methoxybenzene (1731)Methoxybenzene (1731)Methoxybenzenesulfonamide (6)Methoxybenzenesulfonic (3)Methoxybenzenesulfonyl (13)Methoxybenzenesulfonyl (13)Methoxybenzimidamide (5)Methoxybenzo (52)Methoxybenzo (52)Methoxybenzoate (116)Methoxybenzonitrile (67)Methoxybenzoyl (12)Methoxybenzoyl (12)Methoxycarbonylphenylboronic (5)Methoxynaphthalene (54)Methoxynaphthalene (54)Methoxyphenethyl (1)Methoxyphenethyl (1)Methoxyphenol (72)Methoxyphenoxy (41)Methoxyphenoxy (41)Methoxyphenylacetate (4)Methoxyphenylboronic (24)Methoxyphenylboronic (24)Methoxyphenylhydrazine (4)Methoxystyryl (13)Methylacetophenone (6)Methylaniline (183)Methylanisole (3)Methylanthracene (5)Methylbenzaldehyde (101)Methylbenzamide (90)Methylbenzamido (3)Methylbenzenesulfinamide (4)Methylbenzenesulfonamide (81)Methylbenzenesulfonic (9)Methylbenzenesulfonyl (4)Methylbenzenesulfonyl (4)Methylbenzimidamide (6)Methylbenzoate (193)Methylbenzohydrazide (7)Methylbenzothioamide (6)Methylbenzothioamide (6)Methylbenzotrifluoride (5)Methylbenzoyl (24)Methylbenzoyl (24)Methylnaphthalene (34)Methylnaphthalene (34)Methylphenol (107)Methylphenoxy (18)Methylphenoxy (18)Methylphenyl (527)Methylphenylacetonitrile (45)Methylphenylboronic (24)Methylphenylhydrazine (10)Methylpropiophenone (5)Methylpropiophenone (5)Naphthaldehyde (28)Naphthalene (459)Naphthalene (459)Naphthaleneboronic (15)Naphthalenesulfonic (7)Naphthamide (15)Naphthonitrile (18)Nitrobenzenesulfonyl (8)Nitrobenzo (54)Nitrobenzoyl (13)Nitronaphthalene (24)Nitrophenoxy (43)Nitrophenyl (723)Nitrophenylboronic (14)Nitrotoluene (27)Octylbenzene (11)Octylbenzene (11)Paracyclophane (2)Paracyclophane (2)Pentafluorobenzene (13)Pentylbenzene (5)Pentylbenzene (5)Pentylbenzoate (2)Pentylphenol (4)Pentylphenyl (5)Pentylphenyl (5)Perfluorophenoxy (5)Perfluorophenyl (31)Phenoxyacetate (5)Phenoxyaniline (8)Phenoxybenzaldehyde (5)Phenoxybenzoate (5)Phenoxyethyl (6)Phenoxyethyl (6)Phenoxymethyl (7)Phenoxymethyl (7)Phenoxyphenyl (61)Phenoxyphenyl (61)Phenoxypropan (4)Phenylacetamide (34)Phenylacetonitrile (8)Phenylacetyl (2)Phenylacetyl (2)Phenylacrylamide (3)Phenylalaninol (4)Phenylamino (31)Phenylaniline (19)Phenylanthracene (16)Phenylbenzamide (23)Phenylbenzenesulfonamide (3)Phenylbutanoate (12)Phenylbutoxy (2)Phenylbutoxy (2)Phenylcarbamoyl (5)Phenylcyclohexanone (6)Phenylcyclopropanecarboxylic (6)Phenylcyclopropyl (7)Phenylcyclopropyl (7)Phenyldiazenyl (4)Phenylene (169)Phenylene (169)Phenylenediamine (13)Phenylenedimethanamine (5)Phenylethanamine (12)Phenylethane (14)Phenylethane (14)Phenylethanol (9)Phenylethanone (20)Phenylethoxy (2)Phenylethyl (69)Phenylethyl (69)Phenylethylisocyanate (2)Phenylhex (3)Phenylimino (1)Phenylisocyanate (9)Phenylisoserine (4)Phenylmethanesulfonyl (2)Phenylmethanesulfonyl (2)Phenylmethanone (2)Phenylmethoxy (4)Phenylmethoxy (4)Phenylmethyl (8)Phenylmethyl (8)Phenylnaphthalene (6)Phenylpentan (11)Phenylpentan (11)Phenylpropanamide (15)Phenylpropyl (20)Phenylpyrazolo (8)Phenylsulfinyl (3)Phenylsulfinyl (3)Phenylsulfonyl (88)Phenylsulfonyl (88)Phenylthio (24)Phenylthio (24)Phenylthiophene (23)Phenylthiophene (23)Phenylthiourea (6)Phenylurea (3)Phenylurea (3)Phenylvinyl (9)Phthalate (23)Phthalimide (12)Phthalonitrile (9)Propoxybenzaldehyde (4)Propoxyphenyl (29)Propoxyphenyl (29)Propoxyphenylboronic (79)Propylphenyl (26)Propylphenyl (26)Pyrenes (52)Quaternaphthalene (6)Quaterphenyl (15)Quaterphenyl (15)Styryl (12)Sulfamoylphenyl (3)Sulfophenyl (4)Sulfophenyl (4)Terephthalaldehyde (11)Terephthalate (13)Terphenyl (239)Terphenyl (239)Tetraaniline (6)Tetrabenzaldehyde (7)Tetrafluorobenzene (17)Tetrahydrobenzo (70)Tetrahydrobenzo (70)Tetrahydronaphthalene (149)Tetrahydronaphthalene (149)Tetralone (12)Tetramethylbenzene (9)Tetramethylbenzene (9)Tetramethylbiphenyl (57)Tetramethylbiphenyl (57)Tetraphenyl (11)Tetraphenyl (11)Toluenesulfonyl (68)Tolyl (412)Tolyl (412)Tolylamino (3)Tolylazanediyl (4)Tolylazanediyl (4)Tolylethynyl (3)Tolyloxy (19)Tolyloxy (19)Tolylphosphine (8)Tolylphosphine (8)Tolylthio (3)Tolylthio (3)Trianiline (7)Tribenzaldehyde (5)Tribromobenzene (7)Trichlorobenzene (20)Trichlorophenoxy (3)Trichlorophenylboronic (6)Triethylbenzene (5)Trifluorophenyl (56)Trifluorophenylboronic (154)Triiodobenzene (5)Triisopropylbenzene (9)Triisopropylphenyl (6)Triisopropylphenyl (6)Trimethoxybenzene (43)Trimethoxystyryl (5)Trimethylaniline (18)Trimethylbenzene (28)Trimethylphenol (6)Trimethylphenyl (20)Trimethylphenyl (20)Trimethylpropiophenone (4)Triphenylphosphoranylidene (9)Triphenylphosphoranylidene (9)Triphenylvinyl (11)Trityl (19)Trityl (19)Tritylamino (2)Trityloxy (2)Tritylthio (3)Tritylthio (3)
Benzyl Bromides (1066)
1-(Bromomethyl)-2-(Trifluoromethyl)Benzene (13)1-(Bromomethyl)-2-Chlorobenzene (28)1-(Bromomethyl)-2-Fluorobenzene (50)1-(Bromomethyl)-3-(Trifluoromethyl)Benzene (17)1-(Bromomethyl)-3-Chlorobenzene (27)1-(Bromomethyl)-3-Fluorobenzene (47)1-(Bromomethyl)-3-Methoxybenzene (19)1-Bromo-2-(Bromomethyl)Benzene (34)2-(2-(Bromomethyl)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (9)2-(Bromomethyl)-1,3-Difluorobenzene (12)2-(Bromomethyl)Benzonitrile (15)Methyl 2-(Bromomethyl)Benzoate (33)
Benzyl Chlorides (646)
1-(Chloromethyl)-2-Fluorobenzene (8)1-(Chloromethyl)-3-Fluorobenzene (11)Dichlorobenzyl (39)
Bromides (52779)
(1-Bromoethyl)Benzene (11)(2,2-Dibromovinyl)Benzene (6)(2-(4-Bromophenyl)Ethene-1,1,2-Triyl)Tribenzene (11)(2-Bromo-6-Fluorophenyl)Methanol (4)(2-Bromoethyl)Benzene (33)(2-Bromophenyl)(Phenyl)Methanone (3)(2-Bromophenyl)Boronic Acid (39)(2-Bromophenyl)Hydrazine (8)(2-Bromophenyl)Methanamine (12)(2-Bromophenyl)Methanol (39)(3-Bromo-2-Fluorophenyl)Boronic Acid (7)(3-Bromo-2-Methoxyphenyl)Boronic Acid (6)(3-Bromophenyl)Boronic Acid (65)(3-Bromopropyl)Benzene (10)(3-Bromopyridin-2-Yl)Methanol (7)(4-Bromophenyl)(Phenyl)Methanone (9)(5-Bromopyridin-2-Yl)Methanamine (5)(5-Bromopyridin-2-Yl)Methanol (5)(Bromoethynyl)Benzene (5)(Dibromomethyl)Benzene (6)1,2,3-Tribromobenzene (5)1,2,4-Tribromobenzene (13)1,2-Dibromo-3-Chlorobenzene (3)1,2-Dibromo-3-Fluorobenzene (9)1,2-Dibromo-3-Methylbenzene (9)1,2-Dibromo-4-Fluorobenzene (11)1,2-Dibromobenzene (64)1,3-Dibromo-2,4-Difluorobenzene (5)1,3-Dibromo-2,4-Dimethylbenzene (3)1,3-Dibromo-2-Chlorobenzene (8)1,3-Dibromo-2-Fluorobenzene (15)1,3-Dibromo-2-Iodobenzene (4)1,3-Dibromo-2-Methoxybenzene (11)1,3-Dibromo-2-Methylbenzene (14)1,3-Dibromo-2-Nitrobenzene (4)1,4-Dibromo-2-Iodobenzene (3)1-(2-Bromophenyl)Ethan-1-Amine (10)1-(2-Bromophenyl)Ethan-1-One (27)1-(5-Bromopyridin-2-Yl)Piperazine (6)1-(Azetidin-1-Yl)-2-Bromoethan-1-One (3)1-(Benzyloxy)-2-Bromobenzene (12)1-(Benzyloxy)-3-Bromobenzene (12)1-(Benzyloxy)-4-Bromobenzene (8)1-(Bromomethyl)-2-Iodobenzene (9)1-(Bromomethyl)-2-Methoxybenzene (14)1-(Bromomethyl)-2-Methylbenzene (14)1-(Bromomethyl)-2-Nitrobenzene (23)1-(Bromomethyl)-3-Methylbenzene (11)1-Benzyl-3-Bromobenzene (7)1-Benzyl-4-Bromo-1H-Pyrazole (5)1-Bromo-2,3-Dichlorobenzene (18)1-Bromo-2,3-Difluorobenzene (67)1-Bromo-2,3-Dimethoxybenzene (8)1-Bromo-2,3-Dimethylbenzene (23)1-Bromo-2,4-Difluorobenzene (59)1-Bromo-2-(Bromomethyl)Benzene (34)1-Bromo-2-(Difluoromethyl)Benzene (5)1-Bromo-2-(Methylsulfonyl)Benzene (4)1-Bromo-2-(Tert-Butyl)Benzene (7)1-Bromo-2-(Trifluoromethoxy)Benzene (22)1-Bromo-2-Chloro-3-Fluorobenzene (20)1-Bromo-2-Chloro-3-Methoxybenzene (6)1-Bromo-2-Chloro-3-Methylbenzene (9)1-Bromo-2-Chloro-4-Nitrobenzene (5)1-Bromo-2-Cyclopropylbenzene (3)1-Bromo-2-Ethoxybenzene (16)1-Bromo-2-Ethylbenzene (13)1-Bromo-2-Fluoro-3-(Trifluoromethyl)Benzene (4)1-Bromo-2-Fluoro-3-Methoxybenzene (7)1-Bromo-2-Fluoro-3-Methylbenzene (11)1-Bromo-2-Fluoro-3-Nitrobenzene (11)1-Bromo-2-Fluoro-4-Nitrobenzene (13)1-Bromo-2-Iodobenzene (65)1-Bromo-2-Isopropylbenzene (10)1-Bromo-2-Phenoxybenzene (3)1-Bromo-3-(Trifluoromethyl)Benzene (100)1-Bromo-3-Chloro-2-Fluorobenzene (9)1-Bromo-3-Chloro-2-Methylbenzene (6)1-Bromo-3-Cyclopropylbenzene (6)1-Bromo-3-Fluoro-2-Iodobenzene (4)1-Bromo-3-Fluoro-2-Methoxybenzene (12)1-Bromo-3-Fluoro-2-Methylbenzene (17)1-Bromo-3-Fluoro-2-Nitrobenzene (10)1-Bromo-3-Iodobenzene (70)1-Bromo-3-Methoxybenzene (187)1-Bromo-3-Methyl-2-Nitrobenzene (3)1-Bromo-3-Nitrobenzene (235)1-Bromo-3-Phenoxybenzene (8)1-Bromo-4-(Phenylsulfonyl)Benzene (7)1-Bromo-4-Chloro-2-Fluorobenzene (22)1-Bromo-4-Fluoro-2-Methoxybenzene (11)1-Bromo-4-Fluoro-2-Methylbenzene (18)1-Bromo-4-Iodobenzene (67)1-Bromo-4-Phenoxybenzene (8)1-Bromo-4-Styrylbenzene (5)1-Bromobicyclo[1.1.1]Pentane (3)1-Bromoisoquinoline (20)1-Bromonaphthalene (4)2,3-Dibromopyridine (21)2,4-Dibromo-1-Chlorobenzene (8)2,4-Dibromo-1-Fluorobenzene (18)2,4-Dibromo-1-Methoxybenzene (6)2,4-Dibromoaniline (18)2,4-Dibromophenol (16)2,4-Dibromopyridine (5)2,4-Dibromothiazole (5)2,5-Dibromopyrazine (4)2,5-Dibromopyridine (26)2,5-Dibromothiazole (5)2,5-Dibromothiophene (18)2,6-Dibromo-3-Fluoropyridine (3)2,6-Dibromoaniline (17)2,6-Dibromobenzaldehyde (4)2,6-Dibromobenzonitrile (4)2,6-Dibromophenol (22)2,6-Dibromopyrazine (9)2,6-Dibromopyridin-4-Amine (3)2,6-Dibromopyridine (28)2-(2-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(2-Bromophenyl)Acetic Acid (23)2-(2-Bromophenyl)Acetonitrile (10)2-(4-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(Bromomethyl)Furan (3)2-(Bromomethyl)Pyridine (27)2-Amino-3-Bromobenzoic Acid (8)2-Amino-3-Bromobenzonitrile (7)2-Amino-3-Bromophenol (3)2-Amino-6-Bromophenol (3)2-Bromo-1,1'-Biphenyl (12)2-Bromo-1,3,4-Thiadiazole (11)2-Bromo-1,3,4-Trifluorobenzene (16)2-Bromo-1,3,4-Trimethylbenzene (4)2-Bromo-1,3-Dichlorobenzene (12)2-Bromo-1,3-Difluorobenzene (43)2-Bromo-1,3-Dimethoxybenzene (7)2-Bromo-1,3-Dimethylbenzene (35)2-Bromo-1,4-Dichlorobenzene (12)2-Bromo-1,4-Difluorobenzene (64)2-Bromo-1,4-Dimethoxybenzene (11)2-Bromo-1,4-Dimethylbenzene (22)2-Bromo-1-Chloro-3-Fluorobenzene (9)2-Bromo-1-Chloro-4-Fluorobenzene (20)2-Bromo-1-Chloro-4-Methylbenzene (6)2-Bromo-1-Chloro-4-Nitrobenzene (9)2-Bromo-1-Fluoro-3-Nitrobenzene (9)2-Bromo-1-Fluoro-4-(Trifluoromethyl)Benzene (4)2-Bromo-1-Fluoro-4-Methoxybenzene (12)2-Bromo-1-Fluoro-4-Methylbenzene (17)2-Bromo-1-Fluoro-4-Nitrobenzene (23)2-Bromo-1-Methoxy-3-Methylbenzene (3)2-Bromo-1-Methoxy-4-Methylbenzene (7)2-Bromo-1-Methyl-4-Nitrobenzene (12)2-Bromo-1H-Benzo[D]Imidazole (4)2-Bromo-1H-Imidazole (13)2-Bromo-1H-Pyrrole (11)2-Bromo-3-(Trifluoromethyl)Pyridine (4)2-Bromo-3-Chloroaniline (4)2-Bromo-3-Chloropyridine (25)2-Bromo-3-Fluoroaniline (13)2-Bromo-3-Fluoropyridine (26)2-Bromo-3-Hydroxybenzaldehyde (4)2-Bromo-3-Methoxybenzaldehyde (4)2-Bromo-3-Methoxypyridine (7)2-Bromo-3-Methylaniline (6)2-Bromo-3-Methylphenol (4)2-Bromo-3-Methylpyrazine (5)2-Bromo-3-Methylpyridine (25)2-Bromo-3-Nitrobenzoic Acid (4)2-Bromo-3-Nitropyridine (5)2-Bromo-4-(Trifluoromethyl)Aniline (9)2-Bromo-4-Chloro-1-Fluorobenzene (16)2-Bromo-4-Chloro-1-Methoxybenzene (7)2-Bromo-4-Chloro-1-Methylbenzene (11)2-Bromo-4-Chloro-1-Nitrobenzene (5)2-Bromo-4-Chloroaniline (15)2-Bromo-4-Chlorophenol (11)2-Bromo-4-Chloropyridine (7)2-Bromo-4-Fluoro-1-Methoxybenzene (12)2-Bromo-4-Fluoro-1-Methylbenzene (21)2-Bromo-4-Fluoro-1-Nitrobenzene (23)2-Bromo-4-Fluoroaniline (28)2-Bromo-4-Fluorobenzaldehyde (7)2-Bromo-4-Fluorobenzoic Acid (8)2-Bromo-4-Fluorobenzonitrile (7)2-Bromo-4-Fluorophenol (10)2-Bromo-4-Methoxy-1-Nitrobenzene (6)2-Bromo-4-Methoxyaniline (6)2-Bromo-4-Methoxybenzaldehyde (8)2-Bromo-4-Methoxybenzoic Acid (4)2-Bromo-4-Methylaniline (14)2-Bromo-4-Methylbenzoic Acid (5)2-Bromo-4-Methylpyridine (6)2-Bromo-4-Methylthiazole (7)2-Bromo-4-Nitroaniline (12)2-Bromo-5-(Trifluoromethyl)Pyridine (6)2-Bromo-5-Chloropyrazine (6)2-Bromo-5-Chloropyridine (22)2-Bromo-5-Fluoroaniline (18)2-Bromo-5-Fluorobenzaldehyde (7)2-Bromo-5-Fluorobenzoic Acid (11)2-Bromo-5-Fluoropyridine (33)2-Bromo-5-Methoxybenzaldehyde (6)2-Bromo-5-Methoxypyridine (11)2-Bromo-5-Methylpyridine (19)2-Bromo-5-Methylthiazole (7)2-Bromo-5-Nitropyridine (11)2-Bromo-6-(Trifluoromethyl)Aniline (5)2-Bromo-6-(Trifluoromethyl)Pyridine (6)2-Bromo-6-Chloroaniline (10)2-Bromo-6-Chlorophenol (5)2-Bromo-6-Chloropyrazine (5)2-Bromo-6-Chloropyridine (23)2-Bromo-6-Fluoroaniline (14)2-Bromo-6-Fluorobenzaldehyde (15)2-Bromo-6-Fluorobenzoic Acid (11)2-Bromo-6-Fluorobenzonitrile (7)2-Bromo-6-Fluorophenol (9)2-Bromo-6-Fluoropyridine (21)2-Bromo-6-Iodoaniline (4)2-Bromo-6-Methoxyaniline (5)2-Bromo-6-Methoxyphenol (5)2-Bromo-6-Methoxypyridine (15)2-Bromo-6-Methylaniline (11)2-Bromo-6-Methylbenzoic Acid (5)2-Bromo-6-Methylphenol (7)2-Bromo-6-Methylpyrazine (5)2-Bromo-6-Methylpyridine (17)2-Bromo-6-Nitroaniline (14)2-Bromo-6-Nitrophenol (9)2-Bromo-6-Phenylpyridine (4)2-Bromo-9,9-Diphenyl-9H-Fluorene (5)2-Bromo-9H-Fluorene (15)2-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)2-Bromo-N,N-Dimethylaniline (5)2-Bromo-N-Methylaniline (8)2-Bromo-N-Phenylacetamide (5)2-Bromobenzene-1,3-Diol (7)2-Bromobenzene-1,4-Diol (4)2-Bromobenzenesulfonyl Chloride (8)2-Bromobenzo[D]Thiazole (28)2-Bromodibenzo[B,D]Furan (6)2-Bromofuran (21)2-Bromoimidazo[1,2-A]Pyridine (5)2-Bromonaphthalene (4)2-Bromonicotinic Acid (5)2-Bromooxazole (7)2-Bromopyrazine (15)2-Bromopyridin-3-Amine (10)2-Bromopyridin-3-Ol (7)2-Bromopyridine (10)2-Bromopyridine 1-Oxide (6)2-Bromopyrimidine (22)2-Bromoquinazoline (4)3,4-Dibromoaniline (4)3,4-Dibromophenol (3)3,5-Dibromopyridine (12)3-(Bromomethyl)Pyridine (18)3-Bromo-1,1'-Biphenyl (12)3-Bromo-1,5-Naphthyridine (8)3-Bromo-1-Methyl-1H-Pyrazole (16)3-Bromo-1H-Pyrrole (16)3-Bromo-1H-Pyrrolo[2,3-B]Pyridine (7)3-Bromo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Bromo-2-Chlorobenzaldehyde (4)3-Bromo-2-Chlorobenzoic Acid (7)3-Bromo-2-Chloropyridin-4-Amine (3)3-Bromo-2-Chloropyridine (20)3-Bromo-2-Fluoroaniline (15)3-Bromo-2-Fluorobenzaldehyde (9)3-Bromo-2-Fluorobenzoic Acid (10)3-Bromo-2-Fluorobenzonitrile (10)3-Bromo-2-Fluorophenol (5)3-Bromo-2-Fluoropyridine (21)3-Bromo-2-Hydroxybenzaldehyde (10)3-Bromo-2-Hydroxybenzoic Acid (4)3-Bromo-2-Hydroxybenzonitrile (3)3-Bromo-2-Methoxypyridine (20)3-Bromo-2-Methylpyridine (27)3-Bromo-4-Chloroaniline (13)3-Bromo-4-Chlorobenzoic Acid (6)3-Bromo-4-Chlorophenol (5)3-Bromo-4-Fluoroaniline (22)3-Bromo-4-Fluorobenzaldehyde (7)3-Bromo-4-Fluorobenzamide (3)3-Bromo-4-Fluorobenzoic Acid (10)3-Bromo-4-Fluorophenol (11)3-Bromo-4-Hydroxybenzaldehyde (9)3-Bromo-4-Hydroxybenzoic Acid (3)3-Bromo-4-Methoxyaniline (7)3-Bromo-4-Methoxybenzaldehyde (9)3-Bromo-4-Methoxybenzoic Acid (7)3-Bromo-4-Methylaniline (14)3-Bromo-4-Methylbenzoic Acid (9)3-Bromo-4-Methylpyridine (13)3-Bromo-5'-Phenyl-1,1':3',1''-Terphenyl (4)3-Bromo-5-Chloropyridine (14)3-Bromo-5-Fluoropyridine (18)3-Bromo-5-Methylpyridine (14)3-Bromo-5-Nitropyridine (10)3-Bromoaniline (187)3-Bromoazetidine (3)3-Bromobenzene-1,2-Diamine (11)3-Bromobenzene-1,2-Diol (8)3-Bromobenzo[B]Thiophene (5)3-Bromobenzoic Acid (159)3-Bromobenzonitrile (110)3-Bromofuran (13)3-Bromoimidazo[1,2-A]Pyridine (26)3-Bromoimidazo[1,2-A]Pyrimidine (6)3-Bromoisoquinoline (10)3-Bromoisoxazole (7)3-Bromopicolinic Acid (9)3-Bromopicolinonitrile (13)3-Bromopyrazolo[1,5-A]Pyrimidine (11)3-Bromopyridazine (25)3-Bromopyridin-2-Amine (30)3-Bromopyridin-2-Ol (17)3-Bromopyridine 1-Oxide (8)3-Bromopyrrolidine (6)3-Bromothiophene (6)4-(Bromomethyl)-1,1'-Biphenyl (13)4-(Bromomethyl)Pyridine (8)4-Bromo-1,5-Naphthyridine (5)4-Bromo-1-Methyl-1H-Pyrazole (14)4-Bromo-1-Phenyl-1H-Imidazole (9)4-Bromo-1-Phenyl-1H-Pyrazole (11)4-Bromo-1H-Benzo[D]Imidazole (14)4-Bromo-1H-Indole (25)4-Bromo-1H-Pyrazolo[3,4-B]Pyridine (4)4-Bromo-1H-Pyrrolo[2,3-B]Pyridine (9)4-Bromo-2-Chloro-1-Iodobenzene (4)4-Bromo-2-Chloropyridine (29)4-Bromo-2-Fluoro-1-Iodobenzene (8)4-Bromo-2-Fluoropyridine (4)4-Bromo-2-Iodoaniline (8)4-Bromo-2-Methoxypyridine (4)4-Bromo-3-(Trifluoromethyl)Aniline (7)4-Bromo-3-Chloroaniline (21)4-Bromo-3-Fluoroaniline (29)4-Bromo-3-Methylaniline (19)4-Bromo-3-Methylpyridine (5)4-Bromo-3-Nitroaniline (8)4-Bromo-N,N-Diphenylaniline (10)4-Bromo-N-Phenylaniline (6)4-Bromo-N-Phenylbenzenesulfonamide (23)4-Bromobenzo[C][1,2,5]Thiadiazole (14)4-Bromobenzo[D][1,3]Dioxole (6)4-Bromobenzo[D]Thiazole (9)4-Bromobenzofuran (3)4-Bromoindoline (4)4-Bromoisoindolin-1-One (3)4-Bromoisoquinolin-1(2H)-One (3)4-Bromoisoquinoline (33)4-Bromopyridazine (5)4-Bromopyridine (31)4-Bromopyrimidine (24)4-Bromothiazole (10)5-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)5-Bromo-1-Methyl-1H-Indole (3)5-Bromo-1H-1,2,4-Triazole (6)5-Bromo-1H-Benzo[D][1,2,3]Triazole (5)5-Bromo-1H-Benzo[D]Imidazole (13)5-Bromo-1H-Indazole (14)5-Bromo-1H-Pyrazole (11)5-Bromo-1H-Pyrazolo[3,4-B]Pyridine (11)5-Bromo-1H-Pyrazolo[3,4-C]Pyridine (5)5-Bromo-1H-Pyrrolo[2,3-B]Pyridine (13)5-Bromo-2,3-Dihydro-1H-Indene (8)5-Bromo-2,3-Dihydrobenzofuran (6)5-Bromo-2-Chloro-4-Methylpyridine (5)5-Bromo-2-Chloropyridine (40)5-Bromo-2-Chloropyrimidine (6)5-Bromo-2-Fluoropyridine (22)5-Bromo-2-Methoxypyridine (29)5-Bromo-2-Methylpyridine (23)5-Bromo-2-Methylpyrimidine (5)5-Bromo-2-Phenylpyridine (3)5-Bromo-4-Methylpyridin-2-Amine (5)5-Bromo-6-Chloropyridin-2-Amine (3)5-Bromo-7H-Pyrrolo[2,3-D]Pyrimidine (3)5-Bromobenzo[B]Thiophene (3)5-Bromobenzo[D][1,3]Dioxole (12)5-Bromobenzo[D]Oxazole (3)5-Bromoimidazo[1,2-A]Pyridine (6)5-Bromoindoline (8)5-Bromoisoindolin-1-One (8)5-Bromoisoquinoline (17)5-Bromonicotinaldehyde (12)5-Bromonicotinic Acid (6)5-Bromonicotinonitrile (6)5-Bromopicolinic Acid (11)5-Bromopicolinonitrile (13)5-Bromopyrazin-2-Ol (5)5-Bromopyridin-2-Amine (35)5-Bromopyridin-2-Ol (18)5-Bromopyridin-3-Amine (10)5-Bromopyridin-3-Ol (6)5-Bromoquinoxaline (6)5-Bromothiazole (8)6-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)6-Bromo-1,2,3,4-Tetrahydroquinoline (6)6-Bromo-1-Methyl-1H-Indole (3)6-Bromo-1H-Indazole (23)6-Bromo-1H-Indole (15)6-Bromo-1H-Pyrazolo[4,3-B]Pyridine (4)6-Bromo-1H-Pyrrolo[2,3-B]Pyridine (6)6-Bromo-1H-Pyrrolo[3,2-B]Pyridine (7)6-Bromo-1H-Pyrrolo[3,2-C]Pyridine (5)6-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)6-Bromo-3,4-Dihydroquinolin-2(1H)-One (4)6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (12)6-Bromo-[1,2,4]Triazolo[4,3-A]Pyridine (8)6-Bromobenzo[B]Thiophene (4)6-Bromobenzo[D]Oxazole (3)6-Bromobenzo[D]Thiazole (7)6-Bromochroman-4-One (6)6-Bromoimidazo[1,2-A]Pyrimidine (5)6-Bromoindoline-2,3-Dione (4)6-Bromoisoindolin-1-One (4)6-Bromoisoquinoline (9)6-Bromonicotinaldehyde (10)6-Bromonicotinic Acid (9)6-Bromonicotinonitrile (7)6-Bromopicolinic Acid (5)6-Bromopyrazolo[1,5-A]Pyrimidine (7)6-Bromopyridin-2-Amine (8)6-Bromopyridin-3-Amine (12)6-Bromopyridin-3-Ol (13)6-Bromoquinazoline (7)6-Bromoquinoxaline (9)7-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)7-Bromo-1H-Indazole (18)7-Bromo-1H-Indole (28)7-Bromo-1H-Pyrrolo[2,3-C]Pyridine (4)7-Bromo-2,3-Dihydrobenzofuran (6)7-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (7)7-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)7-Bromo-3,4-Dihydronaphthalen-1(2H)-One (8)7-Bromobenzo[B]Thiophene (5)7-Bromobenzo[D]Thiazole (8)7-Bromobenzofuran (6)7-Bromochromane (7)7-Bromoindoline (3)7-Bromoisoquinoline (6)8-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)8-Bromochromane (6)8-Bromoimidazo[1,2-A]Pyridine (15)8-Bromoisoquinoline (17)8-Bromoquinazoline (8)9-Bromoanthracene (5)Bromocyclohexane (7)Ethyl 2-Bromo-2-Phenylacetate (6)Methyl 2-(2-Bromophenyl)Acetate (8)Methyl 2-Bromo-2-Phenylacetate (7)Methyl 2-Bromo-3-Nitrobenzoate (3)Methyl 2-Bromo-5-Fluorobenzoate (8)Methyl 2-Bromo-6-Fluorobenzoate (7)Methyl 2-Bromo-6-Methylbenzoate (8)Methyl 2-Bromobenzoate (69)Methyl 3-(Bromomethyl)Benzoate (16)Methyl 3-Bromo-4-Chlorobenzoate (6)Methyl 3-Bromo-4-Fluorobenzoate (7)Methyl 3-Bromo-4-Methoxybenzoate (10)Methyl 3-Bromo-4-Methylbenzoate (9)Methyl 3-Bromobenzoate (153)Methyl 3-Bromopicolinate (9)Methyl 4-Amino-3-Bromobenzoate (8)Methyl 5-Amino-2-Bromobenzoate (6)Methyl 6-Bromonicotinate (6)N-(2-Benzoylphenyl)-2-Bromoacetamide (3)Tert-Butyl 2-(Bromomethyl)Morpholine-4-Carboxylate (3)Tert-Butyl 3-Bromo-1H-Indole-1-Carboxylate (9)Tert-Butyl 3-Bromopiperidine-1-Carboxylate (4)Bromoacetyl (14)Bromoaniline (2)Bromoanthracene (5)Bromoanthracene (5)Bromobenzaldehyde (15)Bromobenzamide (7)Bromobenzimidamide (6)Bromobenzyl (36)Bromobut (2)Bromobut (2)Bromobutoxy (4)Bromobutoxy (4)Bromobutyl (6)Bromobutyl (6)Bromochroman (26)Bromochroman (26)Bromocyclopropanecarboxylate (1)Bromoethoxy (22)Bromoethoxy (22)Bromoethyl (86)Bromoethyl (86)Bromoethynyl (6)Bromohexyl (11)Bromohexyl (11)Bromomethyl (759)Bromonicotinaldehyde (5)Bromonicotinamide (5)Bromooctyl (3)Bromopentyl (8)Bromopentyl (8)Bromopropane (10)Bromopropane (10)Bromopropoxy (6)Bromopropoxy (6)Bromopropyl (25)Bromopropyl (25)Bromothiochroman (4)Bromothiochroman (4)Bromovinyl (2)Dibromo (698)Dibromo (698)Dibromoanthracene (3)Dibromoanthracene (3)Dibromobenzaldehyde (8)Dibromobenzonitrile (8)Dibromomethyl (6)Dibromomethyl (6)Tetrabromo (10)Tetrabromo (10)Tribromo (9)Tribromo (9)
Carbamates (7952)
Carboxylic Acid Salts (668)
Carboxylic Acids (58150)
1,2,3,4-Tetrahydroisoquinoline-1-Carboxylic Acid (19)1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (12)1,5-Naphthyridine-3-Carboxylic Acid (6)1-((Benzyloxy)Carbonyl)Piperidine-2-Carboxylic Acid (5)1-((Benzyloxy)Carbonyl)Piperidine-3-Carboxylic Acid (3)1-((Benzyloxy)Carbonyl)Pyrrolidine-3-Carboxylic Acid (6)1-Methyl-1H-Indole-2-Carboxylic Acid (8)1-Naphthoic Acid (23)1-Phenyl-1H-Imidazole-4-Carboxylic Acid (5)1-Phenyl-1H-Pyrazole-3-Carboxylic Acid (10)1-Phenyl-1H-Pyrazole-4-Carboxylic Acid (19)1-Phenyl-1H-Pyrazole-5-Carboxylic Acid (3)1-Phenylcyclobutane-1-Carboxylic Acid (16)1-Phenylcyclohexane-1-Carboxylic Acid (6)1-Phenylcyclopropane-1-Carboxylic Acid (23)1H-Benzo[D]Imidazole-2-Carboxylic Acid (7)1H-Benzo[D]Imidazole-4-Carboxylic Acid (6)1H-Benzo[D]Imidazole-5-Carboxylic Acid (4)1H-Imidazole-2-Carboxylic Acid (7)1H-Imidazole-4-Carboxylic Acid (4)1H-Indazole-3-Carboxylic Acid (23)1H-Indazole-4-Carboxylic Acid (9)1H-Indazole-5-Carboxylic Acid (4)1H-Indazole-7-Carboxylic Acid (6)1H-Indole-3-Carboxylic Acid (28)1H-Indole-4-Carboxylic Acid (10)1H-Indole-5-Carboxylic Acid (4)1H-Indole-6-Carboxylic Acid (5)1H-Indole-7-Carboxylic Acid (7)1H-Pyrazole-4-Carboxylic Acid (9)1H-Pyrazole-5-Carboxylic Acid (10)1H-Pyrrole-2-Carboxylic Acid (30)1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid (5)1H-Pyrrolo[2,3-C]Pyridine-2-Carboxylic Acid (4)1H-Pyrrolo[3,2-B]Pyridine-3-Carboxylic Acid (6)2,3-Difluorobenzoic Acid (35)2,3-Dihydrobenzo[B][1,4]Dioxine-2-Carboxylic Acid (3)2,3-Dihydrobenzo[B][1,4]Dioxine-6-Carboxylic Acid (3)2,4-Difluorobenzoic Acid (29)2,5-Dichlorobenzoic Acid (13)2,5-Difluorobenzoic Acid (32)2,6-Dichlorobenzoic Acid (13)2,6-Difluorobenzoic Acid (33)2-(1,3-Dioxoisoindolin-2-Yl)Propanoic Acid (3)2-(1H-Indol-1-Yl)Acetic Acid (5)2-(1H-Indol-3-Yl)Acetic Acid (28)2-(2-Bromophenyl)Acetic Acid (23)2-(2-Chlorophenyl)Acetic Acid (24)2-(2-Fluorophenyl)Acetic Acid (43)2-(2-Hydroxyphenyl)Acetic Acid (8)2-(2-Methoxyphenyl)Acetic Acid (16)2-(2-Methyl-1H-Indol-3-Yl)Acetic Acid (5)2-(2-Nitrophenyl)Acetic Acid (20)2-(2-Oxo-2H-Chromen-4-Yl)Acetic Acid (4)2-(3-Fluorophenyl)Acetic Acid (50)2-(3-Hydroxyphenyl)Acetic Acid (8)2-(3-Methoxyphenyl)Acetic Acid (23)2-(4-Chlorophenoxy)Acetic Acid (3)2-(4-Fluorophenyl)Acetic Acid (30)2-(4-Methoxyphenyl)Acetic Acid (21)2-(4-Nitrophenyl)Acetic Acid (9)2-(Benzofuran-3-Yl)Acetic Acid (3)2-(M-Tolyl)Acetic Acid (16)2-(Morpholin-2-Yl)Acetic Acid (5)2-(O-Tolyl)Acetic Acid (17)2-(P-Tolyl)Acetic Acid (9)2-(Phenylamino)Benzoic Acid (11)2-(Pyridin-3-Yl)Acetic Acid (14)2-(Pyrrolidin-1-Yl)Benzoic Acid (3)2-(Pyrrolidin-2-Yl)Acetic Acid (8)2-(Pyrrolidin-3-Yl)Acetic Acid (6)2-(Thiazol-4-Yl)Acetic Acid (9)2-(Trifluoromethoxy)Benzoic Acid (8)2-(Trifluoromethyl)Benzoic Acid (33)2-Amino-2-(2-Fluorophenyl)Acetic Acid (11)2-Amino-3,3-Diphenylpropanoic Acid (4)2-Amino-3-(2-Fluorophenyl)Propanoic Acid (17)2-Amino-3-Bromobenzoic Acid (8)2-Amino-3-Chlorobenzoic Acid (7)2-Amino-6-Chlorobenzoic Acid (5)2-Benzoylbenzoic Acid (10)2-Bromo-4-Fluorobenzoic Acid (8)2-Bromo-4-Methylbenzoic Acid (5)2-Bromo-6-Fluorobenzoic Acid (11)2-Bromo-6-Methylbenzoic Acid (5)2-Chloro-3-Methoxybenzoic Acid (6)2-Chloro-3-Methylbenzoic Acid (4)2-Chloro-3-Nitrobenzoic Acid (4)2-Chloro-4-Fluorobenzoic Acid (9)2-Chloro-4-Methylbenzoic Acid (3)2-Chloro-6-Fluorobenzoic Acid (8)2-Chlorobenzoic Acid (130)2-Cyclohexylacetic Acid (14)2-Fluoro-4-Methylbenzoic Acid (7)2-Fluoro-5-Methoxybenzoic Acid (9)2-Fluorobenzoic Acid (220)2-Fluorocyclopropane-1-Carboxylic Acid (7)2-Iodobenzoic Acid (47)2-Methoxyisonicotinic Acid (13)2-Methyl-2-Phenylpropanoic Acid (20)2-Methyl-3-Nitrobenzoic Acid (7)2-Naphthoic Acid (14)2-Nitrobenzoic Acid (65)2-Oxo-2-Phenylacetic Acid (17)2-Oxo-2H-Chromene-3-Carboxylic Acid (14)2-Phenoxypropanoic Acid (13)3-((Tert-Butoxycarbonyl)Amino)-4-(2-Fluorophenyl)Butanoic Acid (9)3-(1H-Indol-3-Yl)Propanoic Acid (4)3-(2-Fluorophenyl)Acrylic Acid (17)3-(3-Chlorophenyl)Acrylic Acid (10)3-(3-Chlorophenyl)Propanoic Acid (11)3-(3-Methoxyphenyl)Propanoic Acid (9)3-(Benzyloxy)Benzoic Acid (5)3-(Chlorosulfonyl)Benzoic Acid (15)3-(Methylsulfonyl)Benzoic Acid (6)3-(Phenyldiazenyl)Benzoic Acid (7)3-(Piperazin-1-Yl)Benzoic Acid (3)3-(Trifluoromethoxy)Benzoic Acid (19)3-(Trifluoromethyl)Benzoic Acid (52)3-Benzamidopropanoic Acid (3)3-Bromo-2-Chlorobenzoic Acid (7)3-Bromo-2-Fluorobenzoic Acid (10)3-Bromo-2-Hydroxybenzoic Acid (4)3-Bromo-4-Chlorobenzoic Acid (6)3-Bromo-4-Fluorobenzoic Acid (10)3-Bromo-4-Hydroxybenzoic Acid (3)3-Bromo-4-Methoxybenzoic Acid (7)3-Bromo-4-Methylbenzoic Acid (9)3-Bromobenzoic Acid (159)3-Chloro-2-Fluorobenzoic Acid (9)3-Chloro-2-Methoxybenzoic Acid (4)3-Chloro-4-Fluorobenzoic Acid (8)3-Chloro-4-Methoxybenzoic Acid (5)3-Chlorobenzoic Acid (144)3-Fluoro-4-Methoxybenzoic Acid (6)3-Fluorobenzoic Acid (206)3-Fluoropicolinic Acid (6)3-Iodobenzoic Acid (55)3-Methoxy-4-Nitrobenzoic Acid (4)3-Methylpicolinic Acid (13)3-Nitrobenzoic Acid (109)3-Phenoxybenzoic Acid (6)3-Phenoxypropanoic Acid (14)4-(1H-Pyrazol-1-Yl)Benzoic Acid (3)4-(Benzyloxy)Benzoic Acid (5)4-(Phenyldiazenyl)Benzoic Acid (4)4-(Trifluoromethyl)Nicotinic Acid (3)4-Amino-3-Chlorobenzoic Acid (6)4-Benzamidobenzoic Acid (3)4-Cyclohexylbenzoic Acid (6)4-Fluoro-3-Iodobenzoic Acid (5)4-Fluorobenzoic Acid (114)4-Methylnicotinic Acid (5)4-Morpholinobenzoic Acid (5)4-Nitrobenzoic Acid (35)4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid (3)4-Oxo-4-(Phenylamino)Butanoic Acid (7)4-Oxo-4-Phenylbutanoic Acid (16)4-Oxopiperidine-2-Carboxylic Acid (3)4-Phenoxybenzoic Acid (4)4-Phenylbutanoic Acid (19)5'-(4-Carboxyphenyl)-[1,1':3',1''-Terphenyl]-4,4''-Dicarboxylic Acid (7)5-Oxotetrahydrofuran-2-Carboxylic Acid (4)5-Phenyl-1H-Pyrazole-3-Carboxylic Acid (15)5-Phenylfuran-2-Carboxylic Acid (6)5-Phenylisoxazole-3-Carboxylic Acid (15)6,6-Dimethylmorpholine-3-Carboxylic Acid (5)6-Methoxypicolinic Acid (9)6-Methylnicotinic Acid (6)6-Methylpicolinic Acid (12)6-Oxopiperidine-2-Carboxylic Acid (3)6-Phenylpicolinic Acid (3)7-Fluoro-1H-Indole-2-Carboxylic Acid (5)[1,1'-Biphenyl]-2-Carboxylic Acid (24)[1,1'-Biphenyl]-3-Carboxylic Acid (40)Azetidine-2-Carboxylic Acid (6)Benzo[B]Thiophene-2-Carboxylic Acid (32)Benzo[D]Thiazole-6-Carboxylic Acid (5)Benzofuran-2-Carboxylic Acid (21)Benzofuran-3-Carboxylic Acid (6)Benzoic Acid (3524)Benzoylglycine (15)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid (6)Chromane-2-Carboxylic Acid (6)Chromane-3-Carboxylic Acid (4)Cyclobutanecarboxylic Acid (23)Cyclohex-1-Ene-1-Carboxylic Acid (4)Cyclohex-3-Ene-1-Carboxylic Acid (7)Cyclohexanecarboxylic Acid (83)Cyclopentanecarboxylic Acid (26)Cyclopropanecarboxylic Acid (11)Ethyl 5-Oxopyrrolidine-2-Carboxylate (3)Furan-2-Carboxylic Acid (32)Furan-3-Carboxylic Acid (11)Imidazo[1,2-A]Pyridine-2-Carboxylic Acid (21)Imidazo[1,2-A]Pyridine-3-Carboxylic Acid (14)Imidazo[1,2-A]Pyridine-5-Carboxylic Acid (3)Imidazo[1,2-A]Pyridine-7-Carboxylic Acid (5)Imidazo[1,2-A]Pyridine-8-Carboxylic Acid (6)Imidazo[1,2-A]Pyrimidine-3-Carboxylic Acid (5)Indoline-2-Carboxylic Acid (3)Isonicotinic Acid (23)Isoquinoline-1-Carboxylic Acid (10)Isoquinoline-3-Carboxylic Acid (7)Isoquinoline-4-Carboxylic Acid (12)Isoquinoline-5-Carboxylic Acid (5)Isoquinoline-6-Carboxylic Acid (3)Isoxazole-3-Carboxylic Acid (8)Isoxazole-5-Carboxylic Acid (7)Methyl Benzofuran-2-Carboxylate (6)Methyl Isoquinoline-3-Carboxylate (3)Morpholine-2-Carboxylic Acid (12)Morpholine-3-Carboxylic Acid (10)Nicotinic Acid (53)Oxazole-4-Carboxylic Acid (4)Picolinic Acid (22)Piperidine-2-Carboxylic Acid (26)Piperidine-3-Carboxylic Acid (14)Piperidine-4-Carboxylic Acid (12)Proline (13)Pyrazine-2-Carboxylic Acid (34)Pyrazolo[1,5-A]Pyrimidine-3-Carboxylic Acid (7)Pyridazine-3-Carboxylic Acid (7)Pyridine-2,6-Dicarboxylic Acid (9)Pyrimidine-2-Carboxylic Acid (11)Pyrimidine-4-Carboxylic Acid (17)Pyrimidine-5-Carboxylic Acid (7)Pyrrolidine-3-Carboxylic Acid (14)Tetrahydrofuran-2-Carboxylic Acid (4)Tetrahydrofuran-3-Carboxylic Acid (4)Thiazole-2-Carboxylic Acid (9)Thiazole-4-Carboxylic Acid (5)Thiazole-5-Carboxylic Acid (10)Thiophene-3-Carboxylic Acid (8)Tryptophan (22)Aceticacid (1248)Acetylbenzoic Acid (3)Acrylic (95)Aminobenzoic (7)Aminobutanoic (8)Aminoheptanoic (6)Aminohexanoic (10)Aminonicotinic Acid (4)Aminopentanoic (8)Aminophenylacetic Acid (22)Aminopropanoic (11)Aminoundecanoic Acid (4)Benzenedicarboxylic (6)Benzenedicarboxylic Acid (6)Benzylpropanoic Acid (75)Benzylsuccinic Acid (6)Boronobenzoic (4)Bromobutanoic (5)Bromododecanoate (3)Bromoisonicotinic Acid (4)Bromonicotinic (8)Bromonicotinic Acid (9)Bromophenylacetic Acid (15)Bromovalerate (4)Butanoic (124)Chlorobenzoic (35)Chloromandelic Acid (3)Chromene-Carboxylic Acid (1)Cyanonicotinic (5)Cyanonicotinic Acid (3)Diacetic (19)Diacetic (19)Diaminobenzoic (7)Diaminobutanoic (5)Diaminohexanoic (4)Dibenzoic (40)Dibromobenzoic (10)Dibromobenzoic Acid (10)Dibromonicotinic Acid (7)Dicarboxylic (183)Dicarboxylic (183)Dichlorobenzoic (21)Dichlorobenzoic Acid (22)Dichloroisonicotinic (6)Dichloroisonicotinic Acid (6)Dichlorophenylacetic Acid (4)Dienoate (14)Dienoic (10)Difluorobenzoic (54)Difluorobutanoic (3)Difluoroisonicotinic Acid (7)Difluorophenylacetic (7)Difluorophenylacetic Acid (7)Diiodobenzoic (5)Diisophthalic (17)Diisophthalic Acid (9)Diisopropylbenzoic Acid (4)Dimethoxybenzoic (33)Dimethoxyphenylacetic Acid (3)Dimethylbenzoic (32)Dimethylbutanoic (13)Dimethylbutanoic (13)Dimethylpropanoic (5)Diphenylpropanoic (8)Diyldimethanol (17)Enedioic (8)Enoic (127)Ethoxybenzoic (9)Ethylbenzoic (11)Ethylbenzoic Acid (12)Ethynylbenzoic (6)Ethynylbenzoic Acid (5)Fluoroisophthalic Acid (4)Fluorophenylacetic (10)Fluorophenylacetic Acid (11)Fluorophthalic (5)Fluorophthalic Acid (3)Fluoropicolinic (12)Formylbenzoic (22)Formylbenzoic Acid (19)Guanidinopentanoic (8)Heptanoic (6)Heptanoic (6)Hexacarboxylic Acid (5)Hexanoic (25)Hexanoic (25)Hydrazinylbenzoic (6)Hydrazinylbenzoic Acid (5)Hydroxynicotinic (15)Indolecarboxylic (2)Isophthalic (29)Isophthalic Acid (15)Isopropoxybenzoic (8)Isopropoxybenzoic Acid (7)Isopropylbenzoic (13)Isopropylnicotinic Acid (4)Malonate (39)Mercaptobenzoic (6)Mercaptobenzoic Acid (4)Mercaptopropanoic (11)Methoxybenzoic (142)Methoxybutanoic (4)Methoxybutanoic (4)Methoxyisophthalic Acid (5)Methoxyphenylacetic (10)Methoxyphenylacetic Acid (12)Methoxypropanoic (7)Methoxypropanoic (7)Methylbenzoic (174)Methylbutanoic (32)Methylbutanoic (32)Methylcinnamic Acid (9)Methylhexanoic (8)Methylhexanoic (8)Methylisophthalic Acid (17)Methylnicotinic (46)Methyloctanoic (6)Methylpentanoic (108)Methylpentanoic (108)Methylpropanoic (57)Naphthoic (64)Nitrobenzoic (161)Nitroisonicotinic Acid (5)Nitroisophthalic Acid (3)Nitronicotinic (10)Nitropicolinic (11)Octanoic (6)Octanoic (6)Oxoacetic (22)Oxobutanoic (57)Oxobutanoic (57)Oxodecanoic (5)Oxodecanoic (5)Oxododecanoic (9)Oxododecanoic (9)Oxoheptanoic (5)Oxoheptanoic (5)Oxoheptanoic Acid (4)Oxohexadecanoic (13)Oxohexadecanoic (13)Oxohexanoic (10)Oxohexanoic (10)Oxooctadecanoic (7)Oxooctadecanoic (7)Oxopentanoic (37)Oxopentanoic (37)Oxopropanoic (8)Pentanedioic (18)Pentanedioic (18)Pentanoic (27)Phenoxybenzoic (5)Phenylacetic (35)Phenylbutanoic (47)Phenylpentanoic (11)Phenylpropanoic (45)Propanoic (1168)Propenoic (6)Pyridazinecarboxylic (1)Succinic (13)Sulfamoylbenzoic (15)Sulfobenzoic (5)Terephthalic (7)Tetraacetic (5)Tetrabenzoic (13)Tetrabenzoic Acid (14)Tetracarboxylic (13)Tribenzoic (15)Tribenzoic Acid (14)Tricarboxylic (18)Trichlorobenzoic (5)Trichlorobenzoic Acid (4)Trifluorobenzoic (12)Trifluorobenzoic Acid (11)Trifluorobutanoic (3)Trifluoromethylbenzoic (5)Trifluoromethylbenzoic Acid (4)Trifluoropentanoic (4)Trifluorophenylacetic Acid (16)Trifluoropropanoic (4)Triiodobenzoic (4)Trimethylbenzoic Acid (4)
Chlorides (77742)
(2,3-Dichlorophenyl)Boronic Acid (11)(2,6-Dichlorophenyl)Boronic Acid (6)(2-Chloroethoxy)Benzene (5)(2-Chlorophenyl)(Phenyl)Methanone (19)(2-Chlorophenyl)Hydrazine (16)(2-Chlorophenyl)Methanamine (28)(2-Chlorophenyl)Methanol (40)(2-Chloropyridin-4-Yl)Boronic Acid (6)(3,4-Dichlorophenyl)Boronic Acid (10)(3-Chloro-4-Fluorophenyl)Boronic Acid (8)(3-Chlorophenyl)(Phenyl)Methanone (19)(3-Chlorophenyl)Boronic Acid (121)(3-Chlorophenyl)Hydrazine (12)(3-Chlorophenyl)Methanamine (19)(3-Chlorophenyl)Methanol (38)(3-Chloropyridin-2-Yl)Methanamine (6)(4-Chlorophenyl)(Phenyl)Methanone (11)(5-Chloropyridin-2-Yl)Methanamine (5)(Chloromethanetriyl)Tribenzene (7)(Chloromethylene)Dibenzene (5)1,2,3,4-Tetrachlorobenzene (8)1,2,4-Trichlorobenzene (26)1,2-Dibromo-3-Chlorobenzene (3)1,2-Dichloro-3-Fluorobenzene (13)1,2-Dichloro-3-Methoxybenzene (7)1,2-Dichloro-3-Methylbenzene (8)1,2-Dichloro-4-Fluorobenzene (15)1,2-Dichloro-4-Methoxybenzene (11)1,2-Dichloro-4-Nitrobenzene (16)1,3-Dibromo-2-Chlorobenzene (8)1,3-Dichloro-2-Fluorobenzene (23)1,3-Dichloro-2-Iodobenzene (5)1,3-Dichloro-2-Methoxybenzene (9)1,3-Dichloro-2-Nitrobenzene (5)1,3-Dichloroisoquinoline (14)1,4-Dichloro-2-Fluorobenzene (11)1,4-Dichloro-2-Methoxybenzene (8)1-(2-Chlorophenyl)Ethan-1-One (40)1-(2-Chlorophenyl)Piperazine (4)1-(3-Chlorophenyl)-1H-Pyrazole (3)1-(3-Chlorophenyl)-N-Methylmethanamine (8)1-(3-Chlorophenyl)Ethan-1-One (38)1-(3-Chlorophenyl)Pyrrolidine (3)1-(Benzyloxy)-2-Chlorobenzene (16)1-(Benzyloxy)-3-Chlorobenzene (6)1-(Bromomethyl)-2-Chlorobenzene (28)1-(Bromomethyl)-3-Chlorobenzene (27)1-(Chloromethyl)-2-Methylbenzene (7)1-Benzyl-2-Chlorobenzene (9)1-Benzyl-3-Chlorobenzene (3)1-Benzyl-4-Chlorobenzene (6)1-Bromo-2,3-Dichlorobenzene (18)1-Bromo-2-Chloro-3-Methylbenzene (9)1-Bromo-3-Chloro-2-Fluorobenzene (9)1-Bromo-3-Chloro-2-Methylbenzene (6)1-Bromo-4-Chloro-2-Fluorobenzene (22)1-Chloro-2,3-Difluorobenzene (27)1-Chloro-2,4-Difluorobenzene (35)1-Chloro-2,4-Dimethoxybenzene (7)1-Chloro-2-(Chloromethyl)Benzene (12)1-Chloro-2-(Trifluoromethoxy)Benzene (20)1-Chloro-2-(Trifluoromethyl)Benzene (81)1-Chloro-2-Cyclopropylbenzene (7)1-Chloro-2-Ethoxybenzene (14)1-Chloro-2-Fluoro-3-Iodobenzene (5)1-Chloro-2-Fluoro-4-Nitrobenzene (9)1-Chloro-2-Iodobenzene (65)1-Chloro-2-Isocyanatobenzene (6)1-Chloro-2-Isothiocyanatobenzene (7)1-Chloro-2-Methyl-3-Nitrobenzene (6)1-Chloro-2-Nitrobenzene (138)1-Chloro-2-Phenoxybenzene (10)1-Chloro-2-Propoxybenzene (5)1-Chloro-3,5-Dimethylbenzene (8)1-Chloro-3-(Chloromethyl)Benzene (7)1-Chloro-3-(Trifluoromethoxy)Benzene (18)1-Chloro-3-(Trifluoromethyl)Benzene (101)1-Chloro-3-Fluoro-2-Methylbenzene (10)1-Chloro-3-Fluoro-2-Nitrobenzene (6)1-Chloro-3-Iodo-2-Methylbenzene (3)1-Chloro-3-Iodobenzene (77)1-Chloro-3-Methoxybenzene (126)1-Chloro-3-Nitrobenzene (161)1-Chloro-3-Phenoxybenzene (5)1-Chloro-4-(Trifluoromethoxy)Benzene (8)1-Chloro-4-Iodobenzene (49)1-Chloro-4-Methoxybenzene (98)1-Chloro-4-Phenoxybenzene (13)1-Chloroanthracene-9,10-Dione (6)1-Chloroisoquinoline (20)1-Chloronaphthalene (24)2,3,5-Trichloropyridine (13)2,3,6-Trichloropyridine (16)2,3-Dichloroaniline (18)2,3-Dichlorobenzaldehyde (7)2,3-Dichlorophenol (9)2,3-Dichloropyridine (38)2,4,5-Trichloropyrimidine (6)2,4,6-Trichloropyridine (5)2,4,6-Trichloropyrimidine (14)2,4-Dibromo-1-Chlorobenzene (8)2,4-Dichloro-1-Fluorobenzene (27)2,4-Dichloro-1-Methoxybenzene (18)2,4-Dichloro-1-Nitrobenzene (19)2,4-Dichloro-6-Methylpyridine (8)2,4-Dichloro-6-Methylpyrimidine (7)2,4-Dichlorobenzaldehyde (8)2,4-Dichlorobenzonitrile (4)2,4-Dichloropyridine (50)2,4-Dichloroquinazoline (19)2,4-Dichlorothiazole (4)2,5-Dichlorophenol (7)2,5-Dichloropyrazine (4)2,5-Dichloropyridine (32)2,6-Dichloro-3-Fluoropyridine (10)2,6-Dichloro-3-Methylpyridine (5)2,6-Dichloro-3-Nitropyridine (6)2,6-Dichloro-4-Methylpyridine (5)2,6-Dichloroaniline (27)2,6-Dichlorobenzoic Acid (13)2,6-Dichlorobenzonitrile (8)2,6-Dichloronicotinonitrile (8)2,6-Dichlorophenol (16)2,6-Dichloropyrazine (14)2,6-Dichloropyridin-3-Amine (11)2,6-Dichloropyridine (49)2-(2-Chlorophenyl)Acetic Acid (24)2-(2-Chlorophenyl)Acetonitrile (16)2-(2-Chlorophenyl)Ethan-1-Ol (8)2-(2-Chlorophenyl)Pyridine (3)2-(2-Chlorophenyl)Pyrrolidine (17)2-(3-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(3-Chlorophenyl)Acetonitrile (16)2-(4-Chlorophenoxy)Acetic Acid (3)2-(Chloromethyl)-1H-Benzo[D]Imidazole (9)2-(Chloromethyl)-3-Methylpyridine (12)2-(Chloromethyl)Furan (3)2-(Chloromethyl)Pyridine (12)2-(Chloromethyl)Pyridine 1-Oxide (4)2-(Chloromethyl)Pyrimidine (5)2-(Chloromethyl)Thiazole (5)2-Amino-3-Chlorobenzoic Acid (7)2-Amino-3-Chlorobenzonitrile (3)2-Amino-6-Chlorophenol (5)2-Bromo-1,3-Dichlorobenzene (12)2-Bromo-1,4-Dichlorobenzene (12)2-Bromo-1-Chloro-4-Methylbenzene (6)2-Bromo-4-Chloro-1-Iodobenzene (6)2-Bromo-4-Chloro-1-Methoxybenzene (7)2-Bromo-4-Chloro-1-Methylbenzene (11)2-Bromo-4-Chloroaniline (15)2-Bromo-4-Chlorophenol (11)2-Bromo-6-Chloroaniline (10)2-Bromo-6-Chlorophenol (5)2-Chloro-1,1'-Biphenyl (8)2-Chloro-1,3,5-Triazine (10)2-Chloro-1,3-Difluorobenzene (27)2-Chloro-1,3-Dimethoxybenzene (3)2-Chloro-1,3-Dinitrobenzene (2)2-Chloro-1,4-Difluorobenzene (25)2-Chloro-1,4-Dimethoxybenzene (4)2-Chloro-1-Fluoro-4-Nitrobenzene (16)2-Chloro-1-Methyl-3-Nitrobenzene (4)2-Chloro-1-Phenylethan-1-One (20)2-Chloro-1H-Benzo[D]Imidazole (17)2-Chloro-3,6-Dimethylpyridine (4)2-Chloro-3-(Trifluoromethyl)Aniline (3)2-Chloro-3-(Trifluoromethyl)Pyridine (12)2-Chloro-3-Fluoropyridin-4-Amine (3)2-Chloro-3-Hydroxybenzaldehyde (4)2-Chloro-3-Methoxypyridine (12)2-Chloro-3-Methylaniline (4)2-Chloro-3-Methylbenzoic Acid (4)2-Chloro-3-Methylbenzonitrile (5)2-Chloro-3-Methylpyrazine (7)2-Chloro-3-Methylpyridine (17)2-Chloro-3-Nitropyridine (10)2-Chloro-4,6-Dimethylpyridine (7)2-Chloro-4-(Trifluoromethyl)Pyridine (9)2-Chloro-4-Ethoxypyridine (5)2-Chloro-4-Fluoro-1-Nitrobenzene (13)2-Chloro-4-Fluoroaniline (19)2-Chloro-4-Fluoropyridine (10)2-Chloro-4-Methoxypyridine (22)2-Chloro-4-Methyl-1-Nitrobenzene (6)2-Chloro-4-Methylaniline (7)2-Chloro-4-Methylbenzoic Acid (3)2-Chloro-4-Methylpyridine (31)2-Chloro-4-Methylpyrimidine (16)2-Chloro-4-Methylthiazole (5)2-Chloro-4-Phenylpyrimidine (7)2-Chloro-5-(Trifluoromethyl)Pyridine (4)2-Chloro-5-Fluoropyridin-4-Amine (3)2-Chloro-5-Fluoropyridine (16)2-Chloro-5-Methoxyaniline (8)2-Chloro-5-Methylpyridine (11)2-Chloro-5-Methylpyrimidine (5)2-Chloro-5-Methylthiazole (5)2-Chloro-5-Nitropyridine (8)2-Chloro-6-(Trifluoromethyl)Aniline (4)2-Chloro-6-(Trifluoromethyl)Pyridine (16)2-Chloro-6-Fluoroaniline (8)2-Chloro-6-Fluorophenol (5)2-Chloro-6-Fluoropyridine (14)2-Chloro-6-Iodophenol (3)2-Chloro-6-Methoxyaniline (3)2-Chloro-6-Methoxyphenol (4)2-Chloro-6-Methoxypyridine (24)2-Chloro-6-Methyl-3-Nitropyridine (4)2-Chloro-6-Methylaniline (11)2-Chloro-6-Methylnicotinonitrile (10)2-Chloro-6-Methylphenol (5)2-Chloro-6-Methylpyrazine (12)2-Chloro-6-Methylpyridine (49)2-Chloro-6-Nitroaniline (11)2-Chloro-7H-Purine (3)2-Chloro-7H-Pyrrolo[2,3-D]Pyrimidine (13)2-Chloro-9H-Purine (5)2-Chloro-N-Phenylacetamide (26)2-Chloro-N-Phenylaniline (8)2-Chloroaniline (214)2-Chlorobenzamide (16)2-Chlorobenzene-1,3-Diamine (3)2-Chlorobenzene-1,3-Diol (4)2-Chlorobenzene-1,4-Diamine (6)2-Chlorobenzenesulfonyl Chloride (24)2-Chlorobenzenethiol (7)2-Chlorobenzo[D]Oxazole (11)2-Chlorobenzo[D]Thiazole (21)2-Chlorobenzoic Acid (130)2-Chlorobenzonitrile (99)2-Chlorobenzoyl Chloride (13)2-Chlorocyclohexa-2,5-Diene-1,4-Dione (4)2-Chlorofuran (3)2-Chloroisonicotinaldehyde (19)2-Chloroisonicotinic Acid (17)2-Chloroisonicotinonitrile (7)2-Chloronaphthalene (6)2-Chloronicotinic Acid (7)2-Chloronicotinonitrile (9)2-Chlorooxazole (7)2-Chlorophenol (163)2-Chloropyrazine (24)2-Chloropyridin-3-Amine (11)2-Chloropyridin-3-Ol (9)2-Chloropyridin-4-Amine (28)2-Chloropyridine 1-Oxide (10)2-Chloroquinoxaline (39)2-Chlorothiazole (32)2-Chlorothiophene (20)3,4-Dichloroaniline (21)3,5-Dichloropyridine (16)3,6-Dichloropyridazine (20)3-(3-Chlorophenyl)Propanoic Acid (11)3-(Chloromethyl)Pyridine (22)3-Chloro-1,1'-Biphenyl (12)3-Chloro-1-Methyl-1H-Pyrazole (7)3-Chloro-1-Phenylpropan-1-One (10)3-Chloro-1H-Indazole (13)3-Chloro-2-Fluoroaniline (9)3-Chloro-2-Fluorobenzaldehyde (9)3-Chloro-2-Fluorobenzoic Acid (9)3-Chloro-2-Fluorobenzonitrile (7)3-Chloro-2-Fluoropyridine (13)3-Chloro-2-Hydroxybenzaldehyde (5)3-Chloro-2-Methoxypyridine (16)3-Chloro-2-Methylaniline (11)3-Chloro-2-Methylpyridine (4)3-Chloro-2-Nitroaniline (5)3-Chloro-4-(Trifluoromethyl)Aniline (5)3-Chloro-4-Fluoroaniline (18)3-Chloro-4-Fluorobenzoic Acid (8)3-Chloro-4-Hydroxybenzaldehyde (7)3-Chloro-4-Methylaniline (12)3-Chloro-4-Methylpyridazine (7)3-Chloro-4-Nitroaniline (5)3-Chloro-5-Fluoropyridine (10)3-Chloro-5-Methylpyridine (7)3-Chloro-5-Nitropyridine (5)3-Chloro-9H-Carbazole (3)3-Chlorobenzaldehyde (106)3-Chlorobenzene-1,2-Diamine (6)3-Chlorobenzene-1,2-Diol (6)3-Chlorobenzenesulfonyl Chloride (21)3-Chlorobenzo[B]Thiophene (6)3-Chlorobenzoic Acid (144)3-Chlorobenzonitrile (100)3-Chloroimidazo[1,2-A]Pyridine (3)3-Chloroisoquinoline (20)3-Chlorophenol (113)3-Chloropicolinic Acid (9)3-Chloropicolinonitrile (6)3-Chloropyridazine (44)3-Chloropyridin-2-Amine (17)3-Chloropyridin-2-Ol (10)3-Chlorothiophene (17)4,5-Dichloropyrimidine (7)4,6-Dichloro-2-Methylpyrimidine (7)4,6-Dichloropyridin-2-Amine (6)4,6-Dichloropyridin-3-Amine (4)4,6-Dichloropyrimidine (14)4-Chloro-1,5-Naphthyridine (6)4-Chloro-1-Phenylbutan-1-One (8)4-Chloro-1H-Indazole (18)4-Chloro-1H-Indole (21)4-Chloro-1H-Pyrazole (10)4-Chloro-1H-Pyrazolo[3,4-B]Pyridine (5)4-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (5)4-Chloro-1H-Pyrazolo[4,3-C]Pyridine (7)4-Chloro-1H-Pyrrolo[3,2-C]Pyridine (10)4-Chloro-2,6-Dimethylpyridine (4)4-Chloro-2-Methoxypyridine (6)4-Chloro-2-Phenylpyrimidine (5)4-Chloro-3-Fluoroaniline (17)4-Chloro-3-Methylaniline (11)4-Chloro-3-Methylpyridine (7)4-Chloro-5-Methylpyrimidine (8)4-Chloro-N-Phenylaniline (6)4-Chlorobenzene-1,3-Diol (6)4-Chlorobenzenesulfonic Acid (4)4-Chlorobenzenesulfonyl Chloride (12)4-Chlorobenzo[D]Thiazole (7)4-Chloroindoline-2,3-Dione (6)4-Chloroisoquinoline (11)4-Chloronicotinic Acid (4)4-Chloropyridazine (16)4-Chloropyridin-2-Amine (6)4-Chloropyridine (31)4-Chloroquinazoline (39)5,6-Dichloro-1H-Benzo[D]Imidazole (4)5,6-Dichloropyridin-2-Amine (4)5-Bromo-4-Chloropyrimidine (4)5-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)5-Chloro-1H-Imidazole (2)5-Chloro-1H-Indazole (9)5-Chloro-1H-Indole (64)5-Chloro-1H-Indole-2-Carboxylic Acid (6)5-Chloro-1H-Pyrazole (8)5-Chloro-1H-Pyrazolo[4,3-B]Pyridine (6)5-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)5-Chloro-1H-Pyrrolo[3,2-B]Pyridine (6)5-Chloro-2,3-Dihydrobenzofuran (5)5-Chloro-2-Fluoropyridine (13)5-Chloro-2-Methoxypyridine (10)5-Chloro-2-Methylpyridine (10)5-Chlorobenzo[B]Thiophene (4)5-Chlorobenzo[D]Oxazole (5)5-Chlorobenzo[D]Thiazole (5)5-Chloroimidazo[1,2-A]Pyridine (3)5-Chloroindolin-2-One (3)5-Chloroisoquinoline (6)5-Chloropicolinic Acid (7)5-Chloropicolinonitrile (6)5-Chloropyrazolo[1,5-A]Pyrimidine (24)5-Chloropyridin-2-Amine (26)5-Chloropyridin-2-Ol (15)5-Chloropyridin-3-Amine (7)5-Chloropyrimidine (8)5-Chloroquinazoline (4)6-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)6-Chloro-1,2,3,4-Tetrahydroquinoline (3)6-Chloro-1H-Benzo[D]Imidazole (25)6-Chloro-1H-Indazole (14)6-Chloro-1H-Indole (19)6-Chloro-1H-Pyrazolo[4,3-C]Pyridine (8)6-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)6-Chloro-1H-Pyrrolo[3,2-C]Pyridine (13)6-Chloro-2,3-Dihydrobenzofuran (3)6-Chloro-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Chloro-3-Nitropyridin-2-Amine (4)6-Chloro-5-(Trifluoromethyl)Pyridin-2-Amine (3)6-Chlorobenzo[D]Oxazole (4)6-Chlorobenzo[D]Thiazole (6)6-Chlorochroman-4-One (6)6-Chlorochromane (6)6-Chloroindoline (3)6-Chloroindoline-2,3-Dione (5)6-Chloronicotinaldehyde (24)6-Chloronicotinic Acid (4)6-Chloropicolinic Acid (12)6-Chloropicolinonitrile (9)6-Chloropyridazin-3(2H)-One (5)6-Chloropyridin-2-Amine (21)6-Chloropyridin-2-Ol (9)6-Chloropyridin-3-Amine (4)6-Chloropyridine-3-Sulfonyl Chloride (5)6-Chloroquinoxaline (3)7-Chloro-1,2,3,4-Tetrahydroisoquinoline (5)7-Chloro-1H-Indazole (7)7-Chloro-1H-Indole (29)7-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)7-Chloro-2,3-Dihydrobenzofuran (3)7-Chloro-3,4-Dihydronaphthalen-1(2H)-One (6)7-Chlorobenzo[D]Thiazole (6)7-Chlorochromane (5)7-Chloroisoquinoline (6)7-Chloropyrazolo[1,5-A]Pyrimidine (8)8-Chlorochromane (5)8-Chloroimidazo[1,2-A]Pyridine (7)8-Chloroisoquinoline (7)8-Chloroquinazoline (5)Ethyl 4,6-Dichloronicotinate (4)Ethyl 5-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloropicolinate (7)Ethyl 7-Chloro-1H-Indole-2-Carboxylate (5)Methyl 2,6-Dichlorobenzoate (7)Methyl 2-Chloro-4-Fluorobenzoate (5)Methyl 2-Chloro-6-Fluorobenzoate (7)Methyl 2-Chlorobenzoate (79)Methyl 2-Chloroisonicotinate (11)Methyl 2-Chloronicotinate (6)Methyl 3-Chlorobenzoate (88)Methyl 3-Chloropicolinate (9)Methyl 6-Chloropicolinate (11)N-(2-Chlorophenyl)Acetamide (16)N-(3-Chlorophenyl)Benzenesulfonamide (6)N-(3-Chlorophenyl)Quinazolin-4-Amine (10)N-(4-Chlorophenyl)Acetamide (9)Phenyl Carbonochloridate (5)Pyridine-2-Sulfonyl Chloride (9)Pyridine-3-Sulfonyl Chloride (25)Tert-Butyl (2-Chloropyridin-4-Yl)Carbamate (4)Chloroacetamide (17)Chloroacetyl (12)Chloroaniline (18)Chlorobenzaldehyde (18)Chlorobenzamide (12)Chlorobutyl (6)Chlorobutyl (6)Chlorocarbonyl (7)Chloroethoxy (10)Chloroethoxy (10)Chloroethyl (89)Chloromethyl (478)Chloropicolinaldehyde (8)Chloropicolinamide (5)Chloropropane (18)Chloropropane (18)Chloropropoxy (2)Chloropropoxy (2)Chloropropyl (23)Dichloride (28)Dichloroaniline (9)Dichloroanthracene (3)Dichlorobenzaldehyde (13)Dichlorobenzamide (8)Dichloroisonicotinaldehyde (4)Dichloromethyl (3)Dichloromethyl (3)Dichloronicotinaldehyde (6)Dichloronicotinic (6)Dichloronicotinic (6)Dichloronicotinic Acid (5)Dichloropalladium (4)Dichloropalladium (4)Tetrachloro (2)Tetrachloro (2)Trichloro (36)Trichloro (36)Trichloroacetimidate (5)Trichloroaniline (6)Trichlorobenzaldehyde (4)Trichloromethyl (11)Trichloromethyl (11)
Diazoes (3)
Difluoromethyls (32559)
(Difluoromethyl)Benzene (63)1-(Difluoromethoxy)-2-Fluorobenzene (11)1-(Difluoromethyl)-2-Fluorobenzene (13)1-Bromo-2-(Difluoromethyl)Benzene (5)2-(Difluoromethoxy)Phenol (5)2-(Difluoromethyl)Pyridine (21)3-(Difluoromethyl)Pyridine (5)4-(Difluoromethoxy)Aniline (6)5-(Difluoromethyl)-1H-Pyrazole (6)
Esters (51086)
(2R,3S)-2-((Benzoyloxy)Methyl)Tetrahydrofuran-3-Yl Benzoate (8)(9H-Fluoren-9-Yl)Methyl (3-Phenylpropyl)Carbamate (24)1,3-Dioxoisoindolin-2-Yl 2-Phenylacetate (5)1-Benzyl 2-Methyl Pyrrolidine-1,2-Dicarboxylate (7)1-Benzyl 3-Methyl Piperidine-1,3-Dicarboxylate (3)1-Benzyl 4-(Tert-Butyl) Piperazine-1,4-Dicarboxylate (10)1H-Indol-3-Yl Acetate (4)2,5-Dioxopyrrolidin-1-Yl Benzoate (8)2-((Tert-Butoxycarbonyl)Amino)Benzoic Acid (11)2-(Diethylamino)Ethyl Benzoate (3)2-Ethylhexyl Benzoate (13)2-Hydroxyethyl Benzoate (3)2-Phenoxyacetyl Chloride (3)4-Cyanophenyl Benzoate (11)Allyl Benzoate (5)Azetidin-3-Yl Acetate (3)Benzoic Anhydride (6)Benzyl Acetate (11)Benzyl Benzoate (12)Benzyl Benzylcarbamate (16)Benzyl Cyclohexylcarbamate (9)Benzyl Morpholine-4-Carboxylate (5)Benzyl Phenylcarbamate (15)Benzyl Piperidine-1-Carboxylate (50)Butyl Benzoate (10)Dimethyl Isophthalate (32)Dimethyl Phthalate (14)Dimethyl Pyridine-2,6-Dicarboxylate (7)Ethane-1,2-Diyl Dibenzoate (11)Ethyl 1-Phenyl-1H-Pyrazole-3-Carboxylate (4)Ethyl 1-Phenyl-1H-Pyrazole-4-Carboxylate (13)Ethyl 1-Phenylcyclopropane-1-Carboxylate (4)Ethyl 1H-1,2,4-Triazole-3-Carboxylate (3)Ethyl 1H-Imidazole-2-Carboxylate (6)Ethyl 1H-Indole-3-Carboxylate (6)Ethyl 1H-Pyrazole-4-Carboxylate (11)Ethyl 1H-Pyrrole-2-Carboxylate (24)Ethyl 1H-Pyrrole-3-Carboxylate (8)Ethyl 2-(Imidazo[1,2-A]Pyridin-3-Yl)Acetate (3)Ethyl 2-(Pyridin-2-Yl)Acetate (15)Ethyl 2-Aminobenzoate (23)Ethyl 2-Aminothiazole-4-Carboxylate (6)Ethyl 2-Aminothiazole-5-Carboxylate (5)Ethyl 2-Bromo-2-Phenylacetate (6)Ethyl 2-Fluorobenzoate (37)Ethyl 2-Hydroxybenzoate (18)Ethyl 2-Iodobenzoate (4)Ethyl 2-Methylbenzoate (26)Ethyl 2-Methylnicotinate (6)Ethyl 2-Nitrobenzoate (9)Ethyl 2-Oxo-2-(Phenylamino)Acetate (8)Ethyl 2-Oxo-2-Phenylacetate (18)Ethyl 2-Oxo-2H-Chromene-3-Carboxylate (5)Ethyl 2-Phenoxyacetate (10)Ethyl 2-Phenylacetate (60)Ethyl 2-Phenylcyclopropane-1-Carboxylate (5)Ethyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (6)Ethyl 3-Aminobenzoate (19)Ethyl 3-Fluorobenzoate (34)Ethyl 3-Hydroxybenzoate (12)Ethyl 3-Iodobenzoate (11)Ethyl 3-Nitrobenzoate (22)Ethyl 3-Oxo-3-Phenylpropanoate (41)Ethyl 3-Phenylpropanoate (17)Ethyl 4-Aminobenzoate (23)Ethyl 4-Chloropyrimidine-5-Carboxylate (5)Ethyl 5-Fluoro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloro-1H-Indole-2-Carboxylate (5)Ethyl Benzo[B]Thiophene-2-Carboxylate (9)Ethyl Cinnamate (26)Ethyl Cyclohex-1-Ene-1-Carboxylate (5)Ethyl Cyclohexanecarboxylate (33)Ethyl Cyclopropanecarboxylate (8)Ethyl Furan-2-Carboxylate (6)Ethyl Imidazo[1,2-A]Pyridine-2-Carboxylate (25)Ethyl Imidazo[1,2-A]Pyridine-3-Carboxylate (13)Ethyl Isonicotinate (12)Ethyl Isoxazole-3-Carboxylate (8)Ethyl Isoxazole-4-Carboxylate (5)Ethyl Morpholine-2-Carboxylate (4)Ethyl Nicotinate (25)Ethyl Oxazole-4-Carboxylate (8)Ethyl Oxazole-5-Carboxylate (3)Ethyl Oxirane-2-Carboxylate (4)Ethyl Picolinate (41)Ethyl Piperidine-2-Carboxylate (9)Ethyl Piperidine-3-Carboxylate (14)Ethyl Piperidine-4-Carboxylate (10)Ethyl Pyrazine-2-Carboxylate (10)Ethyl Pyridazine-3-Carboxylate (6)Ethyl Pyrimidine-4-Carboxylate (7)Ethyl Pyrimidine-5-Carboxylate (5)Ethyl Quinazoline-2-Carboxylate (4)Ethyl Thiazole-2-Carboxylate (7)Ethyl Thiazole-4-Carboxylate (7)Ethyl Thiazole-5-Carboxylate (7)Ethyl Thiophene-2-Carboxylate (19)Ethyl Thiophene-3-Carboxylate (11)Hexyl Benzoate (5)Isobutyl Benzoate (10)Isopropyl Benzoate (10)Methyl 1-Naphthoate (7)Methyl 1H-Benzo[D]Imidazole-2-Carboxylate (3)Methyl 1H-Imidazole-2-Carboxylate (4)Methyl 1H-Imidazole-5-Carboxylate (8)Methyl 1H-Indazole-3-Carboxylate (23)Methyl 1H-Indazole-4-Carboxylate (10)Methyl 1H-Indazole-5-Carboxylate (3)Methyl 1H-Indazole-6-Carboxylate (9)Methyl 1H-Indazole-7-Carboxylate (8)Methyl 1H-Indole-3-Carboxylate (21)Methyl 1H-Indole-4-Carboxylate (9)Methyl 1H-Indole-5-Carboxylate (7)Methyl 1H-Indole-6-Carboxylate (9)Methyl 1H-Indole-7-Carboxylate (7)Methyl 1H-Pyrazole-4-Carboxylate (10)Methyl 1H-Pyrrole-2-Carboxylate (30)Methyl 1H-Pyrrole-3-Carboxylate (5)Methyl 1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate (3)Methyl 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylate (4)Methyl 1H-Pyrrolo[2,3-B]Pyridine-6-Carboxylate (3)Methyl 2,6-Dichlorobenzoate (7)Methyl 2,6-Difluorobenzoate (17)Methyl 2-(1H-Indol-3-Yl)Acetate (3)Methyl 2-(2-Bromophenyl)Acetate (8)Methyl 2-(4-Hydroxyphenyl)Acetate (10)Methyl 2-(Bromomethyl)Benzoate (33)Methyl 2-(Chlorosulfonyl)Benzoate (7)Methyl 2-(Morpholin-3-Yl)Acetate (3)Methyl 2-(Pyridin-2-Yl)Acetate (9)Methyl 2-(Trifluoromethyl)Benzoate (14)Methyl 2-Amino-2-Phenylacetate (38)Methyl 2-Aminobenzoate (95)Methyl 2-Aminothiazole-4-Carboxylate (6)Methyl 2-Bromo-2-Phenylacetate (7)Methyl 2-Bromo-3-Nitrobenzoate (3)Methyl 2-Bromo-5-Fluorobenzoate (8)Methyl 2-Bromo-6-Fluorobenzoate (7)Methyl 2-Bromo-6-Methylbenzoate (8)Methyl 2-Bromobenzoate (69)Methyl 2-Chloro-4-Fluorobenzoate (5)Methyl 2-Chloro-6-Fluorobenzoate (7)Methyl 2-Chlorobenzoate (79)Methyl 2-Cyanobenzoate (22)Methyl 2-Fluorobenzoate (132)Methyl 2-Hydroxybenzoate (74)Methyl 2-Iodobenzoate (28)Methyl 2-Methoxybenzoate (70)Methyl 2-Methyl-2H-Indazole-3-Carboxylate (3)Methyl 2-Methylbenzoate (101)Methyl 2-Naphthoate (11)Methyl 2-Nitrobenzoate (54)Methyl 2-Phenoxyacetate (12)Methyl 2-Phenoxybenzoate (4)Methyl 2-Phenylacetate (114)Methyl 3-(Benzyloxy)Benzoate (5)Methyl 3-(Bromomethyl)Benzoate (16)Methyl 3-(Trifluoromethyl)Benzoate (22)Methyl 3-Amino-3-Phenylpropanoate (27)Methyl 3-Aminobenzoate (88)Methyl 3-Bromo-4-Chlorobenzoate (6)Methyl 3-Bromo-4-Fluorobenzoate (7)Methyl 3-Bromo-4-Methoxybenzoate (10)Methyl 3-Bromo-4-Methylbenzoate (9)Methyl 3-Bromobenzoate (153)Methyl 3-Bromopyrazine-2-Carboxylate (5)Methyl 3-Chlorobenzoate (88)Methyl 3-Cyanobenzoate (29)Methyl 3-Fluorobenzoate (136)Methyl 3-Formylbenzoate (23)Methyl 3-Hydroxybenzoate (58)Methyl 3-Iodo-4-Methylbenzoate (6)Methyl 3-Iodobenzoate (47)Methyl 3-Methoxybenzoate (72)Methyl 3-Methylbenzoate (75)Methyl 3-Nitrobenzoate (109)Methyl 3-Oxo-3-Phenylpropanoate (16)Methyl 3-Phenylpropanoate (28)Methyl 4-Amino-3-Bromobenzoate (8)Methyl 4-Amino-3-Iodobenzoate (7)Methyl 4-Amino-3-Nitrobenzoate (9)Methyl 4-Aminobenzoate (71)Methyl 4-Fluorobenzoate (75)Methyl 4-Nitrobenzoate (29)Methyl 4-Oxocyclohexane-1-Carboxylate (5)Methyl 4-Oxopiperidine-2-Carboxylate (3)Methyl 4-Phenoxybenzoate (3)Methyl 5-Amino-2-Bromobenzoate (6)Methyl 5-Hydroxypicolinate (5)Methyl 5-Oxopyrrolidine-2-Carboxylate (3)Methyl 5-Phenylisoxazole-3-Carboxylate (6)Methyl 6-Bromopyrazine-2-Carboxylate (7)Methyl 6-Chloropyrazine-2-Carboxylate (5)Methyl 6-Methoxynicotinate (4)Methyl [1,1'-Biphenyl]-4-Carboxylate (8)Methyl Azetidine-2-Carboxylate (3)Methyl Benzo[B]Thiophene-2-Carboxylate (27)Methyl Benzo[D]Oxazole-2-Carboxylate (3)Methyl Benzo[D]Thiazole-6-Carboxylate (5)Methyl Bicyclo[1.1.1]Pentane-1-Carboxylate (10)Methyl Cinnamate (37)Methyl Cyclobutanecarboxylate (24)Methyl Cyclohex-3-Ene-1-Carboxylate (3)Methyl Cyclohexanecarboxylate (45)Methyl Cyclopentanecarboxylate (18)Methyl Cyclopropanecarboxylate (8)Methyl Furan-2-Carboxylate (20)Methyl Imidazo[1,2-A]Pyridine-8-Carboxylate (3)Methyl Indoline-6-Carboxylate (3)Methyl Isonicotinate (16)Methyl Isoquinoline-4-Carboxylate (6)Methyl L-Phenylalaninate (7)Methyl Morpholine-2-Carboxylate (4)Methyl Morpholine-3-Carboxylate (10)Methyl Nicotinate (52)Methyl Oxazole-4-Carboxylate (9)Methyl Piperidine-2-Carboxylate (12)Methyl Piperidine-3-Carboxylate (19)Methyl Prolinate (43)Methyl Pyrazine-2-Carboxylate (19)Methyl Pyridazine-3-Carboxylate (7)Methyl Pyrimidine-2-Carboxylate (10)Methyl Pyrimidine-4-Carboxylate (11)Methyl Pyrimidine-5-Carboxylate (5)Methyl Pyrrolidine-3-Carboxylate (9)Methyl Thiazole-2-Carboxylate (6)Methyl Thiazole-4-Carboxylate (6)Methyl Thiophene-3-Carboxylate (34)Phenyl (1R,4R)-[1,1'-Bi(Cyclohexane)]-4-Carboxylate (6)Phenyl Dimethylcarbamate (5)Phenyl Ethyl(Methyl)Carbamate (5)Propyl Benzoate (11)Tert-Butyl (1-Phenylethyl)Carbamate (19)Tert-Butyl (2,3-Dihydro-1H-Inden-1-Yl)Carbamate (3)Tert-Butyl (2-Phenylcyclopropyl)Carbamate (3)Tert-Butyl (3-Oxocyclohexyl)Carbamate (3)Tert-Butyl (Morpholin-2-Ylmethyl)Carbamate (3)Tert-Butyl (Tetrahydrofuran-3-Yl)Carbamate (4)Tert-Butyl 1H-Benzo[D]Imidazole-1-Carboxylate (3)Tert-Butyl 1H-Imidazole-1-Carboxylate (6)Tert-Butyl 1H-Indazole-1-Carboxylate (29)Tert-Butyl 1H-Indole-1-Carboxylate (18)Tert-Butyl 1H-Pyrrole-1-Carboxylate (8)Tert-Butyl 1H-Pyrrole-2-Carboxylate (3)Tert-Butyl 1H-Pyrrolo[2,3-B]Pyridine-1-Carboxylate (9)Tert-Butyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (19)Tert-Butyl 3-((Methylsulfonyl)Oxy)Pyrrolidine-1-Carboxylate (5)Tert-Butyl 3-Oxopiperazine-1-Carboxylate (7)Tert-Butyl 4-Phenylpiperazine-1-Carboxylate (23)Tert-Butyl 4-Phenylpiperidine-1-Carboxylate (16)Tert-Butyl Azetidine-1-Carboxylate (64)Tert-Butyl Benzoate (66)Tert-Butyl Benzylcarbamate (52)Tert-Butyl Bicyclo[1.1.1]Pentan-1-Ylcarbamate (5)Tert-Butyl Cyclopentylcarbamate (28)Tert-Butyl Isoindoline-2-Carboxylate (13)Tert-Butyl Methyl(Phenyl)Carbamate (9)Tert-Butyl Morpholine-4-Carboxylate (23)Tert-Butyl O-Tolylcarbamate (11)Tert-Butyl Phenethylcarbamate (12)Tert-Butyl Piperazine-1-Carboxylate (30)Tert-Butyl Pyrrolidine-1-Carboxylate (21)Acetoxymethyl (85)Acetoxyphenyl (1)Acetyloxy (54)Acrylate (118)Acryloyloxy (3)Adipate (17)Adipate (17)Amino-Carboxylate (2)Aminobenzoate (18)Aminobenzylcarbamate (8)Aminobutanoate (14)Aminocyclobutanecarboxylic Acid (4)Aminocyclohexanecarboxylic (16)Aminocyclohexanecarboxylic Acid (10)Aminocyclopentanecarboxylic (13)Aminoheptanoate (9)Aminohexanoate (6)Aminoisonicotinate (4)Aminoisophthalate (5)Aminonicotinate (7)Aminopentanedioate (15)Aminopentanoate (7)Aminopropanoate (16)Benzoyloxy (14)Benzylcarbamate (8)Bromobenzoate (26)Bromobutanoate (9)Bromocyclopropanecarboxylate (1)Bromodecanoate (20)Bromoisonicotinate (8)Bromoisophthalate (3)Bromonicotinate (13)Bromopropanoate (9)Bromoundecanoate (3)Butoxycarbonyl (1675)Butoxycarbonyl (1675)Carbamate (1536)Chlorobenzoate (49)Chloroformate (4)Chloropicolinate (30)Chloropropanoate (5)Cyanoacrylate (6)Decanedioate (9)Decanedioate (9)Decanoate (7)Decanoate (7)Diacetate (56)Diacetoxy (1)Diacrylate (15)Diaminobenzoate (7)Dibromobenzoate (4)Dicarbamate (14)Dichlorobenzoate (24)Dichloroisonicotinate (9)Dimethacrylate (1)Dimethylbutanoate (14)Dimethylcarbamate (3)Dimethylnicotinate (10)Dimethylnicotinate (10)Dipropanoate (6)Dipropanoate (6)Diyldicarbamate (5)Dodecanoate (11)Enecarboxylate (9)Enoate (116)Ethoxycarbonyl (70)Ethylbutanoate (6)Ethynylbenzoate (7)Ethynylbenzylcarbamate (3)Glutarate (3)Glutarate (3)Hexanoate (14)Hexanoate (14)Indoline-Carboxylate (1)Iodoacrylate (6)Iodobutanoate (4)Iodopropanoate (1)Isobutyrate (18)Isobutyrate (18)Methacrylate (87)Methacryloyloxy (7)Methoxycarbonyl (169)Methoxycarbonyl (169)Methoxyisonicotinate (11)Methoxyisonicotinate (11)Methoxynicotinate (24)Methoxynicotinate (24)Methoxypropanoate (5)Methoxypropanoate (5)Methylacrylate (13)Methylbutanoate (38)Methylmalonate (6)Methylnicotinate (57)Methylpentanoate (17)Methylpropanoate (47)Nitropicolinate (13)Nonanedioate (4)Nonanedioate (4)Oxoacetate (21)Oxoacetate (21)Oxobutanoate (56)Oxobutanoate (56)Oxoheptanoate (8)Oxoheptanoate (8)Oxohexanoate (14)Oxohexanoate (14)Oxopentanoate (31)Oxopropanoate (39)Oxopropanoate (39)Pentanoate (13)Pentanoate (13)Phenylacrylate (5)Phenylpropanoate (31)Propanoate (276)Propylpentanoate (5)Propylpentanoate (5)Succinate (23)Succinate (23)Sulfamoylbenzoate (6)Tetraacetate (7)Tetraacetate (7)Tetradecanoate (10)Tetradecanoate (10)Thiophenecarboxylate (1)Tosylcarbamate (4)Tosyloxy (12)Triacetate (12)Triacetate (12)Vinylbenzoate (3)Vinylcyclopropanecarboxylic Acid (3)
Ethers (82403)
Butoxy-Phenyl-Boronic Acid/Ester (76)Diethoxy (14)Diethoxy (14)Diethoxyethyl (9)Diethoxyethyl (9)Diethoxymethyl (8)Diethoxymethyl (8)Dimethoxyethyl (8)Dimethoxypropane (11)Dimethoxypropane (11)Dioxane (153)Dioxepine (7)Dioxepine (7)Disulfide (38)Methoxyphenylboronic-Acid (32)(1S,4Ar,7Ar)-1-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-1,4A,5,7A-Tetrahydrocyclopenta[C]Pyran (4)(2,2,2-Trifluoroethoxy)Benzene (18)(2-(Benzyloxy)Phenyl)Boronic Acid (23)(2-(Phenoxymethyl)Phenyl)Boronic Acid (3)(2-Chloro-3-Methoxyphenyl)Boronic Acid (5)(2-Chloroethoxy)Benzene (5)(2-Methoxyethoxy)Benzene (32)(3-(Benzyloxy)Phenyl)Boronic Acid (9)(3-(Phenoxymethyl)Phenyl)Boronic Acid (3)(3-Chloro-2-Methoxyphenyl)Boronic Acid (4)(3-Phenoxyphenyl)Methanol (3)(4-(Benzyloxy)Phenyl)Boronic Acid (26)(4-(Phenoxymethyl)Phenyl)Boronic Acid (6)(4-Methoxyphenyl)(Phenyl)Methanone (7)(9H-Fluoren-9-Yl)Methyl (2-(Benzyloxy)Ethyl)Carbamate (6)(9H-Fluoren-9-Yl)Methyl (4-Methoxybenzyl)Carbamate (7)(Allyloxy)Benzene (19)(Ethoxymethyl)Benzene (7)(Hexyloxy)Benzene (7)(Methoxymethyl)Benzene (30)(Prop-2-Yn-1-Yloxy)Benzene (13)(R)-2-Phenoxytetrahydro-2H-Pyran (7)(S)-7-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-7,8,9,10-Tetrahydrotetracene-5,12-Dione (5)1,2-Bis(Benzyloxy)Benzene (11)1,2-Dichloro-3-Methoxybenzene (7)1,2-Dichloro-4-Methoxybenzene (11)1,2-Difluoro-3-Methoxybenzene (28)1,2-Difluoro-4-Methoxybenzene (19)1,2-Dimethoxybenzene (225)1,2-Diphenoxyethane (11)1,3-Bis(Benzyloxy)Benzene (8)1,3-Dibromo-2-Methoxybenzene (11)1,3-Dichloro-2-Methoxybenzene (9)1,3-Diiodo-2-Phenoxybenzene (3)1,3-Dimethoxybenzene (239)1,3-Diphenoxybenzene (8)1,4-Dichloro-2-Methoxybenzene (8)1,4-Dimethoxybenzene (66)1-(2-Methoxyphenyl)Ethan-1-One (34)1-(3-(Benzyloxy)Phenyl)Ethan-1-One (3)1-(3-Methoxyphenyl)Ethan-1-One (38)1-(3-Methoxyphenyl)Piperazine (4)1-(4-(Benzyloxy)Phenyl)Ethan-1-One (4)1-(4-Methoxybenzyl)-1H-Pyrazole (5)1-(Benzyloxy)-2-Bromobenzene (12)1-(Benzyloxy)-2-Chlorobenzene (16)1-(Benzyloxy)-2-Fluorobenzene (10)1-(Benzyloxy)-2-Methoxybenzene (19)1-(Benzyloxy)-2-Methylbenzene (12)1-(Benzyloxy)-2-Nitrobenzene (3)1-(Benzyloxy)-3-Bromobenzene (12)1-(Benzyloxy)-3-Chlorobenzene (6)1-(Benzyloxy)-3-Fluorobenzene (14)1-(Benzyloxy)-3-Methylbenzene (8)1-(Benzyloxy)-3-Nitrobenzene (10)1-(Benzyloxy)-4-Bromobenzene (8)1-(Benzyloxy)-4-Iodobenzene (3)1-(Bromomethyl)-2-Methoxybenzene (14)1-(Bromomethyl)-3-Methoxybenzene (19)1-(Difluoromethoxy)-2-Fluorobenzene (11)1-Benzyl-4-Methoxybenzene (8)1-Bromo-2,3-Dimethoxybenzene (8)1-Bromo-2-Chloro-3-Methoxybenzene (6)1-Bromo-2-Ethoxybenzene (16)1-Bromo-2-Fluoro-3-Methoxybenzene (7)1-Bromo-2-Phenoxybenzene (3)1-Bromo-3-Methoxybenzene (187)1-Bromo-3-Phenoxybenzene (8)1-Bromo-4-Phenoxybenzene (8)1-Chloro-2,4-Dimethoxybenzene (7)1-Chloro-2-Ethoxybenzene (14)1-Chloro-2-Phenoxybenzene (10)1-Chloro-2-Propoxybenzene (5)1-Chloro-3-Fluoro-2-Methoxybenzene (4)1-Chloro-3-Methoxybenzene (126)1-Chloro-3-Phenoxybenzene (5)1-Chloro-4-Methoxybenzene (98)1-Chloro-4-Phenoxybenzene (13)1-Cyclopropyl-3-(4-(Quinolin-4-Yloxy)Phenyl)Urea (6)1-Ethoxy-2,3-Difluorobenzene (9)1-Ethoxy-2-Fluorobenzene (37)1-Ethoxy-3-Nitrobenzene (7)1-Fluoro-2-(Trifluoromethoxy)Benzene (20)1-Fluoro-2-Isopropoxybenzene (18)1-Fluoro-2-Phenoxybenzene (11)1-Fluoro-3-Methoxybenzene (213)1-Fluoro-3-Phenoxybenzene (8)1-Fluoro-4-(Trifluoromethoxy)Benzene (14)1-Fluoro-4-Methoxybenzene (125)1-Fluoro-4-Phenoxybenzene (8)1-Iodo-2-Methoxybenzene (50)1-Iodo-3-Methoxybenzene (48)1-Iodo-4-Methoxybenzene (34)1-Iodo-4-Phenoxybenzene (4)1-Methoxy-2-(Trifluoromethyl)Benzene (21)1-Methoxy-3-(Trifluoromethoxy)Benzene (9)1-Methoxy-3-(Trifluoromethyl)Benzene (40)1-Methoxy-3-Nitrobenzene (108)1-Methoxy-4-(Phenoxymethyl)Benzene (3)1-Methoxy-4-(Trifluoromethyl)Benzene (18)1-Methoxy-4-Nitrobenzene (90)1-Methoxynaphthalene (18)1-Methyl-3-Phenoxybenzene (9)1-Nitro-2-Phenoxybenzene (4)1-Nitro-4-Phenoxybenzene (5)1-Phenoxy-3-(Trifluoromethyl)Benzene (2)1-Phenoxy-4-(Trifluoromethyl)Benzene (2)1-Phenyl-3-(4-(Pyridin-4-Yloxy)Phenyl)Urea (8)2,3,5,6,8,9,11,12-Octahydrobenzo[B][1,4,7,10,13]Pentaoxacyclopentadecine (8)2,3-Dimethoxypyridine (7)2,4,6-Triphenoxy-1,3,5-Triazine (4)2,4-Dibromo-1-Methoxybenzene (6)2,4-Dichloro-1-Methoxybenzene (18)2,4-Difluoro-1-Methoxybenzene (25)2,4-Dimethoxy-1-Nitrobenzene (5)2,4-Dimethoxypyrimidine (13)2,6-Dimethoxypyridine (11)2-(2-Methoxyphenyl)Acetic Acid (16)2-(3-Isopropoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(3-Methoxyphenyl)Acetic Acid (23)2-(4-(Benzyloxy)Phenyl)Acetonitrile (3)2-(4-Methoxyphenyl)Acetic Acid (21)2-(Benzyloxy)Benzaldehyde (13)2-(Benzyloxy)Naphthalene (5)2-(Benzyloxy)Phenol (5)2-(Methoxymethyl)Morpholine (4)2-(Methoxymethyl)Pyrrolidine (6)2-(Phenoxymethyl)Oxirane (13)2-(Phenoxymethyl)Pyridine (5)2-(Phenoxymethyl)Tetrahydro-2H-Pyran (5)2-Bromo-1,3-Dimethoxybenzene (7)2-Bromo-1,4-Dimethoxybenzene (11)2-Bromo-1-Fluoro-4-Methoxybenzene (12)2-Bromo-1-Methoxy-3-Methylbenzene (3)2-Bromo-1-Methoxy-4-Methylbenzene (7)2-Bromo-3-Methoxypyrazine (5)2-Bromo-4-Methoxy-1-Nitrobenzene (6)2-Bromo-4-Methoxyaniline (6)2-Bromo-4-Methoxybenzaldehyde (8)2-Bromo-4-Methoxybenzoic Acid (4)2-Bromo-5-Methoxybenzaldehyde (6)2-Bromo-6-Methoxyaniline (5)2-Bromo-6-Methoxyphenol (5)2-Chloro-1,3-Dimethoxybenzene (3)2-Chloro-1,4-Dimethoxybenzene (4)2-Chloro-3-Methoxybenzaldehyde (7)2-Chloro-3-Methoxybenzoic Acid (6)2-Chloro-4-Fluoro-1-Methoxybenzene (10)2-Chloro-4-Methoxypyrimidine (14)2-Chloro-5-Methoxyaniline (8)2-Chloro-6-Methoxyaniline (3)2-Chloro-6-Methoxyphenol (4)2-Ethoxynaphthalene (4)2-Ethoxypyridine (20)2-Ethoxypyrimidine (7)2-Fluoro-1,3-Dimethoxybenzene (8)2-Fluoro-1-Methoxy-4-Nitrobenzene (8)2-Fluoro-4-Methoxyaniline (6)2-Fluoro-5-Methoxybenzoic Acid (9)2-Fluoro-5-Methoxypyridine (4)2-Fluoro-6-Methoxypyridine (6)2-Isopropoxypyridine (16)2-Methoxy-1,1'-Biphenyl (7)2-Methoxy-1,3,5-Triazine (10)2-Methoxy-4-Methylpyridine (5)2-Methoxy-5-Methylpyridine (5)2-Methoxy-6-Methylpyridine (14)2-Methoxy-6-Nitrophenol (5)2-Methoxybenzamide (9)2-Methoxybenzenesulfonyl Chloride (15)2-Methoxynaphthalene (22)2-Methoxyphenol (201)2-Methoxypyrazine (45)2-Methoxypyridine (435)2-Methoxypyrimidin-4-Amine (6)2-Methoxypyrimidine (59)2-Methoxythiophene (7)2-Methyl-N-Phenylaniline (7)2-Phenoxyacetonitrile (11)2-Phenoxyaniline (4)2-Phenoxybenzonitrile (5)2-Phenoxyethan-1-Ol (14)2-Phenoxypropanoic Acid (13)2-Phenoxypyrimidine (8)2-Phenoxytetrahydro-2H-Pyran (6)2-Phenoxythiazole (5)2-Propoxypyridine (9)3,5-Dimethoxypyridine (4)3-(3-Methoxyphenyl)Propanoic Acid (9)3-(Benzyloxy)Aniline (12)3-(Benzyloxy)Benzaldehyde (13)3-(Benzyloxy)Benzoic Acid (5)3-(Benzyloxy)Phenol (5)3-(Methoxymethyl)Morpholine (4)3-Chloro-2-Methoxybenzoic Acid (4)3-Chloro-4-Methoxyaniline (6)3-Chloro-4-Methoxybenzaldehyde (7)3-Chloro-4-Methoxybenzoic Acid (5)3-Ethoxypyridine (12)3-Fluoro-2-Methoxypyridine (14)3-Fluoro-4-Methoxybenzoic Acid (6)3-Methoxypiperidine (7)3-Methoxypyridazine (17)3-Methoxypyridine (51)3-Methoxythiophene (9)3-Phenoxyaniline (2)3-Phenoxybenzaldehyde (7)3-Phenoxybenzoic Acid (6)3-Phenoxybenzonitrile (5)3-Phenoxypropanoic Acid (14)3-Phenoxypyrrolidine (5)4-(3-Phenoxypropyl)Morpholine (7)4-(Benzyloxy)Aniline (8)4-(Benzyloxy)Benzaldehyde (23)4-(Benzyloxy)Benzoic Acid (5)4-(Benzyloxy)Phenol (2)4-(Difluoromethoxy)Aniline (6)4-(Dimethoxymethyl)Pyrimidine (5)4-(Phenylethynyl)Phenol (7)4-Chloro-2-Methoxypyrimidine (12)4-Chloro-5-Methoxypyrimidine (7)4-Chloro-6-Methoxypyrimidine (5)4-Ethoxypyridine (7)4-Ethoxypyrimidine (6)4-Methoxy-1,1'-Biphenyl (4)4-Methoxy-1H-Indazole (7)4-Methoxy-1H-Indole (11)4-Methoxy-2-Methylpyrimidine (8)4-Methoxy-N-Phenylaniline (5)4-Methoxy-N-Phenylbenzenesulfonamide (3)4-Methoxybenzenesulfonamide (5)4-Methoxypyridazine (8)4-Methoxypyridine (136)4-Methoxypyrimidin-2-Amine (6)4-Methoxypyrimidine (102)4-Phenoxyaniline (6)4-Phenoxybenzaldehyde (12)4-Phenoxybenzoic Acid (4)4-Phenoxypyridine (7)4-Phenoxypyrimidine (5)4-Phenoxyquinoline (5)4-Phenoxytetrahydro-2H-Pyran (5)5-(Benzyloxy)Pyrimidine (5)5-Fluoro-2-Methoxypyridine (15)5-Methoxy-1H-Benzo[D]Imidazole (2)5-Methoxy-1H-Indazole (5)5-Methoxy-1H-Indole (11)5-Methoxy-2-Methyl-1H-Indole (5)5-Methoxy-2-Nitroaniline (7)5-Methoxyindoline (4)5-Methoxyisobenzofuran-1(3H)-One (5)5-Methoxyisoquinoline (6)6-Methoxy-1,2,3,4-Tetrahydroisoquinoline (3)6-Methoxy-1H-Indazole (14)6-Methoxy-1H-Indole (12)6-Methoxy-1H-Pyrrolo[2,3-B]Pyridine (3)6-Methoxy-3,4-Dihydroisoquinolin-1(2H)-One (3)6-Methoxybenzo[D]Thiazole (6)6-Methoxybenzofuran (4)6-Methoxychromane (5)6-Methoxyisoindolin-1-One (3)6-Methoxyquinoxaline (6)7-(Benzyloxy)Quinoline (6)7-Methoxy-1,2,3,4-Tetrahydroisoquinoline (6)7-Methoxy-1H-Indazole (5)7-Methoxy-1H-Indole (8)7-Methoxy-3,4-Dihydroquinolin-2(1H)-One (3)7-Methoxyisoquinoline (5)8-Methoxyisoquinoline (7)8-Methoxyquinazoline (3)Butoxybenzene (51)Ethoxybenzene (285)Ethyl 2-Phenoxyacetate (10)Isobutoxybenzene (22)Isopropoxybenzene (85)Methoxycyclohexane (7)Methyl 2-Methoxybenzoate (70)Methyl 2-Phenoxyacetate (12)Methyl 2-Phenoxybenzoate (4)Methyl 3-(Benzyloxy)Benzoate (5)Methyl 3-Methoxybenzoate (72)Methyl 4-Phenoxybenzoate (3)N,N-Dimethyl-2-Phenoxyethan-1-Amine (17)N-(2-Phenoxyphenyl)Methanesulfonamide (4)N-(4-Phenoxyphenyl)Acetamide (4)N-Phenyl-N-(4-(Quinolin-4-Yloxy)Phenyl)Cyclopropane-1,1-Dicarboxamide (5)Phenethoxybenzene (23)Propoxybenzene (63)Tert-Butoxybenzene (17)Tert-Butyl 3-Methoxypyrrolidine-1-Carboxylate (6)Tert-Butyl 4-Phenoxypiperidine-1-Carboxylate (12)Tert-Butyl 5-Methoxy-1H-Indole-1-Carboxylate (6)
Fluorinated Building Blocks (98883)
(2,3-Difluorophenyl)Boronic Acid (33)(2,6-Difluorophenyl)Boronic Acid (28)(2-Chloro-6-Fluorophenyl)Boronic Acid (9)(2-Fluorobenzyl)Hydrazine (6)(2-Fluorophenyl)(Phenyl)Methanone (15)(2-Fluorophenyl)Boronic Acid (229)(2-Fluorophenyl)Hydrazine (22)(2-Fluorophenyl)Methanamine (49)(2-Fluorophenyl)Methanol (60)(3-Fluorophenyl)(Phenyl)Methanone (5)(3-Fluorophenyl)Boronic Acid (169)(3-Fluorophenyl)Methanol (58)(4-Fluorophenyl)(Phenyl)Methanone (8)(4-Fluorophenyl)Boronic Acid (93)(4-Fluorophenyl)Methanamine (27)(4-Fluorophenyl)Methanol (29)1,1-Difluorocyclobutane (14)1,1-Difluorocyclohexane (18)1,2,3,4,5-Pentafluorobenzene (51)1,2,3,4-Tetrafluorobenzene (74)1,2,3-Trifluorobenzene (157)1,2,4-Trifluorobenzene (211)1,2-Dibromo-3-Fluorobenzene (9)1,2-Dibromo-4-Fluorobenzene (11)1,2-Dichloro-3-Fluorobenzene (13)1,2-Dichloro-4-Fluorobenzene (15)1,2-Difluoro-3-Iodobenzene (13)1,2-Difluoro-3-Methoxybenzene (28)1,2-Difluoro-3-Methylbenzene (23)1,2-Difluoro-3-Nitrobenzene (23)1,2-Difluoro-4-Methoxybenzene (19)1,2-Difluoro-4-Nitrobenzene (43)1,2-Difluorobenzene (658)1,3-Dibromo-2,4-Difluorobenzene (5)1,3-Dibromo-2-Fluorobenzene (15)1,3-Dichloro-2-Fluorobenzene (23)1,3-Difluoro-2-Iodobenzene (12)1,3-Difluoro-2-Methylbenzene (18)1,3-Difluoro-2-Nitrobenzene (16)1,4-Dichloro-2-Fluorobenzene (11)1,4-Difluoro-2-Iodobenzene (8)1,4-Difluoro-2-Nitrobenzene (28)1,4-Difluorobenzene (362)1-(2-Fluorophenyl)Ethan-1-Amine (80)1-(2-Fluorophenyl)Ethan-1-One (58)1-(2-Fluorophenyl)Piperazine (8)1-(2-Fluorophenyl)Propan-1-Amine (8)1-(3-Fluorophenyl)Ethan-1-One (63)1-(4-Fluorophenyl)Ethan-1-One (36)1-(Benzyloxy)-2-Fluorobenzene (10)1-(Benzyloxy)-3-Fluorobenzene (14)1-(Bromomethyl)-2-Fluorobenzene (50)1-(Bromomethyl)-3-Fluorobenzene (47)1-(Chloromethyl)-2-Fluorobenzene (8)1-(Chloromethyl)-3-Fluorobenzene (11)1-Benzyl-4-Fluorobenzene (2)1-Bromo-2,3-Difluorobenzene (67)1-Bromo-2,4-Difluorobenzene (59)1-Bromo-2-Chloro-3-Fluorobenzene (20)1-Bromo-2-Fluoro-3-Methylbenzene (11)1-Bromo-3-Fluoro-2-Methoxybenzene (12)1-Bromo-3-Fluoro-2-Methylbenzene (17)1-Bromo-3-Fluoro-2-Nitrobenzene (10)1-Bromo-4-Fluoro-2-Methoxybenzene (11)1-Bromo-4-Fluoro-2-Methylbenzene (18)1-Chloro-2,3-Difluorobenzene (27)1-Chloro-2,4-Difluorobenzene (35)1-Chloro-3-Fluoro-2-Methoxybenzene (4)1-Chloro-3-Fluoro-2-Methylbenzene (10)1-Cyclohexyl-2-Fluorobenzene (4)1-Ethoxy-2,3-Difluorobenzene (9)1-Ethoxy-2-Fluorobenzene (37)1-Ethynyl-2-Fluorobenzene (10)1-Fluoro-2,3-Dimethylbenzene (8)1-Fluoro-2-(Methylsulfonyl)Benzene (5)1-Fluoro-2-Iodo-4-Methylbenzene (3)1-Fluoro-2-Iodobenzene (102)1-Fluoro-2-Isopropoxybenzene (18)1-Fluoro-2-Methylbenzene (255)1-Fluoro-2-Phenoxybenzene (11)1-Fluoro-3,5-Dimethylbenzene (12)1-Fluoro-3-(Methylsulfonyl)Benzene (10)1-Fluoro-3-Iodo-2-Methylbenzene (3)1-Fluoro-3-Iodobenzene (94)1-Fluoro-3-Methoxybenzene (213)1-Fluoro-3-Methylbenzene (254)1-Fluoro-3-Nitrobenzene (216)1-Fluoro-3-Phenoxybenzene (8)1-Fluoro-4-Iodobenzene (65)1-Fluoro-4-Methoxybenzene (125)1-Fluoro-4-Methylbenzene (140)1-Fluoro-4-Phenoxybenzene (8)1-Fluorobicyclo[1.1.1]Pentane (4)1-Fluoronaphthalene (23)2'-Fluoro-1,1':4',1''-Terphenyl (6)2,2',3,3',5,5',6,6'-Octafluoro-1,1'-Biphenyl (4)2,3-Difluoroaniline (34)2,3-Difluorobenzaldehyde (18)2,3-Difluorobenzoic Acid (35)2,3-Difluorobenzonitrile (29)2,3-Difluorophenol (36)2,3-Difluoropyridine (13)2,4-Dibromo-1-Fluorobenzene (18)2,4-Dichloro-1-Fluorobenzene (27)2,4-Difluoro-1-Iodobenzene (14)2,4-Difluoro-1-Methoxybenzene (25)2,4-Difluoro-1-Nitrobenzene (46)2,4-Difluoroaniline (44)2,4-Difluorobenzaldehyde (19)2,4-Difluorobenzoic Acid (29)2,4-Difluorobenzonitrile (21)2,4-Difluorophenol (21)2,5-Difluoroaniline (34)2,5-Difluorobenzoic Acid (32)2,5-Difluoropyridine (8)2,6-Difluoroaniline (23)2,6-Difluorobenzaldehyde (25)2,6-Difluorobenzoic Acid (33)2,6-Difluorobenzonitrile (28)2,6-Difluorophenol (24)2,6-Difluoropyridine (29)2-(2-Fluorophenyl)Acetic Acid (43)2-(2-Fluorophenyl)Acetonitrile (30)2-(2-Fluorophenyl)Pyrrolidine (16)2-(3-Fluorophenyl)Acetic Acid (50)2-(3-Fluorophenyl)Pyrrolidine (5)2-(4-Fluorophenyl)-1H-Indole (4)2-(4-Fluorophenyl)Acetic Acid (30)2-(Bromomethyl)-1,3-Difluorobenzene (12)2-Amino-2-(2-Fluorophenyl)Acetic Acid (11)2-Amino-3-(2-Fluorophenyl)Propanoic Acid (17)2-Amino-3-Fluorobenzoic Acid (11)2-Bromo-1,3,4-Trifluorobenzene (16)2-Bromo-1,3-Difluorobenzene (43)2-Bromo-1,4-Difluorobenzene (64)2-Bromo-1-Chloro-3-Fluorobenzene (9)2-Bromo-1-Chloro-4-Fluorobenzene (20)2-Bromo-1-Fluoro-4-Methylbenzene (17)2-Bromo-4-Chloro-1-Fluorobenzene (16)2-Bromo-4-Fluoro-1-Methoxybenzene (12)2-Bromo-4-Fluoro-1-Methylbenzene (21)2-Bromo-4-Fluoroaniline (28)2-Bromo-4-Fluorobenzaldehyde (7)2-Bromo-4-Fluorobenzonitrile (7)2-Bromo-4-Fluorophenol (10)2-Bromo-5-Fluoroaniline (18)2-Bromo-5-Fluorobenzaldehyde (7)2-Bromo-5-Fluorobenzoic Acid (11)2-Bromo-6-Fluoroaniline (14)2-Bromo-6-Fluorophenol (9)2-Chloro-1,3-Difluorobenzene (27)2-Chloro-1,4-Difluorobenzene (25)2-Chloro-3-Fluoropyridine (20)2-Chloro-4-Fluoro-1-Methoxybenzene (10)2-Chloro-4-Fluoroaniline (19)2-Chloro-4-Fluorobenzaldehyde (10)2-Chloro-4-Fluorobenzoic Acid (9)2-Chloro-4-Fluorobenzonitrile (9)2-Chloro-4-Fluorophenol (9)2-Chloro-5-Fluoropyrimidine (6)2-Chloro-6-Fluoroaniline (8)2-Chloro-6-Fluorobenzoic Acid (8)2-Chloro-6-Fluorobenzonitrile (5)2-Chloro-6-Fluorophenol (5)2-Fluoro-1,3-Dimethoxybenzene (8)2-Fluoro-1,3-Dimethylbenzene (14)2-Fluoro-1-Iodo-4-Methylbenzene (5)2-Fluoro-3-Methylbenzaldehyde (8)2-Fluoro-3-Methylpyridine (14)2-Fluoro-4-Methoxyaniline (6)2-Fluoro-4-Methyl-1-Nitrobenzene (13)2-Fluoro-4-Methylbenzoic Acid (7)2-Fluoro-4-Methylpyridine (6)2-Fluoro-5-Methylpyridine (6)2-Fluoro-6-Methylpyridine (20)2-Fluoro-N-Methylbenzamide (12)2-Fluoro-N-Phenylaniline (4)2-Fluoro-N-Phenylbenzenesulfonamide (6)2-Fluoroaniline (262)2-Fluorobenzaldehyde (175)2-Fluorobenzamide (32)2-Fluorobenzenesulfonamide (12)2-Fluorobenzenesulfonyl Chloride (31)2-Fluorobenzoic Acid (220)2-Fluoropyridine (15)2-Fluoropyrimidine (9)3,3-Difluoropiperidine (29)3,3-Difluoropyrrolidine (29)3,4-Difluoroaniline (44)3,4-Difluorophenol (19)3,5-Difluoropyridine (12)3-((Tert-Butoxycarbonyl)Amino)-4-(2-Fluorophenyl)Butanoic Acid (9)3-Chloro-2-Fluoroaniline (9)3-Fluoro-1,1'-Biphenyl (16)3-Fluoro-2-Iodoaniline (8)3-Fluoro-2-Methylaniline (9)3-Fluoro-2-Methylpyridine (15)3-Fluoro-4-Nitroaniline (7)3-Fluoroaniline (289)3-Fluorobenzaldehyde (137)3-Fluorobenzamide (26)3-Fluorobenzenesulfonyl Chloride (22)3-Fluorobenzoic Acid (206)3-Fluorophenol (180)3-Fluoropiperidine (26)3-Fluoropyridin-2-Amine (12)3-Fluoropyridin-4-Amine (4)3-Fluorothiophene (6)4,4-Difluoropiperidine (5)4-(2-Fluorophenyl)Morpholine (8)4-(4-Fluorophenyl)Thiazole (9)4-Chloro-5-Fluoro-2-Methylpyrimidine (5)4-Fluoro-1-Methyl-2-Nitrobenzene (12)4-Fluoro-1H-Indazole (22)4-Fluoro-1H-Indole (24)4-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (6)4-Fluoro-2-Iodoaniline (7)4-Fluoro-2-Nitroaniline (14)4-Fluoroaniline (225)4-Fluorobenzaldehyde (78)4-Fluorobenzamide (19)4-Fluorobenzenesulfonyl Chloride (26)4-Fluorobenzo[D]Thiazole (6)4-Fluorobenzoic Acid (114)4-Fluorobenzonitrile (89)4-Fluoroisoquinoline (6)4-Fluorophenol (111)4-Fluoropyrimidine (8)5-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)5-Fluoro-1H-Benzo[D][1,2,3]Triazole (4)5-Fluoro-1H-Benzo[D]Imidazole (12)5-Fluoro-1H-Indole (50)5-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (9)5-Fluoro-2,3-Dihydro-1H-Indene (3)5-Fluoro-2,3-Dihydrobenzofuran (5)5-Fluoro-2-Methylpyridine (8)5-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)5-Fluorochromane (6)5-Fluoroindoline (3)5-Fluoroisoindolin-1-One (3)5-Fluoropyridin-2-Amine (15)5-Fluoropyrimidine (11)6-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroquinoline (3)6-Fluoro-1H-Indazole (15)6-Fluoro-1H-Indole (17)6-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (3)6-Fluorobenzo[D]Thiazole (5)6-Fluorochromane (6)6-Fluoropyridin-2-Amine (8)6-Fluoropyridin-3-Amine (4)7-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)7-Fluoro-1,2,3,4-Tetrahydroquinoline (3)7-Fluoro-1H-Indazole (12)7-Fluoro-1H-Indole (24)7-Fluorobenzo[D]Thiazole (9)7-Fluoroindoline-2,3-Dione (6)7-Fluoroisoquinoline (3)8-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)8-Fluorochromane (5)8-Fluoroimidazo[1,2-A]Pyridine (3)8-Fluoroisoquinoline (10)8-Fluoroquinazoline (4)Benzenesulfonyl Fluoride (51)Ethyl 2-Fluorobenzoate (37)Ethyl 3-Fluorobenzoate (34)Fluorobenzene (9967)Methyl 2,6-Difluorobenzoate (17)Methyl 2-Fluorobenzoate (132)Methyl 3-Fluorobenzoate (136)Methyl 4-Fluorobenzoate (75)Methyl 6-Fluoronicotinate (4)N-(3-Fluorophenyl)Acetamide (14)N-(4-Fluorophenyl)Benzamide (3)Pentafluoro(Phenyl)-L6-Sulfane (19)Phenyl Trifluoromethanesulfonate (27)Tert-Butyl (4-Fluorophenyl)Carbamate (9)Trifluoro(Phenyl)Borate (80)Dichlorofluorobenzene (23)Difluoro (900)Difluoroaniline (37)Difluorobenzaldehyde (33)Difluorobenzamide (6)Difluorobenzenesulfonamide (5)Difluorobenzoate (59)Difluoroethyl (27)Difluoroethyl (27)Difluoromethoxy (198)Difluoromethoxy (198)Difluoropropan (7)Difluoropropan (7)Fluindamine (32)Fluoroacetanilide (5)Fluoroacetophenone (8)Fluoroaniline (65)Fluoroanisole (9)Fluorobenzaldehyde (69)Fluorobenzamide (28)Fluorobenzenesulfonamide (7)Fluorobenzenethiol (6)Fluorobenzylamine (10)Fluorobromobenzene (3)Fluorocinnamic (10)Fluorocinnamic (10)Fluorocinnamic Acid (9)Fluorocyclopropanecarboxylic (9)Fluoroethoxy (4)Fluoroethyl (8)Fluoroethyl (8)Fluoroindan (3)Fluoroindan (3)Fluoroisonicotinaldehyde (7)Fluoroisonicotinate (8)Fluoroisonicotinic (13)Fluoroisonicotinic Acid (13)Fluoromethyl (15)Fluoromethyl (15)Fluoronicotinaldehyde (20)Fluoronicotinamide (3)Fluoronicotinic (19)Fluoronicotinic (19)Fluoronicotinic Acid (14)Fluorophenylisocyanate (3)Fluoropropan (15)Fluoropropan (15)Fluorostyryl (7)Fluorosulfonyl (12)Fluorosulfonyl (12)Hexafluoro (9)Hexafluoro (9)Hexafluoropropan (4)Hexafluoropropan (4)Nonafluoro (2)Nonafluoro (2)Octafluoro (2)Octafluoro (2)Pentafluoro (4)Pentafluorobenzoate (4)Tetrafluoro (12)Tetrafluoro (12)Tetrafluoroaniline (7)Tetrafluoroethoxy (3)Tetrafluoroethoxy (3)Trifluoro (271)Trifluoro (271)Trifluoroacetamide (8)Trifluoroacetyl (13)Trifluoroaniline (11)Trifluorobenzaldehyde (9)Trifluorobenzoate (14)Trifluorobut (36)Trifluorobut (36)Trifluoroethan (2)Trifluoroethan (2)Trifluoroethanamine (23)Trifluoroethanol (6)Trifluoroethoxy (60)Trifluoroethoxy (60)Trifluoroethyl (63)Trifluoromethanesulfonamide (4)Trifluoromethanesulfonyl (22)Trifluoromethoxy (478)Trifluoromethoxy (478)Trifluoromethylthio (5)Trifluoromethylthio (5)Trifluoropropane (36)Trifluoropropanoate (5)Trifluoropropyl (9)
Guanidines (777)
Biguanide (2)Biguanide (2)
Hydrazides (3103)
Pyrazine-2-Carbohydrazide (3)Acetohydrazide (17)Acetohydrazide (17)Chlorobenzhydrazide (3)Dihydrazide (5)Dihydrazide (5)Fluorobenzohydrazide (6)
Hydrazines (6258)
(2-Bromophenyl)Hydrazine (8)(2-Chlorophenyl)Hydrazine (16)(2-Fluorobenzyl)Hydrazine (6)(2-Fluorophenyl)Hydrazine (22)(3-Chlorophenyl)Hydrazine (12)2-Hydrazineylpyridine (32)2-Hydrazineylpyrimidine (6)3-Hydrazineylpyridine (8)4-Hydrazineylpiperidine (5)Isonicotinohydrazide (6)Phenylhydrazine (153)Picolinohydrazide (5)Dichlorophenylhydrazine (3)Hydrazinecarbothioamide (2)Hydrazinecarboxamide (1)Hydrazinylbenzoate (6)
Hydrazones (2043)
1-Benzylidene-2-Phenylhydrazine (4)
Hydroxylamines (623)
N-Hydroxybenzamide (8)
Iodides (14074)
(2-Iodophenyl)(Phenyl)Methanone (4)(2-Iodophenyl)Methanol (12)(3-Iodophenyl)Boronic Acid (5)(3-Iodophenyl)Methanol (13)1,2-Benziodoxol-3-(1H)-One (6)1,2-Difluoro-3-Iodobenzene (13)1,2-Diiodobenzene (10)1,3-Dibromo-2-Iodobenzene (4)1,3-Dichloro-2-Iodobenzene (5)1,3-Difluoro-2-Iodobenzene (12)1,3-Diiodo-2-Phenoxybenzene (3)1,3-Diiodobenzene (59)1,4-Dibromo-2-Iodobenzene (3)1,4-Difluoro-2-Iodobenzene (8)1-(2-Iodophenyl)Ethan-1-One (4)1-(3-Iodophenyl)Ethan-1-One (7)1-(Benzyloxy)-4-Iodobenzene (3)1-(Bromomethyl)-2-Iodobenzene (9)1-Benzyl-4-Iodo-1H-Pyrazole (5)1-Bromo-2-Iodobenzene (65)1-Bromo-3-Fluoro-2-Iodobenzene (4)1-Bromo-3-Iodobenzene (70)1-Bromo-4-Iodobenzene (67)1-Chloro-2-Fluoro-3-Iodobenzene (5)1-Chloro-2-Iodobenzene (65)1-Chloro-3-Iodo-2-Methylbenzene (3)1-Chloro-3-Iodobenzene (77)1-Chloro-4-Iodobenzene (49)1-Ethyl-2-Iodobenzene (6)1-Fluoro-2-Iodo-4-Methylbenzene (3)1-Fluoro-2-Iodobenzene (102)1-Fluoro-3-Iodo-2-Methylbenzene (3)1-Fluoro-3-Iodobenzene (94)1-Fluoro-4-Iodobenzene (65)1-Iodo-2,3-Dimethylbenzene (8)1-Iodo-2,4-Dimethylbenzene (9)1-Iodo-2-(Trifluoromethoxy)Benzene (6)1-Iodo-2-(Trifluoromethyl)Benzene (13)1-Iodo-2-Isopropylbenzene (4)1-Iodo-2-Methoxybenzene (50)1-Iodo-2-Methylbenzene (91)1-Iodo-2-Nitrobenzene (36)1-Iodo-3-(Trifluoromethoxy)Benzene (6)1-Iodo-3-(Trifluoromethyl)Benzene (30)1-Iodo-3-Methoxybenzene (48)1-Iodo-3-Methylbenzene (60)1-Iodo-3-Nitrobenzene (45)1-Iodo-4-Methoxybenzene (34)1-Iodo-4-Phenoxybenzene (4)2,4-Difluoro-1-Iodobenzene (14)2,6-Dichloro-4-Iodopyridine (4)2,6-Diiodoaniline (8)2,6-Diiodophenol (16)2-Bromo-3-Iodopyridine (6)2-Bromo-4-Chloro-1-Iodobenzene (6)2-Bromo-6-Iodoaniline (4)2-Bromo-6-Iodopyridine (5)2-Chloro-3-Iodopyridin-4-Amine (3)2-Chloro-3-Iodopyridine (13)2-Chloro-4-Iodopyridine (19)2-Chloro-5-Iodopyridine (18)2-Chloro-6-Iodophenol (3)2-Chloro-6-Iodopyridine (9)2-Fluoro-1-Iodo-4-Methylbenzene (5)2-Fluoro-3-Iodopyridine (8)2-Fluoro-6-Iodoaniline (7)2-Hydroxy-3-Iodobenzaldehyde (3)2-Iodo-1,3-Dimethylbenzene (15)2-Iodo-1,4-Dimethylbenzene (5)2-Iodo-1-Methyl-4-Nitrobenzene (3)2-Iodo-4-Methylaniline (5)2-Iodo-6-Methylpyridine (5)2-Iodo-6-Nitroaniline (3)2-Iodo-9H-Fluorene (8)2-Iodo-N,N-Dimethylaniline (3)2-Iodoaniline (87)2-Iodobenzaldehyde (17)2-Iodobenzamide (4)2-Iodobenzene-1,3-Diol (3)2-Iodobenzoic Acid (47)2-Iodobenzonitrile (26)2-Iodonaphthalene (5)2-Iodophenol (63)2-Iodopyrazine (25)2-Iodopyridine (27)2-Iodopyrimidine (8)2-Iodothiophene (14)3-Chloro-2-Iodoaniline (3)3-Chloro-4-Iodoaniline (3)3-Fluoro-2-Iodoaniline (8)3-Iodo-1-Methyl-1H-Pyrazole (6)3-Iodo-1H-Pyrrolo[2,3-B]Pyridine (11)3-Iodo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Iodo-2-Methylaniline (4)3-Iodoaniline (32)3-Iodobenzaldehyde (28)3-Iodobenzoic Acid (55)3-Iodobenzonitrile (27)3-Iodoimidazo[1,2-A]Pyridine (10)3-Iodophenol (21)3-Iodopyridazine (5)3-Iodopyridin-2-Amine (12)3-Iodopyridin-2-Ol (4)3-Iodopyridin-4-Amine (6)3-Iodopyridin-4-Ol (4)3-Iodopyridine (37)3-Iodotetrahydrofuran (3)4-Bromo-2-Chloro-1-Iodobenzene (4)4-Bromo-2-Fluoro-1-Iodobenzene (8)4-Bromo-2-Iodoaniline (8)4-Chloro-2-Iodoaniline (9)4-Chloro-3-Iodoaniline (3)4-Chloro-5-Iodopyrimidine (6)4-Fluoro-2-Iodoaniline (7)4-Fluoro-3-Iodobenzoic Acid (5)4-Iodo-1,1'-Biphenyl (9)4-Iodo-1H-Pyrazole (9)4-Iodo-N,N-Diphenylaniline (3)4-Iodopyridine (17)4-Iodopyrimidine (9)5-Bromo-2-Iodopyridine (5)5-Iodo-1H-Imidazole (4)5-Iodo-1H-Pyrazole (4)5-Iodo-7H-Pyrrolo[2,3-D]Pyrimidine (4)5-Iodopyridin-2-Amine (17)5-Iodopyridin-2-Ol (8)5-Iodopyrimidine (5)6-Chloro-5-Iodopyridin-2-Amine (3)Ethyl 2-Iodobenzoate (4)Ethyl 3-Iodobenzoate (11)Methyl 2-Iodobenzoate (28)Methyl 3-Iodo-4-Methylbenzoate (6)Methyl 3-Iodobenzoate (47)Methyl 4-Amino-3-Iodobenzoate (7)N-(2-Iodophenyl)Acetamide (8)Phenyl(O-Tolyl)Iodonium (14)Tert-Butyl 3-Iodo-1H-Indole-1-Carboxylate (7)Diiodo (19)Diiodobenzoate (5)Iodoaniline (60)Iodoanisole (5)Iodobenzaldehyde (38)Iodobenzamide (6)Iodobutane (1)Iodobutane (1)Iodoethoxy (6)Iodoethoxy (6)Iodoethyl (5)Iodoethyl (5)Iodomethyl (26)Iodomethyl (26)Iodonicotinaldehyde (6)Iodonicotinic (14)Iodonicotinic (14)Iodopropyl (4)Iodopropyl (4)
Isocyanates and Isothiocyanates (237)
(Isothiocyanatomethyl)Benzene (6)1-Chloro-2-Isocyanatobenzene (6)1-Chloro-2-Isothiocyanatobenzene (7)Isocyanatobenzene (47)Isothiocyanatobenzene (39)Isocyanate (4)Isocyanate (4)
Isocyanides (69)
Isocyanato (7)Isocyanide (1)Isothiocyanato (5)Isothiocyanato (5)
Ketones (39985)
(1E,4E)-1,5-Diphenylpenta-1,4-Dien-3-One (7)(1E,6E)-1,7-Diphenylhepta-1,6-Diene-3,5-Dione (7)(2-Aminophenyl)(Phenyl)Methanone (30)(2-Bromophenyl)(Phenyl)Methanone (3)(2-Chlorophenyl)(Phenyl)Methanone (19)(2-Fluorophenyl)(Phenyl)Methanone (15)(2-Hydroxyphenyl)(Phenyl)Methanone (24)(2-Iodophenyl)(Phenyl)Methanone (4)(3-Chlorophenyl)(Phenyl)Methanone (19)(3-Fluorophenyl)(Phenyl)Methanone (5)(3-Nitrophenyl)(Phenyl)Methanone (5)(4-Aminophenyl)(Phenyl)Methanone (4)(4-Bromophenyl)(Phenyl)Methanone (9)(4-Chlorophenyl)(Phenyl)Methanone (11)(4-Fluorophenyl)(Phenyl)Methanone (8)(4-Hydroxyphenyl)(Phenyl)Methanone (3)(4-Methoxyphenyl)(Phenyl)Methanone (7)(4-Nitrophenyl)(Phenyl)Methanone (3)(R)-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-8-One (8)1,3-Dioxoisoindolin-2-Yl 2-Phenylacetate (5)1,3-Diphenylpropan-1-One (9)1,4-Diazepan-5-One (9)1,4-Dihydroisoquinolin-3(2H)-One (5)1-(1H-Indazol-1-Yl)Ethan-1-One (7)1-(1H-Indol-1-Yl)Ethan-1-One (9)1-(1H-Indol-3-Yl)Ethan-1-One (6)1-(1H-Pyrrolo[2,3-B]Pyridin-3-Yl)Ethan-1-One (4)1-(2-(Trifluoromethyl)Phenyl)Ethan-1-One (9)1-(2-Aminophenyl)Ethan-1-One (29)1-(2-Bromophenyl)Ethan-1-One (27)1-(2-Chlorophenyl)Ethan-1-One (40)1-(2-Fluorophenyl)Ethan-1-One (58)1-(2-Hydroxyphenyl)-2-Phenylethan-1-One (6)1-(2-Hydroxyphenyl)-3-Phenylprop-2-En-1-One (11)1-(2-Hydroxyphenyl)Ethan-1-One (74)1-(2-Iodophenyl)Ethan-1-One (4)1-(2-Methoxyphenyl)Ethan-1-One (34)1-(2-Nitrophenyl)Ethan-1-One (24)1-(3-(Benzyloxy)Phenyl)Ethan-1-One (3)1-(3-Aminophenyl)Ethan-1-One (18)1-(3-Chlorophenyl)Ethan-1-One (38)1-(3-Fluorophenyl)Ethan-1-One (63)1-(3-Hydroxyphenyl)Ethan-1-One (20)1-(3-Iodophenyl)Ethan-1-One (7)1-(3-Methoxy-2-Nitrophenyl)Ethan-1-One (4)1-(3-Methoxyphenyl)Ethan-1-One (38)1-(3-Nitrophenyl)Ethan-1-One (25)1-(3-Nitrophenyl)Propan-1-One (4)1-(4-(Benzyloxy)Phenyl)Ethan-1-One (4)1-(4-Fluorophenyl)Ethan-1-One (36)1-([1,1'-Biphenyl]-4-Yl)Ethan-1-One (5)1-(Benzofuran-2-Yl)Ethan-1-One (3)1-(Imidazo[1,2-A]Pyridin-3-Yl)Ethan-1-One (3)1-(M-Tolyl)Ethan-1-One (37)1-(Naphthalen-2-Yl)Ethan-1-One (3)1-(O-Tolyl)Ethan-1-One (26)1-(Piperidin-1-Yl)Ethan-1-One (13)1-(Pyrazin-2-Yl)Ethan-1-One (5)1-(Pyridin-2-Yl)Ethan-1-One (36)1-(Pyridin-3-Yl)Ethan-1-One (29)1-(Pyridin-4-Yl)Ethan-1-One (14)1-(Pyrimidin-2-Yl)Ethan-1-One (5)1-(Pyrimidin-4-Yl)Ethan-1-One (6)1-(Pyrrolidin-1-Yl)Ethan-1-One (9)1-(Thiazol-2-Yl)Ethan-1-One (9)1-(Thiophen-2-Yl)Ethan-1-One (17)1-Aminoanthracene-9,10-Dione (8)1-Benzylindoline-2,3-Dione (5)1-Benzylpiperidin-3-One (5)1-Chloroanthracene-9,10-Dione (6)1-Hydroxyanthracene-9,10-Dione (12)1-Methylpiperazin-2-One (6)1-Methylpyrrolidin-2-One (13)1-Phenylbutan-1-One (13)1-Phenylpentan-1-One (12)1-Phenylpiperidin-2-One (8)1-Phenylpropan-2-One (36)2,2,2-Trifluoro-1-Phenylethan-1-One (51)2,2-Dimethyl-1-Phenylpropan-1-One (8)2,2-Dimethyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2,3,4,9-Tetrahydro-1H-Carbazol-1-One (7)2,3-Dihydrofuran-3-One (9)2,3-Dihydropyridin-2-One (5)2,5-Dichlorobenzoic Acid (13)2-Amino-1-(Pyrrolidin-1-Yl)Ethan-1-One (5)2-Benzalacetophenone (36)2-Benzoylbenzoic Acid (10)2-Chloro-1-Phenylethan-1-One (20)2-Chlorocyclohexa-2,5-Diene-1,4-Dione (4)2-Chloroquinazolin-4(3H)-One (4)2-Hydroxy-1,2-Diphenylethan-1-One (3)2-Hydroxy-1-Phenylethan-1-One (8)2-Hydroxycyclohexa-2,5-Diene-1,4-Dione (3)2-Hydroxyquinolin-4(1H)-One (3)2-Methoxycyclohexa-2,5-Diene-1,4-Dione (7)2-Methyl-1-Phenylpropan-1-One (20)2-Methyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2-Methyl-3,4-Dihydroisoquinolin-1(2H)-One (6)2-Methylcyclohexa-2,5-Diene-1,4-Dione (5)2-Methylcyclohexan-1-One (3)2-Methylisoindolin-1-One (7)2-Methylisoindoline-1,3-Dione (5)2-Methylpyridazin-3(2H)-One (7)2-Oxo-2-Phenylacetaldehyde (12)2-Oxo-2-Phenylacetic Acid (17)3,3-Difluoropiperidin-4-One (3)3,3-Dimethylcyclohexan-1-One (4)3,3-Dimethylpiperidin-4-One (3)3,4-Dihydroquinoxalin-2(1H)-One (7)3-Acetyl-2H-Chromen-2-One (3)3-Aminopyrrolidin-2-One (5)3-Bromo-1H-Pyrrole-2,5-Dione (3)3-Chloro-1-Phenylpropan-1-One (10)3-Fluoropiperidin-4-One (3)3-Hydroxy-2-Phenyl-4H-Chromen-4-One (22)3-Hydroxypyrrolidin-2-One (4)3-Methylcyclohexan-1-One (9)3-Methylene-2,3-Dihydro-1H-Inden-1-One (5)3-Methylpiperazin-2-One (7)3-Methylpyrimidin-4(3H)-One (6)3-Oxo-3-Phenylpropanenitrile (21)3-Oxo-N-Phenylbutanamide (10)3-Phenyl-1-(Pyrrolidin-1-Yl)Propan-1-One (5)3-Phenyl-2-Thioxoimidazolidin-4-One (6)3-Phenylacrylaldehyde (29)3-Phenylimidazolidine-2,4-Dione (4)4,4,4-Trifluoro-1-Phenylbutane-1,3-Dione (10)4-(1,2,2-Triphenylvinyl)Benzaldehyde (5)4-(Hydroxymethyl)Pyrrolidin-2-One (4)4-Benzylmorpholin-3-One (6)4-Bromoisoindolin-1-One (3)4-Bromopyridazin-3(2H)-One (3)4-Chloro-1-Phenylbutan-1-One (8)4-Chloropyridazin-3(2H)-One (4)4-Fluoroindoline-2,3-Dione (3)4-Hydroxy-2H-Chromen-2-One (10)4-Hydroxydihydrofuran-2(3H)-One (14)4-Hydroxypiperidin-2-One (3)4-Hydroxypyrrolidin-2-One (7)4-Methyl-2H-Chromen-2-One (27)4-Methylisobenzofuran-1(3H)-One (3)4-Oxo-4-Phenylbutanoic Acid (16)4-Phenylbutan-2-One (15)4-Phenylcyclohexan-1-One (11)4-Phenylmorpholin-3-One (6)4-Phenylpyrrolidin-2-One (7)5,6-Dihydrobenzo[D]Thiazol-7(4H)-One (5)5-(Aminomethyl)Pyrrolidin-2-One (3)5-(Hydroxymethyl)Pyrrolidin-2-One (7)5-Bromoisoindolin-1-One (8)5-Bromoisoindoline-1,3-Dione (3)5-Bromopyrimidin-4(3H)-One (3)5-Chloroisoindoline-1,3-Dione (3)5-Chloropyrimidin-4(3H)-One (4)5-Chloropyrimidine-2,4(1H,3H)-Dione (3)5-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)5-Fluorochroman-4-One (3)5-Fluoroindolin-2-One (4)5-Fluoroisoindolin-1-One (3)5-Fluoropyrimidin-4(3H)-One (3)5-Fluoropyrimidine-2,4(1H,3H)-Dione (3)5-Hydroxy-2-Phenyl-4H-Chromen-4-One (36)5-Hydroxypiperidin-2-One (3)5-Methoxy-2-Phenyl-4H-Chromen-4-One (10)5-Methyl-3,4-Dihydronaphthalen-1(2H)-One (6)5-Methylindolin-2-One (3)5-Oxopyrrolidine-2-Carboxylic Acid (4)6-Bromoisoindolin-1-One (4)6-Fluorochroman-4-One (5)6-Fluoroindoline-2,3-Dione (3)6-Fluoroisobenzofuran-1(3H)-One (3)6-Hydroxy-2,3-Dihydro-1H-Inden-1-One (3)6-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)6-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (5)6-Methoxyisoindolin-1-One (3)6-Methyl-2,3-Dihydro-1H-Inden-1-One (3)7,8-Dihydroquinolin-5(6H)-One (5)7-(Diethylamino)-2H-Chromen-2-One (9)7-Bromo-3,4-Dihydronaphthalen-1(2H)-One (8)7-Bromochroman-4-One (4)7-Bromoindoline-2,3-Dione (3)7-Bromoquinazolin-4(3H)-One (4)7-Chloro-3,4-Dihydronaphthalen-1(2H)-One (6)7-Fluorochroman-4-One (5)7-Fluoroindolin-2-One (3)7-Fluoroquinazolin-4(3H)-One (4)7-Hydroxy-2H-Chromen-2-One (23)7-Methoxy-2H-Chromen-2-One (12)7-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (6)7-Methoxychroman-4-One (3)7-Methylindoline-2,3-Dione (7)8-Bromochroman-4-One (4)8-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)8-Fluoroisoquinolin-1(2H)-One (3)8-Methylchroman-4-One (4)Acetophenone (1123)Azepan-2-One (18)Benzo[Cd]Indol-2(1H)-One (5)Benzofuran-2(3H)-One (7)Chroman-2-One (5)Cyclobutanone (24)Cyclohex-2-En-1-One (27)Cyclohexane-1,3-Dione (12)Cyclopent-2-En-1-One (21)Cyclopentane-1,3-Dione (6)Dihydro-2H-Pyran-2,6(3H)-Dione (5)Dihydrofuran-2,5-Dione (12)Dihydrofuran-3(2H)-One (8)Dihydrothiophen-3(2H)-One (4)Ethene-1,1-Diyldibenzene (10)Ethyl 2-Oxo-2-Phenylacetate (18)Ethyl 3-Oxo-3-Phenylpropanoate (41)Furan-2(5H)-One (26)Isoquinolin-1-Ol (9)Methyl 3-Oxo-3-Phenylpropanoate (16)Morpholin-3-One (11)Phenyl(3-(Trifluoromethyl)Phenyl)Methanone (3)Phenyl(M-Tolyl)Methanone (3)Phenyl(P-Tolyl)Methanone (4)Phenyl(Pyridin-3-Yl)Methanone (9)Phenyl(Thiophen-2-Yl)Methanone (6)Piperidine-2,4-Dione (5)Propiophenone (59)Pyrimidine-4,6(1H,5H)-Dione (3)Tert-Butyl (2-Oxopiperidin-3-Yl)Carbamate (4)Tert-Butyl (2-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (3-Oxocyclohexyl)Carbamate (3)Tert-Butyl (5-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (6-Oxopiperidin-3-Yl)Carbamate (3)Tert-Butyl 2-Oxopiperidine-1-Carboxylate (3)Tert-Butyl 2-Oxopyrrolidine-1-Carboxylate (15)Tert-Butyl 4-Oxopiperidine-1-Carboxylate (16)Tetrahydropyrimidin-2(1H)-One (6)Acetylacetonate (26)Bromoethanone (4)Butanedione (6)Butanedione (6)Butanone (10)Butanone (10)Carbonyl-Phenyl-Boronic Acid/Ester (184)Chloroethanone (2)Dicarbonyl (2)Dicarbonyl (2)Dichloroacetophenone (5)Dienone (2)Diethanone (5)Diethanone (5)Dione (1793)Dioxobutanoate (2)Enone (21)Ethanone (1019)Heptanedionato (7)Heptanedionato (7)Hydroxyethanone (3)Methyl-Pyrazolone (87)Oxoacetaldehyde (4)Oxoazepane (3)Oxoazepane (3)Oxochroman (5)Oxotetrahydro (11)Pyrimidinone (3)Tetraone (48)Tetraone (48)Trifluoroacetophenone (9)Trifluoroethanone (15)
Mercaptos (10)
Mercaptopropanoate (10)
Nitrates and Nitrites (1)
Nitriles (28530)
Acetonitrile (255)Acrylonitrile (8)Aminobutanenitrile (5)Aminocyclohexanecarbonitrile (6)Bromobenzonitrile (15)Bromonicotinonitrile (9)Bromophenylacetonitrile (2)Butanenitrile (2)Butanenitrile (2)Chlorobenzonitrile (27)Chloroisonicotinonitrile (4)Chloronicotinonitrile (40)Cyanide (434)Cyanide (434)Cyanoacetamide (4)Cyanoacetate (14)Cyanobenzaldehyde (4)Cyanobenzoate (27)Cyanobenzoic (20)Cyanoethyl (15)Cyanoethyl (15)Cyanoisonicotinate (4)Cyanomethyl (42)Cyanomethyl (42)Cyanonicotinate (8)Cyanophenoxy (8)Cyanophenyl (64)Cyanophenylboronic (5)Cyanopropan (4)Cyanopropan (4)Diacetonitrile (1)Diaminobenzonitrile (8)Dibromoisonicotinonitrile (3)Dicarbonitrile (45)Dicarbonitrile (45)Dichlorobenzonitrile (12)Dichloroisonicotinonitrile (4)Difluorobenzonitrile (41)Fluorobenzonitrile (85)Fluoroisonicotinonitrile (5)Fluoronicotinonitrile (14)Fluorophenylacetonitrile (8)Fluoropicolinonitrile (13)Formylnicotinonitrile (5)Formylnicotinonitrile (5)Hydrazinylbenzonitrile (6)Iodobenzonitrile (44)Iodonicotinonitrile (8)Malononitrile (43)Malononitrile (43)Methoxyisonicotinonitrile (7)Methoxyisonicotinonitrile (7)Methoxynicotinonitrile (18)Methoxynicotinonitrile (18)Methylnicotinonitrile (57)Methylnicotinonitrile (57)Methylpropanenitrile (9)Methylpropanenitrile (9)Nitropicolinonitrile (10)Oxopropanenitrile (8)Phenylacrylonitrile (21)Propanenitrile (41)Propanenitrile (41)Pyrazino-Nitrile (50)Tetrafluorobenzonitrile (5)Thiocyanatoaniline (3)Tricarbonitrile (5)Tricarbonitrile (5)Trifluorobenzonitrile (7)Trifluoromethylbenzonitrile (5)1-Phenyl-1H-Pyrazole-4-Carbonitrile (17)1-Phenylcyclobutane-1-Carbonitrile (7)1-Phenylcyclopropane-1-Carbonitrile (19)1H-Imidazole-4-Carbonitrile (2)1H-Indazole-3-Carbonitrile (9)1H-Indole-2-Carbonitrile (9)1H-Indole-3-Carbonitrile (17)1H-Indole-5-Carbonitrile (5)1H-Indole-6-Carbonitrile (4)1H-Indole-7-Carbonitrile (6)1H-Pyrazole-4-Carbonitrile (5)1H-Pyrrole-2-Carbonitrile (7)1H-Pyrrole-3-Carbonitrile (9)2,3-Difluorobenzonitrile (29)2,4-Dichlorobenzonitrile (4)2,4-Difluorobenzonitrile (21)2,6-Dibromobenzonitrile (4)2,6-Dichlorobenzonitrile (8)2,6-Difluorobenzonitrile (28)2-(1,3,2-Dioxaborinan-2-Yl)Benzonitrile (4)2-(2-Bromophenyl)Acetonitrile (10)2-(2-Chlorophenyl)Acetonitrile (16)2-(2-Fluorophenyl)Acetonitrile (30)2-(3-Chlorophenyl)Acetonitrile (16)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (14)2-(4-(Benzyloxy)Phenyl)Acetonitrile (3)2-(Bromomethyl)Benzonitrile (15)2-(Piperazin-1-Yl)Benzonitrile (6)2-(Pyridin-2-Yl)Acetonitrile (8)2-(Pyridin-3-Yl)Acetonitrile (6)2-(Trifluoromethoxy)Benzonitrile (7)2-(Trifluoromethyl)Benzonitrile (35)2-Amino-3-Bromobenzonitrile (7)2-Amino-3-Chlorobenzonitrile (3)2-Amino-6-Chlorobenzonitrile (3)2-Aminonicotinonitrile (6)2-Bromo-6-Fluorobenzonitrile (7)2-Chloro-3-Methylbenzonitrile (5)2-Chloro-4-Fluorobenzonitrile (9)2-Chloro-6-Fluorobenzonitrile (5)2-Chloro-N-Methylaniline (4)2-Chlorobenzonitrile (99)2-Hydroxybenzonitrile (45)2-Iodobenzonitrile (26)2-Naphthonitrile (15)2-Nitrobenzonitrile (37)2-Oxo-2H-Chromene-3-Carbonitrile (4)2-Phenoxyacetonitrile (11)2-Phenoxybenzonitrile (5)2-Phenylacetonitrile (172)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (25)3-(Trifluoromethoxy)Benzonitrile (11)3-(Trifluoromethyl)Benzonitrile (47)3-Bromo-2-Fluorobenzonitrile (10)3-Bromo-2-Hydroxybenzonitrile (3)3-Bromobenzonitrile (110)3-Chloro-2-Fluorobenzonitrile (7)3-Chlorobenzonitrile (100)3-Chloropyrazine-2-Carbonitrile (6)3-Fluoropicolinonitrile (5)3-Hydroxybenzonitrile (40)3-Iodobenzonitrile (27)3-Nitrobenzonitrile (59)3-Oxo-3-Phenylpropanenitrile (21)3-Phenoxybenzonitrile (5)4-Amino-2-Chlorobenzonitrile (8)4-Chloropyrimidine-5-Carbonitrile (6)4-Cyanophenyl Benzoate (11)4-Cyclohexylbenzonitrile (10)4-Fluorobenzonitrile (89)4-Nitrobenzonitrile (25)5-Fluoropicolinonitrile (5)6-Methylnicotinonitrile (7)6-Methylpicolinonitrile (10)[1,1'-Biphenyl]-2-Carbonitrile (12)[1,1'-Biphenyl]-4-Carbonitrile (27)Benzo[B]Thiophene-2-Carbonitrile (3)Benzo[D]Thiazole-2-Carbonitrile (11)Benzonitrile (1312)Furan-2-Carbonitrile (8)Imidazo[1,2-A]Pyridine-6-Carbonitrile (3)Isonicotinonitrile (16)Isoquinoline-1-Carbonitrile (7)Methyl 2-Cyanobenzoate (22)Methyl 3-Cyanobenzoate (29)Morpholine-2-Carbonitrile (4)Nicotinonitrile (82)Pyrazine-2-Carbonitrile (15)Pyrimidine-2-Carbonitrile (14)Pyrimidine-4-Carbonitrile (9)Pyrimidine-5-Carbonitrile (6)Pyrrolidine-2-Carbonitrile (9)Pyrrolidine-3-Carbonitrile (6)Thiazole-5-Carbonitrile (7)Thiophene-2-Carbonitrile (23)Thiophene-3-Carbonitrile (13)
Nitroes (23699)
(2-Nitrophenyl)Boronic Acid (13)(2-Nitrophenyl)Methanol (29)(2-Nitrovinyl)Benzene (28)(3-Nitrophenyl)(Phenyl)Methanone (5)(3-Nitrophenyl)Boronic Acid (32)(3-Nitrophenyl)Methanol (31)(4-Nitrophenyl)(Phenyl)Methanone (3)(4-Nitrophenyl)Methanol (17)1,2-Dichloro-4-Nitrobenzene (16)1,2-Difluoro-3-Nitrobenzene (23)1,2-Difluoro-4-Nitrobenzene (43)1,2-Dimethyl-3-Nitrobenzene (6)1,2-Dinitrobenzene (6)1,3-Dibromo-2-Nitrobenzene (4)1,3-Dichloro-2-Nitrobenzene (5)1,3-Difluoro-2-Nitrobenzene (16)1,3-Dimethyl-2-Nitrobenzene (9)1,3-Dinitrobenzene (31)1,4-Difluoro-2-Nitrobenzene (28)1,4-Dimethyl-2-Nitrobenzene (10)1-(2-Nitrophenyl)Ethan-1-One (24)1-(3-Methoxy-2-Nitrophenyl)Ethan-1-One (4)1-(3-Nitrophenyl)Ethan-1-One (25)1-(3-Nitrophenyl)Propan-1-One (4)1-(Benzyloxy)-2-Nitrobenzene (3)1-(Benzyloxy)-3-Nitrobenzene (10)1-(Bromomethyl)-2-Nitrobenzene (23)1-(Methylsulfonyl)-3-Nitrobenzene (7)1-(Tert-Butyl)-2-Nitrobenzene (4)1-(Tert-Butyl)-3-Nitrobenzene (7)1-Bromo-2-Chloro-4-Nitrobenzene (5)1-Bromo-2-Fluoro-3-Nitrobenzene (11)1-Bromo-2-Fluoro-4-Nitrobenzene (13)1-Bromo-3-Methyl-2-Nitrobenzene (3)1-Bromo-3-Nitrobenzene (235)1-Chloro-2-Fluoro-4-Nitrobenzene (9)1-Chloro-2-Methyl-3-Nitrobenzene (6)1-Chloro-2-Nitrobenzene (138)1-Chloro-3-Fluoro-2-Nitrobenzene (6)1-Chloro-3-Nitrobenzene (161)1-Ethoxy-3-Nitrobenzene (7)1-Fluoro-3-Nitrobenzene (216)1-Iodo-2-Nitrobenzene (36)1-Iodo-3-Nitrobenzene (45)1-Methoxy-3-Nitrobenzene (108)1-Methoxy-4-Nitrobenzene (90)1-Methyl-2-Nitrobenzene (176)1-Methyl-3-Nitrobenzene (147)1-Methyl-4-Nitrobenzene (82)1-Nitro-2-(Trifluoromethoxy)Benzene (8)1-Nitro-2-(Trifluoromethyl)Benzene (32)1-Nitro-2-Phenoxybenzene (4)1-Nitro-3-(Trifluoromethoxy)Benzene (9)1-Nitro-3-(Trifluoromethyl)Benzene (82)1-Nitro-4-Phenoxybenzene (5)1-Nitronaphthalene (3)2,4-Dichloro-1-Nitrobenzene (19)2,4-Difluoro-1-Nitrobenzene (46)2,4-Dimethoxy-1-Nitrobenzene (5)2,4-Dimethyl-1-Nitrobenzene (15)2-((2-Nitrophenyl)Amino)Ethan-1-Ol (5)2-(2-Nitrophenyl)Acetic Acid (20)2-(4-Nitrophenyl)Acetic Acid (9)2-Bromo-1-Chloro-4-Nitrobenzene (9)2-Bromo-1-Fluoro-3-Nitrobenzene (9)2-Bromo-1-Fluoro-4-Nitrobenzene (23)2-Bromo-1-Methyl-4-Nitrobenzene (12)2-Bromo-3-Nitrobenzoic Acid (4)2-Bromo-4-Chloro-1-Nitrobenzene (5)2-Bromo-4-Fluoro-1-Nitrobenzene (23)2-Bromo-4-Nitroaniline (12)2-Bromo-6-Nitroaniline (14)2-Bromo-6-Nitrophenol (9)2-Chloro-1,3-Dinitrobenzene (2)2-Chloro-1-Fluoro-4-Nitrobenzene (16)2-Chloro-1-Methyl-3-Nitrobenzene (4)2-Chloro-3-Nitrobenzoic Acid (4)2-Chloro-4-Fluoro-1-Nitrobenzene (13)2-Chloro-4-Methyl-1-Nitrobenzene (6)2-Chloro-4-Nitrophenol (5)2-Chloro-5-Nitropyrimidine (5)2-Chloro-6-Nitroaniline (11)2-Chloro-6-Nitrophenol (7)2-Fluoro-1-Methoxy-4-Nitrobenzene (8)2-Fluoro-4-Methyl-1-Nitrobenzene (13)2-Iodo-1-Methyl-4-Nitrobenzene (3)2-Iodo-6-Nitroaniline (3)2-Methoxy-5-Nitropyridine (8)2-Methoxy-6-Nitrophenol (5)2-Methyl-3-Nitrobenzoic Acid (7)2-Methyl-3-Nitropyridine (9)2-Methyl-6-Nitroaniline (10)2-Nitro-1H-Pyrrole (5)2-Nitro-N-Phenylaniline (3)2-Nitrobenzaldehyde (53)2-Nitrobenzoic Acid (65)2-Nitrobenzonitrile (37)2-Nitrofuran (9)2-Nitronaphthalene (4)2-Nitropyridine (40)2-Nitrothiophene (20)3-Chloro-2-Nitroaniline (5)3-Chloro-4-Nitroaniline (5)3-Fluoro-4-Nitroaniline (7)3-Methoxy-2-Nitrobenzaldehyde (3)3-Methoxy-4-Nitrobenzoic Acid (4)3-Methyl-5-Nitropyridine (4)3-Nitroaniline (98)3-Nitrobenzaldehyde (49)3-Nitrobenzamide (17)3-Nitrobenzene-1,2-Diol (6)3-Nitrobenzenesulfonamide (8)3-Nitrobenzoic Acid (109)3-Nitrobenzonitrile (59)3-Nitrophenol (72)3-Nitropyridin-2-Ol (11)3-Nitropyridin-4-Amine (5)3-Nitropyridine (54)3-Nitrothiophene (6)4,4,5,5-Tetramethyl-2-(2-Nitrophenyl)-1,3,2-Dioxaborolane (5)4-Fluoro-1-Methyl-2-Nitrobenzene (12)4-Fluoro-2-Nitroaniline (14)4-Hydroxy-3-Nitrobenzaldehyde (5)4-Methyl-3-Nitroaniline (8)4-Methyl-3-Nitropyridine (8)4-Nitro-1H-Indazole (10)4-Nitro-1H-Indole (6)4-Nitro-1H-Pyrazole (8)4-Nitroaniline (65)4-Nitrobenzaldehyde (18)4-Nitrobenzene-1,3-Diol (5)4-Nitrobenzoic Acid (35)4-Nitrobenzonitrile (25)4-Nitrophenol (67)4-Nitropyridine (11)5-(4-Nitrophenyl)Oxazole (3)5-Methoxy-2-Nitroaniline (7)5-Methyl-2-Nitroaniline (6)5-Nitro-1H-Indazole (5)5-Nitro-1H-Indole (6)5-Nitro-1H-Pyrazole (9)5-Nitro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Nitro-2,3-Dihydrobenzofuran (3)5-Nitrobenzo[D][1,3]Dioxole (4)5-Nitrobenzo[D]Thiazole (3)5-Nitroisoquinoline (7)5-Nitronicotinic Acid (5)5-Nitropyridin-2-Amine (6)6-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)6-Nitro-1H-Indazole (9)6-Nitro-1H-Indole (8)6-Nitrobenzo[D]Thiazole (3)7-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)7-Nitro-1H-Indazole (11)7-Nitro-1H-Indole (11)Ethyl 2-Nitrobenzoate (9)Ethyl 3-Nitrobenzoate (22)Ethyl Cinnamate (26)Methyl 2-Nitrobenzoate (54)Methyl 3-Nitrobenzoate (109)Methyl 4-Amino-3-Nitrobenzoate (9)Methyl 4-Nitrobenzoate (29)N-(2-Nitrophenyl)Acetamide (11)N-Methyl-2-Nitroaniline (20)N-Methyl-4-Nitroaniline (6)Nitrobenzene (2303)Difluoronitrobenzene (9)Dinitro (7)Dinitroaniline (5)Nitroacetophenone (7)Nitroaniline (211)Nitrobenzaldehyde (100)Nitrobenzamide (35)Nitrobenzenesulfonamide (26)Nitrobenzonitrile (106)Nitrobenzotrifluoride (16)Nitroisophthalate (4)
Oximes (560)
Phenols (1790)
1,2,3,4-Tetrahydroisoquinolin-5-Ol (3)1,2,3,4-Tetrahydroisoquinolin-6-Ol (6)1-(2-Hydroxyphenyl)Ethan-1-One (74)1-(3-Hydroxyphenyl)Ethan-1-One (20)1-Hydroxyanthracene-9,10-Dione (12)2,3-Dichlorophenol (9)2,3-Difluorophenol (36)2,4-Dibromophenol (16)2,4-Difluorophenol (21)2,5-Dichlorophenol (7)2,6-Dibromophenol (22)2,6-Dichlorophenol (16)2,6-Difluorophenol (24)2,6-Diiodophenol (16)2,6-Dimethylphenol (19)2-(2-Hydroxyphenyl)Acetic Acid (8)2-(3-Hydroxyphenyl)Acetic Acid (8)2-(Benzyloxy)Phenol (5)2-(Difluoromethoxy)Phenol (5)2-(Tert-Butyl)Phenol (56)2-(Trifluoromethoxy)Phenol (8)2-(Trifluoromethyl)Phenol (23)2-Amino-3-Bromophenol (3)2-Amino-3-Chlorophenol (4)2-Aminophenol (107)2-Benzylphenol (8)2-Bromo-3-Methylphenol (4)2-Bromo-6-Methylphenol (7)2-Bromobenzene-1,3-Diol (7)2-Bromobenzene-1,4-Diol (4)2-Chloro-4-Fluorophenol (9)2-Chloro-4-Nitrophenol (5)2-Chloro-6-Methylphenol (5)2-Chloro-6-Nitrophenol (7)2-Chlorobenzene-1,3-Diol (4)2-Chlorophenol (163)2-Ethylphenol (10)2-Hydroxy-N-Phenylbenzamide (3)2-Hydroxybenzamide (14)2-Hydroxybenzonitrile (45)2-Iodobenzene-1,3-Diol (3)2-Iodophenol (63)2-Isopropylphenol (28)2-Methoxyphenol (201)3,4-Dibromophenol (3)3,4-Difluorophenol (19)3-(Benzyloxy)Phenol (5)3-(Trifluoromethoxy)Phenol (12)3-(Trifluoromethyl)Phenol (43)3-Bromo-2-Fluorophenol (5)3-Bromo-4-Chlorophenol (5)3-Bromo-4-Fluorophenol (11)3-Bromobenzene-1,2-Diol (8)3-Chloro-4-Hydroxybenzaldehyde (7)3-Chlorobenzene-1,2-Diol (6)3-Chlorophenol (113)3-Fluorophenol (180)3-Hydroxybenzonitrile (40)3-Iodophenol (21)3-Nitrobenzene-1,2-Diol (6)3-Nitrophenol (72)4-(Benzyloxy)Phenol (2)4-(Trifluoromethyl)Phenol (18)4-Amino-2-Fluorophenol (9)4-Amino-3-Chlorophenol (5)4-Benzylphenol (14)4-Chlorobenzene-1,3-Diol (6)4-Fluorophenol (111)4-Hydroxybenzenesulfonic Acid (5)4-Nitrobenzene-1,3-Diol (5)4-Nitrophenol (67)6-Hydroxy-2,3-Dihydro-1H-Inden-1-One (3)Ethyl 2-Hydroxybenzoate (18)Ethyl 3-Hydroxybenzoate (12)M-Cresol (147)Methyl 2-(4-Hydroxyphenyl)Acetate (10)Methyl 2-Hydroxybenzoate (74)Methyl 3-Hydroxybenzoate (58)O-Cresol (164)P-Cresol (71)Pyrocatechol (134)Resorcinol (147)Aminophenol (9)Bromophenol (13)Chlorophenol (28)Dibromophenol (9)Dichlorophenol (17)Difluorophenol (36)Dihydroxybenzaldehyde (16)Dihydroxybenzamide (6)Dihydroxybenzoate (15)Dihydroxybenzoic (17)Dihydroxybenzonitrile (6)Dihydroxyphenyl (97)Dihydroxystyryl (4)Diiodophenol (7)Fluorophenol (73)Hydroxyacetophenone (16)Hydroxybenzaldehyde (88)Hydroxybenzamide (24)Hydroxybenzenesulfonic (4)Hydroxybenzenesulfonic Acid (3)Hydroxybenzoate (113)Hydroxybenzohydrazide (4)Hydroxybenzoic (89)Hydroxybenzonitrile (60)Hydroxybenzoyl (1)Hydroxyphenoxy (7)Hydroxyphenylacetic (7)Hydroxyphenylacetic Acid (7)Hydroxyphenylboronic (8)Hydroxypropiophenone (3)Iodophenol (41)Nitrophenol (134)Tetrafluorophenol (9)Trifluorophenol (5)Trihydroxybenzaldehyde (5)Trihydroxybenzoate (12)Trihydroxybenzoic (5)Trihydroxybenzoic Acid (4)Trihydroxyphenyl (10)
Phosphoruses (830)
1,1,1-Trifluoro-N-(4-Oxido-2,6-Diphenyldinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepin-4-Yl)Methanesulfonamide (16)Diethyl Benzylphosphonate (17)Dimethyl(Phenyl)Phosphine Oxide (20)Ethyltriphenylphosphonium (2)Methyltriphenylphosphonium (3)Phenyl Phosphate (3)Phenylphosphonic Acid (6)Diethoxyphosphoryl (5)Diisopropylphosphoramidite (4)Dimethoxyphosphoryl (4)Dimethoxyphosphoryl (4)Dimethylphosphine (28)Dioxaphosphepine (146)Diphosphonic (9)Phosphorothioate (1)
Polycyclic Aromatic Hydrocarbons (4)
Protective Groups (23)
Saturated Aliphatic Fused Rings (2)
(8Ar,12Br,14Br)-1,2,3,4,4A,5,6,6A,6B,7,8,8A,9,10,11,12,12A,12B,13,14B-Icosahydropicene (2)
Silicon Compounds (450)
1-(Triisopropylsilyl)-1H-Pyrrolo[2,3-B]Pyridine (8)Tert-Butyldimethyl(Phenoxy)Silane (17)Tetraphenylsilane (7)Trimethoxy(Phenyl)Silane (6)Trimethyl(Phenyl)Silane (22)Trimethyl(Phenylethynyl)Silane (23)Butyldimethylsilyl (94)Butyldimethylsilyl (94)Butyldimethylsilyloxy (8)Dimethylsilane (16)Dimethylsilane (16)Dimethylsilyl (4)Tetramethyldisiloxane (3)Tetramethyldisiloxane (3)Triethoxysilyl (13)Triethoxysilyl (13)Triisopropylsilyl (22)Triisopropylsilyl (22)Trimethoxysilane (19)Trimethoxysilane (19)Trimethylsilane (155)
Sulfamides (10219)
2-Fluoro-N-Phenylbenzenesulfonamide (6)2-Fluorobenzenesulfonamide (12)2-Methylbenzenesulfonamide (8)3-Nitrobenzenesulfonamide (8)4-Amino-N-Phenylbenzenesulfonamide (3)4-Bromo-N-Phenylbenzenesulfonamide (23)4-Chloro-N-Phenylbenzenesulfonamide (4)4-Methoxy-N-Phenylbenzenesulfonamide (3)4-Methoxybenzenesulfonamide (5)4-Methyl-N-Phenylbenzenesulfonamide (13)N,N-Diethylbenzenesulfonamide (8)N,N-Dimethylbenzenesulfonamide (23)N-(2-Phenoxyphenyl)Methanesulfonamide (4)N-(3-Chlorophenyl)Benzenesulfonamide (6)N-(O-Tolyl)Benzenesulfonamide (4)N-(Tert-Butyl)Benzenesulfonamide (14)N-Ethylbenzenesulfonamide (8)N-Isopropylbenzenesulfonamide (8)N-Methyl-N-(4-Phenylpyrimidin-2-Yl)Methanesulfonamide (7)N-Methylbenzenesulfonamide (15)N-Phenylbenzenesulfonamide (81)N-Phenylmethanesulfonamide (37)Phenylmethanesulfonamide (13)Pyridine-2-Sulfonamide (6)Dimethylsulfamoyl (5)Dimethylsulfamoyl (5)Methanesulfonamide (54)Methanesulfonamide (54)Methylmethanesulfonamide (3)Methylmethanesulfonamide (3)Methylsulfonamido (4)Methylsulfonamido (4)Sulfinamide (55)Sulfinamide (55)
Sulfides (10126)
(S)-2-(Phenylthio)Tetrahydro-2H-Pyran (5)1,2-Diphenyldisulfane (19)2-((Pyridin-2-Ylmethyl)Thio)-1H-Benzo[D]Imidazole (7)2-(Methylthio)Benzo[D]Thiazole (6)2-(Methylthio)Pyridine (5)2-(Methylthio)Pyrimidin-4-Amine (10)2-(Methylthio)Pyrimidine (19)2-(Methylthio)Thiazole (5)2-(Propylthio)Pyrimidine (5)4,6-Dichloro-2-(Methylthio)Pyrimidine (9)4-Chloro-2-(Methylthio)Pyrimidine (29)4-Methyl-2-(Methylthio)Pyrimidine (7)5-Bromo-2-(Methylthio)Pyrimidine (6)Benzyl(Phenyl)Sulfane (5)Ethyl(Phenyl)Sulfane (8)Pentafluoro(Phenyl)-L6-Sulfane (19)Phenyl(Trifluoromethyl)Sulfane (23)Methylthio (432)
Sulfonates (1162)
4-Methylbenzenesulfonate (9)
Sulfones (3928)
(4-(Methylsulfonyl)Phenyl)Boronic Acid (6)(Ethylsulfonyl)Benzene (8)1-(Methylsulfonyl)-3-Nitrobenzene (7)1-(Methylsulfonyl)Piperazine (5)1-(Methylsulfonyl)Piperidine (6)1-(Phenylsulfonyl)-1H-1,2,4-Triazole (6)1-(Phenylsulfonyl)-1H-Imidazole (5)1-(Phenylsulfonyl)Azetidine (7)1-Bromo-2-(Methylsulfonyl)Benzene (4)1-Bromo-4-(Phenylsulfonyl)Benzene (7)1-Fluoro-2-(Methylsulfonyl)Benzene (5)1-Fluoro-3-(Methylsulfonyl)Benzene (10)1-Methyl-3-(Methylsulfonyl)Benzene (5)2-(Methylsulfonyl)Aniline (3)2-(Methylsulfonyl)Pyridine (11)2-(Methylsulfonyl)Pyrimidine (25)3-(Methylsulfonyl)Aniline (7)3-(Methylsulfonyl)Benzoic Acid (6)3-(Methylsulfonyl)Pyridine (5)Benzenesulfonyl Fluoride (51)Tetrahydro-2H-Thiopyran 1,1-Dioxide (8)Tetrahydrothiophene 1,1-Dioxide (13)
Sulfonic Acids (1262)
2-Aminobenzenesulfonic Acid (9)2-Methylbenzenesulfonic Acid (8)3-Aminobenzenesulfonic Acid (6)4-Chlorobenzenesulfonic Acid (4)4-Hydroxybenzenesulfonic Acid (5)Naphthalene-2-Sulfonic Acid (4)Pyridine-3-Sulfonic Acid (6)Aminobenzenesulfonic (4)Bromobenzenesulfonic Acid (4)Disulfonic (9)Disulfonic (9)Ethanesulfonic (3)Methanesulfonic (2)Methanesulfonic (2)Methylbenzenesulfonate (144)Propanesulfonic Acid (2)Trifluoromethanesulfonic (4)
Sulfonyl Chlorides (4028)
1H-Pyrazole-4-Sulfonyl Chloride (8)2-Bromobenzenesulfonyl Chloride (8)2-Chlorobenzenesulfonyl Chloride (24)2-Fluorobenzenesulfonyl Chloride (31)2-Methoxybenzenesulfonyl Chloride (15)2-Methylbenzenesulfonyl Chloride (22)3-(Chlorosulfonyl)Benzoic Acid (15)3-(Trifluoromethyl)Benzenesulfonyl Chloride (13)3-Chlorobenzenesulfonyl Chloride (21)3-Fluorobenzenesulfonyl Chloride (22)4-Chlorobenzenesulfonyl Chloride (12)4-Fluorobenzenesulfonyl Chloride (26)Isoquinoline-5-Sulfonyl Chloride (3)Methyl 2-(Chlorosulfonyl)Benzoate (7)Phenylmethanesulfonyl Chloride (20)Fluorobenzenesulfonyl (12)
Sulfonyl Hydrazides (25)
Benzenesulfonohydrazide (12)
Sulfoxides (333)
(Methylsulfinyl)Benzene (7)
Thioesters (625)
Thiols (469)
1H-Benzo[D]Imidazole-2-Thiol (10)2-Chlorobenzenethiol (7)2-Mercaptoquinazolin-4(3H)-One (3)Benzo[D]Oxazole-2-Thiol (6)Benzo[D]Thiazole-2-Thiol (11)Phenylmethanethiol (16)Pyridine-2-Thiol (8)Pyrimidine-2-Thiol (6)Dithiole (9)Dithiole (9)Ethanethioate (9)Ethanethioate (9)Methanethiol (6)
Thiophenols (3045)
Thioureas (1128)
1,3-Diphenylthiourea (8)1-Phenylthiourea (33)Carbamimidothioate (4)
Trifluoromethyls (28892)
(2,2,2-Trifluoroethoxy)Benzene (18)(2-(Trifluoromethoxy)Phenyl)Boronic Acid (5)(2-(Trifluoromethyl)Phenyl)Boronic Acid (20)(2-(Trifluoromethyl)Phenyl)Methanol (10)(2-Fluoro-3-(Trifluoromethyl)Phenyl)Boronic Acid (6)(3-(Trifluoromethoxy)Phenyl)Boronic Acid (9)(3-(Trifluoromethoxy)Phenyl)Methanol (4)(3-(Trifluoromethyl)Phenyl)Boronic Acid (41)(3-(Trifluoromethyl)Phenyl)Methanol (22)(4-(Trifluoromethyl)Phenyl)Boronic Acid (23)(Perfluoropropane-2,2-Diyl)Dibenzene (7)(Trifluoromethyl)Benzene (1335)1,3-Bis(Trifluoromethyl)Benzene (70)1-(2-(Trifluoromethyl)Phenyl)Ethan-1-One (9)1-(3-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(3-(Trifluoromethyl)Phenyl)Ethan-1-Amine (25)1-(4-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(Bromomethyl)-2-(Trifluoromethyl)Benzene (13)1-(Bromomethyl)-3-(Trifluoromethyl)Benzene (17)1-Bromo-2-(Trifluoromethoxy)Benzene (22)1-Bromo-2-Fluoro-3-(Trifluoromethyl)Benzene (4)1-Bromo-3-(Trifluoromethyl)Benzene (100)1-Chloro-2-(Trifluoromethoxy)Benzene (20)1-Chloro-2-(Trifluoromethyl)Benzene (81)1-Chloro-3-(Trifluoromethoxy)Benzene (18)1-Chloro-3-(Trifluoromethyl)Benzene (101)1-Chloro-4-(Trifluoromethoxy)Benzene (8)1-Fluoro-2-(Trifluoromethoxy)Benzene (20)1-Fluoro-2-(Trifluoromethyl)Benzene (126)1-Fluoro-3-(Trifluoromethyl)Benzene (98)1-Fluoro-4-(Trifluoromethoxy)Benzene (14)1-Fluoro-4-(Trifluoromethyl)Benzene (53)1-Iodo-2-(Trifluoromethyl)Benzene (13)1-Iodo-3-(Trifluoromethyl)Benzene (30)1-Methoxy-2-(Trifluoromethyl)Benzene (21)1-Methoxy-3-(Trifluoromethoxy)Benzene (9)1-Methoxy-3-(Trifluoromethyl)Benzene (40)1-Methoxy-4-(Trifluoromethyl)Benzene (18)1-Methyl-2-(Trifluoromethoxy)Benzene (5)1-Methyl-2-(Trifluoromethyl)Benzene (43)1-Methyl-3-(Trifluoromethyl)Benzene (22)1-Nitro-2-(Trifluoromethoxy)Benzene (8)1-Nitro-2-(Trifluoromethyl)Benzene (32)1-Nitro-3-(Trifluoromethoxy)Benzene (9)1-Nitro-3-(Trifluoromethyl)Benzene (82)1-Phenoxy-3-(Trifluoromethyl)Benzene (2)1-Phenoxy-4-(Trifluoromethyl)Benzene (2)1-Phenyl-3-(Trifluoromethyl)-1H-Pyrazole (5)2,2,2-Trifluoro-1-Phenylethan-1-Amine (48)2,2,2-Trifluoro-1-Phenylethan-1-Ol (27)2,2,2-Trifluoro-1-Phenylethan-1-One (51)2-(2,2,2-Trifluoroethoxy)Pyridine (8)2-(Trifluoromethoxy)Aniline (18)2-(Trifluoromethoxy)Benzaldehyde (7)2-(Trifluoromethoxy)Benzoic Acid (8)2-(Trifluoromethoxy)Benzonitrile (7)2-(Trifluoromethoxy)Phenol (8)2-(Trifluoromethoxy)Pyridine (6)2-(Trifluoromethyl)-1,1'-Biphenyl (8)2-(Trifluoromethyl)Aniline (58)2-(Trifluoromethyl)Benzaldehyde (27)2-(Trifluoromethyl)Benzamide (6)2-(Trifluoromethyl)Benzoic Acid (33)2-(Trifluoromethyl)Benzonitrile (35)2-(Trifluoromethyl)Phenol (23)2-(Trifluoromethyl)Pyrazine (6)2-(Trifluoromethyl)Pyridine (6)2-(Trifluoromethyl)Pyrimidine (27)2-(Trifluoromethyl)Quinazoline (4)2-(Trifluoromethyl)Thiazole (11)2-(Trifluoromethyl)Thiophene (10)2-Bromo-1-Fluoro-4-(Trifluoromethyl)Benzene (4)2-Bromo-4-(Trifluoromethyl)Aniline (9)2-Bromo-6-(Trifluoromethyl)Aniline (5)2-Chloro-3-(Trifluoromethyl)Aniline (3)2-Chloro-4-(Trifluoromethyl)Pyrimidine (6)2-Chloro-6-(Trifluoromethyl)Aniline (4)2-Methoxy-3-(Trifluoromethyl)Pyridine (6)2-Methoxy-5-(Trifluoromethyl)Pyridine (4)2-Phenoxy-5-(Trifluoromethyl)Pyridine (7)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-5-(Trifluoromethyl)Pyridine (3)3-(Trifluoromethoxy)Aniline (22)3-(Trifluoromethoxy)Benzaldehyde (10)3-(Trifluoromethoxy)Benzoic Acid (19)3-(Trifluoromethoxy)Benzonitrile (11)3-(Trifluoromethoxy)Phenol (12)3-(Trifluoromethyl)-1H-Pyrrolo[2,3-B]Pyridine (3)3-(Trifluoromethyl)Aniline (102)3-(Trifluoromethyl)Benzaldehyde (31)3-(Trifluoromethyl)Benzenesulfonyl Chloride (13)3-(Trifluoromethyl)Benzoic Acid (52)3-(Trifluoromethyl)Benzonitrile (47)3-(Trifluoromethyl)Phenol (43)3-(Trifluoromethyl)Pyridazine (3)3-(Trifluoromethyl)Pyridin-2-Ol (5)3-(Trifluoromethyl)Pyridine (51)3-Chloro-4-(Trifluoromethyl)Aniline (5)4,4,4-Trifluoro-1-Phenylbutane-1,3-Dione (10)4,4,5,5-Tetramethyl-2-(2-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethoxy)Phenyl)-1,3,2-Dioxaborolane (5)4-(Trifluoromethoxy)Aniline (26)4-(Trifluoromethyl)-2H-Chromen-2-One (6)4-(Trifluoromethyl)Phenol (18)4-(Trifluoromethyl)Pyridine (14)4-(Trifluoromethyl)Pyrimidin-2-Amine (6)4-(Trifluoromethyl)Pyrimidine (12)4-(Trifluoromethyl)Thiazole (7)4-Bromo-3-(Trifluoromethyl)Aniline (7)5-(Trifluoromethyl)Pyridin-2-Amine (5)5-(Trifluoromethyl)Pyridin-2-Ol (8)6-(Trifluoromethyl)-1H-Indazole (6)6-(Trifluoromethyl)-1H-Indole (5)6-(Trifluoromethyl)Pyridin-2-Amine (11)6-(Trifluoromethyl)Pyridin-3-Amine (5)Methyl 2-(Trifluoromethyl)Benzoate (14)Methyl 3-(Trifluoromethyl)Benzoate (22)N-Phenyl-4-(Trifluoromethyl)Aniline (3)Phenyl(3-(Trifluoromethyl)Phenyl)Methanone (3)Phenyl(Trifluoromethyl)Sulfane (23)Trifluoromethyl-Picolinamide (7)Trifluoromethylaniline (3)
Ureas (1841)
Other Function Groups (5)
Organocatalysts
Chiral Hydrogen-Bonding Organocatalysts (79)
Chiral Phosphoric Acids (161)
4-Hydroxy-2,6-Diphenyldinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepine 4-Oxide (20)
Cinchona Alkaloids (32)
MacMillan Imidazolidinone Organocatalysts (15)
NHTf (59)
Proline-Based Organocatalysts (51)
Other Organocatalysts (45)
Organometallic Reagents
Organoborons (34731)
(1-(Tert-Butoxycarbonyl)-1H-Indol-2-Yl)Boronic Acid (17)(1-Phenyl-1H-Pyrazol-4-Yl)Boronic Acid (4)(1H-Indazol-4-Yl)Boronic Acid (3)(1H-Indazol-6-Yl)Boronic Acid (4)(1H-Indol-2-Yl)Boronic Acid (3)(2,3-Dichlorophenyl)Boronic Acid (11)(2,3-Difluorophenyl)Boronic Acid (33)(2,6-Dichlorophenyl)Boronic Acid (6)(2,6-Difluorophenyl)Boronic Acid (28)(2-(Phenoxymethyl)Phenyl)Boronic Acid (3)(2-(Trifluoromethoxy)Phenyl)Boronic Acid (5)(2-(Trifluoromethyl)Phenyl)Boronic Acid (20)(2-Bromophenyl)Boronic Acid (39)(2-Chloro-3-Methoxyphenyl)Boronic Acid (5)(2-Chloro-6-Fluorophenyl)Boronic Acid (9)(2-Fluoro-3-(Trifluoromethyl)Phenyl)Boronic Acid (6)(2-Fluorophenyl)Boronic Acid (229)(2-Nitrophenyl)Boronic Acid (13)(3,4-Dichlorophenyl)Boronic Acid (10)(3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Methanol (7)(3-(Benzyloxy)Phenyl)Boronic Acid (9)(3-(Phenoxymethyl)Phenyl)Boronic Acid (3)(3-(Phenylcarbamoyl)Phenyl)Boronic Acid (3)(3-(Trifluoromethoxy)Phenyl)Boronic Acid (9)(3-(Trifluoromethyl)Phenyl)Boronic Acid (41)(3-Bromo-2-Fluorophenyl)Boronic Acid (7)(3-Bromo-2-Methoxyphenyl)Boronic Acid (6)(3-Bromophenyl)Boronic Acid (65)(3-Chloro-2-Methoxyphenyl)Boronic Acid (4)(3-Chloro-4-Fluorophenyl)Boronic Acid (8)(3-Chlorophenyl)Boronic Acid (121)(3-Fluorophenyl)Boronic Acid (169)(3-Iodophenyl)Boronic Acid (5)(3-Nitrophenyl)Boronic Acid (32)(4-(Benzyloxy)Phenyl)Boronic Acid (26)(4-(Methylsulfonyl)Phenyl)Boronic Acid (6)(4-(Phenoxymethyl)Phenyl)Boronic Acid (6)(4-(Phenylcarbamoyl)Phenyl)Boronic Acid (11)(4-(Trifluoromethyl)Phenyl)Boronic Acid (23)(4-Cyclohexylphenyl)Boronic Acid (7)(4-Fluorophenyl)Boronic Acid (93)(5-(Trifluoromethyl)Pyridin-3-Yl)Boronic Acid (4)(6-Phenoxypyridin-3-Yl)Boronic Acid (5)(9H-Fluoren-2-Yl)Boronic Acid (6)(E)-4,4,5,5-Tetramethyl-2-Styryl-1,3,2-Dioxaborolane (16)1,3,2-Dioxaborinane (6)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzyl)Piperazine (5)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Piperazine (10)1-(5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Yl)Piperazine (6)1-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole (6)2,7-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-9H-Fluorene (7)2-(1,3,2-Dioxaborinan-2-Yl)Benzonitrile (4)2-(1,3,2-Dioxaborolan-2-Yl)-1-Methyl-1H-Indole (6)2-(2-(Bromomethyl)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (9)2-(2-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(3-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(3-Cyclopropylphenyl)-1,3,2-Dioxaborolane (5)2-(3-Isopropoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (14)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (7)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-(4-(Benzyloxy)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(4-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(4-Cyclopropylphenyl)-1,3,2-Dioxaborolane (8)2-(4-Fluorophenyl)-1,3,2-Dioxaborinane (5)2-([1,1'-Biphenyl]-4-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(Cyclohex-1-En-1-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (16)2-(Furan-2-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (6)2-(M-Tolyl)-1,3,2-Dioxaborinane (4)2-Benzyl-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (12)2-Chloro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (4)2-Chloro-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (14)2-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-Fluoro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (3)3-(1,3,2-Dioxaborinan-2-Yl)Aniline (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (25)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (74)3-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)3-Fluoro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)3-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)4,4,5,5-Tetramethyl-2-(2-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(2-Nitrophenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethoxy)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(Naphthalen-1-Yl)-1,3,2-Dioxaborolane (19)4,4,5,5-Tetramethyl-2-(Naphthalen-2-Yl)-1,3,2-Dioxaborolane (12)4,4,5,5-Tetramethyl-2-(Thiophen-2-Yl)-1,3,2-Dioxaborolane (23)4,4,5,5-Tetramethyl-2-(Thiophen-3-Yl)-1,3,2-Dioxaborolane (10)4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1,2,3,6-Tetrahydropyridine (11)4-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Indole (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Indoline (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinonitrile (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Amine (9)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyrimidine (27)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Thiazole (7)[1,1'-Biphenyl]-4-Ylboronic Acid (29)Benzo[B]Thiophen-2-Ylboronic Acid (5)Benzofuran-2-Ylboronic Acid (8)Benzyl (4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Carbamate (5)Cyclohex-1-En-1-Ylboronic Acid (4)Ethyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (6)Isoquinolin-4-Ylboronic Acid (3)Methyl 5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinate (4)N,N-Diphenyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (6)Naphthalen-1-Ylboronic Acid (4)Naphthalen-2-Ylboronic Acid (8)Phenylboronic Acid (1287)Pyridin-2-Ylboronic Acid (9)Pyridin-3-Ylboronic Acid (49)Pyridin-4-Ylboronic Acid (21)Pyrimidin-5-Ylboronic Acid (9)Tert-Butyl 2-(1,3,2-Dioxaborolan-2-Yl)-1H-Indole-1-Carboxylate (6)Tert-Butyl 4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole-1-Carboxylate (3)Tetraphenylborate (8)Thiophen-2-Ylboronic Acid (20)Fluorene-Phenyl-Boronic Acid/Ester (4)Hydroxymethyl-Phenyl-Boronic-Acid (32)Methoxyphenylboronic-Acid (32)Phenyl-Naphthalene-Boronic Acid/Ester (9)
Organosilicons (73)
Organotins (5)
Other Organometallic Reagents (1)
Phase-Transfer Catalysts
Achiral Phase-Transfer Catalysts (61)
Chiral Phase-Transfer Catalysts (25)
Specialty Synthesis
Ionic Liquids (584)
Synthetic Reagents
C-C Bond Formation (62)
Condensation Agents (75)
Fluorination Reagents (20)
Halogenation Reagents (20)
Inorganic Salts (25228)
Phase Transfer Catalysts (33)
Other Synthetic Reagents (105)
Materials Science
Electronic Materials
Contact Printing & Self-Assembly Materials (73)
Liquid Crystal (LC) Materials (468)
Molecular Conductors (75)
Organic Field-Effect Transistor (OFET) Materials (103)
Thiophenes (1)
Organic Light-Emitting Diode (OLED) Materials (22)
4-(Diphenylamino)Benzaldehyde (8)4-Bromo-N,N-Bis(4-Methoxyphenyl)Aniline (3)4-Methoxy-N,N-Diphenylaniline (5)4-Methyl-N,N-Diphenylaniline (6)
Photoresist Materials (259)
Silane Coupling Agents (224)
Energy and Battery Materials
Battery Additives (75)
Battery Electrolytes Materials (16)
Battery Solvent Materials (24)
Electrode Active Materials (4)
Ionic Liquids (584)
Organic Redox Flow Battery Materials (26)
Solution & Vapor Deposition Precursors (31)
Material Building Blocks
Alkyl Chain Building Blocks (88)
Ligands for Functional Metal Complexes (220)
Liquid Crystal (LC) Building Blocks (347)
Phthalocyanine Building Blocks (37)
Small Molecule Semiconductor Building Blocks (1157)
Organic Frameworks and Supramolecular Materials
Covalent Organic Framework (COF) Linkers (1087)
Metal Organic Framework (MOF) Linkers (1692)
Metal Organic Frameworks (MOFs) (58)
Organic Framework Building Blocks (217)
Supramolecular Host Materials (122)
Polymer Additives
Antioxidants (85)
Crosslinking Agents (85)
Flame Retardants (44)
Light Stabilizers (67)
Plasticizers (81)
Polymerization Catalysts (155)
Polymerization Initiators (134)
Polymerization Reagents (229)
Surfactants (310)
Other Additives (36)
Polymer Reagents
Dendrimer Materials (57)
Ion Exchange Resins (5)
Monomers (1603)
Photopolymer Monomers (183)
Polybenzoxazole and Polyimide Raw Materials (239)
Polymer Semiconductor Monomers (270)
Polymers (804)
Quantum Dots and Micro/Nano Materials
Nanocarbon Materials (44)
Quantum Dot (QD) Capping Agents (172)
Quantum Dot (QD) Synthetic Reagents (12)
Solar Cells and Photonic Materials
Donor Intermediates & Acceptor Intermediates (1039)
Dye-Sensitized Solar Cell (DSSC) Materials (93)
Dyes and Pigments (391)
Organic Non-Linear Optical (NLO) Materials (20)
Organic Photo-Voltaics (OPVs) Materials (183)
Perovskite Solar Cell (PSC) Materials (238)
Visible Light Photoredox Catalysts (24)
Other Functional Materials
Aggregation-Induced Emission Materials (124)
Inorganic Compounds and Ceramic Materials (33)
Magnetic Materials (48)
Life Science
Inhibitors/Agonists
ADC (373)
ADC Linker (373)
Angiogenesis (1713)
ALK (86)Bcr-Abl (105)BTK (149)EGFR (404)FAK (56)FGFR (136)FLT3 (134)HER2 (31)HIF (111)JAK (245)PDGFR (127)Src (110)Syk (40)VDA (1)VEGFR (270)
Anti-Infection (4743)
3CLpro (41)Antibacterial (2089)Antifungal (523)Antiparasitic (639)Antiprotozoal (3)Antiviral (49)Arenavirus (5)BVDV (3)CMV (28)Dengue Virus (36)EBV (15)Enterovirus (34)FCoV (3)Filovirus (14)Flavivirus (64)GraR (1)HBV (150)HCV (222)HHV (1)HIV (444)HIV Integrase (38)HIV Protease (69)HPV (10)HRV (3)HSV (75)Influenza Virus (250)LpxC (2)M2 proton channel (2)MERS-CoV (1)Neuraminidase (4)NNRTI (12)NRTI (22)Orthopoxvirus (24)Penicillin-Binding Protein (7)PLP (13)Prion (1)Protein Synthesis (3)Reverse Transcriptase (98)RSV (43)SAMHD1 (1)SARS-CoV (296)SQLE (6)TMV (12)Viral MTase (3)Virus Protease (60)VSV (1)β-lactamase (51)
Antibody-Drug Conjugate/ADC Related (649)
ADC Linker (373)ADC Toxins (123)Payload-Linker Conjugate (165)
Apoptosis (2439)
Apoptosis (2139)Apoptosis Inducer (1403)Bcl-2 (195)Bcl-6 (6)BRK (3)c-Myc (47)c-RET (64)C/EBP (2)Caspase (170)DAPK (12)Ferroptosis (109)FKBP (15)GDNF Receptor (2)IAP (48)IDO (69)MDM2 (143)MRCK (2)Necroptosis (33)p32 (1)p53 (41)PERK (35)PKD (10)Pyroptosis (13)RIP Kinase (84)Survivin (12)Thymidylate Synthase (24)TNF (22)TNF Receptor (117)TNF-alpha (30)
Autophagy (732)
ATG4B (4)ATTECs (3)AUTACs (7)Autophagy (717)Beclin1 (1)FKBP (15)LC3 (1)LRRK2 (32)Lysosome (1)mitoNEET (1)Mitophagy (3)PPT (1)SPHK (27)TFEB (1)ULK (17)
Cell Cycle (4587)
Antifolate (31)APC (6)Aurora Kinase (86)BUB (3)Casein Kinase (101)CDK (475)Chk (46)CRISPR/Cas9 (7)CRM1 (16)DHFR (55)DNA polymerase θ (2)DNA/RNA Synthesis (619)DOCK (3)DYRK (60)E2F (2)eIF (43)Endonuclease (3)FOXM1 (3)G-quadruplex (6)Haspin Kinase (8)HDAC (334)HGF (1)HSF (4)HSP (160)IRE1 (28)Kinesin (35)Lats kinase (1)LIMK (17)Mad2 (1)Microtubule/Tubulin (305)MKLP (2)Mps1 (21)MTH2 (1)Nucleoside Antimetabolite/Analog (1439)p21 (1)PAK (29)PDI (1)PKMYT1 (2)PLK (50)PPAR (192)PTEN (5)RAD51 (17)Rho (14)RNA polymerase 2 (1)RNA polymerase 1 (2)ROCK (89)Separase (1)Sirtuin (130)SRPK (51)STK33 (2)TACC (3)Telomerase (20)TOPK (1)Topoisomerase (270)Wee1 (16)YB-1 (5)
Cytoskeleton (727)
Actin (1)Arp2/3 Complex (6)CYTH (1)Cytoplasmic dynein (1)Dynamin (14)FAK (56)Filamin-A (1)Gap Junction (11)Integrin (135)Kinesin (35)MARK (1)Microtubule/Tubulin (305)MLCK (5)Mps1 (21)Myosin (25)PAK (29)ROCK (89)Spastin (1)
DNA Damage (3017)
ADAR (1)AP endonuclease (1)ATAD5 (1)ATM/ATR (67)Aurora Kinase (86)Casein Kinase (101)ClpP (5)CRISPR/Cas9 (7)DNA Alkylator/Crosslinker (75)DNA-PK (39)DNA/RNA Synthesis (619)HDR (1)HSP (160)MRE11 (1)MTH1 (8)Nucleoside Antimetabolite/Analog (1439)OGG (3)p97 (15)PARP (175)RAD51 (17)RAD52 (3)Telomerase (20)Topoisomerase (270)WRN (5)YB-1 (5)
Endocrinology/Hormones (826)
5 Alpha Reductase (2)ACE (76)Adrenergic Receptor (183)Androgen Receptor (96)Aromatase (8)ERR (219)GHSR (21)Glucocorticoid Receptor (44)GNRH Receptor (19)Mineralocorticoid Receptor (12)Opioid Receptor (54)Progesterone Receptor (9)PTHR (1)Renin (18)Sepiapterin reductase (2)SSTR (28)Taste receptor (3)Thyroid Hormone Receptor (7)TPO (4)TRHR (1)TSH Receptor (17)TTR (7)
Endoplasmic Reticulum Stress (561)
Antioxidant (31)IRE1 (28)JNK (78)PDI (1)PERK (35)ROS (394)
Epigenetics (2361)
AMPK (107)Aurora Kinase (86)DNA Methyltransferase (42)Epigenetic Reader Domain (393)FTO (15)HDAC (334)HIF (111)Histone Acetyltransferase (92)Histone Demethylase (147)Histone Methyltransferase (294)JAK (245)MBD-containing protein (1)METTL3 (10)MicroRNA (16)PAD (24)PARP (175)Pim (58)PKC (158)SF3B1 (3)Sirtuin (130)TET (8)
Ferroptosis Signaling Pathway (78)
ABC Transporter (2)ACC (22)GPx (24)GTPCH (1)SCD (18)SLC (6)VDAC (6)
GPCR/G Protein (3464)
5-HT Receptor (394)Adenosine Receptor (169)Adenylyl Cyclase (1)Adiponectin Receptor (2)Adrenergic Receptor (183)Amylin receptor (1)Angiotensin Receptor (73)Apelin Receptor (22)Bombesin Receptor (7)Bradykinin Receptor (17)cAMP (35)Cannabinoid Receptor (62)CaSR (23)CCR (89)CGRP Receptor (14)Chemerin Receptor (2)Cholecystokinin Receptor (32)CRF Receptor (19)CXCR (112)Dopamine Receptor (170)Endothelin Receptor (47)Epac (9)G protein (2)GHSR (21)GLP Receptor (25)Glucagon Receptor (51)GNRH Receptor (19)GPCR (200)GPCR19 (2)GPR109A (1)GPR119 (2)GPR139 (3)GPR24 (1)GPR35 (1)GPR40 (7)GPR52 (4)GPR6 (3)GPR68 (2)GPR84 (1)GPR88 (10)Guanylate Cyclase (30)HCAR (2)Histamine Receptor (236)ICMT (61)Kisspeptin Receptor (2)LHCGR (39)LPA Receptor (11)LPL Receptor (118)Melanocortin Receptor (25)mGluR (228)Motilin Receptor (1)MRGPR (13)Neuropeptide Y receptor (8)Neurotensin Receptor (13)NMUR (2)NPFF receptor (3)Opioid Receptor (54)OXTR (10)P2Y Receptor (77)PACAP Receptor (3)PAFR (39)PAR (55)Prostaglandin Receptor (216)Ras (275)RGS (6)RXFP Receptor (14)Sigma Receptor (52)SOS (7)SRPK (51)SSTR (28)SUCNR1 (5)TAAR (8)TSH Receptor (17)Urotensin Receptor (7)Vasopressin Receptor (23)β-arrestin (17)
Hedgehog (Hh) (831)
BMI-1 (3)c-Myc (47)Casein Kinase (101)CDK (475)Cytoplasmic dynein (1)Gli (6)GSK-3 (125)PKA (59)Smo (36)ULK (17)
Hippo (80)
Lats kinase (1)MAP4K (47)MST (2)TEAD (10)YAP (28)
Immunology/Inflammation (2700)
AIM2 (5)AP-1 (15)Arginase (15)Calcineurin (8)CCR (89)CD19 (1)CD20 (2)CD22 (2)CD28 (2)CD28-B7 (1)CD3 (3)CD38 (10)CD47 (6)CD6 (1)CD73 (26)CD80 (1)cGAS (8)Complement System (45)COX (347)CRTH2 (9)CTLA-4 (2)CXCR (112)CYPA (1)FAP (17)FKBP (15)FLAP (17)FPR (17)Galectin (3)Glucocorticoid Receptor (44)Glycoprotein VI (3)GM-CSF (2)Histamine Receptor (236)HMGB (1)IFNAR (24)IL (173)IL Receptor (9)Immunology & Inflammation Related (76)IRAK (71)IRF3 (1)LAG-3 (1)LanC-like protein (1)Legumain (1)LTA4H (3)LTR (71)MALT1 (24)MIF (18)MyD88 (6)NADPH Oxidase (32)NFAT (11)NLR (73)NO Synthesis (6)NOS (185)NOT (1)Nrf2 (99)PD-1/PD-L1 (80)PG Synthase (31)PSMA (13)Pyroptosis (13)ROS (394)Ros1 (18)S100A9 (1)Scavenger receptor (1)SIK (15)SOD (4)SPHK (27)STING (99)TENT (1)Thrombopoietin Receptor (11)Tim3 (4)TLR (163)TSPO (2)VISTA (1)XBP1 (1)
JAK-STAT-Signaling (838)
EGFR (404)JAK (245)Pim (58)STAT (160)
MAPK/ERK Pathway (713)
AP-1 (15)ERK (166)HPK1 (2)JNK (78)KLF (5)MAP3K (24)MAP3K12 (1)MAP4K (47)MAP4K4 (5)MAP4K6 (1)MEK (100)MK2 (11)MLK (14)MNK (11)p38 MAPK (163)Raf (106)RSK (33)TAOK (1)
Membrane Transporter/Ion Channel (1706)
ABC Transporter (2)AKK1 (3)ANT (1)AQP (5)AQP3 (1)ARF (2)ATP synthase (19)ATPase (41)BCRP (23)Calcium Channel (270)CFTR (61)Chloride Channel (29)CRAC Channel (14)CRM1 (16)EAAT (3)Efflux pump (1)ENT (2)Ferroportin (2)GABA Receptor (186)GLUT (32)Glutamate transporter (21)Glycine transporter (22)HCN Channel (2)IBAT (10)ITPKA (2)MAT (24)MCT (17)Na+/Ca2+ Exchanger (15)Na+/K+ ATPase (15)Na/HCO3 cotransporter (1)NKCC (1)Oct (11)OCTN (1)Organic Anion Transporter (1)P-gp (53)P2X Receptor (79)Piezo (4)Potassium Channel (285)Proton Pump (55)SEO1 (1)SGLT (44)SLC (6)Sodium Channel (194)SV2 (2)TRP Channel (180)UCP (1)URAT1 (18)Urea Transporter (2)VDAC (6)VRAC (1)
Metabolic Enzyme (3494)
15-PGDH (2)2OG Oxygenase (1)3-PGDH (2)3MST (1)6PGD (3)ACAT (38)ACC (22)ACMSD (2)Aconitate hydratase (1)ACS (3)Adenosine Deaminase (12)Adenosylhomocysteinase (8)ADP-ribosyltransferase (1)AhR (50)AKR (15)ALDH (30)Aldose Reductase (54)Aminopeptidase (28)Antifolate (31)AO (2)ApoE (1)Arginase (15)Asparagine synthetase (1)ATF/CREB proteins (2)ATP Citrate Lyase (6)ATP synthase (19)BDK (1)Beta-glucuronidase (3)Carbonic Anhydrase (120)Carboxylesterase (23)Carboxypeptidase (7)Cardiolipin Peroxidase (1)Cathepsin (98)Ceramidase (4)CETP (15)Cholesterol Transporter (1)CPA (5)CPSI (2)Creatine kinase (1)Cryptochrome (5)CSE (2)CYP51 (1)D-amino acid oxidase (3)D6D (1)DAPA synthase (1)Decarboxylase (9)Dehydrogenase (157)DGAT (62)DGK (20)Dopamine β-hydroxylase (8)E-NTPDase (1)Elastase (33)Enolase (7)Enteropeptidase (5)ERAP (3)FABP (6)Factor Xa (45)Farnesyl Transferase (4)FAS (34)FBPase (4)Ferroptosis (109)FOXO (3)FPR (17)FTO (15)Fumarate hydratase (2)FVII (2)FXR (74)G0/G1 switch protein 2 (2)Galactosidases (5)GCN (1)GCS (3)GGTase (6)Glucokinase (26)Glucosidase (132)GLUT (32)Glutaminase C (2)Glutathione Reductase (1)Glyoxalase (14)GOAT (1)GPx (24)GSNOR (3)GST (16)Hexokinase (7)HMGCR (45)HPSE (2)Hydrolase (12)Hydroxylase (23)IDH (37)IDO (69)Ketohexokinase (5)LDL (11)LDLR (1)Lipase (93)Lipoxygenase (110)LOX (4)LRH-1 (4)LXR (27)MAGL (2)MASTL (1)MDH (3)MetAP (10)MGAT (7)Mineralocorticoid Receptor (12)Mitochondrial Electron Transport Chain (3)Mitochondrial Metabolism (97)MPC (3)NAMPT (33)Neprilysin (20)NNMT (8)NPP (2)NPR (15)NQO (2)OGT (2)OPA1 (1)P448 (1)P450 (261)PAI-1 (25)PARG (12)PDE (366)PDHK (12)PEPCK (2)PGAM1 (1)PGC-1α (4)PHGDH (5)Phospholipase (108)Phosphorylase (10)PI5P4K (11)PKM1 (2)PKM2 (6)Procollagen C Proteinase (1)Proprotein convertases (5)Pyruvate Kinase (28)QR (2)RAR/RXR (86)RBP (3)REV-ERB (4)ROR (67)SCD (18)sEH (33)SGK (15)SHMT (7)Sialyltransferase (1)Sphingosine acyltransferase (2)SQOR (2)Srx (1)Steroid Sulfatase (8)TDO (3)TGH (1)Thioredoxin (12)Thrombin (42)Thymidylate Synthase (24)Transferase (80)Transketolase (7)TrxR (11)Trypanothione reductase (1)UGT (3)VD/VDR (47)Xanthine Oxidase (50)αKGD (2)
Neuronal Signaling (3822)
5-HT Receptor (394)AAK1 (17)AChE (44)AChR (346)Adenosine Kinase (6)Adrenergic Receptor (183)AMPAR (54)Amylin receptor (1)Amyloid-β (170)Calcium Channel (270)CaMK (54)Cannabinoid Receptor (62)CGRP Receptor (14)Cholecystokinin Receptor (32)Cholinesterase (234)CHT (1)COMT (16)DAT (21)Dopamine Receptor (170)Endorphin (1)Enkephalinase (3)FAAH (45)GABA Receptor (186)Glucosylceramide Synthase (13)GluR (204)GPR119 (2)GPR139 (3)GPR24 (1)Histamine Receptor (236)Huntingtin (3)Imidazoline Receptor (14)Kainate receptor (5)MAO (192)Melanocortin Receptor (25)mGluR (228)MT Receptor (12)NET (3)Neuropeptide Y receptor (8)Neurotensin Receptor (13)NGF (3)NK Receptor (57)NMDA (1)NMDAR (49)Notch (26)Nurr1 (7)OLIG2 (1)Opioid Receptor (54)OX Receptor (50)P2X Receptor (79)Proprotein convertases (5)QC (3)RAGE (3)REST (1)Ryanodine Receptor-1 (1)S100β (1)Secretase (112)SERT (27)Sigma Receptor (52)SMS (4)SSRIs (5)Substance P (2)TAAR (8)Tau Protein (28)TLX (1)Trk Receptor (80)TRP Channel (180)TTR (7)α-synuclein (1)
NF-κB Signaling Pathway (542)
IKK (75)MALT1 (24)NF-κB (420)Nrf2 (99)Pirin (3)RANKL (1)RANKL/RANK (3)RIP Kinase (84)TAK1 (3)
Notch Signaling Pathway (762)
ERK (166)Gli (6)MRCK (2)Notch (26)p53 (41)ROCK (89)TGF-beta/Smad (381)β-catenin (71)
PI3K/AKT/mTOR (1046)
Akt (208)AMPK (107)ATM/ATR (67)DNA-PK (39)FOXO (3)GSK-3 (125)MELK (9)mTOR (187)PDK (22)PDK-1 (3)PI3K (341)PI4K (28)PIKfyve (9)PIN1 (10)PTEN (5)RSK (33)
PPAR Signaling Pathway (2127)
ACS (3)Akt (208)AMPK (107)AQP (5)Bcl-6 (6)FABP (6)FATP (3)IL (173)LXR (27)MMP (176)NF-κB (420)NLR (73)OxPhos (4)PDK-1 (3)PEPCK (2)PPAR (192)RAR/RXR (86)RGS (6)ROS (394)SCD (18)SGK (15)Sirtuin (130)STAT (160)TNF-alpha (30)
Protease (696)
ADAMTS (5)Aspartic Protease (2)Cysteine Protease (25)Dipeptidase 1 (2)DP-IV (2)DPP1 (2)DPP2 (2)DPP4 (72)Glutaminase (26)MMP (176)NEP (4)PE (2)Proteasome (122)Ser/Thr Protease (164)SPP (1)Tyrosinase (101)
Protein Tyrosine Kinase/RTK (2741)
Ack1 (5)ALK (86)Bcr-Abl (105)BMX Kinase (3)BRK (3)BTK (149)c-FMS (60)c-Kit (87)c-Met/HGFR (131)c-RET (64)DDR1/DDR2 Receptor (22)DYRK (60)EGFR (404)Ephrin Receptor (16)ErbB (6)FAK (56)FGF (2)FGFR (136)FLT3 (134)GAK (624)HER2 (31)IGF-1R (28)Insulin Receptor (26)ITK (18)JAK (245)MRCK (2)PDGFR (127)PTK (7)Pyk2 (4)Ros1 (18)SHP2 (48)Src (110)Syk (40)TAM Receptor (50)Tie-2 (16)Trk Receptor (80)VEGFR (270)
Pyroptosis (994)
Caspase (170)Cathepsin (98)IL (173)MyD88 (6)NF-κB (420)TLR (163)
Stem Cells (1524)
BMI-1 (3)Casein Kinase (101)CREB (5)ERK (166)Frizzled (2)Gli (6)GSK-3 (125)Hedgehog (31)JAK (245)LIN28 (4)MST (2)Notch (26)Notum (2)PKA (59)PORCN (10)ROCK (89)sFRP-1 (1)Smo (36)SOD1 (2)STAT (160)TGF-beta/Smad (381)Wnt (104)YAP (28)β-catenin (71)
TGF-beta/Smad (457)
Bcr-Abl (105)PKC (158)ROCK (89)TGF-beta/Smad (381)
Toll-Like Receptor (TLR) (549)
CREB (5)IKK (75)IRAK (71)IRF3 (1)JNK (78)MyD88 (6)p38 MAPK (163)TAK1 (3)TLR (163)
Ubiquitin (370)
DUB (83)E1/E2/E3 Enzyme (142)FBXO (2)NAE (8)p97 (15)Proteasome (122)SUMO (4)
Vitamin D Related/Nuclear Receptor (586)
Androgen Receptor (96)Glucocorticoid Receptor (44)LXR (27)Mineralocorticoid Receptor (12)PPAR (192)Progesterone Receptor (9)RAR/RXR (86)REV-ERB (4)ROR (67)Thyroid Hormone Receptor (7)VD/VDR (47)
Wnt Signaling Pathway (2367)
AP-1 (15)APC (6)ATF/CREB proteins (2)c-Myc (47)Calcineurin (8)CaMK (54)Casein Kinase (101)CDK (475)CREB (5)Frizzled (2)GSK-3 (125)JNK (78)MMP (176)NF-κB (420)NFAT (11)p300/CBP/PROTAC (2)PDE (366)Phospholipase (108)PKC (158)PKG (10)Rho (14)ROCK (89)ROR (67)Wnt (104)β-catenin (71)
Other Inhibitors/Agonists (3183)
20-HETE (2)AIMP2-DX2 (2)Amino Acids and Amino Acid Derivatives (122)Aminoacyl-tRNA Synthetase (18)Anesthetic (3)Anti-inflammation (34)Anti-Thyroid Agent (1)Anti-tumor (7)Anti-ulcer (1)Antioxidant (31)Antispasmodic Agent (3)ASGPR (11)Bcat (11)c-RET (64)Cancer Stem Cells (2)CAR (5)Cardiac transcription factor (2)CBFβ-SMMHC (1)CD20 (2)CD52 (1)CD73 (26)CerK (1)Chelating Agent (16)Choleretic (1)Choline Kinase (3)CNT (1)CRTH2 (9)CSE (2)DCLK (1)DcpS (1)Decarboxylase (9)Dehydrogenase (157)Diabetes (2)Diuretic (1)Drug Metabolite (286)DUE-B (1)E2F (2)ECE (2)Endogenous Metabolite (1202)ERO1 (2)FAP (17)FATP (3)Fer/FerT (1)FPP synthase (1)Fucosyltransferase (4)Fungicide (61)G protein (2)Galectin (3)Galectin-3 (12)GBF1 (1)GCase (4)Glucocorticoid Receptor (44)GRK (21)GTPCH (1)Herbicide (17)HIPK2 (3)Histidine kinase (1)HNF4α (1)HPPD (3)HRGP (1)Hydroxylase (23)IgE (2)IMP1 (1)Importin β (1)Insecticide (27)ITPKA (2)LAT1 (3)LDL (11)Lipase (93)Lipocalin-2 (1)LYTACs (8)MALAT1 (1)MITF (1)MLKL (4)Molecular Glues (41)MPO (6)MTTP (8)Muscle Relaxant (1)MYOF (1)NAADP (1)Neuroprotection/neurogenic Agent (4)NMD (1)NT (2)Nur77 (8)O-GlcNAcase (9)O-glycosylation (1)OSBP (1)OSBPL (1)OSC (2)Osteoclasts/Bone/Osteogenesis (15)OxPhos (4)PAM complex (1)PANK (2)PAX2 (1)PBR (4)PCA1 (1)PCSK9 (7)PDX1 (1)PEPT (1)PFKFB3 (7)Phosphatase (250)Phosphorylase (10)Photosensitizer (6)PIN1 (10)PKG (10)Platelet (5)PME-1 (2)PMO/MNA (4)PNP (1)PREP (20)Protein Synthesis (3)PXR (3)Quorum Sensing (57)RasGAP (2)Rev-ErbA (3)RUNX (7)SAP (1)SMARC (6)SQS (4)SREBP (5)SRPK (51)Sweetener (3)Tgase (2)Thioredoxin (12)TIR1 (1)TNIK (8)TNK (4)TNNI3K (1)UGT1A1 (1)Urease (5)vanin (4)VDA (1)Vitamin (64)VPS (3)XOR (1)α-amylase (15)Others (2570)
Inhibitory Monoclonal Antibody
Human Inhibitory Monoclonal Antibody (62)
Amyloid-β/monoclonal antibody (2)CA Ⅸ/monoclonal antibody (1)CCR/monoclonal antibody (1)CD19/monoclonal antibody (1)CD20/monoclonal antibody (2)CD22/monoclonal antibody (1)CD25/monoclonal antibody (1)CD3/monoclonal antibody (1)CD38/monoclonal antibody (1)CD4/monoclonal antibody (1)CD40/monoclonal antibody (1)CD47/monoclonal antibody (1)CD52/monoclonal antibody (1)CD6/monoclonal antibody (1)CD62p/monoclonal antibody (1)CD73/monoclonal antibody (1)CGRP Receptor/monoclonal antibody (2)Complement System/monoclonal antibody (1)CTLA-4/monoclonal antibody (1)EGFR/monoclonal antibody (2)HER2/monoclonal antibody (2)IFNAR/monoclonal antibody (1)IgE/monoclonal antibody (2)IGF-1R/monoclonal antibody (1)IL-13/monoclonal antibody (1)IL-17a/monoclonal antibody (1)IL-1β/monoclonal antibody (1)IL-23/monoclonal antibody (2)IL-4Ra/monoclonal antibody (1)IL-5/monoclonal antibody (1)IL-5Rα/monoclonal antibody (1)IL-6/monoclonal antibody (3)Integrin/monoclonal antibody (1)KIR/monoclonal antibody (1)LAG-3/monoclonal antibody (1)PCSK9/monoclonal antibody (2)PD-1/PD-L1/monoclonal antibody (4)RANKL /monoclonal antibody (1)Sclerostin/monoclonal antibody (1)SLAMF7/monoclonal antibody (1)TIGIT/monoclonal antibody (1)Tim3/monoclonal antibody (1)TNF Receptor/monoclonal antibody (3)TNF-alpha/monoclonal antibody (2)TROP2/monoclonal antibody (1)VEGFR/monoclonal antibody (1)
Animal Modeling Reagents
Circulatory System Disease Models (11)
Cardiomyopathy Model (1)Heart Disease Correlation Model (2)Heart Failure Model (1)Hyperlipidemia Model (1)Hypertension Model (3)Thrombolysis Model (2)Vascular Inflammation Model (1)
Digestive System Disease Models (17)
Gallstone Model (1)Gastrointestinal Disease Model (8)Liver Disease Model (5)Pancreatic Disease Model (3)
Endocrine System Disease Models (12)
Aging Model (1)Diabetes Model (4)Hyperuricemia Model (8)
Immune and Inflammatory Disease Models (29)
Arthritis Model (1)Cystitis Model (1)Dermatitis Model (1)Ear Edema Model (1)Encephalomyelitis Model (2)Foot Edema Model (2)Gastrointestinal Inflammation and Ulcer Model (8)Gouty Arthritis Model (1)Liver Inflammation Model (2)Myocarditis Model (2)Nephritis Model (1)Pancreatitis Model (5)Psoriasis Model (3)Systemic Lupus Erythematosus Model (2)
Nervous System Disease Models (10)
Alzheimers Disease Model (3)Epilepsy Model (3)Neuropathic Pain Model (1)Parkinsons Disease Model (3)Schizophrenia Model (1)
Otorhinolaryngological Disease Models (4)
Cataract Model (1)Gingival Hyperplasia Model (2)Optic Neuropathy Model (1)Other Otorhinolaryngological Disease Model (1)
Respiratory System Disease Models (1)
Pulmonary Fibrosis Model (1)
Skin Disease Models (1)
Atopic Dermatitis Model (1)
Tumor Models (9)
Breast Tumor Model (2)Colon Tumor Model (1)Esophageal Tumor Model (1)Kidney Tumor Model (1)Liver Tumor Model (1)Lung Tumor Model (2)Skin Tumor Model (2)Uterine Fibroid Model (1)
Urinary System Disease Models (19)
Aging Model (1)Chronic Kidney Disease Model (2)Diabetes Model (4)Hyperuricemia Model (8)Kidney Stone Model (1)Nephrotoxicity Model (1)Renal Injury Model (5)Other Urinary System Disease Model (3)
Antibiotic and Antivirus
Function (144)
Anti-bacterial Antibiotic (2)Anti-fungal Antibiotic (7)Antivirus (66)Cell Culture Antibiotic (4)Insect Repellent (44)Plant Tissue Culture Antibiotic (7)Preservative and Disinfectant (20)
Structure (8731)
Amino Acid Derivative (3)Aminoglycoside (9)Ansamycin (3)Cephalosporin (7)Chloramphenicol (1)Imidazole (6044)Macrolide (8)Nucleoside (8)Penicillin (3)Pyridine / Pyrimidine (5)Quinolone (21)Sulfonamide (18)Tetracycline (6)β-Lactam (4)Other Antibiotics (37)Others (2570)
Biochemical Reagents
Amino Acids (809)
Amino Acid Amide (17)Biologically Modified Amino Acid (30)C-protective Amino Acid (191)N-protective Amino Acid (440)Non-protein Amino Acid (121)Protein Amino Acid (58)Side Chain Protected Amino Acid (25)
Biological Buffers (2603)
Good's Buffer (20)Other Buffers (13)Others (2570)
Cross-Linking Agents (34)
Amino-amino Crosslinker (8)Amino-sulfhydryl Crosslinker (15)Photoreactive Crosslinker (3)Sulfhydryl-carbonyl Crosslinker (1)Sulfhydryl-sulfhydryl Crosslinker (4)Other Reactive Crosslinkers (3)
Denaturants (2)
Surface Active Agent (2)
Detergents (18)
Amphoteric Surfactant (4)Anionic Surfactant (3)Cationic Surfactant (2)Nonionic Surfactant (6)Sulfonated Betaine (3)
Lipids (221)
Aliphatic Acyl (211)Glycerol Lipid (8)Sphingolipid (2)
Polypeptides (42)
Dipeptide and Tripeptide (39)Oligopeptide (3)
Steroids (2634)
Bile Acid (49)Cholestane (3)Estrogen (1)Plant Sterol (10)Steroidal Glycoside (3)Other Steroids (2)Others (2570)
Sugar and Derivatives (153)
Sugar (137)Sugar Alcohol (17)
Sweeteners (For Research Experiments) (19)
Artificial sweetener (7)Natural sweetener (12)
Cancer
Cancer Stem Cells (2471)
Cathepsin (98)CXCR (112)Hedgehog (31)IL (173)IL Receptor (9)Integrin (135)MIF (18)MMP (176)NF-κB (420)NOS (185)Notch (26)PDGFR (127)PPAR (192)STAT (160)TGF-beta/Smad (381)VEGFR (270)Wnt (104)YAP (28)
Tumor Development and Microenvironment Evolution (1827)
ALK (86)AP-1 (15)CAR (5)CCR (89)Complement System (45)COX (347)DDR1/DDR2 Receptor (22)ErbB (6)GABA Receptor (186)GSK-3 (125)IFNAR (24)IRAK (71)JAK (245)LAG-3 (1)NLR (73)Nrf2 (99)PD-1/PD-L1 (80)STING (99)Syk (40)TLR (163)TNF-alpha (30)TNK (4)
Tumor Epigenetics and Gene Regulation (2855)
Aminoacyl-tRNA Synthetase (18)ATM/ATR (67)DNA Methyltransferase (42)DNA/RNA Synthesis (619)Epigenetic Reader Domain (393)HDAC (334)HIF (111)Histone Acetyltransferase (92)Histone Demethylase (147)Histone Methyltransferase (294)METTL3 (10)MicroRNA (16)PAD (24)PARP (175)Pim (58)PKC (158)RNA polymerase 1 (2)Sirtuin (130)TET (8)Topoisomerase (270)
Tumor Growth, Proliferation and Apoptosis (2213)
Akt (208)Aurora Kinase (86)Bcl-2 (195)c-Met/HGFR (131)c-Myc (47)EGFR (404)ERK (166)HER2 (31)MEK (100)MLKL (4)mTOR (187)p53 (41)PI3K (341)PTEN (5)Raf (106)Ras (275)ROR (67)Telomerase (20)
Tumor Metabolism (1272)
ACC (22)ALDH (30)AMPK (107)Arginase (15)ATP Citrate Lyase (6)Dehydrogenase (157)FBPase (4)FTO (15)GLUT (32)Glutaminase (26)Hexokinase (7)IDH (37)IDO (69)MCT (17)MDH (3)NADPH Oxidase (32)OGT (2)P450 (261)PDHK (12)PHGDH (5)PKM2 (6)ROS (394)SHMT (7)SLC (6)SOD (4)SREBP (5)
Cell Biology
Cell Analysis (2)
Cell Proliferation and Cytotoxicity (2)
Cell Apoptosis/Death Detection (1415)
Apoptosis Inducer (1403)Apoptosis Inhibitor (2)Iron death Inhibitor (10)
Cell Culture (329)
Additive and Auxiliary Reagent (134)Cell Assay Reagents (9)Cell Staining (3)Organoid Culture Additive (91)Stem Cell Induction (115)
Enzymology
Enzyme Inhibitors (215)
Acetaldehyde Dehydrogenase Inhibitor (2)Acyltransferase Inhibitor (4)Alkaline Phosphatase Inhibitor (2)Angiotensin Converting Enzyme Inhibitor (4)ATP Enzyme Inhibitor (7)Calcineurin Inhibitor (1)Carbonic Acid Dehydratase Inhibitor (2)Caspase Inhibitor (2)Cyclooxygenase (COX) Inhibitor (53)DNA Topoisomerase II Inhibitor (11)Hypoxia Inducible Factor (HIF) Inhibitor (3)Inosine Monophosphate (IMP) Dehydrogenase Inhibitor (10)Leukotriene A4 Hydrolase Inhibitor (3)Lipoxygenase Inhibitor (11)Monoamine Oxidase Inhibitor (4)NADH Peroxidase Inhibitor (2)Pancreatic Lipase Inhibitor (2)Phosphodiesterase Inhibitor (21)Protease Inhibitor (20)Reverse Transcriptase Inhibitor (16)Starch Glucosidase Inhibitor (3)Thromboxane Synthase Inhibitor (3)Topoisomerase I Inhibitor (8)Tyrosine / EGF Receptor Protein Kinase Inhibitor (33)
Enzyme Preparation (69)
Cyclooxygenase (COX) (52)E3 Ubiquitin Ligase (2)Hydrolase (12)Nitric Oxide Metabolism (3)
Enzyme Substrates (4)
Peroxidase Substrate (2)β-Glucuronidase Substrate (2)
Fluorescent Probe / Staining
Cell Biology Fluorescent Dyes (78)
Apoptosis Dyes (6)BODIPY (21)Cytoplasm Dyes (5)Cytotoxicity Analysis Dyes (12)Endocytosis and pinocytosis Dyes (5)Endoplasmic Reticulum Dyes (1)Exosome Dyes (4)Lipid Droplet Dyes (3)Lysosome Dyes (4)Membrane Dyes (5)Mitochondrial Dyes (5)NOS Dyes (8)Nucleic Acid Dyes (1)Nucleus Dyes (10)PH Indicators (19)ROS Dyes (27)
Fluorescence Labeling Reagents (2810)
Anthocyanine (1)Boron Dipyrrole Methylene  (2)Coumarin (8)Danacyl (2)Fluoressin (8)Nitrobenzoxadiazole (NBD) (2)Pyrene (6)Other Fluorescence Labeling Reagents (215)Others (2570)
Fluorescent Dyes (2743)
Acridine Dye (9)Cancer Analysis Dyes (8)Coumarine Dye (58)Cyanine Dye (24)Neuroscience Analysis Dyes (33)Protein (3)Other Fluorescent Dyes (7)Others (2570)
Molecular Biology
Extraction and Analysis Of Nucleic Acid (6)
Hybridization Reagent (4)Probe (2)
Gene Cloning (21)
Buffer (21)
Nucleic Acid Electrophoresis (5)
Electrophoretic Buffer (3)Gelatin (2)
Natural Products
Acanthaceae (20)
Adhatoda (4)Andrographis (9)Justicia (4)Phlogacanthus (2)Strobilanthes (1)
Aceraceae (2)
Acer (2)
Adiantaceae (2)
Adiantum (2)
Alariaceae (76)
Acanthopanax (5)Aralia (8)Diplopanax (3)Eleutherococcus (3)Hedera (4)Oplopanax (1)Panax (52)
Alismataceae (2)
Alisma (2)
Amaranthaceae (5)
Achyranthes (3)Celosia (1)Cyathula (1)
Amaryllidaceae (23)
Agave (4)Allium (5)Curculigo (10)Lycoris (3)Narcissus (1)
Anacardiaceae (15)
Lannea (1)lodes (1)Mangifera (6)Rhus (4)Toxicodendron (3)
Annonaceae (19)
Annona (2)Fissistigma (6)Goniothalamus (4)Guatteria (1)Miliusa (1)Orophea (2)Polyalthia (2)Uvaria (1)
Apocynaceae (45)
Alstonia (3)Apocynum (1)Aspidosperma (1)Catharanthus (5)Cerbera (5)Kopsia (1)Nerium (10)Plumeria (2)Rauvolfia (9)Thevetia (3)Trachelospermum (4)Voacanga (1)
Aquifoliaceae (3)
Ilex (3)
Araceae (14)
Acorus (10)Eminium (2)Pinellia (2)
Aristolochiaceae (16)
Aristolochia (12)Asarum (3)Holostylis (1)
Asclepiadaceae (20)
Cryptolepis (3)Cynanchum (7)Marsdenia (5)Periploca (5)
Asparagaceae (11)
Eucomis (2)Muscari (1)Scilla (8)
Asteraceae (227)
Achillea (3)Ageratum (1)Ambrosia (2)Arctium (2)Arnica (1)Artemisia (24)Aster (2)Atractylodes (9)Aucklandia (5)Bellis (1)Blumea (4)Cacalia (1)Carpesium (1)Carthamus (7)Centaurea (5)Centipeda (4)Chrysactinia (4)Chrysanthemum (6)Cichorium (2)Cirsium (2)Conyza (1)Coreopsis (1)Cosmos (1)Crepis (3)Cynara (1)Dahlia (2)Dittrichia (1)Doronicum (1)Echinacea (2)Eclipta (6)Elephantopus (1)Erigeron (3)Eupatorium (20)Gnaphalium (1)Gynura (2)Helianthus (4)Heterotheca (1)Inula (8)Kalimeris (1)Laggera (13)Laurentia (1)Ligularia (4)Matricaria (2)Petasites (2)Pulicaria (4)Saussurea (3)Scorzonera (2)Senecio (9)Siegesbeckia (2)Silybum (5)Smallanthus (1)Stevia (10)Tagetes (4)Telekia (1)Tessaria (1)Tussilago (2)Verbesina (1)Vernonia (5)Wedelia (2)Xanthium (6)Zinnia (1)
Athyriaceae (1)
Cystopteris (1)
Balsaminaceae (5)
Impatiens (5)
Berberidaceae (37)
Berberis (3)Bongardia (1)Caulophyllum (2)Dysosma (3)Epimedium (26)Sinopodophyllum (2)
Betulaceae (11)
Alnus (6)Betula (1)Carpinus (1)Corylus (3)
Bignoniaceae (16)
Catalpa (8)Crescentia (2)Incarvillea (1)Kigelia (1)Macfadyena (1)Markhamia (1)Oroxylum (2)
Blechnaceae (1)
Woodwardia (1)
Boraginaceae (18)
Arnebia (2)Echium (1)Ehretia (1)Lithospermum (13)Tournefortia (1)
Burseraceae (12)
Boswellia (4)Canarium (5)Commiphora (3)
Buxaceae (3)
Buxus (3)
By Structure (5427)
Alkaloids (149)Coumarins (22)Lignans (37)Phenols (1790)Phenylpropanane (56)Quinones (34)Natural Products-Other Structure (3364)
Calophyllaceae (8)
Pseudostellaria (2)Stellaria (1)Vaccaria (5)
Campanulaceae (14)
Codonopsis (1)Lobelia (2)Platycodon (10)Sphenoclea (1)
Cannabaceae (11)
Cannabis (3)Humulus (8)
Caprifoliaceae (23)
Lonicera (20)Sambucus (1)Viburnum (2)
Celastraceae (15)
Celastrus (3)Euonymus (1)Maytenus (1)Tripterygium (10)
Cephalotaxaceae (10)
Cephalotaxus (10)
Chenopodiaceae (3)
Kochia (1)Spinacia (1)Suaeda (1)
Chloranthaceae (11)
Chloranthus (10)Sarcandra (1)
Clusiaceae (94)
Alliaria (1)Brassica (6)Calophyllum (6)Cratoxylum (2)Descurainia (1)Eruca (1)Garcinia (47)Hypericum (15)Isatis (2)Lepidium (4)Mammea (1)Mesua (1)Raphanus (3)Sinapis (3)Symphonia (1)
Combretaceae (6)
Calycopteris (1)Combretum (2)Terminalia (3)
Convolvulaceae (2)
Erycibe (1)Ipomoea (1)
Coriariaceae (2)
Coriaria (2)
Cornaceae (3)
Cornus (3)
Crassulaceae (12)
Rhodiola (7)Sedum (5)
Cucurbitaceae (44)
Bolbostemma (1)Bryonia (1)Cucumis (1)Cucurbita (1)Echinocystis (1)Gynostemma (4)Hemsleya (2)Herpetospermum (1)Lagenaria (3)Luffa (1)Momordica (9)Siraitia (17)Trichosanthes (2)
Cupressaceae (11)
Chamaecyparis (2)Juniperus (5)Platycladus (4)
Cyperaceae (5)
Carex (2)Cyperus (3)
Daphniphyllaceae (36)
Aquilaria (10)daphne (3)Daphniphyllum (1)Edgeworthia (1)Excoecaria (1)Pieris (2)Stellera (10)Wikstroemia (8)
Dennstaedtiaceae (1)
Dennstaedtia (1)
Dicksoniaceae (4)
Cibotium (4)
Dioscoreaceae (11)
Dioscorea (11)
Dipsacaceae (2)
Dipsacus (2)
Dryopteridaceae (4)
Dryopteris (4)
Elaeagnaceae (7)
Elaeagnus (2)Hippophae (5)
Equisetaceae (3)
Equisetum (3)
Erythroxylaceae (1)
Erythroxylum (1)
Eucommiaceae (12)
Eucommia (12)
Euphorbiaceae (46)
Breynia (1)Croton (7)Endospermum (1)Euphorbia (10)Excoecaria (1)Flueggea (1)Hevea (3)Jatropha (5)Macaranga (1)Mallotus (1)Phyllanthus (11)Suregada (2)Trigonostemon (2)
Fabaceae (348)
Abrus (1)Acacia (9)Adenanthera (1)Albizia (1)Ammothamnus (1)Antheroporum (1)Astragalus (23)Butea (1)Caesalpinia (18)Cajanus (3)Campylotropis (1)Cassia (26)Cicer (1)Crotalaria (5)Cytisus (3)Dalbergia (10)Derris (13)Desmodium (3)Erythrina (13)Flemingia (3)Genista (1)Glycine (22)Glycyrrhiza (42)Griffonia (1)Hedysarum (1)Lespedeza (5)Leucaena (3)Lotus (5)Lupinus (8)Maackia (4)Medicago (1)Millettia (6)Mimosa (1)Mucuna (2)Ononis (2)Parochetus (2)Phyllodium (1)Pisum (1)Pongamia (1)Prosopis (2)Psoralea (18)Pterocarpus (1)Pueraria (25)Robinia (2)Saraca (1)Senna (1)Sophora (36)Spartium (1)Spatholobus (2)Styphnolobium (1)Trifolium (6)Trigonella (2)Vicia (2)Wisteria (2)
Fagaceae (2)
Castanea (1)Lithocarpus (1)
Gentianaceae (28)
Anthocleista (1)Canscora (1)Gentiana (16)Gentianella (1)Halenia (1)Swertia (8)
Geraniaceae (3)
Geranium (2)Pelargonium (1)
Gesneriaceae (1)
Lysionotus (1)
Ginkgoaceae (9)
Ginkgo (9)
Gnetaceae (4)
Gnetum (4)
Hamamelidaceae (2)
Hamamelis (1)Loropetalum (1)
Hernandiaceae (128)
Ammi (2)Angelica (32)Bupleurum (13)Centella (4)Cnidium (9)Ferula (3)Heracleum (13)Hernandia (2)Ledebouriella (1)Ligusticopsis (1)Ligusticum (9)Notopterygium (7)Oenanthe (1)Petroselinum (2)Peucedanum (20)Pimpinella (1)Saposhnikovia (7)Seseli (1)
Hippocastanaceae (5)
Aesculus (5)
Illiciaceae (6)
Illicium (6)
Iridaceae (19)
Belamcanda (8)Crocus (6)Eleutherine (3)Iris (2)
Juglandaceae (6)
Diospyros (2)Engelhardtia (1)Juglans (1)Sesamum (2)
Juncaceae (5)
Juncus (5)
Lamiaceae (140)
Ajuga (2)Ballota (1)Clinopodium (3)Coleus (2)Dracocephalum (3)Elsholtzia (1)Isodon (5)Lamiophlomis (1)Leonurus (9)Marrubium (2)Mentha (4)Mosla (2)Perilla (4)Phlomis (1)Plectranthus (1)Pogostemon (1)Rosmarinus (6)Salvia (44)Scutellaria (40)Stachys (2)Tectona (1)Thymus (5)
Lauraceae (23)
Cinnamomum (7)Cryptocarya (3)Endlicheria (1)Laurus (1)Lindera (4)Litsea (1)Nectandra (2)Ocotea (4)
Lepidoziaceae (1)
Lepidozia (1)
Lichenes (1)
Usnea (1)
Liliaceae (80)
Aloe (4)Anemarrhena (9)Asparagus (1)Dracaena (11)Fritillaria (3)Hosta (1)Lilium (4)Liriope (3)Ophiopogon (28)Paris (9)Polygonatum (3)Smilax (1)Trillium (1)Tupistra (1)Veratrum (1)
Linaceae (2)
Linum (2)
Loganiaceae (5)
Buddleja (2)Gelsemium (1)Strychnos (2)
Loranthaceae (1)
Taxillus (1)
Lycopodiaceae (3)
Lycopodium (3)
Lygodiaceae (1)
Lygodium (1)
Lythraceae (11)
Lawsonia (4)Punica (7)
Magnoliaceae (24)
Liriodendron (4)Magnolia (19)Michelia (1)
Malvaceae (5)
Abelmoschus (1)Gossypium (1)Guazuma (2)Hibiscus (1)
Meliaceae (24)
Aglaia (12)Amoora (2)Aphanamixis (3)Melia (4)Walsura (3)
Menispermaceae (13)
Cocculus (2)Diploclisia (1)Menispermum (1)Stephania (5)Tinospora (3)Triclisia (1)
Moraceae (69)
Artocarpus (2)Broussonetia (13)Cudrania (16)Morus (37)Trilepisium (1)
Moringaceae (7)
Moringa (7)
Musaceae (13)
Musa (10)Musella (3)
Myricaceae (6)
Morella (6)
Myristicaceae (7)
Myristica (7)
Myrsinaceae (1)
Ardisia (1)
Myrtaceae (27)
allspice (1)Eucalyptus (16)Psidium (6)Rhodomyrtus (1)Syzygium (3)
Nartheciaceae (4)
Narthecium (1)Philydrum (1)Xanthorrhoea (2)
Nelumbonaceae (3)
Nelumbo (3)
Nyctaginaceae (34)
Atropa (1)Boerhavia (3)Capsicum (5)Datura (7)Lycium (3)Mirabilis (1)Nicotiana (2)Physalis (4)Scopolia (1)Solanum (6)Withania (1)
Nyssaceae (51)
Camptotheca (6)Gaultheria (1)Pyrola (2)Rhododendron (5)Vaccinium (37)
Oleaceae (36)
Abeliophyllum (1)Forsythia (12)Fraxinus (4)Jasminum (6)Ligustrum (11)Osmanthus (1)Syringa (1)
Orchidaceae (28)
Anoectochilus (1)Bletilla (2)Cremastra (2)Dendrobium (7)Gastrodia (3)Gymnadenia (8)Pholidota (3)Vanda (1)Vanilla (1)
Orobanchaceae (10)
Cistanche (10)
Paeoniaceae (6)
Paeonia (6)
Palmae (6)
Areca (4)Euterpe (1)Trachycarpus (1)
Pandanaceae (3)
Pandanus (3)
Papaveraceae (26)
Chelidonium (10)Corydalis (8)Glaucium (1)Hylomecon (1)Hypecoum (1)Macleaya (2)Papaver (1)Sanguinaria (2)
Parmeliaceae (4)
Parmelia (4)
Passifloraceae (2)
Passiflora (2)
Pentaphylacaceae (1)
Adinandra (1)
Phyllanthaceae (4)
Securinega (3)Uapaca (1)
Phytolaccaceae (6)
Microtea (1)Phytolacca (5)
Pinaceae (35)
Abies (2)Cedrus (4)Larix (1)Pinus (18)Pseudolarix (9)Tsuga (1)
Piperaceae (28)
Piper (28)
Pittosporaceae (2)
Pittosporum (2)
Plantaginaceae (2)
Picrorhiza (1)Plantago (1)
Plumbaginaceae (2)
Limoniastrum (1)Plumbago (1)
Poaceae (13)
Avena (2)Coix (1)Hordeum (2)Leptochloa (1)Oryza (1)Phyllostachys (1)Poa (2)Saccharum (1)Secale (1)Zea (1)
Podocarpaceae (8)
Podocarpus (8)
Polygalaceae (32)
Polygala (31)Securidaca (1)
Polygonaceae (40)
Atraphaxis (2)Fallopia (3)Polygonum (9)Rheum (22)Rumex (4)
Polypodiaceae (2)
Phymatopteris (2)
Polyporaceae (4)
Ganoderma (2)Polyporus (1)Wolfiporia (1)
Pontederiaceae (1)
Monochoria (1)
Portulacaceae (1)
Talinum (1)
Primulaceae (4)
Lysimachia (3)Primula (1)
Proteaceae (4)
Grevillea (1)Helicia (3)
Ranunculaceae (45)
Aconitum (2)Anemone (6)Cimicifuga (9)Clematis (3)Coptis (6)Delphinium (2)Hydrastis (2)Pulsatilla (10)Semiaquilegia (1)Thalictrum (3)Trollius (1)
Resedaceae (1)
Reseda (1)
Rhamnaceae (16)
Hovenia (1)Rhamnus (11)Ziziphus (4)
Rhizophoraceae (3)
Cassipourea (1)Kandelia (2)
Rosaceae (31)
Agrimonia (4)Crataegus (4)Exochorda (5)Filipendula (2)Malus (1)Photinia (1)Potentilla (1)Pourthiaea (1)Prunus (3)Rosa (3)Rubus (2)Sanguisorba (2)Sorbus (1)Spiraea (1)
Rubiaceae (67)
Borreria (1)Cinchona (2)Coffea (3)Emmenopterys (1)Galium (5)Gardenia (10)Hedyotis (8)Knoxia (2)Mitragyna (1)Morinda (4)Mussaenda (1)Nauclea (2)Paederia (5)Pausinystalia (2)Pentas (1)Rubia (13)Uncaria (6)
Rutaceae (161)
Aegle (1)Boenninghausenia (2)Cedrelopsis (1)Citrus (38)Clausena (7)Dictamnus (8)Euodia (1)Evodia (13)Flindersia (1)Fortunella (1)Glycosmis (3)Haplophyllum (3)Melicope (1)Micromelum (11)Murraya (21)Phebalium (2)Phellodendron (8)Ptaeroxylon (1)Ruta (3)Skimmia (1)Tetradium (1)Toddalia (14)Zanthoxylum (19)
Salicaceae (2)
Populus (2)
Santalaceae (3)
Thesium (3)
Sapindaceae (10)
Dodonaea (10)
Saururaceae (6)
Houttuynia (1)Saururus (5)
Saxifragaceae (11)
Astilbe (1)Bergenia (1)Dichroa (3)Hydrangea (5)Penthorum (1)
Schisandraceae (20)
Kadsura (6)Schisandra (14)
Scrophulariaceae (34)
Bacopa (6)Euphrasia (1)Limnophila (1)Linaria (2)Melampyrum (1)Paulownia (1)Pedicularis (2)Picria (3)Rehmannia (12)Scrophularia (5)
Selaginellaceae (3)
Selaginella (3)
Simaroubaceae (32)
Ailanthus (8)Brucea (8)Eurycoma (1)Picrasma (14)Quassia (1)
Sinopteridaceae (17)
Onychium (4)Pteridium (3)Pteris (10)
Stemonaceae (1)
Stemona (1)
Sterculiaceae (4)
Casearia (1)Gynocardia (2)Hydnocarpus (1)
Styracaceae (3)
Styrax (3)
Tamaricaceae (1)
Tamarix (1)
Taxaceae (8)
Taxus (7)Torreya (1)
Taxodiaceae (5)
Cryptomeria (2)Sequoia (3)
Theaceae (9)
Camellia (9)
Tiliaceae (2)
Microcos (1)Tilia (1)
Toricelliaceae (3)
Toricellia (3)
Tropaeolaceae (1)
Tropaeolum (1)
Typhaceae (4)
Typha (4)
Ulmaceae (1)
Ulmus (1)
Valerianaceae (19)
Nardostachys (4)Patrinia (5)Valeriana (10)
Verbenaceae (39)
Callicarpa (10)Clerodendrum (7)Duranta (1)Gmelina (1)Lippia (1)Stachytarpheta (1)Verbena (2)Vitex (16)
Violaceae (7)
Viola (7)
Viscaceae (2)
Viscum (2)
Vitaceae (18)
Ampelopsis (4)Turpinia (2)Vitis (12)
Winteraceae (4)
Drimys (4)
Zingiberaceae (79)
Aframomum (1)Alpinia (25)Amomum (1)Boesenbergia (2)Curcuma (33)Kaempferia (1)Zingiber (16)
Zygophyllaceae (6)
Peganum (4)Tribulus (2)
Pharmaceutical Research
Animal Modeling Agents (46)
Cardio-cerebrovascular Disease Model (2)Diabete Model (1)Inflammation Model (21)Lifestyle-related Disease Model (10)Nervous System Model (5)Pain and Pruritus Model (8)Tumor Model (6)Other Modeling Agents (6)
Classical Positive Drugs (63)
Cardiovascular System (21)Diabete (30)Digestive System (12)
Drug Analysis (673)
Drug Standard (216)Plant Standard (459)
Drug Delivery (473)
Cationic Lipids (119)Cholesterol (10)Fluorescent Lipids (1)Pegylated Lipids (11)Phospholipids (175)
Pharmacy Related (28)
Biomaterial (2)Classical Raw Material Drug (2)Cosolvents (12)Medicinal Excipient (15)
Small Molecule Positive Drugs (2818)
Anti-allergy (5)Anti-inflammation (34)Anti-osteoporosis (2)Anti-rheumatoid Arthritis (6)Anti-tumor (7)Antivirus (66)Depressurization (19)Diabete (30)Neurotransmitter (36)Reduce Blood Lipid (7)Other Compounds (70)Others (2570)
PROTACS
E3 Ligand-Linker Conjugate (167)
CRBN Ligand-Linkers (117)VHL Ligand-Linkers (50)
E3 Ligands (72)
CRBN Inactive Ligand (4)CRBN Ligand (56)IAP Ligand (2)MDM2 Ligand (2)VHL Ligand (8)
Molecular Glue (31)
Bcl-6/PROTAC (3)Casein Kinase 1α/PROTAC (2)Cyclin K/PROTAC (5)GSPT1/PROTAC (5)IKZF1/3/PROTAC (7)mHTT/PROTAC (2)PDE6D/PROTAC (2)RBM39/PROTAC (4)β-catenin/PROTAC (1)
Warhead (1)
Bcr-Abl/Warhead Ligand (1)
Vesicle
Exosome (2592)
ApoE (1)ARF (2)Calcium Channel (270)Ceramidase (4)FGF (2)HBV (150)HIV (444)HSP (160)HSV (75)Integrin (135)LPL Receptor (118)MicroRNA (16)mTOR (187)Neurotransmitter (36)p53 (41)PD-1/PD-L1 (80)Phospholipase (108)Ras (275)STAT (160)TGF-beta/Smad (381)
Parkinson'S Disease and Alzheimer'S Disease (5781)
Akt (208)AMPAR (54)Apoptosis (2139)Caspase (170)CDK (475)CREB (5)Dopamine Receptor (170)Dopamine β-hydroxylase (8)ERK (166)Glucagon Receptor (51)GPCR (200)GSK-3 (125)IL (173)JAK (245)JNK (78)LRRK2 (32)MyD88 (6)NF-κB (420)Notch (26)p53 (41)PI3K (341)PKA (59)PTEN (5)RAGE (3)Ras (275)Rho (14)ROCK (89)ROS (394)Secretase (112)STAT (160)STING (99)Tau Protein (28)TLR (163)TNF (22)Tyrosinase (101)Tyrosine / EGF Receptor Protein Kinase Inhibitor (33)Wnt (104)α-synuclein (1)β-catenin (71)
Zoology and Botany
Pesticide Composition (104)
Fungicide (61)Herbicide (17)Insecticide (27)
Home Cart Sign in  
/
Inhibitors/Agonists
/
Cell Cycle
/
DNA/RNA Synthesis
/
Folic acid
/
Inhibitors/Agonists
/
Cell Cycle
DNA Damage Other Inhibitors/Agonists
/
DNA/RNA Synthesis
Vitamin
/
Chemical Structure| 59-30-3 Chemical Structure| 59-30-3

Structure of Folic acid
CAS No.: 59-30-3

Chemical Structure| 59-30-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Folic acid (Vitamin B9) is an orally active essential nutrient from the vitamin B group with antidepressant effects. It reduces the risk of neural tube defects in newborns and is used in studies of megaloblastic anemia and macrocytic anemia caused by folate deficiency.

Synonyms: Vitamin B9; Vitamin M; Vitamin Be

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

Quality Control of Folic acid Purity: 98% SDS Specification
COA

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 NMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 CNMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 HPLC

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 LC-MS

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Shameer M. Kondengadan ; Shubham Bansal ; Xiaoxiao Yang ; Binghe Wang ;

DOI:

Abstract: Carbon monoxide (CO) is an endogenous produced molecule and has shown efficacy in animal models of inflammation, organ injury, colitis and cancer metastasis. Because of its gaseous nature, there is a need for developing efficient CO delivery approaches, especially those capable of targeted delivery. In this study, we aim to take advantage of a previously reported approach of enrichment-triggered prodrug activation to achieve targeted delivery by targeting the folate receptor. The general idea is to exploit folate receptor-mediated enrichment as a way to accelerate a biomolecular Diels-Alder reaction for prodrug activation. In doing so, we first need to find ways to tune the reaction kinetics in order to ensure minimal rection without enrichment and optimal activation upon enrichment. In this feasibility study, we synthesized two diene-dienophile pairs and studied their reaction kinetics and ability to target the folate receptor. We found that folate conjugation significantly affects the reaction kinetics of the original diene-dienophile pairs. Such information will be very useful in future designs of similar targeted approaches of CO delivery.

Keywords: Enrichment triggered delivery ; Carbon Monoxide ; Folate conjugate ; Reaction kinetics ; Diels-Alder reaction

Purchased from AmBeed: 7693-46-1 ; ; ;

Alternative Products

Product Details of Folic acid

CAS No. :59-30-3
Formula : C19H19N7O6
M.W : 441.40
SMILES Code : O=C(O)CC[C@@H](C(O)=O)NC(C1=CC=C(NCC2=NC3=C(N=C2)N=C(N)NC3=O)C=C1)=O
Synonyms :
Vitamin B9; Vitamin M; Vitamin Be
MDL No. :MFCD00079305
InChI Key :OVBPIULPVIDEAO-LBPRGKRZSA-N
Pubchem ID :135398658

Safety of Folic acid

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Folic acid

DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Human umbilical vein endothelial cells (HUVECs) 0-1000 nM 24 hours To investigate the effects of folic acid on Ox-LDL-treated HUVECs, results showed that folic acid dose-dependently increased intracellular folate concentration, decreased homocysteine concentration, enhanced methylation potential, and increased DNMT activity. Int J Mol Sci. 2017 May 5;18(5):990.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
ApoE knockout mice High-fat diet-induced atherosclerosis model Intragastric gavage 60 µg/kg Once daily for 20 weeks To investigate the effects of folic acid supplementation on atherosclerosis, results showed that folic acid reduced atherosclerotic lesion size, regulated homocysteine state, increased SAM:SAH ratio, enhanced DNMT activity and expression, altered MCP1 and VEGF promoter methylation, and inhibited MCP1 and VEGF expression. Int J Mol Sci. 2017 May 5;18(5):990.
Caenorhabditis elegans Daf-2(e1370), eat-2(ad465), isp-1(qm150), glp-1(e2141)ts Dietary supplementation 10 nM From L4 stage By supplementing with 5MTHF, it was found that reducing 5MTHF levels can extend lifespan and ameliorate proteotoxicity Nat Commun. 2021 Jun 9;12(1):3486

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00096330 Colorectal Cancer Phase 1 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00693589 Cardiovascular Disease ... More >> Endothelial Dysfunction Less << Phase 2 Completed - -
NCT00372645 Healthy Not Applicable Completed - United Kingdom ... More >> Institute of Food Research Norwich, Norfolk, United Kingdom, NR4 7UA University of Sheffield Sheffield, Yorkshire, United Kingdom, S10 2FN Less <<
NCT00207558 Neural Tube Defects - Spina Bi... More >>fida and Anencephaly Less << Not Applicable Completed - China, Hebei ... More >> Townships Xianghe County, Hebei, China Less <<
NCT01999738 Solid Tumors ... More >>Non Small Cell Lung Carcinoma Less << Phase 1 Active, not recruiting July 31, 2018 United States, Arizona ... More >> Mayo Clinic Phoenix, Arizona, United States, 85054 Honor Health Scottsdale, Arizona, United States, 85258 University of Arizona Cancer Center Tucson, Arizona, United States, 85719 United States, California City of Hope Duarte, California, United States, 91010 United States, Illinois Northwestern University Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 United States, Indiana IU Health Goshen Center for Cancer Care Goshen, Indiana, United States, 46526 Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Horizon BioAdvance Lafayette, Indiana, United States, 47905 United States, Maryland University of Maryland-Greenebaum Cancer Center Baltimore, Maryland, United States, 21201-1595 United States, Michigan Henry Ford Hospital - Josephine Ford Cancer Center Detroit, Michigan, United States, 48202 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14203 Weill Cornell Medical College New York, New York, United States, 10021 United States, Ohio University Hospitals Case Medical Center - Seidman Cancer Center Cleveland, Ohio, United States, 44106 United States, Texas Westchase Clinical Associates Houston, Texas, United States, 77042 University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77230 United States, Vermont University of Vermont Cancer Center Burlington, Vermont, United States, 05401 Less <<
NCT03186196 Overweight and Obesity Not Applicable Completed - -
NCT03472508 Hypertension Phase 4 Recruiting June 30, 2019 China, Anhui ... More >> Anqing Research Center of Anhui Medical University Biomedical Institute Recruiting Anqing, Anhui, China Contact: Qing Jiang, MD          China Peking University First Hosptial Not yet recruiting Beijing, China Contact: Jianping Li, MD          Principal Investigator: Jianping Li, MD          The First People's Hospital of Lianyungang Recruiting Lianyungang, China Contact: Xiaoming Li, MD          Principal Investigator: Xiaoming Li, MD          Second Affiliated Hospital of Nanchang University Recruiting Nanchang, China Contact: Xiaoshu Cheng, MD          Principal Investigator: Xiaoshu Cheng, MD          People's Hospital of Rongcheng Not yet recruiting Rongcheng, China Contact: Chongqian Fang, MD          Principal Investigator: Chongqian Fang, MD Less <<
NCT01956786 Essential Hypertension Phase 2 Phase 3 Unknown February 2014 China, Jiangsu ... More >> The Affiliated Hospital of Xuzhou Medical College Not yet recruiting Xuzhou, Jiangsu, China, 221006 Contact: Wang Zhirong, MD    86-0516-85802111    xzzrw@163.com    Principal Investigator: Wang Zhirong, MD          China, Jiangxi The Second Affiliated Hospital of Nanchang University Recruiting Nanchang, Jiangxi, China, 330006 Contact: Cheng Xiaoshu, MD    86-791-6268844    xiaoshumenfan@126.com    Principal Investigator: Cheng Xiaoshu, MD          China, Shanghai Ruijin Hospital, Shanghai Jiao Tong Univesity Recruiting Shanghai, Shanghai, China, 310000 Contact: Wang Jiguang, MD    86-021-64370045    jiguangw@gmail.com    Principal Investigator: Wang Jiguang, MD Less <<
NCT01848873 Essential Hypertension Phase 2 Phase 3 Unknown August 2013 China, Anhui ... More >> The First Affiliated Hospital of Anhui Medical University Not yet recruiting Hefei, Anhui, China, 230022 China, Beijing Anzhen Hospital,Capital Medical University Recruiting Beijing, Beijing, China, 100029 Peking University First Hospital Recruiting Beijing, Beijing, China, 100036 Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 China, Fujian First Affiliated Hospital of Fujian Medical University Not yet recruiting Fuzhou, Fujian, China, 350005 China, Guangdong Guangdong General Hospital Not yet recruiting Guangzhou, Guangdong, China, 510030 China, Heilongjiang First Affiliated Hospital of Harbin Medical University Not yet recruiting Haibin, Heilongjiang, China, 150001 China, Hubei Union Hospital, Tongji Medical College,Huazhong University of Science and Technology Not yet recruiting Wuhan, Hubei, China, 430022 China, Jiangsu The Affiliated Hospital of Xuzhou Medical College Recruiting Xuzhou, Jiangsu, China, 221006 China, Jiangxi The Second Affiliated Hospital Of Nanchang University Not yet recruiting Nanchang, Jiangxi, China, 330006 China, Liaoning First Affiliated Hospital of China Medical University Not yet recruiting Shenyang, Liaoning, China, 110002 China, Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine Not yet recruiting Shanghai, Shanghai, China, 200025 Zhongshan Hospital Fudan University Not yet recruiting Shanghai, Shanghai, China, 200032 China, Shanxi First Affiliated Hospital of the School of Medicine, Xi'an Jiaotong University Not yet recruiting Xi'an, Shanxi, China, 710061 China, Sichuan West China School of Medicine, West China Hospital ,Sichuan University Not yet recruiting Chengdu, Sichuan, China, 610041 China, Zhejiang Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting Hangzhou, Zhejiang, China, 310009 Less <<
NCT01248260 Fetal Body Size ... More >> Fetal Brain Size Less << Not Applicable Completed - United States, Florida ... More >> University of South Florida, College of Public Health, Department of Epidemiology and Biostatistics Tampa, Florida, United States, 33612 Less <<
NCT00110604 Atherosclerosis ... More >> Vascular Disease Cognitive Decline Hearing Loss Inflammation Age-Related Memory Disorder Less << Not Applicable Completed - Netherlands ... More >> Wageningen University Wageningen, Gelderland, Netherlands, 6700 EV Less <<
NCT01662869 Gastric Cancer Phase 3 Completed - -
NCT00722553 Carcinoma, Transitional Cell ... More >> Bladder Cancer Bladder Neoplasm Less << Phase 2 Completed - United States, Arizona ... More >> The University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724 United States, Georgia Peachtree Hematology/Oncology Consultants Atlanta, Georgia, United States, 30318 United States, New York University of Rochester Cancer Center Rochester, New York, United States, 14642 United States, Utah University of Utah, Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Argentina Centro de Terapia Radiante Cumbres (CAICI) Rosario, Santa Fe, Argentina, 2000 IONC (Instituto Oncológuci de Cordoba) Cordoba, Argentina, X5004BAL Belgium Algemeen Ziekenhuis Middelheim Antwerp, Belgium, 2020 Institut Jules Bordet Brussels, Belgium, 1000 Croatia CH Split Clinic of Oncology and Radiotherapy Split, Croatia, 21000 CHU Zagreb University Hospital Center Rebro in Zagreb Zagreb, Croatia, 10000 Clinic of Oncology and Nuclear Medicine, CH "Sestre Milosrdnice" Zagreb, Croatia, 10000 France Institut Sainte Catherine Avignon, France, 84082 Centre Oscar Lambret Lille Cedex, France, 59020 Centre Hospitalier Rene Dubos Pontoise, France, 95301 Hopital Foch Suresnes, France Institut Gustave Roussy Villejuif Cedex, France, 94 805 Spain Ciutat Sanitari de Vall d'Hebron Barcelona, Spain, 08035 Hospital Del Mar - Barcelona Barcelona, Spain, 8003 Hospital Virgen del Rocio Sevilla, Spain, 41013 Less <<
NCT00722553 - Completed - -
NCT00207532 Spina Bifida and Anencephaly Not Applicable Completed - Honduras ... More >> PROTEXSA San Pedro Sula, Honduras Less <<
NCT03585764 Ovarian Cancer ... More >> Fallopian Tube Cancer Primary Peritoneal Carcinoma Less << Phase 1 Recruiting October 2035 United States, Pennsylvania ... More >> University of Pennsylvania Health System Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Payal D Shah, MD    855-216-0098    PennCancerTrials@emergingmed.com Less <<
NCT02693717 Bladder Cancer ... More >> Urothelial Cancer Less << Phase 2 Recruiting May 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       jgao1@mdanderson.org    MD Anderson Katy Regional Care Center Recruiting Houston, Texas, United States, 77094 Contact: Jennifer Wang, MD          MD Anderson Sugarland Regional Care Center Recruiting Sugar Land, Texas, United States, 77478 Contact: Jennifer Wang, MD Less <<
NCT00998946 Lymphoma, B-Cell Phase 2 Completed - United States, California ... More >> Tower Cancer Research Foundation Beverly Hills, California, United States, 90211 United States, Idaho Kootenai Cancer Center Post Falls, Idaho, United States, 83854 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Kentucky Owsley Brown Frazier Cancer Center Louisville, Kentucky, United States, 40245 United States, Louisiana Overton Brooks VA Medical Center Shreveport, Louisiana, United States, 71101 United States, Montana Frontier Cancer Center and Blood Institute Billings, Montana, United States, 59102 United States, New York New York University Hospital New York, New York, United States, 10016 United States, Oregon Providence Cancer Center Portland, Oregon, United States, 97225 United States, Tennessee The West Clinic (ACORN) Memphis, Tennessee, United States, 38120 United States, Wisconsin Gundersen Lutheran LaCrosse, Wisconsin, United States, 54601 University of Wisconsin, Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53705-2275 Less <<
NCT01393405 - Completed - -
NCT00692315 Autistic Disorder Not Applicable Completed - United States, Arkansas ... More >> Arkansas Children's Hospital Research Institute Little Rock, Arkansas, United States, 72202 Less <<
NCT01290432 Infertility, Female Not Applicable Completed - United States, Florida ... More >> Palm Beach Center for Reproductive Medicine Wellington, Florida, United States, 33414 Less <<
NCT01393405 Ulcerative Colitis Phase 2 Completed - -
NCT03763669 Gestational Diabetes Not Applicable Recruiting February 2020 Italy ... More >> Department of Obstetrics & Gynecology - Policlinico "G. Martino" Recruiting Messina, Italy, 98125 Contact: FRANCESCO CORRADO, professor    +39090221 ext 2182    fcorrado@unime.it    Sub-Investigator: ROSARIO D'ANNA, professor          Sub-Investigator: ANTONINO DI BENEDETTO, professor Less <<
NCT03180307 Ovarian Cancer Phase 3 Recruiting November 2018 United States, California ... More >> University of CA at Irvine Chao Cancer Center Not yet recruiting Orange, California, United States, 92868 Contact: Leslie Randall, MD    714-456-7971    lrandall@uci.edu    Principal Investigator: Leslie Randall, MD          United States, Florida Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Robert Wenham, MD    813-745-4933       Principal Investigator: Robert Wenham, MD          United States, Minnesota Mayo Clinic-Rochester Not yet recruiting Rochester, Minnesota, United States, 55905 Contact: Maureen Lemens, MD    507-293-1487    Lemens.Maureen@mayo.edu    Principal Investigator: Carrie Langstraat, MD          United States, Ohio Kettering Medical Center Recruiting Kettering, Ohio, United States, 45427 Contact: Allison Streifthau, BSN, RN       Allison.Streifthau@ketteringhealth.org    Principal Investigator: Thomas Reid, MD          United States, Pennsylvania University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Janos L Tanyi, MD, PhD    267-279-7255       Principal Investigator: Janos Tanyi, MD Less <<
NCT02097069 Gestational Diabetes Mellitus Not Applicable Unknown - Italy ... More >> Hospital "SS Annunziata" Not yet recruiting Chieti, Italy, 66100 Contact: Ester Vitacolonna, Professor    +393398073446    e.vitacolonna@unich.it    Principal Investigator: Ester Vitacolonna, Professor Less <<
NCT02002195 - Unknown May 2016 Italy ... More >> Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore Recruiting Pesaro, PU, Italy, 61122 Principal Investigator: Vincenzo Catalano, MD          Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio San Salvatore, Recruiting Pesaro, Italy, 61122 Contact: Vincenzo Catalano, MD    0039072136 ext 4001    catalano_v@yahoo.it    Principal Investigator: Vincenzo Catalano, MD Less <<
NCT03748186 Ovarian Cancer ... More >> Ovarian Carcinoma Ovary Cancer Endometrial Cancer Endometrioid Adenocarcinoma Fallopian Tube Cancer Primary Peritoneal Carcinoma Less << Phase 1 Not yet recruiting August 2024 -
NCT02007837 Pregnancy Induced Hypertension Phase 3 Unknown August 2018 Ghana ... More >> La General Hospital Not yet recruiting Accra, Ghana Contact: Patrick Frimpong, MBChB    +233244270320    patrickfrimpong@hotmail.com    Principal Investigator: Patrick Frimpong, MBChB          Ridge Regional Hospital Not yet recruiting Accra, Ghana Contact: Emmanuel K Srofenyoh, MBChB    +233208118509    emmanuelsrofenyoh@gmail.com    Principal Investigator: Emmanuel K Srofenyoh, MBChB Less <<
NCT02111941 Fallopian Tube Clear Cell Aden... More >>ocarcinoma Fallopian Tube Endometrioid Tumor Fallopian Tube Mucinous Neoplasm Fallopian Tube Serous Neoplasm Fallopian Tube Transitional Cell Carcinoma Ovarian Clear Cell Cystadenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Mucinous Cystadenocarcinoma Ovarian Seromucinous Carcinoma Ovarian Serous Cystadenocarcinoma Ovarian Transitional Cell Carcinoma Primary Peritoneal Serous Adenocarcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Stage IIIC Fallopian Tube Cancer Stage IIIC Ovarian Cancer Stage IIIC Primary Peritoneal Cancer Stage IV Fallopian Tube Cancer Stage IV Ovarian Cancer Stage IV Primary Peritoneal Cancer Undifferentiated Fallopian Tube Carcinoma Undifferentiated Ovarian Carcinoma Less << Not Applicable Active, not recruiting December 2018 United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02013362 Peripheral T-cell Lymphoma Phase 1 Phase 2 Completed - Japan ... More >> National Hospital Organization Nagoya Medical Center Nagoya, Aichi, Japan, 460-0001 National Cancer Center Hospital Chuo, Tokyo, Japan, 104-0045 Okayama University Hospital Okayama,, Japan, 700-8558 Less <<
NCT00655980 Major Surgery ... More >> Coronary Artery Disease Less << Not Applicable Completed - United States, Missouri ... More >> Barnes-Jewish Hospital Saint Louis, Missouri, United States, 63110 Less <<
NCT00354081 Coronary Artery Disease ... More >> Myocardial Infarction Cerebrovascular Stroke Less << Phase 3 Completed - Norway ... More >> Department of Heart Disease, Haukeland University Hospital Bergen, Norway, 5021 Department of Cardiology, Stavanger University Hospital Stavanger, Norway, 4011 Less <<
NCT02345746 Metastatic Colorectal Cancer Phase 2 Withdrawn(patient population) December 2013 -
NCT00154700 Esophageal Cancer Phase 2 Completed - Taiwan ... More >> Department of Oncology, National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT01634555 Solid Tumors Phase 2 Completed - United States, Michigan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Detroit, Michigan, United States, 48202 United States, Nevada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Las Vegas, Nevada, United States, 89169 United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Cleveland, Ohio, United States, 44195 United States, Pennsylvania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Philadelphia, Pennsylvania, United States, 19111 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT02031289 Anemia Iron D... More >>eficiency Less << Phase 4 Completed - Switzerland ... More >> University Hospital Zurich, Institute of Anaesthesiology Zurich, ZH, Switzerland, 8091 Less <<
NCT00111267 Cognitive Decline ... More >> Cognitive Symptoms Less << Not Applicable Completed - Netherlands ... More >> Wageningen University Wageningen, Gelderland, Netherlands, 6700 EV Less <<
NCT01047982 Gestational Diabetes Not Applicable Completed - Italy ... More >> Obstetrics and Gynecology Unit, University of Messina and Obstetrics and Gynecology Unit of Modena University Messina and Modena, Italy Less <<
NCT01634555 - Completed - -
NCT03284840 - Enrolling by invitation June 2018 Slovenia ... More >> National Institute of Public Health, Slovenia Ljubljana, Slovenia, 1000 Nutrition Institute, Ljubljana Ljubljana, Slovenia, 1000 University Medical Centre Ljubljana Ljubljana, Slovenia, 1000 Less <<
NCT00214682 Depression De... More >>pressive Disorder Less << Phase 2 Completed - Australia, Australian Capital ... More >>Territory Australian National University Canberra, Australian Capital Territory, Australia, 0200 Less <<
NCT03725878 Birth Defects Not Applicable Recruiting December 31, 2021 China, Shanghai ... More >> Children Hospital of Fudan University Recruiting Shanghai, Shanghai, China, 201102 Contact: Guoying Huang    (21)64931928    gyhuang@shmu.edu.cn Less <<
NCT01864824 Heart Rate He... More >>art Rate Variability Inflammation Less << Phase 1 Completed - Canada, Ontario ... More >> Gage Occupational and Environmental Health St. Michael's Hospital/University of Toronto Toronto, Ontario, Canada, M5T 1R4 Less <<
NCT03524508 Metastatic Biliary Tract Cance... More >>r Less << Phase 2 Recruiting March 2021 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 05505 Contact: Changhoon Yoo, MD          Principal Investigator: Changhoon Yoo, MD Less <<
NCT02802215 Polycystic Ovary Syndrome ... More >> Diabetes, Gestational Less << Phase 2 Phase 3 Unknown September 2016 Egypt ... More >> Ain Shams maternity hospital Recruiting Cairo, Egypt Principal Investigator: Ahmed E Elbohoty, Ph.D. Less <<
NCT00124072 - Completed - -
NCT02586181 Nutritional Supplement Toxicit... More >>y Less << Not Applicable Completed - Germany ... More >> University of Saarland Homburg, Saarland, Germany, 66424 Less <<
NCT00212589 Colorectal Cancer Phase 3 Completed - Denmark ... More >> Department of Oncology, Esbjerg Hospital Esbjerg, Denmark, 6700 Department of Oncology, Odense University Hospital Odense, Denmark, 5000 Department of Oncology, Sonderborg Hospital Sonderborg, Denmark, 6400 Department of Oncology, Vejle Hospital Vejle, Denmark, 7100 Less <<
NCT00970866 Anemia Malnut... More >>rition Stunting Less << Not Applicable Active, not recruiting December 2018 Ghana ... More >> St. Martin de Porre's Hospital Agomanya, Ghana Atua Government Hospital Atua, Ghana Kpong Reproductive and Child Health (RCH) Center Kpong, Ghana Somanya Polyclinic Somanya, Ghana Less <<
NCT01511835 Gestational Diabetes Phase 4 Unknown - Italy ... More >> AGUNCO Recruiting Rome, Italy, 00155 Contact: Gianfranco Carlomagno       gianfranco.carlomagno@agunco.it    Principal Investigator: Vittorio Unfer          Principal Investigator: Gianfranco Carlomagno Less <<
NCT00124072 Cardiovascular Disease Phase 3 Completed - United Kingdom ... More >> CTSU, Richard Doll Building, University of Oxford Oxford, Oxon, United Kingdom, OX3 7LF Less <<
NCT00106886 Cardiovascular Disease ... More >> Myocardial Infarction Stroke Cancer Less << Phase 4 Unknown - Canada, Ontario ... More >> McMaster University and Hamilton Health Sciences Corporation Hamilton, Ontario, Canada, L8L 2X2 Less <<
NCT03384862 Arsenic Exposure Not Applicable Recruiting December 30, 2018 Bangladesh ... More >> Columbia University Bangladesh Recruiting Dhaka, Bangladesh Contact: Faruque Parvez, DrPH Less <<
NCT00217178 Atherosclerosis ... More >> Cardiovascular Disease Less << Phase 4 Unknown - Canada, Ontario ... More >> Hamilton Health Sciences Corp. Hamilton, Ontario, Canada, L8L 2X2 Less <<
NCT03059173 Polycystic Ovary Syndrome ... More >> Reproductive Medicine Less << Phase 3 Not yet recruiting April 2020 -
NCT01665378 Anemia Intrau... More >>terine Growth Retardation Preterm Delivery Iron Deficiency Less << Phase 3 Active, not recruiting September 2019 Vietnam ... More >> Thainguyen University of Medicine and Pharmacy Thai Nguyen, Vietnam Less <<
NCT00289445 Gastrointestinal Neoplasms ... More >> Neoplasm Metastasis Less << Phase 1 Phase 2 Completed - -
NCT01289821 - Completed - -
NCT00198848 Iron Deficiency Anemia Not Applicable Completed - India ... More >> Child In Need Institute Kolkata, West Bengal, India Less <<
NCT00136188 Diabetic Nephropathies Phase 2 Phase 3 Completed - Germany ... More >> CRC, Medizinische Klnik 4 - Nephrology and Hypertension, Uni Erlangen-Nürnberg Erlangen, Germany, 91054 Less <<
NCT01289821 Colorectal Neoplasms Phase 2 Completed - United States, Illinois ... More >> Chicago, Illinois, United States, 60611-2906 Australia, New South Wales Concord, New South Wales, Australia, 2139 Australia, South Australia Woodville South, South Australia, Australia, 5011 Belgium Bruxelles - Brussel, Belgium, 1070 Edegem, Belgium, 2650 Leuven, Belgium, 3000 Germany Stuttgart, Baden-Württemberg, Germany, 70199 Oldenburg, Niedersachsen, Germany, 26133 Herne, Nordrhein-Westfalen, Germany, 44625 Dresden, Sachsen, Germany, 01307 Italy Napoli, Campania, Italy, 80131 Genova, Liguria, Italy, 16132 Ancona, Marche, Italy, 60126 Spain Santander, Cantabria, Spain, 39008 Barcelona, Spain, 08035 Madrid, Spain, 28034 United Kingdom Glasgow, United Kingdom, G12 0YN Manchester, United Kingdom, M20 4BX Less <<
NCT01733329 Postpartum Hemorrhage Phase 4 Completed - Mexico ... More >> Hospital Universitario Dr. José Eleuterio González Monterrey, Nuevo León, Mexico, 64460 Less <<
NCT02385396 Polycystic Ovary Syndrome ... More >> Infertility Less << Phase 2 Completed - Poland ... More >> Medical University of Lublin Lublin, Poland Less <<
NCT01733329 - Completed - -
NCT00291785 Colorectal Cancer Phase 1 Phase 2 Completed - Italy ... More >> Policlinico Universitario "A.Gemelli" Rome, Italy Istituto Clinico Humanitas Rozzano, Italy Less <<
NCT01689766 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00406874 Infertility Phase 2 Terminated(reports indicating ... More >>that increased folic acid intake may increase colin cancer) Less << - United States, California ... More >> Reproductive Partners medical Group Redondo beach, California, United States, 90277 Less <<
NCT03096028 - Not yet recruiting February 28, 2022 India ... More >> KEM Hospital Research Center Not yet recruiting Pune, Maharashtra, India, 411011 Contact: Laila Garda, MD    00-91-20-66037336    research@kemhrcpune.org    Contact: Chittaranjan Yajnik, MD    00-91-20-26061958    diabetes@kemdiabetes.org    Principal Investigator: Rishikesh V Behere, MD Less <<
NCT01062958 - Completed - United States, Alabama ... More >> Women's Clinic Shoals Sheffield, Alabama, United States, 35660 United States, Mississippi Women's Health Associates Flowood, Mississippi, United States, 39232 United States, Texas Gainesville Obstetrics & Gynecology Gainesville, Texas, United States, 76240 Less <<
NCT02764333 Ovarian Cancer Phase 2 Active, not recruiting May 2019 United States, New Jersey ... More >> Memorial Sloan Kettering Cancer Center at Basking Ridge Basking Ridge, New Jersey, United States, 07920 Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States, 07748 United States, New York Memorial Sloan Kettering Cancer Center @ Commack Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center at Rockville Rockville Centre, New York, United States, 11570 Less <<
NCT00787514 - Completed - United Kingdom ... More >> Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT01762306 Abnormal Uterine Bleeding Unre... More >>lated to Menstrual Cycle Less << Not Applicable Unknown June 2013 Thailand ... More >> Faculty of Medicine Siriraj Hospital Mahidol University Recruiting Bangkok, Thailand, 10700 Contact: Korakot Sirimai, Dr.    (66)81-6140655    ksirimai@hotmail.com    Principal Investigator: Korakot Sirimai, Dr.          Sub-Investigator: Tripop Lertbunnaphong, Dr. Less <<
NCT02312219 - Active, not recruiting May 2018 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00860470 Infant Mortality ... More >> Preterm Birth Low Birth Weight Neonatal Mortality Perinatal Mortality Less << Phase 3 Completed - United States, Maryland ... More >> Johns Hopkins School of Public Health Baltimore, Maryland, United States, 21205 Bangladesh JiVitA Project Office Rangpur, Gaibandha District, Bangladesh Less <<
NCT00217100 Kidney Transplant Recipients Phase 3 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00860470 - Completed - -
NCT00755664 Hyperhomocysteinemia Phase 3 Completed - China, Hebei ... More >> The maternal and Children health care hospital Yuanshi county of Shijiazhuang, Hebei, China, 050000 Less <<
NCT03481790 Iron Deficiency Anemia of Preg... More >>nancy Less << Phase 2 Completed - Egypt ... More >> Ain Shams Maternity Hospital Cairo, Egypt Less <<
NCT00441870 Cancer Phase 1 Completed - United States, Maryland ... More >> Greenebaum Cancer Center - University of Maryland Medicine Baltimore, Maryland, United States, 21201 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Nevada Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 Less <<
NCT03522428 Pregnancy Anemia Phase 4 Completed - -
NCT01704794 Other Sickle-cell Disorders Wi... More >>th Crisis, Unspecified Less << Phase 1 Phase 2 Unknown September 2014 Nigeria ... More >> Lagos State University Teaching Hospital Recruiting Ikeja, Lagos, Nigeria, 100001 Contact: A O Dosunmu, M.D.    2348023369785    doyin_dosunmu@yahoo.com    Principal Investigator: A O Dosunmu, M.D.          Sub-Investigator: O O Odusanya, M.D.          Sub-Investigator: I N AKinwunmi, M.D.          Sub-Investigator: A A Akinbami, M.D.          Sub-Investigator: M O Dada, M.D.          Sub-Investigator: T M Balogun, M.D.          Sub-Investigator: C K Yemitan, M.D.          Sub-Investigator: J A Onakoya, M.D.          Sub-Investigator: U O Oyekan, M.D. Less <<
NCT01828710 Asthenozoospermia ... More >> Oligospermia Less << Phase 2 Phase 3 Completed - Italy ... More >> Centre of Physiopathology of Reproduction Catania, CT, Italy, 95010 Less <<
NCT01116141 Rheumatoid Arthritis Phase 2 Completed - -
NCT01412580 - Completed - Tanzania ... More >> MUHAS Dar es Salaam, Tanzania Less <<
NCT03273738 - Not yet recruiting November 15, 2018 -
NCT01436266 Abortion Bloo... More >>d Loss Less << Phase 3 Terminated(Slow enrollment) - United States, Massachusetts ... More >> Boston Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT02839915 Autism Spectrum Disorder Phase 2 Not yet recruiting January 1, 2023 United States, Arizona ... More >> Phoenix Children's Hospital Not yet recruiting Phoenix, Arizona, United States, 85016 Contact: Richard Frye, MD, PhD    602-933-1000       Principal Investigator: Richard Frye, MD, PhD          United States, Georgia Children's Healtcare of Atlanta Not yet recruiting Atlanta, Georgia, United States, 30322 Contact: Nichole Evans, MS    404-785-9345    Andrea.Evans@choa.org    Contact: Lawrence Scahill, PhD    404-785-9400    Lawrence.scahill@emory.edu    Principal Investigator: Lawrence Scahill, PhD          United States, Massachusetts Harvard University Not yet recruiting Lexington, Massachusetts, United States, 02421 Contact: Jennifer Mullett, RN    781-860-1700    JMULLETT@mgh.harvard.edu    Contact: Christopher Christopher, MD    781-860-1700    CMCDOUGLE@mgh.harvard.edu    Principal Investigator: Christopher Christopher, MD Less <<
NCT01436266 - Terminated(Slow enrollment) - -
NCT02541708 Iron-Deficiency Anemia Phase 3 Active, not recruiting April 2018 Tanzania ... More >> Ifakara Health Institute Bagamoyo, Tanzania, 74 Less <<
NCT00098319 Cleft Lip Cle... More >>ft Palate Less << Phase 3 Completed - Brazil ... More >> Hospital de Reabilitação de Anomalias Craniofaciais (HRAC) Bauru, Sao Paulo, Brazil Hospital de Clinicas de Porto Alegre (HCPA) Porto Alegre, Brazil Hospital Santo Antonio-Centrinho: Obras Sociais Irma Dulce Salvador, Brazil Less <<
NCT01426490 Colorectal Cancer Phase 2 Phase 3 Unknown July 2015 Taiwan ... More >> Taichung Verterans General Hospital Recruiting Taichung, Taiwan Contact: Feng-Fan Chiang, MD       hankel.chiang@gmail.com Less <<
NCT02872701 Lung Neoplasms ... More >> Lung Cancer Less << Phase 2 Recruiting October 2018 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Research Coordinator    617-632-8386       Principal Investigator: Sidharta Gangadharan, MD          United States, Pennsylvania University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Sunil Singhal, MD    215-615-5864    sunil.singhal@uphs.upenn.edu    Principal Investigator: Sunil Singhal, MD          University of Pittsburgh Medical Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Julie Ward, BSN    412-647-8583    wardj@upmc.edu    Principal Investigator: Interpal Sarkaria, MD          United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Craig DeDegraaf    713-563-9155    cedegra@mdanderson.org    Principal Investigator: David Rice, M.B., B.Ch.          Netherlands Leiden University Medical Center Recruiting Leiden, Netherlands, 2333 ZA Contact: Research Coordinator       kdvalk@chdr.nl    Principal Investigator: A.L. Vahrmeijer, MD, PhD Less <<
NCT00276198 Iron Deficiency Anemia ... More >> Infectious Diseases Undernutrition Less << Phase 3 Completed - Israel ... More >> Ministry of Health Beer-Sheva, Israel, 10050 Less <<
NCT02645409 Renal Cell Carcinoma Not Applicable Recruiting April 2, 2019 United States, Indiana ... More >> Indiana University Health Hospital Recruiting Indianapolis, Indiana, United States, 46202 Contact: Cindy Franklin    317-274-1798    cf2@iu.edu    Principal Investigator: Chandru P. Sundaram, MD          Indiana University Health Melvin and Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Cindy Franklin    317-274-1798    cf2@iu.edu    Principal Investigator: Chandru P. Sundaram, MD Less <<
NCT01560065 Sperm Quality ... More >> Oligoasthenospermia Less << Phase 4 Completed - Italy ... More >> University of Catania - Department of Surgery - Section of Obstetrics and Gynecology -Center of Physiopathology of Reproduction Catania, Italy Less <<
NCT02651636 Polycystic Ovary Syndrome ... More >> Menstrual Pattern Hyperandrogenism Metabolic Features Less << Not Applicable Completed - -
NCT01902264 Contraception Phase 3 Completed - Mexico ... More >> Mexico, D.F., Distrito Federal, Mexico, CP 14050 Less <<
NCT00004495 End Stage Renal Disease ... More >> Hyperhomocysteinemia Less << Not Applicable Completed - United States, District of Col... More >>umbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 Less <<
NCT00919282 Metastatic Pancreatic Cancer Phase 2 Completed - Germany ... More >> Universitätsmedizin Berlin Berlin, Germany, 13353 Less <<
NCT02294240 Birth Weight Not Applicable Unknown March 2016 Pakistan ... More >> Ali Akbar Shah Karachi, Sindh, Pakistan Ibrahim Hyderi Karachi, Sindh, Pakistan Less <<
NCT01580696 Ovarian Cancer ... More >> Endometrial Cancer Fallopian Cancer Peritoneal Cancer Less << Phase 1 Phase 2 Completed - United States, Virginia ... More >> Mid-Atlantic Gynecologic Oncology & Pelvic Surgery Associates Annandale, Virginia, United States, 22003 Less <<
NCT00905047 Colorectal Cancer Phase 3 Completed - France ... More >> Centre Paul Papin Angers, France, 49033 Centre Hospitalier Armentieres, France, 59280 Centre Hospitalier de Béthune Beuvry, France, 62660 Centre Hospitalier de CHOLET Cholet, France, 49300 Centre Leonard de Vinci Dechy, France, 59187 Polyclinique du Bois Lille, France, 59000 Centre Oscar Lambret Lille, France, 59020 Hopital Saint Vincent de Paul Lille, France, 59020 Centre Hospitalier Regional Lille, France, 59035 Centre Hospitalier Roubaix, France, 59100 Centre Joliot-Curie Saint Martin les Boulogne, France, 62280 Centre Hospitalier Valenciennes, France, 59300 Clinique des Dentellieres Valenciennes, France, 59300 Less <<
NCT01994369 Resectable Breast Cancer Phase 1 Completed - United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00226356 Unipolar Depression Phase 4 Completed - United States, Massachusetts ... More >> Cambridge Health Alliance Cambridge, Massachusetts, United States, 02139 Less <<
NCT00330915 - Completed - -
NCT00330915 Rectal Neoplasms Phase 2 Completed - Sweden ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Göteborg, Sweden, 41685 Less <<
NCT01371357 Hyperhomocysteinemia Phase 3 Completed - Serbia ... More >> Center for Health, Exercise and Sport Sciences Belgrade, Serbia, 11000 Less <<
NCT01626443 PCOS Phase 4 Completed - Italy ... More >> University of Pisa - Department of Endocrinology Pisa, Italy Less <<
NCT00759226 Esophageal Cancer Phase 2 Completed - Germany ... More >> Charite Universitätsmedizin Berlin Berlin, Germany, 13353 Less <<
NCT00901394 Cardiovascular Abnormalities Not Applicable Completed - United States, Missouri ... More >> Barnes Jewish Hospital Saint Louis, Missouri, United States, 63110 Less <<
NCT00626223 Mortality Hyp... More >>erhomocysteinemia Inflammation Less << Not Applicable Completed - Italy ... More >> Nephrology Dialysis and Renal Transplantation Unit, S.Orsola University Hospital Bologna, Italy, 40138 Less <<
NCT03306745 Polycystic Ovary Syndrome ... More >> Infertility, Female Micronutrient Deficiency Less << Not Applicable Completed - Austria ... More >> Medical University of Vienna, Clinical Division of Gynecologic Endocrinology and Reproductive Medicine Vienna, Austria, 1090 Less <<
NCT01672372 Depression Not Applicable Completed - United States, Florida ... More >> University of Miami CRB Miami, Florida, United States, 33136 Less <<
NCT00126347 Healthy Cardi... More >>ovascular Diseases Less << Not Applicable Completed - Netherlands ... More >> Wageningen Centre for Food Sciences Wageningen, Netherlands Less <<
NCT02610881 Anemia Not Applicable Completed - India ... More >> CARE-India Patna, Bihar, India Less <<
NCT00394862 Neural Tube Defects Not Applicable Completed - -
NCT01670955 Anemia Phase 2 Completed - Nigeria ... More >> Lagos State University Teaching Hospital Ikeja, Lagos, Nigeria, 100001 Less <<
NCT03598374 Polycystic Ovarian Syndrome ... More >> Infertility, Female Less << Not Applicable Not yet recruiting December 31, 2021 -
NCT00611000 Colorectal Cancer Phase 1 Completed - -
NCT02019524 Breast Cancer ... More >> Ovarian Cancer Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03594240 Plasma Homocysteine ... More >> HbA1c Level Less << Phase 3 Completed - Egypt ... More >> Nancy Elbarbary Cairo, Egypt, 11361 Less <<
NCT01602016 Autism Spectrum Disorder ... More >> Autistic Disorder Autism Asperger's Syndrome Pervasive Development Disorders Less << Phase 2 Terminated(Non-compliance) - United States, Arkansas ... More >> Arkansas Children's Hospital Research Institute Little Rock, Arkansas, United States, 72205 Less <<
NCT01602016 - Terminated(Non-compliance) - -
NCT00941174 Healthy Phase 1 Completed - Canada, Ontario ... More >> The Hospital For Sick Chidlren Toronto, Ontario, Canada Less <<
NCT00696514 Osteoporosis ... More >>Cognitive Decline Less << Phase 1 Unknown March 2013 Netherlands ... More >> VU University Amsterdam, Institute for Health Sciences Amsterdam, Netherlands Erasmus MC Rotterdam, Netherlands, 3015 GD Wageningen University Wageningen, Netherlands Less <<
NCT02593227 Breast Cancer Phase 2 Active, not recruiting December 2021 United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Kansas University of Kansas Cancer Center Westwood, Kansas, United States, 66205 United States, Maryland University of Maryland - Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Michigan Karmanos Cancer Center Detroit, Michigan, United States, 48201 United States, Missouri MidAmerica Division,Inc Kansas City, Missouri, United States, 64132 United States, New Jersey The Valley Hospital Paramus, New Jersey, United States, 07652 United States, New York Mount Sinai Hospital New York, New York, United States, 10029 Montefiore Medical Center, Einstein Cancer Center New York, New York, United States, 10461 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas Texas Oncology Presbyterian Cancer Center Dallas Dallas, Texas, United States, 75231 Less <<
NCT00202280 First Episode Psychosis Phase 2 Phase 3 Completed - Australia, Victoria ... More >> ORYGEN Youth Health Melbourne, Victoria, Australia, 3052 Less <<
NCT02810275 HIV Infection ... More >> HCV Coinfection Less << Phase 3 Completed - -
NCT00301587 Neural Tube Defects ... More >> Congenital, Hereditary, and Neonatal Diseases and Abnormalities Nervous System Malformations Less << Phase 3 Withdrawn(Company decision to ... More >>not fund further development of women's health new drug development programs.) Less << December 2004 -
NCT03438942 Nutrition Disorders Not Applicable Recruiting September 30, 2019 Poland ... More >> Poznan University of Life Sciences Recruiting Poznań, Poland, 60-624 Contact: Joanna Suliburska, Assoc. Prof.    +48 618487334    jsulibur@up.poznan.pl Less <<
NCT03089684 - Completed - -
NCT02093026 Rheumatoid Arthritis Phase 2 Completed - -
NCT01283971 Rheumatoid Arthritis Phase 4 Terminated(The study was close... More >>d due to the slow enrollment rate.) Less << - -
NCT01283971 - Terminated(The study was close... More >>d due to the slow enrollment rate.) Less << - -
NCT02093026 - Completed - -
NCT01399684 Metastatic Colorectal Cancer Phase 2 Completed - -
NCT01748851 Gastric Carcinoma Stage IV Phase 3 Terminated(Poor enrollment of ... More >>patients) Less << - Korea, Republic of ... More >> Dong-A University Hospital Busan, Korea, Republic of, 602-715 Less <<
NCT02605044 Metastatic Colorectal Cancer Phase 3 Terminated(Sponsor decision ba... More >>sed on portfolio prioritization) Less << - France ... More >> Hopital Europeen George Pomipidou, Hepato-Gastro-enterologie, 20 rue Leblanc Paris, France, 75 Singapore National Cancer Center, 11 Hospital Drive Singapore, Singapore, 169610 United Kingdom Hammersmith Hospital, Department of Cancer Medicine, Imperial College Healthcare Trust, Du Cane Road London, United Kingdom, W12 0HS Less <<
NCT02980510 Metastatic Colorectal Cancer Phase 2 Recruiting January 2024 France ... More >> Institut Sainte Catherine Not yet recruiting Avignon, France Contact: Laurent MINEUR       l.mineur@isc84.org    Principal Investigator: Laurent MINEUR, Dr          Centre Léon Berard Not yet recruiting Lyon, France Contact: Christelle DE LA FOUCHARDIERE       christelle.delafouchardiere@lyon.unicancer.fr    Principal Investigator: Christelle DE LA FOUCHARDIERE, Dr          Chu Saint Eloi Not yet recruiting Montpellier, France Contact: Eric ASSENAT       e-assenat@chu-montpellier.fr    Principal Investigator: Eric ASSENAT, Dr          ICM Val D'Aurelle Recruiting Montpellier, France Contact: Thibault MAZARD       Thibault.Mazard@icm.unicancer.fr    Principal Investigator: Thibault MAZARD, Dr          Institut de Cancérologie de Lorraine Not yet recruiting Nancy, France Contact: Céline GAVOILLE       c.gavoille@nancy.unicancer.fr    Principal Investigator: Céline GAVOILLE, Dr          CHU Carémeau - Institut de Cancérologie du Gard Not yet recruiting Nimes, France Contact: Stéphane OBLED       stephane.obled@chu-nimes.fr    Principal Investigator: Stéphane OBLED, Dr Less <<
NCT01715038 Malnutrition Not Applicable Completed - Bangladesh ... More >> LAMB Parbatipur, Rangpur and Dinajpur Districts, Bangladesh Less <<
NCT01049061 Patients With a Folate-recepto... More >>r Alpha Expressing Solid Tumor Who Are Not Responsive or Resistant to Standard Therapy and Have no Other Appropriate Treatment. Less << Phase 1 Completed - Japan ... More >> Hidaka-shi, Saitama, Japan Chuo-ku, Tokyo, Japan Less <<
NCT02699710 Healthy Volunteer Phase 1 Completed - United Kingdom ... More >> Quotient Clinical Ltd, Clinical Research Unit Nottingham, United Kingdom, NG11 6JS Less <<
NCT00154102 Epidermal Growth Factor Recept... More >>or (EGFR) Expressing Metastatic Colorectal Cancer Less << Phase 3 Completed - -
NCT03326960 - Recruiting December 31, 2019 China, Shanghai ... More >> Shanghai 10th People's Hospital Recruiting Shanghai, Shanghai, China, 200072 Contact: Yanxia Guo, M.D.    021-65982875    guoyx_2000@tongji.edu.cn Less <<
NCT01931293 Atrophic Glossitis, Burning Mo... More >>uth Syndrome Less << Not Applicable Unknown July 2016 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Test2, Taiwan, test3 Contact: Andy Sun, Professor    +886-2-23123456 ext 67702    andysun7702@yahoo.com.tw Less <<
NCT00154102 - Completed - -
NCT00158171 Smoking Cessation ... More >> Tobacco Use Disorder Less << Phase 2 Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00268398 Colorectal Cancer ... More >> Metastatic Cancer Chemotherapy Less << Phase 3 Completed - France ... More >> Institut Sainte Catherine Avignon, France, 84000 Hopital Duffaut Avignon, France, 84902 C.H.G. Beauvais Beauvais, France, 60021 Hopital Saint Andre Bordeaux, France, 33075 Centre Hospitalier Docteur Duchenne Boulogne Sur Mer, France, 62200 Hopital Ambroise Pare Boulogne-Billancourt, France, F-92104 Centre Hospitalier de Briey Briey, France, 54151 Centre Regional Francois Baclesse Caen, France, 14076 Hopital Louis Pasteur Chartres, France, 28018 Hopital Beaujon Clichy, France, 92118 Louis Mourier Hospital Colombes Cedex, France, 92701 Clinique du Parc Croix, France, 59170 Hopital Drevon Dijon, France, 21000 Centre Hospitalier Departemental La Roche Sur Yon, France, F-85025 Hopital Saint - Louis La Rochelle, France, 17000 Hopital Robert Boulin Libourne, France, 33500 Polyclinique Du Bois Lille, France, 59000 Centre Hospital Universitaire Hop Huriez Lille, France, 59037 Polyclinique des Quatre Pavillons Lormont, France, 33310 Hopital Saint Joseph Marseille, France, 13008 Hopital Notre-Dame de Bon Secours Metz, France, 57038 Centre Hospitalier Intercommunal Le Raincy - Montfermeil Montfermeil, France, 93370 Hopital Europeen Georges Pompidou Paris, France, 75015 Hopital Saint Antoine Paris, France, 75571 CHU Pitie-Salpetriere Paris, France, 75651 Hopital Tenon Paris, France, 75970 Hopital Haut Leveque Pessac, France, 33604 Polyclinique De Courlancy Reims, France, F-51100 Clinique Specialise du Littoral-Cote d'Opale Saint Martin Boulogne, France, 62280 Clinique Charcot Sainte Foy Les Lyon, France, 69110 C.H. Senlis Senlis, France, 60309 Hopital Foch Suresnes, France, 92151 Less <<
NCT00340366 - Completed - Ireland ... More >> The Coombe Maternity Hospital Dublin, Ireland Less <<
NCT03101579 Leptomeningeal Metastases Phase 1 Completed - China, Jilin ... More >> The First Hospital of Jilin University Changchun, Jilin, China, 130021 Less <<
NCT02141295 Colorectal Cancer Phase 2 Completed - -
NCT01581307 - Completed - -
NCT03246308 - Recruiting July 7, 2020 Austria ... More >> Medical University of Vienna Recruiting Vienna, Austria Contact: Benedikt Weber, MD    01 404007700    benedikt.weber@meduniwien.ac.at    Contact    01 404007700 Less <<
NCT01581307 Liver Cancer ... More >>Pancreatic Cancer Less << Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00143403 - Completed - -
NCT00488579 Pregnancy Phase 4 Completed - Mozambique ... More >> Universidade Eduardo Mondlande, Faculty of Medicine, Department of Community Health Maputo, Mozambique Less <<
NCT02000778 Ovarian Cancer Phase 1 Completed - United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00143403 Colorectal Neoplasms ... More >> Liver Neoplasms Less << Phase 3 Completed - -
NCT02606539 Gestational Trophoblastic Neop... More >>lasms Less << Phase 2 Phase 3 Unknown August 2017 Egypt ... More >> Mansoura University Hospital Recruiting Mansoura, Dakahlia, Egypt Sub-Investigator: Maher E Kamel elesawi, MSc          Maher Elesawi Kamel Elesawi Recruiting Mit Ghamr, Eldakahlia, Egypt Contact: Maher Elesawi, MD student    01016103662    maherelesawi@yahoo.com    Contact: Reda Hemida, MD    01008622573    redaelshouky@hotmail.com Less <<
NCT02644499 Rheumatoid Arthritis Phase 4 Completed - India ... More >> Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER) Pondicherry, Pondicherry UT, India, 605006 Less <<
NCT01851941 Advanced Gastric Cancer Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT01194453 - Completed - -
NCT01917032 Malnutrition Phase 3 Unknown December 2013 Colombia ... More >> Fundación de Atención a la Niñez (FAN) Recruiting Medellín, Ant, Colombia, 0574 Contact: Viviana Ramírez, Nutricionist    5744480288    nutricion@fan.org.co Less <<
NCT01194453 Non-small Cell Lung Cancer ... More >> Efficacy Less << Phase 2 Completed - China, Guangdong ... More >> Cancer Center of Sun Yat-Sen University (CCSU) Guangzhou, Guangdong, China Less <<
NCT03293641 Sickle Cell Disease ... More >> Zinc Deficiency Infection Less << Not Applicable Completed - -
NCT00116493 Anemia Phase 3 Completed - Pakistan ... More >> Aga Khan University Karachi, Sindh, Pakistan Less <<
NCT03750669 Pancreatic Adenocarcinoma Rese... More >>ctable Neoadjuvant Chemotherapy Less << Phase 2 Recruiting October 20, 2024 China, Zhejiang ... More >> The second affiliated hospital of Zhejiang University Recruiting Hangzhou, Zhejiang, China Contact: Qi Zhang, MD    8613819137113    zhangqi86@zju.edu.cn Less <<
NCT02631876 Epithelial Ovarian Cancer ... More >> Primary Peritoneal Carcinoma Fallopian Tube Cancer Ovarian Cancer Less << Phase 3 Active, not recruiting February 2019 -
NCT01778920 Lung and Pleural Malignancies ... More >> Neoplasms Nodules Adenocarcinoma Less << Phase 1 Completed - United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Philadelphia VA Medical Center, Philadelphia, PA Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01188876 Ovarian Cancer ... More >> Fallopian Tube Cancer Peritoneal Cancer Less << Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01996072 Primary Hyperparathyroidism Phase 1 Completed - United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00197730 HIV Infections ... More >> Pregnancy Complications Less << Phase 3 Completed - Tanzania ... More >> Muhimbili University of Health and Allied Sciences Dar es Salaam, Tanzania Less <<
NCT01188876 - Completed - -
NCT03661931 Lifestyle-related Condition ... More >> Nutrient; Excess Less << Not Applicable Not yet recruiting June 1, 2019 -
NCT01778933 Renal Cell Carcinoma Early Phase 1 Completed - United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00973609 Colorectal Neoplasms Phase 3 Completed - Germany ... More >> AIO-Studien gGmbH Berlin, Germany, 10623 Less <<
NCT01765582 Colorectal Neoplasms Phase 2 Terminated - -
NCT01765582 - Terminated - -
NCT03177122 Sterility Inf... More >>ertility Less << Phase 4 Recruiting July 2019 Lebanon ... More >> American University of Beirut Medical Center Recruiting Beirut, Lebanon Contact: Johnny Awwad, MD    00961 1 350000 ext 5606    jawwad@aub.edu.lb Less <<
NCT00462345 Rheumatoid Arthritis Phase 4 Completed - Korea, Republic of ... More >> Seoul, Korea, Republic of, 110-744 Seoul, Korea, Republic of, 133-792 Seoul, Korea, Republic of, 137701 Seoul, Korea, Republic of, 138-736 Less <<
NCT00785421 Pancreatic Cancer Phase 2 Phase 3 Completed - Germany ... More >> Universitätsmedizin - Berlin - Charite Berlin, Germany, 13353 Less <<
NCT00462345 - Completed - -
NCT03073590 Anemia Not Applicable Completed - Bangladesh ... More >> Icddr,B Dhaka, Bangladesh, 1212 Less <<
NCT02967289 Colon Cancer (High-risk Stage ... More >>III; pT4N1 or pT1 to 4 N2) Less << Phase 3 Recruiting June 2026 Canada, Prince Edward Island ... More >> The PEI Cancer Treatment Centre Queen Elizabeth Hospital Active, not recruiting Charlottetown, Prince Edward Island, Canada Canada, Quebec Hopital Charles LeMoyne Active, not recruiting Greenfield Park, Quebec, Canada Centre hospitalier de l'Université de Montréal Active, not recruiting Montréal, Quebec, Canada Canada, Saskatchewan Allan Blair Cancer Centre Active, not recruiting Regina, Saskatchewan, Canada France Institut de Cancérologie de l'Ouest -site Paul Papin Recruiting Angers, France Contact: Sandrine HIRET, MD          CHD de Vendée Active, not recruiting La Roche-sur-Yon, France Ch Emile Roux Recruiting Le Puy-en-Velay, France Contact: Kheir Eddine BENNMAMMAR          Hospices civils de Lyon - Hôpital Edouard Herriot Active, not recruiting Lyon, France Hôpital privé Jean Mermoz Recruiting Lyon, France Contact: Pascal ARTRU, MD          Icm Val D'Aurelle Recruiting Montpellier, France Contact: Thibault MAZARD          Institut de Cancérologie de l'Ouest -site René Gauducheau Recruiting Nantes, France Contact: Sandrine HIRET          Hôpital Européen Georges Pompidou Recruiting Paris, France Contact: Julien TAIEB, MD          Hôpital Saint Antoine Active, not recruiting Paris, France Centre Hospitalier Annecy Genevois Active, not recruiting Pringy, France Institut Jean Godinot Recruiting Reims, France Contact: ELISE DESOT          CHP Saint Grégoire Recruiting Saint Gregoire, France Contact: Laurent MIGLIANICO, MD          Clinique de la Côte d'Emeraude Active, not recruiting Saint-Malo, France Less <<
NCT01832948 Metastatic Colorectal Cancer Phase 2 Unknown January 2015 China, Zhejiang ... More >> Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China Contact: Liming Zhu, MD    0571-88122222       Principal Investigator: Liming Zhu, MD Less <<
NCT02833350 Rheumatoid Arthritis Phase 2 Completed - -
NCT02481375 Anemia Iron D... More >>eficiency Hemoglobin Disorder Infection Inflammation Less << Not Applicable Completed - Cambodia ... More >> Kampong Chhnang province Kampong Chhnang, Kampong Chhnang Province, Cambodia Less <<
NCT02421887 Male Infertility Phase 2 Active, not recruiting September 2018 United States, California ... More >> Keck School of Medicine of University of Southern California Los Angeles, California, United States, 90089 University of California San Francisco San Francisco, California, United States, 94115 Stanford University Sunnyvale, California, United States, 94087 United States, Georgia Augusta University Augusta, Georgia, United States, 30912 United States, Michigan Wayne State University Southfield, Michigan, United States, 48034 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 Carolinas Medical Center - Women's Institute Charlotte, North Carolina, United States, 28204 United States, Oklahoma University of Oklahoma Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania Pennsylvania State University Hershey, Pennsylvania, United States, 17033 University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03431597 Micronutrient Deficiencies ... More >> Hyperhomocysteinemia Less << Phase 2 Active, not recruiting December 2018 Gambia ... More >> Keneba Field Station Banjul, Gambia Less <<
NCT02481375 - Completed - -
NCT01991873 Metastatic Colorectal Cancer Phase 2 Recruiting June 2018 Germany ... More >> St.-Antonius-Hospital Eschweiler Recruiting Eschweiler, Germany, 52249 Contact: Schlegel, Dr. med.    02403/76-1281       Zentrum für Tumorbiologie und Integrative Medizin, Klinikum Wilhelmshaven Not yet recruiting Wilhelmshaven, Germany, 26389 Contact: Dr. Tanja Trarbach Less <<
NCT01472016 Advanced Solid Tumors Phase 1 Completed - -
NCT03600623 Locally Advanced Pancreatic Ca... More >>ncer Borderline Pancreatic Inoperable Cancer Pancreatic Cancer Less << Early Phase 1 Recruiting July 2021 United States, Alabama ... More >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Anna Messer, RN, BSN, MS    205-975-0370    amesser@uabmc.edu    Contact: Ravi K Paluri, MD    205-975-2477    rpaluri@uabmc.edu Less <<
NCT02785068 Colorectal Cancer Phase 1 Phase 2 Withdrawn October 2018 -
NCT02773147 HIV Phase 2 Recruiting November 2018 Sweden ... More >> Department of Infectious Diseases, Sahlgrenska university hospital Recruiting Gothenburg, Sweden Contact: Magnus Gisslén, MD, PhD    +46313436238    magnus.gisslen@infect.gu.se Less <<
NCT02124226 Low Dose Methotrexate in Sever... More >>e Chronic Asthma Less << Phase 3 Not yet recruiting July 2019 -
NCT00308269 Cancer Phase 1 Completed - United States, Maryland ... More >> Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States, 21201 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT03530267 Colorectal Cancer Phase 2 Recruiting June 15, 2022 Germany ... More >> Phase Drei Not yet recruiting Aschaffenburg, Germany, 63739 Contact: Manfred Welslau, MD          HELIOS Klinikum Bad Saarow Not yet recruiting Bad Saarow, Germany, 15526 Contact: Daniel Pink, Dr.          Klinikum Bayreuth Not yet recruiting Bayreuth, Germany, 95445 Contact: Alexander Kiani, Prof. Dr.          MVZ Seestrasse Not yet recruiting Berlin, Germany, 13347 Contact: Alexander Schmittel, Dr.          Klinikum Bremen Nord Not yet recruiting Bremen, Germany, 28755 Contact: Ruben R. Plentz, Prof. Dr.          Kliniken Essen-Mitte Not yet recruiting Essen, Germany, 45136 Contact: Michael Stahl, Prof. Dr.          Agaplesion Markus Krankenhaus Not yet recruiting Frankfurt, Germany, 60431 Contact: Claus Bolling, MD          Krankenhaus Nordwest GmbH Recruiting Frankfurt, Germany, 60488 Contact: Thorsten O Goetze, PD Dr.          Klinikum Garmisch-Partenkirchen GmbH Not yet recruiting Garmisch-Partenkirchen, Germany, 82467 Contact: Till Seiler, MD          Nationales Centrum für Tumorerkrankungen (NCT) Not yet recruiting Heidelberg, Germany, 69120 Contact: Anne Berger, MD          Städtisches Klinikum Karlsruhe Not yet recruiting Karlsruhe, Germany, 76133 Contact: Margarethe Schmier, MD          DRK-Kliniken Nordhessen gGmbH Not yet recruiting Kassel, Germany, 34121 Contact: Mathias Kleiss, MD          Ortenau Klinikum Lahr Not yet recruiting Lahr, Germany, 77933 Contact: Matthias Egger, MD          Onkologisches Zentrum Not yet recruiting Lebach, Germany, 66822 Contact: Stefan Bauer, PD Dr.          Klinikum Ludwigshafen Not yet recruiting Ludwigshafen, Germany, 67063 Contact: Ralf Jakobs, Prof. Dr.          Klinikum Magdeburg gGmbH Not yet recruiting Magdeburg, Germany, 39130 Contact: Christoph Kahl, Prof. Dr.          Tagestherapiezentrum am ITM Universitätsmedizin Mannheim Recruiting Mannheim, Germany, 68167 Contact: Ralf D Hofheinz, Prof. Dr.          Kliniken Ostalb Not yet recruiting Mutlangen, Germany, 73557 Contact: Holger Hebart, Prof. Dr.          Klinikum der Universität München-Großhadern Not yet recruiting München, Germany, 81377 Contact: Volker Heinemann, Prof. Dr.          Kliniken des Landkreises Neumarkt in der Oberpfalz Not yet recruiting Neumarkt In Der Oberpfalz, Germany, 92318 Contact: Eva Horndasch          Studienzentrum Onkologie Ravensburg Recruiting Ravensburg, Germany, 88212 Contact: Tobias Dechow, Prof. Dr.          Clinical Research Stolberg GmbH Not yet recruiting Stolberg, Germany, 52222 Contact: Matthias Groschek          Klinikum Mutterhaus Trier Not yet recruiting Trier, Germany, 54290 Contact: Rolf Mahlberg, MD          Universitätsklinikum Tübingen Not yet recruiting Tübingen, Germany, 72076 Contact: Hans-Georg Kopp, Prof. Dr.          Klinikum Wilhelmshaven Not yet recruiting Wilhelmshaven, Germany, 26389 Contact: Tanja Trarbach, Dr. Less <<
NCT03360435 - Recruiting November 18, 2019 United States, Florida ... More >> University of Florida Recruiting Gainesville, Florida, United States, 32611 Less <<
NCT01832688 - Completed - Niger ... More >> Helen Keller International Zinder, Niger Less <<
NCT01494506 Metastatic Pancreatic Cancer Phase 3 Completed - -
NCT01484756 Upper Respiratory Tract Infect... More >>ion Less << Phase 3 Completed - Indonesia ... More >> Faculty of Medicine, University of Indonesia Jakarta, Indonesia, 10430 Less <<
NCT03626922 Metastatic Colorectal Cancer Phase 1 Not yet recruiting November 2022 -
NCT03142516 Colorectal Neoplasms ... More >> Colorectal Carcinoma Colorectal Cancer Metastatic Neoplasm Metastasis Less << Phase 2 Recruiting February 28, 2021 Spain ... More >> ICO L´Hospitalet de Llobregat - Hospital Durán i Reynals Recruiting L'Hospitalet de Llobregat, Barcelona, Spain, 08908 Contact: Gemma Soler González, MD       gsoler@iconcologia.net    Hospital Sant Joan Despí-Moises Broggi Recruiting Sant Joan Despí, Barcelona, Spain, 08970 Contact: Gemma Soler González, MD       gemma.solergonzalez@sanitatintegral.org    Hospital Universitario Puerta de Hierro-Majadahonda Recruiting Majadahonda, Madrid, Spain, 28222 Contact: Ana Ruíz Casado, MD       arcasado@salud.madrid.org    Hospital Universitario Rey Juan Carlos Recruiting Móstoles, Madrid, Spain, 28933 Contact: Brezo Martínez-Amores, MD       brezo.martinez@hospitalreyjuancarlos.es    Hospital Clínic Recruiting Barcelona, Spain, 08036 Contact: Estela Pineda Losada, MD       epineda@clinic.cat    Hospital General Universitario de Elda Recruiting Elda, Spain, 03600 Contact: Cristina Llorca Ferrándiz, MD       cllorcaf@yahoo.es    Complejo Asistencial Universitario de León (CAULE) Recruiting León, Spain, 24001 Contact: Carmen Castañón López, MD       carmencastanon@yahoo.es    Hospital Universitario Arnau de Vilanova Recruiting Lleida, Spain, 25198 Contact: Antonieta Salud Salvia, MD       asaluds@hotmail.com    Hospital Universitario la Paz Recruiting Madrid, Spain, 28046 Contact: Jaime Feliu Batlle, MD       jaimefeliu@hotmail.com    Centro Integral Oncológico Clara Campal - Hospital HM Sanchinarro Recruiting Madrid, Spain, 28050 Contact: Antonio Cubillo Gracián, MD       acubillo@hmhospitales.com    Hospital General Universitario Morales Meseguer Recruiting Murcia, Spain, 30008 Contact: Alberto Carmona Bayonas, MD       alberto.carmonabayonas@gmail.com    Hospital Universitario Son Espases Recruiting Palma, Spain, 07020 Contact: Mónica Guillot Morales, MD       monicam.guillot@ssib.es    Hospital Parc Taulí Recruiting Sabadell, Spain, 08208 Contact: Ismael Macías Declara, MD       imacias@tauli.cat    Hospital Universitario y Politécnico La Fe Recruiting Valencia, Spain, 46009 Contact: Jorge Antonio Aparicio Urtasun, MD       aparicio_josurt@gva.es    Hospital Clínico Universitario Lozano Blesa Recruiting Zaragoza, Spain, 50009 Contact: Pilar Escudero Emperador, MD       PILARESCUDERO@telefonica.net    Hospital Universitario Miguel Servet Recruiting Zaragoza, Spain, 50009 Contact: Vicente Alonso Orduña, MD       alonord@gmail.com Less <<
NCT02135887 - Recruiting March 31, 2019 Taiwan ... More >> Microbio Co., Ltd. Recruiting Taipei, Taiwan Contact: Kristin Fan    886-4-2325-1900 ext 108    kristin.fan@microbio.com.tw Less <<
NCT01494506 - Completed - -
NCT02568046 Metastatic Colorectal Cancer Phase 1 Phase 2 Terminated(Discontinued develo... More >>pment of Sym004 in combination with FOLFIRI) Less << - United States, California ... More >> UCLA School of Medicine Los Angeles, California, United States, 90095 Sharp Memorial Hosptal San Diego, California, United States, 92123 United States, District of Columbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Georgia University Cancer & Blood Center, LLC Athens, Georgia, United States, 30607 United States, Michigan University of Michigan Health System Ann Arbor, Michigan, United States, 48109 Spain Hospital del Mar Barcelona, Spain, 08003 Hospital Universitari Vall d'Hebron Barcelona, Spain, 08035 Hospital Universitario Madrid Sanchinarro Madrid, Spain, 28050 Less <<
NCT03280979 Gestational Trophoblastic Dise... More >>ase Less << Phase 2 Phase 3 Not yet recruiting October 2019 -
NCT03489538 - Completed - Austria ... More >> Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT03294252 Digestive Cancer Phase 1 Phase 2 Recruiting June 7, 2021 France ... More >> ICO René Gauducheau Recruiting Saint-Herblain, France, 44805 Contact: DUMONT Frédéric, MD    +33 2 40 67 99 00    frederic.dumont@ico.unicancer.fr Less <<
NCT00636610 - Completed - -
NCT00932113 - Completed - -
NCT03751176 Colorectal Cancer Metastatic Phase 2 Recruiting December 2021 Spain ... More >> ICO Girona Dr. Josep Trueta Recruiting Gerona, Barcelona, Spain, 17007 Contact: Xavier Hernández, MD       xhernandez@iconcologia.net    Hospital de Granollers Recruiting Granollers, Barcelona, Spain, 08402 Contact: Rosa Gallego, MD       mrgallego@fhag.es    Hospital Mutua de Terrassa Recruiting Terrassa, Barcelona, Spain, 08221 Contact: Julén Fernández, MD       julenfernandez@mutuaterrassa.cat    Hospital General Universitario de Elche Recruiting Alicante, Elche, Spain, 03203 Contact: Javier Gallego, MD       j.gallegoplazas@gmail.com    Hospital Universitario Fundación Alcorcón Recruiting Alcorcón, Madrid, Spain, 28922 Contact: Juan Carlos Cámara       jccamara@fhalcorcon.es    H. Universitari Sant Joan de Reus Recruiting Reus, Tarragona, Spain, 43204 Contact: Féliz Muñoz, MD       felix.munoz@grupsagessa.com    Hospital de La Ribera de Alzira Recruiting Alzira, Valencia, Spain, 46600 Contact: Teresa Taberner, MD       mttb2@hotmail.com    Hospital Universitario Vall d`Hebron Recruiting Barcelona, Spain, 08035 Contact: Jaume Capdevila, MD       jacapdevila@vhebron.net    Hospital Clínic de Barcelona Recruiting Barcelona, Spain, 08036 Contact: Joan Maurel, MD       JMAUREL@clinic.cat    Hospital de la Santa Creu I Sant Pau Recruiting Barcelona, Spain, 08041 Contact: Anna Virgili, MD       avirgili@santpau.cat    Hospital Universtiario la Paz Recruiting Madrid, Spain, 28046 Contact: Nuria Rodriguez, MD       nuria.rodriguez@salud.madrid.org    CIOCC Sanchinarro Recruiting Madrid, Spain, 28050 Contact: Rafaél Álvarez, MD       ralvarezgallego@hmhospitales.com    Complejo Hospitalario de Navarra Recruiting Navarro, Spain, 31008 Contact: Ruth Vera, MD       ruth.vera.garcia@cfnavarra.es    Corporació Sanitaria Parc Taulí Recruiting Sabadell, Spain, 08208 Contact: ismael Macías, Md       imacias@tauli.cat    Fundación Instituto Valenciano de Oncología Not yet recruiting Valencia, Spain, 46009 Contact: Carlos Fernandez-Martos, MD          Hospital Universitario Dr. Peset Recruiting Valencia, Spain, 46017 Contact: Carles Bosch, MD       bosch_car@gva.es    Hospital Universitario y Politécnico La Fe Not yet recruiting Valencia, Spain, 46026 Contact: Jorge Aparicio, MD       japariciou@seom.org Less <<
NCT00636610 Metastatic Colorectal Cancer Phase 2 Completed - -
NCT00932113 Psoriasis Phase 4 Completed - United States, Massachusetts ... More >> Tufts Medical Center, Department of Dermatology Boston, Massachusetts, United States, 02111 Less <<
NCT02379091 Rheumatoid Arthritis Phase 2 Completed - Bulgaria ... More >> Plovdiv, Bulgaria Ruse, Bulgaria Sofia, Bulgaria Czechia Ceske Budejovice, Czechia Praha 2, Czechia Uherske Hradiste, Czechia Zlin, Czechia Japan Fukuoka-shi, Fukuoka-Ken, Japan Iizuka-shi, Fukuoka-Ken, Japan Kitakyusyu-shi, Fukuoka-Ken, Japan Sapporo-shi, Hokkaido, Japan Takarazuka-shi, Hyogo-Ken, Japan Morioka-shi, Iwate-Ken, Japan Kawasaki-shi, Kanagawa-Ken, Japan Kumamoto-shi, Kumamoto-Ken, Japan Miyagi-gun, Miyagi-Ken, Japan Nagasaki-shi, Nagasaki-Ken, Japan Sasebo-shi, Nagasaki-Ken, Japan Hamamatsu-shi, Shizuoka-Ken, Japan Nishimuro-gun, Wakayama-Ken, Japan Korea, Republic of Seoul, Gyeonggi-do, Korea, Republic of Poland Bydgoszcz, Poland Torun, Poland Russian Federation Kazan, Russian Federation Saint-Petersburg, Russian Federation Ulyanovsk, Russian Federation Voronezh, Russian Federation Spain La Coruna, Spain Sevilla, Spain United Kingdom Romford, Essex, United Kingdom London, Greater London, United Kingdom Less <<
NCT02379091 - Completed - -
NCT00329368 Cancer Phase 1 Completed - United States, Illinois ... More >> Southern Illinois University School of Medicine Springfield, Illinois, United States, 62794 United States, Michigan Great Lakes Cancer Institute Breslin Cancer Center Lansing, Michigan, United States, 48910 United States, Texas The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT01643187 Malnutrition Phase 2 Unknown December 2013 Guatemala ... More >> APEVIHS Not yet recruiting Retalhuleu, Guatemala Contact: Victor Alfonso    +502 42196935    valfonso@apevihs.org    Principal Investigator: Victor Alfonso Less <<
NCT01474486 Congestive Heart Failure ... More >> Ischemic Cardiomyopathy Less << Not Applicable Completed - United States, Arizona ... More >> Phoenix VA Health Care System Phoenix, Arizona, United States, 85012 Less <<
NCT01198574 Anemia Phase 3 Completed - Myanmar ... More >> Nyaung Done Township Pathein, Irrawaddy Division, Myanmar Less <<
NCT01689662 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT02359968 Esophageal Neoplasms Phase 2 Unknown October 2018 France ... More >> University Hospital of Lille Recruiting Lille, France, 59000 Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Antoine ADENIS, MD Less <<
NCT00909974 Intrauterine Growth Retardatio... More >>n Low Birth Weight Less << Phase 4 Completed - Burkina Faso ... More >> Centre Muraz, 2054, Avenue Mamadou KONATE Bobo-Dioulasso, Burkina Faso Less <<
NCT01850680 Rheumatoid Arthritis Phase 1 Completed - Japan ... More >> Investigational Site Number 392001 Sendai-Shi, Japan Investigational Site Number 392002 Sendai-Shi, Japan Less <<
NCT00197548 Pregnancy Pre... More >>mature Birth Infant, Low Birth Weight Pregnancy Outcomes Less << Phase 3 Completed - -
NCT02143219 Pancreatic Metastatic Cancer ... More >> Toxicity Less << Phase 2 Recruiting July 2021 France ... More >> ICO Paul Papin Recruiting Angers, France, 49000 Contact: Olivier CAPITAIN, MD    +33 2 41 35 27 00    olivier.capitain@ico.unicancer.fr    Principal Investigator: Olivier CAPITAIN, MD          CH Vendée Not yet recruiting La Roche Sur Yon, France, 85925 Contact: Roger FAROUX, MD    02 51 44 61 68       Principal Investigator: Roger FAROUX, MD          Sub-Investigator: Cécile GARCEAU, MD          Sub-Investigator: Morgane AMIL, MD          Sub-Investigator: François DEWAELE, MD          Sub-Investigator: Jean-Pierre LAFARGUE, MD          Sub-Investigator: Matthieu SCHNEE, MD          Sub-Investigator: Vincent MACE, MD          Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Antoine ADENIS, MD    03.20.29.55.00       Principal Investigator: Antoine ADENIS, MD          Sub-Investigator: Farid EL HAJBI, MD          Sub-Investigator: Eric AMELA, MD          Sub-Investigator: Charlotte PEUGNIEZ, MD          ICM (Val d'Aurelle) Not yet recruiting Montpellier Cedex 5, France, 34298 Contact: Emmanuelle SAMALIN, MD    04 67 67 25 92       Sub-Investigator: Emmanuel SAMALIN, MD          Sub-Investigator: Blandine GALLET-SUCHET, MD          Sub-Investigator: Laurence DALSTEIN, MD          Sub-Investigator: Marc YCHOU, MD          ICO René Gauducheau Recruiting Nantes - St Herblain, France, 44805 Contact: Sandrine HIRET, MD    +33 2 40 67 99 00 ext 9357    sandrine.hiret@ico.unicancer.fr    Principal Investigator: Sandrine HIRET, MD          Sub-Investigator: Jean-Yves DOUILLARD, Pr          Sub-Investigator: Jaafar BENNOUNA, Pr          Sub-Investigator: Hélène SENELLART, MD          Centre Eugène marquis Not yet recruiting Rennes, France, 35042 Contact: Bérengère LECONTE, MD    02 99 28 54 65       Principal Investigator: Bérengère LECONTE, MD          Sub-Investigator: Evelyne BOUCHER, MD          Sub-Investigator: Sylvain MANFREDI, MD          Sub-Investigator: Julien EDELINE, MD Less <<
NCT03414502 Rheumatoid Arthritis Phase 3 Recruiting August 2019 United States, Nebraska ... More >> University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States, 68198 Contact: Cindy Marr, LPN    402-559-4873    cmarr@unmc.edu    Contact: Lucie Case, RN    402-559-7594    lacase@unmc.edu    Principal Investigator: James R O'Dell, MD Less <<
NCT02762838 Rheumatoid Arthritis Phase 3 Active, not recruiting May 2018 Russian Federation ... More >> State Budgetary Higher Vocational Education Institution I.M. Sechenov First Moscow State Medical University Moscow, Russian Federation North-Western State Medical University n.a. I.I.Mechnikov St.Petersburg, Russian Federation Less <<
NCT00707889 Advanced Colorectal Cancer ... More >> Adenocarcinoma of the Colon Adenocarcinoma of the Rectum Less << Phase 2 Completed - -
NCT00613717 Iron Deficiency Anemia ... More >> Iron Deficiency Less << Not Applicable Completed - China ... More >> Peking University First Hospital Beijing, China, 100034 Less <<
NCT02574663 Pancreatic Cancer ... More >> Colorectal Cancer Rectal Cancer Gastric Cancer Esophageal Cancer Gastrointestinal Stromal Tumor (GIST) Less << Phase 1 Active, not recruiting February 2019 United States, Tennessee ... More >> TG Therapeutics Trial Site Nashville, Tennessee, United States, 37203 Less <<
NCT00266487 Acute Myocardial Infarction Not Applicable Completed - Norway ... More >> Institute of Community Medicine, University of Tromsø Tromsø, Norway, N-9037 Less <<
NCT01239693 Infant Malnutrition ... More >> Malnutrition in Pregnancy Less << Phase 3 Completed - Malawi ... More >> University of Malawi, College of Medicine Mangochi, Malawi Less <<
NCT01198574 - Completed - -
NCT02392767 Endothelial Dysfunction ... More >> Hyperhomocysteinemia Hypertension Grade I, Subgroup "Borderline" (WHO) Less << Not Applicable Completed - Germany ... More >> BioTeSys Esslingen, Germany, 73728 Less <<
NCT02392767 - Completed - -
NCT01953536 Breast Neoplasms Phase 2 Withdrawn November 2016 -
NCT01913093 - Active, not recruiting May 2019 Canada, Ontario ... More >> The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT02546921 Human Cancers Phase 1 Recruiting December 2019 United Kingdom ... More >> Guy's and St Thomas's Hospital Recruiting London, United Kingdom, SE1 9RT Contact: Person       james.spicer@kcl.ac.uk    Principal Investigator: James Spicer, Dr          The Royal Marsden Hospital Not yet recruiting London, United Kingdom Contact: Person          Principal Investigator: Udai Banerfi, Dr Less <<
NCT01523457 Metastatic Pancreatic Cancer ... More >> Pancreatic Cancer Less << Phase 2 Completed - United States, Connecticut ... More >> Smilow Cancer Center New Haven, Connecticut, United States, 06510 Less <<
NCT02794922 Temporomandibular Joint Disord... More >>er Less << Phase 2 Completed - China ... More >> Prince Philip Dental Hospital Hong Kong, China Less <<
NCT01689714 Ovarian Carcinoma ... More >> Recurrent Endometrial Carcinoma Less << Phase 2 Completed - -
NCT00378456 Trisiomy 21 (Down Syndrome) Not Applicable Completed - United Kingdom ... More >> Institute of Child Health Birmingham, United Kingdom Peninsular Medical School Exeter, United Kingdom Institute of Child Health, London London, United Kingdom Less <<
NCT01523457 - Completed - -
NCT01111864 Bacterial Infections Not Applicable Completed - Kenya ... More >> Kikoneni Clinic Kikoneni, Kwale district, Kenya Less <<
NCT00852189 Cancer Phase 1 Completed - United States, Indiana ... More >> Horizon Oncology Center Lafayette, Indiana, United States, 47905 United States, Maryland Greenebaum Cancer Center - University of Maryland Baltimore, Maryland, United States, 21201 Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Barbara Ann Karmanos Cancer Institute - Wayne State University Detroit, Michigan, United States, 48201 Great Lakes Cancer Institute - Michigan State University Lansing, Michigan, United States, 48910 Providence Cancer Institute Southfield, Michigan, United States, 48075 Less <<
NCT03010579 Anemia Lympho... More >>ma Hematopoietic Stem Cell Transplantation Less << Phase 4 Recruiting December 2018 China, Beijing ... More >> Peking University Cancer Hospital & Institute Recruiting Beijing, Beijing, China, 100142 Contact: Wei Ping Liu       dreaming2217@126.com    Contact: Xiao Pei Wang       cadillac570@163.com Less <<
NCT02293902 - Completed - -
NCT01183780 Colorectal Cancer Phase 3 Completed - -
NCT02069704 Metastatic Colorectal Cancer Phase 1 Completed - Argentina ... More >> Hospital de Gastroenterologia "Dr. Carlos Bonorino Udaondo" Buenos Aires, Argentina Instituto Oncológico de Rosario Rosario, Argentina Brazil Fundaçáo Pio XII - Hospital do Cancer de Barretos Barretos, Brazil Hospital Caridade Ijui, Brazil Hospital Sao Lucas da Pucrs Porto Alegre, Brazil Centro de Pesquisa do Instituto Brasileiro de Controle do Câncer - IBCC São Paulo, Brazil Hosp. A.C Camargo São Paulo, Brazil Instituto do Cancer del estado de S. Paulo (ICEPS ) São Paulo, Brazil India M S Patel Cancer Centre- Shree Krishna Hospital Karamsad, Gujarat, India, 388 325 Sri Ramachandra Hospital Chennai, India Tata Hospital Mumbai, India Central India Canter Research Institute Nagpur, India Curie Manavta Cancer Center Nashik, India Regional Cancer Center & Medical College Thiruvananthapuram, India Spain Centro Oncológico Clara Campal Madrid, Spain Ukraine Dnipropetrovsk City Multiple-discipline Clinical Hospital №4 Dnipropetrovsk, Ukraine Kharkiv Regional Clinical Oncology Center Kharkiv, Ukraine Danylo Halytskiy Lviv National Medical University Lviv, Ukraine Less <<
NCT00680732 Malaria Malar... More >>ia in Pregnancy Less << Phase 4 Completed - Burkina Faso ... More >> Centre Muraz Bobo-Dioulasso, Burkina Faso, BP 390 Less <<
NCT00403247 Schizophrenia ... More >> Schizoaffective Disorder Less << Not Applicable Completed - United States, New York ... More >> The Nathan Kline Institute for Psychiatric Research Orangeburg, New York, United States, 10962 Less <<
NCT02772965 Pediatric Crohn's Disease Phase 3 Recruiting December 2020 -
NCT03113890 Major Depressive Disorder ... More >> PTSD Less << Not Applicable Recruiting August 1, 2020 United States, Massachusetts ... More >> McLean Hospital Recruiting Belmont, Massachusetts, United States, 02478 Contact: Kerry J Ressler, MD PhD    617-855-4210    kressler@partners.org    Contact: Ying Cao, MD    617-855-3172    ycao9@partners.org    Principal Investigator: Kerry J Ressler, MD PhD Less <<
NCT01708278 - Completed - -
NCT03061409 Nutrient Deficiency Not Applicable Recruiting July 2018 United States, Massachusetts ... More >> Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University Recruiting Boston, Massachusetts, United States, 02111 Contact: Kimberly Dupiton, BA    617-556-3012    Kimberly.Dupiton@tufts.edu Less <<
NCT00354978 Colorectal Cancer Phase 2 Completed - United States, Texas ... More >> Lyndon Baines Johnson General Hospital Houston, Texas, United States, 77030 UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01183780 - Completed - -
NCT00354978 - Completed - -
NCT01708278 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 1 Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT00671346 - Active, not recruiting January 2021 Norway ... More >> Department of Heart Disease, Haukeland University Hospital Bergen, Norway, 5021 University of Tromsø Tromsø, Norway, 9037 Less <<
NCT01937507 - Terminated(PI Decision) - -
NCT01937507 Metastatic Breast Cancer Phase 2 Terminated(PI Decision) - United States, Arizona ... More >> Western Regional Medical Center Inc Goodyear, Arizona, United States, 85338 Less <<
NCT02293902 Rheumatoid Arthritis Phase 3 Completed - -
NCT00822380 Anemia Not Applicable Completed - -
NCT02930343 Rheumatoid Arthritis Phase 4 Recruiting August 2018 India ... More >> Department of Clinical Immunology , Jawaharlal Institute of Post graduate Medical Educationa and Research Recruiting Pondicherry, India, 605006 Contact: Dr. Vir Singh Negi, DM    0413-2297358    vsnegi22@yahoo.co.in    Contact: Dr. Pooja Belani, MD    8940482248    drpoojabelani@gmail.com Less <<
NCT00642577 Colorectal Cancer Phase 3 Completed - China ... More >> Beijing, China, 100021 Beijing, China, 100036 Beijing, China, 100071 Chongqing, China, 400042 Guangdong, China, 510515 Guangzhou, China, 510060 Nanjing, China, 210002 Qingdao, China, 266003 Shanghai, China, 200003 Shanghai, China, 200080 Tianjin, China, 300060 Wuhan, China, 430030 Less <<
NCT01406106 Hypercholesterolemia Not Applicable Unknown December 2012 -
NCT01308255 Rheumatoid Arthritis Phase 4 Completed - United Kingdom ... More >> Chapel Allerton Hospital Leeds, West Yorkshire, United Kingdom, LS7 4SA Less <<
NCT03431974 Psoriasis Phase 2 Recruiting March 2021 United States, Washington ... More >> Premier Clinical Research Recruiting Spokane, Washington, United States, 99202 Contact: Kim Walter, CCRC    509-343-3710 ext 1135    KWalter@premierclinicalresearch.com    Contact: Kristyn R Aalto    509-343-3710 ext 1152    kaalto@premierclinicalresearch.com    Principal Investigator: Tiffany S Hanf, M.D.          Sub-Investigator: William P Werschler, M.D. Less <<
NCT01283646 Lack or Loss Appetite Nonorgan... More >>ic Origin Less << Phase 3 Completed - Brazil ... More >> Faculdade de Medicina do ABC Santo André, SP, Brazil Clínica A/Z São Paulo, SP, Brazil Clínica Dr. Felício Savioli São Paulo, SP, Brazil Less <<
NCT00172250 - Completed - -
NCT03494114 COPD Phase 1 Enrolling by invitation October 31, 2020 United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00257439 - Unknown - Denmark ... More >> Department of Nephrology, Aalborg Hospital Recruiting Aalborg, Denmark, DK-9000 Contact: Jakob Sølling, MD, PhD    +45 9932 1111 ext 2237    aas.u19116@nja.dk    Principal Investigator: Henrik Birn, MD, PhD Less <<
NCT00056225 Alzheimer's Disease Phase 3 Completed - -
NCT01533740 - Completed - Italy ... More >> 'Tor Vergata' University Hospital Rome, Lazio, Italy, 00133 Less <<
NCT01160419 Gastric Cancer Phase 2 Unknown May 2014 Germany ... More >> University of Munich, Klinikum Grosshadern Munich, Germany Less <<
NCT01878916 - Completed - Turkey ... More >> Istanbul University Cerrahpasa Medical Faculty Istanbul, Turkey Less <<
NCT01420679 Peripheral T-cell Lymphoma Phase 3 Terminated - -
NCT01087632 Metabolic Syndrome Not Applicable Completed - Italy ... More >> Federico II University - Department of Internal Medicine Naples, Italy Less <<
NCT03504423 Pancreatic Cancer Metastatic Phase 3 Recruiting March 2022 United States, North Carolina ... More >> Wake Forest Baptist Health Recruiting Winston-Salem, North Carolina, United States, 27157 Principal Investigator: Caio Max Rocha Lima, MD Less <<
NCT00923273 - Completed - -
NCT00923273 Carcinoma, Non-Small-Cell Lung Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02467504 Rheumatoid Arthritis Phase 2 Unknown June 2017 China, Beijing ... More >> Department of Rheumatology and Immunology, Peking University People's Hospital Recruiting Beijing, Beijing, China, 100044 Contact: Xiaoying Zhang, MD    +8613810001444    xiaoying19880307@163.com Less <<
NCT03206151 Metastatic Colorectal Cancer Phase 3 Recruiting April 28, 2021 China, Beijing ... More >> Cancer hospital Chinese academy of medical sciences Not yet recruiting Beijing, Beijing, China, 100021 Contact: yuankai shi, doctor    +8613701251865    syuankaipumc@126.com    China, Tianjin Tianjing medical university cancer institute and hospital Recruiting Tianjin, Tianjin, China, 300000 Contact: yi ba, doctor    +8613752157916    yiba999@163.com Less <<
NCT02393378 Rheumatoid Arthritis Phase 2 Completed - Czech Republic ... More >> Pardubice, Czech Republic Praha 3, Czech Republic Estonia Tallinn, Estonia Tartu, Estonia Russian Federation Moscow, Russian Federation Yaroslavl, Russian Federation Spain Santiago de Compostela, La Coruna, Spain Fuenlabrada, Madrid, Spain La Coruna, Spain Madrid, Spain United Kingdom London, Greater London, United Kingdom Salford, Greater Manchester, United Kingdom Oxford, Oxfordshire, United Kingdom Less <<
NCT00964080 Gastric Adenocarcinoma ... More >> Gastroesophageal Junction Adenocarcinoma Esophageal Adenocarcinoma Less << Phase 1 Phase 2 Unknown April 2015 United States, Texas ... More >> Mary Crowley Medical Research Center Dallas, Texas, United States, 76201 MD Anderson Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Georgia A.Gvamichava National Center of Cancer Tbilisi, Georgia, 0177 Medulla Chemotherapy and Immunotherapy Clinic Tbilisi, Georgia, 0186 Less <<
NCT03703063 Pancreatic Adenocarcinoma Phase 1 Recruiting September 17, 2021 United States, Washington ... More >> Virginia mason medical Center Recruiting Seattle, Washington, United States, 98101 Contact: Vincent J Picozzi, MD    206-223-6193    Vincent.Picozzi@virginiamason.org    Principal Investigator: Vincent Picozzi, MD Less <<
NCT03207724 Pancreatic Cancer ... More >> Cachexia Weight Loss Less << Phase 1 Recruiting June 2019 United States, California ... More >> Cedars-Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Bethi Luu    310-248-6512    Thanh-Toai.Luu@cshs.org    Principal Investigator: Andrew Hendifar, MD          Sub-Investigator: Stephen Shiao, MD          Sub-Investigator: Arvind Shinde, MD          Sub-Investigator: Richard Tuli, MD Less <<
NCT01646554 Colorectal Cancer Metastatic ... More >> Liver Metastases KRAS Mutated Colorectal Cancer Less << Phase 2 Phase 3 Withdrawn December 2016 -
NCT01795131 Nutritional Anemia in Mothers.... More >> Nutritional Anemia in Infants. Less << Phase 2 Phase 3 Completed - Bangladesh ... More >> Maternal and Child Health Training Institute Dhaka, Bangladesh, 1205 Less <<
NCT00759811 Heart Failure ... More >> Myocardial Ischemia Less << Phase 2 Phase 3 Completed - Brazil ... More >> Instituto de Cardiologia do Rio Grande do Sul / Fundação Universitária de Cardiologia Porto Alegre, Rio Grande do Sul, Brazil, 90620001 Less <<
NCT00145314 Metastatic Colorectal Cancer Phase 3 Completed - Norway ... More >> The Nordic Colorectal Cancer Biomodulation Group Oslo, Norway, NO-0407 Less <<
NCT01971112 Upper Respiratory Infections ... More >> Lower Respiratory Tract Infections Less << Not Applicable Unknown December 2014 Ecuador ... More >> Atucucho neighborhood Recruiting Quito, Pichincha, Ecuador Contact: Fernando E Sempertegui, MD    593 2 2557673    fersempert@biociencias-ceb.org    Principal Investigator: Fernando E Sempertegui, MD Less <<
NCT03413267 Food Structure Impact on Micro... More >>nutrient Bioavailability Less << Not Applicable Recruiting December 31, 2018 France ... More >> Centre de Recherche en Nutrition HUmaine d'Auvergne Recruiting Clermont-Ferrand, France, 63009 Contact: Ruddy Richard, Prof    +33 4 73 60 82 50    ruddy.richard@udamail.fr    Contact: Nathalie Meunier, PhD    +33 4 73 60 82 53    meunier@chu-clermontferrand.fr    Principal Investigator: Ruddy Richard, Prof          Sub-Investigator: Amandine Prulière          Sub-Investigator: Françoise Laporte Less <<
NCT02504671 Arthritis, Rheumatoid Phase 2 Completed - -
NCT01360996 Polycystic Ovary Syndrome Phase 4 Completed - United States, Louisiana ... More >> Woman's Hospital Baton Rouge, Louisiana, United States, 70815 Less <<
NCT01095211 Cognitive Function ... More >> Metabolic Improvements Less << Not Applicable Completed - Germany ... More >> Dr. Eckert- Sankt Ingbert, Saarland, Germany, 66386 Less <<
NCT02959125 Pregnancy Pro... More >>tein-Energy Malnutrition Anemia Less << Not Applicable Active, not recruiting December 20, 2017 Indonesia ... More >> Demak District Health Office Demak, Central Java, Indonesia, 50566 Public Health Center of Karangawen 2 Demak, Jawa Tengah, Indonesia Less <<
NCT00004734 Stroke Cerebr... More >>al Infarction Myocardial Infarction Less << Phase 3 Completed - United States, North Carolina ... More >> Wake Forest University School of Medicine Winston Salem, North Carolina, United States, 27157-1068 Less <<
NCT01926236 Biliary Tract Cancer ... More >> Gallbladder Cancer Cholangiocarcinoma Ampullary Cancer Less << Phase 3 Active, not recruiting February 2019 United Kingdom ... More >> Queen Elizabeth Hospital Birmingham, United Kingdom Bristol Haematology & Oncology Centre Bristol, United Kingdom North Cumbria University Hospitals Carlisle, United Kingdom Beatson West of Scotland Cancer Centre Glasgow, United Kingdom, G12 0YN Castle Hill Hospital Hull, United Kingdom St James' Hospital Leeds, United Kingdom Clatterbridge Cancer Centre Liverpool, United Kingdom Guy's and St Thomas' Hospital London, United Kingdom Hammersmith Hospital London, United Kingdom Royal Free Hospital London, United Kingdom University College London London, United Kingdom Maidstone Hospital Maidstone, United Kingdom The Christie NHS Foundation Trust Manchester, United Kingdom Nottingham City Hospital Nottingham, United Kingdom Churchill Hospital Oxford, United Kingdom Weston Park Hospital Sheffield, United Kingdom Southampton General Hospital Southampton, United Kingdom Less <<
NCT00759811 - Completed - -
NCT01360996 - Completed - -
NCT03193788 Bladder Cancer ... More >> Ureter Cancer Transitional Cell Carcinoma Less << Phase 3 Recruiting June 2020 Korea, Republic of ... More >> Hallym University Medical Center, Hallym University College of Medicine Recruiting Anyang, Korea, Republic of Contact: Ho Young Kim       ksfam@daum.net    Keimyeong University Dongsan Medical Center Recruiting Daegu, Korea, Republic of, 700-712 Contact: Jin Young Kim, MD       takgu@dsmc.or.kr    Fatima Hospital Recruiting Daegu, Korea, Republic of Contact: Jung Lim Lee       junglim3@gmail.com    Chungnam University Hospital Recruiting Daejeon, Korea, Republic of, 301-721 Contact: Hyo Jin Lee, MD, PhD.       cymed@cnu.ac.kr    National Health Insurance Service Ilsan Hospital Recruiting Goyang, Korea, Republic of Contact: Soo Jung Hong       suzzy901@nhimc.or.kr    Hallym University Dongtan Sacred Heart Hospital Recruiting Hwaseong-si, Korea, Republic of Contact: Hyun Ae Jung       hyunaejung@hallym.or.kr    Gil Medical Center Recruiting Incheon, Korea, Republic of, 21565 Contact: Inkeun Park, MD       ingni79@hanmail.net    Dong-A University Medical Center Recruiting Pusan, Korea, Republic of Contact: Suee Lee          Inje University Haeundae Paik Hospital Recruiting Pusan, Korea, Republic of Contact: Il-Hwan Kim       onelement@daum.net    Pusan National University Hospital, Pusan National University School of Medicine Recruiting Pusan, Korea, Republic of Contact: Hyo Jung Kim       leonkim80@naver.com    Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Jae-Lyun Lee, MD, PhD    82 2 3010 5977    jaelyun@amc.seoul.kr    Chung Ang University Hospital Recruiting Seoul, Korea, Republic of, 156-755 Contact: Hee Joon Kim, MD       heejun.dino11@gmail.com    Inje University Sanggye Paik Hospital Recruiting Seoul, Korea, Republic of Contact: Byeong Seok Sohn       imbs@paik.ac.kr    Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine Recruiting Seoul, Korea, Republic of Contact: Yun-Gyoo Lee       gosciny@gmail.com    Korea University Anam Hospital Recruiting Seoul, Korea, Republic of Contact: Yoon Ji Choi       yoonji23@hanmail.net    Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine Recruiting Seoul, Korea, Republic of Contact: Bhum Suk Keam          Contact       bhumsuk@snu.ac.kr    Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea Recruiting Seoul, Korea, Republic of Contact: In-Ho Kim       ihkmd@naver.com    Yonsei Cancer Center Recruiting Seoul, Korea, Republic of Contact: Sang Joon Shin       ssj338@yuhs.ac    St. Vincent's Hospital, The Catholic University of Korea Recruiting Suwon, Korea, Republic of Contact: Byoung Yong Shim       shimby@catholic.ac.kr    Uijeongbu St Mary's hospital, Catholic university of Korea Recruiting Uijeongbu, Korea, Republic of Contact: Yoon Ho Ko       koyoonho@catholic.ac.kr    Pusan National University Yangsan Hospital Recruiting Yangsan, Korea, Republic of Contact: Kwonoh Park       parkkoh@hanmail.net Less <<
NCT02120599 Pregnancy Mod... More >>erate Malnutrition Less << Not Applicable Completed - Malawi ... More >> Blantyre District Blantyre, Malawi Chikwawa District Chikwawa, Malawi Less <<
NCT00985062 Subfertility Not Applicable Completed - Netherlands ... More >> Erasmus Medical Center Rotterdam, Zuid-Holland, Netherlands, 3015GD Less <<
NCT01577654 Non Small Cell Lung Cancer Phase 2 Completed - -
NCT01984099 Hydatidiform Mole Phase 3 Completed - Philippines ... More >> Philippine General Hospital, University of the Philippines Manila Taft Avenue, Ermita, Manila, Manila, Philippines, 1000 Less <<
NCT02674022 Pregnancy Aut... More >>istic Disorder Folic Acid Deficiency Less << Not Applicable Unknown - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 Less <<
NCT01228734 Metastatic Colorectal Cancer Phase 3 Completed - China, Fujian ... More >> Fujian Province Cancer Hospital Fuzhou, Fujian, China, 350014 Fuzhou General Hospital Fuzhou, Fujian, China, 350025 China, Guangdong First Hospital Affiliated to Guangzhou University of Chinese Medicine Guangzhou, Guangdong, China, 510405 Nanfang Hospital Guangzhou, Guangdong, China, 510515 China, Heilongjiang The Tumor Hospital of Harbin Medical University Harbin, Heilongjiang, China, 150040 China, Hubei Union Hospital of Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China, 430023 China, Jilin Jilin Cancer Hospital Changchun, Jilin, China, 130012 First Affiliated Hospital of Jilin University Changchun, Jilin, China, 130021 China, Shandong The Affiliated Hospital of Medical College Qingdao University Qingdao, Shandong, China, 266003 China, Zhejiang The First Affiliated Hospital of College of Medicine, Zhejiang University Hangzhou, Zhejiang, China, 310009 Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China, 310016 China 307 Hospital of PLA Beijing, China, 100071 The General Hospital of the People's Liberation Army Beijing, China, 100853 Affiliated Hospital of Bengbu Medical College Bengbu, China, 233004 The Xiangya 2nd Hospital of Central South University Changsha, Hunan, China, 410011 Southwest Hospital Chongqing, China, 400038 Yunnan Provincial Tumor Hospital KunMing, Yunnan, China, 650118 The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China, 330006 Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, China, 200025 Fudan University Shanghai Cancer Center Shanghai, China, 200032 Shanghai First People's Hospital Shanghai, China, 200080 Fudan University Zhongshan Hospital Shanghai, China The First Affiliated Hospital of Soochow University Shuzhou, Jiangsu, China, 215006 Tianjin People's Hospital Tianjin, China, 30000 Xijing Hospital the 4th Military Medical University of PLA Xi'an, China, 710032 Less <<
NCT00216099 Prostate Cancer Phase 2 Completed - United States, Illinois ... More >> Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Elkhart Clinic Elkhart, Indiana, United States, 46515 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Quality Cancer Center (MCGOP) Indianapolis, Indiana, United States, 46202 Community Regional Cancer Center Indianapolis, Indiana, United States, 46256 Arnett Cancer Care Lafayette, Indiana, United States, 47904 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 AP&S Clinic Terre Haute, Indiana, United States, 47804 United States, Michigan Center for Hematology/Oncology of S. Michigan Jackson, Michigan, United States, 49201 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, New Jersey Hematology Oncology Associates S.J., P.A. Mt. Holly, New Jersey, United States, 08060 United States, Pennsylvania Consultants in Medical Oncology & Hematology Drexel Hill, Pennsylvania, United States, 19026 Pennsylvania Oncology-Hematology Associates Philadelphia, Pennsylvania, United States, 19106 Less <<
NCT01228734 - Completed - -
NCT00216099 - Completed - -
NCT00168688 Pregnancy Bir... More >>th Weight Less << Phase 1 Completed - Guinea-Bissau ... More >> Bandim Health Project Bissau, Guinea-Bissau, Apartado 861 Less <<
NCT00730509 Cystic Fibrosis Not Applicable Completed - Italy ... More >> Verona University Verona, Italy, 37134 Less <<
NCT02737644 - Recruiting December 31, 2018 China, Shanghai ... More >> Children Hospital of Fudan University Recruiting Shanghai, Shanghai, China, 201102 Contact: Guoying Huang    (21)64931928    gyhuang@shmu.edu.cn Less <<
NCT01590719 Gastric Cancer Phase 2 Completed - -
NCT02355119 Pancreatic Cancer Phase 3 Unknown December 2018 Italy ... More >> Azienda Ospedaliero-Universitaria Pisana Recruiting Pisa, PI, Italy, 56126 Contact: Enrico Vasile, MD, PhD    +39 050 992466    envasile@tin.it    Principal Investigator: Enrico Vasile, MD, PhD Less <<
NCT02795299 Rheumatoid Arthritis Phase 2 Withdrawn(Study not started du... More >>e to Sponsor decision to not move forward with compound.) Less << September 2019 -
NCT00433927 Neoplasm Metastasis ... More >> Colorectal Cancer Less << Phase 3 Unknown December 2016 Germany ... More >> University of Munich - Klinikum Grosshadern Munich, Germany, 81377 Less <<
NCT01193192 - Terminated(Inadequate number o... More >>f charts available for Test Group) Less << - United States, Oklahoma ... More >> Five Oaks Medical Group Chickasha, Oklahoma, United States, 73018 Norman Regional Health System Norman, Oklahoma, United States, 73071 Norman Regional Health System Norman, Oklahoma, United States, 73072 Less <<
NCT02769533 Patients With Suspected Malign... More >>ancies of the Pituitary Gland Less << Phase 1 Recruiting - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Sunil Singhal, MD    855-216-0098    PennCancerTrials@emergingmed.com    Principal Investigator: Sunil Singhal, MD Less <<
NCT01293162 - Completed - Italy ... More >> Ambulatorio Ipertensione e Unità Coronarica Federico II University Napoli, Italy, 80131 Less <<
NCT02027285 Aging Not Applicable Completed - Italy ... More >> University of Bologna-Department of Speciality, Diagnostic and Experimental Medicine Bologna, Italy, 40126 Less <<
NCT00037466 - Completed - -
NCT00861094 Esophageal Cancer Phase 2 Phase 3 Completed - France ... More >> CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 Hopital Saint Andre Bordeaux, France, 33075 Institut Bergonie Bordeaux, France, 33076 Hopital Ambroise Pare Boulogne-Billancourt, France, F-92104 Polyclinique Du Parc Caen, France, 14052 Centre Regional Francois Baclesse Caen, France, 14076 Hopital Du Bocage Dijon, France, 21034 Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Oscar Lambret Lille, France, 59020 Centre Hospital Regional Universitaire de Limoges Limoges, France, 87042 Centre Leon Berard Lyon, France, 69373 CHU de la Timone Marseille, France, 13385 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Antoine Lacassagne Nice, France, 06189 Hopital Europeen Georges Pompidou Paris, France, 75015 Hopital Saint-Louis Paris, France, 75475 Hopital Tenon Paris, France, 75970 CHU Poitiers Poitiers, France, 86021 Institut Jean Godinot Reims, France, 51056 CHU - Robert Debre Reims, France, 51092 Centre Eugene Marquis Rennes, France, 35042 Hopital Charles Nicolle Rouen, France, 76031 Clinique Armoricaine De Radiologie Saint Brieuc, France, F-22015 Centre Paul Strauss Strasbourg, France, 67065 Institut Claudius Regaud Toulouse, France, 31052 Clinique Du Parc Toulouse, France, 31078 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT02947750 Renal Insufficiency, Chronic Phase 2 Recruiting November 2021 United States, Georgia ... More >> Emory University Hospital Midtown Recruiting Atlanta, Georgia, United States, 30308 Contact: Dana DaCosta    404-727-7762    drdacos@emory.edu    Principal Investigator: Jeanie Park, MD          Emory University Hospital Recruiting Atlanta, Georgia, United States, 30322 Contact: Dana DaCosta    404-727-7762    drdacos@emory.edu    Principal Investigator: Jeanie Park, MD          Atlanta VA Health Care System Recruiting Decatur, Georgia, United States, 30033 Contact: Dana DaCosta    404-727-7762    drdacos@emory.edu    Contact: Melanie Kankam    404-321-6111 ext 7040    mljeffe@emory.edu    Principal Investigator: Jeanie Park, MD Less <<
NCT00341120 - Completed - Sweden ... More >> Malmo University Hospital Malmo, Sweden Less <<
NCT03726450 Male Infertility Not Applicable Not yet recruiting August 1, 2019 -
NCT02520206 - Unknown August 2015 -
NCT01532011 Advanced Cancers ... More >> Solid Tumors Less << Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01217086 Rheumatoid Arthritis Phase 3 Completed - Korea, Republic of ... More >> Hanyang University Medical Center Seoul, Korea, Republic of Less <<
NCT00097669 Stroke Transi... More >>ent Ischemic Attack Less << Not Applicable Completed - -
NCT01443065 Malignant Neoplasm of Esophagu... More >>s Malignant Neoplasm of Stomach Less << Phase 2 Active, not recruiting January 2019 France ... More >> Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT00778830 Metastatic Colorectal Cancer Phase 1 Phase 2 Completed - Singapore ... More >> Research Site Singapore, Singapore Less <<
NCT03099265 Pancreatic Cancer Phase 2 Recruiting August 2022 United States, Connecticut ... More >> Smilow Cancer Hospital Recruiting New Haven, Connecticut, United States, 06510 Less <<
NCT01358552 - Terminated(Insufficient number... More >> of participants) Less << - United States, Texas ... More >> Noe Lira, M.D. Corpus Christi, Texas, United States, 78411 Less <<
NCT00778830 - Completed - -
NCT00730093 Pregnancy Not Applicable Completed - Denmark ... More >> Aarhus Universitetshospital, Skejby Skejby, Jylland, Denmark, 8200 Less <<
NCT01204307 Advanced Non-Squamous Non-Smal... More >>l Cell Lung Cancer Less << Phase 2 Completed - Taiwan ... More >> Chang Gung Memorial Hospital, Kaohsiung Branch Kaohsiung, Taiwan Chang Gung Memorial Hospital Taipei, Taiwan, 10507 McKay Memorial Hospital Taipei, Taiwan Shin Kong Wu Ho-Su Memorial Hospital Taipei, Taiwan Less <<
NCT00551213 Colorectal Cancer Phase 2 Completed - -
NCT01715363 Patients With Colorectal Cance... More >>r With Unresectable Synchronous Metastasis in Whom Resection of the Primitive Tumour is Indicated Less << Phase 2 Terminated(Recruitment difficu... More >>lties) Less << - France ... More >> Institut Gustave Roussy Villejuif, Val de Marne, France, 94805 Less <<
NCT00551213 - Completed - -
NCT01726959 - Unknown - United States, North Carolina ... More >> Carolinas Medical Center - NorthEast Recruiting Concord, North Carolina, United States, 28025 Contact: Sheri Brosnahan, RN, OCN, CCRC    704-403-4165    sheri.brosnahan@carolinashealthcare.org    Principal Investigator: Gordon K Lam, MD Less <<
NCT02363374 Rectal Neoplasms ... More >> Rectal Cancer Stage II Rectal Cancer Stage III Less << Phase 2 Active, not recruiting June 2023 Germany ... More >> University Clinic Erlangen, Bavaria, Germany RWTH Aachen Aachen, Germany University Clinic Bochum, Germany Clinic for Radiotherapy Chemnitz, Germany Diacura Clinic for Radiotherapy Coburg, Germany Internist Practice Dresden, Germany University Clinic Dresden, Germany University Clinic Esslingen, Germany University Hospital Frankfurt Goethe University Frankfurt, Germany, 60590 University Clinic Freiburg, Germany University Clinic Göttingen, Germany University Clinic Heidelberg, Germany HELIOS Park-Klinikum Leipzig Leipzig, Germany University Clinic Leipzig, Germany University Clinic Mannheim, Germany Hospital Miria Hilf Moenchengladbach, Germany Pius Hospital Oldenburg Oldenburg, Germany University Clinic Oldenburg, Germany Hospital Barmherziger Brueder Regensburg, Germany University Clinic Regensburg, Germany University Clinic Rostock, Germany University Clinic Wuerzburg, Germany Less <<
NCT01506167 - Completed - United Kingdom ... More >> Royal United Hospital Bath; Diabetes and Lipid Research, Wolfson Centre Bath, United Kingdom, BA1 3NG Wexham Park Hospital; Oncology Berkshire, United Kingdom, SL2 4HL Queen Elizabeth Hospital Birmingham, United Kingdom, B15 2TH Birmingham Heartlands Hospital; Dept of Oncology Birmingham, United Kingdom, B9 5SS Bishop Auckland Hospital;Oncology Department Bishop Auckland, United Kingdom, DL14 6AD University Hospital of North Staffordhire Blackpool, United Kingdom, FY3 8NR Bradford Royal Infirmary; Dept of Medical Oncology C/O Ward15 Bradford, United Kingdom, BD9 6RJ Bristol Haematology and Oncology Centre Bristol, United Kingdom, BS2 8ED West Suffolk Hospital Nhs Trust; Gi Corridor Bury St Edmunds, United Kingdom, IP33 2QZ Kent & Canterbury Hospital Canterbury, United Kingdom, CT1 3NG Cumberland Infirmary; Oncology Department Carlisle, United Kingdom, CA2 7HY Broomfield Hospital; Oncology Chelsmford, United Kingdom, CM1 7ET University Hospital North Tees Cleveland, United Kingdom, TS19 8PE Castle Hill Hospital; Academic Oncology Cottingham, United Kingdom, HU16 5JQ Darlington Memorial Hospital Darlington, United Kingdom, DL3 6HX Russells Hall Hospital; Dept of Hematology Dudley, United Kingdom, DY1 2HQ University Hospital of North Durham; Oncology Durham, United Kingdom, DH15TW Harrogate Hospital Harrogate, United Kingdom, HG2 8AY Northhwick Park Hospital;Oncology Department Harrow, United Kingdom, HA1 3UJ Ipswich Hospital; Oncology Pharmacy Ipswich, United Kingdom, IP4 5PD Kidderminster Hospital; Oncology Dept Kidderminster, United Kingdom, DY11 6RJ Royal Free Hospital; Dept of Oncology London, United Kingdom, NW3 2QG Guys Hosp./Med. Onc./3rd Fl. T; Clinical Trial Office London, United Kingdom, SE1 9RT Queen Elizabeth Hospital London, United Kingdom, SE18 4QH Macclesfield District General Hospital Macclesfield, United Kingdom, SK10 3BL Maidstone & Tonbridge Wells Hospital; Kent Oncology Center Maidstone, United Kingdom, ME16 9QQ The James Cook University Hospital Middlesborough, United Kingdom, TS4 3BW Freeman Hospital Newcastle upon Tyne, United Kingdom, NE7 7DN North Tyneside General Hospital North Shields, United Kingdom, NE29 8NH Mount Vernon Cancer Centre Northwood, United Kingdom, HA6 2RN Nottingham University Hospitals City Campus Nottingham, United Kingdom, NG5 1PB Peterborough City Hospital, Edith Cavell Campus; Oncology Department Peterborough, United Kingdom, PE3 9GZ Derriford Hospital; Gastroenterology Plymouth, United Kingdom, PL6 8DH Queen's Hospital Romford, United Kingdom, RM7 0AG Scunthorpe General Hospital; Dept of Oncology Scunthorpe, United Kingdom, DN16 7BH Stafford Hospital; Oncology Department Stafford, United Kingdom, ST16 3SA The Royal Marsden Hospital Sutton, United Kingdom, SM2 5PT Great Western Hospital, Swindon Cancer Research Unit; Osprey Unit Level 3 Swindon, United Kingdom, SN3 6BB Torbay Hospital; Oncology Torquay, United Kingdom, TQ2 7AA Royal Cornwall Hospital; Dept of Clinical Oncology Truro, United Kingdom, TR1 3LJ Walsall Manor Hospital Walsall, United Kingdom, WS2 9PS Royal Hampshire County Hospital; Winchester & Andover Breast Unit Winchester, United Kingdom, SO22 5DG The Royal Wolverhampton Hospitals NHS Trust Wolverhampton, United Kingdom, WV10 0QP Less <<
NCT00300404 Schizophrenia ... More >> Major Depression Less << Phase 3 Completed - -
NCT00003558 Carcinoma of Unknown Primary Phase 3 Unknown - Netherlands ... More >> Academisch Ziekenhuis Maastricht Maastricht, Netherlands, 6202 AZ St. Elisabeth Ziekenhuis Tilburg, Netherlands, 5022 GC Less <<
NCT00500292 Colorectal Ca... More >>ncer Less << Phase 2 Completed - France ... More >> Research Site Lille Cedex, France Research Site Toulouse Cedex 9, France Hungary Research Site Budapest, Hungary Research Site Debrecen, Hungary Research Site Szeged, Hungary Korea, Republic of Research Site Seoul, Korea, Republic of Slovakia Research Site Bratislava, Slovakia Research Site Poprad, Slovakia Research Site Trnava, Slovakia Research Site Zilina, Slovakia Spain Research Site Hospitalet deLlobregat, Spain Research Site Oviedo, Spain Research Site Santander, Spain Taiwan Research Site Taipei, Taiwan Research Site Tao-Yuan, Taiwan Less <<
NCT00500292 - Completed - -
NCT01091506 Schizophrenia Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital (MGH) Schizophrenia Program at Freedom Trail Clinic Boston, Massachusetts, United States Less <<
NCT02226380 Gastric Cancer ... More >> Effects of Chemotherapy Surgery Less << Phase 2 Unknown - China, Beijing ... More >> Department of Oncology and Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China, 100032 Contact: Xiang Wang, Master    +86(10)69158315    wangxiang5123@126.com    Principal Investigator: Xiao yi Li, Doctor          Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100032 Contact: Xiao yi Li, Mater    +86(10)69154910    li.xiaoyi@263.net Less <<
NCT00651040 Polymyositis ... More >>Dermatomyositis Less << Phase 3 Completed - Czech Republic ... More >> Revmatologicky ustav Prague, Czech Republic, 12850 Less <<
NCT00651040 - Completed - -
NCT02701517 Unrecognized Condition: Mature... More >> B or T-cell Neoplasm Less << Phase 2 Terminated(The trial was stopp... More >>ed before the targeted number of patients was reached due to lack of support.) Less << - Poland ... More >> Department of Propedeutic Oncology, Medical University of Gdansk Gdansk, Poland Spain Clinical Hematology Department. ICO-Hospital Germans Trias i Pujol. Jose Carreras Research Institute Badalona, Barcelona, Spain Hospital Clinic I Provincial Barcelona, Spain Santa Creu I Sant Pau Hospital Barcelona, Spain Hospital Universitario de Salamanca Salamanca, Spain Less <<
NCT03028467 Arthritis, Rheumatoid Phase 2 Completed - Japan ... More >> GSK Investigational Site Aichi, Japan, 440-8510 GSK Investigational Site Aichi, Japan, 455-8530 GSK Investigational Site Aichi, Japan, 457-8511 GSK Investigational Site Chiba, Japan, 260-8712 GSK Investigational Site Chiba, Japan, 270-2296 GSK Investigational Site Fukuoka, Japan, 810-8563 GSK Investigational Site Fukuoka, Japan, 814-0180 GSK Investigational Site Hyogo, Japan, 665-0827 GSK Investigational Site Hyogo, Japan, 673-1462 GSK Investigational Site Ibaraki, Japan, 312-0057 GSK Investigational Site Kanagawa, Japan, 222-0036 GSK Investigational Site Kanagawa, Japan, 240-8521 GSK Investigational Site Kanagawa, Japan, 245-8575 GSK Investigational Site Nagasaki, Japan, 857-1195 GSK Investigational Site Osaka, Japan, 543-8555 GSK Investigational Site Osaka, Japan, 586-8521 GSK Investigational Site Wakayama, Japan, 649-2211 Less <<
NCT02548169 Pancreatic Cancer Phase 1 Unknown April 2018 United States, Texas ... More >> Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States, 75246 Contact: Grace Townsend    214-818-8382    grace.townsend@baylorhealth.edu    Contact: Gaby Ethington    214-818-8326    gabriele@BaylorHealth.edu    Principal Investigator: Carlos Becerra          Sub-Investigator: Scott Celinski Less <<
NCT00630149 Nasopharyngeal Neoplasms Phase 2 Completed - China, Guangdong ... More >> Cancer Center of Sun-Yat Sen University (CCSYSU) GuangZhou, Guangdong, China, 510000 Less <<
NCT02885753 Colorectal Neoplasms Phase 3 Recruiting June 2023 France ... More >> CHU Not yet recruiting Angers, France Contact: Antoine BOUVIER          Institut de cancérologie de l'Ouest Not yet recruiting Angers, France Contact: Véronique GUERIN-MEYER          Institut Sainte Catherine Not yet recruiting Avignon, France Contact: Laurent MINEUR          Polyclinique Bordeaux Nord Not yet recruiting Bordeaux, France Contact: Cedric LECAILLE          Centre Hospitalier Sud Francilien Not yet recruiting Corbeil-essonnes, France Contact: Samy LOUAFI          Chu Le Bocage Not yet recruiting Dijon, France Contact: Sylvain MANFREDI          CHU Not yet recruiting Grenoble, France Contact: Victoire GRANGER          Chd Vendee Not yet recruiting La Roche Sur Yon, France Contact: Roger FAROUX          Not yet recruiting Longjumeau, France Contact: Samy LOUAFI          Hôpital du Scorff Not yet recruiting Lorient, France Contact: Joëlle EGRETEAU          Hopital Europeen Not yet recruiting Marseille, France Contact: Yves RINALDI          Hopital Saint Joseph Not yet recruiting Marseille, France Contact: Hervé PERRIER          Centre d'Imagerie médicale du Confluent- IRIS GRIM Not yet recruiting Nantes, France Contact: Jean-Marie PASQUIER          CHU Not yet recruiting Nantes, France Contact: Yann TOUCHEFEU          Hôpial Privé du Confluent Le Confluent Centre Catherine de Sienne Not yet recruiting Nantes, France Contact: Hélène CASTANIE          CHR Not yet recruiting Orleans, France Contact: Jean-Paul LAGASSE          Ch de Bicetre Not yet recruiting Paris, France Contact: Anne THIROT BIDAULT          Gh La Pitie Salpetriere Not yet recruiting Paris, France Contact: Olivier DUBREUIL          HEGP Recruiting Paris, France Contact: Simon PERNOT          Hopital St Joseph Not yet recruiting Paris, France Contact: Nabil BABA HAMED          Hôpital Cochin Not yet recruiting Paris, France Contact: Romain CORIAT          Hôpital Europeen G Pompidou Not yet recruiting Paris, France Contact: Julien TAIEB          Saint Louis Not yet recruiting Paris, France Contact: Thomas APARICIO          CH Not yet recruiting Perpignan, France Contact: Faiza KHEMISSA          CHU Not yet recruiting Pessac, France Contact: Denis SMITH          CHU Not yet recruiting Poitiers, France Contact: David TOUGERON          Centre Eugène Marquis Not yet recruiting Rennes, France Contact: Samuel LE SOURD          CHU Not yet recruiting Rouen, France Contact: Alice GANGLOFF          Saint Gregoire - Chp Not yet recruiting Saint Gregoire, France Contact: Laurent MIGLIANICO          Saint- Etienne Chu Not yet recruiting Saint- Etienne, France Contact: Jean Marc PHELIP          Chu Rangueil Not yet recruiting Toulouse, France Contact: Rosine GUIMBAUD          GR Not yet recruiting Villejuif, France Contact: Michel DUCREUX          Hôpital Paul BROUSSE Not yet recruiting Villejuif, France Contact: Mohamed BOUCHAHDA Less <<
NCT00540241 - Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bad Homburg, Germany, 61352 Less <<
NCT02768181 Stunting in Under-2 Children Not Applicable Enrolling by invitation November 2018 Bangladesh ... More >> ICDDR,B Dhaka, Bangladesh, 1212 Less <<
NCT00153998 Colorectal Cancer ... More >> Liver Metastases Less << Phase 2 Completed - Austria ... More >> Medizinische Universitaet Wien, Universitaetsklinik für Chirurgie Wien, Austria, A-1090 Germany Kreiskrankenhaus Aschersleben Aschersleben, Germany, 06449 Charite-Campus Benjamin Franklin, Innere Medizin Berlin, Germany, 12200 Charite-Campus, Virchow-Klinikum, Innere Medizin Berlin, Germany, 13353 Allgemeines Krankenhaus Celle Celle, Germany, 29223 University Hospital "Carl Gustav Carus" Dresden, Germany, 01307 Florence-Nightingale-Krankenhaus Duesseldorf, Germany, 40489 Universitaet Erlangen-Nuernberg, Chirurgie Erlangen, Germany, 91054 Westdeutsches Tumorzentrum, Universitaetsklinikum Essen Essen, Germany, 45112 Johann Wolfgang Goethe Universitaet, Chirurgie Frankfurt Main, Germany, 60596 Westpfalz-Klinikum GmbH Innere Medizin I Kaiserslautern, Germany, 67653 UKSH Campus Kiel, II. Medizinische Klinik Kiel, Germany, 24116 Staedtisches Klinikum Magdeburg-Olvenstedt Magdeburg, Germany, 39130 Universitaetsklinik Mannheim gGmbH, III. Medizinische Klinik Mannheim, Germany, 68167 Klinikum Grosshadern, III. Medizinische Klinik Muenchen, Germany, 81377 Klinikum Oldenburg GmbH Oldenburg, Germany, 26133 Klinikum Passau, II. Medizinische Klinik Passau, Germany, 94032 Klinikum der Hansestadt Stralsund GmbH, Medizinische Klinik Stralsund, Germany, 18435 Krankenhaus der Barmherzigen Brueder Trier, Chirurgie Trier, Germany, 54292 Universitaetsklinikum Tuebingen Tuebingen, Germany, 72076 Universitaetsklinikum Wuerzburg, Chirurgie Wuerzburg, Germany, 97080 Less <<
NCT00002722 Gastric Cancer Phase 2 Completed - -
NCT01681472 - Completed - -
NCT00019136 Ovarian Cancer Phase 1 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 Less <<
NCT00003287 Colorectal Cancer Phase 3 Completed - -
NCT01681472 Colonic Neoplasms Phase 1 Phase 2 Completed - Sweden ... More >> Sahlgrenska University Hospital Gothenburg, Sweden, 461 85 Less <<
NCT03031236 Maltreatment Not Applicable Completed - Bangladesh ... More >> Fahmida Tofail, PhD Dhaka, Bangladesh Less <<
NCT00091312 Colorectal Cancer Phase 3 Unknown - Egypt ... More >> National Cancer Institute - Cairo Cairo, Egypt France Centre Hospitalier Universitaire Ambroise Pare - Boulogne Boulogne Billancourt, France, F-92104 Hopital Du Bocage Dijon, France, 21034 Germany Medizinische Klinik I Dresden, Germany, D-01307 Italy Ospedali Riuniti di Bergamo Bergamo, Italy, 24100 Azienda Ospedaliero Careggi Florence, Italy, 50139 Universita Degli Studi di Florence - Policlinico di Careggi Florence, Italy, 50139 Portugal Instituto Portugues de Oncologia Centro do Porto, S. A. Porto, Portugal, 4200-072 Spain Hospital Universitario de Elche Elche Alicante, Spain, E-03203 Less <<
NCT00197704 Tuberculosis Phase 3 Completed - United States, Massachusetts ... More >> Harvard School of Public Health Boston, Massachusetts, United States, 02115 Less <<
NCT01442649 Colorectal Cancer Phase 2 Active, not recruiting December 2018 France ... More >> Centre rené Gauducheau Saint-herblain, France, 44805 Less <<
NCT00809796 Colorectal Cancer Phase 1 Phase 2 Completed - Canada, Quebec ... More >> Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 Less <<
NCT01173315 Type 2 Diabetes Phase 2 Completed - -
NCT00004150 Colorectal Cancer Phase 3 Completed - -
NCT00467142 Colorectal Cancer Phase 2 Completed - France ... More >> Institut Bergonie Bordeaux, France, 33076 Less <<
NCT03556956 Colorectal Cancer Metastatic Phase 2 Phase 3 Active, not recruiting December 31, 2020 Russian Federation ... More >> Omsk Clinical oncology dispensary Omsk, Russian Federation, 644013 Less <<
NCT00479479 Vitamin B 12 Deficiency Not Applicable Completed - Norway ... More >> Laboratory of Clinical Biochemistry and Department of Pediatrics; Haukeland University Hospital Bergen, Norway, 5018 Less <<
NCT03287882 Adolescents A... More >>nemia Pregnancy Empowerment Less << Phase 3 Recruiting April 30, 2021 Pakistan ... More >> Matiari Research and Training Centre Recruiting Matiari, Sindh, Pakistan Contact: Zulfiqar A Bhutta, PhD, MBBS    011922134930051 ext 1054 Less <<
NCT00064181 Colorectal Cancer Phase 3 Completed - Belgium ... More >> Ziekenhuis Network Antwerpen Middelheim Antwerp, Belgium, 2020 Institut Jules Bordet Brussels, Belgium, 1000 Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels, Belgium, 1090 Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 Cazk Groeninghe - Campus St-Niklaas Kortrijk, Belgium, B-8500 St. Elizabeth Ziekenhuis Turnhout, Belgium, 2300 Egypt National Cancer Institute - Cairo Cairo, Egypt Germany Charite - Campus Charite Mitte Berlin, Germany, D-10117 General Hospital Celle, Germany, 29223 Universitatsklinikum Carl Gustav Carl Carus Dresden, Germany, D-01307 Kliniken Essen - Mitte Essen, Germany, D-45136 Klinikum der J.W. Goethe Universitaet Frankfurt, Germany, D-60590 Klinikum der Albert - Ludwigs - Universitaet Freiburg Freiburg, Germany, D-79106 Allgemeines Krankenhaus Hagen Hagen, Germany, D-58095 Allgemeines Krankenhaus Altona Hamburg, Germany, 22763 Universitaets-Krankenhaus Eppendorf Hamburg, Germany, D-20246 St. Marien Hospital Hamm, Germany, 59065 Westpfalz-Klinikum GmbH Kaiserslautern, Germany, D-67653 Vinzentiuskrankenhaus Landau, Germany, D-76829 Onkologische Schwerpunktpraxis Leer Leer, Germany, D-26789 Universitaetsklinkum Magdeburg der Otto-von-Guericke-Universitaet Magdeburg Magdeburg, Germany, D-39120 Kreiskrankenhaus Meissen Meissen, Germany, D-01662 Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 Eberhard Karls Universitaet Tuebingen, Germany, D-72076 Universitaets-Hautklinik Wuerzburg Wuerzburg, Germany, D-97080 Hungary National Institute of Oncology Budapest, Hungary, 1122 Israel Rambam Medical Center Haifa, Israel, 31096 Wolfson Medical Center Holon, Israel, 58100 Less <<
NCT00004885 Colorectal Cancer Phase 3 Completed - -
NCT01775501 Hepatocellular Cancer Phase 2 Active, not recruiting December 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02125 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Less <<
NCT00075595 Colorectal Cancer Phase 2 Unknown - France ... More >> Hopital Drevon Dijon, France, 21000 Centre Hospital Universitaire Hop Huriez Lille, France, 59037 Clinique Saint Jean Lyon, France, 69008 Hopital Saint Joseph Marseille, France, 13008 Intercommunal Hospital Montfermeil, France, 93370 American Hospital of Paris Neuilly Sur Seine, France, F-92202 Hopital Europeen Georges Pompidou Paris, France, 75015 Hopital Bichat - Claude Bernard Paris, France, 75018 Hopital Saint Antoine Paris, France, 75571 Hopital Tenon Paris, France, 75970 Clinique Ste - Marie Pontoise, France, 95300 Polyclinique De Courlancy Reims, France, F-51100 Clinique Armoricaine De Radiologie Saint Brieuc, France, F-22015 Clinique de l'Orangerie Strasbourg, France, 67010 Centre Medico-Chirurgical Foch Suresnes, France, 92151 Less <<
NCT00402883 Lung Cancer Phase 2 Terminated(Terminated due to b... More >>evacizumab and chemoradiotherapy toxicity) Less << - United States, Florida ... More >> Gainsville Hematology Oncology Associates Gainesville, Florida, United States, 32605 Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States, 33805 United States, Georgia Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Tennessee Associates in Hematology Oncology Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00263354 Stomach Neoplasms Phase 2 Completed - -
NCT00402883 - Terminated(Terminated due to b... More >>evacizumab and chemoradiotherapy toxicity) Less << - -
NCT00806663 Metastatic Colorectal Cancer ... More >> Liver Metastases Less << Phase 2 Completed - Germany ... More >> Innere Univ.-Klinik u. Poliklinik Tumorforschung Essen, Germany, D-45122 Klinik für Tumorbiologie Freiburg, Germany, D-79106 Medizinische Universitätsklinik der Albert-Ludwigs-Universität Freiburg Freiburg, Germany, D-79106 Marienhospital Herne, Germany, D-44625 Less <<
NCT00003001 Colorectal Cancer Phase 1 Phase 2 Unknown - United States, New York ... More >> State University of New York Health Sciences Center - Stony Brook Stony Brook, New York, United States, 11790-7775 Less <<
NCT01013805 Rectal Cancer Phase 2 Completed - Australia, Victoria ... More >> Peter MacCallum Cancer Centre Melbourne, Victoria, Australia, 8006 Less <<
NCT01244399 - Completed - Italy ... More >> Agunco Obstetrics & Gynecology Center Rome, Italy, 00155 Less <<
NCT00578305 - Completed - -
NCT00578305 Rheumatoid Arthritis Phase 3 Completed - -
NCT00439517 Previously Untreated Metastati... More >>c Colorectal Cancer Less << Phase 2 Completed - -
NCT03629587 - Completed - -
NCT02360345 Solid Tumours Phase 1 Unknown June 2016 United Kingdom ... More >> The Royal Marsden NHS Foundation Trust Recruiting Sutton, Surrey, United Kingdom, SM2 5PT Contact: Udai Banerji, MBBS, PhD    020 8661 3993    udai.banerji@icr.ac.uk Less <<
NCT02629549 Neoplasms Pit... More >>uitary Neoplasms Less << Phase 1 Active, not recruiting September 2020 United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03470376 Hypercholesterolemia ... More >> Inflammation Atherosclerosis Less << Phase 4 Completed - -
NCT00439517 - Completed - -
NCT00002842 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT00845936 Drug Induced Weight Gain Phase 4 Unknown May 2010 Israel ... More >> Beer-Yaacov MHC Not yet recruiting Beer Yaacov, Israel, 70350 Contact: Pazit Leibovich, MD    972-9284065    pazit.leib@gmail.com    Sub-Investigator: Pazit Leibovich, MD Less <<
NCT00002842 - Completed - -
NCT00114400 Atherosclerosis Phase 2 Phase 3 Completed - United States, California ... More >> Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine Los Angeles, California, United States, 90033 Less <<
NCT00227019 - Completed - -
NCT00227019 Non-small Cell Lung Cancer (NS... More >>CLC) Lung Cancer Neoplasm Metastasis Less << Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 United States, New Hampshire Norris Cotton Cancer Center Lebanon, New Hampshire, United States, 03756 United States, New Jersey Cooper Cancer Institute Voorhees, New Jersey, United States, 08043 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 Less <<
NCT02129257 Metastatic Colorectal Cancer Phase 2 Completed - Greece ... More >> Agios Georgios Chania General Hospital Chania, Mournies, Greece, 73300 2nd Dept of Internal Medicine, Agios Savvas Cancer Hospital Athens, Greece, 11522 251 Airforce Hospital Athens, Greece, 11525 2nd Dept of Internal Medicine, General Hospital of Athens "Hippokratio" Athens, Greece, 11527 Oncology Unit, 3rd Dept of Internal Medicine, Athens School of Medicine, Sotiria General Hospital Athens, Greece, 11527 Oncology Section, Dept of Clinical Therapeutics, General Hospital of Athens "Alexandra" Athens, Greece, 11528 Division of Oncology, 2nd Dept of Internal Medicine, University Hospital "Attiko" Athens, Greece, 12462 2nd Dept of Medical Oncology, Agii Anargiri Cancer Hospital Athens, Greece, 14564 3rd Dept of Medical Oncology, Agii Anargiri Cancer Hospital Athens, Greece, 14564 3rd Dept of Medical Oncology, Hygeia Hospital Athens, Greece, 15123 1st Dept of Medical Oncology, Metropolitan Hospital Athens, Greece, 18547 2nd Dept of Medical Oncology, Metropolitan Hospital Athens, Greece, 18547 Dept of Medical Oncology, University Hospital of Heraklion Heraklio, Greece, 71110 Dept of Medical Oncology, Ioannina University Hospital Ioannina, Greece, 45500 Oncology Dept, University Hospital of Larissa Larissa, Greece, 41334 Division of Oncology, Dept of Internal Medicine, University Hospital of Patras Patras, Greece Thermi Clinic S.A. Thermi, Greece, 57001 Dept of Medical Oncology, Papageorgiou General Hospital Thessaloniki, Greece, 56429 Less <<
NCT01205711 Colorectal Cancer Phase 2 Completed - United Kingdom ... More >> Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Centre for Cancer Research and Cell Biology at Queen's University Belfast Belfast, Northern Ireland, United Kingdom, BT9 7AB Wales Cancer Trials Unit Cardiff, Wales, United Kingdom, CF11 9LJ Velindre Cancer Center at Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL Less <<
NCT00265850 - Active, not recruiting - -
NCT00705445 Malnutrition ... More >>Diarrhea Pneumonia Growth Less << Phase 2 Phase 3 Completed - Pakistan ... More >> The Aga Khan University Karachi, Sindh, Pakistan, 75300 Project Office, Matiari Matiari, Sindh, Pakistan, 75300 Less <<
NCT00265850 Colorectal Cancer Phase 3 Active, not recruiting December 2017 -
NCT01526135 Pancreatic Adenocarcinoma (Duc... More >>tal Adenocarcinoma) Less << Phase 3 Active, not recruiting September 2021 -
NCT00243412 - Completed - -
NCT00831181 Colorectal Cancer Phase 2 Completed - United States, New York ... More >> Beth Israel Medical Center - Philipps Ambulatory Care Center New York, New York, United States, 10003 St. Luke's-Roosevelt Hospital Center - Roosevelt Division New York, New York, United States, 10019 Less <<
NCT03754569 Epithelial Ovarian Cancer Not Applicable Recruiting July 1, 2019 France ... More >> Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix Recruiting Paris, France, 75013 Contact: Henri M AZAIS, MD PhD    +33 6 30 99 22 44    henri.azais@aphp.fr Less <<
NCT03504618 - Completed - Vietnam ... More >> Hanoi Medical University Hanoi, Vietnam, 10000 Less <<
NCT00831181 - Completed - -
NCT00660582 Metastatic Colorectal Cancer Phase 2 Completed - Denmark ... More >> Department of Oncology, Aalborg University Hospital Aalborg, Denmark, 9800 Department of Oncology, Herlev University Hospital Herlev, Denmark, 2630 Department of Oncology, Odense University Hospital Odense, Denmark, 5000 Norway Department of Oncology, Haukeland University Hospital Bergen, Norway Kreftsenteret, Ullevaal University Hospital Oslo, Norway, 0407 Sweden Section of Oncology, Uppsala University Hospital Uppsala, Sweden, 751 85 Less <<
NCT02704520 Rectal Cancer Phase 2 Phase 3 Recruiting December 2021 United Kingdom ... More >> Hampshire Hospitals NHS Foundation Trust Recruiting Basingstoke, Hampshire, United Kingdom, RG24 9NA Contact: Megan Topping    01256 313918    megan.topping@hhft.nhs.uk    Contact: Caroline Palmer    01256 313918    caroline.palmer@hhft.nhs.uk    Principal Investigator: Brendan Moran, MD          Sub-Investigator: Mit Dattani, MD          Salisbury NHS Foundation Trust Recruiting Salisbury, Wiltshire, United Kingdom, SP2 8BJ Contact: Sophia Strong-Sheldrake    01722 336262 ext 4191    sophia.strong-sheldrake@salisbury.nhs.uk    Contact: Julie Attlee    01722 336262 ext 4191    julie.attlee@salisbury.nhs.uk    Principal Investigator: Graham Branagan, MD          Sub-Investigator: Alaaeldin Shablak, MD          Bristol Royal Infirmary Recruiting Bristol, United Kingdom, BS2 8ED Contact: Robert Hollister    +44 1173426742    robert.hollister@uhbristol.nhs.uk    Principal Investigator: Stephen Falk, MD          Colchester General Hospital Recruiting Colchester, United Kingdom, CO4 5JL Contact: Lucy Thorogood    +44 1206 745 355    lucy.thorogood@colchesterhospital.nhs.uk    Contact: Celine Driscoll    +44 1206 745 355    celine.driscoll@colchesterhospital.nhs.uk    Principal Investigator: Bruce Sizer, MD          NHS Lanarkshire - Hairmyres Hospital Recruiting East Kilbride, United Kingdom, G75 8RG Contact: Louise Devlin    +44 1355 585329    louise.devlin@lanarkshire.scot.nhs.uk    Contact: Angela Scullion    +44 1355 585 329    angela.scullion@lanarkshire.scot.nhs.uk    Principal Investigator: Cindy Chew, MD          Diana Princess of Wales Hospital Recruiting Grimsby, United Kingdom, DN33 2BA Contact: Jonathan Hatton    +44 3033 303555    jonathan.hatton@nhs.net    Principal Investigator: Rajarshi Roy, MD          University Hospital of North Tees Recruiting Stockton-on-Tees, United Kingdom, TS19 8PE Contact: Helen Wilson    +44 1642 383 277    Helen.Wilson2@nth.nhs.uk    Contact: Lynda Poole    +44 1642 383 277    Lynda.Poole@nth.nhs.uk    Principal Investigator: David Wilson, MD          Royal Marsden NHS Foundation Trust Recruiting Sutton, United Kingdom, SM2 5PT Contact: Michelle Frost    44 (0) 208 915 6067    michelle.frost@rmh.nhs.uk    Contact: Ceri Evans    44 (0)208 642 6011 ext 4280    ceri.evans@rmh.nhs.uk    Principal Investigator: Sheela Rao, MD Less <<
NCT00278889 - Completed - -
NCT03242616 Breast Neoplasms Phase 2 Recruiting December 31, 2019 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Seock-Ah Im    82-2-2072-0850    moisa@snu.ac.kr Less <<
NCT01686256 Ovarian Cancer ... More >> Endometrial Cancer Less << Phase 1 Completed - United States, Indiana ... More >> Indiana University Medical Center Indianapolis, Indiana, United States Less <<
NCT00004997 5q Minus Syndrome ... More >> Myelodysplastic Syndrome Less << Phase 2 Completed - United States, Maryland ... More >> Warren G. Magnuson Clinical Center (CC) Bethesda, Maryland, United States, 20892 Less <<
NCT00278889 Colorectal Cancer Phase 2 Completed - -
NCT00243412 Rheumatoid Arthritis Phase 2 Completed - -
NCT01061736 Rheumatoid Arthritis Phase 2 Phase 3 Completed - -
NCT01010581 Rheumatoid Arthritis Phase 2 Completed - Bulgaria ... More >> MHAT "Kaspela" Department of Rheumatology Plovdiv, Bulgaria Diagnostic Consulting Centre "Sv. Anna" Sofia, Bulgaria Military Medical Academy Sofia, Bulgaria National Multiprofile Transport Hospital "Tsar Boris III" Internal Clinic Sofia, Bulgaria UMHAT "Sveti Ivan Rilski" Sofia, Bulgaria Czech Republic Rheumatology Outpatient Clinic Hlučín, Czech Republic Diagnostic Center Mediscan Praha 11, Czech Republic Institute of Rheumatology Praha, Czech Republic Poland Centrum Miriada, Prywatny Gabinet Specjalistyczny Białystok, Poland Mazowieckie Centrum Badań Klinicznych s.c. Grodzisk Mazowiecki, Poland Śląskie Centrum Osteoporozy Katowice, Poland Specjalistyczny Ośrodek ALL-MED Kraków, Poland NZOZ Reumed Lublin, Poland Prof. Dr Hab. n. m. Leszek Szczepański Lublin, Poland Poznański Ośrodek Medyczny NOVAMED Poznań, Poland Wojewódzki Szpital Reumatologiczny Sopot, Poland NZOZ "Nasz Lekarz" Toruń, Poland Centrum Leczenia Chorób Cywilizacyjnych Sp. z o. o. S. K. A. Warszawa, Poland Centrum Medyczne Osteomed NZOZ Lecznica Specjalistów Warszawa, Poland NZOZ Materia Medica Wrocław, Poland Romania Clinic Hospital Sf. Maria Bucharest, Romania Emergency Hospital "Prof. Dr. Gerota" Bucharest, Romania SC Duomedical Bucharest, Romania SC Ianuli Med Consult Bucharest, Romania County Hospital Cluj - Rheumatology clinic Cluj Napoca, Romania Clinical County Hospital of Targoviste Targoviste, Dambovita, Romania Private Practice Prof. Dr. Mioara Banciu Timisoara, Romania Less <<
NCT00323011 Colorectal Cancer Phase 2 Terminated(drug not available) - United States, California ... More >> USCNorris Hospital Los Angeles, California, United States, 90033 Less <<
NCT00726713 Type 2 Diabetic Peripheral Neu... More >>ropathy (DPN) Less << Phase 4 Completed - United States, Alabama ... More >> University of Alabama at Birmingham School of Medicine Birmingham, Alabama, United States, 35294 United States, Louisiana Tulane University Health Sciences Center New Orleans, Louisiana, United States, 70112 United States, Nebraska Omaha VA Medical Center Omaha, Nebraska, United States, 68105 United States, Texas Dallas Diabetes and Endocrine Center Dallas, Texas, United States, 75230 dgd Research, Inc. San Antonio, Texas, United States, 78229 Scott and White Hospital & Clinic Temple, Texas, United States, 76504 Less <<
NCT00726713 - Completed - -
NCT00916630 Central Nervous System Lymphom... More >>a Less << Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00965653 Rheumatoid Arthritis Phase 1 Completed - Canada, Newfoundland and Labra... More >>dor St John's, Newfoundland and Labrador, Canada, A1A 5E8 Canada, Ontario Kitchener, Ontario, Canada, N2M 5N6 Canada, Quebec Trois-rivieres, Quebec, Canada, G8Z 1Y2 New Zealand Christchurch, New Zealand, 8011 Spain La Coruna, La Coruña, Spain, 15006 Santiago de Compostela, La Coruña, Spain, 15706 Sevilla, Spain, 41009 Less <<
NCT01061736 - Completed - -
NCT01639326 Metastatic Colorectal Cancer Phase 2 Unknown September 2018 Spain ... More >> Hospital de Mataró Recruiting Mataró, Catalunya/Barcelona, Spain Contact: Pilar Lines, MD          Principal Investigator: Pilar Lines, MD          Hospital Universitari Mutua de Terrassa Recruiting Terrassa, Catalunya/Barcelona, Spain, 08221 Contact: Julen Fernandez, MD          Principal Investigator: J. Fernandez, MD          Hospital de la Santa Creu i Sant Pau Recruiting Barcelona, Spain, 08025 Contact: David Páez, MD       DPaez@santpau.cat    Principal Investigator: David Paez, MD Less <<
NCT01900431 Uveitis Phase 2 Completed - United States, Massachusetts ... More >> Investigational Site Number 840008 Worcester, Massachusetts, United States, 01608 United States, Nebraska Investigational Site Number 840009 Omaha, Nebraska, United States, 68198-5540 United States, New York Investigational Site Number 840005 Slingerlands, New York, United States, 12159 United States, Ohio Investigational Site Number 840007 Cleveland, Ohio, United States, 44195 United States, Texas Investigational Site Number 840006 Arlington, Texas, United States, 76012 Czechia Investigational Site Number 203001 Brno, Czechia, 62500 Investigational Site Number 203002 Praha 2, Czechia, 12808 France Investigational Site Number 250001 Paris, France, 75013 Investigational Site Number 250002 Paris, France, 75571 Italy Investigational Site Number 380001 Milano, Italy, 20132 Investigational Site Number 380003 Padova, Italy, 35128 Investigational Site Number 380004 Reggio Emilia, Italy, 42100 Spain Investigational Site Number 724003 Barcelona, Spain, 08028 Investigational Site Number 724001 Barcelona, Spain, 08907 Turkey Investigational Site Number 792001 Ankara, Turkey, 06100 Investigational Site Number 792005 Ankara, Turkey, 06100 Investigational Site Number 792002 Istanbul, Turkey, 34093 Investigational Site Number 792003 Istanbul, Turkey, 34098 Investigational Site Number 792004 Izmir, Turkey, 35100 Investigational Site Number 792006 Izmir, Turkey, 35100 Less <<
NCT02606305 Epithelial Ovarian Cancer ... More >> Primary Peritoneal Cancer Fallopian Tube Cancer Less << Phase 1 Phase 2 Recruiting July 2021 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 United States, Ohio The Ohio State University Recruiting Hilliard, Ohio, United States, 43026 United States, Oklahoma Peggy and Charles Stephenson Oklahoma Cancer Center Recruiting Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Belgium Universitaire Ziekenhuizen (UZ) Leuven - Gasthuisberg - Leuvens Kankerinstituut Recruiting Leuven, Belgium, 3000 Canada Hamilton Health Sciences Center Recruiting Hamilton, Canada Centre Hospitalier de l'universite de Montreal (CHUM) Recruiting Montreal, Canada McGill University Recruiting Montreal, Canada Spain MD Anderson Suspended Madrid, Spain, 28033 Less <<
NCT01900431 - Completed - -
NCT01057589 Head and Neck Neoplasms Phase 2 Completed - Belgium ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Edegem, Belgium, 2650 France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Herblain, France, 44805 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dresden, Germany, 01307 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Essen, Germany, 45122 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, 30625 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leipzig, Germany, 04103 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy, 20133 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pamplona, Spain, 31008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46014 United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cardiff, South Glamorgan, United Kingdom, CF14 2TL For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, United Kingdom, SW3 6JJ Less <<
NCT03228550 Aging Cogniti... More >>ve Decline Less << Phase 2 Recruiting October 1, 2018 United Kingdom ... More >> Bournemouth University Recruiting Bournemouth, Dorset, United Kingdom, BH1 3LT Contact: Simon C Dyall, PhD    01202 961896    sdyall@bournemouth.ac.uk    Contact: Paul Fairbairn, MSc    01202 965008    pfairbairn@bournemouth.ac.uk Less <<
NCT01057589 - Completed - -
NCT02676882 Depressive Disorder ... More >> Pregnancy Less << Not Applicable Active, not recruiting December 2018 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00606502 Non-small Cell Lung Cancer Phase 2 Completed - -
NCT01762826 - Unknown September 2013 -
NCT01134341 Cutaneous T-cell Lymphoma ... More >> Mycosis Fungoides Sezary Syndrome Primary Cutaneous Anaplastic Large Cell Lymphoma Less << Phase 1 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania, United States, 15213 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Italy Ospedale Sant'Orsola - Policlinico Sant'Orsola Bologna, Italy, 40138 Less <<
NCT00859911 Micronutrient Deficiencies Not Applicable Unknown October 2011 Bangladesh ... More >> Save the Children Dhaka, Dhaka Division, Bangladesh Less <<
NCT02575092 Homocysteine ... More >>Coronary Disease Angioplasty,Balloon,Coronary Contrast Media Nephropathy Hypertension Less << Phase 2 Phase 3 Recruiting December 31, 2018 China, Chongqing ... More >> TIAN Jie Recruiting Fuling, Chongqing, China, 408099 Contact: Lu J Gang, MD    023-72220740    lujiangang1211@sina.com Less <<
NCT02317705 Ovarian Cancer Phase 2 Completed - United States, California ... More >> University of CA at Irvine Chao Cancer Center Orange, California, United States, 92868 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Minnesota Mayo Clinic-Rochester Rochester, Minnesota, United States, 55905 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00606502 - Completed - -
NCT02978222 Platinum Sensitive Ovarian Can... More >>cer Ovarian Cancer Less << Phase 2 Recruiting December 2020 United States, Alabama ... More >> UAB Gynecology Oncology Recruiting Birmingham, Alabama, United States, 35233 Contact: Terry Sirles, RN       tsirles@uabmc.edu    Principal Investigator: Charles A Leath, III, MD, MSPH          United States, Arizona Mayo Clinic Cancer Center Recruiting Phoenix, Arizona, United States, 85054 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Camoriano John, MD          United States, California Women's Cancer Research Foundation Recruiting Newport Beach, California, United States, 92663 Contact: Katrina Lopez    949-642-5165    katrinal@gynoncology.com    Principal Investigator: Alberto A Mendivil, MD          Sarcoma Oncology Research Center Withdrawn Santa Monica, California, United States, 90403 United States, Connecticut The Stamford Hospital/Bennett Cancer Center Recruiting Stamford, Connecticut, United States, 06904 Contact: Maureen Magnani, RN    203-358-8879    officeofresearch@stamhealth.org    Principal Investigator: Salvatore Del Prete, MD          United States, Florida Mayo Clinic Florida Recruiting Jacksonville, Florida, United States, 32224 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Gerardo Colon-Otero, MD          Mt. Sinai Comprehensive Cancer Center Recruiting Miami Beach, Florida, United States, 33140 Contact: Yvonne Enriquez-Nunez    305-674-2625    yvonne.enriquez-nunez@msmc.com    Principal Investigator: Elissa Krill-Jackson, MD          Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Eleni Rokakis    813-745-3593    eleni.rokakis@moffitt.org    Principal Investigator: Robert Wenham, MD          Florida Cancer Specialist Recruiting West Palm Beach, Florida, United States, 33401 Contact: askSARAH    844-482-4812    asksarah@scresearch.com    Principal Investigator: Howard Goodman, MD          United States, Minnesota Mayo Clinic Rochester Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Matthew Block, MD, PhD          United States, Mississippi Research Partners Recruiting Jackson, Mississippi, United States, 39202 Contact: Suzanne Griffith    601-506-8298    suzanne.researchpartners@gmail.com    Principal Investigator: Scott Berry, MD          United States, Missouri MidAmerica Division, Inc. c/o Research Medical Center Recruiting Kansas City, Missouri, United States, 64132 Contact: askSARAH    844-482-4812    asksarah@scresearch.com    Principal Investigator: Kristopher S LyBarger, DO          United States, New Mexico University Of New Mexico Comprehensive Cancer Center Recruiting Albuquerque, New Mexico, United States, 87102 Contact: Erin Dibble    505-272-4443    echilcoat@salud.unm.edu    Principal Investigator: Carolyn Muller, MD          United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Roisin O'Cearbhaill, MD    646-888-4227       Principal Investigator: Roisin O'Cearbhaill, MD          Hematology/Oncology Lenox Hill Hospital Recruiting New York, New York, United States, 10075 Contact: Christina Persaud, RN, CCRP    212-434-3644    cpersaud9@northwell.edu    Principal Investigator: Jeannine Villella, DO          United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Jennifer Mewshaw    919.684.3780    jennifer.mewshaw@duke.edu    Principal Investigator: Angela Alvarez Secord, MD          United States, Oregon OHSU Recruiting Portland, Oregon, United States, 97239 Contact: Yukie Bean    503-418-4522    beany@ohsu.edu    Principal Investigator: Koenraad De Geest, MD          United States, Pennsylvania Abington Memorial Hospital Recruiting Abington, Pennsylvania, United States, 19001 Contact: Ashley Douglas, RN    215-885-0220       Principal Investigator: Mark S Shahin, MD          United States, Tennessee Tennessee Oncology/Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact: askSARAH    844-482-4812    asksarah@scresearch.com    Principal Investigator: Erika Hamilton, MD Less <<
NCT02762682 - Completed - India ... More >> PGIMER Chandigarh, India, 160012 Less <<
NCT01606241 Recurrent Breast Carcinoma ... More >> Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Stage IIA Breast Cancer Stage IIA Fallopian Tube Cancer Stage IIA Ovarian Cancer Stage IIB Breast Cancer Stage IIB Fallopian Tube Cancer Stage IIB Ovarian Cancer Stage IIC Fallopian Tube Cancer Stage IIC Ovarian Cancer Stage IIIA Breast Cancer Stage IIIA Fallopian Tube Cancer Stage IIIA Ovarian Cancer Stage IIIA Primary Peritoneal Cancer Stage IIIB Breast Cancer Stage IIIB Fallopian Tube Cancer Stage IIIB Ovarian Cancer Stage IIIB Primary Peritoneal Cancer Stage IIIC Breast Cancer Stage IIIC Fallopian Tube Cancer Stage IIIC Ovarian Cancer Stage IIIC Primary Peritoneal Cancer Stage IV Fallopian Tube Cancer Stage IV Ovarian Cancer Stage IV Primary Peritoneal Cancer Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00422773 Metastatic Colorectal Cancer Phase 1 Phase 2 Completed - Germany ... More >> Universitaetsklinikum Carl Gustav Carus, Medizinische Klinik Dresden, Sachsen, Germany, 01307 Westdeutsches Tumorzentrum, Universitaetsklinikum Essen Essen, Germany, 45112 Universitaetsklinik Mannheim GmbH, III. Medizinische Klinik Mannheim, Germany, 68167 Less <<
NCT00109551 Nutrition Phase 3 Completed - United States, Maryland ... More >> Johns Hopkins Bloomberg School of Public Health Baltimore, Maryland, United States, 21205-2103 United States, New York Cornell University Division of Nutritional Sciences Ithaca, New York, United States, 14853 Nepal Nepal Nutrition Intervention Project-Sarlahi Kathmandu and Sarlahi District, Nepal Less <<
NCT02149992 Gestational Diabetes Mellitus ... More >>as Antepartum Condition Less << Not Applicable Unknown August 2016 United States, Oregon ... More >> Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: Amy M Valent, DO    503-502-7220    valent@ohsu.edu    Principal Investigator: Amy M Valent, DO Less <<
NCT03673995 Polycystic Ovary Syndrome ... More >> Menstrual Problem Hirsutism Less << Not Applicable Active, not recruiting September 30, 2018 Italy ... More >> Altamedica Reproductive Medicine Roma, Italy, 00198 Less <<
NCT00034463 Metastases Ca... More >>ncer Less << Phase 1 Completed - United States, Texas ... More >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. San Antonio, Texas, United States Less <<
NCT03376490 - Completed - Singapore ... More >> SingHealth Polyclinics - Marine Parade Polyclinic Singapore, Singapore, 440080 Less <<
NCT00611507 Stomach Neoplasms Phase 2 Completed - Colombia ... More >> Sanofi-Aventis Bogota, Colombia Less <<
NCT02106650 Relapsed Peripheral T-Cell Lym... More >>phoma Refractory Peripheral T-Cell Lymphoma Less << Phase 2 Recruiting December 2018 United States, Kansas ... More >> Cancer Center of Kansas Recruiting Wichita, Kansas, United States, 67214 Contact: Shaker Dakhil          Principal Investigator: Shaker Dakhil, MD          United States, Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States, 98109 Contact: Andrei Shustov          Principal Investigator: Andrei Shustov, MD Less <<
NCT02221154 Polycystic Ovary Syndrome Phase 4 Terminated(Difficulty recruiti... More >>ng) Less << - France ... More >> CHI de Créteil Créteil, France, 94000 CHD Vendée La Roche sur Yon, France, 85925 CHU de Nantes Nantes, France, 44093 CH de Saint Nazaire Saint Nazaire, France, 44606 Less <<
NCT00782041 Uterine Neoplasms Phase 2 Terminated(protocol violation) - Thailand ... More >> Sanofi aventis administrative office Bangkok, Thailand Less <<
NCT03766594 Miscarriage, Recurrent Phase 1 Completed - Egypt ... More >> Ain SHams Maternity Hospital Cairo, Abbaseya, Egypt, 002 Less <<
NCT00642408 Multiple Micronutrient Deficie... More >>ncies During Pregnancy Less << Phase 4 Completed - Burkina Faso ... More >> Centre Muraz, 2054, Avenue Mamadou KONATE Bobo-Dioulasso, Burkina Faso, BP 390 Less <<
NCT02817503 Hypertension ... More >>Hyperhomocysteinemia Less << Phase 4 Unknown December 2016 China, Shandong ... More >> the People's Hospital of Rongcheng Rongcheng, Shandong, China, 264300 Less <<
NCT02079948 Inflammation ... More >>Aging Less << Phase 2 Withdrawn(Potential participan... More >>ts had concerns about taking the study drug (methotrexate).) Less << - -
NCT02376478 - Completed - -
NCT01704599 Psoriasis Phase 1 Phase 2 Terminated(side effect and poo... More >>r clinical outcome) Less << - -
NCT01949116 - Completed - -
NCT00525785 Stomach Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02383901 - Completed - Hungary ... More >> Semmelweis Egyetem II. Sz. Gyermekklinika Budapest, Hungary, 1094 Norway Oslo University Hospital Oslo, Norway, N-0424 Poland Intytut Matki Dziecka Klinika Chirurgii Onkologicznej Dzieci i Młodzieży Warszawa, Poland, 01 211 Sweden Skåne University Hospital Lund, Sweden, 221 85 Karolinska University Hospital, Sweden Stockholm, Sweden, SE-17176 Less <<
NCT01118624 Breast Cancer ... More >> Breast Tumors Neoplasms, Breast Cancer of the Breast Human Mammary Carcinoma Less << Phase 2 Completed - United States, Oregon ... More >> Providence Cancer Center Portland, Oregon, United States, 97213 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 Czech Republic Fakultní nemocnice Olomouc Olomouc, Czech Republic, 775 20 Multiscan, s.r.o. Pardubice, Czech Republic, 532 03 Fakultní nemocnice Královské Vinohrady - FNKV Praha, Czech Republic, 100 34 France Centre Lutte Contre le Cancer Val d'Aurelle (CRLC) Montpellier, Cedex 5, France, 34298 Centre Régional de Lutte Contre le Cancer Alexis Vautrin Vandoeuvre, les Nancy Cedex, France, 54511 Centre Georges François Leclerc Dijon Cedex, France, 21079 Centre Léon Bérard Lyon Cedex, France, 69373 Institut Paoli Calmettes Marseille, France, 13273 Institut Jean-Godinot Reims Cedex 09, France, 51056 Hungary University of Debrecen Medical and Health Science Center Debrecen, Hajdú-Bihar, Hungary, 4032 Semmelweis University Budapest Budapest, Hungary, H-1082 National Health Centre of Hungary Budapest, Hungary, H-1145 Less <<
NCT00580073 - Terminated(Loss of funding) - -
NCT00580073 Rectal Cancer Phase 2 Terminated(Loss of funding) - United States, Wisconsin ... More >> University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT01949116 HIV Infections Phase 2 Completed - United States, Alabama ... More >> Alabama CRS Birmingham, Alabama, United States, 35294 United States, California University of Southern California CRS Los Angeles, California, United States, 90033-1079 UCLA CARE Center CRS Los Angeles, California, United States, 90035 UCSD Antiviral Research Center CRS San Diego, California, United States, 92103 Ucsf Hiv/Aids Crs San Francisco, California, United States, 94110 Harbor-UCLA CRS Torrance, California, United States, 90502 United States, Colorado University of Colorado Hospital CRS Aurora, Colorado, United States, 80045 United States, Illinois Northwestern University CRS Chicago, Illinois, United States, 60611 United States, Maryland Johns Hopkins University CRS Baltimore, Maryland, United States, 21205 United States, Massachusetts Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS Boston, Massachusetts, United States, 02115 United States, Missouri Washington University Therapeutics (WT) CRS Saint Louis, Missouri, United States, 63110-1010 United States, New Jersey New Jersey Medical School Clinical Research Center CRS Newark, New Jersey, United States, 07103 United States, North Carolina Chapel Hill CRS Chapel Hill, North Carolina, United States, 27599 Greensboro CRS Greensboro, North Carolina, United States, 27401 United States, Ohio Cincinnati Clinical Research Site Cincinnati, Ohio, United States, 45219 Case Clinical Research Site Cleveland, Ohio, United States, 44106 Ohio State University CRS Columbus, Ohio, United States, 43210 United States, Pennsylvania Penn Therapeutics, CRS Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh CRS Pittsburgh, Pennsylvania, United States, 15213 United States, Rhode Island The Miriam Hospital Clinical Research Site (TMH CRS) CRS Providence, Rhode Island, United States, 02906 United States, Tennessee Vanderbilt Therapeutics (VT) CRS Nashville, Tennessee, United States, 37204 United States, Texas Houston AIDS Research Team CRS Houston, Texas, United States, 77030 Less <<
NCT02889081 - Completed - China ... More >> Children Hospital of Fudan University Shanghai, China, 201102 Less <<
NCT01369030 - Completed - United States, North Carolina ... More >> Moses Cone Family Practice Center Greensboro, North Carolina, United States, 27401 United States, Tennessee Vanderbilt University School of Medicine Nashville, Tennessee, United States, 37212 Less <<
NCT01369030 - Completed - -
NCT01704599 - Terminated(side effect and poo... More >>r clinical outcome) Less << - -
NCT00461448 Rheumatoid Arthritis Phase 1 Completed - Iran, Islamic Republic of ... More >> Division of Rheumatoloy, Sina Teaching Hospital, Tabriz Medical Sciences University Tabriz, East Azerbaidjan, Iran, Islamic Republic of Sheikh-ol-Raees Ultra Specialized Clinic Tabriz, East Azerbaidjan, Iran, Islamic Republic of Less <<
NCT01156896 Iron Deficiency Not Applicable Completed - Thailand ... More >> Hospital for Tropical Diseases, Mahidol University Bangkok, Thailand, 10400 Less <<
NCT00641862 Pregnancy Phase 3 Active, not recruiting April 2019 India ... More >> St. John's Medical Research Institute, St. John's National Academy of Health Sciences Bangalore, Karnataka, India, 560-034 Less <<
NCT00641862 - Active, not recruiting - -
NCT01360723 - Unknown - Taiwan ... More >> Department of Urology, China Medical University Hospital Recruiting Taichung, Taiwan, 404 Contact: Chao-Hsiang Chuang, PhD    886-4-22052121 ext 4439    urology8395@yahoo.com.tw    Principal Investigator: Chi-Jung Chung, PhD Less <<
NCT00851084 Colorectal Neoplasms ... More >> Neoplasm Metastasis Less << Phase 2 Completed - -
NCT01370954 - Completed - United States, North Carolina ... More >> Falls Neurology and Memory Center Hickory, North Carolina, United States, 28601 Less <<
NCT00348933 Angelman Syndrome ... More >> Nervous System Diseases Less << Not Applicable Completed - United States, California ... More >> Rady Children's Hospital San Diego San Diego, California, United States, 92123 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States United States, South Carolina Greenwood Genetics Center Greenwood, South Carolina, United States United States, Texas Baylor College of Medicine Houston, Texas, United States Less <<
NCT00348933 - Completed - -
NCT02969070 Hypercholesterolemia ... More >> Endothelial Dysfunction Less << Phase 3 Unknown March 2017 Italy ... More >> University of Naples "Federico II" Recruiting Naples, Italy, 80131 Contact: Giuseppe Giugliano, MD, PhD    +390817462240    giuseppe.giugliano@unina.it    Sub-Investigator: Raffaele Izzo, MD          Sub-Investigator: Maurizio Galderisi, MD          Sub-Investigator: Giuseppe Giugliano, MD, PhD Less <<
NCT00341068 - Completed - United States, Maryland ... More >> National Human Genome Research Institute (NHGRI), 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03174652 - Completed - Thailand ... More >> Shoklo Malaria Research Unit Mae Sot, Tak, Thailand, 63110 Less <<
NCT01185379 Cognitive Function ... More >> Mood Well-being Cerebral Blood Flow Less << Not Applicable Completed - United Kingdom ... More >> Northumbria University Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST Less <<
NCT01691365 Diabetes Obes... More >>ity Less << Phase 4 Completed - -
NCT01178788 Preterm Delivery ... More >> Neonatal Complications Less << Phase 3 Completed - Italy ... More >> University of Modena and Reggio Emilia Modena, Italy, 41100 Less <<
NCT03263377 Malnutrition Not Applicable Completed - -
NCT01953419 Gastric Cancer Phase 2 Completed - China, Guangdong ... More >> Sun Yat-sen UniversityCancer center Guangzhou, Guangdong, China, 510060 Less <<
NCT00851084 - Completed - -
NCT02036346 Colorectal Resection ... More >> Ileostomy Less << Not Applicable Completed - Greece ... More >> University Hospital of Larissa Larissa, Thessaly, Greece, 41110 Less <<
NCT00065390 Autoimmune Disease ... More >> Lymphatic Disease Lymphoproliferative Disorder Less << Phase 1 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT00501410 Colorectal Cancer Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01304888 Malnutrition Not Applicable Completed - Mexico ... More >> Instituto Nacional de Salud Publica Cuernavaca, Morelos, Mexico, 62100 Less <<
NCT02384850 Colorectal Neoplasm Phase 1 Completed - Belgium ... More >> University Hospital Antwerpen Antwerpen, Belgium, 1200 Germany University Hospital Hamburg Hamburg, Germany, 20246 Less <<
NCT00944255 - Completed - -
NCT02604693 - Recruiting December 2019 United States, Colorado ... More >> National Jewish Health Recruiting Denver, Colorado, United States, 80206 Contact: Peggy M Mroz, MSPH    303-398-1730    mrozp@njhealth.org    Principal Investigator: Lisa Maier, MD Less <<
NCT02275676 - Unknown September 2016 Germany ... More >> University Hospital Muenster Recruiting Muenster, Germany, 48149 Principal Investigator: Frank Lenze, Dr.          Principal Investigator: Hauke Heinzow, Dr. Less <<
NCT00081289 Colorectal Cancer Phase 2 Completed - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 United States, Florida Baptist-South Miami Regional Cancer Program Miami, Florida, United States, 33176 United States, Illinois Ingalls Cancer Care Center at Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 United States, New Jersey Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton Marlton, New Jersey, United States, 08053 United States, Pennsylvania Northeast Radiation Oncology Center Dunmore, Pennsylvania, United States, 18512 Less <<
NCT01688791 Advanced Cancer Phase 1 Terminated - -
NCT02663388 - Recruiting January 2026 France ... More >> University of Lorraine, CHU Nancy Recruiting Vandoeuvre Les Nancy, France, 54511 Contact: laurent brunaud       l.brunaud@chu-nancy.fr    Contact: laurent brunaud Less <<
NCT00081289 - Completed - -
NCT01571219 Rheumatoid Arthritis Phase 3 Completed - Korea, Republic of ... More >> Hanyang University Medical Center Seoul, Korea, Republic of Less <<
NCT01189448 Congenital Toxoplasmosis Phase 3 Completed - France ... More >> Hôpital Louis Mourier Colombes, Hauts-de-Saine, France, 92700 Less <<
NCT01862003 Metastatic Colorectal Cancer ... More >> Recurrent Colorectal Cancer Less << Phase 2 Active, not recruiting December 2020 United Kingdom ... More >> Barts Health NHS Trust London, United Kingdom Guy's and St Thomas' NHS Foundation Trust London, United Kingdom University College London Hospital NHS Foundation Trust London, United Kingdom The Christie NHS Foundation Trust Manchester, United Kingdom Less <<
NCT03126253 - Completed - Bangladesh ... More >> Data analysis Sylhet, Bangladesh, 3114 Less <<
NCT03231722 Metastatic Colorectal Cancer Phase 3 Recruiting July 15, 2021 Italy ... More >> Fondazione IRCCS Istituto Nazionale Tumori Recruiting Milan, Italy, 20133 Contact: Filippo de Braud, MD          Fondazione IRCCS Istituto Oncologico Veneto Recruiting Padova, Italy, 35128 Contact: Sara Lonardi, MD          A.O. Universitaria Pisana - Pisa (Pi) Oncologia Medica Recruiting Pisa, Italy, 56126 Contact: Gianluca Masi, MD          Principal Investigator: Alfredo Falcone, MD          Azienda Ospedaliera Universitaria Integrata Verona Recruiting Verona, Italy, 37126 Contact: Giampaolo Tortora, MD Less <<
NCT02251678 Plaque Psoriasis Phase 1 Completed - United States, Illinois ... More >> NMFF Dermatology Clinic Chicago, Illinois, United States, 60611 NM Lake Forest Hospital/ Women's Center Lake Forest, Illinois, United States, 60045 United States, New Jersey TKL Research Fair Lawn, New Jersey, United States, 07410 United States, Ohio University Hospitals Case Medical Center / Dept of Dermatology Cleveland, Ohio, United States, 44106 Less <<
NCT01689727 Pituitary Tumors Phase 2 Completed - United States, Georgia ... More >> Emory Hospital Atlanta, Georgia, United States Less <<
NCT03217097 Neuroendocrine Tumors Phase 4 Not yet recruiting October 2021 France ... More >> Hôpital Sud - CHU Amiens Not yet recruiting Amiens, France, 80054 Contact: Vincent HAUTEFEUILLE, MD          Principal Investigator: Vincent HAUTEFEUILLE, MD          CHU d'Angers Not yet recruiting Angers, France, 49933 Contact: Sandrine LABOUREAU, MD          Principal Investigator: Sandrine LABOUREAU, MD          Hôpital Beaujon - APHP Not yet recruiting Clichy, France, 92118 Contact: Olivia HENTIC, MD          Principal Investigator: Olivia HENTIC, MD          Hôpital François Mitterrand - CHU Dijon Bourgogne Not yet recruiting Dijon, France, 21000 Contact: Côme LEPAGE, MD          Principal Investigator: Côme LEPAGE, MD          Hôpital André Michalon - CHU Grenoble Alpes Not yet recruiting La Tronche, France, 38700 Contact: Victoire GRANGER, MD          Principal Investigator: Victoire GRANGER, MD          Centre Oscar Lambret Not yet recruiting Lille, France, 59020 Contact: Eric DANSIN, MD          Principal Investigator: Eric DANSIN, MD          Hôpital Claude Hurriet - CHRU Lille Not yet recruiting Lille, France, 59037 Contact: Christine DO CAO, MD          Principal Investigator: Christine DO CAO, MD          Hôpital Edouard Herriot - Hospices Civils de Lyon Not yet recruiting Lyon, France, 69003 Contact: Thomas WALTER, MD          Principal Investigator: Catherine LOMBARD BOHAS, MD          Sub-Investigator: Thomas WALTER, MD          Hôpital Privé Jean Mermoz Not yet recruiting Lyon, France, 69008 Contact: Jérôme DESRAMES, MD          Principal Investigator: Jérôme DESRAMES, MD          Centre Léon Bérard Not yet recruiting Lyon, France, 69373 Contact: Matthieu SARABI, MD          Principal Investigator: Matthieu SARABI, MD          Institut Paoli Calmettes Not yet recruiting Marseille, France, 13009 Contact: Patricia NICCOLI, MD          Principal Investigator: Patricia NICCOLI, MD          Hôpital Saint Eloi - CHU Montpellier Not yet recruiting Montpellier, France, 34090 Contact: Eric ASSENAT, MD          Principal Investigator: Eric ASSENAT, MD          Hôpital Saint Louis - APHP Not yet recruiting Paris, France, 75010 Contact: Thomas APARICIO, MD          Principal Investigator: Thomas APARICIO, MD          Hôpital Cochin - APHP Not yet recruiting Paris, France, 75014 Contact: Romain CORIAT, MD          Principal Investigator: Romain CORIAT, MD          CH Annecy Genevois Not yet recruiting Pringy, France, 74374 Contact: Mathieu BACONNIER, MD          Principal Investigator: Mathieu BACONNIER, MD          Hôpital Robert Debré - CHU Reims Not yet recruiting Reims, France, 51092 Contact: Guillaume CADIOT, MD          Principal Investigator: Guillaume CADIOT, MD          Hôpital Nord - CHU Saint Etienne Not yet recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Nicolas WILLIET, MD          Principal Investigator: Nicolas WILLIET, MD          Institut de Cancérologie de la Loire Not yet recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Léa SABAN-ROCHE, MD          Principal Investigator: Léa SABAN-ROCHE, MD          Hôpital Rangueil - CHU Toulouse Not yet recruiting Toulouse, France, 31059 Contact: Rosine GUIMBAUD, MD          Principal Investigator: Rosine GUIMBAUD, MD          Hôpital Trousseau - CHU Tours Not yet recruiting Tours, France, 37044 Contact: Thierry LECOMTE, MD          Principal Investigator: Thierry LECOMTE, MD          Institut Gustave Roussy Not yet recruiting Villejuif, France, 94805 Contact: Eric BAUDIN, MD          Principal Investigator: Eric BAUDIN, MD Less <<
NCT01594333 Cardiovascular Disease Phase 3 Active, not recruiting December 2019 -
NCT02063256 Male Subfertility ... More >> Oligospermia Asthenospermia Teratospermia Less << Phase 2 Phase 3 Unknown December 2016 Italy ... More >> Ospedale Sant'Anna. Dipartimento di Ostetricia e Neonatologia. S.C. Biochimica Clinica "Baldi e Riberi" Settore Malattie Metaboliche - Dipartimento di Medicina di Laboratorio A.O.U. Citta' della Salute e della Scienza Presidio San Giovanni Battista - Moli Recruiting Torino, Italy, 10126 Contact: Aldo Maina, MD    0039011313 ext 5735    amaina@cittadellasalute.to.it    Sub-Investigator: Marco Manenti, MD          Sub-Investigator: Cinzia Racca, MScBiol          Sub-Investigator: Maria Paola Puccinelli, M Chem          Sub-Investigator: Emanuele Pesce Less <<
NCT03216811 Hypercholesterolemia Phase 2 Completed - Italy ... More >> University Hospital of Ferrara Cona, Ferrara, Italy, 44124 Less <<
NCT02076659 Rheumatoid Arthritis Phase 1 Completed - Italy ... More >> Policlinico San Matteo, Pavia Pavia, Italy Pisa University Hospital Pisa, Italy Azienda Ospedaliera San Camillo-Forlanini Roma Roma, Italy Policlinico A. Gemelli, Università Cattolica del Sacro Cuore Roma, Italy Siena University Hospital Siena, Italy Less <<
NCT01739101 Delayed Childbearing ... More >> Pregnancy Health Behavior Lifestyle Less << Not Applicable Completed - Sweden ... More >> The Student Health Centre Uppsala, Sweden, 753 10 Less <<
NCT02996825 Estrogen Receptor Negative ... More >> HER2/Neu Negative Progesterone Receptor Negative Recurrent Breast Carcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Recurrent Uterine Corpus Carcinoma Triple-Negative Breast Carcinoma Folate Receptor Alpha Positive Less << Phase 1 Recruiting March 2019 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Mihaela C. Cristea, MD    800-826-4673    mcristea@coh.org    Principal Investigator: Mihaela C. Cristea, MD          City of Hope Rancho Cucamonga Recruiting Rancho Cucamonga, California, United States, 91730 Contact: Valerie Estala    626-256-4673 ext 81699    vestala@coh.org    Principal Investigator: Behnam Ebrahimi, MD Less <<
NCT03719924 Squamous Cell Carcinoma Phase 2 Not yet recruiting April 15, 2022 -
NCT01798173 Cirrhosis With Hepatocellular ... More >>Carcinoma Cirrhosis Without Hepatocellular Carcinoma Less << Not Applicable Unknown - France ... More >> Hôpital Jean Minjoz Recruiting Besancon, France, 25000 Contact: Carine RICHOU    3 81 66 84 21 ext +33       Principal Investigator: Carine RICHOU          Sub-Investigator: Jean-Paul CERVONI          Sub-Investigator: Vincent DI MARTINO          Sub-Investigator: Thierry THEVENOT          Hôpital du Bocage Recruiting Dijon, France, 21079 Contact: Jean-Louis JOUVE    3 80 29 37 50 ext +33       Principal Investigator: Jean-Louis JOUVE          Sub-Investigator: Laurent BEDENNE          Sub-Investigator: Jean FAIVRE          Sub-Investigator: Patrick HILLON          Sub-Investigator: Come LEPAGE          Sub-Investigator: Anne MINELLO          Sub-Investigator: Alice GAGNAIRE          Sub-Investigator: Boris GUIU          Centre Hospitalier de METZ Recruiting Metz, France, 57038 Contact: Jean-Jacques RAABE    3 87 55 33 50 ext +33       Principal Investigator: Jean-Jacques RAABE          Sub-Investigator: Brigitte LE GUILLOU          CHU Robert DEBRE Recruiting Reims, France, 51092 Contact: Gérard THIEFFIN    3 26 78 37 65 ext +33       Principal Investigator: Gérard THIEFFIN          Sub-Investigator: Olivier BOUCHE          Sub-Investigator: Alexandra HEURGUE          Sub-Investigator: Brigitte BERNARD CHABERT          Sub-Investigator: Stéphanie LAGARDE          Sub-Investigator: Aude BERTIN          Sub-Investigator: Elodie SCAGLIA          Sub-Investigator: Florent EHRHARD          Clinique médicale B. Hôpital Civil-Hôpitaux Universitaires Completed Strasbourg, France, 67091 Hôpital de BRABOIS Completed Vandoeuvre-les-nancy, France, 54511 Less <<
NCT02435927 Solid Tumors Phase 1 Recruiting June 2020 Singapore ... More >> National Cancer Centre Recruiting Singapore, Singapore, 169610 Less <<
NCT03707535 Rheumatoid Arthritis Phase 3 Not yet recruiting December 2020 China ... More >> Peking Union Medical College Hospital Not yet recruiting Beijing, China, 100730 Contact: Xiaofeng Zeng Less <<
NCT02189148 - Recruiting March 2018 Canada, Alberta ... More >> South Alberta Maternal Fetal Medicine Centre, University of Calgary Recruiting Calgary, Alberta, Canada Contact: Karla Sanchez    403-943-8383    Karla.GarciaSanchez@albertahealthservices.ca    Contact: Jennifer Mercer    403-944-8448    Jennifer.Mercer@albertahealthservices.ca    Sub-Investigator: Jo-Ann Johnson, MD, FRCSC          Canada, Ontario Sinai Health System, Mount Sinai Hospital Not yet recruiting Toronto, Ontario, Canada, M5G 1X5 Contact: Amara Mathews, Dr    416-586-4417    Amara.Mathews@sinaihealthsystem.ca    Contact: Sara Halawa       Sara.Halawa@sinaihealthsystem.ca    Sub-Investigator: Nan Okun, Dr          Canada, Quebec CHU Ste-Justine Recruiting Montreal, Quebec, Canada, H3T 1C5 Contact: François Audibert, MD, MSc       francois.audibert@umontreal.ca    Contact: Hasna Meddour    514 345-4931 ext 7169    hasna.meddour@recherche-ste-justine.qc.ca    Sub-Investigator: François Audibert, MD, MSc          CHU de Québec Recruiting Quebec city, Quebec, Canada, G1V 4G2 Contact: Emmanuel Bujold, MD, MSc    418-525-4444 ext 47530    emmanuel.bujold@crchudequebec.ulaval.ca    Contact: Sylvie Tapp, MSc    418-525-4444 ext 46039    sylvie.tapp@crchudequebec.ulaval.ca    Principal Investigator: Emmanuel Bujold, MD, MSc Less <<
NCT01312987 Malnutrition ... More >>Undernutrition Less << Not Applicable Completed - -
NCT00898404 - Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT01328171 Metastatic Colorectal Cancer Phase 2 Active, not recruiting January 2022 Germany ... More >> Klinikum Esslingen Esslingen, Baden-Württemberg, Germany, 73730 SLK-Kliniken Heilbronn GmbH Heilbronn, Baden-Württemberg, Germany, 74078 Ortenau Klinikum Lahr, Baden-Württemberg, Germany, 77933 Klinikum Ludwigsburg Ludwigsburg, Baden-Württemberg, Germany, 71640 Universitätsklinikum Mannheim Mannheim, Baden-Württemberg, Germany, 68135 Klinikum Schwäbisch Gmünd Mutlangen, Baden-Württemberg, Germany, 73557 Kreiskliniken Esslingen gGmbH Klinik Nürtingen Nürtingen, Baden-Württemberg, Germany, 72622 Schwerpunktpraxis und Tagesklinik Onkologie Hämatologie Gastroenterologie Palliativmedizin Drs. Höring, Respondek, Schwinger, Thunert Stuttgart, Baden-Württemberg, Germany, 70190 Universitätsklinikum Ulm Zentrum für Innere Medizin Ulm, Baden-Württemberg, Germany, 89081 Klinikum Augsburg Augsburg, Bayern, Germany, 86156 Leopoldina-Krankenhaus der Stadt Schweinfurth gGmbH Schweinfurt, Bayern, Germany, 97422 Klinikum der J.W. Goethe-Universität Frankfurt Frankfurt, Hessen, Germany, 60590 Universitätsklinikum Gießen und Marburg GmbH Marburg, Hessen, Germany, 35043 Franziskus Hospital Niels-Stensen-Kliniken Klinik für Internistische Onkologie und Hämatologie Georgsmarienhütte, Niedersachsen, Germany, 49124 Marienhospital Osnabrück Niels-Stensen-Kliniken Klinik für Innere Medizin Osnabrück, Niedersachsen, Germany, 49074 St. Vincenz-Krankenhaus Paderborn, Nordrhein-Westfalen, Germany, 33098 Klinikum Mutterhaus der Borromäerinnen gGmbH Trier, Rheinland-Pfalz, Germany, 54290 Universitätsklinikum Halle Halle, Sachsen-Anhalt, Germany, 6120 Universitätsklinikum Jena Jena, Thüringen, Germany, 7740 Less <<
NCT03350516 Pregnancy Related Phase 3 Recruiting October 15, 2020 India ... More >> St. John's Research Institute Recruiting Bangalore, India Contact: Anura Kurpad, MD, PhD       a.kurpad@sjri.res.in    Tanzania Africa Academy for Public Health Not yet recruiting Dar Es Salaam, Tanzania Contact: Mary Mwanyika-Sando, MD, MPH       mmwanyika.sando@gmail.com    Ifakara Health Institute Not yet recruiting Dar Es Salaam, Tanzania Contact: Honorati Masanja, PhD       hmasanja@ihi.or.tz Less <<
NCT02539537 Pancreatic Cancer ... More >> Carcinoma Less << Phase 3 Recruiting March 2022 France ... More >> CHU Amiens - Hôpital Nord Recruiting Amiens, France Principal Investigator: Vincent HAUTEFEUILLE, Dr          Institut de cancérologie de l'Ouest - Site Paul Papin Active, not recruiting Angers, France, 49933 Centre hospitalier d'Auxerre Recruiting Auxerre, France Contact: Anne-Laure VILLING, Dr          Centre hospitalier Henri Duffaut Recruiting Avignon, France Contact: Thibault BROTELLE, Dr          Hôpital Avicenne Active, not recruiting Bobigny, France, 93000 Institut Bergonié Active, not recruiting Bordeaux, France, 33076 Polyclinique Bordeaux Nord Active, not recruiting Bordeaux, France, 33077 CH Boulogne sur Mer Active, not recruiting Boulogne sur Mer, France, 62321 CHU Côte de Nacre Active, not recruiting Caen, France, 14033 Centre François Baclesse Active, not recruiting Caen, France, 14076 Hôpital Trousseau Recruiting Chambray-les-tours, France Principal Investigator: Thierry LECOMTE, Dr          Hôpitaux civils de Colmar Recruiting Colmar, France Contact: Gilles BREYSACHER, Dr          CHD Vendée Active, not recruiting La Roche Sur Yon, France, 85925 Centre Hospitalier de Laon Active, not recruiting Laon, France, 02000 Centre Oscar Lambret Recruiting Lille, France, 59020 Principal Investigator: Antoine ADENIS, Pr          Hôpital Privé Jean Mermoz Active, not recruiting Lyon, France, 69008 Hôpital Edouard Herriot - Lyon Recruiting Lyon, France, 69437 Principal Investigator: Julien FORESTIER, Dr          Hôptal Européen Active, not recruiting Marseille, France, 13003 Hôpital De La Timone Active, not recruiting Marseille, France, 13365 Centre Hospitalier de Meaux Active, not recruiting Meaux, France, 77000 CHU Hotel Dieu Recruiting Nantes, France Contact: Yann TOUCHEFEU, Dr          Centre Antoine Lacassagne Recruiting Nice, France Principal Investigator: Philippe FOLLANA, Dr          Hôpital Saint Antoine Active, not recruiting Paris, France, 75571 Groupe hospitalier Paris Saint Joseph Recruiting Paris, France Principal Investigator: Nabil BABA HAMED, Dr          Groupe hospitalier Pitié Salpétrière Recruiting Paris, France Contact: Jean-Baptiste BACHET, Dr          CHU - Robert Debre Recruiting Reims, France, 51092 Principal Investigator: Olivier BOUCHE, Dr          CHU Rouen Recruiting Rouen, France Principal Investigator: Frédéric DI FIORE, Dr          Hôpital Privé des Côtes d'Armor Active, not recruiting Saint Brieuc, France, 22190 Centre Regional René Gauducheau Recruiting Saint Herblain, France Principal Investigator: Olivier CAPITAIN, Dr          Centre Hospitalier de Saint Malo Active, not recruiting Saint Malo, France, 35403 Institut de cancérologie Lucien Neuwirth Active, not recruiting Saint Priest En Jarez, France, 42271 Clinique mutualiste de l'Estuaire Recruiting Saint-Nazaire, France Principal Investigator: Catherine LIGEZA, Dr          Hôpital privé Saint Claude Recruiting Saint-quentin, France Principal Investigator: Pierre VANELSLANDER, Dr          Centre Hospitalier de Soissons Recruiting Soissons, France, 02209 Principal Investigator: Sarah MONTEMBAULT, Dr          Centre Hospitalier de Rangueil Recruiting Toulouse, France, 31059 Principal Investigator: Rosine GUIMBAUD, Pr          Institut de Cancérologie de Lorraine Active, not recruiting Vandoeuvre Les Nancy, France, 54519 Gustave Roussy Recruiting Villejuif, France Principal Investigator: Michel DUCREUX, Pr Less <<
NCT03067012 Oncology Meta... More >>bolic Disease Gastric Cancer Less << Not Applicable Active, not recruiting July 30, 2017 -
NCT01314417 Non-infectious Intermediate an... More >>d Posterior Uveitis Less << Phase 1 Phase 2 Terminated(This study was term... More >>inated due to lack of recruitment.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01676636 - Completed - Bangladesh ... More >> International Center for Diarrheal Disease Research Dhaka, Bangladesh Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT01879995 - Completed - Switzerland ... More >> University Hospital Zurich, Division of Endocrinology, Diabetes and Clinical Nutrition Zurich, ZH, Switzerland, 8091 University Children's Hospital Zurich, Switzerland, CH-8032 Less <<
NCT03024385 - Enrolling by invitation November 2019 United States, Mississippi ... More >> Univeristy of Mississippi Medical Center Jackson, Mississippi, United States, 39216 Less <<
NCT03308487 Maternal Vitamin D Status Not Applicable Recruiting September 2018 Iran, Islamic Republic of ... More >> National Nutrition and Food Technology Research Institute Recruiting Tehran, Iran, Islamic Republic of, 19395-4741 Contact: Tirang R Neyestani, PhD    00989123507663    neytr@yahoo.com Less <<
NCT01314417 - Terminated(This study was term... More >>inated due to lack of recruitment.) Less << - -
NCT01878422 Metastatic Colorectal Cancer Phase 3 Completed - Italy ... More >> Dipartimento Oncologia Ematologia - Policlinico S.Orsola-Malpighi - Università di Bologna Bologna, BO, Italy Ist. di Ematologia e Oncologia Medica "L. e A. Seragnoli" - Università di Bologna Bologna, BO, Italy Ospedale Bellaria-Maggiore, AUSL Città di Bologna Bologna, BO, Italy P.O. San lazzaro Alba, CN, Italy Ospedale Buffalini - ASL Cesena Cesena, FC, Italy Irccs Irst Meldola (FC), FC, Italy, 47014 Azienda Ospedaliero - Università di Ferrara Ferrara, FE, Italy Ospedale Vito Fazzi Lecce, LE, Italy Ospedale Ramazzini - ASL Modena Carpi, MO, Italy Centro Oncologico Modenese - Policlinico di Modena Modena, MO, Italy Ospedale degli Infermi - AUSL di Ravenna Faenza, RA, Italy Ospedale Civile di Lugo -AUSL di Ravenna Lugo, RA, Italy Ospedale S.Maria delle Croci Ravenna, RA, Italy ospedale Civile Cattolica Cattolica, RN, Italy Ospedale Infermi - Azienda USL di Rimini Rimini, RN, Italy AOU S.Giovanni Battista di Torino (Molinette) Presidio San Lazzaro Torino, TO, Italy Azienda Sanitaria Ospedaliera S. Giovanni Battista - Molinette Torino, TO, Italy Ospedale Cardinal Massaia Asti, Italy Azienda ULSS 1 di Belluno Belluno, Italy Ospedale A.Perrino Brindisi, Italy Azienda Osp. Maggiore della Carità Novara, Italy Azienda Ospedaliero Universitaria di Parma Parma, Italy Ospedale di Piacenza, ASL Piacenza Piacenza, Italy Less <<
NCT02224092 Heart Health Markers ... More >> General Nutritional Status Less << Not Applicable Completed - Russian Federation ... More >> Russian Institute of Nutrition Moscow, Russian Federation Less <<
NCT00170404 Mycobacterium Tuberculosis Phase 3 Completed - Tanzania ... More >> Muhimbili University, College of Health Sciences Dar Es Salaam, Tanzania Less <<
NCT01987102 Osteosarcoma Phase 1 Phase 2 Completed - Czechia ... More >> Fakultní nemocnice Brno Klinika detske onkologie Brno, Czechia, 62500 Fakultní nemocnice v Motole Prague, Czechia, 15006 Hungary Semmelweis Egyetem II. Sz. Gyermekgyógyászati Klinika Budapest, Hungary, 1094 Poland Instytut Matki i Dziecka Warszawa, Poland, 01-211 Sweden Department of Oncology, Skåne University Hospital Lund, Sweden, 22185 Less <<
NCT03665441 Pancreatic Adenocarcinoma Phase 3 Not yet recruiting November 2020 -
NCT01684098 Recurrent or Metastatic Cancer... More >> Head and Neck Cancer Pancreas Cancer Bladder Cancer Testicular Cancer Less << Phase 2 Completed - -
NCT00368732 - Completed - United States, California ... More >> California Birth Defects Monitoring Program Berkeley, California, United States, 94710 Less <<
NCT03642600 PCOS Obesity ... More >> Metabolic Syndrome Less << Phase 4 Not yet recruiting December 30, 2019 -
NCT03507244 Leptomeningeal Metastasis Phase 1 Phase 2 Recruiting December 31, 2019 China, Jilin ... More >> The First Hospital of Jilin University Recruiting Changchun, Jilin, China, 130021 Contact: Zhenyu Pan, Professor    +8615804302753    dr-zypan@163.com    Contact: Guozi Yang, Professor    +8615804302755    guoziyang_1982@163.com Less <<
NCT00148629 Anemia Low Bi... More >>rth Weight Neonatal Mortality Less << Phase 3 Unknown - Tanzania ... More >> Public Health Laboratory "Ivo de Carneri" Wawi, Zanzibar, Tanzania Less <<
NCT01368549 - Unknown January 2012 United States, Alabama ... More >> Endocrinology Associates Montgomery, Alabama, United States, 36106 Less <<
NCT01946074 Advanced Solid Tumors Phase 1 Recruiting January 27, 2020 United States, Arizona ... More >> HonorHealth Research Institute - Pima /ID# 105677 Active, not recruiting Scottsdale, Arizona, United States, 85258-2345 Scottsdale Healthcare /ID# 105678 Completed Scottsdale, Arizona, United States, 85258-4566 United States, California University of California, Los Angeles /ID# 141389 Completed Los Angeles, California, United States, 90095 UC Davis Comp Cancer Ctr /ID# 141164 Completed Sacramento, California, United States, 95817 Stanford Univ School of Med /ID# 123758 Completed Stanford, California, United States, 94305-2200 United States, Illinois Illinois Cancer Care, PC /ID# 151970 Recruiting Peoria, Illinois, United States, 61615 United States, Indiana Horizon Oncology Research /ID# 138022 Recruiting Lafayette, Indiana, United States, 47905 United States, North Carolina Duke Univ Med Ctr /ID# 105679 Active, not recruiting Durham, North Carolina, United States, 27710 United States, Tennessee Tennessee Oncology-Sarah Cannon Research Institute /ID# 143280 Completed Nashville, Tennessee, United States, 37203 United States, Texas Mary Crowley Cancer Research /ID# 123757 Completed Dallas, Texas, United States, 75246 Less <<
NCT03152370 Neoadjuvant Therapy in Rectal ... More >>Cancer Less << Phase 1 Recruiting January 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 United States, New York Weill Cornell Recruiting New York, New York, United States, 10065 Poland Marie-Skodowska Curie Cancer Centre Recruiting Warsaw, Poland United Kingdom The Christie Recruiting Manchester, United Kingdom Mount Vernon Hospital Recruiting Northwood, United Kingdom Less <<
NCT00865189 Rectal Cancer Phase 2 Completed - France ... More >> ICO Paul Papin; Oncologie Medicale. Angers, France, 49055 Angers, France, 49055 HOPITAL JEAN MINJOZ; Oncologie Besancon, France, 25030 Besancon, France, 25030 Hopital Saint Andre; Département de Radiothérapie Et D'Oncologie Médicale Bordeaux, France, 33075 Bordeaux, France, 33075 Centre Georges Francois Leclerc; Oncologie 3 Dijon, France, 21079 Dijon, France, 21079 Hopital Albert Michallon; Radiotherapie La Tronche, France, 38700 La Tronche, France, 38700 Centre Oscar Lambret; Radiotherapie Lille, France, 59020 Lille, France, 59020 Centre Hospitalier Andre Boulloche; Departement D'Oncologie Montbeliard, France, 25209 Montbeliard, France, 25209 Centre Val Aurelle Paul Lamarque; Radiotherapie Montpellier, France, 34928 Montpellier, France, 34928 Polyclinique Gentilly; CHIMIOTHERAPIE AMBULATOIRE Nancy, France, 54100 Nancy, France, 54100 Centre Antoine Lacassagne; Hopital De Jour A2 Nice, France, 06189 Nice, France, 06189 Hopital Saint Louis; Radiotherapie Oncologie Paris, France, 75475 Paris, France, 75475 Ch Pitie Salpetriere; Oncologie Medicale Paris, France, 75651 Paris, France, 75651 HOPITAL TENON; Cancerologie Medicale Paris, France, 75970 Paris, France, 75970 Ch Lyon Sud; Radiotherapie Sct Jules Courmont Pierre Benite, France, 69495 Pierre Benite, France, 69495 Chu La Miletrie; Radiotherapie Poitiers, France, 86021 Poitiers, France, 86021 Ico Rene Gauducheau; Oncologie Saint Herblain, France, 44805 Saint Herblain, France, 44805 Centre Paul Strauss; Oncologie Medicale Strasbourg, France, 67065 Strasbourg, France, 67065 Polyclinique Du Parc; Centre De Hautes Energies Toulouse, France, 31078 Toulouse, France, 31078 Hopital Bretonneau; Clinique D'Oncologie & de Radiotherapie Tours, France, 37044 Tours, France, 37044 Centre Alexis Vautrin; Oncologie Medicale Vandoeuvre Les Nancy, France, 54511 Vandoeuvre Les Nancy, France, 54511 Less <<
NCT02588781 Colorectal Cancer Phase 2 Recruiting July 2018 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, seoul, korea, Republic of, Korea, Republic of, 135-710 Contact: yoonJeong Ahn    221487395 ext 82       Principal Investigator: SeungTae Kim, M.D., Ph.D. Less <<
NCT00005338 - Completed - -
NCT00865189 - Completed - -
NCT03203525 Liver Cancer Phase 1 Not yet recruiting December 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact       siqingfu@mdanderson.org Less <<
NCT00734448 Gestational Diabetes Mellitus Not Applicable Unknown December 2014 Italy ... More >> University of Messina - Recruiting Messina, Sicilia, Italy, 98100 Contact: francesco corrado, researcher    39-090-2211 ext 2176    francesco.corrado@unime.it    Principal Investigator: rosario d'anna, professor          Sub-Investigator: francesco corrado, researcher Less <<
NCT03468335 Locally Advanced Pancreatic Ca... More >>ncer Metastatic Pancreatic Cancer Less << Phase 3 Recruiting October 31, 2020 Germany ... More >> Klinikum St. Marien Amberg Not yet recruiting Amberg, Germany, 92224 Contact: Ludwig Fischer von Weikersthal, Dr.          HELIOS Klinikum Bad Saarow Not yet recruiting Bad Saarow, Germany, 15526 Contact: Daniel Pink, Dr.          "St.Josef-Hospital Klinikum der Ruhr-Universität Bochum " Not yet recruiting Bochum, Germany, 44791 Contact: Anke Reinacher-Schick, Prof. Dr.          Städtisches Klinikum Brandenburg Not yet recruiting Brandenburg, Germany, 14770 Contact: Markus Deckert, Prof. Dr.          MVZ Klinikum Coburg GmbH Not yet recruiting Coburg, Germany, 96450 Contact: Christof Lamberti, PD Dr.          BAG Onkologische Gemeinschaftspraxis Dresden Not yet recruiting Dresden, Germany, 01307 Contact: Lutz Jacobasch, Dr.          MVZ Onkologische Kooperation Harz Not yet recruiting Goslar, Germany, 38642 Contact: Maik-Oliver Zahn, Dr.          Universitätsmedizin Göttingen Not yet recruiting Göttingen, Germany, 37075 Contact: Alexander König, Dr.          Facharztzentrum Eppendorf Not yet recruiting Hamburg, Germany, 20249 Contact: Susanna Hegewisch-Becker, Prof. Dr.          Medi Projekt Not yet recruiting Hannover, Germany, 30171 Contact: Michael Königsmann, Prof. Dr.          Onkologische Schwerpunktpraxis im Medicinum Not yet recruiting Hildesheim, Germany, 31135 Contact: Werner Freier, Dr.          Universitätsklinikum des Saarlandes Not yet recruiting Homburg, Germany, 66421 Contact: Frank Lammert, Prof. Dr.          DRK-Kliniken Nordhessen Not yet recruiting Kassel, Germany, 34121 Contact: Mathias Kleiß, Dr.          St. Elisabeth-Krankenhaus GmbH Not yet recruiting Köln - Hohenlind, Germany, 50935 Contact: Nikolaus Ansorge, Dr.          Uniklinikum Köln GmbH Not yet recruiting Köln, Germany, 50937 Contact: Dirk Waldschmidt, Dr.          Klinikum Landshut gGmbH Not yet recruiting Landshut, Germany, 84034 Contact: Juliana Ababei, Dr.          "Onkologie Unter Ems MVM mbH Studienzentrum Unter Ems" Not yet recruiting Leer, Germany, 26789 Contact: Lothar Müller, Dr.          Klinikum der Stadt Ludwigshafen am Rhein gGmbH Not yet recruiting Ludwigshafen, Germany, 67063 Contact: Ralf Jakobs, Prof. Dr.          Universitätsmedizin Mannheim Recruiting Mannheim, Germany, 68167 Contact: Nadine Schulte, Dr.          Uniklinikum Marburg Not yet recruiting Marburg, Germany, 35043 Contact: Eike Gallmeier, Prof. Dr.          Krankenhaus Neuperlach Not yet recruiting München, Germany, 81737 Contact: Meinolf Karthaus, Prof. Dr.          Klinikum Nürnberg Nord Not yet recruiting Nürnberg, Germany, 90419 Contact: Gabriele Siegler, Dr.          Ambulantes Therapiezentrum Hämatologie / Onkologie Not yet recruiting Offenburg, Germany, 77654 Contact: Henning Pelz, Dr.          Studienzentrum Onkologie Ravensburg Not yet recruiting Ravensburg, Germany, 88212 Contact: Thomas Decker, Prof. Dr.          Elblandklinikum Riesa Not yet recruiting Riesa, Germany, 01589 Contact: Jörg Schubert, Prof. Dr.          Klinikum Südstadt Rostock Not yet recruiting Rostock, Germany, 18059 Contact: Beate Krammer-Steiner, Dr.          Caritas-Klinik St. Theresia Recruiting Saarbrücken, Germany, 66113 Contact: Manfred Lutz, Prof. Dr.          Caritas-Klinik St. Theresia Not yet recruiting Saarbrücken, Germany, 66113 Contact: Manfred Lutz, Prof. Dr.          Leopoldina Krankenhaus Not yet recruiting Schweinfurt, Germany, 97422 Contact: Stephan Kanzler, Prof. Dr.          Diakonie Klinikum gGmbH Not yet recruiting Schwäbisch Hall, Germany, 74523 Contact: Thomas Geer, Dr.          Universitätsklinikum Ulm Not yet recruiting Ulm, Germany, 89081 Contact: Thomas Ettrich, Dr.          Schwarzwald-Baar-Klinikum Not yet recruiting Villingen-Schwenningen, Germany, 78052 Contact: Christof Burkart, Dr.          Kliniken Nordoberpfalz Klinikum Weiden Not yet recruiting Weiden, Germany, 92637 Contact: Alaa-Eddin Harba, Dr.          "Medizinische Studiengesellschaft Onkologie Nord-West GmbH" Not yet recruiting Westerstede, Germany, 26655 Contact: Dietmar Reichert, Dr.          Hämatologisch-Onkologische Praxis Würselen Not yet recruiting Würselen, Germany, 52146 Contact: Christoph Maintz, Dr. Less <<
NCT00032435 End Stage Renal Disease ... More >> Renal Failure Less << Phase 3 Completed - -
NCT02745249 Poor Fetal Growth ... More >> Small-for-gestational Age Premature Birth Less << Not Applicable Completed - United States, District of Col... More >>umbia International Food Policy Research Institute Washington, D.C., District of Columbia, United States, 20006 Less <<
NCT01594086 Cognitive Impairment Not Applicable Completed - Japan ... More >> White Cross Nursing Home Higashimurayama, Tokyo, Japan, 189-0021 Less <<
NCT01711359 Rheumatoid Arthritis Phase 3 Completed - -
NCT00950365 Non-small Cell Lung Cancer Phase 2 Unknown - United States, Massachusetts ... More >> University of Massachusetts Recruiting Worcester, Massachusetts, United States, 01655 Contact: Bilal Piperdi, MD    508-856-3702    piperdib@ummhc.org    Principal Investigator: Bilal Piperdi, MD          Sub-Investigator: William V Walsh, MD          United States, New York Albert Einstein Cancer Center Recruiting Bronx, New York, United States, 10461 Contact: Tianhong Li, MD, PhD    718-904-2900    tli@montefiore.org    Contact: Cheryl Baker, APRN    718-405-8508    cbaker@montefiore.org    Principal Investigator: Tianhong Li, MD, PhD          Montefiore Medical Center Recruiting Bronx, New York, United States, 10467 Contact: Rasim Gucalp, MD    718-920-4826    rgucalp@montefiore.org    Contact: Yoko Eng, RN    718-920-2090    yeng@montefiore.org    Sub-Investigator: Rasim Gucalp, MD Less <<
NCT02461784 - Unknown July 2018 United States, Wisconsin ... More >> University of Wisconsin Hospital & Clinics Recruiting Madison, Wisconsin, United States, 53792 Contact: Jenny Vue    608-263-4185    jxvue@medicine.wisc.edu    Contact: Sumona Saha    608-263-4185    ssaha@medicine.wisc.edu Less <<
NCT00299130 Rheumatoid Arthritis Phase 3 Completed - -
NCT02352337 Metastatic Pancreatic Cancer Phase 2 Active, not recruiting February 2019 -
NCT00299130 - Completed - -
NCT02540642 Type 2 Diabetes ... More >> Vitamin B12 Deficiency Hyperhomocysteinemia Less << Not Applicable Completed - India ... More >> Smt Kashibai Navale Medical College and Hospital Pune, Maharashtra, India, 411041 Less <<
NCT01711359 - Completed - -
NCT02836977 Stage III Colon Cancer Not Applicable Active, not recruiting February 29, 2024 Taiwan ... More >> Chung-Ho Memorial Hospital, Kaohsiung Medical University: Kaohsiung, Taiwan, 807 Less <<
NCT00298272 Rheumatoid Arthritis Phase 2 Terminated(Sponsor decided to ... More >>end long term extension phase for business reasons unrelated to safety.) Less << - United States, Alabama ... More >> Research Site Huntsville, Alabama, United States, 35801 United States, Arizona Research Site Paradise Valley, Arizona, United States, 85253 United States, California Research Site Palm Desert, California, United States, 92260 United States, Florida Research Site Jupiter, Florida, United States, 33458 Research Site Sarasota, Florida, United States, 34239 United States, Idaho Research Site Boise, Idaho, United States, 83702 United States, Michigan Research Site Kalamazoo, Michigan, United States, 49048 United States, Missouri Research Site St. Louis, Missouri, United States, 63141 United States, Ohio Research site Chardon, Ohio, United States, 44024 Research Site Mayfield Village, Ohio, United States, 44143 United States, Oklahoma Research Site Oklahoma City, Oklahoma, United States, 73103 Research Site Tulsa, Oklahoma, United States, 74135 United States, Pennsylvania Research Site Duncansville, Pennsylvania, United States, 16635 United States, Texas Research Site Dallas, Texas, United States, 75231 Research Site Houston, Texas, United States, 77074 Research Site San Antonio, Texas, United States, 78217 United States, Utah Research Site Salt Lake City, Utah, United States, 84132 United States, Vermont Research Site Burlington, Vermont, United States, 05401 Less <<
NCT03641183 Pancreas Cancer Phase 1 Phase 2 Recruiting March 31, 2020 United States, Alabama ... More >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Ravikumar Paluri, MD    205-934-2992    rpaluri@uabmc.edu    Principal Investigator: Ravikumar Paluri, MD Less <<
NCT01514942 PCOS Phase 4 Completed - Italy ... More >> Istituto di Patologia Ostetrica e Ginecologica Catania, Italy Less <<
NCT02133521 Acute Ischemic Stroke ... More >> Partial Anterior Circulation Infarct Lacunar Anterior Circulation Infarct Less << Phase 2 Phase 3 Recruiting February 2019 Indonesia ... More >> Neurology Department, Dr. Kariadi General Hospital Completed Semarang, Central Java, Indonesia Neurology Department, Kota Semarang District Public Hospital Not yet recruiting Semarang, Central Java, Indonesia Contact: Riri G Sari, MD., SpS    +6224 671 1500    riri.gusnita@yahoo.com    Principal Investigator: Riri G Sari, MD., SpS          Sub-Investigator: Mintarti Mintarti, MD., SpS          Sub-Investigator: Dyah N Widhiana, MD., SpS          Neurology Department, Pasar Rebo Hospital Recruiting Jakarta, DKI Jakarta, Indonesia Contact: Gotot S PW, Sp. S, MD    +621 8400 109       Principal Investigator: Gotot S PW, Sp. S, MD          Sub-Investigator: Ridwan Ridwan, Sp. S, MD          Sub-Investigator: Donny H Hamid, Sp. S, MD          Neurology Department, Haji Surabaya Hospital Recruiting Surabaya, East Java, Indonesia Contact: Diah H Soeryaningtias, dr., SpS    +6231 592 4000 ext 5910    diahningtyas05@gmail.com    Principal Investigator: Diah H Soeryaningtias, MD. , SpS          Sub-Investigator: Wida Mardiana, MD. , SpS          Sub-Investigator: Neimy Novitasari, MD. , SpS          Sub-Investigator: Nuning Puspitaningrum, MD. , SpS          Stroke/Cerebrobascular Division, Neurology Department, Dr. Soetomo Hospital Completed Surabaya, East Java, Indonesia Cerebrovascular, Neurosonology, and Intervention, Neurology Division, Neurology Department, Dr. Cipto Mangunkusumo Hospital Recruiting Jakarta, Indonesia Contact: Diatri N Lastri, Sp.S(K), MD       nari_ade@yahoo.com    Contact: Mohammad Kurniawan, Sp.S., FICA       mkurniawan.md@gmail.com    Sub-Investigator: Mohammad Kurniawan, Sp.S, MD          Sub-Investigator: Salim Harris, Sp.S(K), MD          Principal Investigator: Diatri N Lastri, Sp.S(K), MD Less <<
NCT00710359 Vitamin B 12 Deficiency Not Applicable Completed - Norway ... More >> Department of Pediatrics, Haukeland University Hospital Bergen, Norway, 5021 Less <<
NCT02362984 Acute Ischemic Stroke Phase 3 Terminated(Major technical hin... More >>drance in recruitment.) Less << - Indonesia ... More >> RSUD R. Syamsudin, SH Sukabumi, West Java, Indonesia, 43113 Less <<
NCT00298272 - Terminated(Sponsor decided to ... More >>end long term extension phase for business reasons unrelated to safety.) Less << - -
NCT03272022 - Active, not recruiting February 8, 2025 -
NCT03378141 Anemia Undern... More >>utrition Underweight Stunting Maternal Malnutrition Less << Not Applicable Recruiting December 30, 2020 United States, District of Col... More >>umbia International Food Policy Research Institute Recruiting Washington, District of Columbia, United States, 20006 Contact: Phuong Nguyen    202-826-4088    p.h.nguyen@cgiar.org Less <<
NCT00710138 Vitamin B 12 Deficiency Not Applicable Completed - Norway ... More >> Department of Pediatrics, Haukeland University Hospital Bergen, Norway, 5021 Less <<
NCT01276379 Colorectal Cancer Phase 2 Completed - Spain ... More >> Hospital Provincial de Castellón Castelló de la Plana, Castellón, Spain Hospital Son Espases Palma, Malllorca, Spain Hospital Son Llàtzer Palma, Mallorca, Spain Hospital Sant Joan de Reus Reus, Tarragona, Spain Complejo Hospitalario Universitario de Albacete Albacete, Spain Hospital Infanta Cristina de Badajoz Badajoz, Spain Hospital de Barbastro Barbastro, Spain Hospital Clínic de Barcelona Barcelona, Spain Hospital General Yagüe Burgos, Spain Hospital Sant Jaume de Calella Calella, Spain Hospital San Pedro de Alcántara Cáceres, Spain Hospital General Universitario de Elche Elche, Spain Hospital de Jaén Jaén, Spain Hospital Universitario de Gran Canaria Dr. Negrín Las Palmas de Gran Canaria, Spain Hospital Universitari Arnau de Vilanova de Lleida Lleida, Spain Fundación Jimenez Díaz Madrid, Spain Hospital de Móstoles Madrid, Spain Hospital Universitario la Paz Madrid, Spain Hospital de Mataró Mataró, Spain Clínica Universitaria de Navarra Pamplona, Spain Hospital de Navarra Pamplona, Spain Hospital de Sagunto Sagunto, Spain Mutua de Terrassa Terrassa, Spain Hospital Virgen de la Salud Toledo, Spain Instituto Valenciano de Oncología Valencia, Spain Hospital Clínico Universitario Lozano Blesa Zaragoza, Spain Hospital Miguel Servet Zaragoza, Spain Less <<
NCT03088189 - Recruiting March 31, 2023 India ... More >> Diabetes Unit, Kem Hospital Research Centre Recruiting Pune, Maharashtra, India, 411014 Contact: Chittaranjan S Yajnik, MD          Principal Investigator: Chittaranjan S Yajnik, MD , FRCP Less <<
NCT01647984 Ventricular and Atrial Extrasy... More >>toles Less << Phase 4 Completed - Italy ... More >> Ambulatorio Ipertensione e Unità Coronarica Federico II University Naples, Italy, 80131 Less <<
NCT00314990 Deep-Vein Thrombosis ... More >> Pulmonary Embolism Less << Not Applicable Completed - Netherlands ... More >> Leyenburg Hospital (currently HAGA-hospital) The Hague, Netherlands, 2545 CH Less <<
NCT01118624 - Completed - -
NCT02022358 Osteosarcoma ... More >>Spindle Cell Sarcoma of Bone Less << Phase 2 Terminated(Recruitment almost ... More >>complete, has been slow and challenging) Less << - United Kingdom ... More >> University College Hospital London, United Kingdom, NW1 2PG Less <<
NCT02437955 Anemia; Deficiency, Nutritiona... More >>l, With Poor Iron Absorption Less << Not Applicable Completed - Senegal ... More >> Université Cheikh Anta Diop Dakar, Senegal Less <<
NCT02928224 BRAF V600E-mutant Metastatic C... More >>olorectal Cancer Less << Phase 3 Recruiting July 2019 -
NCT03172325 Active Rheumatoid Arthritis Phase 3 Completed - -
NCT01266408 - Recruiting December 2025 Germany ... More >> Center for Epidemiology and Health Research Recruiting Berlin, Germany, 10115 Contact: Suzanne Reed, MSc, PhD    +49 30 945 101 63    reed@zeg-berlin.de    Contact: Klaas Heinemann, PhD, MD, MBA    +49 30 945 101 24    k.heinemann@zeg-berlin.de    Principal Investigator: Juergen C Dinger, PhD, MD Less <<
NCT01608750 Nonulcer Dyspepsia Phase 4 Unknown June 2013 Turkey ... More >> Bezmialem medical faculty Not yet recruiting Istanbul, Turkey Contact: Birol Baysal    +905057758585    babbaysal@gmail.com    Principal Investigator: Birol Baysal Less <<
NCT01540747 Polycystic Ovary Syndrome Phase 4 Completed - Italy ... More >> Praxi Pro Vita Centro di Fertilità Rome, Italy Less <<
NCT02197624 - Completed - United States, New York ... More >> Human Metabolic Research Unit, Cornell University Ithaca, New York, United States, 14853 Less <<
NCT02826408 Signs and Symptoms Not Applicable Completed - Jordan ... More >> Istishari Hospital Amman, Jordan, 11184 Less <<
NCT00421668 Diarrheal Illnesses ... More >> Respiratory Illness Growth Faltering Less << Phase 3 Completed - Tanzania ... More >> Muhimbili Uinverstiy College of Health Sciences Dar es Salaam, Tanzania Less <<
NCT01420874 Colorectal Cancer ... More >> Cancer of Pancreas Pancreatic Neoplasm Malignant Neoplasm of Large Intestine Malignant Tumor of Colon Colon Carcinoma Cancer of Colon Pancreatic Cancer Less << Phase 1 Active, not recruiting June 2019 United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48601 Less <<
NCT00555542 Rheumatoid Arthritis Phase 2 Completed - China ... More >> Department of Medicine and Therapeutics Hong Kong, China Less <<
NCT00473200 Hyperhomocysteinemia Phase 1 Completed - United States, Texas ... More >> Baylor University Medical Center Dallas, Texas, United States, 75204 Less <<
NCT03710876 Malignant Pleural Mesothelioma Phase 3 Not yet recruiting November 2024 -
NCT03151096 High Blood Pressure ... More >> MTHFR C677T Genotype Less << Not Applicable Recruiting November 2019 Gambia ... More >> MRC Clinic Keneba Recruiting Keneba, West Kiang, Gambia Contact: Modou Jobe, MD    +220-4495443 ext 2902    mojobe@mrc.gm Less <<
NCT01384994 Colorectal Cancer ... More >> KRAS Wildtype After Resection of Liver Metastases Less << Phase 2 Unknown August 2014 Germany ... More >> Ludwig-Maximilians - University of Munich Recruiting Munich, Germany, 81377 Contact: Volker Heinemann, Prof. Dr. med.    +49 89 7095 ext 0    volker.heinemann@med.uni-muenchen.de    Contact: Clemens Giessen, Dr. med.    +49 89 7095 ext 0    clemens.giessen@med.uni-muenchen.de    Principal Investigator: Volker Heinemann, Prof. Dr. med. Less <<
NCT00176540 Fatigue Unspe... More >>cified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific Less << Not Applicable Terminated(slow accrual) - United States, New Jersey ... More >> Cancer Institute of New Jersey at Hamilton Hamilton, New Jersey, United States, 08690 Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 Less <<
NCT01454180 Advanced Pancreatic Carcinoma Phase 2 Completed - Spain ... More >> Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain, 28950 Hospital Universitario Madrid Sanchinarro Madrid, Spain, 28050 Less <<
NCT00549848 Acute Lymphoblastic Leukemia Phase 3 Active, not recruiting November 30, 2020 United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01652482 Colorectal Cancer Phase 2 Completed - -
NCT02576067 Vascular Inflammation ... More >> Atherosclerotic Cardiovascular Disease Less << Phase 3 Active, not recruiting May 31, 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02199 United States, New York Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Canada, Ontario St. Michael's Hospital Toronto, Ontario, Canada Less <<
NCT00500682 Chronic Kidney Disease Phase 3 Completed - -
NCT00500682 - Completed - -
NCT00501046 Chronic Kidney Disease Phase 3 Completed - -
NCT00448513 Healthy Not Applicable Completed - Japan ... More >> Shizuoka General Hospital Shizuoka, Japan, 420-0881 Less <<
NCT00806819 Carcinoma, Non-Small-Cell Lung Phase 3 Completed - -
NCT01246310 Depression PC... More >>OS Less << Phase 4 Unknown - Italy ... More >> Agunco Recruiting Rome, Italy, Rome Contact: Vittorio Unfer, MD       vunfer@gmail.com    Contact: Gianfranco Carlomagno, PhD       gianfranco.carlomagno@gmail.com    Principal Investigator: Vittorio Unfer, MD          Principal Investigator: Gianfranco Carlomagno, PhD Less <<
NCT03106077 Malignant Neoplasm of Breast Phase 2 Recruiting June 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       smoulder@mdanderson.org Less <<
NCT01836575 Non Small Cell Lung Carcinoma Phase 3 Completed - United States, Florida ... More >> The Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States, 33140 Brazil Instituto do Câncer do Ceará - ICC Fortaleza, Ceará, Brazil Hospital Lifecenter Belo Horizonte, Minas Gerais, Brazil Hospital Caridade de Ijuí - CACON Ijuí, RS, Brazil Hospital São Lucas Porto Alegre, RS, Brazil Centro de Pesquisas Oncológicas - CEPON Florianópolis, Santa Catarina, Brazil Hospital Amaral Carvalho Jaú, São Paulo, Brazil INCA Rio de Janeiro, Brazil Instituto do Câncer Arnaldo Vieira de Carvalho São Paulo, Brazil Less <<
NCT00501046 - Completed - -
NCT01896752 - Completed - Denmark ... More >> Department of Pediatrics, Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT02368860 Pancreatic Cancer Phase 1 Recruiting June 2019 Singapore ... More >> National Cancer Centre Recruiting Singapore, Singapore, 169610 Contact: Lanying Wang    64368267    nctwly@nccs.com.sg Less <<
NCT03332602 Iron-deficiency Not Applicable Completed - Switzerland ... More >> Human Nutrition Laboratory, ETH Zurich Zurich, Switzerland, 8092 Less <<
NCT01479855 - Unknown December 2013 Norway ... More >> OsloUH, Ullevål Recruiting Oslo, Norway, 0424 Principal Investigator: Ingun D Ulstein, MD PhD Less <<
NCT00994864 Colon Cancer Not Applicable Active, not recruiting December 2022 Belgium ... More >> Clinique St-Luc Bouge Bouge, Belgium, 5004 Hôpital Erasme Brussels, Belgium, 1000 Jules Bordet Institute Brussels, Belgium, 1000 CHU Brugmann Brussels, Belgium, 1020 IRIS Etterbeek-Ixelles Brussels, Belgium, 1050 Clin Université St-Luc Bruxelles Brussels, Belgium, 1200 HIS IZZ Bracops Brussels, Belgium Grand Hôpital Charleroi Charleroi, Belgium UZ Antwerp Edegem, Belgium, 2650 UZ Gent Gent, Belgium, 9000 AZ Groeninge Kortrijk, Belgium, 8500 CHR Citadelle de Liege Liege, Belgium, 4000 CHU De Liège Liège, Belgium, 4000 Clinique St-Joseph Liège, Belgium, 4000 ZNA - Jan Palfijin Merksem, Belgium, 2170 CHU Ambroise Paré Mons, Belgium, 7000 CHR Namur Namur, Belgium, 5000 AZ Damiaan Oostende, Belgium, 8400 clinique St Pierre Ottignies Ottignies, Belgium AZ Turnhout Turnhout, Belgium Clinique Universites UCL Mont-Godinne Yvoir, Belgium, 5530 Less <<
NCT00806819 - Completed - -
NCT01281800 Mesothelioma Phase 2 Unknown - Slovenia ... More >> Institute of Oncology Ljubljana Recruiting Ljubljana, Slovenia, 1000 Contact: Viljem Kovac, MD    +386 1 5879 504    vkovac@onko-i.si    Sub-Investigator: Matjaz Zwitter, MD, PhD          Principal Investigator: Viljem Kovac, MD Less <<
NCT02666417 Anemia, Iron-Deficiency Not Applicable Completed - Kenya ... More >> Msambweni District Hopsital Msambweni, Kwale County, Kenya Less <<
NCT03775343 - Recruiting May 2020 Austria ... More >> Medical University Vienna Recruiting Vienna, Austria, 1090 Contact: Marita Windpassinger, MD    +43140400 ext 41020    marita.windpassinger@meduniwien.ac.at    Contact: Olga Plattner, MD    +43140400 ext 41020    olga.plattner@meduniwien.ac.at    Principal Investigator: Marita Windpassinger, MD Less <<
NCT01378052 - Unknown - Taiwan ... More >> Department of Urology, China Medical University Hospital Recruiting Taichung, 404, Taiwan Contact: Chao-Hsiang Chuang, PhD    886-4-22052121 ext 4439    urology8395@yahoo.com.tw Less <<
NCT00166465 Locally Advanced Unresectable ... More >>or Stage IV Colorectal Cancer Less << Phase 1 Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01804790 Cancer of the Rectum Phase 3 Active, not recruiting January 2022 France ... More >> Centre hospitalier Universitaire d'Amiens Amiens, France ICO - Site Paul Papin Angers, France Centre hospitalier d'Auxerre Auxerre, France Centre Hospitalier de Beauvais Beauvais, France Institut de Cancérologie de Franche Comté Besancon, France Centre Hospitalier de Blois Blois, France Hopital Avicenne Bobigny, France Clinique Tivoli Bordeaux, France Hopital Saint Andre Bordeaux, France Institut Bergonie Bordeaux, France Centre Francois Baclesse Caen, France Chd de La Roche Sur Yon - Les Oudairies La Roche-sur-yon, France Centre Bourgogne Lille, France Centre Oscar Lambret Lille, France Centre Léon Bérard Lyon, France Hopital Prive Jean Mermoz Lyon, France Ap Hm - Hopital de La Timone - Adultes Marseille, France Institut de Cancérologie de Franche Comté Montbeliard, France Centre Azuréen de cancérologie Mougins, France Hopital Emile Muller Mulhouse, France centre Alexis Vautrin Nancy, France Polyclinique de Gentilly Nancy, France Centre Antoine Lacassagne Nice, France Groupe Hospitalier La Pitie-Salpetriere Paris, France Institut Mutualiste Montsouris Paris, France Hopital Haut Leveque Pessac, France Centre Hospitalier Regional D'Annecy Pringy, France Hopital Robert Debre Reims, France Institut Jean Godinot Reims, France Clinique Armoricaine de Radiologie Saint-brieuc, France Hopital Saint Gregoire Saint-gregoire, France Clinique Mutualiste de L'Estuaire Saint-nazaire, France Centre Hospitalier de la Réunion - Site du GHSR Saint-pierre, France ICO - Site René Gauducheau St Herblain, France Centre Paul Strauss Strasbourg, France Gustave Roussy Villejuif, France Less <<
NCT01745198 - Completed - United States, California ... More >> Hoag Memorial Hospital Newport Beach, California, United States, 92663 Less <<
NCT02620345 Fibroids Phase 4 Completed - -
NCT03526900 Non-small Cell Lung Cancer Sta... More >>ge IV Less << Phase 2 Recruiting December 15, 2022 Spain ... More >> Hospital General Universitario de Elche Not yet recruiting Elche, Alicante, Spain, 03203 Contact: María Guirado, MD          Principal Investigator: María Guirado, MD          Hospital Universitari Germans Tries i Pujol Recruiting Badalona, Barcelona, Spain, 08916 Contact: Enric Carcereny, PhD    + 93 430 20 06    ecarcereny@iconcologia.net    Principal Investigator: Enric Carcereny          Hospital Universitari de Bellvitge Recruiting L'Hospitalet de Llobregat, Barcelona, Spain, 08908 Contact: Ernest Nadal, phD    +34 32607744    esnadal@iconcologia.net    Principal Investigator: Ernest Nadal          Complejo Hospitalario de la Coruña Recruiting La Coruña, Coruña, Spain, 15006 Contact: Rosario García Campelo, MD-phD          Principal Investigator: Rosario García Campelo          Hospital Insular de Gran Canaria Not yet recruiting Las Palmas de Gran Canaria, Las Palmas, Spain Contact: Delvys Rodríguez, MD    +34 93 430 20 06    delvysra@yahoo.com    Principal Investigator: Delvys Rodríguez, MD          Complexo Hospitalario Universitario de Vigo Recruiting Vigo, Pontevedra, Spain, 36036 Contact: Gerardo Huidobro          Principal Investigator: Gerardo Huidobro, MD          Hospital General de Alicante Not yet recruiting Alicante, Spain, 03010 Contact: Bartomeu Massutí, MD-phD          Principal Investigator: Bartomeu Massutí          H.U.Vall D´Hebrón Recruiting Barcelona, Spain, 08035 Contact: Enriqueta Felip, MD    +34932746085    efelip@vhebron.net    Principal Investigator: Enriqueta Felip, MD          Hospital de Santa Creu i Sant Pau Recruiting Barcelona, Spain, 08041 Contact: Ivana Sullivan, MD          Principal Investigator: Ivana Sullivan, MD          Hospital Dr. Josep Trueta Recruiting Girona, Spain, 17007 Contact: Joaquim Bosch, MD          Principal Investigator: Joaquim Bosch, MD          Hospital Fundación Jiménez Díaz Not yet recruiting Madrid, Spain, 28040 Contact: Manuel Dómine, MD          Principal Investigator: Manuel Dómine          H. La Paz Recruiting Madrid, Spain Contact: Javier de Castro, MD          Principal Investigator: Javier de castro, MD          Hospital General Universitario de Valencia Recruiting Valencia, Spain, 46014 Contact: Ana Blasco Cordellat, MD          Principal Investigator: Ana Blasco, MD          Hospital La Fe Not yet recruiting Valencia, Spain, 46026 Contact: Óscar Juan, MD          Principal Investigator: Óscar Juan, MD          Hospital Clínico Universitario de Valladolid Recruiting Valladolid, Spain, 47003 Contact: Rafael López, MD          Principal Investigator: Rafael López, MD Less <<
NCT01046500 Metabolic Syndrome Phase 2 Unknown December 2014 Italy ... More >> University Hospital Recruiting Messina, Italy Contact: Rosario D'Anna, associate professor    +39 090 2217324    rosariodanna@tin.it    Principal Investigator: Rosario D'Anna, associate professor Less <<
NCT02662504 Malignant Pleural Mesothelioma Phase 2 Completed - France ... More >> CHRU de Lille Hôpital Calmette Lille, France Less <<
NCT01063049 Preparation for Colonoscopy Phase 4 Completed - United States, Illinois ... More >> Gastroenterology Services Downers Grove, Illinois, United States, 60515 Less <<
NCT00001341 Neoplasm Phase 1 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00737373 Gastric Cancer ... More >> Adenocarcinoma of the Esophagogastric Junction Less << Phase 2 Completed - Germany ... More >> Krankenhaus Nordwest Frankfurt, Germany, 60488 Less <<
NCT00849615 Gastric Cancer ... More >> Adenocarcinoma of the Esophagogastric Junction Less << Phase 2 Completed - Germany ... More >> Krankenhaus Nordwest Frankfurt, Germany, 60488 Less <<
NCT00018460 Cardiovascular Diseases Not Applicable Completed - United States, Maryland ... More >> VA Maryland Health Care System Baltimore, Maryland, United States, 21201 Less <<
NCT01964534 Metastatic Pancreatic Cancer Phase 2 Active, not recruiting July 2017 France ... More >> Institut de cancérologie de l'Ouest - Paul Papin Angers, France Institut Sainte Catherine Avignon, France Hôpital Avicenne Bobigny, France Hôpital Beaujon Clichy, France Hôpital Henri Mondor Créteil, France Hôpital Privé Jean Mermoz Lyon, France CHU la Timone Marseille, France Centre Hospitalier Layné Mont de Marsan, France Hôpital Européen Georges Pompidou Paris, France Hôpital Pitié-Salpêtrière Paris, France Hôpital Saint Antoine Paris, France Institut Mutualiste Montsouris Paris, France CHU de Reims Hôpital Robert Debré Reims, France Institut de Cancérologie de l'Ouest - Réné Gauducheau Saint Herblain, France, 44805 Hôpital Trousseau - CHRU Tours Tours, France Less <<
NCT01522612 Colorectal Cancer Metastatic Phase 2 Terminated(poor accrual) - Belgium ... More >> AZ Turnhout - Campus Sint Elisabeth Turnhout, Belgium Cyprus Bank Of Cyprus Oncology Centre Nicosia, Cyprus Spain Hospital General Vall D'Hebron Barcelona, Spain Less <<
NCT00835185 Metastatic Colorectal Cancer Phase 2 Completed - Belgium ... More >> ImClone Investigational Site Brussels, Belgium, 1000 ImClone Investigational Site Haine Saint-Paul, Belgium, 7100 Spain ImClone Investigational Site Barcelona, Spain, 08035 ImClone Investigational Site Madrid, Spain, 28040 ImClone Investigational Site Valencia, Spain, 46010 Less <<
NCT03121807 Metastatic Gastric Cancer Not Applicable Recruiting December 1, 2019 Taiwan ... More >> Chung-Ho Memorial Hospital, Kaohsiung Medical University: Recruiting Kaohsiung, Taiwan, 807 Contact: Jaw-Yuan Wang, PhD       cy614112@ms14.hinet.net    Contact: Cheng-Jen Ma, MD       kmu880402@gmail.com    Principal Investigator: Jaw-Yuan Wang, Ph.D.          Sub-Investigator: Cheng-Jen Ma, MD Less <<
NCT01853813 Colorectal Cancer Stage II Phase 2 Completed - Italy ... More >> A.O. Treviglio-Caravaggio, P.le Ospedale n1 Treviglio, Bergamo, Italy, 24047 Ospedale Civile Carrara, Massa Carrara, Italy, 54033 A.O. Ospedale S.Paolo Milano, MI, Italy, 20100 Istituto Oncologico Veneto Padova, PD, Italy, 35124 Ospedale Santa Croce Fano, PS, Italy, 61032 Azienda Ospedaliera San Carlo Potenza, PZ, Italy, 85100 Università Policlinico Umberto I Roma, RM, Italy, 00186 A.O. Universitaria - Ospedali Riuniti Ancona, Italy, 60100 A.O. Ospedale G.Rummo Benevento, Italy, 82100 Istituto Ospedaliero Fondazione Poliambulanza Brescia, Italy, 25124 Ospedale Maggiore Policlinico Milano, Italy, 20122 IRCCS Istituto Europeo di Oncologia Milano, Italy, 20141 A.O. S.Giovanni Calabita Fatebenefratelli Roma, Italy, 00186 Less <<
NCT00862784 - Completed - -
NCT00835185 - Completed - -
NCT00628459 Anemia Undern... More >>utrition Less << Not Applicable Completed - Burkina Faso ... More >> District Sanitaire de Kongoussi Kongoussi, Burkina Faso Less <<
NCT01063049 - Completed - -
NCT03146273 Vitamin Deficiency Not Applicable Not yet recruiting July 1, 2017 -
NCT00986440 Colorectal Cancer Phase 2 Completed - -
NCT00862784 Colorectal Carcinoma Phase 2 Completed - Canada, Ontario ... More >> ImClone Investigational Site Ottawa, Ontario, Canada, K1H 8L6 ImClone Investigational Site Toronto, Ontario, Canada, M5G-2M9 Canada, Quebec ImClone Investigational Site Montreal, Quebec, Canada, H2L 4M1 Spain ImClone Investigational Site Barcelona, Spain ImClone Investigational Site Santander, Spain ImClone Investigational Site Seville, Spain ImClone Investigational Site Valencia, Spain Less <<
NCT00933998 Diabetic Peripheral Neuropathy Not Applicable Completed - United States, South Carolina ... More >> Carolina Musculoskeletal Institute Aiken, South Carolina, United States, 29841 Less <<
NCT00735241 Colorectal Carcinoma ... More >> Liver Metastases Less << Phase 2 Phase 3 Withdrawn(Withdrawn by the stu... More >>dy sponsor.) Less << March 2009 United States, Michigan ... More >> William Beaumont Hospital Royal Oak, Michigan, United States, 48073 United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States, 28208 United States, Washington Sacred Heart Medical Center Spokane, Washington, United States, 99204 Less <<
NCT00005482 - Completed - -
NCT03656549 Non Small Cell Lung Cancer ... More >> Mesothelioma Less << Phase 2 Not yet recruiting October 1, 2021 Netherlands ... More >> Jeroen Bosch Hospital Not yet recruiting 's-Hertogenbosch, Netherlands Contact: Bonne Biesma       b.biesma@jbz.nl    Principal Investigator: Bonne Biesma          Sub-Investigator: Jeroen Derijks          Antoni van Leeuwenhoek Not yet recruiting Amsterdam, Netherlands Contact: Sjaak Burgers       s.burgers@nki.nl    Principal Investigator: Sjaak Burgers          Sub-Investigator: Alwin Huitema          Maastricht University Medical centre Not yet recruiting Maastricht, Netherlands Contact: Anne-Marie Dingemans       a.dingemans@mumc.nl    Principal Investigator: Anne-Marie Dingemans          Radboud university medical centre Not yet recruiting Nijmegen, Netherlands Contact: Rob ter Heine       R.terHeine@radboudumc.nl    Principal Investigator: Rob ter Heine          Sub-Investigator: Nikki de Rouw          Sub-Investigator: Michel van den Heuvel          Erasmus University Medical Centre Not yet recruiting Rotterdam, Netherlands Contact: Joachim Aerts       j.aerts@erasmusmc.nl    Principal Investigator: Joachim Aerts          Sub-Investigator: Ron Mathijsen Less <<
NCT01040195 Seronegative Spondyloarthropat... More >>hies Less << Phase 3 Completed - India ... More >> Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow, UP, India, 226014 Less <<
NCT03317210 Anemia Phase 4 Completed - -
NCT03442283 - Active, not recruiting June 2018 -
NCT03655821 Non Small Cell Lung Cancer ... More >> Mesothelioma Less << Phase 4 Not yet recruiting September 1, 2021 Netherlands ... More >> Jeroen Bosch Hospital Not yet recruiting 's-Hertogenbosch, Netherlands Contact: Bonne Biesma       b.biesma@jbz.nl    Principal Investigator: Bonne Biesma          Sub-Investigator: Jeroen Derijks          Antoni van Leeuwenhoek Not yet recruiting Amsterdam, Netherlands Contact: Sjaak Burgers       s.burgers@nki.nl    Principal Investigator: Sjaak Burgers          Sub-Investigator: Alwin Huitema          Maastricht University Medical centre Not yet recruiting Maastricht, Netherlands Contact: Anne-Marie Dingemans       a.dingemans@mumc.nl    Principal Investigator: Anne-Marie Dingemans          Radboud university medical centre Not yet recruiting Nijmegen, Netherlands Contact: Rob ter Heine       R.terHeine@radboudumc.nl    Principal Investigator: Rob ter Heine          Sub-Investigator: Nikki de Rouw          Sub-Investigator: Michel van den Heuvel          Erasmus University Medical Centre Not yet recruiting Rotterdam, Netherlands Contact: Joachim Aerts       j.aerts@erasmusmc.nl    Principal Investigator: Joachim Aerts          Sub-Investigator: Ron Mathijsen Less <<
NCT01374373 Antineoplastic Chemotherapy In... More >>duced Anemia Less << Phase 4 Completed - Argentina ... More >> Centro Oncologico de Investigaciones Buenos Aires Berazategui, Buenos Aires, Argentina Hospital Zonal Especializado en Oncología de Lanus Lanus Este, Buenos Aires, Argentina, CP 1824 Centro de Medicina Integral e Investigación Clínica Buenos Aires, Argentina Less <<
NCT02723578 Metastatic Colorectal Cancer Phase 2 Active, not recruiting November 2018 Korea, Republic of ... More >> Yonsei University Health System, Severance Hospital Seoul, Korea, Republic of, 03722 Less <<
NCT00415194 Head and Neck Neoplasms Phase 3 Completed - -
NCT01165021 Non Small Cell Lung Cancer Phase 2 Completed - Italy ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy, 20133 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Novara, Italy, 28100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orbassano, Italy, 10043 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Padova, Italy, 35100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pisa, Italy, 56100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rome, Italy, 00144 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sondalo, Italy, 23039 Less <<
NCT00415194 - Completed - -
NCT03655834 Non Small Cell Lung Cancer ... More >> Mesothelioma Less << Phase 4 Not yet recruiting September 1, 2021 Netherlands ... More >> Jeroen Bosch Hospital Not yet recruiting 's-Hertogenbosch, Netherlands Contact: Bonne Biesma       b.biesma@jbz.nl    Principal Investigator: Bonne Biesma          Sub-Investigator: Jeroen Derijks          Antoni van Leeuwenhoek Not yet recruiting Amsterdam, Netherlands Contact: Sjaak Burgers       s.burgers@nki.nl    Principal Investigator: Sjaak Burgers          Sub-Investigator: Alwin Huitema          Maastricht University Medical centre Not yet recruiting Maastricht, Netherlands Contact: Anne-Marie Dingemans       a.dingemans@mumc.nl    Principal Investigator: Anne-Marie Dingemans          Radboud university medical centre Not yet recruiting Nijmegen, Netherlands Contact: Rob ter Heine       R.terHeine@radboudumc.nl    Principal Investigator: Rob ter Heine          Sub-Investigator: Nikki de Rouw          Sub-Investigator: Michel van den Heuvel          Erasmus University Medical Centre Not yet recruiting Rotterdam, Netherlands Contact: Joachim Aerts       j.aerts@erasmusmc.nl    Principal Investigator: Joachim Aerts          Sub-Investigator: Ron Mathijsen Less <<
NCT00744900 Lung Cancer Phase 2 Completed - France ... More >> Centre Hôspitalier du Pays d'Aix, Service des Maladies Respiratoires Aix En Provence, France, 13616 CHU d'Angers, Service de Pneumologie Angers, France, 49033 Médecine 4, C.H.G. de la Fontonne Antibes Antibes, France, 06606 CHU brest, institut de cancérologie et d'hématologie Brest, France, 29200 Centre François Baclesse Caen, France, 14000 Centre Hospitalier René Dubos - Pontoise, Service d'Oncologie - Hématologie Clinique Cergy Pontoise, France, 95303 Centre Hospitalier, Service de Pneumologie Charleville, France, 08 000 CHI, Service de Pneumologie Creteil, France, 94010 Pneumologie, Centre hôspitalier, DRAGUIGNAN Draguignan, France, 83300 CH GAP GAP, France, 05000 Centre Hospitalier Départemental, Service de Pneumologie, La Roche Sur Yon, France, 85000 Hôpital A. Mignot, Service de Pneumologie Le Chesnay, France, 78157 Hopital de la Croix Rousse Lyon, France, 69317 Centre Hôspitalier, Service de Pneumo-Neuro Mantes La Jolie, France, 78200 Hôpital Sainte Margueritte Marseilles, France, 13274 Serv. de Pneumo-Allergo, CH de Martigues Martigues, France, 13695 Serv. de Pneumo - Hôpital St Antoine Paris, France, 75571 Service Pneumologie, Pavillon 1A, CH de Lyon-Sud Pierre-benite, France, 69495 Hôpital Pontchailloux, Service de Pneumologie. Rennes, France, 35033 CHG, Service de Pneumologie Roanne, France, 42300 Luc THIBERVILLE Rouen, France, 76031 CHU de ROUEN, Hôpital Bois Guillaume, Serv. de Pneumo. Rouen, France, 76233 Institut de Cancérologie de la Loire Saint-Priest en Jarez Cedex, France, 42271 CHU, Service du Pr. Carles Toulouse, France, 31059 Pneumologie, Centre Hospitalier VILLEFRANCHE sur SAONE, France, 69655 Less <<
NCT01165021 - Completed - -
NCT00197678 HIV Infections Phase 3 Completed - United States, Massachusetts ... More >> Harvard School of Public Health Boston, Massachusetts, United States, 02115 Less <<
NCT02934529 Metastatic Colorectal Cancer Phase 3 Recruiting March 2022 Germany ... More >> Klinikum der Universitaet Muenchen - Campus Grosshadern Recruiting Munich, Germany, 81377 Contact: Volker Heinemann, Prof    +49 89 44000    volker.heinemann@med.uni-muenchen.de Less <<
NCT00786058 - - - -
NCT03537833 - Recruiting September 1, 2020 France ... More >> Chu Reims Recruiting Reims, France, 51092 Contact: Damien JOLLY    326788472 ext 33    djolly@chu-reims.fr Less <<
NCT00383669 HIV Infections Phase 3 Completed - Tanzania ... More >> Muhimbili University College of Health Sciences Dar es Salaam, Tanzania Less <<
NCT03043950 - Recruiting January 2023 Germany ... More >> Praxis für interdisziplinäre Onkologie & Hämatologie Recruiting Freiburg i.Br., Baden-Württemberg, Germany, 79110 Contact: Dieter Semsek, Dr.    +4976138687 ext 25    semsek@onkologie-freiburg.de    Contact: Manuela Rees    +4976138687 ext 25    rees@onkologie-freiburg.de Less <<
NCT02151851 Rheumatoid Arthritis Phase 3 Completed - China ... More >> 037 Baotou, China 001 Beijing, China 002 Beijing, China 013 Beijing, China 021 Beijing, China 025 Beijing, China 033 Beijing, China 014 Bengbu, China 011 Changchun, China 034 Changchun, China 017 Changsha, China 019 Changsha, China 007 Chengdu, China 012 Chengdu, China 004 Guangzhou, China 015 Hangzhou, China 008 Harbin, China 005 Hefei, China 022 Jinan, China 031 Kunming, China 028 Nanjing, China 009 Shanghai, China 018 Shanghai, China 020 Shanghai, China 030 Shanghai, China 038 Shijiazhuang, China 010 Tianjin, China 006 Wuhan, China 035 Xi'an, China 016 Xian, China Less <<
NCT01678079 Pregnancy Phase 1 Completed - United States, Maryland ... More >> The Johns Hopkins Bloomberg School of Public Health Baltimore, Maryland, United States, 21213 United States, Texas Baylor College of Medicine Houston, Texas, United States Bangladesh International Center for Diarrheal Disease Research Dhaka, Bangladesh Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT02033551 Breast Cancer ... More >> Ovarian Cancer Colon Cancer Lung Cancer Gastric Cancer Solid Tumors Less << Phase 1 Completed - United States, Arizona ... More >> Site Reference ID/Investigator# 117416 Scottsdale, Arizona, United States, 85258 United States, Texas Site Reference ID/Investigator# 117415 San Antonio, Texas, United States, 78229 Netherlands Site Reference ID/Investigator# 117337 Groningen, Netherlands, 9713 GZ Site Reference ID/Investigator# 117338 Maastricht, Netherlands, 6229 HX Spain Site Reference ID/Investigator# 117451 Madrid, Spain, 28050 Less <<
NCT01718054 Sickle Cell Disease Phase 2 Phase 3 Unknown September 2017 Tanzania ... More >> Muhimbili University of Heath and Allied Sciences (MUHAS) Dar es Salaam, Tanzania Less <<
NCT01217814 - Terminated(Due to delay in the... More >> study and the impact on the development timelines, not due to any identified safety concerns) Less << - -
NCT02102022 Advanced Gastrointestinal (GI)... More >> Malignancies Hepatocellular Carcinoma Gastric Cancer Colorectal Cancer Less << Phase 1 Phase 2 Recruiting October 2019 United States, California ... More >> California Pacific Medical Center Recruiting San Francisco, California, United States, 94115 Contact: Ari Baron, MD          Principal Investigator: Ari Baron, MD          United States, Georgia Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Mehmet Akce, MD          Principal Investigator: Mehmet Akce, MD          United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Benjamin Tan, MD          Principal Investigator: Benjamin Tan, MD          United States, New York Memorial Sloan-Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: James Harding, MD          Principal Investigator: James Harding, MD          United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: Gina Vaccaro, MD          Principal Investigator: Gina Vaccaro, MD          United States, Washington University of Washington Recruiting Seattle, Washington, United States, 98109 Contact: Stacey Cohen          Principal Investigator: Stacey Cohen, MD          Taiwan Chang Gung Medical Foundation - Kaohsiung Recruiting Kaohsiung, Taiwan, 833 Contact: Kung-Ming Rau, M.D.          National Cheng Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Chia-Jui Yen, M.D.          Mackay Memorial Hospital Recruiting Taipei, Taiwan, 10491 Contact: Tsang-En Wang, M.D.          Taipei Veterans General Hospital Recruiting Taipei, Taiwan Contact: Yee Chao, M.D.          Tri-Service General Hospital Recruiting Taipei, Taiwan Contact: Yee Chao, MD          Chang Gung Medical Foundation - Linkou Recruiting Taoyuan, Taiwan Contact: Tsai-Sheng Yang, MD          United Kingdom Royal Free Hospital Recruiting London, United Kingdom, NW3 2QG Contact: Timothy Meyer, MD Less <<
NCT00623857 Malaria Phase 3 Completed - Tanzania ... More >> Kilimanjaro Christian Medical Centre Moshi, Tanzania Less <<
NCT00006292 Rheumatoid Arthritis Phase 2 Completed - United States, Maryland ... More >> National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Bethesda, Maryland, United States, 20892 Less <<
NCT01342874 - Completed - Italy ... More >> University of Chieti Chieti, CH, Italy, 66100 Less <<
NCT02031029 - Terminated(Stopped by the spon... More >>sor due to discrepancies in the recruitment process.) Less << - Norway ... More >> Akershus University Hospital Lørenskog, Norway, NO-1478 Stavanger University Hospital, urological department Stavanger, Norway, NO-4011 Less <<
NCT02151851 - Completed - -
NCT01802645 Colorectal Cancer Phase 2 Recruiting July 2020 Germany ... More >> Universitätsklinikum der RWTH Aachen Recruiting Aachen, Germany, 52074 Contact: Ulf-Peter Neumann, Prof. Dr.    0241 8085660    chirurgie@ukaachen.de    Principal Investigator: Ulf-Peter Neumann, Prof. Dr.          Charité Campus Virchow Recruiting Berlin, Germany, 13353 Contact: Daniel Seehofer, PD Dr. med.    030/ 450 652062    daniel.seehofer@charite.de    Principal Investigator: Daniel Seehofer, PD Dr. med.          Überörtliche Gemeinschaftspraxis Hämatologie/ Onkologie Not yet recruiting Bocholt, Germany, 46397 Contact: Volker Burstedde, Dr. med.    02871/2182669    Dr.burstedde@gmx.de    Klinikum Coburg GmbH Not yet recruiting Coburg, Germany, 96450 Contact: Christof Lamberti, PD Dr. med.    09561 / 22-5413    christof.lamberti@klinikum-coburg.de    Onkologie Dülmen GbR Not yet recruiting Coesfeld, Germany, 48653 Contact: Manfred Glados, Dr. med.    02541/971893    onko-studien@glados.eu    Universitätsklinikum Carl Gustav Carus Recruiting Dresden, Germany, 01307 Contact: Gunnar Folprecht, PD Dr. med.    +49 351 458 4794    Gunnar.Folprecht@uniklinikum-dresden.de    Contact: Olga Schubert    +49 351 7965620    olga.schubert@uniklinikum-dresden.de    Principal Investigator: Gunnar Folprecht, PD Dr. med.          Klinikum der Johann Wolfgang Goethe Universität Frankfurt am Main Recruiting Frankfurt/ Main, Germany, 60590 Contact: Wolf Otto Bechstein, Prof. Dr.       wolf.bechstein@kgu.de    Universitätsmedizin Göttingen Recruiting Göttingen, Germany, 37075 Contact: Torsten Liersch, PD Dr. med.    0551/ 398323    tliersch@chirurgie-goettingen.de    Principal Investigator: Torsten Liersch, PD Dr. med.          Universitätsklinikum Hamburg-Eppendorf Recruiting Hamburg, Germany, 20246 Contact: Dirk Arnold, Prof. Dr.    040/ 7410 55489    d.arnold@uke.de    Principal Investigator: Dirk Arnold, Prof. Dr.          Klinikum Landshut gGmbH Recruiting Landshut, Germany, 84034 Contact: Florian Loehe, Prof. Dr.    0871 698 3338    florian.loehe@klinikum-landshut.de    University hospital Leipzig Recruiting Leipzig, Germany, 04103 Contact: Florian Lordick, Pr.    +49 341 97 12560    Florian.Lordick@medizin.uni-leipzig.de    Principal Investigator: Florian Lordick, Pr.          Johannes-Gutenberg-Universität Recruiting Mainz, Germany, 55131 Contact: Markus Möhler, PD Dr.    +49 6131 17 6863    markus.moehler@unimedizin-mainz.de    Principal Investigator: Markus Möhler, PD Dr.          Klinikum Oldenburg GmbH Recruiting Oldenburg, Germany, 26133 Contact: Claus-Henning Köhne, Prof. Dr.    +49 441 403-2610    onkologie@klinikum-oldenburg.de    Principal Investigator: Claus-Henning Köhne, Prof.          Rems-Murr-Klinikum Winnenden Not yet recruiting Winnenden, Germany, 71364 Contact: Markus Schaich, Prof. Dr.    07195-591 39240    Markus.Schaich@rems-murr-kliniken.de    Universitätsklinikum Würzburg Recruiting Würzburg, Germany, 97080 Contact: Volker Kunzmann, PD Dr. med.    0931/20140746    kunzmann_v@medizin.uni-wuerzburg.de    Principal Investigator: Volker Kunzmann, PD Dr. med. Less <<
NCT01079507 - Unknown - Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Dong Hwan Kim, M.D., Ph. D.    +82-2-3410-1768    dr.dennis.kim@samsung.com    Principal Investigator: Dong Hwan Kim, M.D.,Ph.D. Less <<
NCT00589667 Head and Neck Cancer Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00755950 Acute Hepatitis A ... More >> Acute Hepatitis B Acute Hepatitis C Acute Hepatitis E Acute EBV Hepatitis Acute CMV Hepatitis Less << Phase 2 Phase 3 Terminated(Low enrollment) - Egypt ... More >> Alexandria University Hospital Alexandria, Alexandria Governorate, Egypt Tanta Fever Hospital Tanta, Gharbeya Governorate, Egypt Banha Fever Hospital Benha, Kaluobeya Governorate, Egypt Less <<
NCT01217814 Rheumatoid Arthritis Phase 2 Terminated(Due to delay in the... More >> study and the impact on the development timelines, not due to any identified safety concerns) Less << - United States, New Jersey ... More >> Investigational Site Number 840026 Freehold, New Jersey, United States, 07728 United States, New York Investigational Site Number 840043 New York, New York, United States, 11201 United States, Tennessee Investigational Site Number 840025 Jackson, Tennessee, United States, 38305 United States, Texas Investigational Site Number 840038 Austin, Texas, United States, 78705 Colombia Investigational Site Number 170004 Barranquilla, Colombia Investigational Site Number 170005 Barranquilla, Colombia Investigational Site Number 170007 Bucaramanga, Colombia Czechia Investigational Site Number 203002 Uherske Hradiste, Czechia, 68601 Italy Investigational Site Number 380002 Firenze, Italy, 50141 Investigational Site Number 380005 Genova, Italy, 16132 Mexico Investigational Site Number 484008 Durango, Mexico, 34270 Investigational Site Number 484002 Guadalajara, Mexico, 44690 Spain Investigational Site Number 724004 Oviedo, Spain, 33006 Investigational Site Number 724002 Valencia, Spain, 46009 Less <<
NCT02125136 Ductal Adenocarcinoma of the P... More >>ancreas Less << Phase 2 Recruiting October 2020 Germany ... More >> Universitätsklinikum Würzburg/Comprehensive Cancer Center Mainfranken Recruiting Würzburg, Bayern, Germany, 97080 Contact: Volker Kunzmann, Prof. Dr.       kunzmann_v@medizin.uni-wuerzburg.de    Principal Investigator: Volker Kunzmann, Prof. Dr. Less <<
NCT00589667 - Completed - -
NCT00612677 Lung Cancer Phase 2 Terminated(slow accrual - the ... More >>1 patient accrued did not go on treatment) Less << - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02653612 Lung Cancer Phase 1 Withdrawn(This study has been ... More >>terminated, without having enrolled any participants) Less << - United States, Pennsylvania ... More >> Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01218516 Adenocarcinoma of the Lung Phase 2 Completed - -
NCT00612677 - Terminated(slow accrual - the ... More >>1 patient accrued did not go on treatment) Less << - -
NCT01442935 Colorectal Cancer Phase 2 Active, not recruiting February 2019 France ... More >> Centre Val d'Aurelle Montpellier, France, 34298 Less <<
NCT01562080 Hyperlipidemia ... More >> Low-density-lipoprotein-type Elevated Triglycerides Less << Phase 2 Phase 3 Completed - Spain ... More >> Hosp. Universitario San Joan Reus, Tarragona, Spain Less <<
NCT00780169 Metastatic Colorectal Cancer Phase 1 Completed - Canada, Ontario ... More >> The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 Less <<
NCT00651456 Mesothelioma Phase 2 Phase 3 Completed - -
NCT02275429 Metabolic Diseases Not Applicable Completed - France ... More >> Reunion Island University Hospital Saint Denis, Reunion Island, France, 97410 Less <<
NCT01729481 Metastatic Pancreatic Adenocar... More >>cinoma Less << Phase 2 Active, not recruiting December 2017 Germany ... More >> University of Munich Munich, Germany, 81377 Less <<
NCT03570307 Medical; Abortion, Fetus Not Applicable Not yet recruiting June 2020 -
NCT00944320 - Completed - -
NCT01508000 Colorectal Cancer Metastatic ... More >> Liver Metastases KRAS Wild Type Colorectal Cancer Less << Phase 2 Terminated(Low or poor accrual... More >>) Less << - Austria ... More >> Allgemeines Krankenhaus der Stadt Wien Vienna, Austria, A-1090 Belgium Hopital Universitaire Brugmann Brussels, Belgium Universitair Ziekenhuis Gent Gent, Belgium AZ Groeninge Kortrijk - Campus Kennedylaan Kortrijk, Belgium AZ Turnhout - Campus Sint Elisabeth Turnhout, Belgium Centre Hospitalier Peltzer-La Tourelle Verviers, Belgium France Institut Sainte Catherine Avignon, France Institut Bergonie Bordeaux, France CHU Ambroise Pare Boulogne Billancourt, France, F-92104 Assistance Publique - Hôpitaux de Paris - Hopital De Bicetre AP-HP Le Kremlin Bicetre, France Centre Hospitalier Saint Joseph Saint Luc Lyon, France Centre Leon Berard Lyon, France Hopital Prive Jean Mermoz Lyon, France Centre Antoine Lacassagne Nice, France Hopital Europeen Georges Pompidou Paris, France, 75015 Groupe Hospitalier Diaconesses Croix Saint-Simon - Site Reuilly Paris, France CHU de Lyon - Centre Hospitalier Lyon Sud Pierre-Benite (lyon), France CHU de Reims - Hôpital Robert Debré Reims, France Hopital Charles Nicolle Rouen, France CHU Saint-Etienne - CHU de Saint-Etienne - Hopital Nord Saint Priest en Jarez, France Centre Hospitalier Privé Saint-Grégoire Saint-Gregoire, France CHU d'Amiens - CHU Amiens - Hopital Sud Salouel, France Netherlands The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis Amsterdam, Netherlands Spain Hospital General Vall D'Hebron Barcelona, Spain Switzerland Hôpitaux universitaires de Genève - HUG - site de Cluse-Roseraie Geneve, Switzerland Less <<
NCT00781196 Gingival Overgrowth Phase 3 Completed - India ... More >> All India Institute of Medical Sciences New Delhi, Delhi, India, 110029 Less <<
NCT00120822 Malaria PHASE3 COMPLETED 2025-01-04 Medical Research Council, Labo... More >>ratories, Banjul, PO Box 273, Gambia Less <<
NCT01297361 Vitamin B12 Deficiency ... More >> Folic Acid Deficiency Less << Not Applicable Completed - Israel ... More >> Clalit health services Kfar Yassif, Israel, 24908 Less <<
NCT00703196 Cervical Cancer ... More >> Precancerous Condition Less << Phase 2 Completed - United States, Alabama ... More >> UAB Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 Less <<
NCT01360086 Adenocarcinoma of the Gastroes... More >>ophageal Junction Gastric Cancer Less << Phase 2 Completed - France ... More >> Centre Hospitalier Regional et Universitaire de Lille Lille, France, 59037 CHU - Robert Debre Reims, France, 51092 Less <<
NCT03746340 - Enrolling by invitation March 31, 2019 China, Shanghai ... More >> Shanghai Ninth People's Hospital , Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai, China, 200011 Less <<
NCT03253666 - Enrolling by invitation December 2022 -
NCT00491907 Heart Failure Phase 4 Terminated(recruitment is fini... More >>shed) Less << - -
NCT00709332 Drug Interactions ... More >> Contraception Pharmacokinetics Less << Phase 1 Completed - -
NCT00794885 Primary Hypertension Phase 4 Completed - China, Anhui ... More >> Anqing Branch, Anhui Institute of Biomedical Research Anqing City, Anhui, China, 246000 China, Jiangsu Lianyungang Center for Advanced Research in Cardiovascular Diseases Lianyungang, Jiangsu, China, 222003 Less <<
NCT01210040 Malaria Not Applicable Completed - Burkina Faso ... More >> Institute de Recherche en Sciences de la Sante, Direction Regionale de l'Ouest (IRSS-DRO) - / Centre Muraz Bobo-Dioulasso 01, Burkina Faso, 01 B.P. 545 Less <<
NCT01183065 - Completed - -
NCT01050556 High Blood Arsenic Due to Chro... More >>nic Arsenic Exposure Less << Phase 4 Completed - Bangladesh ... More >> Columbia University Arsenic Research Project Dhaka, Bangladesh Less <<
NCT01183065 Head and Neck Cancer Phase 2 Completed - United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering at Mercy Medical Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital Sleepy Hollow, New York, United States Less <<
NCT00520247 Plasma Total Homocysteine Leve... More >>l Blood Pressure Less << Phase 2 Completed - China, Anhui ... More >> Inistitute for Biomedicine, Anhui Medical University Hefei, Anhui, China, 230032 Less <<
NCT01469936 Fibromyalgia Not Applicable Unknown December 2016 France ... More >> Unité de Recherche Clinique en Immunologie de Lyon Sud Pierre-Bénite, France, 69495 Less <<
NCT03279289 Metastatic Colorectal Cancer Phase 2 Recruiting July 2021 Spain ... More >> Spanish Cooperative Group for Digestive Tumour Therapy (TTD) Recruiting Madrid, Spain, 28046 Contact: Inmaculada Ruiz de Mena, PhD    0034 91 378 82 75    ttd@ttdgroup.org Less <<
NCT02588105 Advanced Solid Tumours Phase 1 Recruiting August 30, 2019 United States, Colorado ... More >> Research Site Recruiting Aurora, Colorado, United States, 80045 United States, New York Research Site Recruiting New York, New York, United States, 10033 Korea, Republic of Research Site Recruiting Seoul, Korea, Republic of, 03080 Spain Research Site Recruiting Barcelona, Spain, 08035 United Kingdom Research Site Recruiting Manchester, United Kingdom, M20 4BX Less <<
NCT02837107 Healthy Not Applicable Unknown December 2017 -
NCT01328522 Rheumatoid Arthritis Phase 1 Completed - United States, California ... More >> Investigational Site Number 840003 Beverly Hills, California, United States, 90211 United States, Florida Investigational Site Number 840001 Ocala, Florida, United States, 34471 United States, Pennsylvania Investigational Site Number 840004 Duncansville, Pennsylvania, United States, 16635 United States, Texas Investigational Site Number 840002 Dallas, Texas, United States, 75235 Less <<
NCT01867697 Metastatic Colorectal Cancer Phase 2 Active, not recruiting March 2020 Denmark ... More >> Aalborg University Hospital Aalborg, Denmark, 9100 Aarhus University Hospital Aarhus, Denmark, 8000 Rigshospitalet Copenhagen, Denmark, 2100 Sydvestjysk Hospital Esbjerg, Denmark, 6700 Herlev University Hospital Herlev, Denmark, 2730 Herning Hospital Herning, Denmark Naestved Hospital Naestved, Denmark, 4700 Odense University Hospital Odense, Denmark, 5000 Roskilde Hospital Roskilde, Denmark, 4000 Norway Haukeland University Hospital Bergen, Norway, 5021 Trondheim University Hospital Trondheim, Norway Sweden Akademiska University Hospital Uppsala, Sweden, 751 85 Less <<
NCT03164655 Colorectal Cancer Metastatic Phase 2 Recruiting November 2021 France ... More >> Ico Paul Papin Active, not recruiting Angers, France Centre Eugene Marquis Active, not recruiting Rennes, France Chp Saint Gregoire Active, not recruiting Saint-Grégoire, France Gustave Roussy Recruiting Villejuif, France, 94 Contact: Valérie Boige, PU PH    33 (0)1 42 11 43 11    valerie.boige@gustaveroussy.fr Less <<
NCT03518151 Diet Modification Not Applicable Completed - -
NCT00067600 Osteoporosis Phase 1 Completed - United States, Oregon ... More >> Kaiser Permanente Center for Health Research Portland, Oregon, United States, 97227 Less <<
NCT03105583 - Enrolling by invitation October 2017 -
NCT00448682 Gastric Cancer Phase 2 Terminated - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 Less <<
NCT00448682 - Terminated - -
NCT00903695 Mild Cognitive Impairment Phase 2 Terminated(Risk/benefit ratio ... More >>did not indicate further study would be useful, or fair to future subjects.) Less << - United States, Oklahoma ... More >> Univ. of Okla. Health Sciences Center & VAMC OKC Oklahoma City, Oklahoma, United States, 73104 Veterans Affairs Medical Center Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT03711682 Type 2 Diabetes Mellitus Phase 2 Completed - El Salvador ... More >> Unidad Comunitaria de Salud Familiar Intermedia de Comasagua (UCSFI-Comasagua) Comasagua, La Libertad, El Salvador, 0504 Less <<
NCT03162510 Gastric Cancer in Situ ... More >> Pancreatic Cancers Biliary Cancers Less << Phase 1 Recruiting October 2019 Taiwan ... More >> Taiwan Cooperative Oncology Group, National Health Research Institutes Recruiting Taipei, Taiwan Contact: Tsang-Wu Liu, MD    +886-2-26534401 ext 25150    walter@nhri.org.tw    Principal Investigator: Li-Tzong Chen, MD PHD          Principal Investigator: Nai-Jung Chiang, MD Less <<
NCT00903695 - Terminated(Risk/benefit ratio ... More >>did not indicate further study would be useful, or fair to future subjects.) Less << - -
NCT03371667 Allogeneic Disease ... More >> GVH - Graft Versus Host Reaction GVHD, Acute Stem Cell Transplant Complications Less << Phase 3 Not yet recruiting November 2020 France ... More >> Saint Antoine Hospital - Hematology Department Not yet recruiting Paris, France, 75012 Contact: mohamad Mohty, PU-PH    01.49.28.26.20    mohamad.mohty@inserm.fr    Contact: Florent Malard, CCU-AH    01.49.28.26.20    malardf@yahoo.fr Less <<
NCT01320527 Alzheimer's Disease ... More >> Mild Cognitive Impairment Less << Phase 2 Completed - United States, Florida ... More >> Naples Medical Center Naples, Florida, United States, 34102 United States, Maryland University of Maryland Baltimore, Maryland, United States, 21201 United States, Massachusetts Primary Care Cardiology Research Ayer, Massachusetts, United States, 01432 Rivercourt Residences Groton, Massachusetts, United States, 014590 Mary Immaculate Residential Lawrence, Massachusetts, United States, 01841 D'Youville Senior Care Lowell, Massachusetts, United States, 01854 United States, New Jersey Neurocognitive Institute Mt. Arlington, New Jersey, United States, 07856 United States, Utah Advanced Memory Dynamics Layton, Utah, United States, 84040 Less <<
NCT02593136 Anemia Malnut... More >>rition Less << Not Applicable Completed - India ... More >> CARE-India Patna, Bihar, India Less <<
NCT00210405 Anemia Not Applicable Completed - Haiti ... More >> World Vision-Haiti Regional Office Hinche, Haiti Less <<
NCT01506947 - Completed - -
NCT01945879 Pancreatic Cancer Phase 1 Phase 2 Completed - Germany ... More >> Charité - Universitätsmedizin Berlin Berlin, Germany, 13353 Less <<
NCT03079388 Pregnancy Mal... More >>nutrition in Pregnancy Nutrition Disorders Stunting Less << Not Applicable Recruiting March 2019 Sierra Leone ... More >> 1 Moriba Street Recruiting Pujehun, Pujehun District, Sierra Leone Contact: Claire Westcott, PA    +232-88-111-007       Sub-Investigator: David T Hendrixson, MD          Sub-Investigator: Aminata Koroma Less <<
NCT01769547 Advanced Malignant Pleural Mes... More >>othelioma MPM Less << Phase 2 Terminated(Stage 1 accrual com... More >>pleted. Study did not proceed to Stage 2 accrual.) Less << - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Canada, Ontario Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Ottawa General Hospital Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 Northeast Cancer Centre, Health Sciences North Sudbury, Ontario, Canada, P3E 5J1 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 1X6 Less <<
NCT01506947 Moderate to Severe Secondary H... More >>yperparathyroidism Stage 5 Chronic Kidney Diseases Less << Phase 4 Completed - -
NCT03006432 OESOPHAGO-GASTRIC CARCINOMA Phase 3 Recruiting August 2022 -
NCT00193414 Lung Cancer Phase 2 Completed - United States, Tennessee ... More >> Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT03630991 Acute Myeloid Leukemia ... More >> Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome Myelodysplastic/Myeloproliferative Neoplasm Secondary Acute Myeloid Leukemia Less << Phase 2 Recruiting December 31, 2020 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       mohanian@mdanderson.org Less <<
NCT00202787 Colorectal Cancer Phase 2 Completed - Spain ... More >> Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD) Madrid, Spain, 28046 Less <<
NCT00921661 Colorectal Neoplasms ... More >> Neoplasm Metastasis Less << Phase 1 Completed - Japan ... More >> Sanofi-Aventis Administrative Office Tokyo, Japan Less <<
NCT00258024 Anaemia Malar... More >>ia Less << Not Applicable Completed - Ghana ... More >> Afiya Sekyere district Kumasi, Ashanti region, Ghana Less <<
NCT01703390 Metastatic Colorectal Cancer Phase 2 Recruiting August 2018 Austria ... More >> AKH Linz, Innere Medizin 3, Zentrum für Hämatologie und medizinische Onkologie Recruiting Linz, Oberösterreich, Austria, 4021 Principal Investigator: Michael Fridrik, MD          A.ö. Bezirkskrankenhaus Kufstein, Innere Medizin / Hämatologie / Onkologie Recruiting Kufstein, Tirol, Austria, 6330 Principal Investigator: August Zabernigg, MD          LKH Feldkirch, Interne E Recruiting Feldkirch, Vorarlberg, Austria, 6807 Principal Investigator: Thomas Winder, MD          LKH Bludenz Innere Medizin Recruiting Bludenz, Austria, 6700 Principal Investigator: Othmar Thurnes, MD          LKH Bregenz Recruiting Bregenz, Austria, 6900 Principal Investigator: Franz X Schmid, Dr          KH Dornbirn, Innere Medizin Recruiting Dornbirn, Austria, 6850 Principal Investigator: Guntram Winder, MD          Universitätsklinikum Graz Recruiting Graz, Austria, 8036 Principal Investigator: Helmuth Samonigg, MD          LKH Hohenems, Interne Intensivmedizin Recruiting Hohenems, Austria, 6845 Principal Investigator: Günter Höfle, MD          Krankenhaus d. Barmherzigen Schwestern Linz Recruiting Linz, Austria, A-4010 Principal Investigator: Andreas Petzer, MD          Universitätsklinik für Innere Medizin III mit Hämatologie, internistischer Onkologie, Infektologie, Rheumatologie und Onkologisches Zentrum Recruiting Salzburg, Austria, 5020 Principal Investigator: Richard Greil, MD          Medizinische Universität Wien, Univ.Klinik für Innere Medizin I, Abteilung für Onkologie Recruiting Vienna, Austria, 1090 Principal Investigator: Gerald Prager, MD Less <<
NCT01258127 - Unknown August 2015 China, Sichuan ... More >> Cancer Hospital of Sichuan Province Recruiting Chengdu, Sichuan, China, 610041 Contact: Qiang Li, MD    +86-28-88867774    ghealth2008@gmail.com Less <<
NCT03374852 Pancreatic Ductal Adenocarcino... More >>ma Less << Phase 2 Withdrawn(PI Left institution ... More >>on 8/6/2018 and study has been final reported with IRB. Never opened to accrual) Less << October 2020 -
NCT00193414 - Completed - -
NCT02280330 Iodine Deficiency ... More >> Iodine Deficiency Disorder Hypothyroidism Less << Phase 4 Completed - Philippines ... More >> La Trinidad Benguet Day Care Centers La Trinidad, Benguet, Philippines, 2601 Less <<
NCT00539916 Cardiovascular Disease Risk Fa... More >>ctors Less << Not Applicable Completed - France ... More >> Hopital Saint André - Service de Médecine Interne - Pathologie Vasculaire Bordeaux, France, 33075 Less <<
NCT01482962 Relapsed Peripheral T-Cell Lym... More >>phoma Refractory Peripheral T-Cell Lymphoma Less << Phase 3 Completed - -
NCT03331640 Metastatic Pancreatic Ductal A... More >>denocarcinoma Less << Phase 2 Recruiting January 2023 Germany ... More >> Praxis für Innere Medizin Recruiting Friedrichshafen, Germany Contact: Helmut Oettle, Prof. Dr. Less <<
NCT01482962 - Completed - -
NCT02514278 Rectal Cancer Phase 3 Recruiting March 2022 France ... More >> Service de Chirurgie Digestive, CHU Amiens Picardie Recruiting Amiens, France Contact: Jean-Marc REGIMBEAU       regimbeau.jean-marc@chu-amiens.fr    Service de Chirurgie Digestive, CHU de Besançon Recruiting Besançon, France Contact: Georges MANTION       georges.mantion@chu-besancon.fr    Service de Chirurgie Digestive, Hôpital Saint-André - CHU de Bordeaux Recruiting Bordeaux, France Contact: Eric RULLIER       eric.rullier@chu-bordeaux.fr    Service de Chirurgie Digestive, Institut Bergonié Not yet recruiting Bordeaux, France Contact: Serge EVRARD       S.Evrard@bordeaux.unicancer.fr    Service de Chirurgie Digestive, CHU Estaing - CHRU Clermont Ferrand Recruiting Clermont-Ferrand, France Contact: Denis PEZET       dpezet@chu.clermontferrand.fr    Service de Chirurgie Digestive, Hôpital Beaujon - APHP Not yet recruiting Clichy, France Contact: Yves PANIS       yves.panis@bjn.aphp.fr    Service de Chirurgie Digestive, Centre Georges François Leclerc - Dijon Recruiting Dijon, France Contact: David ORRY       dorry@cgfl.fr    Service de Chirurgie Digestive, Hôpital Albert Michallon - CHU de Grenoble Not yet recruiting La Tronche, France Contact: Jean-Luc FAUCHERON       JLFaucheron@chu-grenoble.fr    Service de Chirurgie Digestive, Centre Oscar Lambret - Lille Not yet recruiting Lille, France Contact: Mehrad JAFARI       m-jafari@o-lambret.fr    Service de Chirurgie Digestive, CHRU de Lille Not yet recruiting Lille, France Contact: Christophe MARIETTE       christophe.mariette@chru-lille.fr    Service de Chirurgie Digestive, Centre Léon Bérard - Lyon Recruiting Lyon, France Contact: Michel RIVOIRE       rivoire@lyon.fnclcc.fr    Service de Chirurgie Digestive, Hôpital Lyon Sud - CHU Lyon Recruiting Lyon, France Contact: Eddy COTTE       eddy.cotte@chu-lyon.fr    Service de Chirurgie Digestive, CHU de la Timone - Marseille Not yet recruiting Marseille, France Contact: Igor SIELEZNEFF       Bernard.Sastre@mail.ap-hm.fr    Service de Chirurgie Digestive, Institut Paoli Calmette - Marseille Not yet recruiting Marseille, France Contact: Bernard LELONG       lelongb@ipc.unicancer.fr    Service de Chirurgie Digestives, Hôpital Européen de Marseille Recruiting Marseille, France Contact: Antoine CAMERLO       a.camerlo@hopital-europeen.fr    Service de Chirurgie Digestive, CHU Saint-Eloi - Montpellier Not yet recruiting Montpellier, France Contact: Jean-Michel FABRE       jm-fabre@chu-montpellier.fr    Service de Chirurgie Digestive, Institut du Cancer de Montpellier Recruiting Montpellier, France Contact: Philippe ROUANET       phillipe.rouanet@montpellier.unicancer.fr    Service d'Oncologie et Radiothérapie, Centre Azuréen de Cancérologie Not yet recruiting Mougins, France Contact: Philippe RONCHIN       ronchinp@yahoo.fr    Service de Chirurgie Digestive,Institut de Cancérologie de Lorraine Recruiting Nancy, France Contact: Frédéric MARCHAL       f.marchal@nancy.unicancer.fr    Service de Chirurgie Digestive, Hôtel Dieu - CHU de Nantes Not yet recruiting Nantes, France Contact: Guillaume MEURETTE       guillaume.meurette@chu-nantes.fr    Service de Chirurgie Digestive, CHU Carémeau - Nîmes Recruiting Nîmes, France Contact: Michel PRUDHOMME       michel.prudhomme@chu-nimes.fr    Service de Chirurgie Digestive et Oncologique, Hôpital Bicêtre - APHP Recruiting Paris, France Contact: Stéphane BENOIST       stephane.benoist@aphp.fr    Service de Chirurgie Digestive, Hôpital les Diaconnesses Recruiting Paris, France Contact: Henri MOSNIER       hmosnier@hopital-dcss.org    Service de Chirurgie Digestive, Hôpital Pitié Salpetrière - APHP Not yet recruiting Paris, France Contact: Medhi KAROUI       medhi.karoui@psl.aphp.fr    Service de Chirurgie Digestive, Hôpital Saint-Antoine - APHP Recruiting Paris, France Contact: Emmanuel TIRET       emmanuel.tiret@sat.aphp.fr    Service de Chirurgie Digestive, Hôpital Saint-Louis - APHP Paris Not yet recruiting Paris, France Contact: Mircea CHIRICA       mircea.chirica@sls.aphp.fr    Service de Chirurgie Digestive, Hôpital Pontchaillou - CHU Rennes Recruiting Rennes, France Contact: Bernard MEUNIER       bernard.meunier@chu-rennes.fr    Service de Chirurgie Digestive, Hôpital Charles Nicolle - CHU de Rouen Recruiting Rouen, France Contact: Jean-Jacques TUECH       jean-jacques.tuech@chu-rouen.fr    Service de Chirurgie Digestive, Hôpital Purpan - CHU de Toulouse Not yet recruiting Toulouse, France Contact: Guillaume PORTIER       portier.g@chu-toulouse.fr    Service de chirurgie digestive, CHRU de Nancy -Hôpital de Brabois Recruiting Vandœuvre-lès-Nancy, France Contact: Adeline GERMAIN       a.germain@chru-nancy.fr    Département de chirurgie digestive, Institut Gustave Roussy Not yet recruiting Villejuif, France Contact: Léonor BENHAIM       leonor.benhaim@gustaveroussy.fr Less <<
NCT02914392 - Recruiting December 2020 China, Shanghai ... More >> Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China Contact: Chen Sun    8621-25078485       Principal Investigator: Sun Jing          China School of environmental science and engineering, Shanghai jiaotong university Active, not recruiting Shanghai, China Less <<
NCT00199797 Colorectal Cancer Phase 1 Completed - Germany ... More >> Krankenhaus Nordwest Frankfurt, Germany, 60488 Switzerland UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT01640782 Adenocarcinoma of the Stomach ... More >> Adenocarcinoma of the Gastroesophageal Junction Less << Phase 3 Completed - -
NCT01930838 - Unknown December 2016 Denmark ... More >> Department of Endocrinology and Metabolism, Aarhus University Hospital Not yet recruiting Aarhus, Denmark, 8000 Contact: Sigrid Bjerge Gribsholt, MD    +4561651148    sigrgrib@rm.dk    Contact: Joan Bach Nielsen, MD       joannils@rm.dk Less <<
NCT02664584 - Unknown December 2018 Ireland ... More >> St James's Hospital Dublin, Dublin8, Ireland United Kingdom Human Intervention Studies Unit, Ulster University Coleraine, Londonderry, United Kingdom, BT52 1SA Clinical Translational Research and Innovation Centre (C-TRIC), Altnagelvin Hospital Londonderry, United Kingdom, BT47 6SB Less <<
NCT03594760 Prostate Cancer Phase 3 Not yet recruiting November 2024 Canada, Quebec ... More >> Centre Hospitalier de l'université de Montréal Montréal, Quebec, Canada, H2X 0C1 Less <<
NCT00002570 Colorectal Cancer Phase 3 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 10309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Louisiana CCOP - Ochsner New Orleans, Louisiana, United States, 70121 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Clinic Saint Cloud, Minnesota, United States, 56303 United States, North Dakota Quain & Ramstad Clinic, P.C. Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Less <<
NCT03234452 Disbiosis Abd... More >>ominal Pain Constipation Diarrhea Stress Less << Not Applicable Completed - Italy ... More >> Centro Ricerche Cliniche di Verona Srl, Verona, (Vr), Italy, 37100 Less <<
NCT02016586 Breast Feeding Not Applicable Completed - Vietnam ... More >> Bin Luc District Health Centre- Dong Du Ha Nam, Vietnam Binh Luc District Health Center - An Lao Ha Nam, Vietnam Binh Luc District Health Center - Binh Nghia Ha Nam, Vietnam Binh Luc District Health Center - Trang An Ha Nam, Vietnam An Lao District Health Center - Bat Trang Hai Phong, Vietnam An Lao District Health Center - Quoc Tuan Hai Phong, Vietnam An Lao District Health Center - Thai Son Hai Phong, Vietnam An Lao District Health Centre- Quoc Trung Hai Phong, Vietnam An Lao District Health Centre- Truang Tho Hai Phong, Vietnam Yen Mo District Health Center - Yen Dong Ninh Binh, Vietnam Yen Mo District Health Center - Yen Hoa Ninh Binh, Vietnam Yen Mo District Health Center - Yen Thanh Ninh Binh, Vietnam Phu Binh District Health Center - Kha Son Thai Nguyen, Vietnam Phu Binh District Health Center - Tan Khanh Thai Nguyen, Vietnam Phu Binh District Health Center - Tan Kim Thai Nguyen, Vietnam Phu Binh District Health Centre- Tan Duc Thai Nguyen, Vietnam Phu Binh District Health Centre- Tan Hoa Thai Nguyen, Vietnam Phu Binh District Health Centre- Xuan Phuong Thai Nguyen, Vietnam Less <<
NCT01871649 Psoriatic Arthritis Phase 3 Completed - Netherlands ... More >> Reade Amsterdam, Noord Holland, Netherlands, 1056 AB Academic Medical Center/University of Amsterdam Amsterdam, Noord Holland, Netherlands, 1105 AZ Less <<
NCT01212718 Colorectal Cancer ... More >> Non Resectable Metastasis Reference Lesion Biopsy Thymidylate Synthase Quantitation Less << Phase 2 Completed - Germany ... More >> Department of General, Visceral, and Transplantations Surgery, Univeristy of Ulm Ulm, Germany Less <<
NCT01930929 - Unknown July 2016 Denmark ... More >> Department of Endocrinology and Internal Medicine Recruiting Aarhus, Denmark, 8000 Contact: Sigrid Gribsholt, MD Less <<
NCT02069041 Carcinoma, Hepatocellular Phase 1 Completed - Taiwan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tainan, Taiwan, 70403 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 10048 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taoyuan City, Taiwan, 33305 Less <<
NCT02069041 - Completed - -
NCT01930851 - Completed - Denmark ... More >> department of endocrinology and metabolism, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT02970916 Metastatic Colorectal Cancer Phase 2 Active, not recruiting May 2019 Spain ... More >> Spanish Cooperative Group for the Treatment of Digestive Tumors Madrona, Spain, 28007 Less <<
NCT03697733 Abnormal Uterine Bleeding Not Applicable Not yet recruiting November 1, 2019 -
NCT02374996 - Completed - United States, Michigan ... More >> Wayne State University Clinical Research Center Detroit, Michigan, United States, 48202 Less <<
NCT02759120 Idiopathic Pulmonary Fibrosis Phase 3 Recruiting July 2019 -
NCT03008824 - Unknown June 2018 United Kingdom ... More >> University of Warwick Recruiting Coventry, United Kingdom, CV47AL Contact: Ponnusamy Saravanan, FRCP PhD    00442476865329    p.saravanan@warwick.ac.uk    Contact: Amitha Gopinath, MBA    00442476153592    amitha.gopinath@geh.nhs.uk    Principal Investigator: Ponnusamy Saravanan, FRCP PhD          Sub-Investigator: Nigel Stallard, PhD Less <<
NCT03179657 - Active, not recruiting December 2027 -
NCT01613079 Arthritis, Rheumatoid Phase 2 Phase 3 Completed - China, Beijing ... More >> Deptment of Rheumatology, Peking Union Medical College Hospital Beijing, Beijing, China, 100032 Less <<
NCT01999023 Chronic Renal Disease Not Applicable Unknown December 2014 Taiwan ... More >> Taichung Veterans General Hospital Not yet recruiting Taichung, Taiwan, 40705 Contact: Yi-Chia Huang, PhD    +886424730022 ext 12198    ych@csmu.edu.tw    Principal Investigator: Cheng-Hsu Chen, MD, PhD Less <<
NCT01528163 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 2 Completed - Belgium ... More >> Clinique Saint-Pierre Ottignies, Brabant Wallon, Belgium, 1340 Cliniques universitaires Saint-Luc, Centre du Cancer, Oncologie Médicale Brussels, Bruxelles Capitale, Belgium, 1200 RHMS Baudour Baudour, Hainaut, Belgium, 7331 Grand Hôpital de Charleroi Charleroi, Hainaut, Belgium, 6000 Hôpital de Jolimont Haine-Saint-Paul, Hainaut, Belgium, 7100 CHU Tivoli Centre René Goffin La Louvière, Hainaut, Belgium, 7100 CHU Ambroise PARE Mons, Hainaut, Belgium, 7000 CHU de Charleroi site Vésale Montigny-Le-Tilleul, Hainaut, Belgium, 6110 Centre Hospitalier Wallonie Picarde Tournai, Hainaut, Belgium, 7500 CHU de Mont Godinne Yvoir, Namur, Belgium, 5530 Universitair Ziekenhuis Brussel (Campus Jette) Brussel, Belgium, 1090 Universitair Ziekenhuis Gent Gent, Belgium, 9000 CHR Citadelle Liège, Belgium, 4000 CHU de Liège Sart Tilman Liège, Belgium, 4000 Clinique et Maternité Sainte-Elisabeth Namur, Belgium, 5000 Luxembourg Centre Hospitalier de Luxembourg Luxembourg, Luxembourg, L-1210 Less <<
NCT00820313 Coronary Heart Disease ... More >> Biomarkers of Cardiovascular Disease Less << Not Applicable Unknown May 2009 United States, California ... More >> Preventive Medicine Research Institute Sausalito, California, United States, 94965 Less <<
NCT00266227 - Completed - -
NCT01749982 Arsenic Metabolites Measured i... More >>n Urine Less << Phase 4 Completed - Bangladesh ... More >> Columbia University Arsenic Research Project Dhaka, Bangladesh Less <<
NCT01749982 - Completed - -
NCT02190565 Anaemia Not Applicable Withdrawn(Business decision - ... More >>strategy changes and budget limitations) Less << - Sweden ... More >> Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Institutet Stockholm, Sweden, SE-171 76 Less <<
NCT00176280 Renal Cell Carcinoma Phase 2 Withdrawn(Slow accrual) - -
NCT02145000 Severe Rotavirus Gastroenterit... More >>is Less << Phase 3 Active, not recruiting December 2019 Niger ... More >> Madarounfa Health District Madarounfa, Maradi, Niger Less <<
NCT00188266 Stomach Neoplasms Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT02118402 Anemia Iron D... More >>eficiency Diarrhea Malaria Respiratory Tract Infections (RTI) Antibiotics Gut Inflammation Prebiotics Less << Not Applicable Completed - Kenya ... More >> Kikoneni Health Center Kikoneni, Kwale County, Kenya Less <<
NCT00266227 Rheumatoid Arthritis Phase 3 Completed - -
NCT01659424 Rectal Cancer Phase 2 Withdrawn(No participants were... More >> enrolled) Less << - United States, New York ... More >> Beth Isael Medical Center New York, New York, United States, 10003 St-Lukes Roosevelt Hospital Medical Center New York, New York, United States, 10018 Less <<
NCT01569919 Malignant Ple... More >>ural Mesothelioma Less << Phase 2 Unknown December 2014 United Kingdom ... More >> Velindre Cancer Centre Recruiting Cardiff, South Wales, United Kingdom, CF14 2TL Sub-Investigator: Mick Button Less <<
NCT03337360 Male Subfertility Not Applicable Recruiting April 1, 2021 Netherlands ... More >> Canisius-Wilhelmina Hospital Not yet recruiting Nijmegen, Gelderland, Netherlands Contact: Cathelijne van Heteren, MD, PhD       c.v.heteren@cwz.nl    Principal Investigator: Cathelijne van Heteren, MD, PhD          Jeroen Bosch Ziekenhuis Not yet recruiting 's-Hertogenbosch, Netherlands, 5200ME Contact: Jan Peter de Bruin, MD PhD       j.d.bruin@jbz.nl    Principal Investigator: Jan Peter de Bruin, MD PhD          Gelre Ziekenhuizen Not yet recruiting Apeldoorn, Netherlands, 7334DZ Contact: Maaike Traas, MD PhD       m.traas@gelre.nl    Principal Investigator: Maaike Traas, MD PhD          Rijnstate Recruiting Arnhem, Netherlands, 6815AD Contact: Annemiek Nap, MD PhD       ANap@rijnstate.nl    Principal Investigator: Annemiek Nap, MD PhD          Maasziekenhuis Pantein Not yet recruiting Boxmeer, Netherlands, 5835DV Contact: Esther Haagen, MD       e.haagen@pantein.nl    Principal Investigator: Esther Haagen, MD          Slingeland Ziekenhuis Recruiting Doetinchem, Netherlands, 7002BL Contact: Rogier Donker, MD PhD       R.Donker@slingeland.nl    Principal Investigator: Rogier Donker, MD PhD          Nij Geertgen Not yet recruiting Elsendorp, Netherlands, 5424SM Contact: Marieke Schoonenberg, MD       marieke.schoonenberg@nijgeertgen.nl    Contact: Martine Nijs, MSc PhD       Martine.Nijs@nijgeertgen.nl    Principal Investigator: Marieke Schoonenberg, MD          Medisch Centrum Kinderwens Not yet recruiting Leiderdorp, Netherlands Contact: Tessa Cox, MD       t.cox@mckinderwens.nl    Maastricht UMC+ Not yet recruiting Maastricht, Netherlands, 6229HX Contact: Ron van Golde, MD PhD       ron.van.golde@mumc.nl    Principal Investigator: Ron van Golde, MD PhD          Radboudumc Recruiting Nijmegen, Netherlands, 6500HB Contact: Roos Smits, MSc       roos.smits@radboudumc.nl    Contact: Kathrin Fleischer, Dr       kathrin.fleischer@radboudumc.nl    Sub-Investigator: Roos Smits, MSc          Principal Investigator: Kathrin Fleischer, Dr          Elisabeth-TweeSteden Ziekenhuis Not yet recruiting Tilburg, Netherlands, 5022GC Contact: Jesper Smeenk, MD PhD       j.smeenk@etz.nl    Principal Investigator: Jesper Smeenk, MD PhD          Bernhoven Ziekenhuis Not yet recruiting Uden, Netherlands, 5400AS Contact: Marcel Hoekstra, MD PhD       m.hoekstra@bernhoven.nl    Principal Investigator: Marcel Hoekstra, MD PhD          Máxima Medisch Centrum Not yet recruiting Veldhoven, Netherlands, 5504DB Contact: Jacques Maas, MD PhD       Jacques.Maas@mmc.nl    Principal Investigator: Jacques Maas, MD PhD          Nij Barrahus Not yet recruiting Wolvega, Netherlands Contact: Harold Mous, MD       harold.mous@nijbarrahus.nl Less <<
NCT03573570 Anemia Not Applicable Enrolling by invitation November 15, 2019 India ... More >> Institute for Financial Management and Research (IFMR) and Cuddalore district, Tamil Nadu Chennai, Tamil Nadu, India, 600006 Less <<
NCT03032549 Dietary Supplements Not Applicable Completed - -
NCT00191308 Non-Small Cell Lung Cancer ... More >> Carcinoma Less << Phase 2 Completed - Poland ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bystra Slaska, Poland, 43-360 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poznan, Poland, 60-569 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland, 02-781 Less <<
NCT01260415 Colorectal Cancer ... More >> Liver Metastases Less << Phase 2 Completed - Canada, Ontario ... More >> London Regional Cancer Centre London, Ontario, Canada The Ottawa Hospital Cancer Center Ottawa, Ontario, Canada Mount Sinai Hospital Toronto, Ontario, Canada Princess Margaret Hospital Toronto, Ontario, Canada Less <<
NCT01660958 Nutritional Deficiencies ... More >> Developmental Delay Less << Not Applicable Completed - India ... More >> National Institute of Nutrition Hyderabad, Andhra Pradesh, India, 500007 Less <<
NCT01307241 - Unknown December 2015 Mexico ... More >> Instituto Nacional de Cancerologia Mexico city, DF, Mexico, 14080 Less <<
NCT01572324 Biliary Tract Cancer Phase 2 Completed - China, Beijing ... More >> Peking University Cancer Hospital Beijing, Beijing, China, 100142 Less <<
NCT00191308 - Completed - -
NCT02355444 Hypertension Not Applicable Completed - Ireland ... More >> Human Nutrition Studies Unit, School of Food & Nutritional Sciences, UCC Cork, Ireland Less <<
NCT02022046 - Completed - Taiwan ... More >> Kaohsiung Chang Gung Memorial Hospital Kaohsiung, Taiwan, 833 Less <<
NCT00005483 - Completed - -
NCT00943137 Cancer (Advanced Stage) Phase 2 Unknown June 2017 Singapore ... More >> National University Hospital Singapore, Singapore, 119074 Less <<
NCT01538316 Primary Prevention of Prostate... More >> Cancer Less << Not Applicable Unknown April 2014 Germany ... More >> Institute of Nutritional Medicine, University of Hohenheim Recruiting Stuttgart, Germany, 70599 Contact: Antje Damms Machado, dipl. troph.       antje.machado@uni-hohenheim.de    Principal Investigator: Stephan C Bischoff, MD, Prof.          Department of Urology, University Hospital Tübingen Recruiting Tübingen, Germany, 72076 Contact: Stefan Aufderklamm, MD          Principal Investigator: Arnulf Stenzl, MD, Prof. Less <<
NCT02404337 Homocystinuria Phase 2 Completed - France ... More >> Assistance Publique - Hôpitaux de Paris Paris, France, 75019 Less <<
NCT01088958 Anemia, Iron-deficiency Phase 4 Completed - Kenya ... More >> CDC/Kenya Medical Research Institute Kisumu, Kenya Less <<
NCT02620137 Iron Deficiency Anemia Phase 3 Completed - -
NCT00311298 Tuberculosis ... More >>HIV Diabetes Less << Phase 3 Completed - Tanzania ... More >> Mwanza Medical Centre, NIMR Mwanza, Tanzania Less <<
NCT02974556 Colon Cancer ... More >>Intraperitoneal Rectal Cancer Less << Phase 3 Not yet recruiting September 2025 Italy ... More >> ASST Nord Milano P.O. Città di Sesto S. Giovanni Not yet recruiting Milano, PD, Italy, 35031 Contact: Gianandrea Baldazzi, MD       gbaldazzi@hotmail.com    Principal Investigator: Gianandrea Baldazzi, MD          Sub-Investigator: Diletta Cassini, MD          ASO S. Croce e Carle Not yet recruiting Cuneo, Italy, 12100 Contact: Felice Borghi, MD       borghi.f@ospedale.cuneo.it    Principal Investigator: Felice Borghi, MD          Sub-Investigator: Maria Carmela Giuffrida, MD          Azienda Ospedaliera dei Colli Napoli, Italy, 80131 Istituto Nazionale Tumori IRCCS Fondazione Pascale di Napoli Napoli, Italy, 80131 Ospedale di Rimini Not yet recruiting Rimini, Italy, 47923 Contact: Gianluca Garulli, MD       lucagarulli@gmail.com    Principal Investigator: Gialuca Garulli, MD          Sub-Investigator: Basilio Pirrera, MD          University of Rome Sapienza Not yet recruiting Roma, Italy, 00161 Contact: Paolo Sammartino, MD PhD    336615632 ext +39    paolo.sammartino@uniroma1.it    Contact: Tommaso Cornali, MD    3489012376 ext +39    tommaso.cornali@uniroma1.it    Principal Investigator: Paolo Sammartino, MD PhD          Sub-Investigator: Tommaso Cornali, MD          Sub-Investigator: Fabio Accarpio, MD PhD          Sub-Investigator: Daniele Biacchi, MD Phd          Ospedale Sant'Eugenio Not yet recruiting Rome, Italy, 00144 Contact: Massimo Carlini, MD FACS       maxcarlini@tiscali.it    Principal Investigator: Massimo Carlini, MD          Sub-Investigator: Domenico Spoletini, MD          Sub-Investigator: Daniela Apa, MD          Azienda Ospedaliera Universitaria Integrata di Verona Verona, Italy, 37126 Less <<
NCT03176030 - Withdrawn(Study team submitted... More >> IRAS form and the ethic committee advised that this pilot study is more service evaluation and no REC ethical approval was required.) Less << March 31, 2018 United Kingdom ... More >> Southampton Genral Hospital Southampton, United Kingdom, SO16 6YD Less <<
NCT01375816 Colorectal Cancer Phase 2 Terminated(efficacy interim an... More >>alysis as per protocol) Less << - France ... More >> Hopital Saint Antoine Paris, France, 75012 Less <<
NCT01315990 Colorectal Cancer Metastatic Phase 4 Unknown March 2018 Germany ... More >> Universitätsmedizin Mainz Mainz, Germany, 55131 Less <<
NCT01689636 Ovarian Cancer ... More >> Healthy Volunteers Less << Phase 1 Completed - United States, Missouri ... More >> Washington University Medical Center St. Louis, Missouri, United States Less <<
NCT03593759 Cardiac Sarcoidosis ... More >> Sarcoidosis Less << Phase 3 Not yet recruiting December 2023 United States, Virginia ... More >> Virginia Commonwealth University Not yet recruiting Richmond, Virginia, United States, 23298-0053 Contact: Jordana Kron, MD    804-828-7565    jordana.kron@vcuhealth.org    Principal Investigator: Jordana Kron, MD          Canada, Alberta Libin Cardiovascular Institute of Alberta Not yet recruiting Calgary, Alberta, Canada, T2N 2T9 Contact: Russell Quinn, MD    403-220-5500    frquinn@ucalgary.ca    Principal Investigator: Russell Quinn, MD          Canada, British Columbia St. Paul's Hospital Not yet recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Contact: Mustafa Toma, MD    604 806 9986    MToma@providencehealth.bc.ca    Principal Investigator: Mustafa Toma, MD          Canada, Ontario Hamilton Health Sciences Centre Not yet recruiting Hamilton, Ontario, Canada, L8L 2X2 Contact: Jeff Healey, MD    905-527-4322 ext 40319    jeffrey.healey@phri.ca    Principal Investigator: Jeff Healey, MD          University of Ottawa Heart Institute Not yet recruiting Ottawa, Ontario, Canada, K1Y 4W7 Contact: David H Birnie, MD    613-696-7269    dbirnie@ottawaheart.ca    Principal Investigator: David Birnie, MD          University Health Network Not yet recruiting Toronto, Ontario, Canada, M5G 2C4 Contact: Andrew Ha, MD    416-340-5206    andrew.ha@uhn.ca    Principal Investigator: Andrew Ha, MD          Canada, Quebec Montreal Heart Institute Not yet recruiting Montreal, Quebec, Canada, H1T 1C8 Contact: Lena Rivard, MD    514-376-3330    lena.rivard@gmail.com    Principal Investigator: Lena Rivard, MD Less <<
NCT00467909 Healthy Not Applicable Completed - India ... More >> St John's research Institute Bangalore, Karnataka, India, 560034 Less <<
NCT00522821 IgG Deficiency ... More >> Infections Less << Phase 4 Completed - Netherlands ... More >> AMC Amsterdam, Netherlands VU Amsterdam, Netherlands Jeroen Bosch Ziekenhuis Den Bosch, Netherlands UMCG Groningen, Netherlands LUMC Leiden, Netherlands AZM Maastricht, Netherlands UMC St Radboud Nijmegen, Netherlands Erasmus MC Rotterdam, Netherlands UMCU Utrecht, Netherlands Less <<
NCT01920997 - Unknown - China, Shanghai ... More >> Shanghai University of Traditional Chinese Medicine Recruiting Shanghai, Shanghai, China, 210038 Contact: Yang Jie, MD    +86-0510-85350351    yangjie@wuxiph.com    Principal Investigator: He Qing, MD Less <<
NCT03449901 Soft Tissue Sarcoma Phase 2 Recruiting February 9, 2025 United States, California ... More >> Sarcoma Oncology Center Not yet recruiting Santa Monica, California, United States, 90403 Contact: Sant P Chawla, M.D.    310-552-9999       Principal Investigator: Sant P Chawla, M.D.          United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Brian A Van Tine, M.D., Ph.D.    314-362-5817    bvantine@wustl.edu    Principal Investigator: Brian A Van Tine, M.D., Ph.D.          Sub-Investigator: Douglas Adkins, M.D.          Sub-Investigator: Angie Hirbe, M.D.          Sub-Investigator: Jingqin (Rosy) Luo, Ph.D. Less <<
NCT00728273 Healthy Phase 2 Completed - Thailand ... More >> Institute of Nutrition, Mahidol University Nakhon Pathom, Thailand, 73170 Less <<
NCT00212147 Avitaminosis ... More >>Delirium, Dementia, Amnestic, Cognitive Disorders Less << Not Applicable Completed - United States, New York ... More >> New York Methodist Hospital Brooklyn, New York, United States, 11215 WeillMedical College of Cornell University New York, New York, United States, 10021 Less <<
NCT03281369 Gastric Adenocarcinoma or Gast... More >>roesophageal Junction Adenocarcinoma Less << Phase 1 Phase 2 Recruiting November 13, 2021 -
NCT02578680 - Active, not recruiting - -
NCT03771560 Autism Spectrum Disorder Phase 2 Phase 3 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 Less <<
NCT01511055 Ovarian Cancer Phase 2 Terminated(Accrual temporarily... More >> suspended, followed by study closure due to technical problems with investigational camera.) Less << - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00514410 Depression Phase 4 Completed - United Kingdom ... More >> North West Wales Trust Bangor, Gwynedd, United Kingdom, LL57 2PW Swansea University Swansea, United Kingdom, SA2 8PP Cardiff University Wrexham, United Kingdom, LL13 7YP Less <<
NCT03581773 Mucositis Phase 2 Recruiting December 20, 2020 Denmark ... More >> Aarhus University Hospital, Department of oncology Recruiting Aarhus, Central Region Of Denmark, Denmark, 8000 Contact: Frede Donskov, MD DMSc    004527147015    Frede.Donskov@auh.rm.dk    Contact: Niels Fristrup, MD PhD    004520914161    niels.fristrup@rm.dk    Department of Oncology, Herlev Hospital Not yet recruiting Herlev, Denmark, 2730 Contact: Poul Geertsen, MD, PhD    +45 4488 4488    Poul.Geertsen@regionh.dk    Sub-Investigator: Anne Kirstine Moeller, MD PhD          Department of Oncology, Odense University Hospital Not yet recruiting Odense, Denmark, 5000 Contact: Niels Viggo Jensen, MD    +45 6611 3333    Niels.Viggo.Jensen@rsyd.dk Less <<
NCT02578680 Non-Small-Cell Lung Carcinoma Phase 3 Active, not recruiting April 15, 2019 -
NCT00130585 Folate Bioavailability ... More >> Healthy Less << Not Applicable Completed - Netherlands ... More >> Wageningen University Wageningen, Netherlands, 6700EV Less <<
NCT00853879 Parkinson's Disease Not Applicable Terminated - United States, New York ... More >> The Feinstein Institute For Medical Recearch Manhasset, New York, United States, 11030 Less <<
NCT03283176 - Not yet recruiting February 1, 2019 -
NCT00672360 Autism Phase 2 Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00300352 Coronary Artery Disease Phase 2 Unknown - United Kingdom ... More >> University of Oxford Recruiting Oxford, United Kingdom, OX3 9DU Less <<
NCT00717730 Diarrhea Pneu... More >>monia Less << Phase 2 Completed - India ... More >> Society for Essential Health Action and Training New Delhi, Delhi, India Less <<
NCT00452829 Recurrent Neural Tube Defects Phase 1 Completed - United Kingdom ... More >> Neural Development Unit, Institute of Child Health London, United Kingdom, WC1N 1EH Less <<
NCT01584050 Vitamin B12 Deficiency Not Applicable Completed - Canada, British Columbia ... More >> University of British Columbia Vancouver, British Columbia, Canada Malaysia Universiti Putra Malaysia Serdang, Selangor, Malaysia Less <<
NCT02953522 Overweight and Obesity Not Applicable Completed - -
NCT02786823 Diabetes Mellitus, Type 2 Phase 2 Phase 3 Completed - India ... More >> All India Institute of Medical Sciences, Bhubaneswar Bhubaneswar, Odisha, India, 751019 Less <<
NCT00145184 Tuberculosis Phase 3 Terminated(Slow recruitment) - Tanzania ... More >> Muhimbili University, College of Health Sciences Dar Es Salaam, Tanzania Less <<
NCT01540344 Peritoneal Carcinomatosis ... More >> Colorectal Cancer Metastatic Less << Phase 2 Terminated(Slow recruitment.) - Germany ... More >> Charité Campus Mitte, Humboldt-University Berlin Berlin, Germany, 10117 Medical Center of the Friedrich-Alexander-University Erlangen- Nürnberg Erlangen, Germany, 91054 Cologne-Merheim Medical Center, University Witten/Herdecke Koeln, Germany, 51058 University Hospital Regensburg Regensburg, Germany, 93042 St. John of God Hospital Regensburg Regensburg, Germany, 93049 University Hospital, University of Tuebingen Tuebingen, Germany, 72076 University Hospital Wuerzburg, Julius-Maximilians University Wuerzburg, Germany, 97080 Less <<
NCT00789490 Iron Deficiency ... More >> Folic Acid Deficiency Less << Phase 1 Completed - Canada, Ontario ... More >> The Hospital For Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT03398291 Pancreatic Cancer ... More >> Liver Metastases Surgery Less << Phase 3 Recruiting June 1, 2025 China, Shanghai ... More >> Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: XianJun Yu, M.D., Ph.D.    +86-21-6417-5590    yuxianjun@fudanpci.org    Contact: Si Shi, M.D.    +86-21-6417-5590    shisi@fudanpci.org    Principal Investigator: Xianjun Yu, M.D., Ph.D. Less <<
NCT02346162 Overweight Ob... More >>ese Less << Not Applicable Active, not recruiting June 2019 United States, Oregon ... More >> Kaiser Permanente Center for Health Research Portland, Oregon, United States, 97227 Less <<
NCT01676740 Excessive Amount of Blood / Fl... More >>uid Transfusion Less << Not Applicable Unknown February 2014 Israel ... More >> Meir Medical Center Not yet recruiting Kfar Saba, Israel, 44281 Contact: Martin H Ellis, MD    972-9-7471822    martinel@clalit.org.il Less <<
NCT02302729 Undernutrition Not Applicable Completed - Guatemala ... More >> APEVIHS (Association for the Prevention and Study of HIV/AIDS) Retalhuleu, Guatemala Less <<
NCT02989311 Anemia Iron D... More >>eficiency Less << Not Applicable Completed - Kenya ... More >> Msambweni County Referral Hospital Msambweni, Kwale County, Kenya Less <<
NCT01748864 Healthy Phase 1 Completed - United States, Florida ... More >> MD Clinical Hallendale, Florida, United States United States, Indiana Horizon Oncology Lafayette, Indiana, United States Less <<
NCT02366091 Coronary Artery Disease Phase 2 Recruiting November 2018 United States, Maryland ... More >> Johns Hopkins Hospital Recruiting Baltimore, Maryland, United States, 21287 Contact: Tricia Steinberg, MSN    443-287-3469    asteinb3@jhmi.edu Less <<
NCT02588898 - Completed - Germany ... More >> University of Saarland Homburg, Saarland, Germany, 66424 Less <<
NCT02727920 Energy Drinks Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins Bloomberg School of Public Health Baltimore, Maryland, United States, 21205 Less <<
NCT02866448 Cardiovascular Disease Not Applicable Withdrawn(Funding delayed beyo... More >>nd acceptable start date) Less << - United Kingdom ... More >> University of Reading Reading, Berkshire, United Kingdom, RG6 6AP Less <<
NCT00055432 Ovarian Cancer ... More >> Peritoneal Cancer Less << Phase 2 Terminated - United States, Georgia ... More >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Atlanta, Georgia, United States Less <<
NCT00670800 Polycystic Ovary Syndrome Not Applicable Completed - United States, Michigan ... More >> University of Michigan, Michigan Clinical Research Unit Ann Arbor, Michigan, United States, 48109 Less <<
NCT00670800 - Completed - -
NCT00731276 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - Singapore ... More >> National Cancer Centre - Singapore Singapore, Singapore, 169610 Less <<
NCT02422927 Atherosclerosis ... More >> Inflammation Hypercholesterolemia Less << Phase 4 Completed - -
NCT01226550 Peritoneal Carcinosis (PC) Phase 1 Phase 2 Completed - France ... More >> Service de Chirurgie Générale et Thoracique, Centre Hospitalier Lyon-Sud Pierre Bénite Cedex, France, 69495 Less <<
NCT01397305 Rectal Cancer Phase 1 Phase 2 Completed - Sweden ... More >> Sahlgrenska University Hospital Göteborg, Sweden, 416 85 Less <<
NCT03004807 Vitamin Deficiency ... More >> Mineral Deficiency Aging Less << Not Applicable Recruiting November 2020 United States, Oregon ... More >> Linus Pauling Science Center Recruiting Corvallis, Oregon, United States, 97331 Contact: Alexander J Michels, PhD    541-737-8730    Alexander.Michels@oregonstate.edu    Contact: Sandra Uesugi, RN    541-737-3594    Sandra.Uesugi@oregonstate.edu    Principal Investigator: Tory M Hagen, PhD          Sub-Investigator: Kathy Magnusson, PhD, DVM Less <<
NCT02919462 Carcinoma, Non-Small-Cell Lung... More >> Secondary Advanced Stage IIIB High Thymidylate Synthase Expression Less << Phase 2 Terminated(low recruitement ra... More >>te) Less << - Italy ... More >> Ircc Irst Meldola, FC, Italy, 47014 U.O. Oncologia Medica Faenza, RA, Italy, 48018 Claudio Dazzi Ravenna, RA, Italy, 48121 Ospedale di Piacenza, ASL Piacenza Piacenza, Italy U.O. Oncologia Ospedale degli Infermi Rimini, Italy Less <<
NCT03218709 Hyperuricemia Phase 4 Recruiting April 2018 China, Guangdong ... More >> Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Min Xia, Ph.D       xiamin@mail.sysu.edu.cn    Contact: Yi Guo, Ph.D       guoyi_019@126.com Less <<
NCT02683369 Non-anemic Iron Deficiency Phase 2 Phase 3 Completed - United States, Maryland ... More >> Center for Integrative Medicine University of Maryland Baltimore, Maryland, United States, 21201 Less <<
NCT00002593 Colorectal Cancer Phase 3 Completed - -
NCT03549494 Stomach Neoplasm ... More >> Gastrointestinal Neoplasms Digestive System Neoplasm Esophageal Neoplasms Head and Neck Neoplasms Gastrointestinal Disease Digestive System Disease Esophageal Diseases Stomach Diseases Esophagogastric Junction Disorder Less << Phase 2 Not yet recruiting October 1, 2019 Cuba ... More >> National Institute of Oncology and Radiobiology (INOR) Not yet recruiting Havana, La Habana, Cuba, 10400 Contact: Luis E. Alsina Tul, Dr.    +53-78388589    lealsina@infomed.sld.cu    Principal Investigator: Luis E. Alsina Tul, Dr.          Sub-Investigator: Yanelys Mir Espinosa, Dr.          Sub-Investigator: Giselle Álvarez Pérez, BSc          Sub-Investigator: Karelia Silvera Candó, BSc          Sub-Investigator: Zaida Lastre Sosa, BSc          Sub-Investigator: Janet Lamadrid García, Dr.          Sub-Investigator: Danay Corrales Otero, Dr.          Sub-Investigator: Marta Lugioyo Lugo, BSc          Sub-Investigator: Juan J. Lence Anta, Dr. Less <<
NCT01235767 Low Birth Weight ... More >> Preterm Birth Less << Not Applicable Completed - Vietnam ... More >> National Institute of Nutrition Hanoi, Vietnam Less <<
NCT01274962 Operable T2-3N+M0 Rectal Cance... More >>r (Stage III) Less << Phase 2 Active, not recruiting December 2020 Canada, Quebec ... More >> Hôpital de Gatineau Gatineau, Quebec, Canada, J8T 8R2 Hôpital Charles LeMoyne Greenfield Park, Quebec, Canada, J4V 2H1 Centre Hospitalier Pierre-Boucher Longueuil, Quebec, Canada, J4M 2A5 Sir Mortimer B. Davis - Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 CHUM-Hôpital St-Luc Montréal, Quebec, Canada, H2X 3J4 Hôpital Honoré-Mercier Saint-Hyacinthe, Quebec, Canada, J2S 4Y8 Hôpital du Suroît Salaberry-De-Valleyfield, Quebec, Canada, J6T 6C1 Canada CHUQ - Hôtel-Dieu de Québec Québec, Canada, G1R 2J6 Less <<
NCT03713112 Deprescribing ... More >> Multi-disciplinary Rounds Less << Not Applicable Recruiting August 20, 2019 Singapore ... More >> Bright Vision Hospital Recruiting Singapore, Singapore, 547530 Contact: Wong Peng Yong, Andrew, MBBS    62485755 ext 5749    med10056@yahoo.co.uk    Contact: Belinda Soh Qimin    62485755    belinda.soh@bvh.org.sg    Sub-Investigator: Charissa Ann Ee Jia Ming          Sub-Investigator: Tan Wanting          Sub-Investigator: Low Lian Leng, MBBS          Principal Investigator: Wong Peng Yong, Andrew, MBBS Less <<
NCT00885885 Colorectal Cancer Phase 2 Completed - Spain ... More >> Spanish Cooperative Group for Gastrointestinal Tumour Therapy Madrid, Spain, 28046 Less <<
NCT00299104 Rheumatoid Arthritis Phase 3 Completed - -
NCT03297970 - Completed - Colombia ... More >> FINUSAD - Foundation for Research in Nutrition and Health Bogota, Colombia University of La Sabana Chia, Colombia Less <<
NCT01119560 - Active, not recruiting - -
NCT01051167 Metastatic Colorectal Cancer Phase 2 Completed - Germany ... More >> University of Duisburg-Essen Medical School Essen, Nordrhein-Westfalen, Germany, 45122 Alfried Krupp von Bohlen und Halbach Krankenhaus gGmbH Essen, Nordrhein-Westfalen, Germany, 45131 Prosper Hospital Recklinghausen Recklinghausen, Nordrhein-Westfalen, Germany, 45659 Less <<
NCT03601494 Diabetic Neuropathies ... More >> Chronic Pain Less << Not Applicable Completed - Egypt ... More >> Emad Zarief Kamel Said Assiut, Egypt, 71111 Less <<
NCT03589833 Arthritis, Rheumatoid Phase 2 Recruiting July 2020 China, Beijing ... More >> Deptment of Rheumatology, Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100032 Contact: Xuan Zhang, MD          Principal Investigator: Xuan Zhang, MD Less <<
NCT00784082 - Completed - France ... More >> Hopital Louis Mourier Colombes, France, 92701 Less <<
NCT02826837 Advanced Colorectal Cancer Phase 1 Phase 2 Not yet recruiting February 1, 2022 -
NCT03083847 Malaria Phase 1 Recruiting June 30, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT00299104 - Completed - -
NCT03446872 - Recruiting February 28, 2022 Korea, Republic of ... More >> Severance Hospital, Yonsei University Health System - Gastroenterology Recruiting Seoul, Korea, Republic of, 03722 Severance Hospital, Yonsei University Health System - Oncology Recruiting Seoul, Korea, Republic of, 03722 Gangnam Severance Hospital, Yonsei University Health System Recruiting Seoul, Korea, Republic of, 06273 Samsung Medical Center - Oncology Recruiting Seoul, Korea, Republic of, 06351 Korea University Guro Hospital Recruiting Seoul, Korea, Republic of, 08308 Ajou University Hospital Recruiting Suwon, Korea, Republic of, 16499 Less <<
NCT01183494 Metastatic Colorectal Cancer Phase 1 Active, not recruiting December 2018 United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Italy CRO-National Cancer Institute Aviano, Italy, 33081 Less <<
NCT02620800 Metastatic Pancreas Adenocarci... More >>noma Less << Phase 1 Phase 2 Completed - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 United States, Massachusetts Tufts - New England Medical Center Boston, Massachusetts, United States, 02111 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48103 Karmanos Cancer Center Wayne State University Detroit, Michigan, United States, 48201 United States, New York Cornell University Weill Medical College New York, New York, United States, 10065 United States, South Carolina Gibbs Cancer Center and Research Institute Spartanburg, South Carolina, United States, 29303 United States, Washington Virginia Mason Cancer Center Seattle, Washington, United States, 98101 Less <<
NCT03688230 Metastatic Colorectal Cancer Phase 2 Not yet recruiting August 2021 -
NCT02463513 Participants With the MTHFR 67... More >>7TT Genotype Less << Not Applicable Unknown December 2017 United Kingdom ... More >> Northern Ireland Clinical Research Facility (NICRF) Belfast, N.Ireland, United Kingdom, BT9 7AB Human Intervention Studies Unit, University of Ulster Coleraine, N.Ireland, United Kingdom, BT52 1SA Clinical Translational Research and Innovation Centre (C-TRIC) Londonderry, N.Ireland, United Kingdom, BT47 6SB Less <<
NCT01992705 Resectable Pancreatic Cancer Early Phase 1 Recruiting December 2020 United States, Maryland ... More >> University of Maryland Medical Center Recruiting Baltimore, Maryland, United States, 21201 Sub-Investigator: William Regine, MD          Sub-Investigator: Yixing Jiang, MD          Sub-Investigator: Nader Hanna, MD          Sub-Investigator: H. Richard Alexander, MD          Sub-Investigator: Navesh Sharma, DO, PhD          Sub-Investigator: Mark Mishra, MD Less <<
NCT00065806 Lupus Erythematosus, Systemic Phase 3 Completed - United States, North Carolina ... More >> Duke Medical Center / Duke Clinical Research Institute Durham, North Carolina, United States, 27715 Less <<
NCT00308516 Rectal Cancer ... More >> Cancer of the Rectum Colorectal Cancer Less << Phase 2 Completed - United States, Alabama ... More >> Northeast Alabama Regional Medical Center Anniston, Alabama, United States, 36207 United States, Arkansas Northeast Arkansas Clinic Jonesboro, Arkansas, United States, 72401 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Integrated Community Oncology Network Jacksonville, Florida, United States, 32256 Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States, 33805 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Pennsylvania Consultants in Medical Oncology and Hematology Drexel Hill, Pennsylvania, United States, 19026 United States, South Carolina Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology Nashville, Tennessee, United States, 37205 United States, Texas South Texas Oncology and Hematology San Antonio, Texas, United States, 78258 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Less <<
NCT02290756 Infant Development Not Applicable Unknown September 2016 Pakistan ... More >> Center for Global Public Health Recruiting Islamabad, Pakistan, 44000 Contact: Momina Salim, MPH    +92-302-8558590    momina.salim@live.com    Contact: Tahira E Reza, MSc       reza.tahira@gmail.com Less <<
NCT02925429 - Completed - -
NCT03558464 Stunting Anem... More >>ia Micronutrient Deficiency Less << Not Applicable Recruiting April 30, 2021 Kenya ... More >> One Acre Fund Recruiting Kakamega, Kenya Contact: Kelvin Musau, MSc    +254711534867    kelvin.musau@oneacrefund.org    Principal Investigator: Kelvin Musau, MSc          Sub-Investigator: Haley Kawaja, MSc          Sub-Investigator: Marion Kiprotich, MSc Less <<
NCT02511054 Malaria Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00308516 - Completed - -
NCT01344837 - Not yet recruiting - United States, Pennsylvania ... More >> Gynecologic Oncology Group Active, not recruiting Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT03598920 - Recruiting December 31, 2021 Czechia ... More >> Ostrava University Recruiting Ostrava, Moravian-Silesian Region, Czechia, 70103 Contact: Marek Bužga, Ass.Prof.,MSc.,Ph.D.    0042055346 ext 1770    marek.buzga@osu.cz    Principal Investigator: Marek Bužga, Ass.Prof.,MSc.,Ph.D.          Vítkovice Hospital Ostrava Recruiting Ostrava, Moravian-Silesian Region, Czechia, 703 00 Contact: Jan Boženský, MD    0042059563 ext 3530    jan.bozensky@vtn.agel.cz    Principal Investigator: Jan Boženský, MD          University Hospital Ostrava Recruiting Ostrava, Moravian-Silesian Region, Czechia, 708 52 Contact: Petr Vávra, Ass.Prof.,MD,Ph.D.    0042059737 ext 2544    petr.vavra@fno.cz    Contact: Jiří Hynčica    0042059737 ext 2587    jiri.hyncica@fno.cz    Principal Investigator: Evžen Machytka, MD,Ph.D.          Sub-Investigator: Christian Kufa, MD Less <<
NCT02552433 - Enrolling by invitation September 2019 Netherlands ... More >> Catharina Hospital Eindhoven, Noord-Brabant, Netherlands, 5623 EJ Sint Antonius Hospital Nieuwegein, Utrecht, Netherlands, 3430 EM Rijnstate Hospital Arnhem, Netherlands Less <<
NCT03426371 Metastatic Colorectal Cancer Phase 3 Recruiting December 2023 China, Beijing ... More >> 307 Hospital of PLA Recruiting Beijing, Beijing, China, 100071 Contact: Jianming Xu    010-56943977    Hjc1126@sina.com Less <<
NCT01073332 Excessive Physical Exercise, U... More >>nspecified Less << Not Applicable Completed - United States, California ... More >> University of California, Los Angeles Los Angeles, California, United States, 90095 Less <<
NCT01161316 Metastatic Colorectal Cancer Phase 2 Completed - Spain ... More >> Spanish Cooperative Group for Gastrointestinal Tumour Therapy Madrid, Spain, 28046 Less <<
NCT00941655 Gastric Cancer Phase 3 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00065806 - Completed - -
NCT01498055 - Unknown December 2013 China, Chong Qing ... More >> Liang Gong Recruiting Chong Qing, Chong Qing, China, 400038 Contact: Liang Gong    13983965893    gonglw1@gmail.com    Sub-Investigator: Liang Gong Less <<
NCT03259919 Polycystic Ovary Syndrome Phase 2 Completed - Norway ... More >> Departments of Obstetrics and Gynecology and Endocrinology, St. Olav's Hospital Trondheim, Norway Less <<
NCT00227617 Gastrointestinal Carcinoid Tum... More >>or Islet Cell Tumor Lung Cancer Neoplastic Syndrome Neuroendocrine Tumor Less << Phase 2 Phase 3 Unknown June 2016 United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Kaiser Permanente Medical Center - Vallejo Vallejo, California, United States, 94589 Less <<
NCT03087500 - Withdrawn(Funding fell through... More >>) Less << December 2019 -
NCT00659061 Anemia Not Applicable Completed - Pakistan ... More >> AKU-Peds Naushero Feroze Site Office Naushero Feroze, Sindh, Pakistan Less <<
NCT00941655 - Completed - -
NCT02774057 Iron Deficiency Anemia ... More >> Inflammatory Bowel Disease Less << Phase 4 Recruiting August 2017 Lebanon ... More >> American University of Beirut - Medical Center Recruiting Beirut, Lebanon Contact: Ala' I. Sharara, MD    009611350000 ext 5345    as08@aub.edu.lb    Principal Investigator: Ala' I Sharara, MD Less <<
NCT01362582 Pancreatic Cancer Phase 3 Terminated - Germany ... More >> Onkologische Schwerpunktpraxis und Tagesklinik Bad Soden, Germany, 65812 Krankenhaus Nordwest Frankfurt Frankfurt am Main, Germany, 60488 University Hospital of Heidelberg / National Center for Tumordiseases Heidelberg, Germany, 69120 Asklepios Klinik Weißenfels Weißenfels, Germany, 06667 Less <<
NCT00659061 - Completed - -
NCT00396812 Rheumatoid Arthritis Phase 1 Phase 2 Terminated(The perceived risk-... More >>benefit ratio for individuals with early active RA) Less << - United States, Colorado ... More >> University of Colorado Health Sciences Center Denver, Colorado, United States, 80262 Less <<
NCT03426904 Colon Cancer Phase 3 Not yet recruiting February 28, 2026 -
NCT00954512 - Terminated(This study was term... More >>inated for business reasons.) Less << - -
NCT01749956 Rectal Cancer Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33916 Woodlands Medical Specialists Pensacola, Florida, United States, 32503 Florida Cancer Specialists St. Petersburg, Florida, United States, 33705 Space Coast Cancer Center Titusville, Florida, United States, 32796 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 United States, Ohio Oncology Hematology Care, Inc. Cincinnati, Ohio, United States, 45242 United States, Oklahoma Oklahoma University Oklahoma City, Oklahoma, United States, 71304 United States, South Carolina South Carolina Oncology Associates Columbia, South Carolina, United States, 29210 United States, Tennessee Tennessee Oncology - Chattanooga Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37203 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23230 Less <<
NCT01265823 Psoriasis Phase 4 Completed - Mexico ... More >> Site Reference ID/Investigator# 50942 Circuito Comercial Satelite, Mexico Site Reference ID/Investigator# 40964 Iztapalapa, Mexico, 04230 Site Reference ID/Investigator# 50943 Mexico City, Mexico, 06780 Site Reference ID/Investigator# 40965 Monterrey, Mexico, 64460 Site Reference ID/Investigator# 40962 Monterrey, Mexico, 64718 Site Reference ID/Investigator# 40662 Toluca de Lerdo, Mexico, 50120 Site Reference ID/Investigator# 41062 Toluca de Lerdo, Mexico, 50120 Site Reference ID/Investigator# 40963 Zapopan, Mexico, 45190 Less <<
NCT01749956 - Completed - -
NCT00396812 - Terminated(The perceived risk-... More >>benefit ratio for individuals with early active RA) Less << - -
NCT01660711 Pancreatic Adenocarcinoma Phase 2 Active, not recruiting July 2018 United States, Illinois ... More >> NorthShore University HealthSystem Evanston, Illinois, United States, 60201 Less <<
NCT03058094 NSCLC Phase 3 Not yet recruiting January 2020 China, Beijing ... More >> Beijing Cancer Hospital Not yet recruiting Beijing, Beijing, China, 100000 Contact: Jian Fang          Chinese General PLA Hospital Not yet recruiting Beijing, Beijing, China, 100000 Contact: Yi Hu          Peking Union Medical College Hospital Not yet recruiting Beijing, Beijing, China, 100000 Contact: Mengzhao Wang          China, Chongqing Xinqiao Hospital Army Medical University Not yet recruiting Chongqing, Chongqing, China, 400000 Contact: Dong Wang          China, Fujian Fujian Cancer Hospital Not yet recruiting Fuzhou, Fujian, China, 350000 Contact: Cheng Huang          Fuzhou General Hospital of Nanjing Military Command Not yet recruiting Fuzhou, Fujian, China, 350000 Contact: Xuenong Ouyang          China, Hebei Tumor Hospital of Hebei Province Not yet recruiting Shijiazhuang, Hebei, China, 050000 Contact: Cuimin Ding          China, Heilongjiang Harbin Medical University Cancer Hospital Not yet recruiting Harbin, Heilongjiang, China, 150000 Contact: Gongyan Chen          China, Henan Henan Cancer Hospital Not yet recruiting Zhengzhou, Henan, China, 450000 Contact: Zhiyong Ma          China, Jiangsu Jiangsu Province Hospital Not yet recruiting Nanjing, Jiangsu, China, 210000 Contact: Yongqian Shu          Nanjing General Hospital Not yet recruiting Nanjing, Jiangsu, China, 210000 Contact: Yong Song          China, Liaoning The First Affiliated Hospital of Dalian Medical University Not yet recruiting Dalian, Liaoning, China, 116000 Contact: Jiwei Liu          The second Hospital of Dalian Medical University Not yet recruiting Dalian, Liaoning, China, 116000 Contact: Yang Zhang          The First Affiliated Hospital of China Medical University Not yet recruiting Shenyang, Liaoning, China, 110000 Contact: Yunpeng Liu          China, Shanghai Fudan University Shanghai Cancer Center Not yet recruiting Shanghai, Shanghai, China, 200000 Contact: Jianhua Chang          China, Sichuan Sichuan Cancer Hospital & Institute Not yet recruiting Chengdu, Sichuan, China, 610000 Contact: Ping Yu          West China Hospital,Sichuan University Not yet recruiting Chengdu, Sichuan, China, 610000 Contact: You Lu          China, Tianjin Tianjin Medical University Cancer Institute & Hospital Not yet recruiting Tianjin, Tianjin, China, 300000 Contact: Kai Li          China, Zhejiang The First Affiliated Hospital,Zhejiang University Not yet recruiting Hangzhou, Zhejiang, China, 310000 Contact: Qiong Zhao          Zhejiang Cancer Hospital Not yet recruiting Hangzhou, Zhejiang, China, 310000 Contact: Yiping Zhang          China Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting Beijing, China, 100021 Principal Investigator: Yuankai Shi, Professor Less <<
NCT02697981 Pregnancy Not Applicable Unknown December 2017 -
NCT01265823 - Completed - -
NCT01747551 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02214 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT01628211 Colorectal Cancer Phase 2 Recruiting June 2018 Italy ... More >> Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento Entero-proctologico Recruiting Napoli, Italy, 80131 Less <<
NCT03399071 Gastric Adenocarcinoma ... More >> Oesophageal Adenocarcinoma Less << Phase 2 Recruiting August 15, 2025 United Kingdom ... More >> The Royal Marsden Hospital Recruiting London, United Kingdom, SW3 6JJ Contact: Marco Gerlinger, MD, FRCP    02071535234    marco.gerlinger@icr.ac.uk Less <<
NCT01747551 - Completed - -
NCT02657785 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Phase 3 Enrolling by invitation December 2024 China, Beijing ... More >> Navy General Hospital Beijing, Beijing, China, 100048 Less <<
NCT03386942 Solid Tumors Phase 1 Recruiting September 1, 2020 Japan ... More >> Eisai Trial Site Recruiting Chuo-ku, Tokyo, Japan Less <<
NCT02270632 Rheumatoid Arthritis Phase 2 Unknown April 2018 Germany ... More >> Universitatsklinikum Essen Recruiting Essen, Germany Principal Investigator: Christof Specker, Prof.          Universitatsklinikum Freiburg Recruiting Freiburg, Germany Principal Investigator: Reinhard Voll, MD          Schön Klinik Hamburg Eilbek Recruiting Hamburg, Germany Principal Investigator: Jürgen Wollenhaupt, Prof          Italy Ospedale Luigi Sacco, Milano Recruiting Milano, Italy Principal Investigator: Piercarlo Sarzi Puttini, Prof.          Azienda Ospedaliera Universitaria Senese Recruiting Siena, Italy Principal Investigator: Mauro Galeazzi, Prof.          Azienda Ospedaliera Universitaria Integrata Verona Recruiting Verona, Italy Principal Investigator: Ombretta Viapiana, Dr          Switzerland HFR Fribourg - Hôpital Cantonal Recruiting Fribourg, Switzerland Principal Investigator: Jean Dudler, MD          Centre Hospitalier Universitaire Vaudois Recruiting Lausanne, Switzerland Principal Investigator: Zufferey Pascal, MD Less <<
NCT02836158 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Phase 3 Recruiting December 2030 China, Beijing ... More >> Navy General Hospital Recruiting Beijing, Beijing, China, 100048 Contact: Liren Qian, M.D.    +861066957676    qlr2007@126.com Less <<
NCT00954512 Neoplasms Phase 1 Phase 2 Terminated(This study was term... More >>inated for business reasons.) Less << - -
NCT00507741 Ovarian Cancer ... More >> Endometrial Cancer Less << Phase 2 Completed - -
NCT03628625 Miscarriage M... More >>issed Abortion Less << Phase 2 Recruiting December 10, 2018 Egypt ... More >> Ain Shams University, Maternity Hospital Recruiting Cairo, Egypt Contact: Dina Mansour Less <<
NCT01571024 Advanced Solid Tumors ... More >> Metastatic Colorectal Cancer Metastatic Pancreatic Cancer Less << Phase 1 Completed - United States, North Carolina ... More >> University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Less <<
NCT00320073 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT01134666 - Terminated(The study was disco... More >>ntinued due to slow recruitment and subjects not completing follow up period.) Less << - India ... More >> Indo- American Cancer Institute & Research Centre Hyderabad, Andhra Pradesh, India, 500034 NVS Ramakrishna's Clinic Hyderabad, Andhra Pradesh, India, 500063 Dr. Nikhil's Clinic Secunderabad, Andhra Pradesh, India, 500025 Nikhil Gharyalpatil's Clinic Secunderabad, Andhra Pradesh, India, 500025 Ravi Kumar's Clinic Hyderabad, Andrapradesh, India, 500001 Ambaa Hospitals Hyderabad, Andrapradesh, India, 500008 Swarna Sai Hospital Hyderabad, Andrapradesh, India, 500059 Manipal Centre For Clinical Research Mangalore, Bangalore, India, 575 001 Medical College Calicut Kerala, Calicut, India, 673016 Hemato Oncology Clinic Ahmedabad, Gujarat, India, 380009 Kattimani Oncology Clinic Hubli, Karnataka, India, 580020 SKIMS Srinagar, Kashmir, India, 190001 S. K. I. M. S. Srinagar, Kashmir, India, 190010 Dr. T. P. Sahoo's Clinic Bhopal, Madhya Pradesh, India, 462001 BND Onco Centre Mumbai, Maharashtra, India, 400014 Joy Hospital Mumbai, Maharashtra, India, 400071 Ruby Hall Clinic Pune, Maharashtra, India, 411001 Grace Nursing Home Aizwal, Mizoram, India, 796 009 Lilavati Hospital Bandra, Mumbai, India, 400050 S.L.Raheja Hospital Mahim, Mumbai, India, 400016 Apollo Cancer Institute Delhi, New Delhi, India, 110044 Rajiv Gandhi Cancer Institute & Research Delhi, New Delhi, India, 110085 Fortis Escorts Hospital Amritsar, Punjab, India, 143004 Dr. Rajeev Bedi's Clinic Chandigarh, Punjab, India, 160101 D.M.C Hospital Ludhiana, Punjab, India, 141001 IVY Hospital Mohali, Punjab, India, 160071 Cancer Clinic Jaipur, Rajasthan, India, 302004 SMS Hospital Jaipur, Rajasthan, India, 302004 Bhagwan Mahaveer Cancer Hospital Jaipur, Rajasthan, India, 302006 Bhagwan Mahaveer Cancer Hospital & Research Centre Jaipur, Rajasthan, India, 302030 Vyas Cancer Care Jodhpur, Rajasthan, India, 3420003 TC 14/ 764 Sreemangalam Trivandrum, Tamilnadu, India, 695011 Shati Gopal Hospital Ghaziabad, Uttar Pradesh, India, 201014 Annapurna Medical and Cancer Relief Society Lucknow, Uttar Pradesh, India, 226007 Chittaranjan National Cancer Institute Kolkata, West Bengal, India, 700026 Apollo Gleneagles Cancer Hospital Kolkata, West Bengal, India, 700054 Nothern Railway Central Hospital Delhi, India, 110055 Indraprastha Apollo Hospital Delhi, India, 110076 Shanti Mukand Hospital Delhi, India, 110092 Dharamshila Cancer Hospital & Research Centre Delhi, India, 110096 Less <<
NCT03230396 Nutrient Pharmacokinetics Not Applicable Completed - -
NCT03406299 Biliary Tract Neoplasms Phase 2 Recruiting December 31, 2020 Taiwan ... More >> Taiwan Cooperative Oncology Group, National Health Research Institutes Recruiting Taipei, Taiwan Contact: Tsang-Wu Liu, MD    +886-2-26534401 ext 25150    walter@nhri.org.tw    Principal Investigator: Li-Tzong Chen, MD PHD          Principal Investigator: Nai-Jung Chiang, MD Less <<
NCT01002924 Solid Tumors Phase 2 Completed - United States, Maryland ... More >> Center for Blood and Cancer Disorders Bethesda, Maryland, United States, 20817 Less <<
NCT03736720 Locally Advanced Digestive Sys... More >>tem Neuroendocrine Carcinoma Locally Advanced Pancreatic Neuroendocrine Carcinoma Metastatic Digestive System Neuroendocrine Carcinoma Metastatic Pancreatic Neuroendocrine Carcinoma Refractory Digestive System Neuroendocrine Carcinoma Refractory Pancreatic Neuroendocrine Carcinoma Unresectable Digestive System Neuroendocrine Carcinoma Unresectable Pancreatic Neuroendocrine Carcinoma Less << Phase 2 Not yet recruiting September 5, 2022 United States, New York ... More >> Roswell Park Cancer Institute Not yet recruiting Buffalo, New York, United States, 14263 Contact: Renuka V. Iyer    716-845-8195    Renuka.Iyer@roswellpark.org    Principal Investigator: Renuka V. Iyer Less <<
NCT01257139 Non Small-cell Lung Cancer Phase 3 Completed - France ... More >> CH du Pays d'Aix Aix en Provence, France CHU Amien Picardie Amiens, France Centre Hospitalier Universitaire d'Angers Angers, France Centre Hospitalier d'Annecy Annecy, France Centre Hospitalier Général de la Fontonne Antibes Antibes, France CH de Bastia Bastia, France Centre Hospitalier de Beauvais Beauvais, France CHU Bordeaux Hôpital Haut Lévêque Bordeaux Pessac, France Centre Hospitalier Universaitaire de Brest Brest, France HIA Tonnerre Brest, France Centre François Baclesse Caen, France CH René Dubos - Pontoise Cergy Pontoise, France Centre Hospitalier Charleville mézières Charleville Mézières, France CHI Créteil Créteil, France Centre hospitalier de Draguignan Draguignan, France Centre Hospitalier de Elbeuf Elbeuf, France CH Gap Gap, France CH La Roche sur Yon La Roche sur Yon, France Hôpital A Mignot Le Chesnay Le Chesnay, France Centre Omar Lambret Lille, France Hôpital du Cluzeau Limoges, France CHR Longjumeau Longjumeau, France Centre Hospitalier de Bretagne Sud Lorient, France Hôpital de la Croix Rousse Lyon, France Centre Hospitalier Mantes La Jolie, France Hôpital Sainte Marguerite Marseille, France Institut Paoli-Calmette Marseille, France Centre Hospitalier Martigues, France Hôpital Saint Farron Meaux, France Centre Hospitalier de Mulhouse Mulhouse, France CHR Orléans Orléans, France Paris Hôpital saint Antoine Paris, France Centre Catalan Perpignan, France Centre Hospitalier de Périgueux Périgueux, France Rennes Hospital University Rennes, France, 35033 CHU Rouen Hôpital Boisguillaume Rouen, France Hôpital Charles Nicolle Rouen, France Hôpital Yves Le Foll saint Brieuc, France CHU Saint Etienne - Hôpital Nord Saint Etienne, France Centre Hospitalier Général Salon de Provence Salon de Provence, France Institut de Cancérologie de la Loire St Priest en Jarez, France Hôpital d'Instruction des Armées Toulon Naval, France Hôpital Font-Pre Toulon, France CHU Touloues Toulouse, France Centre Hospitalier De Villefranche sur Saone Villefranche sur Saone, France Less <<
NCT02876315 Vitamin D Deficiency Not Applicable Active, not recruiting December 2019 United States, Oregon ... More >> Oregon State University Corvallis, Oregon, United States, 97331 Less <<
NCT02896803 Pancreatic Neoplasms Phase 2 Recruiting August 2018 Brazil ... More >> Instituto do Câncer do Estado de São Paulo Recruiting São Paulo, Brazil, 01246-000 Contact: Tiago Castria, MD PhD    +5511 3893-2000    tiagobiachi@yahoo.com.br Less <<
NCT02275468 Stage 3 Chronic Kidney Disease... More >> Stage 4 Chronic Kidney Disease Less << Phase 2 Completed - China, Beijing ... More >> Guang anmen Hospital, China Academy of Chinese Medical Sciences Beijing, Beijing, China, 100053 Fangshan Hospital of Traditional Chinese Medicine Beijing, Beijing, China China Guang'an Men Hospital South Beijing, China Less <<
NCT02049281 Solid Tumor Phase 1 Terminated - -
NCT01849900 Pregnancy Not Applicable Active, not recruiting June 30, 2017 United States, Michigan ... More >> Calvin College Nursing Department Community sites Grand Rapids, Michigan, United States, 49546 Less <<
NCT00511485 Adenocarcinoma of the Lung Phase 2 Completed - -
NCT01718873 Colorectal Cancer Phase 3 Active, not recruiting June 2018 Italy ... More >> Istituto Nazionale Tumori Fondazione G. Pascale Napoli, Italy Less <<
NCT01123811 Adenocarcinoma of Stomach or E... More >>sophagogastric Junction Less << Phase 2 Completed - Germany ... More >> Städtische Kliniken Esslingen Esslingen, Baden-Württemberg, Germany, 73730 Klinikum Ludwigsburg, Medizinische Klinik I Ludwigsburg, Baden-Württemberg, Germany, 71640 Universitätsklinikum Ulm, Abt. Innere Medizin I Ulm, Baden-Württemberg, Germany, 89070 Klinikum rechts der Isar der technischen Universität München, III. Medizinische Klinik: Hämatologie / Onkologie München, Bayern, Germany, 81675 Medizinische Hochschule Hannover, Abteilung Gastroenterologie, Hepatologie und Endokrinologie Hannover, Niedersachsen, Germany, 30623 Universitätsklinkum Essen, Innere Klinik und Poliklinik - Tumorforschung Essen, Nordrhein-Westfalen, Germany, 45122 Kliniken Essen-Mitte / Evang. Huyssens-Stiftung, Klinik für Innere Medizin I und Internistische Onkologie / Hämatologie Essen, Nordrhein-Westfalen, Germany, 45136 Prosper-Hospital Recklinghausen, Medizinische Klinik I Recklinghausen, Nordrhein-Westfalen, Germany, 45659 Klinikum der Johannes Gutenberg-Universität, I. Medizinische Klinik u. Poliklinik Mainz, Rheinland-Pfalz, Germany, 55101 Charité - Campus Benjamin Franklin, Medizinische Klinik I Berlin, Germany, 12200 Less <<
NCT03522649 Previously Treated Metastatic ... More >>Colorectal Cancer Less << Phase 3 Recruiting November 2021 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Less <<
NCT03009058 Metastatic Cancer Phase 1 Phase 2 Terminated(Commercial reasons) - France ... More >> Centre Léon Bérard, Dpt Medecine & INSERM Lyon, France, 69373 Gustave Roussy Cancer Center Villejuif, France, 94805 United Kingdom St George's University of London, Institute of Infection and Immunity London, United Kingdom, SW17 0RE Royal Marsden Hospital Foundation Trust London, United Kingdom, SW3 6JJ Less <<
NCT01650428 Rectal Cancer Phase 2 Active, not recruiting February 2019 United Kingdom ... More >> Blackpool Victoria Hospital Blackpool, United Kingdom Beatson West of Scotland Cancer Centre Glasgow, United Kingdom Charing Cross Hospital London, United Kingdom Guy's and St Thomas' Hospital London, United Kingdom Hammersmith Hospital London, United Kingdom North MiddlesexHospital London, United Kingdom Royal Marsden Hospitals NHS Foundation Trust London, United Kingdom UCLH London, United Kingdom Mount Vernon Hospital Middlesex, United Kingdom Wexham Park Hospital Slough, United Kingdom Lister Hospital Stevenage, United Kingdom Less <<
NCT01019096 - Completed - United States, New York ... More >> Highland Hospital Rochester, New York, United States, 14620 Strong Memorial Hospital Rochester, New York, United States, 14642 Less <<
NCT01555190 Polycystic Ovary Syndrome ... More >> Hirsutism Menstrual Irregularity Less << Not Applicable Unknown - Italy ... More >> Catholic University of Sacred Heart Recruiting Rome, Italy, 00168 Contact: Maurizio Guido, Medical Doctor    00390630156013    maurizioguido@libero.it    Principal Investigator: Maurizio Guido, doctor Less <<
NCT03040219 Primary Malnurtrition Phase 4 Not yet recruiting December 1, 2017 Egypt ... More >> Marian girgis Not yet recruiting Cairo, Egypt Contact: Marian Girgis Less <<
NCT03319979 - Completed - -
NCT00709189 Female Contraception ... More >> Contraception Therapeutic Equivalency Pharmacokinetics Less << Phase 1 Completed - -
NCT01743196 - Completed - United States, Georgia ... More >> University of Georgia Athens, Georgia, United States, 30602 Less <<
NCT00709982 Drug Interactions ... More >> Healthy Pharmacokinetics Less << Phase 1 Completed - -
NCT00709644 Pharmacokinetics ... More >> Therapeutic Equivalency Contraceptives, Oral Less << Phase 1 Completed - -
NCT01768182 Human Immunodeficiency Virus (... More >>HIV) Infection Less << Not Applicable Completed - Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, RS, Brazil Less <<
NCT00709267 Healthy|Pharmacokinetics PHASE1 COMPLETED 2025-12-04 -
NCT00737126 Diabetic Nephropathies ... More >> Hyperhomocysteinemia Less << Not Applicable Completed - Mexico ... More >> Hospital Universitario "José E. González" Monterrey, Nuevo León, Mexico, 64460 Less <<
NCT01857310 Pregnancy Liv... More >>e Birth Spontaneous Abortion Less << Not Applicable Active, not recruiting December 2019 United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Minnesota Center for Reproductive Medicine Minneapolis, Minnesota, United States, 55407 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 Less <<
NCT02150291 Hepatitis C Phase 4 Unknown November 2015 Egypt ... More >> Ain Shams University Hospitals Recruiting Cairo, Abbasiya, Egypt, 11566. Contact: Osama A Ahmed    01006154809    dros1977@hotmail.com    Principal Investigator: Nermeen N Ashoush Less <<
NCT02066688 Colorectal Neoplasms Phase 2 Phase 3 Unknown December 2017 China ... More >> Renji Hospital Recruiting Shanghai, China, 200001 Contact: Jing-yuan Fang, MD,Ph D.       jingyuanfang2007@126.com Less <<
NCT02444013 Kidney Diseases ... More >> Urologic Diseases Less << Phase 4 Unknown May 2017 China, Guangdong ... More >> Department of Cardiology, the Third Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510630 Contact: Suhua Li, M.D.    86-020-85252168    IMUAWUB@163.com    Principal Investigator: Jinlai Liu, M.D. Less <<
NCT00459264 Depression Bi... More >>polar Disorder Less << Not Applicable Completed - United Kingdom ... More >> University Department of Psychiatry Oxford, Oxfordshire, United Kingdom, OX3 7JX Less <<
NCT00249288 - Completed - -
NCT00249288 Schizophrenia Phase 4 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT03561142 Rectal Cancer ... More >> Rectal Neoplasms Rectal Cancer Stage II Rectal Cancer Stage III Less << Phase 2 Recruiting April 16, 2024 Germany ... More >> University Hospital Erlangen Not yet recruiting Erlangen, Germany Contact: Oliver Ott, Prof.          University Hospital Frankfurt Not yet recruiting Frankfurt, Germany Contact: Claus Rödel, Prof.          University Hospital Tübingen Recruiting Tübingen, Germany Contact: Cihan Gani, Dr.          University Hospital Würzburg Not yet recruiting Würzburg, Germany Contact: Bülent Polat, Dr. Less <<
NCT02916121 Schizophrenia Not Applicable Unknown December 2018 Taiwan ... More >> Taipei Medical University - WanFang Hospital Taipei, Taiwan Less <<
NCT00570856 Kidney Transplantation Phase 4 Terminated - -
NCT01481272 Diffuse Large B Cell Lymphoma Phase 2 Completed - Poland ... More >> Dolnośląskie Centrum Transplantacji Komórkowych Wrocław, Dolnośląskie, Poland, 53-439 Instytut Hematologii i Transfuzjologii Warszawa, Mazowieckie, Poland, 02-776 Centrum Onkologii - Istytut im. M.Sklodowskiej-Curie Warszawa, Mazowieckie, Poland, 02-781 Szpital Specjalistyczny w Brzozowie Podkarpacki Ośrodek Onkologiczny im. ks. Bronisława Markiewicza Brzozów, Podkarpackie, Poland, 16-200 Uniwersyteckie Cenrum Medyczne Gdańsk, Pomorskie, Poland, 80-952 Szpital Morski im. PCK Oddz. Onkologii i Radioterapii Gdynia, Pomorskie, Poland, 81-519 Klinika Transplantacji Szpiku i Onkohematologii; Centrum Onkologii Instytut im. M.Sklodowskiej-Curie, Oddz. w Gliwicach Gliwice, Slaskie, Poland, 44-101 Oddz. Hematologii, Samodzielny Publiczny ZOZ MSW z Warminsko-Mazurskim Centrum Onkologii w Olsztynie Olsztyn, Warminsko-Mazurskie, Poland, 10-228 Less <<
NCT01558193 Aggression Not Applicable Completed - United Kingdom ... More >> Swansea University Swansea, Wales, United Kingdom, SA2 8PP Less <<
NCT00470158 - Completed - -
NCT00470158 Anemia Diarrh... More >>ea Iron Less << Phase 4 Completed - Bangladesh ... More >> ICDDR,B Dhaka, Mohakhali, Bangladesh, 1212 Less <<
NCT00692159 Neoplasm Phase 1 Completed - United States, Arizona ... More >> Scottsdale, Arizona, United States, 85260 United States, California Santa Monica, California, United States, 90404 United States, Ohio Cleveland, Ohio, United States, 44106 Less <<
NCT03305276 - Recruiting May 16, 2024 Italy ... More >> San Giovanni e Ruggi Hospital Recruiting Salerno, Italy, 84100 Contact: Guido Iaccarino, MD    39089672335    guido.iaccarino@sangiovannieruggi.it Less <<
NCT00722592 Ovarian Cancer Phase 2 Completed - -
NCT00000724 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 3 Completed - United States, New Jersey ... More >> Warner-Lambert Parke-Davis Morris Plains, New Jersey, United States, 07950 Less <<
NCT00000998 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 1 Completed - United States, California ... More >> Los Angeles County - USC Med Ctr Los Angeles, California, United States, 90033 Less <<
NCT03246321 Colorectal Neoplasms ... More >> Cecal Neoplasms Peritoneal Metastases Peritoneal Carcinomatosis Less << Phase 1 Phase 2 Not yet recruiting October 1, 2019 Netherlands ... More >> Catharina Hospital Not yet recruiting Eindhoven, Netherlands, 5623 EJ Contact: Koen Rovers, MD    +31402396350    koen.rovers@catharinaziekenhuis.nl    Contact: Ignace de Hingh, MD, PhD    +31402397150    ignace.d.hingh@catharinaziekenhuis.nl    Principal Investigator: Ignace de Hingh, MD, PhD          Principal Investigator: Koen Rovers, MD          Sub-Investigator: Simon Nienhuijs, MD, PhD          Sub-Investigator: Geert-Jan Creemers, MD, PhD          Sub-Investigator: Maarten Deenen, PhD Less <<
NCT01460316 - Completed - France ... More >> Service de Cardiologie Pédiatrique, CHU Brabois Enfants Vandoeuvre les Nancy, France, 54500 Less <<
NCT01959672 Pancreatic Adenocarcinoma ... More >> Resectable Pancreatic Carcinoma Stage I Pancreatic Cancer Stage IA Pancreatic Cancer Stage IB Pancreatic Cancer Stage II Pancreatic Cancer Stage IIA Pancreatic Cancer Stage IIB Pancreatic Cancer Stage III Pancreatic Cancer Less << Phase 2 Active, not recruiting December 2019 United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 Less <<
NCT02231723 Metastatic Pancreatic Adenocar... More >>cinoma Less << Phase 1 Active, not recruiting - United States, Arizona ... More >> Mayo Clinic Arizona Phoenix, Arizona, United States, 85054 United States, Georgia Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Indiana Parkview Research Center Fort Wayne, Indiana, United States, 46845 Indiana University Health Goshen Center for Cancer Care Goshen, Indiana, United States, 46526 Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Nevada Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89014 United States, Ohio The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Tennessee The University of Tennessee Medical Center Knoxville, Tennessee, United States, 37920 United States, Texas Texas Oncology - Austin Midtown Austin, Texas, United States, 78705 Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas, Texas, United States, 75246 Texas Oncology - SAT&BC San Antonio, Texas, United States, 78216 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23502 Less <<
NCT02817256 Complications of Other Bariatr... More >>ic Procedure Less << Not Applicable Unknown November 2018 United Arab Emirates ... More >> Faculty of Medicine and Health Sciences UAE University Al Ain, AB, United Arab Emirates Faculty of Medicine and Health Sciences Al Ain, United Arab Emirates Less <<
NCT00000730 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 3 Terminated - United States, South Carolina ... More >> Julio Arroyo West Columbia, South Carolina, United States, 29169 Less <<
NCT02024607 Advanced Gastrointestinal Canc... More >>er Less << Phase 1 Phase 2 Active, not recruiting - United States, Arizona ... More >> Mayo Clinic Campus in Arizona Phoenix, Arizona, United States, 85054 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33916 United States, Georgia Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Indiana Parkview Research Center Fort Wayne, Indiana, United States, 46845 Indiana University Health Goshen Center for Cancer Care Goshen, Indiana, United States, 46526 Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 Indiana University Health Arnett Hospital Lafayette, Indiana, United States, 47905 Indiana University Health Ball Memorial Hospital Muncie, Indiana, United States, 47303 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55901 United States, Ohio Oncology Hematology Care, Inc. Cincinnati, Ohio, United States, 45242 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 Institute for Translational Oncology Research, Greenville Health System Greenville, South Carolina, United States, 29605 United States, Tennessee Tennessee Oncology - Chattanooga Chattanooga, Tennessee, United States, 37404 Tennessee Oncology - Nashville Nashville, Tennessee, United States, 37203 Canada, Ontario Ottawa Hospital Cancer Center Ottawa, Ontario, Canada, K1H 8L6 Less <<
NCT03126435 FOLFIRINOX Pa... More >>ncreas Cancer Pancreatic Adenocarcinoma Less << Phase 3 Recruiting July 2020 -
NCT00321685 Rectal Adenocarcinoma ... More >> Stage II Rectal Cancer AJCC v7 Stage III Rectal Cancer AJCC v7 Less << Phase 2 Active, not recruiting May 1, 2020 -
NCT02921256 Rectal Adenocarcinoma ... More >> Stage II Rectal Cancer AJCC v7 Stage III Rectal Cancer AJCC v7 Less << Phase 2 Recruiting - -
NCT02730546 Gastric Cardia Adenocarcinoma ... More >> Gastroesophageal Junction Adenocarcinoma Stage IB Gastric Cancer AJCC v7 Stage II Gastric Cancer AJCC v7 Stage IIA Gastric Cancer AJCC v7 Stage IIB Gastric Cancer AJCC v7 Stage IIIA Gastric Cancer AJCC v7 Stage IIIB Gastric Cancer AJCC v7 Less << Phase 1 Phase 2 Recruiting April 15, 2021 United States, Arizona ... More >> Mayo Clinic Hospital Recruiting Phoenix, Arizona, United States, 85054 Contact: Clinical Trials Referral Office    866-776-0015       Principal Investigator: Daniel H. Ahn          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Harry H. Yoon Less <<
NCT02620865 Metastatic Pancreatic Adenocar... More >>cinoma Recurrent Pancreatic Carcinoma Stage III Pancreatic Cancer Stage IV Pancreatic Cancer Less << Phase 1 Phase 2 Active, not recruiting December 2018 United States, Michigan ... More >> Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT00321685 - Active, not recruiting - -
NCT01827553 Pancreatic Cancer Phase 3 Recruiting April 2022 -
NCT01263912 Infant Nutrition Not Applicable Completed - Canada, British Columbia ... More >> BC Children's Hospital Research Institute, University of British Columbia Vancouver, British Columbia, Canada, V5Z4H4 Less <<
NCT01897454 Pancreatic Adenocarcinoma ... More >> Stage IIA Pancreatic Cancer Stage IIB Pancreatic Cancer Stage III Pancreatic Cancer Less << Phase 2 Unknown - United States, New York ... More >> Montefiore Medical Center-Weiler Hospital Recruiting Bronx, New York, United States, 10461 Contact: Jennifer W. Chuy    718-405-8404    JCHUY@montefiore.org    Principal Investigator: Jennifer W. Chuy Less <<
NCT00137657 HIV Malaria ... More >> Diarrhea Pneumonia Opportunistic Infections Less << Phase 4 Completed - Kenya ... More >> CDC KEMRI Research Institute Kisumu, Kenya Less <<
NCT00002525 Colorectal Cancer Phase 3 Terminated(The study was stopp... More >>ed before reaching its accrual goal due to slow accrual) Less << - United States, Illinois ... More >> Loyola University Medical Center Maywood, Illinois, United States, 60153 Less <<
NCT00381862 Colorectal Cancer ... More >> Nausea and Vomiting Less << Phase 2 Completed - United States, Georgia ... More >> St. Josephs/Cander Hospital Savannah, Georgia, United States, 31405 United States, Hawaii Kaiser Permanente Hilo, Hawaii, United States, 86720 United States, Illinois Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 United States, Missouri Kansas City Cancer Center Kansas City, Missouri, United States, 64104 United States, Oregon OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 United States, Texas Texas A & M university / Scott and White Clinic Temple, Texas, United States, 76508 Less <<
NCT00949832 Nutritional Rickets Phase 4 Completed - Nigeria ... More >> Jos University Teaching Hospital Jos, Plateau, Nigeria, 930001 Less <<
NCT03397485 Undernutrition Not Applicable Completed - Mexico ... More >> Insituto Nacional de Salud Publica Cuernavaca, Morelos, Mexico, 62100 Less <<
NCT00002525 - Terminated(The study was stopp... More >>ed before reaching its accrual goal due to slow accrual) Less << - -
NCT03300609 Colorectal Adenocarcinoma ... More >> RAS Wild Type Stage III Colorectal Cancer AJCC v7 Stage IIIA Colorectal Cancer AJCC v7 Stage IIIB Colorectal Cancer AJCC v7 Stage IIIC Colorectal Cancer AJCC v7 Stage IV Colorectal Cancer AJCC v7 Stage IVA Colorectal Cancer AJCC v7 Stage IVB Colorectal Cancer AJCC v7 Less << Phase 3 Recruiting February 27, 2023 United States, California ... More >> USC/Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Dana Agafitei    323-865-0467    Raluca.Agafitei@med.usc.edu Less <<
NCT02997228 Colorectal Adenocarcinoma ... More >> Mismatch Repair Deficiency Stage IV Colorectal Cancer AJCC v7 Stage IVA Colorectal Cancer AJCC v7 Stage IVB Colorectal Cancer AJCC v7 Less << Phase 3 Recruiting April 30, 2022 -
NCT03610256 Obesity, Morbid Not Applicable Not yet recruiting September 2022 France ... More >> Département de Chirurgie Digestive et Viscérale - Clinique de l'Anjou Not yet recruiting Angers, France, 49000 Contact: Philippe TOPART, MD          Principal Investigator: Philippe TOPART, MD          Service de Chirurgie Digestive et Métabolique - Hôpital Avicenne - APHP Not yet recruiting Bobigny, France, 93000 Contact: Christophe BARRAT, MD          Principal Investigator: Christophe BARRAT, MD          Service de Chirurgie Digestive et Endocrinienne - Groupe Hospitalier Pellegrin Not yet recruiting Bordeaux, France, 33076 Contact: Caroline GRONNIER, MD          Principal Investigator: Caroline GRONNIER, MD          Service de Chirurgie Digestive et Viscérale - Clinique La Parisière Not yet recruiting Bourg-de-Péage, France, 26300 Contact: Jean Louis LORIN, MD          Principal Investigator: Jean Louis LORIN, MD          Service de Chirurgie Générale et Digestive - Hôpital Louis Mourier Not yet recruiting Colombes, France, 92700 Contact: Daniela CALABRESE, MD          Principal Investigator: Daniela CALABRESE, MD          Service de Chirurgie Digestive - Centre Hospitalier Intercommunal de Créteil Not yet recruiting Créteil, France, 94000 Contact: Andrea LAZZATI, MD          Sub-Investigator: Andrea LAZZATI, MD          Département de Chirurgie Digestive - CHU Grenoble Not yet recruiting Grenoble, France, 38043 Contact: Fabian RECHE, MD          Principal Investigator: Fabian RECHE, MD          Service de Chirurgie Générale et Endocrinienne - Hôpital Huriez Not yet recruiting Lille, France, 59037 Contact: Robert CAIAZZO, MD          Principal Investigator: Robert CAIAZZO, MD          Service de Chirurgie Digestive et Bariatrique - Hôpital Edouard Herriot - HCL Not yet recruiting Lyon, France, 69437 Contact: Maud ROBERT, MD          Principal Investigator: Maud ROBERT, MD          Service de Chirurgie Générale, Digestive et Endocrinienne - Hôpital Nord Not yet recruiting Marseille, France, 13015 Contact: Olivier EMUNGANIA, MD          Principal Investigator: Olivier EMUNGANIA, MD          Service de Chirurgie Digestive et Endocrinienne - Hôtel Dieu Not yet recruiting Nantes, France, 44000 Contact: Claire BLANCHARD LOUIS, MD          Principal Investigator: Claire BLANCHARD LOUIS, MD          Service de Chirurgie Digestive et Transplantation - Hôpital Archet II Not yet recruiting Nice, France, 06202 Contact: Antonio IANNELLI, MD          Principal Investigator: Antonio IANNELLI, MD          Département de Chirurgie Digestive et Hépatobiliaire - Hôpital Pitié Salpétrière Not yet recruiting Paris, France, 75013 Contact: Adriana TORCIVIA, MD          Principal Investigator: Adriana TORCIVIA, MD          Département de Chirurgie Digestive - Institut Mutualiste Montsouris Not yet recruiting Paris, France, 75014 Contact: Guillaume POURCHER, MD          Principal Investigator: Guillaume POURCHER, MD          Service de Chirurgie Digestive - Hôpital Bichat Not yet recruiting Paris, France, 75018 Contact: Simon MSIKA, MD          Principal Investigator: Simon MSIKA, MD          Service de Chirurgie Digestive, Générale et Cancérologique - HEGP Not yet recruiting Paris, France, 75908 Contact: Tigran POGHOSYAN, MD          Principal Investigator: Tigran POGHOSYAN, MD          Service d'Endocrinologie, Diabète et Nutrition - Centre Hospitalier Lyon Sud - HCL Not yet recruiting Pierre-Bénite, France, 69495 Contact: Emmanuel DISSE, MD          Principal Investigator: Emmanuel DISSE, MD          Département de Chirurgie Digestive et Hépatobiliaire - Centre Hospitalier Privé Saint Grégoire Not yet recruiting Saint-Grégoire, France, 35760 Contact: Adrien STERKERS, MD          Principal Investigator: Adrien STERKERS, MD          Service de Chirurgie Générale et Digestive - Hôpital Purpan Not yet recruiting Toulouse, France, 31059 Contact: Maël CHALRET DURIEU, MD          Principal Investigator: Maël CHALRET DURIEU, MD          Service de Chirurgie Digestive, Hépatobiliaire et Endocrinienne - Hôpital Brabois adultes Not yet recruiting Vandœuvre-lès-Nancy, France, 54511 Contact: Laurent BRUNAUD, MD          Principal Investigator: Laurent BRUNAUD, MD Less <<
NCT00381862 - Completed - -
NCT00959075 Heart Failure Phase 4 Completed - Canada, Ontario ... More >> Niagara North Family Health Team St. Catharines, Ontario, Canada, L2R 1R5 Less <<
NCT00523419 Osteosarcoma Phase 2 Completed - France ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bordeaux, France, 33076 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lyon, France, 69437 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Marseille, France, 13385 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Villejuif, France, 94805 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelberg, Germany, 69120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munich, Germany, 81377 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bologna, Italy, 40136 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy, 20133 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Torino, Italy, 1053 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08025 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28050 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pamplona, Spain, 31008 United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Newcastle-Upon-Tyne, Tyneside, United Kingdom, NE4 6BE Less <<
NCT03552471 BRCA1 Gene Mutation ... More >> BRCA2 Gene Mutation Folate Receptor Alpha Positive Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Recurrent Uterine Corpus Carcinoma Recurrent Uterine Serous Carcinoma Recurrent Uterine Carcinosarcoma Platinum Resistant Ovarian Cancer Less << Phase 1 Recruiting August 29, 2021 United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Floor Backes, MD    614-293-3873       Principal Investigator: Floor Backes Less <<
NCT00084838 - Completed - -
NCT00031057 HIV Infections Not Applicable Completed - United States, New York ... More >> Beth Israel Med Ctr New York, New York, United States, 10003 United States, North Carolina Univ of North Carolina Chapel Hill, North Carolina, United States, 275997215 United States, Ohio Case Western Reserve Univ Cleveland, Ohio, United States, 44106 Less <<
NCT00523419 - Completed - -
NCT01524315 Heart Failure ... More >> Acidosis, Lactic Thiamine Deficiency Less << Phase 4 Unknown December 2013 Austria ... More >> Medical University Vienna Vienna, Austria, 1090 Less <<
NCT02095730 Unstable Corneas Phase 3 Unknown - United States, California ... More >> LaserVue Eye Not yet recruiting Santa Rosa, California, United States, 95403 Contact: Jay Bansal, MD    707-522-6200    bansal@laservue.com    Principal Investigator: Jay Bansal, MD          United States, Colorado Icon Lasik Not yet recruiting Denver, Colorado, United States, 80210 Contact: Richard Anderson, OD    720-524-1001    ra@icondenver.com    Principal Investigator: Douglas Campbell, DO          United States, Florida Gulani Vision Institute Not yet recruiting Jacksonville, Florida, United States, 32216 Contact: Arun Gulani, MD    904-296-7393    gulanivision@gulani.com    Principal Investigator: Arun Gulani, MD          United States, Georgia Eye Consultants of Atlanta Not yet recruiting Atlanta, Georgia, United States, 30339 Contact: Teresa Long    404-351-2220    teresa_long@eyeconsultants.net    Principal Investigator: W. Barry Lee, MD          United States, Illinois Midwest Center for Sight Not yet recruiting Des Plaines, Illinois, United States, 60016 Contact: James Katz, MD    847-824-3127    jamesakatz@aol.com    Principal Investigator: James Katz, MD          Bond Eye Associates Not yet recruiting Pekin, Illinois, United States, 61554 Contact: William Bond, MD    309-353-6660    pekineye@yahoo.com    Principal Investigator: William Bond, MD          United States, Kansas Discover Vision Center Not yet recruiting Leawood, Kansas, United States, 66211 Contact: Misty Robe, Associate's    816-478-1230    mrobe@discovervision.com    Principal Investigator: John Doane, MD          United States, Mississippi Southern Eye Center Not yet recruiting Hattiesburg, Mississippi, United States, 39402 Contact: Cameron Griffith, MD    318-464-0306    csgriff1@earthlink.net    Principal Investigator: Cameron Griffith, MD          United States, Missouri Mercy Clinic Eye Specialists Not yet recruiting Springfield, Missouri, United States, 65807 Contact: Stephanie Sekscinski    417-820-9393    stephanie.sekscinski@mercy.net    Principal Investigator: Shachar Tauber, MD          United States, Nevada LASIK of Nevada Not yet recruiting Las Vegas, Nevada, United States, 89123 Contact: Valerie Serett    702-636-2010    vserette@yahoo.com    Principal Investigator: Richard Rothman, MD          Sub-Investigator: Rajy Rouweyha, MD          United States, Pennsylvania James Lewis MD PC Not yet recruiting Elkins Park, Pennsylvania, United States, 19027 Contact: James Lewis, MD    215-886-9090    jslewis@jameslewis.com    Principal Investigator: James Lewis, MD          Memorial Eye Institute Not yet recruiting Harrisburg, Pennsylvania, United States, 17112 Contact: Sherrie Reed    717-657-2020    crosslinkstudy@memorialeye.com    Principal Investigator: Bennett Chotiner, MD          Principal Investigator: Erik Chotiner, MD          United States, South Carolina Carolina Eye Care Not yet recruiting Mt. Pleasant, South Carolina, United States, 29464 Contact: Helga Sandoval, MD    843-881-3937    helga.sandoval@carolinaeyecare.com    Principal Investigator: Kerry Solomon, MD          Sub-Investigator: Charlene Grice, MD          United States, Tennessee Loden Vision Centers Not yet recruiting Goodlettsville, Tennessee, United States, 37072 Contact: Katie Lambeth    615-859-3937    klamberth@lodenvision.com    Principal Investigator: James Loden, MD          United States, Texas Parkhurst NuVision Not yet recruiting San Antonio, Texas, United States, 78229 Contact: Amy Ford    210-428-6788    nuvision.amy@gmail.com    Principal Investigator: Gregory D Parkhurst, MD          United States, Virginia Liberty Laser Eye Center Not yet recruiting Vienna, Virginia, United States, 22182 Contact: Travis A Johnson, Bachelor's    571-234-5678 ext 104    tjohnson@libertylasereye.com    Principal Investigator: Nancy A Tanchel, MD Less <<
NCT02235337 Sports Related Concussion Not Applicable Completed - United States, Virginia ... More >> University of Virginia Charlottesville, Virginia, United States, 22908 James Madison University Harrisonburg, Virginia, United States, 22807 Less <<
NCT02888691 Type 1 Diabetes Not Applicable Completed - Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT00084838 Central Nervous System Tumor, ... More >>Pediatric Less << Phase 2 Completed - United States, California ... More >> Stanford Cancer Center Stanford, California, United States, 94305-5826 United States, Connecticut Yale Cancer Center New Haven, Connecticut, United States, 06520-8028 United States, Georgia AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Scottish Rite Campus Atlanta, Georgia, United States, 30342 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis, Minnesota, United States, 55404 United States, Nevada Sunrise Hospital and Medical Center Las Vegas, Nevada, United States, 89109 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 Less <<
NCT00148733 Pneumonia Phase 2 Phase 3 Completed - Nepal ... More >> Siddhi Memorial Hospital (SMH),Bhelukhel, Bhimsensthan Bhaktapur, Nepal, P.O.Box 40 Less <<
NCT00148733 - Completed - -
NCT02538354 Crohn Disease Not Applicable Unknown December 2017 Netherlands ... More >> University Medical Center Groningen Recruiting Groningen, Netherlands, 9713GZ Contact: Gerard Dijkstra, Prof.    0503616161    g.dijkstra@umcg.nl    Contact: Julius von Martels, Drs.    0503616161    j.z.h.von.martels@umcg.nl    Principal Investigator: Gerard Dijkstra, professor Less <<
NCT02515214 - Unknown September 2017 Belgium ... More >> UZ Leuven Recruiting Leuven, Belgium, 3000 Contact: Roland Devlieger, MD, PhD    +32 16 34 22 12    roland.devlieger@uzleuven.be    Principal Investigator: Roland Devlieger, MD, PhD          Sub-Investigator: Goele Jans, MSc Less <<
NCT00003821 Endometrial Cancer Phase 2 Withdrawn - United States, Missouri ... More >> Division of Gynecologic Oncology Saint Louis, Missouri, United States, 63110 United States, North Carolina East Carolina University School of Medicine Greenville, North Carolina, United States, 27858-4354 United States, Ohio Gynecologic Oncologists of NE Ohio Akron, Ohio, United States, 44302 United States, Texas Simmons Cancer Center - Dallas Dallas, Texas, United States, 75235-9154 Texas Oncology, P.A. Dallas, Texas, United States, 75246 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT02756026 Micronutrient Deficiency Not Applicable Completed - Bangladesh ... More >> International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) Dhaka, Bangladesh Less <<
NCT02772237 Sports-related Concussion Phase 2 Recruiting December 2019 United States, Virginia ... More >> University of Virginia Recruiting Charlottesville, Virginia, United States, 22904 Contact: Jeremy B Kent Less <<
NCT02929459 Gut Microbiota Phase 2 Recruiting December 2018 Netherlands ... More >> Medical Microbiology, UMCG Groningen Recruiting Groningen, Netherlands, 9713 Contact: Mehdi Sadaghian Sadabad, D.V.M PhD    +31-50-36 15 186    m.sadaghian@umcg.nl Less <<
NCT02622386 Psoriasis Phase 2 Recruiting June 2019 United States, Michigan ... More >> University of Michigan Department of Dermatology Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Jennifer Bell    734-936-4075    jennbell@med.umich.edu    Contact: Bethany Ruffino    734-763-8076    bruffino@med.umich.edu Less <<
NCT03552016 Axial Myopia ... More >>Refractive Errors Less << Phase 2 Recruiting October 10, 2021 United States, Missouri ... More >> Eye Institute East Recruiting Columbia, Missouri, United States, 65201 Contact: Mohannad Al-Samarraie, MD    573-882-7389    alsamarraiem@health.missouri.edu    Contact    573-882-8920 Less <<
NCT02446977 Ischemic Stroke Phase 2 Completed - Spain ... More >> Complejo Hospitalario Universitario de Santiago Santiago de Compostela, A Coruña, Spain, 15706 Less <<
NCT03300440 Mood Disorders ... More >> Depression Less << Not Applicable Active, not recruiting June 2019 Austria ... More >> Medical University of Graz, Department of Psychiatry and Psychotherapeutic Medicine Graz, Styria, Austria, 8036 Less <<
NCT03095235 Keratoconus C... More >>ornea Ectasia Less << Not Applicable Recruiting January 2018 United States, Missouri ... More >> University of Missouri Recruiting Columbia, Missouri, United States, 65212 Contact: Lindsey M McDaniel, MD    573-882-1506       Contact: John Jarstad, MD    5738821506 Less <<
NCT03531190 Head and Neck Cancer Not Applicable Not yet recruiting November 30, 2018 -
NCT03634735 Fatigue Phase 4 Recruiting February 2020 Denmark ... More >> Aarhus University Hospital Recruiting Aarhus, Central Region, Denmark, 8000 Contact: Palle Bager, Ph.d    51500697    pallbage@rm.dk    Contact: Jens F Dahlerup, DMSc       jensdahl@rm.dk    Principal Investigator: Christian L Hvas, Ph.d. Less <<
NCT03089671 Pelvic Floor Disorders ... More >> Ureter; Kink Less << Not Applicable Recruiting December 2019 Canada, Ontario ... More >> Sunnybrook Health Sciences Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Louise-Helene Gagnon, MD, FRCSC    416-480-5845    louise-helene.gagnon@sunnybrook.ca    Mount Sinai Hospital Recruiting Toronto, Ontario, Canada, M5G 1Z5 Contact: Colleen D McDermott, MD    4165864800 ext 6490    colleen.mcdermott@sinaihealthsystem.ca    Contact: Danny Lovatsis, MD    4165864800    danny.lovatsis@sinaihealthsystem.ca Less <<
NCT00937027 Psoriasis Phase 1 Completed - United States, Texas ... More >> Baylor Research Institute Dallas, Texas, United States, 75246 Less <<
NCT01505140 Infertility N... More >>utrition Disorders Less << Phase 2 Completed - United States, California ... More >> University of California, Los Angeles Los Angeles, California, United States, 90095-6919 Less <<
NCT01383343 Recurrent Colon Carcinoma ... More >> Recurrent Rectal Carcinoma Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer Less << Phase 1 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01474044 Chronic Atrophic Gastritis (CA... More >>G) Less << Phase 4 Completed - China, Shanxi ... More >> Xijing Hospital of Digestive Diseases Xi'an, Shanxi, China, 710032 Less <<
NCT01307956 - Terminated(Drug manufacturer -... More >> Amgen requested, per DSMB observation in POWER trial.) Less << - -
NCT00272116 Diarrhea Pneu... More >>monia Acute Respiratory Tract Infection Less << Not Applicable Completed - India ... More >> All India Institute of Medical Sciences New Delhi, Delhi, India, 110029 Less <<
NCT00557193 Acute Lymphoblastic Leukemia ... More >> Acute Undifferentiated Leukemia Childhood T Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Completed - -
NCT00408005 T Acute Lymphoblastic Leukemia... More >> T Lymphoblastic Lymphoma Less << Phase 3 Completed - -
NCT01307956 Adenocarcinoma of the Gastroes... More >>ophageal Junction Esophageal Adenocarcinoma Stage IIA Esophageal Cancer Stage IIB Esophageal Cancer Less << Phase 2 Terminated(Drug manufacturer -... More >> Amgen requested, per DSMB observation in POWER trial.) Less << - United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 Less <<
NCT02890355 Metastatic Pancreatic Adenocar... More >>cinoma Recurrent Pancreatic Carcinoma Stage IV Pancreatic Cancer AJCC v6 and v7 Less << Phase 2 Active, not recruiting - -
NCT00720109 - Completed - -
NCT00720109 Adult B Acute Lymphoblastic Le... More >>ukemia With t(9;22)(q34;q11.2); BCR-ABL1 Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1 Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 2 Phase 3 Completed - -
NCT00792948 - Active, not recruiting - -
NCT03356678 - Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Seoul, Korea, Republic Of, Korea, Republic of, 135-710 81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea Seoul, Korea, Republic of, 06351 Less <<
NCT02811900 - Recruiting December 2026 France ... More >> Service de Chirurgie Digestive et Endocrinienne Recruiting Strasbourg, France, 67000 Contact: Didier Mutter, MD, PhD    +33 (0)3 90 11 90 41    didier.mutter@chru-strasbourg.fr    Contact: Michel Vix, MD    +33 (0)3 69 55 10 52    michel.vix@chru-strasbourg.fr Less <<
NCT01256398 Acute Lymphoblastic Leukemia ... More >> Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 2 Active, not recruiting - -
NCT03150602 Peripheral T Cell Lymphoma ... More >> Progression, Disease Less << Phase 4 Recruiting December 31, 2020 Taiwan ... More >> Ntional Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Bor-Sheng Ko, PhD    886-23123456 ext 63576    kevinkomd@gmail.com    Contact: Brook Chung, MSc    886-87297521    brook.chung@mundipharma.com.tw    Principal Investigator: Bor-Sheng Ko, PhD Less <<
NCT03597061 Weight, Body ... More >>Diet Habit Less << Not Applicable Not yet recruiting July 31, 2019 United States, Ohio ... More >> University of Cincinnati Not yet recruiting Cincinnati, Ohio, United States, 45219 Less <<
NCT01190930 Acute Lymphoblastic Leukemia ... More >> Adult B Lymphoblastic Lymphoma Ann Arbor Stage I B Lymphoblastic Lymphoma Ann Arbor Stage II B Lymphoblastic Lymphoma Childhood B Acute Lymphoblastic Leukemia Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Childhood B Lymphoblastic Lymphoma Down Syndrome Hypodiploid B Acute Lymphoblastic Leukemia Intrachromosomal Amplification of Chromosome 21 Philadelphia Chromosome Positive Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Active, not recruiting - -
NCT00311311 Atherosclerosis ... More >> Kidney Failure Less << Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, New York ... More >> Pfizer Investigational Site Rochester, New York, United States, 14642 Canada, Alberta Pfizer Investigational Site Calgary, Alberta, Canada, T2N 2T9 Pfizer Investigational Site Edmonton, Alberta, Canada, T6G 2B7 Canada, Ontario Pfizer Investigational Site Hamilton, Ontario, Canada, L8N 4A6 Pfizer Investigational Site London, Ontario, Canada, N6A 5A5 Pfizer Investigational Site Toronto, Ontario, Canada, M5B 1W8 Pfizer Investigational Site Toronto, Ontario, Canada, M5C 2T2 Canada, Quebec Pfizer Investigational Site Montreal, Quebec, Canada, H1T 2M4 Less <<
NCT00311311 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT02101853 B Acute Lymphoblastic Leukemia Phase 3 Recruiting - -
NCT00557193 - Completed - -
NCT02112916 Adult T Acute Lymphoblastic Le... More >>ukemia Ann Arbor Stage II Adult Lymphoblastic Lymphoma Ann Arbor Stage II Childhood Lymphoblastic Lymphoma Ann Arbor Stage III Adult Lymphoblastic Lymphoma Ann Arbor Stage III Childhood Lymphoblastic Lymphoma Ann Arbor Stage IV Adult Lymphoblastic Lymphoma Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma Childhood T Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Suspended(Other - Temporary cl... More >>osure) Less << - -
NCT02779283 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Less << Phase 1 Recruiting June 1, 2019 United States, Oregon ... More >> OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Stephen E. Spurgeon    503-494-8950    spurgeos@ohsu.edu    Principal Investigator: Stephen E. Spurgeon Less <<
NCT02912559 Colon Adenocarcinoma ... More >> DNA Repair Disorder Lynch Syndrome Stage III Colon Cancer AJCC v7 Stage IIIA Colon Cancer AJCC v7 Stage IIIB Colon Cancer AJCC v7 Stage IIIC Colon Cancer AJCC v7 Less << Phase 3 Recruiting July 1, 2020 -
NCT02828358 Acute Leukemia of Ambiguous Li... More >>neage Childhood B Acute Lymphoblastic Leukemia KMT2A Gene Rearrangement Mixed Phenotype Acute Leukemia Less << Phase 2 Suspended(Met accural pending ... More >>evaluation of enrolled pats.) Less << September 30, 2019 -
NCT00002590 Lymphoma Phase 2 Completed - -
NCT00792948 Acute Lymphoblastic Leukemia ... More >> Adult Acute Lymphoblastic Leukemia in Remission Adult B Acute Lymphoblastic Leukemia Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Adult L1 Acute Lymphoblastic Leukemia Adult L2 Acute Lymphoblastic Leukemia Adult T Acute Lymphoblastic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 2 Active, not recruiting September 24, 2019 -
NCT03007147 B Acute Lymphoblastic Leukemia... More >> BCR-ABL1 Fusion Protein Expression Minimal Residual Disease Philadelphia Chromosome Positive T Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Recruiting June 30, 2026 -
NCT03668977 Pregnancy and Early Lactation ... More >>Among Women Living in an Area Endemic for Malnutrition Less << Not Applicable Recruiting May 2021 Nepal ... More >> Nepal Nutrition Intervention Project - Sarlahi Recruiting Hariaun, Sarlahi District, Nepal Contact: Subarna K Khatry, MD    977-1-55504914    skhatry@wlink.com.np    Sub-Investigator: Joanne Katz, ScD          Sub-Investigator: Sheila Isanaka, PhD          Sub-Investigator: Saskia dePee, PhD          Sub-Investigator: Juliette Bedford, PhD          Sub-Investigator: Swaraj Rajbhandari, MD          Sub-Investigator: Steven LeClerq, MPH          Sub-Investigator: Lindsey Allen, PhD          Sub-Investigator: Tsering Lama, PhD Less <<
NCT02801240 Colitis, Ulcerative ... More >> Crohn's Disease Less << Not Applicable Completed - United States, Oregon ... More >> National University of Natural Medicine Portland, Oregon, United States, 97201 Less <<
NCT03577704 Advanced Solid Tumors Phase 1 Phase 2 Recruiting October 30, 2021 China, Shanghai ... More >> Shanghai East Hospital Recruiting Shanghai, Shanghai, China, 200123 Contact: Jin E Li, Phd    （021）38804518 ext 22228    lijin@csco.org.cn    Contact: Jin E Li       lijin@csco.org.cn    Principal Investigator: Jin Li, PhD          Sub-Investigator: Ye Guo, PhD Less <<
NCT02883049 B Acute Lymphoblastic Leukemia... More >> Central Nervous System Leukemia Ph-Like Acute Lymphoblastic Leukemia Testicular Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Recruiting - -
NCT00005585 Leukemia Phase 3 Completed - -
NCT01046864 Gastro-Intestinal Cancer Phase 1 Completed - United States, California ... More >> Usc/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Texas Texas Oncology Dallas, Texas, United States, 75246 Scott & White Memorial Hospital And Clinic Temple, Texas, United States, 76508 Canada, Alberta Local Institution Edmonton, Alberta, Canada, T6G 1Z2 Canada, Ontario Local Institution Ottawa, Ontario, Canada, K1H 8L6 France Local Institution Villejuif Cedex, France, 94800 Less <<
NCT02483026 Disorder of Bone Density and S... More >>tructure, Unspecified Vitamin D Deficiency Less << Not Applicable Active, not recruiting August 2020 Israel ... More >> Hadassah hebrew university medical center Jerusalem, Israel, 91120 Less <<
NCT02553460 Acute Lymphoblastic Leukemia Phase 1 Phase 2 Recruiting October 2031 United States, California ... More >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Paul Gaynon, MD    323-361-4110    pgaynon@chla.usc.edu    Principal Investigator: Paul Gaynon, MD          Children's Hospital of Orange County Recruiting Orange, California, United States, 92868 Contact: Ivan Kirov, MD    714-997-3000    ikirov@choc.org    Principal Investigator: Ivan Kirov, MD          Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Norman J. Lacayo, MD    650-497-8953    lacayon@stanford.edu    Principal Investigator: Norman J. Lacayo, MD          Rady Children's Hospital and Health Center Recruiting San Diego, California, United States, 92123 Contact: Deborah Schiff, MD    858-966-5983    dschiff@chsd.org    Principal Investigator: Deborah Schiff, MD          United States, Minnesota Children's Hospital and Clinics of Minnesota Recruiting Minneapolis, Minnesota, United States, 55102 Contact: Michael Richards, MD    612-813-5193    Michael.richards@childrensmn.org    Principal Investigator: Michael Richards, MD          United States, North Carolina St. Jude Affiliate-Charlotte Recruiting Charlotte, North Carolina, United States, 28204 Contact: Christine Bolen, MD    704-384-1900    cybolen@novanthealth.org    Principal Investigator: Christine Bolen, MD          United States, Ohio Cincinnati Children's Hospital Recruiting Cincinnati, Ohio, United States, 45229 Contact: Erin Breese, MD, PhD    513-636-2799    erin.breese@cchmc.org    Principal Investigator: Erin Breese, MD, PhD          Rainbow Babies & Children's Hospital Recruiting Cleveland, Ohio, United States, 44106 Contact: Yousif Matloub, MD    216-844-5437    yousif.matloub@uhhospitals.org    Principal Investigator: Yousif Matloub, MD          United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: Bill Chang, MD    503-494-1080    changb@ohsu.edu    Principal Investigator: Bill Chang, MD          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tanja A. Gruber, MD, PhD    866-278-5833    tanja.gruber@stjude.org    Contact: Referral Office    866-278-5833    referralinfo@stjude.org    Principal Investigator: Tanja A. Gruber, MD, PhD          United States, Virginia Children's Hospital of the King's Daughters (CHKD) Recruiting Norfolk, Virginia, United States, 23507 Contact: Eric Lowe, MD    757-668-7243    eric.lowe@chkd.org    Principal Investigator: Eric Lowe, MD          Canada, Alberta Alberta Children's Hospital Recruiting Calgary, Alberta, Canada, T3A 6A8 Contact: Victor A. Lewis, MD    403-220-6898    victor.lewis@ahs.ca    Principal Investigator: Victor A. Lewis, MD          Stollery Children's Hospital Recruiting Edmonton, Alberta, Canada, T6G 2B7 Contact: Sunil Desai, M.B.Ch.B., FRCP(c)    780-248-5415    sunil.desai@ahs.ca    Principal Investigator: Sunil Desai, M.B.Ch.B., FRCP(c)          Canada, British Columbia Children's & Women's Health Centre of British Columbia Recruiting Vancouver, British Columbia, Canada, V6H 3V4 Contact: Kirk R. Schultz, MD    604-875-2345 ext 6477    kschultz@mail.ubc.ca    Principal Investigator: Kirk R. Schultz, MD          Canada, Ontario McMaster Children's Hospital at Hamilton Health Sciences Recruiting Hamilton, Ontario, Canada, L85 4J9 Contact: Uma Athale, MD    905-521-2100 ext 73376    athaleu@mcmaster.ca    Principal Investigator: Uma Athale, MD          Canada, Quebec The Montreal Children's Hospital (MUHC-McGill) Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Catherine Vezina, MD    514-412-4445    catherine.vezina@muhc.mcgill.ca    Principal Investigator: Catherine Vezina, MD          Centre Hospitalier Universitaire Sainte-Justine Recruiting Montreal, Quebec, Canada, HcT 1C5 Contact: Henrique Bittencourt, MD    514-345-4931    henrique.bittencourt.hsj@ssss.gouv.qc.ca    Contact: Yvan Samson       yvan.samson@umontreal.ca    Principal Investigator: Henrique Bittencourt, MD          Centre Hospitalier Universitaire de Quebec Recruiting Québec, Quebec, Canada, G1V 4G2 Contact: Bruno Michon, MD    418-525-4444    bruno.michon@mail.chuq.qc.ca    Principal Investigator: Bruno Michon, MD Less <<
NCT03034850 - Completed - -
NCT00090701 Lung Neoplasms Phase 2 Withdrawn - United States, California ... More >> Pfizer Investigational Site Poway, California, United States, 92064 United States, District of Columbia Pfizer Investigational Site Washington, District of Columbia, United States, 20007 United States, Florida Pfizer Investigational Site Tampa, Florida, United States, 33612 United States, New York Pfizer Investigational Site New York, New York, United States, 10021 Less <<
NCT02999867 Type2 Diabetes Mellitus Not Applicable Completed - China, Beijing ... More >> Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing, China, 100730 Less <<
NCT00876018 Physical Fitness ... More >> Nutritional Status Less << Phase 4 Completed - India ... More >> GSK Investigational Site Bangalore, Karnataka, India, 560034 Less <<
NCT01001559 - Completed - United States, Texas ... More >> Red Oak Psychiatry Associates, PA Houston, Texas, United States Less <<
NCT00876018 - Completed - -
NCT01001559 - Completed - -
NCT02138617 Colon Cancer Phase 2 Recruiting May 2022 United States, Indiana ... More >> IU Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Principal Investigator: Bert O'Neil, MD          IU Arnett Hospital Terminated Lafayette, Indiana, United States, 47905 United States, North Carolina University of North Carolina Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Julie White, RN    919-843-7115    julie_white@med.unc.edu    Principal Investigator: Hanna Sanoff, MD          Carolina Healthcare Systems Recruiting Charlotte, North Carolina, United States, 28204 Principal Investigator: Jai Patel, MD          Cone Health Cancer Center Recruiting Greensboro, North Carolina, United States, 27403 Principal Investigator: Gary Sherrill, MD          Rex Healthcare Recruiting Raleigh, North Carolina, United States, 27607 Principal Investigator: Jeremiah Boles, MD          United States, Virginia Bon Secours Cancer Institute Recruiting Midlothian, Virginia, United States, 23114 Contact: William J Irvin, Jr., MD    804-893-8717    william_irvin@bshsi.org    Principal Investigator: William J Irvin, Jr., MD Less <<
NCT00150839 Depressive Disorder, Major Phase 4 Unknown December 2009 Germany ... More >> Department of Psychiatry and Psychotherapy, University Erlangen-Nuremberg Recruiting Erlangen, Bavaria, Germany, 91054 Contact: Stefan Bleich, MD    004991318534262    stefan.bleich@uk-erlangen.de    Principal Investigator: Stefan Bleich, MD          Sub-Investigator: Julia Wilhelm, MD          Sub-Investigator: Helge Frieling, MD Less <<
NCT03155269 Growth and Development Not Applicable Completed - India ... More >> GSK Investigational Site Pune, India, 411001 Less <<
NCT01381354 Multiple Sclerosis Phase 1 Completed - United States, Iowa ... More >> Univeristy of Iowa/ VA Iowa City VA Medical Center Iowa City, Iowa, United States, 52246 Less <<
NCT03572023 Acute Coronary Syndrome ... More >> Non Obstructive Coronary Atherosclerosis Less << Not Applicable Recruiting September 2020 Russian Federation ... More >> Vyacheslav Ryabov Recruiting Tomsk, Tomsk, Tomskii Region, Russian Federation, 634012 Contact: Vyacheslav Ryabov, PhD    +73822553689    rvvt@cardio-tomsk.ru    Contact: Darya Vorobeva    +73822558360    darya.lipnyagova@yandex.ru Less <<
NCT00957905 Recurrent Extragonadal Seminom... More >>a Recurrent Malignant Extragonadal Germ Cell Tumor Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor Recurrent Malignant Testicular Germ Cell Tumor Recurrent Ovarian Germ Cell Tumor Stage III Testicular Cancer Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor Stage IV Extragonadal Seminoma Stage IV Ovarian Germ Cell Tumor Less << Phase 2 Completed - United States, California ... More >> Tower Cancer Research Foundation Beverly Hills, California, United States, 90211-1850 City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania UPMC-Presbyterian Hospital Pittsburgh, Pennsylvania, United States, 15213 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Wisconsin Riverview Hospital Wisconsin Rapids, Wisconsin, United States, 54494 Less <<
NCT00217737 Colon Mucinous Adenocarcinoma ... More >> Colon Signet Ring Cell Adenocarcinoma Lynch Syndrome Stage IIA Colon Cancer AJCC v7 Stage IIB Colon Cancer AJCC v7 Stage IIC Colon Cancer AJCC v7 Less << Phase 3 Active, not recruiting - -
NCT00957905 - Completed - -
NCT03607643 Cancer of Pancreas ... More >> Cancer of Liver Cancer of Rectum Cancer of Colon Cancer, Gall Bladder Myeloma Multiple Glioblastoma Multiforme Less << Phase 1 Phase 2 Not yet recruiting December 15, 2020 United States, Florida ... More >> Southwest Cancer Center Not yet recruiting Orlando, Florida, United States, 32806 Contact: Sarah Katta, DO    407-426-8660    sarahfk1978@yahoo.com    Contact: Philip Arlen, PhD    407-443-0656    parlen@leafvertical.com Less <<
NCT01759823 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - India ... More >> Postgraduate Institute of Medical Education and Research Chandigarh, UT, India, 160012 Less <<
NCT02042443 - Completed - -
NCT00126191 Burkitt Lymphoma ... More >> Non-Hodgkins Lymphoma Atypical Burkitt Lymphoma Less << Phase 2 Terminated(closed due to slow ... More >>accrual) Less << - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00126191 - Terminated(closed due to slow ... More >>accrual) Less << - -
NCT02042443 Adult Cholangiocarcinoma ... More >> Advanced Adult Hepatocellular Carcinoma BCLC Stage C Adult Hepatocellular Carcinoma BCLC Stage D Adult Hepatocellular Carcinoma Hilar Cholangiocarcinoma Localized Non-Resectable Adult Liver Carcinoma Recurrent Adult Liver Carcinoma Recurrent Childhood Liver Cancer Recurrent Extrahepatic Bile Duct Carcinoma Recurrent Gallbladder Carcinoma Stage II Gallbladder Cancer Stage III Childhood Hepatocellular Carcinoma Stage IIIA Gallbladder Cancer Stage IIIB Gallbladder Cancer Stage IV Childhood Hepatocellular Carcinoma Stage IV Distal Bile Duct Cancer Stage IVA Gallbladder Cancer Stage IVB Gallbladder Cancer Unresectable Extrahepatic Bile Duct Carcinoma Less << Phase 2 Completed - -
NCT02508077 Recurrent Colorectal Carcinoma... More >> Stage IVA Colorectal Cancer Stage IVB Colorectal Cancer Less << Phase 2 Terminated(Poor Accrual) - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 City of Hope Antelope Valley Lancaster, California, United States, 93534 City of Hope Rancho Cucamonga Rancho Cucamonga, California, United States, 91730 South Pasadena Cancer Center South Pasadena, California, United States, 91030 Less <<
NCT02508077 - Terminated(Poor Accrual) - -
NCT03440892 - Recruiting January 2020 Sweden ... More >> Dept of Rheumatology and Inflammation research Recruiting Gothenburg, Sweden Contact: Sofia T Silfverswärd       sofia.silfversward@rheuma.gu.se Less <<
NCT00133991 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Pennsylvania Drexel University College of Medicine - Center City Hahnemann Campus Philadelphia, Pennsylvania, United States, 19102 Less <<
NCT00450801 Lymphoma Phase 2 Completed - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 Less <<
NCT00133991 - Completed - -
NCT00450801 - Completed - -
NCT00878254 Mantle-Cell Lymphoma Phase 2 Recruiting December 2019 United States, Florida ... More >> University of Miami Recruiting Miami, Florida, United States, 33186 Contact: Izidore S. Lossos, MD    305-243-4785    ilossos@med.miami.edu    Principal Investigator: Izidore S Lossos, MD Less <<
NCT03337087 Biliary System Disorder ... More >> BRCA1 Gene Mutation BRCA2 Gene Mutation Gastroesophageal Junction Adenocarcinoma Homologous Recombination Deficiency Metastatic Pancreatic Adenocarcinoma PALB2 Gene Mutation Stage IV Colorectal Cancer AJCC v7 Stage IV Pancreatic Cancer AJCC v6 and v7 Stage IVA Colorectal Cancer AJCC v7 Stage IVB Colorectal Cancer AJCC v7 Less << Phase 1 Phase 2 Not yet recruiting December 31, 2022 United States, Arizona ... More >> Mayo Clinic in Arizona Recruiting Scottsdale, Arizona, United States, 85259 Contact: Clinical Trial Referral Office    855-776-0015       Principal Investigator: Tanios S. Bekaii-Saab          United States, Georgia Emory University Hospital/Winship Cancer Institute Not yet recruiting Atlanta, Georgia, United States, 30322 Contact: Christina S. Wu    404-778-0202    christina.wu@emoryhealthcare.org    Principal Investigator: Christina S. Wu          United States, Minnesota Mayo Clinic Not yet recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Wen Wee MA          United States, Utah Huntsman Cancer Institute/University of Utah Not yet recruiting Salt Lake City, Utah, United States, 84112 Contact: Susan Sharry    801-585-3453    susan.sharry@hci.utah.edu    Principal Investigator: Ignacio Garrido-Laguna Less <<
NCT00387387 Neoplasms, Colorectal Phase 1 Completed - India ... More >> GSK Investigational Site Hyderabad, Andhra Pradesh, India, 500482 GSK Investigational Site Parel, India, 400012 United Kingdom GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 2QQ GSK Investigational Site Oxford, Oxfordshire, United Kingdom, OX3 7LJ GSK Investigational Site Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT02597608 Child Nutritional Status ... More >> Household Dietary Diversity Maternal Nutrition Knowledge and Practices Less << Not Applicable Completed - Bangladesh ... More >> International Food Policy Research Institute Dhaka, Bangladesh Less <<
NCT03692429 Colorectal Cancer Phase 1 Recruiting October 18, 2033 Belgium ... More >> Institut Jules Bordet Not yet recruiting Brussels, Belgium, 1000 Contact: Michel Dubuisson          Principal Investigator: Leila Shaza, MD          UZ Antwerpen Recruiting Edegem, Belgium, 2650 Contact: Hans Prenen, MD          Principal Investigator: Hans Prenen, MD          UZ Leuven Active, not recruiting Leuven, Belgium, 3000 United Kingdom Guy's and St Thomas' NHS Foundation Trust Not yet recruiting London, United Kingdom, SE1 9RT Contact: Sophie Papa, MD          Principal Investigator: Sophie Papa, MD          The Christie NHS Foundation Trust Not yet recruiting Manchester, United Kingdom, M20 4BX Contact: Fiona Thistlethwaite, MD          Principal Investigator: Fiona Thistlethwaite, MD Less <<
NCT01724931 Rheumatoid Arthritis Phase 2 Completed - Ukraine ... More >> Centre of Immunobiologic Therapy, State Institution "Institute of Emergency and Reconstructive Surgery Donets'k, Ukraine, 83045 Department of Hospital Therapy #1, Regional Clinical Hospital for occupational diseases 104 Donetsk, Ukraine, 83059 Communal Establishment of Health Protection, Regional Hospital of Veterans of War, Rheumatology Department Kharkiv, Ukraine, 61137 Department of Rheumatology, Communal Establishment of Health Protection "Kharkiv City Clinical Hospital #8" Kharkiv, Ukraine, 61178 National Scientific Center "M.D. STRAZHESKO INSTITUTE OF CARDIOLOGY, MAS OF UKRAINE" Kyiv, Ukraine, 03151 Department of Rheumatology and Allergology, Kyiv Regional Clinical Hospital №1 Kyiv, Ukraine, 04107 Lviv Regional Clinical Hospital, Department of Rheumatology Lviv, Ukraine, 79010 Department of Cardio-Rheumatology, Communal Institution "Odesa Regional Clinical Hospital" Odesa, Ukraine, 65025 Crimean State Medical University n.a. S.I. Georgievsky based on Rheumatology Department of Crimean Republic Institution "Clinical Territorial Medical Association "University Clinic" Simferopol, Ukraine, 95017 Railway Clinical Hospital of Uzhorod Station of Lviv Railroad Administration, Therapeutic Department Uzhorod, Ukraine, 88009 Department of Rheumatology, Vinnytsya Regional Clinical Hospital n.a. M.I Vinnytsa, Ukraine, 21018 Zaporizhzhya City Multiple Discipline Clinical Hospital #9, Department of Therapy Zaporizhzhya, Ukraine, 69065 Department of Rheumatology, Zaporizhzhia Regional Clinical Hospital Zaporizhzhya, Ukraine, 69600 Department of Therapy, City Clinical Hospital № 6 Zaporizhzhya, Ukraine Department of Therapy, City Hospital № 7 Zaporizhzhya, Ukraine Less <<
NCT03071796 Health Behavior Not Applicable Completed - Germany ... More >> University of Halle-Wittenberg Halle (Saale), Germany, 06120 Less <<
NCT00054938 Systemic Lupus Erythematosus ... More >> Lupus Less << Phase 2 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital, RBB Brigham Arthritis Center Boston, Massachusetts, United States, 02115 Less <<
NCT00491075 Renal Cell Carcinoma Phase 2 Terminated(Closed early for po... More >>or accrual.) Less << - United States, Texas ... More >> UT MD . Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00959647 Ovarian Cancer ... More >> Basal Cell Carcinoma Metastatic Colorectal Cancer Less << Phase 2 Completed - United States, Arizona ... More >> Scottsdale, Arizona, United States, 85258 United States, California Oakland, California, United States, 94609 Palm Springs, California, United States, 92262 Stanford, California, United States, 94305 United States, Maryland Baltimore, Maryland, United States, 21231 United States, Michigan Ann Arbor, Michigan, United States, 48109-0934 Detroit, Michigan, United States, 48201 United States, Nevada Las Vegas, Nevada, United States, 89106 United States, Ohio Cincinnati, Ohio, United States, 45242 United States, Texas Houston, Texas, United States, 77030 Less <<
NCT01401387 Adenocarcinoma of the Pancreas... More >> Normal Pancreatic Exocrine Function Less << Phase 4 Withdrawn(study never started) May 2013 Netherlands ... More >> Erasmus Medical Center Rotterdam, Zuid-Holland, Netherlands, 3000 WB Less <<
NCT01548144 Advanced Cancers Phase 1 Active, not recruiting April 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02319018 Malignant Digestive System Neo... More >>plasm Less << Phase 1 Completed - United States, Connecticut ... More >> Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States, 06510 Yale University New Haven, Connecticut, United States, 06520 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Michigan Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Tennessee Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT00959647 - Completed - -
NCT00001013 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 3 Completed - United States, California ... More >> Los Angeles County - USC Med Ctr Los Angeles, California, United States, 90033 United States, District of Columbia George Washington Univ Med Ctr Washington, District of Columbia, United States, 20037 United States, Florida Univ of Miami School of Medicine Miami, Florida, United States, 331361013 United States, Illinois Northwestern Univ Med School Chicago, Illinois, United States, 60611 United States, Louisiana Charity Hosp / Tulane Univ Med School New Orleans, Louisiana, United States, 70112 Louisiana State Univ Med Ctr / Tulane Med School New Orleans, Louisiana, United States, 70112 Tulane Univ School of Medicine New Orleans, Louisiana, United States, 70112 United States, Massachusetts Univ of Massachusetts Med Ctr Worcester, Massachusetts, United States, 01655 United States, New York Bronx Municipal Hosp Ctr/Jacobi Med Ctr Bronx, New York, United States, 10461 Jack Weiler Hosp / Bronx Municipal Hosp Bronx, New York, United States, 10465 Montefiore Med Ctr / Bronx Municipal Hosp Bronx, New York, United States, 10467 SUNY / Erie County Med Ctr at Buffalo Buffalo, New York, United States, 14215 City Hosp Ctr at Elmhurst / Mount Sinai Hosp Elmhurst, New York, United States, 11373 Beth Israel Med Ctr / Peter Krueger Clinic New York, New York, United States, 10003 Mount Sinai Med Ctr New York, New York, United States, 10029 Univ of Rochester Medical Center Rochester, New York, United States, 14642 SUNY - Stony Brook Stony Brook, New York, United States, 117948153 SUNY / State Univ of New York Syracuse, New York, United States, 13210 United States, Ohio Holmes Hosp / Univ of Cincinnati Med Ctr Cincinnati, Ohio, United States, 452670405 Univ Hosp of Cleveland / Case Western Reserve Univ Cleveland, Ohio, United States, 44106 United States, Pennsylvania Milton S Hershey Med Ctr Hershey, Pennsylvania, United States, 170330850 Thomas Jefferson Med College Philadelphia, Pennsylvania, United States, 19107 United States, South Carolina Julio Arroyo West Columbia, South Carolina, United States, 29169 Less <<
NCT03176264 Metastatic Colorectal Cancer Phase 1 Completed - Australia, New South Wales ... More >> Novartis Investigative Site St Leonards, New South Wales, Australia, 2065 United Kingdom Novartis Investigative Site Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT00491075 - Terminated(Closed early for po... More >>or accrual.) Less << - -
NCT00762034 Non-small Cell Lung Cancer Phase 3 Completed - -
NCT00762034 - Completed - -
NCT02087241 Previously Untreated Stage IV ... More >>Non-Squamous Non Small Cell Lung Cancer Less << Phase 2 Terminated(The sponsor decided... More >> to terminate the study.) Less << - United States, Colorado ... More >> Research Site Englewood, Colorado, United States United States, Florida Research Site Fort Myers, Florida, United States Research Site Orlando, Florida, United States United States, Illinois Research Site Peoria, Illinois, United States United States, Indiana Research Site Fort Wayne, Indiana, United States United States, Kansas Research Site Wichita, Kansas, United States United States, Ohio Research Site Cincinnati, Ohio, United States United States, Tennessee Research Site Nashville, Tennessee, United States Less <<
NCT03764553 Esophageal Cancer Phase 2 Not yet recruiting August 1, 2023 Netherlands ... More >> Academic Medical Center, Medical Oncology Amsterdam, Netherlands, 1100 DD Less <<
NCT00382720 Stomach Neoplasms Phase 2 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States Belgium Sanofi-Aventis Administrative Office Diegem, Belgium France Sanofi-Aventis Administrative Office Paris, France Germany Sanofi-Aventis Administrative Office Frankfurt, Germany Hungary Sanofi-Aventis Administrative Office Budapest, Hungary Italy Sanofi-Aventis Administrative Office Milan, Italy Portugal Sanofi-Aventis Administrative Office Porto Salvo, Portugal Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation Spain Sanofi-Aventis Administrative Office Barcelona, Spain Switzerland Sanofi-Aventis Administrative Office Genève, Switzerland Turkey Sanofi-Aventis Administrative Office Istanbul, Turkey United Kingdom Sanofi-Aventis Administrative Office Guildford Surrey, United Kingdom Less <<
NCT02087241 - Terminated(The sponsor decided... More >> to terminate the study.) Less << - -
NCT03651934 Pregnant Women Not Applicable Not yet recruiting June 1, 2020 -
NCT02465749 Retinitis Pigmentosa Early Phase 1 Not yet recruiting June 2025 China, Guangdong ... More >> State Key Laboratory of Ophthalmology,Zhongshan Ophthalmic Center, Sun Yat-sen University Not yet recruiting Guangzhou, Guangdong, China, 510060 Contact: Qianying Qao, PHD    13751829105/18922103820    gaoqy@mail.sysu.edu.cn Less <<
NCT00382720 - Completed - -
NCT02660333 Morbid Obesity Not Applicable Completed - Brazil ... More >> Polydoro Ernani de São Thiago University Hospital Florianópolis, SC, Brazil, 88040900 Less <<
NCT03411369 Ischemic Heart Disease Not Applicable Completed - -
NCT01046825 Mature B-Cell Lymphoma Phase 2 Phase 3 Recruiting October 31, 2022 United States, California ... More >> Rady Children's Hospital San Diego Recruiting San Diego, California, United States, 92123 Contact: Deborah Schiff, MD    858-966-5811    dschiff@rchsd.org    Principal Investigator: Deborah Schiff, MD          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: John T Sandlund, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: John T Sandlund, MD          Egypt Children's Cancer Hospital Recruiting Cairo, Egypt, 11787 Contact: Hany Abdel Rahman, MD          Principal Investigator: Hany Abdel Rahman, MD          Singapore National University Health System Recruiting Singapore, Singapore, 119228 Contact: Allen Yeoh, MD       allen_yeoh@nuhs.edu.sg    Principal Investigator: Allen Yeoh, MD Less <<
NCT03582020 Nutritional Evaluation Not Applicable Recruiting June 3, 2020 Germany ... More >> Friedrich-Schiller-University Recruiting Jena, Thuringia, Germany, 07743 Contact: Christine Dawczynski, PhD    +49 3641 949656    christine.dawczynski@uni-jena.de    Contact: Stefan Lorkowski, PhD    +49 3641 949711    stefan.lorkowski@uni-jena.de Less <<
NCT03550794 Sepsis Kidney... More >> Injury Thiamine Deficiency Less << Phase 2 Recruiting June 2022 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Ari Moskowitz, MD    617-754-5864    amoskowi@bidmc.harvard.edu Less <<
NCT02709668 Depression Phase 4 Completed - -
NCT02868489 Obesity Quali... More >>ty of Life Less << Not Applicable Recruiting March 2018 United States, California ... More >> Faculty of Medical Offices - LLU Recruiting Loma Linda, California, United States, 92354 Contact: Taimmie Wharton    909 558 1000 ext 22126    TWharton@llu.edu    Contact: Tammie Wharton, PhD (c), MS, RD    909 677 9593    fkazzi@llu.edu Less <<
NCT03428958 Colorectal Cancer ... More >> Colorectal Neoplasms Colorectal Carcinoma Colorectal Tumors Neoplasms, Colorectal Less << Phase 1 Recruiting December 2019 United States, Tennessee ... More >> Vanderbilt University Not yet recruiting Nashville, Tennessee, United States, 37232 Principal Investigator: Kristen Ciombor, MD          Principal Investigator: Jordan Berlin, MD          United States, Washington Seattle Cancer Center Not yet recruiting Seattle, Washington, United States, 98109-1023 Principal Investigator: Andrew Coveler, MD          United Kingdom The Beatson West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom, G12 0YN Principal Investigator: Jeff Evans, MB BS MD          Principal Investigator: Janet Graham, MBChB, MRCP          University of Oxford Recruiting Oxford, United Kingdom, OX3 7LE Principal Investigator: Sarah Blagden, PhD, FRCP Less <<
NCT03450707 Cardiac Arrest Phase 2 Recruiting February 2023 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Katherine M Berg, MD    617-667-5864    kberg@bidmc.harvard.edu    Principal Investigator: Katherine M Berg, MD Less <<
NCT03247816 - Active, not recruiting October 1, 2018 United Kingdom ... More >> Southampton General Hospital Southampton, United Kingdom Less <<
NCT02440087 - Completed - France ... More >> Hopital Nord Chu42 St Priest En Jarez, France Less <<
NCT01344525 Obesity Weigh... More >>t Loss Less << Not Applicable Recruiting May 2029 Germany ... More >> University of Heidelberg Recruiting Heidelberg, Germany, 69120 University of Hohenheim Recruiting Stuttgart, Germany, 70599 University of Tübingen Recruiting Tübingen, Germany, 72076 Less <<
NCT01179789 Aged Healthy Early Phase 1 Completed - Germany ... More >> Charité - Universitätsmedizin Berlin Berlin, Germany, 10117 Less <<
NCT00003298 Gastric Cancer Phase 2 Completed - -
NCT01964755 Epstein Barr Virus Associated ... More >>Non Hodgkin's Lymphoma Epstein Barr Virus Associated Hodgkin's Lymphoma Post-Transplant Lymphoproliferative Disease Less << Phase 2 Completed - United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 United States, North Carolina University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27999 Less <<
NCT01805765 Menopause Phase 2 Phase 3 Unknown March 2014 China, Shanghai ... More >> Shanghai University of Traditional Chinese Medicine Recruiting Shanghai, Shanghai, China, 201108 Less <<
NCT00078468 Colorectal Neoplasms Phase 2 Completed - United States, California ... More >> Pfizer Investigational Site Poway, California, United States, 92064 United States, District of Columbia Pfizer Investigational Site Washington, District of Columbia, United States, 20007 United States, Florida Pfizer Investigational Site Tampa, Florida, United States, 33612 United States, New York Pfizer Investigational Site New York, New York, United States, 10021 Less <<
NCT01213485 - Completed - France ... More >> Neuilly-sur-seine, France, 92521 Less <<
NCT01820767 Chronic Kidney Disease Phase 3 Completed - Spain ... More >> Hospital El Bierzo. Servicio de Nefrología. Ponferrada, (León)., Spain, 24411, Hospital de León León, Spain, 24008 Less <<
NCT03327415 - Completed - France ... More >> EMERY Yves Montrouge, France, 92129 Less <<
NCT00973258 Pre-Frail or Frail State Phase 3 Completed - Singapore ... More >> Alexandra Hospital, Singapore Singapore, Singapore Less <<
NCT03693807 Colorectal Cancer ... More >> Cholangiocarcinoma Less << Phase 2 Recruiting September 2020 United States, New Jersey ... More >> Memorial Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Nancy Kemeny, MD    646-888-4180       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Nancy Kemeny, MD    646-888-4180       Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Nancy Kemeny, MD    646-888-4180       United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Nancy Kemeny, MD, PhD    646-888-4180       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Nancy Kemeny, MD    646-888-4180       Principal Investigator: Nancy Kemeny, MD          Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Nancy Kemeny, MD    646-888-4180       Principal Investigator: Nancy Kemeny, MD          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Nancy Kemeny, MD    646-888-4180 Less <<
NCT01858649 Metastatic Colorectal Cancer Phase 2 Recruiting May 2019 Belgium ... More >> Clinique Saint Luc Recruiting Bouge, Belgium, 5004 Contact: Laurence Jacqmin       laurence.jacqmin@slbo.be    CHIREC Recruiting Brussels, Belgium, 1180 Contact: sandrine roland, MD    02.434.46.64    roland_sandrine@yahoo.fr    Contact: eugene mucyo    02.434.46.64    datamanagercci@skynet.be    Cliniques universitaires Saint-Luc Recruiting Brussels, Belgium, 1200 Contact: Marc Van den Eynde, MD    0032764 ext 1041    marc.vandeneynde@uclouvain.be    Principal Investigator: Marc Van den Eynde, MD          Grand Hopital de Charleroi Recruiting Charleroi, Belgium, 6000 Contact: Javier Carrasco, MD PhD    00327110 ext 4701    javier.carrasco@ghdc.be    Principal Investigator: Javier Carrasco, MD PhD          AZ Groeninge Recruiting Kortrijk, Belgium, 8500 Contact: philippe vergauwe, MD       philippe.vergauwe@azgroeninge.be    Contact: Fien Verplancke    056 63 33 38    fien.verplancke@azgroeninge.be    Centre Hospitalier Jolimont Lobbes Recruiting La Louvière, Belgium, 7100 Contact: Benedicte Petit, MD    +32.64.23.39.87    benedicte.petit@entitejolimontoise.be    Principal Investigator: Benedicte Petit, MD          CHC Liège clinique Saint Joseph Recruiting Liège, Belgium, 4000 Contact: Gauthier Demolin, MD    +32.4.224.89.92    gauthier.demolin@chc.be    Principal Investigator: Gauthier Demolin, MD          CHU liège (Sart Timan) Recruiting Liège, Belgium, 4000 Contact: Daniel Van Daele, MD    +32.04.242.55.21    daniel.vandaele@chu.ulg.ac.be    Principal Investigator: Daniel Van Daele, MD          Clinique Maternité Saint Elisabeth Recruiting Namur, Belgium, 5000 Contact: Jean-Charles Goeminne, MD    +32.81.720.761    jeancharles.goeminne@cmsenamur.be    Principal Investigator: Jean-Charles Goeminne, MD          Clinique Saint Pierre Ottignies Recruiting Ottignies, Belgium, 1340 Contact: Jean-Charles Coche, MD    +32.10.437.479    jc.coche@skynet.be    Principal Investigator: Jean-Charles Coche, MD          CHU-UCL Dinant-Godinne Recruiting Yvoir, Belgium, 5530 Contact: Lionel D'hondt, MD PhD    +32.81.42.38.53    lionel.dhondt@uclouvain.be    Principal Investigator: Lionel D'Hondt, MD PhD Less <<
NCT00003298 - Completed - -
NCT00004228 Lymphoma Phase 3 Unknown - -
NCT00005977 Leukemia Lymp... More >>homa Less << Phase 3 Completed - -
NCT01280643 Metastatic Colorectal Cancer Not Applicable Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Less <<
NCT00200551 Renal Transplantation Phase 4 Completed - France ... More >> Besançon Universitary Hospital France, Besançon, France, 25030 Montpellier Universitary Hospital Montpellier, France, 34059 Nantes University Hospital Nantes, France, 44093 Nice Universitary Hospital Nice, France, 06202 Strasbourg Universitary Hospital Strasbourg, France, 67091 Less <<
NCT00003783 Leukemia Phase 2 Completed - -
NCT00075725 Leukemia Phase 3 Completed - -
NCT00004228 - Unknown - -
NCT00096135 - Completed - -
NCT00002618 Lymphoma Phase 3 Completed - United States, Kansas ... More >> Via Christi Regional Medical Center-Saint Francis Campus Wichita, Kansas, United States, 67214 United States, Louisiana MBCCOP - LSU Medical Center New Orleans, Louisiana, United States, 70112 United States, North Carolina Memorial Mission Hospital Asheville, North Carolina, United States, 28801 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425-0721 United States, Texas Medical City Dallas Hospital Dallas, Texas, United States, 75230 San Antonio Military Pediatric Cancer and Blood Disorders Center Lackland Air Force Base, Texas, United States, 78236-5300 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284 United States, Virginia Cancer Center, University of Virginia HSC Charlottesville, Virginia, United States, 22908 Puerto Rico University of Puerto Rico School of Medicine Medical Sciences Campus San Juan, Puerto Rico, 00936-5067 Switzerland Clinique de Pediatrie Geneva, Switzerland, 1211 Less <<
NCT00480870 Alzheimer Disease ... More >> Sleep Apnea, Obstructive Less << Phase 4 Completed - Brazil ... More >> Instituto do Sono Sao Paulo, Brazil, 04020-060 Less <<
NCT01230983 Cardiac Toxicity ... More >> Leukemia Lymphoma Less << Phase 3 Completed - -
NCT00541073 Malignant Mesothelioma Phase 2 Completed - France ... More >> Centre Oscar Lambret Lille, France, 59020 Less <<
NCT00742924 Sarcoma Phase 1 Completed - -
NCT00742924 - Completed - -
NCT02634749 Infant Development ... More >> Body Composition, Beneficial Dietary Modification Less << Not Applicable Active, not recruiting January 2020 Sweden ... More >> Paediatrics, Department of Clinical Sciences Umeå, Sweden, 90185 Less <<
NCT01928290 Stomach Neoplasms ... More >> Esophageal Neoplasms Less << Phase 2 Active, not recruiting July 23, 2021 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00075725 - Completed - -
NCT00145769 Adenocarcinoma of Rectum Phase 3 Completed - Australia, Australian Capital ... More >>Territory The Canberra Hospital Garran, Australian Capital Territory, Australia, 2605 Australia, New South Wales Macarthur Cancer Therapy Centre Campbelltown, New South Wales, Australia, 2560 Royal Prince Alfred Hospital Camperdown, New South Wales, Australia, 2050 Liverpool Hospital Liverpool, New South Wales, Australia, 1871 Newcastle Mater Misericordiae Hospital Newcastle, New South Wales, Australia, 2310 Nepean Cancer Care Centre Penrith, New South Wales, Australia, 2751 Prince of Wales Hospital Randwick, New South Wales, Australia, 2031 Royal North Shore Hospital Sydney, New South Wales, Australia, 2069 Riverina Cancer Care Centre Wagga Wagga, New South Wales, Australia, 2650 Westmead Hospital Wentworthville, New South Wales, Australia, 2145 Australia, Queensland Mater Private Hospital Brisbane, Queensland, Australia Royal Brisbane Hospital Herston, Queensland, Australia, 4029 Mater QRI South Brisbane, Queensland, Australia, 4101 North Queensland Oncology Service Townsville, Queensland, Australia, 4810 East Coast Cancer Centre Tugun, Queensland, Australia, 4224 Princess Alexandra Hospital Woolloongabba, Queensland, Australia, 4102 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Australia, Tasmania Launceston General Hospital Launceston, Tasmania, Australia, 7250 Australia, Victoria Peter MacCallum Cancer Centre Bendigo, Victoria, Australia Box Hill Hospital Box Hill, Victoria, Australia Monash Medical Centre East Bentleigh, Victoria, Australia, 3165 Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia, 3002 St Vincents Melbourne Fitzroy, Victoria, Australia Western Hospital Footscray, Victoria, Australia Frankston Hospital Frankston, Victoria, Australia Andrew Love Cancer Centre, Geelong Hospital Geelong, Victoria, Australia, 3220 Peter MacCallum Cancer Centre Melbourne, Victoria, Australia, 3002 Alfred Hospital Prahran, Victoria, Australia, 3181 Murray Valley Private Hospital Wodonga, Victoria, Australia, 3690 Australia, Western Australia Sir Charles Gairdner Hospital Nedlands, Western Australia, Australia, 6009 Royal Perth Hospital Perth, Western Australia, Australia, 6000 New Zealand Auckland Hospital Auckland, New Zealand, 1001 Waikato Hospital Hamilton, New Zealand, 3200 Wellington Hospital Wellington, New Zealand, 7902 Less <<
NCT00003671 Leukemia Phase 2 Completed - -
NCT00120484 Sleep Disorders, Circadian Rhy... More >>thm Less << Not Applicable Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital, Harvard Medical School Boston, Massachusetts, United States, 02115 Less <<
NCT00208611 Parkinson's Disease Phase 2 Phase 3 Terminated(Funding ended and e... More >>nrollment not completed within a certain time period) Less << - United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30329 Less <<
NCT00096135 Leukemia Not Applicable Completed - -
NCT00235573 - Completed - -
NCT00235573 Disorder of Vitamin B12 Not Applicable Completed - United States, Florida ... More >> General Clinical Research Center, Shands Hospital, University of Florida Gainesville, Florida, United States, 32610-0322 Less <<
NCT02959541 Colon Cancer ... More >>Chemotherapy Less << Not Applicable Completed - -
NCT00279552 Vitamin B12 Deficiency Phase 2 Completed - Denmark ... More >> Department for Clinical Biochemistry Aarhus, Denmark, 8000 Less <<
NCT00288769 Recurrent Aphthous Stomatitis Not Applicable Completed - Israel ... More >> Ben-Gurion University of the Negev Beer Sheva, Israel Less <<
NCT00243022 - Terminated(Slow accrual) - -
NCT00326833 Vitamin B12 Deficiency Phase 4 Unknown December 2010 Denmark ... More >> Anne-Mette Hvas Aarhus N, Denmark, 8200 Less <<
NCT00350116 Chronic Plaque Psoriasis Phase 3 Completed - Germany ... More >> Dep. Dermatology and Allergology, Ruhr-University Bochum Bochum, Germany, 44791 Less <<
NCT00699478 Vitamin B12 Deficiency Phase 2 Completed - Korea, Republic of ... More >> Yonsei university college of medicine Seoul, Korea, Republic of, 120-752 Less <<
NCT00826657 Vitamin B12 Deficiency Not Applicable Completed - Mexico ... More >> Universidad Autonoma de Queretaro Queretaro, Mexico Less <<
NCT02842580 Colorectal Neoplasms Phase 2 Recruiting July 2021 France ... More >> CHU Robert DEBRE Recruiting Reims, France Contact: Olivier BOUCHE          Saint Etienne - Chu Recruiting Saint Etienne, France Contact: Jean Marc PHELIP Less <<
NCT00306358 Vitamin B12 Absorption Not Applicable Completed - Denmark ... More >> Aarhus Sygehus Aarhus, Denmark, 8000 Less <<
NCT01127724 Recurrent Aphthous Stomatitis Not Applicable Terminated(difficulties in rec... More >>ruiting participants) Less << - Israel ... More >> Clalit Health Service (HMO) Beer-Sheva, Israel Less <<
NCT01201005 Biochemical Cobalamin Status ... More >> Motor Neurodevelopment Less << Not Applicable Completed - Norway ... More >> Haukeland University Hospital Bergen, Norway, 5021 Less <<
NCT01366937 - Completed - United States, California ... More >> Usda, Ars, Whnrc Davis, California, United States, 95616 Less <<
NCT00243022 Brain and Central Nervous Syst... More >>em Tumors Cerebral Edema Less << Phase 2 Terminated(Slow accrual) - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT01476007 Vitamin B 12 Deficiency Not Applicable Completed - Spain ... More >> Gerencia Atención Primaria, Madrid Madrid, Spain, 28035 Less <<
NCT01661309 Vitamin B12 Deficiency Not Applicable Completed - United Kingdom ... More >> University of West London London, Middlesex, United Kingdom, TW8 9GA Less <<
NCT00944723 Zinc Deficiency Phase 4 Completed - Senegal ... More >> Helen Keller International Dakar, Senegal Less <<
NCT03351296 Pancreatic Cancer Phase 2 Not yet recruiting June 2023 France ... More >> Gustave Roussy Not yet recruiting Villejuif, Val De Marne, France, 94805 Contact: Michel Ducreux, MD, PhD    0142116017 ext +33    michel.ducreux@gustaveroussy.fr    Contact: Dune Lemettre    0142116643 ext +33    dune.lemettre@gustaveroussy.fr Less <<
NCT01306123 Focus: Bioavailability Phase 1 Completed - Sweden ... More >> Karolinska Trial Alliance, Karolinska University Hospital, Huddinge Stockholm, Sweden, 141 86 Less <<
NCT01762072 Healthy Not Applicable Unknown - China, Zhejiang ... More >> Zhejiang university Not yet recruiting Hangzhou, Zhejiang, China, 310029 Contact: Duo Li, PhD    86-571-88982024    duoli@zju.edu.cn Less <<
NCT01832129 Vitamin B 12 Deficiency Phase 4 Completed - Switzerland ... More >> Pharmaceutical Care Research Group Basel, Switzerland, CH-4056 Less <<
NCT00944398 Zinc Deficiency Phase 4 Completed - Senegal ... More >> Helen Keller International Dakar, Senegal Less <<
NCT02037087 Short Message Service ... More >> Text Messaging Less << Not Applicable Completed - China, Shaanxi ... More >> Xi'an Jiaotong University Xi'an, Shaanxi, China, 710049 Less <<
NCT01953757 Diabetic Neuropathy Not Applicable Completed - United States, District of Col... More >>umbia Physicians Committee for Responsible Medicine Washington, District of Columbia, United States, 20016 Less <<
NCT01690962 Diabetic Neuropathy Not Applicable Completed - United States, District of Col... More >>umbia Physicians Committee for Responsible Medicine Washington, District of Columbia, United States, 20016 Less <<
NCT02270749 Vitamin B12 Deficiency Phase 4 Unknown December 2016 Netherlands ... More >> Rijnstate hospital Recruiting Arnhem, Netherlands, 6800WC Contact: Wendy Schijns, MD    0031880057353    wschijns@rijnstate.nl    Principal Investigator: Frits Berends, MD PhD          Sub-Investigator: Wendy Schijns, MD Less <<
NCT02272842 Development V... More >>itamin Deficiency Malnutrition Less << Phase 2 Phase 3 Active, not recruiting February 28, 2020 Nepal ... More >> Siddhi Memorial Hospital (SMH),Bhelukhel, Bhimsensthan Bhaktapur, Nepal, P.O.Box 40 Less <<
NCT00052442 Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT02322892 - Completed - -
NCT00002914 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer Less << Phase 2 Completed - -
NCT00004238 Lung Cancer Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT02832726 Healthy Not Applicable Completed - -
NCT02679833 Cobalamin Deficiency Not Applicable Completed - Germany ... More >> University of Saarland Homburg, Saarland, Germany, 66421 Institute of Alternative and Sustainable Nutrition Giessen, Germany, 35444 Less <<
NCT02322892 Coronary Artery Bypass ... More >> Cardiac Surgical Procedures Less << Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT02457507 Cognitive Decline Phase 4 Completed - China ... More >> The Chinese University of Hong Kong Hong Kong, China Less <<
NCT03592277 Sepsis Septic... More >> Shock Less << Phase 2 Recruiting December 1, 2019 United States, Connecticut ... More >> Saint Francis Hospital and Medical Center Recruiting Hartford, Connecticut, United States, 06105 Contact: David S Shapiro, MD       DShapiro@stfranciscare.org Less <<
NCT03735316 Vasoplegic Syndrome Phase 2 Recruiting December 31, 2020 United States, Minnesota ... More >> Mayo Clinic Saint Mary's Hospital Recruiting Rochester, Minnesota, United States, 55902 Contact: Midhat Mujic, R.R.T., L.R.T.    507-293-2612    mujic.midhat@mayo.edu    Contact: Brenda Anderson, R.N.    507-255-7157    anderson.brenda@mayo.edu Less <<
NCT02087462 Sciatica Due to Intervertebral... More >> Disc Disorder Less << Not Applicable Unknown June 2014 China, Sichuan ... More >> Chengdu university of Traditonal Chinese Medcine Recruiting Chengdu, Sichuan, China, 610075 Contact: Xi Wu, A.P.    86-15928830710    wuxi403@hotmail.com    Principal Investigator: Song Jin, M.D.          Sub-Investigator: Ling Qiu, physician          Sub-Investigator: Min Chen, physician          Sub-Investigator: Yongmao Chen, physician          Sub-Investigator: Xiaohong Fan, physician          Sub-Investigator: Tingting Liao, physician          Sub-Investigator: Jie Zhang, Physician          Sub-Investigator: Lei Lan, Doctor          Sub-Investigator: Jun Lin, Postgraduate          Sub-Investigator: Chen Du, Postgraduate Less <<
NCT03071666 Pregnancy Related ... More >> Vitamin B 12 Deficiency Anemia Less << Phase 2 Phase 3 Recruiting December 31, 2021 Nepal ... More >> Manjeswori Ulak Recruiting Bhaktapur, Nepal, P.O.Box 40 Contact: Manjeswori Ulak, MD/MPhil    6612945    manjeswori@gmail.com    Contact: Shyam S Dhaubhadel       founder@smf.org.np    Sub-Investigator: Merina Shrestha, MD          Principal Investigator: Ram K Chandyo, MD PhD          Principal Investigator: Laxman Shrestha, MD Professor Less <<
NCT01114282 Multiple Myeloma Phase 1 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT03437824 Vitamin B 12 Deficiency Early Phase 1 Recruiting July 1, 2021 United States, California ... More >> Keck Medicine of USC - Downtown Los Angeles Recruiting Los Angeles, California, United States, 90017 Contact: Michael M Johns, MD    323-865-9839    michael.johns@med.usc.edu Less <<
NCT01178944 Adenocarcinoma of the Gastroes... More >>ophageal Junction Esophageal Undifferentiated Carcinoma Gastric Adenocarcinoma Gastric Squamous Cell Carcinoma Recurrent Esophageal Adenocarcinoma Recurrent Esophageal Squamous Cell Carcinoma Recurrent Gastric Carcinoma Stage IIIB Esophageal Adenocarcinoma Stage IIIB Esophageal Squamous Cell Carcinoma Stage IIIB Gastric Cancer Stage IIIC Esophageal Adenocarcinoma Stage IIIC Esophageal Squamous Cell Carcinoma Stage IIIC Gastric Cancer Stage IV Esophageal Adenocarcinoma Stage IV Esophageal Squamous Cell Carcinoma Stage IV Gastric Cancer Undifferentiated Gastric Carcinoma Less << Phase 2 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Rochester General Hospital Rochester, New York, United States, 14621 Less <<
NCT01558921 Rectal Cancer Phase 3 Active, not recruiting June 8, 2022 -
NCT01178944 - Completed - -
NCT03365583 - Active, not recruiting November 2018 Turkey ... More >> Marmara University School of Medicine Istanbul, Turkey Less <<
NCT02111967 - Completed - Switzerland ... More >> Pharmaceutical Care Research Group Basel, Switzerland, 4056 Less <<
NCT03598998 Recurrent Mature T- and NK-Cel... More >>l Non-Hodgkin Lymphoma Recurrent Mycosis Fungoides Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Refractory Mycosis Fungoides Less << Phase 1 Phase 2 Not yet recruiting April 27, 2021 United States, California ... More >> City of Hope Medical Center Not yet recruiting Duarte, California, United States, 91010 Contact: Alex F. Herrera, MD    626-256-4673 ext 62405    aherrera@coh.org    Principal Investigator: Alex F. Herrera, MD          United States, Nebraska University of Nebraska Medical Center Not yet recruiting Omaha, Nebraska, United States, 68198 Contact: Matthew A. Lunning, MD    402-559-3848    mlunning@unmc.edu    Principal Investigator: Matthew A. Lunning, MD          United States, New Jersey Hackensack University Medical Center Not yet recruiting Hackensack, New Jersey, United States, 07601 Contact: Tatyana A. Feldman, MD    551-996-4469    Tatyana.Feldman@Hackensackmeridian.org    Principal Investigator: Tatyana A. Feldman, MD Less <<
NCT01590095 Malnutrition ... More >>Diarrhea Child Development Less << Not Applicable Active, not recruiting December 2018 Bangladesh ... More >> Dr. Mahbubur Rahman Dhaka, Bangladesh, 1212 Less <<
NCT02731859 - Recruiting January 2019 Germany ... More >> Klinikum Augsburg Recruiting Augsburg, Germany Contact: Heinle          Donau-Ries Klinik Donauwörth Recruiting Donauwörth, Germany Contact: Eberl          St. Martinus Krankenhaus Düsseldorf Recruiting Düsseldorf, Germany, 40215 Contact: Gijbels          Klinikum Forchheim Recruiting Forchheim, Germany Contact: Dewald          Universitätsklinikum Freiburg- Abt. Innere Medizin II Recruiting Freiburg, Germany Contact: Dr. Laubner/Prof. Seufert          Marienhospital Gelsenkirchen Recruiting Gelsenkirchen, Germany Contact: Dederichs          Universitätsmedizin Göttingen Recruiting Göttingen, Germany Contact: Raddatz          Evangelisches Krankenhaus Köln-Weyertal Recruiting Köln, Germany Contact: Loeff          Krankenhaus Emmaus-Niesky Recruiting Niesky, Germany Contact: Stengel          Elisabeth Klinikum Schmalkalde Recruiting Schmalkalden, Germany Contact: Jung          Petrus Krankenhaus Wuppertal Recruiting Wuppertal, Germany Contact: Göbel Less <<
NCT03405675 - Active, not recruiting December 31, 2020 Singapore ... More >> National University of Singapore Singapore, Singapore, 119260 Less <<
NCT02249468 - Terminated(Stop the study for ... More >>futility based on recommendation from Independent Data Committee.) Less << - Singapore ... More >> National University Hospital Singapore, Singapore, 119074 Less <<
NCT01704105 Malnutrition ... More >>Diarrhea Child Development Less << Not Applicable Completed - Kenya ... More >> Innovations for Poverty Action, Kenya Kisumu, P.O Box 2663, Kenya, 40100 Less <<
NCT03493100 Geriatric Patients Not Applicable Completed - Germany ... More >> University of Hohenheim Stuttgart, Germany, 70599 Less <<
NCT01187888 Progressive Supranuclear Palsy Phase 3 Terminated(IMP used off label ... More >>by phys. in pat. with PSP. Thus no more eligible patients were available for the study(pre-treatm.with Rasagiline=exclusion criterion) Less << - Germany ... More >> Department of Neurology and Palliative Care Klinikum der Universität München (Hospital of the University of Munich) München, Germany, 81377 Less <<
NCT02687919 Multiple Sclerosis, Relapsing-... More >>remitting Less << Not Applicable Completed - United States, Iowa ... More >> University of Iowa Iowa City, Iowa, United States, 52241 Less <<
NCT02405585 Pancreatic Cancer ... More >> Pancreatic Carcinoma Non-resectable Less << Phase 2 Terminated - United States, Kentucky ... More >> University of Louisville Louisville, Kentucky, United States, 40292 United States, Massachusetts Lahey Clinic Burlington, Massachusetts, United States United States, New Mexico New Mexico Cancer Care Alliance Albuquerque, New Mexico, United States, 87106 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Less <<
NCT01069445 Healthy Elderly People Not Applicable Completed - France ... More >> Pôle de gerontology Clinique Hôpital Xavier Arnozan , University Hospital, Bordeaux Pessac, France, 33600 Less <<
NCT02067026 Overweight He... More >>althy Subjects Less << Not Applicable Completed - Italy ... More >> Fondazione Edmund Mach -Centro Ricerca ed Innovazione San Michele all'Adige, TN, Italy, 38010 Unità di Dietetica e Nutrizione Clinica, Ospedale S. Chiara, Via Orsi 1 Trento, TN, Italy, 38100 Less <<
NCT01467115 Head and Neck Cancer Phase 2 Completed - United States, Pennsylvania ... More >> Hahnemann University Hospital Philadelphia, Pennsylvania, United States, 19102 Less <<
NCT03406221 Health Pregna... More >>ncy Infant Nutrition Child Less << Not Applicable Completed - -
NCT02021799 Pregnancy Not Applicable Completed - Tanzania ... More >> Nyerere Dispensary Buswelu, Tanzania Less <<
NCT03383510 Sustainability ... More >> Microbiota Pesticides Organic Food Less << Not Applicable Completed - Sweden ... More >> Mälardalens University Västerås, Sweden, 721 23 Less <<
NCT01795170 - Withdrawn(The study couldn't b... More >>e initiated as we did not secure funding.) Less << November 2016 United States, Colorado ... More >> Children's Hospital Colorado Aurora, Colorado, United States, 80045 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Canada, British Columbia BC Children's Hospital Vancouver, British Columbia, Canada, V6H 3V4 Germany Hannover Medical School Hannover, Germany Netherlands Maxima Medical Center Veldhoven, Netherlands Switzerland Kinderspital Zürich Zürich, Switzerland United Kingdom University College London London, United Kingdom Less <<
NCT03447275 - Completed - -
NCT01477112 Diabetes Mellitus ... More >> Oxidative Stress Iron Metabolism Disorders Less << Not Applicable Completed - Venezuela ... More >> Hospital Baudilio Lara Barquisimeto, Lara, Venezuela Less <<
NCT02676349 Pancreatic Carcinoma Phase 2 Recruiting January 2024 France ... More >> Institut Bergonié Recruiting Bordeaux, France Contact: BECHADE Dominique, MD          Polyclinique Bordeaux Nord Recruiting Bordeaux, France Contact: LECAILLE Cédric, MD          CHU Morvan Not yet recruiting Brest, France Contact: METGES Jean-Philippe, MD          Hôpital Beaujon Recruiting Clichy, France, 92110 Contact: HAMMEL Pascal, PR          Chu Colmar Recruiting Colmar, France Contact: Gilles Breysacher, MD          Hôpital Henri Mondor (APHP) Recruiting Creteil, France Contact: BAUMGAERTNER Isabelle, MD          CH Bicêtre (APHP) Not yet recruiting Le Kremlin-Bicêtre, France Contact: THIROT-BIDAULT Anne, MD          Centre Oscar Lambret Recruiting Lille, France Contact: Xavier Mirabel, MD          Chru Lille Recruiting Lille, France Contact: PIESSEN Guillaume, MD          Infirmerie Protestante de Lyon Not yet recruiting Lyon, France Contact: TAVAN David, MD          Hopital européen Marseille Recruiting Marseille, France Contact: RINALDI Yves, MD          Hôpital La Timone Recruiting Marseille, France Contact: DAHAN Laëtitia, MD          Institut Paoli CALMETTES Recruiting Marseille, France Contact: DELPERO Jean-Robert, MD          Institut du Cancer de Montpellier Recruiting Montpellier, France Contact: PORTALES Fabienne, MD          Chu Nantes Recruiting Nantes, France Contact: Nicolas REGENET, MD          Hôpital Cochin (APHP) Recruiting Paris, France Contact: CORIAT Romain, MD          Institut Mutualiste Montsouris Recruiting Paris, France Contact: LOUVET Christophe, MD          Pitié Salpêtrière (APHP) Recruiting Paris, France Contact: BACHET Jean-Baptiste, MD          Hôpital Haut-Lévêque Recruiting Pessac, France Contact: VENDRELY Véronique, MD          CHU Reims Recruiting Reims, France Contact: BOUCHE Olivier, MD          Centre Eugène Marquis Recruiting Rennes, France Contact: SULPICE Laurent, MD          Chu Rouen Recruiting Rouen, France Contact: SCHWARZ Lillian          CHP Saint Grégoire Recruiting Saint Grégoire, France Contact: MIGLIANO Laurent, MD          Institut de Cancérologie de l'Ouest Recruiting Saint-Herblain, France Contact: THIBAUDEAU Emilie, MD          Chru Tours Recruiting Tours, France Contact: LECOMTE Thierry, MD          Chru Nancy Recruiting Vandoeuvre-les-nancy, France Contact: AYAV Ahmet, MD          Institut de Cancérologie de Lorraine Recruiting Vandoeuvre-les-nancy, France Contact: CONROY Thierry, MD Less <<
NCT02567981 Micronutrient Deficiency Not Applicable Recruiting September 2020 El Salvador ... More >> FUSAL Recruiting Santa Elena, El Salvador Contact: María J Dominguez, BA    (503) 2241-6900 Less <<
NCT00515216 Stomach Neoplasms ... More >> Esophageal Neoplasms Less << Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT01225744 Metastatic Colorectal Cancer Phase 2 Completed - United Kingdom ... More >> North Wales Cancer Treatment Centre Llansantffraid Glan Conwy, United Kingdom, LL18 5UJ The Royal Marsden London and Surrey, United Kingdom The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX Less <<
NCT00098787 Colorectal Cancer Phase 2 Completed - -
NCT00572741 Autistic Disorder Not Applicable Completed - United States, Arkansas ... More >> Arkansas Children's Hospital Research Institute Little Rock, Arkansas, United States, 72202 Less <<
NCT02428647 Diarrhea Not Applicable Completed - Lao People's Democratic Republ... More >>ic National Institute of Public Health Vientiane, Lao People's Democratic Republic Less <<
NCT01047293 Colorectal Cancer Phase 1 Phase 2 Completed - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Utah Cancer Specialists Salt Lake City, Utah, United States Less <<
NCT00193219 Colon Cancer Phase 2 Completed - United States, Indiana ... More >> Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Maine Mercy Hospital Portland, Maine, United States, 04101 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Mississippi Jackson Oncology Associates Jackson, Mississippi, United States, 39202 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Tennessee Chattanooga Oncology and Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT01047293 - Completed - -
NCT00098787 - Completed - -
NCT00193219 - Completed - -
NCT02551627 Growth and Development Not Applicable Withdrawn October 1, 2017 -
NCT00515216 - Completed - -
NCT00694824 - Completed - Italy ... More >> Nhephrology Dialysis Transplantation Unit St.Orsola University Hospital Bologna, Italy, 40100 Less <<
NCT02641691 Cancer of Rectum ... More >> Cancer of the Rectum Neoplasm, Rectum Rectal Cancer Rectum Cancer Rectum Neoplasms Adenocarcinoma of the Rectum Less << Phase 1 Recruiting July 31, 2019 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Hyun Kim, M.D.    314-362-8502    kim.hyun@wustl.edu    Sub-Investigator: Hyun Kim, M.D.          Sub-Investigator: Steven Hunt, M.D.          Sub-Investigator: Parag Parikh, M.D.          Sub-Investigator: Elisa Birnbaum, M.D.          Sub-Investigator: Sekhar Dharmarajan, M.D.          Sub-Investigator: Sean Glasgow, M.D.          Sub-Investigator: Kian-Huat Lim, M.D., Ph.D.          Sub-Investigator: Manik Amin, M.D.          Sub-Investigator: Matthew Mutch, M.D.          Sub-Investigator: Anna Roshal, M.D.          Sub-Investigator: Matthew Silviera, M.D.          Sub-Investigator: Rama Suresh, M.D.          Sub-Investigator: Benjamin R Tan, M.D.          Sub-Investigator: Paul Wise, M.D.          Sub-Investigator: Katrina Pederson, M.D.          Sub-Investigator: Michael Roach, M.D.          Sub-Investigator: Radhika Smith, M.D.          Sub-Investigator: Andrea Wang-Gillam, M.D., Ph.D.          Sub-Investigator: Haeseong Park, M.D.          Sub-Investigator: Nikolaos Trikalinos, M.D. Less <<
NCT02658214 Small Cell Lung Carcinoma ... More >> Carcinoma, Squamous Cell of Head and Neck Stomach Neoplasms Triple Negative Breast Neoplasms Ovarian Neoplasms Fallopian Tube Neoplasms Peritoneal Neoplasms Esophagogastric Junction Neoplasms Carcinoma, Pancreatic Ductal Esophageal Squamous Cell Carcinoma Less << Phase 1 Recruiting June 28, 2019 United States, Georgia ... More >> Research Site Withdrawn Augusta, Georgia, United States, 30912 United States, Pennsylvania Research Site Withdrawn Pittsburgh, Pennsylvania, United States, 15232 Japan Research Site Recruiting Chuo-ku, Japan, 104-0045 Research Site Recruiting Kashiwa, Japan, 277-8577 Korea, Republic of Research Site Recruiting Seoul, Korea, Republic of, 03080 Research Site Recruiting Seoul, Korea, Republic of, 03722 Research Site Recruiting Seoul, Korea, Republic of, 05505 Research Site Recruiting Seoul, Korea, Republic of, 135-710 Less <<
NCT02896452 - Recruiting August 2020 United States, Minnesota ... More >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Chelsie Van Oort    507-266-3912    VanOort.Chelsie@mayo.edu    Principal Investigator: Alice Y Chang, MD Less <<
NCT00323960 Juvenile Dermatomyositis Phase 3 Unknown May 2011 Italy ... More >> Istituto Giannina Gaslini Recruiting Genoa, Italy, 16147 Less <<
NCT01499732 - Completed - United States, California ... More >> Orrin M. Troum, MD and Medical Associates Santa Monica, California, United States, 90404 Less <<
NCT02591030 Bile Duct Cancer Phase 2 Phase 3 Recruiting September 2023 France ... More >> Chu Picardie Recruiting Amiens, France Principal Investigator: Vincent Heutefeuille          Ico Paul Papin Recruiting Angers, France Principal Investigator: Olivier Capitain          CH Victor Dupouy Recruiting Argenteuil, France Principal Investigator: Arnaud BOUTAN-LAROZE          CH de la Côte Basque Recruiting Bayonne, France, 64109 Principal Investigator: Franck AUDEMAR          CHRU Besançon Recruiting Besançon, France Principal Investigator: Marine Jarry          Hôpital Avicenne Not yet recruiting Bobigny, France Principal Investigator: Thomas Aparicio          Hôpital Saint-André Recruiting Bordeaux, France, 33000 Principal Investigator: Jean-Frédéric Blanc          Polyclinique Nord Recruiting Bordeaux, France, 33000 Principal Investigator: Cedric Lecaille          Hôpital Duchenne Recruiting Boulogne sur Mer, France Principal Investigator: Vincent Bourgeois          Centre François Baclesse Recruiting Caen, France Principal Investigator: Aurélie PARZY          Chu D'Estaing Recruiting Clermont-Ferrand, France Principal Investigator: Caroline Petorin          Hôpitaux Civils Recruiting Colmar, France Principal Investigator: Laurianne Plastaras          Ch Sud Francilien Recruiting Corbeil-Essonnes, France, 91100 Principal Investigator: Samy LOUAFI          Centre de radiothérapie et oncologie du Parc Recruiting Dijon, France, 21000 Principal Investigator: Ariane DARUT-JOUVE          Centre Georges François Leclerc Recruiting Dijon, France Principal Investigator: François GHIRINGHELLI          Hôpital Michallon Recruiting Grenoble, France Principal Investigator: Thomas DECAENS          CHD Vendée Recruiting La Roche sur Yon, France Principal Investigator: Roger Faroux          Clinique du cap d'Or Recruiting La Seyne sur Mer, France Principal Investigator: Mounira EL DEMERY          CH Le Kremlin Bicetre Recruiting Le Kremlin-Bicêtre, France Principal Investigator: Anne THIROT-BIDAULT          CHRU Lille Recruiting Lille, France Principal Investigator: Stéphane CATTAN          Centre Hospitalier de Longjumeau Recruiting Longjumeau, France, 91160 Principal Investigator: Samy LOUAFI          Clinique de la Sauvegarde Not yet recruiting Lyon, France, 69000 Principal Investigator: Isabelle Moullet          Centre Léon Bérard Recruiting Lyon, France Principal Investigator: Françoise DESSEIGNE          Hôpital de la Croix Rousse Recruiting Lyon, France Principal Investigator: Marielle Guillet          Hôpital Lyon Sud Recruiting Lyon, France Principal Investigator: Marion Chauvenet          Hôpital Saint-Joseph Recruiting Marseille, France Principal Investigator: Hervé Perrier          Centre Catherine de Sienne Recruiting Nantes, France Principal Investigator: Hélène Castanie          CHR Orléans Recruiting Orléans, France Principal Investigator: Jérome Meunier          HEGP Recruiting Paris, France Principal Investigator: Julien TAIEB          Hôpital Cochin Recruiting Paris, France Principal Investigator: Romain Coriat          Hôpital Saint-Jean Recruiting Perpignan, France Principal Investigator: Faiza KHEMISSA-AKOUZ          CHU La Miletrie Recruiting Poitiers, France Principal Investigator: David Tougeron          CHU Reims Recruiting Reims, France Principal Investigator: Alexandra Heurgue          Centre Eugène Marquis Recruiting Rennes, France Principal Investigator: Julien Edeline          Hôpital Drôme Nord Recruiting Romans sur Isère, France Principal Investigator: Marie-Claude Goutttebel          Chu Rouen Recruiting Rouen, France Principal Investigator: Pierre Michel          CHU Saint-Etienne Recruiting Saint-Etienne, France, 42055 Principal Investigator: Jean-Marc Phelip, PhD          CH Saint-Jean de Luz Recruiting Saint-Jean de Luz, France, 64500 Principal Investigator: Etienne Mauriac          CH Saint-Quentin Recruiting Saint-Quentin, France Principal Investigator: Innocenti DADAMESSI          Ch Robert Morlevat Recruiting Semur en Auxois, France Principal Investigator: Arnaud Patenotte          CAC Paul Strauss Recruiting Strasbourg, France, 67065 Principal Investigator: Meher BEN ABDELGHANI          CHU Tours Recruiting Tours, France Principal Investigator: Thierry Lecomte Less <<
NCT00125034 - Completed - -
NCT02753127 Colorectal Cancer Phase 3 Recruiting - -
NCT01895257 Colorectal Cancer Phase 3 Recruiting December 2018 Belgium ... More >> University of Antwerp Recruiting Edegem, Antwerp, Belgium, 2650 Principal Investigator: Marc Peeters, MD, PhD          ASZ Aalst Active, not recruiting Aalst, Belgium, 9300 Institut Jules Bordet Active, not recruiting Brussels, Belgium, 1000 CUB Hôpital Erasme Active, not recruiting Brussels, Belgium, 1070 University of St-Luc Recruiting Brussels, Belgium, 1200 Principal Investigator: Marc Van den Eynde          Grand Hôpital de Charleroi Recruiting Charleroi, Belgium, 6000 Principal Investigator: Javier Carrasco, MD          ZOL Genk Recruiting Genk, Belgium, 3600 Contact: Jaarke Vannoote, MD          AZ St-Lucas Gent Not yet recruiting Gent, Belgium, 9000 Contact: Monique Troch, MD          AZ Groeninge Recruiting Kortrijk, Belgium, 8500 Contact: Philippe Vergauwe, MD          CHU de Liège Recruiting Liège, Belgium, 4000 Principal Investigator: Marc Polus, MD Less <<
NCT02218931 Pre-eclampsia ... More >> Obesity Raised Lipids High Blood Pressure Insulin Resistance Gestational Diabetes Small for Gestational Age Stillbirth Less << Not Applicable Completed - United Kingdom ... More >> Barts Health NHS Trust London, United Kingdom, E1 1BB Less <<
NCT01473914 End Stage Renal Disease Phase 3 Completed - Canada, Alberta ... More >> University of Calgary Calgary, Alberta, Canada, T2N 1N4 University of Alberta Edmonton, Alberta, Canada, T6G 2V2 Less <<
NCT03597581 Gastrointestinal Cancer ... More >> Gastrointestinal Neoplasms Colorectal Cancer Colorectal Neoplasms Colorectal Carcinoma Gastric Cancer Gastric Neoplasm Pancreatic Cancer Pancreatic Neoplasm Less << Phase 1 Recruiting April 30, 2021 United States, Texas ... More >> Mary Crowley Cancer Research Recruiting Dallas, Texas, United States, 75230 Contact: James Strauss, MD    972-566-3000 Less <<
NCT00125034 Neoplasm Metastasis ... More >> Colorectal Cancer Less << Phase 2 Completed - -
NCT02852694 Crohn's Disease Phase 4 Recruiting July 2022 France ... More >> Hôpital Necker -Enfants Malades (Service de gastro-enterologie) Recruiting Paris, France, 75015 Contact: Frank RUEMMELE, MD    +33 (0)144492516    frank.ruemmele@aphp.fr Less <<
NCT01168531 Pain Not Applicable Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT01019902 - Completed - United States, New York ... More >> Highland Hospital Rochester, New York, United States, 14642 Less <<
NCT02528929 Irritable Bowel Syndrome Not Applicable Active, not recruiting November 2018 -
NCT03368859 Cancer Phase 2 Recruiting August 21, 2020 -
NCT03544671 Vitamin D Deficiency ... More >> 25-Hydroxyvitamin D3 Deficiency, Selective Less << Not Applicable Completed - Mexico ... More >> Marta Rivera Pasquel Cuernavaca, Morelos, Mexico, 62100 Less <<
NCT00021866 - Completed - -
NCT00478309 Colorectal Cancer ... More >> Healthy, no Evidence of Disease Less << Not Applicable Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States, 19111-2497 Less <<
NCT03287778 Tardive Dyskinesia ... More >> Antipsychotic Agents Less << Not Applicable Recruiting June 30, 2020 United States, North Carolina ... More >> University of North Carolina at Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Lars F Jarskog, MD    919-843-7683    lars_jarskog@med.unc.edu Less <<
NCT00424294 Arthritis, Rheumatoid Phase 2 Terminated(See Detailed Descri... More >>ption field) Less << - -
NCT01742767 NSCLC Phase 2 Unknown April 2015 Germany ... More >> University hospital essen Recruiting Essen, Northrhine westphalia, Germany, 45122 Contact: Diana Cortes-Incio    02017232011    diana.cortez-incio@uk-essen.de Less <<
NCT01784640 Recurrent Non-small Cell Lung ... More >>Cancer Squamous Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 1 Active, not recruiting January 31, 2020 United States, California ... More >> Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 Less <<
NCT01719536 NSCLC Phase 3 Unknown December 2016 -
NCT00424294 - Terminated(See Detailed Descri... More >>ption field) Less << - -
NCT01723800 Recurrent Non-small Cell Lung ... More >>Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 1 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT01829113 Non Squamous Non Small Cell Lu... More >>ng Cancer Less << Phase 2 Completed - United States, Colorado ... More >> Rocky Mountain Cancer Center Denver, Colorado, United States, 80218 United States, Florida Florida Cancer Specialists-South Fort Myers, Florida, United States, 33916 Florida Hospital Cancer Insitute Orlando, Florida, United States, 32804 Florida Cancer Specialists-North Saint Petersburg, Florida, United States, 33705 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Missouri Research Medical Center Kansas City, Missouri, United States, 64132 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, New Jersey Hematology-Oncology Associates of Northern NJ Morristown, New Jersey, United States, 07932 United States, Ohio Oncology Hematology Care, Inc. Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates Columbia, South Carolina, United States, 29210 United States, Tennessee Tennessee Oncology - Chattanooga Chattanooga, Tennessee, United States, 37404 Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas The Center for Cancer and Blood Disorders Fort Worth, Texas, United States, 76104 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Virginia Cancer Institute Richmond, Virginia, United States, 23230 Less <<
NCT03580499 Hot Flashes P... More >>rostate Carcinoma Less << Phase 2 Not yet recruiting February 2021 United States, Pennsylvania ... More >> Sidney Kimmel Cancer Center at Thomas Jefferson University Not yet recruiting Philadelphia, Pennsylvania, United States, 19107 Principal Investigator: Mark Hurwitz, MD Less <<
NCT01860508 Non-small Cell Lung Cancer Not Applicable Unknown - China, Shanghai ... More >> Cancer hospital Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Jia lei Wang, Master    02164175590 ext 8907    luwangjialei@hotmail.com Less <<
NCT01836341 Non-small Cell Lung Cancer Phase 1 Withdrawn April 2015 -
NCT01877902 - Unknown - Spain ... More >> Hospital La Línea Recruiting Algeciras, Cádiz, Spain Contact: José Carlos Roldán          Hospital Punta de Europa Recruiting Algeciras, Cádiz, Spain Contact: Pablo Villanueva Jiménez          Hospital Jerez de la Frontera Recruiting Jerez de la Frontera, Cádiz, Spain Contact: Rocío Gavira Moreno          Hospital Costa del Sol Recruiting Marbella, Cádiz, Spain Contact: Margarita Garrido          Hospital de Puerto Real Recruiting Puerto Real, Cádiz, Spain Contact: Carmen Martínez Díaz          Hospital de Baza Recruiting Baza, Granada, Spain Contact: Francisco Nieto Cobo          Hospital Universitario Torrecardenas Recruiting Almería, Spain Contact: Juan José Fernández Avila          Hospital Universitario Puerta del Mar Recruiting Cádiz, Spain Contact: María José Martínez Bautista          Hospital Universitario Reina Sofía Recruiting Córdoba, Spain Contact: Ana Isabel Gago Sánchez          Hospital San Cecilio Recruiting Granada, Spain Contact: Miguel Damas Fernández Fijares          Hospital Santa Ana Recruiting Granada, Spain Contact: Marcos Camacho Romera          Hospital Universitario Virgen de las Nieves Recruiting Granada, Spain Contact: Inmaculada Vallejo Rodríguez          Hospital Universitario Juan Ramón Jiménez Recruiting Huelva, Spain Contact: Mª Teresa Garrido Martínez          Hospital Regional de Málaga Recruiting Málaga, Spain Contact: Beatriz Mora Rodríguez          Hospital Universitario Virgen de la Victoria Recruiting Málaga, Spain Contact: Begoña Muros de Fuentes          Hospital Universitario Virgen de Valme Recruiting Sevilla, Spain Contact: Silvia Artecho          Hospital Universitario Virgen del Rocío Recruiting Sevilla, Spain Contact: Javier Bautista Paloma          Hospital Universitario Virgen Macarena Recruiting Sevilla, Spain Contact: Nuria Muñoz Muñoz Less <<
NCT01907100 Mesothelioma Phase 3 Completed - -
NCT03707652 Increase in Blood Levels of Ni... More >>cotinamide Adenine Dinucleotide (NAD+) Less << Not Applicable Completed - United States, Florida ... More >> Life Extension Clinical Research, Inc. Fort Lauderdale, Florida, United States, 33308 Less <<
NCT01001910 Recurrent Fallopian Tube Carci... More >>noma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Less << Phase 2 Completed - United States, New York ... More >> Albert Einstein College of Medicine Bronx, New York, United States, 10461 Columbia University Medical Center New York, New York, United States, 10032 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02029690 Pleural Mesothelioma Malignant... More >> Advanced Peritoneal Mesothelioma Malignant Advanced Non-squamous Non-small Cell Lung Carcinoma Stage IIIB/IV (NSCLC) Metastatic Uveal Melanoma Hepatocellular Carcinoma (HCC) Glioma Sarcomatoid Cancers Less << Phase 1 Active, not recruiting February 2019 United States, Minnesota ... More >> Mayo Clinic Rochester Rochester, Minnesota, United States, 55902 United Kingdom Centre for Experimental Cancer Medicine (CECM) London, England, United Kingdom, EC1M 6BQ Cambridge Hospital Cambridge, United Kingdom, CB2 0QQ Guys Hospital London, United Kingdom, SE1 7EH Less <<
NCT01829113 - Completed - -
NCT02004184 Carcinoma, Non-small-cell Lung Phase 3 Terminated(Poor enrollment due... More >> to the introduction of immunotherapy) Less << - Norway ... More >> St Olavs Hospital Trondheim, Norway Less <<
NCT01918761 Non Small Cell Lung Cancer Phase 1 Suspended(poor accrual) September 15, 2018 Austria ... More >> Medizinische Universität Graz Klinische Abteilung für Onkologie Graz, Austria Universitätsklinik für Innere Medizin I Innsbruck, Austria Less <<
NCT02119650 NSCLC (Non-small Cell Lung Car... More >>cinoma) Less << Phase 2 Terminated(The study was termi... More >>nated as other related studies of ruxolitinib did not provide sufficient efficacy to warrant continuation.) Less << - -
NCT02182102 Carcinoma, Non-Small-Cell Lung Phase 1 Completed - -
NCT02119650 - Terminated(The study was termi... More >>nated as other related studies of ruxolitinib did not provide sufficient efficacy to warrant continuation.) Less << - -
NCT02049060 Malignant Pleural Mesothelioma... More >> Nonsquamous Nonsmall Cell Neoplasm of Lung Less << Phase 1 Phase 2 Active, not recruiting December 2017 Italy ... More >> Istituto Clinico Humanitas Rozzano, Milan, Italy, 20089 Less <<
NCT02211833 Carcinoma, Non-Small-Cell Lung Phase 1 Completed - -
NCT02117167 Non-small Cell Lung Cancer Met... More >>astatic Less << Phase 2 Recruiting February 2022 France ... More >> Centre Hospitalier Henri Duffau Recruiting Avignon, France Contact: Nicolas CLOAREC, MD       nicolas.cloarec@ch-avignon.fr    Principal Investigator: Nicolas CLOAREC, MD          Centre Hospitalier Universitaire de Besancon - Hopital Jean Minjoz Recruiting Besancon, France Contact: Virginie WESTEEL, MD       virginie.westeel@univ.fcomte.fr    Principal Investigator: Virginie WESTEEL, MD          Hôpital Avicenne Recruiting Bobigny, France Contact: Boris DUCHEMANN, MD       boris.duchemann@aphp.fr    Principal Investigator: Boris DUCHEMANN, MD          Institut Bergonié Recruiting Bordeaux, France Contact: François Chomy, MD       f.chomy@bordeaux.unicancer.fr    Principal Investigator: François Chomy, MD          Hôpital Ambroise Paré Recruiting Boulogne Billancourt, France Contact: Etienne GIROUX LEPRIEUR, MD       etienne.giroux-leprieur@aphp.fr    Principal Investigator: Etienne GIROUX LEPRIEUR, MD          Hospices Civils de Lyon- Hôpital Louis Pradel Recruiting Bron, France Contact: Nicolas Girard, MD       nicolas.girard@chu-lyon.fr    Principal Investigator: Nicolas Girard, MD          Centre François Baclesse Recruiting Caen, France Contact: Radj Gervais, MD       r.gervais@baclesse.unicancer.fr    Principal Investigator: Radj Gervais, MD          CHU Caen Recruiting Caen, France Contact: Gérard Zalcman, MD       zalcman-g@chu-caen.fr    Principal Investigator: Gérard Zalcman, MD          Chu de Caen - Hopital Cote de Nacre Recruiting Caen, France Contact: Jeannick MADELAINE, MD       madelaine-j@chu-caen.fr    Principal Investigator: Jeannick MADELAINE, MD          Hôpital Louis Pasteur Recruiting Chartres, France Contact: Claire Lethrosne, MD       clethrosne@ch-chartres.fr    Principal Investigator: Claire Lethrosne, MD          centre Jean Perrin Recruiting Clermont-Ferrand, France Contact: Xavier Durando, MD       xavier.durando@cjp.fr    Principal Investigator: Xavier Durando, MD          CHU Clermont Ferrand - Hôpital Gabriel Montpied Recruiting Clermont-Ferrand, France Contact: Henri Janicot, MD       hjanicot@chu-clermontferrand.fr    Principal Investigator: Henri Janicot, MD          Hopitaux Civils de Colmar Recruiting Colmar, France Contact: Lionel MOREAU, MD       lionel.moreau@ch-colmar.fr    Principal Investigator: Lionel MOREAU, MD          Centre Hopsitalier Intercommunal de Créteil Recruiting Créteil, France Contact: Isabelle Monnet, MD       isabelle.monnet@chicreteil.fr    Principal Investigator: Isabelle Monnet, MD          Centre Georges François Leclerc Recruiting Dijon, France Contact: Bruno Coudert, MD       bcoudert@cgfl.fr    Principal Investigator: Bruno Coudert, MD          CHU Grenoble Recruiting Grenoble, France Contact: Denis Moro-Sibilot, MD       Dmoro-Sibilot@chu-grenoble.fr    Principal Investigator: Denis Moro-Sibilot, MD          Chd Vendee Recruiting La Roche Sur Yon, France Contact: Tifenn L'HARIDON, MD          Principal Investigator: Tifenn L'HARIDON, MD          CH du Mans Recruiting Le Mans, France Contact: Olivier Molinier, MD       omolinier@ch-lemans.fr    Principal Investigator: Olivier Molinier, MD          Centre Oscar Lambret Recruiting Lille, France Contact: Eric Dansin, MD       e-dansin@o-lambret.fr    Principal Investigator: Eric Dansin, MD          CHRU de Lille Recruiting Lille, France Contact: Alexis Cortot, MD       Alexis.CORTOT@CHRU-LILLE.FR    Principal Investigator: Alexis Cortot, MD          Centre Léon Bérard Recruiting Lyon, France Contact: Maurice Pérol, MD       maurice.perol@lyon.unicancer.fr    Principal Investigator: Maurice Pérol, MD          Hôpital Nord Recruiting Marseille, France Contact: Fabrice Barlesi, MD       fabrice.barlesi@ap-hm.fr    Principal Investigator: Fabrice Barlési, MD          Institut Paoli Calmettes Recruiting Marseille, France Contact: Anne MADROSZYK, MD       madroszyka@ipc.unicancer.fr    Principal Investigator: Anne MADROSZYK, MD          Institut de cancérologie de l'Ouest Recruiting Nantes, France Contact: Jaafar Bennouna, MD       jaafar.bennouna@ico.unicancer.fr    Principal Investigator: Jaafar Bennouna, MD          Centre Antoine Lacassagne Recruiting Nice, France Contact: Josiane OTTO, MD       josiane.otto@nice.unicancer.fr    Principal Investigator: Josiane OTTO, MD          Chr Orleans Recruiting Orleans, France Contact: Hugues MOREL, MD       hugues.morel@chr-orleans.fr    Contact: , MD          Principal Investigator: Hugues MOREL          AH-HP Hôpital Saint Louis Recruiting Paris, France Contact: Damien Pouessel, MD       damien.pouessel@sls.aphp.fr    Principal Investigator: Damien Pouessel, MD          AP-HP Hôpital Cochin Recruiting Paris, France Contact: Jeanne Chapron, MD       jeanne.chapron@cch.aphp.fr    Principal Investigator: Jeanne Chapron, MD          AP-HP Hôpital Européen Georges Pompidou Withdrawn Paris, France AP-HP Hôpital Tenon Recruiting Paris, France Contact: Marie Wislez, MD       marie.wislez@tnn.aphp.fr    Principal Investigator: Marie Wislez, MD          Institut Curie Recruiting Paris, France Contact: Catherine Daniel, MD       catherine.daniel@curie.fr    Principal Investigator: Catherine Daniel, MD          Centre Hospitalier de Pau Recruiting PAU, France Contact: Aldo RENAULT, MD       aldo.renault@ch-pau.fr    Principal Investigator: Aldo RENAULT, MD          Centre Hospitalier Lyon Sud Recruiting Pierre Bénite, France Contact: Jean-Pierre Souquet, MD       pierre-jean.souquet@chu-lyon.fr    Principal Investigator: Jean-Pierre Souquet, MD          CHR Pontchailloux Withdrawn Rennes, France Chru Strasbourg - Nouvel Hopital Civil Recruiting Strasbourg, France Contact: Philippe BARTHELEMY, MD          Principal Investigator: Philippe BARTHELEMY, MD          CHI de Toulon - Hôpital Sainte-Musse Recruiting Toulon, France Contact: Xavier TCHIKNAVORIAN, MD          Principal Investigator: Xavier TCHIKNAVORIAN, MD          CHU Toulouse -Hôpital Larrey Recruiting Toulouse, France Contact: Julien Mazières, MD       mazieres.j@chu-toulouse.fr    Principal Investigator: Julien Mazières, MD          Hôpital Bretonneau Recruiting Tours, France Contact: Eric Pichon, MD       e.pichon@chu-tours.fr    Principal Investigator: Eric Pichon, MD          Gustave Roussy Recruiting Villejuif, France Contact: Benjamin Besse, MD       Benjamin.BESSE@gustaveroussy.fr    Principal Investigator: Benjamin Besse, MD          Sub-Investigator: Jean-Charles Soria, MD Less <<
NCT02259582 Nonsquamous Nonsmall Cell Neop... More >>lasm of Lung Less << Phase 2 Completed - -
NCT03069313 - Completed - -
NCT02185690 Lungcancer Phase 1 Recruiting April 2019 Canada, Alberta ... More >> Cross Cancer Institute Recruiting Edmonton, Alberta, Canada, T6G1Z2 Contact: Quincy Chu, MD    780-432-8248    quincy.chu@albertahealthservices.ca    Sub-Investigator: Quincy Chu, MD          Canada, Ontario Juravinski Cancer Centre Recruiting Hamilton, Ontario, Canada, L8V 5C2 Contact: Peter Ellis, MD    905-387-9711 ext 64609    Peter.Ellis@jcc.hhsc.ca    Sub-Investigator: Peter Ellis, MD          The Ottawa Hospital Regional Cancer Centre Recruiting Ottawa, Ontario, Canada, K1G 3Y9 Contact: Scott Laurie, MD    613-737-7700 ext 70175    slaurie@ottawahospital.on.ca    Sub-Investigator: Scott Laurie, MD          Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G2M9 Contact: Natasha Leighl, MD    416-946-4645    Natasha.Leighl@uhn.ca    Contact: Maggie Sawczak, CRA    416-946-4501 ext 5444    Maggie.Sawczak@uhn.ca    Principal Investigator: Natasha Leighl, MD Less <<
NCT02284490 Brain Metastases Phase 2 Unknown November 2017 China, Shandong ... More >> Neurosurgery, Shandong Cancer Hospital and Institute Jinan, Shandong, China, 250117 Less <<
NCT03069313 Relief of Joint Pain Not Applicable Completed - -
NCT02337530 Non-Small Cell Lung Cancer Phase 2 Active, not recruiting December 31, 2018 Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Abbotsford Centre Abbotsford, British Columbia, Canada, V2S 0C2 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, New Brunswick Regional Health Authority B, Zone 2 Saint John, New Brunswick, Canada, E2L 4L2 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston Kingston, Ontario, Canada, K7L 5P9 Lakeridge Health Oshawa Oshawa, Ontario, Canada, L1G 2B9 Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 Mount Sinai Hospital Toronto, Ontario, Canada, M5G 1X5 University Health Network Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 Less <<
NCT02274038 Non-small Cell Lung Cancer ... More >> Starting Pemetrexed Based Therapy Unresectable Cancer Less << Not Applicable Active, not recruiting November 2020 United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02397239 - Recruiting - Taiwan ... More >> National Cheng Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Szu-Chun Yang, M.D.    +886 972402279    yangszuchun@gmail.com Less <<
NCT01877967 Alteration of Cognitive Functi... More >>on Disturbance in Affect (Finding) Less << Not Applicable Unknown July 2015 Ireland ... More >> Institute of Neuroscience, Trinity College, Dublin Dublin, Co. Dublin, Ireland, 0000 Less <<
NCT02407366 Non-small Cell Lung Cancer Phase 2 Unknown December 2017 China, Guangxi ... More >> The people's Hospital of the Guangxi Zhuang Autonomous Region Recruiting Nanning, Guangxi, China, 530021 Contact: GuoSheng Feng, professor    +86-771-218-6508    fengguosheng88988@163.com Less <<
NCT02436733 Malignant Pleural Mesothelioma Phase 2 Recruiting April 2020 Belgium ... More >> UZ Antwerpen Recruiting Antwerpen, Belgium Contact: Jan Van Meerbeeck, Prof          UZ Gent Recruiting Gent, Belgium Contact: Veerle Surmont, Prof          France Assistance Publique - Hopitaux de Marseille - Hopital Nord Recruiting Marseille, France Contact: Pascal-Alexandre Thomas, Prof          Netherlands The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis Recruiting Amsterdam, Netherlands Contact: Paul Baas, Prof          Erasmus MC Hospital Recruiting Rotterdam, Netherlands Contact: Joachim Aerts, Prof Less <<
NCT02259582 - Completed - -
NCT02397928 Malignant Pleural Mesothelioma Phase 2 Completed - Belgium ... More >> Antwerp University Hospital, Thoracic Oncology Antwerp, Belgium France Goustave Roussy - Cancer Campus Grand Paris Villejuif, France Germany Universitätsklinikum Halle (Saale) Halle, Germany Italy A.S.O. "SS Antonio e Biagio e Cesare Arrigo" Alessandria, Italy Cliniche Humanitas Gavazzeni Bergamo, Italy Ospedale Villa Scassi Genoa, Italy Ospedaliera di Perugia Perugia, Italy Ospedaliero Universitaria Pisana Pisa, Italy Netherlands Erasmus Mc Rotterdam, Netherlands Poland Medical University Gdansk Gdansk, Poland Katedra i Klinika Onkologii Uniwersytetu Medycznegi im. Karola Marcinkowskiego w Poznaniu Poznań, Poland Klinika Nowotworów Pluca I Klatki Piersiowej Warsaw, Poland Spain Vall d' Hebron Institute of Oncology (VHIO) Hospital Vall d'Hebron Barcelona, Spain Less <<
NCT01139775 Non Small Cell Lung Cancer Phase 1 Phase 2 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mannheim, Baden-Wurttemberg, Germany, 68167 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munster, Nordhein-Westfalen, Germany, 48149 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Coswig, Sachsen, Germany, 01640 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 14165 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany, 60596 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, 30625 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelberg, Germany, 69126 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Homburg, Germany, 66421 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Immenhausen, Germany, 34376 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lübeck, Germany, 23538 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, D-55131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rheine, Germany, 48431 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ulm, Germany, 89081 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oviedo, Asturias, Spain, 33006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mataro, Barcelona, Spain, 08304 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pozuelo de Alarcon, Madrid, Spain, 28223 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08908 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Girona, Spain, 17007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28046 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28050 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sevilla, Spain, 41013 Less <<
NCT02347917 Malignant Pleural Mesothelioma... More >> Non-Small Cell Lung Cancer Less << Phase 1 Phase 2 Completed - Japan ... More >> National Cancer Center Hospital East Chiba, Japan National Cancer Center Hospital Tokyo, Japan Less <<
NCT02497053 Malignant Pleural Mesothelioma Phase 2 Unknown - Egypt ... More >> Ain Shams University Hospitals Recruiting Cairo, Egypt Contact: Omar Abdel-Rahman, MD    26858397    omar.abdelrhman@med.asu.edu.eg    Contact: Ahmed Nagi, MD       ahmedalynagy@yahoo.com    Principal Investigator: Omar Abdel-Rahman, MD          Sub-Investigator: Ahmed Nagi, MD Less <<
NCT01139775 - Completed - -
NCT02498860 Adenocarcinoma ... More >> Lung Neoplasm Less << Phase 2 Unknown December 2018 Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Recruiting Hwasun, Jeonnam, Korea, Republic of, 519-763 Contact: Young-Chul Kim, MD, PhD    82-61-379-7614    kyc0923@jnu.ac.kr    Contact: In-Jae Oh, MD, PhD    82-61-379-7617    droij@jnu.ac.kr    Sub-Investigator: Cheol-Kyu Park, MD          Kyungpook National University Medical Center Recruiting Daegu, Kyungpook, Korea, Republic of Contact: Seung Soo Yoo, MD, PhD    82-10-9133-0641    007md@hanmail.net    Principal Investigator: Seung Soo Yoo, MD, PhD          Chungnam National University Hospital Recruiting Daejeon, Korea, Republic of Contact: Jeong Eun Lee, MD, PhD    82-42-280-7035    vov-x@hanmail.net    Contact: Chaeuk Chung, MD, PhD    82-42-280-7247    universe7903@gmail.com    Pusan National University Hospital Recruiting Pusan, Korea, Republic of, 602-739 Contact: Min-Ki Lee, MD, PhD       leemk@pusan.ac.kr    Principal Investigator: Min-Ki Lee, MD, PhD          Kosin University Gospel Hospital Recruiting Pusan, Korea, Republic of Contact: Taewon Jang, MD, PhD       jangtw@ns.kosinmed.or.kr    Principal Investigator: Tae-Won Jang, MD, PhD          Sub-Investigator: Maan-Hong Jung, MD, PhD          Sub-Investigator: Chulho Oak, MD, PhD          Korea university Guro hospital Recruiting Seoul, Korea, Republic of Contact: Sung Yong Lee       syl0801@korea.ac.kr    Severance hospital Recruiting Seoul, Korea, Republic of Contact: Eun Young Kim, MD, PhD    82-2-2228-2267    NARAE97@yuhs.ac Less <<
NCT02488694 Non-small-cell Lung Cancer Wit... More >>h Somatic EGFR Mutations Less << Phase 2 Terminated(unsufficient recrui... More >>tment) Less << - Germany ... More >> Universitätsklinikum Essen Essen, Germany Less <<
NCT00266292 Cardiovascular Heart Disease ... More >> Metabolic Syndrome Less << Not Applicable Unknown - Denmark ... More >> Department of Human Nutrition Frederiksberg, Denmark, DK-1958 Less <<
NCT02531854 Carcinoma, Non-Small-Cell Lung Phase 2 Not yet recruiting - -
NCT02595840 - - - -
NCT03408639 Anemia in End-Stage Renal Dise... More >>ase Less << Phase 3 Completed - -
NCT02607592 Carcinoma，Non-Small-Cell Lung Phase 3 Recruiting August 2020 China, Guangdong ... More >> Sun Yat-sen University of cancer center Recruiting Guangzhou, Guangdong, China, 510000 Contact: li-kun chen, doctor    13798019964 Less <<
NCT02631460 NSCLC Phase 2 Recruiting December 2019 China, Guangdong ... More >> Sun yat-sen University Cancer Center Recruiting Guang Zhou, Guangdong, China, 510060 Contact: Yan Huang, MD       huangyan@sysucc.org.cn    Principal Investigator: Yan Huang, MD Less <<
NCT02603003 Non-small Cell Lung Cancer(NSC... More >>LC) Less << Phase 1 Active, not recruiting December 2019 -
NCT02669719 Non Small Cell Lung Cancer Phase 2 Recruiting January 2019 China, Shanghai ... More >> Shanghai Chest Hospital Recruiting Shanghai, Shanghai, China, 200030 Contact: Baohui Han, MD    86-21-62821990 ext 61201    xkyyhan@gmail.com    Principal Investigator: Baohui Han, MD Less <<
NCT02639767 Malignant Pleural Mesothelioma Phase 1 Withdrawn(Lack of accrual) - United States, New Jersey ... More >> Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center at Phelps Sleepy Hollow, New York, United States, 10591 Memorial Sloan Kettering West Harrison West Harrison, New York, United States, 10604 Less <<
NCT02737774 Lung Adenocarcinoma Phase 2 Unknown April 2017 -
NCT02838745 Mesothelioma Phase 1 Recruiting August 2018 United States, Texas ... More >> Baylor St Lukes Recruiting Houston, Texas, United States, 77030 Contact: Michelle G Almarez, BBA    713-798-3680    Michelle.Almarez@bcm.edu    Contact: Bryan Burt, MD    713-798-8266    Bryan.Burt@bcm.edu    Principal Investigator: Bryan Burt, MD Less <<
NCT02868892 Adenocarcinoma of the Cervix ... More >> Adenosquamous Cell Carcinoma of the Cervix Less << Phase 2 Terminated(departure of PI fro... More >>m institution and poor population for study participation) Less << - United States, Arizona ... More >> Western Regional Medical Center, Inc. Goodyear, Arizona, United States, 85338 Less <<
NCT02937116 Cancer, Solid Tumor Phase 1 Unknown December 2018 -
NCT02784171 Mesothelioma Phase 2 Recruiting December 2019 Canada, Alberta ... More >> Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Desiree Hao    403 521-3706       Cross Cancer Institute Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Contact: Quincy Chu    780 432-8248       Canada, British Columbia BCCA - Cancer Centre for the Southern Interior Recruiting Kelowna, British Columbia, Canada, V1Y 5L3 Contact: Delia Sauciuc    250 712-3900 ext 683930       BCCA - Fraser Valley Cancer Centre Recruiting Surrey, British Columbia, Canada, V3V 1Z2 Contact: Christopher Lee    604 930-4017       Canada, Manitoba CancerCare Manitoba Recruiting Winnipeg, Manitoba, Canada, R3E 0V9 Contact: David Dawe    204 787-8644       Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Recruiting Hamilton, Ontario, Canada, L8V 5C2 Contact: John Goffin    905 387-9495       London Regional Cancer Program Recruiting London, Ontario, Canada, N6A 5W9 Contact: Mark D. Vincent    519 685-8640       Ottawa Hospital Research Institute Recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: Paul Wheatley-Price    613 737-7700 ext 79859       University Health Network Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Penelope A. Bradbury    416 946-4501 ext 3544       Canada, Quebec CHUM-Centre Hospitalier de l'Universite de Montreal Recruiting Montreal, Quebec, Canada, H2X 3E4 Contact: Marie Florescu    514 890-8444       The Research Institute of the McGill University Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Scott Owen    514 398-8307       University Institute of Cardiology and Recruiting Quebec City, Quebec, Canada, G1V 4G5 Contact: Catherine Labbe    418 656-8711 ext 5504       Canada, Saskatchewan Allan Blair Cancer Centre Recruiting Regina, Saskatchewan, Canada, S4T 7T1 Contact: Mussawar Iqbal    306 766-2691       Italy Oncologia SS Antonio e Biagio Alessandria Recruiting Alessandria, AL, Italy, 15121 Contact: Federica Grosso          Azienda Ospedaliera San Giuseppe Moscati Recruiting Avellino, AV, Italy, 83100 Contact: Gridelli Cesare          Oncologia Medica Humanitas Gavazzeni Bergamo Not yet recruiting Bergamo, BG, Italy, 24125 Contact: Giovanni Luca Ceresoli          Azienda Ospedaliera Garibaldi Nesima Recruiting Catania, CT, Italy, 95123 Contact: Roberto Bordonaro          Oncologia Medica IRCCS Arcispedale Maria Recruiting Reggio Emilia, RE, Italy, 42123 Contact: Maria Pagano          Istituti Fisioterapici Ospitalieri IFO Istituto Recruiting Rome, RM, Italy, 00144 Contact: Fabiana Letizia Cecere          PO A Perrino ASL Brindisi - UOC Oncologia Medica Recruiting Brindisi, Italy, 72100 Contact: Saverio Cinieri          AOU Policlinico Vittorio Emanuele UOC di Oncologia Recruiting Catania, Italy, 95125 Contact: Hector Jose Soto Parra    2 8224-4459       U.O. di Oncologia Ospedale Villa Scassi Recruiting Genova, Italy, 16149 Contact: Manlio Mencoboni    010 410-2639       Intstituto Scientifico Romangnolo Recruiting Meldola, Italy, 47014 Contact: Marco Angelo Burgio    054 373-9100       Instituto Nazionale Tumori Recruiting Milan, Italy Contact: Maria Chiara Garassino          U.O.C. di Oncologia U.L.S.S. 13 Recruiting Mirano, Italy, 30035 Contact: Francesco Rosetti    3904 1579-4002       Azienda Ospedaliera di Rilievo Nazionale Not yet recruiting Napoli, Italy, 80131 Contact: Giacomo Carteni          Dott. Fortunato Ciardiello,Cattedra Oncologia Medica Recruiting Napoli, Italy, 80131 Contact: Fortunato Ciardiello    081 566-6745       Unita Sperimentazioni Cliniche Istituto per lo Recruiting Napoli, Italy, 80131 Contact: Alessandro Morabito    081 590-3571       Azienda USL di Piacenza, Ospedale Gugliemimo Salieto Recruiting Piacenza, Italy, 29100 Contact: Luigi Cavanna    052 330-2697 Less <<
NCT02951897 Lung Adenocarcinoma, Stage I ... More >> Diagnoses Diseases Circulating Tumor Cells Treatment Less << Not Applicable Recruiting December 2019 China ... More >> Daping hospital Recruiting Chongqing, China Contact: Bo Deng    +86-13637782166    deng.bo@dphospital.tmmu.edu.cn Less <<
NCT02725918 Non-small Cell Lung Cancer Phase 2 Recruiting June 2020 China, Guangdong ... More >> Guangdong Lung cancer institute Recruiting Guangzhou, Guangdong, China, 510080 Contact: Qing Zhou, MD    86 13544561166    gzzhouqing@126.com Less <<
NCT02964689 Advanced Non-small Cell Lung C... More >>ancer KRAS Gene Mutation Lung Cancer Less << Phase 1 Recruiting September 2020 Switzerland ... More >> Universitaetsspital Basel Recruiting Basel, Switzerland, 4031 Contact: Sacha Rothschild, MD    +41 (0)61 265 25 25    sacha.rothschild@usb.ch    Principal Investigator: Sacha Rothschild, MD          IOSI Ospedale Regionale di Bellinzona e Valli Recruiting Bellinzona, Switzerland, 6500 Contact: Patrizia Froesch, MD    +41 (0)91 811 48 40    patrizia.froesch@eoc.ch    Principal Investigator: Patrizia Froesch, MD          Kantonsspital Graubuenden Recruiting Chur, Switzerland, CH-7000 Contact: Michael Mark, MD    +41 (0)81 256 61 11    michael.mark@ksgr.ch    Principal Investigator: Michael Mark, MD          Kantonsspital St. Gallen Recruiting St. Gallen, Switzerland, 9007 Contact: Martin Früh, MD    +41 (0)71 494 11 11    martin.frueh@kssg.ch    Principal Investigator: Martin Früh, MD Less <<
NCT02974933 Nonsmall Cell Lung Cancer Phase 2 Recruiting November 2018 China, Hubei ... More >> Ou wuling Recruiting Wuhan, Hubei, China, 430079 Contact: Ou Wu ling, 40    13469989766 ext 86    609700817@qq.com Less <<
NCT02964013 Neoplasms Phase 1 Recruiting December 1, 2020 United States, Arizona ... More >> Call for Information (Investigational Site 0013) Recruiting Gilbert, Arizona, United States, 85234 United States, California Call for Information (Investigational Site 0012) Recruiting Duarte, California, United States, 91010 United States, Colorado Call for Information (Investigational Site 0006) Recruiting Aurora, Colorado, United States, 80045 United States, Connecticut Call for Information (Investigational Site 0003) Recruiting New Haven, Connecticut, United States, 06511 United States, Michigan Call for Information (Investigational Site 0009) Recruiting Detroit, Michigan, United States, 48201 United States, New Jersey Call for Information (Investigational Site 0005) Recruiting Hackensack, New Jersey, United States, 07601 United States, North Carolina Call for Information (Investigational Site 0011) Recruiting Charlotte, North Carolina, United States, 28204 United States, Pennsylvania Call for Information (Investigational Site 0010) Recruiting Pittsburgh, Pennsylvania, United States, 15232 United States, Tennessee Call for Information (Investigational Site 0004) Recruiting Nashville, Tennessee, United States, 37203 United States, Texas Call for Information (Investigational Site 0001) Recruiting San Antonio, Texas, United States, 78229 Australia Merck Sharp & Dohme Recruiting North Ryde, Australia Contact: Australian Medical Information Centre    61 2 8988 8428       Israel Merck Sharp & Dohme Co. Ltd. Recruiting Hod Hasharon, Israel Contact: Dan Goldstaub    972-9-9533326       Korea, Republic of MSD Korea LTD Recruiting Seoul, Korea, Republic of, 4130 Contact: TaeYoun Jo    8223312313 Less <<
NCT03023319 Carcinoma, Non-Small-Cell Lung... More >> Mesothelioma Bladder Cancer Ovarian Cancer Peritoneal Cancer Thymoma Thymus Cancer Uterine Cervical Cancer Less << Phase 1 Recruiting July 2020 United States, Ohio ... More >> UC Health Recruiting Cincinnati, Ohio, United States, 45219 Contact: UCCI Clinical Trials Office    513-584-7698    kastla@ucmail.uc.edu Less <<
NCT01947140 Lymphoid Malignancies ... More >> Multiple Myeloma Lymphoma Hodgkin Lymphoma Non-hodgkin Lymphoma Less << Phase 1 Phase 2 Recruiting December 2018 United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10019 Contact: Renee Lichtenstein    212-326-5720    rl2619@cumc.columbia.edu    Principal Investigator: Jennifer E Amengual, MD Less <<
NCT03050437 Carcinoma, Non-Small-Cell Lung Phase 2 Recruiting March 2017 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Myung-Ju Ahn, Ph.D.    822-3410-1795    silkahn@skku.edu Less <<
NCT03164694 Lung Cancer Phase 2 Recruiting May 20, 2020 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Si-Yu Wang, Doctor    +86 20 87343439    wsysums@163.net Less <<
NCT03134872 Lung Neoplasms ... More >> Carcinoma, Non-Small-Cell Lung Respiratory Tract Neoplasms Thoracic Neoplasms Lung Diseases Respiratory Tract Disease Neoplasms by Site Neoplasm, Bronchial Carcinoma, Bronchogenic Less << Phase 3 Recruiting December 31, 2019 China, Shanghai ... More >> Tongji University, Shanghai Pulmonary Hospital Recruiting Shanghai, Shanghai, China, 200433 Contact: Caicun Zhou, MD,PhD    86-021-65115006 ext 3050    caicunzhoudr@126.com Less <<
NCT02980991 Lung Adenocarcinoma Phase 2 Unknown April 2018 China ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, China, 200032 Contact: Haiquan Chen, MD    +86-21 64175590 ext 1707    hqchen1@yahoo.com    Contact: Xinghua Cheng, MD,PhD    +8618017317567    chengxinghua_001@163.com    Principal Investigator: Haiquan Chen, MD Less <<
NCT03242915 Non-small Cell Lung Cancer Phase 2 Recruiting August 2022 United States, Illinois ... More >> Rush Universtiy Medical Center Recruiting Chicago, Illinois, United States, 60612 Contact: Mary Jo Fidler, MD          Principal Investigator: Mary Jo Fidler, MD          United States, Michigan The University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Shirish M Gadgeel, M.D.    734-647-6883    sgadgeel@med.umich.edu    Principal Investigator: Shirish M Gadgeel, M.D.          Barbara Ann Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Misako Nagaska, MD          Principal Investigator: Misako Nagaska, MD          United States, New York Montefiore Cancer Center Recruiting Bronx, New York, United States, 10467 Contact: Balazs Halmos, MD          Principal Investigator: Balazs Halmos, MD          United States, Tennessee Sarah Cannon Recruiting Nashville, Tennessee, United States, 37203 Contact: Melissa Johnson, MD          Principal Investigator: Melissa Johnson, MD Less <<
NCT03190239 Advanced Non-squamous Non-smal... More >>l-cell Lung Cancer Less << Phase 2 Not yet recruiting December 30, 2019 China ... More >> Xinqiao Hospital of Chongqing Chongqing, China, 400000 Less <<
NCT03201146 Lung Cancer N... More >>on Small Cell Lung Cancer Combination Chemotherapy Apatinib Less << Phase 1 Phase 2 Recruiting August 1, 2020 China, Sichuan ... More >> West China Hospital, Sichuan University Recruiting Chengdu, Sichuan, China, 610041 Contact: You Lu, MD    86-028-85422114    radyoulu@hotmail.com    Contact: Meijuan Huang, MD    86-028-85422114    hmj107@163.com Less <<
NCT03319537 Mesothelioma Phase 1 Phase 2 Recruiting October 2020 United States, New Jersey ... More >> Memorial Sloan Kettering at Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Majorie Zauderer, MD    646-888-4656       Memoral Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Marjorie Zauderer, MD    646-888-4656       Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Marjorie Zauderer, MD    646-888-4656       United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Marjorie Zauderer, MD    646-888-4656       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Majorie Zauderer, MD    646-888-4656       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Marjorie Zauderer, MD    646-888-4656       Contact: Andrea Cercek, MD    646-888-4189       Principal Investigator: Marjorie Zauderer, MD          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Marjorie Zauderer, MD    646-888-4656 Less <<
NCT03298763 Adenocarcinoma of Lung Phase 1 Phase 2 Not yet recruiting March 1, 2024 United Kingdom ... More >> University College London Hospital Not yet recruiting London, United Kingdom Less <<
NCT03366064 Non-small Cell Lung Cancer Phase 1 Recruiting October 2020 Korea, Republic of ... More >> Asan Medical Center - University of Ulsan College of Medicine Recruiting Seoul, Korea, Republic of, 138-736 Contact: Kyoo H. Lee, MD    82-2-2224-3210    khlee2@amc.seoul.kr Less <<
NCT02868892 - Terminated(departure of PI fro... More >>m institution and poor population for study participation) Less << - -
NCT03376737 Lung Adenocarcinoma Phase 2 Recruiting June 2019 China, Henan ... More >> Henan Cancer Hospital Recruiting Zhengzhou, Henan, China, 450008 Contact: Guowei Zhang       dugu4986@126.com Less <<
NCT03380468 Lung Neoplasms Phase 2 Phase 3 Recruiting December 31, 2025 China, Shanghai ... More >> Fudan University Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Chen Haiquan, MD    +86-21 64175590 ext 1707    hqchen1@yahoo.com Less <<
NCT03489616 Carcinoma, Non-Small-Cell Lung Not Applicable Recruiting December 31, 2019 China, Shandong ... More >> Shandong Cancer Hospital and Institute Recruiting Jinan, Shandong, China, 250000 Contact: MINGHUAN LI, Doctor    13153035389 ext 0531-67626112    Sy_lmh2001@163.com    Contact: JIMING YU, Doctor    13806406293 ext 0531-87984729    jn7984729@public.jn.sd.cn    SHANDONG Cancer Hospital Recruiting Jinan, Shandong, China, 250000 Less <<
NCT03472053 Non Small Cell Lung Cancer Sta... More >>ge IIIB Less << Phase 2 Active, not recruiting June 30, 2019 India ... More >> Vardhman Mahavir Medical College & Hospital New Delhi, Delhi, India, 110029 Unique Hospital and Research Institute Surat, Gujarat, India, 395002 Aadhar Health Institute Hisar, Hariyana, India, 125005 HCG Manavata Cancer Center Nashik, Maharashtra, India, 422004 Deenanath Mangeshkar Hospital & Research Center Pune, Maharashtra, India, 411004 Tata Memorial Hospital Mumbai, Maharastra, India, 400012 Navsanjeevani Hospital Nashik, Maharastra, India, 422002 Chirayu Cancer Hospital Bhopal, MP, India, 462030 Sparsh Hospitals and Critical Care Bhubaneswar, Odisa, India, 751007 SMS Medical College & Hospital Jaipur, Rajasthan, India, 302016 Nehru Hospital & Post Graduate Institute of Medical Education Chandigarh, India, 160012 Less <<
NCT03351842 Chemotherapy, Adjuvant ... More >> Lung Adenocarcinoma, Stage I Treatment Histological Type of Neoplasm Less << Phase 2 Recruiting September 1, 2024 China ... More >> Thoracic Surgery Department of Shanghai Pulmonary Hospital Recruiting Shanghai, China, 200000 Contact: Yingran Shen    86-18117166317    elaineshen91@gmail.com Less <<
NCT03515837 Non-small Cell Lung Cancer Phase 3 Recruiting June 15, 2023 -
NCT03562871 NSCLC Phase 1 Phase 2 Recruiting February 2022 Spain ... More >> Servicio de Oncología-El médico del Virgen de la Victoria Recruiting Málaga, Andalusia, Spain, 29010 Contact: José M Trigo Pérez, Dr          Insituto Oncologico Dr Rosell. Hospital Universitario Quiron Dexeus Not yet recruiting Barcelona, Catalonia, Spain, 08028 Contact: Santiago Viteri, Prof          Hospital Universitario de Vall d'Hebron Recruiting Barcelona, Catalonia, Spain, 08035 Contact: Enriqueta Felip, Dr          Hospital Universitari de Girona Doctor Josep Trueta Recruiting Girona, Catalonia, Spain, 17007 Contact: Joaquim Bosch, Dr          Hospital Universitario 12 Octubre Recruiting Madrid, Community Of Madrid, Spain, 28041 Contact: Luis Paz-Ares, Dr          Centro Integral Oncologico Clara Campal, Hospital Universitario HM Sanchinarro Not yet recruiting Madrid, Community Of Madrid, Spain, 28050 Hospital Universitario Ramón y Cajal Not yet recruiting Madrid, Community Of Madrid, Spain, 28134 Contact: Pilar Garrido, Dr          Hospital Puerta del Hierro Majadahonda Recruiting Madrid, Community Of Madrid, Spain Contact: Mariano Provencio, Dr          Hospital Clinico Universitario de València Not yet recruiting València, Horta De València, Spain, 46010 Contact: Amelia Insa, Dr          Hospital Universitario La Paz Recruiting Madrid, Spain, 28050 Contact: Javier de Castro Carpeno, DR    +34917277000    javier.decastro@salud.madrid.org Less <<
NCT03623776 Efficacy and Safety Phase 2 Active, not recruiting July 1, 2023 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT03513666 NSCLC Phase 2 Recruiting June 2019 China, Shanghai ... More >> Shanghai Pulmonary Hospita Recruiting Shanghai, Shanghai, China Contact: Caicun Zhou Less <<
NCT03607539 Lung Neoplasms Phase 3 Not yet recruiting September 2020 -
NCT03664024 Non-Small Cell Lung Cancer Phase 2 Recruiting March 4, 2022 United States, Maryland ... More >> Harry & Jeanette Weinberg Cancer Institute ( Site 0901) Recruiting Baltimore, Maryland, United States, 21237 Contact: Study Coordinator    443-777-7364       Canada, Quebec CISSS de la Monteregie-Centre ( Site 0801) Recruiting Greenfield Park, Quebec, Canada, J4V 2H1 Contact: Study Coordinator    45046650003226       Hungary Orszagos Koranyi TBC es Pulmonologiai Intezet ( Site 0400) Recruiting Budapest, Hungary, 1121 Contact: Study Coordinator    +36302005233       Petz Aladar Megyei Oktato Korhaz ( Site 0402) Recruiting Gyor, Hungary, 9024 Contact: Study Coordinator    +3696418244       Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet ( Site 0401) Recruiting Szolnok, Hungary, 5900 Contact: Study Coordinator    +36209323256       Israel Meir Medical Center ( Site 0501) Recruiting Kfar-Saba, Israel, 4428132 Contact: Study Coordinator    +97297472414       Chaim Sheba Medical Center ( Site 0500) Recruiting Ramat Gan, Israel, 5262000 Contact: Study Coordinator    +97235307096       Spain Hospital Universitario Insular de Gran Canaria ( Site 0700) Recruiting Las Palmas de Gran Canaria, Gran Canaria, Spain, 35001 Contact: Study Coordinator    +34928441738       H.U. Vall de Hebron ( Site 0701) Recruiting Barcelona, Spain, 08035 Contact: Study Coordinator    +34932746085       Hospital General Universitario 12 de Octubre ( Site 0703) Recruiting Madrid, Spain, 28041 Contact: Study Coordinator    +34914692313       Hospital Universitario Central de Asturias ( Site 0704) Recruiting Oviedo, Spain, 33011 Contact: Study Coordinator    +34609804227 Less <<
NCT03544814 Lung Adenocarcinoma ... More >> EGFR Activating Mutation Less << Phase 2 Completed - -
NCT03269162 NSCLC Phase 3 Active, not recruiting September 30, 2019 -
NCT03663205 Non-Small Cell Lung Cancer Phase 3 Recruiting September 23, 2020 China ... More >> Shanghai Chest Hospital Recruiting Shanghai, China Less <<
NCT03671538 Non-squamous Non-small Cell Lu... More >>ng Cancer Less << Not Applicable Not yet recruiting August 31, 2020 -
NCT03607149 Non-small Cell Lung Cancer Phase 4 Recruiting January 6, 2021 France ... More >> CH William Morey Not yet recruiting Chalon-sur-Saône, France, 71100 Contact: Marie-Fleur QUILLOT       Fleur-marie.quilot@ch-chalon71.fr    Contact: Jerome POIROT       jerome.poirot@ch-chalon71.fr    Centre Georges Francois Leclerc Recruiting Dijon, France, 21079 Contact: Bruno COUDERT    03 80 73 75 28    bcoudert@cgfl.fr    Contact: Emilie REDERSTORFF    03.45.34.81.16    erederstorff@cgfl.fr    Principal Investigator: Bruno COUDERT          Sub-Investigator: Aurélie LAGRANGE          Sub-Investigator: Laure FAVIER          Centre Universitaire Hospitalier de Dijon Not yet recruiting Dijon, France, 21079 Contact: Pascal FOUCHER    03 80 29 37 72    pascal.foucher@chu-dijon.fr Less <<
NCT02535312 Advanced Malignant Solid Neopl... More >>asm Advanced Peritoneal Malignant Mesothelioma Advanced Pleural Malignant Mesothelioma Recurrent Peritoneal Malignant Mesothelioma Recurrent Pleural Malignant Mesothelioma Stage III Non-Small Cell Lung Cancer AJCC v7 Stage III Ovarian Cancer AJCC v6 and v7 Stage III Pleural Malignant Mesothelioma AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIA Ovarian Cancer AJCC v6 and v7 Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Stage IIIB Ovarian Cancer AJCC v6 and v7 Stage IIIC Ovarian Cancer AJCC v6 and v7 Stage IV Non-Small Cell Lung Cancer AJCC v7 Stage IV Ovarian Cancer AJCC v6 and v7 Stage IV Pleural Malignant Mesothelioma AJCC v7 Thymoma Unresectable Solid Neoplasm Less << Phase 1 Phase 2 Recruiting - United States, California ... More >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Site Public Contact    800-826-4673    becomingapatient@coh.org    Principal Investigator: Marianna Koczywas          Los Angeles County-USC Medical Center Recruiting Los Angeles, California, United States, 90033 Contact: Site Public Contact    323-865-0451       Principal Investigator: Anthony El-Khoueiry          USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Site Public Contact    323-865-0451       Principal Investigator: Anthony El-Khoueiry          Keck Medical Center of USC Pasadena Recruiting Pasadena, California, United States, 91105 Contact: Site Public Contact    323-865-0451       Principal Investigator: Anthony El-Khoueiry          University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Site Public Contact    916-734-3089       Principal Investigator: Karen L. Kelly          United States, Colorado University of Colorado Hospital Recruiting Aurora, Colorado, United States, 80045 Contact: Site Public Contact    720-848-0650       Principal Investigator: Stephen Leong          United States, Maryland University of Maryland/Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Site Public Contact    800-888-8823       Principal Investigator: Edward A. Sausville          United States, Michigan University of Michigan Comprehensive Cancer Center Suspended Ann Arbor, Michigan, United States, 48109 United States, Minnesota Mayo Clinic Active, not recruiting Rochester, Minnesota, United States, 55905 United States, Ohio Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Site Public Contact    800-293-5066    Jamesline@osumc.edu    Principal Investigator: Gregory A. Otterson          United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Site Public Contact    412-647-8073       Principal Investigator: Liza C. Villaruz          United States, Tennessee Vanderbilt University/Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Site Public Contact    800-811-8480       Principal Investigator: Leora Horn          United States, Wisconsin University of Wisconsin Hospital and Clinics Active, not recruiting Madison, Wisconsin, United States, 53792 Less <<
NCT03700333 Carcinoma, Non-Small-Cell Lung Phase 3 Not yet recruiting October 20, 2019 -
NCT03760575 Mesotheliomas Pleural Phase 1 Not yet recruiting November 2021 United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Evan W Alley    588-216-0098    penncancertrials@emergingmed.com Less <<
NCT02535325 Non-Squamous Non-Small Cell Lu... More >>ng Carcinoma Stage III Large Cell Lung Carcinoma AJCC v7 Stage III Lung Adenocarcinoma AJCC v7 Stage III Non-Small Cell Lung Cancer AJCC v7 Stage IIIA Large Cell Lung Carcinoma AJCC v7 Stage IIIA Lung Adenocarcinoma AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIB Large Cell Lung Carcinoma AJCC v7 Stage IIIB Lung Adenocarcinoma AJCC v7 Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Stage IV Large Cell Lung Carcinoma AJCC v7 Stage IV Lung Adenocarcinoma AJCC v7 Stage IV Non-Small Cell Lung Cancer AJCC v7 Less << Phase 1 Recruiting - United States, Ohio ... More >> Case Western Reserve University Recruiting Cleveland, Ohio, United States, 44106 Contact: Tithi Biswas    800-641-2422       Principal Investigator: Tithi Biswas Less <<
NCT02498106 Psychiatric Hospitalization Not Applicable Recruiting June 2019 Netherlands ... More >> GGZ Centraal Recruiting Ermelo, Gelderland, Netherlands, 3853 LC Contact: Nico Meijwaard, MD    035 655 7555    n.meijwaard@ggzcentraal.nl    GGZ Eindhoven Recruiting Eindhoven, Noord-Braband, Netherlands, 5626 ND Contact: Joost Stolker, Dr.    040 297 0170    Joost.Stolker@dewoenselsepoort.nl    Fivoor Recruiting Den Dolder, Utrecht, Netherlands, 3734 AC Contact: Henk Nijman, Prof. dr.    088-0282220    H.Nijman@altrecht.nl    GGZ Delfland Recruiting Delft, Zuid-Holland, Netherlands Contact: Erik van Duijn, MD    015 260 7607    e.vanDuijn@ggz-delfland.nl    Rivierduinen Recruiting Oegstgeest, Netherlands, 2342 EB Contact: Jan P.A. M. Bogers, MD    (+31)071 890 71 30    j.bogers@ggzleiden.nl    Parnassia Recruiting The Hague, Netherlands, 2512 HN Contact: Constant Mouton, MD    (+31) 088-357 55 75    C.Mouton@parnassiagroep.nl Less <<
NCT02600611 - Completed - -
NCT03706287 Lung Cancer Metastatic Phase 1 Phase 2 Not yet recruiting March 10, 2021 China, Sichuan ... More >> Sichuan Cancer Hospital Not yet recruiting Chengdu, Sichuan, China, 610041 Contact: juan li, doctor    +8613880276636    dr.lijuan@gmail.com    Contact: rui shi, doctor    +8613880898008    shirui729@hotmail.com    Principal Investigator: ping yu, doctor          Principal Investigator: juan li, doctor          China Chengdu fifth people's hospital Not yet recruiting Chengdu, China Contact: mei mei          Principal Investigator: mei mei          People's hospital of deyang city Deyang, China The affiliated hospital of southwest medical university Not yet recruiting Luzhou, China Contact: Sheng Lin          Principal Investigator: Sheng Lin          Nanchong central hospital Not yet recruiting Nanchong, China Contact: xin hu          Principal Investigator: xin hu          Suining central hospital Not yet recruiting Suining, China Contact: qiang zhou          Principal Investigator: qiang zhou Less <<
NCT02600611 Skin Structures and Soft Tissu... More >>e Infections Less << Phase 3 Completed - -
NCT02607618 - Completed - -
NCT03768037 Advanced Non-squamous NSCLC Phase 4 Recruiting November 26, 2020 China, Beijing ... More >> Beijing Chest Hospital Recruiting Beijing, Beijing, China, 101149 Contact: Shucai Zhang    86-010-89509324    sczhang6304@163.com    Contact: Zhe Liu    86-010-89509323    liuzhe1968@aliyun.com Less <<
NCT03355768 Lymphoma, T-Cell, Peripheral Phase 3 Not yet recruiting January 2020 United States, New York ... More >> Center for Lymphoid Malignancies at CUMC Not yet recruiting New York, New York, United States, 10019 Contact: Michelle Malanga, MPA    212-326-5731    mm4629@cumc.columbia.edu Less <<
NCT02426658 Stage IV Non-Small Cell Lung C... More >>ancer Less << Phase 2 Recruiting November 2019 United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Stefan C. Grant    336-713-5172    scgrant@wakehealth.edu    Principal Investigator: Stefan C. Grant Less <<
NCT02607618 Skin Structures and Soft Tissu... More >>e Infections Less << Phase 3 Completed - -
NCT02709512 Mesothelioma Phase 2 Phase 3 Recruiting June 2021 -
NCT00273650 Autistic Disorder Phase 2 Phase 3 Completed - United States, California ... More >> UC Davis MIND Institute Sacramento, California, United States, 95817 Less <<
NCT02788552 Wernicke-Korsakoff Syndrome Phase 4 Recruiting December 2017 Australia, Northern Territory ... More >> Alice Springs Hospital Recruiting Alice Springs, Northern Territory, Australia, 0810 Contact: Kylie Dingwall, PhD    +61 8 89514753    kylie.dingwall@menzies.edu.au    Contact: Jennifer Delima, MBBS    +61 8 89517777    Jennifer.Delima@nt.gov.au    Principal Investigator: Kylie Dingwall, PhD          Sub-Investigator: Jennifer Delima, MBBS          Sub-Investigator: Robert Batey, MBBS          Sub-Investigator: Stephen Bowden, PhD          Sub-Investigator: Jon Currie, MBBS Less <<
NCT03274648 BehçEt Disease Not Applicable Not yet recruiting January 2018 -
NCT01517139 - Completed - China ... More >> Chinese Center for Disease Contron & Prevention Bejing, China Less <<
NCT00786643 - Completed - -
NCT02162537 Non-small Cell Lung Cancer Met... More >>astatic Non-small Cell Lung Cancer Adenocarcinoma of Lung Metastatic to Brain Cerebral Metastases Less << Phase 3 Recruiting January 2019 France ... More >> Centre Hospitalier du Pays d'Aix Recruiting Aix En Provence, France, 13613 Contact: Jacques LE TREUT       jletreut@ch-aix.fr    Principal Investigator: Jacques LE TREUT          Centre Hospitalier Victor Dupouy Recruiting Argenteuil, France, 95100 Contact: Christine RAYNAUD       christine.raynaud@ch-argenteuil.fr    Principal Investigator: Christine RAYNAUD          Centre d'Oncologie et de Radiothérapie du Pays Basque Recruiting Bayonne, France, 64100 Contact: Aurélien BLOUET       aurelien.blouet@oncologie-pays-basque.org    Principal Investigator: Aurélien BLOUET          Centre Hospitalier Recruiting Beauvais, France, 60021 Contact: Jacky CREQUIT       Jacky.crequit@orange.fr    Principal Investigator: Jacky CREQUIT          Hôpital Avicenne Not yet recruiting Bobigny, France, 93000 Contact: Antoine CARPENTIER       antoine.carpentier@avc.aphp.fr    Principal Investigator: Antoine CARPENTIER          HIA de Clermont-Tonnerre Not yet recruiting Brest, France, 22240 Contact: Nicolas PALEIRON       nicolas.paleiron@free.fr    Principal Investigator: Nicolas PALEIRON          CHU Recruiting Brest, France, 29200 Contact: Gilles ROBINET       gilles.robinet@chu-brest.fr    Principal Investigator: Gilles ROBINET          Centre François Baclesse Recruiting Caen, France, 14000 Contact: Radj GERVAIS       r.gervais@baclesse.fr    Principal Investigator: Radj GERVAIS          Centre Hospitalier Recruiting Charleville Meziere, France, 08000 Contact: Stéphane CHOUABE       Schouabe@ch-charleville-mezieres.fr    Principal Investigator: Stéphane CHOUABE          Centre Hospitalier Laennec Recruiting Creil, France, 60109 Contact: Sandrine LOUTSKI-VETTESE       sandrine.loutski@ch-creil.fr.fr    Principal Investigator: Sandrine LOUTSKI-VETTESE          Centre Hospitalier Intercommunal Recruiting Creteil, France, 94010 Contact: Isabelle MONNET       isabelle.monnet@chicreteil.fr    Principal Investigator: Isabelle MONNET          Centre Hospitalier Recruiting Draguignan, France, 83300 Contact: Hervé LE CAER       herve.lecaer@ch-draguignan.fr    Principal Investigator: Hervé LE CAER          Centre Hospitalier Recruiting GAP, France, 05000 Contact: Pascal THOMAS       pascal.thomas@chicas-gap.fr    Principal Investigator: Pascal THOMAS          Centre Hospitalier Robert Boulin Recruiting Libourne, France, 33500 Contact: Samir ABDICHE       samir.abdiche@ch-libourne.fr    Principal Investigator: Samir ABDICHE          Hôpital Le Cluzeau Recruiting Limoges, France, 87042 Contact: Alain VERGNENEGRE       avergne@unilim.fr    Principal Investigator: Alain VERGNENEGRE          Centre Hospitalier Régional Recruiting Longjumeau, France, 91161 Contact: Gérard OLIVIERO       gerard.oliviero@ch-longjumeau.fr    Principal Investigator: Gérard OLIVIERO          Centre Hospitalier de Bretagne Sud Recruiting Lorient, France, 56322 Contact: Régine LAMY       r.lamy@ch-bretagne-sud.fr    Principal Investigator: Régine LAMY          Centre Léon Bérard Recruiting Lyon, France, 69373 Contact: Maurice PEROL       maurice.perol@lyon.unicancer.fr    Principal Investigator: Maurice PEROL          Centre Hospitalier Les Chanaux Recruiting Macon, France, 71000 Contact: Dominique ARPIN       doarpin@ch-macon.fr    Principal Investigator: Dominique ARPIN          Centre Hospitalier F. QUESNAY Recruiting Mantes La Jolie, France, 78200 Contact: Jean-Bernard AULIAC       j-b.auliac@ch-mantes-la-jolie.rss.fr    Principal Investigator: Jean-Bernard AULIAC          Institut Paoli Calmette Recruiting Marseille, France, 13000 Contact: Anne MADROSZYC       madroszyca@marseille.fnclcc.fr    Principal Investigator: Anne MADROSZYC          Hôpital Nord APHM Recruiting Marseille, France, 13915 Contact: Laurent GREILLIER       laurent.greillier@mail.ap-hm.fr    Principal Investigator: Laurent GREILLIER          Centre Hospitalier Recruiting Meaux, France, 77108 Contact: Chrystèle LOCHER       ch-locher@ch-meaux.fr    Principal Investigator: Chrystèle LOCHER          Centre Hospitalier Intercommunal Recruiting Meulan, France, 78250 Contact: Etienne LEROY-TERQUEM       etiennelt@hotmail.fr    Principal Investigator: Etienne LEROY-TERQUEM          Clinique du Pont de Chaume Recruiting Montauban, France, 82000 Contact: Franck THOUVENY       fthouveny@clinique-pontdechaume.fr    Principal Investigator: Franck THOUVENY          Centre Hospitalier Recruiting Perigueux, France, 24019 Contact: Jean-Yves DELHOUME       jy.delhoume@ch-perigeux.fr    Principal Investigator: Jean-Yves DELHOUME          Centre Catalan d'Oncologie Recruiting Perpignan, France, 66000 Contact: Sabine VIEILLOT       sabinevieillot@gmail.com    Principal Investigator: Sabine VIEILLOT          Centre Hospitalier René Dubos Recruiting Pontoise, France, 95303 Contact: Gislaine FRABOULET       gislaine.fraboulet@ch-pontoise.fr    Principal Investigator: Gislaine FRABOULET          Centre Hospitalier de la Région d'Annecy (CHRA) Recruiting Pringy, France, 74374 Contact: Chantal DECROISETTE       cdecroisette@ch-annecy.fr    Principal Investigator: Chantal DECROISETTE          Centre Hospitalier Intercommunal de Cornouaille Recruiting Quimper, France, 29107 Contact: Anne-Marie CHIAPPA       am.chiappa@ch-cornouaille.fr    Principal Investigator: CHIAPPA Anne-Marie          Hôpital Pontchailloux Recruiting Rennes, France, 35033 Contact: Hervé LENA       herve.lena@chu-rennes.fr    Principal Investigator: Hervé LENA          Hôpital Charles Nicolle Recruiting Rouen, France, 79031 Contact: Suzanna BOTA       Suzanna.bota@chu-rouen.fr    Principal Investigator: Suzanna BOTA          Clinique Mutualiste de l'Estuaire Recruiting Saint Nazaire, France, 44600 Contact: Philippe DEGUIRAL       philippe.deguiral@mla.fr    Principal Investigator: Philippe DEGUIRAL          Institut de Cancérologie de la Loire (I.C.L) Recruiting Saint Priest En Jarez, France, 42271 Contact: Pierre FOURNEL       pierre.fournel@icloire.fr    Principal Investigator: Pierre FOURNEL          Centre Hospitalier de Salon de Provence Recruiting Salon de Provence, France, 13658 Contact: Jacques LE TREUT       jletreut@ch-aix.fr    Principal Investigator: Jacques LE TREUT          Centre Hospitalier Recruiting Sens, France, 89108 Contact: GONZALEZ Gilles       ggonzalez@ch-sens.fr    Principal Investigator: GONZALEZ Gilles          Centre Paul Strauss Recruiting Strasbourg, France, 67000 Contact: Roland SCHOTT       rschott@strasbourg.unicancer.fr    Principal Investigator: Roland SCHOTT          Hopital d'Instruction des Armées Sainte Anne Recruiting Toulon, France, 83800 Contact: Henri BERARD       hberard@libertysurf.fr    Principal Investigator: Henri BERARD          Hôpital Larrey Recruiting Toulouse, France, 31059 Contact: Laurence BIGAY-GAME       bigaygame.l@chu-toulouse.fr    Principal Investigator: Laurence BIGAY-GAME          Clinique Pasteur Recruiting Toulouse, France, 31076 Contact: Olivier GALLOCHER       o.gallocher@clinique-pasteur.com    Principal Investigator: Olivier GALLOCHER          Centre Hospitalier Recruiting Villefranche Sur Saone, France, 69655 Contact: Lionel FALCHERO       lfalchero@ch-villefranche.fr    Principal Investigator: Lionel FALCHERO Less <<
NCT01704703 Stage IV Colorectal Cancer Phase 2 Completed - Spain ... More >> Spanish Cooperative Group for Digestive Tumour Therapy Madrid, Spain, 28046 Less <<
NCT01333735 - Completed - Belgium ... More >> Université Bruxelles, Belgium, 1050 France INSERM Caen, Calvados, France, 14000 CHU Caen, Calvados, France, 14033 Centre François BACLESSE Caen, Calvados, France, 14076 Hôpital Saint-Louis Paris, Ile de France, France, 75475 Hopital Pitié-Sapètrière Paris, Ile de France, France, 75651 Hopital TENON Paris, Ile de France, France, 75970 CHRU Hôpital Claude Huriez Lille, Nord, France, 59000 Hopital gériatrique des Bateliers Lille, Nord, France, 59037 Université Lille, Nord, France, 59653 CHU, Hôpital Bois Guillaume Rouen, Seine Maritime, France, 76000 CHU Rouen, Seine Maritime, France, 76000 Centre Henri BECQUEREL Rouen, Seine Maritime, France, 76038 Hôpital Charles FOIX IVRY sur SEINE, France, 94206 Hopitaux universitaires Strasbourg, France, 67091 Less <<
NCT02036944 - Terminated(Study stopped d/t l... More >>ack of enrollment and no compelling data.) Less << - United States, Washington ... More >> Providence Medical Research Center Spokane, Washington, United States, 99204 Less <<
NCT00786643 Colorectal Cancer Phase 2 Completed - United States, Tennessee ... More >> The West Clinic Memphis, Tennessee, United States, 38120 Less <<
NCT01289925 Inflammation Not Applicable Terminated - United States, Maryland ... More >> Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Less <<
NCT00389805 Lung Cancer U... More >>nspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Phase 2 Completed - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT03186326 Metastatic Colorectal Cancer ... More >> MSI Less << Phase 2 Recruiting March 31, 2025 -
NCT00898820 - Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03671772 - Not yet recruiting August 31, 2021 Hong Kong ... More >> Department of psychiatry, Faculty of Medicine, The Chinese University of Hong Kong Enrolling by invitation Hong Kong, Hong Kong Less <<
NCT00389805 - Completed - -
NCT03258385 Early Pregnancy Not Applicable Recruiting December 31, 2019 Bangladesh ... More >> Maternal and Child Health Training Institute Recruiting Dhaka, Bangladesh, 1205 Contact: Ishrat Jahan, MBBS, MPH    +8801713009029 Less <<
NCT01490437 Urothelial Carcinoma Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00408226 Advanced Cancer ... More >> Non-Small Cell Lung Cancer Less << Phase 1 Phase 2 Completed - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Washington Swedish Cancer Institute Seattle, Washington, United States, 98122 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00381706 - Completed - -
NCT00415168 - Completed - -
NCT00415636 Cancer Phase 1 Completed - United States, Arizona ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Scottsdale, Arizona, United States, 85258 Less <<
NCT00381706 Esophageal Cancer Phase 2 Completed - -
NCT00418886 Non Small Cell Lung Cancer ... More >> Lung Cancer Less << Phase 3 Active, not recruiting December 2019 -
NCT00415168 Gastric Cancer Phase 2 Completed - Russian Federation ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barnaul, Russian Federation, 656049 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ivanovo, Russian Federation, 153040 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kazan, Russian Federation, 420029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation, 117997 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Petersburg, Russian Federation, 197758 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stavropol, Russian Federation, 355001 Less <<
NCT00415636 - Completed - -
NCT00418886 - Active, not recruiting - -
NCT00424242 Brain and Central Nervous Syst... More >>em Tumors Chronic Myeloproliferative Disorders Leukemia Lymphoma Lymphoproliferative Disorder Metastatic Cancer Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Precancerous Condition Secondary Myelofibrosis Unspecified Adult Solid Tumor, Protocol Specific Less << Early Phase 1 Active, not recruiting March 2020 United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT00424723 Neuroendocrine Tumors Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Center Boston, Massachusetts, United States, 02115 Less <<
NCT03482063 Neurocognitive Function ... More >> Mood Less << Phase 3 Recruiting July 31, 2019 Australia, Victoria ... More >> Swinburne University of Technology Recruiting Hawthorn, Victoria, Australia, 3122 Contact: Lauren Young    +613 9214 3793       Principal Investigator: Andrew Pipingas, Prof Less <<
NCT00447421 - Terminated(Interim results of ... More >>another trial showed inferior activity of treatment) Less << - -
NCT01858662 Metastatic Colorectal Cancer Phase 2 Terminated(due to poor recrutm... More >>ent) Less << - Belgium ... More >> Grand Hôpital de Charleroi Charleroi, Hainaut, Belgium, 6000 clinique Saint Luc Bouge, Belgium, 5004 Cliniques universitaires Saint-Luc - UCL Brussels, Belgium, 1200 Centre Hospitalier Jolimont Lobbes La Louvière, Belgium, 7100 CHU liège (Sart Timan) Liège, Belgium, 4000 Clinique Saint Pierre Ottignies Ottignies, Belgium, 1340 CHU-UCL Dinant-Godinne Yvoir, Belgium, 5530 Less <<
NCT00197756 - Completed - United States, Massachusetts ... More >> Harvard School of Public Health Boston, Massachusetts, United States, 02115 Less <<
NCT00461786 Ovarian Cancer ... More >> Peritoneal Cancer Less << Phase 2 Completed - United States, Pennsylvania ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Philadelphia, Pennsylvania, United States Less <<
NCT00447421 Small Cell Lung Cancer ... More >> Carcinoma, Small Cell SCLC Less << Phase 1 Phase 2 Terminated(Interim results of ... More >>another trial showed inferior activity of treatment) Less << - Belgium ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leuven, Belgium, 3000 Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Amsterdam, Netherlands, 1081 HV For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Den Bosch, Netherlands, 5211 NL For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rotterdam, Netherlands, 3075 EA Less <<
NCT00475657 Small Cell Lung Cancer Phase 2 Terminated(Terminated due to l... More >>ack of efficacy) Less << - Spain ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ferrol, Spain, 15405 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Coruña, Spain, 15002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lugo, Spain, 27004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ourense, Spain, 15009 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santiago de Compostela, Spain, 15706 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vigo, Spain, 36211 Less <<
NCT00461786 - Completed - -
NCT00475657 - Terminated(Terminated due to l... More >>ack of efficacy) Less << - -
NCT00470405 Lymphoma Soli... More >>d Tumor Less << Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00482014 Non-Small-Cell Lung Cancer Phase 1 Phase 2 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States, 90095 United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wichita, Kansas, United States, 67214 United States, Missouri For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St Louis, Missouri, United States, 63110 United States, Nevada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Las Vegas, Nevada, United States, 89135 United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Burlington, North Carolina, United States, 27216 United States, Tennessee For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States, 38120 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Corpus Christi, Texas, United States, 78405 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75390 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Temple, Texas, United States, 76508 India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Delhi, India, 110085 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trivandrum, India, 695 011 Less <<
NCT01619228 Premature Birth of Newborn Not Applicable Terminated(PI left the institu... More >>tion resulting in the study being closed early.) Less << - United States, Ohio ... More >> Cincinnati Childrens Hospital Medical Center Neonatal Intensive Care Unit Cincinnati, Ohio, United States, 45229 University Hospital Neonatal Intensive Care Unit Cincinnati, Ohio, United States, 45267 Less <<
NCT00490373 Pancreatic Cancer Phase 2 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany Less <<
NCT00489359 - Completed - -
NCT00497315 Non-Small Cell Lung Cancer Phase 2 Completed - Belgium ... More >> ZNA Middelheim Antwerpen, Antwerp, Belgium, 2020 University Hospital Antwerp Edegem, Antwerp, Belgium, 2650 St Augustinus Ziekenhuis Wilrijk, Antwerp, Belgium, 2610 Less <<
NCT00494026 - Terminated(Study stopped early... More >> based on interim results of another trial, showing inferior activity of pemetrexed/carboplatin compared to etoposide/carboplatin in SCLC.) Less << - -
NCT00427466 Sarcoma Phase 2 Completed - Germany ... More >> Medical Center II, University of Tuebingen Tuebingen, Germany, 72076 Less <<
NCT00482014 - Completed - -
NCT00497770 - Completed - -
NCT00489359 Ovarian Cancer ... More >> Primary Peritoneal Cancer Less << Phase 1 Phase 2 Completed - Argentina ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bahia Blanca, Argentina, B8000HXM For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Buenos Aires, Argentina, C1199ACK For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ramos Mejia, Argentina, B1704ESN For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salta, Argentina, 4400 Canada, Alberta For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Calgary, Alberta, Canada, T2N 4N2 Canada, Ontario For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toronto, Ontario, Canada, M5G 2M9 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 13353 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bonn, Germany, 53127 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chemnitz, Germany, D-09116 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Duesseldorf, Germany, 40489 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Erlangen, Germany, D-91054 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Essen, Germany, DE-45145 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 22081 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jena, Germany, D-07743 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kiel, Germany, D-24105 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, 55131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tübingen, Germany, 72076 Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gdansk, Poland, 80-402 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Olsztyn, Poland, 10-228 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland, 00909 Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Göteborg, Sweden, 416 85 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lund, Sweden, 22241 Less <<
NCT00494026 Small Cell Lung Cancer Phase 2 Terminated(Study stopped early... More >> based on interim results of another trial, showing inferior activity of pemetrexed/carboplatin compared to etoposide/carboplatin in SCLC.) Less << - Italy ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orbassano, Italy, 10043 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Parma, Italy, 43100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Sisto, Italy, 06156 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Terni, Italy, 05100 Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poznan, Poland, 60-569 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland, 02-781 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Palma de Mallorca, Spain, 07014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46010 United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Southampton, Hants, United Kingdom, SO16 6YD For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guilford, Surrey, United Kingdom, GU2 7XX For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wolverhampton, West Midlands, United Kingdom, WV10 0QP Less <<
NCT00497770 - Completed - -
NCT00503997 - Completed - -
NCT00503997 Head and Neck Cancer Phase 2 Completed - United States, Kentucky ... More >> Mitchell Memorial Cancer Center at Owensboro Medical Health System Owensboro, Kentucky, United States, 42303 Purchase Cancer Group - Paducah Paducah, Kentucky, United States, 42002 United States, Tennessee West Tennessee Cancer Center at Jackson-Madison County General Hospital Jackson, Tennessee, United States, 38301 Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37064 MBCCOP - Meharry Medical College - Nashville Nashville, Tennessee, United States, 37208 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00508144 Lung Cancer Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00516100 Non-small Cell Lung Cancer Phase 1 Phase 2 Unknown August 2012 United States, California ... More >> Cedars-Sinai Outpatient Cancer Center Los Angeles, California, United States, 90048 Comprehensive Cancer Center at Desert Regional Medical Center Palm Springs, California, United States, 92262 California Pacific Medical Center San Francisco, California, United States, 94115 United States, New Jersey Trinitas Comprehensive Cancer Center Elizabeth, New Jersey, United States, 07207 Less <<
NCT00520936 Osteosarcoma ... More >>Medulloblastoma Sarcoma, Ewing's Neuroblastoma (Measurable Disease) Neuroblastoma (Metaiodobenzylguanidine Positive Evaluable) Rhabdomyosarcoma Ependymoma Non-brainstem High-grade Glioma Less << Phase 2 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Arcadia, California, United States, 91066 Less <<
NCT00529100 Non-Small Cell Lung Cancer Phase 1 Phase 2 Completed - Canada, Alberta ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Edmonton, Alberta, Canada, T6G 1Z2 Canada, Ontario For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamilton, Ontario, Canada, L8V 5C2 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ottawa, Ontario, Canada, K1H 8L6 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00520936 - Completed - -
NCT00506051 Carcinoma Non... More >>-Small Cell Lung Lung Cancer Less << Phase 1 Completed - -
NCT00530621 Non-small Cell Lung Cancer Phase 2 Completed - -
NCT00538681 Lung Cancer Phase 2 Completed - Belgium ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leuven, Belgium, 3000 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gauting, Germany, 82131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. GroBhansdorf, Germany, D-22927 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, D 21075 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelberg, Germany, 69126 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bergamo, Italy, 24128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Catania, Italy, 95100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Padova, Italy, 35128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trento, Italy, 38100 Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Otwock, Poland, 05-400 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poznan, Poland, 60-569 Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bucharest, Romania, 022328 Less <<
NCT00619424 Lung Cancer, Non-Small Cell Phase 1 Completed - United States, Colorado ... More >> GSK Investigational Site Aurora, Colorado, United States, 80045 United States, New York GSK Investigational Site Buffalo, New York, United States, 14263 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37203 Italy GSK Investigational Site Orbassano (TO), Piemonte, Italy, 10043 Less <<
NCT00508144 - Completed - -
NCT00606021 - Completed - -
NCT00529100 - Completed - -
NCT00691301 - Completed - -
NCT00668499 Mesothelioma Phase 1 Phase 2 Withdrawn(Sponsor withdrew sup... More >>port) Less << April 2011 United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT00606021 Non Small Cell Lung Cancer Phase 2 Completed - Egypt ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Assiut, Egypt, 0000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cairo, Egypt, 11372 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mounofia, Egypt, 32514 Lebanon For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beirut, Lebanon Saudi Arabia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Riyadh, Saudi Arabia, 11211 Less <<
NCT01908452 Tardive Dyskinesia Phase 3 Withdrawn(Not funded) - Israel ... More >> Be'er Sheva Mental Health Center Be'er Sheva, Israel, 84170 Sha'ar Menashe Mental Health Center Hadera, Israel Tirat Carmel Mental Health Center Haifa, Israel Less <<
NCT00691301 Cervical Cancer Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange, California, United States, 92868 United States, Mississippi University of Mississippi Cancer Clinic Jackson, Mississippi, United States, 39216 United States, Nevada Women's Cancer Center - La Canada Las Vegas, Nevada, United States, 89169 United States, Ohio MetroHealth Cancer Care Center at MetroHealth Medical Center Cleveland, Ohio, United States, 44109 United States, Oklahoma Oklahoma University Cancer Institute Oklahoma City, Oklahoma, United States, 73104 Cancer Care Associates - Saint Francis Campus Tulsa, Oklahoma, United States, 74136-1929 United States, Texas Parkland Memorial Hospital Dallas, Texas, United States, 75235 Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 Lyndon B. Johnson General Hospital Houston, Texas, United States, 77026-1967 M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 United States, Virginia Carilion Gynecologic Oncology Associates Roanoke, Virginia, United States, 24016 Less <<
NCT00701857 Esophageal Cancer Phase 1 Completed - United States, Arizona ... More >> University of Arizona Cancer Center Tucson, Arizona, United States, 85724 Less <<
NCT00712062 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Withdrawn(Lack of accrual) - -
NCT00715611 Mesothelioma Phase 2 Recruiting July 2019 United States, Florida ... More >> Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Bradford Perez, MD    888-663-3488       Principal Investigator: Bradford Perez, MD          United States, Massachusetts Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Raymond Mak, MD    617-632-3591       United States, Minnesota Mayo Clinic Cancer Center Recruiting Rochester, Minnesota, United States, 55905 Contact: Nina Garces, MD    507-538-3270       United States, New Jersey Memorial Sloan Kettering at Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Andreas Rimner, MD    212-639-6025       United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting Commack, New York, United States, 11725 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering West Harrison Recruiting Harrison, New York, United States, 10604 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Andreas Rimner, MD    212-639-6025       Contact: Valerie Rusch, MD    212-639-5873       Principal Investigator: Andreas Rimner, MD          Memorial Sloan Kettering at Mercy Medical Center Recruiting Rockville Centre, New York, United States Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Recruiting Sleepy Hollow, New York, United States, 10591 Contact: Andreas Rimner, MD    212-639-6025       United States, Texas Md Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Daniel Gomez, MD          Principal Investigator: Daniel Gomez, MD Less <<
NCT00700336 Malignant Pleural Mesothelioma... More >> Solid Tumors Less << Phase 1 Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale, Arizona, United States Arizona Cancer Center Tucson, Arizona, United States United States, California City of Hope Duarte, California, United States United States, Illinois University of Chicago Chicago, Illinois, United States United States, Michigan Karmanos Cancer Institute/Wayne State University Detroit, Michigan, United States United States, Nevada Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 United States, New Mexico University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87131 United States, New York Memorial-Sloan Kettering Cancer Center New York, New York, United States, 10022 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States United States, Pennsylvania Penn State Milton S. Hershey Medical Ctr. Hershey, Pennsylvania, United States, 17033 United States, Texas Cancer Therapy & Research Center San Antonio, Texas, United States, 78229 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States Less <<
NCT00745875 - Completed - -
NCT00732303 - Terminated(Study terminated du... More >>e to withdrawal of pharmaceutical funding) Less << - -
NCT00732303 Non-Small Cell Lung Cancer Phase 2 Terminated(Study terminated du... More >>e to withdrawal of pharmaceutical funding) Less << - United States, Illinois ... More >> Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 NorthShore University Health System - Kellogg Cancer Center Evanston, Illinois, United States, 60201 Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Cancer Care Center of Southern Indiana Bloomington, Indiana, United States, 47403 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 IN Onc/Hem Associates Indianapolis, Indiana, United States, 46202 Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 Community Regional Cancer Center Indianapolis, Indiana, United States, 46256 Horizon Oncology Center Lafayette, Indiana, United States, 47905 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 Monroe Medical Associates Munster, Indiana, United States, 46321 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 Providence Medical Group Terre Haute, Indiana, United States, 47802 United States, Missouri Siteman Cancer Center St. Louis, Missouri, United States, 63110 United States, New Jersey Hematology Oncology Associates S.J., P.A. Mt. Holly, New Jersey, United States, 08060 United States, Oregon Providence Portland Medical Center Portland, Oregon, United States, 97213 United States, Pennsylvania Pennsylvania Oncology-Hematology Associates Philadelphia, Pennsylvania, United States, 19106 Fox Chase Cancer Center Extramural Research Program Rockledge, Pennsylvania, United States, 19046 Less <<
NCT00749346 Non-small Cell Lung Cancer ... More >> NSCLC Less << Phase 1 Phase 2 Completed - Switzerland ... More >> CCRC Basel, Switzerland Kantonspital Graubunden Chur, Switzerland Kantonspital Fribourg Fribourg, Switzerland Kantonspital Winterthur Winterthur, Switzerland Less <<
NCT00745875 Non Small Cell Lung Cancer ... More >> Lung Cancer Less << Phase 2 Completed - Bulgaria ... More >> research Site Pleven, Bulgaria Research Site Sofia, Bulgaria Research Site Varna, Bulgaria Czech Republic Research Site Jicin, Czech Republic Research Site Prague, Czech Republic France Research Site Cedex, France Research Site Strasbourg, France Romania Research Site Bucharest, Romania Research Site Cluj-Napoca, Romania Ukraine Research Site Chernivtsi, Ukraine Research Site Kiev, Ukraine Research Site Sumy, Ukraine Research Site Uzngorod, Ukraine Less <<
NCT00789373 Non-Small Cell Lung Cancer Phase 3 Completed - -
NCT00786331 Advanced Non-Small Cell Lung C... More >>ancer Less << Phase 2 Unknown December 2009 Italy ... More >> Azienda Ospedaliero-Universitaria Umberto I, Clinica di Oncologia Medica Active, not recruiting Ancona, Italy, 60020 Azienda Ospedaliera Ospedali Riuniti di Bergamo, UO di Oncologia Medica Recruiting Bergamo, Italy, 24128 Principal Investigator: Roberto Labianca, MD          Azienda Istituti Ospitalieri di Cremona, UO di Oncologia Medica Recruiting Cremona, Italy, 26100 Principal Investigator: Rodolfo Passalacqua, MD          Azienda Sanitaria Ospedaliera S. Croce e Carle, UO di Oncologia Medica Recruiting Cuneo, Italy, 12100 Principal Investigator: Marco Merlano, MD          Ospedale S. Croce, U.O. di Oncologia Medica Recruiting Fano, PU, Italy, 61032 Principal Investigator: Rodolfo Mattioli, MD          Azienda Ospedaliera Careggi, UO di Oncologia Medica Recruiting Firenze, Italy, 50139 Principal Investigator: Francesco Di Costanzo, MD          EO Ospedali Galliera, SC Oncologia Medica Recruiting Genova, Italy, 16128 Principal Investigator: Andrea Decensi, MD          Ospedale Versilia, UO di Oncologia Medica Recruiting Lido di Camaiore, LU, Italy, 55043 Principal Investigator: Domenico Amoroso, MD          USL 6, Presidio Ospedaliero di Livorno, U.O. di Oncologia MedicaAzienda Recruiting Livorno, Italy, 57122 Principal Investigator: Alfredo Falcone, MD          Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-IRST, Oncologia Medica Recruiting Meldola, FC, Italy, 47014 Principal Investigator: Dino Amadori, MD          Istituto Nazionale Tumori, SC di Oncologia 2 Recruiting Milano, Italy, 20133 Principal Investigator: Emilio Baietta, MD          Azienda Ospedaliero-Universitaria di Modena-Policlinico, U.O. di Oncologia Medica ed Ematologia Recruiting Modena, Italy, 41100 Principal Investigator: Fausto Barbieri, MD          AO S. Gerardo, Nuovo Ospedale S. Gerardo-settore A, Oncologia Medica Not yet recruiting Monza, MI, Italy, 20052 Principal Investigator: Paolo Bidoli, MD          Azienda Ospedaliero-Universitaria di Parma, UOC di Oncologia Medica Recruiting Parma, Italy, 43100 Principal Investigator: Andrea Ardizzoni, MD          Ospedale Silvestrini, S.C. di Oncologia Medica Recruiting Perugia, Italy, 06156 Principal Investigator: Lucio Crinò, MD          Arcispedale Santa Maria Nuova, UO di Oncologia Medica Recruiting Reggio Emilia, Italy, 42100 Principal Investigator: Corrado Boni, MD          Azienda Ospedaliera S. Camillo-Forlanini, U.O. di Oncologia Medica Recruiting Roma, Italy, 00151 Principal Investigator: Filippo De Marinis, MD          Ospedale SS. Annunziata, UO di Oncologia Medica Recruiting Sassari, Italy, 07100 Principal Investigator: Antonio Contu, MD          Azienda Sanitaria Ospedaliera Molinette, U.O. di Oncologia Medica Recruiting Torino, Italy, 10126 Principal Investigator: Libero Ciuffreda, MD          P.O. Treviglio-Caravaggio, U.O. di Oncologia Medica Not yet recruiting Treviglio, BG, Italy, 24047 Principal Investigator: Barni Sandro, MD          Policlinico "G. B. Rossi"-Borgo Roma, U.O. di Oncologia Medica Clinicizzata Recruiting Verona, Italy, 37126 Principal Investigator: Antonio Santo, MD Less <<
NCT02018965 HIV Phase 2 Completed - Canada, Quebec ... More >> Montreal Chest Institute Montreal, Quebec, Canada, H2W1T7 Less <<
NCT00794417 Advanced Carcinoma ... More >> Non-small Cell Lung Cancer Less << Phase 1 Phase 2 Completed - United States, Arizona ... More >> Arizona Cancer Institute, LLC Tucson, Arizona, United States, 85715 United States, Arkansas University of Arkansas for Medical Science Little Rock, Arkansas, United States, 72205 United States, California Stanford University Medical Center Stanford, California, United States, 94305 United States, Florida Palm Beach Institute of Hematology and Oncology Boynton Beach, Florida, United States, 33435 United States, Illinois Edward Hines Jr. VA Medical Center Hines, Illinois, United States, 60141 United States, Kentucky Kentucky Cancer Clinic Hazard, Kentucky, United States, 41701 United States, Maryland Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231-1000 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, New Mexico UNM Cancer Clinic Albuquerque, New Mexico, United States, 87131 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, North Carolina Presbyterian Hospital Center for Cancer Research Charlotte, North Carolina, United States, 28204 United States, Pennsylvania Erie Regional Cancer Center Erie, Pennsylvania, United States, 16505 United States, West Virginia Schiffler Cancer Center - Medical Oncology Division Wheeling, West Virginia, United States, 26003 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT02076347 Type 2 Diabetes ... More >> Vitamin B12 Deficiency Neuropathy Anemia Less << Not Applicable Completed - United States, Ohio ... More >> The Ohio State University General Internal Medicine Columbus, Ohio, United States, 43221 Less <<
NCT00824408 - Completed - -
NCT02061267 Metabolic Syndrome Not Applicable Unknown December 2014 Spain ... More >> Instituto de la Grasa, CSIC Seville, Spain, 41012 Less <<
NCT00846443 Local Advanced Non-Small Cell ... More >>Lung Cancer Less << Phase 1 Unknown - China, Shanghai ... More >> Department of Radiation Oncolory, Cancer Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Liang Xiahou, MB    862164175590 ext 1404    xiahouliang@hotmail.com    Principal Investigator: Xiaolong Fu, MD Less <<
NCT00867009 Non-Small-Cell Lung Cancer Phase 2 Completed - Austria ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Graz, Austria, 8036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salzburg, Austria, 5020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wels, Austria, 4600 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 13125 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Halle, Germany, D-06120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Homburg, Germany, 66421 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mannheim, Germany, 68167 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tuebingen, Germany, 72076 Greece For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Athens, Greece, 11527 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Patras, Greece, 26500 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bari, Italy, 70126 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bergamo, Italy, 24128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Palermo, Italy, 90146 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Potenza, Italy, 85028 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Torino, Italy, 10100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Treviso, Italy, 31100 Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Amsterdam, Netherlands, 1081 HV For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Groningen, Netherlands, 9713 GZ For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Maastricht, Netherlands, 6229 HX For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. S-Hertogenbosch, Netherlands, 5211 NL Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lleida, Spain, 25198 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Reus, Spain, 43201 Less <<
NCT00789373 - Completed - -
NCT00864513 - Terminated(At interim analysis... More >> the study did not meet the response criteria to continue) Less << - -
NCT00864513 Pancreas Cancer Phase 2 Terminated(At interim analysis... More >> the study did not meet the response criteria to continue) Less << - United States, District of Col... More >>umbia Georgetown University Hospital/Lombardi Cancer Center Washington, District of Columbia, United States, 20007 Less <<
NCT00824408 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - Bahamas ... More >> 1230.5.00118 Boehringer Ingelheim Investigational Site Nassau, Bahamas Canada, Alberta 1230.5.00104 Boehringer Ingelheim Investigational Site Edmonton, Alberta, Canada Canada, British Columbia 1230.5.00114 Boehringer Ingelheim Investigational Site Kelowna, British Columbia, Canada 1230.5.00109 Boehringer Ingelheim Investigational Site Surrey, British Columbia, Canada 1230.5.00107 Boehringer Ingelheim Investigational Site Vancouver, British Columbia, Canada Canada, Ontario 1230.5.00105 Boehringer Ingelheim Investigational Site Hamilton, Ontario, Canada 1230.5.00119 Boehringer Ingelheim Investigational Site Kitchener, Ontario, Canada 1230.5.00116 Boehringer Ingelheim Investigational Site Oshawa, Ontario, Canada 1230.5.00108 Boehringer Ingelheim Investigational Site Ottawa, Ontario, Canada 1230.5.00110 Boehringer Ingelheim Investigational Site Toronto, Ontario, Canada Canada, Quebec 1230.5.00102 Boehringer Ingelheim Investigational Site Montreal, Quebec, Canada 1230.5.00106 Boehringer Ingelheim Investigational Site Montreal, Quebec, Canada Less <<
NCT00867009 - Completed - -
NCT00867711 - Completed - Italy ... More >> Istituto Clinico Humanitas Rozzano, Milano, Italy, 20089 Less <<
NCT00886678 Non-Small Cell Lung Cancer Phase 2 Unknown July 2010 China, Zhejiang ... More >> Zhejiang Cancer Hospital Hangzhou, Zhejiang, China, 310022 Less <<
NCT02140814 Polycystic Kidney Disease Phase 2 Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT00887549 Non-Small Cell Lung Cancer Phase 2 Completed - Ireland ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dublin, Ireland United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Derby, Derbyshire, United Kingdom, DE22 3NE For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Exeter, Devon, United Kingdom, EX2 5DW For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Maidstone, Kent, United Kingdom, ME16 9QQ For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Preston, Lancashire, United Kingdom, PR2 9HT For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Liverpool, Merseyside, United Kingdom, L14 3PE For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Northwood, Middlesex, United Kingdom, HA6 2RN For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Scunthorpe, North Lincolnshire, United Kingdom, DN15 7BH For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Belfast, Northern Ireland, United Kingdom, BT9 7BL For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nottingham, Nottinghamshire, United Kingdom, NG5 1PD For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aberdeen, Scotland, United Kingdom, AB25 2ZN For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wolverhampton, West Midlands, United Kingdom, WV10 0QP For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Grimsby, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Manchester, United Kingdom, M23 9LT Less <<
NCT00895648 Mesothelioma ... More >>Pleural Mesothelioma Less << Phase 2 Terminated(low accrual due to ... More >>competing study for same group of patients) Less << - Canada, Ontario ... More >> University Health Network Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00887549 - Completed - -
NCT00871403 - Completed - -
NCT00906282 - Completed - -
NCT00923637 Non Small Cell Lung Cancer Phase 2 Unknown June 2015 China, Guangdong ... More >> The First Affiliated Hospital of Guangzhou Medical College Recruiting Guangzhou, Guangdong, China, 510120 Contact: Daoyuan Wang, MD    +86-20-83337792    ghealth2008@gmail.com    Contact: Wenlong Shao, MD    +86-20-83337792    myfriends2003@126.com    Principal Investigator: Jianxing He, MD, FACS Less <<
NCT00871403 Lung Cancer, Non-Small Cell Phase 2 Completed - Denmark ... More >> GSK Investigational Site Herlev, Denmark, 2730 United Kingdom GSK Investigational Site Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT02213094 Pregnancy Induced Hypertension... More >> Superimposed Preeclampsia Hypertension Less << Phase 1 Completed - United States, North Carolina ... More >> University of North Carolina Women's Hospital Chapel Hill, North Carolina, United States, 27599-7516 Less <<
NCT00906282 Non Small Cell Lung Cancer Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Medical Oncology Associates of Augusta Augusta, Georgia, United States, 30901 Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, Nebraska Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT02213094 - Completed - -
NCT00942825 Metastatic Non-squamous Non Sm... More >>all Cell Lung Cancer Less << Phase 2 Completed - United States, Nevada ... More >> Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 United States, Pennsylvania Penn State Cancer Institute Hershey, Pennsylvania, United States, 17033 United States, Texas Mary Crowley Cancer Research Centers Dallas, Texas, United States, 75246 Less <<
NCT00940069 Non-small-cell Lung Cancer ... More >> Adenocarcinoma Less << Phase 2 Completed - China, Hunan ... More >> HuNan province tumor hospital ChangSha, Hunan, China, 410013 Less <<
NCT00949650 Carcinoma, Non-Small-Cell Lung... More >> Adenocarcinoma Less << Phase 3 Completed - -
NCT00942825 - Completed - -
NCT01500785 Myocardial Stunning Phase 4 Suspended(Change of schedule) September 15, 2018 Finland ... More >> Heart Center Co. Tampere university hospital Tampere, Finland, 33521 Less <<
NCT00979576 Carcinoma, Non-Small-Cell Lung Phase 1 Terminated - Japan ... More >> 1199.28.003 Boehringer Ingelheim Investigational Site Chiba,Kashiwa, Japan 1199.28.002 Boehringer Ingelheim Investigational Site Miyakojima-ku, Osaka, Japan 1199.28.001 Boehringer Ingelheim Investigational Site Osaka-Sayama, Osaka, Japan Less <<
NCT00949650 - Completed - -
NCT00988858 Non Small Cell Lung Cancer Phase 2 Completed - United States, Arizona ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tucson, Arizona, United States, 85704 United States, Colorado For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Denver, Colorado, United States, 80218 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tampa, Florida, United States, 33612 United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kettering, Ohio, United States, 45409 United States, Oregon For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Portland, Oregon, United States, 97213 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75201 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. The Woodlands, Texas, United States, 77380 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tyler, Texas, United States, 75702 United States, Washington For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yakima, Washington, United States, 98902 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orbassano, Italy, 10043 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 138-736 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 407 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tainan, Taiwan, 70403 Less <<
NCT00979576 - Terminated - -
NCT00988858 - Completed - -
NCT01000480 Non Small Cell Lung Cancer Phase 2 Completed - France ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Le Mans, France, 72000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lyon, France, 69373 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montpellier, France, 34070 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paris, France, 75015 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toulouse, France, 31300 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 14165 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hemer, Germany, 58675 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Köln, Germany, 51109 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lübeck, Germany, 23538 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nürnberg, Germany, 90419 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Avellino, Italy, 50019 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Firenze, Italy, 50139 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy, 20132 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Monza, Italy, 20900 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orbassano, Italy, 10043 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Perugia, Italy, 06156 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sabadell, Spain, 08208 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sevilla, Spain, 41013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46010 Less <<
NCT01020786 Non Small Cell Lung Cancer Phase 4 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 460-0001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 277 8577 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ehime, Japan, 790-0007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 812-8582 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 062-0931 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 673-8558 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 236-0051 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kumamoto, Japan, 860-8556 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miyagi, Japan, 980-8574 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Niigata, Japan, 951-8520 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Okayama, Japan, 700-8558 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 589-8511 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shizuoka, Japan, 411-8777 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tochigi, Japan, 320-0834 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 113-8677 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yamaguchi, Japan, 755-0241 Less <<
NCT01000480 - Completed - -
NCT01755078 Hemodialysis ... More >>Hyperphosphatemia Cardiovascular Events Less << Phase 4 Completed - -
NCT00996567 Cancer Phase 2 Completed - Belgium ... More >> UZ Antwerpen Antwerpen, Belgium University Hospital Ghent Ghent, Belgium, 9000 AZ St. Maarten Mechelen, Belgium, 2800 Netherlands AMC Heerlen Heerlen, Netherlands Less <<
NCT01087970 Head and Neck Neoplasms Phase 2 Completed - -
NCT01088906 Carcinoma, Non Small Cell Lung Phase 2 Terminated(No safety reasons. ... More >>Low recruitment.) Less << - Spain ... More >> H. Clínica Benidorm Benidorm, Alicante, Spain, 03501 H. General de Elche Elche, Alicante, Spain, 03202 H. Germans Trias i Pujol Badalona, Barcelona, Spain, 088916 H. Insular de Gran Canarias Las Palmas de Gran Canarias, Gran Canarias, Spain, 35016 H. Universitario de Canarias La Laguna, Tenerife, Spain, 38320 MD Anderson Madrid, Spain, 28033 Hospital 12 de Octubre Madrid, Spain, 28041 H. Morales Messeguer Murcia, Spain, 30008 Less <<
NCT01085630 Malignant Mesothelioma Phase 2 Active, not recruiting - -
NCT01020786 - Completed - -
NCT01102231 Stage III Non-small Cell Lung ... More >>Cancer Less << Phase 2 Completed - France ... More >> Clinique de l'Europe Amiens, France Centre Hospitalier Annemasse, France CHU Besancon - Pneumologie Besancon, France, 25000 Bordeaux - Polyclinique Nord Bordeaux, France, 33300 Caen - Centre François Baclesse Caen, France, 14000 Caen - CHU Côte de Nacre Caen, France, 14000 CH Chartres, France CH Cholet, France CHU Clermont-Ferrand, France CH Colmar, France Clinique des Cèdres Cornebarrieu, France Dijon - CAC Dijon, France, 21000 CHU Grenoble Grenoble, France, 38000 Institut d'Oncologie Hartmann Levallois, France CHU (Hôpital Calmette) - Pneumologie Lille, France, 59000 CH Longjumeau, France Clinique des 4 Pavillons Lormont, France Hôpital Louis Pradel Lyon, France Hôpital Nord Marseille, France Centre Hospitalier Montélimar, France CHU Nancy, France CH Nevers, France Centre Hospitalier Niort, France APHP - Hopital Tenon - Pneumologie Paris, France, 75020 Hôpital du Val de Grâce Paris, France Hôpital Saint-Joseph Paris, France Perpignan - Centre Catalan d'Oncologie Perpignan, France, 66000 HCL - Lyon Sud Pierre Bénite, France, 69495 CHU Poitiers, France Centre Hospitalier Rambouillet, France Reims - CHU Reims, France, 51092 Institut Jean Godinot Reims, France Centre Frederic Joliot Rouen, France Centre Etienne Dolet Saint-Nazaire, France Hôpitaux Universitaires - Nouvel Hôpital Civil Strasbourg, France, 63000 Suresnes - Hopital Foch Suresnes, France, 92151 Tours - CHU Tours, France, 37000 Institut Gustave Roussy Villejuif, France, 94800 Less <<
NCT02483962 Venous Insufficiency Phase 2 Completed - South Africa ... More >> University of Johannesburg Johannesburg, Gauteng, South Africa, 2028 Less <<
NCT01143974 Locally Advanced Malignant Neo... More >>plasm Less << Phase 4 Completed - China ... More >> Cancer Institute & Hospital. Chinese Academy of Medical Sciences Beijing, China, 100021 Less <<
NCT01169675 Neoplasms Phase 1 Completed - Canada, Alberta ... More >> 1200.92.1001 Boehringer Ingelheim Investigational Site Edmonton, Alberta, Canada Canada, Ontario 1200.92.1002 Boehringer Ingelheim Investigational Site Hamilton, Ontario, Canada Less <<
NCT01087970 - Completed - -
NCT01126736 Non Small Cell Lung Cancer Phase 1 Phase 2 Unknown May 2015 United States, Arizona ... More >> Tucson, Arizona, United States, 85715 United States, Colorado Denver, Colorado, United States, 80218 United States, Florida Fort Myers, Florida, United States, 33916 United States, New Jersey Mount Holly, New Jersey, United States United States, Tennessee Nashville, Tennessee, United States, 37203 United States, Washington Tacoma, Washington, United States, 98405 Czech Republic Praha, Czech Republic, 15006 Praha, Czech Republic, 18100 Germany Freiburg, Germany, 79106 Heidelberg, Germany, 69126 Italy Milan, Italy, 20132 Rome, Italy Ukraine Dnipropetrovsk, Ukraine, 49102 Donetsk, Ukraine, 83092 Kharkiv, Ukraine, 61024 Kyiv, Ukraine Lviv, Ukraine, 79031 Sumy, Ukraine, 40005 Less <<
NCT02558595 Polycystic Kidney Disease Phase 2 Active, not recruiting December 2018 United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT01189968 Non Small Cell Lung Cancer Phase 1 Completed - Australia, Queensland ... More >> Royal Brisbane & Women's Hospital Herston, Queensland, Australia, 4029 Australia, South Australia Ashford Cancer Centre Research Kurralta Park, South Australia, Australia, 5037 Australia, Victoria Monash Medical Centre Clayton, Victoria, Australia, 3168 Australia, Western Australia Sir Charles Gairdner Hospital Nedlands, Western Australia, Australia, 6009 New Zealand Auckland Hospital Grafton, Auckland, New Zealand Waikato Hospital Hamilton, New Zealand Spain START Madrid Madrid, Spain Less <<
NCT01193959 - Unknown September 2011 Italy ... More >> Istituto Clinico Humanitas Rozzano, Milano, Italy, 20089 Less <<
NCT01215916 Solid Tumors Phase 1 Completed - United States, New Jersey ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Brunswick, New Jersey, United States, 08901 Less <<
NCT01232452 Non-Small-Cell Lung Carcinoma Phase 2 Completed - -
NCT00543608 Hospital-Acquired Pneumonia ... More >> Ventilator-Associated Pneumonia Health-Care-Associated Pneumonia Less << Phase 2 Terminated(Trial terminated du... More >>e to financial resource limitations) Less << May 2009 -
NCT01287520 Advanced Cancer Phase 1 Completed - United States, Florida ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tampa, Florida, United States United States, Tennessee For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nashville, Tennessee, United States Less <<
NCT01232452 - Completed - -
NCT01169675 - Completed - -
NCT01296113 Non-small Cell Lung Cancer ... More >> Hiv-positive Less << Phase 2 Completed - France ... More >> Centre Hospitalier du Pays d'Aix Aix-en-Provence, France Annemasse - CH Ambilly, France, 74100 Annecy - CH Annecy, France, 74374 Avignon - CH Avignon, France CH de la Côte Basque Bayonne, France CHU Besancon - Pneumologie Besancon, France, 25000 Caen - CHU Côte de Nacre Caen, France, 14000 CH Cahors Cahors, France CHU Clermont-Ferrand, France CH Colmar, France CH Compiègne - Pneumologie Compiègne, France Créteil - CHI Créteil, France, 94000 CHU Grenoble - pneumologie Grenoble, France, 38000 Le Mans - Centre Hospitalier Le Mans, France, 72000 CH Longjumeau, France Hôpital de la Croix Rousse Lyon, France Hôpital Louis Pradel Lyon, France APHM - Hôpital Nord Marseille, France, 13000 Montpellier - CHRU Montpellier, France, 34295 Nevers - CH Nevers, France, 58033 Centre Antoine Lacassagne Nice, France CHR d'Orléans La Source Orléans, France APHP - Hopital Tenon - Pneumologie Paris, France, 75020 GH Paris Saint-Joseph Paris, France Hôpital Saint Antoine Paris, France Paris - Pitié-salpêtrière Paris, France Pau - CH Pau, France, 64046 Centre François Magendie - hôpital du Haut-Lévèque Pessac, France HCL - Lyon Sud (Pneumologie) Pierre Bénite, France, 69495 Reims - CHU Reims, France, 51092 Rennes - CHU Rennes, France, 35033 Saint Brieuc - CHG Saint Brieuc, France, 22000 NHC - Pneumologie Strasbourg, France, 63000 Suresnes - Hopital Foch Suresnes, France, 92151 Thonon les bains - CH Thonon les bains, France, 74200 Toulon - CHI Toulon, France, 83000 CHU Toulouse - Pneumologie Toulouse, France Tourcoing - CH Tourcoing, France, 59208 Tours - CHU Tours, France, 37000 CH Valence Valence, France Less <<
NCT01187615 Small Cell Lung Carcinoma Phase 1 Terminated - United States, Connecticut ... More >> New Haven, Connecticut, United States, 06519 United States, Nevada Las Vegas, Nevada, United States, 89135-3011 United States, New York New York, New York, United States, 10065 United States, North Carolina Chapel Hill, North Carolina, United States, 27599 Less <<
NCT02625415 Palmar-Plantar Erythrodysesthe... More >>sia Less << Not Applicable Completed - Cyprus ... More >> Limassol General Hospital Limassol, Cyprus American Medical Center Nicosia, Cyprus, 1311 Less <<
NCT01313663 Lung Cancer, Small Cell Phase 2 Terminated - -
NCT01343264 - Unknown - Germany ... More >> Dr. Horst Schmidt Klinik, Department of Thoracic Surgery Recruiting Wiesbaden, Germany Contact: Joachim Schirren, MD, PhD    +49 611 433132    joachim.schirren@hsk-wiesbaden.de    Principal Investigator: Joachim Schirren, MD, PhD          Sub-Investigator: Servet Bölükbas, MD, PhD Less <<
NCT01876732 - Completed - -
NCT01373463 Nonsquamous Nonsmall Cell Neop... More >>lasm of Lung Nonsmall Cell Lung Cancer Stage III Less << Phase 1 Terminated(Investigator left s... More >>ite) Less << - United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT01876732 Vitamin B12 Deficiency Not Applicable Completed - United States, New York ... More >> Island Rehab Staten Island, New York, United States, 10305 Less <<
NCT01473563 Nonsquamous Non-Small Cell Neo... More >>plasm of Lung Non-Small Cell Lung Cancer Metastatic Non-Small Cell Lung Cancer Stage IIIB Less << Phase 2 Completed - Sweden ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Linkoping, Sweden, 58185 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Solna, Sweden, 17176 United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, Greater London, United Kingdom, SE1 9RT For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Maidstone, Kent, United Kingdom, ME16 9QQ For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nottingham, Nottinghamshire, United Kingdom, NG5 1PD For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aberdeen, Scotland, United Kingdom, AB25 2ZN For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Huddersfield, West Yorkshire, United Kingdom, HD3 3EA For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, United Kingdom, B95SS For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Manchester, United Kingdom, M20 4BX Less <<
NCT03167697 Phenylketonurias ... More >> Hyperphenylalaninaemia, Type I Less << Not Applicable Enrolling by invitation December 31, 2018 United Kingdom ... More >> Queen Elizabeth Hospital Birmingham, United Kingdom Royal Hospital for Sick Children Edinburgh, United Kingdom Queen Elizabeth University Hospital Glasgow, United Kingdom Guys & St Thomas' Hospital London, United Kingdom Royal Victoria Infirmary Newcastle upon Tyne, United Kingdom Southampton General Hospital Southampton, United Kingdom Less <<
NCT01333696 Squamous Cell Carcinoma of Hea... More >>d and Neck Less << Phase 2 Unknown June 2013 China ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, China, 200032 Contact: Ye Guo, MD    86 21 64175590 ext 8906    pattrick_guo@msn.com    Principal Investigator: Ye Guo, MD Less <<
NCT01473563 - Completed - -
NCT01313663 - Terminated - -
NCT01481259 Non-small Cell Lung Cancer Phase 2 Phase 3 Unknown July 2013 China, Guangxi ... More >> Clinical Cancer Center, People's Hospital of Guangxi Zhuang Autonomous Region Recruiting Nanning, Guangxi, China, 530021 Less <<
NCT01531790 Non-Small Cell Lung Cancer Phase 1 Completed - China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China Less <<
NCT01567384 Cancer Neopla... More >>sms Tumors Less << Phase 1 Withdrawn(The sponsor withdrew... More >> support for the study before any patients were enrolled.) Less << October 2013 United States, Georgia ... More >> Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT01553942 Lung Cancer Phase 2 Recruiting December 2020 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Geoffrey Oxnard, MD    617-632-6049    goxnard@partners.org    Principal Investigator: Geoffrey Oxnard, MD          Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Lecia V Sequist, MD MPH    617-724-4000    lvsequist@partners.org    Principal Investigator: Lecia V Sequist, MD MPH Less <<
NCT01630174 - Unknown - China, Shandong ... More >> Shandong Cancer hospital and institute Recruiting Jinan, Shandong, China, 250017 Principal Investigator: Baosheng Li, Ph.D.          Sub-Investigator: Zhongtang Wang, M.D. Less <<
NCT01593293 Non-small Cell Lung Cancer Phase 3 Unknown November 2015 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Sang-We Kim, M.D.    82-2-3010-3215    swkim@amc.seoul.kr Less <<
NCT01775111 Aging Not Applicable Unknown - Austria ... More >> University of Vienna, Centre of Sports Science and University Sports Recruiting Vienna, Austria, 1150 Contact: Barbara Wessner, Ass.-Prof. DI Dr.    +4314277 ext 28772    barbara.wessner@univie.ac.at    Principal Investigator: Barbara Wessner, Ass.-Prof. DI Dr. Less <<
NCT01247558 - Completed - United States, Delaware ... More >> HealthCore, Inc. Wilmington, Delaware, United States, 19801 Less <<
NCT01590160 Lung Cancer - Malignant Pleura... More >>l Mesothelioma Less << Phase 1 Phase 2 Active, not recruiting November 2018 United Kingdom ... More >> UCL Cancer Trials Centre London, United Kingdom, W1T 4TJ Less <<
NCT01564810 Colorectal Neoplasms ... More >> Neoplasm Metastasis Liver Neoplasms Less << Phase 4 Unknown September 2015 China, Shanghai ... More >> Zhongshan Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200000 Contact: jianmin xu , doctor    008613501984869    xujmin@yahoo.com.cn Less <<
NCT00801606 Tuberculosis Phase 3 Completed - India ... More >> Department of Pediatrics, All India Institute of Medical Sciences New Delhi, Delhi, India, 110029 Less <<
NCT03693677 Metastatic Pancreatic Cancer Phase 2 Recruiting December 2024 France ... More >> CH Jacques Puel Recruiting Cholet, France, 49300 Contact: Laurent MOSSER, MD          Hopital Européen Georges Pompidou Recruiting Paris, France Contact: Julien Taieb, Pr Less <<
NCT03671798 - Recruiting April 2022 Hong Kong ... More >> Department of psychiatry, Faculty of Medicine, The Chinese University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Jihui Zhang, PhD Less <<
NCT01488656 Inflammation Not Applicable Completed - -
NCT02999581 Dietary Modification Not Applicable Completed - -
NCT00482456 Anesthesia, General ... More >> Adverse Effects Nitrous Oxide Less << Phase 4 Completed - Austria ... More >> Dept of Anesthesiology, Medical University of Vienna Vienna, Austria, A-1090 Less <<
NCT01619423 Advanced Metastatic (Stage IV)... More >> Colorectal Cancer Less << Phase 1 Phase 2 Completed - -
NCT03660982 - Recruiting September 30, 2020 Hong Kong ... More >> Department of psychiatry, Faculty of Medicine, The Chinese University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Jihui Zhang, PhD Less <<
NCT02529423 Depression Not Applicable Completed - Germany ... More >> Universität Leipzig Leipzig, Saxony, Germany, 04109 Netherlands VU Amsterdan University Amsterdam, North Holland, Netherlands, 1081 Spain University of Balearic Islands Palma de Mallorca, Balearic Islands, Spain, 07122 United Kingdom University of Exeter Exeter, Devon, United Kingdom, EX4 4SB Less <<
NCT01972490 Colorectal Neoplasms Phase 4 Unknown March 2016 China, Shanghai ... More >> Zhongshan Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200000 Contact: jianmin xu, MD    008613501984869    xujmin@aliyun.com Less <<
NCT02952014 Dietary Modification Not Applicable Completed - United States, Texas ... More >> Exercise & Sport Nutrition Laboratory College Station, Texas, United States, 77843 Less <<
NCT02033382 - Active, not recruiting June 2018 United States, New York ... More >> Bellevue Hospital New York, New York, United States, 10016 Less <<
NCT00197743 HIV Infections ... More >> Disease Transmission, Vertical Less << Phase 3 Completed - United States, Massachusetts ... More >> Harvard School of Public Health Boston, Massachusetts, United States, 02115 Less <<
NCT03136679 - Recruiting December 31, 2019 United States, Texas ... More >> Baylor AT&T Memory Center Recruiting Dallas, Texas, United States, 75231 Contact: Jocelyn A. Allgood, RN, MS    214-818-0382    jocelyn.allgood@bswhealth.org    Principal Investigator: Claudia R Padilla, MD          Sub-Investigator: Teodoro Bottiglieri, PhD Less <<
NCT01263080 Schizophrenia Phase 4 Completed - China, Beijing ... More >> Beijing Anding Hospital, Capital Medical University Beijing, Beijing, China, 100088 Less <<
NCT02827201 Metastatic Pancreatic Cancer Phase 2 Active, not recruiting November 2018 France ... More >> Clinique Privée Claude Bernard Albi, France CH Blois, France Clinique Tivoli Ducos Bordeaux, France Hôpital Duchenne Boulogne sur Mer, France CH Pierre Oudot Bourgoin-Jallieu, France Centre François Baclesse Caen, France CHR côte de Nacre Caen, France Centre Hospitalier Sud Francilien Corbeil Essonnes, France Centre GF Leclerc Dijon, France CH de la Dracénie Draguignan, France Ch Jacques Monod Flers, France CH Frejus, France CHU Le Kremlin Bicetre, France CH Le Mans, France CHU Limoges, France Clinique Chenieux Limoges, France CH Longjumeau -, France CH Pierre Benite Lyon, France Hopital Europeen Marseille Marseille, France, 13331 H Layné Mont-de-Marsan, France HEGP Paris, France, 75020 Hôpital La Pitié Salpêtrière Paris, France, 75651 Hôpital Cochin Paris, France CH St Jean Perpignan, France Hôpital Haut Lévèque Pessac, France Centre Cario - Hpca Saint Brieuc Plérin, France Hôpitaux Drome Nord Romans Sur Isere, France CHU Rouen, France CHP Saint Grégoire, France Clinique Privée Strasbourg, France Hopitaux Du Leman Thonon Les Bains, France Clinique Pasteur Groupe ONCORAD GARONNE Toulouse, France Clinique Privée Pasteur Toulouse, France Clinique Privée Saint Jean Toulouse, France Clinique St Jean Languedoc Toulouse, France Gustave Roussy Villejuif, France, 94805 Hôpital Paul Brousse Villejuif, France Less <<
NCT03487016 Metastatic Pancreatic Cancer Phase 2 Not yet recruiting June 2023 -
NCT01244347 Congenital Malformations Phase 3 Unknown September 2016 Italy ... More >> Ospedale di Adria Adria, Rovigo, Italy, 45011 Ospedale San Luca Trecenta, Rovigo, Italy, 45027 Ospedale di Conegliano Conegliano, Treviso, Italy, 31015 Family Health Centre Montebelluna, Treviso, Italy, 31044 Family Health Practice Oderzo, Treviso, Italy, 31046 Family Health Practice Villorba, Treviso, Italy, 31020 Ospedale Sant'Antonio Abate Gallarate, Varese, Italy, 21013 Family Health Practice Camponogara, Venezia, Italy, 30010 Family Health Centre Martellago, Venezia, Italy, 30030 Family Health Practice Mira, Venezia, Italy, 30034 Family Health Centre Noale, Venezia, Italy, 30033 Family Health Centre San Pietro di Stra, Venezia, Italy, 30031 Family Health Centre Vogonovo, Venezia, Italy, 30030 Ospedale di Bussolengo Bussolengo, Verona, Italy, 37012 Ospedale di Legnago Legnago, Verona, Italy, 37045 Ospedale di San Bonifacio San Bonifacio, Verona, Italy, 37047 Family Health Centre Bassano, Vicenza, Italy, 36061 Ospedale San Bassiano Bassano, Vicenza, Italy, 36061 General Practice Dueville, Vicenza, Italy, 36031 General Practice Malo, Vicenza, Italy, 36034 General Practice Schio, Vicenza, Italy, 36014 General Practice Sovizzo, Vicenza, Italy, 36050 Ospedale Boldrini Thiene, Vicenza, Italy, 36016 Ospedale di Valdagno Valdagno, Vicenza, Italy, 36078 Ospedale di Vicenza Vicenza, VI, Italy, 36100 Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Italy, 20100 Azienda Ospedaliera di Padova Padova, Italy, 35100 Family Health Centre Padova, Italy, 35132 Family Health Centre Verona, Italy, 37122 General Practice Verona, Italy, 37126 Ospedale Civile Maggiore Verona, Italy, 37126 General Practice Verona, Italy, 37129 Family Health Centre Verona, Italy, 37131 Policlinico G.B. Rossi Verona, Italy, 37134 Less <<
NCT01976676 Recurrent Abortion Phase 2 Phase 3 Completed - -
NCT01302756 Gestational Diabetes ... More >> Gestational Hypertension Less << Not Applicable Withdrawn - -
NCT03268733 Polycystic Ovary Syndrome Phase 1 Phase 2 Recruiting September 1, 2019 Sudan ... More >> Saad Abul ella fertility Centre Recruiting Khartoum, Sudan, 11111 Contact: Mohammed ibrahim Awad    00249900904060    awad22mohd@gmail.com Less <<
NCT00162409 Folic Acid Deficiency UNKNOWN - Hadassah Medical Organization,... More >> Jerusalem, Israel Less <<
NCT00807807 Heart Diseases Phase 3 Completed - -
NCT00689949 Healthy Not Applicable Completed - Germany ... More >> Haunersche Kinderklinik Muenchen, Germany, D80337 Less <<
NCT00512850 Adenoma of Large Intestine Not Applicable Completed - -
NCT01258660 Contraception Phase 1 Completed - Germany ... More >> Nuvisan GmbH Neu-Ulm, Bayern, Germany, 89231 Less <<
NCT03559842 - Recruiting May 4, 2020 Italy ... More >> Internal Medicine Recruiting Perugia, Italy, 06132 Contact: Graziana Lupattelli, Prof    00390755784023    graziana.lupattelli@unipg.it Less <<
NCT01258660 - Completed - -
NCT01355159 Pregnancy Complications ... More >> Preeclampsia Less << Phase 3 Completed - -
NCT01789723 Non Hodgkin's Lymphoma Phase 1 Withdrawn March 2015 -
NCT02475590 Morbid Obesity Not Applicable Active, not recruiting July 2022 France ... More >> Service de Chirurgie Digestive et Endocrinienne Strasbourg, France, 67 000 Less <<
NCT02384759 Colorectal Neoplasms Phase 2 Unknown July 2018 -
NCT01407432 Male Infertility Phase 3 Completed - France ... More >> Service of gynaecology-obstetrics and medicine of the reproduction, Tenon Hospital - APHP Paris, France, 75020 Less <<
NCT01991639 Frail Elderly ... More >> Malnutrition Less << Not Applicable Completed - Austria ... More >> Institute of Social Medicine, Centre for Public Health Vienna, Austria, 1090 Less <<
NCT01619423 - Completed - -
NCT02732444 - Completed - Brazil ... More >> Hospital of clinics of the federal university of uberlândia Uberlandia, Minas Gerais, Brazil Less <<
NCT01147523 Fatty Liver S... More >>teatohepatitis Less << Phase 2 Completed - Greece ... More >> Second Medical Clinic, Medical School, Aristotle University of Thessaloniki, Ippokration Hospital Thessaloniki, Greece, 54642 Less <<
NCT00727571 - Completed - -
NCT01836432 Pancreatic Cancer ... More >> Pancreatic Carcinoma Non-resectable Locally Advanced Malignant Neoplasm Less << Phase 3 Unknown June 2017 -
NCT02582567 Pregnancy Not Applicable Unknown July 2017 Spain ... More >> Pilar Cabello-Turmo Granada, Spain, 18071 Less <<
NCT00118937 Diabetes Mellitus, Type 1 Phase 4 Completed - -
NCT01928004 Edentulous Complete Denture We... More >>arers Less << Not Applicable Unknown April 2018 Switzerland ... More >> University of Geneva Geneva, Switzerland, 1205 Less <<
NCT00727571 - Completed - -
NCT03406793 Diarrhea Stun... More >>ting Less << Not Applicable Recruiting January 30, 2020 Bangladesh ... More >> Icddr,B Recruiting Dhaka, Bangladesh Contact: Munir Islam, MBBS, PhD    880 2 982 7001-10 ext 2352    mislam@icddrb.org Less <<
NCT00118950 Diabetes Mellitus, Type 2 Phase 4 Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, 2820 Less <<
NCT02799472 Arthritis, Rheumatoid Phase 2 Completed - United States, California ... More >> GSK Investigational Site El Cajon, California, United States, 92020 United States, Florida GSK Investigational Site Fort Lauderdale, Florida, United States, 33309 GSK Investigational Site Miami, Florida, United States, 33015 GSK Investigational Site Pinellas Park, Florida, United States, 33781 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60616 United States, Pennsylvania GSK Investigational Site Duncansville, Pennsylvania, United States, 16635 United States, Tennessee GSK Investigational Site Memphis, Tennessee, United States, 38119 United States, Texas GSK Investigational Site Houston, Texas, United States, 77024 Germany GSK Investigational Site Freiburg, Baden-Wuerttemberg, Germany, 79106 GSK Investigational Site Erfurt, Thueringen, Germany, 99096 GSK Investigational Site Puettlingen, Germany, 66346 Poland GSK Investigational Site Elblag, Poland, 82-300 GSK Investigational Site Nowa Sol, Poland, 67-100 GSK Investigational Site Piaseczno, Poland, 05-500 GSK Investigational Site Warszawa, Poland, 00-660 GSK Investigational Site Warszawa, Poland, 03-291 GSK Investigational Site Wroclaw, Poland, 51-128 Less <<
NCT00798772 HIV Infection Not Applicable Completed - Canada, Ontario ... More >> The Ottawa Hospital, General Campus Ottawa, Ontario, Canada, K1H 8L6 Less <<
NCT02463435 Severe Obesity Not Applicable Completed - Brazil ... More >> Unidade de Pesquisa Clínica do Hospital das Clínicas/UFG Goiânia, Goiás, Brazil, 74605-020 Less <<
NCT01263782 Lung Cancer Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02896907 Pancreatic Adenocarcinoma ... More >> Recurrent Pancreatic Carcinoma Stage III Pancreatic Cancer Stage IV Pancreatic Cancer Unresectable Pancreatic Carcinoma Less << Early Phase 1 Active, not recruiting January 1, 2019 United States, Pennsylvania ... More >> Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT02637778 Cardiovascular Diseases Not Applicable Completed - -
NCT01746199 Malaria in Pregnancy ... More >> HIV Infection Less << Phase 3 Unknown - Central African Republic ... More >> Maternité de l'Hôpital communautaire Not yet recruiting Bangui, Central African Republic Maternité de l'Hôpital de l'Amitié Not yet recruiting Bangui, Central African Republic Maternité de la Gendarmerie Nationale Not yet recruiting Bangui, Central African Republic Maternité du centre de santé des Castors Not yet recruiting Bangui, Central African Republic Less <<
NCT00068692 Rectal Mucinous Adenocarcinoma... More >> Rectal Signet Ring Cell Adenocarcinoma Recurrent Rectal Carcinoma Stage IIA Rectal Cancer AJCC v7 Stage IIB Rectal Cancer AJCC v7 Stage IIC Rectal Cancer AJCC v7 Stage IIIA Rectal Cancer AJCC v7 Stage IIIB Rectal Cancer AJCC v7 Stage IIIC Rectal Cancer AJCC v7 Stage IVA Rectal Cancer AJCC v7 Stage IVB Rectal Cancer AJCC v7 Less << Phase 3 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT01845922 Refeeding Syndrome Phase 4 Unknown February 2014 Denmark ... More >> Rigshospitalet Recruiting Copenhagen ø, Denmark, 2100 Contact: Irene Wessel, MD, Phd    004535458322       Sub-Investigator: Katrine B. Dester, M.S. student          Sub-Investigator: Henrik Carlsen, M.S. student          Sub-Investigator: Martine D. Hansen, M.S. student Less <<
NCT00068692 - Completed - -
NCT00034619 Colorectal Cancer Phase 2 Completed - United States, Alabama ... More >> "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Huntsville, Alabama, United States United States, Massachusetts "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Pittsfield, Massachusetts, United States United States, Michigan "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Kalamazoo, Michigan, United States United States, New York "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Latham, New York, United States United States, North Carolina "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Asheville, North Carolina, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Goldsboro, North Carolina, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Hendersonville, North Carolina, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Winston-Salem, North Carolina, United States United States, Ohio "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Columbus, Ohio, United States United States, Oregon "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Bend, Oregon, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Portland, Oregon, United States United States, Pennsylvania "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Philadelphia, Pennsylvania, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Pittsburgh, Pennsylvania, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Reading, Pennsylvania, United States United States, South Carolina "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Charleston, South Carolina, United States United States, Utah "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Ivins, Utah, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Ogden, Utah, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Provo, Utah, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" St. George, Utah, United States United States, Washington "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Bellevue, Washington, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Seattle, Washington, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Spokane, Washington, United States Less <<
NCT00035061 Urologic Neoplasms ... More >> Metastases, Neoplasm Less << Phase 2 Completed - United States, California ... More >> Los Angeles, California, United States Palo Alto, California, United States United States, Florida Boca Raton, Florida, United States Tampa, Florida, United States United States, Illinois Decatur, Illinois, United States United States, Indiana Indianapolis, Indiana, United States Lafayette, Indiana, United States Muncie, Indiana, United States South Bend, Indiana, United States United States, Kansas Lenexa, Kansas, United States United States, Kentucky Saint Mathews, Kentucky, United States United States, Massachusetts Boston, Massachusetts, United States United States, Nebraska Omaha, Nebraska, United States United States, Ohio Cleveland, Ohio, United States United States, Pennsylvania Philadelphia, Pennsylvania, United States Pittsburgh, Pennsylvania, United States United States, Tennessee Nashville, Tennessee, United States United States, Texas Fort Worth, Texas, United States Houston, Texas, United States United States, Washington Seattle, Washington, United States Less <<
NCT03472820 Lifestyle Die... More >>t Healthy Less << Not Applicable Recruiting April 1, 2019 United States, Oregon ... More >> NUNM Helfgott Research Institute Recruiting Portland, Oregon, United States, 97201 Contact: Trina Soileau Research Coordinator    503-552-1746    tsoileau@nunm.edu    Contact: Emily Stack Research Coordinator    503-552-1777    estack@nunm.edu    Principal Investigator: Ryan Bradley, ND, MPH Less <<
NCT00040625 - - - United States, New Jersey ... More >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Basking Ridge, New Jersey, United States Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician Porto Alegre, RS, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician Sao Paulo, Brazil Egypt "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Cairo, Egypt For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician Cairo, Egypt Saudi Arabia For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician Jeddah, Saudi Arabia Less <<
NCT01277406 Advanced Colorectal Carcinoma Phase 1 Phase 2 Completed - Germany ... More >> KTB-Klinik für Tumorbiologie, Klinik für Internistische Onkologie Freiburg, Germany University of Heidelberg Heidelberg, Germany Universitaetsklinikum Tuebingen; Med. Klinik und Poliklinik II Tuebingen, Germany Less <<
NCT00051506 Lung Neoplasms Phase 2 Completed - United States, Arkansas ... More >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Springdale, Arkansas, United States United States, California For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Los Angeles, California, United States United States, Florida For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Fort Myers, Florida, United States For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Miami, Florida, United States United States, New York For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Latham, New York, United States United States, North Carolina For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Burlington, North Carolina, United States For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Chapel Hill, North Carolina, United States United States, South Carolina For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Charleston, South Carolina, United States Less <<
NCT00706888 Cardiovascular Risk Factors Not Applicable Completed - France ... More >> Biofortis Nantes, France Less <<
NCT02799472 - Completed - -
NCT00065533 Breast Cancer Phase 2 Completed - Argentina ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Buenos Aires, Argentina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Capitol Federal, Argentina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. S.M. De Tucuman, Argentina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Tucuman, Argentina Belgium For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Brussels, Belgium For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Leuven, Belgium For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Namur, Belgium Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Munich, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Wiesbaden, Germany Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Bucuresti, Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Cluj, Romania Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Badalona, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Barcelona, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Madrid, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Malaga, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Santander, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Valencia, Spain United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Newcastle Upon Tyne, Tyne and Wear, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Birmingham, West Midlands, United Kingdom Less <<
NCT00051493 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - United States, Texas ... More >> Houston, Texas, United States Less <<
NCT00763633 Nausea and Vomiting Complain i... More >>n Early Pregnancy Less << Phase 4 Unknown October 2008 Indonesia ... More >> Dept. Obstetric Gynecology Univ. Indonesia Recruiting Jakarta, Indonesia, 13210 Contact: Noroyono Wibowo, MD, PhD    +6221 3915041    wibowonoroyono@yahoo.com    Principal Investigator: Noroyono Wibowo, MD, PhD          Sub-Investigator: Yuditiya Purwosunu, MD Less <<
NCT00835731 Cervical Ripening Not Applicable Completed - United States, Massachusetts ... More >> Planned Parenthood League of Massachusetts Boston, Massachusetts, United States, 02215 Less <<
NCT00070473 Unspecified Childhood Solid Tu... More >>mor, Protocol Specific Less << Phase 1 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 323669 Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States, 94305 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010-2970 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Maryland NCI - Pediatric Oncology Branch Bethesda, Maryland, United States, 301496 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Fairview University Medical Center - University Campus Minneapolis, Minnesota, United States, 55455 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Mississippi University of Mississippi Medical Center Jackson, Mississippi, United States, 39216-4505 United States, New York Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 SUNY Upstate Medical University Hospital Syracuse, New York, United States, 13210 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Oregon Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239-3098 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 215590 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 Baylor University Medical Center - Houston Houston, Texas, United States, 832822 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 206987 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada Canada, Quebec Hopital Sainte Justine Montreal, Quebec, Canada Less <<
NCT00078260 Non-Small Cell Lung Cancer Phase 3 Completed - Turkey ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ankara, Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gaziantep, Turkey Less <<
NCT00835731 - Completed - -
NCT00003706 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Texas ... More >> San Antonio Cancer Institute San Antonio, Texas, United States, 78229-3264 Less <<
NCT00767689 Hand and Foot Syndrome Not Applicable Unknown May 2010 United States, Illinois ... More >> John H stroger Jr hospital of cook county Recruiting Chicago, Illinois, United States, 60612 Less <<
NCT00079872 Colorectal Cancer Phase 2 Completed - Australia, Victoria ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician NSW, QLD, South Australia, Victoria, Australia Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Woodville, Australia Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Frankfurt/Main, Germany Greece For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Krete, Greece Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Amsterdam, Netherlands Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Sevilla, Spain Less <<
NCT00087100 Endometrial Cancer Phase 2 Completed - -
NCT00087087 Ovarian Cancer ... More >> Primary Peritoneal Cavity Cancer Less << Phase 2 Completed - -
NCT00087113 Cervical Cancer Phase 2 Completed - United States, Arkansas ... More >> Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 United States, California Doctors Medical Center Modesto, California, United States, 95350-4138 United States, Connecticut Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States, 06105 United States, Illinois Hinsdale Hematology Oncology Associates Hinsdale, Illinois, United States, 60521 United States, Missouri CCOP - Kansas City Kansas City, Missouri, United States, 64131 St. John's Regional Health Center Springfield, Missouri, United States, 65804 United States, Nevada Women's Cancer Center - Las Vegas Las Vegas, Nevada, United States, 89102 United States, New York SUNY Downstate Medical Center Brooklyn, New York, United States, 11203 SUNY Upstate Medical University Hospital Syracuse, New York, United States, 13210 United States, North Carolina Hope A Women's Cancer Center Asheville, North Carolina, United States, 28801 Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 United States, Ohio Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 MetroHealth's Cancer Care Center at MetroHealth Medical Center Cleveland, Ohio, United States, 44109 Hillcrest Cancer Center at Hillcrest Hospital Mayfield Heights, Ohio, United States, 44124 United States, Oklahoma Oklahoma University Medical Center Oklahoma City, Oklahoma, United States, 73104 Cancer Care Associates - Midtown Tulsa Tulsa, Oklahoma, United States, 74104 United States, Oregon Williamette Gynecologic Oncology P.C. Salem, Oregon, United States, 97301 United States, Pennsylvania Rosenfeld Cancer Center at Abington Memorial Hospital Abington, Pennsylvania, United States, 19001 Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest Allentown, Pennsylvania, United States, 18105 United States, Texas Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 United States, Virginia Massey Cancer Center at Virginia Commonwealth University Richmond, Virginia, United States, 23298-0037 Less <<
NCT00087698 Pleural Neoplasms Phase 2 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Francisco, California, United States United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States United States, Maryland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baltimore, Maryland, United States United States, Massachusetts For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Boston, Massachusetts, United States United States, Michigan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Detroit, Michigan, United States United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New York, New York, United States United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Houston, Texas, United States Less <<
NCT00072865 Breast Cancer ... More >> Neoplasm Metastasis Less << Phase 2 Completed - Russian Federation ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Moscow, Russia, Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Saint Petersburg, Russia, Russian Federation Less <<
NCT00102804 Non-Small Cell Lung Cancer Phase 3 Completed - -
NCT00087698 - Completed - -
NCT00106002 Breast Cancer ... More >> Breast Neoplasms, Male Carcinoma, Ductal Less << Phase 2 Completed - United States, Texas ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75204 Less <<
NCT00102804 - Completed - -
NCT00106002 - Completed - -
NCT00109096 Ovarian Neoplasms ... More >> Primary Peritoneal Cancer Less << Phase 2 Completed - Belgium ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bruxelles, Belgium For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leuven, Belgium Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Erlangen, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Homburg/Saar, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jena, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Magdeburg, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munchen, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wolfsburg, Germany Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jaen, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Malaga, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Palma De Mallorca, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sabadell, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leeds, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Newcastle-Upon-Tyne, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sutton, United Kingdom Less <<
NCT00005636 Malignant Mesothelioma Phase 3 Completed - United States, New Jersey ... More >> Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT01136512 - Completed - United States, New York ... More >> Staten Island University Hospital Staten Island, New York, United States, 10305 Less <<
NCT00111839 Lung Cancer N... More >>on Small Cell Lung Carcinoma Less << Phase 2 Completed - -
NCT00107419 Sarcoma Phase 2 Completed - -
NCT00111839 - Completed - -
NCT00190801 Gastrointestinal Neoplasms Phase 2 Completed - Korea, Republic of ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goyang-Si, Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. In Cheon, Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of Less <<
NCT00117962 - Completed - -
NCT00096187 Gestational Trophoblastic Tumo... More >>r Less << Phase 2 Terminated - United States, Alabama ... More >> Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham Birmingham, Alabama, United States, 35294 United States, California Providence Saint Joseph Medical Center - Burbank Burbank, California, United States, 91505 Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange, California, United States, 92868 United States, Illinois Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Hinsdale Hematology Oncology Associates Hinsdale, Illinois, United States, 60521 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242 United States, Missouri St. John's Regional Health Center Springfield, Missouri, United States, 65804 Hulston Cancer Center at Cox Medical Center South Springfield, Missouri, United States, 65807 United States, New Jersey Cancer Institute of New Jersey at Cooper - Voorhees Voorhees, New Jersey, United States, 08043 United States, North Carolina Blumenthal Cancer Center at Carolinas Medical Center Charlotte, North Carolina, United States, 28232-2861 Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Wilson Medical Center Wilson, North Carolina, United States, 27893-3428 United States, Ohio Charles M. Barrett Cancer Center at University Hospital Cincinnati, Ohio, United States, 45267 Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus, Ohio, United States, 43210-1240 Riverside Methodist Hospital Cancer Care Columbus, Ohio, United States, 43214-3998 Hillcrest Cancer Center at Hillcrest Hospital Mayfield Heights, Ohio, United States, 44124 Lake/University Ireland Cancer Center Mentor, Ohio, United States, 44060 United States, Oklahoma Oklahoma University Cancer Institute Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania Rosenfeld Cancer Center at Abington Memorial Hospital Abington, Pennsylvania, United States, 19001 McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center Reading, Pennsylvania, United States, 19612-6052 United States, Texas Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 UMC Southwest Cancer and Research Center Lubbock, Texas, United States, 79415-3364 Less <<
NCT00190840 Carcinoma, Non-Small Cell Lung Phase 2 Completed - Australia, New South Wales ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wollongong, New South Wales, Australia, 2500 Australia, Queensland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chermside, Queensland, Australia, 4032 Australia, South Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ashford, South Australia, Australia, 5035 Australia, Victoria For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fitzroy, Victoria, Australia, 3065 China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hong Kong, China Egypt For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alexandria, Egypt For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cairo, Egypt, 11796 India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyderabad, Andhra Pradesh, India, 500004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ludhiana, Punjab, India, 141001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chandigarh, India, 160012 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chennai, India, 600035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Delhi, India, 110085 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goyang-Si, Gyeonggi-Do, Korea, Republic of, 411764 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oradea, Bihor, Romania, 3700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Craiova, Dolj, Romania, 1100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bucuresti, Romania, 72435 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Iasi, Romania, 6600 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Eskisehir, Turkey Less <<
NCT00190762 Mesothelioma Phase 3 Completed - Canada, Ontario ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9:00 AM - 5:00 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician Ottawa, Ontario, Canada, K1H8L6 Less <<
NCT00190918 Trophoblastic Neoplasms ... More >> Uterine Neoplasms Hydatidiform Mole Choriocarcinoma Less << Phase 2 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group 215-854-0770 Philadelphia, Pennsylvania, United States Less <<
NCT00191191 Non-small Cell Lung Cancer Phase 2 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Chiba, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Ehime, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Fukuoka, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Gifu, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Gunma, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Hokkaido, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Hyogo, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Kanagawa, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Kumamoto, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Miyagi, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Niigata, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Okayama, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Osaka, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Saitama, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Shizuoka, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Tokyo, Japan Less <<
NCT00190983 Cervical Intraepithelial Neopl... More >>asia Uterine Neoplasms Genital Neoplasms, Female Less << Phase 2 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group 215-854-0770 Philadelphia, Pennsylvania, United States Less <<
NCT00190983 - Completed - -
NCT00191412 Liver Cancer Phase 2 Completed - United States, Colorado ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Denver, Colorado, United States Less <<
NCT00117962 Lung Cancer Phase 2 Completed - -
NCT00203931 Non-small Cell Lung Cancer Phase 2 Terminated(Slow accrual and ev... More >>idence from other studies showing benefit of early initiation of pemetrexed after first-line therapy) Less << - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00203931 - Terminated(Slow accrual and ev... More >>idence from other studies showing benefit of early initiation of pemetrexed after first-line therapy) Less << - -
NCT00191191 - Completed - -
NCT00191750 Carcinoma, Small Cell Phase 2 Completed - United States, Colorado ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Aurora, Colorado, United States United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Chapel Hill, North Carolina, United States United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Dallas, Texas, United States Less <<
NCT00198133 - Completed - -
NCT00198133 Thymoma Thymi... More >>c Carcinoma Less << Phase 2 Completed - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00192088 Advanced Gastric Carcinoma Phase 2 Completed - Italy ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ancona, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bari, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bergamo, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brescia, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Firenze, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gorgonzola, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mantova, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Padova, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Parma, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Roma, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Varese, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Verona, Italy Less <<
NCT00227565 Lung Cancer Phase 2 Completed - -
NCT00216216 Small Cell Lung Cancer Phase 2 Terminated(The results from th... More >>e interim analysis were not favorable to continue this trial.) Less << - United States, Delaware ... More >> Helen F. Graham Cancer Center Newark, Delaware, United States, 19713 United States, Illinois Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Elkhart Clinic Elkhart, Indiana, United States, 46515 Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Center for Cancer Care at Goshen Health System Goshen, Indiana, United States, 46527 Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Community Regional Cancer Center Indianapolis, Indiana, United States, 46256 Arnett Cancer Care Lafayette, Indiana, United States, 47904 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 Center for Cancer Care, Inc., P.C. New Albany, Indiana, United States, 47150 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 Northern Indiana Oncology Associates South Bend, Indiana, United States, 46617 AP&S Clinic Terre Haute, Indiana, United States, 47804 United States, Missouri Siteman Cancer Center St. Louis, Missouri, United States, 63110 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 Less <<
NCT00216203 - Completed - -
NCT00227630 Malignant Mesothelioma Phase 2 Completed - Belgium ... More >> Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 Italy Istituto Nazionale per la Ricerca sul Cancro Genoa, Italy, 16132 Azienda Ospedaliera Di Parma Parma, Italy, 43100 Universita Degli Studi di Udine Udine, Italy, 33100 Netherlands Sint Antonius Ziekenhuis Nieuwegein, Netherlands, 3435 CM Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands, 3008 AE United Kingdom Princess Royal Hospital at Hull and East Yorkshire NHS Trust Hull, England, United Kingdom, HU8 9HE Edinburgh Cancer Centre at Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Less <<
NCT01230359 Autism Spectrum Disorders ... More >> Stable Clinical Condition in the Last 3 Months Less << Not Applicable Completed - Qatar ... More >> Rumailah Hospital Doha, Qatar, 3050 Less <<
NCT00216203 Non-Small Cell Lung Cancer Phase 1 Phase 2 Completed - United States, Illinois ... More >> Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Cancer Care Center of Southern Indiana Bloomington, Indiana, United States, 47403 Elkhart Clinic Elkhart, Indiana, United States, 46515 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Center for Cancer Care at Goshen Health System Goshen, Indiana, United States, 46527 Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 United States, Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Ohio Oncology Hematology Care, Inc. Cincinnati, Ohio, United States, 45242 United States, Texas Texas Oncology Cancer Center Austin, Texas, United States, 78731 Less <<
NCT00230542 Ovarian Cancer ... More >> Peritoneal Cancer Fallopian Tube Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00248495 - Completed - -
NCT00251550 Malignant Pleural Mesotherioma Phase 1 Phase 2 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Aichi, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Ehime, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Fukuoka, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Hokkaido, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Okayama, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Osaka, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Tokyo, Japan Less <<
NCT00259285 Non-Small-Cell Lung Cancer Phase 2 Terminated(Trial was stopped e... More >>arly due to low enrollment.) Less << - Spain ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barakaldo, Spain, 48903 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Coruña, Spain, 15006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pamplona, Spain, 31008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46014 Less <<
NCT00248495 Lung Cancer Phase 2 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00259285 - Terminated(Trial was stopped e... More >>arly due to low enrollment.) Less << - -
NCT00265785 Lung Cancer Phase 2 Terminated(Closed due to poor ... More >>accrual) Less << - -
NCT00268437 - Terminated(Trial closed early ... More >>because, during an interim analysis, the primary endpoint fell short.) Less << - -
NCT00265785 - Terminated(Closed due to poor ... More >>accrual) Less << - -
NCT00269152 Non-Small Cell Lung Cancer Phase 2 Completed - France ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bordeaux, France, 33076 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paris, France, 75571 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rennes, France, 35033 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St Priest En Jarez, France, 42270 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toulouse, France, 31059 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bad Berka, Germany, 99437 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bielefeld, Germany, D-33604 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Großhansdorf, Germany, D-22927 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Halle, Germany, D-06120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, D-30625 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kassel, Germany, 34125 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Köln, Germany, D-51109 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Loewenstein, Germany, 74245 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, D-55131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mannheim, Germany, 68167 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28046 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santiago De Compostela, Spain, 15706 Less <<
NCT00269152 - Completed - -
NCT00268437 Esophageal Cancer Phase 2 Terminated(Trial closed early ... More >>because, during an interim analysis, the primary endpoint fell short.) Less << - -
NCT00280748 Lung Cancer M... More >>etastatic Cancer Less << Phase 2 Terminated(Slow accrual) - United States, North Carolina ... More >> Alamance Oncology/Hematology Associates, LLP Burlington, North Carolina, United States, 27216 Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT00290017 Carcinoma, Non-Small-Cell Lung... More >> Lung Cancer Neoplasms, Lung Neoplasms, Pulmonary Less << Phase 3 Terminated(FDA Hold May 2007) - -
NCT00280748 - Terminated(Slow accrual) - -
NCT00293579 Head and Neck Cancer Phase 2 Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00293579 - Completed - -
NCT00276783 Brain and Central Nervous Syst... More >>em Tumors Lymphoma Metastatic Cancer Less << Phase 2 Active, not recruiting December 2019 United States, Illinois ... More >> Hematology-Oncology Associates of Illinois Chicago, Illinois, United States, 60611-2998 Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT00316225 Non-small Cell Lung Cancer ... More >> Mesothelioma Lung Neoplasms Less << Phase 2 Completed - Denmark ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kobenhavn, Denmark, 2100 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, 30625 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28041 Less <<
NCT00297089 Lung Cancer N... More >>SCLC Non-Small-Cell Lung Cancer Less << Phase 1 Phase 2 Completed - -
NCT00320515 Neoplasm, Gastric Phase 1 Phase 2 Completed - Argentina ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Buenos Aires, Argentina, 1264 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tucumain, Argentina, 4000 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 136-705 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ciudad Obregon, Mexico, 85100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guadalajara, Mexico, 44280 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tainan, Taiwan, 704 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 112 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 Less <<
NCT00320515 - Completed - -
NCT00321308 Carcinoma, Non-Small Cell Lung Phase 2 Terminated(See Termination Rea... More >>son in Detailed Description.) Less << - United States, Arizona ... More >> Pfizer Investigational Site Litchfield Park, Arizona, United States, 85340 Pfizer Investigational Site Sun City, Arizona, United States, 85351 United States, Arkansas Pfizer Investigational Site Bentonville, Arkansas, United States, 72712 Pfizer Investigational Site Fayetteville, Arkansas, United States, 72703 United States, Florida Pfizer Investigational Site Hudson, Florida, United States, 34667 Pfizer Investigational Site New Port Richey, Florida, United States, 34655 United States, New Jersey Pfizer Investigational Site Mahwah, New Jersey, United States, 07430 Pfizer Investigational Site Midland Park, New Jersey, United States, 07432 Pfizer Investigational Site Paramus, New Jersey, United States, 07652 Pfizer Investigational Site Westwood, New Jersey, United States, 07675 United States, New York Pfizer Investigational Site Oneida, New York, United States, 13421 Pfizer Investigational Site Oswego, New York, United States, 13126 Pfizer Investigational Site Syracuse, New York, United States, 13210-2306 Pfizer Investigational Site Syracuse, New York, United States, 13210 United States, Ohio Pfizer Investigational Site Sylvania, Ohio, United States, 43560 United States, Washington Pfizer Investigational Site Seattle, Washington, United States, 89109 Pfizer Investigational Site Seattle, Washington, United States, 98195 Germany Pfizer Investigational Site Grosshansdorf, Germany, 22927 Pfizer Investigational Site Mannheim, Germany, 68167 Italy Pfizer Investigational Site Torino, Italy, 10126 Less <<
NCT00316225 - Completed - -
NCT00334594 Malignant Mesothelioma Phase 2 Completed - Germany ... More >> Universitaetsklinikum Freiburg Freiburg, Germany, D-79106 Switzerland Kantonsspital Aarau Aarau, Switzerland, CH-5001 Kantonsspital Baden Baden, Switzerland, CH-5404 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Spital Tiefenau Bern 4, Switzerland, 3004 Inselspital Bern Bern, Switzerland, CH-3010 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital Olten Olten, Switzerland, CH-4600 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 SpitalSTS AG Simmental-Thun-Saanenland Thun, Switzerland, 3600 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT00330044 Inoperable Non Small Cell Lung... More >> Cancer Less << Phase 1 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00343720 Non-Small Cell Lung Cancer Phase 2 Completed - Belgium ... More >> Hopital de Jolimont Haine-Saint-Paul, Belgium, 7100 Less <<
NCT00350792 - Completed - -
NCT00370292 Non Small Cell Lung Cancer Phase 2 Completed - Italy ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy Less <<
NCT00372788 Non-small Cell Lung Cancer Phase 2 Completed - United States, California ... More >> Research Site Los Angeles, California, United States United States, Michigan Research Site Ann Arbor, Michigan, United States United States, New York Research Site New York, New York, United States United States, Tennessee Research Site Nashville, Tennessee, United States Bulgaria Research Site Plovdiv, Bulgaria Research Site Sofia, Bulgaria Research Site Varna, Bulgaria Romania Research Site Cluj-Napoca, Romania Less <<
NCT00291707 Head and Neck Cancer Phase 1 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00374868 Urologic Neoplasms Phase 1 Phase 2 Completed - Spain ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pamplona, Spain, 31008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sabadell, Spain, 08208 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santander, Spain, 39008 Less <<
NCT00374868 - Completed - -
NCT00377520 Neoplasms Neo... More >>plasms by Site Urogenital Neoplasms Genital Neoplasms, Female Uterine Neoplasms Endometrial Neoplasms Cancer of Endometrium Endometrial Cancer Cancer of the Endometrium Endometrium Cancer Neoplasms, Endometrial Less << Phase 2 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group 215-854-0770 Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT01093378 - Completed - France ... More >> Laboratoire d'Histologie- Embryologie - Cytogénétique - CECOS Bondy, France, 93143 Less <<
NCT00380718 Non-small Cell Lung Cancer Phase 4 Completed - Taiwan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 407 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 112 Less <<
NCT00380718 - Completed - -
NCT00383266 Esophageal Neoplasms Phase 2 Terminated(Low accrual) - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00389688 Lung Cancer Phase 2 Terminated(low accrual) - Belgium ... More >> Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 Less <<
NCT00386815 Malignant Pleural Mesothelioma Phase 2 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 464-8681 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 811-1395 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 060-8648 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 663-8501 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Okayama, Japan, 702-8055 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 589-8511 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 104-0045 Less <<
NCT00370292 - Completed - -
NCT00843453 Vitamin B12 Deficiency Not Applicable Completed - United States, Maryland ... More >> Long View Nursing Home Manchester, Maryland, United States, 21102 Stella Maris Nursing Home Timonium, Maryland, United States, 21093 Less <<
NCT00350792 Non Small Cell Lung Cancer Phase 2 Completed - France ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bobigny, France, 93009 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brest, France, 29609 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Caen, France, 14076 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Le Mans, France, 72000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lille, France, 59000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nantes, France, 44202 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vandoeuvre Les Nancy, France, 54511 Less <<
NCT00383266 - Terminated(Low accrual) - -
NCT00377520 - Completed - -
NCT00402051 - Completed - -
NCT00402051 Non-Small-Cell Lung Cancer Phase 2 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Coswig, Germany, D-01640 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany, 65929 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Großhansdorf, Germany, D-22927 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Halle, Germany, D-06120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, D-21075 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hofheim, Germany, D-65719 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Homburg/Saar, Germany, 66421 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Immenhausen, Germany, D-34376 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leipzig, Germany, 04207 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Luebeck, Germany, 23538 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, 55131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Muenchen, Germany, 81664 Less <<
NCT02135393 Healthy Not Applicable Completed - United Kingdom ... More >> Freeman Hospital Newcastle Upon Tyne, Tyneside, United Kingdom, NE7 7DN Institute of Food Research Norwich, United Kingdom, NR47UA Less <<
NCT02221752 Iron Deficiency ... More >> Iron Deficiency Anemia Less << Not Applicable Completed - China ... More >> Peking University First Hospital Beijing, China, 100034 Less <<
NCT03720249 Hyperhomocysteinemia Not Applicable Not yet recruiting December 31, 2022 China, Guangdong ... More >> SunYat-sen University Guangzhou, Guangdong, China, 510080 Less <<
NCT01687127 One-carbon Metabolism in Healt... More >>hy Individuals Less << Not Applicable Not yet recruiting December 31, 2019 Canada, British Columbia ... More >> Children's and Women's Health Centre of BC (incl. Sunny Hill), Child and Family Research Institute Not yet recruiting Vancouver, British Columbia, Canada, V5Z 4H4 Contact: Yvonne Lamers, PhD    604-827-1776    yvonne.lamers@ubc.ca    Contact: Amy McMahon, PhD    604-822-1250    amy.mcmahon@ubc.ca    Sub-Investigator: Jehannine C Austin, PhD          Sub-Investigator: Amanda Skoll, MD, FRCSC Less <<
NCT02318446 Epilepsy Phase 3 Unknown May 2016 India ... More >> Smt. Kashibai Navale Medical College and General Hospital Not yet recruiting Pune, Maharashtra, India, 411041 Contact: Uma A. Bhosale, MD    02024106 ext 148    umabhosale2000@gmail.com Less <<
NCT01490944 Anaemia Phase 2 Unknown January 2013 India ... More >> Kirti Nagar Slums Recruiting New Delhi, Delhi, India, 110015 Contact: Gurdayal S Toteja, Ph.D    +91-11-23731633    gstoteja@gmail.com    Contact: Priyanka Gupta, M.Sc    +91-11-26890602    priyankaicmr@gmail.com    Principal Investigator: Gurdayal S Toteja, Ph.D          Principal Investigator: Priyanka Gupta, M.Sc Less <<
NCT01570088 Red Blood Cell Folate Phase 2 Completed - Canada, British Columbia ... More >> University of British Columbia Vancouver, British Columbia, Canada, V6T 1Z4 Less <<
NCT03674333 Dyslipidemias Not Applicable Not yet recruiting March 15, 2019 Pakistan ... More >> Shaheed Zulfiqar Ali Bhutto Medical University, Pakistan Institute of Medical Sciences Hospital Not yet recruiting Islamabad, Pakistan, 44000 Contact: Fibhaa Syed, FCPS, MRCP    923335300002    Fibhaasyed@gmail.com Less <<
NCT02235948 Arsenic Poisoning ... More >> Toxic Effect of Arsenic and Its Compounds Less << Phase 2 Unknown December 2016 -
NCT01766310 Hyperhomocysteinemia ... More >> Obesity Less << Phase 4 Completed - Thailand ... More >> Department of Pediatrics, Queen Sirikit National Institute of Child Health Bangkok, Thailand, 10400 Queen Sirikit National Institute of Child Health Bangkok, Thailand, 10400 Less <<
NCT01493674 Eating Disorders Phase 4 Completed - Spain ... More >> Hospital Universitario La Paz Madrid, Spain, 28046 Less <<
NCT01583959 Rheumatoid Arthritis Phase 4 Completed - India ... More >> New OPD, #3035, Level 3, Rheumatology Clinic, Tuesday and Friday Chandigarh, India, 160012 Less <<
NCT01766310 - Completed - -
NCT02908581 Chronic Arsenic Poisoning Phase 2 Completed - Bangladesh ... More >> Laksham Upazilla Health Complex Comilla, Bangladesh Less <<
NCT01741077 - Completed - Canada, Ontario ... More >> The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT03595163 Sevoflurane P... More >>ropofol Homocysteine Cochlear Hearing Loss Less << Not Applicable Enrolling by invitation October 30, 2018 China ... More >> Shanghai ninth people's hospital Shanghai, China Less <<
NCT02124642 Pregnancy Not Applicable Completed - United States, Georgia ... More >> Athens Regional Medical Center Midwifery Practice Athens, Georgia, United States, 30606 Less <<
NCT01105351 the Effect of MTHFR C677T on F... More >>olate Metabolism Less << Not Applicable Completed - Germany ... More >> University of Saarland Homburg, Saarland, Germany, 66424 Less <<
NCT02300948 Pregnancy Phase 4 Completed - Canada, Ontario ... More >> The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT01841658 Obesity Not Applicable Completed - United States, Georgia ... More >> University of Georgia Athens, Georgia, United States, 30602 Less <<
NCT03421483 Folate Not Applicable Not yet recruiting May 2, 2019 -
NCT02373033 Folic Acid Deficiency Not Applicable Completed - Egypt ... More >> Mansoura University Mansoura, Egypt, 35516 Less <<
NCT02397291 IUGR Pregnanc... More >>y Less << Not Applicable Suspended June 2020 United States, Colorado ... More >> University of Colorado Denver Anschutz Medical Campus Aurora, Colorado, United States, 80045 Less <<
NCT03359057 Contraception Phase 3 Completed - Brazil ... More >> Galeno Desenvolvimento de Pesquisas Clinicas Ltda. - ME Campinas, SP, Brazil Less <<
NCT01039792 Autistic Disorder Phase 2 Phase 3 Completed - United States, California ... More >> UCSF San Francisco, California, United States, 94143 Less <<
NCT01030575 Infant, Newborn ... More >> Infant, Low Birth Weight Infant, Small for Gestational Age Infant, Premature Retinopathy of Prematurity Bronchopulmonary Dysplasia (BPD) Less << Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, California Stanford University Palo Alto, California, United States, 94304 United States, Connecticut Yale University New Haven, Connecticut, United States, 06504 United States, Georgia Emory University Atlanta, Georgia, United States, 30303 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Massachusetts Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Michigan Wayne State University Detroit, Michigan, United States, 48201 United States, New Mexico University of New Mexico Albuquerque, New Mexico, United States, 87131 United States, New York University of Rochester Rochester, New York, United States, 14642 United States, North Carolina RTI International Durham, North Carolina, United States, 27705 Duke University Durham, North Carolina, United States, 27710 United States, Ohio Case Western Reserve University, Rainbow Babies and Children's Hospital Cleveland, Ohio, United States, 44106 United States, Rhode Island Brown University, Women & Infants Hospital of Rhode Island Providence, Rhode Island, United States, 02905 United States, Texas University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75235 University of Texas Health Science Center at Houston Houston, Texas, United States, 77030 United States, Utah University of Utah Salt Lake City, Utah, United States, 84108 Less <<
NCT01039792 - Completed - -
NCT01000233 Heart Valve Disease ... More >> Aortic Stenosis Less << Phase 2 Phase 3 Unknown October 2012 Spain ... More >> Hospital Universitario Son Dureta Recruiting Palma, Balearic Islands, Spain, 07014 Contact: Carlos Fernandez-Palomeque, MD    +34971175504    carlos.palomeque@ssib.es    Principal Investigator: Carlos Fernandez-Palomeque, MD          Sub-Investigator: Guillem Frontera, MD          Sub-Investigator: Grases Felix, PhD          Sub-Investigator: Bethencourt Armando, Phd MD          Sub-Investigator: Joan Alguersuary, MD          Sub-Investigator: Josep Francesc Forteza, PhD MD          Sub-Investigator: Andres Grau, MD          Sub-Investigator: Jose Ignacio Saez de Ibarra, MD          Sub-Investigator: Rosa Gonzalez, MD          Sub-Investigator: Rafael Prieto, PhD MD          Sub-Investigator: Antonia Costa, PhD          Sub-Investigator: Onofre Caldes, MD Less <<
NCT02293109 Contiguous Stage II Adult Lymp... More >>hoblastic Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage IV Adult Lymphoblastic Lymphoma Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 1 Recruiting December 2018 United States, California ... More >> University of California Davis Recruiting Sacramento, California, United States, 95817 Contact: Mehrdad Abedi    916-734-3771    mabedi@ucdavis.edu    Principal Investigator: Mehrdad Abedi Less <<
NCT01070810 - Completed - -
NCT01085331 Metastatic Colorectal Cancer Phase 1 Phase 2 Terminated(Conduct the randomi... More >>zed Phase 2 part not recommended due to the achieved MTD for pimasertib (45mg/day) in combination with FOLFIRI) Less << - Belgium ... More >> Research Site Leuven, Belgium Italy Research Site Napoli, Italy Spain Research Site Barcelona, Spain Less <<
NCT02270788 Acute Myeloid Leukemia Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01085331 - Terminated(Conduct the randomi... More >>zed Phase 2 part not recommended due to the achieved MTD for pimasertib (45mg/day) in combination with FOLFIRI) Less << - -
NCT01111292 - Terminated(The study was close... More >>d prematurely due to poor accrual.) Less << - -
NCT01111292 Colon Carcinoma ... More >> Dysplasia in Crohn Disease Low Grade Dysplasia in Ulcerative Colitis Rectal Carcinoma Less << Phase 1 Phase 2 Terminated(The study was close... More >>d prematurely due to poor accrual.) Less << - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, New York Mount Sinai Medical Center New York, New York, United States, 10029 Less <<
NCT01115504 Chronic Heart Failure Phase 3 Completed - Iran, Islamic Republic of ... More >> Faculty of medicine, Azad university Shahrood, Semnan, Iran, Islamic Republic of Less <<
NCT01096004 Obesity Phase 1 Completed - Sweden ... More >> Research Site Goteborg, Sweden Less <<
NCT01173471 Raised Intraocular Pressure Phase 2 Completed - United States, California ... More >> Research Site Newport Beach, California, United States United States, Georgia Research Site Atlanta, Georgia, United States Research Site Morrow, Georgia, United States United States, Kansas Research Site Overland Park, Kansas, United States United States, North Carolina Research Site Charlotte, North Carolina, United States Research Site Durham, North Carolina, United States United States, Tennessee Research Site Memphis, Tennessee, United States Sweden Research Site Lund, Sweden Research Site Molndal, Sweden Research Site Stockholm, Sweden United Kingdom Research Site Nottingham, United Kingdom Less <<
NCT02420717 Leukemia Phase 2 Recruiting July 2023 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01070810 Septic Shock Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01173471 - Completed - -
NCT01254006 Glaucoma Not Applicable Completed - Italy ... More >> Univerisity La Sapienza Latina, Italy Less <<
NCT02427620 Lymphoma Phase 2 Recruiting June 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01204216 Diabetes Mellitus ... More >> Impaired Fasting Glucose Prediabetes Less << Not Applicable Completed - United States, Ohio ... More >> Cincinnati VA Medical Center, Cincinnati, OH Cincinnati, Ohio, United States, 45220 Less <<
NCT01281878 Primary Hyperoxaluria Type I Phase 2 Completed - Germany ... More >> Children´s Hospital University of Cologne Cologne, NRW, Germany, 50931 Less <<
NCT01338844 Infertility Phase 4 Completed - Italy ... More >> San Raffaele Hospital Milan, Italy Research Center for Reproductive Medicine Villa Mafalda Roma, Italy Agunco Rome, Italy Less <<
NCT01318889 Oral Mucositis (Ulcerative) Du... More >>e to Radiation Less << Phase 2 Unknown September 2011 Iran, Islamic Republic of ... More >> ShaheedBeheshti medical university Recruiting Tehran, Iran, Islamic Republic of Contact: Fahimeh Anbari, postgraduate student          Sub-Investigator: Jamileh beigom Taheri, professor          Principal Investigator: Fahimeh Anbari, Resident Less <<
NCT01386866 Advanced Solid Tumors Phase 1 Completed - -
NCT01305057 Dry Skin Not Applicable Completed - Japan ... More >> Cosmos Technical Center Itabashi-ku, Tokyo, Japan, 174-0046 Less <<
NCT01433952 Pharmacokinetics in Healthy Su... More >>bjects Less << Phase 1 Completed - United States, Massachusetts ... More >> Baystate Medical Center Springfield, Massachusetts, United States, 01199 Less <<
NCT01396486 Pediatric Bipolar Spectrum Dis... More >>orders Less << Phase 4 Recruiting January 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Abigail Farrell, BS    617-643-6617    aefarrell@partners.org    Contact: Elizabeth Noyes, BA    617-726-4651    enoyes@partners.org    Principal Investigator: Janet Wozniak, MD Less <<
NCT02877303 Leukemia Acut... More >>e Lymphoblastic Leukemia Less << Phase 2 Recruiting November 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01462279 - Completed - -
NCT01462279 Acute Respiratory Failure Not Applicable Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States, 02115 Less <<
NCT01192113 Peripheral Neuropathy Phase 4 Completed - China, Anhui ... More >> The 1st Hospital of Anhui Medical University Hefei, Anhui, China China, Beijing The General Hospital of the People's Liberation Army Beijing, Beijing, China The institute of rehabilitation medicine Beijing, Beijing, China China, Guangdong Nanfang Hospital of Nanfang Medical Unversity Guangzhou, Guangdong, China The 1st People Hospital of Guangzhou Guangzhou, Guangdong, China China, Guangxi the 1st Hospital affliated to Guangxi Medical University Nanning, Guangxi, China China, Hebei The 3rd Hospital of Hebei Medical University Shijiazhuang, Hebei, China China, Hubei the people Hospital Wuhan, Hubei, China Tongji Hospital Wuhan, Hubei, China Xiehe Hospital Wuhan, Hubei, China China, Jiangsu the 1st Hospital of Nanjing Nanjing, Jiangsu, China Zhong Xi Yi Jie He Hospital of Jiangsu Nanjing, Jiangsu, China the 2nd Hospital of Suzhou University Suzhou, Jiangsu, China Subei People Hospital Yangzhou, Jiangsu, China The 1st People Hospital of Yangzhou Yangzhou, Jiangsu, China the Affiliated Hospital of Jiangsu University Zhenjiang, Jiangsu, China China, Shanghai Changhai Hospital Shanghai, Shanghai, China Ruijing Hospital Shanghai, Shanghai, China the 10th People Hospital of Shanghai Shanghai, Shanghai, China the 10th People Hospital Shanghai, Shanghai, China China, Tianjin The 1st Center Hospital of Tianjin Tianjin, Tianjin, China China The institute of rehabilitation medicine Beijing, China Rui Jin Hospital Shanghai, China Shenzhen Hospital of Beijing University Shenzhen, China Less <<
NCT01533324 Carcinoma Liv... More >>er Diseases Hepatocellular Carcinoma Less << Phase 2 Unknown December 2016 China, Shanghai ... More >> Eastern Hepatobiliary Surgery Hospital Recruiting Shanghai, Shanghai, China, 200438 Contact: Xie Feng, attending physician    +8613386272885    hunanxiefeng@yahoo.com.cn    Principal Investigator: Xie Feng, attending physician Less <<
NCT03121911 Expiratory Flow Limitation ... More >> Recent Myocardial Infarction Less << Not Applicable Not yet recruiting October 31, 2020 -
NCT01574261 Polycystic Ovary Syndrome Early Phase 1 Unknown - Italy ... More >> Università cattolica S. Cuore Recruiting Rome, Italy, 00168 Less <<
NCT02624700 Breast Cancer ... More >> Metastatic Breast Cancer Recurrent Breast Cancer Less << Phase 2 Recruiting April 1, 2025 United States, Virginia ... More >> Virginia Commonwealth University/Massey Cancer Center Recruiting Richmond, Virginia, United States, 23298 Contact: Alison Ryan, NP    804-628-1936    masseysiit@vcu.edu    Contact: Andrew S Poklepovic, MD    804-628-2321    andrew.poklepovic@vcuhealth.org    Principal Investigator: Andrew S Poklepovic, MD Less <<
NCT01503892 Diabetes Peri... More >>pheral Neuropathy Less << Not Applicable Unknown - United States, Pennsylvania ... More >> St. Luke's Hospital and Health Network Recruiting Bethlehem, Pennsylvania, United States, 18015 Contact: Edwin S. Hart III, DPM    610-868-4300    ehart@footmed.com Less <<
NCT02965248 Locally Advanced Colorectal Ca... More >>ncer Less << Phase 3 Recruiting November 2023 China, Shanghai ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Guoxiang Cai, M.D. Ph.D.    +86 13611831623    gxcai@fudan.edu.cn Less <<
NCT01626924 Perinatal Asphyxia Phase 2 Terminated(Recruitment too slo... More >>w and site decided to use hypothermia (exclusion criteria)) Less << - Turkey ... More >> T.R. Ministry of Health Izmir Tepecik Training and Research Hospital Izmir, Turkey, 35540 Yıl University Medical Faculty Hospital Van, Turkey, 65080 Less <<
NCT03258762 Toxoplasmosis Phase 1 Completed - Australia, Victoria ... More >> GSK Investigational Site Melbourne, Victoria, Australia, 3004 Less <<
NCT01572506 Anemia Not Applicable Completed - United States, District of Col... More >>umbia VA Medical Center, Washington D.C. Washington, District of Columbia, United States, 20422 United States, Maryland National Institute of Aging, Clinical Research Unit Baltimore, Maryland, United States, 21224 Less <<
NCT01668017 Advanced Solid Tumors ... More >> Hepatocellular Carcinoma Less << Phase 1 Terminated(The sponsor decided... More >> not to conduct the expansion part of trial (part 2)) Less << - Japan ... More >> Please contact Merck Serono Co., Ltd for recruiting locations in, Japan Less <<
NCT01668017 - Terminated(The sponsor decided... More >> not to conduct the expansion part of trial (part 2)) Less << - -
NCT01713036 Locally Advanced or Metastatic... More >> Solid Tumors Less << Phase 1 Completed - Hungary ... More >> Research Site Budapest, Hungary Less <<
NCT01725412 Diabetic Nephropathy Phase 4 Unknown - Canada, Saskatchewan ... More >> Royal University Hospital Recruiting Saskatoon, Saskatchewan, Canada, S7K 0M7 Contact: Gudrun Caspar-Bell Less <<
NCT01693068 - Completed - -
NCT03268577 - Completed - United States, Maryland ... More >> NCI Division of Cancer Control and Population Sciences Bethesda, Maryland, United States, 20892 Less <<
NCT01693068 N-Ras Mutated Locally Advanced... More >> or Metastasis Malignant Cutaneous Melanoma Less << Phase 2 Completed - -
NCT01713036 - Completed - -
NCT03488225 Acute Lymphocytic Leukemia Phase 2 Recruiting March 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       ejabbour@mdanderson.org Less <<
NCT01864057 Beriberi Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Cambodia Svai Chrum Clinic Mesang District, Prey Veng, Cambodia Less <<
NCT01754792 Type 2 Diabetes ... More >> Impaired Glucose Tolerance Healthy Less << Not Applicable Completed - Spain ... More >> University Hospital Dr Peset Valencia, Spain, 46017 Less <<
NCT01875445 Trichotillomania ... More >> Hair Pulling Less << Phase 2 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01738763 Healthy Insul... More >>in Sensitivity Less << Not Applicable Completed - Spain ... More >> University Hospital Dr Peset Valencia, Spain, 46017 Less <<
NCT01875445 - Completed - -
NCT01954082 Retinopathy of Prematurity (RO... More >>P) Less << Phase 3 Terminated(Study terminated du... More >>e to safety concerns; participant follow up will continue until March 2018) Less << - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, California University of California - Los Angeles Los Angeles, California, United States, 90025 Stanford University Palo Alto, California, United States, 94304 United States, Georgia Emory University Atlanta, Georgia, United States, 30303 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Michigan Wayne State University Detroit, Michigan, United States, 48201 United States, Missouri Children's Mercy Hospital Kansas City, Missouri, United States, 64108 United States, New Mexico University of New Mexico Albuquerque, New Mexico, United States, 87131 United States, New York University of Rochester Rochester, New York, United States, 14642 United States, North Carolina RTI International Durham, North Carolina, United States, 27705 Duke University Durham, North Carolina, United States, 27710 United States, Ohio Cincinnati Children's Medical Center Cincinnati, Ohio, United States, 45267 Case Western Reserve University, Rainbow Babies and Children's Hospital Cleveland, Ohio, United States, 44106 Research Institute at Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Pennsylvania Univeristy of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Rhode Island Brown University, Women & Infants Hospital of Rhode Island Providence, Rhode Island, United States, 02905 United States, Texas University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75235 University of Texas Health Science Center at Houston Houston, Texas, United States, 77030 Less <<
NCT01936363 Ovarian Cancer Phase 2 Completed - -
NCT01936363 - Completed - -
NCT03746106 Vitamin B1 Deficiency ... More >> Thiamine Deficiency Less << Phase 4 Not yet recruiting October 2019 -
NCT01985685 - Completed - -
NCT02011191 End Stage Renal Disease ... More >> Restless Legs Syndrome Less << Not Applicable Completed - -
NCT02017444 Idiopathic Intracranial Hypert... More >>ension Less << Phase 2 Completed - United Kingdom ... More >> University Hospital Birmingham (Queen Elizabeth Hospital) Birmingham, West Midlands, United Kingdom, B15 2TH Less <<
NCT01985685 Critically Ill ... More >> Respiratory Failure Less << Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01992874 - Completed - -
NCT02050672 Couple Sterility Not Applicable Unknown - Italy ... More >> TECNOLAB Recruiting Milan, Italy Contact: Patrizia Rubino, PhD    0270103344       Principal Investigator: Patrizia Rubino, PhD Less <<
NCT01954082 - Terminated(Study terminated du... More >>e to safety concerns; participant follow up will continue until March 2018) Less << - -
NCT02053324 Liver Metastases Phase 1 Recruiting June 2019 Austria ... More >> Allgemeines Krankenhaus Wien Recruiting Wien, Austria, 1090 Contact: HAUG ALEXANDER, M.D.    +43 1 40400 ext 39360    alexander.haug@meduniwien.ac.at    Principal Investigator: HAUG ALEXANDER, M.D.          Italy Ospedale S. Maria Goretti Recruiting Latina, Rome, Italy, 04100 Contact: CIANNI ROBERTO, M.D.    +39 0773 655 3659    r.cianni@ausl.latina.it    Principal Investigator: CIANNI ROBERTO, M.D.          Ospedale dell' Angelo di Mestre Recruiting Mestre, Venice, Italy, 30174 Contact: SICOLO MICHELE, M.D.    +39 041 965 7626 ext 7629    michele.sicolo@ulss12.ve.it    Principal Investigator: SICOLO MICHELE, M.D.          S. Andrea Hospital Recruiting Rome, Italy, 00189 Contact: SCOPINARO FRANCESCO, M.D.    +39 06 337 75538    francesco.scopinaro@uniroma1.it    Principal Investigator: SCOPINARO FRANCESCO, M.D.          Switzerland Universtitätsspital Basel Withdrawn Basel, Switzerland, 4031 Less <<
NCT01992874 Neoplasms Phase 1 Completed - United States, Massachusetts ... More >> Please Contact U.S. Medical Information Located in Rockland, Massachusetts, United States Less <<
NCT01985191 Neoplasm Malignant Phase 1 Completed - France ... More >> Investigational Site Number 250001 Villejuif Cedex, France, 94805 Netherlands Investigational Site Number 528001 Amsterdam, Netherlands, 1066 CX Investigational Site Number 528003 Rotterdam, Netherlands, 3075 EA Investigational Site Number 528002 Utrecht, Netherlands, 3584 CX Less <<
NCT02133898 Depression Not Applicable Recruiting May 2019 United States, Florida ... More >> Shands Hospital Room HD-G-17 Recruiting Gainesville, Florida, United States, 32610 Contact: Herbert Ward, M.D.    352-265-7041    hward@ufl.edu    Contact: Dana Mason, M.D.    352-273-8540    dmason@ufl.edu    Principal Investigator: Herbert Ward, M.D. Less <<
NCT02419495 Advanced Cancers Phase 1 Recruiting December 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02156843 Diabetic Nephropathy ... More >> Diabetic Kidney Disease Less << Phase 3 Terminated March 2018 -
NCT02221063 Thiamin Deficiency Phase 1 Completed - Cambodia ... More >> (Various Villages), Prey Veng, Cambodia Less <<
NCT02379468 Diabetic Foot Ulcer Phase 3 Completed - Egypt ... More >> Tanta University Tanta, Please select, Egypt Alexandria University Alexandria, Egypt, 21500 Ain Shames University Cairo, Egypt Suez Canal University Suez, Egypt Less <<
NCT02633462 Polycystic Ovary Syndrome ... More >> Periodontitis Insulin Resistance Less << Phase 2 Unknown October 2016 -
NCT02464865 Obesity Child... More >> Thiamine Deficiency Less << Phase 4 Completed - Thailand ... More >> Faculty of Medicine Siriraj Hospital Bangkok, Thailand, 10700 Less <<
NCT02528526 Pancreatic Neoplasms ... More >> Hepatocellular Cancer Cholangiocarcinoma Colorectal Neoplasms Less << Phase 1 Phase 2 Unknown December 2016 Switzerland ... More >> University Hospital Zurich, Visceral Surgery Recruiting Zurich, ZH, Switzerland, 8091 Contact: Pierre-Alain Clavien, MD, PhD    +41 (0)44 255 33 00    clavien@access.uzh.ch    Contact: Perparim Limani, MD    +41 (0)44 255 33 00    perparim.limani@usz.ch    Sub-Investigator: Panagiotis Samaras, MD          Sub-Investigator: Bernhard Pestalozzi, MD          Sub-Investigator: Alexander Jetter, MD          Sub-Investigator: Michael Linecker, MD          Sub-Investigator: Rolf Graf, PhD          Sub-Investigator: Bostjan Humar, PhD          Sub-Investigator: Henrik Petrowsky, MD          Sub-Investigator: Philipp Kron, MD          Sub-Investigator: Roger Stupp, MD Less <<
NCT02757898 Anemia Phase 1 Recruiting January 2020 United States, Georgia ... More >> Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: John D Roback, MD, PhD    404-712-1774    jroback@emory.edu Less <<
NCT02767245 Thyrotoxicosis Not Applicable Completed - Thailand ... More >> Faculty of Medicine Ramathibodi Hospital, Mahidol University Bangkok, Thailand, 10400 Less <<
NCT02734628 Wound Healing Phase 4 Completed - Germany ... More >> Hamburg, Germany, 22869 Less <<
NCT02811133 Bipolar Disorder ... More >> Anxiety Disorders Anxiety Less << Phase 1 Phase 2 Not yet recruiting March 2019 United States, Pennsylvania ... More >> Child and Adolescent Bipolar Services-WPIC Bellefield Not yet recruiting Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT02813278 Colorectal Cancer Phase 3 Completed - China, Guangxi ... More >> Yang Yang Nanning, Guangxi, China, 530021 Less <<
NCT02961803 Adrenomyeloneuropathy ... More >> Adrenoleukodystrophy AMN Less << Phase 2 Phase 3 Completed - France ... More >> Hôpital Bicêtre Le Kremlin Bicêtre, France, 94275 Cedex Groupe Hospitalier Pitié-Salpêtrière Paris, France, 75651 Germany MS-Ambulanz Fachkrankenhaus Hubertusburg Wermsdorf, Germany, 04779 Spain Hospital Duran i Reynals / Bellvitge Barcelona, Spain, 08908 Less <<
NCT03055442 - Completed - Greece ... More >> Iakentro Advanced Medical Centre, IVF Unit Thessaloniki, Greece Less <<
NCT01343901 - Completed - -
NCT02423811 Cancer Stem Cell Phase 2 Unknown - Taiwan ... More >> National Cheng Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Forn-Chia Lin, M.D., Ph.D.    886-6-2353535 ext 2463    fornchia@mail.ncku.edu.tw Less <<
NCT03073070 Diabetes Red ... More >>Blood Cell Survival Less << Phase 1 Recruiting September 2022 United States, Iowa ... More >> University of Iowa Recruiting Iowa City, Iowa, United States, 52242 Contact: Guohua An, MD, PhD    319-467-4600    guohua-an@uiowa.edu    Contact: Demet Nalbant, PhD    319-335-8485    demet-nalbant@uiowa.edu Less <<
NCT01343901 - Completed - -
NCT03093181 Skin Care Not Applicable Completed - Brazil ... More >> GSK Investigational Site Valinhos, Brazil, 13271-130 Less <<
NCT03122678 Septic Shock ... More >>Shock, Septic Lactic Acidosis Thiamine Deficiency Less << Phase 1 Recruiting April 1, 2018 United States, Florida ... More >> Cleveland Clinic Florida Recruiting Weston, Florida, United States, 33331 Contact: Jinesh Mehta, MD    954-659-5450    mehtaj@ccf.org    Contact: Felix Hernandez, MD    954-659-5450    HernanF@ccf.org Less <<
NCT03201601 Polycystic Ovarian Syndrome ... More >> Infertility Less << Phase 2 Phase 3 Unknown October 31, 2017 -
NCT02646839 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Myelodysplastic Syndromes Less << Phase 2 Enrolling by invitation June 2020 United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Children's Hospital Oakland Oakland, California, United States, 94609 Stanford University Medical Center Palo Alto, California, United States, 94305 Rady Children's Hospital San Diego, California, United States, 92123 University of California, San Francisco San Francisco, California, United States, 94143 United States, Illinois Lurie Children's Hospital Chicago, Illinois, United States, 60611 United States, New York New York Medical Center Valhalla, New York, United States, 10595 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbilt University - Monroe Carell Jr. Children's Hospital Nashville, Tennessee, United States, 37232 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT03203564 Phase I Study in Healthy Volun... More >>teers to Evaluate ECG Effect Less << Phase 1 Completed - Sweden ... More >> CTC Clinical Trial Consultants Uppsala, Sweden, 75185 Less <<
NCT02974257 Cardiac Arrest ... More >> Shock Lactic Acidosis Thiamin Deficiency Less << Phase 2 Recruiting August 2021 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Katherine M Berg, MD    617-667-5864    kberg@bidmc.harvard.edu    Principal Investigator: Katherine M Berg, MD Less <<
NCT03107234 - Recruiting July 17, 2018 France ... More >> CHU Amiens Picardie Recruiting Amiens, Picardie, France, 80054 Contact: Jean GONDRY, PhD    +33322533694    gondry.jean@chu-amiens.fr Less <<
NCT03215433 - Recruiting June 2018 France ... More >> CHU Dijon Bourgogne Recruiting Dijon, France, 21079 Contact: Thibault MOREAU    3 80 29 30 89 ext +33    thibault.moreau@chu-dijon.fr Less <<
NCT03153436 Myoinositol C... More >>ryopreservation Human Sperm Less << Phase 1 Phase 2 Completed - -
NCT03188328 Inoperable Solid Tumors or Lym... More >>phomas Less << Phase 1 Recruiting June 2019 United States, Texas ... More >> Dep. of Investigational Cancer Therapeutics - U. T. M. D. Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: vivek Subbiah, MD    713-563-0393 ext 0393    VSubbiah@mdanderson.org Less <<
NCT03228030 Heart Failure ... More >> Heart Failure With Reduced Ejection Fraction Thiamine Deficiency Congestive Heart Failure Less << Phase 1 Recruiting September 2020 Canada, Ontario ... More >> McMaster University Recruiting Hamilton, Ontario, Canada, L8N3Z5 Contact: Catherine Demers, MD, MSc, FRCPC    905-521-2100 ext 73324    demers@hhsc.ca Less <<
NCT03302806 - Recruiting March 1, 2018 France ... More >> Nantes University Hospital Recruiting Nantes, France, 44093 Contact: David Laplaud, Pr       david.laplaud@chu-nantes.fr Less <<
NCT03263442 Hematopoietic Stem Cell Transp... More >>lantation Delirium Thiamine Deficiency Less << Phase 2 Enrolling by invitation October 16, 2020 United States, North Carolina ... More >> University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27514 Less <<
NCT03364686 Healthy Volunteers Phase 2 Not yet recruiting December 2024 -
NCT03427086 Amyotrophic Lateral Sclerosis Phase 2 Active, not recruiting December 10, 2018 Lebanon ... More >> American univeristy of Beirut medical center Beirut, Lebanon, 1107 2020 Less <<
NCT03313297 Diabetes Mellitus, Type 2 Phase 2 Recruiting April 1, 2019 United Kingdom ... More >> Leeds Teaching Hospitals Trust Recruiting Leeds, United Kingdom, LS9 7TF Contact: Ana Tiganescu, PhD    00441133438336    a.tiganescu@leeds.ac.uk Less <<
NCT03548311 Amyotrophic Lateral Sclerosis Phase 3 Recruiting March 31, 2020 Japan ... More >> Nagoya University Hospital Recruiting Nagoya, Aichi, Japan, 466-8560 Contact: Naoki Atsuta, MD    81-52-741-2111       Miyoshi Neurological Clinic Recruiting Miyoshi, Hiroshima, Japan, 728-0013 Contact: Masaya Oda, MD          Sapporo Medical University Hospital Recruiting Sapporo, Hokkaido, Japan, 060-8543 Contact: Shun Shimohama, MD    81-11-611-2111       Kobe Central Munincipal Medical center Recruiting Kobe, Hyogo, Japan, 650-0047 Contact: Nobuo Kohara, MD    81-78-302-4321       Ioh National Hospital Recruiting Kanazawa, Ishikawa, Japan, 920-0192 Contact: Kiyonobu Komai, MD    81-76-258-1180       Kitasato University East Hospital Recruiting Sagamihara, Kanagawa, Japan, 252-0380 Contact: Makiko Nagai, MD    81-42-748-9111       Shiga Medical University Hospital Recruiting Otsu, Shiga, Japan, 520-2192 Contact: Makoto Urushidani, MD    81-77-548-2111       Chiba University Hospital Recruiting Chiba, Japan, 260-8677 Contact: Satoshi Kuwabara, MD    81-43-222-7171    kuwabara-s@faculty.chiba-u.jp    Murakami Karindo Hospital Recruiting Fukuoka, Japan, 819-8585 Contact: Hitoshi Kikuchi, MD    81-92-811-3331       Okayama University Hospital Recruiting Okayama, Japan, 770-8558 Contact: Koji Abe, MD    88-86-223-7151    abekabek@cc.okayama-u.ac.jp    Tokushima University Hospital Recruiting Tokushima, Japan, 770-8503 Contact: Hiroyuki Nodera, MD    81-88-633-9658    hnodera@tokushima-u.ac.jp    Juntendo University Hospital Recruiting Tokyo, Japan, 113-8431 Contact: Kazuaki Kanai, MD          Toho University Hospital Recruiting Tokyo, Japan, 143-8541 Teikyo University Hospital Recruiting Tokyo, Japan, 173-8606 Contact: Masahiro Sonoo, MD          Tokyo Metropolitan Neurological Hospital Recruiting Tokyo, Japan, 183-0042 Wakayama Medical University Hospital Recruiting Wakayama, Japan, 641-8509 Contact: Hidefumi Ito, MD    81-73-447-2300 Less <<
NCT03552211 - Enrolling by invitation April 30, 2019 France ... More >> CHU Clermont-FERRAND Clermont-Ferrand, France, 63003 Less <<
NCT03520348 Dry Eye Dry E... More >>ye Syndrome of Unspecified Lacrimal Gland Less << Phase 1 Recruiting June 30, 2018 Mexico ... More >> Centro Oftalmológico San Angel Recruiting Guadalajara, Jalisco, Mexico, 44200 Contact: Anel De Luca Brown, MD    +521 33 36149482    draaneldeluca@gmail.com    Contact: Daniel Carrizales, PhD    +521 33 13710056    investigación@oftalmologicosanangel.com Less <<
NCT03626337 - Not yet recruiting January 15, 2020 -
NCT03306732 Cardiac Surgery Phase 4 Completed - Russian Federation ... More >> Meshalkin Research Institute of Pathology of Circulation Novosibirsk, Russian Federation Less <<
NCT03616288 Thiamine Deficiency Not Applicable Not yet recruiting August 2020 Cambodia ... More >> Helen Keller International Kampong Thom, Kapmong Thom Province, Cambodia Less <<
NCT03746821 Healthy Volunteers ... More >> Biotin Excretion Less << Not Applicable Recruiting December 30, 2018 United Kingdom ... More >> SPD Development Company Ltd Recruiting Bedford, Bedfordshire, United Kingdom, MK44 3UP Contact: Pauline A Parsons    +44 (01234) 835398    pauline.parsons@spdspark.com    Contact: Sharon Bond    +44 (01234) 835000    sharon.bond@spdspark.com    Principal Investigator: Pauline A Parsons Less <<
NCT03717896 Diabetic Ketoacidosis Phase 2 Not yet recruiting October 1, 2023 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT03554668 - Recruiting June 1, 2019 United Kingdom ... More >> Glasgow Royal Infirmary Recruiting Glasgow, United Kingdom, G4 0SF Contact: Donogh Maguire, MB BCh    0141 2115166    Donogh.Maguire@gla.ac.uk    Contact: Blyth Mark, Mb BCh    0141 2114000    Mark.Blyth@ggc.scot.nhs.uk Less <<
NCT01820091 Non-Small Cell Lung Cancer Phase 1 Withdrawn April 2015 -
NCT03667443 PCOS Myo-inos... More >>itol-resistance Less << Not Applicable Not yet recruiting February 1, 2020 -
NCT01353482 Malignant Pleural Mesothelioma Phase 1 Phase 2 Withdrawn(UCL CTC were informe... More >>d by Merck Sharp & Dohme on 22.08.11 that support for the trial had been withdrawn in light of results from another trial with trial drug.) Less << - -
NCT01469000 Carcinoma, Non Small Cell Lung Phase 2 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changchun, China, 130012 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China, 410013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sichuan, China, 610041 Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 464-8681 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 277 8577 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 650-0046 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 228-0329 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Okayama, Japan, 710-8602 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 589-8511 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shizuoka, Japan, 411-8777 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 104-0045 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yamaguchi, Japan, 755-0241 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cheong Ju-City, Korea, Republic of, 361-711 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Incheon, Korea, Republic of, 405-760 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 135 720 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Suwon-City, Korea, Republic of, 442-723 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jhonghe City, Taiwan, 235 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kaohsiung, Taiwan, 824 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Keelung, Taiwan, 204 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kuei Shan Hsiang, Taiwan, 33305 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Niao Sung Hsiang, Taiwan, 833 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 40705 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 100 Less <<
NCT01502202 Non Small Cell Lung Cancer ... More >> Adenocarcinoma Less << Phase 2 Unknown February 2015 Korea, Republic of ... More >> National Cancer Center Recruiting Goyang-si, Gyenggido, Korea, Republic of, 410-769 Contact: Sung Jin Yoon, RN    +82-31-920-0405    jinijiniya@ncc.re.kr    Contact: Jin Soo Lee, MD. Ph.D.    +82-31-920-1501    jslee@ncc.re.kr Less <<
NCT01544179 Non-Small Cell Lung Cancer Phase 3 Active, not recruiting December 31, 2018 -
NCT01639001 NSCLC (Non-small Cell Lung Can... More >>cer) Less << Phase 3 Active, not recruiting January 2019 -
NCT02399566 Lung Adenocarcinoma Phase 4 Not yet recruiting January 2019 -
NCT02468661 Non-Small Cell Lung Cancer Phase 1 Phase 2 Recruiting March 31, 2020 -
NCT01469000 - Completed - -
NCT01579630 NSCLC Phase 2 Phase 3 Unknown June 2014 Taiwan ... More >> Veterans General Hospital -Taipei Taipei, Taiwan, 112 Less <<
NCT03240211 PTCL CTCL Phase 1 Recruiting December 2020 United States, New York ... More >> 51 West 51st Street, Suite 200 Recruiting New York, New York, United States, 10019 Contact: Michelle Malanga    212-326-5731    mm4629@cumc.columbia.edu    Italy University of Bologna Not yet recruiting Bologna, Italy Principal Investigator: Pier Luigi Zinzani, MD, PhD          Korea, Republic of Samsung Medical Center Not yet recruiting Seoul, Korea, Republic of Principal Investigator: Won Seog Kim, MD, PhD Less <<
NCT02557490 Colon Cancer Liver Metastasis Phase 4 Unknown December 2017 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Zhu Xu, Master    0086-10-88195476    zhux387@263.net    Principal Investigator: Zhu Xu, Master Less <<
NCT02562599 Nasopharyngeal Carcinoma Phase 2 Unknown August 2018 China, Hubei ... More >> Hubei Cancer hospital Recruiting Wu Han, Hubei, China, 430079 Contact: Han Guang, PH.D          Principal Investigator: Hu Desheng, M.D Less <<
NCT01769066 NSCLC Phase 2 Phase 3 Completed - China, Shanghai ... More >> Cancer hospital Fudan University Shanghai, Shanghai, China, 200032 Less <<
NCT01639001 - Active, not recruiting - -
NCT02723253 Rectal Neoplasms Phase 2 Completed - -
NCT01783834 Previous Treated Metastatic No... More >>n-small Cell Lung Cancer Less << Phase 2 Completed - Korea, Republic of ... More >> Gachon university Gil Medical Center Incheon, Korea, Republic of Less <<
NCT01544179 - Active, not recruiting - -
NCT01828099 Non-Small Cell Lung Cancer Phase 3 Active, not recruiting April 11, 2022 -
NCT02618356 Metastatic Colon Cancer Phase 2 Recruiting November 2017 China, Shanghai ... More >> Fudan University Cancer Hospital Recruiting ShangHai, Shanghai, China, 200032 Contact: Wei Jian Guo    13816066360    mingzhuhuang0718@163.com Less <<
NCT01064648 Epithelioid Mesothelioma ... More >> Pleural Malignant Mesothelioma Recurrent Malignant Mesothelioma Sarcomatoid Mesothelioma Less << Phase 1 Phase 2 Active, not recruiting - -
NCT03568383 Tuberculosis, MDR Phase 3 Not yet recruiting December 22, 2024 -
NCT02886195 EGFR Gene Mutation Phase 3 Enrolling by invitation July 2019 -
NCT02992886 Rectal Neoplasms Malignant Phase 2 Recruiting September 2022 China, Beijing ... More >> Department of Radiation Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Recruiting Beijing, Beijing, China, 100021 Contact: Wenyang Liu, MD       liuwenyang26@163.com Less <<
NCT01982955 Non-small Cell Lung Cancer Phase 1 Phase 2 Active, not recruiting October 16, 2018 Germany ... More >> Please contact the Merck KGaA Communication Center located in Darmstadt, Germany Less <<
NCT01828099 - Active, not recruiting - -
NCT02134912 Adenocarcinoma of the Lung ... More >> Large Cell Lung Cancer Recurrent Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 2 Terminated(science has moved f... More >>orward and there is no intent to complete the study) Less << - -
NCT03196843 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 4 Recruiting August 2022 China, Liaoning ... More >> Lv Xiupeng Recruiting Dalian, Liaoning, China, 116000 Contact: Xiupeng Lv, M.D.    18098876707    lvxiupeng@foxmail.com Less <<
NCT03344614 Colorectal Cancer Phase 2 Recruiting July 1, 2019 China, Beijing ... More >> Chinese PLA General Hospital (301 Military Hospital) Recruiting Beijing, Beijing, China, 100853 Contact: Haiyan Si, M.D.    +8613911070673    sihaiyan2008@sina.com Less <<
NCT01951469 Non-small Cell Lung Cancer ... More >> Brain Metastases EGFR Mutation Less << Phase 2 Recruiting June 2019 China, Guangdong ... More >> Sun Yat-sen University of Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: li-kun Chen, doctor    13798019964    chenlk@sysucc.org.cn    Principal Investigator: li-kun Chen, doctor Less <<
NCT03392103 Gastric Cancer Phase 2 Recruiting December 2019 China, Hubei ... More >> Zhongnan Hopital of Wuhan University Recruiting Wuhan, Hubei, China, 430071 Contact: Fuxiang Zhou, M.D.    +86（0）2767813155    fuxiang.zhou@whu.edu.cn    Contact: Jing Dai, M.D.    +86（0）2767813155    daijing1116@163.com Less <<
NCT03110484 Biliary Tract Cancer Phase 2 Not yet recruiting June 2019 Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT02518802 Lung Neoplasms Phase 3 Recruiting January 2020 China, Shaanxi ... More >> Tangdu Hospital of the Fourth Millitary Medical University Recruiting Xi'an, Shaanxi, China, 710038 Contact: Li Xiaofei, MD    +8629,84777436    lxfchest@fmmu.edu.cn    Contact: Yan Xiaolong, MD    +862984717558    yanxiaolong@fmmu.edu.cn Less <<
NCT02148380 Non-Small-Cell Lung Cancer Not Applicable Completed - China ... More >> Shanghai Chest Hospital Shanghai, China, 200030 Less <<
NCT03585530 Esophagus Squamous Cell Carcin... More >>oma Less << Phase 2 Not yet recruiting July 15, 2022 -
NCT02977169 Non-small Cell Lung Cancer Sta... More >>ge IIIA Radiotherapy Less << Phase 2 Recruiting December 2019 China, Shanghai ... More >> Shanghai Chest Hospital Recruiting Shanghai, Shanghai, China Contact: Xiaolong Fu, PhD    +862122200000 ext 3602    xlfu1964@126.com Less <<
NCT03086538 Colo-rectal Cancer Phase 2 Recruiting December 2018 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 06351 Contact: seungtae kim, MD,PhD Less <<
NCT03151161 Lung, Carcinoma Phase 2 Not yet recruiting May 2019 China, Guangdong ... More >> Recruiting Guanzhou, Guangdong, China, 510000 Contact: Long Hao, Prof    +86 2087343261    longhao@sysucc.org.cn    Contact: Ruping Xing    +86 2087343736    xingrp@sysucc.org.cn Less <<
NCT03460678 Carcinoma, Non-Small-Cell Lung Phase 4 Recruiting December 2019 Jordan ... More >> King Hussein Cancer Center (KHCC) Recruiting Amman, Jordan, 11118 Principal Investigator: Taher Abu Hijleh, MD          Sub-Investigator: Samir Yaser, MD          Sub-Investigator: Kamal Al Rabi, MD          Lebanon American University of Beirut Medical Center Not yet recruiting Beirut, Lebanon, 1107 2020 Principal Investigator: Arafat Tfayli, MD Less <<
NCT03374280 Non Small Cell Lung Cancer Phase 2 Recruiting December 30, 2021 China, Guangdong ... More >> The first affiliated hospital of Guangzhou MC Recruiting Guangzhou, Guangdong, China, 510120 Contact: Haihong Yang, MD    0862083062825    bjrf2009@yahoo.com    Principal Investigator: Haihong Yang, Dr. Less <<
NCT00001014 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 3 Completed - United States, California ... More >> Ucsf Aids Crs San Francisco, California, United States, 94110 United States, Illinois Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States, 60611 United States, Louisiana Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU New Orleans, Louisiana, United States, 70112 United States, Missouri Washington U CRS St. Louis, Missouri, United States United States, New York SUNY - Buffalo, Erie County Medical Ctr. Buffalo, New York, United States, 14215 United States, Ohio Case CRS Cleveland, Ohio, United States, 44106 Less <<
NCT02974426 Non-small Cell Lung Cancer Sta... More >>ge IIIA Radiotherapy Less << Phase 3 Recruiting December 2020 China, Shanghai ... More >> Shanghai Chest Hospital Recruiting Shanghai, Shanghai, China Contact: Xiaolong Fu, PhD    +862122200000 ext 3602    xlfu1964@126.com Less <<
NCT00004317 Toxoplasmosis Phase 4 Recruiting December 2030 United States, Illinois ... More >> University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Rima McLeod    773-834-4152 Less <<
NCT01922830 NAFLD Not Applicable Active, not recruiting January 2019 Israel ... More >> Tel Aviv Sourasky Medical Center Tel Aviv, Israel, 64239 Less <<
NCT03737994 ALK Gene Rearrangement ... More >> ALK Positive Non-Squamous Non-Small Cell Lung Carcinoma Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8 Less << Phase 2 Not yet recruiting December 13, 2025 -
NCT00002816 Leukemia Phase 3 Completed - -
NCT00005596 Leukemia Phase 3 Completed - -
NCT03559049 Stage IV Non-small Cell Lung C... More >>ancer Less << Phase 1 Phase 2 Not yet recruiting July 2027 United States, Michigan ... More >> The University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT02951637 Lung Adenocarcinoma Phase 2 Not yet recruiting December 2019 -
NCT00098839 Recurrent Childhood Acute Lymp... More >>hoblastic Leukemia Less << Phase 1 Phase 2 Completed - -
NCT00103285 B-cell Childhood Acute Lymphob... More >>lastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Completed - -
NCT00103285 - Completed - -
NCT00098839 - Completed - -
NCT00392834 Lymphoma Phase 2 Completed - United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles, California, United States, 90095-1793 UCSF Medical Center at Parnassus San Francisco, California, United States, 94143-0296 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, New York Albert Einstein Cancer Center at Albert Einstein College of Medicine Bronx, New York, United States, 10461 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Pennsylvania Oncology Hematology Associates, Incorporated - Philadelphia Philadelphia, Pennsylvania, United States, 19106 United States, Washington Floyd and Delores Jones Cancer Institute at Virginia Mason Medical Center Seattle, Washington, United States, 98101 United States, West Virginia West Virginia University Health Sciences Center - Charleston Charleston, West Virginia, United States, 25304 Less <<
NCT00262925 - Terminated(slow accrual) - -
NCT00392834 - Completed - -
NCT00416819 Brain and Central Nervous Syst... More >>em Tumors Lymphoma Less << Not Applicable Completed - -
NCT00336024 Untreated Childhood Medullobla... More >>stoma Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor Less << Phase 3 Completed - -
NCT00454194 Lung Cancer Phase 2 Completed - -
NCT00262925 Recurrent Adult Acute Lymphobl... More >>astic Leukemia Less << Phase 2 Terminated(slow accrual) - -
NCT00336024 - Completed - -
NCT00061997 Lung Cancer P... More >>recancerous Condition Less << Phase 1 Completed - Canada, British Columbia ... More >> British Columbia Cancer Agency - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Less <<
NCT00473486 Carcinoma, Non-Small-Cell Lung Phase 1 Phase 2 Terminated(Sorafenib administe... More >>red in the combination with pemetrexed-carboplatin appears to enhance thrombocytopenia compared to historical data.) Less << - Germany ... More >> University of Muenster, Dept. of Medicine, Hematology / Oncology Muenster, Germany, 48145 Less <<
NCT00573690 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT03503552 - Completed - Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 Less <<
NCT00703638 Breast Cancer ... More >> Colorectal Cancer Head and Neck Cancer Lung Cancer Mesothelioma Pancreatic Cancer Prostate Cancer Sarcoma Less << Phase 1 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01254266 Morbid Obesity Not Applicable Unknown September 2014 Israel ... More >> Rabin Medical Center Recruiting Petah Tikva, Israel Contact: silvana Fennig, MD    +97239253761    silvanaf@clalit.org.il    Principal Investigator: Silvana Fennig, M.D. Less <<
NCT00089960 Gastrointestinal Cancer Phase 2 Completed - -
NCT00279266 Peripheral Neuropathy ... More >> Diabetes Mellitus Diabetes Complications Less << Not Applicable Withdrawn(inadequate recruitme... More >>nt) Less << - United States, California ... More >> Loma Linda University Department of Neurology Loma Linda, California, United States, 92354 Less <<
NCT00157716 Coronary Artery Bypass Graft S... More >>urgery Myocardial Ischemia Reperfusion Injury Myocardial Revascularization Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710-7510 Canada, Quebec Montreal Heart Institute Montreal, Quebec, Canada, H1T 1C8 Less <<
NCT00454194 - Completed - -
NCT00320021 Diabetic Nephropathy Phase 2 Completed - -
NCT00402766 Mesothelioma Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00320060 Diabetic Nephropathy Phase 2 Completed - -
NCT00349726 Infant, Newborn ... More >> Infant, Low Birth Weight Infant, Small for Gestational Age Infant, Premature Retinopathy of Prematurity Bronchopulmonary Dysplasia (BPD) Less << Phase 2 Completed - United States, Connecticut ... More >> Yale University New Haven, Connecticut, United States, 06504 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Michigan Wayne State University Detroit, Michigan, United States, 48201 United States, New Mexico University of New Mexico Albuquerque, New Mexico, United States, 87131 United States, New York University of Rochester Rochester, New York, United States, 14642 United States, North Carolina RTI International Durham, North Carolina, United States, 27705 Duke University Durham, North Carolina, United States, 27710 United States, Ohio Case Western Reserve University, Rainbow Babies and Children's Hospital Cleveland, Ohio, United States, 44106 United States, Rhode Island Brown University, Women & Infants Hospital of Rhode Island Providence, Rhode Island, United States, 02905 United States, Texas University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75235 United States, Utah University of Utah Salt Lake City, Utah, United States, 84108 Less <<
NCT00342836 AKT Phase 1 Completed - Canada ... More >> British Columbia Cancer Agency (BCCA) Vancouver, Canada Less <<
NCT01412879 Lymphoma Phase 2 Active, not recruiting August 2021 -
NCT01412879 - Active, not recruiting - -
NCT00402506 Coronary Artery Bypass Graft S... More >>urgery Myocardial Ischemia Reperfusion Injury Less << Phase 3 Completed - United States, North Carolina ... More >> Duke Clinical Research Institute Durham, North Carolina, United States, 27705 Canada, Quebec Montreal Heart Institute Montreal, Quebec, Canada, H1T 1C8 Less <<
NCT00467623 - Completed - Denmark ... More >> Nils Milman Copenhagen, Denmark, 2100 Less <<
NCT00444613 Amyotrophic Lateral Sclerosis ... More >>(ALS) Less << Phase 2 Phase 3 Completed - Japan ... More >> Nagoya-shi, Aichi, Japan Akita-shi, Akita, Japan Aomori-shi, Aomori, Japan Chiba-shi, Chiba, Japan Touon-shi, Ehime, Japan Fukuoka-shi, Fukuoka, Japan Kitakyusyu-shi, Fukuoka, Japan Fukushima-shi, Fukushima, Japan Maebashi-shi, Gunma, Japan Higashihiroshima-shi, Hiroshima, Japan Miyoshi-shi, Hiroshima, Japan Otake-shi, Hiroshima, Japan Sapporo-shi, Hokkaido, Japan Kanazawa-shi, Ishikawa, Japan Ichinoseki-shi, Iwate, Japan Sagamihara-shi, Kanagawa, Japan Yokohama-shi, Kanagawa, Japan Nangoku-shi, Kochi, Japan Kyoto-shi, Kyoto, Japan Tsu-shi, Mie, Japan Sendai-shi, Miyagi, Japan Watari-gun, Miyagi, Japan Nagano-shi, Nagano, Japan Higashisonogi-gun, Nagasaki, Japan Kashiwazaki-shi, Niigata, Japan Niigata-shi, Niigata, Japan Tsukubo-gun, Okayama, Japan Ginowan-shi, Okinawa, Japan Toyonaka-shi, Osaka, Japan Hasuda-shi, Saitama, Japan Saitama-shi, Saitama, Japan Otsu-shi, Shiga, Japan Hamamatsu-shi, Shizuoka, Japan Shizuoka-shi, Shizuoka, Japan Shimotsuke-shi, Tochigi, Japan Tokushima-shi, Tokushima, Japan Yoshinogawa-shi, Tokushima, Japan Bunkyo-ku, Tokyo, Japan Kodaira-shi, Tokyo, Japan Ota-ku, Tokyo, Japan Wakayama-shi, Wakayama, Japan Yonezawa-shi, Yamagata, Japan Shimonoseki-shi, Yamaguchi, Japan Yanai-shi, Yamaguchi, Japan Less <<
NCT00490113 Kidney Stones Phase 2 Withdrawn(Drug unavailable) - -
NCT01535053 Choriocarcinoma ... More >> FIGO Stage I Gestational Trophoblastic Tumor FIGO Stage II Gestational Trophoblastic Tumor FIGO Stage III Gestational Trophoblastic Tumor Hydatidiform Mole Less << Phase 3 Active, not recruiting - -
NCT00519714 Hypertriglyceridemia Phase 2 Phase 3 Completed - Canada, Quebec ... More >> Institut de Cardiologie de Montreal Montreal, Quebec, Canada, H1T 1C8 Less <<
NCT00360867 Solid Tumors Phase 2 Terminated(Amgen decision) - -
NCT00448786 Solid Tumors Phase 1 Completed - -
NCT00093873 Tumors Phase 1 Completed - -
NCT00568776 Alzheimer Disease Phase 2 Completed - -
NCT01450384 Unspecified Adult Solid Tumor Phase 1 Completed - United States, Virginia ... More >> Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT00834210 - Completed - -
NCT00834210 Acne Vulgaris Phase 4 Completed - United States, California ... More >> Fremont, California, United States Less <<
NCT01741558 Myocardial Infarction Phase 2 Unknown December 2014 Brazil ... More >> Instituto de Cardiologia do Rio Grande do Sul / Fundação Universitária de Cardiologia Not yet recruiting Porto Alegre, Rio Grande do Sul, Brazil, 90620001 Contact: Daniel M. Moreira, MD. MSc.    554884175590    danielmedeirosmoreira@gmail.com    Principal Investigator: Daniel M. Moreira, MD. MSc.          Sub-Investigator: Carlos AM Gottschall, MD MSc PhD          Instituto de Cardiologia de Santa Catarina Not yet recruiting São José, Santa Catarina, Brazil, 88103901 Contact: Daniel M. Moreira, MD. MSc    554884175590    danielmedeirosmoreira@gmail.com    Sub-Investigator: Maria E. Lueneberg, MD.          Principal Investigator: Daniel M. Moreira, MD. MSc.          Sub-Investigator: Roberto L. da Silva, MD.          Sub-Investigator: Tammuz Fattah, MD. Less <<
NCT00663481 Healthy Adults Phase 1 Completed - United States, Maryland ... More >> Parexel International - Baltimore CPRU Baltimore, Maryland, United States, 21225 Less <<
NCT00680706 Heart Failure ... More >> Diabetes Less << Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Baystate Medical Center Springfield, Massachusetts, United States, 01199 Less <<
NCT00568776 - Completed - -
NCT01758666 Osteosarcoma Not Applicable Unknown December 2016 -
NCT00731588 Neonatal Anemia Phase 2 Completed - United States, Iowa ... More >> University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 University of Iowa Iowa City, Iowa, United States, 52242 Less <<
NCT00680706 - Completed - -
NCT00770107 Heart Failure Not Applicable Completed - Switzerland ... More >> Kantonsspital Luzern Luzern, Switzerland, 6000 Less <<
NCT00734253 Diabetic Nephropathy Phase 2 Completed - United States, Illinois ... More >> The Collaborative Study Group Chicago, Illinois, United States, 60607 Less <<
NCT00783705 Non-small Cell Lung Cancer ... More >> Squamous Lung Dysplasia Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New Mexico Albuquerque Veterans Administration Medical Center Albuquerque, New Mexico, United States, 87108-5128 Canada, British Columbia BCCA-Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Less <<
NCT00791752 Healthy Phase 1 Completed - Sweden ... More >> Research Site Gotteborg, Sweden Less <<
NCT00783705 - Completed - -
NCT00799747 Healthy Phase 1 Completed - Japan ... More >> Research Site Fukuoka, Japan Less <<
NCT00839280 Skin Abnormalities Phase 2 Completed - France ... More >> Villeurbanne, France, 69503 Less <<
NCT00804570 Alcohol Dependence Phase 2 Completed - United States, Indiana ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States, 46260 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lafayette, Indiana, United States, 47905 United States, Maryland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baltimore, Maryland, United States, 21205 United States, Massachusetts For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Belmont, Massachusetts, United States, 02478 United States, Minnesota For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rochester, Minnesota, United States, 55905 United States, Nebraska For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Omaha, Nebraska, United States, 68133 United States, New Hampshire For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lebanon, New Hampshire, United States, 03756 United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New York, New York, United States, 10016 United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chapel Hill, North Carolina, United States, 27599 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Charlotte, North Carolina, United States, 28211 United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cincinnati, Ohio, United States, 45237 United States, Oregon For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Portland, Oregon, United States, 97210 United States, Pennsylvania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Philadelphia, Pennsylvania, United States, 19104 United States, Rhode Island For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Providence, Rhode Island, United States, 02908 United States, South Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Charleston, South Carolina, United States, 29425 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Antonio, Texas, United States, 78229 United States, Washington For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seattle, Washington, United States, 98104 Less <<
NCT00106626 Advanced Cancer Phase 1 Completed - -
NCT00841048 Diabetes Mellitus Type 2 Phase 1 Completed - Sweden ... More >> Research Site Gothenburg, Sweden Less <<
NCT00106626 - Completed - -
NCT00839462 Erythema Phase 2 Completed - France ... More >> Villeurbanne, France, 69503 Less <<
NCT00894920 Biotin Deficiency Not Applicable Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT00934050 - Completed - -
NCT00953823 - Completed - Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada Less <<
NCT00957580 Leukemia, Myeloid, Acute ... More >> Hematologic Neoplasms Less << Phase 2 Terminated(The trial has been ... More >>terminated due to an estimated low probability of clinical benefit based on limited anti-leukemic effects observed in safety run-in (Part 1)) Less << - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States Dana Farber Cancer Institute Boston, Massachusetts, United States United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States France Hospital Hotel Dieu, Service D'Hematologie Nantes, Cedex, France Hospital Edouard Herriot, Service d'Hematologie Clinique Lyon Cedex, France Hospital Saint Louis, Service des Maladies du Sang Paris, France CHU du Haut-Leveque, Service des Maladies du Sang Unite de Recherche Clinique Pessac, France Less <<
NCT00804570 - Completed - -
NCT00934050 Alzheimer's Disease Phase 2 Completed - -
NCT00917293 Tardive Dyskinesia Phase 2 Terminated(modified formulatio... More >>n under investigation) Less << - Canada, British Columbia ... More >> Vancouver Island Health Authority Victoria, British Columbia, Canada, V8R 4Z3 Canada, Ontario Centre for Addiction and Mental Health Toronto, Ontario, Canada, M5T 1R8 Windsor Regional Hospital Windsor, Ontario, Canada, N9C 3Z4 India Schizophrenia Research Foundation (SCARF) Mental Health Centre Chennai, TamilNadu, India, 600101 Less <<
NCT00859196 Wound Healing ... More >> Cell Proliferation Gene Expression Less << Phase 4 Completed - Germany ... More >> Hamburg, Germany, 22869 Less <<
NCT00982865 Solid Tumors ... More >>Cancer Less << Phase 1 Completed - Australia ... More >> Westmead Hospital Westmead, Australia Belgium Jules Bordet Institute Brussels, Belgium, B-1000 Ghent University Hospital Ghent, Belgium France Institute Bergonié Bordeaux, France Hôpital Beaujon Paris, France, 92118 Hopital Saint Louis Paris, France Centre Eugène Marquis Rennes, France Institute Claudius Regaud Toulouse, France, 03 31052 Netherlands Netherlands Cancer Institute - Antonie van Leeuwenhoek Hospital Amsterdam, Netherlands Less <<
NCT00957580 - Terminated(The trial has been ... More >>terminated due to an estimated low probability of clinical benefit based on limited anti-leukemic effects observed in safety run-in (Part 1)) Less << - -
NCT00982865 - Completed - -
NCT02357147 Mesothelioma, Malignant Phase 2 Active, not recruiting November 30, 2018 -
NCT03508921 Overactive Bladder ... More >> Urinary Tract Infections Less << Phase 4 Recruiting September 1, 2019 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Less <<
NCT02634801 Plaque Psoriasis Phase 3 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Augsburg, Germany, 86179 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 10783 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bochum, Germany, 44803 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bonn, Germany, 53105 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Buxtehude, Germany, 21614 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dresden, Germany, 01307 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Erlangen, Germany, 91054 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Essen, Germany, 45122 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany, 60590 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Friedrichshafen, Germany, 88045 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gelsenkirchen, Germany, 45883 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 20354 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hanau, Germany, 63450 For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician. Kiel, Germany, 24105 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lübeck, Germany, 23538 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mannheim, Germany, 68167 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Münster, Germany, 48149 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Selters, Germany, 56242 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stuttgart, Germany, 70178 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tübingen, Germany, 72076 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ulm, Germany, 89081 Less <<
NCT02309892 Non-Small Cell Lung Cancer Phase 1 Recruiting December 2018 United States, Ohio ... More >> University Hospitals Case Medical Center Recruiting Cleveland, Ohio, United States United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States Less <<
NCT02123628 Diabetes Mellitus Phase 4 Completed - France ... More >> Dron Hospital Tourcoing, Nord, France, 59200 Less <<
NCT03454048 Malaria,Falciparum ... More >> Gametocytes Controlled Human Malaria Infection Transmission Less << Not Applicable Recruiting December 1, 2018 Netherlands ... More >> Radboud university medical center Recruiting Nijmegen, Gelderland, Netherlands, 6525 GA Contact: Isaie Reuling    024 361 9515 ext +31    isaie.reuling@radboudumc.nl Less <<
NCT03710772 CD20 Positive ... More >> Mantle Cell Lymphoma Less << Phase 2 Not yet recruiting May 18, 2023 United States, Texas ... More >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Luhua (Michael) Wang    713-792-2860       Principal Investigator: Luhua (Michael) Wang Less <<
NCT03599596 Malaria Phase 1 Not yet recruiting February 1, 2019 -
NCT02021006 Vesicoureteral Reflux ... More >> Renal Hypodysplasia, Nonsyndromic, 1 Chronic Kidney Disease Less << Phase 3 Recruiting December 2021 Italy ... More >> Pediatric Nephrology Dialysis and Transplant Unit IRCCS Ca'Granda Recruiting Milan, Italy, 20122 Contact: Giovanni Montini, Professor    +390255032336    giovanni.montini@unimi.it    Principal Investigator: Giovanni Montini, Professor Less <<
NCT03366766 Non-Squamous Non-Small Cell Lu... More >>ng Carcinoma Stage I Non-Small Cell Lung Cancer Stage IA Non-Small Cell Lung Carcinoma Stage IB Non-Small Cell Lung Carcinoma Stage II Non-Small Cell Lung Cancer Stage IIA Non-Small Cell Lung Carcinoma Stage IIB Non-Small Cell Lung Carcinoma Stage IIIA Non-Small Cell Lung Cancer Less << Phase 2 Recruiting July 2022 United States, Pennsylvania ... More >> Abington Hospital - Jefferson Health Not yet recruiting Abington, Pennsylvania, United States, 19001 Contact: Mark Sundemeyer, MD    215-481-2400       Principal Investigator: Mark Sundemeyer, MD          Sidney Kimmel Cancer Center at Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Ralph Zinner, MD    215-503-5098    ralph.zinner@jefferson.edu    Lankenau Institute for Medical Research Not yet recruiting Wynnewood, Pennsylvania, United States, 19096 Contact: Paul Gilman, MD    484-476-4837       Principal Investigator: Paul Gilman, MD Less <<
NCT02639091 Medical Oncology Phase 1 Active, not recruiting June 28, 2019 United States, Illinois ... More >> Chicago, Illinois, United States, 60637 United States, Maryland Bethesda, Maryland, United States, 20892 United States, Michigan Detroit, Michigan, United States, 48202 United States, South Carolina Charleston, South Carolina, United States, 29425 Italy Milano, Lombardia, Italy, 20089 Milano, Lombardia, Italy, 20133 Less <<
NCT03228108 Complication ... More >>Infection Prostate Cancer Less << Phase 4 Not yet recruiting February 2021 Netherlands ... More >> Catharina Hospital Not yet recruiting Eindhoven, Netherlands Contact: Evert Koldewijn, Dr.    +31402397040    evert.koldewijn@catharinaziekenhuis.nl    Canisius Wilhelmina Hospital Not yet recruiting Nijmegen, Netherlands Contact: Rik Somford, Dr.    +31243658832    r.somford@cwz.nl    Radboud University Medical Center Not yet recruiting Nijmegen, Netherlands Contact: Eva Kolwijck, Dr.    +31243614356    eva.kolwijck@radboudumc.nl    Contact: Sofie Tops-van Kuppevelt, Drs.    +31243614356    sofie.tops@radboudumc.nl Less <<
NCT02657434 Non-Small Cell Lung Cancer Phase 3 Recruiting November 30, 2019 -
NCT03709147 Advanced LKB1-inactive Lung Ad... More >>enocarcinoma Less << Phase 2 Not yet recruiting September 10, 2023 Italy ... More >> Marina Chiara Garassino Not yet recruiting Milan, Italy, 20133 Contact: MARINA CHIARA GARASSINO, MD    0223903813 ext +39    marina.garassino@istitutotumori.mi.it Less <<
NCT03061058 Stomach Neoplasms ... More >> Chemotherapy Effect Chemotherapeutic Toxicity Less << Phase 3 Recruiting December 2019 China, Anhui ... More >> Ma'anshan People's Hospital Recruiting Ma'anshan, Anhui, China Contact: Fenglin Zhang, MD          Contact: Fangbo Cui, MD          China, Jiangsu Jiangyin People's Hospital Recruiting Jiangyin, Jiangsu, China Contact: Weisheng Shen, MD          Contact: Lei Xi, MD          Nanjing Gaochun People's Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Rongfu Wei, MD          Contact: Yajun Xin, MD          Nanjing Lishui People's Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Chunlan Nie, MD          Contact: Hui Xu, MD          The Comprehensive Cancer Center of Nanjing Drum Tower Hospital Recruiting Nanjing, Jiangsu, China, 210008 Contact: Yang Yang, MD,PhD,MSCR    0086-18602568379    wing_young7@hotmail.com    Contact: Baorui Liu, MD, PhD    0086-13770621908    baoruiliu07@163.com    Suqian People's Hospital Recruiting Suqian, Jiangsu, China Contact: Chuanwen You, MD          Contact: Qing Zhu, MD          Xuzhou Central Hospital Recruiting Xuzhou, Jiangsu, China Contact: Sanyuan Sun, MD          Contact: Yuan Yuan, MD          Affiliated Hospital of Jiangsu University Recruiting Zhenjiang, Jiangsu, China Contact: Xiaoqing Li, MD          Contact: Meilian Cheng, MD Less <<
NCT03062800 Advanced Nsclc Phase 2 Recruiting October 2018 China, Shandong ... More >> Qilu hospital of Shandong University Recruiting Jinan Shi, Shandong, China, 250012 Contact: Shuguang Li, MD.    +86 18560082862    lishuguang96@163.com    Principal Investigator: Xiuwen Wang, MD. Less <<
NCT02899195 Mesothelioma ... More >>Pleural Mesothelioma Less << Phase 2 Active, not recruiting December 2020 -
NCT03305341 Small Cell Lung Cancer Phase 3 Active, not recruiting May 28, 2020 United States, Maryland ... More >> Medicine Invention Design, Inc. (MIDI) - c/o - MIDINC Clinical Investigator Working Site Gaithersburg, Maryland, United States, 20877 Less <<
NCT03348670 Small Cell Lung Cancer Phase 3 Active, not recruiting May 28, 2020 United States, Maryland ... More >> Medicine Invention Design, Inc. (MIDI) - c/o - MIDINC Clinical Investigator Working Site North Bethesda, Maryland, United States, 20852 Less <<
NCT03215706 Non-Small Cell Lung Cancer Phase 3 Recruiting May 20, 2020 -
NCT02804646 Adenocarcinoma of Lung Phase 4 Unknown December 2018 China, Anhui ... More >> Anhui provincial hospital Recruiting Hefei, Anhui, China, 230000 Contact: Lejie Cao, prefessor       sycaolejie@163.com    Contact: Nana Hu       493305821@qq.com Less <<
NCT03681470 Acne Vulgaris Phase 4 Recruiting October 30, 2019 United States, New York ... More >> Mount Sinai West Recruiting New York, New York, United States, 10023 Less <<
NCT03381066 Completely Resected NSCLC With... More >> Common EGFR Mutations Less << Phase 3 Not yet recruiting December 2023 Korea, Republic of ... More >> Department of Oncology, Yonsei University College of Medicine Not yet recruiting Seoul, Korea, Republic of, 03722 Contact: Byoung Chul Cho, MD    82 2 2228 0880    cbc1971@yuhs.ac Less <<
NCT01706692 - Recruiting June 2021 Switzerland ... More >> Aarau Cantonal Hospital Recruiting Aarau, Switzerland, CH-5001 Contact: Marcus Streit, Dr. med.    062 838 68 38    markus.streit@ksa.ch    Principal Investigator: Marcus Streit, Dr. med.          Basel University Hospital Recruiting Basel, Switzerland, CH-4031 Contact: Peter Itin, Prof.       pitin@uhbs.ch    Principal Investigator: Peter Itin, Prof.          Inselspital - Bern University Hospital Recruiting Bern, Switzerland, CH-3001 Contact: Luca Borradori, Prof. Dr.    031 632 2111    Luca.Borradori@insel.ch    Principal Investigator: Luca Borradori, Prof. Dr.          Centre Hospitalier Universitaire Vaudois (CHUV) Recruiting Lausanne, Switzerland, CH-1011 Contact: Michel Gilliet, Prof.       michel.gilliet@chuv.ch    Principal Investigator: Curdin Conrad, PD Dr. med.          St. Gallen Cantonal Hospital Recruiting St. Gallen, Switzerland, CH-9007 Contact: Damian Bühler, Dr. med.       damian.buehler@kssg.ch    Principal Investigator: Mark Anliker, Dr. med.          Zurich University Hospital Recruiting Zurich, Switzerland, CH-8091 Contact: Alexander Navarini, Dr.       alexander.navarini@usz.ch    Principal Investigator: Lars French, Prof. Less <<
NCT03530397 Selected Advanced Solid Tumors Phase 1 Recruiting March 27, 2023 Australia ... More >> Research Site Recruiting Melbourne, Australia, 3000 Research Site Recruiting Melbourne, Australia, 3004 Research Site Recruiting Randwick, Australia, 2031 Italy Research Site Not yet recruiting Milano, Italy, 20133 Korea, Republic of Research Site Not yet recruiting Incheon, Korea, Republic of, 21565 Research Site Recruiting Seoul, Korea, Republic of, 03080 Research Site Recruiting Seoul, Korea, Republic of, 03722 Research Site Recruiting Seoul, Korea, Republic of, 05505 Research Site Recruiting Seoul, Korea, Republic of, 06351 Taiwan Research Site Not yet recruiting Taichung, Taiwan, 40705 Research Site Not yet recruiting Tainan, Taiwan, 70403 Research Site Not yet recruiting Taipei, Taiwan, 10048 Less <<
NCT03498222 Carcinoma, Non-Small-Cell Lung Phase 1 Not yet recruiting December 31, 2021 -
NCT03765957 Psoriasis Early Phase 1 Not yet recruiting June 1, 2021 -
NCT00470223 Sarcoma Phase 3 Terminated(IDMC decision upon ... More >>interim efficacy analysis) Less << April 2025 France ... More >> Centre Paul Papin Angers, France, 49036 Institut Gustave Roussy Angers, France, 49036 Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Besancon, France, 25030 CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 Institut Bergonie Bordeaux, France, 33076 CHU Hopital A. Morvan Brest, France, 29609 CHU de Caen Caen, France, 14033 Centre Regional Francois Baclesse Caen, France, 14076 CHR Clermont Ferrand, Hotel Dieu Clermont-Ferrand, France, 63003 Centre Jean Perrin Clermont-Ferrand, France, 63011 Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Hospitalier Universitaire de Dijon Dijon, France, 21079 CHU de Grenoble - Hopital Michallon Grenoble, France, 38043 Centre Oscar Lambret Lille, France, 59020 Centre Leon Berard Lyon, France, 69373 Hopital Edouard Herriot - Lyon Lyon, France, 69437 Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 CHU de la Timone Marseille, France, 13385 Hopital d'Enfants de la Timone Marseille, France, 13385 CHU Nord Marseille, France, 13915 Hopital Arnaud de Villeneuve Montpellier, France, 34295 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Centre Antoine Lacassagne Nice, France, 06189 Hopital de l'Archet CHU de Nice Nice, France, F-06202 Institut Curie Hopital Paris, France, 75248 Hopital Jean Bernard Poitiers, France, 86021 Centre Eugene Marquis Rennes, France, 35042 Hopital Charles Nicolle Rouen, France, 76031 Centre Henri Becquerel Rouen, France, 76038 Institut de Cancerologie de la Loire Saint Priest en Jarez, France, 42270 Hopitaux Universitaire de Strasbourg Strasbourg, France, 67091 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Hopital des Enfants Toulouse, France, 31059 C.H. Bastien de Clocheville Tours, France, 3700 CHRU de Tours - Hopital Trousseau Tours, France, 37044 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Less <<
NCT03173053 Staphylococcus Aureus ... More >> Motility Disorder Less << Not Applicable Recruiting August 8, 2021 Denmark ... More >> Aalborg Universitetshospital Not yet recruiting Aalborg, Denmark, 9000 Principal Investigator: Henrik Rasmussen, MD, PhD          Rigshospitalet Not yet recruiting Copenhagen, Denmark, 2100 Principal Investigator: Palle B Jeppesen, MD, PhD          Netherlands Radboud UMC Recruiting Nijmegen, Gelderland, Netherlands, 6500HB Principal Investigator: Michelle Gompelman, MD          AMC Not yet recruiting Amsterdam, Noord-Holland, Netherlands, 100DD Principal Investigator: M J Serlie, MD, PhD Less <<
NCT02299466 - Recruiting December 2021 Canada, Alberta ... More >> Foothills Medical Centre Recruiting Calgary, Alberta, Canada Contact: Maitreyi Raman, MD    403-943-2580    mkothand@ucalgary.ca    Contact: Sari Czink, RD    403-944-1638    Sari.czink@calgaryhealthregion.ca    Captial Health/University Of Alberta Recruiting Edmonton, Alberta, Canada Contact: Leah Gramlich, MD    780-735-6839    eah.gramlich@ualberta.ca    Contact: Holly Ames, RD    780-407-6021    holly.ames@albertahealthservices.ca    Canada, British Columbia BC Home Parenteral Nutrition Program Recruiting Vancouver, British Columbia, Canada Contact: Scott Whittaker, MD    604-688-6332 x226    scottwhittaker@mac.com    Contact: Holly van Heukelom    604-806-9808    HvanHeukelom@providencehealth.bc.ca    Canada, Manitoba St. Boniface General Hospital Recruiting Winnipeg, Manitoba, Canada, R2H 2A6 Contact: Donald Duerksen, MD       dduerkse@sbgh.mb.ca    Canada, Ontario Hamilton Health Sciences Recruiting Hamilton, Ontario, Canada Contact: David Armstrong, MD       armstro@mcmaster.ca    Contact: Suzanne Hansen, RD    905-521-2100 ext 75358    shansen@hhsc.ca    St. Michael's Hospital Recruiting Toronto, Ontario, Canada Contact: Khursheed Jeejeebhoy, MD    416-864-5348    khushjeejeebhoy@compuserve.com    Contact: Brian Jurewitsch, RN    416.864.5431    jurewitschb@smh.toronto.on.ca    Canada, Quebec Hopital St-Luc Recruiting Montréal, Quebec, Canada, H2X 0C1 Contact: Louise D'Aoust, MD    514-890-8000    louise_daoust@sympatico.ca    McGill University Recruiting Montréal, Quebec, Canada, H3G 1A4 Contact: Errol Marliss, MD    514) 843-1665    marliss.errol@muhc.mcgill.ca    Contact: Sylvie LeBourdias, RN    514-934-1934 ext 35392    Sylvie.Lebourdais@muhc.mcgill.ca    Hotel-Dieu de Quebec Recruiting Québec, Quebec, Canada Contact: Marie-France Boudreault, RN    418-525-4444    marie-france.boudreault@chuq.qc.ca    Canada, Saskatchewan Saskatchewan Adult HTPN Program Recruiting Regina, Saskatchewan, Canada, S4T 1A5 Contact: Danielle Stevenson, RN    +1-306-766-2746    Danielle.Stevenson@rqhealth.ca Less <<
NCT03228537 Biphasic Mesothelioma ... More >> Epithelioid Mesothelioma Stage I Pleural Malignant Mesothelioma AJCC v7 Stage IA Pleural Malignant Mesothelioma AJCC v7 Stage IB Pleural Malignant Mesothelioma AJCC v7 Stage II Pleural Malignant Mesothelioma AJCC v7 Stage III Pleural Malignant Mesothelioma AJCC v7 Less << Phase 1 Recruiting June 1, 2020 -
NCT03635957 Gout Phase 2 Recruiting December 2019 United States, Washington ... More >> Western Washington Arthritis Clinic Recruiting Bothell, Washington, United States, 98021 Contact: Nicole Bruggman    425-248-2635    nbruggman@wwmedgroup.com    Principal Investigator: Jeff R Peterson, MD          Arthritis Northwest PLLC Recruiting Spokane, Washington, United States, 99204 Contact: Terri Cone    509-838-6500 ext 310    tcone@arthritisnw.com    Principal Investigator: Howard Kenney, MD Less <<
NCT02525172 Pompe Disease Phase 4 Recruiting July 2020 Taiwan ... More >> Yin-Hsiu Chien Recruiting Taipei, Taiwan, 100 Contact: Yin-Hsiu Chien    +886223123456    chienyh@ntu.edu.tw    Principal Investigator: Yin-Hsiu Chien Less <<
NCT03640403 Malaria,Falciparum ... More >> Anemia Less << Phase 4 Not yet recruiting December 2021 Tanzania ... More >> National Institute for Medical Research Not yet recruiting Tanga, Tanzania, 255 Contact: Centre Director    +255272646084    tanga@nimr.or.tz    Contact: Vito Baraka, PhD    +255715380010    vitobaraka@gmail.com    Principal Investigator: Geofrey Makenga, MD, MSc          Sub-Investigator: Vito Baraka, PhD          Sub-Investigator: Filbert Fransis, MSc          Sub-Investigator: Rashid Madebe, MSc          Sub-Investigator: Edwin Liheluka, MSc Less <<
NCT01725945 Asthma Hypert... More >>ension Less << Not Applicable Completed - United States, California ... More >> Kaiser Permanente, Hayward Medical Center, Allergy Department Hayward, California, United States, 94545 Kaiser Permanente, San Francisco Medical Center, Allergy Department San Francisco, California, United States, 94115 Less <<
NCT02517918 Solid Tumor O... More >>steosarcoma Less << Phase 1 Recruiting October 2019 France ... More >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Maud Toulmonde, Doctor          Centre Léon Bérard Not yet recruiting Lyon, France, 69008 Contact: Jean-Yves BLAY, Professor          Institut Curie Not yet recruiting Paris Cedex 05, France, 75248 Contact: Sophie PIPERNO-NEUMANN, Doctor          Institut Gustave Roussy Not yet recruiting Villejuif Cedex, France, 94805 Contact: Julien DOMONT, Doctor Less <<
NCT03744793 Infiltrating Bladder Urothelia... More >>l Carcinoma Sarcomatoid Variant Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant Metastatic Urothelial Carcinoma MTAP Negative Less << Phase 2 Not yet recruiting January 1, 2020 United States, Texas ... More >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Amishi Y. Shah    713-792-2830       Principal Investigator: Amishi Y. Shah Less <<
NCT02881684 Obesity Not Applicable Recruiting December 2018 Hong Kong ... More >> The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Michele MA Yuen, MBBS    (852) 6073 2211    micheleyuen@hotmail.com    Contact: Carol HY Fong, MSc Stat    (852) 2255 3711    kalofong@gmail.com Less <<
NCT02634801 - Completed - -
NCT02373579 Acute Lymphoblastic Leukemia Phase 2 Completed - -
NCT01465867 Pregnancy Inf... More >>ertility Auto-immune Thyroiditis Less << Not Applicable Completed - Italy ... More >> Azienda ospedaliero-universitaria Careggi Florence, Italy, 50134 Istituto Auxologico Italiano Milan, Italy, 20095 Ospedale Maggiore Policlinico Milan, Italy, 20122 University Federico II Naples, Italy, 80131 University "Piemonte Orientale, A. Avogadro" Novara, Italy, 28100 Torvergata University of Rome - Ospedale S. Eugenio Rome, Italy, 00145 European Hospital Rome, Italy, 00148 Ospedale S. Giovanni Calibita Fatebenefratelli Rome, Italy, 00153 Department of Experimental Medicine, "Sapienza" University of Rome Rome, Italy, 00161 Department of Gynecological/Obstetric/Urological Sciences, "Sapienza" University of Rome Rome, Italy, 00161 Dpt of Experimental Medicine Rome, Italy, 00161 Less <<
NCT03672474 Alzheimer Disease Not Applicable Recruiting October 19, 2019 France ... More >> Montpellier University Hospital, Gui de Chauliac Recruiting Montpellier, France, 34295 Contact: Audrey Gabelle, MD, PhD    0467336029    a-gabelle@chu-montpellier.fr Less <<
NCT03488992 Metabolic Syndrome Not Applicable Completed - Canada, Ontario ... More >> KGK Synergize London, Ontario, Canada, N6A 5R8 Less <<
NCT02423551 Gastrointestinal Tract Not Applicable Completed - United States, Massachusetts ... More >> USARIEM Natick, Massachusetts, United States, 01760 Less <<
NCT00200226 Endometrial Biopsy Phase 3 Completed - Canada, Newfoundland and Labra... More >>dor Women's Health Centre, Eastern Health St. John's, Newfoundland and Labrador, Canada, A1E 5K9 Canada, Nova Scotia Obstetrics and Gynecology Associates Dartmouth, Nova Scotia, Canada, B2Y 4W2 Less <<
NCT00004920 Malignant Mesothelioma Phase 3 Completed - -
NCT00003528 Recurrent Childhood Acute Lymp... More >>hoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Less << Phase 1 Completed - Switzerland ... More >> Swiss Pediatric Oncology Group - Geneva Geneva, Switzerland, 1205 Less <<
NCT02542865 Growth and Development Not Applicable Completed - India ... More >> GSK Investigational Site Pune, India, 411001 Less <<
NCT00004254 Malignant Mesothelioma Phase 2 Completed - Italy ... More >> Ospedale Bellaria Bologna, Italy, I-40139 Istituto Nazionale per la Ricerca sul Cancro Genoa, Italy, 16132 Istituto Nazionale per lo Studio e la Cura dei Tumori Naples, Italy, 80131 Universita Degli Studi di Udine Udine, Italy, 33100 Netherlands Antoni van Leeuwenhoekhuis Amsterdam, Netherlands, 1066 CX Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1117 MB Less <<
NCT00303550 Skin Diseases, Bacterial Phase 3 Completed - United States, Illinois ... More >> Edward Hospital & Health Services Naperville, Illinois, United States, 60540 United States, Wyoming Wyoming Medical Center Casper, Wyoming, United States, 82601 Less <<
NCT01754012 Aging Not Applicable Completed - France ... More >> Auvergne Research Center on Human Nutrition Clermont-Ferrand, France, 63009 Italy University of Bologna-Department of Speciality, Diagnostic and Experimental Medicine Bologna, Italy, 40126 Netherlands University of Wageningen-Division of Human Nutrition Wageningen, Netherlands, 6703 HD Poland Warsaw University of Life Science SGGW-WULS-Department of Human Nutrition Warsaw, Poland, 02-776 United Kingdom Department of Nurition-University of East Anglia Norwich, United Kingdom, NR4 7TJ Less <<
NCT00387322 Lung Cancer U... More >>nspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Phase 2 Completed - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT00299520 Complicated Skin and Skin Stru... More >>cture Infection Less << Phase 3 Completed - United States, California ... More >> e-Study Site National City, California, United States, 91950 United States, Idaho VA Medical Center Boise, Idaho, United States, 83702 United States, Indiana Infectious Disease of Indiana Indianapolis, Indiana, United States, 46260 United States, Maryland Judith Stone. M.D. Cumberland, Maryland, United States, 21502 United States, Ohio ID Clinical Research, Ltd. Toledo, Ohio, United States, 43608 Less <<
NCT03525730 HIV-1-infection Phase 1 Phase 2 Recruiting April 2020 Netherlands ... More >> Erasmus MC Recruiting Rotterdam, Netherlands, 3015 CN Contact: Casper Rokx, MD PhD    +31681336328    c.rokx@erasmusmc.nl    Sub-Investigator: Henrieke Prins, MD          Sub-Investigator: Jeroen van Kampen, MD PhD          Sub-Investigator: Yvonne Muller, PhD          Sub-Investigator: Tokameh Mahmoudi, PhD          Sub-Investigator: Charles Boucher, MD PhD          Sub-Investigator: Annelies Verbon, MD PhD          Sub-Investigator: David Burger, PHD Less <<
NCT01199159 Hysterectomy Not Applicable Completed - Hong Kong ... More >> University of Hong Kong Hong Kong, Hong Kong Less <<
NCT00440414 Non Small Cell Lung Cancer Phase 3 Completed - Greece ... More >> University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupolis, Greece 401 Military Hospital, Medical Oncology Unit Athens, Greece Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece IASO General Hospital of Athens, 1st Department of Medical Oncology Athens, Greece Laikon General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece Sismanogleio General Hospital, 1st, 2nd Department of Pulmonary Diseases Athens, Greece Sotiria General Hospital, 1st, 3rd, 8th Dep of Pulmonary Diseases Athens, Greece Metaxa's Anticancer Hospital of Piraeus,1st Dep of Medical Oncology Piraeus, Greece Theagenion Anticancer Hospital of Thessaloniki Thessaloniki, Greece Less <<
NCT00003305 Leukemia Phase 2 Completed - United States, California ... More >> Advanced Urology Medical Center Anaheim, California, United States, 92801 South Coast Urological Medical Group Laguana Hills, California, United States, 92653 United States, Connecticut Urology Specialists, P.C. Waterbury, Connecticut, United States, 06708 United States, Florida Barzell, Whitmore, Treiman and Dunne - The Urology Treatment Center Sarasota, Florida, United States, 34239 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637 United States, Maryland 206 Research Associates Greenbelt, Maryland, United States, 20770 Mid Atlantic Clinical Research Rockville, Maryland, United States, 20850 United States, New Jersey Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 United States, New York Medical & Clinical Research Associates, LLC Bay Shore, New York, United States, 11706 Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 United States, Texas Medical City Dallas Hospital Dallas, Texas, United States, 75230 Urology Centers of North Texas Dallas, Texas, United States, 75231 Urology San Antonio Research San Antonio, Texas, United States, 78229 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Less <<
NCT00877812 Vitamin B6 Deficiency Not Applicable Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32611 Less <<
NCT00447057 Histological or Cytological Di... More >>agnosis of Locally Advanced or Metastatic NSCLC of Nonsquamous Histology and Not Amenable to Curative Therapy. Less << Phase 2 Completed - Austria ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salzburg, Austria, 5020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vienna, Austria, A-1140 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bochum, Germany, 44791 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Freiburg, Germany, 79106 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gauting, Germany, 82131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gerlingen, Germany, 70839 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, D 21075 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, 30625 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Immenhausen, Germany, 34376 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trier, Germany, 54219 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tübingen, Germany, 72076 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ulm, Germany, 89075 Hungary For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Deszk, Hungary, 6772 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Matrahaza, Hungary, 3233 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nyiregyhaza, Hungary, H-4400 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Szekesfehervar, Hungary, 8000 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alicante, Spain, 03010 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28050 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46010 Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Linkoping, Sweden, 58185 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lund, Sweden, 221 85 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Solna, Sweden, 17176 Less <<
NCT00939718 Major Depressive Disorder Not Applicable Unknown September 2010 Pakistan ... More >> Aga Khan University Karachi, Sindh, Pakistan, 74800 Less <<
NCT00590278 Inoperable or Recurrent Rectal... More >> Cancer Less << Phase 2 Completed - Turkey ... More >> Research Site Istanbul, Turkey Less <<
NCT02802566 Obesity Not Applicable Unknown - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02115 Contact: Mary Herlihy, MD          Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Sarbattama Sen, MD       ssen2@partners.org    Contact: Annie Penfield-Cyr, BS       apenfield-cyr@partners.org Less <<
NCT00573989 Head and Neck Cancer Phase 1 Phase 2 Terminated(Drug Supply Issue) - United States, North Carolina ... More >> UNC Linberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT00447057 - Completed - -
NCT00573989 - Terminated(Drug Supply Issue) - -
NCT00577707 Non Small Cell Lung Cancer ... More >> Lung Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00227539 Lung Cancer Phase 2 Completed - United States, Washington ... More >> Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 University of Washington School of Medicine Seattle, Washington, United States, 98195 Less <<
NCT00577707 - Completed - -
NCT00550173 - Completed - -
NCT00281125 Non-Small Cell Lung Cancer and... More >> Pleural Mesothelioma Less << Phase 1 Phase 2 Terminated(Suspended due to da... More >>ta issues revealed at DSMB meeting. Planned amendment but was never submitted. Study was then closed.) Less << - United States, Nevada ... More >> Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 Less <<
NCT00227539 - Completed - -
NCT00550173 Non-Small-Cell Lung Cancer Phase 2 Completed - Brazil ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barretos, Brazil, 14784700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ijui, Brazil, 98700 000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. São Paulo, Brazil, 01277-900 China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100730 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanning, China, 530000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200030 Hong Kong For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sha Tin, Hong Kong India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ahmedabad, India, 380016 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bhopal, India, 462001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyderabaad, India, 500082 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jaipur, India, 302013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kochin, India, 682304 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kolkata, India, 700 026 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madurai, India, 625020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mohali, India, 160062 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mumbai, India, 400 026 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Delhi, India, 110017 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vishakhapatnam, India, 530002 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jin-Ju-Si, Korea, Republic of, 660-702 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 138-736 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Suwon-City, Korea, Republic of, 442-723 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changhua, Taiwan, 500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 407 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poole, Dorset, United Kingdom, BH15 2JB For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chelmsford, Essex, United Kingdom, CM1 7ET For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aberdeen, Scotland, United Kingdom, AB25 2ZN For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guildford, Surrey, United Kingdom, GU2 7XX For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Manchester, United Kingdom, M20 4BX Less <<
NCT00903292 Non-Small Cell Lung Cancer Not Applicable Unknown December 2010 Taiwan ... More >> National Cheng-Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Hui-Shu Yang, Bachelor    +886-6-2353535 ext 4289    huishuyang@gmail.com Less <<
NCT01762319 Abnormal Uterine Bleeding Unre... More >>lated to Menstrual Cycle Less << Not Applicable Unknown June 2013 Thailand ... More >> Faculty of Medicine Siriraj Hospital Mahidol University Recruiting Bangkok, Thailand, 10700 Contact: Korakot Sirimai, Dr.    (66)81-6140655    ksirimai@hotmail.com    Principal Investigator: Korakot Sirimai, Dr.          Sub-Investigator: Tripop Lertbunnaphong, Dr. Less <<
NCT03351751 Healthy Volunteers Phase 1 Completed - United States, Connecticut ... More >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 Less <<
NCT00390000 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Active, not recruiting December 2018 United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00409006 Non-small Cell Lung Cancer Phase 2 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fujian, China, 350014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Qingdao, China, 266003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 201900 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 137-701 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changhua, Taiwan, 500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 Less <<
NCT00409006 - Completed - -
NCT00989690 Lung Cancer Phase 3 Unknown - Italy ... More >> Istituto Scientifico H. San Raffaele Recruiting Milan, Italy, 20132 Contact: Vanesa Gregor, MD    39-02-2643-7623 Less <<
NCT00410904 Recurrent Non-small Cell Lung ... More >>Cancer Less << Phase 2 Completed - United States, Maryland ... More >> University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Michigan Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT00528281 Lung Cancer, Non-Small Cell Phase 1 Completed - Germany ... More >> GSK Investigational Site Heidelberg, Baden-Wuerttemberg, Germany, 69126 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 Italy GSK Investigational Site Orbassano (TO), Piemonte, Italy, 10043 Poland GSK Investigational Site Poznan, Poland, 60-569 United Kingdom GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE7 7DN Less <<
NCT01295801 - Unknown September 2011 China, Beijing ... More >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Less <<
NCT01348412 Colorectal Cancer ... More >> Liver Metastases Less << Phase 2 Completed - France ... More >> Centre Georges François Leclerc Dijon, France, 21000 Less <<
NCT01475617 Bariatric Surgery Candidate Phase 2 Phase 3 Completed - United States, Maryland ... More >> The John's Hopkins Center for Bariatric Surgery (JHCBS) Baltimore, Maryland, United States, 21224-2780 Less <<
NCT02209545 Fibroids Phase 4 Recruiting May 2020 United States, Illinois ... More >> Northwestern University, Prentice Women's Hospital Recruiting Chicago, Illinois, United States, 60611 Principal Investigator: Magdy Milad, MD Less <<
NCT00768755 Carcinoma, Non-Small Cell Lung Phase 1 Phase 2 Completed - -
NCT00410904 - Completed - -
NCT02640417 Low Back Pain Phase 4 Active, not recruiting October 2018 -
NCT01806272 Nasopharyngeal Cancers Phase 2 Unknown August 2014 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Wei LUO, M.D.    +862087343483    luowei2@mail.sysu.edu.cn Less <<
NCT00768755 - Completed - -
NCT00907179 Non-Small Cell Lung Cancer Phase 1 Terminated(Widespread use firs... More >>tline Pemetrexed; slow recruitment; funding withdrawn..) Less << - United States, Pennsylvania ... More >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01936831 Tuberculosis Early Phase 1 Recruiting March 15, 2019 South Africa ... More >> TASK Applied Science CRS (31718) Recruiting Bellville, South Africa, 7531 Contact: Jeannine du Bois, MB, ChB       dr.jeannine@task.org.za    Principal Investigator: Andreas Diacon, MD, PhD Less <<
NCT00891579 Non Small Cell Lung Cancer Phase 2 Completed - China, Guangdong ... More >> Lung Cancer Research Institute & Cancer Center of Guangdong General Hospital Guangzhou, Guangdong, China, 510080 China 307 hospital of People's Liberation Army Beijing, China Peking Union Hospital Beijing, China Jilin Tumor Hospital Changchun, China Nanjing General Hospital of Nanjing Military Command Nanjing, China Shanghai Chest Hospital Shanghai, China The first hospital of China medical university Shenyang, China Less <<
NCT01565538 Lung Cancer Phase 2 Completed - China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT02498327 Venous Insufficiency Phase 2 Completed - South Africa ... More >> University of Johannesburg Johannesburg, Gauteng, South Africa, 2028 Less <<
NCT01565538 - Completed - -
NCT01578668 Lung Adenocarcinoma ... More >> Brain Metastases Less << Phase 2 Completed - China, Guangdong ... More >> The first affiliated hospital of Guangzhou MC Guangzhou, Guangdong, China, 510120 Less <<
NCT01664533 - Completed - Belgium ... More >> Aalst, Belgium, 9300 Antwerpen, Belgium, 2020 Boussu, Belgium, 7360 Bruxelles, Belgium, 1200 Charleroi, Belgium, 6000 Dendermonde, Belgium, 9200 Duffel, Belgium, 2570 Edegem, Belgium, 2650 Frameries, Belgium, 7080 Genk, Belgium, 3600 Gilly, Belgium, 6060 Gosselies, Belgium, 6041 Liege, Belgium, 4000 Mons, Belgium, 7000 Montegnée, Belgium, 4420 Namur, Belgium, 5000 Ottignies, Belgium, 1340 Roeselare, Belgium, 8800 Sint Niklaas, Belgium, 9100 Tournai, Belgium, 7500 Turnhout, Belgium, 2300 Less <<
NCT01017874 Non Small Cell Lung Cancer Phase 3 Completed - Hong Kong ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kowloon, Hong Kong Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Incheon, Korea, Republic of, 405-760 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 110-744 Singapore For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore, 258499 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kuei Shan Hsiang, Taiwan, 33305 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Liouying/Tainan, Taiwan, 736 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Puzih City, Taiwan, 613 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 407 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 100 Thailand For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bangkok, Thailand, 10700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiang Mai, Thailand, 50200 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hat Yai, Thailand, 90110 Less <<
NCT00738881 Recurrent Non-Small Cell Lung ... More >>Carcinoma Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer Less << Phase 3 Terminated(Slow accrual) - -
NCT00738881 - Terminated(Slow accrual) - -
NCT01066195 Non-small Cell Lung Cancer Phase 3 Unknown - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT01732380 Inoperable Esophageal Cancer S... More >>tage I-III Less << Phase 2 Unknown July 2013 China, Jiangsu ... More >> The First People`s Hospital of Lianyungang Recruiting Lianyungang, Jiangsu, China, 222002 Contact: Xiaodong Jiang, Doctor       jxdysy1970@163.com Less <<
NCT01017874 - Completed - -
NCT02321579 Liver Cirrhosis ... More >> Liver Cancer Less << Not Applicable Unknown July 2017 Taiwan ... More >> Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 40705 Contact: Yi-Chia Huang, PhD    +886-4-24730022 ext 12198    ych@csmu.edu.tw    Principal Investigator: Shao-Bin Cheng, MD Less <<
NCT01664533 - Completed - -
NCT01184287 Non-Small Cell Lung Cancer Phase 2 Withdrawn(Program discontinued... More >>) Less << - United States, California ... More >> Tower Cancer Research Foundation Beverly Hills, California, United States, 90211 United States, Michigan Van Andel Research Institute Grand Rapids, Michigan, United States, 49503 United States, Montana Sletten Cancer Specialists Great Falls, Montana, United States, 59405 United States, New York The Cancer Institute at NYU Langone Medical Center New York, New York, United States, 10016 United States, Ohio Tri-county Hematology-Oncology Associates, Inc Canton, Ohio, United States, 44718 United States, Utah Northern Utah Associates Ogden, Utah, United States, 84403 Less <<
NCT01154140 Non Squamous Lung Cancer Phase 3 Completed - -
NCT01211275 Malignant Pleural Mesothelioma Phase 1 Phase 2 Completed - Netherlands ... More >> Antoni van Leeuwenhoekziekenhuis (NKI-AVL) Amsterdam, Noord-Holland, Netherlands, 1066 CX Less <<
NCT01154140 - Completed - -
NCT01959061 Colorectal Cancer Metastatic Phase 4 Recruiting December 2017 China, Shanghai ... More >> Zhongshan Hospital Fudan University Recruiting Shanghai, Shanghai, China, 2000032 Contact: Jianhua Wang Less <<
NCT01192243 Toxicity Non-... More >>small Cell Lung Cancer Less << Phase 2 Unknown - China, Shanghai ... More >> Cancer hospital Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Jianhua Chang, MD,PhD    13916619284    changjianhua@hotmail.com Less <<
NCT01336842 Solid Tumors ... More >>Non-Small Cell Lung Cancer (NSCLC) Less << Phase 1 Completed - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 Less <<
NCT01928160 Recurrent Non-small Cell Lung ... More >>Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 2 Withdrawn(study not accruing) - -
NCT03456063 Non-Small-Cell Lung Phase 3 Recruiting November 20, 2024 -
NCT01664754 Stage IV Non-small Cell Lung C... More >>ancer Less << Phase 1 Active, not recruiting September 30, 2019 United States, California ... More >> Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 Less <<
NCT03456076 Carcinoma, Non-Small-Cell Lung Phase 3 Recruiting September 30, 2026 -
NCT02524444 Malaria in Pregnant HIV + Pati... More >>ents Less << Phase 1 Completed - Nigeria ... More >> University College Hospital Ibadan, OYO State, Nigeria, 200001 Less <<
NCT03478111 Rheumatoid Arthritis Phase 3 Recruiting July 1, 2019 China, Beijing ... More >> Peking University People's Hospital Recruiting Beijing, Beijing, China, 100044 Contact: Yin Su, Ph.D    +8613321120132    suyin0921@163.com Less <<
NCT00698815 Recurrent Non-Small Cell Lung ... More >>Carcinoma Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Stage IV Non-Small Cell Lung Cancer AJCC v7 Less << Phase 2 Completed - -
NCT01666977 Non Small Cell Lung Cancer Phase 1 Phase 2 Completed - -
NCT00698815 - Completed - -
NCT03456817 Graft-versus-host-disease ... More >> Relapse Less << Phase 2 Not yet recruiting September 2023 -
NCT02677181 aGVHD Phase 4 Unknown December 2018 China, Beijing ... More >> Liping Dou Recruiting Beijing, Beijing, China, 100853 Contact: Daihong Liu, doctor    86-13681171597    daihongrm@163.com    Contact: Liping Dou, doctor    86-13681207138    lipingruirui@163.com    Principal Investigator: Daihong Liu, doctor Less <<
NCT03492658 Rheumatoid Arthritis ... More >> Rheumatic Diseases Less << Phase 4 Not yet recruiting September 2021 -
NCT02527005 Malaria Pregn... More >>ant HIV Less << Phase 1 Completed - Nigeria ... More >> University College Hospital, Ibadan, Oyo, Nigeria, 200001 Less <<
NCT03495960 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Not yet recruiting October 31, 2023 Italy ... More >> Bari IRCCS Istituto Tumori Bari, Italy Meldola, IRST - ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI Meldola, Italy Milano, IRCCS Ospedale San Raffaele Milan, Italy, 20132 Milano - Îstituto Besta Milan, Italy Milano Niguarda Milan, Italy Modena, Policlinico Universitario Modena, Italy Padova, Istituto Oncologico Veneto Padova, Italy Parma, Azienda Ospedaliera Parma, Italy Pescara, Presidio Ospedaliero UOS dipartimentale centro di diagnosi e terapia Linfomi Pescara, Italy Piacenza Piacenza, Italy Ravenna - Ospedale di Ravenna - IRST Ravenna, Italy Reggio Emilia - Arcispedale Santa Maria Nuova - IRCCS Reggio Emilia, Italy Roma - Ospedale S. Andrea Roma, Italy Roma - Unicampus-Bio Roma, Italy S. Giovanni Rotondo - Casa Sollievo della sofferenza San Giovanni Rotondo, Italy Siena - Azienda Ospedaliera Universitaria Senese Siena, Italy Terni - Ospedale di Terni Terni, Italy Torino neurooncologia - AOU CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO Torino, Italy Tricase - Ospedale "Card. G. Panico" Tricase, Italy Udine, Azienda Ospedaliera Universitaria Udine, Italy Switzerland Basel - Universitätsspital Recruiting Basel, Switzerland Contact: Benjamin kasenda, MD          Principal Investigator: Benjamin Kasenda          IOSI - Oncology Institute of Southern Switzerland Bellinzona, Switzerland, 6500 Bern - Inselspital Bern, Switzerland Lausanne - CHUV Lausanne, Switzerland St. Gallen - Kantonsspital Saint Gallen, Switzerland Less <<
NCT03505008 Rheumatoid Arthritis Phase 4 Recruiting February 2022 Japan ... More >> Keio University Recruiting Tokyo, Japan Contact: Hiroya Tamai, MD    +81-3-5363-3786    h.tamai@keio.jp Less <<
NCT03509012 Carcinoma, Squamous Cell of He... More >>ad and Neck Carcinoma, Non-Small-Cell Lung Small Cell Lung Carcinoma Less << Phase 1 Recruiting April 4, 2022 United States, Arizona ... More >> Research Site Recruiting Tucson, Arizona, United States, 85719 United States, Colorado Research Site Recruiting Aurora, Colorado, United States, 80045 United States, Missouri Research Site Not yet recruiting Saint Louis, Missouri, United States, 63110 United States, New Jersey Research Site Withdrawn Middletown, New Jersey, United States, 07748 Japan Research Site Recruiting Koto-ku, Japan, 135-8550 Research Site Recruiting Sunto-gun, Japan, 411-8777 Korea, Republic of Research Site Recruiting Seoul, Korea, Republic of, 03080 Research Site Recruiting Seoul, Korea, Republic of, 03722 Research Site Recruiting Seoul, Korea, Republic of, 05505 Research Site Recruiting Seoul, Korea, Republic of, 135-710 Taiwan Research Site Not yet recruiting Kaohsiung, Taiwan, 807 Research Site Not yet recruiting Taipei, Taiwan, 10002 Less <<
NCT03488901 - Not yet recruiting December 2018 France ... More >> Centre Français de Référence des Maladies Trophoblastiques Not yet recruiting Pierre-Bénite, France, 69495 Contact: Pierre-Adrien BOLZE, Dr    04 78 86 56 40 ext +33    pierre-adrien.bolze@chu-lyon.fr    Contact: François GOLFIER, Pr    04 78 86 66 78 ext +33    francois.golfier@chu-lyon.fr Less <<
NCT02557425 - Active, not recruiting December 2021 Uganda ... More >> Tororo District Hospital Tororo, Uganda Less <<
NCT03518242 Breast Cancer Female Phase 2 Recruiting January 30, 2022 Uganda ... More >> Uganda Cancer Institute Recruiting Kampala, Uganda Contact: Manoj Menon Less <<
NCT03518112 Leukemia Acut... More >>e Lymphoblastic Leukemia Less << Phase 2 Recruiting December 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77339 Contact       ejabbour@mdanderson.org Less <<
NCT03519971 Non-Small Cell Lung Cancer Phase 3 Recruiting August 1, 2022 -
NCT03522415 Moderately to Severely Active ... More >>Rheumatoid Arthritis Less << Phase 3 Recruiting January 30, 2021 China, Jiangxi ... More >> Jiujiang No.1 peoples's hospital Recruiting Jiujiang, Jiangxi, China, 332000 Contact: Ju Liu Less <<
NCT03535519 - Not yet recruiting May 31, 2020 -
NCT02550080 Allergic Cutaneous Vasculitis ... More >> Urticaria Psoriasis Acne Bullous Skin Diseases Sterile Pustulosis Leprosy Pneumocystis Pneumonia Less << Phase 4 Recruiting May 2019 China, Shandong ... More >> Shandong Provincial Institute of Dermatology and Venereology Recruiting Jinan, Shandong, China, 250000 Contact: Furen Zhang    +86-531-87298808    zhangfuren@hotmail.com Less <<
NCT02575755 Pregnancy Inf... More >>ections, Plasmodia Drug Kinetics Clinical Efficacy Less << Phase 4 Unknown October 2016 Papua New Guinea ... More >> Papua New Guinea Institute of Medical Research Recruiting Madang, Madang Province, Papua New Guinea, 511 Contact: Brioni R Moore, BSc, PhD    (+61) 0466266334    brioni.moore@uwa.edu.au    Contact: Leanne J Robinson, BSc, PhD, MPH    (+675) 422 2909    robinson@wehi.edu.au Less <<
NCT03637400 Methicillin-resistant Staphylo... More >>coccus Aureus Skin Infection Less << Phase 2 Not yet recruiting November 1, 2022 United States, California ... More >> Harbor-UCLA Medical Center Not yet recruiting Torrance, California, United States, 90509 Contact: Donna Phantran, MPH          Principal Investigator: Loren G Miller, MD          United States, Missouri Washington University Not yet recruiting Saint Louis, Missouri, United States, 63130 Contact: Mary Boyle          Sub-Investigator: Stephanie Fritz, MD Less <<
NCT03531073 - Recruiting April 2023 United Kingdom ... More >> Oxford University Hospitals NHS Trust Recruiting Oxford, Oxfordshire, United Kingdom, OX3 7LD Contact: Laura C Coates, MBChB    01865737838    laura.coates@ndorms.ox.ac.uk    Contact: Marion Watson    01865737905    marion.watson@ndorms.ox.ac.uk Less <<
NCT03553238 Leukemia, Acute ... More >> Leukemia, T Cell Leukemia, Lymphoblastic Less << Phase 2 Phase 3 Recruiting August 30, 2020 China, Guangdong ... More >> Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Hongsheng Zhou, MD, PhD    +862062787349    zhs1@i.smu.edu.cn Less <<
NCT03564704 Leukemia Leuk... More >>emia, Acute Adult Lymphoblastic Lymphoma Leukemia, Lymphoblastic Leukemia, T Cell Adult Acute Lymphoblastic Leukemia Lymphoblastic Lymphoma Lymphoblastic Leukemia Less << Phase 2 Phase 3 Recruiting May 30, 2021 China, Guangdong ... More >> Department of Hematology, Nanfang Hospital Recruiting Guangzhou, Guangdong, China, 510515 Contact: Hongsheng Zhou    +862062787349    zhs1@i.smu.edu.cn Less <<
NCT03535558 - Recruiting December 31, 2018 United States, New Jersey ... More >> Janssen Investigative Site Recruiting Titusville, New Jersey, United States, 08560 Less <<
NCT03117751 Acute Lymphoblastic Leukemia ... More >> Acute Lymphoblastic Lymphoma Less << Phase 2 Phase 3 Recruiting March 31, 2028 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Hiroto Inaba, MD, PhD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Hiroto Inaba, MD, PhD Less <<
NCT03520842 KRAS Gene Mutation ... More >> Metastatic Malignant Neoplasm in the Brain Recurrent Non-Small Cell Lung Carcinoma Stage IV Non-Small Cell Lung Cancer AJCC v7 Less << Phase 2 Recruiting June 1, 2020 United States, California ... More >> Stanford University School of Medicine Recruiting Palo Alto, California, United States, 94304 Contact: Vivian Tsang    650-723-0186    tsangv@stanford.edu    Principal Investigator: Sukhmani Padda Less <<
NCT03572075 Endometriosis Not Applicable Recruiting April 2019 Italy ... More >> Gynecology and Physiopathology of Human Reproductive Unit, University of Bologna, S. Orsola-Malpighi Hospital Recruiting Bologna, BO, Italy, 40138 Contact: Simona Del Forno    00393288948806    simona.delforno2@unibo.it    Principal Investigator: Mohamed Mabrouk          Principal Investigator: Renato Seracchioli          Principal Investigator: Simona Del Forno          Sub-Investigator: Diego Raimondo          Sub-Investigator: Alessandro Arena Less <<
NCT03566576 Non-squamous Non-small Cell Lu... More >>ng Cancer Less << Not Applicable Not yet recruiting October 1, 2018 -
NCT03589326 Lymphoblastic Leukemia, Acute,... More >> Adult Acute Lymphoid Leukemia Leukemia, Acute Lymphoblastic Leukemia, Lymphoblastic Ph1 Chromosome Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Less << Phase 3 Recruiting July 4, 2026 United States, California ... More >> City of Hope - Duarte Recruiting Duarte, California, United States, 91010 United States, South Carolina Saint Francis Cancer Center Recruiting Greenville, South Carolina, United States, 29607 United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030-4000 Methodist Hospital Recruiting San Antonio, Texas, United States, 78229 Less <<
NCT03599960 Blastic Plasmacytoid Dendritic... More >> Cell Neoplasm (BPDCN) Less << Phase 2 Not yet recruiting May 2022 France ... More >> Chu Amiens Not yet recruiting Amiens, France, 80054 Contact: GRUSON Bérengère, MD          Chu Besancon Not yet recruiting Besancon, France, 25030 Contact: DECONINCK ERIC, MD, PhD Less <<
NCT03609112 - Recruiting October 2019 France ... More >> Gustave Roussy Recruiting Villejuif, Val De Marne, France, 94805 Contact: Christelle DUFOUR, MD    0142114211 ext +33    christelle.dufour@gustaveroussy.fr Less <<
NCT03569995 Primary CNS Lymphoma Phase 2 Recruiting June 15, 2025 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Gangnam-gu,, Korea, Republic of, 06351 Contact: Kaeun Park, CRA    82-70-7014-4162    kaeun.park@samsung.com Less <<
NCT03589950 Lung Neoplasms ... More >> Docetaxel Pemetrexed S-1 Anlotinib Less << Phase 2 Not yet recruiting August 1, 2021 China, Jiangsu ... More >> The Affiliated Lianyungang Hospital of Xuzhou Medical University Not yet recruiting Lianyungang, Jiangsu, China, 222002 Contact: xiaodong jiang, MD    18961326201    jxdysy1970@163.com    Sub-Investigator: lijun liang, MM          Sub-Investigator: yixuan wen, MM Less <<
NCT03256136 Lung Cancer Phase 2 Recruiting October 31, 2024 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02115 Contact: Daniel B Costa, MD    617-667-9236       Principal Investigator: Daniel B Costa, MD          Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Amanda J Redig, MD, PhD    617-632-6036       Principal Investigator: Amanda J Redig, MD, PhD          Massachusetts general Hospital Recruiting Boston, Massachusetts, United States, 02214 Contact: Alice T Shaw, MD, PhD    617-643-0563       Principal Investigator: Alice T Shaw, MD, PhD Less <<
NCT03613181 Leptomeningeal Carcinomatosis ... More >> Leptomeningeal Metastases Brain Metastases HER2-negative Breast Cancer Less << Phase 3 Not yet recruiting January 2021 -
NCT03137771 Recurrent Non-Small Cell Lung ... More >>Carcinoma Stage IV Non-Small Cell Lung Cancer Less << Phase 2 Recruiting April 2022 -
NCT03571321 Acute Lymphoblastic Leukemia ... More >> ALL, Childhood ALL Less << Phase 1 Not yet recruiting September 5, 2024 United States, Illinois ... More >> University of Chicago Medical Center Not yet recruiting Chicago, Illinois, United States, 60637 Contact: Howie Weiner    773-702-2084    hweiner@medicine.bsd.uchicago.edu    Contact: Peggy Green, RN    (773) 702-0267    mgreen@medicine.bsd.uchicago.edu    Principal Investigator: Emily Currant, MD Less <<
NCT03628521 Lung Cancer A... More >>dvanced Stage Less << Phase 1 Recruiting December 31, 2020 China, Shanghai ... More >> Shanghai Chest Hospital Recruiting Shanghai, Shanghai, China, 200030 Contact: Baohui Han, MD，PhD    +8618930858216    18930858216@163.com Less <<
NCT03605251 Rheumatoid Arthritis Phase 2 Not yet recruiting June 2020 Japan ... More >> Taiho Pharmaceutical Co., Ltd selected site Not yet recruiting Tokyo, Japan Less <<
NCT03636685 NSCLC Adenoca... More >>rcinoma Squamous Cell Carcinoma Less << Phase 1 Phase 2 Not yet recruiting August 14, 2020 -
NCT03631784 Non-small Cell Lung Cancer Phase 2 Recruiting January 12, 2022 United States, California ... More >> St Joseph Heritage Healthcare ( Site 1403) Recruiting Santa Rosa, California, United States, 95403 Contact: Study Coordinator    707-521-3830       United States, Indiana Parkview Cancer Institute ( Site 1415) Recruiting Fort Wayne, Indiana, United States, 46845 Contact: Study Coordinator    833-724-8356       United States, Massachusetts UMass Memorial Medical Center ( Site 1417) Recruiting Worcester, Massachusetts, United States, 01655 Contact: Study Coordinator    508-334-5539       United States, Michigan Henry Ford Hospital ( Site 1418) Recruiting Detroit, Michigan, United States, 48202 Contact: Study Coordinator    313-916-2635       United States, Nebraska St. Francis Cancer Treatment Center ( Site 1421) Recruiting Grand Island, Nebraska, United States, 68803 Contact: Study Coordinator    308-398-5450       United States, New Jersey Rutgers Cancer Institute of New Jersey ( Site 1422) Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Study Coordinator    732-235-6048       United States, Oklahoma CTCA Southwestern ( Site 1428) Recruiting Tulsa, Oklahoma, United States, 74133 Contact: Study Coordinator    918-286-5448       Australia, New South Wales Blacktown Hospital Western Sydney Local Health District ( Site 0204) Recruiting Blacktown, New South Wales, Australia, 2148 Contact: Study Coordinator    +61403170371       MNCCI Port Macquarie Base Hospital ( Site 0200) Recruiting Port Macquarie, New South Wales, Australia, 2444 Contact: Study Coordinator    +61265801818       Australia, Victoria Ballarat Health Services ( Site 0206) Recruiting Ballarat, Victoria, Australia, 3350 Contact: Study Coordinator    +61353204735       Korea, Republic of Chungbuk National University Hospital ( Site 1003) Recruiting Cheongju si, Chungcheongbuk Do, Korea, Republic of, 28644 Contact: Study Coordinator    +82432696015       Samsung Medical Center ( Site 1001) Recruiting Seoul, Korea, Republic of, 06351 Contact: Study Coordinator    +82234103459       Ulsan University Hospital ( Site 1000) Recruiting Ulsan, Korea, Republic of, 44033 Contact: Study Coordinator    +82522508832       Poland Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 0811) Recruiting Bydgoszcz, Poland, 85-796 Contact: Study Coordinator    +48523743029       Osrodek Badan Klinicznych przy Szpitalu Specjalistycznym ( Site 0802) Recruiting Krakow, Poland, 31-826 Contact: Study Coordinator    +48721295010       Centrum Onkologii Instytut im. Marii Sklodowskiej Curie ( Site 0800) Recruiting Warszawa, Poland, 02-781 Contact: Study Coordinator    +48225463066       Russian Federation Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 0910) Recruiting Kazan, Russian Federation, 420029 Contact: Study Coordinator    +79172662851       N.N. Blokhin National Medical Oncology Research Centre ( Site 0902) Recruiting Moscow, Russian Federation, 115478 Contact: Study Coordinator    +79031990755       National Medical Research Center of Oncology n.a. N. N. Petrov ( Site 0904) Recruiting St. Petersburg, Russian Federation, 197758 Contact: Study Coordinator    +79117500005       Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 0903) Recruiting Ufa, Russian Federation, 450054 Contact: Study Coordinator    +79050058625       Spain Hospital Universitari Vall d Hebron ( Site 1101) Recruiting Barcelona, Spain, 08035 Contact: Study Coordinator    +34934894158       Hospital Clinic de Barcelona ( Site 1100) Recruiting Barcelona, Spain, 08036 Contact: Study Coordinator    +34932275402       Clinica Universitaria de Navarra ( Site 1102) Recruiting Madrid, Spain, 28027 Contact: Study Coordinator    +349135319027502 Less <<
NCT03643276 Acute Lymphoblastic Leukemia, ... More >>Pediatric Less << Phase 3 Recruiting July 14, 2028 -
NCT03656094 Non-small Cell Lung Cancer Met... More >>astatic Less << Phase 2 Not yet recruiting November 1, 2021 Korea, Republic of ... More >> Jong-Mu Sun Not yet recruiting Seoul, Korea, Republic of, 06351 Contact: Jong-Mu Sun    82234103459 ext 82234103459    jongmu.sun@skku.edu Less <<
NCT03647956 NSCLC Stage IIIB ... More >> NSCLC Stage IV EGFR Activating Mutation Less << Phase 2 Recruiting April 3, 2020 Hong Kong ... More >> Department of Clinical Oncology Recruiting Hong Kong, Hong Kong Principal Investigator: Tai-Chung Lam, FRCR          Sub-Investigator: Chi-Leung Chiang, FRCR          Sub-Investigator: Victor Ho-Fun Lee, MD          Sub-Investigator: Tsz-Him So, MBBS Less <<
NCT03649061 Arthritis, Rheumatoid Phase 4 Recruiting December 2022 Belgium ... More >> Imelda Ziekenhuis Bonheiden Not yet recruiting Bonheiden, Antwerpen, Belgium, 2820 Contact: Els Van Essche, MD          Sub-Investigator: Kathleen Declerck, MD          Sub-Investigator: Stijn Michiels, MD          UZA Not yet recruiting Edegem, Antwerpen, Belgium, 2650 Contact: Luc De Clerck, MD, PhD          AZ Herentals Not yet recruiting Herentals, Antwerpen, Belgium, 2200 Contact: Luk Corluy, MD          ZNA Jan Palfijn Not yet recruiting Merksem, Antwerpen, Belgium, 2170 Contact: Kurt de Vlam, MD, PhD          Sub-Investigator: Rik Joos, MD, PhD          Sub-Investigator: Elke Geens, MD          GHdC Saint Joseph Not yet recruiting Gilly, Henegouwen, Belgium, 6060 Contact: Marc Vanden Berghe, MD          Reuma centrum Genk Not yet recruiting Genk, Limburg, Belgium, 3600 Contact: Philip Remans, MD, PhD          Reuma Clinic Genk Not yet recruiting Genk, Limburg, Belgium, 3600 Contact: Johan Vanhoof, MD          Sub-Investigator: Marleen Coppens, MD          Sub-Investigator: Pascale Volders, MD          Sub-Investigator: Anne Sileghem, MD          Sub-Investigator: Piet Geusens, MD, PhD          Reuma Instituut Hasselt Not yet recruiting Hasselt, Limburg, Belgium, 3500 Contact: Jan Lenaerts, MD          Sub-Investigator: Isabelle De Wergifosse, MD          Sub-Investigator: Christine Langenaken, MD          OLV Ziekenhuis Aalst Not yet recruiting Aalst, Oost Vlaanderen, Belgium, 9300 Contact: Tom Zwaenepoel, MD          Sub-Investigator: Isabelle Ravelingien, MD          Sub-Investigator: Bert Vander Cruysse, MD, PhD          Sub-Investigator: Murielle Stubbe, MD          Sub-Investigator: Marijke Van Hoydonck, MD          Regionaal Ziekenhuis Heilig Hart Leuven Not yet recruiting Leuven, Vlaams Brabant, Belgium, 3000 Contact: Veerle Taelman, MD          UZ Leuven Recruiting Leuven, Vlaams Brabant, Belgium, 3000 Contact: Patrick Verschueren, MD, PhD    +32 16 34 25 41    patrick.verschueren@uzleuven.be    Sub-Investigator: Rene Westhovens, MD, PhD          AZ St Lucas Brugge Not yet recruiting Brugge, West Vlaanderen, Belgium, 8310 Contact: Caroline Verbist, MD          Sub-Investigator: Bea Mayaert, MD          Sub-Investigator: Mieke Devinck, MD          CHU Saint Pierre Not yet recruiting Brussel, Belgium, 1000 Contact: Silvana Di Romana, MD          Cliniques Universitaire Saint Luc (UCL) Not yet recruiting Brussel, Belgium, 1000 Contact: Patrick Durez, MD, PhD          Sub-Investigator: Bernard Lauwerys, MD, PhD          CHU Liège Not yet recruiting Liège, Belgium, 4000 Contact: Michel Malaise, MD, PhD Less <<
NCT02099240 Osteomyelitis Early Phase 1 Recruiting September 2019 United States, Kentucky ... More >> University of Louisville Recruiting Louisville, Kentucky, United States, 40202 Contact: Julio A Ramirez, MD    502-852-1148    jarami01@louisville.edu    Contact: David Seligson, MD    502-852-0923    d0seli01@louisville.edu    Sub-Investigator: Forest Arnold, DO          Sub-Investigator: Timothy Wiemkwn, PhD          Sub-Investigator: Robert Kelley, PhD          Sub-Investigator: James Summersgill, PhD          Sub-Investigator: Ruth Carrico, PhD          Sub-Investigator: Julie Harting, PharmD          Sub-Investigator: Paula Peyrani, MD          Principal Investigator: David Seligson, MD          Sub-Investigator: Craig Roberts, MD          Principal Investigator: Julio Ramirez, MD Less <<
NCT03680092 GVHD Hematolo... More >>gic Neoplasms Less << Phase 2 Not yet recruiting August 2020 United States, California ... More >> UC San Diego Moores Cancer Center La Jolla, California, United States, 92093 Less <<
NCT03690895 - Completed - France ... More >> Fondation Ophtalmologique A. de Rotchschild Paris, France, 75019 Less <<
NCT03660059 Rheumatoid Arthritis (RA) Phase 3 Recruiting August 2022 China ... More >> Site CN00058 Recruiting Inner Mongolia, China Site CN00047 Recruiting Shantou, China Site CN00059 Recruiting Wuhan, China Site CN00049 Recruiting Zhuzhou, China Korea, Republic of Site KR00037 Recruiting Gwangju, Korea, Republic of Site KR00036 Recruiting Incheon, Korea, Republic of Site KR00033 Recruiting Seoul, Korea, Republic of Site KR00034 Recruiting Seoul, Korea, Republic of Site KR00035 Recruiting Seoul, Korea, Republic of Taiwan Site TW00025 Recruiting Taipei, Taiwan Site TW00026 Recruiting Taipei, Taiwan Less <<
NCT03692416 Vasculitis Phase 3 Not yet recruiting May 11, 2021 -
NCT03706703 Lung Cancer Phase 2 Recruiting September 1, 2020 China, Guangdong ... More >> Affiliated Cancer Hospital & Institute of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510000 Contact: Chuan Jin, post-graduate    020-66673666    18302078099@163.com Less <<
NCT03631199 Non-small Cell Lung Cancer Phase 3 Not yet recruiting October 21, 2022 -
NCT03703271 Gestational Trophoblastic Neop... More >>lasia Less << Phase 3 Not yet recruiting December 31, 2022 China, Zhejiang ... More >> Weiguo Lv Hangzhou, Zhejiang, China Less <<
NCT00701129 Pompe Disease ... More >> Glycogen Storage Disease Type II Less << Phase 4 Completed - United States, Kentucky ... More >> Kosair Children's Hospital Louisville, Kentucky, United States, 40202 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT03684980 Central Nervous System Lymphom... More >>a Less << Early Phase 1 Recruiting October 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Lauren Schaff, MD    212-610-0485       Contact: Christian Grommes    212-639-4058       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Lauren Schaff, MD    212-610-0485       Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Lauren Schaff, MD    212-610-0485       United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Lauren Schaff, MD    212-610-0485       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Lauren Schaff, MD    212-610-0485       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Lauren Schaff, MD          Contact: Christian Grommes, MD    212-639-4058 Less <<
NCT03719560 Diffuse Large B Cell Lymphoma Phase 2 Not yet recruiting December 31, 2025 United States, Rhode Island ... More >> Kayla Rosati Providence, Rhode Island, United States, 02903 Less <<
NCT00701129 - Completed - -
NCT03713944 NSCLC Stage IV ... More >> NSCLC, Recurrent Less << Phase 2 Not yet recruiting November 2021 United States, Indiana ... More >> Indiana Univeristy Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT03699631 Hematologic Malignancy Phase 2 Not yet recruiting April 1, 2021 -
NCT03719105 NK-Cell Lymphoma ... More >> NK-Cell Leukemia Peripheral T Cell Lymphoma Less << Early Phase 1 Not yet recruiting December 31, 2023 -
NCT03728478 Oligoarthritis, Juvenile ... More >> Polyarthritis, Juvenile, Rheumatoid Factor Negative Less << Phase 3 Not yet recruiting December 2021 -
NCT03737708 Rheumatoid Arthritis (RA) Phase 4 Recruiting February 2021 Korea, Republic of ... More >> Site KR82003 Recruiting Daegu, Korea, Republic of Less <<
NCT03736161 Psoriatic Arthritis Phase 3 Recruiting February 28, 2019 Bangladesh ... More >> Bangabandhu Sheikh Mujib Medical University Recruiting Dhaka, Bangladesh, 1205 Contact: Prayush Sharma, MBBS    +8801535157897    drprayush@gmail.com Less <<
NCT03746223 Primary Intraocular Lymphoma Phase 2 Not yet recruiting October 15, 2025 -
NCT03753581 Electric Stimulation Therapy Not Applicable Enrolling by invitation March 30, 2020 Spain ... More >> Juan Avendaño-Coy Toledo, Spain, 45071 Less <<
NCT03757364 - Completed - Poland ... More >> University of Warmia and Mazury Olsztyn, Warminsko-mazurskie, Poland, 10-900 Less <<
NCT03380871 Carcinoma, Non-Small-Cell Lung... More >> Lung Cancer Nonsquamous Nonsmall Cell Neoplasm of Lung Less << Phase 1 Recruiting February 2021 United States, California ... More >> University of California - Los Angeles Recruiting Santa Monica, California, United States, 90404 Contact: Virginia Del Casal, BSN       fdelcasal@mednet.ucla.edu    Principal Investigator: Edward Garon, MD          United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Alice Shaw, M.D., Ph.D.          Principal Investigator: Alice Shaw, M.D., Ph.D.          Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Jenna Scanlon    617-632-4764    jennae_scanlon@dfci.harvard.edu    Principal Investigator: Mark Awad, M.D., Ph.D          United States, Missouri Washington University in St. Louis Recruiting Saint Louis, Missouri, United States, 63130 Contact: Usha Rawat, MPH    314-286-2098    rawat@wustl.edu    Contact: Cindy Fogal, PhD, CCRP    314-362-1518    clfogal@wustl.edu    Principal Investigator: Ramaswamy Govindan, MD          United States, Tennessee Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact    615-339-4214    asksarah@sarahcannon.com    Principal Investigator: David Spigel, M.D. Less <<
NCT03762018 Pleural Mesothelioma Malignant... More >> Advanced Less << Phase 3 Not yet recruiting December 31, 2024 -
NCT01837329 Non-Small Cell Lung Cancer Phase 1 Recruiting October 2018 United States, New York ... More >> University of Rochester Recruiting Rochester, New York, United States, 14642 Contact: Amy Jasek    585-273-1912    Amy_Jasek@urmc.rochester.edu    Principal Investigator: David Dougherty, MD Less <<
NCT03739853 Psoriatic Arthritis Phase 4 Not yet recruiting February 2022 -
NCT03758677 Non Small Cell Lung Cancer Phase 2 Not yet recruiting November 20, 2021 China, Jilin ... More >> The First Hospital of Jilin University Not yet recruiting Changchun, Jilin, China, 130021 Contact: Kewei Ma    008613756060506    makw@jlu.edu.cn    Contact: Yinghui Xu    008613944826247    305682733@qq.com Less <<
NCT03775460 Erythema Nodosum Leprosum Not Applicable Not yet recruiting April 1, 2022 -
NCT03775486 Non-small Cell Lung Cancer NSC... More >>LC Less << Phase 2 Not yet recruiting May 23, 2022 -
NCT02758353 Malaria Still... More >>births Less << Not Applicable Completed - -
NCT03770299 Non-Small Cell Lung Cancer ... More >> Non-Small-Cell Lung Carcinoma Circulating Tumor DNA Less << Phase 2 Not yet recruiting March 14, 2024 United States, Florida ... More >> Local Institution Not yet recruiting Jacksonville, Florida, United States, 32224 Contact: Site 0015          United States, Kentucky Local Institution Not yet recruiting Lexington, Kentucky, United States, 40503-1489 Contact: Site 0014          United States, South Carolina Local Institution Not yet recruiting Charleston, South Carolina, United States, 29414 Contact: Site 0010          United States, Texas Local Institution Not yet recruiting Tyler, Texas, United States, 75701 Contact: Site 0013          Germany Local Institution Not yet recruiting Gauting, Germany, 82131 Contact: Site 0005          Local Institution Not yet recruiting Grosshansdorf, Germany, 22927 Contact: Site 0006          Local Institution Not yet recruiting Heidelberg, Germany, 69126 Contact: Site 0007          Switzerland Local Institution Not yet recruiting Lausanne, Switzerland, 1011 Contact: Site 0009          Local Institution Not yet recruiting Zuerich, Switzerland, 8091 Contact: Site 0008          United Kingdom Local Institution Not yet recruiting London, United Kingdom, NW1 2BU Contact: Site 0001 Less <<
NCT02793622 Malaria Phase 3 Active, not recruiting June 2019 Uganda ... More >> IDRC - Tororo Research Clinic Tororo, Uganda Less <<
NCT03096275 Takayasu Arteritis Phase 3 Recruiting December 1, 2018 China, Hebei ... More >> Hebei Provincial Hospital Not yet recruiting Shijiazhuang, Hebei, China, 050051 Contact: Fengxiao Zhang, MD    13722879168    fengxiao.zhang@cstar.org.cn    Contact: Wei Lin, MD    17736909239    linwei272@163.com    China, Inner Mongolia the Affiliated Hospital of Inner Mongolia Medical University Not yet recruiting Huhehaote, Inner Mongolia, China, 010050 Contact: Hongbin Li, MD    13948536552    hongbin.li@cstar.org.cn    Contact: Ning Tie, MD    13948610720    tieting@126.com    China, Shanxi Xijing Hospital Not yet recruiting Xian, Shanxi, China, 710032 Contact: Zhenbiao Wu, MD    13700235112    ping.zhu@cstar.org.cn    Contact: Weitong Chen, MD    15771943030    chenweitong0818@163.com    China Beijing Chaoyang Hospital Not yet recruiting Beijing, China, 100020 Contact: Yi Zheng, MD    13911170090    yi.zheng@cstar.org.cn    Contact: Yongfeng Zhang, MD    13671239495    zyf760116@sina.com    Peking Union Medical College Hospital Recruiting Beijing, China, 100032 Contact: Xinping Tian, MD    86-13691165939    tianxp6@126.com    Contact: Shi Rong, MD    86-13601248311    rongshipumch@126.com    Sub-Investigator: XInping Tian, MD          Beijing Xuanwu Hospital Not yet recruiting Beijing, China, 100053 Contact: Xiaoxia Li, MD    13501164945    xiaoxia.li@cstar.org.cn    Contact: Yi Zhao, MD    13811038669    zhaoyi_peking@163.com    General Hospital of Tianjing Medical University Not yet recruiting Tianjin, China, 300052 Contact: Wei Wei, MD    13920182411    wei.wei@cstar.org.cn    Contact: Na Zhang, MD    13820489562    lunazhang22@hotmail.com Less <<
NCT02831023 Malaria Phase 2 Completed - Mali ... More >> Malaria Research and Training Centre Bamako, Mali Less <<
NCT03602898 Acute Lymphoblastic Leukemia i... More >>n Remission Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Acute Myeloid Leukemia in Remission Blasts 5 Percent or Less of Bone Marrow Nucleated Cells Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Donor Minimal Residual Disease Myelodysplastic Syndrome Myelofibrosis Myeloproliferative Neoplasm Recurrent Acute Myeloid Leukemia Recurrent Hodgkin Lymphoma Recurrent Non-Hodgkin Lymphoma Refractory Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Less << Phase 2 Not yet recruiting September 17, 2023 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Not yet recruiting Seattle, Washington, United States, 98109 Contact: Masumi Ueda    206-667-4546       Principal Investigator: Masumi Ueda Less <<
NCT02909712 Malaria Pregn... More >>ancy Cardiotoxicity Parasitemia Less << Phase 2 Unknown September 2017 Tanzania ... More >> Handeni District Hospital Recruiting Handeni, Tanga Region, Tanzania Contact: George Mtove Less <<
NCT02865005 Acne Vulgaris Phase 3 Completed - -
NCT03775824 - Active, not recruiting June 1, 2019 -
NCT02416388 Acute Myeloid Leukemia (AML) Phase 2 Phase 3 Recruiting - -
NCT02929719 Acne Vulgaris Phase 1 Completed - -
NCT02836002 Malaria Phase 1 Phase 2 Completed - Netherlands ... More >> Radboud university medical center Nijmegen, Gelderland, Netherlands, 6525 GA Less <<
NCT02959970 Acne Vulgaris Phase 4 Completed - United States, Alabama ... More >> Kirklin Clinic Birmingham, Alabama, United States, 35233 United States, California Center for Dermatology Clinical Research Fremont, California, United States, 94538 Quest Dermatology Research Northridge, California, United States, 91324 Southern California Dermatology Santa Ana, California, United States, 92701 Redwood Family Dermatology Santa Rosa, California, United States, 95401 United States, Florida Center for Clinical and Cosmetic Research Aventura, Florida, United States, 33180 Baumann Cosmetic and Research Institute Miami Beach, Florida, United States, 33137 United States, Kentucky Dermresearch, PLLC Louisville, Kentucky, United States, 40217 United States, Michigan Hamzavi Dermatology Fort Gratiot, Michigan, United States, 48059 United States, Missouri Saint Louis University Dermatology Saint Louis, Missouri, United States, 63104 United States, Nebraska Skin Specialists, PC Omaha, Nebraska, United States, 68144 United States, New York Skin Specialty Dermatology New York, New York, United States, 10155 United States, North Carolina Health Sciences/Department of Dermatology Winston-Salem, North Carolina, United States, 27106 United States, Pennsylvania KGL Skin Study Center Broomall, Pennsylvania, United States, 19008 Department of Dermatology, UPCII Hershey, Pennsylvania, United States, 17033 United States, Texas Arlington Research Center, Inc. Arlington, Texas, United States, 76011 DermResearch, LLC Austin, Texas, United States, 78759 University of Texas Medical School at Houston Houston, Texas, United States, 77030 Austin Institute for Clinical Research, Inc. Pflugerville, Texas, United States, 78660 United States, Washington Premier Clinical Research Spokane, Washington, United States, 99202 Less <<
NCT02944461 Acne Phase 4 Unknown November 2017 United States, California ... More >> Dermatology and Laser Surgery Recruiting Sacramento, California, United States, 95819 Contact: Emil Tanghetti, M.D.          United States, Kentucky DermResearch, PLLC Recruiting Louisville, Kentucky, United States, 40014 Contact: Deborah Zuidema, M.S.N.    502-456-4161    dbzuidema@aol.com    Principal Investigator: Leon H. Kircik, M.D.          United States, Nevada James Q. DelRosso DO, LLC Recruiting Las Vegas, Nevada, United States, 89117 Contact: James Q. DelRosso, D.O. Less <<
NCT03738943 Receptor Blockade Early Phase 1 Not yet recruiting June 1, 2021 -
NCT02795884 NSCLC Phase 3 Withdrawn(Because of reconside... More >>ration of using erlotinib(EGFR Tyrosine kinase inhibitor) as adjuvant aim) Less << November 2020 -
NCT03009526 Malaria Pregn... More >>ancy Less << Phase 3 Active, not recruiting December 31, 2018 Malawi ... More >> Malaria Alert Center, University of Malawi College of Medicine Liwonde, Malawi Less <<
NCT03057990 Myelodysplastic Syndromes Phase 1 Not yet recruiting June 2020 -
NCT02120807 Stage IV Lung Adenocarcinoma Phase 1 Active, not recruiting April 2019 United States, New Jersey ... More >> Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering West Harrison Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT02093962 - Terminated(At the interim anal... More >>ysis, the futility boundary was not met and the study was stopped due to insufficient efficacy.) Less << - -
NCT03035305 Malaria Not Applicable Completed - Mali ... More >> Amcp/Alima Kolokani Circle, Koulikoro region, Mali Less <<
NCT03132194 Acne Vulgaris Phase 1 Completed - -
NCT03208179 Pregnancy Mal... More >>aria in Pregnancy Malaria Less << Phase 3 Not yet recruiting October 2019 Kenya ... More >> Ahero Sud-countyHospital Not yet recruiting Ahero, Kisumu, Kenya Contact: Simon Kariuki, PhD    + 254725389246    SKariuki@kemricdc.org    Homa Bay County Hospital Not yet recruiting Homa Bay, Kenya Contact: Simon Kariuki, PhD    + 254725389246    SKariuki@kemricdc.org    Rabour Sub-county Hospital Not yet recruiting Kisumu, Kenya Contact: Simon Kariuki, PhD    + 254725389246    SKariuki@kemricdc.org    Malawi Chikwawa District Hospital Not yet recruiting Chikwawa, Malawi Contact: Victor Mwapasa, PhD    +265999981496    vmwapasa@gmail.com    Mangochi District Hospital Not yet recruiting Mangochi, Malawi Contact: Kenneth Maleta, PhD    +265888232202    ken.maleta@gmail.com    Tanzania Handeni District Hospital Handeni, Tanzania Korogwe District Hospital Korogwe, Tanzania Less <<
NCT03378427 Prosthetic Joint Infection Not Applicable Recruiting January 15, 2020 France ... More >> GHU Garches Recruiting Garches, France, 92380 Contact: Aurélien DINH, M.D.    +33 (0)1 47 10 77 58    aurelien.dinh@aphp.fr    Hôpital de la Croix Rousse Recruiting Lyon, France, 69004 Contact: Tristan FERRY, M.D. Ph. D.    +33 (0)4 72 07 17 55    tristan.ferry@univ-lyon1.fr Less <<
NCT02093962 Non-small Cell Lung Cancer Phase 2 Terminated(At the interim anal... More >>ysis, the futility boundary was not met and the study was stopped due to insufficient efficacy.) Less << - -
NCT03006991 - Recruiting December 2023 China, Guangdong ... More >> Guangzhou Women and Children's Medical Center Recruiting Guandong, Guangdong, China, 510000 Contact: Huasong Zeng, Doctor    18902268736 ext +86    734242355@qq.com    Contact: Hongwei Li, Master    18038767213 ext +86    734242355@qq.com Less <<
NCT03087890 HIV-1-infection ... More >> Pneumocystis Pneumonia Opportunistic Infections Preventive Therapy Antibiotic Side Effect Less << Phase 4 Recruiting October 30, 2018 Tanzania ... More >> Amana Regional Referral Hospital Recruiting Dar es Salaam, Tanzania Contact: Joel Manyahi, MD    +255712251709    manyahijoel@yahoo.com    Contact: Bjorn Blomberg, MD, PhD    +4793262119    bjorn.blomberg@uib.no    Mbagala District Hospital Recruiting Dar es Salaam, Tanzania Contact: Joel Manyahi, MD    +255712251709    manyahijoel@yahoo.com    Contact: Bjorn Blomberg, MD, PhD    +4793262119    bjorn.blomberg@uib.no    Mnazimmoja Health Centre Recruiting Dar Es Salaam, Tanzania Contact: Joel Manyahi, MD    +255712251709    manyahijoel@yahoo.com    Contact: Bjorn Blomberg, MD, PhD    +4793262119    bjorn.blomberg@uib.no    Mwananyamala Regional Referral Hospital Recruiting Dar es Salaam, Tanzania Contact: Joel Manyahi, MD    +255712251709    manyahijoel@yahoo.com    Contact: Bjorn Blomberg, MD, PhD    +4793262119    bjorn.blomberg@uib.no    Pasada Upendano Recruiting Dar es Salaam, Tanzania Contact: Joel Myanyahi, MD    +255712251709    manyahijoel@yahoo.com    Contact: Bjørn Blomberg, MD, PhD    +4793262119    bjorn.blomberg@uib.no    Temeke Regional Referral Hospital Recruiting Dar es Salaam, Tanzania Contact: Joel Manyahi, MD    +255712251709    manyahijoel@yahoo.com    Contact: Bjorn Blomberg, MD, PhD    +4793262119    bjorn.blomberg@uib.no Less <<
NCT02163447 Malaria Phase 3 Completed - Uganda ... More >> IDRC Research Clinic -Tororo District Hospital Tororo, Uganda Less <<
NCT03016260 - Recruiting December 2018 Czechia ... More >> Institute of Rheumatology Recruiting Prague, Czechia Contact: Jiří Vencovský          France CHU-Montpellier Recruiting Montpellier, France Contact: Christian Jorgensen          CHU Nice Recruiting Nice, France Contact: Veronique Breuil          CHU Strasbourg Hautepierre Recruiting Strasbourg, France Contact: Jacques-Eric Gottenberg          Israel Tel Aviv Surasky Medical Center Not yet recruiting Tel Aviv, Israel Contact: Nadir Arber          Netherlands Leiden University Medical Center Not yet recruiting Leiden, Netherlands Contact: Tom Huizinga          Turkey Istanbul University Recruiting Istanbul, Turkey Contact: Ahmet Gül          University of Marmara Recruiting İstanbul, Turkey Contact: Nevsun Inunç Less <<
NCT03022747 Lymphoblastic Leukemia, Acute,... More >> Childhood Less << Phase 2 Recruiting April 2019 Finland ... More >> Dept of Pediatrics and Adolescents, Oulu University Hospital, Box 23, 90029 OYS, Finland Not yet recruiting Oulu, Finland, 90029 OYS Contact: Riita Niinimäki, MD, PhD    +358 8 3155832    riita.niinimaki@ppshp.fi    Sweden Childrens' Cancer Centre, Queen Silvias Childrens and Adolescents Hospital Recruiting Gothenburg, Sweden, 416 85 Contact: Lene Karlsson, MD    +46 313435610    lene.karlsson@vgregion.se    Linköping University Hospital, Dept of Pediatrics Not yet recruiting Linköping, Sweden, 58185 Contact: Hartmut Vogt, MD, PhD    +46 101031343    hartmut.vogt@regionostergotland.se Less <<
NCT03020030 Acute Lymphoblastic Leukemia, ... More >>Pediatric Less << Phase 3 Recruiting December 2026 United States, Massachusetts ... More >> Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Lewis Silverman, MD    617-632-6191    lewis_silverman@dfci.harvard.edu    Principal Investigator: Lewis Silverman, MD          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Lewis Silverman, MD    617-632-6191    lewis_silverman@dfci.harvard.edu    Principal Investigator: Lewis Silverman, MD          United States, New York Montefiore Medical Center Recruiting Bronx, New York, United States, 104617 Contact: Lisa Gennarini, MD       lfigueir@montefiore.org    Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Kara Kelly, MD       Kara.Kelly@RoswellPark.org    Columbia University Medical Center, Morgan Stanley Children's Hospital of New York-Presbyterian Recruiting New York, New York, United States, 10032 Contact: Justine Kahn, MD       jk2034@cumc.columbia.edu    Principal Investigator: Justine Kahn, MD          United States, Rhode Island Hasbro Children's Hospital / Rhode Island Hospital Recruiting Providence, Rhode Island, United States, 02903 Contact: Jennifer Welch, MD       jwelch@lifespan.org    Canada, Quebec Hospital Sainte Justine, University of Montreal Recruiting Montreal, Quebec, Canada Contact: Jean-Marie LeClerc, MD       jean-marie.leclerc@umontreal.ca    Principal Investigator: Jean-Marie LeClerc, MD          Centre Hospitalier U. de Quebec Recruiting Quebec City, Quebec, Canada Contact: Bruno Michon, MD       bruno.michon@mail.chuq.qc.ca    Principal Investigator: Bruno Michon, MD Less <<
NCT03016013 Moderate and Severe RheumatoId... More >> Arthritis Less << Phase 3 Recruiting December 2019 China, Beijing ... More >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Fengchun Zhang Less <<
NCT03126071 Advanced Colorectal Cancer Phase 2 Recruiting February 15, 2020 China, Jiangsu ... More >> Jiangsu Cancer Institute & Hospital Recruiting Nanjing, Jiangsu, China, 210009 Contact: Liangjun Zhu    +8613905199123    zhulj98@foxmail.com    Contact: Yuejiao Zhong    +861370575447    zhongyuejiao@163.com    Nantong Tumor Hospital Active, not recruiting Nantong, Jiangsu, China, 226000 The First Affiliated Hospital of Soochow University Recruiting Suzhou, Jiangsu, China, 215000 Contact: Chunrong Zhu, M.D.    +8613063870566    zcr050311@163.com    Contact: Feng Xiong    +8613270971002    greenlemontea@126.com    China, Shanghai Rui Jin Hospital Shanghai Jiao Tong University School of Medicine Not yet recruiting Shanghai, Shanghai, China, 200025 Contact: Jun Zhang, M.D. Less <<
NCT03041181 Non-Squamous Non-Small Cell Lu... More >>ng Cancer (NSCLC) Adenocarcinoma of the Lung Lung Cancer Squamous Cell Lung Cancer Less << Phase 2 Recruiting September 2020 United States, Indiana ... More >> St. Vincent Anderson Regional Hospital Recruiting Anderson, Indiana, United States, 46016 Contact: Kellie Ballman    765-648-4106    kellie.ballman@ascension.org    Principal Investigator: Praveen Ranaganath, MD          Indiana University Melvin and Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Nasser Hanna, M.D.       nhanna@iu.edu    Contact: Maggie Uhrich    317-274-4505    muhrich@iu.edu    IU Health Central Indiana Cancer Center Recruiting Indianapolis, Indiana, United States, 46219 Contact: Melody Sands    317-678-2700    MSands1@iuhealth.org    Principal Investigator: Andrew Greenspan, MD          Community Regional Cancer Care Recruiting Indianapolis, Indiana, United States, 46256 Contact: Kelly Verel    317-497-2836    KVerel@ecommunity.com    Principal Investigator: Radhika Walling, MD          IU Health Ball Memorial Hospital Cancer Center Recruiting Muncie, Indiana, United States, 47303 Contact: Stacey Cadogan    765-281-2030    scadogan@iuhealth.org    Principal Investigator: William Fisher, MD          Community Healthcare System Recruiting Munster, Indiana, United States, 46321 Contact: Mary Shields    219-836-6879    mshields@comhs.org    Principal Investigator: Mohamad Kassar, MD          United States, Minnesota HealthPartners Institute Recruiting Minneapolis, Minnesota, United States, 55440 Contact: Jennifer Collier    651-254-3391    Jennifer.Collier@parknicollet.com    Principal Investigator: Arkadiusz Dudek, MD, PhD          United States, Texas University of Texas Medical Branch at Galveston Recruiting Galveston, Texas, United States, 77555 Contact: Renee Brown    409-772-9583    renbrown@utmb.edu    Principal Investigator: Maurice Willis, MD          United States, Virginia University of Virginia Health System Recruiting Charlottesville, Virginia, United States, 22908 Contact: Marian Abdelmalek    434-924-5834    MKA6S@hscmail.mcc.virginia.edu    Principal Investigator: Richard Hall, MD Less <<
NCT03063983 Osteosarcoma Phase 2 Recruiting January 31, 2022 Brazil ... More >> Grupo de Apoio ao Adolescente e a Criança com Câncer Recruiting Sao Paulo, Brazil, 04039001 Contact: Antonio S Petrilli    +55 (11) 5080-8400    sergiopetrilli@graacc.org.br    Contact: Andreza A Senerchia    +55 (11) 5080-8400    andrezasenerchia@graacc.org.br Less <<
NCT03058900 Psoriatic Arthritis Not Applicable Recruiting July 1, 2019 Denmark ... More >> Dept. of Rheumatology at Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Torkell J. Ellingsen, Prof PhD       torkell.ellingsen@rsyd.dk    Contact: Maja S. Kragsnaes, PhD student       maja.kragsnaes@dadlnet.dk    Sub-Investigator: Maja S. Kragsnaes, PhD student          Principal Investigator: Torkell J. Ellingsen, Prof PhD          Diagnostic Centre at Silkeborg Regional Hospital Not yet recruiting Silkeborg, Denmark, 8600 Contact: Maja S. Kragsnaes, PhD student Less <<
NCT02707666 Pleural Mesothelioma Phase 1 Recruiting September 2018 United States, Illinois ... More >> University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Mehwish Ahmad    773-834-1472    mahmad3@medicine.bsd.uchicago.edu    Contact: Buerkley Rose, RN    773 834 4002    brose@medicine.bsd.uchicago.edu    Principal Investigator: Hedy Kindler, M.D. Less <<
NCT02163447 - Completed - -
NCT03066466 Acute Myeloid Leukemia ... More >> Acute Lymphocytic Leukemia Myelodysplastic Syndrome Less << Phase 3 Recruiting February 28, 2021 United States, Illinois ... More >> Loyola University Medical Center Recruiting Maywood, Illinois, United States, 60153 Contact: Patrick Stiff, MD    708-327-3148    pstiff@lumc.edu    Contact: Mary Lee, RN    708-327-2241    mlee@luc.edu Less <<
NCT03161223 Lymphoma, T-Cell Phase 1 Phase 2 Recruiting June 30, 2020 United States, New York ... More >> Center for Lymphoid Malignancies at CUMC Recruiting New York, New York, United States, 10019 Contact: Michelle Malanga, MPA          Principal Investigator: Owen A O'Connor, M.D., PhD          Sub-Investigator: Jennifer E Amengual, M.D.          Sub-Investigator: Ahmed Sawas, M.D.          Sub-Investigator: Changchun Deng, M.D.          Sub-Investigator: Lorenzo Falchi, M.D.          Italy University of Bologna Not yet recruiting Bologna, Italy Principal Investigator: Pier Luigi Zinzani, M.D., PhD.          Korea, Republic of Samsung Medical Center Not yet recruiting Seoul, Korea, Republic of Principal Investigator: Won Seog Kim, M.D., Ph.D. Less <<
NCT03058471 Early Chikungunya Arthritis Not Applicable Completed - India ... More >> PGIMER Chandigarh, India, 160012 Less <<
NCT02211729 Malaria Respi... More >>ratory Infections Less << Phase 3 Completed - Burkina Faso ... More >> Hounde district Hospital Hounde, Burkina Faso Mali Bougouni Koulikoro District hospital Bougouni, Mali Less <<
NCT03071276 Acute Myeloid Leukemia (AML) Phase 2 Recruiting September 2019 United States, Arizona ... More >> Phoenix Children's Hospital Recruiting Phoenix, Arizona, United States, 85016 Contact: Jessica Boklan, MD    602-933-0920    jboklan@phoenixchildrens.com    Principal Investigator: Jessica Boklan, MD          United States, California Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Norman J. Lacayo, MD    650-497-8953    lacayon@stanford.edu    Principal Investigator: Normal J. Lacayo, MD          United States, Illinois University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Jennifer McNeer, MD    773-834-7424    jmcneer@peds.uchicago.edu    Principal Investigator: Jennifer McNeer, MD          United States, Michigan Children's Hospital of Michigan Recruiting Detroit, Michigan, United States, 48201 Contact: Jeffrey W. Taub, MD    313-745-5515    jtaub@med.wayne.edu    Principal Investigator: Jeffrey W. Taub, MD          United States, North Carolina Duke University Medical Center Completed Durham, North Carolina, United States, 27710 United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Jeffrey E. Rubnitz, MD, PhD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Jeffrey E. Rubnitz, MD, PhD          United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Kenneth M. Heym, MD    682-885-4007    kenneth.heym@cookchildrens.org    Principal Investigator: Kenneth M. Heym, MD Less <<
NCT03064854 Non-small Cell Lung Cancer Phase 1 Recruiting February 15, 2022 -
NCT03088540 Carcinoma，Non-Small-Cell Lung ... More >> Lung Carcinomas, Non-Small-Cell Non-small-cell Lung Carcinoma Nonsmall Cell Lung Cancer Less << Phase 3 Recruiting September 20, 2022 -
NCT03083808 Non-Small-Cell Lung Cancer Phase 2 Recruiting December 2019 United States, Illinois ... More >> University of Illinois Cancer Center Recruiting Chicago, Illinois, United States, 60612 Contact: Margaret Gavor    312-355-4200    mgavor2@uic.edu    Principal Investigator: Lawrence Feldman, MD          United States, Indiana Indiana University Melvin and Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Greg Durm, MD    317-656-4260    gdurm@iu.edu    Contact: Ashley Hudson    317-278-5638    ashnhuds@iu.edu    United States, Iowa University of Iowa Hospital Clinics Recruiting Iowa City, Iowa, United States, 52242 Contact: Sarah Heady    319-384-4241    sarah-heady@uiowa.edu    Principal Investigator: Muhammad Furgan, MD          United States, Minnesota University of Minnesota Medcical Center Recruiting Minneapolis, Minnesota, United States, 55455 Principal Investigator: Naomi Fujioka, MD          United States, Wisconsin University of Wisconsin Recruiting Madison, Wisconsin, United States, 53705 Contact: Hilary Hernan    608-263-2079    hernan@wisc.edu    Principal Investigator: Ticiana Leal, MD Less <<
NCT02795949 Enterobacteriaceae Infections Phase 3 Recruiting February 2020 Spain ... More >> Jerez de la Frontera Hospital Recruiting Jerez de la Frontera, Cádiz, Spain, 11138 Contact: Salvador Pérez Cortes, MD       salvador.perez.cortes.sspa@juntadeandalucia.es    La Línea de La Concepción Hospital Terminated La Línea de La Concepción, Cádiz, Spain University Hospital Donostia Recruiting San Sebastian, Gipúzcoa, Spain, 20080 Contact: Maialen Ibarguren Pinilla, MD       MAIALEN.IBARGURENPINILLA@osakidetza.eus    Cruces Hospital Recruiting Baracaldo, País Vasco, Spain Contact: Josune Goikoetxea Agirre       ANEJOSUNE.GOIKOETXEAAGIRRE@osakidetza.net    San Juan de Dios del Aljarafe Hospital Terminated Bormujos, Sevilla, Spain, 41930 University General Hospital of Alicante Recruiting Alicante, Spain, 03012 Contact: Esperanza Merino de Lucas, MD       merino_luc@gva.es    University Hospital Mutua de Tarrasa Recruiting Barcelona, Spain, 08221 Contact: Lucía Gómez García, MD       lgomez@mutuaterrassa.es    University Hospital of Bellvitge Recruiting Barcelona, Spain Contact: Guillermo Cuervo Requena       guillermocuervo@hotmail.com    University Hospital Puerta del Mar Recruiting Cádiz, Spain, 11009 Contact: Francisca Guerrero Sánchez, MD, PhD       fcam.gs@gmail.com    Puerto Real Hospital Recruiting Cádiz, Spain Contact: Patricia Jimenez, MD       patriciajaguilar@gmail.com    La Coruña Hospital Recruiting La Coruña, Spain Contact: German Bou Arévalo       germanbou@canalejo.org    Universitary Hospital of Leon Recruiting León, Spain Contact: Jose Manuel Guerra Laso       jmglaso@gmail.com    University Hospital La Princesa Recruiting Madrid, Spain, 28002 Contact: Ana Salas Aparicio, MD       asalasapa@yahoo.es    University Hospital La Paz Recruiting Madrid, Spain, 28046 Contact: Belen Loeches Yagüe, MD, Ms.C       bloeches@yahoo.es    Universitary Hospital of Orense Recruiting Orense, Spain Contact: MªDolores Díaz Lòpez       Maria.Dolores.Diaz.Lopez@sergas.es    Son Espases Hospital Recruiting Palma de Mallorca, Spain, 07010 Contact: Mª Luisa Martín Pena, MD       lmartinpena@ssib.es    University Clinic of Navarra Recruiting Pamplona, Spain, 31008 Contact: José Ramón Yuste Ara, MD, PhD          University Hospital Marqués de Valdecilla Recruiting Santander, Spain, 30008 Contact: Mª Carmen Fariñas Álvarez, MD, PhD       mcfarinas@humv.es    University Hospital Virgen Macarena Recruiting Seville, Spain, 41071 Contact: Luis Eduardo López Cortés, MD, PhD       luiselopezcortes@gmail.com    Universitary Hospital of Vigo Recruiting Vigo, Spain Contact: MªTeresa Pérez Rodriguez       maria.teresa.perez.rodriguez2@sergas.es    University Hospital of Zaragoza Recruiting Zaragoza, Spain, 28046 Contact: José Ramón Paño Pardo, MD, PhD       joserrapa@gmail.com Less <<
NCT03085914 Solid Tumors ... More >>Colorectal Cancer (CRC) Adenocarcinoma (PDAC) Lung Cancer UC (Urothelial Cancer) Head and Neck Cancer Less << Phase 1 Phase 2 Active, not recruiting January 2020 United States, Arizona ... More >> Mayo Clinic Arizona Phoenix, Arizona, United States, 85054 United States, California University of California San Diego Medical Center, Moores Cancer Center La Jolla, California, United States, 92093 The Angeles Clinic and Research Institute Los Angeles, California, United States, 90025 United States, Florida Mayo Clinic Jacksonville, Florida, United States, 32224 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Carolina Bio-Oncology Institute, PLLC Huntersville, North Carolina, United States, 28078 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Pennsylvania University of Pennsylvania Health System Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15237 United States, Tennessee Tennessee Oncology - Nashville; The Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Vanderbilt University; Henry Joyce Cancer Clinic Nashville, Tennessee, United States, 37232 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT03103334 Healthy Phase 1 Completed - -
NCT03121014 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndromes Less << Phase 2 Recruiting April 24, 2024 United States, Illinois ... More >> University of Illinois at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: Damiano Rondelli, MD    312-413-3547    drond@uic.edu Less <<
NCT03088059 Carcinoma, Squamous Cell of He... More >>ad and Neck Less << Phase 2 Recruiting December 2021 Belgium ... More >> ZNA Middelheim Recruiting Antwerp, Belgium Cliniques Universitaires Saint-Luc Recruiting Brussel, Belgium Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet Recruiting Brussel, Belgium Grand Hopital de Charleroi - Grand Hôpital de Charleroi - Site Notre Dame Recruiting Charleroi, Belgium Universitair Ziekenhuis Antwerpen Recruiting Edegem, Belgium Universitair Ziekenhuis Gent Recruiting Gent, Belgium Hopital De Jolimont Recruiting Haine-Saint-Paul, Belgium AZ Groeninge Kortrijk - Campus Kennedylaan Recruiting Kortrijk, Belgium U.Z. Leuven - Campus Gasthuisberg Not yet recruiting Leuven, Belgium GasthuisZusters Antwerpen - Sint-Augustinus Recruiting Wilrijk, Belgium CHU Dinant Godinne - UCL Namur Recruiting Yvoir, Belgium France CHU de Bordeaux - Groupe Hospitalier Saint-André - Hopital Saint-Andre Recruiting Bordeaux, France Centre Georges-Francois-Leclerc Recruiting Dijon, France Institut de Cancerologie de l'Ouest (ICO) - Centre Rene Gauducheau Recruiting Nantes, France Centre Antoine Lacassagne Recruiting Nice, France Institut Curie Recruiting Paris, France Institut de Cancérologie de Lorraine Recruiting Vandoeuvre Les Nancy, France Gustave Roussy Recruiting Villejuif, France Italy Azienda Ospedaliera Papa Giovanni XXIII Not yet recruiting Bergamo, Italy Ospedale Bellaria Not yet recruiting Bologna, Italy Azienda Ospedaliero-Universitaria Careggi Not yet recruiting Firenze, Italy Fondazione IRCCS Istituto Nazionale dei Tumori Recruiting Milano, Italy Ospedale San Paolo Not yet recruiting Milano, Italy Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" Not yet recruiting Napoli, Italy United Kingdom University Hospitals Birmingham NHS Foundation Trust (UHB) - UHB-Queen Elisabeth Medical Centre Not yet recruiting Birmingham, United Kingdom NHS Lothian - Western General Hospital Not yet recruiting Edinburgh, United Kingdom NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital Not yet recruiting Glasgow, United Kingdom Guy's and St Thomas' NHS - Guy s and St Thomas' NHS - Guy's Hospital Not yet recruiting London, United Kingdom Oxford University Hospitals NHS Trust - Churchill Hospital Not yet recruiting Oxford, United Kingdom Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital Not yet recruiting Sheffield, United Kingdom Less <<
NCT03107299 Methotrexate ... More >>Polyarthritis; Rheumatoid Less << Not Applicable Recruiting July 1, 2017 France ... More >> CHU Amiens Picardie Recruiting Amiens, Picardie, France, 80054 Contact: Vincent GOEB, PhD    +33322668259    goeb.vincent@chu-amiens.fr Less <<
NCT01445392 Mesothelioma Phase 1 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03138694 - Not yet recruiting October 2019 -
NCT02867800 Sickle Cell Disease ... More >> Graft Versus Host Disease Less << Phase 1 Recruiting December 2019 United States, District of Col... More >>umbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Shahleen Ahmed, CRC    202-476-6850    szahmed@childrensnational.org    Principal Investigator: Allistair Abraham, MD          United States, Georgia Children's Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30322 Contact: Kelsey Rogowski, MPH    404-785-7749    Kelsey.Rogowski@choa.org    Principal Investigator: Ann Haight, MD          United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611 Contact: Nicole Fisher, CRC    312-227-4871    nfisher@luriechildrens.org    Principal Investigator: Sonali Chaudhury, MD          United States, New York Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Danielle Dietzen, NP    212-305-8443    dad9025@nyp.org    Contact: Jean Sosna, RN MS    212-305-2050    js4403@cumc.columbia.edu    Principal Investigator: Monica Bhatia, MD          United States, North Carolina North Carolina Cancer Hospital Not yet recruiting Chapel Hill, North Carolina, United States, 27514 Contact: Juanita Cuffee    919-962-8733    cuffee@med.unc.edu    Principal Investigator: Kimberly Kasow, MD          United States, Ohio Nationwide Children's Hospital Recruiting Columbus, Ohio, United States, 43205 Contact: Mary Beth Scholz, RN    614-722-3654    Mary.Scholz@nationwidechildrens.org    Principal Investigator: Hemalatha Rangarajan, MD Less <<
NCT03123718 DLBCL Phase 3 Not yet recruiting June 30, 2021 Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Hwasun-gun, Jeollanam-do, Korea, Republic of, 519-809 Less <<
NCT03147612 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia With BCR-ABL1 Philadelphia Chromosome Positive Recurrent Acute Lymphoblastic Leukemia Refractory Acute Lymphoblastic Leukemia Less << Phase 2 Recruiting February 8, 2024 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Elias Jabbour    713-792-4764       Principal Investigator: Elias Jabbour Less <<
NCT03131973 Rheumatoid Arthritis Phase 1 Completed - United States, Texas ... More >> PPD Development, LP Austin, Texas, United States, 78744 Less <<
NCT03150693 B Acute Lymphoblastic Leukemia Phase 3 Recruiting August 2024 -
NCT03120949 Rheumatoid Arthritis Phase 3 Recruiting November 2021 -
NCT03235947 Urinary Tract Infection ... More >> Asymptomatic Bacteriuria Less << Phase 4 Completed - Mexico ... More >> Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Mexico City, Mexico, 14080 Less <<
NCT03155347 Rheumatoid Arthritis Phase 3 Recruiting June 20, 2020 China ... More >> The First Affiliated Hospital of Baotou Medical College Recruiting Baotou, China, 014010 Peking University First Hospital Recruiting Beijing, China, 100034 Peking University People's Hospital Recruiting Beijing, China, 100044 China-Japan Friendship Hospital Recruiting Beijing, China, 10029 Beijing Union Hospital Recruiting Beijing, China, 100730 Affiliated Hospital of Bengbu Medical College Recruiting Bengbu, China, 233004 the First Hospital of Jilin University Active, not recruiting Changchun, China, 130021 West China Hospital, Sichuan University Recruiting Chengdu, China, 610041 Guangdong General Hospital Recruiting Guangzhou, China, 510080 The Third Affiliated Hospital of Sun Yat-Sen University Withdrawn Guangzhou, China, 510630 The 1st Affiliated Hospital of Harbin Medical University Recruiting Harbin, China, 150001 The First Affiliated Hospital of Anhui Medical University Recruiting Hefei, China, 230022 Affiliated Hospital of Inner Mongolia Medical College Recruiting Hohhot, China, 010050 Qilu Hospital of Shandong University Recruiting Jinan, China, 250012 The First Affilliated Hospital of Kunming Medical College Recruiting Kunming, China, 650032 Jiangsu Province Hospital Recruiting Nanjing, China, 210036 The Second Hospital of Shanxi Medical University Recruiting Taiyuan, China Tianjin Medical University General Hospital Recruiting Tianjin (天津), China, 300052 First Affiliated Hospital of Medical College of Xi'an Jiaotong University Withdrawn Xi'an, China, 710061 Less <<
NCT03163966 Rheumatoid Arthritis, DMARD-na... More >>ive and Early Disease Patients Less << Phase 2 Recruiting December 2018 Czechia ... More >> Institute of Rheumatology Recruiting Prague, Czechia Less <<
NCT03164616 Non Small Cell Lung Cancer NSC... More >>LC Less << Phase 3 Recruiting September 24, 2021 -
NCT03175978 Myelodysplastic Syndromes ... More >> Leukemia, Myelomonocytic, Chronic Anemia, Refractory, With Excess of Blasts Less << Phase 1 Phase 2 Recruiting September 2020 United States, Minnesota ... More >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Mrinal S Patnaik, MBBS    507-284-5096    patnaik.mrinal@mayo.edu    Principal Investigator: Mrinal S Patniak, MBBS          Sub-Investigator: Aref Al-Kali, MD          Sub-Investigator: Hassan Alkhateeb, MD          Sub-Investigator: Kebede H Begna, MD          Sub-Investigator: Michelle A Elliott, MD          Sub-Investigator: Christopher Hook, MD          Sub-Investigator: Scott H Kaufman, MD, PhD          Sub-Investigator: Mark R Litzow, MD          Sub-Investigator: Mustaqeem A Siddiqui, MD          Sub-Investigator: Alexandra P Wolansky-Spinner, MD          Sub-Investigator: Naseema Gangat, MBBS          Sub-Investigator: William J Hogan, MBBCh          Sub-Investigator: Animesh D Pardanani, MBBS, PhD          Sub-Investigator: Mithun Shah, MD, PhD          Sub-Investigator: Darci L Zblewski, APRN, CNP          Regions Cancer Care Center Recruiting Saint Paul, Minnesota, United States, 55101 Contact: Yan Ji, MD    651-254-3572       Principal Investigator: Yan Ji, MD          Sub-Investigator: Daniel Anderson, MD          Sub-Investigator: Kurt Demel, MD          Sub-Investigator: Randolph Hurley, MD          Sub-Investigator: Balkrishna Jahagirdar, MD          Sub-Investigator: Priya Kumar, MD          Sub-Investigator: Steven McCormack, MD          Sub-Investigator: Gary Shaprio, MD          Sub-Investigator: Peter Hurley, MD          Sub-Investigator: Daniel Schneider, MD          Sub-Investigator: Stephanie Kroon, PAC Less <<
NCT03148860 Psoriatic Arthritis Phase 3 Recruiting June 30, 2020 Germany ... More >> CIRI Recruiting Frankfurt am Main, Hessia, Germany, 60526 Contact: Micheala Koehm, MD Less <<
NCT03177291 Lung Cancer N... More >>on Small Cell Lung Cancer Advanced Cancer Metastatic Lung Cancer Squamous Cell Lung Cancer Non-Squamous Non-Small Cell Neoplasm of Lung Less << Phase 1 Recruiting April 2022 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Germaine Gonzalez-Vazquez    813-745-6636    germain.gonzalezvazquez@moffitt.org    Contact: Jhanelle Gray, M.D.    813-745-7282    jhanelle.gray@moffitt.org    Principal Investigator: Jhanelle Gray, M.D.          Sub-Investigator: Scott Antonia, M.D., Ph.D.          Sub-Investigator: Alberto Chiappori, M.D.          Sub-Investigator: Benjamin Creelan, M.D.          Sub-Investigator: Eric Haura, M.D.          Sub-Investigator: Tawee Tanvetyanon, M.D.          Sub-Investigator: Charles Williams, Jr., M.D. Less <<
NCT03178552 Non-Small Cell Lung Cancer Phase 2 Phase 3 Recruiting January 2, 2022 -
NCT02875314 Medulloblastoma ... More >> Central Nervous System Embryonal Tumors Less << Phase 4 Recruiting September 2020 -
NCT01471197 Lung Cancer - Non Small Cell Phase 2 Terminated(Administrative reas... More >>ons) Less << - United States, California ... More >> Marin Specialty Care, Inc. Greenbrae, California, United States, 94904 United States, Illinois Medical And Surgical Specialists, Llc Galesburg, Illinois, United States, 61401 Quincy Medical Group Quincy, Illinois, United States, 62301 United States, Kentucky Montgomery Cancer Center Mount Sterling, Kentucky, United States, 40353 United States, Maryland Meritus Center For Clinical Research Hagerstown, Maryland, United States, 21742 United States, North Carolina Carolina Biooncology Institute Huntersville, North Carolina, United States, 28078 United States, Virginia Blue Ridge Cancer Care Christiansburg, Virginia, United States, 24073 Belgium Local Institution Brugge, Belgium, 8310 Local Institution Sint Niklaas, Belgium, 9100 France Local Institution Paris, France, 75014 Germany Local Institution Hamburg, Germany, 21075 Local Institution Heidelberg, Germany, 69126 Spain Local Institution Benidorm-Alicante, Spain, 03501 Less <<
NCT03193931 Cancer of Head and Neck Phase 2 Recruiting September 1, 2023 Germany ... More >> Medizinsche Hochschule Hannover Recruiting Hannover, Germany, 30625 Less <<
NCT01471197 - Terminated(Administrative reas... More >>ons) Less << - -
NCT03204136 - Not yet recruiting December 1, 2019 China, Shanghai ... More >> Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health；Shanghai Inflammatory Bowel Disease Research Center；Renji Hospital, School of Medicine, Shanghai Jiao Tong University Not yet recruiting Shanghai, Shanghai, China, 200000 Contact: Jun Shen, MD    8613651829887    shenjun@vip.163.com Less <<
NCT03217734 Psoriasis Phase 2 Phase 3 Recruiting October 10, 2018 United States, California ... More >> Bakersfield Dermatology and Skin Cancer Medical Group Recruiting Bakersfield, California, United States, 93309 Contact: Chali M Garcia    661-327-3756    chalig@bakersfieldderm.com    Contact: Stacey Underhill    661-327-3756    sunderhill@bakersfieldderm.com    Principal Investigator: Jeffrey J Crowley, MD          Clinical Science Institute Recruiting Santa Monica, California, United States, 90404 Contact: Maria Giles    310-828-8887    mgiles@csird.com    Principal Investigator: Paul S Yamauchi, MD          United States, Maryland DermAssociates, PC Recruiting Rockville, Maryland, United States, 20850 Contact: Lauren Miller    301-355-3183    lmiller@dermassociates.com    Contact: Thomas M Blondo    301-355-3183    tblondo@dermassociates.com    Principal Investigator: Benjamin N Lockshin, MD          Sub-Investigator: Janet C Lin, MD          United States, Texas Modern Research Associates, PLLC Recruiting Dallas, Texas, United States, 75231 Contact: Stacy Reed    214-361-2008    stacy@mradallas.com    Contact: Valencia Garcia    214-361-2008    valencia@mradallas.com    Principal Investigator: Jennifer C Cather, MD          Sub-Investigator: Melodie Young, NP Less <<
NCT03206671 Mature B-cell Non-Hodgkin Lymp... More >>homa Less << Phase 3 Recruiting August 2024 -
NCT03173040 Niu Bang Zi Pill ... More >> Rheumatoid Arthritis Less << Phase 2 Phase 3 Recruiting December 2018 China, Shanghai ... More >> Longhua Hospital Recruiting Shanghai, Shanghai, China Contact: Qianqian Liang Less <<
NCT00513474 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114-2617 Less <<
NCT00513474 - Completed - -
NCT03303677 Chronic Rhinosinusitis (Diagno... More >>sis) Less << Phase 3 Withdrawn(Withdrawn by sponsor... More >>) Less << November 1, 2019 United States, Florida ... More >> Univeristy of Florida Gainesville, Florida, United States, 32611 Less <<
NCT02345850 Acute Leukemia ... More >> Myelodysplasia Less << Phase 3 Recruiting September 2021 -
NCT03230708 Malignant Ascites Phase 1 Phase 2 Recruiting February 1, 2018 China, Hubei ... More >> Hui ting Xu Recruiting Wuhan, Hubei, China, 027 Contact: Hui ting Xu, MD    15307176219 ext 86    2891533@qq.com Less <<
NCT03219437 Psoriasis Phase 3 Recruiting September 20, 2021 Brazil ... More >> Hospital Universitario de brasilia HUB/Ebserh /ID# 164526 Not yet recruiting Brasília, Distrito Federal, Brazil, 70840-901 PUC Trials-Nucleo de Pesquisa clinica da Escola de Medicina da PUCPR /ID# 164401 Recruiting Curitiba, Parana, Brazil, 80230-130 Hospital de Clinicas de Porto Alegre /ID# 164565 Recruiting Porto Alegre, Rio Grande Do Sul, Brazil, 90035-903 Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu /ID# 164743 Recruiting Botucatu, Sao Paulo, Brazil, 18618-686 Hospital de Clinicas da Universidade Estadual de Campinas - UNICAMP /ID# 164521 Recruiting Campinas, Sao Paulo, Brazil, 13083-888 Hospital das Clinicas da Faculdade de Medicina de Ribeirão Preto - USP /ID# 164768 Recruiting Ribeirão Preto, Sao Paulo, Brazil, 14048-900 Faculdade de Medicina do ABC /ID# 164519 Recruiting Santo André, Sao Paulo, Brazil, 09060-870 Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto /ID# 164723 Not yet recruiting Sao Jose Do Rio Preto, Sao Paulo, Brazil, 15090-000 Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo - HC /ID# 164805 Recruiting São Paulo, Sao Paulo, Brazil, 05403-000 Instituto de Dermatologia e Estética do Brasil /ID# 164754 Recruiting Rio de Janeiro, Brazil, 22470-220 Less <<
NCT02864251 Non-Small-Cell Lung Carcinoma Phase 3 Recruiting December 31, 2023 -
NCT03239600 Autoimmune Diseases Phase 2 Withdrawn(The study is stopped... More >> for Portfolio prioritization.) Less << October 12, 2017 United Kingdom ... More >> GSK Investigational Site Cambridge, United Kingdom, CB2 0GG Less <<
NCT03244462 Inflammation Phase 1 Completed - Netherlands ... More >> PRAHealthSciences Groningen, Netherlands, 9728 NZ Less <<
NCT03246750 Extranodal NK/T-cell Lymphoma Phase 1 Phase 2 Not yet recruiting February 2022 -
NCT03254589 Rheumatoid Arthritis ... More >> Stiffness, Aortic Endothelial Dysfunction Cardiovascular Risk Factor Less << Phase 4 Recruiting September 30, 2020 Australia, South Australia ... More >> Southern Adelaide Local Health Network Recruiting Bedford Park, South Australia, Australia, 5042 Contact: Arduino Mangoni, MD, PhD Less <<
NCT03256721 Nonsmall Cell Lung Cancer Phase 2 Recruiting May 26, 2019 China, Fujian ... More >> Fuzhou general hospital Recruiting Fuzhou, Fujian, China, 365000 Contact: Zongyang YU, PhD    13509327806    yuzy527@sina.com    Contact: Xiaoyan HUANG, Master    15860818302    170889977@qq.com Less <<
NCT03263572 Malignant Neoplasms Stated as ... More >>Primary Lymphoid Haematopoietic Acute Lymphoblastic Leukemia Less << Phase 2 Recruiting November 2023 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       ejabbour@mdanderson.org Less <<
NCT02899299 Mesothelioma Phase 3 Active, not recruiting September 28, 2021 -
NCT03233230 Rheumatoid Arthritis Phase 2 Recruiting July 5, 2020 -
NCT03218059 Cesarean Scar Pregnancy ... More >> Menstruation Less << Not Applicable Not yet recruiting December 2018 China, Shanghai ... More >> Department of Gynecology, Shanghai First Maternity and Infant Hospital, affiliated to Tongji University Not yet recruiting Shanghai, Shanghai, China, 201204 Contact: Xipeng Wang    0086-13817806602    xipengwang@hotmail.com Less <<
NCT02688140 Acute Promyelocytic Leukemia Phase 3 Recruiting January 2022 France ... More >> French-Belgian-Swiss APL study group Not yet recruiting Multiple Locations, France Contact: Pierre Fenaux, Prof. Dr.       pierre.fenaux@avc.ap-hop-paris.fr    Contact: Lionel Ades, Dr.       lionel.ades@sls.aphp.fr    Germany AML-CG study group Recruiting Multiple Locations, Germany Contact: Eva Lengfelder, Prof. Dr.       Eva.Lengfelder@umm.de    AML-SG study group Recruiting Multiple Locations, Germany Contact: Richard F. Schlenk, Prof. Dr.       Richard.Schlenk@uniklinik-ulm.de    OSHO study group Recruiting Multiple Locations, Germany Contact: Dietger Niederwieser, Prof. Dr.       Dietger.Niederwieser@medizin.uni-leipzig.de    SAL study group Recruiting Multiple Locations, Germany Contact: Uwe Platzbecker, Prof. Dr.    +49 351 458 ext 3192    uwe.platzbecker@uniklinikum-dresden.de    Contact: Michaela Sauer    +49 351 458 ext 3192    michaela.sauer@uniklinikum-dresden.de    Italy GIMEMA study group Not yet recruiting Multiple Locations, Italy Contact: Francesco Lo-Coco, Prof. Dr.       Francesco.lo.coco@uniroma2.it    Contact: Fabio Efficace, Dr.       f.efficace@gimema.it    Netherlands HOVON study group Not yet recruiting Multiple Locations, Netherlands Contact: Edo Vellenga, Prof. Dr.       e.vellenga@umcg.nl    Spain PETHEMA study group Not yet recruiting Multiple Locations, Spain Contact: Miguel A. Sanz, Prof. Dr.       sanz_mig@gva.es    Contact: Pau Montesinos, Prof. Dr.       montesinos_pau@gva.es Less <<
NCT03257852 Rheumatoid Arthritis (RA) Phase 2 Completed - Japan ... More >> Site JP00002 Asahikawa, Japan Site JP00027 Asahikawa, Japan Site JP00029 Beppu, Japan Site JP00015 Chiba, Japan Site JP00008 Fukuoka, Japan Site JP00009 Fukuoka, Japan Site JP00026 Fukuoka, Japan Site JP00016 Ichinomiya, Japan Site JP00012 Kanuma, Japan Site JP00028 Kawachinagano, Japan Site JP00005 Kitamoto, Japan Site JP00025 Kobe, Japan Site JP00030 Kobe, Japan Site JP00010 Kumamoto, Japan Site JP00006 Kyoto, Japan Site JP00018 Meguro, Japan Site JP00020 Nagano, Japan Site JP00014 Nagoya, Japan Site JP00011 Oita, Japan Site JP00022 Okayama, Japan Site JP00003 Osaki, Japan Site JP00019 Sagamihara, Japan Site JP00007 Sanuki, Japan Site JP00001 Sapporo, Japan Site JP00023 Shimonoseki, Japan Site JP00021 Shizuoka, Japan Site JP00004 Takasaki, Japan Site JP00017 Tomakomai, Japan Site JP00013 Toyohashi, Japan Site JP00024 Tsukuba, Japan Site JP00031 Yokohama, Japan Less <<
NCT03286634 Down Syndrome ... More >> Acute Lymphoblastic Leukemia Childhood Cancer Less << Phase 2 Recruiting March 31, 2033 Hong Kong ... More >> Prince of Wales Hospital Recruiting Shatin, New Territories, Hong Kong Contact: Chi Kong Li, MBBS       ckli@cuhk.edu.hk    Japan Kagoshima University Hospital Recruiting Kagoshima, Japan, 890-8544 Contact: Yasuhiro Okamoto       okamoto@m2.kufm.kagoshima-u.ac.jp    Malaysia University of Malaya Medical Centre Not yet recruiting Kuala Lumpur, Malaysia, 59100 Contact: Hany Arrifin, MBBS       hany@ummc.edu.my    Subang Jaya Medical Centre Not yet recruiting Subang Jaya, Malaysia, 47500 Contact: Hai Peng Lin, MBBS       flslhp@gmail.com    Sub-Investigator: Lee Lee Chan, MBBS          Singapore National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Allen Yeoh, MBBS       allen_yeoh@nuhs.edu.sg    KK Women's and Children's Hospital Not yet recruiting Singapore, Singapore, 229899 Contact: Ah Moy Tan, MBBS       tan.ah.moy01@singhealth.com.sg    Taiwan National Taiwan University Children's Hospital Not yet recruiting Taipei, Taiwan, 100 Contact: Tsamn Lin Dong, MD       dtlin@ntuh.gov.tw    Mackay Memorial Hospital Not yet recruiting Taipei, Taiwan, 10449 Contact: Hsi-Che Liu, MD       hsiche@mmh.org.tw    Chang Gung Memorial Hopsital, Linkou Not yet recruiting Taoyuan, Taiwan, 333 Contact: Shih-Hsiang Chen, MD       samechen@cgmh.org.tw Less <<
NCT03307785 Metastatic Cancer ... More >> Advanced Cancer Solid Tumor Non Small Cell Lung Cancer Metastatic Non Small Cell Lung Cancer Stage IIIB Non Small Cell Lung Cancer Less << Phase 1 Recruiting March 2020 United States, Arizona ... More >> Honor Health Recruiting Scottsdale, Arizona, United States, 85258 Principal Investigator: Jasgit Sachdev, MD          United States, California California Cancer Associates for Research and Excellence (cCare) Recruiting Encinitas, California, United States, 92024 Principal Investigator: Alberto Bessudo, MD          United States, Florida Florida Cancer Specialist Recruiting Sarasota, Florida, United States, 34232 Principal Investigator: Manish Patel, MD          United States, Ohio Gabrail Cancer Center Research Recruiting Canton, Ohio, United States, 44718 Principal Investigator: Nashat Gabrail, MD          United States, Tennessee Tennessee Oncology Recruiting Nashville, Tennessee, United States, 37203 Principal Investigator: Erika Hamilton, MD          United States, Texas MD Anderson Recruiting Houston, Texas, United States, 77030 Principal Investigator: Timothy Yap, MD Less <<
NCT03317496 Non-small Cell Lung Cancer ... More >> Urothelial Cancer Less << Phase 2 Recruiting October 2, 2021 -
NCT02351687 Malnutrition Not Applicable Completed - Malawi ... More >> St. Louis Nutrition Project Blantyre, Malawi Less <<
NCT03324412 Rheumatoid Arthritis Phase 2 Phase 3 Not yet recruiting September 30, 2019 -
NCT03337815 Rheumatoid Arthritis Phase 2 Phase 3 Recruiting September 30, 2019 China, Beijing ... More >> Guang'anmen Hospital Recruiting Beijing, Beijing, China, 100053 Contact: Quan Jiang    +8688001060    doctorjq@126.com Less <<
NCT03332719 Rheumatoid Arthritis Phase 3 Completed - Argentina ... More >> Instituto Medico CER Bs As, Argentina Less <<
NCT03327116 Atopic Dermatitis Not Applicable Active, not recruiting July 2019 Brazil ... More >> Hospital das Clínicas of the University of São Paulo Medical School, Department of Dermatology São Paulo, SP, Brazil, 05403900 Less <<
NCT03321890 Peripheral T-cell Lymphoma Phase 2 Recruiting December 31, 2020 China, Guangdong ... More >> Department of Medical Oncology,Sun Yat-Sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Zhiming Li, DM    +86-13719189172    Lizhm@sysucc.org.cn    Contact: Yu Wang, DM    86-20-87343765    Wangyu@sysucc.org.cn Less <<
NCT03337698 Carcinoma, Non-Small-Cell Lung Phase 1 Phase 2 Recruiting April 20, 2022 United States, Connecticut ... More >> Smilow Cancer Hospital at Yale New Haven Recruiting New Haven, Connecticut, United States, 06510 United States, Massachusetts Massachusetts General Hospital Not yet recruiting Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 United States, New York Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749 Recruiting New York, New York, United States, 10032 United States, Tennessee Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Australia, Victoria Peter Mac Callum Cancer Center Recruiting East Melbourne, Victoria, Australia, 3002 France Centre Léon Bérard Recruiting Lyon, France, 69008 Hôpital Nord Not yet recruiting Marseille, France, 13915 Institut Universitaire du Cancer de Toulouse-Oncopole; PHARMACIE Recruiting Toulouse, France, 31100 Korea, Republic of Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Severance Hospital, Yonsei University Health System; Pharmacy Recruiting Seoul, Korea, Republic of, 03722 University of Ulsan College of Medicine - Asan Medical Center (AMC) - Asan Cancer Center (ACC) Recruiting Songpa-gu, Korea, Republic of, 05505 Spain Clínica Universidad de Navarra Recruiting Pamplona, Navarra, Spain, 31620 Hospital Universitari Vall d'Hebron Recruiting Barcelona, Spain, 08035 Fundación Jimenez Díaz Recruiting Madrid, Spain, 28040 South Texas Accelerated Research Therapeutics Madrid - CIOCC - Universitario Sanchinarro Recruiting Madrid, Spain, 28050 United Kingdom Barts Cancer Institute Recruiting London, United Kingdom, E1 2AT Royal Marsden Hospital; Institute of Cancer Research Recruiting Sutton, United Kingdom, SM2 5PT Less <<
NCT03352622 Pharmacological Action Not Applicable Recruiting September 17, 2020 Colombia ... More >> Pablo Tobon Uribe Hospital Recruiting Medellin, Colombia Less <<
NCT03360760 Osteosarcoma of Pelvis Not Applicable Recruiting February 2025 China, Beijing ... More >> Peking University People's Hospital Recruiting Beijing, Beijing, China, 100034 Contact: Jie Xu, M.D.    86 15901040835    xujie_pkuph@sina.com Less <<
NCT03424525 Bacterial Infections Phase 1 Recruiting November 2019 United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Jenny Cai, BS    215-898-4346    jenny.cai@uphs.upenn.edu Less <<
NCT03384654 Precursor Cell Lymphoblastic L... More >>eukemia-Lymphoma Less << Phase 2 Recruiting August 10, 2021 -
NCT03112603 Graft-versus-host Disease (GVH... More >>D) Less << Phase 3 Recruiting January 2022 -
NCT03390946 Osteosarcoma ... More >>Feasibility Treatment Response Biomarker Less << Phase 2 Not yet recruiting December 31, 2020 Korea, Republic of ... More >> National Cancer Center Not yet recruiting Goyang-si, Gyeonggi, Korea, Republic of, 10408 Contact: Byung-Kiu Park, M.D., Ph.D.    82-31-920-1240    bkpark@ncc.re.kr    Contact: Mi Mi Kwon, RN    82-31-920-1240    rnjsalal@ncc.re.kr Less <<
NCT03383406 Diffuse Large B Cell Lymphoma Phase 2 Enrolling by invitation December 31, 2025 -
NCT03348904 Lung Cancer Phase 3 Terminated(Study halted premat... More >>urely and will not resume; participants are no longer being examined or receiving intervention.) Less << - United States, California ... More >> Pacific Cancer Medical Center, Inc Anaheim, California, United States, 92801 United States, Kansas Cancer Center of Kansas Wichita, Kansas, United States, 67214 Less <<
NCT03489629 Cystic Fibrosis Phase 2 Recruiting December 31, 2020 United States, Colorado ... More >> National Jewish Health Not yet recruiting Denver, Colorado, United States, 80206 Contact: Sherstin Lommatzsch, MD          United States, Indiana Indiana University Not yet recruiting Indianapolis, Indiana, United States, 46202 Contact: Clement Ren, MD          United States, Michigan University of Michigan Health System Not yet recruiting Ann Arbor, Michigan, United States, 48109 Contact: Amy Filbrun, MD          United States, Missouri St. Louis Children's Hospital Recruiting Saint Louis, Missouri, United States, 63110 Contact: Andrea Coverstone, MD          United States, North Carolina N.C. Memorial Hospital and N.C. Children's Hospital Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Marianne Muhlebach, MD          United States, Texas University of Texas Southwestern Medical Center Not yet recruiting Dallas, Texas, United States, 75390 Contact: Preeti Sharma, MD          Cook Children's Medical Center Not yet recruiting Fort Worth, Texas, United States, 76104 Contact: Karen Schultz, MD          United States, Washington University of Washington Medical Center and Seattle Children's Recruiting Seattle, Washington, United States, 98195 Contact: Chris Goss, MD Less <<
NCT03402048 Stage IV, NSCLC ... More >> Lung Neoplasms Bronchial Neoplasms Carcinoma, Bronchogenic Lung Diseases Neoplasms Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms Less << Phase 3 Recruiting December 2018 Italy ... More >> IRCSSIstituto Scientifico Romagnolo per lo studio e la cura dei tumori IRST Recruiting Meldola, Forlì, Italy Contact: Marco Angelo Burgio, MD          Istituto Nazionale Tumori Recruiting Aviano, Pordenone, Italy Contact: Alessandra Bearz, MD          Ospedale di Faenza Recruiting Faenza, Ravenna, Italy Contact: Alessandro Gamboni, MD          Ospedale di Lugo Recruiting Lugo, Ravenna, Italy Contact: Gianni Michele Turolla, MD          AUSL Rimini-Oncologia Medica Cattolica Recruiting Cattolica, Rimini, Italy Contact: Maximilian Papi, MD          AOU San Luigi Gonzaga, Department of Oncology, University of Turin Recruiting Orbassano, Turin, Italy, 10043 Contact: Silvia Novello, MD, PhD    +390119026978    silvia.novello@unito.it    Ospedale Giovanni Paolo II Recruiting Bari, Italy Contact: Domenico Galetta, MD          AO Cannizzaro Recruiting Catania, Italy Contact: Giuseppe Banna, MD          AOU Santa Croce e Carle Recruiting Cuneo, Italy Contact: Ida Colantonio, MD          Azienda Ospedaliera Careggi Recruiting Firenze, Italy Contact: Fabiana Cecere, MD          Istituto Nazionale per la Ricerca sul Cancro Recruiting Genova, Italy Contact: Francesco Grossi, MD          Ospedale Galliera Recruiting Genova, Italy Contact: Carlotta Defferrari, MD          Azienda Ospedaliera Fatebenefratelli Recruiting Milano, Italy Contact: Gabriella Farina, MD          Ospedale S. Raffaele Recruiting Milano, Italy Contact: Vanesa Gregorc          AO San Gerardo Recruiting Monza, Italy Contact: Paolo Bidoli, MD          Istituto Oncologico Veneto Recruiting Padova, Italy Contact: Adolfo Favaretto, MD          Ospedale Santa MAria della Misericordia Recruiting Perugia, Italy Contact: Lucio Crinò, MD          Ospedale S MAria delle Croci Recruiting Ravenna, Italy Contact: Claudio Dazzi, MD          Arcispedale Santa Maria Nuova Recruiting Reggio Emilia, Italy Contact: Corrado Boni, MD          AUSL Rimini-Oncologia medica Recruiting Rimini, Italy Contact: Maximilian Papi, MD          Istituto Nazionale Tumori Regina Elena Recruiting Roma, Italy Contact: Francesco Cognetti, MD          Ospedale S. Giovanni Addolorata Recruiting Roma, Italy Contact: oLGA Martelli, MD          Policlinico Umberto I- Università la Sapienza Recruiting Roma, Italy Contact: Enrico Cortesi, MD          AOU Sassari Recruiting Sassari, Italy Contact: Lorenzo Cordero, MD          Azienda Ospedaliera Sondalo Recruiting Sondalo, Italy Contact: Giuseppe Valmadre, MD          Ospedale Santa Chiara Recruiting Trento, Italy Contact: Orazio Caffo, MD          AOU S.M. Misericordia Recruiting Udine, Italy Contact: Alessandro Follador, MD          AOU Verona Recruiting Verona, Italy Contact: Gianpaolo Tortora, MD Less <<
NCT03369795 Schizophrenia Phase 2 Not yet recruiting January 1, 2020 -
NCT03402087 Lupus Psoriat... More >>ic Arthritis Less << Phase 1 Completed - United States, Utah ... More >> Local Institution Salt Lake City, Utah, United States, 84124 Less <<
NCT03403140 Rheumatoid Arthritis Phase 3 Active, not recruiting October 31, 2018 Argentina ... More >> Instituto Medico CER Bs As, Argentina Less <<
NCT03408210 Myelodysplastic Syndromes ... More >> Acute Leukemia Less << Not Applicable Recruiting August 2022 China, Beijing ... More >> Affiliated Hospital to Academy of Military Medical Sciences (307 Hospital of PLA) Recruiting Beijing, Beijing, China, 100071 Contact: Xiao Lou, M.D., Ph.D.    +8610-66947122    louxiao@163.com Less <<
NCT03408223 Acute Leukemia Not Applicable Recruiting December 2022 China, Beijing ... More >> Affiliated Hospital to Academy of Military Medical Sciences (307 Hospital of PLA) Recruiting Beijing, Beijing, China, 100071 Contact: Xiao Lou, M.D., Ph.D.    +8610-66947122    louxiao@163.com Less <<
NCT03411798 Ankylosing Spondylitis Phase 4 Recruiting December 30, 2019 China, Guangdong ... More >> Nanfang Hospital Recruiting Guangzhou, Guangdong, China, 510515 Contact: Weizhou Jiang, master    +86 15622776993    orthopaedjoe@163.com    Contact: Jun Xiao, doctor    +86 18665000156    orthopaedxj@163.com Less <<
NCT03424629 Moderate and Severe Plaque Pso... More >>riasis Less << Phase 1 Not yet recruiting December 31, 2019 China ... More >> Peking University Third Hospital Not yet recruiting Beijing, China Contact: Chunting Li, doctor          Tianjin Ever Union Biotechnology Co., Ltd. Not yet recruiting Beijing, China Contact: Zhengnan Li, master Less <<
NCT03408756 Psoriasis Vulgaris Phase 4 Not yet recruiting December 30, 2019 -
NCT03432598 Locally Advanced or Metastatic... More >> Lung Cancer Less << Phase 2 Recruiting July 2019 China, Beijing ... More >> Chinese Academy of Medical Sciences Tumor Hospital Recruiting Beijing, Beijing, China, 100021 Contact: Lijuan Zhao    861087788495    cancergcp@163.com    Principal Investigator: Jie Wang, MD          Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Jun Huang    861088196023    hj19840804@163.com    Principal Investigator: Jun Zhao, MD          Beijing Chest Hospital Recruiting Beijing, Beijing, China, 133500 Contact: Jing Liu    861089509157    liujingworkbj@126.com    Principal Investigator: Zhe Liu, MD          China, Henan Henan Cancer Hospital Recruiting Zhengzhou, Henan, China, 450008 Contact: Hongxia Li    8637165588007    51lihongxia@sina.com    Principal Investigator: Zhiyong Ma, MD          China, Jiangsu Jaingsu People's Hospital Recruiting Nanjing, Jiangsu, China, 210029 Contact: Mingmin Sun    862568136221    jsphkj@163.com    Principal Investigator: Yongqian Shu, MD          China, Jilin Jilin University First Hospital Recruiting Changchun, Jilin, China, 130021 Contact: Fei Wang    8643188786014    wangfei5780@126.com    Principal Investigator: Ying Cheng, MD          Jilin Cancer Hospital Recruiting Changchun, Jilin, China, 132000 Contact: Yan Xi    8643185879120    417064629@qq.com    Principal Investigator: Ying Cheng, MD Less <<
NCT03171831 Thalassemia Major Phase 4 Recruiting April 1, 2022 China, Guangxi ... More >> First Affiliated Hospital of Guangxi Medical University Recruiting Nanning, Guangxi, China, 510515 Contact: Yongrong Lai, MD    +86（0771）5356510    laiyongrong@hotmail.com Less <<
NCT02493283 Methemoglobinemia ... More >> Linear IgA Bullous Dermatosis Less << Phase 1 Completed - Germany ... More >> Department of Clinical Pharmacology, Ernst-Moritz-Arndt-University Greifswald Greifswald, Mecklenburg-Vorpommern, Germany, 17487 Less <<
NCT03449758 Rheumatoid Arthritis Phase 4 Recruiting July 31, 2019 France ... More >> Investigational Site Number 250007 Recruiting Argenteuil, France Investigational Site Number 250006 Recruiting Besancon, France, 25030 Investigational Site Number 250027 Recruiting Bobigny, France, 93000 Investigational Site Number 250016 Recruiting Bordeaux, France, 33076 Investigational Site Number 250014 Recruiting Caen, France, 14033 Investigational Site Number 250019 Recruiting Cannes, France, 06414 Investigational Site Number 250013 Recruiting Cholet, France, 49325 Investigational Site Number 250002 Recruiting Clermont Ferrand, France, 63003 Investigational Site Number 250009 Recruiting Echirolles, France, 38434 Investigational Site Number 250005 Recruiting La Roche Sur Yon, France, 85025 Investigational Site Number 250004 Recruiting Lille Cedex, France, 59037 Investigational Site Number 250012 Recruiting Limoges Cedex, France, 87000 Investigational Site Number 250021 Recruiting Lyon, France, 69495 Investigational Site Number 250018 Recruiting Montivilliers, France Investigational Site Number 250029 Recruiting MONTPELLIER Cedex 5, France, 34295 Investigational Site Number 250025 Recruiting NANTES Cedex 1, France, 44035 Investigational Site Number 250026 Recruiting Nice cedex 1, France, 06001 Investigational Site Number 250020 Recruiting Paris Cedex 10, France, 75475 Investigational Site Number 250011 Recruiting PARIS Cedex 13, France, 75013 Investigational Site Number 250010 Recruiting Paris, France, 75012 Investigational Site Number 250015 Recruiting Paris, France, 75014 Investigational Site Number 250028 Recruiting Paris, France, 75015 Investigational Site Number 250031 Recruiting Poitiers, France, 86021 Investigational Site Number 250023 Recruiting Pontoise, France, 95300 Investigational Site Number 250017 Recruiting RENNES Cedex, France, 35022 Investigational Site Number 250008 Recruiting Rouen, France, 76000 Investigational Site Number 250001 Recruiting St Etienne, France, 42055 Investigational Site Number 250022 Recruiting Toulouse, France, 31200 Investigational Site Number 250003 Recruiting Tours, France, 37000 Less <<
NCT03425643 Non-small Cell Lung Cancer Phase 3 Recruiting June 29, 2026 -
NCT03445871 Rheumatoid Arthritis Phase 4 Recruiting January 2020 France ... More >> Chu Saint Etienne Recruiting Saint-etienne, France, 42100 Principal Investigator: Hubert MAROTTE, MD PhD          Sub-Investigator: Thierry THOMAS, MD PhD          Sub-Investigator: Béatrice PALLOT-PRADES, MD          Sub-Investigator: Karima BOUSSOUALIM, MD          Sub-Investigator: Adamah AMOUZOUGAN, MD          Sub-Investigator: Lambert MIJOLA, MD Less <<
NCT02723994 Leukemia Phase 2 Recruiting May 2024 -
NCT01209520 Lung Cancer N... More >>on Small Cell Lung Carcinoma Hypermethylation Less << Not Applicable Completed - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 Less <<
NCT02723955 Cancer Phase 1 Recruiting May 18, 2020 United States, California ... More >> GSK Investigational Site Recruiting Duarte, California, United States, 91010 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, New York GSK Investigational Site Recruiting New York, New York, United States, 10016 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting New York, New York, United States, 10032 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Pennsylvania GSK Investigational Site Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Tennessee GSK Investigational Site Recruiting Nashville, Tennessee, United States, 37203 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting Nashville, Tennessee, United States, 37232-6307 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Australia, Victoria GSK Investigational Site Recruiting Heidelberg, Victoria, Australia, 3084 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Melbourne, Victoria, Australia, 3000 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Australia, Western Australia GSK Investigational Site Recruiting Nedlands, Western Australia, Australia, 6009 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Canada, Ontario GSK Investigational Site Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    France GSK Investigational Site Not yet recruiting Bordeaux Cedex, France, 33076 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting Lyon cedex 08, France, 69373 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Paris, France, 75005 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Villejuif cedex, France, 94805 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Italy GSK Investigational Site Recruiting Siena, Toscana, Italy, 53100 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Netherlands GSK Investigational Site Recruiting Amsterdam, Netherlands, 1066 CX Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Spain GSK Investigational Site Recruiting Barcelona, Spain, 08035 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Barcelona, Spain, 08036 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Madrid, Spain, 28040 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Málaga, Spain, 29010 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Sevilla, Spain, 41009 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT01209520 - Completed - -
NCT02821559 Metastatic Colorectal Cancer Phase 2 Completed - France ... More >> CHRU de Besançon Besançon, France Less <<
NCT02439450 Non-small Cell Lung Cancer Phase 1 Phase 2 Recruiting December 2021 -
NCT02724904 Lymphoma Phase 1 Phase 2 Withdrawn(Drug logistics) December 2021 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT02743923 Carcinoma, Non-Small Cell Lung Phase 3 Recruiting April 2020 Netherlands ... More >> VUmc Medical Center Recruiting Amsterdam, Noord-Holland, Netherlands, 1081HV Contact: Idris Bahce, MD       i.bahce@vumc.nl    Principal Investigator: Idris Bahce, MD          Medical spectrum Twente Recruiting Enschede, Overijssel, Netherlands, 7500 KA Contact: Hugo Schouwink, MD       J.Schouwink@mst.nl    Principal Investigator: Hugo Schouwink, MD          Meander Medical Center Recruiting Amersfoort, Utrecht, Netherlands, 3818 ES Contact: Joop van den Brand, MD       JJG.vanden.Brand@meandermc.nl    Principal Investigator: Joop van den Brand, MD          ZGT Recruiting Almelo, Netherlands, 7609 PP Contact: Jeske Staal, MD       j.staal@zgt.nl    Principal Investigator: Jeske Staal, MD          Antoni van Leeuwenhoek Recruiting Amsterdam, Netherlands, 1066CX Contact: Egbert Smit       e.smit@nki.nl    Principal Investigator: Egbert Smit, MD          OLVG Not yet recruiting Amsterdam, Netherlands, 1090 HM Contact: A Moons, MD       A.Moons-Pasic@olvg.nl    Principal Investigator: A Moons, MD          Gelre Ziekenhuis Recruiting Apeldoorn, Netherlands Contact: Niels Pronk, MD       n.pronk@gelre.nl    Principal Investigator: Niels Pronk, MD          Amphia Hospital Recruiting Breda, Netherlands Contact: Nicolaas van Walree, MD       nwalree@amphia.nl    Principal Investigator: Nicolaas van Walree, MD          Jeroen Bosch Hospital Recruiting Den Bosch, Netherlands Contact: Bonne Biesma, MD       b.biesma@jbz.nl    Principal Investigator: Bonne Biesma, MD          Haga Recruiting Den Haag, Netherlands, 2545 CH Contact: Pepijn Brocken, MD       p.brocken@hagaziekenhuis.nl    Principal Investigator: Pepijn Brocken, MD          Deventer Ziekenhuis Recruiting Deventer, Netherlands Contact: Suzy Samii, MD       s.samii@dz.nl    Principal Investigator: Suzy Samii, MD          Albert Schweitzer ziekenhuis Recruiting Dordrecht, Netherlands Contact: Eric van Thiel, MD       EricvanThiel@asz.nl    Principal Investigator: Eric van Thiel, MD          Ziekenhuis Gelderse Vallei Recruiting Ede, Netherlands Contact: Wouter de Jong, MD       jongw@zgv.nl    Principal Investigator: Wouter de Jong, MD          Maxima Medisch Centrum Recruiting Eindhoven, Netherlands, 5631 BM Contact: Arjen van Henten, MD       a.vanhenten@mmc.nl    Principal Investigator: Arjen van Henten, MD          Groene Hart Recruiting Gouda, Netherlands Contact: ten Heuvel, MD       alexandra.ten.heuvel@ghz.nl    Principal Investigator: ten Heuvel, MD          UMCG Recruiting Groningen, Netherlands, 9713 GZ Contact: Harry Groen, MD       h.j.m.groen@umcg.nl    Principal Investigator: Harry Groen, MD          Martini Ziekenhuis Recruiting Groningen, Netherlands Contact: John van Putten, MD       jwg.van.putten@mzh.nl    Principal Investigator: John van Putten, MD          Tergooi ziekenhuizen Recruiting Hilversum, Netherlands Contact: Jan Maarten van Haarst, MD       jvanhaarst@tergooi.nl    Principal Investigator: Jan Maarten van Haarst, MD          Spaarne Gasthuis Recruiting Hoofddorp, Netherlands, 2130 AT Contact: Frans Krouwels, MD       fkrouwels@spaarnegasthuis.nl    Principal Investigator: Frans Krouwels, MD          Medisch Centrum Leeuwarden Recruiting Leeuwarden, Netherlands Contact: Venmans, MD          Principal Investigator: Venmans, MD          Maastricht University Medical Center Recruiting Maastricht, Netherlands Contact: Anne-Marie Dingemans, MD       a.dingemans@mumc.nl    Principal Investigator: Anne-Marie Dingemans, MD          Maasstad ziekenhuis Recruiting Rotterdam, Netherlands, 3007 AC Contact: Susan van 't Westeinde, MD       westeindes@maasstadziekenhuis.nl    Contact: , MD          Principal Investigator: Susan van 't Westeinde, MD          St. Fransicus Gasthuis Recruiting Rotterdam, Netherlands, 3045 PM Contact: Wessel Hanselaar, MD       w.hanselaar@franciscus.nl    Principal Investigator: Wessel Hanselaar, MD          Medical Center Haaglanden Recruiting the Hague, Netherlands Contact: Klaar Maas, MD       k.maas@mchaaglanden.nl    Principal Investigator: Klaar Maas, MD          Diakonessenhuis Utrecht Recruiting Utrecht, Netherlands, 3582 KE Contact: Leontine van Elden, MD       lvelden@diakhuis.nl    Principal Investigator: Leontine van Elden, MD          St. Antonius ziekenhuis Recruiting Utrecht, Netherlands Contact: Franz Schramel, MD       f.schramel@antoniusziekenhuis.nl    Principal Investigator: Franz Schramel, MD          VieCuri Medisch Centrum voor Noord-Limburg Recruiting Venlo, Netherlands Contact: Vivian van Kampen, MD       vvankampen@viecuri.nl    Principal Investigator: Vivian van Kampen, MD          Isala Klinieken Recruiting Zwolle, Netherlands, 8000 GK Contact: Jos Stigt       j.a.stigt@isala.nl    Principal Investigator: Jos Stigt, MD Less <<
NCT02744196 Rheumatoid Arthritis Phase 3 Completed - -
NCT02760368 Rheumatoid Arthritis Phase 3 Completed - Bulgaria ... More >> DCC 'Sv. Pantaleymon' OOD Pleven, Bulgaria, 5800 UMHAT "Kaspela", EOOD Plovdiv, Bulgaria, 4002 UMHAT "Sv. Ivan Rilski", EAD Sofia, Bulgaria, 1431 MC "Synexus - Sofia", EOOD Sofia, Bulgaria, 1784 Russian Federation Regional State Budgetary Healthcare Institution "Barnaul City Hospital #4" Barnaul, Altai Region, Russian Federation, 656050 Medical Center LLC "Maksimum Zdoroviya" Kemerovo, Kemerovo Oblast, Russian Federation, 650056 SAHI of Kemerovo region "Regional Clinical Hospital for War Veterans" Kemerovo, Kemerovskaya Oblast, Russian Federation, 650000 Budgetary Healthcare Institution "Kursk Regional Clinical Hospital" of Healthcare Committee of Kursk region Kursk, Kurskaya Oblast, Russian Federation, 305007 SPb SBHI "Clinical Rheumatological Hospital #25", Fourth Rheumatology Unit Saint Petersburg, Leningradskaya Oblast, Russian Federation, 190068 State Budgetary Healthcare Institution of Moscow "City Clinical Hospital #1 n.a. Pirogov" Healthcare Departament of Moscow Moscow, Moscovskaya Oblast, Russian Federation, 119094 FSBEI HE "First Moscow State Medical University n.a. I.M. Sechenov of MoH of Russian Federation", UCH #1 Moscow, Moscovskaya Oblast, Russian Federation, 119991 FSBEI HE "FMSMU n.a. I.M. Sechenov of MoH of RF", University Hospital #2, Departament of New Drugs Introduction Moscow, Moscovskaya Oblast, Russian Federation, 119991 SBEI HPE "First Moscow State Medical University n.a. I.M. Sechenov of MoH of Russian Federation" UCH #3 Moscow, Moscovskaya Oblast, Russian Federation, 119991 State Budgetary Healthcare Institution "City Clinical Hospital # 15 n.a O.M. Filatov" of Moscow Healtheare Department Moscow, Moscow Region, Russian Federation, 111539 SBHI of Moscow "City Clinical Hospital #4 of Moscow Healthcare Departament" Moscow, Moskovskaya Oblast, Russian Federation, 115093 SBHI of Nizhny Novgorod Region "Nizhny Novgorod Regional Clinical Hospital n.a.Semashko" Nizhniy Novgorod, Nizhegorodskaya Oblast, Russian Federation, 603126 State Autonomous Healthcare Institution of Novosibirsk region "City Polyclinic #1" Novosibirsk, Novosibirsk Oblast, Russian Federation, 630099 LLC "Clinical Diagnostic Center "Ultramed" Omsk, Omskaya Oblast, Russian Federation, 644024 Budgetary Healthcare Institution of Omsk Region "Regional Clinical Hospital" Omsk, Omskaya Oblast, Russian Federation, 644111 SBHI of the Republic of Karelia "Republican Hospital named after V.A. Baranov" Petrozavodsk, Republic Of Karelia, Russian Federation, 185019 State Budgetary Healthcare Institution "Republican Clinical Hospital n.a. G.G. Kuvatov" Ufa, Respublic Of Bashkortostan, Russian Federation, 450005 SBEI HPE "Rostov State Medical University" of Ministry of Health of the Russian Federation Rostov, Rostovskaya Oblast, Russian Federation, 344022 SBEI HPE "SSMU n.a. V.I. Razumovsky of MoH of RF", Clinical Hospital n.a. S.R. Mirotvorcev, Therapeutic Departament Saratov, Saratovskaya Oblast, Russian Federation, 410012 State Healthcare Institution "Regional Clinical Hospital" Saratov, Saratovskaya Oblast, Russian Federation, 410053 Non-governmental Healtheare Institution "Regional Clinical Hospital at Smolensk station of OJSC "Russian Railways" Smolensk, Smolenskaya Oblast, Russian Federation, 214025 SBHI of Stavropol Region "Stavropol Regional Clinical Hospital" Stavropol', Stavropol Region, Russian Federation, 355017 State Budgetary Healthcare Institution of Sverdlovsk Region "Sverdlovsk Regional Clinical Hospital #1" Ekaterinburg, Sverdlovskaya Oblast, Russian Federation, 620102 SBEI HPE "Ural State Medical University" of MoH of RF based MBI "Central City Clinical Hospital #6" Ekaterinburg, Sverdlovskaya Oblast, Russian Federation, 620149 State Autonomous Healthcare Institution "Republican Clinical Hospital of Ministry of Health of Tatarstan Republic Kazan', The Republic Of Tatarstan, Russian Federation, 420064 State Healthcare Institution of Tula region "Tula Regional Clinical Hospital" Tula, Tulskaya Oblast, Russian Federation, 300053 State Healthcare Institution "Ulyanovsk Regional Clinical Hospital" Ulyanovsk, Ulyanovskaya Oblast, Russian Federation, 432063 SBHI of Vladimir Region "Regional Clinical Hospital", Rheumatology Departament Vladimir, Vladimirskaya Oblast, Russian Federation State Autonomous Helthcare Institution of Yaroslavl region "Clinical Hospital of Emergency Care n.a. Solovyev" Yaroslavl', Yaroslavsakaya Oblast, Russian Federation, 150003 SBHI "Yaroslavl Regional Clinical Hospital", Rheumatology department Yaroslavl', Yaroslavskaya Oblast, Russian Federation, 150062 FSBSI "Scientific Research Institute of Rheumatology n.a. V.A. Nasonova" Moscow, Russian Federation, 115522 LLC "Tekhnologii Zdoroviya" Saint Petersburg, Russian Federation, 191144 SBHI "North-West Federat Medical Research Center n.a. V.A.Almazov" of the Ministry of Healthcare of the Russian Federation Saint Petersburg, Russian Federation, 197341 Less <<
NCT02748785 - Completed - -
NCT02748785 Arthritis, Rheumatoid Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT02760433 Rheumatoid Arthritis Phase 3 Recruiting January 2020 -
NCT02764281 Extranodal NK-T-Cell Lymphoma,... More >> Nasal Type Less << Phase 3 Recruiting December 2020 China, Shanghai ... More >> Shanghai Ninth People's Hospital Recruiting Shanghai, Shanghai, China, 200011 Contact: Qi Zhu, MD    +8621-23271699    zhuqi70@hotmail.com    Shanghai Eye and ENT Hospital of Fudan University Recruiting Shanghai, Shanghai, China, 200031 Contact: Hao Ding, MD    +86-21-64377134    eentding@163.com    Xinhua Hospital Recruiting Shanghai, Shanghai, China, 200092 Contact: Rong Tao, MD    +86-21-25077603    hkutao@hotmail.com    Shanghai Dong Fang hospital Recruiting Shanghai, Shanghai, China, 200120 Contact: Hai-Feng Lan, MD    +8621-61569716    lanhf2013@163.com    Shanghai Tong Ren Hospital Recruiting Shanghai, Shanghai, China, 200336 Contact: Li-Gen Liu, MD    +86-21-52039999    liuligen@medmail.com.cn    China, Xinjiang Xin Jiang People's Hospital Recruiting Urumqi, Xinjiang, China, 830001 Contact: Xiao-Yan Zhang, MD    +86-991-8562209    279222677@qq.com Less <<
NCT02766465 Sickle Cell Disease Phase 2 Recruiting March 2023 -
NCT02746380 Arthritis, Rheumatoid Phase 3 Active, not recruiting February 2018 Japan ... More >> Mochida Investigational site Tokyo, Japan Korea, Republic of LGLS Investigational site Seoul, Korea, Republic of Less <<
NCT02776605 ALL Phase 2 Recruiting December 2020 Spain ... More >> Hospital Germans Trias i Pujol Recruiting Badalona, Spain Contact: Josep Mª Ribera, Dr       jribera@iconcologia.net    Hospital Clinic Recruiting Barcelona, Spain, 08036 Contact: Jordi Esteve, Dr       JESTEVE@clinic.ub.es    Hospital Universitario Vall d'Hebron Recruiting Barcelona, Spain Contact: Pere Barba, Dr       pebarba@vhebron.net    Hospital 12 de Octubre Recruiting Madrid, Spain Contact: Mª Pilar Martinez Sánchez, Dr       mpmartinezs.hdoc@salud.madrid.org    Hospital Virgen de la Victoria Recruiting Málaga, Spain Contact: Mª José Moreno, Dr       mjmorenorico@hotmail.com    Hospital Clinico Universitario de Salamanca Recruiting Salamanca, Spain Contact: Jesús Maria Hernández Rivas, Dr       jmhr@usal.es    Hospital Marques de Valdecilla Recruiting Santander, Spain Contact: Mª Aranzazu Bermudez, Dr       mbermudez@humv.es    C H Santiago de Compostela Recruiting Santiago de Compostela, Spain Contact: Natalia Alonso, Dr       natalia.alonso.vence@sergas.es    Hospital Virgen del Rocio Recruiting Sevilla, Spain Contact: Jose Gonzalez Campos, Dr       jose.gonzalez.sspa@juntadeandalucia.es    Hospital Clinico de Valencia Recruiting Valencia, Spain Contact: Mª del Mar Tormo, Dr       tormo_mar@gva.es    Hospital La Fe Recruiting Valencia, Spain Contact: Pau Montesinos, Dr       montesinos_pau@gva.es Less <<
NCT02777736 Diffuse Large B-cell Lymphoma Phase 3 Recruiting December 2019 Czech Republic ... More >> University Hospital Brno-Bohunice Recruiting Brno, Czech Republic, 62500 Contact: Andrea Janikova, M.D.,Ph.D.          University Hospital Hradec Králové Recruiting Hradec Králové, Czech Republic, 50005 Contact: David Belada, M.D., Ph.D.          University Hospital Ostrava Recruiting Ostrava, Czech Republic, 708 52 Contact: Juraj Ďuraš, M.D.          University Hospital Pilsen Recruiting Pilsen, Czech Republic, 304 60 Contact: Martin Pachner, M.D.          University Hospital Kralovske Vinohrady Recruiting Prague, Czech Republic, 100 34 Contact: Heidi Mocikova, M.D., Ph.D.          General University Hospital Prague Recruiting Prague, Czech Republic, 12808 Contact: Robert Pytlik, M.D. Less <<
NCT02777788 Cancer Phase 2 Phase 3 Active, not recruiting December 2019 -
NCT02760407 Rheumatoid Arthritis Phase 3 Recruiting May 2020 -
NCT02787473 Squamous Cell Lung Cancer Phase 2 Recruiting September 2020 China, Zhejiang ... More >> Hangzhou First People's Hospital Recruiting Hangzhou, Zhejiang, China, 310006 Contact: Shirong Zhang, Dr.    086057156007650    shirley4444@gmail.com Less <<
NCT02764515 Rheumatoid Arthritis Phase 4 Recruiting November 2017 China, Anhui ... More >> the Affiliated Hospital to Bangbu Medical University Recruiting Bangbu, Anhui, China, 233000 Contact: Zhijun Li, MD    13955289810    zhijun.li@cstar.org.cn    Contact: Changhao Xie, MD    15255227208    uglboy2002@126.com    The First Affiliated Hospital of Bengbu Medical College Recruiting Bengbu, Anhui, China Contact: Xin Wang, MD    86-13515529256    273084414@qq.com    Contact: Zhijun Li, MD    86-13956955150    lizhijundr@126.com    AnHui provincial hospital Recruiting Hefei, Anhui, China Contact: Li Wang, MD    86-15055148790    wang_liy@aliyun.com    Contact: Xiangpei Li, MD    86-13515605909    13515605909@126.com    China, Guangdong Nanfang Hospital Recruiting Guangzhou, Guangdong, China Contact: Jinjun Zhao, MD    86-13710596450    zhao7749@126.com    Contact: Min Yang, MD    86-13802911770    minyanggz@163.com    The Third Affiliated Hospital to SUN YAT-SEN University Recruiting Guangzhou, Guangdong, China Contact: Linkai Fang, MD    86-13751889563    fanglinkai1984@163.com    Contact: Jieruo Gu, MD    13922280820    gujieruo@163.com    China, Heilongjiang The First Affiliated Hospital of Harbin Medcial University Recruiting Haerbin, Heilongjiang, China Contact: Juan Gao, MD    86-15304803480    happygigi@163.com    Contact: Zhiyi Zhang, MD    86-13303608999    zhangzhiyi2014@163.com    China, Henan The first affiliated hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China Contact: Jiameng Lu, MD    86-18637184930    lujiameng2003@126.com    Contact: Shengyun Liu, MD    86-13837192659    shengyun@medmail.com.cn    China, Hubei Minda Hospital of Hubei Province Recruiting Enshi, Hubei, China Contact: Linchong Su, MD    86-15571781515    "linchongsu@126.com    Contact: Yang Xiang, MD    86-13607249969    xiangy1961@yahoo.com.cn    China, Jiangsu Jiangsu Province Hospital Recruiting Nanjing, Jiangsu, China Contact: Chengyin Li, MD    86-13914751367    lcyzjf@hotmail.com    Contact: Miaojia Zhang, MD    86-13611505999    miaojia_zhang@163.com    Affiliated Hospital of Nantong University Recruiting Nantong, Jiangsu, China Contact: Yunfei Xia, MD    15896275028    xiayf1986@163.com    Contact: Zhanyun Da, MD    86-18962940001    dazhanyun@163.com    China, Shanxi Xijing Hospital Recruiting Xian, Shanxi, China, 710032 Contact: Zhenbiao Wu, MD    13700235112    ping.zhu@cstar.org.cn    Contact: Weitong Chen, MD    15771943030    chenweitong0818@163.com    China, Yunnan the Affiliated Hospital of Kunming Medical University Recruiting Kunming, Yunnan, China, 650032 Contact: Jian Xu, MD    13888566797    jian.xu@cstar.org.cn    Contact: Shu Li, MD    15198785584    gglis@126.com    China Guang'anmen Hospital,China Academy of Chinese Medical Sciences Recruiting Beijing, China, 100010 Contact: Hailong Wang, MD    86-13810112190    wang.hailong@139.com    Contact: Quan Jiang, MD    86-13901081632    doctorjq@126.com    Peking Union Medical College Hospital Recruiting Beijing, China, 100032 Contact: Xinping Tian, MD    86-13691165939    tianxp6@126.com    Contact: Shi Rong, MD    86-13601248311    rongshipumch@126.com    Sub-Investigator: XInping Tian, MD          Guang Hua hospital Recruiting Shanghai, China Contact: Xiaolin Yang, MD    86-13701816768    lindayoung365@hotmail.com    Contact: Dongyi He, MD    021-62805833    dongyihe@medmail.com.cn    Zhongshan Hospital Fudan University Recruiting Shanghai, China Contact: Huiyong Chen, MD    86-13817629793    zsneike@163.com    Contact: Lindi Jiang, MD    86-13701973875    jianglindi@medmail.com.cn Less <<
NCT01974323 Acne Vulgaris Phase 3 Completed - United States, California ... More >> Beverly Hills, California, United States United States, Florida Aventura, Florida, United States Canada, Ontario Windsor, Ontario, Canada Less <<
NCT02786563 - Withdrawn(Strategic considerat... More >>ions) Less << - China, Beijing ... More >> Peking University Peoples Hospit /ID# 148961 Beijing, Beijing, China, 100044 China, Shaanxi Xijing Hospital /ID# 148960 Xian, Shaanxi, China, 710032 China Hosp Ppl Liberation Army 301 /ID# 148962 Beijing, China, 100034 Renji Hosp, Shanghai Jiaotong /ID# 148959 Shanghai, China, 200127 Less <<
NCT02764762 Crohn Disease Phase 4 Recruiting September 13, 2022 -
NCT01974141 - Completed - -
NCT01974323 - Completed - -
NCT02879981 - Completed - Peru ... More >> Hospital Emergencias Pediatricas; Unidad de Investigación Pediátrica La Victoria, Peru, 15033 Clinica Internacional, Sede San Borja; Unidad de Investigacion de Clínica Internacional Lima, Peru, Lima 41 Clínica Anglo Americana-CENTRO DE INVESTIGACION PEDIATRIA CAA San Isidro, Peru, 27 Less <<
NCT02799888 Graft-versus-host Disease ... More >> Hematopoietic Stem Cell Transplantation Less << Phase 2 Unknown April 2017 China, Beijing ... More >> Department of Hematopoietic Stem Cell Transplantation Recruiting Beijing, Beijing, China, 100071 Less <<
NCT01974141 Acne Vulgaris Phase 3 Completed - United States, California ... More >> Encino, California, United States Canada, Ontario North Bay, Ontario, Canada Less <<
NCT02818725 Infiltrating Urothelial Carcin... More >>oma KRAS Gene Mutation Less << Phase 3 Unknown September 2017 France ... More >> Hopital Saint Andre Bordeaux, France, 33075 Institut Bergonie Bordeaux, France, 33076 Centre Francois Baclesse Caen, France, 14076 Hopital Henri Mondor Creteil, France, 94010 Centre Leon Berard Lyon, France, 69008 Institut Paoli Calmettes Marseille, France, 13273 Centre Alexis Vautrin Nancy, France, 54511 Centre Rene Gauducheau Nantes, France, 44800 Chu de Nimes Nimes, France, 30029 Institut Curie Paris, France, 75005 Diaconesses - Croix St Simon Paris, France, 75012 Pitie Salpetriere Paris, France, 75013 Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Institut Cancerologie de La Loire St Priest En Jarez, France, 42270 Hopitaux Universitaires Strasbourg, France, 67091 Institut Claudius Regaud Toulouse, France, 31052 Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT02419755 - Terminated(Accrual goals were ... More >>no longer feasible based on restrictions imposed by the DSMB.) Less << - -
NCT02419755 Mixed Lineage Acute Leukemia ... More >> Acute Myeloid Leukemia Acute Lymphoid Leukemia Less << Phase 2 Terminated(Accrual goals were ... More >>no longer feasible based on restrictions imposed by the DSMB.) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT02825147 Nasal Type Extranodal NK/T-Cel... More >>l Lymphoma Less << Phase 2 Completed - China ... More >> Shanghai Ruijin Hospital Shanghai, China, 200025 Less <<
NCT02902640 - Completed - Peru ... More >> Clínica Providencia; Centro de Investigación de Enfermedades Respiratorias Lima, Peru, 15088 Clinica de Especialidades Medicas Lima, Peru, Lima 41 Clinica San Borja; Instituto de Enfermedades Respiratorias EFEH Lima, Peru, Lima 41 Centro de Investigaciones Medicas/Hospital Maria Auxiliadora San Juan de Miraflores, Peru, 15801 Less <<
NCT02831855 Rheumatoid Arthritis Phase 4 Recruiting December 17, 2018 -
NCT02814175 Psoriatic Arthritis Phase 4 Recruiting March 20, 2020 -
NCT02829424 Psoriasis Phase 4 Recruiting October 2020 France ... More >> Assistance Publique Hôpitaux de Marseille Recruiting Marseille Cedex 05, France, 13385 Contact: Marie RICHARD, Pr    +33 4 91 387 991 ext +33    mrichard@ap-hm.fr    Contact: Jean DHORNE    04 91 38 14 75 ext +33    jean.dhorne@ap-hm.fr Less <<
NCT02592408 Malaria Phase 4 Completed - Sudan ... More >> New Halfa Hospital New Halfa, Kassalla, Sudan, 31112 Gizeria Slang Hospital Khartoum, Sudan, 11111 Less <<
NCT02837965 - Unknown - France ... More >> Chu Reims Recruiting France, Reims, France, 51092 Contact: Damien JOLLY    326788472 ext 33    djolly@chu-reims.fr Less <<
NCT02845596 Severe Aplastic Anemia Not Applicable Recruiting May 2020 United States, California ... More >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Nini Huynh    323-361-5286    huhuynh@chla.usc.edu    Principal Investigator: Michael Pulsipher, MD          United States, Colorado Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Wendy Moore    720-777-6353    Wendy.moore2@childrenscolorado.org    Principal Investigator: Taizo Nakano, MD          United States, Massachusetts Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Maggie Malsch, MSN       maggie.malsch@childrens.harvard.edu    Contact: Leah Cheng       leah.cheng@childrens.harvard.edu    Principal Investigator: David A Williams, MD          United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Jeanette Haugh    551-996-3457    jeanette.haugh@hackensackmeridian.org    Principal Investigator: Alfred Gillio, MD          United States, Pennsylvania Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Barbara McGlynn    215-590-1303    mcglynn@email.chop.edu    Principal Investigator: Timothy Olson, MD          United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Margaret Nagel    832-824-1538    menagel@texaschildrens.org    Principal Investigator: Alison Bertuch, MD          United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States, 98109 Contact: Bernie McLaughlin    206-667-4916    bmclaugh@fredhutch.org    Principal Investigator: Lauri Burroughs, MD Less <<
NCT02829008 Metastatic Breast Cancer Phase 2 Active, not recruiting April 2020 China, Beijing ... More >> Cancer Hospital, ChineseAMS Beijing, Beijing, China, 100021 Less <<
NCT02837146 Rheumatoid Arthritis Phase 3 Recruiting December 2019 Belgium ... More >> Maria S Stoenoiu Recruiting Brussels, Belgium, 1200 Contact: Maria S. Stoenoiu, MD, PhD    +3227649917    maria.stoenoiu@uclouvain.be    Contact: Marie M M'Zoughui    +3227645390    marie.mzoughui@uclouvain.be Less <<
NCT02845882 Lymphoblastic Lymphoma Phase 2 Phase 3 Recruiting December 2025 China ... More >> West China Second University Hospital Recruiting Chengdu, China Contact: Xia Guo, M.D.       guoxkl@163.com    Shanghai Children's Medical Center Recruiting Shanghai, China, 200127 Contact: Yi-Jin Gao, M.D.    86-21-38626161 ext 82064    gaoyijin@scmc.com.cn    Contact: Jing-yan Gao, M.D. Less <<
NCT03593304 Vincristine Induced Neurotoxic... More >>ity Acute Lymphoblastic Leukaemia Less << Phase 2 Phase 3 Recruiting September 30, 2019 Bangladesh ... More >> Bangabandhu Sheikh Mujib Medical University Recruiting Dhaka, Shahbag, Bangladesh, 1000 Contact: Ferdaush Ahmed Sojib, MBBS    +8801678792930    ferdaushahmedsojib@gmail.com    Contact: Md. Sayedur Rahman, MBBS, Mphil    +01971840757    srkhasru@gmail.com    Dhaka Medical College Hospital Recruiting Dhaka, Bangladesh Contact: Ferdaush Ahmed Sojib, MBBS    01678792930    ferdaushahmedsojib@gmail.com    Contact: Tasneem Ara, MBBS,FCPS,Mphil    +8801552314402 Less <<
NCT02939573 Primary Cutaneous Vasculitis ... More >> Cutaneous Polyarteritis Nodosa IgA Vasculitis Henoch-Sch?nlein Purpura Less << Phase 2 Recruiting December 2019 United States, Kansas ... More >> University of Kansas Medical Center Recruiting Kansas City, Kansas, United States Contact: Theresa Howard       thoward2@kumc.edu    United States, Massachusetts Boston University School of Medicine Recruiting Boston, Massachusetts, United States, 02118 Contact: Christopher Zammitti       zammitti@bu.edu    United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Katrina Pierce       pierce.katrina@mayo.edu    United States, New York Northwell Health Recruiting Lake Success, New York, United States, 11042 Contact: Anita Haridat       aharidat@northwell.edu    Hospital for Special Surgery Recruiting New York, New York, United States, 10021 Contact: Beemnet Amdemicael       amdemicaelb@hss.edu    United States, Ohio Cleveland Clinic Recruiting Cleveland, Ohio, United States Contact: Elizabeth Kisela       kiselae@ccf.org    United States, Pennsylvania Penn State Hershey Medical Center Completed Hershey, Pennsylvania, United States, 17033 University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Michelle Hampton       Michelle.Hampton@uphs.upenn.edu    United States, Utah University of Utah Recruiting Salt Lake City, Utah, United States Contact: Lisa Webber       lisa.webber@hsc.utah.edu    Canada, Ontario St. Joseph's Healthcare Recruiting Hamilton, Ontario, Canada Contact: Sandra Messier       smessier@stjoes.ca    University of Toronto Mount Sinai Hospital Recruiting Toronto, Ontario, Canada Contact: Judy Vendramini       judy.vendramini@sinaihealthsystem.ca    Canada, Quebec McGill University Health Centre Recruiting Montréal, Quebec, Canada, H4A 3J1 Contact: Michele Tobaly       michele.tobaly@muhc.mcgill.ca Less <<
NCT02859077 Non-Small-Cell Lung Cancer Phase 3 Unknown July 2018 -
NCT02339441 - Completed - -
NCT02032407 - Completed - -
NCT02032407 Acne Vulgaris Phase 4 Completed - United States, District of Col... More >>umbia Washington, District of Columbia, United States Less <<
NCT02862457 Neoplasms Car... More >>cinoma, Non-Small-Cell Lung Less << Phase 1 Recruiting November 30, 2020 Japan ... More >> MSD K.K. Recruiting Chiyoda-Ku, Tokyo, Japan, 102-8667 Contact: Japan Call Center    81-3-6272-1957 Less <<
NCT02862574 Rheumatoid Arthritis Phase 2 Terminated(Study was terminate... More >>d by sponsor and decision was not due to any safety signals.) Less << - United States, California ... More >> Stanford University Palo Alto, California, United States, 94304 United States, Florida Omega Research Consultants, LLC DeBary, Florida, United States, 32713 United States, Nevada G. Timothy Kelly, MD Las Vegas, Nevada, United States, 89128 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, New Mexico Albuquerque Center for Rheumatology Albuquerque, New Mexico, United States, 87102 United States, Pennsylvania Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 United States, Texas Tekton Research Austin, Texas, United States, 78728 Accurate Clinical Research San Antonio, Texas, United States, 78229 Less <<
NCT02862574 - Terminated(Study was terminate... More >>d by sponsor and decision was not due to any safety signals.) Less << - -
NCT02867306 Rheumatoid Arthritis Phase 1 Completed - Moldova, Republic of ... More >> Site MD37301 Chisinau, Moldova, Republic of, MD-2025 Less <<
NCT02487069 Acute Leukemia ... More >> Chronic Myeloid Leukemia Myelodysplastic Syndrome Less << Not Applicable Recruiting August 2020 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Zhiping Fan    +86-020-62787883    hnfzping@hotmail.com Less <<
NCT02879669 To Determine Safety, Tolerabil... More >>ity and Efficacy of ONCOS-102 in Combination With Chemotherapy Less << Phase 1 Phase 2 Recruiting - France ... More >> Centre Georges-François Leclerc Recruiting Dijon, France Contact: Nicolas Isambert, MD          CHU de Rennes - Pontchaillou Recruiting Rennes, France Contact: Hervé Lena, MD          Spain Hospital Universitario Quirón Recruiting Barcelona, Spain Contact: Santiago Viteri          Vall d'Hebron Univerity Hospital Recruiting Barcelona, Spain Contact: Susanna Cedres, MD          Hospital Universitari de Girona Doctor Josep Trueta - Institut Català d'Oncologia Recruiting Girona, Spain Contact: Joaquim Bosch          Hospital 12 de octubre Recruiting Madrid, Spain Contact: Luis Paz-Ares, MD          Hospital Universitario HM Sanchinarro Recruiting Madrid, Spain Contact: Javier de Castro, MD Less <<
NCT02874092 Rheumatoid Arthritis Phase 4 Recruiting November 15, 2018 United States, New York ... More >> New York University School of Medicine Recruiting New York, New York, United States, 10016 Contact: Jessica Poon       jessica.poon@nyumc.org    Principal Investigator: Jeffrey Berger, MD Less <<
NCT02885181 Rheumatoid Arthritis Phase 2 Completed - United States, Florida ... More >> Omega Research Consultants DeBary, Florida, United States, 32713 Sarasota Arthritis Research Center Sarasota, Florida, United States, 34239 United States, Georgia Medical Associates of North Georgia Canton, Georgia, United States, 30114 United States, Kentucky Center For Arthritis and Osteoporosis Elizabethtown, Kentucky, United States, 42701 United States, New Mexico Albuquerque Center For Rheumatology Albuquerque, New Mexico, United States, 87102 United States, Pennsylvania Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 United States, Texas Accurate Clinical Management - Najam Houston, Texas, United States, 77084 Accurate Clinical Research Inc. Stafford, Texas, United States, 77477 Medical Center Research LLC Webster, Texas, United States, 77598 Bulgaria MHAT-Plovdiv AD Plovdiv, Bulgaria, 4000 Umhat Kaspela Plovdiv, Bulgaria, 4003 NMTH Tsar Boris III Sofia, Bulgaria, 1233 Czechia A-Shine s.r.o. Plzen, Czechia, 31200 Medical Plus, S.R.O. Uherske Hradiste, Czechia, 68601 Georgia LLC Arensia Exploratory Medicine T'bilisi, Georgia, 0112 Moldova, Republic of ARENSIA Exploratory Medicine Phase I Unit, Republican Clinical Hospital Chisinau, Moldova, Republic of, MD-2025 Poland ClinicMed Badurski i wspolnicy Spolka Jawna Bialystok, Poland, 15-879 Ukraine Kharkiv City Hospital 8 Kharkiv, Ukraine, 140176 Medical Center_Clinic of International Institute of clinical Studies Kyiv, Ukraine, 2068 Less <<
NCT02881086 Acute Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Less << Phase 3 Recruiting June 2025 Germany ... More >> University Hospital of Frankfurt (Main) Recruiting Frankfurt (Main), Germany, 60590 Less <<
NCT02882087 Moderate and Severe Rheumatoid... More >> Arthritis Less << Phase 2 Recruiting December 2019 China, Shanghai ... More >> Renji Hospital Shanghai Jiaotong University School of Medicine Recruiting Shanghai, Shanghai, China Contact: Chunde Bao Less <<
NCT02885181 - Completed - -
NCT02944825 Urolithiasis ... More >>UTI Less << Not Applicable Recruiting January 2018 United States, California ... More >> University of California, San Diego Recruiting San Diego, California, United States, 92101 Contact: Roger L Sur, MD    619-543-2628    rlsur@ucsd.edu    Contact: Seth K Bechis, MD    619-543-2628    sbechis@ucsd.edu Less <<
NCT02884635 Rheumatoid Arthritis Phase 2 Completed - Japan ... More >> Site JP00022 Aichi, Japan Site JP00023 Aichi, Japan Site JP00017 Chiba, Japan Site JP00026 Ehime, Japan Site JP00025 Fukui, Japan Site JP00012 Fukuoka, Japan Site JP00018 Fukuoka, Japan Site JP00019 Fukuoka, Japan Site JP00006 Gunma, Japan Site JP00024 Gunma, Japan Site JP00010 Hiroshima, Japan Site JP00011 Hiroshima, Japan Site JP00001 Hokkaido, Japan Site JP00002 Hokkaido, Japan Site JP00003 Hokkaido, Japan Site JP00004 Iwate, Japan Site JP00005 Iwate, Japan Site JP00016 Kagoshima, Japan Site JP00007 Kanagawa, Japan Site JP00021 Kanagawa, Japan Site JP00014 Kumamoto, Japan Site JP00015 Kumamoto, Japan Site JP00013 Nagasaki, Japan Site JP00020 Oita, Japan Site JP00008 Shizuoka, Japan Site JP00009 Shizuoka, Japan Site JP00027 Tokyo, Japan Less <<
NCT02886728 Rheumatoid Arthritis Phase 3 Active, not recruiting May 2019 -
NCT02885597 Juanbi Pill R... More >>heumatoid Arthritis Less << Phase 2 Phase 3 Recruiting December 2020 China, Shanghai ... More >> Longhua Hospital, Shanghai University of TCM Recruiting Shanghai, Shanghai, China, 200032 Contact: Qianqian Liang, Doctor    86-021-64875390    liangqianqiantcm@126.com    Contact: Qiong Wang    86-13671779096    13671779096@163.com    Principal Investigator: Yongjun Wang, Doctor Less <<
NCT02878161 Rheumatoid Arthritis Phase 4 Enrolling by invitation December 2019 -
NCT02894645 Acute Lymphoblastic Leukemia (... More >>ALL) Less << Phase 4 Unknown - Malaysia ... More >> University of Malaya Medical Centre Recruiting Kuala Lumpur, Malaysia, 59100 Contact: Hany Arrifin, MBBS    +603 7949 6785    hany@ummc.edu.my    Subang Jaya Medical Centre Recruiting Subang Jaya, Malaysia, 47500 Contact: Hai Peng Lin, MBBS       flslhp@gmail.com    Contact: Lee Lee Chan, MBBS       drchanleelee@gmail.com    Singapore National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Allen Yeoh, MBBS    (+65) 6772 4406    allen_yeoh@nuhs.edu.sg    KK Women's and Children's Hospital Recruiting Singapore, Singapore, 229899 Contact: Ah Moy Tan, MBBS    (+65) 63941039    tan.ah.moy01@singhealth.com.sg Less <<
NCT02889796 Rheumatoid Arthritis Phase 3 Active, not recruiting April 2019 -
NCT02897700 Breast Cancer Phase 1 Recruiting December 2020 China, Jiangxi ... More >> Ganzhou City People's Hospital Recruiting Ganzhou, Jiangxi, China, 341000 Contact: Xiao-Ming Zhong, M.D    86-18160779919    jxthrz@qq.com    China, Jilin China-Japan Union Hospital, Jilin University Recruiting Changchun, Jilin, China, 130033 Contact: Xian-Ling Cong, M.D    86-0431-89876626    congxl888@hotmail.com    China Shanghai 10th People's Hospital, Tongji University School of Medicine Recruiting Shanghai, China, 200072 Contact: Da Fu, Ph.D    86-15921527578    fu800da900@126.com Less <<
NCT02900742 Cancer Phase 3 Unknown December 2016 -
NCT02897817 - Completed - France ... More >> Nordic Pharma Paris, France, 75007 Less <<
NCT02902861 Psoriasis Vulgaris Phase 3 Completed - Germany ... More >> Psoriasis-Zentrum, Universitäts-Hautklinik Kiel Kiel, Schleswig-Holstein, Germany, 24105 Less <<
NCT03668964 Healthy Volunteers Not Applicable Enrolling by invitation April 2019 Ireland ... More >> Atlantia Cork, Blackpool Cork, Ireland, T12HH60 Less <<
NCT02905110 Brain Tumor Recurrent Early Phase 1 Recruiting November 2020 United States, Texas ... More >> UTHealth & Children's Memorial Hermann Hospital Recruiting Houston, Texas, United States, 77030 Contact: David Sandberg, M.D.    713-500-7410    David.I.Sandberg@uth.tmc.edu    Contact: Bangning Yu, R.N., PhD    713 500-7363    Bangning.Yu@uth.tmc.edu Less <<
NCT02912676 Acute Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Less << Phase 1 Phase 2 Recruiting December 2018 Denmark ... More >> Department of Pediatrics, Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Kjeld Schmiegelow, MD    +45 3545 1357    kjeld.schmiegelow@rh.regionh.dk    Contact: Rikke H Larsen, MD    +45 35457093    rikke.hebo.larsen.01@regionh.dk    Sub-Investigator: Rikke H Larsen, MD          Rigshospitalet, Department of Hematology Recruiting Copenhagen, Denmark, 2100 Contact: Cecilie U Rank, M.D.    +45 35454534    cecilie.utke.rank@regionh.dk    Contact: Ove J Nielsen, M.D.    +45 35451144    ove.jul.nielsen@regionh.dk Less <<
NCT01020539 Acute Myelogenous Leukemia ... More >> Myelodysplastic Syndrome Juvenile Myelomonocytic Leukemia Less << Phase 1 Active, not recruiting March 2018 United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT02921984 Salivary Gland Tumors ... More >> Head and Neck Cancer Less << Phase 1 Completed - China, Shanghai ... More >> Shanghai ninth people's hospital Shanghai, Shanghai, China, 200011 Less <<
NCT02897011 Rheumatoid Arthritis ... More >> Influenza Methotrexate Less << Not Applicable Unknown August 2017 Korea, Republic of ... More >> Seoul National Univ. Bundang Hospital Recruiting Bundang, Gyeonggi-do, Korea, Republic of, 463-870 Contact: Yun Jong Lee, MD PhD    +82-31-787-4051    leeyn35@gmail.com    Principal Investigator: Yun Jong Lee, MD PhD          Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Eun Bong Lee, MD PhD    82-2-2072-3944    leb7616@snu.ac.kr    Contact: Hyun Mi Kwon, MD    82-2-2072-3198    hmikwon@gmail.com    Principal Investigator: Eun Bong Lee, MD PhD          SMG-SNU Boramae Medical Center Recruiting Seoul, Korea, Republic of, 156-707 Contact: Kichul Shin, MD PhD    +82-2-870-3204    kideb1@snu.ac.kr    Principal Investigator: Kichul Shin, MD PhD Less <<
NCT02930954 Non-small-cell Lung Cancer Phase 2 Unknown December 2018 China ... More >> Department of Oncology, Shanghai pulmonary hospital Shanghai, China, 200433 Less <<
NCT02934204 Primary CNS Lymphoma Phase 2 Recruiting February 2019 China, Guangdong ... More >> Guangdong general hospital Recruiting Guangzhou, Guangdong, China, 510080 Contact: Sichu Liu, MD PhD    +86 20 81884713 ext 80411    sisi.lau@foxmail.com Less <<
NCT02916979 Leukemia, Lymphoid ... More >> Leukemia, Myeloid Myelodysplastic Syndromes Myelofibrosis Lymphoma, Malignant Multiple Myeloma Waldenstrom Macroglobulinemia Less << Phase 1 Recruiting December 2019 United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Recruiting Lebanon, New Hampshire, United States, 03756 Contact: Research Nurse    800-639-6918    cancer.research.nurse@dartmouth.edu    Principal Investigator: Kenneth Meehan, MD Less <<
NCT03014687 Antibiotics P... More >>ituitary Adenoma Less << Phase 4 Recruiting July 2019 United States, Arizona ... More >> Barrow Brain and Spine Recruiting Phoenix, Arizona, United States, 85013 Contact: Heidi Jahnke, RN,MSN    602-406-6976    heidi.jahnke@dignityhealth.org    Principal Investigator: Andrew Little, MD          Principal Investigator: James Evans, MD          Principal Investigator: Varun Kshettry, MD Less <<
NCT02940561 Psoriasis Rhe... More >>umatoid Arthritis Less << Phase 1 Unknown October 2016 India ... More >> Saviour Hospital Recruiting Ahmedabad, Gujarat, India, 380009 Contact: Smita Nagpal, MD    9825721525    nagpalsmita@gmail.com    Principal Investigator: Smita Nagpal, MD          Sub-Investigator: Khushbu Jain, MD          Sub-Investigator: Ravindra Wadhawan, MD          Sterling Hospital Recruiting Ahmedabad, Gujarat, India, 380052 Contact: Piyush Joshi, MD    +91 8879102056    pnjoshi2005@gmail.com    Principal Investigator: Piyush Joshi, MD          Sub-Investigator: Sapan C Pandya, MD          Kanoria Hospital Recruiting Gandhinagar, Gujurat, India, 382428 Contact: Saurabh Kapadia, MD    +91-9824261031    drsaurabhkapadia@yahoo.com    Principal Investigator: Saurabh Kapadia, MD Less <<
NCT01323062 Non Small Cell Lung Cancer (NS... More >>CLC) Less << Phase 1 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center, UNC Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT02944396 Non-Small Cell Lung Cancer Phase 1 Phase 2 Active, not recruiting January 2, 2019 United States, Alabama ... More >> University of Alabama /ID# 155135 Birmingham, Alabama, United States, 35233 United States, California Icri /Id# 155593 Whittier, California, United States, 90603 United States, Colorado Univ of Colorado Cancer Center /ID# 153820 Aurora, Colorado, United States, 80045 United States, Illinois University of Chicago /ID# 153824 Chicago, Illinois, United States, 60637-1443 United States, Indiana Goshen Center for Cancer Care /ID# 153822 Goshen, Indiana, United States, 46526 United States, North Carolina Duke Univ Med Ctr /ID# 153821 Durham, North Carolina, United States, 27710 Less <<
NCT02947113 Non-Small Cell Lung Cancer Phase 2 Withdrawn(New studies availabl... More >>e with immunotherapy so recruitment is no longer acceptable.) Less << November 2017 -
NCT02651259 Tuberculosis Phase 1 Phase 2 Active, not recruiting March 31, 2019 Haiti ... More >> Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS Port-au-Prince, Haiti, HT-6110 Kenya Kenya Medical Research Institute / Walter Reed Project Clinical Research Center, Kericho CRS Kericho, Kenya, 20200 Malawi Malawi CRS Lilongwe, Central Malawi, Malawi Thailand Siriraj Hospital ,Mahidol University NICHD CRS Bangkok, Bangkoknoi, Thailand, 10700 Zimbabwe Harare Family Care CRS Harare, Zimbabwe Less <<
NCT02935387 Arthritis, Rheumatoid Phase 4 Recruiting November 2023 Netherlands ... More >> Reumazorg Zuidwest Nederland Recruiting Goes, Netherlands Contact: F. Fodili          UMC Utrecht Recruiting Utrecht, Netherlands Contact: Jacob M van Laar       remindra@umcutrecht.nl Less <<
NCT02960438 Rheumatoid Arthritis Phase 2 Active, not recruiting September 1, 2019 -
NCT02940990 NSCLC SBRT ... More >> GM-CSF Less << Phase 2 Not yet recruiting - China, Shanghai ... More >> Shanghai Chest Hospital Not yet recruiting Shanghai, Shanghai, China Contact: Xiaolong Fu, PhD    +862122200000 ext 3602    xlfu1964@126.com Less <<
NCT02117752 Healthy Volunteers Phase 1 Completed - United States, New Jersey ... More >> Fair Lawn, New Jersey, United States Less <<
NCT02108483 Healthy Volunteers Phase 1 Completed - United States, New Jersey ... More >> Fair Lawn, New Jersey, United States Less <<
NCT03042260 Lupus Erythematosus, Systemic Phase 4 Recruiting August 2019 Mexico ... More >> Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Recruiting Mexico Distrito Federal, DF, Mexico, 14080 Contact: Andrea Wisniowski, MD    5554870900 ext 2420    andiewsk@gmail.com    Contact: Jennifer Cuellar-Rodriguez, MD    5554870900 ext 2421    jennifer.cuellar@infecto.mx    Principal Investigator: Jennifer M Cuellar-Rodriguez Less <<
NCT02117739 Healthy Volunteers Phase 1 Completed - United States, New Jersey ... More >> Fair Lawn, New Jersey, United States Less <<
NCT02969044 - Completed - -
NCT02969044 Rheumatoid Arthritis Phase 2 Completed - -
NCT02986503 - Completed - Germany ... More >> Cooperative Osteosarcoma Study Group Stuttgart, Germany, D-70176 Italy Istituti Ortopedici Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors Bologna, Italy, 40136 Sweden Scandinavian Sarcoma Group Lund, Sweden, SE-221 85 Less <<
NCT02066038 Lung, Carcinoma Phase 2 Unknown March 2016 -
NCT02607423 Stage IIIA Non-Small Cell Lung... More >> Cancer Less << Phase 2 Withdrawn(The study failed to ... More >>meet its accrual targets.) Less << - United States, Pennsylvania ... More >> ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT02996500 Rheumatoid Arthritis Phase 2 Completed - -
NCT02639650 Gestational Trophoblastic Neop... More >>lasms Less << Phase 3 Recruiting March 2021 China, Zhejiang ... More >> Weiguo Lv Recruiting Hangzhou, Zhejiang, China Contact: Weiguo Lv, Doctor Less <<
NCT03077711 Urinary Tract Infections, Recu... More >>rrent Less << Phase 4 Active, not recruiting June 2019 United States, Illinois ... More >> NorthShore Univeristy HealthSystem Skokie, Illinois, United States, 60076 Less <<
NCT03053167 ColoRectal Cancer Phase 2 Recruiting December 2020 China, Liaoning ... More >> The First Hospital of China Medical University Recruiting Shenyang, Liaoning, China, 110001 Contact: Yunpeng Liu, MD., PhD    86-24-83282312    cmuliuyunpeng@hotmail.com    Principal Investigator: Yunpeng Liu, MD., PhD. Less <<
NCT03001219 Rheumatoid Arthritis Phase 2 Completed - -
NCT03083613 Gastric Cancer ... More >> Gastroesophageal Junction Adenocarcinoma Less << Phase 2 Unknown December 2018 China ... More >> Chinese Academy of Medical Sciences Recruiting Beijing, China, 10000 Contact: Ai ping Zhou    8610-87788145    zhouap1825@126.com Less <<
NCT02998528 Non Small Cell Lung Cancer Phase 3 Recruiting November 8, 2028 -
NCT03003962 Non Small Cell Lung Carcinoma ... More >>NSCLC Less << Phase 3 Recruiting December 31, 2020 -
NCT03002844 Nonsmall Cell Lung Cancer ... More >> EGFR Gene Mutation Less << Phase 2 Unknown December 2018 -
NCT02969083 Upper Tract Urothelial Carcino... More >>ma Less << Phase 2 Recruiting October 2023 Netherlands ... More >> Leiden University Medical Centre Recruiting Leiden, South Holland, Netherlands Less <<
NCT02393833 Breast Cancer Phase 3 Active, not recruiting - Italy ... More >> Istituto Europeo di Oncologia (IEO Milano, Italy Nigeria Ibadan, Nigeria Peru Lima, Peru Less <<
NCT01669941 Pregnancy Mal... More >>aria Less << Phase 4 Completed - Kenya ... More >> Lwak Mission Hospital Rarieda, Nyanza, Kenya Siaya District Hospital Siaya, Nyanza, Kenya, 40600 Bondo District Hospital Bondo, Kenya, 40601 Madiany sub-District Hospital Madiany, Kenya Less <<
NCT02399189 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Recruiting April 2019 China, Beijing ... More >> Lijuan Deng Recruiting Beijing, Beijing, China, 100142 Contact: Lijuan Deng, MD    1088196109    lijuan_deng@hotmail.com    Contact: Yuqin Song, MD    1088196109    songyuqin622@sina.com Less <<
NCT02396043 Lymphoma, Lymphoblastic Phase 2 Recruiting March 2020 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting GuangZhou, Guangdong, China, 510060 Contact: Zhongjun Xia, MD.    0086-02087342438    zhongjunxia_64@sina.com Less <<
NCT02475876 Bacterial Infections Phase 1 Active, not recruiting May 30, 2019 United States, Arkansas ... More >> Arkansas Children's Hospital Little Rock, Arkansas, United States, 72202 United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60611 United States, Michigan University of Michigan C.S. Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 Less <<
NCT00982111 - Suspended - -
NCT00982111 Non Small Cell Lung Cancer Phase 3 Suspended December 31, 2018 -
NCT03388528 Mitochondrial Diseases Not Applicable Recruiting September 7, 2018 United Kingdom ... More >> Grainne Gorman Recruiting Newcastle upon Tyne, Tyne And Wear, United Kingdom, NE2 4HH Contact: David Houghton, PhD    07729221941    david.houghton@ncl.ac.uk    Contact: Paula Hynd, BSc    0191 208 3084    paula.hynd@ncl.ac.uk Less <<
NCT02485548 Head and Neck Squamous Cell Ca... More >>ncer Less << Phase 3 Unknown June 2018 China, Jiangsu ... More >> Jiangsu Cancer Hospital Recruiting Nanjing, Jiangsu, China, 210009 Contact: Xuesong Jiang, M.D.       13851700790@126.com    Sub-Investigator: Xuesong Jiang, M.D. Less <<
NCT02419469 Leukemia Prec... More >>ursor-B Acute Lymphoblastic Leukemia Lymphoblastic Lymphoma Lymphoma Less << Phase 2 Terminated(Slow Accrual) - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02405676 Mature B-cell Non-Hodgkin Lymp... More >>homa Less << Phase 2 Phase 3 Recruiting December 2024 China, Sichuan ... More >> West China Second University Hospital of Sichuan University Recruiting Chengdu, Sichuan, China Contact: Yi-Ping Zhu, MD       zhuyiping@918.com    Contact: Xia Guo, MD       guoxkl@163.com Less <<
NCT02412670 Localized Urothelial Carcinoma... More >> of the Renal Pelvis and Ureter Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter Regional Urothelial Carcinoma of the Renal Pelvis and Ureter Less << Phase 2 Active, not recruiting - -
NCT02413047 Inflammatory Bowel Disease ... More >> Ulcerative Colitis Crohn's Disease Less << Not Applicable Recruiting December 2018 United States, Indiana ... More >> Indiana University Hospital Recruiting Indianapolis, Indiana, United States, 46062 Contact: Matthew Bohm, DO    317-948-4579    mbohm@iu.edu    Sub-Investigator: Monika Fischer, MD          Sub-Investigator: Sashi Sagi, MD Less <<
NCT02422641 Metastatic Breast Cancer ... More >> Leptomeningeal Disease Less << Phase 2 Recruiting April 2019 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Joy Fisher       jfisher@jhmi.edu    United States, Missouri Siteman Cancer Center- Washington University School of Medicine in St. Louis Recruiting Saint Louis, Missouri, United States, 63130 Contact: Jian Li Campain, MD    314-362-5677    campain.jian@wustl.edu    United States, North Carolina Comprehensive Cancer Center at Wake Forest University (CCCWFU) Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Cindy Miller       cytmill@wakehealth.edu Less <<
NCT02419469 - Terminated(Slow Accrual) - -
NCT02409342 Non-Squamous Non-Small Cell Lu... More >>ng Cancer, Squamous Non-Small Cell Lung Cancer Less << Phase 3 Active, not recruiting April 23, 2020 -
NCT02433184 Rheumatoid Arthritis Phase 4 Unknown August 2017 United Kingdom ... More >> Institute of Rheumatic & Musculoskeletal Medicine, Chapel Allerton Hospital Recruiting Leeds, West Yorkshire, United Kingdom, LS7 4SA Contact: Maya Buch    0113 392 3043    m.buch@leeds.ac.uk Less <<
NCT01812954 - Completed - -
NCT02220985 Accelerated Phase Chronic Myel... More >>ogenous Leukemia, BCR-ABL1 Positive Acute Biphenotypic Leukemia Acute Leukemia of Ambiguous Lineage Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Allogeneic Hematopoietic Stem Cell Transplantation Recipient Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Blastic Plasmacytoid Dendritic Cell Neoplasm Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Donor Lymphoblastic Lymphoma Myelodysplastic Syndrome With Excess Blasts Myelodysplastic Syndrome With Excess Blasts-1 Myelodysplastic Syndrome With Excess Blasts-2 Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Refractory Acute Lymphoblastic Leukemia Refractory Acute Myeloid Leukemia Less << Phase 2 Recruiting - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute (UPCI) Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Alison Sehgal    412-864-7764    sehgalar@upmc.edu    Principal Investigator: Alison Sehgal          United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Marie Bleakley    206-667-6572    mbleakle@fredhutch.org    Principal Investigator: Marie Bleakley Less <<
NCT02456844 Rheumatoid Arthritis Phase 1 Completed - -
NCT02458339 Brain Tumor, Recurrent ... More >> Malignant Neoplasm of Fourth Ventricle of Brain Less << Phase 1 Recruiting June 2019 United States, Texas ... More >> UTHealth & Children's Memorial Hermann Hospital Recruiting Houston, Texas, United States, 77030 Contact: Bangning Yu, RN, PhD    713-500-7363    Bangning.Yu@uth.tmc.edu    Principal Investigator: David I Sandberg, MD Less <<
NCT02453282 Non-Small-Cell Lung Carcinoma ... More >>NSCLC Less << Phase 3 Active, not recruiting December 31, 2019 -
NCT01722539 Healthy Phase 3 Completed - Congo ... More >> Mokali health area of Biyela health zone, in Kinshasa province. Kinshasa, Kinshasa province, Congo Less <<
NCT02208037 Acute Leukemia ... More >> Chronic Myelogenous Leukemia Myelodysplasia Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse Hodgkin's Lymphoma Less << Phase 2 Completed - -
NCT02478424 Graft vs Host Disease Phase 2 Unknown June 2017 -
NCT02480153 Rheumatoid Arthritis Phase 3 Completed - -
NCT02466581 Rheumatoid Arthritis Phase 4 Recruiting December 2021 Sweden ... More >> Karolinska Institutet Recruiting Stockholm, Sweden, 171 76 Contact: Ronald van Vollenhoven, MD, prof    +46(8)51776077    ronald.van.vollenhoven@ki.se    Contact: Monica Ryden Aulin, PhD    +46(8)51771110    monica.ryden.aulin@ki.se Less <<
NCT02477826 Non-Small Cell Lung Cancer Phase 3 Recruiting December 31, 2020 -
NCT02480946 Arthritis, Rheumatoid Phase 1 Completed - United Kingdom ... More >> Covance Royal Liverpool Clinical Research Unit,Royal Liverpool University Hospital Liverpool, Merseyside, United Kingdom, L7 8XP Covance Clinical Research Unit Ltd. Leeds, West Yorkshire, United Kingdom, LS2 9LH NIHR/Wellcome Trust Imperial Clinical Research Facility (CRF) London, United Kingdom, W12 0HS Less <<
NCT02451774 Acute Lymphoblastic Leukemia Phase 2 Phase 3 Recruiting December 2020 Mexico ... More >> Hospital Civil de Guadalajara "Dr. Juan I. Menchaca" Recruiting Guadalajara, Jalisco, Mexico, 44340 Contact: Ramon O Gonzalez Ramella, PhD    5213331719826    glezramella@hotmail.com    Contact: Fabiola P Medina Barajas, PhD    5213313461917    favyri@hotmail.com Less <<
NCT02265770 Childhood Ependymoma Phase 2 Phase 3 Recruiting August 2026 -
NCT02489903 Small Cell Carcinoma ... More >> Carcinoma, Non-Small-Cell Lung Neuroendocrine Tumors Ovarian Epithelial Cancer Less << Phase 2 Recruiting July 2020 United States, California ... More >> Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Melanie San Pedro-Salcedo    650-724-1388    msanpedro@stanford.edu    Principal Investigator: Sukhmani Padda, MD          United States, Connecticut VA Connecticut Cancer Center Recruiting West Haven, Connecticut, United States, 06516 Contact: Jessica Jordan    203-932-5711 ext 3287    jessica.jordan@va.gov    Principal Investigator: Michal Rose, MD          United States, Indiana Memorial Hospital of South Bend Recruiting South Bend, Indiana, United States, 46601 Contact: Amie Lake    574-647-6784    ALake@beaconhealthsystem.org    Contact: Mary Jane Danner    574-647-7309    MDanner@beaconhealthsystem.org    Principal Investigator: Thomas J Reid, MD, PhD          United States, Kentucky Baptist Health Recruiting Lexington, Kentucky, United States, 40503 Contact: Stephanie Cason    859-260-3197    stephanie.cason@bhsi.com    Contact: Micheal F Stephens    859-260-6456    micheal.stephens@BHSI.com    Principal Investigator: Arvinda Padmanabhan, MD          United States, Maryland Walter Reed National Military Medical Center Recruiting Bethesda, Maryland, United States, 20889 Contact: Sonja Skeete    301-319-4599    sonja.t.skeete.ctr@mail.mil    Principal Investigator: Karen Zeman, MD          United States, Michigan Henry Ford Allegiance Health Recruiting Jackson, Michigan, United States, 49201 Contact: Kris Strzalkowski, RN    517-205-1522    KSTRZAL1@hfhs.org    Contact: Natalie Peterson, RN OCN    (517) 205-1549    npeters8@hfhs.org    Principal Investigator: Malcolm Trimble, MD          United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Dan Blume    314-362-0872    dan.blume@wustl.edu    Principal Investigator: Daniel Morgensztern, MD          United States, Ohio University of Cincinnati Cancer Institute Recruiting Cincinnati, Ohio, United States, 45267 Contact: Lauren Hendricks    513-584-5725    hendrilu@ucmail.uc.edu    Principal Investigator: John C Morris, MD          United States, Tennessee University of Tennessee Medical Center Withdrawn Knoxville, Tennessee, United States, 37920 United States, Virginia Virginia Cancer Specialists Recruiting Fairfax, Virginia, United States, 22031 Contact: Karin Choquette, MSN, RN    703-208-9268    Karin.Choquette@USONCOLOGY.COM    Principal Investigator: Alexander Spira, MD          United States, West Virginia West Virginia University Recruiting Morgantown, West Virginia, United States, 26506 Contact: Carla Ross, RN    304-581-1158    cjross@hsc.wvu.edu    Principal Investigator: Patrick Ma, MD Less <<
NCT01042288 Non-Small-Cell Lung Cancer Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Ft. Myers, Florida, United States, 33916 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Georgia Medical Oncology Associates of Augusta Augusta, Georgia, United States, 30901 Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 Norton Cancer Institute Louisville, Kentucky, United States, 40207 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, New Hampshire Portsmouth Regional Hospital Portsmouth, New Hampshire, United States, 03801 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Oklahoma Cancer Centers of Southwest Oklahoma Lawton, Oklahoma, United States, 73505 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Less <<
NCT02480153 - Completed - -
NCT02518750 Acute Lymphoblastic Leukemia ... More >> Lymphoma, Non-Hodgkin's Leukemia, T-Cell Leukemia, B-Cell Less << Phase 2 Terminated(Due to slow accrual... More >>) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT02593903 Hypospadias Not Applicable Completed - United States, Wisconsin ... More >> Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT02593903 - Completed - -
NCT01042288 - Completed - -
NCT02594267 Peripheral T-Cell Lymphoma (PT... More >>CL) Less << Phase 1 Recruiting December 2018 United States, Washington ... More >> Seattle Cancer Care Alliance/University of Washington Recruiting Seattle, Washington, United States, 98109 Contact: Andrei Shustov, MD          Principal Investigator: Andrei Shustov, MD Less <<
NCT02523976 Acute,Leukemia, Lymphoid Phase 2 Enrolling by invitation August 2019 China, Tianjin ... More >> Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin, China, 300020 Less <<
NCT02528435 - Completed - -
NCT02531841 Diffuse Large B-cell-lymphoma Phase 3 Recruiting December 2019 Germany ... More >> University Hospital Freiburg - Department for Hematology, Oncology and Stem cell Transplantion Recruiting Freiburg, Baden-Wuerttemberg, Germany, 79106 Contact: Juergen Finke, PhD    +49761270 ext 34080    juergen.finke@uniklinik-freiburg.de    Contact: Elisabeth Schorb, PhD    +49761270 ext 33210    elisabeth.schorb@uniklinik-freiburg.de    Klinikum Stuttgart, Clinic of Hematology, Oncology and Palliative Care, Stuttgart Cancer Center / Tumor Center Eva Mayr-Stihl Recruiting Stuttgart, Baden-Wuerttemberg, Germany, 70174 Contact: Gerald Illerhaus, PhD    +49 711 278 ext 30400    G.Illerhaus@klinikum-stuttgart.de    Contact: Kristina Mikesch, PhD    +49 711 278 ext 30403    k.mikesch@klinikum-stuttgart.de Less <<
NCT02504268 Rheumatoid Arthritis Phase 3 Active, not recruiting March 20, 2020 -
NCT02486718 Non-Small Cell Lung Cancer Phase 3 Active, not recruiting September 25, 2026 -
NCT01773122 Acne Vulgaris Phase 1 Completed - United States, Texas ... More >> College Station, Texas, United States Less <<
NCT02535806 Acute Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Less << Phase 2 Terminated(Funding source disc... More >>ontinued) Less << - United States, Missouri ... More >> Children's Mercy Hospital Kansas City, Missouri, United States, 64108 Less <<
NCT01785836 Acne Vulgaris Phase 1 Withdrawn(Study was never init... More >>iated due to company decision. No study subjects were ever enrolled or dosed.) Less << October 2013 -
NCT01773122 - Completed - -
NCT02557100 Rheumatoid Arthritis Phase 4 Active, not recruiting April 5, 2019 -
NCT02624440 Multiple Myeloma ... More >> Infection Less << Phase 2 Unknown July 2017 Denmark ... More >> Department of Hematology, Aalborg University Hospital Recruiting Aalborg, Denmark, 9000 Principal Investigator: Henrik Gregersen, MD          Department of Hematology, Aarhus University Hospital Recruiting Aarhus, Denmark, 8000 Principal Investigator: Niels Frost Andersen, MD          Department of Hematology, Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Principal Investigator: Annette Juul Vangsted, MD          Department of Hematology, Esbjerg Sygehus Recruiting Esbjerg, Denmark, 6700 Principal Investigator: Per Trøllund Pedersen          Department of Hematology, Herlev Hospital Recruiting Herlev, Denmark, 2730 Principal Investigator: Carsten Helleberg, MD          Department of Hematology, Hospitalsenheden Vest Recruiting Holstebro, Denmark, 7500 Principal Investigator: Robert Schou Pedersen          Department of Hematology, Odense University Hospital Recruiting Odense, Denmark, 5000 Principal Investigator: Niels Abildgaard, MD          Department of Hematology, Roskilde Hospital Recruiting Roskilde, Denmark, 4000 Principal Investigator: Ulf Christian Frølund, MD Less <<
NCT02553018 Arthritis, Rheumatoid Phase 3 Completed - France ... More >> SARAUX Brest, France HUDRY Paris, France Less <<
NCT01088620 Carcinoma, Non-Small-Cell Lung Phase 2 Suspended(the DSMB stopped the... More >> trial due to unacceptable side effects in the experimental arm which has not yet been verified) Less << January 2014 Germany ... More >> Schwerpunktpraxis für Hämatologie und Internistische Onkologie, Gesundheitszentrum St. Marien GmbH Amberg, Germany, 92224 Universitätsklinikum Charité - Campus Mitte Berlin, Germany, 10117 Charité Campus Benjamin Franklin Medizinische Klinik m. S. Hämatologie und Onkologie Berlin, Germany, 12200 HELIOS Klinikum Emil von Behring - Lungenklinik Heckeshorn Berlin, Germany, 14165 Augusta-Kranken-Anstalt gGmbH Bochum, Germany, 44791 Johanniter-Krankenhaus Bonn Bonn, Germany, 53113 Carl-Thiem-Klinikum Cottbus gGmbH Cottbus, Germany, 03048 Medizinische Fakultät Carl Gustav Carus der Technischen Universität Dresden Medizinische Klinik 1 Dresden, Germany, 01307 Katholisches Klinikum Duisburg/St. Johannes-Hospital Duisburg, Germany, 47166 Klinikum Frankfurt (Oder) GmbH Frankfurt (Oder), Germany, 15236 Krankenhaus Großhansdorf GmbH Onkologischer Schwerpunkt Großhansdorf, Germany, 22927 Krankenhaus - Martha-Maria Halle-Dölau GmbH Halle/Saale, Germany, 06120 Universitätsklinikum Halle (Saale), Klinik und Poliklinik für Innere Medizin I Halle/Saale, Germany, 06120 Universitätsklinikum Jena, Klinik für Innere Medizin I Jena, Germany, 07740 Onkologische Schwerpunktpraxis Dr. Stauch Kronach, Germany, 96317 Kliniken der Stadt Köln, Krankenhaus Merheim Köln, Germany, 51109 UK-SH, Campus Lübeck, Med. Klinik III Lübeck, Germany, 23538 LMU-Klinikum der Universität München, Medizinische Klinik München-Innenstadt München, Germany, 80336 Oncologianova GmbH Recklinghausen, Germany, 45657 Uniklinikum Ulm, Klinik für Innere Medizin II, Pneumologie Ulm, Germany, 89081 Less <<
NCT02551575 Rheumatoid Arthritis Phase 2 Phase 3 Unknown December 2017 China, Beijing ... More >> Guang'anmen Hospital Bei Jing, Beijing, China, 100052 Less <<
NCT02631564 - Unknown December 2018 China, Shanghai ... More >> Fudan University Zhongshan Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: Bo Zhou, M.D,Ph.D    8621-18616880602 Less <<
NCT02568033 Non Small Cell Lung Cancer Early Phase 1 Unknown October 2017 United States, New Jersey ... More >> MD Anderson Cancer Center at Cooper Recruiting Camden, New Jersey, United States, 08103 Contact: Kim Krieger    856-735-6237 Less <<
NCT02542293 Non Small Cell Lung Carcinoma ... More >>NSCLC Less << Phase 3 Active, not recruiting March 29, 2019 -
NCT02576574 First Line Non-Small Cell Lung... More >> Cancer Less << Phase 3 Active, not recruiting September 5, 2024 -
NCT02578511 Acute Lymphoblastic Leukemia i... More >>n Complete Remission Lymphoblastic Lymphoma in Complete Remission Mixed Phenotype Acute Leukemia in Complete Remission Less << Phase 1 Withdrawn(No enrollment, anoth... More >>er competing study and difficult to find the right person to enroll on this study.) Less << - United States, Wisconsin ... More >> Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT02579564 Malignant Hydrothorax ... More >> Non Small Cell Lung Cancer Less << Phase 3 Unknown December 2018 -
NCT02590510 Meningeal Carcinomatosis Phase 4 Unknown - -
NCT02591615 Non-Small Cell Lung Cancer Phase 2 Recruiting December 2019 United States, California ... More >> UCSD Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Contact: Lyudmila Bazhenova, MD          Principal Investigator: Lyudmila Bazhenova          United States, Illinois The University of Chicago Medical Center Recruiting Chicago, Illinois, United States, 60637 Contact: Jyoti Patel, MD          Principal Investigator: Jyoti Patel          NorthShore University HealthSystem Recruiting Evanston, Illinois, United States, 60201 Contact: Thomas Hensing, MD          Principal Investigator: Thomas Hensing          United States, Iowa Medical Oncology & Hematology Associates Recruiting Des Moines, Iowa, United States, 50309 Contact: Robert Behrens, MD          Principal Investigator: Robert Behrens          United States, Maine EMMC Cancer Care Recruiting Brewer, Maine, United States, 04412 Contact: Antoine Harb, MD          Principal Investigator: Antoine Harb          United States, Maryland University of Maryland, Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Katherine Scilla, MD          Principal Investigator: Katherine Scilla          United States, Minnesota Metro MN Community Oncology Research Consortium Recruiting Minneapolis, Minnesota, United States, 55416 Contact: Arkadiusz Dudek, MD          Principal Investigator: Arkadiusz Dudek          United States, Missouri University of Missouri - Ellis Fischel Cancer Center Recruiting Columbia, Missouri, United States, 65212 Contact: Puja Nistala, MD          Principal Investigator: Puja Nistala          Missouri Baptist Medical Center Recruiting Saint Louis, Missouri, United States, 63131 Contact: Bryan Faller, MD          Principal Investigator: Bryan Faller          United States, Nebraska Nebraska Methodist Hospital Recruiting Omaha, Nebraska, United States, 68114 Contact: Robert Langdon, MD          Principal Investigator: Robert Langdon          United States, New Hampshire NH Oncology (Concord) Recruiting Concord, New Hampshire, United States, 03301 Contact: Douglas Weckstein, MD          Principal Investigator: Douglas Weckstein          NH Oncology Recruiting Hooksett, New Hampshire, United States, 03106 Contact: Douglas Weckstein, MD          Principal Investigator: Douglas Weckstein          Dartmouth Hitchcock Medical Center Recruiting Lebanon, New Hampshire, United States, 03756 Contact: Konstantin Dragnev, MD          Principal Investigator: Konstantin Dragnev          United States, New York Hematology Oncology Associates of Central New York, PC Recruiting East Syracuse, New York, United States, 13057 Contact: Jeffrey Kirshner, MD          Principal Investigator: Jeffrey Kirshner          SUNY Upstate Medical University Recruiting Syracuse, New York, United States, 13210 Contact: Stephen Graziano, MD          Principal Investigator: Stephen Graziano          United States, North Carolina Wake Forest Baptist Health Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: William Petty, MD          Principal Investigator: William Petty          United States, Ohio The Ohio State University Recruiting Columbus, Ohio, United States, 43210 Contact: Gregory Otterson, MD          Principal Investigator: Gregory Otterson          United States, Oklahoma University of Oklahoma Health Sciences Center Stephenson Cancer Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Raid Aljumaily, MD          Principal Investigator: Raid Aljumaily          United States, South Carolina Lexington Oncology/ Lexington Medical Center Recruiting West Columbia, South Carolina, United States, 29169 Contact: James Wells, MD          Principal Investigator: James Wells Less <<
NCT02591823 - Unknown May 2016 India ... More >> Columbia Asia Hospitals Recruiting Bangalore, Karnataka, India, 560055 Principal Investigator: Sharath Kumar, MBBS,MD,DNB Less <<
NCT01951885 Chronic Myelogenous Leukemia ... More >> Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Acute Biphenotypic Leukemia Myelodysplastic Syndrome Myeloproliferative Neoplasm Non-Hodgkin Lymphoma Hodgkins Disease Chronic Lymphocytic Leukemia Multiple Myeloma Less << Phase 3 Recruiting July 2019 United States, Ohio ... More >> University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Withdrawn Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Betty Hamilton, MD    216-444-2529    hamiltb2@ccf.org    Principal Investigator: Betty Hamilton, MD Less <<
NCT02604342 Non-small Cell Lung Cancer Phase 3 Completed - -
NCT02608112 - Completed - -
NCT02611037 Malignant Pleural Mesothelioma... More >> Mesothelioma Less << Phase 2 Recruiting December 2020 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 22612 Contact: Malesa Pereira    813-745-4090    malesa.pereira@moffitt.org    Contact: Bela Kis    813-745-8425    bela.kis@moffitt.org    Principal Investigator: Bela Kis, M.D., Ph.D.          Sub-Investigator: Scott Antonia, M.D.          Sub-Investigator: Ghassan El-Haddad, M.D.          Sub-Investigator: Jacques-Pierre Fontaine, M.D.          Sub-Investigator: Lary Robinson, M.D.          Sub-Investigator: Tawee Tanvetyanon, M.D.          Sub-Investigator: Benjamin Creelan, M.D.          Sub-Investigator: Junsung Choi, M.D.          Sub-Investigator: Daniel Jeong, M.D.          Sub-Investigator: Brian Morse, M.D. Less <<
NCT02604342 - Completed - -
NCT02611492 Philadelphia Chromosome Positi... More >>ve Adult Acute Lymphoblastic Leukemia Less << Phase 3 Recruiting December 2025 France ... More >> Hopital Saint Louis Recruiting Paris, France, 75010 Contact: Hervé Dombret, MDPhD    +33 (0)1 57 27 68 47    herve.dombret@aphp.fr Less <<
NCT02342145 Beta-Thalassemia Major Phase 4 Unknown December 2018 China, Fujian ... More >> Union hospital of fujian medical university Recruiting Fuzhou, Fujian, China, 350000 the zhongshan hospital of Xiamen University Recruiting Xia'men, Fujian, China, 361000 China, Guangxi The affiliated hospital of guangxi medical university Recruiting Nanning, Guangxi, China, 530021 Contact: yongrong lai, PhD    86-771-5356746    laiyongrong@263.net    China, Jiangsu Affiliated Drum Tower Hospital, Nanjing medical university Recruiting Nanjing, Jiangsu, China, 210000 China, Yunnan Kunming general hospital of chengdu military region Recruiting Kunming, Yunnan, China, 650000 Less <<
NCT02621333 Lung Adenocarcinoma Phase 2 Unknown September 2018 China, Henan ... More >> Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university Recruiting ZhengZhou, Henan, China, 450008 Contact: Quanli Gao, M.D.    +8615038171966    guaoquanli2015@126.com    Contact: Lingdi Zhao, M.D.    +8637165587483    lingdi1010@sohu.com    Principal Investigator: Quanli Gao, M.D. Less <<
NCT02623426 Uveitis Macul... More >>ar Edema Less << Phase 3 Recruiting July 2020 -
NCT02627417 Adult Immune Thrombocytopenia ... More >>(ITP) Dapsone Less << Phase 3 Recruiting May 2019 France ... More >> Henri Mondor Hospital Recruiting Creteil, France, 94010 Less <<
NCT02629159 Rheumatoid Arthritis Phase 3 Active, not recruiting August 10, 2020 -
NCT02631239 Extranodal NK/T-cell Lymphoma,... More >> Nasal Type Less << Phase 3 Recruiting November 2018 China, Shanghai ... More >> Ruijin Hospital Recruiting Shanghai, Shanghai, China, 200021 Contact: Weili Zhao, Prof    64370045 ext 610707    zhao.weili@yahoo.com    Contact: Pengpeng Xu, MD    64370045 ext 610707    xpproc@msn.com Less <<
NCT02641977 - Completed - Germany ... More >> Internistische und rheumatologische Praxis Gladbeck Gladbeck, Germany, 45964 Less <<
NCT02644044 To Evaluate the Effect of Ther... More >>apy With IT MTX on the Disease Course of Patients With Progressive MS Less << Early Phase 1 Unknown January 2018 -
NCT02251821 Primary Myelofibrosis ... More >> Secondary Myelofibrosis Less << Phase 2 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Rachel B. Salit    206-667-1317    rsalit@fredhutch.org    Principal Investigator: Rachel B. Salit Less <<
NCT01870050 Lichen Simples Chronicus and P... More >>rurigo Less << Not Applicable Not yet recruiting November 2019 United States, Illinois ... More >> J H Stroger Hospital of Cook County Not yet recruiting Chicago, Illinois, United States, 60612 Contact: Joerg Albrecht, MD    312-864-4480    jalbrecht@cookcountyhhs.org    Principal Investigator: Joerg Albrecht          Sub-Investigator: Warren Piette, MD Less <<
NCT02574078 Non-Small Cell Lung Cancer Phase 1 Phase 2 Active, not recruiting April 15, 2019 -
NCT02222493 Rheumatoid Arthritis Phase 3 Completed - -
NCT02638948 Rheumatoid Arthritis Phase 2 Completed - -
NCT02654587 Non Small Cell Lung Cancer Phase 3 Recruiting December 2021 -
NCT02647762 Rheumatoid Arthritis Phase 3 Recruiting June 2019 Bosnia and Herzegovina ... More >> Can-Fite Investigational Site #252 Not yet recruiting Banja Luka, Bosnia and Herzegovina Contact: Study Coordinator          Can-Fite Investigational Site #253 Not yet recruiting Mostar, Bosnia and Herzegovina Contact: Study Coordinator          Can-Fite Investigational Site #251 Not yet recruiting Sarajevo, Bosnia and Herzegovina Contact: Study Coordinator          Can-Fite Investigational Site #254 Not yet recruiting Sarajevo, Bosnia and Herzegovina Contact: Study Coordinator          Can-Fite Investigational Site #255 Not yet recruiting Tuzla, Bosnia and Herzegovina Contact: Study Coordinator          Canada Can-Fite Investigational Site #751 Recruiting Barrie, Canada Contact: Study Coordinator          Israel Can-Fite Investigational Site #309 Recruiting Ashkelon, Israel Contact: Study Coordinator          Can-Fite Investigational Site #302 Recruiting Haifa, Israel Contact: Study Coordinator          Moldova, Republic of Can-Fite Investigational Site #581 Recruiting Chisinau, Moldova, Republic of Contact: Study Coordinator          Can-Fite Investigational Site #582 Recruiting Chisinau, Moldova, Republic of Contact: Study Coordinator          Can-Fite Investigational Site #583 Recruiting Chisinau, Moldova, Republic of Contact: Study Coordinator          Poland Can-Fite Investigational Site #401 Not yet recruiting Białystok, Poland Contact: Study Coordinator          Can-Fite Investigational Site #402 Not yet recruiting Bochnia, Poland Contact: Study Coordinator          Can-Fite Investigational Site #403 Not yet recruiting Poznań, Poland Contact: Study Coordinator          Can-Fite Investigational Site #404 Not yet recruiting Szczecin, Poland Contact: Study Coordinator          Can-Fite Investigational Site #405 Not yet recruiting Zamość, Poland Contact: Study Coordinator          Romania Can-Fite Investigational Site #559 Not yet recruiting Brăila, Romania Contact: Study Coordinator          Can-Fite Investigational Site #551 Not yet recruiting Bucuresti, Romania Contact: Study Coordinator          Can-Fite Investigational Site #552 Not yet recruiting Bucuresti, Romania Contact: Study Coordinator          Can-Fite Investigational Site #553 Not yet recruiting Bucuresti, Romania Contact: Study Coordinator          Can-Fite Investigational Site #556 Not yet recruiting Bucuresti, Romania Contact: Study Coordinator          Can-Fite Investigational Site #558 Not yet recruiting Constanţa, Romania Contact: Study Coordinator          Can-Fite Investigational Site #557 Not yet recruiting Craiova, Romania Contact: Study Coordinator          Can-Fite Investigational Site #560 Not yet recruiting Iaşi, Romania Contact: Study Coordinator          Can-Fite Investigational Site #561 Not yet recruiting Iaşi, Romania Contact: Study Coordinator          Can-Fite Investigational Site #555 Not yet recruiting Oradea, Romania Contact: Study Coordinator          Can-Fite Investigational Site #554 Not yet recruiting Timişoara, Romania Contact: Study Coordinator          Serbia Can-Fite Investigational Site #211 Not yet recruiting Belgrad, Serbia Contact: Study Coordinator          Can-Fite Investigational Site #212 Not yet recruiting Belgrad, Serbia Contact: Study Coordinator          Can-Fite Investigational Site #216 Not yet recruiting Leskovac, Serbia Contact: Study Coordinator          Can-Fite Investigational Site #215 Not yet recruiting Niš, Serbia Contact: Study Coordinator          Can-Fite Investigational Site #213 Not yet recruiting Novi Sad, Serbia Contact: Study Coordinator          Can-Fite Investigational Site #217 Not yet recruiting Vranje, Serbia Contact: Study Coordinator          Can-Fite Investigational Site #214 Not yet recruiting Šabac, Serbia Contact: Study Coordinator Less <<
NCT02655705 Psoriasis Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, KS009 Less <<
NCT02660762 Leukaemia,Lymphoblastic Phase 2 Recruiting January 2019 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting GuangZhou, Guangdong, China, 510060 Contact: yue lu, MD.    0086-02087342438    dr_luyue@sina.com Less <<
NCT03389555 Sepsis Septic... More >> Shock Metabolic Disturbance Less << Phase 2 Phase 3 Recruiting September 30, 2019 United States, Arizona ... More >> Mayo Clinic - Arizona Not yet recruiting Phoenix, Arizona, United States, 85054 Contact: Ayan Sen, MD          United States, Massachusetts Brigham and Women's Hospital Not yet recruiting Boston, Massachusetts, United States, 02115 Contact: Peter Hou, MD          Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Ari Moskowitz, MD    617-754-3464    amoskowitz@bidmc.harvard.edu    Contact: Jocelyn Portmann    617-754-2881    jportman@bidmc.harvard.edu    Principal Investigator: Michael W Donnino, MD          Mount Auburn Hospital Not yet recruiting Cambridge, Massachusetts, United States, 02138 Contact: Jessica McCannon, MD          United States, Michigan Detroit Receiving Hospital Not yet recruiting Detroit, Michigan, United States, 48201 Contact: Robert Sherwin, MD          Harper University Hospital Not yet recruiting Detroit, Michigan, United States, 48201 Contact: Robert Sherwin, MD          Henry Ford Hospital Not yet recruiting Detroit, Michigan, United States, 48202 Contact: Bruno DiGiovine, MD          Sinai Grace Hospital Not yet recruiting Detroit, Michigan, United States, 48235 Contact: Robert Sherwin, MD          Beaumont Hospital Recruiting Royal Oak, Michigan, United States, 48073 Contact: Ronald Otero, MD          United States, New York North Shore University Hospital Recruiting Manhasset, New York, United States, 11030 Contact: Jonathan Gong, MD          Long Island Jewish Hospital Recruiting New York, New York, United States, 11040 Contact: Lance Becker, MD          United States, Pennsylvania University Of Pittsburgh Medical Center Not yet recruiting Pittsburgh, Pennsylvania, United States, 15213 United States, Texas The University of Texas Health Science Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Pratik Doshi, MD Less <<
NCT02663622 Acute Myeloid Leukemia (AML) ... More >> Chronic Myelogenous Leukemia (CML) Myelodysplastic Syndrome (MDS) Chronic Myelomonocytic Leukemia (CMML) Less << Phase 2 Active, not recruiting August 2022 United States, Indiana ... More >> Indiana University School of Medicine Indianapolis, Indiana, United States, 46202 United States, Michigan The University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT02734732 Prostate Infection Phase 2 Unknown May 2017 Sweden ... More >> Östersunds hospital Not yet recruiting Östersund, Jämtland, Sweden, 83130 Contact: Karl-Johan Lundström       karl_johan@hotmail.com    Sundsvalls hospital Recruiting Sundsvall, Västernorrland, Sweden Contact: Johan Styrke, MD    0046-70-2992048    johan.styrke@umu.se    Helsingborgs Hospital Not yet recruiting Helsingborg, Sweden, 25187 Contact: Magnus Wagenius, M.D          Umea University Hospital Recruiting Umea, Sweden, 90185 Contact: Jon Fridriksson, MD       jon.fridriksson@umu.se    Ängelholm hospital Not yet recruiting Ängelholm, Sweden, 26281 Contact: Magbus Wagenius, M.D Less <<
NCT02662634 Non-small Cell Lung Cancer (NS... More >>CLC) Less << Phase 2 Unknown March 2018 United States, Nebraska ... More >> Cancer Research Network of Nebraska / Oncology Associates Recruiting Omaha, Nebraska, United States, 68118 Contact: Tony Romero, MS, CCRC    402-697-2229    tromero@gucancer.com    Principal Investigator: Stephen Lemon, MD Less <<
NCT00717808 Rheumatoid Arthritis Phase 1 Withdrawn(Due to unforeseen ci... More >>rcumstances this study will not now start.) Less << September 2009 -
NCT02222493 - Completed - -
NCT01170871 Advanced Solid Tumors Phase 1 Withdrawn(Sponsor withdrew sup... More >>port) Less << - United States, California ... More >> Los Angeles County+University of Southern California Medical Center Los Angeles, California, United States, 90033 USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT02660684 Graft Versus Host Disease Phase 4 Completed - Korea, Republic of ... More >> Daegu, Gyeongsangnam-do, Korea, Republic of Hwasun-gun, Jeonranam-do, Korea, Republic of Seoul, Korea, Republic of Less <<
NCT02690922 ph+ Acute Lymphoblastic Leukem... More >>ia Less << Phase 4 Unknown May 2017 China, Hubei ... More >> Tongji hospital Enrolling by invitation Wuhan, Hubei, China, 430000 Less <<
NCT02684071 Recurrent Childhood Medullobla... More >>stoma Recurrent Childhood Ependymoma Childhood Atypical Teratoid/Rhabdoid Tumor Embryonal Tumor With Abundant Neuropil and True Rosettes Metastatic Malignant Neoplasm to the Leptomeninges Less << Phase 2 Recruiting February 2020 United States, Florida ... More >> Nicklaus Children's Hospital Recruiting Miami, Florida, United States, 33155 Contact: Ziad A Khatib, MD    305-662-8386    ziad.khatib@mch.com    Contact: Matthew Bittle, Supervisor    786-624-2838    matthew.bittle@nicklaushealth.org    Sub-Investigator: John Ragheb, MD          Sub-Investigator: Guillermo De Angulo, MD          Sub-Investigator: Sanjiv Bhatia, MD          Sub-Investigator: Toba Niazi, MD          Sub-Investigator: David Sandberg, MD          Sub-Investigator: Ana Diaz, ARNP          Principal Investigator: Ziad A Khatib, MD Less <<
NCT02693210 Rheumatoid Arthritis Phase 2 Completed - -
NCT02706873 Rheumatoid Arthritis Phase 3 Active, not recruiting March 28, 2021 -
NCT02481310 Adult Burkitt Lymphoma ... More >> B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma Diffuse Large B-Cell Lymphoma MYC Gene Mutation Plasmablastic Lymphoma Less << Phase 1 Phase 2 Recruiting July 2020 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Barbara Pro, MD    312-695-6180       Principal Investigator: Barbara Pro, MD          United States, Massachusetts Tufts University Recruiting Medford, Massachusetts, United States, 02155 Contact: Andreas Klein, MD    617-636-2694       Principal Investigator: Andreas Klein, MD          United States, New Jersey Rutgers Cancer Institute of New Jersey Recruiting New Brunswick, New Jersey, United States, 08901 Contact: Andrew Evens, DO, MSc          Principal Investigator: Andrew Evens, DO, MSc          United States, Ohio Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: Deepa Jagadeesh, MD    216-445-6503       Principal Investigator: Deepa Jagadeesh, MD          United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Mehdi Hamadani, MD    414-805-0505       Principal Investigator: Mehdi Hamadani, MD Less <<
NCT02706951 Rheumatoid Arthritis Phase 3 Active, not recruiting August 7, 2020 -
NCT02714634 Rheumatoid Arthritis ... More >> Insufficient Response to Methotrexate. Less << Phase 4 Not yet recruiting February 2020 -
NCT02714998 Ectopic Pregnancy ... More >> Infertility Less << Not Applicable Completed - Turkey ... More >> Ege University School of Medicine Department of Obstetrics and Gynecology Izmir, Turkey, 35100 Less <<
NCT02715908 Rheumatoid Arthritis Phase 3 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT02504359 Plasma Cell Leukemia ... More >> Recurrent Plasma Cell Myeloma Less << Phase 1 Recruiting July 1, 2021 United States, North Carolina ... More >> Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Cristina Gasparetto    919-668-1017    cristina.gasparetto@duke.edu    Principal Investigator: Cristina Gasparetto          United States, Oregon OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Emma C. Scott    503-494-2398    scottem@ohsu.edu    Principal Investigator: Emma C. Scott Less <<
NCT02722694 Rheumatoid Arthritis (RA) Phase 3 Unknown December 2017 China, Beijing ... More >> Peking union medical college hospital Recruiting Beijing, Beijing, China Contact: Xiaofeng Zeng    86-10-69158793    xiaofeng.zeng@cstar.org.cn Less <<
NCT02698657 Rheumatoid Arthritis (RA) Phase 1 Completed - United States, Alabama ... More >> Site US10002 Anniston, Alabama, United States, 36207 United States, Florida Site US10008 DeBary, Florida, United States, 32713-1818 Site US10004 Jacksonville, Florida, United States, 32216 Site US10009 Miami Lakes, Florida, United States, 33014 United States, Pennsylvania Site US10003 Duncansville, Pennsylvania, United States, 16635 United States, Tennessee Site US10010 Memphis, Tennessee, United States, 38119 United States, Texas Site US10001 Dallas, Texas, United States, 75231 Poland Site PL48009 Elblag, Poland, 82-300 Site PL48011 Krakow, Poland, 31-637 Site PL48006 Lodz, Poland, 91-347 Site PL48007 Stalowa Wola, Poland Site PL48003 Warszawa, Poland, 00-660 Site PL48008 Wroclaw, Poland, 50-556 Less <<
NCT02710734 Urothelial Carcinoma of the Bl... More >>adder Less << Phase 2 Recruiting April 2023 United States, Pennsylvania ... More >> Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Daniel Geynisman, MD    215-728-4300    daniel.geynisman@fccc.edu    Principal Investigator: Daniel Geynisman, MD Less <<
NCT02715947 Psoriasis Vulgaris Phase 2 Unknown December 2017 China, Hunan ... More >> Xiangya Hospital Central South University Recruiting Changsha, Hunan, China, 410008 Contact: Yijing He, MD, PhD    +86-1587481262    yijinghe@gmail.com Less <<
NCT02710396 Carcinoma, Non-Small-Cell Lung... More >> Cancer of the Head and Neck Urinary Bladder Neoplasms Esophageal Squamous Cell Carcinoma Carcinoma, Transitional Cell Less << Phase 2 Recruiting March 31, 2023 United States, Connecticut ... More >> Yale Cancer Center Not yet recruiting New Haven, Connecticut, United States, 06510 Contact: Roy Herbst, MD    203-785-6879    roy.herbst@yale.edu    Principal Investigator: Roy Herbst, MD          United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Not yet recruiting Baltimore, Maryland, United States, 21231 Contact: Julie Brahmer, MD    410-502-7159    brahmju@jhmi.edu    Principal Investigator: Julie Brahmer, MD          United States, New York Laura & Isaac Perlmutter Cancer Center at NYU Langone Not yet recruiting New York, New York, United States, 10016 Contact: Leena Gandhi, MD, PhD       Leena.Gandhi@nyumc.org    Principal Investigator: Leena Gandhi, Md, PhD          Columbia University Recruiting New York, New York, United States, 10032 Contact: Anurita Sadhu, BA    212-342-3747    as5055@cumc.columbia.edu    Contact: Sara Marcus, MPH    (212) 304-5579    sm4100@columbia.edu    Sub-Investigator: Catherine Shu, MD          Sub-Investigator: Mark Stoopler, MD          Principal Investigator: Naiyer Rizvi, MD          United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Hossein Borghaei, DO    215-728-6900    Hossein.Borghaei@fccc.edu    Principal Investigator: Hossein Borghaei, DO Less <<
NCT02087696 Arthritis, Rheumatoid Phase 4 Unknown July 2016 Spain ... More >> Hospital Universitario Araba (Sede Txagorritxu) Active, not recruiting Vitoria-Gasteiz, Alava, Spain, 01009 Hospital del la Agencia Valenciana de Salud Vega Baja Recruiting Orihuela, Alicante, Spain, 03314 Principal Investigator: María Isabel Tevar          Hospital Universitari de Bellvitge Active, not recruiting Hospitalet de Llobregat, Barcelona, Spain, 08907 Hospital Universitario Marques de Valdecilla Active, not recruiting Santander, Cantabria, Spain, 39008 Hospital Can Misses Recruiting Ibiza, Islas Baleares, Spain, 07800 Principal Investigator: Ana Urruticoechea          Hospital Universitari Son Espases Active, not recruiting Mallorca, Islas Baleares, Spain, 07120 Hospital Universitario de Canarias Recruiting San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain, 38320 Principal Investigator: Sagrario Bustabad          Hospital de Sagunto Recruiting Sagunto, Valencia, Spain, 46520 Principal Investigator: Antonio Gracia          Hospital Galdakao-Usansolo Active, not recruiting Galdácano, Vizcaya, Spain, 48960 Hospital Universitari Vall d´Hebron Recruiting Barcelona, Spain, 08035 Principal Investigator: Sara Marsal Barril, MD; PhD          Hospital Universitario Puerta del Mar Active, not recruiting Cádiz, Spain, 11009 Hospital Universitario Reina Sofía Recruiting Córdoba, Spain, 14004 Principal Investigator: Eduardo Collantes          Hospital San Cecilio Recruiting Granada, Spain, 18012 Principal Investigator: Enrique Raya          Hospital Universitario de Guadalajara Active, not recruiting Guadalajara, Spain, 19002 Complejo hospitalario Universitario de A Coruña Recruiting La Coruña, Spain, 15006 Principal Investigator: Francisco Blanco          Complejo Asistencial Universitario de León Active, not recruiting León, Spain, 24080 Hospital Universitario de La Princesa Recruiting Madrid, Spain, 28006 Principal Investigator: Rosario García de Vicuña          Hospital Civil Recruiting Málaga, Spain, 29009 Principal Investigator: María Ángeles Belmonte, MD          Hospital Clínico Universitario de Valencia Recruiting Valencia, Spain, 46010 Principal Investigator: Pilar Trenor          Hospital Universitario Dr. Peset Recruiting Valencia, Spain, 46017 Principal Investigator: Juan José Alegre Less <<
NCT02097173 Psoriasis Phase 1 Completed - United States, Texas ... More >> Clinical Trials of Texas, Inc. San Antonio, Texas, United States, 78229 Less <<
NCT02097264 Inflammation ... More >>Rheumatoid Arthritis Less << Phase 2 Withdrawn September 2015 -
NCT02097745 Rheumatoid Arthritis Phase 3 Completed - -
NCT01885910 Acne Vulgaris Phase 4 Completed - United States, Kentucky ... More >> DermResearch, PLLC Louisville, Kentucky, United States, 40217 Less <<
NCT01885910 - Completed - -
NCT01481545 Rectal Cancer Phase 2 Unknown July 2018 -
NCT02105636 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 3 Active, not recruiting October 27, 2020 -
NCT02105636 - Active, not recruiting - -
NCT00769600 Recurrent Non Small Cell Lung ... More >>Cancer Less << Phase 2 Terminated(Low accrual.) - United States, Maryland ... More >> Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 Singapore Singapore General Hospital Jalan Tan Tock Seng, Singapore, 308433 Less <<
NCT02115204 Breast Cancer Phase 3 Completed - Germany ... More >> Ev. Hospital Bethesda Moenchengladbach, Germany, 41061 Less <<
NCT02122081 Adult Acute Lymphoblastic Leuk... More >>emia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Less << Not Applicable Recruiting November 2018 United States, Ohio ... More >> Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Recruiting Columbus, Ohio, United States, 43210 Contact: Nicholas Voss       Nicholas.Voss@osumc.edu    Principal Investigator: Meng X. Welliver, MD Less <<
NCT02097745 - Completed - -
NCT02125266 Uveitis, Posterior ... More >> Uveitis, Intermediate Less << Phase 1 Phase 2 Terminated(Study terminated du... More >>e to unacceptable frequency of drug related adverse events) Less << - United States, Colorado ... More >> Golden, Colorado, United States United States, Georgia Atlanta, Georgia, United States United States, Nebraska Omaha, Nebraska, United States United States, Ohio Cleveland, Ohio, United States United States, Texas Arlington, Texas, United States Less <<
NCT02117024 Non Small Cell Lung Cancer Phase 2 Active, not recruiting September 2018 United States, Arkansas ... More >> Highlands Oncology Group Rogers, Arkansas, United States, 72758 United States, California University of California San Diego La Jolla, California, United States, 92093 University of California at Los Angeles Los Angeles, California, United States, 90029 University of California Davis Sacramento, California, United States, 95817 United States, Georgia Georgia Regents University Augusta, Georgia, United States, 30912 United States, Maryland University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Massachusetts University of Massachusetts Worcester, Massachusetts, United States, 01655 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York SUNY Syracuse Syracuse, New York, United States, 13210 United States, Ohio Gabrail Cancer Center Canton, Ohio, United States, 44718 United States, Oregon Providence Portland Medical Center- Providence Lung Cancer Clinic Portland, Oregon, United States, 97213 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas Texas Oncology PA Texas Cancer Center Abilene, Texas, United States, 79606 Mary Crowley Cancer Center Dallas, Texas, United States, 75201 United States, Washington Cancer Care Northwest Spokane, Washington, United States, 99216 United States, Wisconsin Aurora Research Institute Green Bay, Wisconsin, United States, 54311 Less <<
NCT02124148 Neoplasm Metastasis ... More >> Colorectal Neoplasms Breast Cancer Less << Phase 1 Recruiting February 27, 2020 United States, Florida ... More >> Florida Cancer Specialists Recruiting Sarasota, Florida, United States, 34232 Contact    9413779993       Principal Investigator: Manish Rajni Patel          United States, Oklahoma University of Oklahoma Health Sciences Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact    405-271-4022       Principal Investigator: Kathleen Moore          United States, Tennessee Sarah Cannon Research Institute SCRI Recruiting Nashville, Tennessee, United States, 37203 Contact    615-329-7615       Principal Investigator: SMO Sarah Cannon Research Inst.          Tennessee Oncology PLLC Recruiting Nashville, Tennessee, United States, 37203 Contact    6153297274       Principal Investigator: Johanna Chock Bendell          United States, Texas University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact    713-563-5844       Principal Investigator: David S Hong Less <<
NCT02188472 Oxidative Stress Phase 1 Completed - Denmark ... More >> Department of Clinical Pharmacology Copenhagen, Denmark, 2100 Less <<
NCT02735317 Nasopharyngeal Neoplasms ... More >> Stomatitis Less << Phase 2 Unknown June 2017 China, Guangdong ... More >> Department of Radiation Oncology, Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT02114229 Malignant Rhabdoid Tumor ... More >> Atypical Teratoid Rhabdoid Tumor Less << Phase 2 Recruiting May 2027 United States, California ... More >> Children's Hospital of Los Angeles Withdrawn Los Angeles, California, United States, 90027 Lucille Packard Children's Hospital at Stanford University Medical Center Recruiting Palo Alto, California, United States, 94304 Contact: Sonia Partap, MD    650-723-0993    spartap@stanford.edu    Principal Investigator: Sonia Partap, MD          Rady Children's Hospital Recruiting San Diego, California, United States, 92123 Contact: John Crawford, MD, MS    858-576-1700    jcrawford@rchsd.org    Principal Investigator: John Crawford, MD, MS          United States, Colorado Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Kathleen Dorris, MD    720-777-6672    kathleen.dorris@childrenscolorado.org    Principal Investigator: Kathleen Dorris, MD          United States, District of Columbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Lindsay B. Kilburn, MD    202-476-2800    lkilburn@childrensnational.org    Principal Investigator: Lindsay B. Kilburn, MD          United States, Florida UF Cancer Center at Orlando Health Recruiting Orlando, Florida, United States, 32806 Contact: Amy A. Smith, MD    321-841-7246    amy.smith@orlandohealth.com    Principal Investigator: Amy A. Smith, MD          United States, Georgia Children's Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30322 Contact: Sindy Moon    404-785-1441    cindy.moon@choa.org    Contact: Jaclyn Smith    404-785-0692    jaclyn.smith@choa.org    Principal Investigator: Dolly Aguilera, MD          United States, Minnesota Children's Hospital and Clinics of Minnesota Recruiting Minneapolis, Minnesota, United States, 55102 Contact: Anne Bendel, MD    651-220-6732    anne.bendel@childrensmn.org    Principal Investigator: Anne Bendel, MD          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tabatha E. Doyle, RN    901-595-2544    tabatha.doyle@stjude.org    Principal Investigator: Santhosh Upadhyaya, MD          United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Patricia Baxter, MD    832-824-1000    pabaxter@txch.org    Principal Investigator: Patricia Baxter, MD          United States, Washington Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 Contact: Sarah Leary, MD    866-987-2000    sarah.leary@seattlechildrens.org    Principal Investigator: Sarah Leary, MD Less <<
NCT02133599 ALL Not Applicable Active, not recruiting September 30, 2018 United States, Illinois ... More >> Ann & Robert H. Lurie Children's Hosptial of Chicago Chicago, Illinois, United States, 60611 Less <<
NCT02129699 Lung Cancer Non-small Cell Sta... More >>ge IV Less << Phase 3 Active, not recruiting September 2020 -
NCT02129582 Acute Myeloid Leukemia ... More >> Hematologic Malignancies Acute Lymphocytic Leukemia Non Hodgkin Lymphoma Hodgkin Lymphoma Multiple Myeloma Myelodysplastic Syndrome Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Myelofibrosis Myeloproliferative Syndrome Less << Phase 1 Recruiting May 2019 United States, Ohio ... More >> University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44106-5065 Contact: Paolo F. Caimi    216-844-0139    paolo.caimi@case.edu    Principal Investigator: Paolo F. Caimi Less <<
NCT02141100 Non-Hodgkin Lymphoma Phase 1 Phase 2 Withdrawn October 2016 Denmark ... More >> Dept. of Pediatric Oncology, JMC, Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT02141997 Rheumatoid Arthritis Phase 2 Completed - -
NCT02141997 - Completed - -
NCT02142738 Non-Small Cell Lung Carcinoma Phase 3 Active, not recruiting May 31, 2019 -
NCT02143414 Acute Lymphoblastic Leukemia ... More >> B Acute Lymphoblastic Leukemia B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Philadelphia Chromosome Positive Recurrent Adult Acute Lymphoblastic Leukemia Refractory Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 2 Recruiting - -
NCT02147587 Rheumatoid Arthritis Phase 2 Completed - -
NCT02758990 Obesity Rhini... More >>tis Rhinitis, Allergic Respiratory Sounds Dyspnea Headache Migraine Disorders Arthritis Arthralgia Anxiety Sleep Initiation and Maintenance Disorders Sleep Deprivation Less << Not Applicable Terminated(Recruiting and fina... More >>ncial constraints) Less << - United States, Texas ... More >> Verifomics, LLC Dallas, Texas, United States, 75219 Less <<
NCT02147587 - Completed - -
NCT01336933 Anaplastic Large Cell Lymphoma... More >> Angioimmunoblastic T-cell Lymphoma Hepatosplenic T-cell Lymphoma Peripheral T-cell Lymphoma Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, California Stanford University Stanford, California, United States, 94305 United States, Georgia Emory University School Of Medicine Atlanta, Georgia, United States, 30308 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts University of Massachusetts Medical School Worcester, Massachusetts, United States, 01655 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Siteman Cancer Center at Washington University Saint Louis, Missouri, United States, 63110 United States, Nebraska UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6805 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT02142738 - Active, not recruiting - -
NCT02145078 Recurrent Non-small Cell Lung ... More >>Cancer Stage IV Non-small Cell Lung Cancer Less << Not Applicable Terminated(Slow accrual.) - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT02152696 Persistent Pregnancy of Unknow... More >>n Location Ectopic Pregnancy Less << Phase 3 Recruiting June 2019 United States, California ... More >> University of California San Francisco Recruiting San Francisco, California, United States, 94115 Contact: Rebecca Wong    415-353-4305    rebecca.wong@ucsf.edu    Contact: Nik Lenhart    415-885-3598    lenhartn@obgyn.ucsf.edu    Principal Investigator: Marcelle Cedars, MD          Sub-Investigator: Mitchell Rosen, MD          United States, Colorado Denver Health Recruiting Denver, Colorado, United States, 80204 Contact: Rachel Holm    303-602-9086    rachel.holm@dhha.org    Principal Investigator: Meredith Alston, MD          United States, Connecticut Yale University Recruiting New Haven, Connecticut, United States, 06520 Contact: Yonghee Cho, MD       yonghee.cho@yale.edu    Principal Investigator: Linda Fan, MD          United States, Florida University of South Florida Recruiting Tampa, Florida, United States, 33606 Contact: Linda Odibo    813-259-0655    lodibo@health.usf.edu    Principal Investigator: Shayne Plosker, MD          United States, Georgia Augusta University Recruiting Augusta, Georgia, United States, 30912 Contact: Candelario (Andy) Laserna    706-721-9680    claserna@augusta.edu    Principal Investigator: Michael Diamond, MD          United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Jared Robins, MD    312-926-8244    jared.robins@northwestern.edu    Principal Investigator: Jared Robins, MD          University Of Illinois at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: Susan Ferguson    312-355-4559    sfergu2@uic.edu    Principal Investigator: Mary Stephenson, MD          United States, Michigan Wayne State University Recruiting Southfield, Michigan, United States, 48034 Contact: Michelle Yoscovits    248-352-8200 ext 1032    mbrossoi@med.wayne.edu    Contact: Laure Cedo    248-352-8200 ext 1032    lcedo@med.wayne.edu    Principal Investigator: Puscheck Elizabeth, MD          United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63108 Contact: Caitlin Ashby, MD    314-286-2458    caitlin.ashby@wustl.edu    Principal Investigator: Emily Jungheim, MD          United States, New York University of Rochester Recruiting Rochester, New York, United States, 14642 Contact: Lynda Kochman    585-273-2995    lynda_kochman@urmc.rochester.edu    Principal Investigator: Kathy Hoeger, MD          United States, North Carolina University of North Carolina Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Jaslyn Grullon    919-843-8246    jaslyn_grullon@med.unc.edu    Principal Investigator: Anne Steiner, MD, MPH          Carolinas Medical Center - Women's Institute Recruiting Charlotte, North Carolina, United States, 28204 Contact: Kathy Ramsey    704-355-2949    kathleen.ramsey@carolinashealthcare.org    Principal Investigator: Rebecca Usadi, MD          United States, Oklahoma University of Oklahoma Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Michelle Starkey    405-271-1616    Michelle-Starkey@ouhsc.edu    Principal Investigator: Karl Hansen, MD, PhD          United States, Pennsylvania Pennsylvania State University Recruiting Hershey, Pennsylvania, United States, 17033 Contact: Patsu Rawa    717-531-3692    prawa@pennstatehealth.psu.edu    Principal Investigator: Richard Legro, MD          University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Wahid Youssef    215-615-4890    wahid.yousseff@uphs.upenn.edu    Sub-Investigator: Kurt Barnhart, MD, MSCE          Principal Investigator: Christos Coutifaris, MD, PhD          United States, South Carolina Greenville Health System Recruiting Greenville, South Carolina, United States, 29605 Contact: Allison Moore    864-455-6203    amoore@ghs.org    Principal Investigator: Benjie Mills, MD          United States, Utah University of Utah Recruiting Salt Lake City, Utah, United States, 84132 Contact: Kathryn Szczocta    801-581-7038    kathryn.szczocta@hsc.utah.edu    Principal Investigator: Erica Johnstone, MD Less <<
NCT02174354 - Unknown August 2018 United Kingdom ... More >> King's College London and Guys' and St Thomas' NHS Foundation Trust London, United Kingdom, SE1 9RT Less <<
NCT02171143 Rheumatoid Arthritis ... More >> Pharmacokinetics of ASP2409 Less << Phase 1 Completed - United States, Alabama ... More >> Pinnacle Research Group, LLC Anniston, Alabama, United States, 36027 United States, California West Coast Clinical Trials, LLC Costa Mesa, California, United States, 92626 United States, Florida Clinical Research of West Florida, Inc. Clearwater, Florida, United States, 33765 Riverside Clinical Research Edgewater, Florida, United States, 32132 United States, North Carolina Carolina Phase 1 Research Raleigh, North Carolina, United States, 27612 United States, Ohio Community Research Cincinnati, Ohio, United States, 45255 United States, Oklahoma Lynn Health Science Institute Oklahoma City, Oklahoma, United States, 73122 United States, Pennsylvania Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 United States, Texas Metroplex Clinical Research Center, LLC Dallas, Texas, United States, 75231 Texas Arthritis Research Center San Antonio, Texas, United States, 78217 Less <<
NCT01336933 - Completed - -
NCT02177695 Bladder Cancer Phase 2 Recruiting October 2022 -
NCT02177071 Crohn's Disease Phase 4 Recruiting December 2021 Australia ... More >> St Vincent Hospital Recruiting Melbourne, Australia Contact: NIK DONG, MD       Nik.DING@svha.org.au    Contact: Kylie Parker       kylie.PARKER@svha.org.au    Principal Investigator: NIK DONG          Belgium Gent University Hospital Recruiting Gent, Belgium, 9000 Contact: Martine DE VOS, MD,PhD    003292402371    martine.devos@uzgent.be    Principal Investigator: Martine DE VOS, MD,PhD          CHU LIEGE - Sart Tilman Recruiting Liege, Belgium, 4000 Contact: Edouard LOUIS, MD,PhD    +32436667889    Edouard.Louis@ulg.ac.be    Contact: Sylvie WERTZ    +32 4 366 74 39    swertz@chu.ulg.ac.be    Sub-Investigator: EDOUARD LOUIS, MD          France Chu Amiens Recruiting Amiens, France, 80054 Contact: Jean-Louis DUPAS, MD,PhD    +33 3 22 66 82 08    dupas.jean-louis@chu-amiens.fr    Contact: Martine LECONTE    +33 3 22 66 82 14       Principal Investigator: JEAN LOUIS DUPAS, MD          Chu Besancon Recruiting Besancon, France, 25030 Contact: LUCINE VUITON, MD          Principal Investigator: LUCINE VUITON, MD          Sub-Investigator: STEPHANE KOCH, MD          Caen Unversity Hospital Recruiting Caen, France, 14033 Sub-Investigator: STEPHANIE VIENNOT, MD          Chu Clermont-Ferrand Recruiting Clermont-ferrand, France, 63003 Contact: Gilles BOMMELAER, MD,PhD    +33473750523    gbommelaer@chu-clermontferrand.fr    Sub-Investigator: Gilles BOMMELAER, MD,PhD          Sub-Investigator: ANTONY BUISSON, MD          Hopital Beaujon Recruiting Clichy, France, 92110 Contact: Yoram BOUHNIK, MD,PhD    +33 1 40 87 56 00    yoram.bouhnik@bjn.aphp.fr    Principal Investigator: YORAM BOUHNIK, MD,PhD          Sub-Investigator: Alain ATTAR, MD          Sub-Investigator: Carmen STEFANESCU, MD          Sub-Investigator: Xavier TRETON, MD          Hopital Henri Mondor Not yet recruiting Creteil, France, 94010 Contact: Jean-Charles DELCHIER, MD,PhD    +33149812351    jean-charles.delchier@hmn.aphp.fr    Principal Investigator: Jean-Charles DELCHIER, MD,PhD          Sub-Investigator: Aurelien AMIOT, MD          Chu Kremlin Bicetre Recruiting Kremlin Bicetre, France Sub-Investigator: FRANCK CARBONNEL, MD          Hopital Bicetre Recruiting Le Kremlin Bicetre, France, 94275 Contact: Franck CARBONNEL, MD,PhD    +33 1 45 21 37 22    franck.carbonnel@bct.aphp.fr    Principal Investigator: Franck CARBONNEL, MD,PhD          Chu Lille Recruiting Lille, France Contact: Maria NACHURY, MD          Principal Investigator: Maria NACHURY, MD          Ch Le Raincy Montfermeil Withdrawn Montfermeil, France, 93370 Chu Montpellier Not yet recruiting Montpellier, France, 34295 Contact: ROMAIN ALTWEGG, MD    +33467337394       Sub-Investigator: ROMAIN ALTWEGG, MD          Principal Investigator: GUILLAUME PINETON DE CHAMBRUN, MD          Chu Nantes Recruiting Nantes, France, 44093 Contact: Arnaud BOURREILLE, MD    +33202400830    arnaud.boureille@chu-nantes.fr    Principal Investigator: Arnaud BOURREILLE, MD          Sub-Investigator: Mathurin FLAMANT, MD          CHU NICE Recruiting Nice, France, 06202 Contact: Xavier HEBUTERNE, MD,PhD    +33492066168    hebuterne.x@chu-nice.fr    Principal Investigator: Xavier HEBUTERNE, MD,PhD          Sub-Investigator: Jérome FILIPPI, MD          Hopital Saint Louis Recruiting Paris, France, 75010 Contact: Matthieu ALLEZ, MD, PhD    33 1 42 49 95 97    matthieu.allez@sls.aphp.fr    Principal Investigator: Mathieu ALLEZ, MD, PhD          Sub-Investigator: Jean-Marc GORNET, MD          Sub-Investigator: Clotilde BAUDRY, MD          Sub-Investigator: Joelle BONNET, MD          Hopital St Antoine Recruiting Paris, France, 75012 Contact: Jacques COSNES, MD, PhD    +33 1 49 28 31 70    jacques.cosnes@sat.aphp.fr    Sub-Investigator: Philippe SEKSIK, MD          Principal Investigator: Laurent BEAUGERIE, MD, PhD          Hopital Cochin Not yet recruiting Paris, France, 75014 Contact: Vered ABITBOL, MD    +33158411967    vered@club-internet.fr    Sub-Investigator: Stanislas CHAUSSADE, MD,PhD          Principal Investigator: Vered ABITBOL, MD          Hopital Saint Joseph Recruiting Paris, France, 75014 Contact: ELISE CHANTELOUP, MD       echanteloup@hpsj.fr    Principal Investigator: ELISE CHANTELOUP, MD          Montsouris Mutualist Institute Recruiting Paris, France, 75674 Sub-Investigator: ANTOINE BLAIN, MD          Sub-Investigator: Marion SIMON, MD          CHU Bordeaux - Pessac Recruiting Pessac, France, 33700 Contact: David LAHARIE, MD       david.laharie@chu-bordeaux.fr    Contact: Sylvie RAZAIRE       sylvie.razaire@chu-bordeaux.fr    Principal Investigator: David LAHARIE, MD          CHU LYON Recruiting Pierre Benite, France, 69495 Contact: Bernard FLOURIE, MD,PhD    +33478861288    bernard.flourie@chu-lyon.fr    Principal Investigator: Bernard FLOURIE, MD,PhD          Sub-Investigator: Stéphane NANCEY, MD          Chu Reims Active, not recruiting Reims, France Chu Rennes Recruiting Rennes, France, 35033 Contact: Guillaume BOUGUEN, MD    +33299284347    guillaume.bouguen@chu-rennes.fr    Sub-Investigator: Laurent SIPROUDHIS, MD,PhD          Principal Investigator: GUILLAUME BOUGUEN, MD          Chu Rouen Not yet recruiting Rouen, France, 76031 Contact: Eric LEREBOURS, MD,PhD    +33232888101    eric.lerebours@chu-rouen.fr    Principal Investigator: Eric LEREBOURS, MD,PhD          Sub-Investigator: Guillaume SAVOYE, MD          Chu Saint Etienne Recruiting St Etienne, France, 42270 Contact: Xavier ROBLIN, MD    +33 4 77 82 83 20    xavier.roblin@chu-st-etienne.fr    Principal Investigator: Xavier ROBLIN, MD          Chu Strasbourg Withdrawn Strasbourg, France, 67091 Chu Toulouse Recruiting Toulouse, France, 31403 Contact: Jacques MOREAU, MD    +33561322764    moreau.j@chu-toulouse.fr    Principal Investigator: Jacques MOREAU, MD          Ch Gustave Dron Withdrawn Tourcoing, France, 59208 Chu Tours Recruiting Tours, France, 37044 Contact: Laurence PICON, MD    +33247475916    l.picon@chu-tours.fr    Sub-Investigator: Laurence PICON, MD          Principal Investigator: Alexandre AUBOURG, MD          Chr Valencienne Not yet recruiting Valencienne, France, 59300 Contact: MEDINA BOUALIT, MD          Principal Investigator: MEDINA BOUALIT, MD          Chu Nancy Recruiting Vandoeuvre Les Nancy, France, 54500 Contact: LAURENT PEYRIN BIROULET, MD,PhD    +33383153354       Principal Investigator: Laurent PEYRIN-BIROULET, MD,PhD Less <<
NCT02795572 Peripheral Neuropathy in Breas... More >>t Cancer Patient Less << Phase 2 Terminated(Retirement of the P... More >>rincipal Investigator) Less << - Canada, Alberta ... More >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G1Z2 Less <<
NCT02195453 Non-Small Cell Lung Cancer Phase 4 Unknown December 2016 -
NCT02187055 Rhematoid Arthritis Phase 4 Completed - -
NCT02196480 Juvenile Idiopathic Arthritis Phase 4 Completed - Brazil ... More >> Centro de Dispensação de Medicamentos de Alto Custo (CEDMAC) Sao Paulo, Brazil, 01246-903 Less <<
NCT02196701 Psoriasis Phase 3 Completed - -
NCT02187055 - Completed - -
NCT02200354 Advanced Non-small Cell Lung C... More >>ancer Less << Phase 2 Recruiting March 2019 Japan ... More >> Kobe City Medical Center General Hospital Recruiting Kobe, Hyogo, Japan, 650-0046 Contact: Daichi Fujimoto, MD    +81-78-302-4321 ext 773    daichianzen@yahoo.co.jp Less <<
NCT01789255 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Grade III Lymphomatoid Granulomatosis B-cell Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia Contiguous Stage II Adult Burkitt Lymphoma Contiguous Stage II Adult Diffuse Large Cell Lymphoma Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Contiguous Stage II Adult Lymphoblastic Lymphoma Contiguous Stage II Grade 1 Follicular Lymphoma Contiguous Stage II Grade 2 Follicular Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma Contiguous Stage II Marginal Zone Lymphoma Contiguous Stage II Small Lymphocytic Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Graft Versus Host Disease Intraocular Lymphoma Myelodysplastic Syndrome With Isolated Del(5q) Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Burkitt Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Noncontiguous Stage II Grade 1 Follicular Lymphoma Noncontiguous Stage II Grade 2 Follicular Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Noncontiguous Stage II Marginal Zone Lymphoma Noncontiguous Stage II Small Lymphocytic Lymphoma Post-transplant Lymphoproliferative Disorder Primary Central Nervous System Hodgkin Lymphoma Primary Central Nervous System Non-Hodgkin Lymphoma Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Ringed Sideroblasts Refractory Chronic Lymphocytic Leukemia Refractory Cytopenia With Multilineage Dysplasia Refractory Hairy Cell Leukemia Relapsing Chronic Myelogenous Leukemia Secondary Central Nervous System Hodgkin Lymphoma Secondary Central Nervous System Non-Hodgkin Lymphoma Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Diffuse Small Cleaved Cell Lymphoma Stage I Adult Hodgkin Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Chronic Lymphocytic Leukemia Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage I Marginal Zone Lymphoma Stage I Small Lymphocytic Lymphoma Stage II Adult Hodgkin Lymphoma Stage II Chronic Lymphocytic Leukemia Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Hodgkin Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma Testicular Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 2 Completed - United States, Michigan ... More >> University of Michigan University Hospital Ann Arbor, Michigan, United States, 48109 Less <<
NCT01789255 - Completed - -
NCT02206035 Hematopoietic Stem Cell Transp... More >>lantation Less << Phase 2 Completed - United States, Wisconsin ... More >> Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT02205762 Langerhans Cell Histiocytosis Phase 2 Phase 3 Recruiting July 2023 United States, Arizona ... More >> Phoenix Children's Hospital Recruiting Phoenix, Arizona, United States, 85006 Contact: Michael Henry, MD       mhenry@phoenixchildrens.com    Principal Investigator: Michael Henry, MD          United States, Arkansas Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 Contact: Kimo Stine, MD       stinekimoc@uams.edu    Principal Investigator: Kimo Stine, MD          United States, California Children's Hospital of Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Rima Jubran, MD       rjubran@chla.usc.edu    Principal Investigator: Rima Jubran, MD          Valley Children's Healthcare Not yet recruiting Madera, California, United States, 93636 Contact: David Samuel, MD       DSamuel@valleychildrens.org    Contact: Faisal Razzaqi, MD       FRazzaqi@valleychildrens.org    Principal Investigator: David Samuel, MD          United States, Connecticut Connecticut Children's Medical Center Not yet recruiting Hartford, Connecticut, United States, 06106 Contact: Andrea Orsey, MD       aorsey@connecticutchildrens.org    Principal Investigator: Andrea Orsey, MD          United States, District of Columbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Stephan Ladisch, MD       sladisch@childrensnational.org    Contact: Jay Greenberg, MD       jagreenb@childrensnational.org    United States, Maryland Johns Hopkins University Not yet recruiting Baltimore, Maryland, United States, 21287 Contact: Elias Zambidis, MD       EZambid1@jhmi.edu    Contact: Christine Pratilas, MD       Cpratil1@jhmi.edu    United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Mary Huang, MD    617-726-2737    mshuang@partners.org    Principal Investigator: Mary Huang, MD          Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Barbara Degar, MD    617-632-6801    bdegar@partners.org    Principal Investigator: Barbara Degar, MD          United States, Minnesota Children's Minnesota Recruiting Minneapolis, Minnesota, United States, 55404 Contact: Michael Richards, MD       Michael.richards@childrensmn.org    Contact: Nathan Gossai, MD       nathan.gossai@childrensmn.org    United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Steven Diamond, MD       Steven.Diamond@hackensackmeridian.org    Contact: Burton Appel, MD       Burton.appel@hackensackmeridian.org    United States, New York Cohen Children's Medical Center Recruiting New Hyde Park, New York, United States, 11040 Contact: Carolyn Fein Levy, MD       clevy4@northwell.edu    Contact: Jeffery Lipton, MD       jlipton@northwell.edu    Columbia University / Herbert Irving Cancer Center Recruiting New York, New York, United States, 10032 Contact: Maria Luis Sulis, MD       mls95@cumc.columbia.edu    Contact: Julia Glade Bender, MD       jg589@cumc.columbia.edu    Staten Island University Hospital Recruiting Staten Island, New York, United States, 10305 Contact: Sarah Vaiselbuh, MD    718-226-6435    svaiselbuh@nshs.edu    Principal Investigator: Sarah Vaiselbuh`, MD          SUNY Upstate Medical University Recruiting Syracuse, New York, United States, 13210 Contact: Melanie Comito, MD       comitom@upstate.edu    Contact: Andrea Dvorak, MD       dvoraka@upstate.edu    United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Michael Jordan, MD    513-636-1773    Michael.jordan@cchmc.org    Contact: Ashish Kumar, MD    513-803-1631    ashish.kumar@cchmc.org    United States, South Carolina Medical Universtiy of South Carolina/Hollings Cancer Center Not yet recruiting Charleston, South Carolina, United States, 29425 Contact: Jacqueline Kraveka, DO    843-792-2957    kravekjm@musc.edu    Principal Investigator: Jacqueline Kraveka, DO          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Patrick Campbell, MD       patrick.campbell@stjude.org    Principal Investigator: Patrick Campbell, MD          United States, Washington Providence Sacred Heart Children's Hospital Recruiting Spokane, Washington, United States, 99204 Contact: Stefanos Intzes, MD       stefanos.intzes@providence.org    Contact: Judy Felgenhauer, MD       judy.felgenhauer@providence.org Less <<
NCT02196701 - Completed - -
NCT02202395 Rheumatoid Arthritis Phase 1 Phase 2 Completed - China, Anhui ... More >> The first affiliated hospital of bengbu medical college Bengbu, Anhui, China, 233004 China, Shanghai Changzheng Hospital Shanghai, Shanghai, China, 200003 Zhongshan Hospital Fudan University Shanghai, Shanghai, China, 200032 Shanghai Jiaotong University School of Medicine, Renji Hospital Ethics Committee Shanghai, Shanghai, China, 200127 Changhai Hospital Shanghai, Shanghai, China, 200433 Less <<
NCT02228772 Acute Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma B-cell Adult Acute Lymphoblastic Leukemia T-cell Adult Acute Lymphoblastic Leukemia Less << Phase 1 Recruiting July 2021 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Philip Amrein, MD    617-726-8748    Amrein.Philip@mgh.harvard.edu    Principal Investigator: Philip Amrein, MD          Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Malgotzata McMasters, MD    617-667-9920    mmcmaste@bidmc.harvard.edu    Principal Investigator: Malgorzata McMasters, MD          Dana Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Daniel DeAngelo, MD, Ph.D    617-632-2645    DDEANGELO@PARTNERS.ORG    Principal Investigator: Daniel DeAngelo, MD, Ph.D Less <<
NCT02212561 Acute Myeloid Leukemia (AML) ... More >> Acute Lymphoblastic Leukemia (ALL) Myelodysplastic Syndrome (MDS) Mixed Phenotype Acute Leukemia (MPAL) Less << Phase 1 Completed - United States, Arizona ... More >> Phoenix Children's Hospital Phoenix, Arizona, United States, 85016 United States, California Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States, 94304 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 Less <<
NCT02248792 Severe Plaque Type Psoriasis Phase 4 Unknown - India ... More >> Narayana Med College and Hospital Recruiting Nellore, AP, India, 524003 Contact: Avisa Rao, MD Less <<
NCT01935947 Recurrent Non-Small Cell Lung ... More >>Carcinoma Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer Less << Phase 2 Terminated - United States, California ... More >> USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States, 92663 United States, Maryland Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT02250937 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 2 Recruiting October 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02252042 Head and Neck Squamous Cell Ca... More >>ncer Less << Phase 3 Active, not recruiting January 17, 2019 -
NCT02220894 Non-small Cell Lung Cancer Phase 3 Active, not recruiting January 31, 2020 -
NCT02264990 Non-squamous Non-small Cell Lu... More >>ng Cancer Less << Phase 3 Active, not recruiting July 26, 2019 -
NCT02269358 Crohn's Disease Phase 4 Completed - Israel ... More >> The E. Wolfson.Medical Center Holon, Israel, 58100 Less <<
NCT02252042 - Active, not recruiting - -
NCT01935947 - Terminated - -
NCT01985451 Central Nervous System Tumors Phase 2 Unknown March 2015 -
NCT02265705 Rheumatoid Arthritis Phase 3 Completed - Argentina ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ciudad Autonoma de Buenos Aire, Argentina, C1015ABO For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ciudad Autonoma de Buenos Aire, Argentina, C1431FWO For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ciudad Autonoma de Buenos Aire, Argentina, C1440AAD For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rosario, Argentina, S2000CFJ For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Juan, Argentina, J5402DIL For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Miguel De Tucuman, Argentina, T4000AXL Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sao Paulo, Brazil, 04266-010 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. São Paulo, Brazil, 01244-030 China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100044 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bengbu, China, 233004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China, 410008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China, 410011 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chengdu, China, 610041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guangzhou, China, 510080 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hefei, China, 230001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hefei, China, 230022 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jinan, China, 250012 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kunming, China, 650032 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ningbo, China, 315010 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pingxiang, China, 337055 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200032 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200052 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shantou, China, 515041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tianjin, China, 300052 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wuhan City, China, 430030 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yancheng, China, 224005 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. ZhuZhou, China, 412007 Less <<
NCT02275299 Rheumatoid Arthritis Phase 4 Unknown February 2016 China, Beijing ... More >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100032 Contact: Fengchun Zhang, doctor    +86（10）6915 6114    zhangfccra@yahoo.com.cn Less <<
NCT02273583 High Grade Osteosarcoma Phase 2 Unknown - Brazil ... More >> GRAACC- Institute of Pediatric Oncology Recruiting São Paulo, SP, Brazil, 04023-062 Contact: Antônio Sérgio Petrilli, MD    55-11-5080-8494    sergiopetrilli@graacc.org.br    Principal Investigator: Antônio Sérgio Petrilli, MD Less <<
NCT01137903 Osteomyelitis ... More >> Diabetic Foot Diabetic Foot Ulcers Less << Not Applicable Unknown November 2011 Spain ... More >> José Luis Lázaro Martínez Recruiting Madrid, Spain, 28040 Contact: José Luis Lázaro Martínez, PhD    +34913942203    diabetes@enf.ucm.es    Sub-Investigator: Esther Alicia García Morales, PhD          Sub-Investigator: Silvia Allas Aguado, DP          Sub-Investigator: Máximo Antonio González Jurado, RN, DP, PhD          Sub-Investigator: Gabriel Rivera San Martín, DP          Sub-Investigator: María del Carmen García Carrión, MD, PhD          Sub-Investigator: Juan Vicente Beneit Montesinos, MD,PhD          Principal Investigator: José Luis Lázaro Martínez, PhD          Principal Investigator: Franciso Javier Aragón Sánchez, MD, PhD          Sub-Investigator: Almudena Cecilia Matilla, DP          Sub-Investigator: Yolanda García Álvarez, RN, DP Less <<
NCT02276560 Stage IIIA Non-Small Cell Lung... More >> Cancer Less << Phase 2 Terminated(This study was term... More >>inated due to lack of funding.) Less << - United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Emory - Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Kansas University of Kansas Cancer Center Kansas City, Kansas, United States, 66160 United States, Louisiana Ochsner Cancer Institute New Orleans, Louisiana, United States, 70121 United States, North Carolina Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Rex Cancer Center and Rex of Wakefield Raleigh, North Carolina, United States, 27607 United States, Ohio Case Western Reserve University - Seidman Cancer Center Cleveland, Ohio, United States, 44106 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 United States, Washington Swedish Cancer Institute Seattle, Washington, United States, 98104 Less <<
NCT02276560 - Terminated(This study was term... More >>inated due to lack of funding.) Less << - -
NCT01829295 Uveitis Phase 3 Completed - United States, California ... More >> Francis I Proctor Foundation San Francisco, California, United States, 94143 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Oregon Oregon Health and Science University - Casey Eye Institute Portland, Oregon, United States, 97239 Australia, Victoria Royal Victorian Eye and Ear Hospital Melbourne, Victoria, Australia, 3002 India Aravind Eye Hospital Coimbatore, Tamil Nadu, India Aravind Eye Hospital Madurai, Tamil Nadu, India Aravind Eye Hospital Pondicherry, Tamil Nadu, India Mexico Asociacion Para Evita La Ceguera en Mexico Mexico City, Mexico, D.F., Mexico, 04030 Saudi Arabia King Khaled Eye Specialist Hospital Riyadh, Saudi Arabia Less <<
NCT02280694 Colorectal Cancer Phase 2 Active, not recruiting January 2019 Israel ... More >> Gastrointestinal Oncology Unit, Institute of Oncology, Davidoff Center, Rabin Medical Center, Belinson Campus, Petach Tiqva, Israel Less <<
NCT02296671 Esophagogastric Cancer Phase 2 Withdrawn(Was unable to accrue... More >> any patients) Less << February 2022 -
NCT02277444 Arthritis, Juvenile Phase 3 Active, not recruiting February 21, 2023 -
NCT02299999 Metastatic Breast Cancer Phase 2 Recruiting December 2022 France ... More >> Institut de Cancérologie de l'Ouest/Paul Papin Recruiting Angers, France Contact: Mario CAMPONE, MD       mario.campone@ico.unicancer.fr    Principal Investigator: Mario CAMPONE, MD          Institut Sainte-Catherine Recruiting Avignon, France Contact: Alice Mege, MD       a.mege@isc84.org    Principal Investigator: Alice Mege, MD          Polyclinique Bordeaux Nord Aquitaine Recruiting Bordeaux, France, 33077 Contact: Nadine DOHOLLOU, MD       n.dohollou@bordeauxnord.com    Contact: Nadine DOHOLLOU, MD          Institut Bergonié Recruiting Bordeaux, France Contact: Hervé Bonnefoi, MD       h.bonnefoi@bordeaux.unicancer.fr    Principal Investigator: Hervé Bonnefoi, MD          Centre François Baclesse Recruiting Caen, France Contact: Christelle Lévy, MD       c.levy@baclesse.unicancer.fr    Principal Investigator: Christelle Lévy, MD          Centre Jean Perrin Recruiting Clermont-Ferrand, France Contact: Marie-Ange Mouret Reynier, MD       marie-ange.mouret-reynier@cjp.fr    Principal Investigator: Marie-Ange Mouret Reynier, MD          Ch Alpes Leman Not yet recruiting Contamine Sur Arve, France, 74130 Contact: Carol ALLIOT, MD       calliot@ch-alpes-leman.fr    Contact: Carol ALLIOT, MD          Centre Georges François Leclerc Recruiting Dijon, France, 21079 Contact: Nicolas Isambert, MD       nisambert@cgfl.fr    Principal Investigator: Nicolas Isambert, MD          Chd Vendee Recruiting La Roche-sur-Yon, France, 85925 Contact: Tifenn L'Haridon, MD       tifenn.lharidon@chd-vendee.fr    Contact: Tifenn L'Haridon, MD          Centre Oscar Lambret Recruiting Lille, France Contact: Nuria KOTECKI, MD          Principal Investigator: Nuria KOTECKI, MD          Chu Dupuytren Not yet recruiting Limoges, France, 87000 Contact: Laurence VENAT-BOUVET, MD       laurence.venat-bouvet@chu-limoges.fr    Contact: Laurence VENAT-BOUVET, MD          Hopital Privé Jean Mermoz Not yet recruiting Lyon, France, 69008 Contact: Olfa DERBEL, MD       o.derbelmermoz@gmail.com    Contact: Olfa DERBEL, MD          Centre Hospitalier Lyon Sud Recruiting Lyon, France Contact: Benoit You, MD          Principal Investigator: Benoit You, MD          Centre Léon Bérard Recruiting Lyon, France Contact: Thomas Bachelot, MD       thomas.bachelot@lyon.unicancer.fr    Principal Investigator: Thomas Bachelot, MD          Institut Paoli Calmettes Recruiting Marseille, France Contact: Anthony Gonçalves, MD       goncalvesa@ipc.unicancer.fr    Principal Investigator: Anthony Gonçalves, MD          Institut Régional du Cancer Montpellier Val d'Aurelle Recruiting Montpellier, France Contact: William Jacot, MD       william.jacot@icm.unicancer.fr    Principal Investigator: William Jacot, MD          Centre Alexis Vautrin Recruiting Nancy, France Contact: Elisabeth Luporsi, MD       e.luporsi@nancy.unicancer.fr    Principal Investigator: Elisabeth Luporsi, MD          Institut de Cancérologie de l'Ouest/ René Gauducheau Recruiting Nantes, France Contact: Mario Campone, MD       mario.campone@ico.unicancer.fr    Principal Investigator: Mario Campone, MD          Centre Antoine Lacassagne Recruiting Nice, France Contact: Jean-Marc Ferrero, MD       jean-marc.ferrero@nice.unicancer.fr    Principal Investigator: Jean-Marc Ferrero, MD          Institut Curie Recruiting Paris, France Contact: Marie-Paule Sablin, MD       mariepaule.sablin@curie.fr    Principal Investigator: Marie-Paule Sablin, MD          Centre Eugène Marquis Recruiting Rennes, France Contact: Claudia Lefeuvre-Plesse, MD       c.lefeuvre@rennes.unicancer.fr    Principal Investigator: Claudia Lefeuvre-Plesse, MD          Centre Henri Becquerel Recruiting Rouen, France Contact: Jean-Christophe Théry, MD          Principal Investigator: Jean-Christophe Théry, MD          Institut Curie Recruiting Saint-Cloud, France Contact: Florence COUSSY, MD       florence.coussy@curie.fr    Principal Investigator: Florence COUSSY, MD          Hopitaux Universitaire de Strasbourg - Hopital Civil Recruiting Strasbourg, France Contact: Philippe BARTHELEMY, MD       philippe.barthelemy@chru-strasbourg.fr    Principal Investigator: Philippe BARTHELEMY, MD          Hopitaux Du Leman Recruiting Thonon-les-Bains, France, 74200 Contact: Francesco DEL PIANO, MD       f-delpiano@ch-hopitauxduleman.fr    Contact: Francesco DEL PIANO, MD          Institut Claudius Regaud Recruiting Toulouse, France Contact: Florence Dalenc, MD       dalenc.florence@iuct-oncopole.fr    Principal Investigator: Florence Dalenc, MD          Gustave Roussy Recruiting Villejuif, France Contact: Monica Arnedos, MD       Monica.ARNEDOS@gustaveroussy.fr    Principal Investigator: Monica Arnedos, MD          Sub-Investigator: Fabrice André, MD Less <<
NCT02953184 Antineoplastic Combined Chemot... More >>herapy Protocols Less << Phase 2 Recruiting November 2020 China, Jilin ... More >> First Hospital of Jilin University Recruiting Changchun, Jilin, China, 130021 Contact: Aiping Shi, Doctor    0086-13364308696    13364308696@163.com    Contact: Zhimin Fan, Doctor    0086-13756661286    fanzhimn@163.com    Sub-Investigator: Di Wu, Doctor          Sub-Investigator: Hongyao Jia, Master          Sub-Investigator: Xin Guan, Master          Principal Investigator: Zhimin Fan, Doctor          Principal Investigator: Haibo Wang, Doctor          Sub-Investigator: Gang Nie, Doctor Less <<
NCT02303821 Acute Lymphoblastic Leukemia (... More >>ALL) Less << Phase 1 Recruiting October 18, 2019 -
NCT02923388 Vincristine Induced Peripheral... More >> Neuropathy (VIPN) Less << Phase 2 Recruiting July 2018 Bangladesh ... More >> Bangabandhu Sheikh Mujib Medical University Recruiting Dhaka, Bangladesh Contact: Fatiha Tasmin Jeenia, MBBS    +8801675380399    fatihatasmin@gmail.com    Contact: Md Sayedur Rahman, MBBS, Mphil    +01971840757    srkhasru@gmail.com    Dhaka Medical College Hospital Recruiting Dhaka, Bangladesh Contact: Fatiha Tasmin Jeenia, MBBS    +8801675380399    fatihatasmin@gmail.com    Contact: Tasneem Ara, MBBS, FCPS, Mphil    +8801552314402 Less <<
NCT02288520 - Completed - France ... More >> Nordic Pharma Paris, France, 75007 Less <<
NCT01993810 Stage II Non-Small Cell Lung C... More >>ancer AJCC v7 Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 Stage III Non-Small Cell Lung Cancer AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Less << Phase 3 Recruiting December 31, 2025 United States, Florida ... More >> University of Florida Health Science Center - Jacksonville Recruiting Jacksonville, Florida, United States, 32209 Contact: Site Public Contact    412-339-5294    Roster@nrgoncology.org    Principal Investigator: Bradford S. Hoppe          United States, Illinois Northwestern Medicine Cancer Center Warrenville Suspended Warrenville, Illinois, United States, 60555 United States, Maryland Maryland Proton Treatment Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Site Public Contact    410-369-5226    info@mdproton.com    Principal Investigator: Charles B. Simone          University of Maryland/Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Site Public Contact    800-888-8823       Principal Investigator: Charles B. Simone          Upper Chesapeake Medical Center Recruiting Bel Air, Maryland, United States, 21014 Contact: Site Public Contact    443-643-3010       Principal Investigator: Jack J. Hong          Central Maryland Radiation Oncology in Howard County Recruiting Columbia, Maryland, United States, 21044 Contact: Site Public Contact    443-546-1300       Principal Investigator: Charles B. Simone          Tate Cancer Center Recruiting Glen Burnie, Maryland, United States, 21061 Contact: Site Public Contact    410-553-8100       Principal Investigator: Charles B. Simone          United States, Massachusetts Massachusetts General Hospital Cancer Center Suspended Boston, Massachusetts, United States, 02114 Mass General/North Shore Cancer Center Suspended Danvers, Massachusetts, United States, 01923 United States, Missouri Siteman Cancer Center at West County Hospital Recruiting Creve Coeur, Missouri, United States, 63141 Contact: Site Public Contact    800-600-3606    info@siteman.wustl.edu    Principal Investigator: Jeffrey D. Bradley          Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Site Public Contact    800-600-3606    info@siteman.wustl.edu    Principal Investigator: Jeffrey D. Bradley          United States, New Jersey Memorial Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Site Public Contact    212-639-7592       Principal Investigator: Abraham J. Wu          ProCure Proton Therapy Center-Somerset Suspended Somerset, New Jersey, United States, 08873 United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Site Public Contact    212-639-7592       Principal Investigator: Abraham J. Wu          Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Site Public Contact    212-639-7592       Principal Investigator: Abraham J. Wu          Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Site Public Contact    212-639-7592       Principal Investigator: Abraham J. Wu          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Site Public Contact    212-639-7592       Principal Investigator: Abraham J. Wu          Memorial Sloan Kettering Sleepy Hollow Suspended Sleepy Hollow, New York, United States, 10591 United States, Pennsylvania University of Pennsylvania/Abramson Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Site Public Contact    800-474-9892       Principal Investigator: Samuel Swisher-McClure          Thomas Jefferson University Hospital Active, not recruiting Philadelphia, Pennsylvania, United States, 19107 United States, Tennessee Tennessee Cancer Specialists-Dowell Springs Recruiting Knoxville, Tennessee, United States, 37909 Contact: Site Public Contact    865-244-3209       Principal Investigator: J. B. Wilkinson          United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Site Public Contact    877-312-3961       Principal Investigator: Quynh-Nhu Nguyen          MD Anderson Regional Care Center-Katy Suspended Houston, Texas, United States, 77094 MD Anderson Regional Care Center-Bay Area Suspended Nassau Bay, Texas, United States, 77058 MD Anderson Regional Care Center-Sugar Land Suspended Sugar Land, Texas, United States, 77478 MD Anderson Regional Care Center-The Woodlands Suspended The Woodlands, Texas, United States, 77384 United States, Washington ProCure Proton Therapy Center-Seattle Recruiting Seattle, Washington, United States, 98133 Contact: Site Public Contact    412-339-5294    Roster@nrgoncology.org    Principal Investigator: Ramesh Rengan          University of Washington Medical Center Recruiting Seattle, Washington, United States, 98195 Contact: Site Public Contact    800-804-8824       Principal Investigator: Ramesh Rengan Less <<
NCT02309359 Rheumatoid Arthritis Phase 2 Completed - -
NCT02313389 Primary Central Nervous System... More >> Lymphoma Less << Phase 3 Recruiting June 2021 France ... More >> Groupe Hospitalier Pitie Salpetriere Recruiting Paris, France, 75013 Contact: Khe HOANG-XUAN, MD, PhD    +33 - 1.42.16.03.81    khe.hoang-xuan@psl.aphp.fr Less <<
NCT02305849 Rheumatoid Arthritis Phase 3 Completed - -
NCT02303899 Mesothelioma, Malignant Phase 2 Active, not recruiting December 2017 Italy ... More >> Istituto Clinico Humanitas Rozzano, MI, Italy, 20089 Less <<
NCT02313922 Psoriasis Phase 4 Completed - China, Zhejiang ... More >> the 2Nd Affiliated Hospital,Zhejiang University, Hangzhou, Zhejiang, China, 310009 Less <<
NCT02315326 Refractory/Recurrent Primary C... More >>entral Nervous System Lymphoma (PCNSL) Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL) Less << Phase 1 Phase 2 Recruiting December 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Recruiting Basking Ridge, New Jersey, United States Contact: Christian Grommes, MD    212-639-4058       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Christian Grommes, MD    212-639-4058       United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Christian Grommes, MD    212-639-4058       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Christian Grommes, MD    212-639-4058       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Christian Grommes, MD    212-639-4058       Contact: Ingo Mellinghoff, MD    646-888-3036 Less <<
NCT02313870 Bullous Pemphigoid Phase 3 Unknown December 2015 France ... More >> University Hospital Of Montpellier Recruiting Montpellier, France, 34295 Contact: Olivier Dereure, MD, PhD    04 67 33 69 06 ext +33    o-dereure@chu-montpellier.fr    Principal Investigator: Olivier Dereure, MD, PhD Less <<
NCT02376452 Colorectal Carcinoma Phase 2 Unknown December 2016 China, Shanghai ... More >> Fudan University Cancer Hospital Recruiting ShangHai, Shanghai, China Contact: Jin Li, PhD, M.D    862164175590 ext 1108    fudanlijin@163.com Less <<
NCT02375295 Kidney Stones Phase 4 Recruiting December 2019 United States, Arizona ... More >> Mayo Clinic - Scottsdale/Phoenix, AZ Recruiting Scottsdale, Arizona, United States, 85259 Contact: Mitchell Humphreys, MD       Humphreys.Mitchell@mayo.edu    United States, California University California San Diego Recruiting San Diego, California, United States, 92103 Contact: Roger Sur, MD       rlsur@mail.ucsd.edu    United States, Maryland Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21287 Contact: Brian Matlaga       bmatlag1@jhmi.edu    United States, Massachusetts Harvard University - Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114-3117 Contact: Brian Eisner, MD       BEISNER@PARTNERS.ORG    United States, Minnesota Mayo Clinic - Rochester, MN Recruiting Rochester, Minnesota, United States, 55905 Contact: Amy Krambeck, MD       krambeck.amy@mayo.edu    United States, New Hampshire Dartmouth University Recruiting Lebanon, New Hampshire, United States, 03756-0001 Contact: Vernon Pais, MD       Vernon.M.Pais.Jr@hitchcock.org    United States, New York New York University Recruiting New York, New York, United States, 10016 Contact: Ojas Shah, MD       Ojas.Shah@nyumc.org    United States, North Carolina Duke University Recruiting Durham, North Carolina, United States, 27710 Contact: Michael Lipkin, MD       michael.lipkin@duke.edu    United States, Ohio Ohio State University Recruiting Athens, Ohio, United States, 45701 Contact: Bodo Knudsen, MD       Bodo.Knudsen@osumc.edu    Contact: Janet McGarr       Janet.Mcgarr@osumc.edu    Cleveland Clinic Foundation Recruiting Cleveland, Ohio, United States, 44195 Contact: Manoj Monga, MD       mongam@ccf.org    United States, Tennessee Vanderbilt University Recruiting Nashville, Tennessee, United States, 37235 Contact: Nicole Miller, MD       nicole.miller@Vanderbilt.Edu    Canada, British Columbia The Stone Centre, VGH/UBC Recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Contact: Olga Arsovska    604 875 4111 ext 62421    olga.arsovska@ubc.ca    Sub-Investigator: Ben Chew, MD          Principal Investigator: Dirk Lange, PhD          Sub-Investigator: Ryan Flannigan, MD          Sub-Investigator: Ryan Paterson, MD          Sub-Investigator: Elspeth McDougall, MD Less <<
NCT02168816 Osteomyelitis Phase 2 Terminated(The study was stopp... More >>ed for feasibility (i.e., low recruitment)) Less << - United States, Illinois ... More >> Loyola University Medical Center Maywood, Illinois, United States, 60153 Less <<
NCT02371603 Anaemia Phase 1 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT02322281 Non-small Cell Lung Cancer Phase 3 Terminated(Sponsor discontinue... More >>d development of CO-1686 for NSCLC) Less << - -
NCT00921310 - Terminated(Withdrawal of fundi... More >>ng from sponsor) Less << - -
NCT00921310 Carcinoma, Non-Small-Cell Lung Phase 1 Phase 2 Terminated(Withdrawal of fundi... More >>ng from sponsor) Less << - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT02328755 Acute Myeloid Leukemia Phase 1 Phase 2 Recruiting July 2019 United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: John M Magenau, M.D.    734-936-8785    johnmage@umich.edu    Principal Investigator: John M Magenau, M.D. Less <<
NCT02168816 - Terminated(The study was stopp... More >>ed for feasibility (i.e., low recruitment)) Less << - -
NCT02329080 Diffuse Large B-cell Lymphoma Phase 2 Recruiting December 2023 Czechia ... More >> Facultni nemocnice Recruiting Brno, Czechia Contact: Andrea Janikova          Principal Investigator: Andrea Janikova          FNKV (Facultni Nemocnice Kralovske Vinohrady) Recruiting Praha, Czechia Contact: Heidi Mocikova          Principal Investigator: Heidi Mocikova          Vseobecna facultni nemocnice v Praze Not yet recruiting Praha, Czechia Contact: Robert Pytlik          Principal Investigator: Robert Pytlik          Italy Spedali Civili Recruiting Brescia, Italy Contact: Giuseppe Rossi          Principal Investigator: Giuseppe Rossi          UO Ematologia e CTMO, PO Businco Recruiting Cagliari, Italy Contact: Giuseppina Cabras          Principal Investigator: Giuseppina Cabras          IRST Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Recruiting Meldola, Italy Contact: Gerardo Musuraca          Principal Investigator: Gerardo Musuraca          UO Ematoliga Ospedale dell'Angelo Recruiting Mestre, Italy Contact: Renato Bassan          Principal Investigator: Renato Bassan          Istituto Nazionale Tumori Recruiting Milano, Italy Principal Investigator: Liliana Devizzi          Ospedale Maggiore Policlinico Recruiting Milano, Italy Contact: Maria Cecilia Goldaniga          Principal Investigator: Maria Cecilia Goldaniga          San Raffaele H Scientific Institute Recruiting Milan, Italy Contact: Andres Ferreri, MD       ferreri.andres@hsr.it    Principal Investigator: Andrés JM Ferreri, MD          AOU Policlinico di Modena Recruiting Modena, Italy Contact: Franco Narni          Principal Investigator: Franco Narni          SCDU Ematologia Recruiting Novara, Italy Contact: Gianluca Gaidano          Principal Investigator: Gianluca Gaidano          Ematologia ed Immunologia Clinica - AO di Padova Recruiting Padova, Italy Contact: Renato Zambello          Principal Investigator: Renato Zambello          UO Oncoematologia Ospedale Tortora Recruiting Pagani, Italy Contact: Catello Califano          Principal Investigator: Catello Califano          Villa Sofia - Cervello Recruiting Palermo, Italy Contact: Caterina Patti          Principal Investigator: Caterina Patti          Ematologia AOU Recruiting Parma, Italy Contact: Francesca Re          Principal Investigator: Francesca Re          Ematologia Ospedale S.Maria delle Croci Recruiting Ravenna, Italy Contact: Claudia Cellini          Principal Investigator: Claudia Cellini          A.O. Bianchi-Melacrino-Morelli, Divisione di Ematologia Recruiting Reggio Calabria, Italy Contact: Caterina Stelitano, MD          Principal Investigator: Caterina Stelitano, MD          Arcispedale Santa Maria Nuova, Azienda Ospedaliera di Reggio Emilia Recruiting Reggio Emilia, Italy Contact: Fiorella Ilariucci          Principal Investigator: Fiorella Ilariucci          Ematologia Università La Sapienza Recruiting Roma, Italy Contact: Maurizio Martelli          Principal Investigator: Maurizio Martelli          IRCCS Istituto Regina Elena (IFO) Recruiting Roma, Italy Contact: Francesca Palombi          Principal Investigator: Francesca Palombi          Policlinico Universitario Campus Bio-Medico Recruiting Rome, Italy Contact: Ombretta Annibali          Principal Investigator: Ombretta Annibali          IRCCS Casa Sollievo Della Sofferenza Recruiting San Giovanni Rotondo, Italy Contact: Nicola Cascavilla          Principal Investigator: Nicola Cascavilla          AOU Senese Recruiting Siena, Italy Contact: Alberto Fabbri          Principal Investigator: Alberto Fabbri          AO S.Maria di Terni Recruiting Terni, Italy Contact: Anna Marina Liberati          Principal Investigator: Anna Marina Liberati          SC Ematologia AO Città della Salute e della Scienza Recruiting Torino, Italy Contact: Barbara Botto          Principal Investigator: Barbara Botto          UO Ematologia Ospedale Panico Recruiting Tricase, Italy Contact: Vincenzo Pavone          Principal Investigator: Vincenzo Pavone          AOU Santa Maria della Misericordia Recruiting Udine, Italy Contact: Francesco Zaja          Principal Investigator: Francesco Zaja          UOC Ematologia Policlinico Rossi Recruiting Verona, Italy Contact: Achille Ambrosetti          Principal Investigator: Achille Ambrosetti          Ematologia Ospedale S. Bortolo Recruiting Vicenza, Italy Contact: Maurizio Frezzato          Principal Investigator: Maurizio Frezzato          Netherlands Erasmus MC Recruiting Rotterdam, Netherlands Contact: Jeanette Doorduijn          Principal Investigator: Jeanette Doorduijn          United Kingdom Beatson Cancer Center Recruiting Glasgow, United Kingdom Contact: Pam Mc Kay          Principal Investigator: Pam Mc Kay          Liverpool Aintree Recruiting Liverpool, United Kingdom Contact: Jeffery Smith          Principal Investigator: Jeffery Smith          UCLH University College London Hospitals NHS foundation trust Recruiting London, United Kingdom Contact: Kate Cwynarski          Principal Investigator: Kate Cwynarski          The Christie Hospital Recruiting Manchester, United Kingdom Contact: Kim Linton          Principal Investigator: Kim Linton          Southampton General Hospital Not yet recruiting Southampton, United Kingdom Contact: Andrew Davies          Principal Investigator: Andrew Davies Less <<
NCT02339350 Acute Lymphoblastic Leukemia ... More >> Child Less << Phase 2 Recruiting April 2023 Korea, Republic of ... More >> Seoul National University, College of Medicine Recruiting Seoul, Korea, Republic of Contact: Hee Young Shin, MD, PhD    82-2-2072-2917    hyshin@snu.ac.kr Less <<
NCT02323659 Lymphoma, T-Cell, Cutaneous ... More >> Mycosis Fungoides Less << Phase 4 Recruiting December 2017 Poland ... More >> Centrum Onkologii im. prof. F. Łukaszczyka Recruiting Bydgoszcz, Poland, 85-796 Contact: Ewa Chmielowska, MD, PhD    48523743421    eacagaca@gmail.com Less <<
NCT02347332 Recurrent or Metastatic Head a... More >>nd Neck Carcinoma Less << Phase 3 Active, not recruiting June 2018 -
NCT02349451 Psoriatic Arthritis Phase 2 Completed - -
NCT02357069 Arthritis, Rheumatoid Phase 3 Unknown - Japan ... More >> Mochida Investigational site Tokyo, Japan Korea, Republic of LGLS Investigational site Seoul, Korea, Republic of Less <<
NCT02349451 - Completed - -
NCT01636895 Pregnancy Complications Parasi... More >>tic Less << Phase 4 Unknown February 2013 Nigeria ... More >> Damboa Hospital Borno state and Park Lane hospital Enugu state Recruiting Enugu,, borno State and Enugu state, Nigeria Contact: Elvis N Shu    Cell: + 234 803 317 0257    shuneba@gmail.com    Principal Investigator: Elvis Shu Less <<
NCT02367781 Carcinoma, Non-Small-Cell Lung Phase 3 Active, not recruiting December 28, 2019 -
NCT02374021 Arthritis, Rheumatoid Phase 4 Recruiting March 2022 -
NCT02373813 Rheumatoid Arthritis Phase 3 Active, not recruiting November 12, 2019 -
NCT02383212 Advanced Cancer ... More >> Advanced Malignancies Less << Phase 1 Active, not recruiting December 20, 2019 -
NCT02376790 Psoriatic Arthritis Phase 3 Completed - -
NCT02378298 Ophthalmopathy, Thyroid-Associ... More >>ated Less << Phase 4 Recruiting December 2019 Sweden ... More >> Center for Endocrinology and Metabolism, Sahlgrenska University Hospital Recruiting Gothenburg, Sweden Contact: Ann-Charlotte Olofsson, Nurse          MedTech West, Institute of Neuro Science and Physiology, Department for Clinical Neuro Science and Rehabilitation, Sahlgrenska Academy, University of Gothenburg Active, not recruiting Gothenburg, Sweden Department of Ophthalmology, Sahlgrenska University Hospital/Mölndal Recruiting Mölndal, Sweden Contact: Lena Sjödell, Dr          Department of Rheumatology, Sahlgrenska University Hospital/Mölndal Active, not recruiting Mölndal, Sweden Department of Radiology, Karolinska University Hospital Active, not recruiting Stockholm, Sweden Less <<
NCT02453490 Colorectal Cancer ... More >> Liver Metastasis Less << Phase 3 Recruiting September 2018 China, Guangdong ... More >> The Affiliated Tumor Hospital of Zhongshan University Not yet recruiting Guangzhou, Guangdong, China, 510060 Principal Investigator: Zhi-Zhong Pan, MD/PHD          China, Hubei Wuhan Union Hospital Not yet recruiting Wuhan, Hubei, China, 430022 Principal Investigator: Kai-Xiong Tao, MD/PHD          Zhongnan Hospital Affiliated to Wuhan University Not yet recruiting Wuhan, Hubei, China, 430071 Principal Investigator: Bing Xiong, MD          China, Shanghai Changhai Hospital of Shanghai Recruiting Shanghai, Shanghai, China, 200433 Principal Investigator: Wei Zhang, MD          China, Zhejiang The First Affiliated Hospital of College of Medicine Zhejiang University Not yet recruiting Hangzhou, Zhejiang, China, 310003 Principal Investigator: Jianjiang Lin, M.D.          Second Affiliated Hospitalof Zhejiang University School of Medicine Recruiting Hangzhou, Zhejiang, China, 310009 Contact: Ke-Feng Ding, PhD/MD    86-571-87784827    dingkefeng@zju.edu.cn    Principal Investigator: Ke-Feng Ding, PhD/MD          Sir Run Run Shaw Hospital, Zhejiang University School of Medicine Recruiting Hangzhou, Zhejiang, China, 310016 Principal Investigator: Xuefeng Huang, M.D.          Jinhua People's Hospital Recruiting Jinhua, Zhejiang, China, 321000 Principal Investigator: Jinlin Du, M.D.          The second hospital of Ningbo City Recruiting Ningbo, Zhejiang, China, 315010 Principal Investigator: Xiao-Yu Dai, MD Less <<
NCT02385110 Leukemia Phase 2 Recruiting September 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02387762 Rheumatoid Arthritis Phase 2 Completed - United States, Alabama ... More >> Anniston, Alabama, United States Birmingham, Alabama, United States United States, Arizona Phoenix, Arizona, United States United States, Florida New Port Richey, Florida, United States United States, Nevada Las Vegas, Nevada, United States United States, Oklahoma Oklahoma City, Oklahoma, United States United States, Pennsylvania Altoona, Pennsylvania, United States United States, Tennessee Memphis, Tennessee, United States United States, Texas Webster, Texas, United States Less <<
NCT02389400 Langerhans Cell Histiocytosis Phase 2 Completed - China ... More >> Peking union medical college hospital Beijing, China, 100730 Less <<
NCT02330380 - Completed - United States, Ohio ... More >> University Hospitals Cleveland Medical Center Cleveland, Ohio, United States, 44106 Less <<
NCT02383680 - Unknown June 2016 Switzerland ... More >> Kantonsspital Aarau Recruiting Aarau, Aargau, Switzerland, 5001 Contact: Christoph Fux, PD MD    +41 62 838 68 20    christoph.fux@ksa.ch    Contact: Constanze Spelters, Study Nurse    +41 62 838 68 20    constanze.spelters@ksa.ch    Swiss Tropical and Public Health Institute Recruiting Basel, Basel Stadt, Switzerland, 4051 Contact: Kerstin Kling, MD    +41 61284 ext 8119    kerstin.kling@unibas.ch    Contact: Christoph Hatz, Prof MD    + 41 61284 ext 8255    christoph.hatz@unibas.ch    Universitätsklinik für Infektiologie Inselspital Not yet recruiting Bern, Switzerland, 3010 Contact: Hansjakob Furrer, Prof MD    +41 31 632 27 45    Hansjakob.Furrer@insel.ch    Contact: Cornelia Staehelin, MD    +41 31 632 27 45    cornelia.staehelin@insel.ch    Médecine Tropicale et Humanitaire Hôpitaux Universitaires de Genève Not yet recruiting Geneva, Switzerland, 1211 Contact: Gilles Eperon, MD    +41 (0)22 372 96 15    Gilles.Eperon@hcuge.ch    Contact: Francois Chappuis, Prof MD    +41 (0)22 372 96 15    francois.chappuis@hcuge.ch    PMU | Policlinique médicale universitaire CHUV | Service des maladies infectieuses, Département de médecine Not yet recruiting Lausanne, Switzerland, 1011 Contact: Blaise Genton, Prof MD    +41 21 314 67 68    Blaise.Genton@chuv.ch    University of Zurich, Epidemiology, Biostatistics and Prevention Institute Recruiting Zurich, Switzerland, 8001 Contact: Silja Bühler, MD MSc    +41 44634 ext 4631    silja.buehler@ifspm.uzh.ch    Contact: Sabine Schmid, MD    +41 44634 ext 4608    sabine.schmid@ifspm.uzh.ch Less <<
NCT01856478 Head and Neck Neoplasms Phase 3 Active, not recruiting February 10, 2019 -
NCT01855789 - Completed - -
NCT01858740 Accelerated Phase Chronic Myel... More >>ogenous Leukemia, BCR-ABL1 Positive Acute Biphenotypic Leukemia Acute Leukemia of Ambiguous Lineage Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Chronic Myelogenous Leukemia, BCR-ABL1 Positive Myelodysplastic Syndrome With Excess Blasts-1 Myelodysplastic Syndrome With Excess Blasts-2 Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Less << Phase 2 Active, not recruiting January 30, 2022 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01860040 Non-squamous Cell Non-Metastat... More >>ic Non-Small Cell Lung Cancer Squamous Cell Non-Metastatic Non-Small Cell Lung Cancer Less << Phase 2 Terminated(Poor accrual, no da... More >>ta to analyze) Less << - United States, Arizona ... More >> Western Regional Medical Center Goodyear, Arizona, United States, 85338 Less <<
NCT01860040 - Terminated(Poor accrual, no da... More >>ta to analyze) Less << - -
NCT01860690 Ectopic Pregnancy Phase 4 Unknown February 2014 Israel ... More >> Dr. Zvi Klein Recruiting Kefar-saba, Israel Contact: Zvi Klein, MD    972-9-7472544    kleinz@clalit.org.il    Principal Investigator: Zvi Klein, M.D. Less <<
NCT01855789 Rheumatoid Arthritis Phase 3 Completed - -
NCT01866150 - Completed - United Kingdom ... More >> Cambridge, United Kingdom, CB2 0QQ Chelmsford, United Kingdom, CM1 7ET Cosham, United Kingdom, PO6 3LY Derby, United Kingdom, DE22 3NE Dudley, United Kingdom, DY1 2HQ Edinburgh, United Kingdom, EH4 2XU Harlow, United Kingdom, CM20 1QX London, United Kingdom, E11 1NR London, United Kingdom, SE13 6LH Newcastle Upon Tyne, United Kingdom, NE7 7DN Norwich, United Kingdom, NR4 7UY Portadown, United Kingdom, BT63 5QQ Stoke-on-trent, United Kingdom, ST6 7AG Truro, United Kingdom, TR1 3LJ Wigan, United Kingdom, WN6 9EW Less <<
NCT01862224 Rheumatoid Arthritis Phase 2 Terminated(The study was stopp... More >>ed due to lack of efficacy in a study conducted in a similar population,38518168ARA2002-NCT01679951.) Less << - United States, Maryland ... More >> Frederick, Maryland, United States Moldova, Republic of Chisinau, Moldova, Republic of Less <<
NCT01483690 Acute Lymphoblastic Leukemia ... More >> Precursor B-Cell Lymphoblastic Leukemia Precursor T-Cell Lymphoblastic Leukemia Less << Phase 1 Phase 2 Terminated(Toxicity) - -
NCT01866150 - Completed - -
NCT01870128 Rheumatoid Arthritis Phase 3 Completed - India ... More >> AIIMS New Delhi, Delhi, India, 110029 Less <<
NCT01876004 Ectopic Pregnancy Phase 4 Completed - Brazil ... More >> Federal University of Sao Paulo São Paulo, SP, Brazil Less <<
NCT01868022 Neoplasms Phase 1 Completed - -
NCT01871961 Rheumatoid Arthritis (RA) Phase 1 Completed - United States, Florida ... More >> Rheumatology Arthitis & Rheumatic Care center South Miami, Florida, United States, 33143 Less <<
NCT01662167 Pregnancy, Ectopic Phase 4 Completed - Iran, Islamic Republic of ... More >> Shariaty Hospital Bandar Abbas, Hormozgan, Iran, Islamic Republic of, 79761 Less <<
NCT01661140 - Terminated - -
NCT01875237 Leukemia Myel... More >>oma Myeloproliferative Diseases Less << Phase 1 Phase 2 Terminated - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01661140 Rheumatoid Arthritis Phase 4 Terminated - -
NCT01490723 Leukemia Lymp... More >>homa Less << Phase 2 Active, not recruiting January 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01664910 Lymphoma Leuk... More >>emia Less << Phase 1 Phase 2 Recruiting October 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01668641 Rheumatoid Arthritis Phase 2 Completed - Hungary ... More >> Budai Irgalamsrendi Korhaz, II. Reumatologia Osztaly Budapest, Hungary Orszagos Reumatologiai es Fizioterapias Intezet, I. Reumatologia Osztaly Budapest, Hungary Markhot Ferenc Korhaz, Reumatologiai Osztaly Eger, Hungary Pest Megyei Flor Ferenc Korhaz, Reumatologiai es Fizioterapias Osztaly Kistarcsa, Hungary Moldova, Republic of IMSP Institutel de Cardiologie Chisinau, Moldova, Republic of Russian Federation State Healthcare Institution of city Moscow 'City Clinical Hospital #7' Moscow, Russian Federation State Healthcare Institution 'Ryazan Regional Cardiology Dispensary' Ryazan, Russian Federation Saint-Petersburg State Healthcare Institution 'City Hospital #26' Saint-Petersburg, Russian Federation Saint-Petersburg State Healthcare Institution 'City Mariinskiy Hospital' Saint-Petersburg, Russian Federation Municipal Clinical Healthcare Institution 'Medical-Sanitary Unit of Novoyaroslavskiy Oil Refinery' Yaroslavl, Russian Federation Ukraine Chernivtsi Regional Clinical Hospital Chernivtsi, Ukraine State Institution 'Institute of Urgent and Recovery Surgery n.a. V.K. Gusaka' of AMS of Ukraine Donetsk, Ukraine Communal Institution of Healthcare Kharkiv, Ukraine Institution of Therapy of AMS of Ukraine Kharkiv, Ukraine State Institution 'Institute of Microbiology and Immunology of AMS of Ukraine' Kharkiv, Ukraine State Institution 'Republican Clinical Hospital of MoH of Ukraine' Kiev, Ukraine Lutsk City Clinical Hospital Lutsk, Ukraine Vinnytsa Regional Clinical Hospital Vinnytsa, Ukraine Zaporizhzhia Regional Clinical Hospital Zaporizhzhia, Ukraine Less <<
NCT01661413 - Unknown - Canada, Ontario ... More >> The Hospital for Sick Children Recruiting Toronto, Ontario, Canada, M5G 1X8 Contact: Angela Punnett, MD    (416)813-7703    angela.punnett@sickkids.ca    Principal Investigator: Angela Punnett, MD          Principal Investigator: Lee Dupuis, MD Less <<
NCT01668680 Colorectal Cancer Metastatic Phase 2 Terminated(No satisfactory acr... More >>ual) Less << - Israel ... More >> HaEmek Medical Center Afula, Israel, 18101 Less <<
NCT01723150 Liver Abscess, Pyogenic Phase 4 Completed - Singapore ... More >> Singapore General Hospital Singapore, Singapore, 169856 National University Hospital Singapore, Singapore Tan Tock Seng Hospital Singapore, Singapore Less <<
NCT01670084 B-cell Adult Acute Lymphoblast... More >>ic Leukemia Blastic Phase Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 2 Withdrawn(No Accrual) September 2017 United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01675765 Malignant Pleural Mesothelioma Phase 1 Active, not recruiting December 2018 United States, California ... More >> University of California at San Francisco San Francisco, California, United States, 94115 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Maryland National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Pennsylvania University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01674738 Carcinoma, Non-Small-Cell Lung Phase 2 Withdrawn(Decision of the Spon... More >>sor, as the funding of the study was no longer guaranteed.) Less << - -
NCT01083667 Familial Amyotrophic Lateral S... More >>clerosis Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Weill Cornell Medical Center/New York Presbyterian Hospital New York, New York, United States, 10021 United States, Texas Methodist Neurological Institute Houston, Texas, United States, 77030 Germany Universitäts- und Rehabilitationskliniken Ulm Ulm, Germany Italy Milano Neurological Institute Milan, Italy Sweden Umea University Umea, Sweden Less <<
NCT01667289 Extranodal NK/T-cell Lymphoma,... More >> Nasal Type Less << Phase 2 Terminated(unexpected high gra... More >>de of mucositis observed) Less << June 2017 China, Shanghai ... More >> Fudan University Cancer Hospital Shanghai, Shanghai, China, 200032 Less <<
NCT01083667 - Completed - -
NCT01689532 Arthritis, Rheumatoid Phase 3 Completed - Japan ... More >> Asahikawa, Japan Fukuoka, Japan Hiroshima, Japan Hitachinaka, Japan Kagoshima, Japan Kirishima, Japan Kitakyushu, Japan Kobe, Japan Kumamoto, Japan Matsumoto, Japan Miyagi, Japan Oita, Japan Sapporo, Japan Sendai, Japan Shizuoka, Japan Tokyo, Japan Yokohama, Japan Less <<
NCT01084213 Malaria Pregn... More >>ancy Anaemia Less << Phase 4 Completed - Burkina Faso ... More >> Université de Ouagadougou Ouagadougou, Burkina Faso Gambia Medical Research Council Laboratories Basse, Gambia Ghana Navrongo Health Research Centre Navrongo, Ghana Mali Medical Research and Training Centre Bamako, Mali Less <<
NCT01747278 Pneumonia, Pneumocystis ... More >> Prevention & Control Less << Phase 2 Phase 3 Unknown August 2013 China ... More >> Deptment of Rheumatology, Peking Union Medical College Hospital Recruiting Beijing, China, 100032 Contact: Fengchun Zhang, MD    +86-10-69158794    ZhangFCcra@yahoo.com.cn    Principal Investigator: Fengchun Zhang, MD Less <<
NCT01700400 Non Small Cell Lung Cancer Phase 1 Completed - United States, Arizona ... More >> University of Arizona Cancer Center Tuscon, Arizona, United States, 85724 United States, Kentucky University of Kentucky Markey Cancer Center Lexington, Kentucky, United States, 40536 United States, Oregon Providence Cancer Center Portland, Oregon, United States, 97213 United States, Washington Cancer Research And Biostatistics Clinical Trials Consortium Seattle, Washington, United States, 98101 Less <<
NCT01679951 Rheumatoid Arthritis Phase 2 Terminated(The decision was ma... More >>de to prematurely discontinue this trial due to lack of efficacy.) Less << - -
NCT00222729 Cancer Phase 2 Completed - United States, Pennsylvania ... More >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15216 Less <<
NCT00222729 - Completed - -
NCT01689532 - Completed - -
NCT01507974 Pregnancy Complications Not Applicable Unknown May 2017 Israel ... More >> Dep of OG/GYN, Emek Medical Center Recruiting Afula, Israel Contact: MEIRAV BRAVERMAN, MD    0509384595    meiraval@clalit.org.il    Principal Investigator: Meirav Braverman, MD Less <<
NCT01703910 Adenocarcinoma of Colon ... More >> Adenocarcinoma of Rectum Metastatic Disease Less << Phase 2 Completed - Spain ... More >> Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain, 28950 Hospital Madrid Norte Sanchinarro Madrid, Spain, 28050 Less <<
NCT01066663 Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Leukemia Less << Phase 1 Phase 2 Recruiting February 2022 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02115 Principal Investigator: Robin Joyce, MD          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Principal Investigator: Jennifer Brown, MD, PhD Less <<
NCT01705184 Non-small Cell Lung Cancer Met... More >>astatic Nonsquamous Nonsmall Cell Neoplasm of Lung Less << Phase 2 Completed - France ... More >> Avignon - Institut Sainte-Catherine Avignon, France, 84918 Caen - Centre François Baclesse Caen, France, 14000 Caen - CHU Côte de Nacre Caen, France, 14000 Centre Hospitalier Chauny, France CH du Mans Le Mans, France Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques Marseille, France Mulhouse - CH Mulhouse, France, 68000 Nantes - Centre René Gauducheau Nantes, France, 44805 Hopital Tenon - Pneumologie Paris, France, 75020 HCL - Lyon Sud (Pneumologie) Pierre Bénite, France, 69495 Rennes - CHU Rennes, France, 35033 Strasbourg - NHC Strasbourg, France, 63000 Less <<
NCT01529827 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Aplastic Anemia Burkitt Lymphoma Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Grade III Lymphomatoid Granulomatosis Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia Congenital Amegakaryocytic Thrombocytopenia Diamond-Blackfan Anemia Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Juvenile Myelomonocytic Leukemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Paroxysmal Nocturnal Hemoglobinuria Peripheral T-cell Lymphoma Polycythemia Vera Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Primary Myelofibrosis Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Secondary Myelofibrosis Severe Combined Immunodeficiency Severe Congenital Neutropenia Shwachman-Diamond Syndrome Splenic Marginal Zone Lymphoma T-cell Large Granular Lymphocyte Leukemia Waldenstrom Macroglobulinemia Wiskott-Aldrich Syndrome Less << Phase 2 Active, not recruiting December 1, 2018 United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT01964001 Hepatocellular Carcinoma. Phase 2 Phase 3 Completed - Taiwan ... More >> Taichung Verterans General Hospital Taichung, Taiwan, 40705 Less <<
NCT01708993 Non Small Cell Lung Cancer Phase 2 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Canada, British Columbia BCCA - Abbotsford Centre Abbotsford, British Columbia, Canada, V2S 0C2 BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada, V3V 1Z2 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston Kingston, Ontario, Canada, K7L 5P9 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Lakeridge Health Oshawa Oshawa, Ontario, Canada, L1G 2B9 Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Less <<
NCT01707329 Non-small Cell Lung Cancer Phase 2 Unknown December 2016 China, Hunan ... More >> Hunan Province Tumor Hospital Active, not recruiting Changsha, Hunan, China, 410205 China, Zhejiang Sir Run Run Shaw Hospital Active, not recruiting Hangzhou, Zhejiang, China, 310000 The First Affiliated Hospital of Medical School of Zhejiang University Active, not recruiting Hangzhou, Zhejiang, China, 310000 The Second Affiliated Hospital of Zhejiang University School of Medicine Active, not recruiting Hangzhou, Zhejiang, China, 310000 Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310000 Contact: Zhang Yi Ping, M.D.    0086-13750881678    zyp@medmail.com.cn    Principal Investigator: Zhang Yi Ping, M.D.          The First Affiliated Hospital of Wenzhou Medical College Active, not recruiting Wenzhou, Zhejiang, China, 325000 Less <<
NCT01709578 Rheumatoid Arthritis Phase 3 Completed - -
NCT01529827 - Active, not recruiting - -
NCT01709760 Rheumatoid Arthritis Phase 3 Active, not recruiting December 2019 Taiwan ... More >> Changhua Christian Hospital Changhua, Taiwan Buddhist Tzu Chi General Hospital Chiayi City, Taiwan Kaohsiung Chang Gung Memorial Hospital Kaohsiung, Taiwan Kaohsiung Veterans General Hospital Kaohsiung, Taiwan Taichung Veterans General Hospital Taichung, Taiwan, 407 China Medical University Hospital Taichung, Taiwan Chung Shan Medical University Hospital Taichung, Taiwan Taipei City Hospital Taipei, Taiwan Less <<
NCT01710358 Rheumatoid Arthritis Phase 3 Completed - -
NCT01102686 Gangliosidoses, GM2 ... More >> Sandhoff Disease Tay-Sachs Disease Less << Phase 1 Phase 2 Completed - Canada, Ontario ... More >> The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT01700946 Recurrent B-Cell Childhood Acu... More >>te Lymphoblastic Leukemia Recurrent Childhood B-Lymphoblastic Lymphoma Less << Phase 2 Recruiting October 2021 United States, California ... More >> Rady Children's Hospital and Health Center Completed San Diego, California, United States, 92123 United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Sima Jeha, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Sima Jeha, MD          United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Kenneth M. Heym, MD    682-885-4007       Principal Investigator: Kenneth M. Heym, MD Less <<
NCT01715896 Rheumatoid Arthritis Phase 2 Completed - -
NCT01716039 Ulcerative Colitis Phase 4 Active, not recruiting July 31, 2019 -
NCT01777737 Idiopathic Pulmonary Fibrosis Phase 3 Terminated(Changes in standard... More >>s of care) Less << - Spain ... More >> Hospital Universitario Virgen del Rocío/ Instituto de Biomedicina de Sevilla Sevilla, Spain, 41013 Less <<
NCT01709578 - Completed - -
NCT01714037 Non-small Cell Lung Cancer Phase 1 Terminated - France ... More >> Centre GF Leclerc Dijon, France Centre Léon Bérard Lyon, France Institut de Cancérologie de l'Ouest- Institut René Gauduchau Nantes, France Institut Claudius Regaud Toulouse, France Spain Hospital Universitari Vall d'Hebron Barcelona, Spain Hospital Puerta de Hierro Majadahonda Madrid, Spain Hospital Universitario Virgen del Rocío Seville, Spain United Kingdom Freeman Hospital Newcastle, United Kingdom Less <<
NCT01115244 Dermatitis Herpetiformis Phase 4 Terminated(poor enrollment and... More >> lack of funding) Less << - United States, Tennessee ... More >> Vanderbilt University - One Hundred Oaks Nashville, Tennessee, United States, 37204 Less <<
NCT01724268 RHEUMATOID ARTHRITIS Phase 3 Unknown September 2014 Qatar ... More >> Hamad General Hospital Recruiting Doha, Ad Dawha, Qatar, 3050 Contact: MAGDI H ABDELRAHMAN, MBBS       mrahman1@hmc.org.qa Less <<
NCT01115244 - Terminated(poor enrollment and... More >> lack of funding) Less << - -
NCT01792804 Staphylococcus Aureus Infectio... More >>n Less << Phase 3 Recruiting October 2019 -
NCT01715896 - Completed - -
NCT01737671 Brain Tumor M... More >>alignant Neoplasm of Fourth Ventricle of Brain Less << Early Phase 1 Completed - United States, Texas ... More >> Children's Memorial Hermann Hospital Houston, Texas, United States, 77030 University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01710358 - Completed - -
NCT01232920 Uveitis Phase 3 Completed - India ... More >> Aravind Eye Hospital Coimbatore, Tamil Nadu, India Aravind Eye Hospital Madurai, Tamil Nadu, India Less <<
NCT01737944 - Completed - -
NCT01120145 - Completed - Malawi ... More >> Machinga District Hospital Liwonde, Machinga District, Malawi Less <<
NCT01737944 Rheumatoid Arthritis Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 Less <<
NCT01232920 - Completed - -
NCT01745055 Rheumatoid Arthritis Phase 1 Completed - United States, Florida ... More >> Pfizer Investigational Site Daytona Beach, Florida, United States, 32114 Pfizer Investigational Site Fort Lauderdale, Florida, United States, 33301 Pfizer Investigational Site Miramar, Florida, United States, 33025 United States, Texas Pfizer Investigational Site Dallas, Texas, United States, 75247 Less <<
NCT01743131 Graft vs Host Disease ... More >> Malignancy Less << Phase 2 Active, not recruiting February 2023 -
NCT01746277 Non Small Cell Lung Cancer Phase 2 Unknown June 2016 China ... More >> Department of Respiratory Medicne, Peking Union Medical Hospital Recruiting Beijing, China, 100730 Contact: Mengzhao Wang, MD    010-69155039    mengzhaowang@sina.com    Contact: Jing Zhao, MD    010-69158206    zhaojing0@163.com    Sub-Investigator: Wei Zhong, MD Less <<
NCT01746680 Rheumatoid Arthritis Phase 4 Completed - Korea, Republic of ... More >> Kyung Hee University Hospital Seoul, Korea, Republic of Less <<
NCT01745055 - Completed - -
NCT01749787 Arthritis, Rheumatoid Phase 1 Completed - United States, California ... More >> Protalex Investigative Site Los Angeles, California, United States, 90036 United States, Florida Protalex Investigational Site Sarasota, Florida, United States, 34239 United States, Idaho Protalex Investigational Site Coeur d'Alene, Idaho, United States, 83814 United States, Indiana Protalex Investigational Site Anderson, Indiana, United States, 46011 United States, New Mexico Protalex Investigational Site Albuquerque, New Mexico, United States, 87102 United States, North Carolina Protalex Investigational Site Salisbury, North Carolina, United States, 28144 United States, Pennsylvania Protalex Investigational Site Duncansville, Pennsylvania, United States, 16635 United States, Texas Protalex Investigational Site Allen, Texas, United States, 75013 Less <<
NCT01431170 Congenital Nasolacrimal Duct O... More >>bstruction Less << Phase 1 Completed - United States, New Jersey ... More >> Institute of Ophthalmology and Visual Science, RUTGERS-New Jersey Medical School Newark, New Jersey, United States, 07103 Less <<
NCT01751776 Arthritis, Rheumatoid ... More >> Healthy Less << Phase 1 Completed - Czech Republic ... More >> 1293.2.00049 Boehringer Ingelheim Investigational Site Olomouc, Czech Republic 1293.2.00024 Boehringer Ingelheim Investigational Site Uherske Hradiste, Czech Republic 1293.2.00028 Boehringer Ingelheim Investigational Site Zlin, Czech Republic Germany 1293.2.00015 Boehringer Ingelheim Investigational Site Bad Kreuznach, Germany 1293.2.00010 Boehringer Ingelheim Investigational Site Berlin, Germany 1293.2.00013 Boehringer Ingelheim Investigational Site Berlin, Germany 1293.2.00043 Boehringer Ingelheim Investigational Site München, Germany 1293.2.00012 Boehringer Ingelheim Investigational Site Zerbst, Germany Netherlands 1293.2.00031 Boehringer Ingelheim Investigational Site Amsterdam, Netherlands 1293.2.00032 Boehringer Ingelheim Investigational Site Leeuwarden, Netherlands 1293.2.00038 Boehringer Ingelheim Investigational Site Leiden, Netherlands 1293.2.00040 Boehringer Ingelheim Investigational Site Sneek, Netherlands New Zealand 1293.2.00001 Boehringer Ingelheim Investigational Site Grafton Auckland NZ, New Zealand Poland 1293.2.00039 Boehringer Ingelheim Investigational Site Bialystok, Poland 1293.2.00034 Boehringer Ingelheim Investigational Site Bydgoszcz, Poland 1293.2.00041 Boehringer Ingelheim Investigational Site Bydgoszcz, Poland 1293.2.00025 Boehringer Ingelheim Investigational Site Lublin, Poland 1293.2.00050 Boehringer Ingelheim Investigational Site Poznan, Poland 1293.2.00023 Boehringer Ingelheim Investigational Site Warsaw, Poland 1293.2.00026 Boehringer Ingelheim Investigational Site Warszawa, Poland Spain 1293.2.00021 Boehringer Ingelheim Investigational Site A Coruña, Spain 1293.2.00017 Boehringer Ingelheim Investigational Site Barcelona, Spain 1293.2.00022 Boehringer Ingelheim Investigational Site Granada, Spain 1293.2.00016 Boehringer Ingelheim Investigational Site La Laguna (Sta Cruz Tenerife), Spain 1293.2.00020 Boehringer Ingelheim Investigational Site Santiago de Compostela, Spain Less <<
NCT01808755 Recurrent Urinary Tract Infect... More >>ion Less << Phase 3 Completed - Italy ... More >> Urology Department Fondazione IRCCS Policlinico San Matteo Pavia, Italy, 27100 Less <<
NCT01749111 Acute Myelogenous Leukemia ... More >> Acute Lymphoid Leukemia Myeloproliferative Disease Myelodysplastic Syndrome Chronic Myeloid Leukemia Chronic Myelomonocytic Leukemia Less << Phase 3 Terminated(Lack of accrual) - Brazil ... More >> Instituto Israelita de Ensino e Pesquisa Albert Einstein 's (IIEP) São Paulo, Brazil, 05652-000 Less <<
NCT01808755 - Completed - -
NCT01754389 - Completed - -
NCT01754389 Graft Versus Host Disease Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Insitute Boston, Massachusetts, United States, 02215 Less <<
NCT01754805 Rheumatoid Arthritis Phase 1 Completed - United States, Alabama ... More >> Anniston, Alabama, United States, 36207 Less <<
NCT01431170 - Completed - -
NCT01746992 ALK-negative Anaplastic Large ... More >>Cell Lymphoma Peripherial T Cell Lymphoma,Not Otherwise Specified Angioimmunoblastic T Cell Lymphoma Enteropathy Associated T Cell Lymphoma Hepatosplenic T Cell Lymphoma Subcutaneous Panniculitis Like T Cell Lymphoma Less << Phase 4 Active, not recruiting December 2018 China, Shanghai ... More >> Ruijin hospital Shanghai, Shanghai, China, 200025 Less <<
NCT01144650 Cerebral Stroke ... More >> Cerebrovascular Accident, Acute Cerebrovascular Stroke Stroke, Acute Stroke Less << Phase 2 Phase 3 Unknown November 2010 Mexico ... More >> El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez Recruiting Tlalpan, Mexico City., Mexico, 14269 Contact: Jorge L Alvarado, MSc    (52-55) 5606-3822 ext 1060    jorgelaa3@hotmail.com    Principal Investigator: José A Santos, MD          Sub-Investigator: Rubén Martínez, MD Less <<
NCT01629511 Allogeneic Hematopoietic Stem ... More >>Cell Transplantation Recipient Chronic Lymphocytic Leukemia Prolymphocytic Leukemia Richter Syndrome Less << Phase 1 Phase 2 Terminated - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01758198 Rheumatoid Arthritis Phase 4 Completed - -
NCT01757236 Hip Prosthetic Joint Infection Phase 2 Unknown April 2016 France ... More >> CHRU de Tours Recruiting Tours, Indre et Loire, France, 37044 Contact: Louis BERNARD    +33 (0) 2 47 47 97 74    l.bernard@chu-tours.fr    Principal Investigator: Louis BERNARD          CHU de Nantes Recruiting Nantes, France Contact: David BOUTOILLE          Principal Investigator: David BOUTOILLE          CHU de Poitiers Not yet recruiting Poitiers, France Contact: Gwenaël LE MOAL          Principal Investigator: Gwenaël LE MOAL          Centre de Chirurgie Orthopédique et de la Main Recruiting Strasbourg, France, 67400 Contact: Jeannot GAUDIAS       Jeannot.GAUDIAS@chru-strasbourg.fr    Principal Investigator: Jeannot GAUDIAS          CH de Tourcoing Not yet recruiting Tourcoing, France, 59208 Contact: Eric SENNEVILLE       esenneville@ch-tourcoing.fr    Principal Investigator: Eric SENNEVILLE          Italy Azienda Opedaliera Universitaria San Maria della Misericordia Recruiting Udine, Italy, 33100 Contact: Matteo BASSETTI       mattba@tin.it    Principal Investigator: Matteo BASSETTI          Spain Hospital Clinic of Barcelona Recruiting Barcelona, Spain, 08036 Contact: Alex SORIANO       ASORIANO@clinic.ub.es    Principal Investigator: Alex SORIANO          Hospital General Universitario Gregorio Maranon Not yet recruiting Madrid, Spain, 28007 Contact: Mar SANCHEZ SOMOLINOS          Principal Investigator: Mar SANCHEZ SOMOLINOS          Hospital Son Llatzer Not yet recruiting Palma de Mallorca, Spain, 07198 Contact: Bartolome LLADO FERRER          Principal Investigator: Bartolome LLADO FERRER Less <<
NCT01760226 Diffuse Large B Cell Lymphoma ... More >> Post Transplant Lymphoproliferative Disorder Primary Mediastinal (Thymic) Large B-cell Lymphoma Less << Early Phase 1 Completed - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT01764997 Rheumatoid Arthritis Phase 3 Terminated(Due to small number... More >> of participants entering randomization. Not a safety issue.) Less << - -
NCT01764997 - Terminated(Due to small number... More >> of participants entering randomization. Not a safety issue.) Less << - -
NCT01820897 Urinary Tract Infection ... More >> Asymptomatic Bacteriuria Allograft Rejection Microbiologic Resistance Hospitalization Less << Phase 4 Completed - Mexico ... More >> National Institute of Medical Sciences and Nutrition Salvador Zubiran Mexico city, Distrito Federal, Mexico, 14000 National Institute of Medical Science and Nutrition Salvador Zubiran México, Mexico DF, Mexico, 14000 Less <<
NCT01768572 Rheumatoid Arthritis Phase 3 Completed - -
NCT01769209 B-cell Adult Acute Lymphoblast... More >>ic Leukemia (ALL) Ph-positive Adult Acute Lymphoblastic Leukemia (ALL) Recurrent Adult Acute Lymphoblastic Leukemia (ALL) T-cell Adult Acute Lymphoblastic Leukemia (ALL) Less << Phase 2 Completed - United States, California ... More >> Stanford University, School of Medicine Stanford, California, United States, 94305 Less <<
NCT01768572 - Completed - -
NCT01773395 Myelodysplastic Syndrome ... More >> Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia Less << Phase 2 Recruiting January 2033 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Yi-Bin Chen, MD    617-726-5765    YCHEN6@partners.org    Principal Investigator: Yi-Bin Chen, MD          Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Vincent Ho, MD    617-632-5938    vtho@partners.org    Principal Investigator: Vincent Ho, MD          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Vincent Ho, MD    617-632-5938    vtho@partners.org    Principal Investigator: Vincent Ho, MD          Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Jacalyn Rosenblatt, MD    617-667-9920    jrosenb1@bidmc.harvard.edu    Principal Investigator: Jacalyn Rosenblatt, MD Less <<
NCT01832987 Tuberculosis Phase 2 Completed - Netherlands ... More >> UMCG - Tuberculosis Center Groningen, Netherlands Less <<
NCT01165840 - Completed - -
NCT01769209 - Completed - -
NCT01836120 Gastric Cancer Phase 2 Unknown June 2017 China, Hebei ... More >> Hebei Tumor Hospital Shijiazhuang, Hebei, China, 050011 Less <<
NCT01781988 Lung Cancer C... More >>arboplatin Adverse Reaction Less << Phase 2 Completed - China, Guangdong ... More >> The first affiliated hospital of Guangzhou MC Guangzhou, Guangdong, China, 510120 Less <<
NCT01774578 Non-small Cell Lung Cancer ... More >> Progression of Non-small Cell Lung Cancer Non-small Cell Lung Cancer Recurrent Less << Phase 2 Phase 3 Active, not recruiting - -
NCT01783015 Rheumatoid Arthritis Phase 4 Terminated(This study was prem... More >>aturely terminated on June 25, 2014 due to lack of enrollment.) Less << - Australia, Western Australia ... More >> RK Will Pty Ltd Victoria Park, Western Australia, Australia, 6100 Belgium Cliniques Universitaires Saint-Luc / Service de Rhumatologie Bruxelles, Belgium, 1200 France Hopital Lapeyronie Montpellier, France, 34295 cedex 5 Hong Kong Tseung Kwan O Hospital Tseung Kwan O, New Territories, Hong Kong Tseung Kwan O Hospital Tseung Kwan O, NT, Hong Kong Israel Bnai Zion Medical Ctr Pharmacy Haifa, Israel, 31048 Meir Medical Center pharmacy Kfar Saba, Israel, 44281 Russian Federation LLC "Alliance Biomedical - Russian Group" Izhevsk, Russian Federation, 426063 LLC Research Medical Complex "Your Health" based on City Clinical Hospital #7 Kazan, Russian Federation, 420103 Scientific Institute of Rheumatology of Russian Academy of Medical Science Moscow, Russian Federation, 115522 GBOU VPO Moscow State University of Medicine and Dentistry Moscow, Russian Federation, 129301 Spain Hospital de la Santa Creu i San Pau Barcelona, Spain, 08025 Hospital Regional Universitario Carlos Haya. Hospital Civil Málaga, Spain, 29009 Hospital Regional Universitario Carlos Haya. Málaga, Spain, 29010 Hospital Infanta Luisa Sevilla, Spain, 41010 Less <<
NCT01783015 - Terminated(This study was prem... More >>aturely terminated on June 25, 2014 due to lack of enrollment.) Less << - -
NCT01783197 Non Small Cell Lung Cancer Phase 1 Active, not recruiting December 2018 Canada, British Columbia ... More >> BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston Kingston, Ontario, Canada, K7L 5P9 Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 Less <<
NCT01788189 B-cell Lymphoma Phase 1 Phase 2 Recruiting June 2019 Germany ... More >> Klinik für Hämatologie, Universitätsklinikum Essen Recruiting Essen, Germany, 45147 Contact: Ulrich Dührsen, Prof. Dr. med.    +49-201-723 ext 2417    ulrich.duehrsen@uk-essen.de    Principal Investigator: Ulrich Dührsen, Prof. Dr. med. Less <<
NCT01784549 Non Small Cell Lung Cancer Phase 2 Unknown December 2015 Italy ... More >> IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro Recruiting Genoa, Italy, 16132 Contact: Francesco Grossi, MD    +393355255484    fg1965@libero.it Less <<
NCT01843920 Scleral Buckling Not Applicable Completed - United States, Pennsylvania ... More >> Mid Atlantic Retina- Wills Eye Institute Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01843920 - Completed - -
NCT01790568 Graft vs Host Disease ... More >> Hematologic Neoplasms Non-Neoplastic Hematologic and Lymphocytic Disorder Less << Phase 2 Completed - United States, Michigan ... More >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT01788501 Graft vs Host Disease Phase 2 Phase 3 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT01790568 - Completed - -
NCT01791153 Giant Cell Arteritis Phase 3 Active, not recruiting April 30, 2018 -
NCT01793259 Rheumatoid Arthritis Phase 3 Completed - Germany ... More >> Kerckhoff Clinic Bad Nauheim, Germany, 61231 Less <<
NCT01800162 Persistent Pregnancy of Unknow... More >>n Location Ectopic Pregnancy Less << Phase 1 Phase 2 Terminated(A new protocol was ... More >>written to replace this protocol.) Less << - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Greenville Hospital System University Medical Center Greenville, South Carolina, United States, 29605 Less <<
NCT01791153 - Active, not recruiting - -
NCT00528619 Neoplasms Phase 1 Completed - United States, Colorado ... More >> Pfizer Investigational Site Aurora, Colorado, United States, 80045 Canada, Ontario Pfizer Investigational Site Ottawa, Ontario, Canada, K1H 8L6 Canada, Quebec Pfizer Investigational Site Montreal, Quebec, Canada, H2L 4M1 Less <<
NCT01786018 B-cell Lymphoma Refractory Phase 2 Unknown February 2015 Italy ... More >> Città della Salute e della Scienza di Torino Recruiting Torino, Italy, 10126 Contact: Benedetto Bruno, MD    +390116336728    benedetto.bruno@unito.it Less <<
NCT01802593 Crohn's Disease Phase 4 Terminated(lack of budget and ... More >>failure to reach milestones) Less << - Israel ... More >> The E. Wolfson.Medical Center Holon, Israel, 58100 Less <<
NCT01803282 Tumors Pancre... More >>atic Cancer Non-small Cell Lung Cancer Esophagogastric Cancer Colorectal Cancer Breast Cancer Less << Phase 1 Active, not recruiting February 2019 United States, Alabama ... More >> Alabama Oncology Birmingham, Alabama, United States, 35213 United States, Arizona Pinnacle Oncology Hematology Scottsdale, Arizona, United States, 85258 United States, California Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309 San Diego Pacific Oncology and Hematology Associates, Inc. Encinitas, California, United States, 92024 University of Southern California (USC) Los Angeles, California, United States, 90033 California Pacific Medical Center San Francisco, California, United States, 94115 UCLA Medical Center Santa Monica, California, United States, 90404 United States, Florida Florida Cancer Specialists Sarasota, Florida, United States, 34232 United States, Indiana Parkview Research Center Fort Wayne, Indiana, United States, 46845 Indiana University Health Goshen Center for Cancer Care Goshen, Indiana, United States, 46526 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Cornell University New York, New York, United States, 10021 United States, South Carolina Greenville Health System, Institute for Translational Oncology Research Greenville, South Carolina, United States, 29605 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Vanderbilt Nashville, Tennessee, United States, 37212 United States, Texas UT Southwestern Dallas, Texas, United States, 75390 United States, Utah University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Northwest Medical Specialties Tacoma, Washington, United States, 98405 Less <<
NCT01809210 Locally Advanced or Metastatic... More >> NSCL Cancer Stage IIIB IV Less << Phase 1 Completed - United Kingdom ... More >> Research Site Glasgow, United Kingdom, G12 0YN Research Site London, United Kingdom, W1G 6AD Research Site Manchester, United Kingdom, M20 4BX Research Site Newcastle upon Tyne, United Kingdom, NE7 7DN Less <<
NCT01165840 Obesity Lepro... More >>sy Tuberculosis Less << Phase 4 Completed - United States, Texas ... More >> University of Texas Southwestern Dallas, Texas, United States, 75390 Less <<
NCT01812369 Bladder Cancer Phase 3 Recruiting August 2021 France ... More >> UHRouen Recruiting Rouen, France, 76031 Contact: Christian PFISTER, MD    00332888163    christian.fister@chu-rouen.fr    Principal Investigator: Christian PFISTER, MD Less <<
NCT01809210 - Completed - -
NCT00545948 Carcinoma, Non-Small-Cell Lung Phase 2 Terminated(Study terminated du... More >>e to reproducibility issues with genomics prediction model.) Less << - United States, Florida ... More >> Palm Beach Cancer Institute West Palm Beach, Florida, United States, 33401 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, North Carolina Presbyterian HealthCare Charlotte, North Carolina, United States, 28204 Duke University Medical Center Durham, North Carolina, United States, 27710 Maria Parham Hospital Henderson, North Carolina, United States, 27536 Scotland HealthCare System (Scotland Memorial Hospital) Laurinburg, North Carolina, United States, 28352 Southeastern Regional Medical Center, Gibson Cancer Center Lumberton, North Carolina, United States, 28358 Duke Raleigh Hospital Raleigh, North Carolina, United States, 27609 Johnston Memorial Hospital Authority Smithfield, North Carolina, United States, 27577 Columbus County Hospital Whiteville, North Carolina, United States, 28472 United States, South Carolina Beaufort Memorial Hospital Beaufort, South Carolina, United States, 29902 Coastal Cancer Center Myrtle Beach, South Carolina, United States, 29572 United States, Virginia Community Memorial Health Center South Hill, Virginia, United States, 23970 Less <<
NCT01800162 - Terminated(A new protocol was ... More >>written to replace this protocol.) Less << - -
NCT00545948 - Terminated(Study terminated du... More >>e to reproducibility issues with genomics prediction model.) Less << - -
NCT01810926 Graft Versus Host Disease Phase 2 Unknown October 2016 Italy ... More >> University of Cagliari Active, not recruiting Cagliari, Italy, 09126 San Raffaele Scientific Institute Active, not recruiting Milano, Italy, 20132 University of Milano-Bicocca San Gerardo Hospital Active, not recruiting Monza, Italy, 20052 Bambino Gesù Hospital and Research Institute Recruiting Rome, Italy, 00165 Contact: Maria Ester Bernardo, MD       mebernardo@gmail.com    Principal Investigator: Franco Locatelli Less <<
NCT01828112 Non-Small Cell Lung Cancer Phase 3 Active, not recruiting February 15, 2021 -
NCT01184911 Intermittent Preventive Treatm... More >>ent Placental Malaria Less << Phase 4 Withdrawn(Research plan change... More >>d; no longer conducting clinical trial.) Less << September 2011 Uganda ... More >> Infectious Disease Research Center Tororo, Uganda Less <<
NCT01828112 - Active, not recruiting - -
NCT01840579 Solid Tumor N... More >>on-small Cell Lung Cancer Small Cell Lung Cancer Less << Phase 1 Active, not recruiting April 17, 2020 -
NCT01844895 Rheumatoid Arthritis Phase 3 Completed - -
NCT01823198 Leukemia Phase 1 Phase 2 Recruiting June 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01844895 - Completed - -
NCT01850303 Non Small Cell Lung Cancer (Sq... More >>uamous or Non Squamous) Less << Phase 3 Active, not recruiting December 2018 -
NCT01848652 Cerebral Lymphoma B Cell Refra... More >>ctory Less << Phase 2 Terminated(The laboratory's pa... More >>rtner on this study decides to terminate the contract with the CHRU Brest, because of the difficulty of the recruitment.) Less << - France ... More >> CHRU de Brest Brest, France, 29609 Hôpital Pitié Salpêtrière Paris, France, 75651 CHU de Rennes Hôpital Pontchaillou Rennes, France, 35033 Less <<
NCT01851707 Rheumatoid Arthritis Phase 2 Completed - -
NCT01854372 Newly Diagnosed Diffuse Large ... More >>B-Cell Lymphoma Intermediate (Burkitt-Like) Lymphoma Less << Phase 2 Withdrawn - -
NCT01876082 Progressive Desmoids Tumors Phase 2 Recruiting July 2020 France ... More >> Institut Bergonié Recruiting Bordeaux, Aquitaine, France, 33000 Contact: ITALIANO Antoine, MD       a.italiano@bordeaux.unicancer.fr    Principal Investigator: ITALIANO Antoine, MD Less <<
NCT01878318 Rheumatoid Arthritis Phase 4 Withdrawn June 2015 -
NCT01931150 - Completed - -
NCT01878617 Medulloblastoma Phase 2 Recruiting December 2026 -
NCT01855568 Ectopic Pregnancy Phase 3 Completed - Korea, Republic of ... More >> CHA Gangnam Medical Center Seoul, Korea, Republic of Less <<
NCT01255605 - Completed - Burkina Faso ... More >> Institut Supérieur des Sciences de la Santé/Université Polytechnique de Bobo-Dioulasso Bobo-Dioulasso, Houet, Burkina Faso, 1091 Less <<
NCT01931150 Cetuximab-induced Papulopustul... More >>ar (Acneiform) Rash Who Have Metastatic Colorectal Cancer or Head and Neck Squamous Cell Carcinoma Less << Phase 3 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01848457 Osteosarcoma ... More >>Nephrotoxicity Ototoxicity Less << Phase 2 Active, not recruiting January 2019 United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01823315 Gestational Trophoblastic Dise... More >>ase Gestational Trophoblastic Neoplasia Gestational Trophoblastic Tumor Gestational Trophoblastic Neoplasms Less << Phase 3 Active, not recruiting December 2018 China, Hubei ... More >> Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China, 430030 China, Shandong Qilu Hospital，Shandong University Jinan, Shandong, China, 250012 China, Zhejiang Women's Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China, 310006 Less <<
NCT01884636 Pharmacokinetics of Isavuconaz... More >>ole Pharmacokinetics of Methotrexate Pharmacokinetics of 7-hydroxymethotrexate Healthy Subjects Less << Phase 1 Completed - United States, California ... More >> California Clinical Trials Medical Group Glendale, California, United States, 91026 Less <<
NCT01886651 - Completed - Denmark ... More >> Kjeld Schmiegelow Copenhagen, Denmark, 2100 Less <<
NCT01885611 Hansen's Disease Phase 1 Phase 2 Withdrawn(There was a problem ... More >>with funding and with the acquisition of the lab assays) Less << June 2018 Philippines ... More >> Philippine General Hospital Manila, Philippines, 1000 Less <<
NCT01888874 Rheumatoid Arthritis Phase 2 Completed - -
NCT01895309 - Completed - -
NCT01884623 Head Neck Cancer Squamous Cell... More >> Recurrent Less << Phase 3 Active, not recruiting August 2023 France ... More >> Institut Gustave Roussy Villejuif, Val De Marne, France, 94805 Less <<
NCT01895764 Ankylosing Spondylitis Phase 4 Completed - France ... More >> Rhumatologie, CH de BLOIS Blois, France, 41000 Rhumatologie, CHRU de BREST Brest, France, 29609 Rhumatologie, CHD LA ROCHE SUR YON La Roche Sur Yon, France, 85925 Rhumatologie, CHR du MANS Le Mans, France, 72037 Rhumatologie, CHRU de NANTES Nantes, France, 44093 Rhumatologie / IPROS, CHR d'ORLEANS Orleans, France, 45032 Rhumatologie, CHRU de POITIERS Poitiers, France, 86021 Rhumatologie, CHRU de RENNES Rennes, France, 35203 Rhumatologie, CH de SAINT BRIEUC Saint Brieuc, France, 22027 Médecine polyvalente, CH de SAINT NAZAIRE Saint Nazaire, France, 44606 Rhumatologie, CHRU de TOURS Tours, France, 37044 Less <<
NCT01909427 Rheumatoid Arthritis Phase 2 Completed - Argentina ... More >> Buenos Aires, Argentina Ciudad Autonoma Buenos Aires, Argentina Cordoba, Argentina La Capital, Argentina San Juan, Argentina Colombia Barranquilla, Colombia Bogota, Colombia Medellín, Colombia Czech Republic Jihlava, Czech Republic Praha 5, Czech Republic Praha, Czech Republic Philippines Cebu, Philippines Iloilo City, Philippines Lipa City, Philippines Quezon City, Philippines Poland Bydgoszcz, Poland Grodzisk Mazowiecki, Poland Lodz, Poland Lublin, Poland Poznan, Poland Warszawa, Poland Wroclaw, Poland Russian Federation Barnaul, Russian Federation Ekaterinburg, Russian Federation Kemerovo, Russian Federation Kursk, Russian Federation Moscow, Russian Federation Novosibirsk, Russian Federation Petrozavodsk, Russian Federation Saint-Petersburg, Russian Federation St. Petersburg, Russian Federation Yaroslavl, Russian Federation Thailand Bangkok, Thailand Chiang Mai, Thailand Less <<
NCT01909830 Colorectal Cancer Metastatic Phase 2 Completed - Italy ... More >> UO Oncologia Medica IRCCS IRST Meldola (FC), FC, Italy, 47014 Less <<
NCT01312818 - Terminated(Slow accrual) - -
NCT01707199 Uncomplicated P. Falciparum Ma... More >>laria Less << Not Applicable Unknown December 2013 Afghanistan ... More >> Narang, Asadabad, Watapoor district health centres Recruiting Kunar, Afghanistan Contact: Ghulam Rahim Awab, MD       awabgr@yahoo.com    Principal Investigator: Ghulam Rahim Awab, MD Less <<
NCT01312818 Acute Lymphoblastic Leukemia Phase 2 Terminated(Slow accrual) - United States, Minnesota ... More >> Masonic Cancer Center, University if Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01920737 Leukemia Phase 2 Recruiting August 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Jae Park, MD    212-639-4048       Contact: Martin Tallman, MD          Principal Investigator: Jae Park, MD          Weill Cornell Medical Center Recruiting New York, New York, United States Contact: Ellen Ritchie, MD          Principal Investigator: Ellen Ritchie, MD          United States, North Carolina Duke University Medical Center Active, not recruiting Durham, North Carolina, United States, 27701 United States, Pennsylvania Lehigh Valley Health Network Recruiting Allentown, Pennsylvania, United States, 18103 Contact: Brian Patson, MD    610-402-7880 Less <<
NCT01895309 Rheumatoid Arthritis Phase 3 Completed - Poland ... More >> Investigational Site Kielce, Poland United Kingdom Investigational Site Southampton, Hampshire, United Kingdom Less <<
NCT01973933 Healthy Phase 1 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seoul, Korea, Republic of Less <<
NCT01927484 Reduction in Pain ... More >> Reduction of Inflammation Improvement in Function Less << Phase 2 Unknown September 2013 Egypt ... More >> Faculty of Medicine Alexandria, Egypt, 00203 Less <<
NCT01967758 Astrocytic Tumors ... More >> Glioblastoma Multiforme Anaplastic Astrocytoma Brain Tumor Less << Phase 1 Completed - United States, Oregon ... More >> Providence Cancer Center Portland, Oregon, United States, 97213 Less <<
NCT01927757 Moderate to Severe Rheumatoid ... More >>Arthritis Less << Phase 4 Terminated(Business decision d... More >>ue to slow enrollment) Less << - -
NCT01933282 Lymphoma, Extranodal NK-T-Cell Phase 2 Unknown January 2015 China, Shaanxi ... More >> Department of Hemaology, Xi jing Hospital,The Fourth Military Medical University Recruiting Xi'an, Shaanxi, China, 710032 Contact: rong liang, associate professor    86 13384933870    rongliang1017@gmail.com    Contact: Li Zhu, nurse    86 29 775202    xueyeke@fmmu.edu.cn    Principal Investigator: xie qun chen, professor          Sub-Investigator: Rong Liang, associate professor Less <<
NCT01927757 - Terminated(Business decision d... More >>ue to slow enrollment) Less << - -
NCT01449877 Ocular Toxoplasmosis Phase 3 Completed - Brazil ... More >> University of Campinas - Ophthalmology Department Campinas, São Paulo, Brazil, 13083570 Less <<
NCT01403415 Childhood B Acute Lymphoblasti... More >>c Leukemia Childhood T Acute Lymphoblastic Leukemia Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Lymphoblastic Lymphoma Less << Phase 1 Completed - -
NCT01404429 Rheumatoid Arthritis Phase 4 Completed - India ... More >> New OPD Block, Rheumatology Clinic, Level 3 Chandigarh, India, 160012 Less <<
NCT01401192 Non-small Cell Lung Cancer Phase 2 Unknown - Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Myung-Ju Ahn, M.D., Ph.D.          Sub-Investigator: Jong-Mu Sun, M.D., Ph.D. Less <<
NCT01936181 - Completed - -
NCT01404429 - Completed - -
NCT01936181 Rheumatoid Arthritis Phase 3 Completed - Bulgaria ... More >> Investigational Site Hristo Botev Str., Sliven, Bulgaria, 8800 Lithuania Investigational Site Santariskiu, Vilnius, Lithuania, 08661 Less <<
NCT01941095 Rheumatoid Arthritis Phase 3 Completed - Greece ... More >> District Gen. Hosp. of Athens Laiko; A Propedeutic Internal Medicine Clinic & Research Center Athens, Greece, 115 27 Laiko General Hospital; Dept. of Pathophysiology-Uni of Athens Athens, Greece, 115 27 Hippokratio Hospital; 2Nd Internal Medicine Athens, Greece, 11527 ATTIKO Hospital_4th University Internal Medicine Clinic Haidari, Greece, 124 62 Uni General Hospital of Heraklion; Medicine and Rheumatology Clinical Immunology and Allergy Dept Heraklion, Greece, 711 10 Uni Hospital of Ioannina; Rheumatology Ioannina, Greece, 455 00 University General Hospital of Larissa; Rheumatology Unit Larissa, Greece, 411 10 University Hospital of Patras; Rheumatology Patras, Greece, 265 04 EUROMEDICA Geniki Kliniki Thessalonikis; Rheumatology Department Thessaloniki, Greece, 544 65 General Hospital of Thessaloniki HIPPOKRATIO; Clinical Immunology Unit,2nd Dept of Internal Medicine Thessaloniki, Greece, 546 42 Less <<
NCT01410695 Rheumatoid Arthritis (RA) Phase 2 Phase 3 Terminated(Sponsor decision ba... More >>sed on portfolio prioritization) Less << - Czechia ... More >> ARTMEDI UPD s.r.o Hostivice, Czechia, 25301 Less <<
NCT01411267 Lymphoblastic Leukemia, Acute,... More >> Childhood Myelogenous Leukemia, Acute, Childhood Less << Phase 1 Completed - -
NCT01414257 - Completed - Japan ... More >> University of Occupational and Environmental Health Hospital Kitakyushu-shi, Fukuoka-ken, Japan Less <<
NCT00852371 Malaria Inter... More >>mittent Preventive Treatment Less << Phase 3 Completed - -
NCT01424982 Acute Lymphoblastic Leukemia ... More >> Adult Acute Lymphoblastic Leukemia in Complete Remission B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Philadelphia Chromosome Positive Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 2 Recruiting October 31, 2021 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Elias Jabbour    713-792-7026       Principal Investigator: Elias Jabbour Less <<
NCT01414257 - Completed - -
NCT01438021 Leptomeningeal Metastases Not Applicable Withdrawn(Lack of funding) - -
NCT00857077 Anaemia Malar... More >>ia Less << Not Applicable Completed - Ghana ... More >> Navrongo Health Research Centre Navrongo, Upper East Region, Ghana Less <<
NCT01442545 Rheumatoid Arthritis Phase 1 Completed - United States, Florida ... More >> Daytona Beach, Florida, United States United States, Pennsylvania Duncansville, Pennsylvania, United States United States, Texas Dallas, Texas, United States Germany Berlin, Germany Munich, Germany Less <<
NCT01432145 Breast Cancer ... More >> Ovarian Cancer Less << Phase 2 Completed - United Kingdom ... More >> Churchill Hospital Oxford, United Kingdom, OX3 7LJ Less <<
NCT01442909 Non-small-cell Lung Cancer Phase 4 Completed - Taiwan ... More >> Taipei VGH Taipei City, Taiwan, 112 Less <<
NCT01443078 - Completed - -
NCT01173120 Rheumatoid Arthritis (RA) Phase 3 Completed - -
NCT01443078 Lung Cancer Phase 2 Completed - United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT01446978 Vaccine Response Impaired Phase 2 Unknown August 2016 Sweden ... More >> Dept infectious diseases Eskilstuna, Sweden, 631 88 Department of infectious diseases Stockholm, Sweden, 17176 Dept infectious diseases Uppsala, Sweden, 75185 Dept infectious diseases Örebro, Sweden, 70185 Less <<
NCT01173120 - Completed - -
NCT01446211 Wegeners Granulomatosis Phase 3 Terminated(Change of design co... More >>nsideration) Less << - Czech Republic ... More >> Všeobecná fakultní nemocnice v Praze Praha, Czech Republic, 128 08 Less <<
NCT01498744 Abscess Soft Tissue ... More >> Methicillin-resistant Staphylococcus Aureus (MRSA) Infection Skin Abscess Less << Not Applicable Terminated(The study was close... More >>d due to poor enrollment and lack of interest.) Less << - United States, Illinois ... More >> Ann and Robert H Lurie Children's Hospital Chicago, Illinois, United States, 60611 Less <<
NCT01142726 Rheumatoid Arthritis Phase 3 Completed - -
NCT01448096 Large B Cell Diffuse Lymphoma Phase 2 Active, not recruiting August 2019 Korea, Republic of ... More >> Chonbuk National University Hospital Jeonju, Korea, Republic of, 561-712 Less <<
NCT01450982 Rheumatoid Arthritis Phase 1 Completed - United States, Alabama ... More >> Anniston, Alabama, United States United States, Florida Daytona Beach, Florida, United States United States, Pennsylvania Duncansville, Pennsylvania, United States United States, Texas Dallas, Texas, United States Less <<
NCT01451203 Rheumatoid Arthritis Phase 3 Completed - Japan ... More >> Chubu Region, Japan Chugoku Region, Japan Hokkaido Region, Japan Kanto Region, Japan Kinki Region, Japan Kyushu Region, Japan Shikoku Region, Japan Tohoku Region, Japan Less <<
NCT01142726 - Completed - -
NCT01498744 - Terminated(The study was close... More >>d due to poor enrollment and lack of interest.) Less << - -
NCT01447225 - Completed - -
NCT01447225 Solid Tumors Phase 1 Completed - United States, Indiana ... More >> Lafayette, Indiana, United States, 47905 United States, New York Buffalo, New York, United States, 14263 United States, Ohio Cincinnati, Ohio, United States, 45267 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19111 France Villejuif, France Less <<
NCT01451515 Lymphoblastic Lymphoma Phase 2 Active, not recruiting June 30, 2021 United States, California ... More >> Rady Children's Hospital San Diego San Diego, California, United States, 92123 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01939093 Methamphetamine-induced Psycho... More >>sis Less << Phase 4 Completed - Thailand ... More >> Thanyarak Institute on Drug Abuse Pathumthani, Thailand Less <<
NCT01451203 - Completed - -
NCT00315861 Ovarian Cancer ... More >> Endometrial Cancer Cervical Cancer Lung Cancer Less << Phase 1 Completed - United States, Tennessee ... More >> Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT01454102 Non-small Cell Lung Cancer Phase 1 Active, not recruiting December 29, 2018 United States, California ... More >> Ucla Santa Monica, California, United States, 90404 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Texas Ut Southwestern Medical Center At Dallas Dallas, Texas, United States, 75390-8852 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Canada, Ontario Local Institution Hamilton, Ontario, Canada, L8V 5C2 Local Institution Ottawa, Ontario, Canada, K1H 8L6 Local Institution Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01454934 Non-Small Cell Lung Cancer (NS... More >>CLC) Less << Phase 3 Completed - -
NCT01469013 Arthritis, Rheumatoid Phase 2 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 260-8712 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 812-0025 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hiroshima, Japan, 730-0017 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 063-0811 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 673-1462 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ibaragi, Japan, 316-0035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kagoshima, Japan, 890-0067 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 252-0392 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nagasaki, Japan, 857-1165 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oita, Japan, 870-0823 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Okayama, Japan, 700-8607 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 586-8521 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 130-0013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toyama, Japan, 933-0874 Less <<
NCT01454934 - Completed - -
NCT01480388 Active Rheumatoid Arthritis; R... More >>heumatoid Arthritis Less << Phase 2 Withdrawn(Study was terminated... More >> prematurely due to 2 cases of agranulocytosis in a different clinical trial with this same drug.) Less << March 2014 -
NCT01532804 Metastatic Colorectal Cancer Phase 2 Active, not recruiting December 2018 France ... More >> Val d'Aurelle Cancer Institute Montpellier, France, 34298 Less <<
NCT01491815 Rheumatoid Arthritis Phase 4 Recruiting December 2021 Sweden ... More >> The Karolinska Institutet Recruiting Stockholm, Sweden, 171 76 Contact: Ronald van Vollenhoven, MD, Prof.    +46(0)851776077    ronald.van.vollenhoven@ki.se Less <<
NCT01319448 Malaria Sickl... More >>e Cell Crisis Less << Phase 1 Phase 2 Completed - Nigeria ... More >> Department of Paediatrics and Child Health, University of Ilorin Teaching Hospital Ilorin, Kwara, Nigeria Less <<
NCT01459484 Osteosarcoma Phase 2 Phase 3 Recruiting February 2020 Italy ... More >> I.R.C.C. - Unit of Medical Oncology Not yet recruiting Candiolo, Torino, Italy, 10060 Contact: Giovanni Grignani, MD    +39.011.9933 ext 278    giovanni.grignani@ircc.it    Contact: Luisa Gioeni, Pharmacist    +39.011.9933 ext 278    luisa.gioeni@ircc.it    Sub-Investigator: Giovanni Grignani, MD          Principal Investigator: Massimo Aglietta, MD          Presidio Sanitario Gradenigo Not yet recruiting Torino, TO, Italy, 10153 Contact: Alessandro Comandone, MD    +390118151 ext 211    alessandro.comandone@gradenigo.it    Principal Investigator: Alessandro Comandone, MD          Istituto Ortopedico Rizzoli Recruiting Bologna, Italy, 40136 Contact: Stefano Ferrari, MD    +390516366 ext 411    stefano.ferrari@ior.it    Contact: Emanuela Marchesi, PhD    +390516366 ext 400    emanuela.marchesi@ior.it    Principal Investigator: Stefano Ferrari, MD          A.O. Universitaria Meyer Recruiting Firenze, Italy, 50139 Contact: Angela Tamburini, MD    +3905556 ext 621    a.tamburini@meyer.it    Principal Investigator: Angela Tamburini, MD          Istituto Giannina Gaslini Not yet recruiting Genova, Italy Contact: Carla Manzitti, MD          Principal Investigator: Carla Manzitti, MD          FONDAZIONE IRCCS Istituto Nazionale dei Tumori Recruiting Milano, Italy Contact: Rossella Bertulli, MD          Principal Investigator: Rossella Bertulli, MD          FONDAZIONE IRCCS Istituto Nazionale dei Tumori Recruiting Milano, Italy Contact: Roberto Luksch, MD          Principal Investigator: Roberto Luksch, MD          Istituto Nazionale Tumori "Fondazione G. Pascale" Not yet recruiting Napoli, Italy, 80131 Contact: Gaetano Apice, MD          Principal Investigator: Gaetano Apice, MD          Azienda Ospedaliera di Padova Recruiting Padova, Italy Contact: Gianni Bisogno, MD          Principal Investigator: Gianni Bisogno, MD          Istituti Fisioterapici Ospitalieri di Roma Recruiting Roma, Italy Contact: Virginia Ferraresi, MD          Principal Investigator: Virginia Ferraresi, MD          Ospedale Pediatrico Bambin Gesu' Recruiting Roma, Italy Contact: Raffaele Cozza, MD          Principal Investigator: Raffaele Cozza, MD          Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology Recruiting Torino, Italy, 10126 Contact: Franca Fagioli, MD    +39.011.3135 ext 230    franca.fagioli@unito.it    Principal Investigator: Franca Fagioli, MD Less <<
NCT01496742 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 2 Completed - -
NCT01491958 - Completed - -
NCT01469013 - Completed - -
NCT01498601 Pneumonia Not Applicable Completed - Canada, British Columbia ... More >> Royal Columbian Hospital New Westminster, British Columbia, Canada, V3L 3W7 Less <<
NCT01471444 Disorder Related to Bone Marro... More >>w Transplantation Leukemia Transplantation Infection Less << Phase 3 Active, not recruiting November 1, 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01498601 - Completed - -
NCT01491958 Acute Myelogenous Leukemia ... More >> Acute Lymphocytic Leukemia Myelodysplastic Syndrome Less << Phase 2 Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00349089 Non-small Cell Lung Cancer Phase 2 Unknown December 2013 Belgium ... More >> Ziekenhuis Oost Limburg Genk, Belgium, 3600 Department of Pulmonology (Respiratory Tumor Unit), University Hospital Gasthuisberg, Catholic University Leuven, Belgium. Leuven, Belgium, 3000 Germany Helios-Klinikum Emil von Behring Berlin, Germany, 14109 Klinikum Bremen-Ost Bremen, Germany, 28325 Westdeutsches Tumorzentrum Essen, Germany, 45122 Department of Hematology and Oncology, University of Goettingen Goettingen, Germany, 37075 Lungenzentrum Großhansdorf Großhansdorf, Germany, 22927 Clinic for thoracic diseases at the University of Heidelberg Heidelberg, Germany, 69120 Lungenklinik Hemer Hemer, Germany, 58675 Klinik Löwenstein Loewenstein, Germany, 74245 University of München Muenchen, Germany Oldenburg Hospital Oldenburg, Germany Dr. Horst Schmidt Klinik Wiesbaden, Germany, 65199 Luxembourg Centre Hospitalier du Luxembourg Luxembourg, Luxembourg, L-1210 Less <<
NCT01560052 IgA Glomerulonephritis Not Applicable Recruiting June 2023 -
NCT01258712 Rheumatoid Arthritis (RA) Phase 3 Completed - Taiwan ... More >> Buddhist Dalin Tzu Chi General Hospital Chiayi, Taiwan Chang Gung Memorial Hospital -Kaohsiung Kaohsiung, Taiwan Kaohsiung Medical University Hospital Kaohsiung, Taiwan Kaohsiung Veterans General Hospital Kaohsiung, Taiwan Chung Shan Medical University Hospital Taichung, Taiwan Taichung Veterans General Hospital Taichung, Taiwan National Cheng Kung University Hospital Tainan, Taiwan Cathay General Hospital Taipei, Taiwan National Taiwan University Hospital Taipei, Taiwan Taipei Veterans General Hospital Taipei, Taiwan Tri-Service General Hospital Taipei, Taiwan Chang Gung Memorial Hospital - Linkou Taoyuan, Taiwan Less <<
NCT01500278 Rheumatoid Arthritis Phase 4 Completed - -
NCT01516580 B-cell Non Hodgkin Lymphoma ... More >> Mature B-cell Leukemia Burkitt-type Less << Phase 3 Active, not recruiting December 2021 Belgium ... More >> University Hospitals Leuven Leuven, Belgium, 3000 Canada Children Oncology Group Operations centres Monrovia, Canada China The University of Hong Kong (Clinical Trials Centre) Hong-Kong, China France Institut de Cancérologie Gustave roussy Villejuif, France, 94805 Hungary 2nd Dept. of Pediatrics Semmelweis Univ. Budapest, Hungary, 1094 Italy Associazione Italiana di Ematologia ed Oncologia Pediatrica Padova, Italy, 35128 Netherlands Emma Children's Hospital Amsterdam, Netherlands, 1105 AZ Poland Rectorat of Medical University Wroclaw, Poland Spain Sociedad Española de Hematología y Oncología Pediátricas Valencia, Spain, 46010 United Kingdom University of Birmingham Birmingham, United Kingdom Less <<
NCT01518153 Leukemia Lymp... More >>homa Myeloma Myeloproliferative Diseases Less << Phase 2 Terminated(Objectives not met.... More >>) Less << - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01518153 - Terminated(Objectives not met.... More >>) Less << - -
NCT01519791 Rheumatoid Arthritis Phase 3 Completed - -
NCT01521923 Rheumatoid Arthritis Phase 3 Completed - -
NCT01500278 - Completed - -
NCT00941785 Malaria Phase 2 Phase 3 Completed - Burkina Faso ... More >> IRSS Bobo-Dioulasso, Burkina Faso, BP545 Less <<
NCT01527149 Stage I Mantle Cell Lymphoma ... More >> Stage II Contiguous Mantle Cell Lymphoma Stage II Non-Contiguous Mantle Cell Lymphoma Stage III Mantle Cell Lymphoma Stage IV Mantle Cell Lymphoma Less << Phase 2 Active, not recruiting October 5, 2021 United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Tennessee Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT01521923 - Completed - -
NCT00948896 Malaria Phase 3 Completed - Uganda ... More >> IDRC Research Clinic -Tororo District Hospital Tororo, Uganda Less <<
NCT01526057 Rheumatoid Arthritis Phase 1 Phase 2 Completed - -
NCT00951106 Malaria, Vivax ... More >> Malaria, Falciparum Less << Not Applicable Completed - Peru ... More >> Naval Medical Research Center Detachment Lima, Peru Less <<
NCT00365183 Non-Small Cell Lung Carcinoma Phase 2 Terminated - United States, California ... More >> Huntington Beach, California, United States Long Beach, California, United States United States, Illinois Chicago, Illinois, United States United States, Maryland Baltimore, Maryland, United States United States, Minnesota Minneapolis, Minnesota, United States United States, Missouri St. Louis, Missouri, United States United States, New Mexico Albuquerque, New Mexico, United States Santa Fe, New Mexico, United States United States, New York Armonk, New York, United States United States, Ohio Columbus, Ohio, United States United States, Washington Seattle, Washington, United States Less <<
NCT01595438 Complicated Urinary Tract Infe... More >>ction (cUTI) Including Acute Pyelonephritis Less << Phase 3 Completed - -
NCT01519791 - Completed - -
NCT01599806 Complicated Urinary Tract Infe... More >>ction (cUTI) Including Acute Pyelonephritis Less << Phase 3 Completed - -
NCT01548001 Rheumatoid Arthritis Phase 4 Unknown January 2017 China ... More >> Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine Shanghai, China Less <<
NCT01595438 - Completed - -
NCT00948896 - Completed - -
NCT01595529 Urinary Tract Infection Phase 2 Recruiting December 31, 2019 United States, Pennsylvania ... More >> Children's Hospital of Pittsburgh of UPMC - General Academic Pediatric Recruiting Pittsburgh, Pennsylvania, United States, 15213-3205 Less <<
NCT01599806 - Completed - -
NCT01554696 Arthritis, Rheumatoid Phase 2 Completed - -
NCT01557322 - Completed - -
NCT01540812 - Recruiting December 2019 Spain ... More >> Hospital Germans Trias i Pujol Recruiting Badalona, Barcelona, Spain Contact: Jose Mª Ribera, Dr       jmribera@iconcologia.com Less <<
NCT01557322 - Completed - -
NCT01338792 Hormone-resistant Prostate Can... More >>cer Recurrent Prostate Cancer Less << Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT01558089 - Completed - Greece ... More >> G. Gennimatas General Hospital /Rheumatology Clinic Athens, Attica, Greece, 11527 Ippokrateio General Hospital of Athens / 2nd internal Medicine Clinic of the University of Athens Athens, Attica, Greece, 11527 University General Hospital of Heraklion Heraklion, Creete, Greece, 71110 G. Papanikolaoy Thessaloniki, Exochi, Greece, 570 10 424 Military Hospital Thessaloniki, Thessalonikis, Greece Laiko General Peripheral Hospital Athens, Greece, 115 27 Peripheral University General Hospital of Larissa Larissa, Greece, 41 222 "Olympion therapeutic center" General Clinic of Patras Patras, Greece, 26443 Euromedica Kyanous Stavros Thessaloniki, Greece, 54636 Less <<
NCT01338792 - Completed - -
NCT01558089 - Completed - -
NCT01569152 - Terminated - -
NCT01569152 Rheumatoid Arthritis (RA) Phase 2 Terminated - -
NCT00002701 Leukemia Phase 3 Unknown - -
NCT01572662 Leukemia Acut... More >>e Myeloid Leukemia Acute Lymphocytic Leukemia Chronic Myeloid Leukemia Chronic Lymphocytic Leukemia Myeloproliferative Diseases Non-Hodgkins Lymphoma Hodgkins Lymphoma Multiple Myeloma Myelodysplastic Syndrome Less << Phase 2 Active, not recruiting April 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01631617 Dermatitis, Atopic Phase 2 Recruiting June 30, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT01578499 - Completed - -
NCT01578499 Primary Cutaneous Anaplastic L... More >>arge Cell Lymphoma Mycosis Fungoides Cutaneous T-Cell Lymphoma Less << Phase 3 Completed - -
NCT01578850 - Completed - -
NCT00993694 - Completed - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT01590459 Rheumatoid Arthritis Phase 2 Completed - -
NCT01578850 Rheumatoid Arthritis Phase 4 Completed - -
NCT01588704 Lung Cancer Phase 2 Completed - China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT01594827 Cystic Fibrosis Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins University School of Medicine Baltimore, Maryland, United States, 21205 United States, Ohio Rainbow Babies and Children's Hospital Cleveland, Ohio, United States, 44106 Less <<
NCT01594827 - Completed - -
NCT01587989 Rheumatoid Arthritis Phase 3 Completed - Austria ... More >> Graz-Eggenberg, Austria, 8020 Graz, Austria, 8036 Hollabrunn, Austria, 2020 Innsbruck, Austria, 6020 Linz, Austria, 4020 Salzburg, Austria, 5020 Stockerau, Austria, 2000 Wels, Austria, 4600 Wien, Austria, 1090 Wien, Austria, 1100 Wien, Austria, 1130 Wien, Austria, 1140 Wien, Austria, 1160 Less <<
NCT01650558 HIV Not Applicable Active, not recruiting March 2019 Malawi ... More >> Blantyre Malaria Project Research Clinic Blantyre, Malawi Tisungane Clinic Zomba, Malawi Less <<
NCT01651416 Malaria Anaem... More >>ia Less << Phase 4 Completed - Ghana ... More >> Ejisu-Juaben Municipality Kumasi, Ashanti, Ghana Less <<
NCT01587989 - Completed - -
NCT01598857 Granulomatosis With Polyangiit... More >>is Microscopic Polyangiitis Less << Phase 2 Withdrawn - -
NCT02120274 RNA Virus Infections ... More >> Flaviviridae Infections Hepatitis C Hepatitis C, Chronic Less << Phase 4 Terminated(New Brazilian Guide... More >>lines for Viral Hepatitis C and Coinfetions. It does not include the treatment of chronic HCV Metavir < F3 and abandon the use of interferon.) Less << - Brazil ... More >> Outpatient Clinic of Viral Hepatitis (NUPAIG) São Paulo, Brazil, 04025-001 Less <<
NCT01659866 Infection Phase 4 Unknown August 2016 United States, Illinois ... More >> Northwestern University Department of Urology Chicago, Illinois, United States, 60611 Less <<
NCT01404312 Tuberculosis ... More >>HIV Infections Less << Phase 3 Completed - -
NCT01614197 Lymphoblastic Leukemia, Acute,... More >> Childhood Lymphoblastic Lymphoma Peripheral T-cell Lymphoma Less << Phase 1 Recruiting December 2019 -
NCT01404312 - Completed - -
NCT00976599 Rheumatoid Arthritis Phase 2 Completed - United States, Alabama ... More >> Pfizer Investigational Site Birmingham, Alabama, United States, 35205 Pfizer Investigational Site Birmingham, Alabama, United States, 35209 Pfizer Investigational Site Birmingham, Alabama, United States, 35216 United States, California Pfizer Investigational Site La Jolla, California, United States, 92037 United States, Maryland Pfizer Investigational Site Frederick, Maryland, United States, 21702 United States, Michigan Pfizer Investigational Site Battle Creek, Michigan, United States, 49015 United States, Ohio Pfizer Investigational Site Mayfield Village, Ohio, United States, 44143 Pfizer Investigational Site Mentor, Ohio, United States, 44060 Pfizer Investigational Site Willoughby, Ohio, United States, 44094 United States, Texas Pfizer Investigational Site Dallas, Texas, United States, 75231 Pfizer Investigational Site Dallas, Texas, United States, 75251 Pfizer Investigational Site Mesquite, Texas, United States, 75150 Pfizer Investigational Site Sunnyvale, Texas, United States, 75182 United States, Washington Pfizer Investigational Site Seattle, Washington, United States, 98104 Pfizer Investigational Site Seattle, Washington, United States, 98122 Less <<
NCT01600521 Rheumatoid Arthritis Not Applicable Completed - China ... More >> Beijing Friendship Hospital, Affiliated to Capital Medical University Beijing, China, 100050 Institute of Chinese Medical Sciences, University of Macau Taipa, China Less <<
NCT01612247 Breast Cancer Not Applicable Unknown February 2014 United States, New Hampshire ... More >> Dartmouth Hitchcock Medical Center Not yet recruiting Lebanon, New Hampshire, United States, 03756 Contact: Mary Chamberlin, MD    603-653-9000       Principal Investigator: Mary Chamberlin, MD          United States, New York Maimonides Cancer Center Recruiting Brooklyn,, New York, United States, 11220 Contact: Susan Radoux, MD    718-765-2644    SBurdette-Radoux@maimonidesmed.org    Principal Investigator: Susan Radoux, MD          United States, Vermont University of Vermont Recruiting Burlington, Vermont, United States, 05401 Contact: Marie E Wood, MD    802-656-5487       Contact: Kim Dittus, MD    802-656-5487       Principal Investigator: Marie E Wood, MD Less <<
NCT01618968 Rheumatoid Arthritis (RA) Phase 2 Completed - United States, Pennsylvania ... More >> Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 Less <<
NCT01618955 Rheumatoid Arthritis (RA) Phase 2 Completed - United States, Pennsylvania ... More >> Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 Less <<
NCT01618955 - Completed - -
NCT00976599 - Completed - -
NCT01619176 Rheumatoid Arthritis Not Applicable Completed - China, Shanghai ... More >> Shanghai GuangHua Hospital of integrated traditional and western medicine Shanghai, Shanghai, China, 200052 Less <<
NCT01618968 - Completed - -
NCT01631136 Advanced Non Small Cell Lung C... More >>ancer Less << Phase 3 Completed - -
NCT01632891 HIV-1 Infection ... More >> Pf Subclinical Parasitemia Less << Phase 1 Phase 2 Completed - Kenya ... More >> AMPATH at Moi Univ. Teaching Hosp. Eldoret CRS (12601) Eldoret, Kenya, 30100 Walter Reed Project - Kenya Med. Research Institute Kericho CRS (12501) Kericho, Kenya, 20200 Malawi College of Med. JHU CRS (30301) Blantyre, Malawi University of North Carolina Lilongwe CRS (12001) Lilongwe, Malawi Uganda Joint Clinical Research Centre (JCRC) (12401) Kampala, Uganda Less <<
NCT01617590 Rheumatoid Arthritis Not Applicable Unknown May 2014 China, Shanxi ... More >> rheumatism department,Second hospital of Shanxi medical university Recruiting TaiYuan, Shanxi, China, 030001 Contact: li xiao feng    086-0351-3074231    lixiaofeng_sxey@163.com Less <<
NCT01633970 Cancer Phase 1 Active, not recruiting December 31, 2018 United States, Colorado ... More >> University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, Connecticut Yale University New Haven, Connecticut, United States, 06511 United States, District of Columbia Georgetown University Medical Center Lombardi Cancer Center Washington, District of Columbia, United States, 20007 United States, Illinois Uni of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts Massachusetts General Hospital. Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States, 02215 Dana Farber Can Ins Boston, Massachusetts, United States, 02215 United States, New York Laura and ISAAC Perlmutter Cancer Center at NYU Langone. New York, New York, United States, 10016 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 Carolina BioOncology Institute; Can Therapy & Res Ctr Huntersville, North Carolina, United States, 28078 United States, Tennessee Sarah Cannon Research Inst. Nashville, Tennessee, United States, 37203 Less <<
NCT01636843 Inflammation ... More >>Rheumatoid Arthritis Less << Phase 2 Terminated - -
NCT01633983 Central Serous Chorioretinopat... More >>hy Less << Phase 2 Unknown July 2015 Israel ... More >> Hadassah Hebrew Univercity Medical Center Not yet recruiting Jerusalem, Israel, 91120 Contact: Edward Averbukh, MD    +972-508946140    edwaver@gmail.com    Contact: Samer Khateb, MD, PhD    +972-542504857    samerkhateb@gmail.com    Principal Investigator: Samer Khateb, MD, PhD Less <<
NCT01639521 Anterior Urethral Cancer ... More >> Localized Transitional Cell Cancer of the Renal Pelvis and Ureter Posterior Urethral Cancer Recurrent Bladder Cancer Recurrent Urethral Cancer Regional Transitional Cell Cancer of the Renal Pelvis and Ureter Stage III Bladder Cancer Transitional Cell Carcinoma of the Bladder Ureter Cancer Urethral Cancer Associated With Invasive Bladder Cancer Less << Phase 2 Withdrawn(Lack of funding) - -
NCT01645280 - Completed - -
NCT01654575 Osteoarthritis Not Applicable Completed - Egypt ... More >> Faculty of Medicine, University of Alexandria Alexandria, Egypt Less <<
NCT01646125 - Terminated(An interim analysis... More >> was conducted in May-2014. Upon review of the data, the committee recommended study termination due to futility.) Less << - -
NCT01645280 Arthritis, Rheumatoid Phase 2 Completed - -
NCT01655225 Advanced Cancer ... More >> Metastatic Cancer Non-Hodgkin's Lymphoma Metastatic Breast Cancer Malignant Mesothelioma Non-small Cell Lung Cancer Less << Phase 1 Recruiting March 1, 2021 United States, California ... More >> UCLA Medical Center Recruiting Los Angeles, California, United States, 90095 Contact    3103258252       Principal Investigator: Parvin Fatheddin Peddi          United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact    646-888-4226       Principal Investigator: Anna M Varghese          United States, Oklahoma Peggy and Charles Stephenson Oklahoma Cancer Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact    405-271-8777       Principal Investigator: Raid Aljumaily          United States, Pennsylvania Penn Presbyterian Medical Center Completed Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Sarah Cannon Cancer Center Recruiting Nashville, Tennessee, United States, 37203 Contact    615-239-7615       Principal Investigator: SMO Sarah Cannon Research Inst.          Tennessee Oncology PLLC Recruiting Nashville, Tennessee, United States, 37203 Contact    6153297274       Principal Investigator: Johanna Chock Bendell          Italy Azienda Ospedaliero - Universitaria S. Luigi Gonzaga Completed Orbassano, Torino, Italy, 10043 Puerto Rico Fundacion de Investigacion de Diego Recruiting San Juan, Puerto Rico, 00927 Contact    7877221248       Principal Investigator: Mirelis Acosta-Rivera Less <<
NCT01646125 Advanced Non Small Cell Lung C... More >>ancer (NSCLC) Less << Phase 2 Terminated(An interim analysis... More >> was conducted in May-2014. Upon review of the data, the committee recommended study termination due to futility.) Less << - -
NCT01656551 Non-small Cell Lung Cancer Met... More >>astatic Non-small Cell Lung Cancer Stage IIIB Less << Phase 3 Active, not recruiting September 2018 -
NCT01659242 Rheumatoid Arthritis Phase 4 Terminated - Singapore ... More >> Singapore General Hospital Singapore, Singapore, 169608 Less <<
NCT01651936 Rheumatoid Arthritis Phase 2 Terminated - -
NCT01651936 - Terminated - -
NCT01941940 Rheumatoid Arthritis Phase 3 Completed - -
NCT01766375 Acute Myeloid Leukemia Phase 3 Unknown June 2016 China, Guangxi ... More >> First Affiliated Hospital of Guangxi Medical University Recruiting Nanning, Guangxi, China, 530021 Contact: Lai Yongrong, doctor    0086-13517711828    laiyongrong@263.net    Contact: Zhang Zhongming, doctor    0086-15807801369    zzmmissyou@126.com    Principal Investigator: Lai Yongrong, doctor          Sub-Investigator: Zhang Zhongming, doctor          Sub-Investigator: Li Qiaochuan, doctor Less <<
NCT01942174 Rheumatoid Arthritis Phase 3 Recruiting September 2019 France ... More >> CHU Nord Recruiting Amiens, France, 80054 Contact: Vincent GOEB, PH    03 22 66 80 00    goeb.vincent@chu-amiens.fr    Principal Investigator: Vincent GOEB, PH          CHU Pellegrin Recruiting Bordeaux, France, 33000 Contact: Thierry SCHAEVERBEKE, PU-PH    05 56 79 55 45    thierry.schaeverbeke@chu-pellegrin.fr    Principal Investigator: Thierry SCHAEVERBEKE, PU-PH          CHU La Cavale Blanche Recruiting Brest, France, 29609 Contact: Alain SARAUX, PU-PH    02 98 34 77 07    alain.saraux@univ-brest.fr    Principal Investigator: Alain SARAUX, PU-PH          CHU Montpied Recruiting Clermont-Ferrand, France, 63003 Contact: Martin SOUBRIER, PU-PH    04 73 75 14 88    msoubrier@chu-clermontferrand.fr    Principal Investigator: Martin SOUBRIER, PU-PH          CHU Bicetre Recruiting Le Kremlin Bicetre, France, 94275 Contact: Xavier MARIETTE, PU-PH    01 45 21 37 58    xavier.mariette@bct.aphp.fr    Principal Investigator: Xavier MARIETTE, PU-PH          CH Du Mans Recruiting Le Mans, France, 72000 Contact: Emmanuelle DERNIS, PH    02 43 43 26 56    edernis@ch-lemans.fr    Principal Investigator: Emmanuelle DERNIS, PH          CHU Dupuytren Recruiting Limoges, France, 87042 Contact: Philippe BERTIN, PU-PH    05 55 05 68 70    phillipe.bertin@chu-limoges.fr    Principal Investigator: Phillipe BERTIN, PU-PH          CHU La Conception Recruiting Marseille, France, 13005 Contact: Thao PHAM, PU-PH    04 91 38 34 62    thao.pham@ap-hm.fr    Principal Investigator: Thao PHAM, PU-PH          CHU de Montpellier - Hôpital Lapeyronie Recruiting Montpellier, France, 34295 Contact: Jacques MOREL, PU-PH    04 67 33 87 10    j-morel@chu-montpellier.fr    Contact: Jacques MOREL, PU-PHH    04 67 33 91 71    a-remy@chu-montpellier.fr    Principal Investigator: Jacques MOREL, PU-PH          Sub-Investigator: DAIEN claire, PH          Sub-Investigator: Marlene GENTY, Doctor          CHU de Nice - Hôpital L'Archet 1 Recruiting Nice, France, 06202 Contact: Liana EULLER-ZIEGLER, PU-PH    04 92 03 55 12    euller-ziegler.l@chu-nice.fr    Principal Investigator: Liana EULLER-ZIEGLER, PU-PH          CHU Carémeau Recruiting Nîmes, France, 30029 Contact: Cécile GAUJOUX-VIALA, PH    04 66 68 31 20    cecile.gaujoux.viala@chu-nimes.fr    Principal Investigator: Cécile GAUJOUX-VIALA, PH          CHU Orléans - Hôpital La Source Recruiting Orléans, France, 45000 Contact: Stéphanie RIST, PH    02 38 74 40 14    stephanie.rist@chr-orleans.fr    Principal Investigator: Stéphanie RIST, PH          CHU Saint Antoine Recruiting Paris, France, 75012 Contact: Francis BERENBAUM, PU-PH    01 49 28 25 20    francis.berenbaum@sat.aphp.fr    Principal Investigator: Francis BERENBAUM, PU-PH          CHU La Pitié Salpétrière Recruiting Paris, France, 75013 Contact: Bruno FAUTREL, PU-PH    01 42 17 76 21    bruno.fautrel@psl.aphp.fr    Principal Investigator: Bruno FAUTREL, PU-PH          CHU de Rennes Recruiting Rennes, France, 35056 Contact: Aleth PERDRIGER, PU-PH    02 99 26 71 40    aleth.perdriger@chu-rennes.fr    Principal Investigator: Aleth PERDRIGER, PU-PH          CHU Bois Guillaume Recruiting Rouen, France, 76031 Contact: Olivier VITTECOQ, PU-PH    02 32 88 90 19    olivier.vittecoq@chu-rouen.fr    Principal Investigator: Olivier VITTECOQ, PU-PH          CHU Saint Etienne - Hôpital Nord Recruiting Saint Etienne, France, 42055 Contact: Hubert MAROTTE, PH    04 77 12 76 43    hubert.marotte@chu-st-etienne.fr    Principal Investigator: Hubert MAROTTE, PH          CHU Hautepierre Recruiting Strasbourg, France, 67098 Contact: Jacques-Eric GOTTENBERG, PU-PH    03 88 12 79 33    jacques-eric.gottenberg@chru-strasbourg.fr    Principal Investigator: Jacques-Eric GOTTENBERG, PU-PH          CHU Purpan Recruiting Toulouse, France, 31059 Contact: Arnaud CONSTANTIN, PU-PH    05 61 77 69 76    constantin.a@chu-toulouse.fr    Principal Investigator: Arnaud CONSTANTIN, PU-PH          CHU Trousseau Not yet recruiting Tours, France, 37044 Contact: Philippe GOUPILLE, PU-PH    02 47 47 59 17    goupille@med.univ-tours.fr    Principal Investigator: Philippe GOUPILLE, PU-PH          Monaco CHPG Monaco - Hôpital Prince Grace de Monaco Recruiting Monaco, Monaco, 98000 Contact: Olivier BROCQ, PH    00 377 97 98 84 02    obrocq@chpg.mc    Principal Investigator: Olivier BROCQ, PH Less <<
NCT01951482 Non Squamous Non-small Cell Lu... More >>ng Cancer Brain Metastases Bevacizumab Less << Phase 2 Recruiting June 2020 China, Guangdong ... More >> Sun Yat-sen University of Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: li-kun Chen, doctor    13798019964    chenlk@sysucc.org.cn Less <<
NCT01953770 Childhood Acute Lymphoblastic ... More >>Leukemia Less << Not Applicable Active, not recruiting June 2018 -
NCT01958372 Adenocarcinoma of the Lung ... More >> Adenosquamous Cell Lung Cancer Bronchoalveolar Cell Lung Cancer Large Cell Lung Cancer Recurrent Non-small Cell Lung Cancer Squamous Cell Lung Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Less << Phase 1 Active, not recruiting June 30, 2018 United States, Michigan ... More >> Karmanos Cancer Institute at McLaren Bay Region Bay City, Michigan, United States, 48706 Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Karmanos Cancer Institute at McLaren Lapeer Region Lapeer, Michigan, United States, 48446 Karmanos Cancer Institute at McLaren Central Michigan Mount Pleasant, Michigan, United States, 48858 Karmanos Cancer Institute at McLaren Northern Petoskey, Michigan, United States, 49770 Less <<
NCT01948388 Rheumatoid Arthritis Phase 4 Completed - United States, Florida ... More >> AARDS Research, Inc Aventura, Florida, United States, 33180 Less <<
NCT01941940 - Completed - -
NCT01941095 - Completed - -
NCT01960283 Chronic Urticaria Phase 3 Completed - France ... More >> CHRU BREST Morvan Brest, France, 29000 Chu Mondor Créteil, France, 94000 Ch Le Mans Le Mans, France, 72000 CHRU LILLE Huriez Lille, France, 59000 CHRU NANCY Brabois Nancy, France, 54000 Chru Nantes Nantes, France, 44000 Hopital TENON Paris, France, 75020 CHRU POITIERS La Miléterie Poitiers, France, 86000 Chru Reims Reims, France, 51000 CHRU RENNES Pontchaillou Rennes, France, 35000 Chru Tours Tours, France, 37044 Less <<
NCT01960855 Rheumatoid Arthritis Phase 2 Completed - -
NCT01960855 - Completed - -
NCT02024867 Skin Disease, Bacterial ... More >> Abscess Less << Not Applicable Completed - United States, New York ... More >> Women & Children's Hospital of Buffalo Buffalo, New York, United States, 14222 Less <<
NCT02024867 - Completed - -
NCT01328990 Malaria Phase 1 Phase 2 Completed - Senegal ... More >> Universite Chiekh Anta Diop Dakar, Senegal Less <<
NCT02563327 Tuberculosis Phase 3 Recruiting March 2020 Uganda ... More >> Mulago Hospital Recruiting Kampala, Uganda Contact: Principal Investigator       jlj@case.edu Less <<
NCT01976182 Large Granular Lymphocytes Leu... More >>kemia Less << Phase 2 Recruiting November 2019 -
NCT01975610 Rheumatoid Arthritis Phase 2 Completed - -
NCT01976364 Arthritis, Psoriatic Phase 3 Active, not recruiting July 11, 2019 -
NCT02044965 Urinary Tract Infection Phase 1 Phase 2 Unknown December 2016 Canada, Ontario ... More >> London Health Sciences Centre Not yet recruiting London, Ontario, Canada, N6A 4G5 Contact: Lee-Anne Fochesato    5196858500 ext 56366    leeanne.fochesato@lhsc.on.ca    Principal Investigator: Sumit Dave Less <<
NCT01979536 Anaplastic Large Cell Lymphoma... More >>, ALK-Positive Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell Lymphoma CD30-Positive Neoplastic Cells Present Less << Phase 2 Recruiting December 31, 2021 -
NCT01206465 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Nebraska ... More >> UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6805 Less <<
NCT01984268 Rheumatoid Arthritis Phase 2 Unknown December 2017 United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Recruiting Lebanon, New Hampshire, United States, 03756 Contact: Richard C. Chou, MD PhD    603-650-8622    richard.c.chou@hitchcock.org    Principal Investigator: Richard C Chou, MD PhD          Dartmouth-Hitchcock Medical Center Recruiting Manchester, New Hampshire, United States, 03104 Contact: John H Yost, MD    603-695-2500    john.h.yost@hitchcock.org    Sub-Investigator: John H Yost, MD Less <<
NCT01206465 - Completed - -
NCT02045160 - Unknown December 2017 Taiwan ... More >> National Taiwan University Hospital Active, not recruiting Taipei, TW, Taiwan, 106 National Taiwan University Hospital Recruiting Taipei, TW, Taiwan, 106 Contact: Jin-Han Yang       r01451004@ntu.edu.tw    Principal Investigator: Shu-Wen Lin Less <<
NCT01987479 Rheumatoid Arthritis Phase 3 Completed - Netherlands ... More >> ZGT Almelo; Reumatologie Almelo, Netherlands, 7609 PP Jan Van Breemen Instituut Amsterdam, Netherlands, 1056 AB Gelre Ziekenhuizen; Reumatologie Apeldoorn, Netherlands, 7334 DZ Amphia ziekenhuis, locatie langendijk Breda, Netherlands, 4819 EV Albert Schweitzer Ziekenhuis ; Dordwijk Dordrecht, Netherlands, 3318AT Universitair Medisch Centrum Groningen; Department of Rheumatology Groningen, Netherlands, 9700RB Martini Ziekenhuis Groningen, Netherlands, 9728 MG Kennemer Gasthuis Haarlem, Netherlands, 2035 RC Atrium Medisch Centrum Heerlen, Netherlands, 6419 PC Spaarne Ziekenhuis; Inwendige Geneeskunde Hoofddorp, Netherlands, 2134 TM Medisch Centrum Leeuwarden; Reumatology Leeuwarden, Netherlands, 8934 AD Academisch Ziekenhuis Leiden; Dept of Rheumatology Leiden, Netherlands, 2333 ZA Maastricht University Medical Centre; Rheumatology Maastricht, Netherlands, 6202 ZA Erasmus Medisch Centrum; Reumatologie Rotterdam, Netherlands, 3015 CE Maasstadziekenhuis; Reumatologie Rotterdam, Netherlands, 3079 DZ Vlietland Hospital Schiedam, Netherlands, 3118 JH Antonius Ziekenhuis Sneek; Department of Rheumatology Sneek, Netherlands, 8601 ZK Leyenburg Ziekenhuis; Internal Medecine The Hague, Netherlands, 2545 CH St. Bronovo-Nebo The Hague, Netherlands, 2597 AX University Medical Centre Utrecht; Reumatologie en Klinische Immunologie Utrecht, Netherlands, 3584 GA Less <<
NCT01991158 Extranodal NK/T-cell Lymphoma,... More >> Nasal Type Less << Phase 2 Active, not recruiting November 2020 China, Guangdong ... More >> Department of Medical Oncology, Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT01185353 - Completed - -
NCT01185847 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 2 Completed - Belgium ... More >> Charleroi, Belgium, B6000 Leuven, Belgium, 3000 Liège, Belgium, 4000 France Caen, France, 14033 Marseille, France, 13915 Saint Herblain, France, 44805 Toulouse, France, 31400 Germany Bad Berka, Germany, 99437 Gauting, Germany, 82131 Grosshansdorf, Germany, 22927 Heidelberg, Germany, 69126 Köln, Germany, 51109 Mainz, Germany, 55131 Mannheim, Germany, 68167 Italy Milano, Lombardia, Italy, 20162 Milan, Lombardia, Italy, 20132 Ancona, Marche, Italy Lido Di Camaiore, Toscana, Italy, 55043 Livorno, Toscana, Italy, 57100 Perugia, Umbria, Italy, 06156 Poland Lodz, Poland, 93-509 Otwock, Poland, 05-400 Warszawa, Poland, 02-781 Spain Barcelona, Spain, 08003 Barcelona, Spain, 08035 Madrid, Spain, 28040 Madrid, Spain, 28041 Madrid, Spain, 28046 Madrid, Spain, 28050 Malaga, Spain, 29010 Sevilla, Spain, 41013 United Kingdom London, United Kingdom, SE1 9RT Less <<
NCT01987479 - Completed - -
NCT01187264 Psoriasis Phase 4 Completed - India ... More >> Postgraduate Institute of Medical Education and Research Chandigarh, U.T, India, 160012 Less <<
NCT01185353 Arthritis, Rheumatoid Phase 2 Completed - -
NCT01187810 Acute Myelogenous Leukemia ... More >> Acute Lymphoblastic Leukemia Non-Hodgkin's Lymphoma Less << Phase 1 Active, not recruiting April 2018 United States, Oklahoma ... More >> University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01186328 Lymphoblastic Leukemia, Acute ... More >> Lymphoblastic Leukemia, Acute, Childhood Leukemia, Lymphoblastic, Acute, T Cell Leukemia, Lymphoblastic, Acute Less << Phase 1 Terminated(The company (Enzon ... More >>Pharmaceuticals)providing the drug EZN-3042 decided to end its development of EZN-3042.) Less << - -
NCT01188798 Acute Lymphoblastic Leukemia ... More >> Acute Myelocytic Leukemia Chronic Myelocytic Leukemia Hodgkin's Disease Myelodysplastic Syndrome Less << Phase 3 Completed - United States, Tennessee ... More >> St . Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01188798 - Completed - -
NCT01192165 Cancer Phase 1 Completed - United States, Arizona ... More >> GSK Investigational Site Scottsdale, Arizona, United States, 85259 United States, California GSK Investigational Site Duarte, California, United States, 91010 GSK Investigational Site Sacramento, California, United States, 95817 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80218 United States, Nevada GSK Investigational Site Las Vegas, Nevada, United States, 89169 United States, New York GSK Investigational Site Albany, New York, United States, 12206 United States, South Carolina GSK Investigational Site Greenville, South Carolina, United States, 29605 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75246 GSK Investigational Site Houston, Texas, United States, 77030 GSK Investigational Site Tyler, Texas, United States, 75702 United States, Virginia GSK Investigational Site Norfolk, Virginia, United States, 23502 United States, Washington GSK Investigational Site Vancouver, Washington, United States, 98684 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M5G 2M9 France GSK Investigational Site Caen Cedex 9, France, 14033 GSK Investigational Site Marseille cedex 5, France, 13385 GSK Investigational Site Saint-Herblain cedex, France, 44805 GSK Investigational Site Toulouse cedex, France, 31052 Korea, Republic of GSK Investigational Site Seoul, Korea, Republic of, 120-752 GSK Investigational Site Seoul, Korea, Republic of, 135-710 Less <<
NCT00623155 Malaria Not Applicable Completed - Mali ... More >> Malaria Research and Training Center, Faculty of Medicine Pharmacy and Dentistry, University of Bamako Bamako, Mali Less <<
NCT01197521 Rheumatoid Arthritis Phase 3 Completed - -
NCT01197521 - Completed - -
NCT01198002 Rheumatoid Arthritis Phase 3 Terminated(Terminated not base... More >>d on safety concerns, but due to insufficient efficacy.) Less << - -
NCT01204437 Breast Cancer Phase 2 Phase 3 Completed - Germany ... More >> German Breast Group, GBG Forschungs GmbH Neu-Isenburg, Germany, 63263 Less <<
NCT01204138 Arthritis, Rheumatoid Phase 2 Withdrawn(decision of sponsor ... More >>to withdraw before initiation; 0 patients enrolled) Less << - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01211249 Rheumatoid Arthritis Phase 2 Completed - Belgium ... More >> Cliniques Universitaires Saint-Luc Brussels, Belgium, 1200 KU Leuven Leuven, Belgium, 3000 AZ Alma Sijsele-Damme, Belgium, 8340 Netherlands UMC Leiden Leiden, Netherlands, 2300RC Poland Specjalistyczne Centrum Medyczne NZOZ NOWOMED Kraków, Poland, 30-349 "Linea Corporis" - Chirurgia Plastyczna Sp. z o.o. Warszawa, Poland, 00-235 Mokotowskie Centrum Osteoporozy S.C. Warszawa, Poland, 02-620 Synexus SCM Sp. z o.o. Wrocław, Poland, 50-088 Akademia Medyczna im. Piastów Śląskich we Wroclawiu Katedra i Klinika Reumatologii i Chorób Wewnętrznych UM we Wrocławiu Wrocław, Poland, 50-556 Russian Federation State Educational Institution of Higher Professional Education "Moscow State Medico-Stomatological University of Roszdrav" State Healthcare Institution of City Moscow "City Clinical Ordena Trudovogo Krasnogo Znameny Hospital #23 n.a. "Medsantrud" Moscow, Russian Federation, 109240 State Healthcare Institution of city Moscow "City Clinical Ordena Trudovogo Krasnogo Znameny Hospital #23 n.a. "Medsantrud" Moscow, Russian Federation, 109240 State Educational Institution of Higher Professional Education "Russian State Medical University of Roszdrav" State Healthcare Institution of City Moscow "City Clinical Hospital #15 n.a. O.M. Filatov" Moscow, Russian Federation, 111539 State Healthcare Institution of City Moscow "City Clinical Hospital #4" Moscow, Russian Federation, 115093 State Healthcare Institution of City Moscow "City Clinical Hospital #7" Moscow, Russian Federation, 115446 Institution Russian Academy of Medical Sciences Scientific Research Institution of Rheumatology RAMN Moscow, Russian Federation, 115522 State Healthcare Institution of City Moscow "City Clinical Hospital #1 n.a. Pirogov" Moscow, Russian Federation, 119049 State Educational Institution of Higher Professional Education "Moscow State Medico-Stomatological University of Roszdrav" at the State Healthcare Institution of city Moscow "City Clinical Ordena Trudovogo Krasnogo Znameny hospital #23 n.a. "M Moscow, Russian Federation, 121374 Saint-Petersburg State Healthcare Institution "City Hospital #26" Moscow, Russian Federation, 196247 Saint-Petersburg State Healthcare Institution "City Pokrovskaya Hospital" St Petersburg, Russian Federation, 119106 Institution of Russian Academy of Sciences Saint-Petersburg Clinical Hospital RAN St Petersburg, Russian Federation, 194017 Saint-Petersburg State Healthcare Institution "City Mariinskiy Hospital" St-Petersburg, Russian Federation, 191104 State Educational Institution of Higher Professional Education "Saint-Petersburg State Pediatric Medical Academy of Roszdrav" St. Petersburg, Russian Federation, 194100 Ukraine Chernivtsi Regional Clinical Hospital Chernivtsi, Ukraine, 58000 Donetsk City Hospital No5 Donetsk, Ukraine, 83000 Kharkiv City Clinical Hospital No.27 Kharkiv, Ukraine, 61002 Kharkiv City Clinical Hospital No.8 Kharkiv, Ukraine, 61176 Kyiv City Clinical Hospital No.3 Kyiv, Ukraine, 02125 Central Pool-type Clinical Hospital MoH of Ukraine Kyiv, Ukraine, 04053 Institute of Gerontology AMS of Ukraine Kyiv, Ukraine, 04114 University Clinic, Crimean Medical University Simferopol, Ukraine, 95006 Vinnytsia Regional Hospital Vinnytsia, Ukraine, 21018 Zaporizhzhia Regional Hospital Zaporizhzhya, Ukraine, 69600 Less <<
NCT00960440 Arthritis, Rheumatoid Phase 3 Completed - -
NCT00960440 - Completed - -
NCT00961415 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 3 Completed - -
NCT00965757 "Rheumatoid Arthritis" Phase 3 Completed - -
NCT00965757 - Completed - -
NCT00967057 Leukemia Phase 3 Completed - Australia, South Australia ... More >> Women's and Children's Hospital North Adelaide, South Australia, Australia, 5006 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Christie Hospital Manchester, England, United Kingdom, M20 4BX Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Less <<
NCT00968253 Leukemia Acut... More >>e Lymphocytic Leukemia Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01198002 - Terminated(Terminated not base... More >>d on safety concerns, but due to insufficient efficacy.) Less << - -
NCT00961415 - Completed - -
NCT00973479 Arthritis, Rheumatoid Phase 3 Completed - -
NCT00973479 - Completed - -
NCT00968253 - Completed - -
NCT00974584 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 1 Completed - United States, New York ... More >> Buffalo, New York, United States, 14263 France Villejuif, France, 94805 Netherlands Groningen, Netherlands, 9700 RB Less <<
NCT00973752 Acute Lymphoblastic Leukemia Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00973752 - Completed - -
NCT00976456 Non-squamous Non-small Cell Lu... More >>ng Cancer Less << Phase 3 Completed - Germany ... More >> Krankenhaus Martha-Maria Halle-Doelau Halle, Germany, 06120 Less <<
NCT00974792 Lymphoma Phase 2 Unknown - United Kingdom ... More >> Nottingham City Hospital Recruiting Nottingham, England, United Kingdom, NG5 1PB Contact: A. McMillan    44-115-969-1169 Less <<
NCT00764907 Leukemia Phase 3 Unknown - Czech Republic ... More >> University Hospital Motol Recruiting Prague, Czech Republic, 150 06 Contact: Jan Stary, MD    420-2-2443-6401    jan.stary@lfmotol.cuni.cz Less <<
NCT00767325 Rheumatoid Arthritis Phase 3 Completed - Denmark ... More >> Local Institution Glostrup, Denmark, DK-2600 France Local Institution Bois Guillaume Cedex, France, 76230 Local Institution Boulogne, France, 92104 Local Institution Echirolles, France, 38434 Local Institution Nice Cedex 03, France, 06202 Germany Local Institution Munchen, Germany, 80639 Hungary Local Institution Budapest, Hungary, 1036 Italy Local Institution Jesi (Ancona), Italy, 60035 Local Institution Pisa, Italy, 56126 Local Institution Roma, Italy, 00161 Local Institution Roma, Italy, 00168 Local Institution Siena, Italy, 53100 Local Institution Verona, Italy, 37126 Norway Local Institution Oslo, Norway, N0319 Local Institution Trondheim, Norway, 7006 Spain Local Institution Barcelona, Spain, 08006 Local Institution Madrid, Spain, 28006 Local Institution Madrid, Spain, 28040 Local Institution Madrid, Spain, 28911 Local Institution Madrid, Spain, 28935 United Kingdom Local Institution Leeds, North Yorkshire, United Kingdom, LS7 4SA Less <<
NCT00771953 Lung Cancer N... More >>on Small Cell Lung Cancer Less << Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Florida Mercy Research Institute Miami, Florida, United States, 33133 University of Miami Miami, Florida, United States, 33136 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Maryland University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, New Mexico University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 United States, New York Weill Medical Cornell University New York, New York, United States, 10065 Stony Brook Cancer Center (SUNY) Stony Brook, New York, United States, 11794 United States, Oregon Providence Portland Medical Center Portland, Oregon, United States, 97213 United States, Pennsylvania Abramson Cancer Center of Uof Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, West Virginia West Virginia University Clinical Trials Research Unit Morgantown, West Virginia, United States, 26506 Less <<
NCT00767325 - Completed - -
NCT00779142 - Terminated(recent research ind... More >>icates Lucentis to be an effictive treatment) Less << - -
NCT00779220 Rheumatoid Arthritis Phase 2 Terminated - Japan ... More >> Chubu region Chubu, Japan Chugoku region Chugoku, Japan Hokkaido Region Hokkaido, Japan Kanto Region Kanto, Japan Kinki Region Kinki, Japan Kyusyu region Kyusyu, Japan Sikoku region Sikoku, Japan Less <<
NCT00783536 Rheumatoid Arthritis Phase 4 Withdrawn June 2010 -
NCT00779142 Diabetic Macular Edema Not Applicable Terminated(recent research ind... More >>icates Lucentis to be an effictive treatment) Less << - United States, North Carolina ... More >> Wake Forest Baptist Health Eye Center Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00786552 Thyroid Cancer Phase 2 Unknown November 2013 Germany ... More >> Medical Center II, University of Kiel Recruiting Kiel, Germany, 24105 Contact: Joerg T Hartmann, MD    +49 431 597 2484    joerg.hartmann@uk-sh.de Less <<
NCT00771953 - Completed - -
NCT00785928 - Completed - -
NCT00783510 - Active, not recruiting June 30, 2021 -
NCT00787761 - Completed - -
NCT00791505 Chronic Obstructive Pulmonary ... More >>Disease Sepsis Antibiotics Less << Phase 3 Completed - -
NCT00791531 Malaria Phase 1 Completed - Kenya ... More >> Kenya Medical Research Institute, Center for Clinical Research Nairobi, Kenya, 00200 Less <<
NCT00785928 Rheumatoid Arthritis Phase 2 Completed - -
NCT00835198 - Completed - -
NCT00794898 Arthritis, Rheumatoid Phase 4 Completed - -
NCT00787761 Myeloproliferative Disorders ... More >> Kidney Cancer Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, Georgia ... More >> Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 Less <<
NCT00835198 Acne Vulgaris Phase 4 Completed - United States, Ohio ... More >> Strongsville, Ohio, United States Less <<
NCT00803010 Acute Graft Versus Host Diseas... More >>e Less << Phase 2 Completed - United States, Florida ... More >> H.Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 Less <<
NCT00801580 Lymphoid Leukemia Phase 2 Unknown September 2010 Italy ... More >> Institute of Hematology "L. & A. Seragnoli" Recruiting Bologna, Italy, 40138 Less <<
NCT00798603 Lung Cancer Phase 2 Completed - -
NCT00803010 - Completed - -
NCT00807573 - Completed - -
NCT00807573 Lung Cancer Phase 2 Completed - United States, New Jersey ... More >> Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering at Mercy Medical Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital Sleepy Hollow, New York, United States Less <<
NCT00798603 - Completed - -
NCT00795756 Acute Lymphoblastic Leukemia Phase 2 Phase 3 Completed - Italy ... More >> USC Ematologia, Ospedale Civile Alessandria, (al), Italy USC Ematologia, Ospedali Riuniti Bergamo, (bg), Italy, 24128 Divisione di Ematologia - Spedali Civili Brescia, (bs), Italy Divisione di Ematologia e TMO, Ospedale San Maurizio Bolzano, (bz), Italy Ematologia e centro TMO - Ospedale Armando Businco Cagliari, (ca), Italy S.C. Ematologia - Azienda Ospedaliera S. Croce e Carle Cuneo, (cn), Italy Ematologia e centro TMO, Istituti Ospedalieri Cremona, (cr), Italy Ematologia - AOU Careggi Firenze, (fi), Italy Ematologia e centro TMO - IRCSS Mangiagalli Regina Elena Milano, (mi), Italy Ematologia e centro TMO, Ospedale San Raffaele Milano, (mi), Italy Ematologia e centro TMO, Ospedale San Gerardo Monza, (mi), Italy Oncoematologia e TMO - Dipartimento Oncologico La Maddalena Palermo, (pa), Italy Ematologia 2 - Ospedale San Giovanni Battista Torino, (to), Italy Medicina Interna I - Ospedale di Circolo Varese, (va), Italy Onco-Ematologia - Ospedale Civile Noale, (ve), Italy Ematologia - Ospedale San Bortolo Vicenza, (vi), Italy Less <<
NCT00808210 Rheumatoid Arthritis Phase 2 Terminated(Based on analysis o... More >>f results and consideration of available treatments, the overall benefit to risk profile of ocrelizumab was not favorable in RA.) Less << - -
NCT00646126 Plasmodium Falciparum ... More >> Asymptomatic Parataemia Sub Patent Parasitaemia Less << Phase 3 Completed - Sudan ... More >> Tropical Medicine Research Institute Khartoum, Sudan, 11111 Less <<
NCT00808509 Arthritis, Rheumatoid Phase 4 Completed - Sweden ... More >> Site Reference ID/Investigator# 22062 Linkoping, Sweden, 581 85 Site Reference ID/Investigator# 14022 Lund, Sweden, 22185 Site Reference ID/Investigator# 14023 Malmo, Sweden, 20502 Site Reference ID/Investigator# 14301 Oskarstroem, Sweden, 31392 Site Reference ID/Investigator# 20241 Skoevde, Sweden, 54185 Site Reference ID/Investigator# 4918 Stockholm, Sweden, 171 76 Site Reference ID/Investigator# 14021 Stockholm, Sweden, SE-141 86 Site Reference ID/Investigator# 14302 Uppsala, Sweden, 75185 Less <<
NCT00808639 Bladder Cancer ... More >> Muscle-invasive Bladder Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Lahey Clinic Burlington, Massachusetts, United States, 01805 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00810199 Rheumatoid Arthritis Phase 3 Completed - -
NCT00808639 - Completed - -
NCT00809172 Atopic Dermatitis Phase 3 Completed - France ... More >> Hospices Civils de Lyon Lyon, France Less <<
NCT00382343 Pyelonephritis ... More >> Renal Scars Less << Phase 4 Completed - Italy ... More >> San Polo Hospital Monfalcone, Gorizia, Italy, 34170 San Daniele Hospital San Daniele, Udine, Italy, 33100 Sant'Antonio Abate Hospital Tolmezzo, Udine, Italy, 33028 Sant'Orsola Hospital Bologna, Italy, 48138 Bufalini Hospital Cesena, Italy, 47023 Santa Maria degli Angeli Hospital Pordenone, Italy, 33170 Institute of Child Health IRCCS Burlo Garofolo Trieste, Italy, 34137 Less <<
NCT00810836 Rheumatoid Arthritis Phase 2 Completed - Australia, Queensland ... More >> Research Site Woolloongabba, Queensland, Australia, 4102 Australia, South Australia Research Site Woodville, South Australia, Australia, 5011 Canada, Ontario Research Site Sarnia, Ontario, Canada, N7T4X3 Canada Research Site New Market, Canada Research Site Ottawa, Canada Research Site Rothesay, Canada Czech Republic Research Site Active, not recruiting, Czech Republic Research Site Pardubice, Czech Republic Research Site Uh. Hradiste, Czech Republic Research Site Zlin, Czech Republic India Research Site Bangalore, India Research Site Hyderabaad, India Research Site Hyderabad, India Research Site Lucknow, India Poland Research Site Bialystock, Poland Research Site Grodzisk Mazowiecki, Poland Research Site Lublin, Poland Research Site Poznan, Poland Research Site Torun, Poland Research Site Warsaw, Poland Research Site Warszawa, Poland Slovakia Research Site Banska Bysterica, Slovakia Research Site Bratislava, Slovakia Research Site Kosice, Slovakia Research Site Piestany, Slovakia Less <<
NCT00814138 Myasthenia Gravis Phase 2 Completed - United States, Arizona ... More >> Phoenix Neurological Associates Phoenix, Arizona, United States, 85018 United States, California University of California, San Francisco Fresno, California, United States, 93701 University of California-Irvine Irvine, California, United States, 92697 Forbes Norris MDA/ALS Research Center San Francisco, California, United States, 94115 United States, Florida University of Florida, Health Science Center Jacksonville Jacksonville, Florida, United States, 32209 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Massachusetts Massachusetts General Hospitals Boston, Massachusetts, United States, 02114 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 United States, Pennsylvania Penn State College of Medicine, The Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 The Nerve and Muscle Center of Texas Houston, Texas, United States, 77030 University Health Sciences Center, San Antonio San Antonio, Texas, United States, 78229 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22908 Canada, Ontario University of Toronto Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT00810199 - Completed - -
NCT00808509 - Completed - -
NCT00867789 Abscess Not Applicable Unknown October 2012 United States, Missouri ... More >> Children's Mercy Hospitals and Clinics Recruiting Kansas City, Missouri, United States, 64108 Contact: Joan E Giovanni, MD    816-234-3665    gegiovanni@cmh.edu    Contact: Shirlee Rusk, BSN, CCRC    816-234-3665 Less <<
NCT00814138 - Completed - -
NCT00869518 - Terminated(Poor enrollment) - -
NCT00669890 Acute Myeloid Leukemia ... More >> Juvenile Myelomonocytic Leukemia Myelodysplastic Syndrome Less << Phase 1 Terminated(PI left institution... More >>) Less << - United States, New York ... More >> Morgan Stanley Children's Hospital of NYP New York City, New York, United States, 10032 Less <<
NCT00869518 Staphylococcus Aureus ... More >> HIV Infections Less << Phase 2 Terminated(Poor enrollment) - United States, California ... More >> San Francisco General Hospital San Francisco, California, United States, 94110 Less <<
NCT00870298 Prescribers' Drug Orders Not Applicable Terminated(four adverse events... More >> encountered) Less << - -
NCT00818961 - Terminated(terminated early du... More >>e to meeting end point with fewer patients than anticipated) Less << - -
NCT00095147 Rheumatoid Arthritis Phase 3 Completed - -
NCT00818961 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Terminated(terminated early du... More >>e to meeting end point with fewer patients than anticipated) Less << - United States, Georgia ... More >> Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 Less <<
NCT00822432 - Completed - France ... More >> Pitié-Salpêtrière Hospital Paris, France, 75013 University Hospital Centre of Tours Tours, France, 37000 Less <<
NCT00835471 Carcinoma, Non-Small-Cell Lung Phase 2 Unknown June 2014 Netherlands ... More >> VU medisch centrum Recruiting Amsterdam, Netherlands Contact: Smit       ef.smit@vumc.nl    Principal Investigator: Egbert F. Smit, MD PhD          Rode Kruis Ziekenhuis Recruiting Beverwijk, Netherlands Contact: Rikers       mscrk@rkz.nl    Principal Investigator: C. H. Rikers, MD          Amphia Ziekenhuis Recruiting Breda, Netherlands Contact: Aerts       jaerts@amphia.nl    Principal Investigator: Joachim G. Aerts, MD PhD          Reinier de Graaf Gasthuis Recruiting Delft, Netherlands Contact: Pannekoek       pkoek@rdgg.nl    Principal Investigator: B. J. Pannekoek, MD          Jeroen Bosch Ziekenhuis Recruiting Den Bosch, Netherlands Contact: Biesma       b.biesma@jbz.nl    Principal Investigator: Bonne Biesma, MD PhD          Catharina-Ziekenhuis Recruiting Eindhoven, Netherlands Contact: van den Borne       ben.vd.borne@cze.nl    Principal Investigator: Ben E. van den Borne, MD PhD          Martini Ziekenhuis Recruiting Groningen, Netherlands Contact: van Putten       jwg.van.putten@mzh.nl    Principal Investigator: John W. van Putten, MD PhD          Kennemer Gasthuis Recruiting Haarlem, Netherlands Contact: Weenink       weenink@kg.nl    Principal Investigator: C. Weenink, MD PhD          Academisch Ziekenhuis Maastricht Recruiting Maastricht, Netherlands Contact: Dingemans       a.c.dingemans@lung.azm.nl    Principal Investigator: A. C. Dingemans, MD PhD          Universitair Medisch Centrum Sint Radboud Recruiting Nijmegen, Netherlands Contact: van der Drift       m.vanderdrift@ulc.umcn.nl    Principal Investigator: M. A. van der Drift, MD          Maasstad Ziekenhuis Recruiting Rotterdam, Netherlands Contact: Slingerland       slingerlandr@mcrz.nl    Principal Investigator: Rob Slingerland, MD          Sint Franciscus Gasthuis Recruiting Rotterdam, Netherlands Contact: in 't Veen       h.intveen@sfg.nl    Principal Investigator: J. C. in 't Veen, MD PhD          HagaZiekenhuis Recruiting The Hague, Netherlands Contact: Codrington       h.codrington@hagaziekenhuis.nl    Principal Investigator: Henk E. Codrington, MD          Isala Klinieken Recruiting Zwolle, Netherlands Contact: Stigt       j.a.stigt@isala.nl    Principal Investigator: Jos A. Stigt, MD Less <<
NCT00833053 - Terminated(In Amendment 1 of P... More >>05319 [NCT 00779675], the option to enroll into this study, was discontinued due to low numbers of participants with suboptimal response.) Less << - -
NCT00845832 Rheumatoid Arthritis Phase 2 Terminated(The study was termi... More >>nated early because of a related decision to stop the development of ocrelizumab in rheumatoid arthritis.) Less << - France ... More >> Le Kremlin Bicetre, France, 94275 Montpellier, France, 34295 Paris, France, 75679 Strasbourg, France, 67098 Germany Berlin, Germany, 10117 Berlin, Germany, 14059 Heidelberg, Germany, 69120 Köln, Germany, 50924 Wuerzburg, Germany, 97080 Greece Athens, Greece, 15121 Thessaloniki, Greece, 54636 Netherlands Amsterdam, Netherlands, 1105 AZ Leiden, Netherlands, 2333 ZA Poland Bytom, Poland, 41-902 Lublin, Poland, 20-607 Poznan, Poland, 60-218 Spain Santander, Cantabria, Spain, 39008 Santiago de Compostela, La Coruña, Spain, 15706 Madrid, Spain, 28007 Sevilla, Spain, 41009 Switzerland Bern, Switzerland, 3010 Lausanne, Switzerland, 1011 United Kingdom Newcastle Upon Tyne, United Kingdom, NE1 4LP Southampton, United Kingdom, SO16 6YD Less <<
NCT00846703 Acute Lymphoblastic Leukemia Phase 4 Unknown December 2018 China, Guangdong ... More >> The second affiliated hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510000 Contact: Jianpei Fang, M.D.    +8620-81332003    jpfang2005@163.com    Principal Investigator: Jianpei Fang, M.D. Less <<
NCT00833053 Psoriasis Phase 3 Terminated(In Amendment 1 of P... More >>05319 [NCT 00779675], the option to enroll into this study, was discontinued due to low numbers of participants with suboptimal response.) Less << - -
NCT00847886 Rheumatoid Arthritis Phase 1 Completed - United States, Texas ... More >> Metroplex Clinical Research Center Dallas, Texas, United States, 75235 Less <<
NCT00095147 - Completed - -
NCT00847613 Arthritis, Rheumatoid Phase 3 Completed - -
NCT00892541 Schizophrenia Phase 1 Completed - -
NCT00847613 - Completed - -
NCT00847886 - Completed - -
NCT00850343 Rheumatoid Arthritis Phase 3 Completed - Japan ... More >> Chubu Region, Japan Chugoku Region, Japan Hokkaido Region, Japan Kanto Region, Japan Kinki Region, Japan Kyushu Region, Japan Shikoku Region, Japan Tohoku Region, Japan Less <<
NCT00848354 Rheumatoid Arthritis Phase 4 Completed - Argentina ... More >> Consultorios Especializados en Investigaciones Medicas Capital Federal, Buenos Aires, Argentina, C1425EKF CER San Juan San Juan, Provinica de San Juan, Argentina, 5400 Instituto CAICI Rosario, Santa Fe, Argentina, S2000PBJ OMI Buenos Aires, Argentina, 1015 Centro de Investigaciones en Enfermedades Reumaticas Buenos Aires, Argentina, 1055 Hospital Britanico Buenos Aires, Argentina, 1280 Atencion Integral en Reumatologia Buenos Aires, Argentina, 1426 Investigaciones Reumatológicas y Osteológicas Ciudad Autónoma de Buenos Aires, Argentina, C1114AAH Centro de Osteopatías Médicas Ciudad Autónoma de Buenos Aires, Argentina, C1128AAF Sanatorio Mayo Cordoba, Argentina, 5000 Hospital Escuela Gral. San Martin Corrientes, Argentina, 3400 Centro Medico Privado de Reumatologia San Miguel de Tucuman, Argentina, 4000 Centro de Investigaciones Reumatologicas Tucuman, Argentina, 4000 Chile Dr Miranda Private Practice Santiago, Region Metropolitana, Chile Hospital del Salvador Santiago, Region Metropolitana, Chile Colombia Reumalab Medellin, Antioquia, Colombia Centro de Reumatologia y Ortopedia Barranquilla, Atlantico, Colombia IPS Centro Integral de Rematología del Caribe S.A.S CIRCARIBE S.A.S Sede 1 Barranquilla, Atlantico, Colombia IPS Centro Integral de Rematología del Caribe S.A.S CIRCARIBE S.A.S Sede 2 Barranquilla, Atlantico, Colombia Centro Integral de Reumatologia e Inmunologia LTDA Bogota, Cundinamarca, Colombia, 0000 Foqus Ips Ltda Bogota, Cundinamarca, Colombia Fundacion Instituto de Reumatologia Fernando Chalem Bogota, Cundinamarca, Colombia Riesgo de fractura S.A. Clinica de Artritis y Rehabilitacion Bogota, Cundinamarca, Colombia Preventive Care Ltda Chia, Cundinamarca, Colombia Centro Medico Carlos Ardila Lulle Bucaramanga, Santander, Colombia Servimed EU Bucaramanga, Santander, Colombia Mexico Hospital Angeles Chapalita Guadajara, Jalisco, Mexico, 45040 Centro de Especialidades Medicas del Sureste SA de CV Merida, Yucatan, Mexico Centro de Investigación y Biomedicina de Chihuahua Chihuahua, Mexico, 31000 Hospital Christus Mugerza Chihuahua, Mexico, 31000 Hospital Christus Muguerza del Parque Chihuahua, Mexico, 31000 Panama Centro de Infusion Marbella Panama, Panama Centro de Investigacion Marbella Panama, Panama Less <<
NCT00851318 Rheumatoid Arthritis Phase 3 Completed - Japan ... More >> Chubu Region, Japan Chugoku Region, Japan Hokkaido Region, Japan Kanto Region, Japan Kinki Region, Japan Kyushu Region, Japan Shikoku Region, Japan Tohoku Region, Japan Less <<
NCT00851318 - Completed - -
NCT00845832 - Terminated(The study was termi... More >>nated early because of a related decision to stop the development of ocrelizumab in rheumatoid arthritis.) Less << - -
NCT00853008 Acute Lymphoblastic Leukemia Phase 4 Active, not recruiting January 2019 Spain ... More >> Hospital General Alicante, Spain Hospital Germans Trias i Pujol Badalona, Spain Clínica Teknon Barcelona, Spain Hospital Clínic i Provincial Barcelona, Spain Hospital de Sant Pau Barcelona, Spain Hospital Duran y Reynals Barcelona, Spain Hospital Vall d'Hebrón Barcelona, Spain Hospital General Castellón, Spain Hospital San Pedro de Alcántara Cáceres, Spain Hospital Puerta del Mar Cádiz, Spain Hospital Josep Trueta Girona, Spain Hospital Universitario Guadalajara, Spain Hospital Juan Canalejo La Coruña, Spain Hospital Xeral Lugo, Spain Hospital 12 de Octubre Madrid, Spain Hospital Clínico Universitario Madrid, Spain Hospital de Fuenlabrada Madrid, Spain Hospital Ramón y Cajal Madrid, Spain Hospital Morales Messeguer Murcia, Spain Hospital Carlos Haya Málaga, Spain Hospital Virgen de la Victoria Málaga, Spain Hospital Central de Asturias Oviedo, Spain Hospital Son Llàtzer Palma de Mallorca, Spain Clínica Universitaria de Navarra Pamplona, Spain Hospital Parc Taulí Sabadell, Spain Hospital Clínico Universitario Salamanca, Spain Hospital Marqués de Valdecilla Santander, Spain Hospital Xeral Santiago, Spain Hospital Virgen del Rocio Sevilla, Spain Hospital Joan XXIII Tarragona, Spain Hospital Mútua de Terrassa Terrassa, Spain Hospital Clínico Universitario Valencia, Spain Hospital Dr Pesset Valencia, Spain Hospital General Valencia, Spain Hospital La Fe Valencia, Spain Hospital Clínico Valladolid, Spain Hospital Virgen de la Concha Zamora, Spain Hospital Lozano Blesa Zaragoza, Spain Less <<
NCT00854685 Rheumatoid Arthritis Phase 2 Completed - Sri Lanka ... More >> Departement of Rheumatology, National Hospital Sri Lanka Colombo, Sri Lanka Less <<
NCT00857389 Stem Cell Transplantation ... More >> Leukemia Lymphoma Less << Phase 2 Active, not recruiting March 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00900510 Abscess Not Applicable Withdrawn(Recruitment of this ... More >>population in the hospital setting not practical.) Less << May 2011 United States, North Carolina ... More >> Wake Forest University School of Medicine Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00361114 Malaria Phase 3 Terminated(SP arms were stoppe... More >>d due to high levels of treatment failure.CD not available.) Less << - Tanzania ... More >> Hale Dispensary Korogwe, Tanga Region, Tanzania Less <<
NCT00848354 - Completed - -
NCT00858780 Rheumatoid Arthritis Phase 4 Completed - Denmark ... More >> Pfizer Investigational Site Glostrup, Denmark, DK-2600 Pfizer Investigational Site Hellerup, Denmark, 2900 Finland Pfizer Investigational Site Helsinki, Finland, FI-00029 HUS Pfizer Investigational Site Jyvaskyla, Finland, 40620 Hungary Pfizer Investigational Site Gyula, Hungary, 5701 Pfizer Investigational Site Szombathely, Hungary, 9700 Pfizer Investigational Site Veszprem, Hungary, 8200 Iceland Pfizer Investigational Site Reykjavik, Iceland, 108 Norway Pfizer Investigational Site Bergen, Norway, 5021 Pfizer Investigational Site Lillehammer, Norway, 2609 Pfizer Investigational Site Oslo, Norway, 0319 Sweden Pfizer Investigational Site Lund, Sweden, 221 85 Pfizer Investigational Site Malmo, Sweden, SE-205 02 Pfizer Investigational Site Stockholm, Sweden, 14186 Pfizer Investigational Site Stockholm, Sweden, 17176 Pfizer Investigational Site Uppsala, Sweden, 751 85 Less <<
NCT00850343 - Completed - -
NCT00858780 - Completed - -
NCT00367081 Toxoplasmic Encephalitis ... More >> AIDS Less << Phase 4 Completed - Thailand ... More >> Chiang Mai University hospital (2003-2004) Chiang Mai, Thailand, 50200 Less <<
NCT00859495 Pleural Mesothelioma Phase 2 Unknown December 2014 United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Less <<
NCT00860574 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Blastic Phase Chronic Myelogenous Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Chronic Myelogenous Leukemia Childhood Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 2 Completed - United States, Colorado ... More >> University of Colorado Denver, Colorado, United States, 80217-3364 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00860015 Sarcoma, Soft Tissue Phase 2 Completed - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00863512 Lung Cancer Phase 3 Terminated - -
NCT00863512 - Terminated - -
NCT00866307 B-cell Adult Acute Lymphoblast... More >>ic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Completed - United States, Arizona ... More >> Phoenix Childrens Hospital Phoenix, Arizona, United States, 85016 United States, California Miller Children's Hospital Long Beach, California, United States, 90806 Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Rady Children's Hospital - San Diego San Diego, California, United States, 92123 University of California San Francisco Medical Center-Parnassus San Francisco, California, United States, 94143 United States, Florida Nemours Children's Clinic-Jacksonville South Jacksonville, Florida, United States, 32207 United States, Georgia Children's Healthcare of Atlanta - Egleston Atlanta, Georgia, United States, 30322 United States, Kentucky University of Kentucky Lexington, Kentucky, United States, 40536 Kosair Children's Hospital Louisville, Kentucky, United States, 40202 United States, Michigan C S Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 United States, New York The Steven and Alexandra Cohen Children's Medical Center of New York New Hyde Park, New York, United States, 11040 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Ohio Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Oregon Legacy Emanuel Children's Hospital Portland, Oregon, United States, 97227 Legacy Emanuel Hospital and Health Center Portland, Oregon, United States, 97227 United States, Pennsylvania Children's Oncology Group Philadelphia, Pennsylvania, United States, 19104 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Methodist Children's Hospital of South Texas San Antonio, Texas, United States, 78229 Australia, Western Australia Princess Margaret Hospital for Children Perth, Western Australia, Australia, 6008 Canada, Ontario Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada, K1H 8L1 Less <<
NCT00868192 Ovarian Carcinoma ... More >> Primary Peritoneal Carcinoma Less << Phase 2 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00866749 Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00866307 - Completed - -
NCT00372632 Non HIV Infected Pregnant Wome... More >>n Less << Phase 4 Completed - Rwanda ... More >> Programme Nationale de Controle de Paludisms Kigali, Rwanda Less <<
NCT00448357 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 1 Phase 2 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT00448357 - Completed - -
NCT00380146 Malaria Not Applicable Completed - Mozambique ... More >> Ndlavela Health Centre Ndlavela, Maputo, Mozambique Less <<
NCT00873093 B-cell Adult Acute Lymphoblast... More >>ic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Lymphoblastic Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Lymphoblastic Lymphoma T-cell Adult Acute Lymphoblastic Leukemia T-cell Childhood Acute Lymphoblastic Leukemia Less << Phase 2 Completed - -
NCT00873093 - Completed - -
NCT00883896 Rheumatoid Arthritis Phase 2 Completed - -
NCT00890656 Acute Lymphoblastic Leukemia Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00880815 CD20 Positive ... More >> Chronic Lymphocytic Leukemia Follicular Lymphoma Mantle Cell Lymphoma Marginal Zone Lymphoma Recurrent Diffuse Large B-Cell Lymphoma T-Cell Non-Hodgkin Lymphoma Less << Phase 1 Active, not recruiting February 28, 2020 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00892710 Non Small Cell Lung Cancer Phase 2 Completed - -
NCT00890656 - Completed - -
NCT00899899 - Completed - -
NCT00896168 Arthritis, Rheumatoid Phase 4 Completed - -
NCT00896168 - Completed - -
NCT00902005 - Completed - Norway ... More >> Lillehammer Hospital for Rheumatic Diseases Lillehammer, Oppland, Norway, 2609 Less <<
NCT00901550 Rheumatoid Arthritis Not Applicable Completed - China ... More >> Department of Medicine and Therapeutics Hong Kong, China Prince of Wales Hospital Hong Kong, China The Prince of Wales Hospital Hong Kong, China Less <<
NCT00868192 - Completed - -
NCT00903383 Rheumatoid Arthritis Phase 2 Completed - -
NCT00903383 - Completed - -
NCT00892710 - Completed - -
NCT00905034 Leukemia, Lymphocytic, Acute Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00376155 Malaria Phase 4 Completed - Gambia ... More >> MRC Laboratories Banjul, Gambia, PO Box 273 Less <<
NCT00905034 - Completed - -
NCT00908089 Rheumatoid Arthritis Phase 4 Unknown December 2015 Finland ... More >> Rheumatism Foundation Hospital Heinola, Finland, FI-18120 Helsinki University Central Hospital Helsinki, Finland, FI-00029 HUS Orton Invalid Foundation Hospital Helsinki, Finland, FI-00280 Hämeenlinna Central Hospital Hämeenlinna, Finland, FI-13530 Jyväskylä Central Hospital Jyväskylä, Finland, FI-40620 Kuopio University Hospital Kuopio, Finland, FI-703211 Lappeenranta Central Hospital Lappeenranta, Finland, FI-53130 Oulu University Hospital Oulu, Finland, FI-90029 OYS Satakunta Central Hospital Rauma, Finland, FI-26100 Rovaniemi Central Hospital Rovaniemi, Finland, FI-96100 Seinäjoki Central Hospital Seinäjoki, Finland, FI-60220 Tampere University Hospital Tampere, Finland, FI-33521 Turku University Central Hospital Turku, Finland, FI-21540 Less <<
NCT00905073 Type 1 Diabetes Mellitus Not Applicable Completed - United States, District of Col... More >>umbia Georgetown University Washington DC, District of Columbia, United States, 20007 Less <<
NCT00959517 Uncomplicated Falciparum Malar... More >>ia Less << Phase 2 Completed - Pakistan ... More >> HealthNet International Peshawar, Pakistan Less <<
NCT00913432 Rheumatoid Arthritis Phase 2 Completed - -
NCT00267865 Lymphoma-AIDS-Related ... More >> Brain Neoplasm Less << Phase 2 Recruiting July 31, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    (888) NCI-1937 Less <<
NCT00913458 Active Rheumatoid Arthritis ... More >> Arthritis, Rheumatoid Rheumatoid Arthritis Less << Phase 4 Completed - -
NCT00964691 Malaria Malar... More >>ia in Pregnancy Less << Phase 4 Terminated(Low prevalence of m... More >>alaria, high prevalence of reported allergy to sulphur drugs, high proportion of women not meeting the inclusion criterea.) Less << August 2010 Solomon Islands ... More >> Honiara City Council Honiara, Solomon Islands Less <<
NCT00964366 - Completed - -
NCT00920608 Rheumatoid Arthritis Phase 1 Withdrawn September 2009 -
NCT00918554 Sarcoid-associated Uveitis ... More >> Ocular Sarcoidosis Macular Edema Less << Phase 4 Terminated(insufficient number... More >> of inclusion) Less << - France ... More >> Hôpital Avicenne - Service de Médecine Interne Bobigny, France, 93009 CHU Michallon de Grenoble Grenoble, France, 38043 Less <<
NCT00913458 - Completed - -
NCT00563589 Graft vs Host Disease ... More >> Hematopoietic Stem Cell Transplantation Less << Not Applicable Unknown December 2008 China ... More >> Queen Mary Hospital Recruiting Hong Kong, China Sub-Investigator: AKW Lie, Dr          Sub-Investigator: WY Au, Dr          Sub-Investigator: AYH Leung, Dr          Sub-Investigator: Eric Tse, Dr          Sub-Investigator: YL Kwong, Prof          Sub-Investigator: Raymond Liang, Prof Less <<
NCT00925652 Breast Cancer Phase 2 Active, not recruiting July 2019 United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Indiana Indiana Unversity Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Massachusetts Faulkner Hospital Boston, Massachusetts, United States, 02130 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center Milford, Massachusetts, United States, 01757 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina University of North Carolina Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT00928200 Relapsed Acute Lymphoblastic L... More >>eukemia Allergy to PEG e.Coli Asparaginase Allergy to Native e.Coli Asparaginase Less << Phase 1 Terminated(Study was terminate... More >>d due to lack of accrual.) Less << - United States, Arizona ... More >> Phoenix Children's Hospital Phoenix, Arizona, United States United States, California City of Hope Duarte, California, United States, 91010 Miller Children's Hospital Long Beach, California, United States Childrens Hospital Los Angeles Los Angeles, California, United States, 90027 Oakland Children's Hospital Oakland, California, United States Stanford University Medical Center Palo Alto, California, United States, 94304-1812 UCSF School of Medicine San Francisco, California, United States, 94143-0106 United States, Florida University of Miami Cancer Center Miami, Florida, United States, 33136 United States, Illinois Children's Memorial Chicago, Illinois, United States United States, Maryland Johns Hopkins University Baltimore, Maryland, United States United States, Michigan C.S. Mott Children's Hospital Ann Arbor, Michigan, United States, 48109-0914 United States, Minnesota Childrens Hospital & Clinics of Minnesota Minneapolis, Minnesota, United States, 55404-4597 University of Minnesota Children's Hospital Minneapolis, Minnesota, United States United States, New York New York University Medical Center New York, New York, United States, 10016 Children's Hospital New York-Presbyterian New York, New York, United States, 10032 United States, Ohio Nationwide Childrens Hospital Columbus, Ohio, United States United States, Oregon Oregon Health and Science University Portland, Oregon, United States United States, Tennessee Vanderbilt Children's Hospital Nashville, Tennessee, United States United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Kids Toronto, Ontario, Canada Less <<
NCT00964366 Acne Vulgaris Phase 4 Completed - United States, Pennsylvania ... More >> cyberDERM Broomall, Pennsylvania, United States, 19008 Less <<
NCT00928317 Rheumatoid Arthritis Phase 2 Terminated(Corporate re-priori... More >>tization) Less << - -
NCT00928512 Rheumatoid Arthritis Phase 2 Completed - -
NCT00928512 - Completed - -
NCT00931957 Behcet Syndrome ... More >> Uveal Disease Less << Not Applicable Unknown October 2013 Iran, Islamic Republic of ... More >> Rheumatology Research Center, Behcet's Disease Unit (Shariati Hospital) Recruiting Tehran, Iran, Islamic Republic of, 14114 Contact: Fereydoun Davatchi, MD    (98-21)8802-6956    fddh@davatchi.net    Contact: Bahar Sadeghi, MD    (98-21)8802-6956    bahar@bahars.net    Principal Investigator: Fereydoun Davatchi, MD          Principal Investigator: Farhad Shahram, MD          Principal Investigator: Hormoz Shams, MD          Sub-Investigator: Abdolhadi Nadji, MD          Sub-Investigator: Bahar Sadeghi, MD          Sub-Investigator: Massoomeh Akhlaghi, MD          Sub-Investigator: Tahereh Faezi, MD Less <<
NCT00405704 Vesicoureteral Reflux ... More >> Urinary Tract Infections Less << Phase 3 Completed - -
NCT00932893 Carcinoma, Non-Small-Cell Lung Phase 3 Completed - -
NCT00934648 Rheumatoid Arthritis Phase 4 Completed - Morocco ... More >> Casablanca, Morocco, 20000 Casablanca, Morocco, 20100 Marrakech, Morocco, 40000 Rabat, Morocco, 10150 Salé, Morocco, 15045 Less <<
NCT00945724 Large B-cell Diffuse Lymphoma ... More >>of Testis Less << Phase 2 Recruiting December 2019 Italy ... More >> A.O. SS. Antonio e Biagio e Cesare Arrigo Recruiting Alessandria, Italy Contact: Flavia Salvi, MD          Spedali Civili Recruiting Brescia, Italy Ematologia Ospedale Businco Recruiting Cagliari, Italy Contact: Giuseppina Cabras, MD          S. Martino Hospital Recruiting Genova, Italy European Institute of Oncology Recruiting Milan, Italy Principal Investigator: Giovanni Martinelli, MD          San Raffaele H Scientific Institute Recruiting Milan, Italy Contact: Andres Ferreri, MD       ferreri.andres@hsr.it    Principal Investigator: Andrés JM Ferreri, MD          Policlinico Recruiting Modena, Italy A.O. San Gerardo Recruiting Monza, Italy AOU Maggiore della Carità Recruiting Novara, Italy S. Matteo Recruiting Pavia, Italy Principal Investigator: Luca Arcaini, MD          Ospedale Civile Recruiting Piacenza, Italy U.O. Ematologia AUSL Ravenna Recruiting Ravenna, Italy Arcispedale Santa Maria Nuova Recruiting Reggio Emilia, Italy IFO Regina Elena Recruiting Roma, Italy Principal Investigator: Francesco Pisani, MD          Policlinico Universitario Campus Biomedico Recruiting Roma, Italy Contact: Giuseppe Avvisati, MD          Università La Sapienza Recruiting Rome, Italy Humanitas Recruiting Rozzano, Italy Contact: Monica Balzarotti          Azienda Ospedaliero-Universitaria Recruiting Sassari, Italy A.O. S. Maria Recruiting Terni, Italy A.O.U. San Giovanni Battista-Molinette, S.C. Ematologia 2 Recruiting Torino, Italy, 10134 Contact: Umberto Vitolo, M.D.       uvitolo@molinette.piemonte.it    Principal Investigator: Umberto Vitolo, M.D.          Ospedale di Circolo Fondazione Macchi Recruiting Varese, Italy Contact: Graziella Pinotti, MD          Switzerland IOSI Recruiting Bellinzona, Switzerland, 6500 Contact: Emanuele Zucca, MD    +41 91 8119040    ielsg@ticino.com    Principal Investigator: Emanuele Zucca, M.D. Less <<
NCT00948675 Advanced Non-Small Cell Lung C... More >>ancer Less << Phase 3 Active, not recruiting December 2018 -
NCT00405704 - Completed - -
NCT00932893 - Completed - -
NCT00950989 Rheumatoid Arthritis Phase 2 Completed - -
NCT00952016 Advanced Colorectal Cancer Phase 2 Terminated(Lack of recruitment... More >> - only 2 patients recruited.) Less << - United Kingdom ... More >> The Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT00948675 - Active, not recruiting - -
NCT00429533 Pemphigus Vulgaris Phase 2 Terminated - United States, Illinois ... More >> Northwestern University Medical Center Chicago, Illinois, United States, 60611-3010 Rush-Presbyterian-St. Luke's Medical Center Chicago, Illinois, United States, 60612 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, New Jersey Cooper Hospital/University Medical Center Camden, New Jersey, United States, 08103 United States, New York The New York VA Medical Center, New York University New York, New York, United States, 10010 United States, Ohio Case Western Reserve University School of Medicine Cleveland, Ohio, United States, 44106 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas University of Texas Dallas, Texas, United States, 75235 Less <<
NCT00940524 Leukemia Acut... More >>e Lymphoblastic Leukemia Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00959036 Active Rheumatoid Arthritis Phase 1 Phase 2 Completed - -
NCT00976456 - Completed - -
NCT00981799 Relapsed T-Cell Acute Lymphobl... More >>astic Leukemia Relapsed T-Cell Lymphoblastic Lymphoma Less << Phase 1 Phase 2 Terminated(Slow accrual rate) - -
NCT00989352 Primary Non Hodgkin Lymphoma o... More >>f the Central Nervous System Less << Phase 2 Unknown September 2011 Germany ... More >> University Medical Center Freiburg, Dept. of Internal Medicine I - Hematology and Oncology Recruiting Freiburg, Germany, 79106 Contact: Gerald Illerhaus, PD Dr.    +497612703785    Gerald.Illerhaus@uniklinik-freiburg.de    Contact: Elvira Burger    +497612707378    elvira.burger@uniklinik-freiburg.de    Principal Investigator: Gerald Illerhaus, PD Dr. Less <<
NCT00934648 - Completed - -
NCT00453856 Malaria Phase 4 Terminated(The study was termi... More >>nated because of Early Treatment Failure in child.The justification for this decision are concerns about safety of children.) Less << - Gabon ... More >> Medical Research Unit of the Albert Schweitzer Hospital Lambaréné, Moyen Ogooué, Gabon, B.P. 118 Less <<
NCT00992602 - Completed - -
NCT00993135 - Completed - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00993317 Rheumatoid Arthritis Phase 3 Completed - Korea, Republic of ... More >> Kyungpook National University Hospital Daegu, Korea, Republic of, 700-721 Catholic University Hospital of Daegu Daegu, Korea, Republic of Eulji University Hospital Daejeon, Korea, Republic of, 302-799 Inha University Hospital Inchon, Korea, Republic of Chonnam National University Hospital Kwangju, Korea, Republic of Pusan National University Hospital Pusan, Korea, Republic of Yonsei University Severance Hospital Seoul, Korea, Republic of, 120-752 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Asan Medical Center Seoul, Korea, Republic of, 138-736 Catholic University of Korea ST.Mary's Hospital Seoul, Korea, Republic of, 150-713 Gangnam Severance Hospital Seoul, Korea, Republic of Hanyang Universoty Hospital Seoul, Korea, Republic of KonKuk University Medical Center Seoul, Korea, Republic of Seoul national univeristy Seoul, Korea, Republic of Ajou University Hospital Suwon, Korea, Republic of Less <<
NCT00993343 Graft-versus-host Disease ... More >> Survival Less << Phase 3 Completed - Sweden ... More >> Karolinska University Hospital Stockholm, Sweden, 14186 Less <<
NCT00994097 Non-small Cell Lung Cancer Phase 2 Completed - Italy ... More >> Istituto Nazionale per la ricerca sul cancro Genoa, Italy, 16132 Fondazione San Raffaele del Monte Tabor Milan, Italy, 20132 Istituto Nazionale dei Tumori Milan, Italy, 20133 Istituto Europeo Oncologico Milan, Italy Less <<
NCT00993317 - Completed - -
NCT00992602 Central Nervous System Metasta... More >>ses Leptomeningeal Metastases Recurrent Breast Cancer Stage IV Breast Cancer Tumors Metastatic to Brain Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00989703 Healthy Phase 1 Completed - Belgium ... More >> SGS Stuivenberg Antwerp, Belgium Less <<
NCT01001208 Psoriasis Phase 3 Completed - -
NCT01000610 - Completed - -
NCT01001208 - Completed - -
NCT01000610 Rheumatoid Arthritis Phase 4 Completed - Tunisia ... More >> Hopital Farhat Hached; Service Rhumatologie Sousse, Tunisia, 4000 Hopital Charles Nicole; Service Rhumatologie Tunis, Tunisia, 1006 Hopital La Rabta; Service Rhumatologie Tunis, Tunisia, 1007 Hopital Mongi Slim; Service Rhumatologie Tunis, Tunisia, 2046 Less <<
NCT00799240 Non Small Cell Lung Cancer Phase 2 Completed - United States, Kansas ... More >> Hutchinson Clinic, PA Hutchinson, Kansas, United States, 67502 Kansas University Cancer Center Kansas City, Kansas, United States, 66160 Stormont Vail Healthcare Topeka, Kansas, United States, 66606 United States, Missouri VA Medical Center Kansas City, Missouri, United States, 64128 Less <<
NCT01049633 - - - United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01049438 Methicillin Resistant Staphylo... More >>coccus Aureus Skin Infections Less << Not Applicable Completed - -
NCT01004250 Non-Small Cell Lung Cancer Phase 2 Completed - Denmark ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Copenhagen, Denmark, 2200 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Herlev, Denmark, 2730 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Coswig, Germany, 01640 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany, 60431 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 22087 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamm, Germany, 59071 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, 30625 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Magdeburg, Germany, D-39120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mannheim, Germany, 68167 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lecce, Italy, 73100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Padova, Italy, 35128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rome, Italy, 00144 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rozzano, Italy, 20089 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trento, Italy, 38100 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jaen, Spain, 23007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28046 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pozuelo De Alarcon, Spain, 28223 Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Malmo, Sweden, 205 02 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Solna, Sweden, 17176 Less <<
NCT01003964 Non Small Cell Lung Cancer Phase 2 Unknown December 2014 Korea, Republic of ... More >> National Cancer Center, Korea Goyang-si, Gyeonggi-do, Korea, Republic of Less <<
NCT01004250 - Completed - -
NCT00679302 Skin Diseases, Infectious Phase 4 Completed - United States, Missouri ... More >> Cardinal Glennon Children's Medical Center Saint Louis, Missouri, United States, 63104 Less <<
NCT00627666 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT00679302 - Completed - -
NCT00682578 Uncomplicated Falciparum Malar... More >>ia Vivax Malaria Less << Phase 3 Completed - Afghanistan ... More >> Provincial Malaria Control Centers (MRC) Faryab, Afghanistan Provincial Malaria Control Centers (MRC) Jalalabad, Afghanistan Provincial Malaria Control Centers (MRC) Maimana, Afghanistan Provincial Malaria Control Centers (MRC) Takhar, Afghanistan Less <<
NCT00998166 Non-Small Cell Lung Cancer Phase 2 Terminated(Poor enrollment) - United States, New York ... More >> North Shore University Hospital Lake Success, New York, United States, 11042 Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00131235 Malaria Sexua... More >>lly Transmitted Diseases Preterm Birth Pregnancy Less << Phase 3 Completed - Malawi ... More >> College of Medicine, University of Malawi Mangochi, Mangochi District, Malawi Less <<
NCT00634322 Osteosarcoma Phase 2 Terminated(Lack of enrollment) - -
NCT00634504 Osteosarcoma ... More >>Leukemia Lymphoma Less << Phase 1 Completed - -
NCT01004432 Arthritis Art... More >>hritis, Rheumatoid Autoimmune Diseases Less << Phase 3 Completed - -
NCT00634504 - Completed - -
NCT00131716 Anemia Phase 3 Completed - Gambia ... More >> Medical Research Council Laboratories, Banjul, Gambia Less <<
NCT00639834 Rheumatoid Arthritis Phase 1 Completed - United States, Arizona ... More >> Sun Valley Arthritis Center LTD. Peoria, Arizona, United States, 85381 United States, California Impact Clinical Trials Los Angeles, California, United States, 90036 United States, Florida Centre for Rheumatology, Immunology and Arthritis (CRIA) Fort Lauderdale, Florida, United States, 33334 Coastal Medical Research, Inc Port Orange, Florida, United States, 32127 Lovelace Scientific Resources Venice, Florida, United States, 34233 United States, Maryland Good Samaritan Hospital and Johns Hopkins Hospital Baltimore, Maryland, United States, 21239 United States, Michigan Justus Fiechtner Lansing, Michigan, United States, 48910 United States, New York Columbia University Medical Center New York, New York, United States, 10032 United States, Pennsylvania Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 United States, Washington Arthritis Northwest Rheumatology, PLLC Spokane, Washington, United States, 99204 George Krick, MD Tacoma, Washington, United States, 98405 Germany Universitatsklinikum "Carl Gustav Carus" an der Technischen Universtitat Dresden Dresden, Germany, 01307 klinikum der Universitat zu Koln Koln, Germany, 50924 Klinikum rechts der Isar der TU Munchen Munich, Germany, 81675 Hungary DRC Gyógyszervizsgáló Központ Kft Balatonfüred, Hungary, H-8230 Semmelweis Egyetem Altalanos Orvostudomanyi Kar-I. sz Budapest, Hungary, H-1083 DEOEC Kinikai Farmakologiai Tanszek Debrecen, Hungary, H-4012 First Department of Medicine Szeged, Hungary Ukraine V.K. Gusak Institute of Urgent & Reconstructive Surgery under UAMS, Hospital Therapy and Rehabilitaiton Clinic Donetsk, Ukraine, 83045 Kharkiv Medical Academy of Postgraduate Education, City Clinical General Hospital #25 Kharkiv, Ukraine, 61115 Zaporizhya State Medical University, City Clinical Hopsital #6, Therapeutics Department Zaporizhya, Ukraine, 69035 Zaporizhzhya Regional Clinical Hospital, Rheumatology Department Zaporizhzhya, Ukraine, 69600 United Kingdom The Kellgren Centre for Rheumatology Manchester, United Kingdom Welcome Trust Clinical Research Facility, Southampton General Hospital Southampton, United Kingdom, SO16 6YD Less <<
NCT00635726 Bladder Cancer Phase 2 Terminated(Due to poor accrual... More >>) Less << - Greece ... More >> University General Hospital of Alexandroupolis, Dept. of Medical Oncology Alexandroupolis, Greece 401 Military Hospital, Medical Oncology Unit Athens, Greece Air Forces Military Hospital, Dept. of Medical Oncology Athens, Greece IASO General Hospital of Athens, 1st Dept. of Medical Oncology Athens, Greece Laikon General Hospital, Medical Oncology Unit, Propedeutic Dept. of Internal Medicine Athens, Greece Metaxa's Anticancer Hospital of Piraeus, 1st Dept. of Medical Oncology Piraeus, Greece Theagenion Anticancer Hospital of Thessaloniki Thessaloniki, Greece Less <<
NCT00634322 - Terminated(Lack of enrollment) - -
NCT00642460 Juvenile Idiopathic Arthritis Phase 3 Completed - -
NCT00137553 Malaria, Falciparum Phase 4 Completed - Guinea-Bissau ... More >> Bandim Health Project Apartado 861, Bissau, Guinea-Bissau Less <<
NCT00628095 Arthritis, Rheumatoid Phase 2 Phase 3 Completed - -
NCT00647049 Primary Non Hodgkin Lymphoma o... More >>f the Central Nervous System Less << Phase 2 Unknown August 2013 Germany ... More >> University Hospital Freiburg Recruiting Freiburg, Germany, 79106 Contact: Gerald Illerhaus, Dr.    00497612703785    Gerald.Illerhaus@uniklinik-freiburg.de    Contact: Andreas Zähringer    00497612707378    andreas.zaehringer@uniklinik-freiburg.de Less <<
NCT00642460 - Completed - -
NCT00691600 Abscess Phase 3 Completed - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00146783 Malaria Phase 2 Phase 3 Completed - Ghana ... More >> Navrongo District Hosptial Navrongo, Upper East Region, Ghana Less <<
NCT00645632 Sarcoma Not Applicable Completed - -
NCT00142207 Malaria, Falciparum Phase 3 Completed - Uganda ... More >> Kabale District Health Services (antenatal clinics at selected sites) Kabale, Kabale District, Uganda Less <<
NCT00152204 Malaria, Falciparum ... More >> Anemia Less << Phase 3 Unknown December 2008 Tanzania ... More >> Ifakara Health Research & Development Centre Dar es Salaam, Tanzania, SLP 78373 Less <<
NCT00636909 AML ALL ... More >> CML Chronic Phase, Accelerated Phase, or Blast Crisis CLL MDS RELAPSED NON-HODGKIN'S OR HODGKIN'S LYMPHOMA APLASTIC ANEMIA MULTIPLE MYELOMA MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET) Less << Phase 2 Completed - -
NCT00654368 Rheumatoid Arthritis Phase 4 Completed - Canada, British Columbia ... More >> Research Site Vancouver, British Columbia, Canada, V5Z 3Y1 Research Site Victoria, British Columbia, Canada, V8P 5P6 Research Site Victoria, British Columbia, Canada, V8V 3P9 Canada, Manitoba Research Site Winnipeg, Manitoba, Canada, R3A 1M3 Canada, New Brunswick Research Site Quispamsis, New Brunswick, Canada, E2E 4J8 Canada, Newfoundland and Labrador Research Site St. John's, Newfoundland and Labrador, Canada, A1A 5E8 Research Site St. John's, Newfoundland and Labrador, Canada, A1C 5B8 Canada, Nova Scotia Research Site Sydney, Nova Scotia, Canada, B1S 3N1 Canada, Ontario Research Site Bowmanville, Ontario, Canada, L1C 1P6 Research Site Brampton, Ontario, Canada, L6T 3J1 Research Site Burlington, Ontario, Canada, L7R 4B7 Research Site Hamilton, Ontario, Canada, L8N 1Y2 Research Site London, Ontario, Canada, N6A 4V2 Research Site Mississauga, Ontario, Canada, L5M 2V8 Research Site Newmarket, Ontario, Canada, L3Y 3R7 Research Site Ottawa, Ontario, Canada, K1S 1C2 Research Site St Catharines, Ontario, Canada, L2N 7E4 Research Site Toronto, Ontario, Canada, M5G 1X5 Research Site Toronto, Ontario, Canada, M9B 6H8 Canada, Quebec Research Site Laval, Quebec, Canada, H7T 2P5 Research Site Montreal, Quebec, Canada, H2L 1S6 Research Site Montreal, Quebec, Canada, H3T 1E2 Research Site Montreal, Quebec, Canada, H3Z 2Z3 Research Site Rimouski, Quebec, Canada, G5L 8W1 Research Site Saint Leonard, Quebec, Canada, H1R 1X8 Research Site Saint-Eustache, Quebec, Canada, J7P 4J2 Canada, Saskatchewan Research Site Saskatoon, Saskatchewan, Canada, S7K 0H6 Canada Research Site Quebec, Canada, G1V 3M7 Less <<
NCT00653068 - Active, not recruiting - -
NCT00158574 Malaria Phase 2 Phase 3 Completed - Tanzania ... More >> Ministry of Health, Korogwe and Same District MCH clinics Tanga, Tanga and Kilimanjaro, Tanzania Less <<
NCT00655343 Graft vs Host Disease Phase 3 Completed - Germany ... More >> Universität Freiburg, Medizinische Klinik, Abteilung Innere Medizin I, Hämatologie/Onkologie Freiburg, Baden-Württemberg, Germany, 79110 Less <<
NCT00653068 Childhood Atypical Teratoid/Rh... More >>abdoid Tumor Less << Phase 3 Active, not recruiting - -
NCT00168948 Malaria Anemi... More >>a Less << Phase 4 Unknown - -
NCT00656591 - Unknown December 2008 United Kingdom ... More >> International Child Health, ICH Recruiting London, United Kingdom, WC1N 1EH Contact: Anthony Costello, Dr       a.costello@ich.ucl.ac.uk Less <<
NCT00654368 - Completed - -
NCT00203736 Malaria Not Applicable Completed - Mozambique ... More >> Catuane Clinic Catuane, Matutuine, Mozambique Namaacha Clinic Namaacha, Mozambique Less <<
NCT00167739 Malaria Phase 4 Completed - Gabon ... More >> Medical Research Unit, Lambaréné Lambaréné, Moyen Ogooué, Gabon, B.P. 118 Less <<
NCT00658047 Arthritis, Rheumatoid Phase 2 Completed - Canada, Ontario ... More >> The Rebecca MacDonald Centre for Arthritis and Autoimmune Disease Toronto, Ontario, Canada, M5G 1X5 Less <<
NCT00509015 Malaria, Falciparum Not Applicable Completed - Tanzania ... More >> Kilimanjaro Christian Medical Centre Moshi, Tanzania Less <<
NCT00206739 Malaria Anemi... More >>a Less << Phase 4 Completed - Ghana ... More >> Kumasi Centre for Collaborative Research in Tropical Medicine Kumasi, Ashanti Region, Ghana Less <<
NCT00209781 Pregnancy Not Applicable Unknown - Mozambique ... More >> Centro de Investigaçao em Saude da Manhiça Manhiça, Maputo, Mozambique Less <<
NCT00660647 Arthritis, Rheumatoid Phase 3 Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, DK-8000 Less <<
NCT00167843 Malaria Phase 4 Completed - Gabon ... More >> Medical Research Unit of the Albert Schweitzer Hospital Lambaréné, Moyen Ogooué, Gabon, B.P. 118 Less <<
NCT00209794 Malaria Phase 1 Phase 2 Unknown - Mozambique ... More >> Centro de Investigaçao em Saude da Manhiça Manhiça, Maputo, Mozambique Less <<
NCT00659412 Psoriatic Arthritis Phase 2 Completed - United States, Alabama ... More >> Birmingham, Alabama, United States, 35294 United States, Maryland Wheaton, Maryland, United States, 20902 United States, New York Lake Success, New York, United States, 11042 Rochester, New York, United States, 14642 United States, Washington Seattle, Washington, United States, 98104 Canada, British Columbia Victoria, British Columbia, Canada, V8V 3P9 Canada, Newfoundland and Labrador St Johns, Newfoundland and Labrador, Canada, A1C 5B8 Canada, Ontario London, Ontario, Canada, N6A 4V2 Newmarket, Ontario, Canada, L3Y 3R7 Toronto, Ontario, Canada, K1N 5N1 Toronto, Ontario, Canada, M5T 2S8 Canada, Quebec Montreal, Quebec, Canada, H2L 1S6 Germany Berlin, Germany, D-13125 Frankfurt, Germany, D-60590 Goettingen, Germany, D-37075 Poland Bialystok, Poland, 15-337 Elblag, Poland, 82-300 Kalisz, Poland, 62-800 Krakow, Poland, 30-119 Torun, Poland, 87-100 Warszawa, Poland, 02-637 Russian Federation Moscow, Russian Federation, 107076 Moscow, Russian Federation, 115522 N. Novgorod, Russian Federation, 603600 St Petersburg, Russian Federation, 190068 St. Petersburg, Russian Federation, 194044 Yaroslavl, Russian Federation, 150003 Less <<
NCT00510159 Schistosoma Haematobium Phase 2 Phase 3 Completed - Mali ... More >> Djalakorodji, Mali Less <<
NCT00660816 - Completed - -
NCT00660816 Lung Cancer Phase 2 Completed - United States, Michigan ... More >> Wayne State University Detroit, Michigan, United States, 48202 United States, New York Columbia Presbyterian New York City, New York, United States, 10032 United States, Ohio Lake/University Ireland Cancer Center Cleveland, Ohio, United States, 44060 Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 MetroHealth Medical Center Cleveland, Ohio, United States, 44109 UHHS Chagrin Highlands Medical Center Cleveland, Ohio, United States, 44122 Southwest General Health Center Cleveland, Ohio, United States, 44130 UHHS Westlake Medical Center Cleveland, Ohio, United States, 44145 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Riverside Methodist Hospital Columbus, Ohio, United States, 43124 Ohio State University Columbus, Ohio, United States, 43210 UH-Monarch Mayfield Heights, Ohio, United States, 44124 UH-Firelands Sandusky, Ohio, United States, 44870 Less <<
NCT00666354 Fingernail Psoriasis Phase 2 Unknown January 2009 United Kingdom ... More >> University of Manchester, The Dermatology Centre Salford, Manchester, United Kingdom, M6 8HD Great Western Hospital Rheumatology Department Swindon, Wiltshire, United Kingdom, SN3 6BB Aberdeen Royal Infirmary Dermatology Outpatients Clinic Aberdeen, United Kingdom, AB25 2ZR Royal National Hospital for Rheumatic Diseases Bath, United Kingdom, BA1 1RL University Hospital of Wales, Welsh Institute of Dermatology Cardiff, United Kingdom, CF14 4XN Leeds General Infirmary Department of Dermatology Leeds, United Kingdom, LS1 3EX George Eliot Hospital, Department of Dermatology Nuneaton, United Kingdom, CV10 7DJ Less <<
NCT00669877 Burkitt's Lymphoma ... More >> Burkitt'S-like Lymphoma Less << Phase 2 Completed - United States, Texas ... More >> The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00669812 Lymphoma Smal... More >>l Intestine Cancer Less << Phase 2 Unknown - United Kingdom ... More >> Sir James Spence Institute of Child Health at Royal Victoria Infirmary Recruiting Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Contact: Anne Lennard    44-191-282-4743    a.l.lennard@ncl.ac.uk Less <<
NCT00667342 - Active, not recruiting - -
NCT00667342 Osteosarcoma ... More >>Malignant Fibrous Histiocytoma (MFH) of Bone Less << Phase 2 Active, not recruiting May 2019 United States, California ... More >> Rady Children's Hospital and Health Center San Diego, California, United States, 92123 United States, Maryland Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 NCI/NIH - Pediatric Oncology Branch Bethesda, Maryland, United States, 20892 United States, Tennessee St Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT00671034 B-cell Adult Acute Lymphoblast... More >>ic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Completed - -
NCT00669643 Leprosy Phase 4 Completed - Brazil ... More >> Centro de Referência Nacional Alfredo da Matta - FUAM Manaus, Amazonas, Brazil, 69.065-130 Centro de Referência Nacional Dona Libânia - CDERM Fortaleza, Ceará, Brazil, 60.101-035 Less <<
NCT00669877 - Completed - -
NCT00671034 - Completed - -
NCT00673101 - Recruiting December 2020 France ... More >> Hopital du Haut Leveque Recruiting Pessac, France, 33600 Contact: David Laharie, MD, PhD    33-557-656-439    david.laharie@chu-bordeaux.fr Less <<
NCT00671658 Leukemia Acut... More >>e Lymphoblastic Leukemia Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00673179 - Terminated(Low accrual.) - -
NCT00673179 Osteosarcoma Not Applicable Terminated(Low accrual.) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00519467 Malaria Phase 2 Completed - Gambia ... More >> GSK Investigational Site Banjul, Gambia Malawi GSK Investigational Site Blantyre, Malawi, 30096,BLANTYRE 3 Less <<
NCT00679731 Psoriasis Phase 3 Completed - -
NCT00243542 Acne Vulgaris Phase 4 Completed - -
NCT00683319 - Active, not recruiting - United Kingdom ... More >> Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Less <<
NCT00673920 Rheumatoid Arthritis Phase 3 Terminated(Based on analysis o... More >>f results and consideration of available treatments, the overall benefit to risk profile of ocrelizumab was not favorable in RA.) Less << - -
NCT00684099 Non Small Cell Lung Cancer Phase 1 Phase 2 Completed - Greece ... More >> University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupolis, Greece "IASO" General Hospital of Athnes, Dep of Medical Oncology Athens, Greece "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece Sismanogleio General Hospital, 1st, 2nd Dep of Pulmonary Diseases Athens, Greece Sotiria" General Hospital, 1st Dep of Pulmonary Diseases Athens, Greece "Diabalkaniko" Hospital of Thessaloniki Thessaloniki, Greece "Theagenion" Anticancer Hospital of Thessaloniki Thessaloniki, Greece Less <<
NCT00730028 Staphylococcal Infection Phase 2 Completed - United States, California ... More >> San Francisco General Hospital - Infectious Diseases San Francisco, California, United States, 94110-3518 Harbor UCLA Medical Center - Medicine - Infectious Diseases Torrance, California, United States, 90502-2006 United States, Georgia Morehouse School of Medicine - Morehouse Medical Associates - Atlanta Atlanta, Georgia, United States, 30303-2544 United States, Illinois The University of Chicago - Comer Children's Hospital - Infectious Diseases Chicago, Illinois, United States, 60637-1425 United States, Missouri Washington University School of Medicine in St. Louis - Infectious Diseases Saint Louis, Missouri, United States, 63110-1010 United States, Tennessee Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center Nashville, Tennessee, United States, 37232-2573 Less <<
NCT00686959 Non Small Cell Lung Cancer Phase 3 Completed - -
NCT00730366 Malaria in Pregnancy Phase 3 Completed - Burkina Faso ... More >> District Sanitaire Boromo, Burkina Faso Less <<
NCT00249782 Rosacea Phase 2 Completed - -
NCT00729937 - Completed - -
NCT00688103 Rheumatoid Arthritis Phase 4 Completed - Japan ... More >> Keio University Tokyo, Japan, 160-8582 Less <<
NCT00687648 Breast Cancer Phase 2 Unknown - Singapore ... More >> National Cancer Centre - Singapore Recruiting Singapore, Singapore, 169610 Contact: Wong Nan Soon, MBBS, MRCP, FAMS    65-6-436-8088 Less <<
NCT00686959 - Completed - -
NCT00729937 Staphylococcal Infection Phase 2 Phase 3 Completed - United States, Arizona ... More >> Maricopa Medical Center - Emergency Medicine Phoenix, Arizona, United States, 85008-4973 United States, California University of California Los Angeles - Olive View Medical Center Sylmar, California, United States, 91342-1437 United States, Maryland Johns Hopkins University at Mount Washington - Emergency Medicine Baltimore, Maryland, United States, 21209-3652 United States, Missouri Truman Medical Center - Hospital Hill Kansas City, Missouri, United States, 64108-2640 United States, Pennsylvania Temple University Hospital Philadelphia, Pennsylvania, United States, 19140-5103 Less <<
NCT00688103 - Completed - -
NCT00004784 Liver Cirrhosis, Biliary Phase 3 Completed - -
NCT00502853 Rheumatoid Arthritis Phase 4 Completed - Italy ... More >> Università Degli Studi Di Genova - Dimi; Reumatologia Genova, Liguria, Italy, 16132 Less <<
NCT00689728 Arthritis, Rheumatoid Phase 2 Completed - -
NCT00502853 - Completed - -
NCT00689845 Lymphoma Not Applicable Unknown - United Kingdom ... More >> Leeds Cancer Centre at St. James's University Hospital Recruiting Leeds, England, United Kingdom, LS9 7TF Contact: Contact Person    44-113-206-6400       St. George's Hospital Recruiting London, England, United Kingdom, SW17 0QT Contact: Contact Person    44-208-725-2425    rpetteng@sghms.ac.uk    Christie Hospital Recruiting Manchester, England, United Kingdom, M20 4BX Contact: Contact Person    44-845-226-3000       Mount Vernon Cancer Centre at Mount Vernon Hospital Recruiting Northwood, England, United Kingdom, HA6 2RN Contact: Contact Person    44-1923-826-111       Cancer Research Centre at Weston Park Hospital Recruiting Sheffield, England, United Kingdom, S1O 2SJ Contact: Contact Person    44-114-226-5007    b.w.hancock@sheffield.ac.uk    Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Contact Person    44-238-079-6186    johnsonp@soton.ac.uk    Royal Marsden - Surrey Recruiting Sutton, England, United Kingdom, SM2 5PT Contact: Contact Person    44-208-661-3279    david.cunningham@rmh.nhs.uk    Saint Bartholomew's Hospital Recruiting London, United Kingdom Contact: Contact Person    44-207-796-3979    silvia.montoto@cancer.org.uk Less <<
NCT00695188 Rheumatoid Arthritis Phase 4 Completed - Austria ... More >> Kaiser-Franz-Josef-Spital Wien, Austria, 1100 Rheumazentrum Wien Oberlaa Wien, Austria, 1100 Less <<
NCT00730028 - Completed - -
NCT00695188 - Completed - -
NCT00539838 Systemic Lupus Erythematosus Phase 3 Terminated(The study was termi... More >>nated prematurely when the decision was made that ocrelizumab was not likely to benefit this patient population.) Less << - -
NCT00689728 - Completed - -
NCT00544115 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Precancerous/Nonmalignant Condition Less << Phase 2 Active, not recruiting - -
NCT00006168 Liver Cirrhosis, Biliary Phase 3 Completed - United States, California ... More >> Keck School of Medicine at U.S.C. Los Angeles, California, United States, 90033 U California Medical Center San Francisco, California, United States, 94143 United States, Connecticut Yale University School of Medicine New Haven, Connecticut, United States, 06520-8019 United States, Georgia Emory University School of Medicine Atlanta, Georgia, United States, 30322 United States, Missouri Saint Louis University St. Louis, Missouri, United States, 63104 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-3285 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97201 United States, Pennsylvania Albert Einstein Medical Center Philadelphia, Pennsylvania, United States, 19141 United States, Texas UT Southwestern Medical Center at Dallas Dallas, Texas, United States, 75235-9151 United States, Virginia Medical College of Virginia Richmond, Virginia, United States, 23298-0711 United States, Washington University of Washington Medical Center Seattle, Washington, United States, 98195 Less <<
NCT00702299 Fallopian Tube Cancer ... More >> Ovarian Cancer Peritoneal Cavity Cancer Less << Phase 1 Completed - United States, Arizona ... More >> Arizona Oncology - Scottsdale Scottsdale, Arizona, United States, 85258 Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724-5024 Less <<
NCT00702299 - Completed - -
NCT00706797 Rheumatoid Arthritis Phase 4 Terminated - -
NCT00703976 - Completed - -
NCT00707083 Leukemia Phase 3 Active, not recruiting December 31, 2020 China ... More >> Prince of Wales Hospital Hong Kong, China Queen Mary Hospital - Hong Kong Hong Kong, China Less <<
NCT00705549 Non-Small-Cell Lung Cancer Phase 2 Terminated(Due to poor accrual... More >>) Less << - Greece ... More >> University General Hospital of Alexandroupolis, Dept. of Medical Oncology Alexandroupolis, Greece "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece 401 Military Hospital, Medical Oncology Unit Athens, Greece Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece Sismanogleio General Hospital, 1st, 2nd Dep of Pulmonary Diseases Athens, Greece Sotiria" General Hospital, 1st, 3rd, 8th Dep of Pulmonary Diseases Athens, Greece "Metaxa's" Anticancer Hospital of Piraeus,1st Dep of Medical Oncology Piraeus, Greece "Theagenion" Anticancer Hospital of Thessaloniki Thessaloniki, Greece Less <<
NCT00712114 Rheumatoid Arthritis Phase 1 Phase 2 Completed - United States, California ... More >> Beverly Hills, California, United States, 90211 Less <<
NCT00711854 MRSA Infection Phase 4 Completed - Switzerland ... More >> Geneva University Hospitals Geneva, Switzerland, 1211 Less <<
NCT00703976 Cancer Phase 2 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00752375 Pyelonephritis Phase 3 Withdrawn(No participants) - Canada, Alberta ... More >> Stollery Children's Hospital Edmonton, Alberta, Canada, T6G 2B7 Less <<
NCT00716248 Rheumatoid Arthritis Phase 4 Unknown - Japan ... More >> Department of Rheumatology/Clinical Immunology, Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan, 350-8550 Less <<
NCT00270530 Placental Malaria Infection ... More >> HIV Infections Stillbirth Prematurity Neonatal Deaths Less << Phase 4 Completed - Zambia ... More >> Tropical Diseases Research Centre Ndola, Zambia Less <<
NCT00274235 Malaria Phase 3 Completed - Benin ... More >> Institut de Recherche pour le Développement Cotonou, Benin, 01 BP 4414 RP Less <<
NCT00706797 - Terminated - -
NCT00727987 Rheumatoid Arthritis Phase 3 Completed - -
NCT00727831 Chemotherapeutic Agent Toxicit... More >>y Lymphoma Mucositis Neurotoxicity Less << Phase 1 Phase 2 Completed - United Kingdom ... More >> Leeds General Infirmary Leeds, England, United Kingdom, LS1 3EX Torbay Hospital Torquay, England, United Kingdom, TQ2 7AA Less <<
NCT00720629 - Terminated - -
NCT00574496 Lymphoma Phase 2 Active, not recruiting November 2019 United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00718718 Arthritis, Rheumatoid Phase 2 Completed - -
NCT00718718 - Completed - -
NCT00732875 Arthritis, Rheumatoid Phase 3 Completed - -
NCT00733031 Cancer, Solid... More >> Tumors Advanced Solid Malignancies Less << Phase 1 Terminated(PK results demonstr... More >>ate low and variable plasma concentrations so that achieving therapeutic concentrations is unlikely.) Less << - United States, Colorado ... More >> Research Site Aurora, Colorado, United States United States, Tennessee Research Site Nashville, Tennessee, United States Less <<
NCT00789464 Recurrent Urinary Tract Infect... More >>ion Less << Phase 2 Withdrawn(Withdrawn by PI) - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00734773 Brain and Central Nervous Syst... More >>em Tumors Lymphoma Neurotoxicity Less << Early Phase 1 Withdrawn(Lack of funding) - -
NCT00741221 Non-small-cell Lung Cancer Phase 2 Completed - Greece ... More >> University Hospital of Heraklion Heraklion, Crete, Greece University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupolis, Greece "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece 401 Military Hospital, Medical Oncology Unit Athens, Greece Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece Sismanogleio General Hospital, 1st, 2nd Dep of Pulmonary Diseases Athens, Greece Sotiria" General Hospital, 1st, 3rd, 8th Dep of Pulmonary Diseases Athens, Greece "Metaxa's" Anticancer Hospital of Piraeus,1st Dep of Medical Oncology Piraeus, Greece Theagenion" Anticancer Hospital of Thessaloniki Thessaloniki, Greece Less <<
NCT00720629 Graft Versus Host Disease Phase 2 Terminated - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00741455 Hematologic Malignancies Not Applicable Active, not recruiting December 2023 United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT00289250 Asymptomatic P.Falciparum Mala... More >>ria Less << Phase 3 Completed - Gambia ... More >> Medical Reseearch Council Laboratories The Gambia Banjul, Gambia, POBOX 273 Less <<
NCT00732875 - Completed - -
NCT00360685 Mucositis Gra... More >>ft-versus-host Disease Less << Not Applicable Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00360685 - Completed - -
NCT00743379 Non-Small Cell Lung Cancer ... More >> Prostate Cancer Pancreatic Cancer Less << Phase 1 Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Cancer Center Scottsdale, Arizona, United States, 85259 Premiere Oncology of Arizona Scottsdale, Arizona, United States, 85260 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Louisiana LSU Health Sciences Center Shreveport, Louisiana, United States, 71130 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas UT Health Science Center San Antonio, Texas, United States, 78229 United States, Washington Northwest Medical Specialties Tacoma, Washington, United States, 98405 United States, Wisconsin University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT00754364 NSCLC Phase 2 Terminated(low enrollment rate... More >>) Less << December 2015 Italy ... More >> Istituto Clinco Humanitas Rozzano, Milan, Italy, 20089 Less <<
NCT00760669 - Completed - -
NCT00754572 - Completed - -
NCT00760864 Arthritis, Rheumatoid Phase 2 Completed - -
NCT00760669 - Completed - -
NCT00299247 Plasmodium Falciparum Malaria Phase 3 Withdrawn December 2006 Colombia ... More >> Malaria Vaccine and Drug Development Center Cali, Colombia Universidad del Valle Sede San Fernando Cali, Colombia Less <<
NCT00754572 Rheumatoid Arthritis Phase 3 Completed - -
NCT00751517 Wegener's Granulomatosis ... More >> Churg-Strauss Syndrome Microscopic Polyangiitis Polyarteritis Nodosa Less << Phase 2 Unknown - Italy ... More >> Department of Clinical Medicine Nephrology and Health Science, Parma University Hospital Parma, Italy/Parma, Italy, 43100 Less <<
NCT01004601 Non Small Cell Lung Cancer Not Applicable Completed - Taiwan ... More >> Chang Gung Memorial Hospital Taipei, Taiwan, 10507 Less <<
NCT01004432 - Completed - -
NCT00760968 Arthritis, Rheumatoid Phase 2 Completed - Czech Republic ... More >> Brno-Bohunice, Czech Republic Hlucin, Czech Republic Plzen, Czech Republic Praha, Czech Republic Uherske Hradiste, Czech Republic Zlin, Czech Republic Latvia Daugavpils, Latvia Riga, Latvia Romania Bucharest, Romania Timisoara, Romania Russian Federation Ekaterinburg, Russian Federation Kemerovo, Russian Federation Moscow, Russian Federation Novosibirsk, Russian Federation Petrozavodsk, Russian Federation St. Petersburg, Russian Federation Yaroslavl, Russian Federation Slovakia Kosice, Slovakia Martin, Slovakia Nove Zamky, Slovakia Piestany, Slovakia Poprad, Slovakia Trnava, Slovakia Ukraine Donetsk, Ukraine Kyiv, Ukraine Less <<
NCT01005758 Leukemia Phase 2 Unknown - -
NCT01005680 Non Small Cell Lung Cancer Phase 3 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100730 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changchun, China, 130012 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dalian, China, 116023 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510080 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanning, China, 530000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200433 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sichuan, China, 610041 Less <<
NCT00301054 Anaemia in Children Not Applicable Completed - Ghana ... More >> District Health Directorate Berekum, Brong- Ahafo, Ghana Less <<
NCT01005914 Leukemia Phase 2 Terminated(Increased rate of b... More >>acterial infections) Less << - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 Less <<
NCT01005914 - Terminated(Increased rate of b... More >>acterial infections) Less << - -
NCT01005680 - Completed - -
NCT01009242 Arthritis Rhe... More >>umatoid Arthritis Less << Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Duncansville, Pennsylvania, United States United States, Texas Dallas, Texas, United States San Antonio, Texas, United States Germany Berlin, Germany Cologne, Germany Erlangen, Germany Less <<
NCT01007435 Rheumatoid Arthritis Phase 3 Completed - -
NCT01010503 Rheumatoid Arthritis Phase 4 Completed - Slovakia ... More >> Piestany, Slovakia, 921 12 Less <<
NCT01008852 Active Rheumatoid Arthritis Phase 2 Completed - -
NCT00866918 Childhood Acute Promyelocytic ... More >>Leukemia (M3) Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 3 Completed - -
NCT00866918 - Completed - -
NCT01011920 Central Nervous System Lymphom... More >>a Less << Phase 2 Completed - Germany ... More >> University Hospital Aachen, Germany Universitätsklinikum Erlangen Erlangen, Germany "Klinik für Hämatologie Universitätsklinikum Essen" Essen, Germany Uniklinik Freiburg Freiburg, Germany Universitätskrankenhaus Hamburg-Eppendorf Hamburg, Germany Friedrich Schiller Universitaet Jena Jena, Germany Johannes Gutenberg Universität Mainz Mainz, Germany Technische Universität in München München, Germany Universitätsklinikum Ulm Ulm, Germany Italy A.O. SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy Spedali Civili Brescia, Italy San Raffaele H Scientific Institute Milan, Italy Ospedale Umberto I Nocera Inferiore, Italy Ospedale Civile S.Spirito Pescara, Italy Arcispedale Santa Maria Nuova Reggio Emilia, Italy Istituto Nazionale dei Tumori Regina Elena Roma, Italy Università degli Studi La Sapienza Roma, Italy Humanitas Rozzano, Italy Ospedale Maggiore S. Giovanni Battista Torino, Italy Policlinico G.B. Rossi Verona, Italy Switzerland IOSI - Oncology Institute of Southern Switzerland Bellinzona, Switzerland, 6500 United Kingdom Nottingham City Hospital Nottingham, United Kingdom Queen's Hospital Romford, United Kingdom Less <<
NCT01010503 - Completed - -
NCT01007435 - Completed - -
NCT00492856 - Completed - -
NCT00494897 Acute Lymphoblastic Leukemia Phase 4 Completed - -
NCT00496665 Metastatic Breast Cancer Phase 1 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02215 Less <<
NCT00498589 Ulcerative Colitis Phase 2 Completed - Austria ... More >> University Hospital of Vienna Vienna, Austria, 1090 Belgium ULB - Cliniques Saint Luc Bruxelles, Belgium, 1200 France CHU Amiens - Hôpital Nord Amiens, France, 84000 CH Avignon Avignon, France, 84000 Centre Hospitalier Universitaire de Besançon Besançon, France, 25000 CHU Clermont-Ferrand - Hôpital Hotel Dieu Clermont-Ferrand, France, 63000 APHP - Hôpital Beaujon Clichy, France, 92110 APHP - Hôpital Bicêtre Le Kremlin Bicetre, France, 94270 CHRU Lille - Hôpital Huriez Lille, France, 59037 CHU Nantes - Hôpital Hôtel Dieu Nantes, France, 44000 CHU Nice - Hôpital de l'Archet 2 Nice, France, 06202 APHP - Hôpital Saint Louis Paris, France, 75010 APHP - Hôpital Saint Antoine Paris, France, 75012 APHP - Hôpital Cochin Paris, France, 75014 CHU Bordeaux - Hôpital Haut L'Eveque Pessac, France, 33604 CHU Rouen - Hôpital Charles Nicolle Rouen, France, 76000 CHU St Etienne - Hôpital NOrd Saint Priest, France, 42270 CHU Toulouse - Hôpital Rangueil Toulouse, France, 31403 Israel Sheba Medical Center Tel aviv, Israel, 52621 Italy Istituto Clinico Humanitas Rozzano , Milano, Italy, 20089 Ospedale Casa Sollievo Della Sofferenza San Giovanni Rotondo, Italy, 71013 Netherlands LUMC Leiden, Netherlands, 2333 Less <<
NCT00492856 Leukemia Phase 3 Completed - -
NCT00501826 Leukemia Lymp... More >>hoblastic Lymphoma Leukemia, Lymphoblastic, Acute Less << Phase 2 Recruiting July 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00499889 - Terminated(Support issue.) - -
NCT00502567 Advanced Solid Tumor Phase 1 Completed - United States, Michigan ... More >> Research Site Ann Arbor, Michigan, United States Research Site Detroit, Michigan, United States United States, Tennessee Research Site Nashville, Tennessee, United States Less <<
NCT00504777 Rheumatoid Arthritis Phase 4 Completed - Taiwan ... More >> Changhua, Taiwan, 500 Kaohsiung, Taiwan, 00833 Kaohsiung, Taiwan, 807 Kaohsiung, Taiwan, 813 Taichung, Taiwan, 402 Taichung, Taiwan, 404 Taichung, Taiwan, 407 Taipei, Taiwan, 00112 Taoyuan, Taiwan, 333 Tapei, Taiwan, 114 Less <<
NCT00503594 Lymphoma Phase 2 Unknown July 2012 France ... More >> Groupe hospitalier la Pitié Salpétrière Recruiting Paris, France, 75013 Contact: Antonio OMURO, MD,PhD    + 33(0) 1 42 16 41 60    antonio.omuro@psl.aphp.fr Less <<
NCT00505232 Mantle Cell Lymphoma Phase 2 Completed - Spain ... More >> Hospital Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Hospital Marques de Valdecilla Santander, Cantabria, Spain, 39008 Hospital del Mar Barcelona, Cataluña, Spain, 08003 Hospital Clinico de Valencia Valencia, Comunidad Valenciana, Spain, 46010 Hospital Dr. Peset Valencia, Comunidad Valenciana, Spain, 46017 Hospital Clínico de Santiago de Compostela Santiago de Compostela, Galica, Spain, 15705 Clinica Universitaria de Navarra Pamplona, Navarra, Spain, 31008 Clinica Ruber Madrid, Spain, 28006 Hospital La Princesa Madrid, Spain, 28006 Clinica Moncloa Madrid, Spain, 28008 Hospital Ramon y Cajal Madrid, Spain, 28034 Hospital Universitario Puerta de Hierro Madrid, Spain, 28035 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Quiron Madrid, Spain, 28224 Hospital Morales Meseguer Murcia, Spain, 30008 Hospital Clínico de Salamanca Salamanca, Spain, 37007 Less <<
NCT00499889 Leukemia Phase 2 Terminated(Support issue.) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00506922 Leukemia Lymp... More >>homa Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00506922 - Completed - -
NCT00507403 Ankylosing Spondylitis Phase 4 Completed - France ... More >> University Hospital Jean MINJOZ -Besançon Besancon, France, 25030 University hospital of Tours Tours, France, 37044 Less <<
NCT00439556 CD20 Positive ... More >> Hematopoietic and Lymphoid Cell Neoplasm Lymphocytic Neoplasm Lymphoma Less << Phase 2 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00506155 Bladder Cancer Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00509366 Non Small Cell Lung Cancer Phase 2 Terminated(Study terminated du... More >>e to reproducibility issues with genomics prediction model.) Less << - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Maria Parham Hospital Henderson, North Carolina, United States, 27536 Scotland HealthCare System (Scotland Memorial Hospital) Laurinburg, North Carolina, United States, 28352 Southeastern Regional Medical Center, Gibson Cancer Center Lumberton, North Carolina, United States, 28358 Duke Raleigh Hospital Raleigh, North Carolina, United States, 27609 United States, South Carolina Beaufort Memorial Hospital Beaufort, South Carolina, United States, 29902 Coastal Cancer Center Myrtle Beach, South Carolina, United States, 29572 United States, Virginia Community Memorial Health Center South Hill, Virginia, United States, 23970 Less <<
NCT00507858 Head and Neck Cancer Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00513188 Lymphoma Not Applicable Withdrawn - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 Less <<
NCT00509366 - Terminated(Study terminated du... More >>e to reproducibility issues with genomics prediction model.) Less << - -
NCT00504777 - Completed - -
NCT00509678 Psoriatic Arthritis Phase 1 Completed - United States, California ... More >> University of California, San Diego La Jolla, California, United States, 92037-0943 Stanford University Stanford, California, United States, 94305-5350 United States, New York University of Rochester Rochester, New York, United States, 14642 United States, Washington Swedish Rheumatology Research Seattle, Washington, United States, 98104 Less <<
NCT00516750 Bladder Cancer Phase 2 Terminated(Withdrawn due to la... More >>ck of enrollment.) Less << - Japan ... More >> Nagoya University Hospital Nagoya, Aichi, Japan, 466-8560 Shiga Medical Center for Adults Moriyama, Shiga, Japan, 524-8524 Kyoto University Hospital Kyoto, Japan, 606-8507 National Hospital Organization - Kyoto Medical Center Kyoto, Japan, 612-0861 Osaka Red Cross Hospital Osaka, Japan, 543-8555 Less <<
NCT00516152 Chronic Myeloid Leukemia ... More >> Acute Myelogenous Leukemia Myelodysplasia Acute Lymphocytic Leukemia Severe Aplastic Anemia Non-Hodgkin's Lymphoma Lymphoproliferative Disease Multiple Myeloma Advanced Myeloproliferative Disease Less << Phase 2 Completed - United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94143 Less <<
NCT00517595 Non-Small Cell Lung Cancer Phase 2 Completed - United States, Connecticut ... More >> Medical Oncology & Hematology Waterbury, Connecticut, United States, 06708 United States, Georgia Augusta Oncology Associates Augusta, Georgia, United States, 30901 Central Georgia Cancer Care Macon, Georgia, United States, 31201 Northwest Georgia Oncology Center Marietta, Georgia, United States, 30060 United States, Montana Hematology Oncology Centers of the Northern Rockies Billings, Montana, United States, 59101 United States, Ohio Tri-County Oncology Hematology Associates Canton, Ohio, United States, 44718 United States, Oregon Pacific Oncology, PC Portland, Oregon, United States, 97225 United States, Pennsylvania Pennsylvania Oncology Hematology Associates Philadelphia, Pennsylvania, United States, 19106 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 United States, Virginia Cancer Specialists of Tidewater Chesapeake, Virginia, United States, 23320 Less <<
NCT00517595 - Completed - -
NCT00513981 Brain and Central Nervous Syst... More >>em Tumors Sarcoma Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Completed - Ireland ... More >> Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP University College Hospital London, England, United Kingdom, NW1 2PCE Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00520676 Non-Small Cell Lung Cancer Phase 3 Completed - Australia, Victoria ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ballarat, Victoria, Australia, 3350 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankston, Victoria, Australia, 3199 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wendouree, Victoria, Australia, 3355 Australia, Western Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bunbury, Western Australia, Australia, 6230 Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barretos, Brazil, 14784700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goiania, Brazil, 74075040 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santo André, Brazil, 09060-020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. São Paulo, Brazil, 01224 010 China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200032 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 120-752 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Suwon-City, Korea, Republic of, 442-723 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ulsan, Korea, Republic of, 682-714 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ciudad Obregon, Mexico, 85100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Durango, Mexico, 34208 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mexicali, Mexico, 21000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mexico City, Mexico, 11640 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 404 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 Less <<
NCT00506155 - Completed - -
NCT00520845 - Terminated(slow accrual) - -
NCT00521430 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Nonmalignant Neoplasm Unspecified Adult Solid Tumor, Protocol Specific Less << Not Applicable Completed - Korea, Republic of ... More >> Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT00521924 Rheumatoid Arthritis Phase 3 Terminated(Slow Enrollment) - -
NCT00520676 - Completed - -
NCT00517699 - Terminated(Study was terminate... More >>d early due to lack of enrollment.) Less << - -
NCT00520845 Lung Cancer Phase 2 Terminated(slow accrual) - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00523328 Rheumatoid Arthritis Phase 2 Terminated(Analysis of data fr... More >>om 104RA203 failed to meet primary endpoint.) Less << - United States, California ... More >> Coordinating Research Site Palo Alto, California, United States, 94305 Belgium Coordinating Research Site Liège, Belgium, 4000 Canada, Ontario Coordinating Research Site Toronto, Ontario, Canada, H9P 2V4 United Kingdom Coordinating Research Site Newcastle, United Kingdom, NE1 4LP Less <<
NCT00521924 - Terminated(Slow Enrollment) - -
NCT00517699 Lymphoma Phase 2 Terminated(Study was terminate... More >>d early due to lack of enrollment.) Less << - Canada, Quebec ... More >> Greenfield Park, Quebec, Canada, J4V 2H1 Quebec City, Quebec, Canada, G1J 1Z4 Less <<
NCT00526175 Acute Lymphoblastic Leukemia Phase 4 Completed - Spain ... More >> Complejo Hospitalario Universitario de Albacete Albacete, Spain Hospital General de Alicante Alicante, Spain Hospital de Badalona Germans Trias i Pujol Badalona, Spain Hospital de Sant Pau Barcelona, Spain Hospital del Mar Barcelona, Spain Hospital Valle Hebrón-Materno Infantil Barcelona, Spain Basurtuko Ospitalea Basurto, Spain Complejo Hospitalario Reina Sofía Córdoba, Spain Hospital General de Guadalajara Guadalajara, Spain Complejo Hospitalario León Leon, Spain Hospital Clínico San Carlos de Madrid Madrid, Spain . Hospital Clínico Universitario Virgen de la Victoria Málaga, Spain Complejo Asistencial Son Dureta Palma de Mallorca, Spain Hospital Clinico Universitario Salamanca, Spain Hospital Clínico Universitario de Salamanca Salamanca, Spain Complejo Hospitalario Universitario de Santiago Santiago de Compostela, Spain Hospital General de Segovia Segovia, Spain H.U. Virgen del Rocio Sevilla, Spain Hospital Joan XXIII Tarragona, Spain Hospital Arnau de Vilanova Valencia, Spain Hospital Clínic Valencia, Spain Hospital La Fe Valencia, Spain Hospital Universitario Dr. Peset Valencia, Spain Hospital Clínico de Valladolid Valladolid, Spain Hospital Clínico Lozano Blesa Zaragoza, Spain Less <<
NCT00525213 Rheumatoid Arthritis Phase 2 Completed - -
NCT00523692 Rheumatoid Arthritis Phase 4 Unknown - United Kingdom ... More >> University Hopsital Birmingham NHS Foundation Trust Not yet recruiting Birmingham, West Midlands, United Kingdom, B15 2TH Contact: Paresh Jobanputra, MRCP MD       Paresh.Jobanputra@uhb.nhs.uk    Sandwell and West Birmingham Hospitals NHS Trust Not yet recruiting Birmingham, West Midlands, United Kingdom, B18 7QH Contact: Karim Raza, MRCP PhD       k.raza@bham.ac.uk Less <<
NCT00533429 Non-small Cell Lung Cancer Phase 2 Completed - United States, Arkansas ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bentonville, Arkansas, United States, 72712 United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States, 60611 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Galesburg, Illinois, United States, 61401 United States, Indiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bloomington, Indiana, United States, 47403 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Evansville, Indiana, United States, 47714 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fort Wayne, Indiana, United States, 46815 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States, 46202 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lafayette, Indiana, United States, 47904 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Muncie, Indiana, United States, 47303 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. South Bend, Indiana, United States, 46601 United States, Michigan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jackson, Michigan, United States, 49201 United States, Nebraska For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Omaha, Nebraska, United States, 68114 Less <<
NCT00526409 Acute Lymphoblastic Leukemia Phase 4 Completed - Spain ... More >> Hospital materno Infantil vall d'Hebrón Barcelona, Spain Hospital Niño Jesús Madrid, Spain Hospital Virgen de la Arrixaca Murcia, Spain Hospital Infantil Carlos Haya Málaga, Spain Less <<
NCT00536978 Lymphoma Leuk... More >>emia Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00080119 HIV Infection ... More >> Tuberculosis Pneumocystis Jiroveci Pneumonia Less << Phase 2 Phase 3 Terminated(Data Safety Monitor... More >>ing Board (DSMB) recommended stopping study due to futility) Less << - Botswana ... More >> Princess Marina Hospital Gaborone, Botswana South Africa University of Cape Town, Red Cross Children's Hospital Cape Town, South Africa University of Stellenbosch, Tygerberg Hospital Cape Town, South Africa Nelson R. Mandela School of Medicine, University of KwaZulu Natal, Durban Durban, South Africa, 4001 Perinatal HIV Research Unit at Chris Hani Baragwanath Hospital Johannesburg, South Africa, 2013 Chris Hani Baragwanath Hospital, Harriet Shezi Clinic Johannesburg, South Africa Less <<
NCT00535782 - Completed - -
NCT00537550 Leukemia, Lymphocytic, Acute Not Applicable Completed - Italy ... More >> Az. Ospedaliera S. G. Moscati Avellino, Italy Ist.Ematologia e Oncologia Medica L.e A. Seragnoli Bologna, Italy Ospedale Reg. A di Summa Brindisi, Italy Istituto di Ematologia- Ospedale San Carlo Potenza, Italy Policlinico G.B. Rossi Verona, Italy, 37134 Less <<
NCT00080119 - Terminated(Data Safety Monitor... More >>ing Board (DSMB) recommended stopping study due to futility) Less << - -
NCT00538902 Rheumatoid Arthritis Phase 2 Phase 3 Completed - China, Anhui ... More >> Site Reference ID/Investigator# 6259 Hefei, Anhui, China, 230022 China Site Reference ID/Investigator# 6266 Beijing, China, 100730 Site Reference ID/Investigator# 6241 Beijing, China, 100853 Site Reference ID/Investigator# 6243 Guangzhou, China, 510260 Site Reference ID/Investigator# 6247 Guangzhou, China, 510630 Site Reference ID/Investigator# 6262 Harbin, China, 150001 Site Reference ID/Investigator# 6248 Hepingjiebeikou, China, 100029 Site Reference ID/Investigator# 6250 Shanghai, China, 200001 Site Reference ID/Investigator# 6828 Shanghai, China, 200032 Site Reference ID/Investigator# 6333 Shanghai, China, 200433 Site Reference ID/Investigator# 6264 Xi'an, China, 710032 Less <<
NCT00538902 - Completed - -
NCT00536978 - Completed - -
NCT00544232 Breast Cancer Phase 3 Completed - -
NCT00546546 Crohn's Disease Phase 4 Completed - France ... More >> Chu Amiens Amiens, France, 80054 Chu Besancon Besancon, France, 25030 CHU CAEN Caen, France, 14033 Chu Clermont-Ferrand Clermont-ferrand, France, 63003 Hopital Beaujon Clichy, France, 92110 Hopital Louis Mourrier Colombes, France, 92700 Hopital Bicetre Le Kremlin Bicetre, France, 94275 Chru Lille Lille, France, 59037 Chu Marseille - Hopital Nord Marseille, France, 13915 Ch Le Raincy Montfermeil Montfermeil, France, 93370 Chu Nantes Nantes, France, 44093 CHU NICE Nice, France, 06202 Hopital Lariboisiere Paris, France, 75010 Hopital Saint Louis Paris, France, 75010 Hopital St Antoine Paris, France, 75012 Hopital Cochin Paris, France, 75014 Hopital Georges Pompidou Paris, France, 75015 Hopital Bichat Paris, France, 75018 Institut Mutualiste Montsouris (Imm) Paris, France, 75674 Hopital Haut Leveque Pessac, France, 33604 CHU LYON Pierre Benite, France, 69495 Chu Reims Reims, France, 51092 Chu Rouen Rouen, France, 76031 Chu Strasbourg Strasbourg, France, 67091 Chu Toulouse Toulouse, France, 31403 Chu Tours Tours, France, 37044 Less <<
NCT00548431 Leukemia, Lymphocytic, Acute Phase 2 Completed - Denmark ... More >> Department of Pediatrics, Rigshospitalet Copenhagen, Denmark Department of Pediatrics, University Hospital Odense, Denmark Sweden Department of Pediatrics, Drottning Sylvias Pediatric Hospital Gothenburg, Sweden Less <<
NCT00544154 Arthritis, Rheumatoid Phase 3 Completed - -
NCT00432367 Malaria Anaem... More >>ia Pregnancy Less << Phase 3 Completed - Ghana ... More >> Juaben Government Hospital Juaben, Ashanti, Ghana Less <<
NCT00548431 - Completed - -
NCT00550355 Arthritis, Rheumatoid Phase 1 Completed - -
NCT00477412 Mantle Cell Lymphoma Phase 1 Phase 2 Active, not recruiting April 30, 2020 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00551460 - Completed - -
NCT00535782 Rheumatoid Arthritis Phase 3 Completed - -
NCT00555048 Graft Versus Host Disease ... More >> Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Phase 2 Terminated(Low accrual) - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98104-1024 Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Less <<
NCT00555048 - Terminated(Low accrual) - -
NCT00553202 Leukemia Phase 2 Unknown - -
NCT00556322 Non-Small Cell Lung Cancer Phase 3 Completed - -
NCT00550992 Leukemia Not Applicable Unknown - United States, Massachusetts ... More >> Children's Hospital Boston Recruiting Boston, Massachusetts, United States, 02215 Contact: Lewis B. Silverman, MD    617-632-5285       United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Clinical Trials Office - St. Jude Children's Research Hospital    901-595-4644       United States, Texas M. D. Anderson Cancer Center at University of Texas Recruiting Houston, Texas, United States, 77030-4009 Contact: Clinical Trials Office - M. D. Anderson Cancer Center at the U    713-792-3245       United States, Washington Children's Hospital and Regional Medical Center - Seattle Recruiting Seattle, Washington, United States, 98105 Contact: Blythe Thomson, MD    206-987-2106       Austria St. Anna Children's Hospital Recruiting Vienna, Austria, A-1090 Contact: Georg Mann, MD    43-1-4017-1250       Belgium Hopital Universitaire Des Enfants Reine Fabiola Recruiting Brussels, Belgium, 1020 Contact: Alice Ferster, MD    32-2-477-2678    aferster@ulb.ac.be    Czech Republic University Hospital Motol Recruiting Prague, Czech Republic, 150 06 Contact: Jan Stary, MD    420-2-2443-6401    jan.stary@lfmotol.cuni.cz    France CHR Hotel Dieu Recruiting Nantes, France, 44093 Contact: Francoise Mechinaud, MD    33-1-4249-9046       Germany University Medical Center Hamburg - Eppendorf Recruiting Hamburg, Germany, D-20246 Contact: Gritta Janka-Schaub    49-404-2803-2580       Medizinische Hochschule Hannover Recruiting Hannover, Germany, D-30625 Contact: Martin Schrappe, MD, PhD    49-511-532-6713       Italy Nuovo Ospedale San Gerardo at University of Milano-Bicocca Recruiting Monza, Italy, 20052 Contact: Andrea Biondi, MD    39-039-233-3661    biondi@galactica.it    Netherlands Erasmus MC - Sophia Children's Hospital Recruiting Rotterdam, Netherlands, 3015 GJ Contact: Rob Pieters, MD, MSC, PhD    31-10-463-6691    rob.pieters@erasmusmc.nl    United Kingdom Great Ormond Street Hospital for Children Recruiting London, England, United Kingdom, WC1N 3JH Contact: Phil Ancliff, MD    44-20-7829-8831 Less <<
NCT00556894 Rheumatoid Arthritis Phase 2 Completed - Bulgaria ... More >> Clinic of Rheumatology at MHAT 'Sveti Georgi' Plovdiv, Bulgaria, 4002 Clinic of Rheumatology at MHAT 'Sveti Ivan Rilski' Sofia, Bulgaria, 1612 Clinic of internal diseases at NMTH 'Tzar Boris Treti' Sofia, Bulgaria Second Clinic of Internal Diseases at MHAT 'Stara Zagora' Stara Zagora, Bulgaria, 6000 Clinic of Rheumatology at MHAT 'Sveta Marina' - Varna Varna, Bulgaria, 9010 Czechia University Hospital Hradec Kralove Hradec Kralove, Czechia, 50005 Institute of Rheumatology Prague, Czechia, 12850 Rheumotology Out-patient Clinic Zlin, Czechia, 76001 Israel Haemek Medical Center Afula, Israel Barzilai Medical Center Ashkelon, Israel, 78278 Rambam Medical Center Haifa, Israel, 31096 Hadassah Har-Hazofim Medical Center Jerusalem, Israel Meir Medical Center Kfar-Saba, Israel, 44281 Poland Wojewodzki Szpital Zespolony w Elblagu Elblag, Poland, 82300 Niepubliczny Zaklad Opieki Zdrowotnej Lublin, Poland, 20607 Wojewodzki Zespol Reumatologiczny w Sopocie Sopot, Poland, 81967 Samodzielny Publiczny Szpital Kliniczny Nr 1 P.A.M. w Szczecinie Szczecin, Poland, 71252 Niepubliczny Zaklad Opieki Zdrowotnej "NASZ LEKARZ" Torun, Poland, 87100 Serbia Institute of Rheumatology - Belgrade Belgrade, Serbia, 11000 Institute for Prevention, Treatment, and Rehabilitation of Rheumatoid and Cardiovascular Diseases Niska Banja Niska Banja, Serbia, 18205 Ukraine Central Municipal Clinical Hospital nº1 Donetsk, Ukraine, 83114 Kyiv Central Municipal Hospital Kiev, Ukraine, 01023 City Clinical Hospital N12 Kiev, Ukraine, 01103 National Scientific Centre of AMS of Ukraine Kiev, Ukraine, 03680 O.O. Bogomolets National Medical University Kiev, Ukraine, 04053 Vinnitsya Regional Clinical Hospital Vinnycia, Ukraine, 21018 Less <<
NCT00556894 - Completed - -
NCT00558519 Leukemia Phase 2 Active, not recruiting - -
NCT00556322 - Completed - -
NCT00551460 Leukemia Phase 2 Completed - -
NCT00553202 - Unknown - -
NCT00559585 Rheumatoid Arthritis (RA) Phase 3 Completed - -
NCT00420199 Active Rheumatoid Arthritis Phase 3 Completed - Belgium ... More >> Local Institution Bruxelles, Belgium, 1200 Local Institution Yvoir, Belgium, 5530 Germany Local Institution Berlin, Germany, 14059 Local Institution Berlin, Germany, BE-10117 Netherlands Local Institution Amsterdam, Netherlands, 1105 AZ Spain Local Institution Barcelona, Spain, 08036 Local Institution Barcelona, Spain, 08907 Sweden Local Institution Stockholm, Sweden, 171 76 United Kingdom Local Institution London, Greater London, United Kingdom, SE19RT Local Institution Leeds, North Yorkshire, United Kingdom, LS7 4SA Less <<
NCT00420199 - Completed - -
NCT00560573 Carcinoma, Non-Small-Cell Lung Phase 1 Completed - Belgium ... More >> Pfizer Investigational Site Charleroi, Belgium, 6000 Ireland Pfizer Investigational Site Dublin, Ireland, 8 Spain Pfizer Investigational Site Madrid, Spain, 28041 Pfizer Investigational Site Sevilla, Spain, 41013 Less <<
NCT00559585 - Completed - -
NCT00560573 - Completed - -
NCT00563849 Rheumatoid Arthritis Phase 4 Completed - Korea, Republic of ... More >> Sanofi-Aventis Pusan, Korea, Republic of Less <<
NCT00570817 Methotrexate Induced Nephrotox... More >>icity Less << Not Applicable Completed - Denmark ... More >> Aarhus University Hospital, Skejby Aarhus, Aarhus N, Denmark, 8200 Less <<
NCT00572221 Underperforming Nursing Homes Not Applicable Completed - United States, Massachusetts ... More >> Institute for Aging Research, Hebrew Senior Life Roslindale, Massachusetts, United States, 02131 Less <<
NCT00565409 Arthritis, Rheumatoid Phase 4 Completed - -
NCT00111163 Malaria Anemi... More >>a Less << Not Applicable Completed - Kenya ... More >> Lwak, Abidha, Ongielo and Saradidi clinics Asembo (Rarieda Division), Nyanza Province, Kenya Less <<
NCT03372447 Megaloblastic Anemia Nos ... More >> Pernicious Anemia Less << Phase 4 Recruiting December 1, 2019 Mexico ... More >> Hospital Universitario Dr. Jose E Gonzalez UANL Recruiting Monterrey, Nuevo Leon, Mexico, 64460 Contact: David Gomez-Almaguer, MD    52 8183488510    dgomezalmaguer@gmail.com    Contact: César O Pezina-Cantú, MD    52 8115273932    cpezina@gmail.com    Principal Investigator: David Gomez-Almaguer, MD Less <<
NCT00035035 Pancreatic Neoplasms ... More >> Metastases, Neoplasm Less << Phase 3 Completed - -
NCT00452907 Malaria Phase 4 Completed - Mali ... More >> Sanofi-Aventis Administrative Office Bougoula, Mali Less <<
NCT00613769 Infection Prophylaxis in Colo ... More >>Rectal Surgery Less << Phase 4 Completed - Sweden ... More >> Department of Surgery, University hospital Sahlgrenska/Östra Gothenburg, Sweden, 416 85 Department of Surgery and oncology, Halland Hospital in Halmstad Halmstad, Sweden, 301 85 Department of surgery, Community Hospital i Karlskrona Karlskrona, Sweden, 371 85 Vrinnevi hospital Norrköping, Sweden, 601 82 Department of surgery Skövde, Sweden, 541 85 Department of Surgery, NU-hospitals Uddevalla, Sweden, 451 80 Less <<
NCT00576433 Rheumatoid Arthritis Phase 4 Completed - Russian Federation ... More >> Chelyabinsk, Russian Federation, 454076 Ekaterinburg, Russian Federation, 620102 Irkutsk, Russian Federation, 664047 Kazan, Russian Federation, 420012 Khabarovsk, Russian Federation, 680009 Khanty-Mansiysk, Russian Federation, 628011 Kursk, Russian Federation, 305007 Moscow, Russian Federation, 115522 Nizhny Novgorod, Russian Federation, 603126 Novosibirsk, Russian Federation, 630099 Novosibirsk, Russian Federation, 630117 Ryazan, Russian Federation, 390026 Saint-Petersburg, Russian Federation, 195067 Tjumen, Russian Federation, 625023 UFA, Russian Federation, 450005 Vladivostok, Russian Federation, 690050 Voronezh, Russian Federation, 394066 Yaroslavl, Russian Federation, 150062 Less <<
NCT00577122 Estrogen Receptor-negative Bre... More >>ast Cancer Progesterone Receptor-negative Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer Less << Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California University of California, San Francisco Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Indiana Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, North Carolina University of North Carolina, Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Duke University Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Texas The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00577122 - Completed - -
NCT00579644 Rheumatoid Arthritis Phase 3 Completed - -
NCT00565409 - Completed - -
NCT00578903 Aplastic Anemia Phase 2 Terminated - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT00636935 Pneumocystis Carinii Pneumonia Phase 4 Withdrawn(No patient completed... More >> protocol) Less << - United States, District of Col... More >>umbia George Washington University Medical Faculty Associates Washington, D.C., District of Columbia, United States, 20037 Less <<
NCT00579878 Rheumatoid Arthritis Phase 3 Completed - United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 69198-3025 Less <<
NCT00586846 Osteosarcoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00461578 Malaria Not Applicable Completed - Rwanda ... More >> Programme Nationale Integre de Lutte contre le Paludisme Kigali, Rwanda, BP 2514 Less <<
NCT00587873 Hodgkin's Disease Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00588536 Langerhans Cell Histiocytosis Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00588536 - Completed - -
NCT00589563 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Infection Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Precancerous Condition Secondary Myelofibrosis Small Intestine Cancer Less << Phase 2 Completed - United States, Arizona ... More >> Banner Good Samaritan Medical Center Phoenix, Arizona, United States, 85006 United States, California City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT00589563 - Completed - -
NCT00596154 CNS Lymphoma ... More >>CNS Brain Cancer Non-Hodgkin's Lymphoma Less << Phase 2 Active, not recruiting December 2019 United States, New Jersey ... More >> Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Commack Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00594815 - Completed - -
NCT00422942 Rheumatoid Arthritis Phase 2 Terminated(Study was terminate... More >>d after enrollment of 3 participants due to recruitment difficulties.) Less << - Netherlands ... More >> Amsterdam, Netherlands, 1105 AZ Less <<
NCT00599937 Leukemia, Promyelocytic, Acute Phase 3 Completed - -
NCT00422942 - Terminated(Study was terminate... More >>d after enrollment of 3 participants due to recruitment difficulties.) Less << - -
NCT00603512 Arthritis, Rheumatoid Phase 2 Completed - Japan ... More >> Pfizer Investigational Site Hitachi-shi, Ibaraki, Japan Pfizer Investigational Site Sagamihara, Kanagawa, Japan Pfizer Investigational Site Yahatanishi-ku, Kitakyusyu, Japan Pfizer Investigational Site Koushi, Kumamoto, Japan Pfizer Investigational Site Sendai, Miyagi, Japan Pfizer Investigational Site Kawachinagano, Osaka, Japan Pfizer Investigational Site Kawagoe-shi, Saitama, Japan Pfizer Investigational Site Kitamoto, Saitama, Japan Pfizer Investigational Site Bunkyo-ku, Tokyo, Japan Pfizer Investigational Site Bunkyo-k, Tokyo, Japan Pfizer Investigational Site Chiyoda-ku, Tokyo, Japan Pfizer Investigational Site Koto-ku, Tokyo, Japan Pfizer Investigational Site Meguro-ku, Tokyo, Japan Pfizer Investigational Site Musashimurayama-shi, Tokyo, Japan Pfizer Investigational Site Shinjyuku-ku, Tokyo, Japan Pfizer Investigational Site Chiba, Japan Pfizer Investigational Site Fukuoka, Japan Pfizer Investigational Site Niigata, Japan Less <<
NCT00578903 - Terminated - -
NCT00602667 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Active, not recruiting April 30, 2023 United States, California ... More >> Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States, 94304 Rady Children's Hospital San Diego, California, United States, 92123 United States, Minnesota Children's Hospitals and Clinics of Minnesota - St. Paul Saint Paul, Minnesota, United States, 55102 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75390 Australia, Queensland Lady Cilento Children's Hospital, Brisbane Brisbane, Queensland, Australia, 4029 Less <<
NCT00594815 Lymphoma Not Applicable Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00604916 Pneumonia Early Phase 1 Completed - -
NCT00604461 - Terminated(Slow Accrual) - -
NCT00586846 - Completed - -
NCT00604461 Mesothelioma Phase 1 Phase 2 Terminated(Slow Accrual) - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00118027 Malaria Pregn... More >>ancy Anemia Less << Not Applicable Completed - Uganda ... More >> Mukono District Mukono, Central Uganda, Uganda, P.O Box 7272 Less <<
NCT00605735 Rheumatoid Arthritis, NOS Phase 2 Completed - -
NCT00610883 Non-Hodgkin's Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00120809 Malaria Phase 3 Completed - Gambia ... More >> Medical Research Council Laboratories Banjul, Gambia, PO Box 273 Less <<
NCT00612274 Stem Cell Transplantation Early Phase 1 Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT00614965 Non Small Cell Lung Cancer Phase 2 Completed - Greece ... More >> Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece Less <<
NCT00610883 - Completed - -
NCT00615901 Breast Cancer Not Applicable Completed - United States, New Jersey ... More >> Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering Cancer Center at Mercy Rockville Centre, New York, United States, 11570 Memoral Sloan-Kettering Cancer Center at Phelps Sleepy Hollow, New York, United States, 10591 Less <<
NCT00613457 Leukemia Phase 3 Completed - -
NCT00616122 Breast Cancer Phase 1 Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT00614822 Non Small Cell Lung Cancer Phase 2 Completed - -
NCT00615901 - Completed - -
NCT00616122 - Completed - -
NCT00603512 - Completed - -
NCT00619905 Rheumatoid Arthritis Phase 1 Phase 2 Completed - Germany ... More >> Novartis Investigator Site Berlin, Germany Novartis Investigator Site Hamburg, Germany Novartis Investigator Site Koeln, Germany Novartis Investigator Site Leipzig, Germany Novartis Investigator Site Munich, Germany Novartis Investigator Site Ratingen, Germany Netherlands Novartis Investigator Site Leiden, Netherlands Novartis Investigator Site Nijmegen, Netherlands Switzerland Novartis Investigator Site Bern, Switzerland Novartis Investigator Site Geneva, Switzerland Less <<
NCT00620685 Arthritis, Rheumatoid Phase 2 Completed - United States, Arizona ... More >> Pfizer Investigational Site Phoenix, Arizona, United States, 85013 United States, Colorado Pfizer Investigational Site Colorado Springs, Colorado, United States, 80909 United States, Florida Pfizer Investigational Site Miami, Florida, United States, 33169 United States, Maryland Pfizer Investigational Site Frederick, Maryland, United States, 21702 United States, Michigan Pfizer Investigational Site Bingham Farms, Michigan, United States, 48025 Pfizer Investigational Site Kalamazoo, Michigan, United States, 49007 United States, Pennsylvania Pfizer Investigational Site Duncansville, Pennsylvania, United States, 16635 Less <<
NCT00618501 Leukemia Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT00676130 Cellulitis Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT00621036 Brain and Central Nervous Syst... More >>em Tumors Lymphoma Lymphoproliferative Disorder Small Intestine Cancer Less << Phase 2 Withdrawn(MyVax did not meet i... More >>ts primary endpoints) Less << - United States, Texas ... More >> Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 Less <<
NCT00126971 Malaria Phase 1 Suspended - Mali ... More >> Faladje Missionary Dispensary Faladje, Mali Less <<
NCT00676130 - Completed - -
NCT01017367 Rheumatoid Arthritis Phase 2 Completed - Romania ... More >> Brasov Clinical County Emergency Hospital Rheumatology Department Brasov, Romania, 500365 "Dr. Carol Davila" Central Military Emergency Clinical Hospital Bucharest, Romania, 010825 Sana Medical Center Bucharest, Romania, 011025 "Sf. Maria" Clinical Hospital, Department of Internal Medicine and Rheumatology Bucharest, Romania, 011172 "Sf. Pantelimon" Emergency Clinical Hospital Bucharest, Romania, 21659 Cluj Emergency County Clinical Hospital Rheumatology Department Cluj-Napoca, Romania, 400006 Rehabilitation Hospital, Rheumatology Department Iasi, Romania, 700656 Targu-Mures County Clinical Hospital Rheumatology Department Targu-Mures, Romania, 540136 SC Excentric Company SRL, Rheumatology Department Timisoara, Romania, 300449 Ukraine M. Gorky National Medical University Donetsk, Ukraine, 83003 V.K. Gusak Institute of Urgent & Reconstructive Surgery within the Academy of Medical Sciences of Ukraine, Hospital Therapy and Rehabilitation Clinic Donetsk, Ukraine, 83045 Kharkiv Medical Academy of Postgraduate Education, Department of Cardiology and Functional Diagnostics, Clinical Facility: City Clinical Hospital #8 Kharkiv, Ukraine, 61178 Kyiv City Oleksandrivska Clinical Hospital, Rheumatology Department #2 Kyiv, Ukraine, 01601 O.O. Bogomolets National Medical University, Department of Internal Diseases Propedeutics #2, Clinical facility: City Clinical Hospital #3 Kyiv, Ukraine, 02125 Danylo Halytsky Lviv National Medical University, Department of Clinical Immunology and Allergology, Clinical Facility: Lviv Regional Clinical Hospital, Rheumatology Department Lviv, Ukraine, 79010 Danylo Halytsky Lviv National Medical University, Department of Internal Diseases #2, Dermatology and Venerology within the Faculty of Continuing Education, Clinical facility: City Clinical Hospital #4, Rheumatology Department Lviv, Ukraine, 79014 Public Institution O.I. Minakov City Clinical Hospital #9, Rheumatology Department Odesa, Ukraine, 65026 Zaporizhya State Medical University, Department of Internal Diseases #2, Clinical facility: Medical and Sanitary Unit within the State-Owned Company "Radioprylad" Zaporizhya, Ukraine, 69118 Less <<
NCT00775632 Graft Versus Host Disease ... More >> Bone Marrow Transplantation Less << Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00126906 Malaria, Falciparum ... More >> HIV Infections Less << Not Applicable Completed - Malawi ... More >> Machinga District Hospital Liwonde, Malawi Less <<
NCT01020734 Leukemia Phase 2 Completed - Korea, Republic of ... More >> Inje University - Haeundae Paik Hospital Busan, Korea, Republic of, 612-030 Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT01015547 Juvenile Idiopathic Arthritis Phase 3 Completed - Finland ... More >> Rheumatism Foundation Hospital Heinola, Finland Hospital for Children and Adolescents Helsinki, Finland Kuopio University Hospital Kuopio, Finland Oulu University Central Hospital Oulu, Finland Tampere University Hospital Tampere, Finland Turku University Hospital Turku, Finland Less <<
NCT01027000 - Active, not recruiting - -
NCT01014767 Brain Cancer ... More >>Choroid Plexus Tumors Less << Phase 3 Suspended(PI departure from co... More >>ordinating institution) Less << - United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Texas Children's Cancer Hospital at UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Germany St. Hedwig Children's Hospital, University of Regensburg (International Study Center) Regensburg, Germany Hungary Semmelweis University Budapest, Hungary New Zealand Christchurch Hospital Christchurch, New Zealand Less <<
NCT01031030 Breast Cancer Phase 3 Unknown - -
NCT00502996 Rheumatoid Arthritis Phase 3 Completed - -
NCT01031420 Muscle Invasive Bladder Cancer... More >> High Risk Urothelial Carcinoma of the Upper Urinary Tracts Less << Phase 2 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States, 19107 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00502996 - Completed - -
NCT01027000 Leukemia Lymp... More >>homa Less << Phase 2 Active, not recruiting - -
NCT01034137 Rheumatoid Arthritis Phase 3 Completed - Netherlands ... More >> Alkmaar, Netherlands, 1815 JD Amersfoort, Netherlands, 3818 ES Amsterdam, Netherlands, 1056 AB Apeldoorn, Netherlands, 7300 DS Breda, Netherlands, 4819 EV Den Helder, Netherlands, 1782GZ Emmeloord, Netherlands, 8300 GA Gorinchem, Netherlands, 4204 AA Gouda, Netherlands, 2803 HH Groningen, Netherlands, 9700RB Haarlem, Netherlands, 2035 RC Heerlen, Netherlands, 6419 PC Hilversum, Netherlands, 1213 HX Hoofddorp, Netherlands, 2134 TM Leeuwarden, Netherlands, 8934 AD Leiden, Netherlands, 2333 ZA Nieuwegein, Netherlands, 3430 EM Nijmegen, Netherlands, 6522 JV Sneek, Netherlands, 8601 ZK Utrecht, Netherlands, 3584 CX Woerden, Netherlands, 3447 GN Less <<
NCT01033656 Adult-Onset Still's Disease Phase 2 Completed - Sweden ... More >> Ann Kataja Knight Uppsala, Sweden, 75185 Less <<
NCT01086878 Acquired Immunodeficiency Synd... More >>rome Infant, Newborn Anemia Neutropenia HIV Infections Less << Phase 4 Completed - Botswana ... More >> Scottish Livingstone Hospital Molepolole, Kweneng, Botswana Princess Marina Hospital Gaborone, Botswana Less <<
NCT01041781 Lung Cancer Phase 3 Terminated(DSMB recommendation... More >>) Less << - -
NCT01056614 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Blastic Phase Chronic Myelogenous Leukemia Childhood Acute Myeloid Leukemia in Remission Childhood Chronic Myelogenous Leukemia Childhood Myelodysplastic Syndromes Chronic Phase Chronic Myelogenous Leukemia de Novo Myelodysplastic Syndromes Hematopoietic/Lymphoid Cancer Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Relapsing Chronic Myelogenous Leukemia Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01034137 - Completed - -
NCT01039688 Arthritis, Rheumatoid Phase 3 Completed - -
NCT01103063 Intermittent Preventive Treatm... More >>ent In Pregnancy (IPTp) Less << Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - Benin ... More >> Centre de Santé d'AHOUANSORI-AGUE Cotonou, Benin Hôpital Bethesda Cotonou, Benin Kenya Siaya District Hospital Siaya, Kenya Malawi Zomba Central Hospital Zomba, Malawi Tanzania Teule Hospital Muheza, Tanga, Tanzania Bugando Medical Centre Mwanza, Tanzania, 1903 Nyamagana District Hospital, c/o National Institute for Medical Research, Mwanza Centre Mwanza, Tanzania Nyamagana District Hospital Mwanza, Tanzania Uganda Mulago Hospital Complex Kampala, Uganda Less <<
NCT01103063 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01041781 - Terminated(DSMB recommendation... More >>) Less << - -
NCT00293475 Central Nervous System Lymphom... More >>a Less << Phase 1 Phase 2 Recruiting January 2020 United States, Ohio ... More >> Good Samaritan Hospital - Cincinnati Recruiting Cincinnati, Ohio, United States, 45220 Contact: Robert E. Albright    859-301-5473    darla.hehman@stelizabeth.com    Principal Investigator: Robert E. Albright          Cleveland Clinic Foundation Recruiting Cleveland, Ohio, United States, 44195 Contact: David M. Peereboom    216-445-6068    peerebd@ccf.org    Principal Investigator: David M. Peereboom          Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Edward A. Neuwelt    503-494-5626    neuwelte@ohsu.edu    Principal Investigator: Edward A. Neuwelt          United States, Oregon OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Edward A. Neuwelt    503-494-5626    neuwelte@ohsu.edu    Principal Investigator: Edward A. Neuwelt Less <<
NCT01038349 - Completed - -
NCT00393679 Fever Malaria Phase 3 Completed - Burkina Faso ... More >> Centre Muraz/IRSS Bobo-Dioulasso, Burkina Faso Gabon Albert Schweitzer Hospital Lambaréné, Gabon Mozambique Manhiça Health Research Center Manhica, Mozambique Nigeria Hospital Calabar, Nigeria Rwanda Mashshesha and Rukara Kigali, Rwanda Uganda Jinja and Tororo Kampala, Uganda Mbarara, Mbarara, Uganda Zambia Tropical Diseases Research Centre, P O Box 71769, Ndola, Zambia Less <<
NCT00361335 - Completed - -
NCT00363415 Small Cell Lung Cancer Phase 3 Completed - -
NCT00361335 Rheumatoid Arthritis Phase 3 Completed - -
NCT00363415 - Completed - -
NCT00367237 Arthritis, Psoriatic Phase 3 Completed - -
NCT00365001 Rheumatoid Arthritis Phase 1 Completed - United States, Alabama ... More >> Aniston, Alabama, United States, 36207 United States, Arizona Scottsdale, Arizona, United States, 85251 United States, Arkansas Little Rock, Arkansas, United States, 72202 United States, Florida Jacksonville, Florida, United States, 32216 Palm Harbor, Florida, United States, 34684 United States, Michigan Royal Oak, Michigan, United States, 48073 United States, Nebraska Omaha, Nebraska, United States, 68154 United States, Oklahoma Oklahoma City, Oklahoma, United States, 73103 United States, Pennsylvania Duncansville, Pennsylvania, United States, 16635 United States, Texas Austin, Texas, United States, 78704 New Zealand Christchurch, New Zealand Less <<
NCT00368654 Psoriasis Phase 1 Phase 2 Completed - United States, California ... More >> University of California, Davis Medical Center Department of Dermatology Sacramento, California, United States, 95816 Less <<
NCT00367237 - Completed - -
NCT00369226 Hematologic Malignancies Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00368654 - Completed - -
NCT01039688 - Completed - -
NCT00369629 - Terminated(This was planned as... More >> a phase I/II study originally, but due to a lack of funding, the phase II portion was never conducted.) Less << - -
NCT00369629 Lymphoma Phase 1 Terminated(This was planned as... More >> a phase I/II study originally, but due to a lack of funding, the phase II portion was never conducted.) Less << - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT00369928 Rheumatoid Arthritis Phase 2 Completed - -
NCT00399074 Sickle Cell Anemia ... More >> Malaria Less << Phase 3 Completed - Uganda ... More >> Mulago Hospital Kampala, Central, Uganda, 256 Less <<
NCT00369226 - Completed - -
NCT00226577 Lung Cancer Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00221325 Central Nervous System Lymphom... More >>a Intraocular Lymphoma Less << Phase 1 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 94123 United States, Texas MD Anderson Cancer Center Houston, Texas, United States Less <<
NCT00226577 - Completed - -
NCT00234052 Lung Cancer Phase 2 Active, not recruiting May 2020 United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Rush Cancer Institute at Rush University Medical Center Chicago, Illinois, United States, 60612 Evanston Northwestern Healthcare - Evanston Hospital Evanston, Illinois, United States, 60201-1781 Ingalls Cancer Care Center at Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Advocate Lutheran General Cancer Care Center Park Ridge, Illinois, United States, 60068-1174 Less <<
NCT00219791 Neoplasms Phase 2 Completed - Germany ... More >> Charite - Universitätsmedizin Berlin Berlin, Germany, 12200 Less <<
NCT00235820 Psoriasis Phase 3 Completed - United States, Illinois ... More >> Global Medical Information-Abbott Abbott Park, Illinois, United States, 60064 Less <<
NCT00233558 Rheumatoid Arthritis Phase 4 Terminated(Study terminated du... More >>e to low subject enrollment. Safety results consistent with product label.) Less << - United States, Illinois ... More >> Global Medical Information - Abbott North Chicago, Illinois, United States, 60064 Less <<
NCT00236028 Rheumatoid Arthritis Phase 3 Completed - -
NCT00235859 Rheumatoid Arthritis Phase 3 Completed - -
NCT00241189 Systemic Sclerosis Phase 1 Phase 2 Completed - United States, California ... More >> Philip Clements, MD Los Angeles, California, United States, 90095-1670 Less <<
NCT00243750 Ankylosing Spondylitis Phase 2 Unknown - Germany ... More >> Charité Campus Benjamin-Franklin, Rheumatology Berlin, Germany, 12200 Less <<
NCT00234936 Rheumatoid Arthritis Phase 3 Completed - -
NCT00246064 Arthritis, Rheumatoid Phase 4 Completed - -
NCT00244556 Rheumatoid Arthritis Phase 4 Completed - -
NCT00176553 Neurotoxicity Syndromes Not Applicable Terminated(slow accrual) - United States, New Jersey ... More >> Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 Less <<
NCT00251524 Non-Small Cell Lung Cancer Phase 2 Completed - United States, Ohio ... More >> Veeda Oncology Columbus, Ohio, United States, 43215 Less <<
NCT00252668 Rheumatoid Arthritis Phase 4 Completed - -
NCT00251641 - Completed - -
NCT00253552 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Sarcoma Less << Not Applicable Terminated(Terminated at reque... More >>st of PI as study was outdated.) Less << - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT00254319 Untreated Advanced Non-Small C... More >>ell Lung Cancer Less << Phase 2 Unknown - United States, New Jersey ... More >> The CINJ at Cooper University Hospital Recruiting Voorhees, New Jersey, United States, 08043 Principal Investigator: James Stevenson, MD          Sub-Investigator: Generosa Grana, MD Less <<
NCT00259610 Rheumatoid Arthritis Phase 4 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Less <<
NCT00264550 Rheumatoid Arthritis Phase 3 Completed - -
NCT00264537 Rheumatoid Arthritis Phase 3 Completed - -
NCT00259610 - Completed - -
NCT00234845 Rheumatoid Arthritis Phase 3 Completed - United States, Illinois ... More >> Global Medical Information - Abbott Abbott Park, Illinois, United States, 60064 Less <<
NCT00562835 Acute Lung Injury ... More >> ARDS, Human Less << Phase 2 Phase 3 Unknown February 2009 Italy ... More >> UCSC, Policlinico Universitario A. Gemelli, ICU Not yet recruiting Rome, Italy, 00168 Contact: Massimo Antonelli, MD    +39 06 30 15 32 26    m.antonelli@rm.unicatt.it    Contact: Mariano A Pennisi, MD    + 39 06 30 15 43 86    mpennisi@rm.unicatt.it    Principal Investigator: Massimo Antonelli, MD Less <<
NCT00268489 Lung Cancer Phase 2 Completed - -
NCT00264550 - Completed - -
NCT00268528 - Active, not recruiting - -
NCT00275106 Lymphoma Phase 3 Terminated(Withdrawn due to an... More >> excess of toxic deaths) Less << - Germany ... More >> Kinderklinik Giessen, Germany, D-35385 Ireland Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00304980 Plasmodium Falciparum Malaria Not Applicable Terminated - Zambia ... More >> Tropical Disease Research Center Ndola, Cupperbelt, Zambia Less <<
NCT00276757 Childhood Langerhans Cell Hist... More >>iocytosis Less << Not Applicable Completed - -
NCT00264537 - Completed - -
NCT00278265 T-Cell Large Granular Lymphocy... More >>tic Leukemia Less << Phase 2 Terminated(slow recruitment) - Germany ... More >> Robert Roessle Comprehensive Cancer Center - Charite Campus Buch Berlin, Germany, D-13125 University Hospital Schleswig-Holstein - Kiel Campus Kiel, Germany, D-24105 I. Frauenklinik und Hebammenschule der Ludwig-Maximillians Universitaet Muenchen Munich, Germany, D-80337 Klinikum Schwaebisch Gmuend Stauferklinik Mutlangen, Germany, D-73557 Praxis fuer Haematologie und Interne Onkologie Norderstedt, Germany, 22844 St. Marien - Krankenhaus Siegen GMBH Siegen, Germany, D-57072 Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm Ulm, Germany, D-89081 Less <<
NCT00269867 Rheumatoid Arthritis Phase 3 Completed - -
NCT00278278 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Unknown - United States, Texas ... More >> M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 Less <<
NCT00251641 Psoriasis Phase 3 Completed - -
NCT00280917 - Completed - -
NCT00280917 Rheumatoid Arthritis Phase 2 Completed - -
NCT00281905 Brain and Central Nervous Syst... More >>em Tumors Neuroblastoma Less << Phase 2 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00283985 Lymphoma, Non-Hodgkin Phase 2 Completed - France ... More >> Département Maladies du Sang Angers, France, 49000 CH Annecy Annecy, France Service de Radiothérapie, Polyclinique Bordeaux Nord Bordeaux, France, 33000 CHU Bordeaux Bordeaux, France Service d'Hématologie Clinique - Hôpital Henri Mondor Créteil, France Service d'Hématologie Clinique, CHU Dijon Dijon, France Service d'Hématologie Evry, France, 91080 CHU Grenoble-Hématologie Clinique Grenoble, France CHU Lille - Maladies du Sang Lille, France Service d'Hématologie et de Thérapie Cellulaire - CHU Limoges Limoges, France CH Lorient Lorient, France CHU Lyon - Hématologie Clinique Lyon, France Département d'Oncologie - Institut Paoli Calmettes Marseille, France CHU Montpellier Montpellier, France Hématologie Adulte, Hôpital Necker Paris, France, 75000 Département d'Immuno-Hématologie, Hôpital Saint-Louis Paris, France, 75010 CH Lariboisière Paris, France Hôpital St Antoine Paris, France Service d'Hématologie Clinique, Groupe Hospitalier Necker Paris, France Service d'Hématologie Clinique, Groupe Hospitalier Pitié-Salpétrière Paris, France Service d'Immunologie Clinique 2, Hôpital Saint Louis Paris, France Service d'Hématologie Clinique, CHU de Reims Reims, France Centre Henri Becquerel-Rouen Rouen, France Département Hématologie Clinique Saint-Etienne, France, 42000 CHU Toulouse Toulouse, France Less <<
NCT00282308 - Completed - -
NCT00287924 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health at Royal Victoria Infirmary Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00282308 Rheumatoid Arthritis Phase 2 Completed - -
NCT00276601 Leukemia Phase 2 Completed - United States, Alabama ... More >> Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Florida University of Florida Shands Cancer Center Gainesville, Florida, United States, 32610-0232 United States, Georgia Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 United States, Maryland Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States, 21201 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Nebraska UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-3330 United States, Pennsylvania Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00290498 Lymphoma Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00291915 Rheumatoid Arthritis ... More >> Arthritis Less << Phase 4 Unknown - France ... More >> Hopital Cochin Recruiting Paris, France, 75014 Contact: Maxime DOUGADOS, md    00 33 1 58 41 25 62    maxime.dougados@cch.aphp.fr    Contact: Martin SOUBRIER, MD    00 33 6 81 74 78 85    msoubrier@chu-clermond ferrand.fr    Principal Investigator: maxime DOUGADOS, MD          Sub-Investigator: Martin SOUBRIER          Sub-Investigator: Bernard COMBE, MD          Sub-Investigator: Jean SIBILIA, MD          Sub-Investigator: Olivier MEYER, MD          Sub-Investigator: Xavier PUECHAL, MD          Sub-Investigator: Françis BERENBAUM, PhD          Sub-Investigator: Xavier MARIETTE, MD          Sub-Investigator: Patrice FARDELLONE, MD          Sub-Investigator: René Marc FLIPO, MD          Sub-Investigator: Philippe GOUPILLE, PhD          Sub-Investigator: Thierry SCHAEVERBEKE, PhD          Sub-Investigator: C ZARNITSKY, MD Less <<
NCT00284778 Carcinoma, Non-Small-Cell Lung Phase 3 Completed - France ... More >> Service de Pneumologie, CHU Angers Angers, France, 49033 Service de pneumologie; Centre Hospitalier d'Annecy Annecy, France, 74011 Service de Pneumologie; Centre Hospitalier Beauvais, France, 60 021 Service de Pneumologie ; Centre hospitalier Charleville-Mezieres, France, 08 000 Service de Pneumologie; Centre Hospitalier Draguignan, France, 83300 Service de Pathologie Respiratoire; CHU de Limoges Limoges, France, 87000 Service de Pneumologie; Hôpital de la Croix Rousse Lyon, France, 69317 Service de Pneumologie-Neurologie ; Centre Hospitalier F. Quesnay Mantes La Jolie, France, 78200 Département des Maladies Respiratoires ; Hôpital Sainte Marguerite Marseille, France, 13274 Service de Pneumologie et Réanimation ; Hôpital Hôtel Dieu - Paris Paris, France, 75181 Service de Pneumologie - Hôpital St Antoine, Paris Paris, France, 75571 Service de Pneumologie ; Hôpital saint Antoine, Paris Paris, France Service de Pneumologie-Allergologie; Centre Hospitalier Général Perigueux, France, 24019 Service de Pneumologie; CHG de Roanne Roanne, France, 42300 Clinique Pneumologique; Hôpital Charles Nicolle Rouen, France, 76031 Service de Pneumologie; Hôpital Bois Guillaume Rouen, France, 76233 Service de Pathologie Respiratoire; Hôpital d'Instruction des Armées Sainte-Anne Toulon Naval, France, 83800 Service d'Oncologie Médicale; Clinique Sainte Marguerite Toulon, France, 83000 Less <<
NCT00290433 Lymphoma Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00292422 Rheumatoid Arthritis Phase 2 Completed - United States, Michigan ... More >> Fiechtner Research Inc. Lansing, Michigan, United States, 48910 United States, Missouri Arthritis Consultants Inc. St. Louis, Missouri, United States, 63141 United States, Pennsylvania The Arthritis Group Philadelphia, Pennsylvania, United States, 19152 Poland Centrum Medyczne SpecjalistycznyGabinet Lekarski Bialystok, Poland, 15-337 Oddzial Reumatologii Wojewodzki Szpital Elblag, Poland, 82-300 Osrodek Badan Klinicznych Lublin, Poland, 20-022 Prakyta Lekarza Rodzinnego "Nasz Lekarz" Torun, Poland, 87-100 Klinika Chorob Tkanki Lacznej-Instytut Reumatologiczny Warsawa, Poland, 02-637 Klinika Reumatologii-Instytut Reumatologiczny Warsawa, Poland, 02-637 Centrum Leczenia Chorob Cywilizacyjnych Warsawa, Poland, 02-777 Less <<
NCT00295503 - Completed - -
NCT00323622 - Completed - -
NCT00324922 Osteomyelitis ... More >> Methicillin-resistant Staphylococcus Aureus Less << Not Applicable Unknown May 2011 United States, Washington ... More >> University of Washington Seattle, Washington, United States, 98104 Less <<
NCT00295503 Mesothelioma Phase 2 Completed - United States, Texas ... More >> University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390-8852 Less <<
NCT00296010 Breast Cancer Phase 3 Terminated(Accrual rate was to... More >>o low) Less << - -
NCT00296023 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Not Applicable Completed - United States, California ... More >> Alta Bates Comprehensive Cancer Center Berkeley, California, United States, 94704 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0324 Less <<
NCT00299182 Lymphoma Phase 1 Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00323622 Malaria Phase 2 Completed - Mozambique ... More >> GSK Investigational Site Maputo, Mozambique Less <<
NCT00301808 - Completed - -
NCT00298012 Spondylarthropathies ... More >> Spondylitis, Ankylosing Less << Phase 4 Withdrawn - Finland ... More >> Rheumatism Foundation Hospital Heinola, Finland Helsinki University Central Hospital Helsinki, Finland Central Finland Central Hospital Jyväskylä, Finland Kuopio University Hospital Kuopio, Finland Tampere University Hospital Tampere, Finland Less <<
NCT00301834 Congenital Amegakaryocytic Thr... More >>ombocytopenia Diamond-blackfan Anemia Leukemia Myelodysplastic Syndromes Severe Congenital Neutropenia Less << Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Wisconsin University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Less <<
NCT00301912 Anemia Chroni... More >>c Myeloproliferative Disorders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Withdrawn(Withdrawn because st... More >>udy never opened to accrual) Less << - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT00301834 - Completed - -
NCT00301808 Lung Cancer Phase 2 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Veterans Affairs Medical Center - Detroit Detroit, Michigan, United States, 48201 Less <<
NCT00303810 Brain and Central Nervous Syst... More >>em Tumors Less << Not Applicable Completed - Germany ... More >> University Medical Center Hamburg - Eppendorf Hamburg, Germany, D-20246 Less <<
NCT00119132 Malaria Phase 2 Phase 3 Completed - Ghana ... More >> Ministry of Health, Hohoe district hospital Hohoe, Volta region, Ghana Less <<
NCT00301860 Leukemia Lymp... More >>homa Less << Not Applicable Terminated(lack of efficacy) - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT00308750 Non-small Cell Lung Cancer Phase 2 Completed - United States, North Carolina ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Burlington, North Carolina, United States, 27215 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chapel Hill, North Carolina, United States, 27599 United States, South Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Columbia, South Carolina, United States, 29210 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Houston, Texas, United States, 77060 Less <<
NCT00309569 Early Stage Breast Cancer Phase 3 Completed - -
NCT00301925 Breast Cancer Phase 3 Active, not recruiting September 2024 -
NCT00310050 - Terminated(slow accrual) - -
NCT00309478 Early-Stage Breast Cancer Phase 3 Completed - -
NCT00343187 Rash Non-smal... More >>l-Cell Lung Cancer Less << Phase 2 Terminated(Lack of enrollment) - United States, Illinois ... More >> Northwestern University Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611-2941 United States, Pennsylvania Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00311636 Breast Cancer Phase 3 Completed - Italy ... More >> Ospedale Civile Castelfranco - TV, Italy, 31033 Ospedale Sant Anna Como, Italy, 22100 Ospedale Santa Croce Cuneo, Italy, 12100 Azienda Ospedaliera di Firenze Florence, Italy, 50011 Istituto Nazionale per la Ricerca sul Cancro Genoa, Italy, 16132 Presidio Ospedaliero di Livorno Livorno, Italy, 57100 Carlo Poma Hospital Mantova, Italy, 46100 Federico II University Medical School Naples, Italy, 80131 Seconda Universita di Napoli Naples, Italy, 80131 Istituto G. Pascale Naples, Italy, 81131 Ospedale Silvestrini Perugia, Italy, 06156 Ospedale Santa Chiara Pisa Pisa, Italy, 56126 Istituto Regina Elena Rome, Italy, 00128 Ospedale Civile ASL 1 Sassari, Italy, 07100 Ospedale SS Trinita Sora, Italy, 03039 Ospedale Treviglio Caravaggio Treviglio, Italy, 24047 Ospedale Maggiore dell' Universita Trieste, Italy, 34100 Universita di Torino Turin, Italy, 10126 Less <<
NCT00313625 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00310050 Pancreatic Cancer Phase 1 Terminated(slow accrual) - United States, North Carolina ... More >> Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT00317408 Lymphoma Not Applicable Unknown - -
NCT00317876 Fanconi Anemia Phase 1 Completed - United States, Washington ... More >> Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Brazil Universidade Federal do Parana Curitiba, Parana, Brazil, 80.060-000 Less <<
NCT00344006 Malaria, Falciparum Phase 3 Completed - Burkina Faso ... More >> GSK Investigational Site Bobo-Dioulasso, Burkina Faso Ghana GSK Investigational Site Kintampo, Ghana Kenya GSK Investigational Site Eldoret, Kenya GSK Investigational Site Kilifi, Kenya Nigeria GSK Investigational Site Barkin Ladi, Nigeria GSK Investigational Site Calabar, Nigeria GSK Investigational Site Enugu, Nigeria GSK Investigational Site Ibadan, Nigeria Tanzania GSK Investigational Site Ifakara, Tanzania Less <<
NCT00132561 Malaria Phase 2 Phase 3 Completed - Senegal ... More >> Institut de recherche pour le developpement Dakar, Senegal, BP 1386 Less <<
NCT00316771 Rheumatoid Arthritis Phase 2 Completed - -
NCT00659269 Cancer Phase 3 Completed - United States, New Mexico ... More >> University of New Mexico Cancer Center @ Lovelace Medical Center Albuquerque, New Mexico, United States, 87102 Hematology Oncology Associates Albuquerque, New Mexico, United States, 87106 Cancer Center at Presbyterian Hospital Albuquerque, New Mexico, United States, 87110 University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87131 New Mexico Cancer Care Associates Santa Fe, New Mexico, United States, 87505 Less <<
NCT00324805 Stage IB Non-Small Cell Lung C... More >>arcinoma Stage IIA Non-Small Cell Lung Carcinoma Stage IIB Non-Small Cell Lung Carcinoma Stage IIIA Non-small Cell Lung Cancer Less << Phase 3 Active, not recruiting October 16, 2023 -
NCT00659269 - Completed - -
NCT00325234 Breast Cancer Phase 2 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guetersloh, Germany, 33332 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 22081 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stuttgart, Germany, 70190 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bergamo, Italy, 24128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bologna, Italy, 40139 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Livorno, Italy, 57128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Meldola, Italy, 47014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rome, Italy, 00168 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Giovanni Rotondo, Italy, 71013 South Africa For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Durban, South Africa, 4067 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Morningside, South Africa, 2199 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pretoria, South Africa, 0001 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Girona, Spain, 17007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Coruña, Spain, 15006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lleida, Spain, 25198 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28040 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46010 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Zaragoza, Spain, 50009 Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Besevler/Ankara, Turkey, 06500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bornova, Turkey, 35100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kayseri, Turkey, 38039 Less <<
NCT00141037 - Completed - -
NCT00141037 Kidney Diseases ... More >> Kidney Transplantation Kidney Transplant Renal Transplantation Renal Transplant Less << Phase 1 Phase 2 Completed - United States, Alabama ... More >> University of Alabama - Pediatric Nephrology Birmingham, Alabama, United States, 35233 United States, California Maxine Dunitz Children's Health Center Cedars-Sinai Los Angeles, California, United States, 90048 UCLA - Department of Pediatrics, Division of Nephrology Los Angeles, California, United States, 90095-1752 Stanford University Medical Center, Lucile Packard Children's Hospital Palo Alto, California, United States, 94304 UCSF Children's Hospital San Francisco, California, United States, 94143 United States, Florida University of Florida - Pediatric Nephrology Gainesville, Florida, United States, 32610-0296 United States, Louisiana Children's Hospital of New Orleans-Department of Pediatric Nephrology New Orleans, Louisiana, United States, 70118 United States, Massachusetts Children's Hospital Boston - Division of Nephrology Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Medical Center, C.S. Mott Children's Hospital- Division of Nephrology & Transplantation Ann Arbor, Michigan, United States, 48109 United States, Missouri Children's Mercy Hospital - Department of Nephrology Kansas City, Missouri, United States, 64108 United States, Pennsylvania The Children's Hospital of Philadelphia-Department of Nephrology Philadelphia, Pennsylvania, United States, 19104 United States, Washington Children's Hospital & Regional Medical Center - Division of Nephrology Seattle, Washington, United States, 98105 Less <<
NCT00140517 Malaria in Pregnancy ... More >> Birth Weight Anaemia Less << Not Applicable Completed - Burkina Faso ... More >> Centre Medicale Paul VI Ouagadougou, Burkina Faso, 01-2099 Less <<
NCT00146731 Malaria Phase 3 Completed - Tanzania ... More >> Muheza Designated District Hospital Muheza, Tanga, Tanzania, PB Less <<
NCT00331097 Breast Cancer Phase 3 Completed - Italy ... More >> Azienda Sanitaria S. Giuseppe Moscati Monteforte Irpino, AV, Italy Azienda Ospedaliera G. Rummo Benevento, BN, Italy Policlinico Monteluce Sant'Andrea delle Frate, PG, Italy Azienda Ospedaliera Cardarelli Napoli, Italy, 80131 Istituto Nazionale dei Tumori, Divisione di Oncologia Medica C Napoli, Italy, 80131 Università Federico II, Cattedra di Oncologia Medica Napoli, Italy Az. Osp. Treviglio - Caravaggio Treviglio, Italy Ospedale S. Luca ASL SA 3 Vallo della Lucania, Italy Less <<
NCT00325234 - Completed - -
NCT00164255 Malaria Phase 4 Completed - Tanzania ... More >> Kibaoni Health Centre Ifakara, Kilombero District, Tanzania St Francis Designated District Hospital Ifakara, Kilombero District, Tanzania Less <<
NCT00322907 Clinical Malaria Phase 2 Terminated - Papua New Guinea ... More >> Health centers Madang and Maprik, Madang and East Sepik Province, Papua New Guinea Less <<
NCT00132548 Malaria Phase 3 Completed - Senegal ... More >> Institut de recherche pour le developpement Dakar, Senegal, BP 1386 Less <<
NCT00203814 Malaria Not Applicable Completed - Mozambique ... More >> Boane Clinic Boane, Maputo, Mozambique Magude Clinic Magude, Mozambique Less <<
NCT00335140 Lymphoma Phase 2 Terminated(slow accrual) - -
NCT00230035 Systemic Lupus Erythematosus Phase 2 Withdrawn(Recommended by DSMB ... More >>due to lack of accrual) Less << - United States, California ... More >> UCSD, Thornton Hospital La Jolla, California, United States, 92037-0943 UCLA, Rehabilitation Center Los Angeles, California, United States, 90095-1670 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, New York Feinstein Institute for Medical Research NS-LIJ Health System Manhassat, New York, United States, 11030 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27709 Less <<
NCT00335140 - Terminated(slow accrual) - -
NCT00372294 Chorioretinitis Phase 3 Unknown November 2008 Iran, Islamic Republic of ... More >> Ophthalmic Research Center Tehran, Iran, Islamic Republic of, 16666 Less <<
NCT00343785 Aplastic Anemia Phase 2 Completed - United States, Utah ... More >> Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00343785 - Completed - -
NCT00164359 Malaria, Falciparum Phase 4 Completed - Malawi ... More >> Kawale Health Center Lilongwe, Lilongwe District, Malawi Machinga District Hospital Liwonde, Machinga District, Malawi Matiki Health Center Dwangwa, Nkhotakota District, Malawi Less <<
NCT00346359 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00344253 Uveitis, Intermediate ... More >> Macular Edema Multiple Sclerosis Less << Phase 3 Completed - Germany ... More >> Interdisciplinary Uveitis Center, University of Heidelberg Heidelberg, Germany, 69120 Less <<
NCT00324805 - Active, not recruiting - -
NCT00348413 Graves Ophthalmopathy Not Applicable Completed - Singapore ... More >> Singapore National Centre Singapore, Singapore, 168751 Less <<
NCT00231452 Malaria Not Applicable Completed - Mozambique ... More >> Centro de Investigaçao em Saude da Manhiça Manhiça, Maputo, Mozambique, 1929 Less <<
NCT00345748 Rheumatoid Arthritis Phase 2 Completed - Japan ... More >> Local Institution Nagoya-Shi, Aichi, Japan, 460-0001 Local Institution Nagoya, Aichi, Japan, 466-8550 Local Institution Goshogawara-Shi, Aomori, Japan, 037-0053 Local Institution Chiba-Shi, Chiba, Japan Local Institution Fukui-Shi, Fukui, Japan, 910-0041 Local Institution Fukui-Shi, Fukui, Japan, 910-0067 Local Institution Fukuoka-Shi, Fukuoka, Japan, 810-0065 Local Institution Fukuoka-Shi, Fukuoka, Japan, 812-0025 Local Institution Kitakyushu-Shi, Fukuoka, Japan, 807-8555 Local Institution Higashi-Hiroshima-Shi, Hiroshima, Japan, 739-0002 Local Institution Sapporo City, Hokkaido, Japan, 060-8648 Local Institution Sapporo-City, Hokkaido, Japan, 060-0001 Local Institution Sapporo-City, Hokkaido, Japan, 060-8604 Local Institution Kanzaki-Gun, Hyogo, Japan, 679-2414 Local Institution Kato-Gun, Hyogo, Japan, 673-1462 Local Institution Hitachi-Shi, Ibaraki, Japan, 316-0035 Local Institution Tsukuba-Shi, Ibaraki, Japan, 305-0005 Local Institution Sagamihara-Shi, Kanagawa, Japan, 228-8522 Local Institution Sendai-Shi, Miyagi, Japan, 981-0911 Local Institution Sendai-Shi, Miyagi, Japan, 982-0032 Local Institution Sendai, Miyagi, Japan Local Institution Nagano-Shi, Nagano, Japan, 380-8582 Local Institution Tsukubo-Gun, Okayama, Japan, 701-0304 Local Institution Kawachinagano-Shi, Osaka, Japan, 86-0008 Local Institution Ureshino-Shi, Saga, Japan, 843-0301 Local Institution Iruma-Gun, Saitama, Japan, 350-0495 Local Institution Kawagoe-Shi, Saitama, Japan, 350-8550 Local Institution Kitamoto-Shi, Saitama, Japan, 364-0026 Local Institution Hamamatsu-Shi, Shizuoka, Japan, 430-0906 Local Institution Kawachigun, Tochigi, Japan, 329-1104 Local Institution Arakawa-Ku, Tokyo, Japan, 116-0011 Local Institution Bunkyo-Ku, Tokyo, Japan, 113-0022 Local Institution Bunkyo-Ku, Tokyo, Japan, 113-8519 Local Institution Setagaya-Ku, Tokyo, Japan, 155-0032 Local Institution Shinjuku-Ku, Tokyo, Japan, 162-0054 Local Institution Takaoka-Shi, Toyama, Japan, 933-8525 Local Institution Chiba-Shi, Japan, 260-0801 Local Institution Tochigi, Japan, 329-0498 Less <<
NCT00349674 Systemic Wegener's Granulomato... More >>sis Less << Phase 3 Unknown - France ... More >> Christian PAGNOUX Paris, France, 75 Less <<
NCT00380640 Epidermolysis Bullosa Phase 2 Completed - Canada, Ontario ... More >> The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT00351039 Non-Small Cell Lung Cancer Phase 1 Phase 2 Terminated(slow accrual) - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00343369 Leukemia Not Applicable Unknown - Germany ... More >> Evangelisches Krankenhauus Bielfeld Recruiting Biefeld, Germany, 33617 Contact: N. Jorch, MD    49-52-177-278-050       Klinikum Bremen-Mitte Recruiting Bremen, Germany, D-28205 Contact: Arnulf Pekrun, MD, PhD    49-421-497-3656    arnulf.pekrun@klinikum-bremen-mitte.de    Universitaetsklinikum Duesseldorf Recruiting Duesseldorf, Germany, D-40225 Contact: Contact Person    49-211-311-7990       Universitats - Kinderklinik Recruiting Greiswald, Germany, 17487 Contact: James F. Beck, MD    49-383-486-6325    beck@uni-greifswald.de    University Medical Center Hamburg - Eppendorf Recruiting Hamburg, Germany, D-20246 Contact: Gritta Janka-Schaub    49-404-2803-2580       Kreskrankenhaus Kinderabteilung Recruiting Heide, Germany, 25746 Contact: Streitberger    49-481-785-911       Clinic for Bone Marrow Transplantation and Hematology and Oncology Recruiting Idar-Oberstein, Germany, D-55743 Contact: Wenzel Nuernberger, MD, PhD    49-6781-66-1582    wnuernberger@bmt-center-io.com    Klinikum Krefeld GmbH Recruiting Krefeld, Germany, D-47805 Contact: P. Thomas    49-2151-322-375       Universitaets - Kinderklinik Recruiting Leipzig, Germany, D-04317 Contact: Dieter Koerholz, MD    49-341-9726-246    koerd@medizin.uni-leipzig.de    Johannes Gutenberg University Recruiting Mainz, Germany, D-55101 Contact: P. Gutjahr, MD    49-6131-17-2112       Krankenhaus Neuwerk Klinik fuer Kinder und Jugendmedizin Recruiting Moenchengladbach, Germany, D-41066 Contact: Wolfgang Mueller, MD    49-2161-668-2481       Dr. von Haunersches Kinderspital der Universitaet Muenchen Recruiting Munich, Germany, D-80337 Contact: Arndt Borkhardt    49-89-5160-4498       Staedtisches Krankenhaus Muenchen - Harlaching Recruiting Munich, Germany, D-81545 Contact: Papucek    49-89-6210-2710       Klinik St. Hedwig-Kinderklinik Recruiting Regensburg, Germany, 93049 Contact: Ove Peters    49-941-369-5404       Dr. Horst-Schmidt-Kliniken Recruiting Wiesbaden, Germany, D-65199 Contact: Gerhard Beron, MD    49-611-43-2564       Helios Kliniken Wuppertal University Hospital Recruiting Wuppertal, Germany, D-42283 Contact: B. Dohrn, MD    49-202-896-3823    bdohrn@wuppertal.helios-klinikum.de Less <<
NCT00354107 Anaplastic Large Cell Lymphoma... More >> Recurrent Childhood Anaplastic Large Cell Lymphoma Less << Phase 1 Phase 2 Terminated - United States, Pennsylvania ... More >> Children's Oncology Group Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00354393 Malignant Mesothelioma Phase 2 Unknown - United States, Ohio ... More >> Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00704990 Attention Deficit Hyperactivit... More >>y Disorder Less << Phase 2 Phase 3 Completed - Canada, Ontario ... More >> Robert Schad Naturopathic Clinic Toronto, Ontario, Canada, M2K 1E2 The Center for Addiction and Mental Health Toronto, Ontario, Canada, M5T 2S1 Less <<
NCT00354107 - Terminated - -
NCT00356525 - Terminated(Stopped early due t... More >>o low enrollment) Less << - -
NCT00388310 Skin Diseases, Infectious Not Applicable Completed - United States, Delaware ... More >> Christiana Care Health Services Newark, Delaware, United States, 19718 Less <<
NCT00356525 Lung Neoplasms Phase 2 Terminated(Stopped early due t... More >>o low enrollment) Less << - United States, Florida ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami, Florida, United States, 33179 United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Evanston, Illinois, United States, 60201 United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wichita, Kansas, United States, 67214 United States, Minnesota For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Minneapolis, Minnesota, United States, 55455 United States, Missouri For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Louis, Missouri, United States, 63110 United States, Nebraska For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Omaha, Nebraska, United States, 68114 United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chapel Hill, North Carolina, United States, 27599 United States, Tennessee For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chattanooga, Tennessee, United States, 37404 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States, 38120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nashville, Tennessee, United States, 37203 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Houston, Texas, United States, 77060 Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Caxias Do Sul, Brazil, 95070560 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Porto Alegre, Brazil, 90430-090 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santo Andre, Brazil, 09090780 India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bangalore, India, 560 029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mumbai, India, 400016 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trivandrum, India, 695011 Less <<
NCT00357084 Cancer Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00372619 Leukemia Phase 1 Phase 2 Completed - -
NCT00372619 - Completed - -
NCT00381680 B-cell Childhood Acute Lymphob... More >>lastic Leukemia L1 Childhood Acute Lymphoblastic Leukemia L2 Childhood Acute Lymphoblastic Leukemia Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Completed - -
NCT00369928 - Completed - -
NCT00281879 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Unusual Cancers of Childhood Less << Phase 2 Terminated - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT00382109 B-cell Childhood Acute Lymphob... More >>lastic Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Graft Versus Host Disease L1 Childhood Acute Lymphoblastic Leukemia L2 Childhood Acute Lymphoblastic Leukemia T-cell Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Unknown - -
NCT00382109 - Unknown - -
NCT00381680 - Completed - -
NCT00383331 Non-Small-Cell Lung Cancer Phase 2 Terminated(Trial was stopped e... More >>arly due to low enrollment) Less << - United States, Minnesota ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rochester, Minnesota, United States, 55905 Less <<
NCT00281879 - Terminated - -
NCT00351039 - Terminated(slow accrual) - -
NCT00281983 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Completed - Canada, Quebec ... More >> Maisonneuve-Rosemont Hospital Montreal, Quebec, Canada, H1T 2M4 Germany Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin Berlin, Germany, 12200 Universitaetsklinikum Essen Essen, Germany, 45122 Universitaetsklinikum Goettingen Goettingen, Germany, 37075 Asklepios Klinik St. Georg Hamburg, Germany, D-20099 Medizinische Hochschule Hannover Hannover, Germany, 30625 Universitaets-Kinderklinik Heidelberg Heidelberg, Germany, D-69120 Universitaetsklinikum des Saarlandes Homburg, Germany, 66421 Clinic for Bone Marrow Transplantation and Hematology and Oncology Idar-Oberstein, Germany, D-55743 University Hospital Schleswig-Holstein - Kiel Campus Kiel, Germany, 24116 University Hospital of Leipzig Leipzig, Germany, 04103 Klinikum der Universitaet Regensburg Regensburg, Germany, 93053 Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm Ulm, Germany, 89081 Less <<
NCT00385788 Hodgkin's Disease Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00385788 - Completed - -
NCT00390793 Acute Lymphoblastic Leukemia ... More >> BCR-ABL1 Fusion Protein Expression Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Philadelphia Chromosome Positive Recurrent Acute Lymphoblastic Leukemia t(9;22) Less << Phase 2 Active, not recruiting August 31, 2020 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00118794 Malaria Phase 3 Completed - Gambia ... More >> Medical Research Council Laboratories Banjul, Gambia, POBOX273 Less <<
NCT00118807 Malaria Phase 3 Completed - Gambia ... More >> Medical Research Council Laboratories Banjul, Gambia, POBOX273 Less <<
NCT00383331 - Terminated(Trial was stopped e... More >>arly due to low enrollment) Less << - -
NCT00109837 - Completed - -
NCT00123552 Malaria Phase 3 Completed - Uganda ... More >> Assessment Center - Mulago Hospital Kampala, Uganda Less <<
NCT00109408 Rheumatoid Arthritis Phase 3 Completed - -
NCT00127998 Malaria Not Applicable Completed - Mali ... More >> Faladje Missionary Dispensary Faladje, Mali Koro Health Center Koro, Mali Pongono Community Health Center Pongono, Mali Less <<
NCT00126698 Urinary Tract Infection ... More >> Bacteriuria Less << Phase 4 Completed - Netherlands ... More >> Sint Antonius Hospital Nieuwegein, Utrecht, Netherlands, 3430 EM Less <<
NCT00109837 Leukemia Phase 2 Completed - -
NCT00112645 Neuroblastoma ... More >> Sarcoma Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Pennsylvania ... More >> Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 Less <<
NCT00112034 Multiple Sclerosis, Relapsing-... More >>Remitting Less << Phase 4 Completed - United States, Ohio ... More >> MS Academic Coordinating Center Cleveland, Ohio, United States, 44195 Less <<
NCT00140361 Malaria (Uncomplicated) Phase 4 Completed - Tanzania ... More >> Ngere Ngere Health Center Ngere Ngere, Morogoro Rural, Tanzania Ikwiriri Health Center Ikwiriri, Rufiji, Tanzania Lupiro Health Center Lupiro, Ulanga, Tanzania Less <<
NCT00151541 Acne Vulgaris Phase 3 Completed - -
NCT00125489 Malaria Plasm... More >>odium Falciparum Malaria Less << Phase 4 Completed - Malawi ... More >> Blantyre Malaria Project Blantyre, Malawi Less <<
NCT00132535 Malaria in Pregnancy ... More >> HIV Infections Less << Not Applicable Completed - Uganda ... More >> Uganda AIDS Commission Kampala, Uganda, P.O. Box 10779 Less <<
NCT00158548 Malaria Falci... More >>parum Malaria Vivax Malaria Less << Phase 3 Completed - Pakistan ... More >> HealthNet International Peshawar, Pakistan Less <<
NCT00158561 Malaria Vivax... More >> Malaria Less << Phase 3 Completed - Pakistan ... More >> HealthNet International Peshawar, Pakistan Less <<
NCT00157859 Falciparum Malaria ... More >> Vivax Malaria Less << Not Applicable Completed - Indonesia ... More >> SP9 & SP12 Public Health- Malaria control clinics Timika, Papua, Indonesia Less <<
NCT00168532 Post-Measles Pneumonia ... More >> Measles Less << Phase 3 Completed - Guinea-Bissau ... More >> Bandim Health Project Bissau, Apartado 861, Guinea-Bissau, 1004 Bissau Codex Less <<
NCT00189098 Chronic Otitis Media Not Applicable Completed - Netherlands ... More >> Wilhelmina Children Hospital, University Medical Center Utrecht Utrecht, Netherlands, 3508AB Less <<
NCT00203801 Malaria Not Applicable Completed - Mozambique ... More >> Bela Vista Clinic Bela Vista, Matutuine, Mozambique Namaacha Clinic Namaacha, Mozambique South Africa Ndumo Clinic Ndumo, KwaZulu Natal, South Africa Lulekani Clinic Lulekani, Limpopo, South Africa Naas Clinic Naas, Mpumalanga, South Africa Swaziland Ndzevane Clinic Ndzevane, Swaziland Vuvulane Clinic Vuvulane, Swaziland Less <<
NCT00131703 Malaria Pregn... More >>ancy Less << Phase 3 Completed - -
NCT00164710 Malaria, Falciparum Phase 4 Completed - Malawi ... More >> Kawale Health Center Lilongwe, Lilongwe District, Malawi Machinga District Hospital Liwonde, Machinga District, Malawi Matiki Health Center Dwangwa, Nkhotakota District, Malawi Less <<
NCT00119301 Sarcoma Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00229775 Malaria Not Applicable Completed - Philippines ... More >> Kalinga Health Center Tabuk, Kalinga Province, Philippines Davao Health Center Davao City, Mindinao, Philippines Palawan Health Center Puerto Princesa, Palawan, Philippines Less <<
NCT00121134 Breast Cancer Not Applicable Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94122 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, North Carolina University of North Carolina Durham, North Carolina, United States, 27701 Less <<
NCT00189098 - Completed - -
NCT00162383 Healthy Volunteers Not Applicable Recruiting December 2020 Israel ... More >> Hadassah Medical Organization Recruiting Jerusalem, Israel Contact: Arik Tzukert, DMD    00 972 2 6776095    arik@hadassah.org.il    Contact: Hadas Lemberg, PhD    00 972 2 6777572    lhadas@hadassah.org.il    Principal Investigator: Yoseph Caraco, MD Less <<
NCT00121186 Lymphoma Phase 2 Terminated(poor accrual) - United States, Illinois ... More >> Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, Indiana St. Francis Hospital and Health Centers - Beech Grove Campus Beech Grove, Indiana, United States, 46107 Reid Hospital & Health Care Services, Incorporated Richmond, Indiana, United States, 47374 United States, Kansas Cancer Center of Kansas, PA - Chanute Chanute, Kansas, United States, 66720 Cancer Center of Kansas, PA - Dodge City Dodge City, Kansas, United States, 67801 Cancer Center of Kansas, PA - El Dorado El Dorado, Kansas, United States, 67042 Cancer Center of Kansas, PA - Kingman Kingman, Kansas, United States, 67068 Southwest Medical Center Liberal, Kansas, United States, 67901 Cancer Center of Kansas, PA - Newton Newton, Kansas, United States, 67114 Cancer Center of Kansas, PA - Parsons Parsons, Kansas, United States, 67357 Cancer Center of Kansas, PA - Pratt Pratt, Kansas, United States, 67124 Cancer Center of Kansas, PA - Salina Salina, Kansas, United States, 67042 Cancer Center of Kansas, PA - Wellington Wellington, Kansas, United States, 67152 Associates in Womens Health, PA - North Review Wichita, Kansas, United States, 67203 Cancer Center of Kansas, PA - Medical Arts Tower Wichita, Kansas, United States, 67208 Cancer Center of Kansas, PA - Wichita Wichita, Kansas, United States, 67214 CCOP - Wichita Wichita, Kansas, United States, 67214 Via Christi Cancer Center at Via Christi Regional Medical Center Wichita, Kansas, United States, 67214 Cancer Center of Kansas, PA - Winfield Winfield, Kansas, United States, 67156 United States, New York Highland Hospital of Rochester Rochester, New York, United States, 14620 Interlakes Oncology/Hematology PC Rochester, New York, United States, 14623 James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Ohio Grandview Hospital Dayton, Ohio, United States, 45405 Good Samaritan Hospital Dayton, Ohio, United States, 45406 David L. Rike Cancer Center at Miami Valley Hospital Dayton, Ohio, United States, 45409 Veterans Affairs Medical Center - Dayton Dayton, Ohio, United States, 45428 CCOP - Dayton Dayton, Ohio, United States, 45429 Blanchard Valley Medical Associates Findlay, Ohio, United States, 45840 Charles F. Kettering Memorial Hospital Kettering, Ohio, United States, 45429 Middletown Regional Hospital Middletown, Ohio, United States, 45044 UVMC Cancer Care Center at Upper Valley Medical Center Troy, Ohio, United States, 45373-1300 United States Air Force Medical Center - Wright-Patterson Wright-Patterson Afb, Ohio, United States, 45433-5529 Ruth G. McMillan Cancer Center at Greene Memorial Hospital Xenia, Ohio, United States, 45385 Less <<
NCT00124111 Breast Cancer Phase 2 Completed - -
NCT00129506 Unwanted Pregnancies Phase 4 Completed - Canada, British Columbia ... More >> Wiebe Early Abortion Clinic Vancouver, British Columbia, Canada, V5Z 1H9 Less <<
NCT00121134 - Completed - -
NCT00122382 - Completed - -
NCT00234429 Colorectal Cancer Phase 2 Phase 3 Completed - Spain ... More >> Research Site A Coruna, Spain Research Site Barcelona, Spain Research Site Burgos, Spain Research Site Gijon, Spain Research Site Leon, Spain Research Site Madrid, Spain Research Site Oviedo, Spain Research Site Pamplona, Spain Research Site Valladolid, Spain Less <<
NCT00122382 Rheumatoid Arthritis Phase 3 Completed - -
NCT00131027 Lymphoblastic Leukemia, Acute Phase 3 Unknown September 2011 Japan ... More >> Department of Hematology, Nagoya University Graduate School of Medicine Recruiting Nagoya, Japan, 466-8550 Contact: Fumihiko Hayakawa, MD       bun-hy@med.nagoya-u.ac.jp    Principal Investigator: Fumihiko Hayakawa, MD Less <<
NCT00121186 - Terminated(poor accrual) - -
NCT00129974 Carcinoma, Small Cell Phase 2 Terminated(failure to accrue) - United States, Massachusetts ... More >> Tufts-New England Medical Center Boston, Massachusetts, United States, 02111 Commonwealth Hematology/Oncology Quincy, Massachusetts, United States, 02169 Baystate Medical Center Springfield, Massachusetts, United States, 01199 Less <<
NCT00131053 Lymphoblastic Leukemia, Acute Phase 2 Unknown September 2011 Japan ... More >> Department of Hematology, Nagoya University Graduate School of Medicine Recruiting Nagoya, Japan, 466-8550 Contact: Fumihiko Hayakawa, MD       bun-hy@med.nagoya-u.ac.jp    Principal Investigator: Fumihiko Hayakawa, MD Less <<
NCT00130195 Acute Lymphoblastic Leukemia Phase 2 Completed - Japan ... More >> Department of Hematology, Nagoya University Graduate School of Medicine Nagoya, Japan, 466-8550 Less <<
NCT00129974 - Terminated(failure to accrue) - -
NCT00134030 Localized Osteosarcoma ... More >> Metastatic Osteosarcoma Less << Phase 3 Active, not recruiting - -
NCT00132899 Crohn's Disease Phase 3 Completed - Canada, Ontario ... More >> Robarts Clinical Trials, Robarts Research Institute London, Ontario, Canada, N6A 5K8 Less <<
NCT00136084 Leukemia, Myelocytic, Acute Phase 3 Completed - United States, California ... More >> Stanford University Medical Center Palo Alto, California, United States, 94304 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan Children's Hospital of Michigan (Wayne State University) Detroit, Michigan, United States, 48201 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 MD Anderson Cancer Center Houston, Texas, United States, 77030 Texas Children's Cancer Center Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT00136435 Acute Lymphoblastic Leukemia Phase 2 Active, not recruiting December 2018 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 United States, New York University Of Columbia Medical Center New York, New York, United States Canada, Manitoba Manitoba Blood & Marrow Transplant Program CancerCare Manitoba Winnipeg, Manitoba, Canada Canada, Ontario McMaster University Medical Center Hamilton, Ontario, Canada Queen's University Kingston, Ontario, Canada London Health Sciences Centre London, Ontario, Canada Sunnybrook Health Sciences Centre Toronto, Ontario, Canada Canada, Quebec Hospital Maisonneuve-Rosemont Montreal, Quebec, Canada Royal Victoria Hospital Montreal, Quebec, Canada Canada, Saskatchewan Saskatoon Cancer Centre Saskatoon, Saskatchewan, Canada Canada Queen Elizabeth II Halifax, Canada Less <<
NCT00136084 - Completed - -
NCT00146614 Graft Versus Host Disease ... More >> Hematologic Malignancies Less << Phase 2 Completed - United States, Massachusetts ... More >> Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00137111 - Active, not recruiting - -
NCT00141830 Rheumatoid Arthritis Phase 2 Completed - -
NCT00149214 - Completed - -
NCT00152178 Breast Cancer Phase 3 Completed - Japan ... More >> Osaka Medical Center for Cancer and Cardiovascular Diseases 1-1-3, Nakamichi, Higashinari-ku, Osaka, Osaka, Japan Less <<
NCT00152191 Breast Cancer Phase 3 Completed - Japan ... More >> National Cancer Center 5-1-1, Tsukiji, chuo-ku, Tokyo, Japan Less <<
NCT00149214 Breast Cancer Phase 2 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baden-Baden, Germany, 76532 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 10967 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 20357 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelberg, Germany, D-69115 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cremona, Italy, 26100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rozzano, Italy, 20089 Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation, 129128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Petersburg, Russian Federation, 197022 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jaen, Spain, 23007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sabadell, Spain, 08208 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46010 Less <<
NCT00154336 Rheumatoid Arthritis Phase 2 Completed - Austria ... More >> Novartis Investigative site Graz, Austria, 8036 Novartis Investigative site Vienna, Austria, A-1090 Novartis Investigative site Vienna, Austria, A-1130 Canada, Manitoba Novartis Investigative site Winnipeg, Manitoba, Canada, R3A 1M1 Canada, Ontario Novartis Investigative site Toronto, Ontario, Canada, M5G 1X5 Canada, Quebec Novartis Investigative site Montréal, Quebec, Canada, H3Z 2Z3 Novartis Investigative site Sainte-Foy, Quebec, Canada, G1W 4R4 Finland Novartis Investigative site Helsinki, Finland, 00260 Novartis Investigative site Husu, Finland, 00029 United Kingdom Novartis Investigative site Cannock, Staffordshire, United Kingdom, WS11 2XY Novartis Investigative site Colchester, United Kingdom, CO4 5JL Novartis Investigative site Glasgow, United Kingdom, G11 6NT Novartis Investigative site Manchester, United Kingdom, M41 5SL Multiple Sites Multiple Cities, United Kingdom Novartis Investigative site Stoke-on-Trent, United Kingdom, ST6 7AG Less <<
NCT00153530 Central Nervous System Lymphom... More >>a Less << Phase 4 Completed - Germany ... More >> Charite Campus Benjamin Franklin Berlin, Germany, 12200 Less <<
NCT00161239 T-Cell Lymphoma Not Applicable Terminated(toxicity) - United States, New Jersey ... More >> Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 Less <<
NCT00161655 Psoriasis Art... More >>hritis, Psoriatic Less << Phase 4 Completed - Denmark ... More >> Fredriksberg Alle, Copenhagen, Denmark Gentofte Amtsygehus, Hellerup, Denmark Finland Helsinki, Finland Tampere, Finland Norway Rikshospitalet, Olso, Norway Hudlegekontoret Akutten, Tromso, Norway Sweden Lakarhuset Fasta Centrum, Farsta, Sweden Lakarhuset, Vallingby, Sweden Less <<
NCT00162292 Rheumatoid Arthritis Phase 1 Completed - United States, California ... More >> Desert Medical Advances Palm Desert, California, United States, 92260 Boling Clinical Trials Upland, California, United States, 91786 United States, Florida Delray Research Associates Delray Beach, Florida, United States, 33484 Ocala Rheumatology Research Center Ocala, Florida, United States, 34474 United States, Massachusetts Phase Iii Clinical Research Fall River, Massachusetts, United States, 02720 United States, Texas Covance Clinical Research Unit Inc. Dallas, Texas, United States, 75247 Radiant Research San Antonio Northeast San Antonio, Texas, United States, 78217 Healthcare Discoveries, Inc San Antonio, Texas, United States, 78229 Mexico Local Institution Metepec, Estado De Mexico, Mexico, 52140 Local Institution Leon, Guanajuato, Mexico, 37520 Less <<
NCT00162266 Rheumatoid Arthritis Phase 2 Completed - -
NCT00137111 Lymphoblastic Leukemia, Acute Phase 3 Active, not recruiting November 2020 United States, Tennessee ... More >> St Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 Less <<
NCT00165178 Acute Lymphoblastic Leukemia Phase 3 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02538146 Chronic Pancreatitis Early Phase 1 Terminated(Older participants ... More >>could not tolerate the acidity of the product and withdrew.) Less << - United States, Kentucky ... More >> University of Kentucky Center for Clinical and Translational Science Lexington, Kentucky, United States, 40536 Less <<
NCT00176462 - Completed - -
NCT00259142 Fever Anaemia... More >> Malaria Less << Not Applicable Terminated(Study never started... More >>) Less << - Uganda ... More >> Kayunga District Kayunga, Uganda Less <<
NCT00179699 Non-Small Cell Lung Cancer Phase 1 Terminated - United States, Florida ... More >> MD Anderson - Orlando Orlando, Florida, United States, 32806 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Kentucky Norton Healthcare Louisville, Kentucky, United States, 40202 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, New York North Shore Hem/Onc Associates East Setauket, New York, United States, 11733-3456 Less <<
NCT00160602 Rheumatoid Arthritis Phase 3 Completed - -
NCT00162266 - Completed - -
NCT00174707 Breast Neoplasms Phase 3 Completed - Italy ... More >> Sanofi-Aventis Administrative Office Milan, Italy Less <<
NCT00176462 Acute Lymphocytic Leukemia Phase 2 Completed - United States, New Jersey ... More >> Jersey Shore University Medical Center Neptune, New Jersey, United States, 07754 Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Less <<
NCT00184041 Acute Lymphoblastic Leukemia Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90032 Less <<
NCT00180908 Osteosarcoma ... More >>Localised High Grade Osteosarcoma of the Limbs Less << Phase 3 Completed - France ... More >> Institut Gustave-Roussy Villejuif, France, 94805 Less <<
NCT00184886 Methotrexate ... More >>Vasodilation Less << Not Applicable Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500HB Less <<
NCT00187005 Acute Lymphoblastic Leukemia Phase 3 Terminated(Toxicity) - United States, Tennessee ... More >> St.Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00187083 Acute Lymphoblastic Leukemia Phase 3 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00186875 - Completed - -
NCT00187057 Ataxia-Telangiectasia Not Applicable Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00187070 Lymphoma, Large Cell ... More >> Lymphoma, Non-Hodgkin Less << Not Applicable Completed - United States, Tennessee ... More >> St. Jude Children's Reaearch Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00189488 Graft Versus Host Disease ... More >> Hematologic Malignancies Less << Phase 2 Completed - -
NCT00187161 Non-Hodgkin Lymphoma ... More >> Acute Lymphoblastic Leukemia, Mature B-Cell Less << Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00186875 Acute Lymphoblastic Leukemia ... More >> Lymphoma, Lymphoblastic Less << Phase 2 Completed - United States, California ... More >> Rady Children's Hospital and Health Center San Diego, California, United States, 92123 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00189878 Urticaria Phase 2 Terminated(unable to recruit) - -
NCT00189488 - Completed - -
NCT00190671 Breast Cancer Phase 1 Phase 2 Completed - Austria ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Salzburg, Austria, 5020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Wels, Austria, 4600 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Wien, Austria, A-1100 Czech Republic For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Brno, Czech Republic, 625 00 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Nova Ves Pod Plesi, Czech Republic, 26204 Hungary For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Budapest, Hungary, 1122 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Szeged, Hungary, 6720 Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Gdansk, Poland, 80-210 Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Bucharest, Romania, 022328 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Cluj-Napoca, Romania, 3400 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Iasi, Romania, 6600 Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Moscow, Russian Federation, 129128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Saint Petersburg, Russian Federation, 197022 Less <<
NCT00191347 Breast Cancer Phase 2 Completed - Canada, Ontario ... More >> For additional information regarding investigative sites for thsi trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ottawa, Ontario, Canada Less <<
NCT00190671 - Completed - -
NCT00191503 Adenocarcinoma Phase 2 Completed - Canada, Alberta ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Calgary, Alberta, Canada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Edmonton, Alberta, Canada Less <<
NCT00193011 Breast Cancer Phase 3 Completed - -
NCT00193973 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Completed - Australia, Australian Capital ... More >>Territory The Canberra Hospital Garran, Australian Capital Territory, Australia, 2605 Australia, New South Wales Calvary Mater Newcastle Newcastle, New South Wales, Australia, 2298 Prince of Wales Hospital Randwick, New South Wales, Australia, 2031 Westmead Hospital Wentworthville, New South Wales, Australia, 2145 Illawarra Cancer Care Centre Wollongong, New South Wales, Australia Australia, Queensland Royal Brisbane Hospital Herston, Queensland, Australia, 4029 Mater QRI South Brisbane, Queensland, Australia, 4101 Premion - Tugun Tugun, Queensland, Australia, 4224 Princess Alexandra Hospital Woolloongabba, Queensland, Australia, 4102 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Australia, Victoria Andrew Love Cancer Centre, Geelong Hospital Geelong, Victoria, Australia, 3220 Peter MacCallum Cancer Centre Melbourne, Victoria, Australia, 8006 Australia, Western Australia Sir Charles Gairdner Hospital Nedlands, Western Australia, Australia, 6009 New Zealand Auckland Hospital Auckland, New Zealand, 1001 Christchurch Hospital Christchurch, New Zealand, 4710 Less <<
NCT00191984 Metastatic Colorectal Cancer Phase 2 Completed - France ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Angers, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Lille, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Montfermeil, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Paris, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Suresnes, France Less <<
NCT00194779 Estrogen Receptor-negative Bre... More >>ast Cancer Estrogen Receptor-positive Breast Cancer HER2-positive Breast Cancer Progesterone Receptor-negative Breast Cancer Progesterone Receptor-positive Breast Cancer Stage IA Breast Cancer Stage IB Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00194792 Estrogen Receptor-positive Bre... More >>ast Cancer HER2-negative Breast Cancer Progesterone Receptor-positive Breast Cancer Stage I Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Less << Phase 2 Terminated - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00194779 - Completed - -
NCT00194792 - Terminated - -
NCT00195494 Rheumatoid Arthritis Phase 4 Completed - United States, Colorado ... More >> Denver, Colorado, United States, 80230 Less <<
NCT00195494 - Completed - -
NCT00195663 Early Rheumatoid Arthritis Phase 3 Completed - -
NCT00187122 Lymphoblastic Lymphoma Not Applicable Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00191984 - Completed - -
NCT00195702 Rheumatoid Arthritis Phase 3 Completed - -
NCT00194272 Ectopic Pregnancy Phase 3 Completed - United States, California ... More >> University of Southern California Women's and Children's Hospital Los Angeles, California, United States, 90033 United States, Florida University of Miami Miami, Florida, United States, 33101 United States, Pennsylvania University of Pennsylvania Reproductive Research Unit Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00195871 Lymphoblastic Lymphoma Phase 2 Unknown December 2015 Belgium ... More >> Chr de La Citadelle Liege, Belgium, 4000 Cliniques Universitaires U C L de Mont Godinne Yvoir, Belgium, 5530 France C H U D'Angers Angers, France, 49033 Centre Hospitalier de La Region Annecienne Annecy, France, 74011 Chu de Grenoble Grenoble, France, 38043 Centre Hospitalier de Lens Lens, France, 62300 Edouard Herriot Hospital Lyon, France, 69437 Pierre Benite Hospital Lyon, France, 69495 Institut Paoli Calmettes Marseilles, France, 13273 Saint-Louis Hospital Paris, France, 75000 La Pitie Salpetriere Hospital Paris, France, 75013 Cochin Hospital Paris, France, 75014 Marechal Joffre Hospital Perpignan, France, 66046 Centre Hospitalier de Poitiers Poitiers, France, 86000 Chu de Reims Robert Debre Hospital Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Institut de Cancerologie de La Loire Saint Priest En Jarez, France, 42271 Bretonneau Hospital Tours, France, 37044 Chu de Brabois Vandoeuvre Les Nancy, France, 54511 Less <<
NCT00198978 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Unknown - Germany ... More >> University of Frankfurt, Medical Dept. II Recruiting Frankfurt, Germany, 60590 Contact: Dieter Hoelzer, MD,PhD    ++49(0)6963015194    hoelzer@em.uni-frankfurt.de    Contact: Nicola Goekbuget, MD    ++49(0)6963016365    goekbuget@em.uni-frankfurt.de    Principal Investigator: Dieter Hoelzer, MD,PhD          Sub-Investigator: Nicola Goekbuget, MD Less <<
NCT00199017 Lymphoma, Lymphoblastic Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00199004 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital of Frankfurt, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00199069 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany Less <<
NCT00199095 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00195702 - Completed - -
NCT00198991 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Unknown - Germany ... More >> University of Frankfurt, Medical Dept. II Recruiting Frankfurt, Germany, 60590 Contact: Dieter Hoelzer, MD,PhD    ++49(0)69 6301 5194    hoelzer@em.uni-frankfurt.de    Contact: Nicola Goekbuget, MD    ++49(0)69 6301 6365    goekbuget@em.uni-frankfurt.de    Principal Investigator: Dieter Hoelzer, MD,PhD          Sub-Investigator: Nicola Goekbuget, MD Less <<
NCT00202852 Arthritis, Rheumatoid Phase 3 Completed - -
NCT00199186 Philadelphia Positive Acute Ly... More >>mphoblastic Leukemia Lymphoid Blastic Phase of Chronic Myeloid Leukemia Less << Phase 2 Unknown - Germany ... More >> Medizinische Klinik II, Johann Wolfgang Goethe Universität Recruiting Frankfurt/Main, Germany, 60590 Contact: Oliver G Ottmann, M.D.    ++49-69-6301-0 ext 6221    ottmann@em.uni-frankfurt.de Less <<
NCT00199056 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00195663 - Completed - -
NCT00206219 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 3 Completed - -
NCT00207714 Rheumatoid Arthritis Phase 2 Completed - -
NCT00209859 Rheumatoid Arthritis Phase 4 Completed - Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT00210379 Lymphoma, B Cell Phase 2 Completed - Switzerland ... More >> Oncology Institute of Southern Switzerland (IOSI) Bellinzona, Switzerland, 6500 Less <<
NCT00213538 - Completed - France ... More >> CHU de rouen - Hôpitaux de Rouen Rouen, France, 76031 Less <<
NCT00207714 - Completed - -
NCT00215046 Intraluminal Pulmonary Vein St... More >>enosis Less << Phase 2 Completed - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00391274 Non-Small Cell Lung Cancer Phase 3 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 101149 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510080 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hang Zhou, China, 310022 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nan Jing, China, 210002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200433 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tianjin, China, 300060 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wu Han, China, 430030 Less <<
NCT00199082 Burkitt's Lymphoma ... More >> Burkitt's Leukemia Mediastinal Neoplasms Lymphoblastic Lymphoma Large Cell Anaplastic Lymphoma Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00210314 Lymphoma, B Cell Phase 2 Completed - Switzerland ... More >> Oncology Institute of Southern Switzerland (IOSI) Bellinzona, Switzerland, 6500 Less <<
NCT00391586 Carcinoma, Non-Small-Cell Lung Phase 2 Terminated(PI left institution... More >>.) Less << - United States, New Mexico ... More >> Lovelace Medical Group Albuquerque, New Mexico, United States, 87102 Hematology Oncology Associates NM Albuquerque, New Mexico, United States, 87106 Presbyterian Medical Group Albuquerque, New Mexico, United States, 87110 University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87131 New Mexico Cancer Care Associates Santa Fe, New Mexico, United States, 87505 Less <<
NCT00391274 - Completed - -
NCT00285662 Malaria Anemi... More >>a Less << Not Applicable Completed - Papua New Guinea ... More >> Papua New Guinea Institute of Medical Research Goroka, Papua New Guinea Less <<
NCT00391586 - Terminated(PI left institution... More >>.) Less << - -
NCT00392886 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Unknown - -
NCT00392990 Lymphoma Phase 2 Active, not recruiting October 2019 United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 John H. Stroger Cook County Hospital Chicago, Illinois, United States, 60612 Rush University Medical Center Chicago, Illinois, United States, 60612 Loyola University Medical Center Maywood, Illinois, United States, 60153 Advocate Lutheran General Cancer Care Center Park Ridge, Illinois, United States, 60068-1174 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, New Jersey The Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 Less <<
NCT00394147 Head and Neck Cancer Phase 2 Terminated(stopped for lack of... More >> efficacy) Less << - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00213564 - Completed - France ... More >> CHU de Rouen - Hôpitaux de Rouen Rouen, France, 76031 Less <<
NCT00393471 Active Rheumatoid Arthritis Phase 3 Completed - -
NCT00427076 Staphylococcal Infections ... More >> Meningitis Sepsis Pneumonia Less << Phase 3 Completed - Israel ... More >> Rambam Health Care Campus Haifa, Israel Rabin Medical Center; Beilinson Hospital and Davidoff Cancer Center Petah Tikva, Israel, 49100 Less <<
NCT00287300 Malaria Not Applicable Completed - Malawi ... More >> Mpemba and Madziabango Health Centers Blantyre, Malawi Less <<
NCT00396747 Rheumatoid Arthritis Phase 4 Completed - Belgium ... More >> Université catholique de Louvain Brussels, Belgium, 1200 Less <<
NCT00428818 Infection Not Applicable Completed - -
NCT00295997 Chronic Myeloproliferative Dis... More >>orders Kidney Cancer Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Not Applicable Unknown - United States, California ... More >> UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT00397501 Brain and Central Nervous Syst... More >>em Tumors Breast Cancer Cognitive/Functional Effects Drug/Agent Toxicity by Tissue/Organ Psychosocial Effects of Cancer and Its Treatment Less << Phase 1 Phase 2 Withdrawn(after original appro... More >>val, IRB closed enrollment; major revisions required to re-open.) Less << October 2013 -
NCT00400946 - Active, not recruiting - -
NCT02955706 Alzheimer Disease Phase 4 Recruiting February 2019 Korea, Republic of ... More >> Konkuk university medical center Recruiting Seoul, Korea, Republic of, KS013 Contact: SeolHee Han, MD Less <<
NCT00002902 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00002581 Breast Cancer Phase 3 Completed - United Kingdom ... More >> Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Ninewells Hospital and Medical School Dundee, Scotland, United Kingdom, DD1 9SY Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 9NQ Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT University of Glasgow Glasgow, Scotland, United Kingdom, G61 1BD Raigmore Hospital Inverness, Scotland, United Kingdom, 1V2 3UJ Royal Alexandra Hospital Paisley, Scotland, United Kingdom Ayr Hospital Ayr, United Kingdom, KA6 6DX Falkirk Royal Infirmary Falkirk, United Kingdom, FK1 5RE Less <<
NCT00002580 Breast Cancer Phase 3 Completed - United Kingdom ... More >> University Hospitals of Leicester Leicester, England, United Kingdom, LE1 5WW Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Ninewells Hospital and Medical School Dundee, Scotland, United Kingdom, DD1 9SY Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 9NQ Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT University of Glasgow Glasgow, Scotland, United Kingdom, G61 1BD Raigmore Hospital Inverness, Scotland, United Kingdom, 1V2 3UJ Royal Alexandra Hospital Paisley, Scotland, United Kingdom Ayr Hospital Ayr, United Kingdom, KA6 6DX Falkirk Royal Infirmary Falkirk, United Kingdom, FK1 5RE Less <<
NCT00078793 - Completed - -
NCT00405275 Rheumatoid Arthritis Not Applicable Completed - -
NCT00402558 Myelodysplastic Syndrome ... More >> Leukemia Less << Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00400946 Drug/Agent Toxicity by Tissue/... More >>Organ Leukemia Less << Phase 3 Active, not recruiting June 2019 United States, Massachusetts ... More >> Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Albert Einstein Cancer Center at Albert Einstein College of Medicine Bronx, New York, United States, 10461 Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Rhode Island Hasbro Children's Hospital Providence, Rhode Island, United States, 02903 United States, Virginia INOVA Fairfax Hospital Fairfax, Virginia, United States, 22031 Canada, Ontario McMaster Children's Hospital at Hamilton Health Sciences Hamilton, Ontario, Canada, L8N 3Z5 Canada, Quebec Hopital Sainte Justine Montreal, Quebec, Canada, H3T 1C5 Centre de Recherche du Centre Hospitalier de l'Universite Laval Sainte Foy, Quebec, Canada, GIV 4G2 Puerto Rico San Jorge Children's Hospital Santurce, Puerto Rico, 00912 Less <<
NCT00002919 Bladder Cancer Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00005866 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 3 Completed - -
NCT00002789 Leukemia Phase 3 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT02072759 Glucose Intolerance Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands, 6229 ER Less <<
NCT00084240 Malaria, Falciparum Phase 2 Phase 3 Terminated(See Detailed Descri... More >>ption) Less << - -
NCT00002494 Leukemia Lymp... More >>homa Less << Phase 2 Completed - -
NCT00012311 Breast Cancer Phase 2 Unknown - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 Less <<
NCT00003012 Breast Cancer Phase 3 Completed - United Kingdom ... More >> University Hospitals of Leicester Leicester, England, United Kingdom, LE1 5WW Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Ninewells Hospital and Medical School Dundee, Scotland, United Kingdom, DD1 9SY Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 9NQ Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT University of Glasgow Glasgow, Scotland, United Kingdom, G61 1BD Raigmore Hospital Inverness, Scotland, United Kingdom, 1V2 3UJ Royal Alexandra Hospital Paisley, Scotland, United Kingdom Ayr Hospital Ayr, United Kingdom, KA6 6DX Falkirk Royal Infirmary Falkirk, United Kingdom, FK1 5RE Less <<
NCT00081055 Graft Versus Host Disease ... More >> Leukemia Myelodysplastic Syndromes Less << Phase 2 Withdrawn - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1678 Less <<
NCT00003376 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer Less << Phase 3 Completed - -
NCT00003061 Lymphoma Phase 2 Completed - Belgium ... More >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 France Institut Gustave Roussy Villejuif, France, F-94805 Netherlands Atrium Medical Centre Heerlen, Netherlands, 6419 PC Academisch Ziekenhuis Maastricht Maastricht, Netherlands, 6202 AZ Rotterdam Cancer Institute Rotterdam, Netherlands, 3075 EA Dr. Bernard Verbeeten Instituut Tilburg, Netherlands, 5042 SB Academisch Ziekenhuis Utrecht Utrecht, Netherlands, 3508 GA Less <<
NCT00003209 Cervical Cancer Phase 3 Completed - United Kingdom ... More >> Derbyshire Royal Infirmary Derby, England, United Kingdom, DE1 2QY Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT Less <<
NCT00002463 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT00002768 Leukemia Phase 2 Completed - United States, California ... More >> UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States, 94115-0128 United States, Maryland Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 United States, New Jersey St. Joseph's Hospital and Medical Center Paterson, New Jersey, United States, 07503 Less <<
NCT00003870 Leukemia Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 University of Washington Medical Center Seattle, Washington, United States, 98195-6043 Less <<
NCT00003109 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00003701 Bladder Cancer ... More >> Urethral Cancer Less << Phase 3 Completed - United States, Georgia ... More >> Veterans Affairs Medical Center - Atlanta (Decatur) Decatur, Georgia, United States, 30033 United States, Indiana Indiana University Hospitals Indianapolis, Indiana, United States, 46202 United States, New Jersey Hunterdon Regional Cancer Center Flemington, New Jersey, United States, 08822 Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 South Jersey Hospital - Millville Millville, New Jersey, United States, 08332 Fox Chase Cancer Center at Virtua-Memorial Hospital Burlington County Mount Holly, New Jersey, United States, 08060 Riverview Medical Center Red Bank, New Jersey, United States, 07701 Overlook Hospital Summit, New Jersey, United States, 07902-0220 United States, New York Veterans Affairs Medical Center - New York New York, New York, United States, 10010 NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Hahnemann University Hospital Philadelphia, Pennsylvania, United States, 19102-1192 United States, Tennessee Vanderbilt Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00003953 Breast Cancer Phase 2 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Metro Health Medical Center Cleveland, Ohio, United States, 44109 Less <<
NCT00002456 Graft Versus Host Disease ... More >> Leukemia Lymphoma Less << Phase 3 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00004878 Graft Versus Host Disease ... More >> Leukemia Less << Phase 2 Withdrawn(study never opened) - -
NCT00003680 Breast Cancer Phase 3 Unknown - United Kingdom ... More >> C.R.C. Beatson Laboratories Glasgow, Scotland, United Kingdom, G61 1BD Less <<
NCT00005988 Graft Versus Host Disease ... More >> Leukemia Lymphoma Myelodysplastic Syndromes Myeloma Less << Phase 1 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00083031 Breast Cancer Phase 2 Unknown - United States, Massachusetts ... More >> Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00082797 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - -
NCT00002578 Lymphoma Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033-0800 United States, New York Albert Einstein Comprehensive Cancer Center Bronx, New York, United States, 10461 Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00003640 Bladder Cancer Phase 2 Terminated(low accrual) - Italy ... More >> San Raffaele Hospital Rome, Italy, 00144 Less <<
NCT00002961 Leukemia Phase 3 Terminated(poor accrual) - United States, Alabama ... More >> University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 United States, California Children's Hospital and Health Center San Diego, California, United States, 92123-4282 United States, Florida Nemours Children's Clinic Jacksonville, Florida, United States, 32207 All Children's Hospital St. Petersburg, Florida, United States, 33701 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637 United States, Kentucky Albert B. Chandler Medical Center, University of Kentucky Lexington, Kentucky, United States, 40536-0084 United States, Louisiana Louisiana State University School of Medicine New Orleans, Louisiana, United States, 70112-2822 Tulane University School of Medicine New Orleans, Louisiana, United States, 70112 United States, Missouri Children's Mercy Hospital Kansas City, Missouri, United States, 64108 Cardinal Glennon Children's Hospital Saint Louis, Missouri, United States, 63104 Washington University Medical Center Saint Louis, Missouri, United States, 63110 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Palmetto Richland Memorial Hospital Columbia, South Carolina, United States, 29203 United States, Texas South Texas Cancer Institute San Antonio, Texas, United States, 78229 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-7811 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84132 Canada, Alberta Alberta Children's Hospital Calgary, Alberta, Canada, T2T 5C7 Less <<
NCT00002547 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT00002552 Lymphoma Mult... More >>iple Myeloma and Plasma Cell Neoplasm Less << Phase 2 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT00003187 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Less << Phase 2 Phase 3 Completed - United States, California ... More >> Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Kentucky Albert B. Chandler Medical Center, University of Kentucky Lexington, Kentucky, United States, 40536-0084 United States, Minnesota University of Minnesota Medical School Minneapolis, Minnesota, United States, 55455 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, North Carolina Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Comprehensive Cancer Center of Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157-1082 United States, Ohio Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States, 43210 United States, Pennsylvania Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224 United States, South Carolina University of South Carolina School of Medicine Columbia, South Carolina, United States, 29203 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84132 United States, Virginia Massey Cancer Center Richmond, Virginia, United States, 23298-0037 United States, Wisconsin Midwest Children's Cancer Center Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00083759 Rheumatoid Arthritis Phase 2 Terminated(The biological effe... More >>ct seen with natalizumab was not sufficient to warrant further development in RA.) Less << - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Arizona Clinical Research Unit / University of Arizona Tucson, Arizona, United States, 85719 United States, California Arthritis Medical Clinic of North County, Inc. Escondido, California, United States, 92025-4402 United States, Florida Jacksonville Center for Clinical Research Jacksonville, Florida, United States, 32216 United States, Maine Massachusetts General Hospital Boston, Maine, United States, 02114 United States, Massachusetts Clinical Pharmacology Study Group Worcester, Massachusetts, United States, 01610 United States, Michigan Justus Fiechtner, MD, PC Lansing, Michigan, United States, 48910 United States, Pennsylvania Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 Rheumatic Disease Associates Willow Grove, Pennsylvania, United States, 19090 United States, Texas Radiant Research Dallas, Texas, United States, 75235 Canada, Newfoundland and Labrador St. Clare's Mercy Hospital St. John's, Newfoundland and Labrador, Canada, A1C 5B8 Canada, Ontario The Arthritis Program Research Group Inc. Newmarket, Ontario, Canada, L3Y 3R7 Less <<
NCT00003700 Leukemia Phase 2 Completed - -
NCT00003056 Leukemia Lymp... More >>homa Graft Versus Host Disease Less << Phase 3 Terminated(Interim analysis in... More >>dicated study should be terminated) Less << - United States, California ... More >> Los Angeles, California, United States United States, Florida Jacksonville, Florida, United States United States, Georgia Atlanta, Georgia, United States United States, Indiana Indianapolis, Indiana, United States United States, Kansas Lawrence, Kansas, United States United States, Minnesota Saint Paul, Minnesota, United States United States, Missouri Kansas City, Missouri, United States Saint Louis, Missouri, United States United States, New Jersey Hackensack, New Jersey, United States United States, Pennsylvania Pittsburgh, Pennsylvania, United States United States, Texas San Antonio, Texas, United States United States, Virginia Richmond, Virginia, United States Australia, South Australia Adelaide, South Australia, Australia Less <<
NCT00003423 Lymphoma Phase 3 Unknown - United Kingdom ... More >> Hospital for Sick Children NHS Trust London, England, United Kingdom, WC1N 3JH Less <<
NCT00002955 Pancreatic Cancer Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033-0800 Less <<
NCT00002571 Lymphoma Phase 2 Completed - -
NCT00003019 Desmoid Tumor Phase 2 Completed - -
NCT00083759 - Terminated(The biological effe... More >>ct seen with natalizumab was not sufficient to warrant further development in RA.) Less << - -
NCT00005641 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Terminated(low study accrual) - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00002476 Head and Neck Cancer Phase 3 Completed - India ... More >> Raj Tilak Indore, India, 452001 United Kingdom Royal Sussex County Hospital Brighton, England, United Kingdom, BN2 5BE Middlesex Hospital- Meyerstein Institute London, England, United Kingdom, W1N 8AA Derriford Hospital Plymouth, England, United Kingdom, PL6 8DH Southend General Hospital Westcliff-On-Sea, England, United Kingdom Royal Victoria Hospital Belfast, Northern Ireland, United Kingdom, BT12 6BJ Belfast City Hospital Trust Belfast, Northern Ireland, United Kingdom, BT8 8JR Less <<
NCT00006451 Graft Versus Host Disease ... More >> Leukemia Lymphoma Less << Phase 3 Withdrawn(Withdrawn due to no ... More >>accrual) Less << - United States, Minnesota ... More >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00000739 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 1 Completed - -
NCT00002676 Lymphoma Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Colorado CCOP - Colorado Cancer Research Program, Inc. Denver, Colorado, United States, 80209-5031 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Louisiana CCOP - Ochsner New Orleans, Louisiana, United States, 70121 United States, Michigan CCOP - Kalamazoo Kalamazoo, Michigan, United States, 49007-3731 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, New Jersey CCOP - Northern New Jersey Hackensack, New Jersey, United States, 07601 United States, North Dakota Quain & Ramstad Clinic, P.C. Bismarck, North Dakota, United States, 58501 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Columbus Columbus, Ohio, United States, 43206 CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Less <<
NCT00002043 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Not Applicable Completed - United States, California ... More >> UCLA CARE Ctr Los Angeles, California, United States, 90095 Less <<
NCT00000666 Toxoplasmosis, Cerebral ... More >> HIV Infections Less << Not Applicable Completed - United States, California ... More >> Community Consortium of San Francisco San Francisco, California, United States, 94110 United States, Colorado Denver CPCRA / Denver Public Hlth Denver, Colorado, United States, 802044507 United States, Connecticut Hill Health Corp New Haven, Connecticut, United States, 06519 United States, Delaware Wilmington Hosp / Med Ctr of Delaware Wilmington, Delaware, United States, 19899 United States, Georgia AIDS Research Consortium of Atlanta Atlanta, Georgia, United States, 30308 United States, Illinois AIDS Research Alliance - Chicago Chicago, Illinois, United States, 60657 United States, Louisiana Louisiana Comm AIDS Rsch Prog / Tulane Univ Med New Orleans, Louisiana, United States, 70112 United States, Michigan Comprehensive AIDS Alliance of Detroit Detroit, Michigan, United States, 48201 Henry Ford Hosp Detroit, Michigan, United States, 48202 United States, New Jersey North Jersey Community Research Initiative Newark, New Jersey, United States, 071032842 United States, New York Bronx Lebanon Hosp Ctr Bronx, New York, United States, 10456 Addiction Research and Treatment Corp Brooklyn, New York, United States, 11201 Clinical Directors Network of Region II New York, New York, United States, 10011 Harlem AIDS Treatment Group / Harlem Hosp Ctr New York, New York, United States, 10037 United States, Oregon Portland Veterans Adm Med Ctr / Rsch & Education Grp Portland, Oregon, United States, 972109951 United States, Virginia Richmond AIDS Consortium Richmond, Virginia, United States, 23298 Less <<
NCT02141035 Carpal Tunnel Syndrome ... More >> Compression Neuropathy Less << Phase 2 Phase 3 Completed - Canada, Alberta ... More >> Glenrose Hosptial Edmonton, Alberta, Canada, T5G 0B7 Royal Alexandra Hospital Edmonton, Alberta, Canada, T5H 3V9 University of Alberta Hospital Edmonton, Alberta, Canada, T5R2E1 Less <<
NCT00002785 Leukemia Phase 2 Completed - -
NCT00003592 Head and Neck Cancer Phase 3 Completed - United States, Georgia ... More >> Emory University Hospital - Atlanta Atlanta, Georgia, United States, 30322 Veterans Affairs Medical Center - Atlanta (Decatur) Decatur, Georgia, United States, 30033 United States, Illinois Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 Veterans Affairs Medical Center - Chicago (Lakeside) Chicago, Illinois, United States, 60611 CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Michigan CCOP - Kalamazoo Kalamazoo, Michigan, United States, 49007-3731 United States, Minnesota CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, New Jersey Veterans Affairs Medical Center - East Orange East Orange, New Jersey, United States, 07018-1095 United States, New York Albert Einstein Comprehensive Cancer Center Bronx, New York, United States, 10461 University of Rochester Cancer Center Rochester, New York, United States, 14642 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Tennessee Veterans Affairs Medical Center - Nashville Nashville, Tennessee, United States, 37212 Vanderbilt Cancer Center Nashville, Tennessee, United States, 37232-6838 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Veterans Affairs Medical Center - Milwaukee (Zablocki) Milwaukee, Wisconsin, United States, 53295 South Africa Pretoria Academic Hospital Pretoria, South Africa, 0001 Less <<
NCT00002657 Lymphoma Mult... More >>iple Myeloma and Plasma Cell Neoplasm Less << Phase 2 Completed - -
NCT00002691 Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00001994 Toxoplasmosis, Cerebral ... More >> HIV Infections Less << Not Applicable Completed - United States, California ... More >> Los Angeles County - USC Med Ctr Los Angeles, California, United States, 90033 Infectious Disease Med Group Oakland, California, United States, 94609 San Francisco Gen Hosp San Francisco, California, United States, 941102859 UCSF - San Francisco Gen Hosp San Francisco, California, United States, 94110 Davies Med Ctr San Francisco, California, United States, 94114 United States, District of Columbia Georgetown Univ Med Ctr Washington, District of Columbia, United States, 20007 United States, Georgia Infectious Disease Research Consortium of Georgia Atlanta, Georgia, United States, 30345 United States, Maryland Johns Hopkins Hosp Baltimore, Maryland, United States, 21205 United States, New York Beth Israel Med Ctr New York, New York, United States, 10003 Saint Vincent's Hosp and Med Ctr New York, New York, United States, 10011 Harlem Hosp Ctr New York, New York, United States, 10037 SUNY / Health Sciences Ctr at Stony Brook Stony Brook, New York, United States, 117948153 United States, North Carolina Duke Univ Med Ctr Durham, North Carolina, United States, 27710 United States, Oregon Portland Veterans Adm Med Ctr / Rsch & Education Grp Portland, Oregon, United States, 97210 United States, Tennessee Regional Med Ctr at Memphis Memphis, Tennessee, United States, 38103 United States, Texas Gathe, Joseph, M.D. Houston, Texas, United States, 77004 Baylor College of Medicine Houston, Texas, United States, 77030 United States, Virginia Infectious Disease Physicians Inc Annandale, Virginia, United States, 22203 Canada, Alberta Southern Alberta HIV Clinic / Foothills Hosp Calgary, Alberta, Canada Canada, British Columbia Dr Julio S G Montaner Vancouver, British Columbia, Canada Canada, Ontario Wellesley Hosp Toronto, Ontario, Canada Canada, Quebec Dr Emil Toma / Hotel Dieu de Montreal Montreal, Quebec, Canada Less <<
NCT00005854 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21287 United States, Massachusetts University of Massachusetts Memorial Medical Center Worcester, Massachusetts, United States, 01655 United States, South Carolina University of South Carolina School of Medicine Columbia, South Carolina, United States, 29203 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00006033 Head and Neck Cancer Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00003549 Neuroendocrine Carcinoma of th... More >>e Skin Less << Phase 2 Completed - -
NCT00087711 Non Small Cell Lung Carcinoma Phase 3 Completed - -
NCT00002704 Leukemia Phase 2 Completed - -
NCT00002557 Lymphoma Phase 2 Unknown - South Africa ... More >> University of Cape Town School of Medicine Cape Town, South Africa, 7925 Less <<
NCT00002784 Breast Cancer Phase 3 Completed - Australia, New South Wales ... More >> Newcastle Mater Misericordiae Hospital Newcastle, New South Wales, Australia, NSW 2310 Royal Prince Alfred Hospital, Sydney Sydney, New South Wales, Australia, 2050 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Queen Elizabeth Hospital Adelaide, South Australia, Australia, 5011 Australia, Victoria Royal Melbourne Hospital Parkville, Victoria, Australia, 3050 Switzerland Swiss Institute for Applied Cancer Research Bern, Switzerland, CH-3008 Inselspital, Bern Bern, Switzerland, CH-3010 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Istituto Oncologico della Svizzera Italiana Lugano, Switzerland, CH-6900 Kantonsspital - Saint Gallen Saint Gallen, Switzerland, CH-9007 Universitaetsspital Zurich, Switzerland, CH-8091 Less <<
NCT00002665 Leukemia Neut... More >>ropenia Thrombocytopenia Less << Phase 2 Completed - -
NCT00002831 Leukemia Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02173132 Work Stress W... More >>ork Ability Work Performance Less << Phase 3 Completed - Italy ... More >> University of Catania Catania, Italy, 95126 Less <<
NCT00002542 Breast Cancer Phase 3 Completed - -
NCT00004162 Lymphoma Phase 1 Completed - United States, Alabama ... More >> University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 Less <<
NCT00089037 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00089349 Recurrent Childhood Acute Lymp... More >>hoblastic Leukemia Less << Phase 2 Completed - United States, California ... More >> COG Phase I Consortium Arcadia, California, United States, 91006-3776 Less <<
NCT00089921 Arthritis, Rheumatoid Phase 2 Completed - -
NCT00002865 Leukemia Phase 2 Completed - United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157-1082 Less <<
NCT00003776 Sarcoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00002498 Breast Cancer Phase 2 Unknown - Netherlands ... More >> Leiden University Medical Center Leiden, Netherlands, 2300 ZA St. Radboud University Hospital Nijmegen, Netherlands, 6500 HB Less <<
NCT00002579 Breast Cancer Phase 3 Completed - United Kingdom ... More >> Leicester Royal Infirmary NHS Trust Leicester, England, United Kingdom, LE1 5WW Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Ninewells Hospital and Medical School Dundee, Scotland, United Kingdom, DD1 9SY Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 9NQ Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT University of Glasgow Glasgow, Scotland, United Kingdom, G61 1BD Raigmore Hospital Inverness, Scotland, United Kingdom, 1V2 3UJ Royal Alexandra Hospital Paisley, Scotland, United Kingdom Ayr Hospital Ayr, United Kingdom, KA6 6DX Falkirk Royal Infirmary Falkirk, United Kingdom, FK1 5RE Less <<
NCT00002487 Ovarian Cancer Phase 2 Unknown - Canada, Ontario ... More >> Ottawa Regional Cancer Center - General Division Ottawa, Ontario, Canada, K1H 8L6 Ottawa Regional Cancer Centre - Civic Campus Ottawa, Ontario, Canada, K1Y 4K7 Less <<
NCT00002499 Leukemia Phase 2 Phase 3 Unknown - Argentina ... More >> Grupo Argentino de Tratamiento de la Leucemia Aguda Buenos Aires, Argentina, 1425 Less <<
NCT00002755 Breast Cancer Phase 3 Completed - Ireland ... More >> St. Vincent's Hospital Dublin, Ireland, 4 United Kingdom Addenbrooke's NHS Trust Cambridge, England, United Kingdom, CB2 2QQ Cheltenham General Hospital Cheltenham, England, United Kingdom, GL53 7AN Royal Devon and Exeter Hospital Exeter, England, United Kingdom, EX2 5DW Royal Free Hospital Hampstead, London, England, United Kingdom, NW3 2QG Northwick Park Hospital Harrow, England, United Kingdom, HA1 3UJ Huddersfield Royal Infirmary Huddersfield, West Yorks, England, United Kingdom, HD3 3EA St. James's Hospital Leeds, England, United Kingdom, LS9 7TF St. George's Hospital London, England, United Kingdom, SW17 0QT Middlesex Hospital- Meyerstein Institute London, England, United Kingdom, W1N 8AA Newcastle General Hospital Newcastle Upon Tyne, England, United Kingdom, NE4 6BE Nottingham City Hospital NHS Trust Nottingham, England, United Kingdom, NG5 1PB Derriford Hospital Plymouth, England, United Kingdom, PL6 8DH Weston Park Hospital Sheffield, England, United Kingdom, S1O 2SJ Royal South Hants Hospital Southampton, England, United Kingdom, SO14 0YG Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Royal Infirmary Edinburgh, Scotland, United Kingdom, EH3 9YW Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 9NQ Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT Royal Infirmary Glasgow, Scotland, United Kingdom, G4 0SF Velindre Hospital Cardiff, Wales, United Kingdom, CF4 7XL Less <<
NCT00002554 Leukemia Phase 2 Completed - -
NCT00002744 Leukemia Phase 3 Completed - -
NCT00002790 Graft Versus Host Disease ... More >> Leukemia Myelodysplastic Syndromes Less << Phase 1 Phase 2 Withdrawn - -
NCT00002489 Extragonadal Germ Cell Tumor ... More >> Ovarian Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00003711 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Texas ... More >> Brooke Army Medical Center Fort Sam Houston, Texas, United States, 78234 San Antonio Cancer Institute San Antonio, Texas, United States, 78229 Less <<
NCT00003217 Leukemia Lymp... More >>homa Less << Phase 1 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 United States, California Lucile Packard Children's Hospital at Stanford Palo Alto, California, United States, 94304 United States, Illinois Children's Memorial Hospital, Chicago Chicago, Illinois, United States, 60614 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 University of Rochester Cancer Center Rochester, New York, United States, 14642 State University of New York - Upstate Medical University Syracuse, New York, United States, 13210 United States, Oklahoma Oklahoma Memorial Hospital Oklahoma City, Oklahoma, United States, 73126-0307 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425-0721 United States, Texas Simmons Cancer Center - Dallas Dallas, Texas, United States, 75235-9154 Cook Children's Medical Center - Fort Worth Fort Worth, Texas, United States, 76104 United States, Wisconsin Midwest Children's Cancer Center Milwaukee, Wisconsin, United States, 53226 Canada, Alberta Alberta Children's Hospital Calgary, Alberta, Canada, T2T 5C7 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT00002471 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0752 United States, New York Kaplan Cancer Center New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00045305 - Completed - -
NCT00002524 Lymphoma Phase 2 Completed - United States, Florida ... More >> MD Anderson Cancer Center Orlando Orlando, Florida, United States, 32806 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00002805 Leukemia Phase 2 Completed - -
NCT00096460 Recurrent Grade 1 Follicular L... More >>ymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Follicular Lymphoma Less << Phase 2 Phase 3 Terminated(lower than anticipa... More >>ted accrual) Less << - -
NCT00097383 Breast Cancer Phase 1 Phase 2 Completed - Argentina ... More >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. La Plata, Buenos Aires, Argentina For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Rosario, Santa Fe, Argentina For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Buenos Aires, Argentina For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Ciudad De Buenos Aires, Argentina Belgium For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Brussels, Belgium For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Leuven, Belgium For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Wilrijk, Belgium Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Maceio, AL, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Belo Horizonte, BH, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Curitiba, PR, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Porto Alegre, RS, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Sao Paulo, Sao Paulo/SP, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Sao Paulo, SP, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Sorocaba, SP, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Sao Paulo, Brazil Mexico For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Guadalajara, Jalisco, Mexico For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Mexico, Mexico D.F., Mexico For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Col. Campestre Churubusco, Mexico For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Mexico City, Mexico Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Arquiparque-Miraflores, Alges, Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Coimbra, Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Lisboa, Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Porto, Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Proto, Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Santa Maria Da Feira, Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Santarem, Portugal Less <<
NCT00045305 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259-5499 United States, Florida Mayo Clinic - Jacksonville Jacksonville, Florida, United States, 32224 United States, Massachusetts Tufts-NEMC Cancer Center Boston, Massachusetts, United States, 02111 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Ohio Jewish Hospital Cancer Center Cincinnati, Ohio, United States, 45236 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT00008151 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00098774 Lymphoma Phase 2 Completed - -
NCT00057954 Lymphoma Phase 2 Terminated(Slow accrual) - United States, Colorado ... More >> Aurora Presbyterian Hospital Aurora, Colorado, United States, 80012 Boulder Community Hospital Boulder, Colorado, United States, 80301-9019 Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States, 80933 Porter Adventist Hospital Denver, Colorado, United States, 80210 Presbyterian - St. Luke's Medical Center Denver, Colorado, United States, 80218 St. Joseph Hospital Denver, Colorado, United States, 80218 Rose Medical Center Denver, Colorado, United States, 80220 CCOP - Colorado Cancer Research Program Denver, Colorado, United States, 80224-2522 Swedish Medical Center Englewood, Colorado, United States, 80110 St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center Grand Junction, Colorado, United States, 81502 Sky Ridge Medical Center Lone Tree, Colorado, United States, 80124 Hope Cancer Care Center at Longmont United Hospital Longmont, Colorado, United States, 80502 St. Mary - Corwin Regional Medical Center Pueblo, Colorado, United States, 81004 North Suburban Medical Center Thornton, Colorado, United States, 80229 United States, Florida Mayo Clinic - Jacksonville Jacksonville, Florida, United States, 32224 United States, Massachusetts Tufts-NEMC Cancer Center Boston, Massachusetts, United States, 02111 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, New Jersey Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 United States, Ohio Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00098774 - Completed - -
NCT00101101 Lymphoma Phase 2 Active, not recruiting March 2019 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 Less <<
NCT00095199 Non Small Cell Lung Cancer Phase 3 Completed - -
NCT00101101 - Active, not recruiting - -
NCT00101283 Mesothelioma Phase 2 Completed - -
NCT00095199 - Completed - -
NCT00096460 - Terminated(lower than anticipa... More >>ted accrual) Less << - -
NCT00057954 - Terminated(Slow accrual) - -
NCT00101283 - Completed - -
NCT00101842 Carcinoma, Transitional Cell Phase 1 Phase 2 Completed - United States, Texas ... More >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Dallas, Texas, United States Less <<
NCT00102219 Breast Cancer Phase 2 Completed - Brazil ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Belo Horizonte, BH, Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Rio de Janeiro, Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Sao Paulo, Brazil Greece For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Athens, Greece Hungary For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Budapest, Hungary For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Szekesfehervar, Hungary Peru For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Lima, Peru Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Krakow, Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Lodz, Poland Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Madrid, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Valencia, Spain Venezuela For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Caracas, Venezuela Less <<
NCT00106522 Rheumatoid Arthritis Phase 3 Completed - -
NCT00106535 Rheumatoid Arthritis Phase 3 Completed - -
NCT00405275 - Completed - -
NCT00406419 Rheumatoid Arthritis Phase 3 Terminated(Based on analysis o... More >>f results and consideration of available treatments, the overall benefit to risk profile of ocrelizumab was not favorable in RA.) Less << - United States, California ... More >> Trial Information Support Line South San Francisco, California, United States, 94080 Less <<
NCT00106548 Rheumatoid Arthritis Phase 3 Completed - -
NCT00406393 - Completed - -
NCT00106535 - Completed - -
NCT00407459 Mesothelioma Phase 2 Completed - Italy ... More >> Istituto Clinico Humanitas Rozzano, Milan, Italy, 20089 Less <<
NCT00406393 Leukemia, Myelocytic, Acute ... More >> Leukemia, Lymphocytic, Acute Leukemia, Myeloid, Chronic Myelodysplastic Syndromes Less << Phase 3 Completed - -
NCT00407550 Lung Cancer Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT00307671 Vasculitis We... More >>gener's Granulomatosis Microscopic Polyangiitis Churg-Strauss Syndrome Polyarteritis Nodosa Less << Phase 4 Completed - France ... More >> Hôpital Cochin Paris, France, 75679 Less <<
NCT00105976 Rheumatoid Arthritis Phase 2 Completed - -
NCT00409838 Rheumatoid Arthritis Phase 3 Completed - Korea, Republic of ... More >> Local Institution Seoul, Sungdong-Gu, Korea, Republic of, 133-792 Local Institution Anyang, Korea, Republic of, 431-070 Local Institution Daegu, Korea, Republic of, 705-718 Local Institution Daejeon, Korea, Republic of, 302-799 Local Institution Seoul, Korea, Republic of, 110-744 Local Institution Seoul, Korea, Republic of, 137-040 Local Institution Seoul, Korea, Republic of, 138-736 Less <<
NCT00407550 - Completed - -
NCT00413660 Arthritis, Rheumatoid Phase 2 Completed - -
NCT00317785 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Washington ... More >> Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00419809 Arthritis, Rheumatoid Phase 1 Completed - Australia, New South Wales ... More >> GSK Investigational Site Randwick, Sydney, New South Wales, Australia, 2031 Australia GSK Investigational Site Adelaide, Australia, South Australia 5000 Less <<
NCT00420927 Rheumatoid Arthritis Phase 4 Completed - -
NCT00413660 - Completed - -
NCT00420927 - Completed - -
NCT00422227 - Completed - -
NCT00422383 Rheumatoid Arthritis Phase 3 Completed - -
NCT00409838 - Completed - -
NCT00415935 - Unknown - United Kingdom ... More >> Rheumatology ICH Recruiting London, United Kingdom, WC1N 1EH Contact: Lucy Wedderburn, Dr       l.wedderburn@ich.ucl.ac.uk Less <<
NCT00422227 Rheumatoid Arthritis Phase 4 Completed - Hong Kong ... More >> Hong Kong, Hong Kong India Bangalore, India, 560017 Bangalore, India, 560034 Hyderabaad, India, 500082 New Delhi, India, 110029 Korea, Republic of In Cheon, Korea, Korea, Republic of, 400-711 Seoul, Korea, Korea, Republic of, 110-744 Seoul, Korea, Korea, Republic of, 120-752 Seoul, Korea, Korea, Republic of, 133-792 Seoul, Korea, Korea, Republic of, 137-701 Seoul, Korea, Korea, Republic of, 138-736 Malaysia Ipoh, Perak, Malaysia, 30450 Kuala Lumpur, Malaysia, 68100 Pulau Pinang, Malaysia, 10450 Putrajaya, Malaysia, 62250 Seremban, Malaysia, 70300 Philippines Cebu, Philippines, 6000 Makati City, Philippines, 1200 Manila, Philippines, 1000 Manila, Philippines, 1004 Manila, Philippines, 1500 Quezon City, Philippines, 1102 Singapore Singapore, Singapore, 308433 Taiwan Kaohsiung City, Taiwan, 807 Taipei, Taiwan, 100 Taipei, Taiwan, 112 Thailand Bangkok, Thailand, 10400 Less <<
NCT00322101 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Acute Myeloid Leukemia/Transient Myeloproliferative Disorder Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Childhood Acute Myeloid Leukemia in Remission Childhood Myelodysplastic Syndromes de Novo Myelodysplastic Syndromes Myelodysplastic Syndrome With Isolated Del(5q) Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Less << Phase 3 Completed - United States, Colorado ... More >> HealthOne Presbyterian St. Lukes Medical Center Denver, Colorado, United States United States, Georgia Emory University Altanta, Georgia, United States, 30322 United States, New York Weill Cornell University New York, New York, United States, 10021 United States, Utah University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Veterans Administration Center-Seattle Seattle, Washington, United States, 98108 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Medical College Wisconsin Milwaukee, Wisconsin, United States Germany Technical University Dresden Dresden, Saxony, Germany, 01307 Less <<
NCT00322101 - Completed - -
NCT00422383 - Completed - -
NCT00003650 Lymphoma Phase 3 Unknown - France ... More >> Centre Leon Berard Lyon, France, 69373 Less <<
NCT00424346 - Completed - -
NCT00424502 Rheumatoid Arthritis Phase 4 Completed - Hungary ... More >> Budapest, Hungary, 1023 Budapest, Hungary, 1027 Debrecen, Hungary, 4032 Less <<
NCT00003702 Good Prognosis Metastatic Gest... More >>ational Trophoblastic Tumor Hydatidiform Mole Non-Metastatic Gestational Trophoblastic Tumor Uterine Corpus Choriocarcinoma Less << Phase 3 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00003702 - Completed - -
NCT00003728 Leukemia Lymp... More >>homa Less << Phase 3 Unknown - Belgium ... More >> Ziekenhuis Netwerk Antwerpen Middelheim Antwerp, Belgium, 2020 Hopital Universitaire Des Enfants Reine Fabiola Brussels, Belgium, 1020 Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels, Belgium, 1090 Ghent University Ghent, Belgium, B-9000 Universitair Ziekenhuis Gent Ghent, Belgium, B-9000 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Centre Hospitalier Regional de la Citadelle Liege, Belgium, 4000 Clinique de l'Esperance Montegnee, Belgium, 4420 France Centre Hospitalier Regional et Universitaire d'Angers Angers, France, 49033 CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 CHU de Caen Caen, France, 14033 CHU de Grenoble - Hopital de la Tronche Grenoble, France, 38043 Hopital Debrousse Lyon, France, 69322 Hopital Arnaud de Villeneuve Montpellier, France, 34059 CHR Hotel Dieu Nantes, France, 44035 Hopital de l'Archet CHU de Nice Nice, France, F-06202 CHU - Hopital Robert Debre Paris, France, 75019 Hopital Jean Bernard Poitiers, France, 86021 Hopital Americain Reims, France, 51092 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Hopital des Enfants Toulouse, France, 31026 Portugal Hospital Escolar San Joao Porto, Portugal, 4200 Instituto Portugues de Oncologia Centro do Porto, SA Porto, Portugal, 4200 Less <<
NCT00003593 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 3 Completed - -
NCT00003910 Leukemia Phase 2 Terminated - -
NCT00003893 Breast Cancer Phase 3 Completed - United Kingdom ... More >> Queen Elizabeth Hospital at University of Birmingham Birmingham, England, United Kingdom, B15 2TH Less <<
NCT00424346 Rheumatoid Arthritis Phase 2 Completed - United States, Alabama ... More >> Pinnacle Research Group Anniston, Alabama, United States, 36207 University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Arizona Sun Valley Arthritis Center, Ltd Peoria, Arizona, United States, 85381 Catalina Pointe Arthritis & Rheumatology Specialists Tucson, Arizona, United States, 85704 United States, Florida Arthritis Center Palm Harbor, Florida, United States, 34684 Arthritis Research of Florida, Inc. Palm Harbor, Florida, United States, 34684 United States, Illinois The Arthritis Center Springfield, Illinois, United States, 62704 United States, Missouri St. Louis Cener for Clinical Research St. Louis, Missouri, United States, 63128 United States, New York The Center for Rheumatology Albany, New York, United States, 12206 AAIR Research Center Rochester, New York, United States, 14618 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97239 United States, Washington Tacoma Center for Arthritis Research Tacoma, Washington, United States, 98405 Austria Novartis Vienna, Austria Belgium Novartis Vilvoorde, Belgium Canada, Quebec Novartis Dorval, Quebec, Canada Germany Novartis Nuernberg, Germany Spain Novartis Barcelona, Spain Less <<
NCT00003910 - Terminated - -
NCT00004231 Lymphoma Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT00005802 Leukemia Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00005047 - Terminated(Accrual was halted ... More >>on the basis of the Data and Safety Monitoring Board review of a futility analysis.) Less << - -
NCT00005603 Leukemia Phase 3 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 Lucile Packard Children's Hospital at Stanford Palo Alto, California, United States, 94304 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0128 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010-2970 United States, Illinois Saint Jude Midwest Affiliate Peoria, Illinois, United States, 61637 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Mississippi University of Mississippi Medical Center Jackson, Mississippi, United States, 39216-4505 United States, New York Albert Einstein Clinical Cancer Center Bronx, New York, United States, 10461 Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 State University of New York - Upstate Medical University Syracuse, New York, United States, 13210 United States, Ohio Children's Hospital Medical Center - Cincinnati Cincinnati, Ohio, United States, 45229-3039 United States, Oregon Doernbecher Children's Hospital Portland, Oregon, United States, 97201-3098 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas University of Texas Medical Branch Galveston, Texas, United States, 77555-0361 University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Less <<
NCT00006007 Breast Cancer Phase 2 Completed - -
NCT00006258 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 United States, Pennsylvania Geisinger Medical Center Danville, Pennsylvania, United States, 17822-1320 Canada, Alberta Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada, T2N 4N2 Less <<
NCT00005047 Bladder Cancer Phase 3 Terminated(Accrual was halted ... More >>on the basis of the Data and Safety Monitoring Board review of a futility analysis.) Less << - -
NCT00006455 Lymphoma Phase 3 Unknown - Austria ... More >> St. Anna Children's Hospital Vienna, Austria, A-1090 Belgium U.Z. Gasthuisberg Leuven, Belgium, B-3000 France Institut Gustave Roussy Villejuif, France, F-94805 Germany Kinderklinik Giessen, Germany, D-35385 Italy Azienda Ospedaliera di Padova Padova, Italy, 35128 Netherlands Dutch Childhood Leukemia Study Group Den Haag, Netherlands, 2504 AM Spain Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 Sweden Karolinska University Hospital - Huddinge Stockholm, Sweden, S-171 76 Switzerland University Children's Hospital Zurich, Switzerland, CH-8032 United Kingdom Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Less <<
NCT00006747 Graft Versus Host Disease ... More >> Lymphoma Less << Phase 2 Completed - -
NCT00012051 Lymphoma Phase 3 Completed - Belgium ... More >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 Netherlands HagaZiekenhuis - Locatie Leyenburg 's-Gravenhage, Netherlands, 2545 CH Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands, 5211 NL Meander Medisch Centrum Amersfoort, Netherlands, 3816 CP Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands, 1066 BE Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1081HV Academisch Medisch Centrum at University of Amsterdam Amsterdam, Netherlands, 1105 AZ Medisch Spectrum Twente Enschede, Netherlands, 7500 KA University Medical Center Groningen Groningen, Netherlands, 9713 EZ Medisch Centrum Leeuwarden - Zuid Leeuwarden, Netherlands, 8934 AD Leiden University Medical Center Leiden, Netherlands, 2300 CA Academisch Ziekenhuis Maastricht Maastricht, Netherlands, 6202 AZ Sint Antonius Ziekenhuis Nieuwegein, Netherlands, 3435 CM Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands, NL-6500 HB Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands, 3008 AE University Medical Center Utrecht Utrecht, Netherlands, 3584 CX Isala Klinieken - locatie Sophia Zwolle, Netherlands, 8000 GK Less <<
NCT00014469 Graft Versus Host Disease ... More >> Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00015873 Leukemia Phase 3 Completed - -
NCT00014274 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer Less << Phase 2 Phase 3 Completed - -
NCT00018967 Neurotoxicity ... More >> Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific Less << Not Applicable Completed - -
NCT02189772 ADHD, Predominantly Inattentiv... More >>e Type Less << Phase 2 Completed - Israel ... More >> Rambam Medical Center Haifa, Israel Shalvata Mental Health Center Hod Hasharon, Israel Hadassah-Hebrew University Medical Center, Jerusalem, Israel Geha Medical Centre Petah Tiqva, Israel The Chaim Sheba medical center, Tel Hashomer Ramat Gan, Israel Assaf Harofeh MC Zrifin, Israel Less <<
NCT01223742 Hepatic Encephalopathy Not Applicable Completed - Italy ... More >> Cannizzaro Hospital Catania, Italy, 95126 Less <<
NCT01223768 Hepatic Encephalopathy (Grade ... More >>3 of the West Haven Grading Scale) Less << Not Applicable Completed - Italy ... More >> Cannizzaro Hospital Catania, Italy, 95126 Less <<
NCT00016302 T-cell Childhood Acute Lymphob... More >>lastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT01223729 Minimal Hepatic Encephalopathy Not Applicable Completed - Italy ... More >> Cannizzaro Hospital Catania, Italy, 95126 Less <<
NCT00001256 Inflammation ... More >>Vasculitis Wegener's Granulomatosis Less << Phase 2 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT00004323 Aplastic Anemia Phase 2 Completed - United States, California ... More >> Center for Health Sciences Los Angeles, California, United States, 90024-1714 Less <<
NCT00000596 Lung Diseases ... More >> Pulmonary Fibrosis Sarcoidosis Less << Phase 2 Completed - -
NCT00004748 Liver Cirrhosis, Biliary Phase 3 Completed - -
NCT00004686 Giant Cell Arteritis Phase 2 Completed - -
NCT00006056 Chediak-Higashi Syndrome ... More >> Graft Versus Host Disease X-Linked Lymphoproliferative Syndrome Familial Erythrophagocytic Lymphohistiocytosis Hemophagocytic Lymphohistiocytosis Virus-Associated Hemophagocytic Syndrome Less << Not Applicable Unknown - United States, Minnesota ... More >> Fairview University Medical Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00006054 Immunologic Deficiency Syndrom... More >>es Chediak-Higashi Syndrome Common Variable Immunodeficiency Graft Versus Host Disease X-Linked Lymphoproliferative Syndrome Familial Erythrophagocytic Lymphohistiocytosis Hemophagocytic Lymphohistiocytosis X-linked Agammaglobulinemia Wiskott-Aldrich Syndrome Chronic Granulomatous Disease X-linked Hyper IgM Syndrome Severe Combined Immunodeficiency Leukocyte Adhesion Deficiency Syndrome Virus-Associated Hemophagocytic Syndrome Less << Not Applicable Terminated - United States, Minnesota ... More >> Fairview University Medical Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00005945 Leukemia Phase 3 Completed - -
NCT01311739 Healthy Not Applicable Completed - -
NCT00001880 Neoplasm Metastasis Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00001473 - Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT02541045 Non-alcoholic Steatohepatitis Phase 3 Suspended(lack of resources to... More >> finance the project) Less << August 2019 Mexico ... More >> Hospital General de México Mexico City, DF, Mexico, 06726 Less <<
NCT01399164 Vitamin B-12 Deficiency ... More >> Achlorhydria Less << Not Applicable Completed - United States, California ... More >> Western Human Nutrition Center, University of California Davis Davis, California, United States, 95616 Less <<
NCT00006184 Multiple Myeloma Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00000640 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 3 Completed - -
NCT00006184 - Completed - -
NCT00000643 Toxoplasmosis, Cerebral ... More >> HIV Infections Less << Phase 2 Completed - -
NCT00000674 Toxoplasmosis, Cerebral ... More >> HIV Infections Less << Not Applicable Completed - United States, California ... More >> USC CRS Los Angeles, California, United States, 90033 Stanford CRS Palo Alto, California, United States, 94304 Ucsd, Avrc Crs San Diego, California, United States, 92103 United States, Florida Univ. of Miami AIDS CRS Miami, Florida, United States, 33136 United States, Maryland Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States, 21287 United States, Missouri Washington U CRS St. Louis, Missouri, United States United States, New York SUNY - Buffalo, Erie County Medical Ctr. Buffalo, New York, United States, 14215 NY Univ. HIV/AIDS CRS New York, New York, United States, 10016 Cornell University A2201 New York, New York, United States, 10021 Memorial Sloan-Kettering Cancer Ctr. New York, New York, United States, 10021 United States, North Carolina Unc Aids Crs Chapel Hill, North Carolina, United States, 27599 Duke Univ. Med. Ctr. Adult CRS Durham, North Carolina, United States, 27710 United States, Pennsylvania Pitt CRS Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01312831 Vitamin B 12 Deficiency Not Applicable Completed - -
NCT00000714 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 3 Completed - United States, Florida ... More >> Univ of Miami School of Medicine Miami, Florida, United States, 331361013 United States, Illinois Northwestern Univ Med School Chicago, Illinois, United States, 60611 United States, Indiana Indiana Univ Hosp Indianapolis, Indiana, United States, 462025250 United States, Louisiana Tulane Univ School of Medicine New Orleans, Louisiana, United States, 70112 United States, Maryland Johns Hopkins Hosp Baltimore, Maryland, United States, 21287 United States, Massachusetts Beth Israel Deaconess - West Campus Boston, Massachusetts, United States, 02215 Univ of Massachusetts Med Ctr Worcester, Massachusetts, United States, 01655 United States, New Jersey Warner-Lambert Parke-Davis Morris Plains, New Jersey, United States, 07950 United States, New York Bronx Municipal Hosp Ctr/Jacobi Med Ctr Bronx, New York, United States, 10461 Montefiore Med Ctr / Bronx Municipal Hosp Bronx, New York, United States, 10467 SUNY / Erie County Med Ctr at Buffalo Buffalo, New York, United States, 14215 City Hosp Ctr at Elmhurst / Mount Sinai Hosp Elmhurst, New York, United States, 11373 Beth Israel Med Ctr New York, New York, United States, 10003 Bellevue Hosp / New York Univ Med Ctr New York, New York, United States, 10016 Mount Sinai Med Ctr New York, New York, United States, 10029 Univ of Rochester Medical Center Rochester, New York, United States, 14642 SUNY - Stony Brook Stony Brook, New York, United States, 117948153 United States, North Carolina Duke Univ Med Ctr Durham, North Carolina, United States, 27710 United States, Ohio Case Western Reserve Univ Cleveland, Ohio, United States, 44106 United States, South Carolina Julio Arroyo West Columbia, South Carolina, United States, 29169 United States, Washington Univ of Washington Seattle, Washington, United States, 981224304 Less <<
NCT00000655 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 2 Completed - -
NCT00000715 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 3 Completed - United States, Louisiana ... More >> Tulane Univ School of Medicine New Orleans, Louisiana, United States, 70112 United States, Massachusetts Harvard (Massachusetts Gen Hosp) Boston, Massachusetts, United States, 02114 United States, New York Bronx Municipal Hosp Ctr/Jacobi Med Ctr Bronx, New York, United States, 10461 Mount Sinai Med Ctr New York, New York, United States, 10029 Univ of Rochester Medical Center Rochester, New York, United States, 14642 United States, North Carolina Univ of North Carolina Chapel Hill, North Carolina, United States, 275997215 United States, Ohio Holmes Hosp / Univ of Cincinnati Med Ctr Cincinnati, Ohio, United States, 452670405 Univ Hosp of Cleveland / Case Western Reserve Univ Cleveland, Ohio, United States, 44106 United States, South Carolina Julio Arroyo West Columbia, South Carolina, United States, 29169 Less <<
NCT00000802 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 3 Completed - -
NCT00000811 Bacterial Infections ... More >> Pneumonia, Pneumocystis Carinii HIV Infections Less << Phase 2 Completed - -
NCT00000794 Toxoplasmosis, Cerebral ... More >> HIV Infections Less << Phase 2 Completed - United States, California ... More >> USC CRS Los Angeles, California, United States, 900331079 United States, Florida Univ. of Miami AIDS CRS Miami, Florida, United States, 331361013 United States, Hawaii Queens Med. Ctr. Honolulu, Hawaii, United States, 96816 Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu, Hawaii, United States, 96816 United States, Illinois Northwestern University CRS Chicago, Illinois, United States, 60611 Cook County Hosp. CORE Ctr. Chicago, Illinois, United States, 60612 United States, Indiana Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States, 462025250 Methodist Hosp. of Indiana Indianapolis, Indiana, United States, 46202 United States, Maryland Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States, 21287 United States, Missouri Washington U CRS St. Louis, Missouri, United States, 63110 St. Louis ConnectCare, Infectious Diseases Clinic St. Louis, Missouri, United States United States, New York SUNY - Buffalo, Erie County Medical Ctr. Buffalo, New York, United States, 13210 Beth Israel Med. Ctr. (Mt. Sinai) New York, New York, United States, 10003 NY Univ. HIV/AIDS CRS New York, New York, United States United States, Ohio Univ. of Cincinnati CRS Cincinnati, Ohio, United States, 452670405 The Ohio State Univ. AIDS CRS Columbus, Ohio, United States, 432101228 Less <<
NCT00000826 Bacterial Infections ... More >> Mycoses HIV Infections Less << Phase 1 Completed - United States, California ... More >> Ucsf Aids Crs San Francisco, California, United States United States, Washington University of Washington AIDS CRS Seattle, Washington, United States, 98122 Less <<
NCT00000816 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 4 Completed - -
NCT00000966 Toxoplasmosis, Cerebral ... More >> HIV Infections Less << Phase 1 Completed - United States, California ... More >> Los Angeles County - USC Med Ctr Los Angeles, California, United States, 90033 United States, Florida Univ of Miami School of Medicine Miami, Florida, United States, 331361013 United States, Massachusetts Univ of Massachusetts Med Ctr Worcester, Massachusetts, United States, 01655 United States, New York Bronx Municipal Hosp Ctr/Jacobi Med Ctr Bronx, New York, United States, 10461 Montefiore Med Ctr / Bronx Municipal Hosp Bronx, New York, United States, 10467 Bronx Veterans Administration / Mount Sinai Hosp Bronx, New York, United States, 10468 Nassau County Med Ctr East Meadow, New York, United States, 11554 Bellevue Hosp / New York Univ Med Ctr New York, New York, United States, 10016 Cornell Univ Med Ctr New York, New York, United States, 10021 SUNY - Stony Brook Stony Brook, New York, United States, 117948153 United States, South Carolina Julio Arroyo West Columbia, South Carolina, United States, 29169 Less <<
NCT00001016 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 3 Completed - United States, New Jersey ... More >> Warner-Lambert Parke-Davis Morris Plains, New Jersey, United States, 07950 Less <<
NCT00001028 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 3 Completed - United States, California ... More >> Community Consortium of San Francisco San Francisco, California, United States, 94110 United States, Colorado Denver CPCRA / Denver Public Hlth Denver, Colorado, United States, 802044507 United States, Delaware Wilmington Hosp / Med Ctr of Delaware Wilmington, Delaware, United States, 19899 United States, District of Columbia Veterans Administration Med Ctr / Regional AIDS Program Washington, District of Columbia, United States, 20422 United States, Illinois AIDS Research Alliance - Chicago Chicago, Illinois, United States, 60657 United States, Indiana Wishard Hosp / Indiana Univ Hosp Indianapolis, Indiana, United States, 46202 United States, Louisiana Louisiana Comm AIDS Rsch Prog / Tulane Univ Med New Orleans, Louisiana, United States, 70112 United States, Michigan Comprehensive AIDS Alliance of Detroit Detroit, Michigan, United States, 48201 Henry Ford Hosp Detroit, Michigan, United States, 48202 United States, New Jersey North Jersey Community Research Initiative Newark, New Jersey, United States, 071032842 United States, New York Bronx Lebanon Hosp Ctr Bronx, New York, United States, 10456 Harlem AIDS Treatment Group / Harlem Hosp Ctr New York, New York, United States, 10037 United States, Oregon Portland Veterans Adm Med Ctr / Rsch & Education Grp Portland, Oregon, United States, 972109951 United States, Virginia Richmond AIDS Consortium Richmond, Virginia, United States, 23298 Less <<
NCT00001996 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 2 Completed - United States, California ... More >> East Bay AIDS Ctr Berkeley, California, United States, 94704 Kaiser Foundation Hosp Harbor City, California, United States, 90710 Cedars Sinai Med Ctr Los Angeles, California, United States, 90048 UCLA CARE Ctr Los Angeles, California, United States, 90095 UCI Med Ctr Orange, California, United States, 92668 AIDS Community Research Consortium Redwood City, California, United States, 94063 Davies Med Ctr San Francisco, California, United States, 94114 Dr Patrick Joseph San Ramone, California, United States, 94583 United States, Georgia Infectious Disease Research Consortium of Georgia Atlanta, Georgia, United States, 30345 United States, Massachusetts Massachusetts Gen Hosp Boston, Massachusetts, United States, 02114 Boston City Hosp Boston, Massachusetts, United States, 02118 United States, New York Beth Israel Med Ctr New York, New York, United States, 10003 Saint Vincent's Hosp and Med Ctr New York, New York, United States, 10011 Harlem AIDS Treatment Group / Harlem Hosp Ctr New York, New York, United States, 10037 United States, Ohio Univ of Cincinnati Cincinnati, Ohio, United States, 452670405 United States, Oregon Portland Veterans Adm Med Ctr / Rsch & Education Grp Portland, Oregon, United States, 97210 United States, Pennsylvania Buckley Braffman Stern Med Associates Philadelphia, Pennsylvania, United States, 19107 United States, Tennessee Regional Med Ctr at Memphis Memphis, Tennessee, United States, 38103 United States, Texas Gathe, Joseph, M.D. Houston, Texas, United States, 77004 Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00000748 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 3 Completed - -
NCT00002056 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Not Applicable Completed - United States, Illinois ... More >> LyphoMed Inc Rosemont, Illinois, United States, 60018 Less <<
NCT00002064 Toxoplasmosis, Cerebral ... More >> HIV Infections Less << Not Applicable Completed - United States, California ... More >> Palo Alto Med Foundation Palo Alto, California, United States, 94301 Less <<
NCT00001027 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 1 Completed - United States, California ... More >> Usc La Nichd Crs Los Angeles, California, United States, 90033 UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States, 90095 Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab. Oakland, California, United States United States, District of Columbia Children's National Med. Ctr., ACTU Washington, District of Columbia, United States, 20010 Howard Univ. Washington DC NICHD CRS Washington, District of Columbia, United States, 20060 United States, Illinois Chicago Children's CRS Chicago, Illinois, United States, 60614 Univ. of Chicago - Dept. of Peds., Div. of Infectious Disease Chicago, Illinois, United States, 60637 United States, Louisiana Tulane/LSU Maternal/Child CRS New Orleans, Louisiana, United States, 70112 United States, New York NYU Med. Ctr., Dept. of Medicine New York, New York, United States, 10016 Harlem Hosp. Ctr. NY NICHD CRS New York, New York, United States, 10037 SUNY Upstate Med. Univ., Dept. of Peds Syracuse, New York, United States Puerto Rico San Juan City Hosp. PR NICHD CRS San Juan, Puerto Rico, 00936 Univ. of Puerto Rico Ped. HIV/AIDS Research Program CRS San Juan, Puerto Rico Less <<
NCT00002102 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Not Applicable Completed - United States, Pennsylvania ... More >> United States Bioscience Inc West Conshohocken, Pennsylvania, United States, 19428 Less <<
NCT00001990 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Not Applicable Completed - United States, North Carolina ... More >> Glaxo Wellcome Inc Research Triangle Park, North Carolina, United States, 27709 Less <<
NCT00002002 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Not Applicable Completed - United States, California ... More >> San Francisco Gen Hosp San Francisco, California, United States, 941102859 Less <<
NCT00002120 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 1 Completed - United States, California ... More >> Los Angeles County / Health Research Assoc / Drew Med Ctr Los Angeles, California, United States, 90033 Less <<
NCT00002317 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Not Applicable Completed - United States, Pennsylvania ... More >> United States Bioscience Inc West Conshohocken, Pennsylvania, United States, 19428 Less <<
NCT00002283 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Not Applicable Completed - United States, New Jersey ... More >> Jacobus Pharmaceutical Co Princeton, New Jersey, United States, 08540 Less <<
NCT00002103 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Not Applicable Completed - United States, Pennsylvania ... More >> United States Bioscience Inc West Conshohocken, Pennsylvania, United States, 19428 Less <<
NCT00014911 Diabetes Mellitus, Insulin-Dep... More >>endent Less << Phase 2 Completed - United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, Washington Benaroya Research Institute at Virginia Mason Research Center Seattle, Washington, United States, 98101 Canada, Alberta University of Alberta Edmonton, Alberta, Canada Germany Justus-Leibig University Giessen, Germany, 35385 Italy University of Milan Milan, Italy Switzerland University of Geneva Geneva, Switzerland Less <<
NCT00002434 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Not Applicable Completed - United States, Pennsylvania ... More >> United States Bioscience Inc West Conshohocken, Pennsylvania, United States, 19428 Less <<
NCT00000703 Lymphoma, Non-Hodgkin ... More >> HIV Infections Less << Not Applicable Completed - United States, California ... More >> Los Angeles County - USC Med Ctr Los Angeles, California, United States, 90033 UCLA CARE Ctr Los Angeles, California, United States, 90095 San Francisco AIDS Clinic / San Francisco Gen Hosp San Francisco, California, United States, 941102859 United States, District of Columbia George Washington Univ Med Ctr Washington, District of Columbia, United States, 20037 United States, Louisiana Charity Hosp / Tulane Univ Med School New Orleans, Louisiana, United States, 70112 Louisiana State Univ Med Ctr / Tulane Med School New Orleans, Louisiana, United States, 70112 Tulane Univ School of Medicine New Orleans, Louisiana, United States, 70112 United States, Massachusetts Univ of Massachusetts Med Ctr Worcester, Massachusetts, United States, 01655 United States, New York Bellevue Hosp / New York Univ Med Ctr New York, New York, United States, 10016 Saint Luke's - Roosevelt Hosp Ctr New York, New York, United States, 10025 Mount Sinai Med Ctr New York, New York, United States, 10029 Univ of Rochester Medical Center Rochester, New York, United States, 14642 United States, Pennsylvania Milton S Hershey Med Ctr Hershey, Pennsylvania, United States, 170330850 United States, South Carolina Julio Arroyo West Columbia, South Carolina, United States, 29169 Less <<
NCT00000658 Lymphoma, Non-Hodgkin ... More >> HIV Infections Less << Phase 3 Completed - United States, California ... More >> USC CRS Los Angeles, California, United States, 900331079 UCLA CARE Center CRS Los Angeles, California, United States, 90095 Ucsf Aids Crs San Francisco, California, United States, 941102859 United States, Colorado University of Colorado Hospital CRS Aurora, Colorado, United States, 80262 United States, Illinois Northwestern University CRS Chicago, Illinois, United States, 60611 Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States, 60612 United States, Indiana Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States, 462025250 United States, Maryland Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States United States, Massachusetts Beth Israel Deaconess Med. Ctr., ACTG CRS Boston, Massachusetts, United States, 02118 Beth Israel Deaconess - East Campus A0102 CRS Boston, Massachusetts, United States, 02215 Bmc Actg Crs Boston, Massachusetts, United States United States, Missouri Washington U CRS St. Louis, Missouri, United States United States, New York SUNY - Buffalo, Erie County Medical Ctr. Buffalo, New York, United States, 14215 Beth Israel Med. Ctr. (Mt. Sinai) New York, New York, United States, 02215 NY Univ. HIV/AIDS CRS New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Ctr. New York, New York, United States, 10021 Univ. of Rochester ACTG CRS Rochester, New York, United States, 14642 United States, North Carolina Unc Aids Crs Chapel Hill, North Carolina, United States, 275997215 United States, Ohio Case CRS Cleveland, Ohio, United States The Ohio State Univ. AIDS CRS Columbus, Ohio, United States, 432101228 United States, Pennsylvania Hosp. of the Univ. of Pennsylvania CRS Philadelphia, Pennsylvania, United States, 19104 Pitt CRS Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00014911 - Completed - -
NCT00023244 End-Stage Renal Disease Phase 2 Terminated(Effective August 13... More >>, 2004 Unanticipated high incidence of post-transplant lymphoproliferative disorder) Less << - -
NCT00000834 HIV Infections Phase 1 Completed - United States, California ... More >> Cedars Sinai Med Ctr Los Angeles, California, United States, 90048 United States, District of Columbia Georgetown Univ Med Ctr Washington, District of Columbia, United States, 20007 United States, Kansas Univ of Kansas School of Medicine Wichita, Kansas, United States, 67214 United States, Massachusetts New England Med Ctr Boston, Massachusetts, United States, 02111 United States, Michigan Harper Hosp Detroit, Michigan, United States, 48201 United States, New York Community Research Initiative on AIDS New York, New York, United States, 10001 United States, Texas Univ of Texas Southwestern Med Ctr of Dallas Dallas, Texas, United States, 75235 Less <<
NCT00000727 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 3 Completed - United States, California ... More >> USC CRS Los Angeles, California, United States, 90033 Ucsd, Avrc Crs San Diego, California, United States, 92103 Ucsf Aids Crs San Francisco, California, United States, 94110 United States, Indiana Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States, 46202 United States, Massachusetts Bmc Actg Crs Boston, Massachusetts, United States, 02118 United States, Minnesota University of Minnesota, ACTU Minneapolis, Minnesota, United States, 55455 United States, New York Memorial Sloan-Kettering Cancer Ctr. New York, New York, United States, 10021 United States, Ohio Case CRS Cleveland, Ohio, United States, 44106 United States, Washington University of Washington AIDS CRS Seattle, Washington, United States, 98105 Less <<
NCT00000689 Lymphoma, Non-Hodgkin ... More >> HIV Infections Less << Phase 1 Completed - United States, California ... More >> USC CRS Los Angeles, California, United States, 90033 Less <<
NCT00000734 HIV Infections Not Applicable Completed - United States, Pennsylvania ... More >> Univ of Pittsburgh Med School Pittsburgh, Pennsylvania, United States Less <<
NCT00000723 Lymphoma, Non-Hodgkin ... More >> HIV Infections Less << Not Applicable Terminated - United States, Louisiana ... More >> Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU New Orleans, Louisiana, United States, 70112 Less <<
NCT00000973 Toxoplasmosis, Cerebral ... More >> HIV Infections Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Ctr. New York, New York, United States, 10021 United States, North Carolina Unc Aids Crs Chapel Hill, North Carolina, United States, 27599 Less <<
NCT01492920 Fatigue Malig... More >>nant Ovarian Mixed Epithelial Tumor Neuropathy Neurotoxicity Syndrome Ovarian Brenner Tumor Ovarian Clear Cell Cystadenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Mucinous Cystadenocarcinoma Ovarian Serous Cystadenocarcinoma Pain Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Less << Phase 3 Withdrawn(Withdrawn) - -
NCT00000732 HIV Infections Not Applicable Completed - United States, Pennsylvania ... More >> Univ of Pittsburgh Med School Pittsburgh, Pennsylvania, United States Less <<
NCT00029523 Meningeal Neoplasms Phase 4 Completed - -
NCT01531517 Diabetic Foot Ulcer Phase 3 Terminated(inability to recrui... More >>t patients) Less << - Egypt ... More >> Alexandria University Hospitals Alexandria, Egypt Cairo University Hospitals Alexandria, Egypt Less <<
NCT01553968 Diabetes Mellitus, Type 2 Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands, 6202 AZ Less <<
NCT00000991 Pneumonia, Pneumocystis Carini... More >>i HIV Infections Less << Phase 3 Completed - United States, California ... More >> USC CRS Los Angeles, California, United States, 90033 Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab. Oakland, California, United States, 94609 Ucsd, Avrc Crs San Diego, California, United States, 92103 United States, Florida Univ. of Miami AIDS CRS Miami, Florida, United States, 33136 United States, Illinois Chicago Children's CRS Chicago, Illinois, United States, 60614 United States, Indiana Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States, 46202 United States, Maryland Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital ACTG CRS Boston, Massachusetts, United States, 02114 Beth Israel Deaconess - East Campus A0102 CRS Boston, Massachusetts, United States, 02215 Beth Israel Deaconess Med. Ctr., ACTG CRS Boston, Massachusetts, United States, 02215 United States, Minnesota University of Minnesota, ACTU Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington U CRS St. Louis, Missouri, United States United States, New York SUNY - Buffalo, Erie County Medical Ctr. Buffalo, New York, United States, 14215 Univ. of Rochester ACTG CRS Rochester, New York, United States United States, North Carolina Unc Aids Crs Chapel Hill, North Carolina, United States Duke Univ. Med. Ctr. Adult CRS Durham, North Carolina, United States United States, Ohio Case CRS Cleveland, Ohio, United States, 44106 The Ohio State Univ. AIDS CRS Columbus, Ohio, United States, 43210 United States, Pennsylvania Pitt CRS Pittsburgh, Pennsylvania, United States United States, Washington University of Washington AIDS CRS Seattle, Washington, United States, 98105 Tanzania Mbeya Med. Research Program, Mbeya Referral Hosp. CRS Mbeya, Tanzania Less <<
NCT00034502 Colorectal Cancer Phase 1 Phase 2 Completed - United States, Kansas ... More >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Wichita, Kansas, United States United States, New York For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. New York, New York, United States United States, Pennsylvania For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Pittsburgh, Pennsylvania, United States Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Bielefeld, Nordrhein-Westfalen, Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Halle, Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Hamburg, Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Homburg/Saar, Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Magdeburg, Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Munchen, Germany Less <<
NCT01526564 Peripheral Sensory Neuropathy Phase 3 Completed - -
NCT00034606 Carcinoma, Non-Small-Cell Lung... More >> Lung Neoplasms Neoplasms Less << Phase 2 Completed - United States, Minnesota ... More >> Rochester, Minnesota, United States Less <<
NCT00034593 Urologic Neoplasms Phase 2 Completed - Finland ... More >> "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Helsinki, Finland "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Pikonlinna, Finland "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Turku, Finland France "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Bordeaux Cedex, France For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Lille Cedex, France "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Marseille Cedex 09, France "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Montpellier, France "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Paris Cedex 14, France Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Homburg/Saar, Germany Less <<
NCT00034489 Breast Neoplasms Phase 2 Completed - United States, Minnesota ... More >> Rochester, Minnesota, United States Less <<
NCT00035958 Dermatomyositis Phase 2 Phase 3 Terminated(Incorporating the r... More >>ecommendations of the NIH-formed DSMB in the study procedures would make the project budget over the limit for this funding mechanism.) Less << - United States, Ohio ... More >> Cincinnati Childrens Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT00036153 Rheumatoid Arthritis Phase 3 Completed - -
NCT00037102 Multiple Sclerosis Phase 4 Completed - -
NCT00035074 Inflammatory Bowel Disease Not Applicable Completed - United States, Pennsylvania ... More >> Childrens Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00037115 Demyelinating Disorders ... More >> Multiple Sclerosis Optic Neuritis Myelitis Neuritis Less << Phase 4 Withdrawn(Lack of funding) - United States, Missouri ... More >> MidAmerica Neuroscience Institute Kansas City, Missouri, United States, 64108 Less <<
NCT00036387 Arthritis, Rheumatoid Phase 3 Completed - -
NCT00042406 Rheumatoid Arthritis Phase 2 Phase 3 Terminated - -
NCT00038610 Leukemia Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00038610 - Completed - -
NCT01695317 Migraine Phase 4 Completed - Norway ... More >> Norwegian National Headache Centre Trondheim, Norway, 7489 Less <<
NCT00002738 Leukemia Lymp... More >>homa Sarcoma Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00036374 Rheumatoid Arthritis, Juvenile Phase 3 Completed - -
NCT00002850 - Completed - -
NCT00043732 Rheumatoid Arthritis Phase 2 Completed - -
NCT00002850 Infection Mul... More >>tiple Myeloma Less << Phase 3 Completed - -
NCT00001298 Kidney Diseases Phase 1 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00012324 Liver Cancer Phase 3 Completed - -
NCT00001498 Breast Cancer ... More >> Breast Neoplasms Less << Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00001677 Arthritis, Rheumatoid ... More >> Synovitis Less << Phase 2 Completed - United States, Maryland ... More >> National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Bethesda, Maryland, United States, 20892 Less <<
NCT00002514 Leukemia Phase 3 Completed - -
NCT00002696 Breast Cancer Phase 3 Suspended - Argentina ... More >> Policlinica Privada Instituto De Medicina Nuclear Bahia Blanca, Buenos Aires, Argentina, 8000 Consultorio Oncologico Privado Mar del Plata, Buenos Aires, Argentina, 7600 Centro De Oncologia y Terapia Radiante Santa Rosa, La Pampa, Argentina, 6300 Unidad Oncologica Del Comahue Neuquen, Argentina Consultorio Oncologico Privado Rio Gallegos, Argentina, 9400 Centro Oncologico Del Litoral Santa Fe, Argentina, 3000 Centro Oncologico Tres Arroyos Tres Arroyos, Argentina, 7500 Less <<
NCT00002756 Leukemia Phase 2 Completed - -
NCT00002598 Leukemia Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00002766 Leukemia Lymp... More >>homa Less << Phase 3 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1678 Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States, 94305-5750 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 New York Medical College Valhalla, New York, United States, 10595 United States, North Carolina Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00002766 - Completed - -
NCT00002792 Chronic Myeloproliferative Dis... More >>orders Leukemia Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00002757 Leukemia Lymp... More >>homa Less << Phase 3 Completed - France ... More >> Institut Gustave Roussy Villejuif, France, F-94805 United Kingdom Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Less <<
NCT00002809 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, Pennsylvania ... More >> Fox Chase-Temple Cancer Center Philadelphia, Pennsylvania, United States, 19111-2442 Less <<
NCT00002700 Leukemia Lymp... More >>homa Less << Phase 3 Completed - -
NCT00003013 Breast Cancer Phase 3 Completed - Austria ... More >> Kaiser Franz Josef Hospital Vienna, Austria, A-1100 Czech Republic Radiotherapy Institute Ostrava-Poruba, Czech Republic, 70852 Estonia University of Tartu Tartu, Estonia, 51003 Germany Frauenklinik Vom Roten Kreuz Munich, Germany, 80637 Hungary Semmelweis University Budapest, Hungary, 1082 Uzsoki Hospital Budapest, Hungary, 1145 Italy Policlinico Monteluce Perugia, Italy, 06122 Ospedale St. Santa Chiara Pisa, Italy, 56100 Centro di Riferimento Oncologico - Aviano Trento, Italy, 38100 Universita Degli Studi di Udine Udine, Italy, 33100 Ospedale San Bortolo Vicenza, Italy, 36100 Latvia Latvian Cancer Center Riga, Latvia, 1079 Poland Regional Center of Oncology Bydgoszcz, Poland, 85-796 Jagiellonian University Krakow (Cracow), Poland, 31-826 Szpital Kliniczny NR 1 Poznan, Poland, PL-61-878 Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Warsaw, Poland, 02-781 Russian Federation Russian Academy of Medical Sciences Cancer Research Center Moscow, Russian Federation, 115478 Moscow Clinical Dispenser Moscow, Russian Federation, 129128 N. A. Semashko Central Clinical Hospital Moscow, Russian Federation, 129128 Regional Oncology Clinic Murmansk, Russian Federation, 183047 Petrov Research Institute of Oncology Saint Petersburg, Russian Federation, 197758 Slovakia St. Elizabeth Cancer Institute Hospital Bratislava, Slovakia, SK-81250 Spain Hospital de la Santa Cruz I Sant Pau Barcelona, Spain, 08025 Hospital General Universitari Vall d'Hebron Barcelona, Spain, 08035 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Clinico Universitario - Malaga Malaga, Spain, 29010 Instituto Valenciano De Oncologia Valencia, Spain, 46009 Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 Less <<
NCT00003215 Lymphoma Phase 3 Completed - Austria ... More >> Allgemeines Krankenhaus der Stadt Wien Vienna, Austria, A-1090 Germany Dr. Horst-Schmidt-Kliniken Wiesbaden, Germany, D-65199 Greece Saint Savvas Cancer Hospital of Athens Athens, Greece, 11522 Italy European Institute of Oncology Milano, Italy, 20141 Switzerland Universitatsspital-Basel Basel, Switzerland, CH-4031 Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 Inselspital, Bern Bern, Switzerland, CH-3010 Ratisches Kantons und Regionalspital Chur, Switzerland, CH-7000 Hopital Cantonal Universitaire de Geneve Collonge-Bellerive, Switzerland, CH-1245 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, 1011 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Klinik Hirslanden Zurich, Switzerland, CH-8008 Less <<
NCT00003261 Lymphoma Phase 2 Unknown - Italy ... More >> Centro di Riferimento Oncologico - Aviano Aviano, Italy, 33081 Less <<
NCT00003536 Stage IV Breast Cancer ... More >> Recurrent Breast Cancer Less << Phase 2 Withdrawn - United States, Texas ... More >> Burzynski Clinic Houston, Texas, United States, 77055-6330 Less <<
NCT00002798 Childhood Acute Erythroleukemi... More >>a (M6) Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myelomonocytic Leukemia (M4) Childhood Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Refractory Anemia With Ringed Sideroblasts Secondary Myelodysplastic Syndromes Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 3 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00003273 Brain and Central Nervous Syst... More >>em Tumors Neuroblastoma Retinoblastoma Sarcoma Less << Phase 2 Withdrawn - United States, Hawaii ... More >> Cancer Research Center of Hawaii Honolulu, Hawaii, United States, 96813 United States, Maine Maine Children's Cancer Program Scarborough, Maine, United States, 04074-9308 United States, Michigan Spectrum Health and DeVos Children's Hospital Grand Rapids, Michigan, United States, 49503 United States, Nebraska Children's Hospital of Omaha Omaha, Nebraska, United States, 68114 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Albert Einstein Clinical Cancer Center Bronx, New York, United States, 10461 Winthrop University Hospital Mineola, New York, United States, 11501 NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 Beth Israel Hospital North New York, New York, United States, 10128 State University of New York Health Sciences Center - Stony Brook Stony Brook, New York, United States, 11790-7775 State University of New York - Upstate Medical University Syracuse, New York, United States, 13210 United States, Ohio St. Vincent Mercy Medical Center Toledo, Ohio, United States, 43608 United States, Pennsylvania Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Argentina Children's Hospital Buenos Aires, Argentina, 1425 Canada, British Columbia British Columbia Children's Hospital Vancouver, British Columbia, Canada, V6H 3V4 Less <<
NCT00003437 Leukemia Phase 3 Unknown - United Kingdom ... More >> Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Less <<
NCT00019864 Cardiac Toxicity ... More >> Sarcoma Less << Phase 2 Terminated - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 United States, Oklahoma Oklahoma University Cancer Institute Oklahoma City, Oklahoma, United States, 73104 United States, Texas Cook Children's Medical Center - Fort Worth Fort Worth, Texas, United States, 76104 Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital Houston, Texas, United States, 77030-2399 Less <<
NCT00003577 Breast Cancer Phase 3 Completed - United Kingdom ... More >> University of Cambridge Cambridge, England, United Kingdom, CB2 2QQ Less <<
NCT00020943 Lymphoma Phase 2 Completed - -
NCT00022516 Breast Cancer Phase 3 Completed - -
NCT00022646 Lung Cancer Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Florida Mayo Clinic Jacksonville, Florida, United States, 32224 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Health Plaza Saint Cloud, Minnesota, United States, 56303 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68106 United States, North Dakota Medcenter One Health System Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Toledo Community Hospital Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania CCOP - Geisinger Clinic and Medical Center Danville, Pennsylvania, United States, 17822-2001 Allegheny General Hospital Pittsburgh, Pennsylvania, United States, 15212-4772 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57104 Less <<
NCT00022737 Childhood Acute Lymphoblastic ... More >>Leukemia in Remission Recurrent Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00024050 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00023998 Metastatic Osteosarcoma Phase 2 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00025636 Lymphoma Phase 3 Unknown - -
NCT00028756 Stage III Bladder Cancer ... More >> Stage IV Bladder Cancer Transitional Cell Carcinoma of the Bladder Less << Phase 3 Completed - -
NCT00022126 Leukemia Phase 2 Completed - -
NCT00028600 Multiple Myeloma ... More >> Plasma Cell Neoplasm Less << Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Delaware Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 United States, District of Columbia Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 United States, Iowa Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242-1002 United States, Maryland Union Hospital Cancer Program at Union Hospital Elkton MD, Maryland, United States, 21921 United States, Missouri Siteman Cancer Center at Barnes-Jewish St. Peters Hospital - Saint Louis St Louis, Missouri, United States, 63110 United States, New Jersey Cancer Institute of New Jersey at Cooper - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Mount Sinai Medical Center New York, New York, United States, 10029 United States, North Carolina Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224-1791 Less <<
NCT00030264 Neurofibromatosis Type 1 ... More >> Precancerous Condition Less << Phase 2 Completed - United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00022516 - Completed - -
NCT00033683 Breast Cancer Phase 2 Unknown - -
NCT00030264 - Completed - -
NCT00027573 Kidney Cancer Phase 2 Completed - United States, Arizona ... More >> CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, New Jersey CCOP - Northern New Jersey Hackensack, New Jersey, United States, 07601 United States, Oklahoma CCOP - Oklahoma Tulsa, Oklahoma, United States, 74136 Less <<
NCT00039130 Leukemia Lymp... More >>homa Less << Phase 2 Completed - -
NCT00036868 Breast Cancer Phase 2 Unknown - Belgium ... More >> Ziekenhuis Netwerk Antwerpen Middelheim Antwerp, Belgium, 2020 Institut Jules Bordet Brussels, Belgium, 1000 Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 Denmark Herlev Hospital - University Hospital of Copenhagen Copenhagen, Denmark, DK-2730 Egypt National Cancer Institute of Egypt Cairo, Egypt France Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Netherlands Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands, 1091 HA Leiden University Medical Center Leiden, Netherlands, 2300 CA Nijmegen Cancer Center at Radboud University Medical Center Nijmegen, Netherlands, NL-6500 HB Poland Medical University of Gdansk Gdansk, Poland, 80-211 Serbia Institute of Oncology and Radiology of Serbia Belgrade, Serbia, 11000 South Africa Medical Oncology Centre of Rosebank Johannesburg, South Africa, 2193 United Kingdom Western Infirmary Glasgow, Scotland, United Kingdom, G11 6NT Less <<
NCT00040690 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United Kingdom ... More >> Medical Research Council Clinical Trials Unit London, England, United Kingdom, NW1 2DA Less <<
NCT00039377 - Completed - -
NCT00041132 Lymphoma Phase 2 Completed - -
NCT00049569 L1 Childhood Acute Lymphoblast... More >>ic Leukemia L2 Childhood Acute Lymphoblastic Leukemia Non-T, Non-B Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia T-cell Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00045539 Lymphoma Phase 2 Completed - United States, Alabama ... More >> Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States, 35294-3410 United States, Florida H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Comprehensive Cancer Center at Wake Forest University Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT00041132 - Completed - -
NCT00049634 Chronic Myeloproliferative Dis... More >>orders Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98104 Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Less <<
NCT00053209 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer Less << Phase 2 Completed - -
NCT00039377 Adult Acute Lymphoblastic Leuk... More >>emia in Remission Less << Phase 2 Completed - -
NCT01876329 - Completed - United States, Mississippi ... More >> Keesler Medical Center Keesler AFB, Mississippi, United States, 39534 Less <<
NCT01893359 - Terminated - -
NCT01893359 Hyperopia Hyp... More >>eropic Astigmatism Less << Phase 1 Phase 2 Terminated - United States, California ... More >> Gordon -Weiss-Schanzlin Vision Institute San Diego, California, United States, 92122 United States, Massachusetts Ophthalmic Consultants of Boston Waltham, Massachusetts, United States, 02451 United States, New Jersey Hersh Vision Group Teaneck, New Jersey, United States, 07666 United States, South Dakota Vance Thompson Vision Sioux Falls, South Dakota, United States, 57108 United States, Virginia See Clearly Vision McLean, Virginia, United States, 22102 Less <<
NCT02300740 Healthy Participants Early Phase 1 Completed - Denmark ... More >> Medical Research Laboratories, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT02009709 Keratoconus C... More >>orneal Ectasia Less << Phase 1 Unknown - United States, Illinois ... More >> Mack Eye Center Recruiting Hoffman Estates, Illinois, United States, 60169 Contact: Adam Baruch    847-755-9393    adam@mackeyecenter.com    Principal Investigator: Robert J Mack, M.D.          Sub-Investigator: Monica Kurzawa, OD          Sub-Investigator: Puja Shah, OD Less <<
NCT02258074 Chronic Kidney Disease Phase 3 Active, not recruiting June 2018 United States, California ... More >> University of California at San Diego San Diego, California, United States, 92161 United States, Colorado Denver Nephrology Research Denver, Colorado, United States, 80230 United States, District of Columbia George Washington University Washington, District of Columbia, United States, 20037 United States, Illinois NorthShore University Health System Chicago, Illinois, United States, 60201 Northwestern University Chicago, Illinois, United States, 60611 United States, Utah University of Utah Salt Lake City, Utah, United States, 84112 Utah VA Salt Lake City, Utah, United States, 84112 Less <<
NCT00039130 - Completed - -
NCT02324153 Delirium Deli... More >>rium, Dementia, Amnestic, Cognitive Disorders Delayed Emergence From Anesthesia Cognitive Disorders Less << Phase 2 Recruiting June 30, 2019 United States, Maryland ... More >> Johns Hopkins Bayview Medical Center Recruiting Baltimore, Maryland, United States, 21224 Contact: Kori Kindbom, MA    410-550-0197    kindbom@jhmi.edu    Contact: Karin J Neufeld, MD MPH    410-550-0197    kneufel2@jhmi.edu Less <<
NCT01972854 Keratoconus Phase 3 Terminated - United States, California ... More >> UC Irvine Department of Ophthalmology Irvine, California, United States, 92868 Gordon -Weiss Vision Institute San Diego, California, United States, 92122 United States, Indiana Price Vision Group Indianapolis, Indiana, United States, 46260 United States, Kansas Durrie Vision Overland Park, Kansas, United States, 66211 United States, Massachusetts Ophthalmic Consultants of Boston Waltham, Massachusetts, United States, 02451 United States, New Jersey Hersh Vision Group Teaneck, New Jersey, United States, 07666 United States, Pennsylvania UPMC Eye Center Pittsburgh, Pennsylvania, United States, 15213 United States, South Dakota Vance Thompson Vision Sioux Falls, South Dakota, United States, 57105 United States, Texas Focal Point Vision San Antonio, Texas, United States, 78229 United States, Utah Hoopes Vision Draper, Utah, United States, 84020 United States, Virginia See Clearly Vision McLean, Virginia, United States, 22102 Less <<
NCT02008175 Keratoconus Not Applicable Completed - India ... More >> Vasan Eye Care Hospital Chennai, Tamil Nadu, India, 600015 Less <<
NCT02344238 Medication Adherence Not Applicable Completed - United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT01876329 - Completed - -
NCT01956474 Keratoconus Phase 2 Terminated - United States, Florida ... More >> Center for Excellence in Eye Care Miami, Florida, United States, 33176 United States, Georgia Stulting Research Center at Woolfson Eye Institute Atlanta, Georgia, United States, 30328 United States, Maryland TLC Laser Eye Center Rockville, Maryland, United States, 20852 United States, Massachusetts Talamo Hatch Laser Eye Consultants, LLC Boston, Massachusetts, United States, 02451 United States, Ohio Cleveland Eye Clinic Brecksville, Ohio, United States, 44141 United States, Virginia TLC Laser Eye Center Fairfax, Virginia, United States, 22031 Less <<
NCT02344238 - Completed - -
NCT02415777 Fatigue Phase 4 Completed - Korea, Republic of ... More >> Ilsan Paik Hospital Ilsan, Kyung-gi-do, Korea, Republic of, 411-706 Less <<
NCT02349165 Keratoconus Not Applicable Completed - Netherlands ... More >> University Medical Center Utrecht Utrecht, Netherlands, 3584 CX Less <<
NCT02475343 Keratoconus Not Applicable Unknown June 2016 China, Shandong ... More >> Shandong Provincial Hospital Recruiting Jinan, Shandong, China Contact: Lihua Wang, MD       wang_glasses@163.com Less <<
NCT02418130 Fatigue Phase 4 Completed - Korea, Republic of ... More >> Seoul St. Mary's Hospital Seoul, Korea, Republic of, 137-701 Less <<
NCT02456961 Keratoconus Not Applicable Completed - -
NCT02638376 Keratoconus P... More >>ost LASIK Keratectasia Less << Phase 3 Unknown June 2016 Singapore ... More >> Singapore National Eye Centre Recruiting Singapore, Singapore, 168751 Contact: Chuan Teck Ang, Diploma       ang.chuan.teck@seri.com.sg    Contact: Mohamed Farook Kothubutheen, BSc (Hons)       farook@snec.com.sg    Principal Investigator: Li Lim, MBBS,FRCS          Sub-Investigator: Tiang Hwee, Donald Tan, MBBS,FRCS          Sub-Investigator: Jodhbir S Mehta, MBBS,FRCS          Sub-Investigator: Mei Lan, Cordelia Chan, MBBS,FRCS          Sub-Investigator: Seng Ei Ti, MBBS,FRCS Less <<
NCT02507362 Keratoconus Phase 1 Phase 2 Unknown February 2016 Iran, Islamic Republic of ... More >> Farabi eye hospital Tehran, Iran, Islamic Republic of, 1336616351 Less <<
NCT02615561 Dermatitis, Atopic Not Applicable Completed - Germany ... More >> Karlsruhe, Baden-Württemberg, Germany, 76189 Kehl, Baden-Württemberg, Germany, 77694 Schwäbisch Hall, Baden-Württemberg, Germany, 74523 Welzheim, Baden-Württemberg, Germany, 73642 Altdorf b. Nürnberg, Bayern, Germany, 90518 Neustadt / Aisch, Bayern, Germany, 91413 Rosenheim, Bayern, Germany, 83026 Bramsche, Niedersachsen, Germany, 49565 Bochum, Nordrhein-Westfalen, Germany, 44791 Datteln, Nordrhein-Westfalen, Germany, 45711 Dortmund, Nordrhein-Westfalen, Germany, 44143 Frankenthal, Rheinland-Pfalz, Germany, 67227 Neumünster, Schleswig-Holstein, Germany, 24534 Erfurt, Thüringen, Germany, 99086 Less <<
NCT02689882 Metabolic Disturbance Phase 1 Completed - United States, Washington ... More >> University of Washington Seattle, Washington, United States, 98195 Less <<
NCT02709850 Hypertriglyceridemia ... More >> Familial Hypercholesterolemia Less << Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Clinical Site Toronto, Ontario, Canada, M9L 3A2 Less <<
NCT02712593 Bioavailability Phase 2 Completed - Canada, Ontario ... More >> KGK Synergize Inc. London, Ontario, Canada, N6A 5R8 Less <<
NCT02721537 Concussion, Mild Not Applicable Recruiting June 2019 United States, Minnesota ... More >> University of Minnesota Center for Magnetic Resonance Research Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Stacy Valenzuela, RAC    612-624-9926    majes014@umn.edu    Principal Investigator: Xiao-Hong Zhu, Ph.D.          Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Heather Ondler Hinson    507-284-4799    ondlerhinson.heather@mayo.edu    Contact: Chuck Barta    507-266-5566    barta.charles@mayo.edu    Principal Investigator: Brent A Bauer, MD Less <<
NCT02808182 Impaired Glucose Tolerance Not Applicable Recruiting July 2019 Canada, Quebec ... More >> centre de recherche du CHUS Recruiting Sherbrooke, Quebec, Canada, J1H 5N4 Contact: Frederique Frisch    8193461110    frederique.frisch@usherbrooke.ca Less <<
NCT02701127 Acute Kidney Injury Early Phase 1 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT02835664 Obesity Insul... More >>in Resistance Less << Not Applicable Recruiting December 2018 Netherlands ... More >> Maastricht University Medical Centre Recruiting Maastricht, Netherlands Contact: Carlijn Remie, Msc          Contact: Patrick Schrauwen, Prof.Dr. Less <<
NCT02812238 Atherosclerosis ... More >> Diabetes Coronary Artery Disease Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center Bethesda, Maryland, United States, 20892 Less <<
NCT02942888 Mild Cognitive Impairment ... More >> NAD Less << Not Applicable Recruiting December 2018 United States, Texas ... More >> South Texas Veterans Healthcare System (STVHCS) Recruiting San Antonio, Texas, United States, 78229 Contact: Joan Hecht    210-617-5300 ext 14654    Joan.hecht@va.gov    University of Texas Health San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Becky Powers, MD    210-617-5179    Becky.powers@va.gov Less <<
NCT02762253 Keratoconus Phase 2 Terminated(No IND submitted to... More >> the FDA) Less << - United States, California ... More >> NVISION Camarillo Camarillo, California, United States, 93010 NVISION Sacramento Citrus Heights, California, United States, 95621 NVISION Fullerton Fullerton, California, United States, 92831 NVISION Laguna Hills Laguna Hills, California, United States, 92653 NVISION Newport Beach Newport Beach, California, United States, 92660 NVISION Ontario Ontario, California, United States, 91764 NVISION La Jolla San Diego, California, United States, 92122 Berg Feinfield Vision Center Sherman Oaks, California, United States, 91423 NVISION Torrance Torrance, California, United States, 90505 United States, Nevada NVISION Las Vegas Las Vegas, Nevada, United States, 89119 United States, Oregon Teplick Custom Vision Beaverton, Oregon, United States, 97008 Less <<
NCT02769494 Crohn's Disease ... More >> Oral Ulcer Less << Phase 3 Unknown January 2017 China, Shaanxi ... More >> Xijing Hospital Recruiting Xi'an, Shaanxi, China, 710032 Contact: Yongquan Shi, Ph. D    +86-29-84771515    shiyquan@fmmu.edu.cn Less <<
NCT03030703 Iron-deficiency ... More >> Iron Deficiency Anemia Less << Not Applicable Completed - United States, Kansas ... More >> Physical Activity and Nutrition Research Consortium Manhattan, Kansas, United States, 66502 Less <<
NCT02883478 Keratoconus C... More >>orneal Ectasia Less << Phase 1 Phase 2 Unknown August 2016 -
NCT03041883 Corneal Melting in Boston Kera... More >>toprosthesis Type I Less << Not Applicable Recruiting January 2023 Canada, Quebec ... More >> Centre Hospitalier de l'Université de Montréal Recruiting Montreal, Quebec, Canada, H2X3E4 Contact: Marie-Catherine Tessier    514 890-8000 ext 11550    marie-catherine.tessier.chum@ssss.gouv.qc.ca Less <<
NCT02921659 Aging Phase 1 Phase 2 Completed - United States, Colorado ... More >> Clinical Translational Research Center Boulder, Colorado, United States, 80309 Less <<
NCT03114215 ALS Amyotroph... More >>ic Lateral Sclerosis Motor Neuron Disease Less << Phase 2 Active, not recruiting December 2017 France ... More >> Hopital Gui De Chauliac Montpellier, France, 34000 Less <<
NCT03151239 Glucose Metabolism Disorders Not Applicable Recruiting June 1, 2020 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Sally Torbitzky, RN, BSN    314-362-9950    storbitz@wustl.edu    Contact: Mihoko Yoshino, MD    314-362-8228    myoshino@wustl.edu    Principal Investigator: Samuel Klein, MD Less <<
NCT03136705 Healthy Phase 1 Completed - United States, Illinois ... More >> Center for Translational Metabolism and Health (CTMH), Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT02950441 Aging Phase 2 Recruiting September 2019 United Kingdom ... More >> University Hospitals Birmingham NHS Foundation Trust Recruiting Birmingham, West Midlands, United Kingdom, B15 2TH Contact: Yasir Elhassan, MRCP    +441214158705    y.mohamedelhassan@bham.ac.uk Less <<
NCT03176628 Acute Kidney Injury Not Applicable Recruiting October 31, 2018 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02118 Contact: Petra Simic, MD, PhD    617-724-6700    psimic@bwh.harvard.edu    Contact: Katherine E Brock, BS    617-643-9463    kbrock2@mgh.harvard.edu    Principal Investigator: Eugene Rhee, MD          Sub-Investigator: Ravi I Thadhani, MD, MPH          Sub-Investigator: Petra Simic, MD, PhD Less <<
NCT03151707 Healthy Phase 4 Recruiting July 2019 United States, Massachusetts ... More >> Cagri Yuksel Recruiting Belmont, Massachusetts, United States, 02478 Contact: Cagri Yuksel, MD    617-855-2779    ayuksel@partners.org    Sub-Investigator: Cagri Yuksel, MD          Principal Investigator: Dost Ongur, MD, PhD Less <<
NCT03061474 Alzheimer's Disease ... More >> Mild Cognitive Impairment Less << Phase 2 Recruiting February 28, 2019 United States, California ... More >> University of California, Irvine Recruiting Irvine, California, United States, 92697 Contact: Beatriz Yanez, R.N    949-824-0008    byanez@uci.edu    Contact: Huong Nguyen    949-824-0008    huongtn2@uci.edu    Principal Investigator: Aimee Pierce, M.D.          University of California, Los Angeles Recruiting Los Angeles, California, United States, 90095 Contact: Celine Ossinalde, MA    310-794-6191    cossinalde@mednet.ucla.edu    Principal Investigator: Sarah Kremen, M.D. Less <<
NCT03190044 Migraine Disorders Not Applicable Recruiting December 31, 2019 Italy ... More >> Policlinico Umberto I Recruiting Rome, Italy, 00161 Contact: Cherubino Di Lorenzo, MD, PhD    +393286783246    cherubino.dilorenzo@uniroma1.it    Contact: Francesco Pierelli, MD       francesco.pierelli@uniroma1.it Less <<
NCT03187912 Keratoconus Phase 3 Recruiting - Austria ... More >> Medical University of Vienna, Department of Ophthalmology Recruiting Vienna, Austria, 1090 Less <<
NCT03260166 Cutaneous Lupus Erythematosus ... More >> Systemic Lupus Erythematosus Rash Less << Phase 2 Recruiting February 2019 China, Hunan ... More >> The Second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Xiangqi Tang, MD, PhD    +86-731-84896038    xiangyagcp@126.com    Principal Investigator: Qianjin Lu, MD, PhD          Sub-Investigator: Hai Long, MD, PhD Less <<
NCT03341286 Cancer Qualit... More >>y of Life Chemotherapy Effect Tryptophan Thiamine Less << Phase 2 Not yet recruiting May 2019 Brazil ... More >> Faculdade de medicina do ABC-CEPHO Not yet recruiting Santo André, SP, Brazil, 09060-870 Contact: Andressa Tamashiro    +551149935491    andressa@cepho.org.br    Principal Investigator: Daniel IG Cubero, MD          Sub-Investigator: Claudia VM Sette, MD          Sub-Investigator: Aline APR Lima, MD          Sub-Investigator: Auro Del giglio, MD Less <<
NCT03268902 Malnutrition ... More >>Stunting Cognitive Development Enteric Pathogens Less << Phase 2 Phase 3 Active, not recruiting December 2020 Tanzania ... More >> Haydom Lutheran Hospital Haydom, Manyara, Tanzania Less <<
NCT03419364 Preeclampsia Phase 2 Recruiting December 31, 2019 United States, North Carolina ... More >> UNC at Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Karen Dorman, RN    984-974-9012    kdorman@med.unc.edu    Principal Investigator: Kim Boggess, MD Less <<
NCT03416062 Jaundice; Malignant Phase 3 Active, not recruiting September 2019 Russian Federation ... More >> Irkutsk Regional Clinical Hospital Irkutsk, Russian Federation, 664079 North-West State Medical University named after I.I. Mechnikov Saint Petersburg, Russian Federation, 191015 Less <<
NCT03423342 Heart Failure, Systolic Phase 1 Phase 2 Recruiting June 30, 2019 United States, Washington ... More >> University of Washington Recruiting Seattle, Washington, United States, 98195 Contact: Kevin D O'Brien, MD    206-529-7802    cardiac@uw.edu    Contact: Rong Tian, MD    206 616-5672    rongtian@u.washington.edu Less <<
NCT03432572 Ureteral Injury Early Phase 1 Not yet recruiting March 1, 2019 -
NCT03482167 Mild Cognitive Impairment Phase 1 Phase 2 Not yet recruiting March 2022 United States, Delaware ... More >> Neurovascular Aging Laboratory Not yet recruiting Newark, Delaware, United States, 19713 Contact: Joshua Hobson, MS    302-831-8137    chs-novalab@udel.edu    Principal Investigator: Christopher R Martens, Ph.D. Less <<
NCT03432871 Mitochondrial Diseases ... More >> Mitochondrial Myopathies Progressive External Ophthalmoplegia Progressive Ophthalmoplegia Progressive; Ophthalmoplegia, External Mitochondria DNA Deletion MELAS Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome) Less << Not Applicable Recruiting May 30, 2019 United Kingdom ... More >> Cambridge University Hospitals NHS Foundation Trust Recruiting Cambridge, United Kingdom, CB20QQ Contact: Zoe McIntyre, MSc    0044 1223 331506    mitopatients@mrc-mbu.cam.ac.uk    Contact: Sarah Bird, MSc    0044 1223 331506    mitopatients@mrc-mbu.cam.ac.uk    Principal Investigator: Patrick F Chinnery, MD PhD Less <<
NCT03426553 Oncologic Disorders ... More >> Hematologic Diseases Less << Phase 3 Recruiting July 1, 2018 Russian Federation ... More >> Federal Research Center for pediatric hematology, oncology and immunology Recruiting Moscow, Russian Federation, 117997 Contact: Pavel Trakhtman       trakhtman@mail.ru    Contact: Irina Kumukova       irina_kumukova@mail.ru Less <<
NCT03418935 Jaundice, Obstructive Phase 3 Active, not recruiting September 2019 Russian Federation ... More >> Irkutsk Regional Clinical Hospital Irkutsk, Russian Federation, 664079 North-West State Medical University named after I.I. Mechnikov Saint Petersburg, Russian Federation, 191015 State Budgetary Health Care Institution "City Hospital № 26" Saint Petersburg, Russian Federation, 196247 "BioEk" Ltd. Saint Petersburg, Russian Federation, 197342 Leningrad Regional Clinical Hospital Saint Petersburg, Russian Federation Less <<
NCT03531047 Keratoconus Not Applicable Recruiting November 2021 United Kingdom ... More >> Moorfields Eye Hospital NHS Foundation Trust Recruiting London, United Kingdom, EC1V 2PD Contact: Lucy D Parker    020 7253 3411 ext 2036    moorfields.resadmin@nhs.net    Principal Investigator: Daniel M Gore, MD FRCOphth          Principal Investigator: Bruce D Allan, MD FRCOphth Less <<
NCT03245853 Keratoconus K... More >>eratoconus, Unstable Less << Phase 4 Enrolling by invitation September 30, 2018 United States, Ohio ... More >> Comprehensive EyeCare of Central Ohio Westerville, Ohio, United States, 43082 Less <<
NCT03562468 Cognitive Function ... More >> Mood Sleep Less << Not Applicable Active, not recruiting May 2019 United States, Florida ... More >> MB Clinical Research Boca Raton, Florida, United States, 33487 Less <<
NCT03442751 Progressive Keratoconus Phase 3 Recruiting June 30, 2020 United States, California ... More >> Stanford University School of Medicine Recruiting Palo Alto, California, United States, 94303 Contact: Theresa Enriquez    650-498-4573    Tenriquez@stanfordhealthcare.org    Principal Investigator: Edward Manche, MD          United States, Florida Bascom Palmer Eye Institute Recruiting Miami, Florida, United States, 33136 Contact: Maria Esquiabro    305-326-6508    esquiabro@med.miami.edu    Principal Investigator: Sonia Yoo, MD          United States, Massachusetts Ophthalmic Consultants of Boston Recruiting Waltham, Massachusetts, United States, 02451 Contact: Joanne Berry    617-314-2703    jberry@eyeboston.com    Principal Investigator: Michael Raizman          United States, Minnesota Chu Vision Institute Recruiting Bloomington, Minnesota, United States, 55420 Contact: Nic Jacobs    952-835-6379    nic.jacobs@chuvision.com    Principal Investigator: Y. Ralph Chu, MD          Minnesota Eye Consultants Recruiting Minnetonka, Minnesota, United States, 55305 Contact: Amanda Devers    952-567-6198    aldevers@mneye.com    Principal Investigator: Sherman Reeves, MD          United States, Ohio Comprehensive EyeCare of Central Ohio Recruiting Westerville, Ohio, United States, 43082 Contact: Donna Coury    614-890-5692    dcoury@compeyecare.com    Principal Investigator: Kenneth Beckman          United States, Pennsylvania Vantage Eye Care, LLC Recruiting Bala-Cynwyd, Pennsylvania, United States, 19004 Contact: Cathy Petrocella, COT    484-434-2606    CPetrocella@oppdoctors.com    Principal Investigator: Brandon Ayres          United States, South Carolina David Vroman Not yet recruiting Ladson, South Carolina, United States, 29456 Contact: Margaret Bozic    843-797-3676    mbozic@carolinacataract.com    United States, South Dakota Vance Thompson Vision Recruiting Sioux Falls, South Dakota, United States, 57108 Contact: Keeley Puls    605-371-7065    keeley.puls@vancethompsonvision.com    Principal Investigator: John Berdahl, MD          United States, Texas Slade and Baker Vision Center Recruiting Houston, Texas, United States, 77027 Contact: Chadisty M Pauly    713-626-5544    chad@visiontexas.com    Principal Investigator: Stephen G Slade, MD          Focal Point Vision Recruiting San Antonio, Texas, United States, 78209 Contact: Lisa Navarro    210-614-3600 ext 118    navarro@focalpointvision.com    Principal Investigator: James Lehmann, MD          United States, Utah Hoopes Vision Recruiting Draper, Utah, United States, 84020 Contact: Michele Avila, OD    801-568-0200    mavila@hoopesvision.com    Principal Investigator: Majid Moshifar          United States, Virginia See Clearly Vision Group Recruiting McLean, Virginia, United States, 22102 Contact: Jenny Suy    703-827-4125    jsuy@seeclearly.com    Principal Investigator: Khoa D Hoang Less <<
NCT03501433 Aging Lipemia Not Applicable Recruiting December 2018 United States, Iowa ... More >> Iowa State University Recruiting Ames, Iowa, United States, 50011 Contact: Rudy Valentine, Ph.D.    515-294-3867    rvalenti@iastate.edu    Principal Investigator: Rudy Valentine, Ph.D. Less <<
NCT03565328 Heart Failure Phase 2 Recruiting June 1, 2021 United States, Maryland ... More >> Walter Reed National Military Medical Center Recruiting Bethesda, Maryland, United States, 20889 Contact: Autumn Mains, B.A.    410-627-3494    autumn.mains.ctr@usuhs.edu    National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT03608813 - Completed - -
NCT03685253 Diabetic Neuropathy Peripheral Phase 1 Phase 2 Not yet recruiting October 1, 2023 United States, Maryland ... More >> University of Maryland Not yet recruiting Baltimore, Maryland, United States, 21201 Contact: Neda M Ilieva, B.S.    410-328-6583    inmed@som.umaryland.edu    Contact: James W Russell, MD    (410) 328-3100    jrussell@som.umaryland.edu    Principal Investigator: James W Russell, MD          Sub-Investigator: Lindsay A Zilliox, MD Less <<
NCT03635411 Recovery of Function Phase 1 Not yet recruiting January 2020 -
NCT03727646 Heart Failure，Congestive ... More >> Heart Failure New York Heart Association Class IV Mitochondrial Alteration Less << Early Phase 1 Recruiting July 26, 2019 United States, Washington ... More >> University of Washington Recruiting Seattle, Washington, United States, 98195 Contact: Kevin D O'Brien, MD    206-529-7802    cardiac@uw.edu    Contact: Rong Tian, MD    206 616-5672    rongtian@u.washington.edu Less <<
NCT03754842 Muscle Injury Not Applicable Not yet recruiting July 1, 2020 -
NCT03760770 Keratoconus C... More >>rosslinking Less << Not Applicable Recruiting February 1, 2019 Mexico ... More >> Instituto de oftalmología conde de Valenciana Recruiting Mexico City, Mexico, 06800 Contact: Enrique Graue Hernandez, MD MSc    +52 5554421700 ext 3710    egraueh@gmail.com    Contact: Laura Toro, MD    +52 5554421700 ext 3710    lauratorog@hotmail.com Less <<
NCT03598634 Keratoconus Not Applicable Completed - -
NCT03568968 Parkinson Disease Not Applicable Not yet recruiting October 1, 2021 -
NCT03761511 Friedreich Ataxia Phase 2 Not yet recruiting December 2020 Germany ... More >> University Hospital RWTH Aachen Not yet recruiting Aachen, Germany, 52074 Contact: Jörg B. Schulz, Univ.-Prof.       jschulz@ukaachen.de Less <<
NCT03757585 Non-verbal Learning Disorder ... More >> Autism Spectrum Disorder Autism Less << Phase 4 Not yet recruiting December 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Not yet recruiting Boston, Massachusetts, United States, 02114 Contact: Abigail Farrell, BS    617-643-6617    aefarrell@partners.org    Contact: Elizabeth Noyes, BA    617-726-4651    enoyes@partners.org    Principal Investigator: Janet Wozniak, MD Less <<
NCT03624556 Down Syndrome ... More >> Fragile X Syndrome Less << Not Applicable Recruiting September 1, 2019 Spain ... More >> IMIM (Institut Hospital del Mar d'Investigacions Mèdiques) Recruiting Barcelona, Spain, 08003 Contact: Rafael De la Torre Fornell, PhD    0034933160484    rtorre@imim.es    Principal Investigator: Rafael de la Torre, PhD Less <<
NCT03769285 Non-melanoma Skin Cancer ... More >> Carcinoma, Squamous Cell Carcinoma, Basal Cell Less << Phase 2 Recruiting December 2020 Canada, Ontario ... More >> Toronto General Hospital, University Health Network Recruiting Toronto, Ontario, Canada, M5G 2N2 Contact: Ashley Lau, BMRSc    416-351-3732 ext 2706    ashley.lau@wchospital.ca Less <<
NCT02128802 Severe Obesity ... More >> Renal Failure Less << Not Applicable Recruiting April 2019 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Principal Investigator: Seth Karp, MD Less <<
NCT00237718 End-stage Renal Disease Phase 2 Completed - United States, Tennessee ... More >> Fresenius Medical Care North America Nashville, Tennessee, United States, 37215 Less <<
NCT00101894 Rectal Cancer ... More >> Colon Cancer Less << Phase 1 Completed - -
NCT01709123 Diabetes Mellitus, Type 1 Not Applicable Unknown September 2013 United States, Louisiana ... More >> Louisiana State University Health Sciences Center in Shreveport Recruiting Shreveport, Louisiana, United States, 71130 Contact: Sushil K Jain, Ph.D.    318-675-6086    sjain@lsuhsc.edu    Sub-Investigator: Robert McVie, M.D.          Sub-Investigator: Tommie Stapleton, RN, CCRC          Sub-Investigator: Cynthia Brewer, RN          Sub-Investigator: John Rowell, RN, MSN          Sub-Investigator: Henry R McKnight, RPH          Sub-Investigator: Pat F Bass, M.D.          Sub-Investigator: Shikha Mane, M.D.          Sub-Investigator: David Micinski, BS          Sub-Investigator: Neslihan Gungor, M.D. Less <<
NCT02157207 Healthy Not Applicable Completed - United States, Illinois ... More >> University of Illinois - Chicago Chicago, Illinois, United States, 60612 Less <<
NCT02636582 Ductal Breast Carcinoma In Sit... More >>u HLA-A2 Positive Cells Present Postmenopausal Premenopausal Less << Phase 2 Recruiting - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Elizabeth A. Mittendorf    617-582-9980    emittendorf@bwh.harvard.edu    Principal Investigator: Elizabeth A. Mittendorf          United States, New York Columbia University/Herbert Irving Cancer Center Active, not recruiting New York, New York, United States, 10032 United States, Pennsylvania Thomas Jefferson University Hospital Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Adam C. Berger    215-955-1622    Adam.Berger@jefferson.edu    Principal Investigator: Adam C. Berger          United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Powel H. Brown    713-792-4509    phbrown@mdanderson.org    Principal Investigator: Powel H. Brown Less <<
NCT00117403 Alzheimer's Disease Phase 1 Completed - United States, Arizona ... More >> University of Arizona Tucson, Arizona, United States, 85724 United States, California University of California- Irvine Irvine, California, United States, 92697 University of California, San Diego La Jolla, California, United States, 92037 University of California, Los Angeles Los Angeles, California, United States, 90095 United States, Florida Wien Center, Mount Sinai Medical Center Miami Beach, Florida, United States, 33140 United States, Kentucky University of Kentucky Lexington, Kentucky, United States, 40536 United States, New Jersey University of Medicine and Dentistry of New Jersey Piscataway, New Jersey, United States, 08855 United States, New York Neurological Care of CNY Syracuse, New York, United States, 13210 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44120 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97239 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Medical University of South Carolina North Charleston, South Carolina, United States, 29406 United States, Washington University of Washington Seattle, Washington, United States, 98108 Less <<
NCT03216980 Post Traumatic Stress Disorder Not Applicable Recruiting May 15, 2019 United States, Virginia ... More >> Virginia Commonwealth University Recruiting Richmond, Virginia, United States, 23298 Less <<
NCT01793090 Methylmalonic Aciduria and Hom... More >>ocystinuria,Cblc Type Genetic Disease Retinopathy Less << Phase 2 Completed - Italy ... More >> Bambino Gesù Hospital and Research Institute Rome, Italy, 00165 Less <<
NCT02312466 - Completed - Switzerland ... More >> Human Nutrition Laboratory, ETH Zurich Zurich, Switzerland, 8092 Less <<
NCT00237718 - Completed - -
NCT02690064 Cystic Fibrosis Not Applicable Recruiting December 2018 United States, Georgia ... More >> Georgia Prevention Institute Recruiting Augusta, Georgia, United States, 30912 Contact: Ryan Harris, Ph.D.    706-721-5998    ryharris@gru.edu    Contact: Nichole Seigler, BA    706-721-5998    maseigler@gru.edu Less <<
NCT00995085 Attention Deficit Hyperactivit... More >>y Disorder Less << Phase 1 Completed - Israel ... More >> ADHD Unit, Geha MHC, Israel Petach Tikva, Israel Less <<
NCT03283813 Obesity, Childhood ... More >> Insulin Resistance Zinc Deficiency Inositol Less << Phase 4 Recruiting December 31, 2019 Italy ... More >> AOU Maggiore della Carità - Clinica Pediatrica - Ambulatorio di Auxologia ed Endocrinologia Pediatrica Recruiting Novara, Italy, 28100 Contact: Simonetta Bellone, Professor    0390321660693    simonetta.bellone@med.uniupo.it Less <<
NCT00345618 Embolism Thro... More >>mbosis Less << Phase 3 Completed - -
NCT00225160 HIV Infections ... More >> Distal Symmetric Polyneuropathy Less << Phase 2 Unknown - United Kingdom ... More >> Royal Free Hospital London, United Kingdom, NW3 2QG Less <<
NCT01791647 Polycystic Ovary Syndrome Not Applicable Unknown - Italy ... More >> Catholic University of Sacred Heart Recruiting Rome, Italy, 00168 Contact: Maurizio Guido, Medical Doctor    063057794       Principal Investigator: Maurizio Guido, Medical Doctor Less <<
NCT02077751 Anemia Phase 1 Active, not recruiting June 2018 United States, Iowa ... More >> University of Iowa Iowa City, Iowa, United States, 52242 Less <<
NCT01243242 ADHD Phase 2 Completed - Israel ... More >> Cognitive Neurology unit Rambam Health Care Campus Haifa, Israel ADHD Unit, Geha Mental Health Center Petah Tikva,, Israel Less <<
NCT01243242 - Completed - -
NCT00995085 - Completed - -
NCT02954588 Abdominal Obesity Metabolic Sy... More >>ndrome Less << Not Applicable Recruiting February 2019 Netherlands ... More >> Maastricht University Medical Center Recruiting Maastricht, Netherlands, 6200MD Contact: Mathias Van den Eynde    +31 (0) 433884250    m.vandeneynde@maastrichtuniversity.nl Less <<
NCT00592488 Septic Shock Phase 1 Phase 2 Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00592488 - Completed - -
NCT03034707 Thoracic Diseases ... More >> Parathyroid Diseases Less << Not Applicable Active, not recruiting December 2018 -
NCT01685281 ADHD Predominantly Inattentive... More >> Type Less << Phase 2 Completed - Israel ... More >> Geha Medical Centre Petah Tiqva, Israel Less <<
NCT00775645 Breast Cancer ... More >> Chemotherapeutic Agent Toxicity Fatigue Neuropathy Neurotoxicity Less << Phase 3 Completed - -
NCT01980407 Gastric Cancer Phase 2 Unknown March 2016 China, Jilin ... More >> Jilin Provincial Tumor Hospital Recruiting Changchun, Jilin, China Less <<
NCT01933997 Healthy Adult Subjects Phase 1 Completed - Israel ... More >> Clinical research center Souraski medical center Tel Aviv, Israel Less <<
NCT02051842 NAFLD Pre-dia... More >>betes Less << Phase 4 Unknown January 2017 Mexico ... More >> Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" Recruiting Mexico City, Mexico, 14000 Contact: Aldo Torre, M.D, M.Sc.    54870900 ext 2711    detoal@yahoo.com    Principal Investigator: Aldo Torre, MD MSci Less <<
NCT00775645 - Completed - -
NCT02059642 ADHD Attentio... More >>n-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type Less << Phase 2 Phase 3 Completed - United States, Florida ... More >> Sarkis Clinical Trials Gainesville, Florida, United States, 32607 Miami Research South Miami, Florida, United States, 33173 United States, Illinois Capstone Clinical Research Libertyville, Illinois, United States, 60048 United States, Kansas Psychiatric Associates Overland Park, Kansas, United States, 66211 United States, Kentucky University Kentucky Psychiatry Lexington, Kentucky, United States, 40509 United States, Massachusetts Pediatric Psychopharmacology & Adult ADHD Program, Massachusetts General Hospital Boston, Massachusetts, United States, 21144 United States, Michigan Rochester Center For Behavioral Medicine Rochester Hills, Michigan, United States, 48307 Behavioral Medicine Center Troy, Michigan, United States, 48083 United States, Missouri St. Charles Psychiatric Associates St. Charles, Missouri, United States, 63301 United States, Nevada Center for Psychiatry and Behavioral Medicine Las Vegas, Nevada, United States, 89128 United States, New York Bioscience Research Mount Kisco, New York, United States, 10549 United States, North Carolina Duke University Durham, North Carolina, United States, 27705 Richard H Weisler, MD, PA Raleigh, North Carolina, United States, 27609 United States, Pennsylvania Sequoia Behavioral Healthcare Media, Pennsylvania, United States, 19063 United States, Texas FutureResearch Trials Austin, Texas, United States, 78731 FutureResearch Trials Dallas, LP Dallas, Texas, United States, 75231 Bayou City Research Houston, Texas, United States, 77007 United States, Virginia NeuroScience, Inc. (NSI) Herndon, Virginia, United States, 20170 Israel Neurocognitive unit Rambam MC Haifa, Israel ADHD unit Geha MC Petach Tikva, Israel Less <<
NCT02019056 Alcoholic Fatty Liver Disease ... More >> Alcoholic Hepatitis Less << Phase 2 Completed - Korea, Republic of ... More >> Hanyang university Hospital Guri city, Gyeonggi-do, Korea, Republic of, 471-701 Less <<
NCT02059642 - Completed - -
NCT00054340 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00057811 Childhood Burkitt Lymphoma ... More >> Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Stage I Childhood Large Cell Lymphoma Stage I Childhood Small Noncleaved Cell Lymphoma Stage II Childhood Large Cell Lymphoma Stage II Childhood Small Noncleaved Cell Lymphoma Stage III Childhood Large Cell Lymphoma Stage III Childhood Small Noncleaved Cell Lymphoma Stage IV Childhood Large Cell Lymphoma Stage IV Childhood Small Noncleaved Cell Lymphoma Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 2 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00058461 B-cell Childhood Acute Lymphob... More >>lastic Leukemia Childhood Burkitt Lymphoma Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma L3 Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Less << Phase 2 Terminated - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT02126995 Fragile X Syndrome Phase 2 Completed - United States, Arizona ... More >> Southwest Autism Research & Resource Center Phoenix,, Arizona, United States, 85006 United States, California University of California Davis Pediatrics Sacramento,, California, United States, 95817 United States, Colorado Children's Hospital Colorado Aurora,, Colorado, United States, 80045 United States, Illinois RUSH University Medical Center Chicago,, Illinois, United States, 60612 United States, Maryland Kennedy Krieger Institute Baltimore,, Maryland, United States, 21205 United States, Massachusetts Boston Children's Hospital Boston, Massachusetts, United States, 02115 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Cincinnati Children's Hospital Cincinnati,, Ohio, United States, 45229 United States, Pennsylvania Suburban Research Associates Media,, Pennsylvania, United States, 19063 United States, Texas Baylor College of Medicine Research Houston,, Texas, United States, 77030 United States, Washington Univ. of Washington/Seattle Children's Hospital Seattle,, Washington, United States, 98121 Israel Sheba Academic Medical Center Ramat Gan, Israel Less <<
NCT00057811 - Completed - -
NCT00002835 Lymphoma Phase 3 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT00003436 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 3 Completed - United Kingdom ... More >> Christie Hospital N.H.S. Trust Manchester, England, United Kingdom, M20 4BX Less <<
NCT00003311 Lymphoma Phase 2 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT00059839 Lymphoma Phase 3 Completed - -
NCT00059839 - Completed - -
NCT00005086 Bladder Cancer Phase 2 Completed - United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Louis A. Weiss Memorial Hospital Chicago, Illinois, United States, 60640 Oncology/Hematology Associates of Central Illinois, P.C. Peoria, Illinois, United States, 61602 United States, Indiana Fort Wayne Medical Oncology and Hematology, Inc. Fort Wayne, Indiana, United States, 46885-5099 Less <<
NCT00059865 Extrahepatic Bile Duct Cancer ... More >> Gallbladder Cancer Liver Cancer Less << Phase 1 Phase 2 Completed - -
NCT00061451 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Palo Alto, California, United States United States, Missouri For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Columbia, Missouri, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kansas City, Missouri, United States United States, Montana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Great Falls, Montana, United States United States, Washington For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seattle, Washington, United States Less <<
NCT00061464 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - United States, Florida ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Miami, Florida, United States United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Chicago, Illinois, United States United States, Louisiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Shreveport, Louisiana, United States United States, South Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Columbia, South Carolina, United States Less <<
NCT00061945 Acute Undifferentiated Leukemi... More >>a B-cell Adult Acute Lymphoblastic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia L1 Adult Acute Lymphoblastic Leukemia L1 Childhood Acute Lymphoblastic Leukemia L2 Adult Acute Lymphoblastic Leukemia L2 Childhood Acute Lymphoblastic Leukemia Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia T-cell Adult Acute Lymphoblastic Leukemia T-cell Childhood Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Less <<
NCT01616654 Acne Vulgaris Phase 2 Completed - -
NCT02775266 Diabetes Mellitus ... More >> Periodontitis Less << Not Applicable Completed - India ... More >> Mohans Diabetic Centre Hyderabad, Telangana, India, 500029 Less <<
NCT02809456 Radiation Pneumonitis Phase 2 Enrolling by invitation December 2019 -
NCT00061477 Mesothelioma Phase 2 Completed - United States, Colorado ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tampa, Florida, United States United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States United States, Massachusetts For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Boston, Massachusetts, United States United States, Michigan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Detroit, Michigan, United States United States, New Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Albuquerque, New Mexico, United States United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New York, New York, United States United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cleveland, Ohio, United States United States, Pennsylvania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Philadelphia, Pennsylvania, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pittsburgh, Pennsylvania, United States Less <<
NCT03775395 Hepatocellular Carcinoma Phase 3 Recruiting December 1, 2021 China, Guangdong ... More >> Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD    8620-87343115    shiming@mail.sysu.edu.cn Less <<
NCT02863809 Keratolysis Phase 1 Phase 2 Recruiting March 2020 United States, California ... More >> The Jules Stein Eye Institute Recruiting Los Angeles, California, United States, 90095-7003 Contact: Ellen Pascual       pascual@jsei.ucla.edu    Principal Investigator: Anthony Aldave, MD          UC Davis Health System Eye Center Recruiting Sacramento, California, United States, 95817 Contact: Denise Macias    916-734-6303    dcmacias@ucdavis.edu    Principal Investigator: Mark Mannis, MD          Shiley Eye Institute, University of California, San Diego Recruiting San Diego, California, United States, 92093 Contact: Natalie Afshari, MD          Principal Investigator: Natalie Afshari, MD, FACS          United States, Florida Bascom Palmer eye Institute Not yet recruiting Miami, Florida, United States, 33136 Contact: Marisa Braun       mxb1423@med.miami.edu    Principal Investigator: Victor Perez, MD          United States, Illinois Illinois Eye and Ear Infirmary Recruiting Chicago, Illinois, United States, 60612 Contact: Roxy Ng    312-355-4866    rtoh@uic.edu    Principal Investigator: Jose De La Cruz, MD          United States, Kentucky Cincinnati Eye Institute Recruiting Edgewood, Kentucky, United States, 41017 Contact: Rachel Crabtree    859-331-9000 ext x4120    rcrabtree@cincinattieye.com    Principal Investigator: Edward Holland, MD          United States, Maryland Wilmer Eye Institute Recruiting Baltimore, Maryland, United States, 21287 Contact: Shanna Ingrodi    410-955-5214    singrod1@jhmi.edu    Principal Investigator: Esen Akpek, MD          United States, Michigan W.K. Kellogg Eye Center Recruiting Ann Arbor, Michigan, United States, 48105 Contact: Munira Hussain    734-647-8397    hussain@umich.edu    Principal Investigator: Shahzad Mian, MD          United States, Missouri Tauber Eye Center Recruiting Kansas City, Missouri, United States, 64111 Contact: Megan Hefter    816-531-9100    mh@taubereye.com    Principal Investigator: Joseph Tauber, MD          United States, New York David and Ilene Flaum Eye Institute, University of Rochester Recruiting New York, New York, United States, 14642 Contact: Olga Pikul    585-273-3937    olga.pikul@rochester.edu    Principal Investigator: James Aquavella, MD          United States, Ohio University Hospitals Eye Institute Not yet recruiting Cleveland, Ohio, United States, 44106 Contact: Sangeetha Raghupathy       Sangeetha.Raghupathy@UHhospitals.org    Principal Investigator: Pankaj Gupta, MD, MS          United States, Pennsylvania Wills Eye Recruiting Bala-Cynwyd, Pennsylvania, United States, 19007 Contact: Cathy Petrocella    484-434-2706    cpetrocella@oppdoctors.com    Contact: Aditya Kanesa-thasan, MD    484-434-2706    adityakanesa@gmail.com    United States, Texas Wilford Hall Ambulatory Surgical Center (WHASC) Not yet recruiting Lackland Air Force Base, Texas, United States, 78236 Contact: Douglas Apsey    210-292-2554    Douglas.apsey.2.ctr@us.af.mil    Principal Investigator: Richard Townley, MD Less <<
NCT00061945 - Completed - -
NCT02886702 - Completed - -
NCT02837367 Obesity Dysli... More >>pidemia Less << Not Applicable Recruiting September 2019 Romania ... More >> Clinica II Pediatrie Bega Recruiting Timisoara, Timis, Romania Contact: Iulian Velea, MD, PhD    0771522781    ivelea@umft.ro    Spitalul Judetean Timisoara; Centrul de Diabet Recruiting Timisoara, Timis, Romania Contact: Alexandra Sima, MD, PhD    0770727169    alexa_moisuc@yahoo.com Less <<
NCT02973685 HepatoCellular Carcinoma Phase 3 Recruiting October 2019 China, Guangdong ... More >> Dongguan People's Hospital Recruiting Dongguan, Guangdong, China, 523059 Contact: Wusheng Yu, MD    13827285010    yuwusheng1998@126.com    Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD    8620-87343115    shiming@mail.sysu.edu.cn    The First Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Guosheng Tan, MD    13725254145    tgs1976@163.com    Guangzhou Twelfth People's Hospital Recruiting Guangzhou, Guangdong, China, 510620 Contact: Yuanmin Zhou, MD    15521278919    13430288977@139.com    Principal Investigator: Jinghua Chen, MD          Kaiping Central Hospital Recruiting Kaiping, Guangdong, China, 529300 Contact: Shijie Zhang, MD    13717287622    Shijie_9262511@163.com    China, Hunan The First Affiliated Hospital of University Of South China Recruiting Hengyang, Hunan, China, 421001 Contact: Xiaoping Wu, MD    13975486015    wxp19730806@sina.com    China, Shanxi The First Affiliated Hospital Of Xi'an Jiaotong University Recruiting Xi'an, Shanxi, China, 710061 Contact: Xin Zheng, MD    13649265446    183421344@qq.com Less <<
NCT02971878 Culture Media ... More >> Blastocyst Antioxidants Embryo Human Less << Not Applicable Completed - Sweden ... More >> Fertilitetscentrum Gothenburg, Box 5418, Sweden, 40229 Less <<
NCT03010423 Non-obstructive Coronary Arter... More >>y Disease Less << Phase 4 Recruiting July 30, 2019 China ... More >> Peking union medical college hospital Recruiting Beijing, China Contact    +49 6151 72 5200    service@merckgroup.com Less <<
NCT02088970 Bacterial Keratitis ... More >> Fungal Keratitis Less << Not Applicable Terminated(Difficulties in rea... More >>ching the desired number of patients and intermediate analysis leading to discontinuation of the study.) Less << - France ... More >> Orignac Nantes, France, 44000 Less <<
NCT03048123 Hepatocellular Carcinoma Phase 2 Completed - China, Guangdong ... More >> Cancer Center Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Less <<
NCT03439436 Nasal Congestion Phase 3 Completed - Russian Federation ... More >> Railways clinical hospital n.a.Semashko at Lublino station JSC "RZD" Moscow, Russian Federation, 109386 City Polyclinic #2 Moscow, Russian Federation, 117556 First Moscow State Medical University n. a. I. M. Sechenov Moscow, Russian Federation, 119991 "Scientific and Research centre Eco-safety" Limited Liability Company St Petersburg, Russian Federation, 196143 The First St. Petersburg state medical University n.a. Acad. I. P. Pavlov St Petersburg, Russian Federation, 197022 Less <<
NCT03445728 Myocardial Infarction ... More >> Percutaneous Coronary Intervention Nicorandil Less << Phase 4 Enrolling by invitation December 31, 2021 China ... More >> CHINA Beijing, China Less <<
NCT02160665 Plaque Psoriasis Phase 3 Completed - United States, Illinois ... More >> Altman Dermatology Associates Arlington Heights, Illinois, United States, 60005 Less <<
NCT00147732 Larynx Carcinoma Phase 3 Completed - Netherlands ... More >> Free University Medical Centre Amsterdam, Netherlands University Medical Centre Groningen Groningen, Netherlands Leids University Medical Centre Leiden, Netherlands Maastro Clinic Maastricht, Netherlands Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500 HB University Medical centre Utrecht Utrecht, Netherlands United Kingdom Mount Vernon Hospital Northwood, Middlesex, United Kingdom Less <<
NCT00140166 Acute Schizophrenia Phase 4 Completed - Israel ... More >> Beersheva Mental Health Center Beersheva, Israel Less <<
NCT02160678 Acne Vulgaris Phase 3 Completed - United States, Illinois ... More >> Altman Dermatology Associates Arlington Hts., Illinois, United States, 60005 Less <<
NCT03446599 Vasoplegia Hy... More >>potension Coronary Artery Disease Cardiac Valve Disease Less << Phase 2 Not yet recruiting June 30, 2019 United States, New Hampshire ... More >> Dartmouth-Hitchcock Not yet recruiting Lebanon, New Hampshire, United States, 03756 Contact: Ying Low, MD    603-650-6672    ying.h.low@hitchcock.org    Contact: Athos J Rassias, MD    603.650.5922    athos.j.rassias@hitchcock.org    Sub-Investigator: Aaron J Mancuso, MD          Sub-Investigator: Peter S Burrage, MD          Sub-Investigator: Brian C Spence, MD          Sub-Investigator: Alexander Iribarne, MD Less <<
NCT02218034 Acne Vulgaris Phase 1 Completed - United States, Texas ... More >> College Station, Texas, United States Less <<
NCT00238004 HDL Cholesterol ... More >> Coronary Arteriosclerosis Lipoproteins Less << Phase 4 Unknown - United Kingdom ... More >> Craigavon Cardiac Centre Craigavon, United Kingdom Less <<
NCT00202228 HIV Infections ... More >> AIDS Lactic Acidosis Lipodystrophy Less << Phase 4 Completed - Canada, Ontario ... More >> Queen's University Kingston, Ontario, Canada, K7L 3N6 Less <<
NCT02235480 Nail Psoriasis Phase 2 Completed - Germany ... More >> Investigational site 3 Berlin, Germany Investigational site 4 Berlin, Germany Investigational 2 Hamburg, Germany Investigational site 1 Hamburg, Germany Less <<
NCT02267746 Acne Vulgaris Phase 3 Completed - United States, California ... More >> Encino, California, United States, 91436 Center for Dermatology Clinical Research Fremont, California, United States, 94538 United States, Florida Moore Clinical Research Brandon, Florida, United States, 33511 LCC Medical Research Institute Miami, Florida, United States, 33126 International Dermatology Research Miami, Florida, United States, 33144 FXM Research Corp Miami, Florida, United States, 33175 FXM Research Miramar Miramar, Florida, United States, 33027 Moore Clinical Research Tampa, Florida, United States, 33609 Moore Clinical Research Tampa, Florida, United States, 33618 Atlantic Clinical Research Collaborative Wellington, Florida, United States, 33414 United States, Rhode Island Omega Medical Research Warwick, Rhode Island, United States, 02886 United States, Texas Research Across America Dallas, Texas, United States, 75234 Research Across America Plano, Texas, United States, 75093 United States, Utah Dermatology Research Center Salt Lake City, Utah, United States, 84117 Belize FXM International Belize City, Belize Less <<
NCT03579693 Chronic Kidney Disease ... More >> Sarcopenia Frailty Less << Phase 2 Recruiting April 2020 United States, Washington ... More >> University of Washington Recruiting Seattle, Washington, United States, 98104 Contact: Kidney Research Institute    206-616-8574    info@kri.washington.edu Less <<
NCT03629613 Cardiovascular Diseases Not Applicable Not yet recruiting August 1, 2019 -
NCT00316472 Hyperphosphatemia Phase 1 Completed - United States, Missouri ... More >> Washington University Medical Center Saint Louis, Missouri, United States, 63110 Less <<
NCT02411955 Acne Vulgaris Phase 1 Completed - -
NCT00373295 Marijuana Dependence Phase 2 Completed - United States, New York ... More >> New York State Psychiatric Institute New York, New York, United States, 10032 Less <<
NCT02514200 Keratoconus Phase 2 Active, not recruiting October 2019 -
NCT02303483 Obese Not Applicable Completed - Denmark ... More >> Medical Research Laboratories, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT00311090 Deep Venous Thrombosis Phase 3 Completed - -
NCT00373295 - Completed - -
NCT01368887 Psoriasis Phase 2 Suspended(Sponsor seeking addi... More >>tional financial support before starting the study) Less << April 2014 United States, Massachusetts ... More >> Boston VA Hospital Boston, Massachusetts, United States, 02130 Brockton VA Hospital Brockton, Massachusetts, United States, 02301 Less <<
NCT00176020 Healthy Phase 1 Unknown - -
NCT01379976 Non Small Cell Lung Cancer Phase 3 Terminated(Recruitment was pre... More >>maturely stopped due to difficulty of recruitment encountered by the experimental centers) Less << - Italy ... More >> Istituto Oncologico del Mediterraneo Viagrande, CT, Italy, 95029 Azienda Ospedaliera Ospedale S. Anna Como, Italy, 22020 Azienda Ospedaliera Istituti Ospitalieri Cremona, Italy, 26100 Azienda Ospedaliera di Desio e Vimercate - Presidio Ospedaliero di Desio Desio, Italy, 20832 Ospedale Civile Guastalla, Italy, 42016 Ospedale Alessandro Manzoni Lecco, Italy, 23900 Azienda Ospedaliera Ospedale Civile di Legnano Legnano, Italy, 20025 Azienda Ospedaliera Fatebenefratelli e Oftalmico Milano, Italy, 20121 Istituto Europeo Di Oncologia Milano, Italy, 20141 Azienda Ospedaliera San Paolo Milano, Italy, 20142 Azienda Ospedaliera Ospedale San Carlo Borromeo Milano, Italy, 20153 Azienda Ospedaliero Universitaria di Parma Parma, Italy, 43126 Fondazione Salvatore Maugeri Pavia, Italy, 0381 33329 Azienda Ospedaliera Perugia Perugia, Italy, 06075 Arcispedale S. Maria Nuova Reggio Emilia, Italy, 42100 IRCCS di Reggio Emilia Reggio Emilia, Italy, 42123 Azienda Ospedaliera Busto Arsizio - Presidio Ospedaliero di Saronno Saronno, Italy, 21047 Ospedale SS Annunziata - ASL1 Sassari, Italy, 07100 Azienda Ospedaliera Valtellina e Valchiavenna , Presidio Ospedaliero di Sondrio Sondrio, Italy, 23100 Azienda Ospedaliera di Pavia, Ospedale Civile di Vigevano Vigevano, Italy, 27029 Azienda Ospedaliera di Desio e Vimercate - Presidio Ospedaliero di Vimercate Vimercate, Italy, 20059 Less <<
NCT02525822 Acne Vulgaris Phase 2 Unknown June 2016 -
NCT00435799 Keratoconus Phase 2 Phase 3 Unknown January 2010 Norway ... More >> Eye dpt, Ullevål University Hospital Recruiting Oslo, Norway, N-0407 Contact: Liv Drolsum, Prof MD PhD    +47 22118545    liv.drolsum@uus.no    Contact: Espen F Bakke, MD    +47 22118545    espen.bakke@medisin.uio.no    Principal Investigator: Liv Drolsum, Prof MD PhD          Eye dpt, University Hospital North Norway Recruiting Tromsø, Norway, No-9037 Contact: Aleksandar Stojanovic, MD    +47 77 64 79 20    aleks@online.no    Principal Investigator: Aleksandar Stojanovic, MD Less <<
NCT00508885 Hyperphosphatemia Phase 1 Phase 2 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT02886715 Acne Vulgaris Phase 3 Completed - United States, Arizona ... More >> Fougera Investigational Site Tucson, Arizona, United States, 85712 United States, Arkansas Fougera Investigational Site Conway, Arkansas, United States, 72034 Fougera Investigational Site Hot Springs, Arkansas, United States, 71913 United States, California Fougera Investigational Site Anaheim, California, United States, 92801 Fougera Investigational Site La Mesa, California, United States, 91942 Fougera Investigational Site Long Beach, California, United States, 90806 Fougera Investigational Site Long Beach, California, United States, 90813 Fougera Investigational Site Los Angeles, California, United States, 90010 Fougera Investigational Site North Hollywood, California, United States, 91606 Fougera Investigational Site San Diego, California, United States, 92108 Fougera Investigational Site San Ramon, California, United States, 94582 Fougera Investigational Site Upland, California, United States, 91786 Fougera Investigational Site West Covina, California, United States, 91790 United States, Florida Fougera Investigational Site Coral Gables, Florida, United States, 33134 Fougera Investigational Site Miami Gardens, Florida, United States, 33169 Fougera Investigational Site Miami, Florida, United States, 33015 Fougera Investigational Site Miami, Florida, United States, 33175 Fougera Investigational Site Miramar, Florida, United States, 33027 Fougera Investigational Site Sweetwater, Florida, United States, 33172 United States, Indiana Fougera Investigational Site Plainfield, Indiana, United States, 46168 United States, North Carolina Fougera Investigational Site High Point, North Carolina, United States, 27262 United States, Pennsylvania Fougera Investigational Site Hazleton, Pennsylvania, United States, 18201 Fougera Investigational Site Upper Saint Clair, Pennsylvania, United States, 15241 United States, Tennessee Fougera Investigational Site Chattanooga, Tennessee, United States, 37421 United States, Texas Fougera Investigational Site Austin, Texas, United States, 78759 Less <<
NCT02886702 Plaque Psoriasis Phase 3 Completed - -
NCT02849873 Acne Phase 1 Completed - United States, Alabama ... More >> Valeant Site 01 Birmingham, Alabama, United States, 35201 Less <<
NCT00605930 Progressive Supranuclear Palsy Not Applicable Completed - United States, Kentucky ... More >> Frazier Rehab Louisville, Kentucky, United States, 40202 Less <<
NCT02886715 - Completed - -
NCT00580931 Alzheimer's Disease Phase 1 Phase 2 Completed - United States, California ... More >> UC Irvine School of Medicine Irvine, California, United States, 92697 Less <<
NCT00614445 Nausea and Vomiting of Pregnan... More >>cy Less << Phase 3 Completed - United States, District of Col... More >>umbia Washington Hospital Center Physicians Washington, District of Columbia, United States, 20010 Georgetown University Hospital Washington, District of Columbia, United States, 20057 United States, Maryland National Naval Medical Center Bethesda, Maryland, United States, 20889 United States, Pennsylvania Magee-Womens Hospital of University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 United States, Texas University of Texas Medical Branch Galveston, Texas, United States, 77555-0587 UTMB Pasadena Clinic Pasadena, Texas, United States, 77502 UTMB Regional Maternal & Child Health Program--Pearland Clinic Pearland, Texas, United States, 77581 Less <<
NCT00614445 - Completed - -
NCT00626717 Keratoconus Phase 2 Phase 3 Completed - Germany ... More >> University Eye Hospital Freiburg Freiburg, Baden-Württemberg, Germany, 79106 Less <<
NCT00647699 - Completed - -
NCT02938494 Acne Vulgaris Phase 2 Completed - United States, California ... More >> Valeant Site 03 Encinitas, California, United States, 92024 Valeant Site 04 Fremont, California, United States, 94538 Valeant Site 06 Los Angeles, California, United States, 90036 Valeant Site 14 Sacramento, California, United States, 95819 Valeant Site 01 Santa Monica, California, United States, 90404 United States, Colorado Valeant Site 05 Colorado Springs, Colorado, United States, 80915 United States, Florida Valeant Site 08 Coral Gables, Florida, United States, 33146 Valeant Site 10 Miami, Florida, United States, 33175 Valeant Site 09 Miramar, Florida, United States, 33027 United States, Kentucky Valeant Site 12 Louisville, Kentucky, United States, 40202 Valeant Site 13 Louisville, Kentucky, United States, 40217 United States, Maryland Valeant Site 02 Rockville, Maryland, United States, 20850 United States, Minnesota Valeant Site 07 Fridley, Minnesota, United States, 55432 United States, North Carolina Valeant Site 16 Chapel Hill, North Carolina, United States, 27517 Valeant Site 15 High Point, North Carolina, United States, 27262 United States, Pennsylvania Valeant Site 11 Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00647699 Progressive Keratoconus Phase 3 Completed - United States, California ... More >> Shiley Eye Center La Jolla, California, United States, 92093 Gordon -Weiss Vision Institute San Diego, California, United States, 91222 United States, Florida Center for Excellence in Eye Care Miami, Florida, United States, 33176 United States, Indiana Price Vision Group Indianapolis, Indiana, United States, 46260 United States, Kansas Durrie Vision Kansas City, Kansas, United States, 66211 United States, Maryland Wilmer Eye Institute at Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, Minnesota Minnesota Eye Consultants Minneapolis, Minnesota, United States, 55404 United States, New Jersey Cornea & Laser Eye Institute; Hersh Vision Group Teaneck, New Jersey, United States, 07666 United States, New York Edward Harkness Eye Institute at Columbia University Medical Center New York, New York, United States, 10032 Ophthalmic Consultants of Long Island Rockville Centre, New York, United States, 11570 Less <<
NCT03095872 Photodamaged Skin Phase 3 Completed - Germany ... More >> University Hospital RWTH Aachen Aachen, NRW, Germany, 52057 Less <<
NCT00674661 Ectasia Phase 3 Completed - United States, California ... More >> Shiley Eye Center La Jolla, California, United States, 92093 Gordon -Weiss Vision Institute San Diego, California, United States, 91222 United States, Florida Center for Excellence in Eye Care Miami, Florida, United States, 33176 United States, Indiana Price Vision Group Indianapolis, Indiana, United States, 46260 United States, Kansas Durrie Vision Kansas City, Kansas, United States, 66211 United States, Maryland Wilmer Eye Institute at Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, Minnesota Minnesota Eye Consultants Minneapolis, Minnesota, United States, 55404 United States, New Jersey Cornea & Laser Eye Institute; Hersh Vision Group Teaneck, New Jersey, United States, 07666 United States, New York Edward Harkness Eye Institute at Columbia University Medical Center New York, New York, United States, 10032 Ophthalmic Consultants of Long Island Rockville Centre, New York, United States, 11570 Less <<
NCT00642044 Keratoconus Not Applicable Unknown December 2009 Brazil ... More >> Clementino Fraga Filho University Hospital Recruiting Rio de Janeiro, RJ, Brazil, 21941-913 Contact: Ricardo Lamy       lamy@ufrj.br    Principal Investigator: Ricardo Lamy, MD Less <<
NCT03170596 Atrophic Post Acne Scarring Not Applicable Completed - India ... More >> Dermatology OPD, New OPD Building, Level 5C, Postgraduate Institute of Medical Education and Research Chandigarh, India, 160012 Less <<
NCT03263624 Nail Psoriasis Phase 4 Not yet recruiting November 1, 2018 -
NCT00674661 - Completed - -
NCT00777322 Keratoconus P... More >>ellucid Marginal Degeneration Less << Not Applicable Completed - United Kingdom ... More >> Moorfields Eye Department at St George's Hospital London, United Kingdom, SW17 0QT Less <<
NCT03292640 Acne Vulgaris Phase 3 Completed - United States, California ... More >> Center for Dermatology Clinical Research Inc. Fremont, California, United States, 94538 Less <<
NCT00815256 Cornea Degeneration ... More >> Progressive Keratoconus Less << Phase 3 Unknown - Brazil ... More >> Department of Ophthalmology, Federal University of São Paulo Recruiting São Paulo, SP, Brazil Contact: Patricia Z Serapicos, MD       patricia.serapicos@yahoo.com.br    Contact: Kátia M Bottós, MD       katia.bottos@gmail.com    Principal Investigator: Patricia Z Serapicos, MD Less <<
NCT03341910 Acne Vulgaris Phase 2 Completed - United States, Florida ... More >> International Dermatology Inc. Miami, Florida, United States, 33144 Less <<
NCT00832897 Keratoconus Not Applicable Completed - Brazil ... More >> Federal University of São Paulo São Paulo, Brazil, 04038-000 Less <<
NCT01789333 Keratoconus E... More >>ctasia Less << Not Applicable Recruiting December 30, 2018 United States, New York ... More >> Edward Harkness Eye Institute-Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: MaEdylin Bautista    212-305-5922    mmb2225@columbia.edu    Principal Investigator: Stephen Trokel, MD Less <<
NCT00861523 Hyperemesis Gravidarum Phase 3 Terminated(Difficulties in rec... More >>ruiting patients) Less << - Israel ... More >> Gynecologic department, Haemek medical center Afula, Israel Less <<
NCT00890266 Keratoconus Not Applicable Unknown July 2010 United Kingdom ... More >> Moorfields Eye Department at St George's Hospital London, Greater London, United Kingdom, SW17 0QT Less <<
NCT00912509 Infectious Keratitis Not Applicable Terminated(insufficient effica... More >>cy) Less << - United States, Indiana ... More >> Price Vision Group Indianapolis, Indiana, United States, 46260 Less <<
NCT00925327 Progressive Keratoconus Phase 2 Unknown - United States, Missouri ... More >> Children's Mercy Hospitals and Clinics Not yet recruiting Kansas City, Missouri, United States, 65108 Contact: Erin D. Stahl, MD    816-234-3046       Principal Investigator: Scott E. Olitsky, MD          Sub-Investigator: Erin D. Stahl, MD Less <<
NCT00912509 - Terminated(insufficient effica... More >>cy) Less << - -
NCT03599193 Acne Vulgaris Phase 2 Completed - United States, Texas ... More >> Dr. DuBois Austin, Texas, United States, 73301 Dr. Jones Austin, Texas, United States, 73301 Less <<
NCT03685773 Diabetes Mellitus, Type 2 ... More >> Glucose, High Blood Glucose Metabolism Disorders Less << Phase 2 Not yet recruiting December 2021 -
NCT01054508 Hypercholesterolemia Phase 4 Completed - United Kingdom ... More >> Manchester Royal Infirmary Manchester, United Kingdom, M13 9WL Less <<
NCT02068430 Corneal Ulcers Phase 1 Completed - United States, New York ... More >> Harkness Eye Institute Columbia University New York, New York, United States, 10035 Less <<
NCT01083329 Obesity Phase 2 Completed - France ... More >> Centre d'Investigation Clinique, Purpan University Toulouse Hospital Toulouse, France, 31059 Less <<
NCT01085981 Female Sexual Dysfunction Not Applicable Unknown July 2010 United States, Pennsylvania ... More >> East Suburban Obgyn Not yet recruiting Monroeville, Pennsylvania, United States, 15668 Contact: michae j pelekanos, md    412-856-7500    mipel@aol.com    Contact: vickie lathom    4128567500    vlathom@wpahs.org Less <<
NCT00855257 Acute Coronary Syndrome (ACS) Phase 3 Completed - France ... More >> Hôpital de Rangueil Toulouse, France, 31000 Less <<
NCT01112072 Keratoconus C... More >>orneal Ectasia Less << Phase 3 Active, not recruiting December 2018 United States, New Jersey ... More >> Cornea and Laser Eye Institute Teaneck, New Jersey, United States, 07666 Less <<
NCT01123057 Corneal Ectasia Not Applicable Unknown June 2010 Singapore ... More >> Singapore Eye Research Institute Recruiting Singapore, Singapore, 168751 Contact: Yeng Li Goh    6563224533       Principal Investigator: Li Lim, FRCS Less <<
NCT01081561 Keratoconus E... More >>ctasia Less << Phase 2 Phase 3 Enrolling by invitation June 30, 2021 United States, California ... More >> Cornea Eye Institute, 50 North La Cienaga Blvd, #340 Beverly Hills, California, United States, 90211 Less <<
NCT01143389 Keratoconus P... More >>ost-Refractive Ectasia Less << Phase 2 Completed - United States, Indiana ... More >> Price Vision Group Indianapolis, Indiana, United States, 46260 Less <<
NCT00679666 Progressive Keratoconus ... More >> Corneal Ectasia Less << Phase 2 Phase 3 Withdrawn(Investigator no long... More >>er at university) Less << - United States, Ohio ... More >> The Ohio State University Medical Center Columbus, Ohio, United States, 43210 OSU Havener Eye Institute Dublin, Ohio, United States, 43016 Less <<
NCT01106274 Bullous Keratopathy Not Applicable Completed - -
NCT01118598 Polycystic Ovary Syndrome Phase 4 Completed - United Kingdom ... More >> Hull & East Yorkshire Hospitals NHS Trust Hull, United Kingdom, HU3 2RW Less <<
NCT01190306 Keratoconus Phase 3 Terminated(The sponsor termina... More >>ted the study prior to data analysis for financial reasons.) Less << - United States, Arizona ... More >> Barnet Dulaney Perkins Eye Center Phoenix, Arizona, United States, 85016 United States, Georgia Woolfson Eye Institute Atlanta, Georgia, United States, 30328 United States, Minnesota Minnesota Eye Consultants Bloomington, Minnesota, United States, 55431 United States, New York Pamel Vision & Laser Group New York, New York, United States, 10021 Mt. Sinai Hospital New York, New York, United States, 10029 United States, Ohio OSU Department of Ophthalmoloty Columbus, Ohio, United States, 43212 Revision Advanced Laser Eye Center Columbus, Ohio, United States, 43240 United States, Texas Dell Laser Consultants Austin, Texas, United States, 78746 Slade & Baker Vision Center Houston, Texas, United States, 77027 Less <<
NCT01143389 - Completed - -
NCT01152541 Keratoconus C... More >>orneal Ectasia Less << Phase 3 Active, not recruiting December 2018 United States, New Jersey ... More >> Cornea and Laser Eye Institute Teaneck, New Jersey, United States, 07666 Less <<
NCT01190306 - Terminated(The sponsor termina... More >>ted the study prior to data analysis for financial reasons.) Less << - -
NCT01258491 Healthy Subjects Phase 1 Completed - -
NCT01307527 Brittle Cornea Syndrome ... More >> Ehlers-Danlos Syndrome Type 6 Less << Not Applicable Unknown - Israel ... More >> Hadassah Medical Organization Jerusalem, Israel Less <<
NCT01325298 Keratoconus E... More >>ctasia Corneal Ectasia Less << Phase 2 Unknown May 2014 United States, Illinois ... More >> Mercy Center for Corrective Eye Surgery Recruiting McHenry, Illinois, United States, 60050 Contact: Mark Gurgos, COT    815-363-2020    mgurgos@mhsjvl.org    Contact: Robert L Epstein, MD    815-363-2020    rlepstein@aol.com    Principal Investigator: Robert L Epstein, MD Less <<
NCT01181219 Keratoconus Phase 2 Completed - Norway ... More >> University Hospital North Norway Tromsoe, Troms, Norway, 9000 Less <<
NCT01384773 - - - United States, New York ... More >> Edward Harkness Eye Institute-Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT01200784 Chronic Kidney Disease ... More >> Hemodialysis Hyperphosphatemia Less << Phase 2 Completed - Germany ... More >> Alsfeld, Germany, 36304 Arnstadt, Germany, 99310 Augsburg, Germany, 86157 Berlin Hellersdorf, Germany, 12627 Berlin Kreuzberg, Germany, 10245 Berlin, Germany, 12045 Berlin, Germany, 12203 Berlin, Germany, 12435 Berlin, Germany, 13051 Bielefeld, Germany, 33602 Coburg, Germany, 96450 Darmstadt, Germany, 64295 Dortmund, Germany, 44135 Dülmen, Germany, 48249 Düsseldorf, Germany, 40210 Elsenfeld, Germany, 63820 Erfurt, Germany, 99089 Essen, Germany, 45127 Friedrichsroda, Germany, 99894 Hamburg, Germany, 22297 Hameln, Germany, 31787 Herne, Germany, 44623 Herzberg, Germany, 04916 Iserlohn, Germany, 58638 Jena-Drakendorf, Germany, 07751 Kamen, Germany, 59174 Leverkusen, Germany, 51373 Mannheim, Germany, 68309 Minden, Germany, 32429 Nordhausen, Germany, 99734 Osnabrueck, Germany, 49074 Pfarrkirchen, Germany, 84347 Regensburg, Germany, 93053 Schwabach, Germany, 91126 Tangermünde, Germany, 39590 Wuppertal, Germany, 42283 Less <<
NCT01344187 Keratoconus Phase 3 Completed - United States, California ... More >> UC Irvine Department of Ophthalmology Irvine, California, United States, 92697 United States, Florida Bascolm Palmer Eye Institute Miami, Florida, United States, 33136 United States, Georgia Emory Eye Center Atlanta, Georgia, United States, 30342 United States, Massachusetts Ophthalmic Consultants of Boston Waltham, Massachusetts, United States, 02451 United States, Nebraska Kugler Vision Omaha, Nebraska, United States, 68144 United States, New Jersey Pinceton Eye Goup Princeton, New Jersey, United States, 08540 United States, Ohio Comprehensive Eye Care of Central Ohio Westerville, Ohio, United States, 43082 United States, South Carolina Medical University of South Carolina Storm Eye Institute, Magill Vision Center Mount Pleasant, South Carolina, United States, 29464 United States, South Dakota Vance Thompson Vision Sioux Falls, South Dakota, United States, 57108 United States, Utah Hoopes Vision Draper, Utah, United States, 84020 Less <<
NCT01398852 Keratoconus and Ectasia Phase 3 Terminated - United States, Arizona ... More >> Barnet Dulaney Perkins Eye Center Phoenix, Arizona, United States United States, Georgia Woolfson Eye Institute Atlanta, Georgia, United States United States, Massachusetts Massachusetts Eye And Ear Infirmary Boston, Massachusetts, United States United States, Minnesota Minnesota Eye Consultants Bloomington, Minnesota, United States United States, New York Laser and Corneal Surgery Assoc. PC New York, New York, United States, 10022 Mt Sinai Hospital New York, New York, United States Pamel Vision & Laser Group New York, New York, United States United States, Ohio Cleveland Clinic-Cole Eye Institute Cleveland, Ohio, United States, 44195 ReVision Advanced Laser Eye Center Columbus, Ohio, United States, 43240 OSU Department of Ophthalomogy Columbus, Ohio, United States United States, Texas Dell Laser Consultants Austin, Texas, United States Slade and Baker Vision Center Houston, Texas, United States United States, Utah The Eye Institute of Utah Salt Lake City, Utah, United States, 84107 Less <<
NCT01398852 - Terminated - -
NCT01450410 Dyslipidemias Phase 4 Terminated(Study terminated (h... More >>alted prematurely) as recomended by the drug supplier and medical agencies) Less << May 2013 Spain ... More >> Unitat Funcional de Risc Vascular. Servei Medicina Interna. Hospital Universitari de Bellvitge. L'Hospitalet de Llobregat, Barcelona, Spain, 08907 Less <<
NCT01398839 Ectasia Phase 3 Terminated - United States, Arizona ... More >> Barnet Dulaney Perkins Eye Center Phoenix, Arizona, United States United States, Georgia Woolfson Eye Institute Atlanta, Georgia, United States United States, Minnesota Minnesota Eye Consultants, P.A. Bloomington, Minnesota, United States, 55431 United States, New York Laser and Corneal Surgery Assoc. PC New York, New York, United States, 10022 Mt. Sinai Hospital New York, New York, United States Pamel Vision & Laser Group New York, New York, United States United States, Ohio Cleveland Clinic-Cole Eye Institute Cleveland, Ohio, United States, 44195 The Ohio State University College of Medicine Columbus, Ohio, United States, 43212 ReVision Advanced Laser Eye Center Columbus, Ohio, United States, 43240 United States, Texas Dell Laser Consultants Austin, Texas, United States Slade & Baker Vision Houston, Texas, United States United States, Utah The Eye Institute of Utah Salt Lake City, Utah, United States, 84107 Less <<
NCT01459679 Keratoconus C... More >>orneal Ectasia Less << Phase 3 Terminated - -
NCT01464268 Keratoconus C... More >>orneal Ectasia Less << Phase 3 Active, not recruiting February 2019 United States, New Jersey ... More >> Cornea and Laser Eye Institute Teaneck, New Jersey, United States, 07666 Less <<
NCT01542138 Hyperpigmentation Phase 4 Completed - Mexico ... More >> Dermatology Department. Hospital Central "Dr. Ignacio Morones Prieto" San Luis Potosi, Mexico, 78210 Less <<
NCT01582880 Chemical Injuries ... More >> Unspecified Complication of Corneal Transplant Autoimmune Diseases Ocular Cicatricial Pemphigoid Stevens Johnson Syndrome Lupus Erythematosus, Systemic Rheumatoid Arthritis Other Autoimmune Diseases Less << Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts Eye and Ear Infirmary Boston, Massachusetts, United States, 02114 Less <<
NCT01582880 - Completed - -
NCT01604135 Keratoconus Phase 3 Recruiting May 2019 Sweden ... More >> Department of Ophthalmology, Sahlgrenska University Hospital Recruiting Mölndal, Västra Götalandsregionen, Sweden, 43180 Principal Investigator: Wolf K Wonneberger, MD Less <<
NCT01589809 Neurodegenerative Disorders Phase 2 Active, not recruiting December 2017 United Kingdom ... More >> NIHR/Wellcome Trust Imperial CRF London, Hammersmith, United Kingdom, W12 0HS National Hospital for Neurology and Neurosurgery London, United Kingdom, WC1N 3BG Less <<
NCT01398839 - Terminated - -
NCT01643252 Corneal Ectasia Phase 3 Withdrawn(This study was withd... More >>rawn for business reasons.) Less << - -
NCT01726283 - Completed - United States, Arizona ... More >> Schwartz Laser Eye Center Scottsdale, Arizona, United States, 85260 United States, California Clear View Eye & Laser Medical Center San Diego, California, United States United States, Florida The Center for Excellence in Eye Care Miami, Florida, United States United States, Maryland TLC Laser Eye Center Rockville, Maryland, United States, 20852 United States, Massachusetts Talamo Laser Eye Center Waltham, Massachusetts, United States United States, Minnesota Minnesota Eye Consultants Minneapolis, Minnesota, United States United States, Ohio Cleveland Eye Clinic Breckville, Ohio, United States United States, Virginia TLC Laser Eye Center Fairfax, Virginia, United States, 22031 Less <<
NCT01485211 Progressive Keratoconus ... More >> Thin Corneas Less << Phase 4 Completed - -
NCT01739673 Infectious Keratitis Not Applicable Completed - United States, Arizona ... More >> Schwartz Laser Eye Center Scottsdale, Arizona, United States United States, California Davidorf Eye Group West Hills, California, United States United States, Colorado Corneal Consultants of Colorado, PC Littleton, Colorado, United States United States, Florida Center for Excellence in Eye Care Miami, Florida, United States United States, Minnesota Minnesota Eye Consultants Minneapolis, Minnesota, United States United States, Missouri Ophthalmology Associates Saint Louis, Missouri, United States Less <<
NCT00018954 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 Egypt National Cancer Institute of Egypt Cairo, Egypt India Kidwai Memorial Institute of Oncology Bangalore, India, 560029 Cancer Institute (W.I.A.) Madras, India, 600020 Tata Memorial Centre Mumbai, India, 400012 Less <<
NCT01672814 Keratoconus Phase 3 Completed - United States, New Jersey ... More >> Cornea and Laser Eye Institue - Hersh Vision Group Teaneck, New Jersey, United States, 07666 Less <<
NCT00025545 Leukemia Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT01643226 Keratoconus Phase 3 Completed - United States, California ... More >> Gordon -Weiss Vision Institute San Diego, California, United States, 92122 United States, Indiana Price Vision Group Indianapolis, Indiana, United States, 46260 United States, Kansas Durrie Vision Overland Park, Kansas, United States, 66211 United States, New Jersey Cornea & Laser Eye Institute; Hersh Vision Group Teaneck, New Jersey, United States, 07666 United States, New York Columbia University Harkness Eye Institute New York, New York, United States, 10032 United States, Ohio Cleveland Clinic Cole Eye Institute Cleveland, Ohio, United States, 44195 United States, Pennsylvania UPMC Eye Center Pittsburgh, Pennsylvania, United States, 15213 United States, Virginia See Clearly Vision McLean, Virginia, United States, 22102 Less <<
NCT00063570 Breast Cancer ... More >> Breast Neoplasms Less << Phase 2 Completed - United States, Colorado ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Aurora, Colorado, United States United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Plantation, Florida, United States United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Morrisville, North Carolina, United States United States, Pennsylvania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Philadelphia, Pennsylvania, United States United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Dallas, Texas, United States United States, Washington For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Seattle, Washington, United States Puerto Rico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. San Juan, Puerto Rico Less <<
NCT00063570 - Completed - -
NCT00002970 Recurrent Childhood Acute Lymp... More >>hoblastic Leukemia Recurrent Childhood Lymphoblastic Lymphoma T-cell Childhood Acute Lymphoblastic Leukemia Less << Phase 2 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00002582 Breast Cancer Phase 3 Completed - United Kingdom ... More >> Cancer Research Campaign Trials Unit-Birmingham (CRCTU) Birmingham, England, United Kingdom, B15 2TT Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT Less <<
NCT01803594 Dyslipidemia Not Applicable Completed - United States, California ... More >> UC Davis, Ragle Human Nutrition Center Davis, California, United States, 95616 Less <<
NCT01913964 Work Productivity and Activity... More >> Impairment in Workers With Chronic C Hepatitis Fatigue in Workers With Chronic C Hepatitis Fatigue Less << Phase 4 Completed - -
NCT01921868 Friedreich's Ataxia Not Applicable Unknown June 2017 United States, Florida ... More >> University of South Florida Recruiting Tampa, Florida, United States, 33612 Contact: Tanya Aranca, B.S.    813-974-5909    taranca@health.usf.edu    Contact: Jessica Shaw, MPH    813-974-5909    jshaw@health.usf.edu    Principal Investigator: Theresa Zesiewicz, M.D. Less <<
NCT00002828 Colorectal Cancer Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00005940 Adult Acute Myeloid Leukemia i... More >>n Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Less << Phase 2 Completed - United States, Washington ... More >> Pacific Northwest National Laboratory Richland, Washington, United States, 99352 VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00068250 Brain and Central Nervous Syst... More >>em Tumors Lymphoma Less << Phase 1 Phase 2 Completed - United States, Florida ... More >> Integrated Community Oncology Network Jacksonville Beach, Florida, United States, 32250 Baptist Cancer Institute - Jacksonville Jacksonville, Florida, United States, 32207 Integrated Community Oncology Network at Southside Cancer Center Jacksonville, Florida, United States, 32207 Baptist Medical Center South Jacksonville, Florida, United States, 32258 Integrated Community Oncology Network - Orange Park Orange Park, Florida, United States, 32073 Florida Cancer Center - Palatka Palatka, Florida, United States, 32177 Flagler Cancer Center Saint Augustine, Florida, United States, 32086 United States, Michigan Borgess Medical Center Kalamazoo, Michigan, United States, 49001 West Michigan Cancer Center Kalamazoo, Michigan, United States, 49007-3731 Bronson Methodist Hospital Kalamazoo, Michigan, United States, 49007 United States, Missouri CCOP - Kansas City Kansas City, Missouri, United States, 64131 Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, Nevada CCOP - Nevada Cancer Research Foundation Las Vegas, Nevada, United States, 89106 United States, New Jersey John F. Kennedy Medical Center Edison, New Jersey, United States, 08818 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Oregon Providence Milwaukie Hospital Milwaukie, Oregon, United States, 97222 Providence Cancer Center at Providence Portland Medical Center Portland, Oregon, United States, 97213-2967 CCOP - Columbia River Oncology Program Portland, Oregon, United States, 97225 Providence St. Vincent Medical Center Portland, Oregon, United States, 97225 United States, Pennsylvania Kimmel Cancer Center at Thomas Jefferson University - Philadelphia Philadelphia, Pennsylvania, United States, 19107-5541 United States, South Carolina Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Utah Jon and Karen Huntsman Cancer Center at Intermountain Medical Center Murray, Utah, United States, 84157 Utah Valley Regional Medical Center - Provo Provo, Utah, United States, 84604 United States, Washington Southwest Washington Medical Center Cancer Center Vancouver, Washington, United States, 98668 United States, Wisconsin Community Memorial Hospital Cancer Care Center Menomonee Falls, Wisconsin, United States, 53051 Medical College of Wisconsin Cancer Center Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00069017 Rheumatoid Arthritis Phase 2 Completed - -
NCT00041288 Leukemia Lymp... More >>homa Less << Phase 2 Unknown - -
NCT00003553 Kidney Cancer Phase 2 Unknown - United States, Maryland ... More >> NIH - Warren Grant Magnuson Clinical Center Recruiting Bethesda, Maryland, United States, 20892-1182 Contact: Patient Recruitment    800-411-1222 Less <<
NCT00027547 Leukemia Phase 1 Phase 2 Completed - United States, Oregon ... More >> Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Germany Universitaet Leipzig Leipzig, Germany, D-04103 Less <<
NCT00074841 PLASMODIUM FALCIPARUM MALARIA Phase 2 Phase 3 Completed - India ... More >> Pfizer Investigational Site Dispur Guwahati, Assam, India, 781006 Pfizer Investigational Site Bambolim, Gao, India, 403002 Pfizer Investigational Site Nagpur, Maharashtra, India, 440 018 Pfizer Investigational Site Parel Mumbai, Maharashtra, India, 400012 Pfizer Investigational Site Rourkela, Orissa, India, 769005 Pfizer Investigational Site Vellore, Tamil Nadu, India, 632 004 Pfizer Investigational Site Indore, India, 452001 Less <<
NCT00003868 Leukemia Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00053196 Leukemia Lymp... More >>homa Multiple Myeloma Plasma Cell Neoplasm Myelodysplastic Syndromes Myeloproliferative Neoplasms Less << Phase 2 Completed - United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 United States, Delaware Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 St. Francis Hospital Wilmington, Delaware, United States, 19805 United States, Maryland Union Hospital Cancer Center at Union Hospital Elkton MD, Maryland, United States, 21921 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital St Louis, Missouri, United States, 63110 United States, New Jersey Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224-1791 United States, Virginia Massey Cancer Center at Virginia Commonwealth University Richmond, Virginia, United States, 23298-0037 Less <<
NCT00068250 - Completed - -
NCT00024245 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00070135 - Completed - -
NCT00070174 Leukemia Phase 2 Completed - -
NCT03567629 mCRC Phase 2 Active, not recruiting December 30, 2023 China, Beijing ... More >> Beijing Cancer Hospital Beijing, Beijing, China, 100142 Less <<
NCT00070135 Adult Acute Myeloid Leukemia i... More >>n Remission Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Less << Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Delaware Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 United States, Maryland Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States, 21201 Union Hospital of Cecil County Elkton, Maryland, United States, 21921 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber/Brigham and Women's Cancer Center Boston, Massachusetts, United States, 02115 Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, New Jersey Cancer Institute of New Jersey at Cooper - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Monter Cancer Center of the North Shore-LIJ Health System Lake Success, New York, United States, 11042 CCOP - North Shore University Hospital Manhasset, New York, United States, 11030 Don Monti Comprehensive Cancer Center at North Shore University Hospital Manhasset, New York, United States, 11030 Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 New York Weill Cornell Cancer Center at Cornell University New York, New York, United States, 10021 Mount Sinai Medical Center New York, New York, United States, 10029 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 Less <<
NCT02537158 Hepatocellular Carcinoma Not Applicable Unknown July 2018 China ... More >> Cancer Hospital and Institute, Chinese Academy of Medical Sciences Recruiting Bei jing, China, 100026 Contact: Xinyu Bi, Doctor    86-13911792177    beexy1971@163.com Less <<
NCT02559778 Neuroblastoma Phase 2 Recruiting September 2026 -
NCT02560779 Hepatocellular Carcinoma Phase 1 Phase 2 Recruiting November 2020 United States, Alabama ... More >> University of Alabama Recruiting Birmingham, Alabama, United States, 35294-3300 United States, California City of Hope Withdrawn Duarte, California, United States, 91010 United States, Maryland National Cancer Institute Withdrawn Bethesda, Maryland, United States, 20892 United States, Ohio University Hospitals Recruiting Cleveland, Ohio, United States, 44106 United States, Texas MD Anderson Recruiting Houston, Texas, United States, 77030-4009 Less <<
NCT02538393 Biological Availability Phase 1 Completed - Germany ... More >> Berlin, Germany, 13353 Less <<
NCT02575339 Hepatocellular Carcinoma ... More >> Liver Cancer HCC Less << Phase 1 Phase 2 Active, not recruiting June 2020 United States, Illinois ... More >> Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 University of Illinois Cancer Center Chicago, Illinois, United States, 60612 United States, Indiana Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, North Carolina University of Noth Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27514 United States, Pennsylvania Penn State Cancer Institute Hershey, Pennsylvania, United States, 17033 United States, Wisconsin University of Wisconsin Madison, Wisconsin, United States, 53705 Less <<
NCT03626298 Acne Vulgaris Phase 4 Completed - -
NCT03645187 Colon Cancer Stage Phase 4 Recruiting December 2025 Egypt ... More >> Amira Roushdy Recruiting Tanta, Elgharbia, Egypt, 35111 Contact: amira roushdy, msc    00201095159522 Less <<
NCT03592693 Shock, Septic Phase 2 Recruiting September 2020 Greece ... More >> Evaggelismos General Hospital Recruiting Athens, Attica, Greece, 10676 Contact: Anastasia Kotanidou, MD, PHD    +306977077105    akotanid@gmail.com    Contact: Spyros D Mentzelopoulos, MD, PHD    +306975304909    sdmentzelopoulos@yahoo.com    General Hospital of Nikaia Saint Panteleimon Not yet recruiting Piraeus, Attica, Greece, 18454 Contact: Antonis C Mavrommatis, MD    +30-6944371145    mavro58@yahoo.gr Less <<
NCT03642990 Chemotherapy-induced Periphera... More >>l Neuropathy Breast Cancer Metastatic Less << Phase 2 Not yet recruiting April 2022 United States, Iowa ... More >> University of Iowa Hospitals and Clinics Not yet recruiting Iowa City, Iowa, United States, 52242 Contact: Donna L Hammond, PhD    319-335-9595    donna-hammond@uiowa.edu    Contact: Marian K Anderson, MA    319-353-4578    marian-andersen@uiowa.edu    United States, North Carolina Wake Forest University Not yet recruiting Salem, North Carolina, United States, 27109 Contact: Alexandra Thomas, MD    336-716-7217    althomas@wakehealth.edu Less <<
NCT02562755 Hepatocellular Carcinoma (HCC) Phase 3 Recruiting October 2019 -
NCT03648333 Healthy Male Subjects Phase 1 Completed - -
NCT03649009 Hyperlactatemia Not Applicable Recruiting March 31, 2019 Malaysia ... More >> Universiti Kebangsaan Malaysia Medical Centre Recruiting Cheras, Kuala Lumpur, Malaysia, 56000 Contact: Cheah SK Dr, M.D. Less <<
NCT03641976 Unresectable Metastatic Right-... More >>sided Colon Cancer Starting First-line Combination Chemotherapy Unresectable Metastatic Right-sided Colon Cancer, Stage IV Less << Phase 2 Not yet recruiting August 31, 2022 Korea, Republic of ... More >> Yonsei Cancer Center, Severance Hospital, Yonsei University Health System Not yet recruiting Seoul, Korea, Republic of, 03722 Contact: Joong Bae Ahn, MD,PhD    82-2-2228-8134    vvswm513@yuhs.ac Less <<
NCT03657550 Hypertension Phase 1 Completed - United States, California ... More >> Collaborative Neuroscience Network, LLC Long Beach, California, United States, 90806 Less <<
NCT03654729 Chemotherapy-induced Periphera... More >>l Neuropathy Less << Phase 3 Not yet recruiting September 2022 -
NCT03649633 Septic Shock Phase 1 Phase 2 Recruiting September 2020 Greece ... More >> Evaggelismos General Hospital Recruiting Athens, Attica, Greece, 10676 Contact: Spyros D Mentzelopoulos, MD, PhD    +306975304909    sdmentzelopoulos@yahoo.com    Principal Investigator: Spyros D Mentzelopoulos, MD, PhD          Principal Investigator: Anastasia Kotanidou, MD, PhD          Sub-Investigator: Sotirios Malachias, MD, PhD Less <<
NCT03665779 Induction of Labor Affected Fe... More >>tus / Newborn Rupture of Membranes Prior to Onset of Labor Less << Phase 3 Recruiting May 1, 2019 Egypt ... More >> faculty of medicine - Cairo university Recruiting Cairo, Kasr El Ainy, Egypt, 11562 Contact: mohamed T aneis, MD    202 23653269    viced.research@cu.edu.eg    Principal Investigator: waleed M El khyat, MD Less <<
NCT02599337 Fasting Phase 1 Completed - Canada, Quebec ... More >> Inventiv Health Clinique Inc. Québec, Quebec, Canada, G1P 0A2 Less <<
NCT03635021 Colorectal Cancer Phase 3 Recruiting September 15, 2024 Spain ... More >> Spanish Cooperative Group for the Treatment of Digestive Tumors Recruiting Madrid, Spain, 28007 Contact: Inmaculada Ruiz de Mena, PhD    00913788275    ttd@ttdgroup.org Less <<
NCT02627963 Carcinoma, Renal Cell Phase 3 Active, not recruiting December 2019 -
NCT03698461 Colorectal Neoplasms ... More >> Neoplasm Metastasis Colonic Neoplasms Rectal Neoplasms Less << Phase 2 Not yet recruiting November 2021 Korea, Republic of ... More >> Asan Medical Center Not yet recruiting Seoul, Songpa-gu, Korea, Republic of, 05505 Contact: SunYoung Kim, Ph.D    82-2-3010-3204    sunyoungkim@amc.seoul.kr Less <<
NCT02599090 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Withdrawn(Multi phase study di... More >>d not progress to Phase II. Phase I registered as NCT00734526.) Less << - -
NCT03721653 Metastatic Colorectal Cancer Phase 2 Not yet recruiting April 15, 2021 Italy ... More >> Francesca Vannini Not yet recruiting Pisa, Italia, Italy, 56126 Contact: Francesca Vannini, Biology    050992192    vannini.fr@gmail.com    Principal Investigator: Chiara Cremolini, MD Less <<
NCT03714555 Metastatic Pancreatic Cancer Phase 2 Not yet recruiting November 1, 2020 -
NCT02613572 Age-Related Macular Degenerati... More >>on Less << Phase 1 Phase 2 Active, not recruiting June 2019 United States, Iowa ... More >> University of Iowa Hospitals and Clinics, Department of Ophthalmology & Visual Sciences Iowa City, Iowa, United States, 52242 United States, New Jersey NJ Retina Teaneck, New Jersey, United States, 07666 United States, Oregon Oregon Regina. LLP Eugene, Oregon, United States, 97401 Retina Northwest, P.C. Portland, Oregon, United States, 97210 United States, Pennsylvania Scheie Eye Institute of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03722498 Hepatocellular Carcinoma Phase 2 Recruiting November 1, 2018 China, Guangdong ... More >> Ming Shi Recruiting Guangzhou, Guangdong, China Contact: Ming Shi, MD    (8620)-87343938    shiming@sysu.edu.cn    Principal Investigator: Ming Shi, MD Less <<
NCT02642913 Hepatocellular Carcinoma Phase 1 Phase 2 Recruiting December 2019 United States, California ... More >> University of California San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Robin K Kelley, MD    415-353-9888       United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Benjamin Tan, MD    314-747-7222       Principal Investigator: Benjamin Tan, MD          United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263-0001 Contact: Iyer Renuka, MD    716-845-2300       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: James Harding, MD    646-888-4314       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: James Harding, MD    646-888-4314       Contact: Ghassan Abou-Alfa, MD    646-888-4184 Less <<
NCT03743636 Peripheral Artery Disease Phase 3 Recruiting April 2022 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Mary McDermott, MD    312-503-6419    mdm608@northwestern.edu    Contact: Kathryn Domanchuk, BS    312-503-6438    k-domanchuk@northwestern.edu    Principal Investigator: Mary McDermott, MD Less <<
NCT02636426 Neoplasms Phase 1 Completed - Netherlands ... More >> VU University Medical Center Amsterdam, Noord-Holland, Netherlands, 1081 HV Less <<
NCT03356483 Obsessive-Compulsive Disorder Phase 1 Recruiting July 2022 United States, Connecticut ... More >> Connecticut Mental Health Center Recruiting New Haven, Connecticut, United States, 06519 Contact: Ben Kelmendi, MD    203-974-7752    ben.kelmendi@yale.edu Less <<
NCT03756220 Septic Shock ... More >>Sepsis Less << Phase 2 Recruiting February 28, 2020 Korea, Republic of ... More >> Department of Emergency Medicine, Seoul National University Bundang Hospital, Not yet recruiting Seongnam, Gyeonggi-do, Korea, Republic of Department of Emergency Medicine, Borame Medical Center, Seoul National University, College of Medicine Not yet recruiting Seoul, Korea, Republic of Department of Emergency Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Recruiting Seoul, Korea, Republic of Contact: Tae Gun Shin       taegunshin@skku.edu    Department of Emergency Medicine, Seoul National University College of Medicine, Not yet recruiting Seoul, Korea, Republic of Department of Emergency Medicine, University of Ulsan College of Medicine, Asan Medical Center, Recruiting Seoul, Korea, Republic of Department of Emergency Medicine, Yonsei University College of Medicine Not yet recruiting Seoul, Korea, Republic of Less <<
NCT03775902 Type 2 Diabetes Mellitus Not Applicable Not yet recruiting January 1, 2020 -
NCT02666170 Polycystic Ovary Syndrome Not Applicable Unknown - -
NCT02645981 HCC Phase 2 Phase 3 Active, not recruiting August 2019 China, Jiangsu ... More >> The PLA 81 Hospital Nanjing, Jiangsu, China, 025 China, Sichuan West China Hospital Sichuan University Chengdu, Sichuan, China, 610042 Less <<
NCT03430999 Chemotherapy Induced Periphera... More >>l Neuropathy (CIPN) Less << Phase 1 Completed - United States, California ... More >> WCCT Global Cypress, California, United States, 90630 Less <<
NCT02686905 Complications of Bariatric Pro... More >>cedures Avitaminosis Less << Not Applicable Unknown June 2017 United States, California ... More >> Oliak Center for Weight Loss Recruiting Brea, California, United States, 92821 Contact: David Oliak, MD    714-582-2530    info@droliak.com    Principal Investigator: Rebecca McDorman, BS          Sub-Investigator: Heather Garcia, BS          Sub-Investigator: Corinne Worland, AA          Sub-Investigator: Jordyn Shubin Less <<
NCT01017120 Acne Vulgaris Phase 3 Completed - United States, California ... More >> The Laser Institute for Dermatology Santa Monica, California, United States, 90404 United States, Florida FXM Research Corporation Miami, Florida, United States, 33175 United States, Georgia Atlanta Dermatology & Vein Research Center, PC Alpharetta, Georgia, United States, 30022 Gwinnett Clinical Research Center, Inc. Snellville, Georgia, United States, 30078 United States, Indiana Hudson Dermatology Evansville, Indiana, United States, 47714 United States, Kentucky Dermatology Specialists Louisville, Kentucky, United States, 40202 United States, Michigan Henry Ford Medical Center Detroit, Michigan, United States, 48202 Somerset Skin Centre Troy, Michigan, United States, 48084 United States, Nebraska Skin Specialists, P.C. Omaha, Nebraska, United States, 68144 United States, New York Dermatology Associates of Rochester, PC Rochester, New York, United States, 14623 United States, Rhode Island Clinical Partners, LLC Johnston, Rhode Island, United States, 02919 United States, Texas Suzanne Bruce and Associates, PA Houston, Texas, United States, 77056 Progressive Clinical Research San Antonio, Texas, United States, 78229 United States, Virginia Virginia Clinical Research, Inc. Norfolk, Virginia, United States, 23507 Canada, British Columbia Guildford Dermatology Specialist Surrey, British Columbia, Canada, V3R 6A7 Canada, Manitoba Dermadvances Research Winnipeg, Manitoba, Canada, R3C 1R4 Canada, Ontario Lynderm Research, Inc. Markham, Ontario, Canada, L3P 1A8 North Bay Dermatology Centre North Bay, Ontario, Canada, P1B3Z7 Less <<
NCT01017146 Acne Vulgaris Phase 3 Completed - -
NCT02728050 Acute Biphenotypic Leukemia ... More >> Acute Myeloid Leukemia de Novo Myelodysplastic Syndrome High Risk Myelodysplastic Syndrome Myelodysplastic Syndrome Myeloproliferative Neoplasm Less << Phase 1 Phase 2 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Anna Halpern    206-314-5944    halpern2@uw.edu    Principal Investigator: Anna Halpern Less <<
NCT02733809 Hepatocellular Carcinoma Phase 4 Recruiting December 2024 Saudi Arabia ... More >> King Saud University Medical City Recruiting Riyadh, Saudi Arabia, 7805 Contact: Weam S Husseim    +966541480459    wshussain@ksu.edu.sa    Principal Investigator: Dr. Mazen M Hassanain, MBBS FRCSC FACS PhD          Sub-Investigator: Prof. Ayman A Abdo, MD, FRCPC, FACP          Sub-Investigator: Dr. Khalid A Alswat, MD, ABIM, MRCP,FACP          Sub-Investigator: Prof. Waleed K Alhamoudi          Principal Investigator: Dr. Shouki M Bazarbashi Less <<
NCT02691780 Refractory Solid Tumors Not Applicable Active, not recruiting December 2018 Korea, Republic of ... More >> Samsung Medical Center Seoul, seoul, korea, Republic of, Korea, Republic of, 135-710 Less <<
NCT01019603 Acne Vulgaris Phase 1 Completed - United States, Texas ... More >> DermResearch, Inc. Austin, Texas, United States, 78759 Less <<
NCT03462680 Parkinson's Disease Not Applicable Recruiting September 30, 2019 United States, Georgia ... More >> Charlie Norwood VA Medical Center, Augusta, GA Recruiting Augusta, Georgia, United States, 30904 Contact: Thomas J Hartney, MD    706-733-0188 ext 2510    Tom.Hartney@va.gov    Contact: James P Hill    (706) 733-0188 ext 2508    James.Hill5@va.gov    Principal Investigator: Chandramohan Wakade, MBBS Less <<
NCT01017146 - Completed - -
NCT02760823 Toxicity Phase 2 Unknown January 2018 -
NCT02794337 Carcinoma, Hepatocellular Phase 2 Phase 3 Recruiting January 2022 India ... More >> Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre Recruiting Navi Mumbai, Maharashtra, India, 410210 Contact: Supriya Chopra, MD,DNB    022-27405000 ext 5510    schopra@actrec.gov.in    Advanced Centre of Treatment Research and Education In Cancer,Tata Memorial Centre Recruiting Navi Mumbai, Maharashtra, India, 410210 Contact: Dr Supriya Chopra, MD    91-22-27405000 ext 5491    schopra@actrec.gov.in    Principal Investigator: Supriya Chopra, MD Less <<
NCT01017120 - Completed - -
NCT03540758 Type 2 Diabetes Mellitus ... More >> Glucose Metabolism Disorders Glucose, High Blood Less << Phase 2 Recruiting November 2021 United States, New York ... More >> Albert Einstein College of Medicine Recruiting Bronx, New York, United States, 10461 Contact: Matthew Zhao, B.S.    718-430-2903    matthew.zhao@einstein.yu.edu    Principal Investigator: Meredith Hawkins, M.D., M.S. Less <<
NCT02834546 - Recruiting October 2019 France ... More >> Institut Bergonié Not yet recruiting Bordeaux, France Principal Investigator: Dominique BECHADE, MD          CHU de Limoges Not yet recruiting Limoges, France Principal Investigator: Véronique LOUSTAUD-RATTI, MD          CHU de Montpellier Not yet recruiting Montpellier, France Principal Investigator: Eric ASSENAT, MD          CHU de Bordeaux Recruiting Pessac, France Contact: Clémence FRON, MD    05 57 65 64 39 ext +33    clemence.fron@chu-bordeaux.fr    Contact: Nathalie TERRAS    05 57 62 34 60 ext +33    nathalie.terras@chu-bordeaux.fr    Principal Investigator: Clémence FRON, MD          Sub-Investigator: Jean-Frédéric BLANC, MD-PhD          CHU de Toulouse Not yet recruiting Toulouse, France Principal Investigator: Jean-Marie PERON, MD Less <<
NCT01094717 Psoriasis Not Applicable Terminated(lack of efficacy an... More >>d lack of funding) Less << - United States, Utah ... More >> University of Utah Department of Dermatology Salt Lake City, Utah, United States, 84132 Less <<
NCT02867280 Hepatocellular Carcinoma ... More >> Recurrence Less << Phase 3 Recruiting June 2023 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Minshan Cchen, M.D.    8620-87343117    chenmsh@sysucc.org.cn    Contact: Li Xu, M.D.       xuli@sysucc.org.cn    Principal Investigator: Minshan Chen, M.D. Less <<
NCT02856126 Hepatocellular Carcinoma Phase 3 Recruiting August 2018 China, Guangdong ... More >> Dongguan People's Hospital Recruiting Dongguan, Guangdong, China, 523059 Contact: Wusheng Yu, MD    13827285010    yuwusheng1998@126.com    Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD    8620-87343115    shiming@mail.sysu.edu.cn    The First Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Guosheng Tan, MD    13725254145    tgs1976@163.com    Guangzhou Twelfth People 's Hospital Recruiting Guangzhou, Guangdong, China, 510620 Contact: Yuanmin Zhou, MD    15521278919    13430288977@139.com    Principal Investigator: Jinghua Chen, MD          Kaiping Central Hospital Recruiting Kaiping, Guangdong, China, 529300 Contact: Shijie Zhang, MD    13717287622    Shijie_9262511@163.com    China, Hunan The First Affiliated Hospital of University Of South China Recruiting Hengyang, Hunan, China, 421001 Contact: Xiaoping Wu, MD    13975486015    wxp19730806@sina.com    China, Shanxi The First Affiliated Hospital Of Xi'an Jiaotong University Recruiting Xi'an, Shanxi, China, 710061 Contact: Xin Zheng, MD    13649265446    183421344@qq.com Less <<
NCT03615534 Atherogenic Dyslipidemia ... More >> Obesity Associated Disorder Less << Phase 4 Completed - Iraq ... More >> Al Kindy College of Medicine, University of Baghdad Baghdad, Iraq, 10045 Lewai S Abdulaziz Baghdad, Iraq, 10045 Less <<
NCT01112787 Acne Vulgaris Phase 1 Completed - United States, Arizona ... More >> HillTop Research Corporation Scottsdale, Arizona, United States, 85251 Less <<
NCT02910531 Cystinuria Phase 2 Recruiting December 2022 United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Less <<
NCT03615534 - Completed - -
NCT01115322 Acne Vulgaris Phase 1 Completed - United States, Arizona ... More >> HillTop Research Corporation Scottsdale, Arizona, United States, 85251 Less <<
NCT02908165 Hepatocellular Carcinoma Phase 2 Withdrawn(A future study will ... More >>be taking place using the same patient population.) Less << June 2020 United States, Connecticut ... More >> Smilow Cancer Center New Haven, Connecticut, United States, 06510 Less <<
NCT02937363 G6PD Deficiency Not Applicable Completed - Greece ... More >> Department of Physical Education & Sport Science of the University of Thessaly Trikala, Karyes, Greece, 42100 Less <<
NCT01136005 Cancer Skin R... More >>ash Less << Phase 3 Completed - Netherlands ... More >> Medisch Centrum Alkmaar Alkmaar, Netherlands, 1815 JD Deventer ziekenhuis Deventer, Netherlands, 7400 GC Admiraal de Ruyter Hospital Goes, Netherlands, 4460 BB Leiden University Medical Centre Leiden, Netherlands, 2333 ZA Waterland Hospital Purmerend, Netherlands, 1440AG Zaans Medisch Centrum Zaandam, Netherlands, 1500 EE Less <<
NCT01119651 Acne Vulgaris Phase 1 Completed - United States, Florida ... More >> HillTop Research Corporation Saint Petersburg, Florida, United States, 33710 Less <<
NCT02971696 HCC Phase 3 Completed - Egypt ... More >> El Kahraba Hosital Cairo, N/A = Not Applicable, Egypt, 1234 Ain Shams University Hospital Cairo, Egypt Nasser Institute Cairo, Egypt Less <<
NCT02988440 Hepatocellular Carcinoma Phase 1 Recruiting August 16, 2019 United States, Michigan ... More >> Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Colette Zack       zackc@karmanos.org    Principal Investigator: Philip A. Philip          Canada, Quebec Novartis Investigative Site Recruiting Montreal, Quebec, Canada, H3T 1E2 France Novartis Investigative Site Terminated Clichy, France, 92110 Germany Novartis Investigative Site Completed Essen, Germany, 45147 Hong Kong Novartis Investigative Site Active, not recruiting Hong Kong, Hong Kong Italy Novartis Investigative Site Recruiting Rozzano, MI, Italy, 20089 Japan Novartis Investigative Site Active, not recruiting Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Active, not recruiting Yokohama city, Kanagawa, Japan, 232 0024 Spain Novartis Investigative Site Completed Pamplona, Navarra, Spain, 31008 Taiwan Novartis Investigative Site Active, not recruiting Taipei, Taiwan, 10002 Less <<
NCT02961998 Hepatocellular Carcinoma Phase 4 Completed - -
NCT03037437 Hepatocellular Cancer Phase 2 Recruiting December 2018 United States, Texas ... More >> University of Texas Health Cancer Center Recruiting San Antonio, Texas, United States, 78229 Contact: Epp Goodwin    210-450-5798    goodwine@uthscsa.edu Less <<
NCT03752918 Post Traumatic Stress Disorder Phase 1 Not yet recruiting July 15, 2021 United States, Connecticut ... More >> Connecticut Mental Health Center Not yet recruiting New Haven, Connecticut, United States, 06519 Contact: Benjamin Kelmendi, MD    203-974-7752    ben.kelmendi@yale.edu Less <<
NCT03140332 Hepatocellular Carcinoma ... More >> Perfusion Scanner Less << Not Applicable Recruiting February 27, 2020 France ... More >> CHU Amiens Picardie Recruiting Amiens, Picardie, France, 80054 Contact: Vincent HAUTEFEUILLE, Dr    +33322668206    hautefeuille.vincent@chu-amiens.fr Less <<
NCT01114841 Acne Vulgaris Phase 1 Completed - United States, Arizona ... More >> HillTop Research Corporation Scottsdale, Arizona, United States, 85251 Less <<
NCT03161028 Multiple Sclerosis Phase 2 Recruiting April 1, 2021 United States, Alabama ... More >> University of Alabama at Birmingham Not yet recruiting Birmingham, Alabama, United States, 35294 Contact: Kerry Howard    205-934-1885    kdhoward@uabmc.edu    Contact: John Rinker II, MD       jrinker@uabmc.edu    United States, District of Columbia Washington DC VA Medical Center, Washington, DC Not yet recruiting Washington, District of Columbia, United States, 20422 Contact: Heidi Maloni, PhD    202-745-8000 ext 57873    Heidi.Maloni@va.gov    Contact: Mitchell T Wallin, MD    2027458146    mitchell.wallin@va.gov    United States, Oregon VA Portland Health Care System, Portland, OR Recruiting Portland, Oregon, United States, 97239 Contact: Carin Waslo    503-418-2141    waslo@ohsu.edu    Contact: Cassidy A Taylor    (503) 220-8262    Cassidy.Taylor@va.gov    Principal Investigator: Rebecca I. Spain, MD MSPH          United States, Utah University of Utah Recruiting Salt Lake City, Utah, United States, 84148 Contact: LaWanda Esquibel    801-587-3864    Lawanda.Esquibel@hsc.utah.edu    Contact: Mateo Paz Soldan, MD       miguel.pazsoldan@va.gov    VA Salt Lake City Health Care System, Salt Lake City, UT Recruiting Salt Lake City, Utah, United States, 84148 Contact: Connie Kawai    323-442-5814    constance.kawai@med.usc.edu    Contact: Lawanda Esquibel    8015873864    lawanda.esquibel@hsc.utah.edu    United States, Vermont University of Vermont Recruiting Burlington, Vermont, United States, 05401 Contact: Roman Pettigrew    802-847-6039    Roman.Pettigrew@uvmhealth.org    Contact: Andrew Solomon, MD    8028474589    Andrew.Solomon@uvmhealth.org    United States, Washington VA Puget Sound Health Care System Seattle Division, Seattle, WA Not yet recruiting Seattle, Washington, United States, 98108 Contact: Alicia Sloan, MSW    800-329-8387 ext 63593    alicia.sloan@va.gov    Contact: Jodie Haselkorn, MD       Jodie.Haselkorn@va.gov    Swedish Medical Center Recruiting Seattle, Washington, United States, 98122 Contact: Laura Johnson    206-320-7115    laura.johnson3@swedish.org    Contact: Pavle Repovic, MD    2063202200    Pavle.Repovic@swedish.org    Canada, Ontario Ottawa Hospital Research Institute Not yet recruiting Ottawa, Ontario, Canada, K1Y 4E9 Contact: Carol Freedman    613-737-8104 ext 2    cfreedman@toh.ca    Contact: Mark Freedman, MD       mfreedman@toh.ca Less <<
NCT03113604 - Withdrawn(The study has been s... More >>topped because no one is) Less << - France ... More >> CHU Amiens Picardie Amiens, Picardie, France, 80054 Less <<
NCT03170895 AML FLT3-ITD ... More >>Mutation Less << Phase 2 Recruiting October 1, 2021 Hong Kong ... More >> The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Chunxiao Zhang, SC    852-22554361    chunxiao@hku.hk Less <<
NCT01279629 - Suspended - -
NCT03097848 HCC Not Applicable Recruiting December 31, 2018 China, Chongqing ... More >> Southwest Hospital Recruiting Chongqing, Chongqing, China, 400038 Contact: kuansheng Ma, MD Less <<
NCT03212625 Hepatocellular Carcinoma Phase 4 Active, not recruiting January 31, 2019 Korea, Republic of ... More >> Korea University Guro Hospital Seoul, Korea, Republic of, 08308 Less <<
NCT02989870 HepatoCellular Carcinoma ... More >> Unresectable HepatoCellular Carcinoma Liver Cancer Less << Phase 1 Withdrawn(No Interest. Investi... More >>gator was unable to enroll any participants on study.) Less << - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT03236649 Hepatocellular Carcinoma (HCC) Phase 3 Not yet recruiting August 2019 -
NCT03257514 Cesarean Section; Dehiscence ... More >> Cesarean Scar Niche Less << Phase 2 Completed - Egypt ... More >> Ain Shams University Maternity Hospital Cairo, Abbassia, Egypt, 02002 Less <<
NCT03178656 Portal Vein Tumor Thrombus Phase 4 Recruiting December 15, 2019 China, Hubei ... More >> Hepatic surgery center, Tong ji Hospital Recruiting Wuhan, Hubei, China, 430030 Contact: Xiaoping Chen, Doctor    8602783662851    chenxp@medmail.com.cn    Contact: Qiong Gong, Doctor    8618086496360    dtjgq486@hust.edu.cn    Principal Investigator: peng zhu, doctor Less <<
NCT03211416 Advanced Adult Hepatocellular ... More >>Carcinoma Child-Pugh Class A Stage III Hepatocellular Carcinoma Stage IIIA Hepatocellular Carcinoma Stage IIIB Hepatocellular Carcinoma Stage IIIC Hepatocellular Carcinoma Stage IV Hepatocellular Carcinoma Stage IVA Hepatocellular Carcinoma Stage IVB Hepatocellular Carcinoma Less << Phase 1 Phase 2 Recruiting October 11, 2019 United States, New York ... More >> Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Roswell Park    877-275-7724    ASKRPCI@roswellpark.org    Principal Investigator: Renuka V. Iyer Less <<
NCT03428139 Radicular; Neuropathic, Lumbar... More >>, Lumbosacral Less << Phase 2 Completed - Egypt ... More >> Assiut university faculty of medicine Assiut, Egypt, 7111 Less <<
NCT02449070 Myocardial Infarction Phase 3 Recruiting October 2018 Korea, Republic of ... More >> Pusan National University Hospital Recruiting Pusan, Korea, Republic of Contact: Jun-Hyok Oh, MD       jhoh724@hanmail.net Less <<
NCT02328521 Angina, Unstable ... More >> Diabetes Mellitus Less << Phase 4 Unknown July 2016 China, Beijing ... More >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Yundai Chen, M.D.    86-010-55499309    cyundai@medmail.com.cn Less <<
NCT02435797 Coronary Heart Disease Phase 4 Unknown October 2016 China, Jiangsu ... More >> Xuzhou Central Hospital Recruiting Xuzhou, Jiangsu, China, 221000 Contact: Feng chunguang, PhD    +8618936376559    fcg999@163.com    Sub-Investigator: Feng chunguang, PhD Less <<
NCT03342599 Metabolic Syndrome ... More >> Obesity Less << Not Applicable Completed - United States, California ... More >> University of La Verne Kinesiology Laboratory La Verne, California, United States, 91750 Less <<
NCT03412773 Hepatocellular Carcinoma (HCC) Phase 3 Recruiting May 2022 -
NCT00050271 HIV Infections ... More >> Peripheral Nervous System Diseases Less << Not Applicable Completed - United States, California ... More >> Stanford CRS Palo Alto, California, United States, 94305 United States, Georgia The Ponce de Leon Ctr. CRS Atlanta, Georgia, United States, 30308 United States, Hawaii Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu, Hawaii, United States United States, Illinois Northwestern University CRS Chicago, Illinois, United States, 60611-3015 Cook County Hosp. CORE Ctr. Chicago, Illinois, United States, 60612 United States, Maryland Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States, 21287-8106 United States, Missouri Washington U CRS St. Louis, Missouri, United States, 63108-2138 United States, New York Beth Israel Med. Ctr., ACTU New York, New York, United States, 10003 Weill Med. College of Cornell Univ., The Cornell CTU New York, New York, United States United States, Washington University of Washington AIDS CRS Seattle, Washington, United States, 90033-1079 Puerto Rico Puerto Rico-AIDS CRS San Juan, Puerto Rico, 00936-5067 Less <<
NCT03493841 Multiple Sclerosis ... More >> Progressive Multiple Sclerosis Secondary Progressive Multiple Sclerosis Primary Progressive Multiple Sclerosis Less << Phase 1 Recruiting September 1, 2019 United States, Oregon ... More >> Oregon Health & Science University Recruiting Portland, Oregon, United States, 97239 Contact: Cassidy Taylor       taylocas@ohsu.edu    Principal Investigator: Michelle Cameron Less <<
NCT03491969 Ischemic Heart Failure Phase 4 Not yet recruiting April 30, 2022 -
NCT00033436 Bladder Cancer Phase 3 Completed - United Kingdom ... More >> Sussex Cancer Centre at Royal Sussex County Hospital Brighton, England, United Kingdom, BN2 5BF Bristol Haematology and Oncology Centre Bristol, England, United Kingdom, BS2 8ED Kent and Canterbury Hospital Canterbury, England, United Kingdom, CT2 3NG Derbyshire Royal Infirmary Derby, England, United Kingdom, DE1 2QY Ipswich Hospital NHS Trust Ipswich, England, United Kingdom, IP4 5PD Cookridge Hospital at Leeds Teaching Hospital NHS Trust Leeds, England, United Kingdom, LS16 6QB Christie Hospital NHS Trust Manchester, England, United Kingdom, M20 4BX Clatterbridge Centre for Oncology NHS Trust Merseyside, England, United Kingdom, CH63 4JY Northern Centre for Cancer Treatment at Newcastle General Hospital Newcastle-Upon-Tyne, England, United Kingdom, NE4 6BE Mount Vernon Cancer Centre at Mount Vernon Hospital Northwood, England, United Kingdom, HA6 2RN Nottingham City Hospital NHS Trust Nottingham, England, United Kingdom, NG5 1PB Oldchurch Hospital Romford, England, United Kingdom, RM7 OBE Cancer Research Centre at Weston Park Hospital Sheffield, England, United Kingdom, S1O 2SJ Velindre Cancer Center at Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL Less <<
NCT03518502 Hepatocellular Carcinoma ... More >> Metastasis Less << Phase 4 Recruiting February 28, 2022 Korea, Republic of ... More >> Korea University Ansan Hospital Recruiting Ansan, Gyeonggi-do, Korea, Republic of, 425-707 Contact: Hyung Joon Yim, M.D.    82-31-412-6565    gudwns21@korea.ac.kr    Contact: Sang Jun Suh, M.D.    82-31-412-4926    mothpickle@naver.com    Principal Investigator: Hyung Joon Yim, M.D.          Sub-Investigator: Sang Jun Suh, M.D.          Sub-Investigator: Young Kul Jung, M.D.          Soonchunghyang University Bucheon Hospital Recruiting Bucheon, Gyeonggi-do, Korea, Republic of Contact: Young-Seok Kim          Keimyung University Dongsan Hospital Recruiting Daegu, Korea, Republic of Contact: Woo Jin Chung          Chonnam National University Hwasoon Hospital Recruiting Gwangju, Korea, Republic of Contact: Sung-Bum Cho, M.D.          Seoul Saint Marry Hospital, the Catholic University of Korea Recruiting Seoul, Korea, Republic of Contact: Si-Hyun Bae          Severance Hospital, Yonsei University Recruiting Seoul, Korea, Republic of Contact: Jun Yong Park, M.D. Less <<
NCT03535259 Hepatocellular Carcinoma, Radi... More >>otherapy, Sorafenib Less << Phase 2 Recruiting April 1, 2021 China, Beijing ... More >> Bo Chen Recruiting Beijing, Beijing, China, 100021 Contact: Bo Chen, MD    008613240000876    chenboo@outlook.com    Contact: Yexiong Li, MD    00861087788860    yexiong12@163.com    Principal Investigator: Yexiong Li, MD          Principal Investigator: Bo Chen, MD          Sub-Investigator: Huiying Zeng, MD          Sub-Investigator: Liming Wang, MD Less <<
NCT03565536 Thyroid Cancer, Anaplastic Phase 2 Recruiting October 30, 2019 China, Fujian ... More >> Fujian Medical University Union Hospital Recruiting FuZhou, Fujian, China, 350001 Contact: bo wang, md    13705947900    wangbo@fjmu.edu.cn Less <<
NCT03589690 Metabolic Syndrome Not Applicable Not yet recruiting July 25, 2019 -
NCT03622541 FLT3-ITD Mutation ... More >> AML Less << Phase 2 Recruiting November 2019 Hong Kong ... More >> The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Chunxiao Zhang, SC    852-22554361    chunxiao@hku.hk Less <<
NCT03612037 PreDiabetes Not Applicable Active, not recruiting December 30, 2018 -
NCT03606590 Hepatocellular Carcinoma Phase 2 Recruiting December 2020 Spain ... More >> Vall d'Hebron Institute of Oncology (VHIO) Recruiting Barcelona, Spain Contact: Teresa Macarulla, Dr.    +34-932748855    tmacarulla@vhio.net    Contact: Raquel García Pelaez    +34-934893000    rgarcia@vhio.net    Principal Investigator: Teresa Macarulla Mercade, Dr.          HM Hospitales - Centro Integral Oncológico Clara Campal Recruiting Madrid, Spain, 28050 Contact: Antonio Cubillo, Dr.       acubillo@hmhospitales.com    Principal Investigator: acubillo@hmhospitales.com acubillo@hmhospitales.com, Dr. Less <<
NCT03645980 Hepatocellular Carcinoma Phase 1 Phase 2 Recruiting August 31, 2022 Germany ... More >> Universitätsmedizin Mainz, I. Med. Klinik und Poliklinik Recruiting Mainz, Germany, 55131 Contact: Jens U Marquardt, Dr.med.    +49 6131 17 ext 6863    marquarj@uni-mainz.de Less <<
NCT00580216 Atrial Fibrillation Phase 3 Terminated(early discontinuati... More >>on based on strategic sponsor decision not driven by any safety concern) Less << - -
NCT03517618 Metastatic Colorectal Cancer Phase 2 Completed - Taiwan ... More >> Chang-Gung Memorial Hospital, Linkou Linkou, Taiwan Less <<
NCT03582618 Hepatocellular Carcinoma ... More >> Advanced Cancer Less << Phase 2 Recruiting June 2021 United States, California ... More >> Innovative Clinical Research Institute Recruiting Whittier, California, United States, 90603 United States, South Carolina Charleston Hematology Oncology Associates Recruiting Charleston, South Carolina, United States, 29403 Taiwan National Cheng Kung University Hospital Not yet recruiting Tainan, Taiwan, 704 Less <<
NCT03674060 Healthy, Male Phase 1 Not yet recruiting February 2019 -
NCT00071136 Lung Neoplasms Phase 1 Phase 2 Completed - United States, Florida ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC-GMT - 5 hours, EST), or speak with your personal physician. Ft. Myers, Florida, United States United States, Minnesota For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC-GMT - 5 hours, EST), or speak with your personal physician. Marshfield, Minnesota, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC-GMT - 5 hours, EST), or speak with your personal physician. Minneapolis, Minnesota, United States United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC-GMT - 5 hours, EST), or speak with your personal physician. Rochester, New York, United States United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC-GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States Less <<
NCT00002812 Leukemia Phase 3 Completed - -
NCT00003934 Adult Acute Myeloid Leukemia W... More >>ith t(15;17)(q22;q12) Adult Acute Promyelocytic Leukemia (M3) Childhood Acute Promyelocytic Leukemia (M3) Untreated Adult Acute Myeloid Leukemia Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 3 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 United States, North Carolina Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States, 27157 Less <<
NCT03755791 Hepatocellular Carcinoma Phase 3 Recruiting December 1, 2021 United States, California ... More >> Exelixis Clinical Site #2 Recruiting Rialto, California, United States, 92377 Contact: Exelixis    888-393-5494    druginfo@exelixis.com    United States, Nevada Exelixis Clinical Site #1 Recruiting Las Vegas, Nevada, United States, 89169 Contact: Exelixis    888-393-5494    druginfo@exelixis.com Less <<
NCT00003060 Melanoma (Skin) Phase 1 Unknown - United States, Louisiana ... More >> Louisiana State University School of Medicine Shreveport, Louisiana, United States, 71130-3932 Less <<
NCT00004216 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Texas Mary Crowley Medical Research Center Dallas, Texas, United States, 75246 Less <<
NCT00078559 Kidney Transplantation ... More >> Kidney Disease Less << Phase 1 Phase 2 Completed - United States, Wisconsin ... More >> University of Wisconsin - Department of Medicine Madison, Wisconsin, United States, 53792-1735 Less <<
NCT00048568 Rheumatoid Arthritis Phase 3 Completed - -
NCT00074191 Lymphoma Phase 2 Completed - United States, Oregon ... More >> Oregon Health & Science University Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT00074178 Lymphoma Phase 2 Completed - United States, Oregon ... More >> Oregon Health & Science University Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT00074269 Breast Cancer Phase 2 Terminated(Terminated early du... More >>e to poor enrollment) Less << - United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 Less <<
NCT00078559 - Completed - -
NCT00074269 - Terminated(Terminated early du... More >>e to poor enrollment) Less << - -
NCT00074438 Rheumatoid Arthritis Phase 2 Completed - -
NCT00003388 Lymphoma Phase 2 Completed - United States, California ... More >> Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States, 94304 Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, New Jersey Raritan Bay Medical Center Perth Amboy, New Jersey, United States, 08861 United States, New York Albert Einstein Comprehensive Cancer Center Bronx, New York, United States, 10461 MBCCOP-Our Lady of Mercy Cancer Center Bronx, New York, United States, 10466 Less <<
NCT03558646 - Recruiting February 1, 2019 France ... More >> Saint-Louis Hospital Recruiting Paris, Ile-De-France, France, 75010 Contact: François Dépret, MD.    +33142494348    francois.depret@aphp.fr Less <<
NCT00076206 Rheumatoid Arthritis Phase 2 Terminated - -
NCT00003446 Colorectal Cancer Phase 2 Completed - Argentina ... More >> Grupo Oncologico Cooperativo del Sur Bahia Blanca, Buenos Aires, Argentina, 8000 Less <<
NCT00002531 Leukemia Phase 2 Unknown - Germany ... More >> Klinikum der J.W. Goethe Universitaet Frankfurt, Germany, D-60590 Less <<
NCT00003937 Cardiac Toxicity ... More >> Sarcoma Less << Phase 3 Completed - -
NCT00003632 Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00027924 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00019409 Leukemia Phase 3 Withdrawn - United States, Maryland ... More >> Pediatric Oncology Branch Bethesda, Maryland, United States, 20892 United States, Texas Texas Tech University Health Sciences Center School of Medicine Amarillo, Texas, United States, 79106 India Kidwai Memorial Institute of Oncology Bangalore, India, 560029 Cancer Institute (W.I.A.) Madras, India, 600020 Tata Memorial Centre Mumbai, India, 400012 All-India Institute of Medical Sciences New Delhi, India, 110029 Less <<
NCT00013689 Autoimmune Disease ... More >> Lymphoproliferative Disorder Less << Phase 1 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT00048568 - Completed - -
NCT00002893 Colorectal Cancer Phase 3 Unknown - United Kingdom ... More >> Velindre Hospital Cardiff, Wales, United Kingdom, CF4 7XL Less <<
NCT00424502 - Completed - -
NCT02382328 Carpal Tunnel Syndrome Phase 2 Completed - Mexico ... More >> Antiguo Hospital Civil de Guadalajara Fray Antonio Alcalde Guadalajara, Jalisco, Mexico, 44280 Less <<
NCT00424645 Hematologic Malignancy ... More >> Solid Tumor Less << Phase 1 Phase 2 Terminated(Sponsor terminated ... More >>due to low accrual.) Less << - United States, Texas ... More >> U.T. M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00002532 Leukemia Phase 2 Unknown - Germany ... More >> Medizinische Hochschule Hannover Hannover, Germany, D-30625 Less <<
NCT02966665 Chronic Obstructive Pulmonary ... More >>Disease Pulmonary Artery Hypertension Heart Failure Hypertension Less << Phase 1 Recruiting August 2020 United States, Utah ... More >> George E Wahlen VA Medical Center Recruiting Salt Lake City, Utah, United States, 84132 Contact: Russell Richardson, Ph.D.    801-582-1565    r.richardson@hsc.utah.edu    Contact: Ashley Nelson, MD    801-582-1565 ext 4127    ash.nelson@hsc.utah.edu Less <<
NCT02056366 Type 2 Diabetes ... More >> Cardiac Autonomic Neuropathy Less << Phase 4 Completed - Korea, Republic of ... More >> The Catholic University of Korea Seoul, Korea, Republic of, 137-701 Eulji General Hospital Seoul, Korea, Republic of Sejong General Hospital Seoul, Korea, Republic of Less <<
NCT02066181 Desmoid-Type Fibromatosis Phase 3 Active, not recruiting - -
NCT02050919 Pleomorphic Rhabdomyosarcoma ... More >> Stage IIB Adult Soft Tissue Sarcoma AJCC v7 Stage III Adult Soft Tissue Sarcoma AJCC v7 Stage IV Adult Soft Tissue Sarcoma AJCC v7 Less << Phase 2 Active, not recruiting December 31, 2018 United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 Less <<
NCT02981498 Hepatocellular Carcinoma Phase 2 Recruiting April 2017 China, Guangdong ... More >> Cancer Center, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD       Shiming@sysu.edu.cn Less <<
NCT02069145 Hepatocellular Cancer ... More >> Liver Cancer Less << Phase 1 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Colorado University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, Indiana Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Massachusetts Massachussetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York Mount Sinai Medical Center New York, New York, United States, 10029 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT02072486 Advanced Adult Hepatocellular ... More >>Carcinoma Localized Non-Resectable Adult Hepatocellular Carcinoma Stage III Childhood Hepatocellular Carcinoma Stage IIIA Hepatocellular Carcinoma Stage IIIB Hepatocellular Carcinoma Stage IIIC Hepatocellular Carcinoma Stage IV Childhood Hepatocellular Carcinoma Stage IVA Hepatocellular Carcinoma Stage IVB Hepatocellular Carcinoma Less << Not Applicable Active, not recruiting December 3, 2018 United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT03009461 HepatoCellular Carcinoma ... More >> Portal Vein Thrombosis Less << Phase 2 Recruiting December 2019 China, Beijing ... More >> Peking University Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Xiaodong Wang, MD    008610-88196476    wangxde@gmail.com    Sub-Investigator: Guang Cao, MD          Sub-Investigator: Hui Chen, MD          Sub-Investigator: Jianhai Guo, MD          Sub-Investigator: Haifeng Xu, MD          Sub-Investigator: Peng Liu, MD          Sub-Investigator: Jungang Hu, MD Less <<
NCT02084732 Thyroid Cancer Phase 2 Unknown June 2018 Colombia ... More >> Instituto Nacional de Cancerología Recruiting Bogotá, Cundinamarca, Colombia, 00000 Contact: Yeinnyer C. Muleth, BSc    3340106    ymuleth@cancer.gov.co    Principal Investigator: Luis F Fierro, Md          Sub-Investigator: Gloria Garavito, Md          Sub-Investigator: Andres A Cuellar, Md          Sub-Investigator: Jose A. Carreño, Md          Sub-Investigator: Juan S Castillo, Md Less <<
NCT02103959 Non STEMI Uns... More >>table Angina Less << Phase 2 Completed - -
NCT03031444 Colorectal Cancer Stage IV ... More >> Metastasis Less << Phase 2 Phase 3 Recruiting December 2018 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Kun Wang, MD    86-010-88196559    wang-kun@vip.sina.com    Sub-Investigator: Kemin Jin, MD          Sub-Investigator: Da Xu, MD          Sub-Investigator: Jian Li, MD          Sub-Investigator: Yunfeng Yao, MD          Sub-Investigator: Ming Liu, MD          Sub-Investigator: Baocai Xing, MD          China, Sichuan West China Hospital, Sichuan University Recruiting Chengdu, Sichuan, China, 610041 Contact: Meng Qiu, MD          China, Yunnan First Affiliated Hospital of Kunming Medical University Recruiting Kunming, Yunnan, China, 650032 Contact: Wenliang Li, MD          China, Zhejiang Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Jieer Ying, MD Less <<
NCT03023514 Women Infertility Phase 4 Completed - Greece ... More >> Iakentro Advanced Medical Centre, IVF Unit Thessaloniki, Greece Less <<
NCT01396395 Stable Angina ... More >> Coronary Disease Less << Phase 4 Completed - China ... More >> For Locations in Beijing, China Less <<
NCT02114658 Thyroid Carcinoma Phase 2 Completed - Japan ... More >> Kobe, Hyogo, Japan, 650-0011 Matsumoto, Nagano, Japan, 390-8621 Bunkyo-ku, Tokyo, Japan, 113-8603 Koto-ku, Tokyo, Japan, 135-8550 Osaka, Japan, 545-8586 Less <<
NCT03019666 Multiple Myeloma ... More >> Non-Hodgkin Lymphoma Diffuse Large B Cell Lymphoma Mantle-Cell Lymphoma Follicular Lymphoma Indolent B Cell Lymphoma Primary Mediastinal Lymphoma Lymphoplasmacytic Lymphoma Less << Phase 1 Recruiting March 31, 2020 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski, RN    612-273-2800    tkrepsk1@fairview.org    Principal Investigator: Veronika Bachanova, MD, PhD Less <<
NCT02702492 NHL Solid Tum... More >>ors Less << Phase 1 Recruiting November 2019 United States, Colorado ... More >> University of Colorado Cancer Center Recruiting Aurora, Colorado, United States, 80045 Contact: Stephen Leong, MD       Stephen.Leong@ucdenver.edu    Principal Investigator: Stephen Leong, MD          United States, District of Columbia Georgetown University, Lombardi Comprehensive Cancer Center Recruiting Washington, District of Columbia, United States, 20007 Contact: Michael Pishvaian, MD, PhD       pishvaim@georgetown.edu    Principal Investigator: Michael Pishvaian, MD, PhD          United States, Minnesota Mayo Clinic Rochester Recruiting Rochester, Minnesota, United States, 55905 Contact: Amit Mahipal, MBBS, MPH    507-293-0462    mahipal.amit@mayo.edu    Principal Investigator: Amit Mahipal, MBBS, MPH          United States, New York NYU-Laura & Isaac Perlmutter Cancer Center Recruiting New York, New York, United States, 100016 Contact: Daniel Cho    212-731-5871    daniel.cho@nyumc.org    Principal Investigator: Daniel Cho, MD          United States, Tennessee Vanderbilt-Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Jordan Berlin, MD          Contact       Jordan.Berlin@vanderbilt.edu    Principal Investigator: Jordan Berlin, MD          United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Aung Naing    713-563-0803    anaing@mdanderson.org    Principal Investigator: Aung Naing, MD          Canada, Ontario Princess Margaret Hospital Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Albiruni Razak, MB, BCh    416-586-4800 ext 3883       Principal Investigator: Albiruni Razak, MB, Bch Less <<
NCT02133664 Multiple Sclerosis ... More >> Cognition Less << Phase 1 Phase 2 Completed - United States, Oregon ... More >> Oregon Health and Science University Portland, Oregon, United States, 97239 Less <<
NCT01396395 - Completed - -
NCT03012529 Osteomyelitis ... More >> Diabetes Amputation Less << Phase 4 Recruiting July 30, 2022 -
NCT02122003 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Terminated(availability of new... More >> and more promising therapeutic agents than expected in the experimentation in question) Less << - Italy ... More >> Istituto Tumori Milan, Mi, Italy, 20156 Less <<
NCT03062163 Lipolysis Not Applicable Completed - Thailand ... More >> Faculty of Medicine, Chulalongkorn University Bangkok, Thailand, 10330 Less <<
NCT03045770 Advanced Gastric Cancer Adenoc... More >>arcinoma of Esophagogastric Junction Less << Not Applicable Not yet recruiting December 30, 2019 China, Fujian ... More >> Jianwei Yang Enrolling by invitation Fuzhou, Fujian, China, 350000 Less <<
NCT02133664 - Completed - -
NCT02129322 Hepatocellular Carcinoma Phase 2 Not yet recruiting December 2019 China ... More >> First affiliated hospital, Zhejiang University Not yet recruiting Hangzhou, China Contact: Weijiafang fang          Principal Investigator: Weijia fang, MD Less <<
NCT02150317 Advanced Hepatocellular Carcin... More >>oma Less << Not Applicable Unknown December 2016 China, Shanghai ... More >> Eastern Hepatobiliary Surgery Hospital Recruiting Shanghai, Shanghai, China, 200438 Contact: Ai-jun Li, M.D.    0086-021-81875531    yinlei409@hotmail.com    Contact: Lei Yin, M.D.    0086-021-81875532    dermatology2008@126.com Less <<
NCT03084809 Colorectal Cancer ... More >> Cytokine-induced Killer Cells Postoperative Complications Survival Less << Phase 4 Completed - -
NCT03111810 Iatrogenic Cushing's Disease Phase 2 Recruiting January 2019 United Kingdom ... More >> University of Oxford Recruiting Oxford, United Kingdom Contact: Jeremy W Tomlinson, MD PhD    44(0)1865 857359    jeremy.tomlinson@ocdem.ox.ac.uk    Contact: Nadia Othonos, MD       Nantia.Othonos@ocdem.ox.ac.uk Less <<
NCT02185560 - Recruiting June 30, 2021 Japan ... More >> Recruiting Multiple Locations, Japan Less <<
NCT02187081 HCC Not Applicable Recruiting December 2018 China, Chongqing ... More >> Southwest Hospital Recruiting Chongqing, Chongqing, China, 400038 Contact: Xiaobin Feng          Principal Investigator: Kuansheng Ma, Ph.D Less <<
NCT02143401 Cirrhosis Hep... More >>atitis B Infection Hepatitis C Infection Metastatic Malignant Solid Neoplasm Recurrent Hepatocellular Carcinoma Recurrent Malignant Solid Neoplasm Refractory Malignant Neoplasm Stage IV Hepatocellular Carcinoma AJCC v7 Unresectable Solid Neoplasm Less << Phase 1 Recruiting - United States, Arizona ... More >> Mayo Clinic in Arizona Recruiting Scottsdale, Arizona, United States, 85259 Contact: Site Public Contact    855-776-0015       Principal Investigator: Brian A. Costello          United States, California University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Site Public Contact    916-734-3089       Principal Investigator: Edward J. Kim          United States, Colorado University of Colorado Hospital Recruiting Aurora, Colorado, United States, 80045 Contact: Site Public Contact    720-848-0650       Principal Investigator: Sarah L. Davis          United States, Florida Mayo Clinic in Florida Recruiting Jacksonville, Florida, United States, 32224-9980 Contact: Site Public Contact    855-776-0015       Principal Investigator: Brian A. Costello          United States, Iowa University of Iowa/Holden Comprehensive Cancer Center Recruiting Iowa City, Iowa, United States, 52242 Contact: Site Public Contact    800-237-1225       Principal Investigator: Mohammed M. Milhem          United States, Maryland University of Maryland/Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Site Public Contact    800-888-8823       Principal Investigator: Edward A. Sausville          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Site Public Contact    855-776-0015       Principal Investigator: Brian A. Costello          United States, New York Columbia University/Herbert Irving Cancer Center Recruiting New York, New York, United States, 10032 Contact: Site Public Contact    212-305-6361    nr2616@cumc.columbia.edu    Principal Investigator: Gulam A. Manji          United States, Pennsylvania Thomas Jefferson University Hospital Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Site Public Contact    215-955-6084       Principal Investigator: James A. Posey          United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Site Public Contact    877-312-3961       Principal Investigator: Ahmed O. Kaseb Less <<
NCT02196857 Leukemia Phase 2 Active, not recruiting February 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02178358 Hepatocellular Carcinoma Phase 2 Active, not recruiting December 31, 2018 China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bengbu, China, 233004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changchun, China, 130012 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China, 310016 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hefei, China, 230022 Hong Kong For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hong Kong, Hong Kong For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kowloon, Hong Kong Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Incheon, Korea, Republic of, 405-760 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 135 720 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gwei Shan Township, Taiwan, 333 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Liouying/Tainan, Taiwan, 736 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Puzih City, Taiwan, 613 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tainan, Taiwan, 70403 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 11217 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taoyuan, Taiwan, 33378 Thailand For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bangkok, Thailand, 10330 Less <<
NCT00648986 Brittle Nails Phase 4 Completed - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT03164382 Liver Cancer ... More >>Hepatic Carcinoma Less << Phase 3 Recruiting December 31, 2022 China, Guangdong ... More >> Minimally Invasive Interventional Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Recruiting Guangzhou, Guangdong, China, 500060 Contact: Ming Zhao, MD    86-20-87343272    zhaoming@sysucc.org.cn Less <<
NCT03177395 Paracetamol Overdose Phase 1 Enrolling by invitation December 31, 2018 United Kingdom ... More >> Royal Infirmary of Edinburgh Edinburgh, City Of Edinburgh, United Kingdom, EH16 4SA Less <<
NCT02227914 Advanced Hepatocellular Carcin... More >>oma Less << Phase 1 Phase 2 Withdrawn(Study stopped due to... More >> administrative reasons) Less << - United States, California ... More >> Lahey Hospital & Medical Center Burlington, California, United States United States, Colorado Rocky Mountain Cancer Centers Denver, Colorado, United States United States, Florida University of Miami Hospital & Clinics Miami, Florida, United States United States, Illinois The University of Chicago Medical Center Chicago, Illinois, United States United States, Ohio The Ohio State University, Martha Morehouse Medical Plaza Columbus, Ohio, United States United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States Less <<
NCT03132454 Hematopoietic/Lymphoid Cancer ... More >> Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Less << Phase 1 Recruiting July 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       tkadia@mdanderson.org Less <<
NCT01475123 Coronary Artery Disease ... More >> End Stage Renal Disease Less << Phase 4 Active, not recruiting December 2018 Japan ... More >> Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University Kumamoto, Japan, 860-8556 Less <<
NCT03198507 Helicobacter Pylori Infection ... More >> Dyspepsia Less << Phase 3 Active, not recruiting January 2019 -
NCT02836184 Hyperphosphatemia Phase 4 Unknown September 2016 China, Jiangxi ... More >> Jiujiang NO.1 People's Hospital Recruiting Jiujiang, Jiangxi, China, 332000 Less <<
NCT02240433 Hepatocellular Carcinoma Phase 1 Active, not recruiting February 11, 2019 Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 277 8577 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 241-8515 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Suita-shi, Japan, 565-0871 Less <<
NCT02220088 Hepatocellular Carcinoma Phase 2 Phase 3 Completed - China, Guangdong ... More >> Cancer Center Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Less <<
NCT03222089 Metastatic Colorectal Cancer Phase 2 Withdrawn(Another study enroll... More >>ing the similar group of patient are ongoing) Less << July 20, 2020 China, Fujian ... More >> Rongbo Lin Fuzhou, Fujian, China, 350014 Less <<
NCT03226340 Essential Hypertension Phase 4 Recruiting March 31, 2018 Korea, Republic of ... More >> Hallym University Medical Center Recruiting Anyang, Dongan-gu, Korea, Republic of, 14068 Contact: Sang-Ho Jo    82-31-380-3722    sophi5neo@gmail.com    Kyung Hee University Hospital Recruiting Seoul, Dongdaemun-gu, Korea, Republic of, 02447 Contact: Soo-Joong Kim    82-2-958-8180    soojoong@dreamwiz.com    Hallym University Medical Center Recruiting Seoul, Gangdong-gu,, Korea, Republic of, 05355 Contact: Kyoo-Rok Han    82-2-2224-2405    krheart@hallym.or.kr    Samsung Medical Center Recruiting Seoul, Gangnam-Gu, Korea, Republic of, 06351 Contact: Sung-Ji Park    82-2-3410-0887    tyche.park@gmail.com    Korea Univ. Guro Hospital Recruiting Seoul, Guro, Korea, Republic of, 08308 Contact: Eung-ju Kim, MD,PhD    82-8-2626-3022    withnoel@empas.com    Seoul National University Hospital Recruiting Seoul, Jongno-gu, Korea, Republic of, 03080 Contact: Hyun-Jai Cho    82-2-2072-3931    hyunjaicho@snu.ac.kr    Hanyang University Medical Center Recruiting Seoul, Seongdong-gu, Korea, Republic of, 04763 Contact: Jin-Ho Shin    82-2-2290-8308    jhs2003@hanyang.ac.kr    Asan Medical Center Recruiting Seoul, Songpa-gu, Korea, Republic of, 05505 Contact: Jong-Min Song    82-2-3010-3158    jmsong@amc.seoul.kr    Ajou Univ. Medical Center Recruiting Suwon-si, Yeong-tong, Korea, Republic of, 16499 Contact: Joon-han Shin, MD,PhD    82-31-219-5710    shinjh@ajou.ac.kr    Seoul National University Bundang Hospital Recruiting Seongnam, Korea, Republic of, 463707 Contact: Dong-Ju Choi, MD, PhD    82-31-787-7007    djchoi@snubh.org    Contact: Jin Joo Park, MD    82-31-787 ext 7074    jinjooparkmd@gmail.com Less <<
NCT03235700 Heart Failure With Reduced Eje... More >>ction Fraction Coronary Artery Disease Less << Not Applicable Recruiting February 28, 2020 Korea, Republic of ... More >> Sejong general hospital, 91-121 Sosa 2-Dong, Sosa-Gu Recruiting Bucheon, Gyeonggi, Korea, Republic of, 422-711 Contact: Hyun-Jong Lee, MD    82-10-6217-9315    untouchables@sejongh.co.kr Less <<
NCT03247088 Acute Myeloid Leukemia Phase 1 Phase 2 Recruiting July 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       CR_Study_Registration@mdanderson.org Less <<
NCT03220113 Chronic Migraine Without Aura,... More >> Intractable Migraine With Typical Aura Migraine Disorders Less << Phase 1 Phase 2 Recruiting July 1, 2019 United States, California ... More >> Corona Doctors Medical Clinics Inc Recruiting Corona, California, United States, 92879 Contact: Faro T Owiesy    951-371-9500    owiesymd@gmail.com    Contact: Jovana Martin Murillo    9513719500    coronadoctors@aol.com    Principal Investigator: Faro T Owiesy, MD Less <<
NCT03258684 Sepsis Not Applicable Enrolling by invitation June 30, 2019 China, Guangdong ... More >> Department of Critical Care Medicine of Zhujiang Hospital,Southern Medical University Guangzhou, Guangdong, China, 510282 Less <<
NCT02279719 Hepatocellular Carcinoma Phase 1 Phase 2 Active, not recruiting - -
NCT03252665 ST Segment Elevation Myocardia... More >>l Infarction Less << Phase 4 Not yet recruiting June 30, 2019 China ... More >> Ren Ji Hospital Afflited to School of Medicine, Shanghai Jiao Tong University ShangHai, China Less <<
NCT03259503 Malignant Neoplasms Stated as ... More >>Primary Lymphoid Haematopoietic Lymphoma Less << Phase 1 Phase 2 Not yet recruiting May 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact       ynieto@mdanderson.org Less <<
NCT02292173 Hepatocellular Cancer ... More >> Liver Cancer Less << Phase 1 Active, not recruiting April 2020 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02288507 Hepatocellular Cancer Phase 1 Withdrawn(Closed due to no acc... More >>rual) Less << - United States, Hawaii ... More >> University of Hawaii Honolulu, Hawaii, United States, 96813 Less <<
NCT02311205 Hepatocellular Carcinoma ... More >> Metastasis Less << Phase 2 Active, not recruiting June 2018 Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT02323906 Carcinoma, Hepatocellular Phase 1 Terminated(Slow enrollment and... More >> business decision. No safety concerns were identified for the study drugs.) Less << - United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94115 United States, Florida University of Florida College of Med Gainesville, Florida, United States, 32610-0277 Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-528 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, South Carolina Greenville Hospital System Greenville, South Carolina, United States, 29605 United States, Utah University of Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Less <<
NCT02348125 Autism Spectrum Disorders ... More >> Mitochondrial Diseases Less << Phase 1 Recruiting June 2017 United States, Pennsylvania ... More >> St. Christopher's Hospital for Children Recruiting Philadelphia, Pennsylvania, United States, 19134 Contact: Michael J Goldenthal, PhD    215-427-6786    michael.goldenthal@drexelmed.edu Less <<
NCT02358395 Hepatocellular Carcinoma Phase 1 Completed - Japan ... More >> 4 Sites Tokyo,etc, Japan Less <<
NCT03370848 Flushing Hype... More >>rlipidemias Dyslipidemias Less << Phase 4 Completed - United States, California ... More >> VA West Los Angeles Medical Center Los Angeles, California, United States, 90073 Less <<
NCT03333278 Shock, Septic ... More >> Critically Ill Vasoplegic Syndrome Sepsis Less << Phase 2 Recruiting June 2019 Australia, Victoria ... More >> Monash Medical Center Not yet recruiting Clayton, Victoria, Australia, 3468 Contact: Yahya Shehabi, Prof          Contact: Paul Ritchie, MD          Geelong University Hospital Recruiting Geelong, Victoria, Australia Contact: Neil Orford, A/Prof          Contact: Allison Bone, RN          Austin Health Recruiting Heidelberg, Victoria, Australia, 3084 Contact: Rinaldo Bellomo, Professor    0394965000    rinaldo.bellomo@austin.org.au    Contact: Glenn Eastwood, A/Prof    0394964835 ext 4835    glenn.eastwood@austin.org.au    Alfred Hospital Not yet recruiting Melbourne, Victoria, Australia, 3004 Contact: Andrew Udy, Prof          Contact: Phoebe McCracken          Western Health (Footscray & Sunshine Hospital) Recruiting Melbourne, Victoria, Australia, 3021 Contact: Craig French, A/Prof          Contact: Rebecca Morgan          Royal Melbourne Hospital Recruiting Melbourne, Victoria, Australia, 3050 Contact: Adam Deane, A/Prof          Contact: Deborah Barge          New Zealand Wellington Hospital Recruiting Wellington, New Zealand Contact: Paul Young, Prof          Contact: Anna Hunt Less <<
NCT03335124 Sepsis Septic... More >> Shock Critical Illness Fluid Overload Less << Phase 4 Recruiting December 1, 2018 Slovenia ... More >> Department of Gastroenterology, UMC Ljubljana Recruiting Ljubljana, Slovenia, 1000 Contact: Sebastian Stefanovic, MD    0038651385844    sebastian.stefanovic@gmail.com Less <<
NCT03302299 Tuberculosis ... More >>HIV/AIDS Alcohol Abuse Less << Phase 4 Recruiting August 31, 2021 Uganda ... More >> Mbarara University of Science and Technology/Mbarara Regional Referral Hospital Recruiting Mbarara, Uganda Contact: Christine Ngabirano, BASS    +256 776 418691    ngachrissy28@gmail.com    Contact: Adah Tumwegamire, BCS    +256 774 319258    T_Adah@yahoo.com    Principal Investigator: Winnie R Muyindike, MBChB, MMED          Sub-Investigator: Julian Adong, MBChB Less <<
NCT03377842 Colorectal Cancer ... More >> Neoadjuvant Therapy Less << Phase 2 Not yet recruiting September 1, 2020 -
NCT02354898 Advanced Solid Tumors ... More >> Hepatocellular Carcinoma Less << Phase 1 Completed - Japan ... More >> 5 Sites Chiba, Etc., Japan Less <<
NCT02332031 Drug Interactions Phase 1 Completed - Germany ... More >> Berlin, Germany, 13353 Less <<
NCT03380507 Septic Shock ... More >>Critical Illness Less << Phase 2 Phase 3 Recruiting May 30, 2019 Qatar ... More >> Hamad Medical Corporation Recruiting Doha, Qatar, 3050 Less <<
NCT03374254 Metastatic Colorectal Cancer Phase 1 Recruiting November 26, 2021 United States, California ... More >> City of Hope National Medical Center ( Site 0102) Recruiting Duarte, California, United States, 91010 Contact: Study Coordinator    626-471-9200       United States, Colorado Anschutz Medical Campus, Anschutz Cancer Pavilion ( Site 0106) Recruiting Aurora, Colorado, United States, 80045 Contact: Study Coordinator    303-724-3532       United States, Connecticut Yale Cancer Center ( Site 0108) Recruiting New Haven, Connecticut, United States, 06520 Contact: Study Coordinator    203-785-6661       United States, Florida Moffitt Cancer Center ( Site 0111) Recruiting Tampa, Florida, United States, 33612 Contact: Study Coordinator    813-745-2742       United States, Illinois University of Chicago ( Site 0105) Recruiting Chicago, Illinois, United States, 60637 Contact: Study Coordinator    773-702-7763       United States, New Jersey Rutgers Cancer Institute of New Jersey ( Site 0107) Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Study Coordinator    732-235-2465       United States, Pennsylvania UPMC Cancer Center/Hillman Cancer Center ( Site 0113) Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Study Coordinator    412-623-2677       United States, Texas Baylor Scott and White ( Site 0110) Recruiting Temple, Texas, United States, 76508 Contact: Study Coordinator    254-724-3796       United States, Washington Seattle Cancer Care Alliance ( Site 0104) Recruiting Seattle, Washington, United States, 98109 Contact: Study Coordinator    206-288-6248       Northwest Medical Specialties, PLLC ( Site 0101) Recruiting Tacoma, Washington, United States, 98405 Contact: Study Coordinator    253-428-8738       Canada, Alberta Cross Cancer Institute ( Site 0123) Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Contact: Study Coordinator    7804328248       Canada, Ontario Princess Margaret Cancer Centre ( Site 0122) Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Study Coordinator    4169462263       Canada, Quebec Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0124) Recruiting Montreal, Quebec, Canada, H2X 0C1 Contact: Study Coordinator    514890800025381       Jewish General Hospital ( Site 0121) Recruiting Montreal, Quebec, Canada, H3T 1E2 Contact: Study Coordinator    5143408222 Less <<
NCT00783965 - Completed - -
NCT00779896 Cutaneous T-Cell Lymphoma Phase 1 Phase 2 Unknown December 2012 Canada, Quebec ... More >> McGill University Recruiting Montreal, Quebec, Canada, H2W 1S6 Contact: Penny Chipman    514-398-1444    penny.chipman@mcgill.ca    Contact: Crystal Lameira    514-398-2229    crystal.lameira@mcgill.ca Less <<
NCT01620216 Acute Myeloid Leukemia Arising... More >> From Previous Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Less << Phase 2 Recruiting March 30, 2019 United States, Maryland ... More >> National Heart Lung and Blood Institute Not yet recruiting Bethesda, Maryland, United States, 20824 Contact: Christopher S. Hourigan    301-803-8029    hourigan@nih.gov    Principal Investigator: Christopher S. Hourigan          United States, Oregon OHSU Knight Cancer Institute Not yet recruiting Portland, Oregon, United States, 97239 Contact: Marc Loriaux    503-494-9383    loriauxm@ohsu.edu    Principal Investigator: Marc Loriaux          United States, Texas UT Southwestern/Simmons Cancer Center-Dallas Recruiting Dallas, Texas, United States, 75390 Contact: Robert H. Collins    214-648-4155    robert.collins@utsouthwestern.edu    Principal Investigator: Robert H. Collins          United States, Utah Huntsman Cancer Institute/University of Utah Not yet recruiting Salt Lake City, Utah, United States, 84112 Contact: Tibor J. Kovacsovics    801-585-3229    tibor.kovacsovics@hci.utah.edu    Principal Investigator: Tibor J. Kovacsovics Less <<
NCT02406508 Hepatocellular Carcinoma (HCC) Phase 2 Withdrawn(No enrollment in the... More >> study) Less << - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612 United States, New York Montefiore Medical Center New York, New York, United States, 10467 Less <<
NCT00783965 Skin Carcinoma Phase 2 Completed - United States, California ... More >> Children's Hospital Oakland Research Institute Oakland, California, United States, 94609-1693 Children's Hospital Oakland Research Institiute Oakland, California, United States, 94609 United States, New York Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT02416739 Non-Small-Cell Lung Carcinoma Phase 2 Phase 3 Active, not recruiting June 2020 Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Hwasun, Chonnam, Korea, Republic of, 58128 Less <<
NCT03392623 Melasma Early Phase 1 Completed - -
NCT02425605 Hepatocellular Carcinoma Phase 2 Unknown January 2018 Korea, Republic of ... More >> Department of Internal Medicine, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 120-752 Contact: BeomKyung Kim, M.D., Ph.D.    +82-2-2228-1930    beomkkim@yuhs.ac    Contact: Wonseok Kang, M.D., Ph.D.       WSKANG79@yuhs.ac Less <<
NCT03422159 Sepsis, Severe ... More >> Septic Shock Less << Phase 2 Recruiting June 1, 2019 United States, New Jersey ... More >> Monmouth Medical Center, Southern Campus Not yet recruiting Lakewood, New Jersey, United States, 08701 Contact: Yasmine Elbaga, PharmD          Community Medical Center Recruiting Toms River, New Jersey, United States, 08755 Contact: Andrew V Vassallo, PharmD    732-557-8000 ext 11992    Andrew.Vassallo@rwjbh.org    Contact: Jose Iglesias, DO Less <<
NCT03434379 Carcinoma, Hepatocellular Phase 3 Recruiting June 29, 2022 -
NCT02436902 Hepatocellular Carcinoma Phase 3 Recruiting August 2019 China, Guangxi ... More >> Department of Hepatobilliary Surgery, Affiliated Tumor of Guangxi University Recruiting Nanning, Guangxi, China, 530021 Contact: Bang-De Xiang, MD,PhD    86-771-5330855    xiangbangde@163.com Less <<
NCT02400788 Hepatocellular Carcinoma Phase 1 Phase 2 Completed - Japan ... More >> Chiba, Japan Ishikawa, Japan Kanagawa, Japan Kochi, Japan Kyoto, Japan Osaka, Japan Saga, Japan Shizuoka, Japan Tokyo, Japan Korea, Republic of Busan, Korea, Republic of Daegu, Korea, Republic of Seoul, Korea, Republic of Less <<
NCT02439879 Diabetic Neuropathy Phase 4 Completed - -
NCT02439879 - Completed - -
NCT01656616 - Withdrawn - United States, Maine ... More >> Maine Medical Center Department of Emergency Medicine Portland, Maine, United States, 04102 Less <<
NCT03439891 Stage III Hepatocellular Carci... More >>noma AJCC v8 Stage IIIA Hepatocellular Carcinoma AJCC v8 Stage IIIB Hepatocellular Carcinoma AJCC v7 Stage IIIC Hepatocellular Carcinoma AJCC v7 Stage IV Hepatocellular Carcinoma AJCC v8 Stage IVA Hepatocellular Carcinoma AJCC v8 Stage IVB Hepatocellular Carcinoma AJCC v8 Less << Phase 2 Recruiting December 31, 2020 United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94158 Contact: Robin K. Kelley    877-827-3222    cancertrials@ucsf.edu    Principal Investigator: Robin K. Kelley Less <<
NCT02450149 Refractory Solid Tumors Not Applicable Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, seoul, korea, Republic of, Korea, Republic of, 135-710 Less <<
NCT02460991 Hepatocellular Carcinoma ... More >> Hepatoma Liver Cell Carcinoma Less << Phase 3 Terminated(Slow enrollment) - United States, Alabama ... More >> University of Alabama Hospital Birmingham, Alabama, United States, 35233 United States, California University of Southern California Los Angeles, California, United States, 90033 United States, Kentucky University of Louisville Louisville, Kentucky, United States, 40202 United States, Maryland University of Maryland Medical Center Baltimore, Maryland, United States, 21201 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02460991 - Terminated(Slow enrollment) - -
NCT03110432 - Recruiting February 16, 2021 Germany ... More >> Medizinische Klinik und Poliklinik III Recruiting Dresden, Germany Contact: Andreas Birkenfeld, MD Less <<
NCT03468231 Hepatocellular Carcinoma Phase 3 Recruiting March 9, 2020 China, Guangdong ... More >> Dongguan People's Hospital Recruiting Dongguan, Guangdong, China, 523059 Contact: Wusheng Yu, MD    13827285010    yuwusheng1998@126.com    Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD    86-2087343115    shiming@mail.sysu.edu.cn    Principal Investigator: Ming Shi, MD          The First Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Guosheng Tan, MD    13725254145    tgs1976@163.com    Guangzhou Twelfth People 's Hospital Recruiting Guangzhou, Guangdong, China, 510620 Contact: Yuanmin Zhou, MD    15521278919    13430288977@139.com    Principal Investigator: Jinghua Chen, MD          Kaiping Central Hospital Recruiting Kaiping, Guangdong, China, 529300 Contact: Shijie Zhang, MD    13717287622    Shijie_9262511@163.com    China, Hunan First Affiliated Hospital of University Of South China Recruiting Hengyang, Hunan, China, 421001 Contact: Xiaoping Wu, MD    13975486015    wxp19730806@sina.com    China, Shanxi The First Affiliated Hospital Of Xi'an Jiaotong University Recruiting Xi'an, Shanxi, China, 710061 Contact: Xin Zheng, MD    13649265446    183421344@qq.com Less <<
NCT03485027 Metastatic Colorectal Cancer ... More >> Chemotherapy Effect Less << Phase 2 Recruiting January 24, 2021 China, Shanghai ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Chenchen Wang, M.D Less <<
NCT02474290 Acute Myeloid Leukemia ... More >> Hematopoietic Stem Cell Transplantation Less << Phase 2 Phase 3 Unknown August 2018 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Li Xuan    +86-020-61641613    356135708@qq.com    Principal Investigator: Qifa Liu Less <<
NCT03509662 Cardiac Arrest Phase 2 Not yet recruiting June 1, 2021 -
NCT03466528 Alcohol Withdrawal ... More >> Lactic Acidosis Vitamin B1 Deficiency Magnesium Deficiency Wernicke Encephalopathy Less << Phase 2 Phase 3 Recruiting June 2018 United Kingdom ... More >> Glasgow Royal Infirmary Recruiting Glasgow, United Kingdom, G4 0SF Contact: Donogh Maguire, MB BCh    0141 2115166    Donogh.Maguire@gla.ac.uk    Contact: Alastair Ireland, Mb BCh    0141 2115166    Alastair.Ireland@ggc.scot.nhs.uk Less <<
NCT03509350 Sepsis Phase 3 Recruiting October 2021 United States, Georgia ... More >> Grady Memorial Hospital Recruiting Atlanta, Georgia, United States, 30303 Contact: Lovie Negrin       lovienegrin@emory.edu    Contact: Carmen Polito, MD       CPOLITO@emory.edu    Principal Investigator: Carmen Polito, MD          Emory University Hospital Recruiting Atlanta, Georgia, United States, 30322 Contact: Christine Spainhour       christine.spainhour@emory.edu    Contact: Katherine Nugent, MD       katherine.lyn.nugent@emory.edu    Principal Investigator: Katherine Nugent, MD          Emory Saint Joseph's Hospital Recruiting Atlanta, Georgia, United States, 30342 Contact: Sonya Mathewson       sbmathe@emory.edu    Contact: Larry Busse, MD       laurence.w.busse@emory.edu    Principal Investigator: Larry Busse, MD          United States, Maryland Johns Hopkins Bayview Recruiting Baltimore, Maryland, United States, 21224 Contact: Erin Ricketts       ericket2@jhmi.edu    Contact: David Hager, MD, PhD       dhager1@jhmi.edu    Principal Investigator: David Hager, MD, PhD          Johns Hopkins Hospital Recruiting Baltimore, Maryland, United States, 21287 Contact: Erin Ricketts       ericket2@jhmi.edu    Contact: Jeremiah Hinson       jeremiah.s.hinson@jhmi.edu    Principal Investigator: Jeremiah Hinson, MD, PhD          United States, Tennessee Vanderbilt University Medical Center Not yet recruiting Nashville, Tennessee, United States, 37232 Contact: Wesley Self, MD, MPH       wesley.self@Vanderbilt.Edu    Contact: Matt Semler, MD, MSc       matthew.w.semler@vanderbilt.edu    Principal Investigator: Wesley Self, MD, MPH          United States, Virginia Eastern Virginia Medical School Not yet recruiting Norfolk, Virginia, United States, 23507 Contact: Michael H Hooper, MD, MSc       hoopermh@evms.edu    Contact: Jennifer F May, PhD       jlfreema@sentara.com    Principal Investigator: Michael H Hooper, MD, MSc          Virginia Commonwealth University Not yet recruiting Richmond, Virginia, United States, 23284 Contact: Chris DeWilde, PhD-c, RN       christine.dewilde@vcuhealth.org    Contact: Anna Priday, MS       anna.priday@vcuhealth.org    Principal Investigator: Berry Fowler, MD Less <<
NCT03510715 Hypercholesterolemia Phase 3 Recruiting June 2020 United States, California ... More >> Investigational Site Number 8400004 Recruiting Los Angeles, California, United States, 90027 Austria Investigational Site Number 0400001 Recruiting Wien, Austria, 1090 Brazil Investigational Site Number 0760001 Recruiting Sao Paulo, Brazil, 05403-000 Canada Investigational Site Number 1240002 Recruiting Montreal, Canada, H3T 1C5 Investigational Site Number 1240001 Recruiting Quebec, Canada, G1V 4W2 Denmark Investigational Site Number 2080001 Recruiting Viborg, Denmark, 8800 France Investigational Site Number 2500001 Recruiting Bron Cedex, France, 69677 Italy Investigational Site Number 3800001 Recruiting Palermo, Italy, 90127 Mexico Investigational Site Number 4840006 Recruiting Oaxaca, Mexico, 68000 Netherlands Investigational Site Number 5280001 Recruiting Amsterdam, Netherlands, 1105 AZ Norway Investigational Site Number 5780001 Recruiting Oslo, Norway, 0373 Russian Federation Investigational Site Number 6430002 Recruiting Kemerovo, Russian Federation, 650002 Slovenia Investigational Site Number 7050001 Recruiting Ljubljana, Slovenia, 1000 Spain Investigational Site Number 7240001 Recruiting A Coruna, Spain, 15001 Taiwan Investigational Site Number 1580001 Recruiting Taipei, Taiwan, 112 Turkey Investigational Site Number 7920002 Recruiting Ankara, Turkey, 06500 Investigational Site Number 7920001 Recruiting Izmir, Turkey, 35040 Less <<
NCT03163576 Hyperphosphatemia Phase 4 Not yet recruiting December 2019 -
NCT03528785 Pancreatic Adenocarcinoma Phase 2 Recruiting January 2020 Italy ... More >> Centro Ricerche Cliniche Recruiting Verona, Italy, 37134 Contact: Stefano Milleri, Dr.    +390458126619    stefano.milleri@crc.vr.it    Contact: Giorgia Barbiero, Dr.    +390458126562    giorgia.barbiero@crc.vr.it    Principal Investigator: Davide Melisi, Dr Less <<
NCT03510884 Hypercholesterolaemia Phase 3 Recruiting March 2022 -
NCT03544606 Induction of Labor Affected Fe... More >>tus / Newborn Less << Phase 3 Recruiting January 30, 2019 Egypt ... More >> faculty of medicine - Cairo university Recruiting Cairo, Kasr El Ainy, Egypt, 11562 Contact: mohamed T aneis, MD    202 23653269       Principal Investigator: waleed M El khyat, MD Less <<
NCT02504983 Hepatocellular Carcinoma Phase 4 Unknown July 2018 Taiwan ... More >> Chang Gung Memorial Hospital Recruiting Taoyuan, Taiwan Contact: Chau-Ting Yeh, MD/PhD    +886-3-3281200 ext 8125    chautingy@gmail.com Less <<
NCT03540628 Septic Shock Not Applicable Recruiting February 26, 2020 United States, Michigan ... More >> Lakeland Regional Healthcare Recruiting Saint Joseph, Michigan, United States, 49085 Contact: Brittany J Haines, D.O, M.P.H    219-508-1370    bhaines1@lakelandhealth.org    Contact: Michelino Mancini, DO, FAOECP    2699834081    mmancini@lakelandhealth.org Less <<
NCT03192644 Hepatocellular Carcinoma Phase 3 Recruiting December 31, 2024 China ... More >> Cancer Center of Sun Yat-Sen University Recruiting Guangzhou, China Contact: Shaohua Li, MD       lishaoh@sysucc.org.cn Less <<
NCT00424645 - Terminated(Sponsor terminated ... More >>due to low accrual.) Less << - -
NCT03510468 Healthy Volunteers Phase 1 Recruiting August 30, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT03192618 Hepatocellular Carcinoma Phase 3 Recruiting December 31, 2024 China ... More >> Cancer Center of Sun Yat-Sen University Recruiting Guangzhou, China, +86 Contact: Shaohua Li, MD    +8615088064187    lishaoh@sysucc.org.cn Less <<
NCT00425321 Rheumatoid Arthritis Phase 2 Completed - -
NCT02530476 Leukemia Acut... More >>e Myeloid Leukemia Less << Phase 1 Phase 2 Active, not recruiting December 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00460369 Uncomplicated Malaria Not Applicable Completed - Benin ... More >> Centre de santé Allada, Benin Less <<
NCT02529761 Hepatocellular Carcinoma Not Applicable Unknown October 2018 China, Shaanxi ... More >> Xijing Hospital of digestive disease, Fourth Military Medical University Recruiting Xi'an, Shaanxi, China, 710032 Contact: Han       hangh@fmmu.edu.cn    Principal Investigator: Guohong Han, MD,Ph.D Less <<
NCT00430118 Leukemia Phase 3 Completed - -
NCT00432432 Ankylosing Spondylitis Phase 4 Completed - -
NCT00434135 Non-Small Cell Lung Cancer ... More >> Stage IIIB or IV Less << Phase 2 Completed - Italy ... More >> National Tumor Institute Naples, Italy, 80131 Less <<
NCT00438204 Lung Cancer Phase 2 Terminated(All data collection... More >> has completed.) Less << - United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0942 Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT00434174 Non Small Cell Lung Cancer Phase 1 Completed - Australia, New South Wales ... More >> Novartis Investigative Site Camperdown, New South Wales, Australia, 2050 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3002 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Germany Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Koeln, Germany, 50924 Less <<
NCT00334672 Nonneoplastic Condition Phase 3 Unknown - United Kingdom ... More >> Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Watford General Hospital Herts, England, United Kingdom, WD18 0HB Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Less <<
NCT00330902 Plasmodium Infections Phase 3 Completed - Sudan ... More >> Tropical Medicine Research Institute Khartoum, Sudan Less <<
NCT00438204 - Terminated(All data collection... More >> has completed.) Less << - -
NCT00439283 Ankylosing Spondylitis Phase 3 Completed - France ... More >> CHU Amiens Amiens, France, 80054 CHU Hôpital Minjoz Besançon, France, 25030 Hôpital Avicenne Bobigny, France, 93009 Hôpital Pellegrin Bordeaux, France, 33076 Hôpital Ambroise Paré Boulogne Billancourt, France, 92104 CHU de la Cavale Blanche Brest, France, 29609 CHU Côte de Nacre Caen, France, 14033 Hôpital Gilles de Corbeil Corbeil Essonnes, France, 91106 Hôpital Henri Mondor Creteil, France, 94010 Hôpital Général Dijon, France, 21000 CHU A. Michallon Grenoble, France, 38043 Groupe Hospitalier du Havre Le Havre, France, 76083 Hôpital Bicêtre Le Kremlin Bicêtre, France, 94275 CHRU Hôpital Roger Salengro Lille, France, 59037 CHU Dupuytren Limoges, France, 87042 Centre Hospitalier Saint Philibert Lomme, France, 59160 CH St Joseph - St Luc Lyon, France, 69365 Hôpital de la Conception Marseille, France, 13385 Hôpital Lapeyronie Montpellier, France, 34295 CHU l'Archet 1 Nice, France, 06202 Hôpital Porte Madeleine Orléans, France, 45032 Hôpital de la Pitié Paris, France, 75013 Hôpital Cochin Paris, France, 75014 CHU de Poitiers Poitiers, France, 86021 CHU - Hôpital Sud Rennes, France, 35056 CHU - Hôpital de Bois Guillaume Rouen, France, 76031 CHU Saint-Etienne Saint-Etienne, France, 42055 CHU Hautepierre Strasbourg, France, 67098 Hôpital de Purpan Toulouse, France, 31059 CHU Hôpital Trousseau Tours, France, 37044 CHU Nancy-Brabois Vandoeuvre Les Nancy, France, 54511 Less <<
NCT00440492 Arthritis, Rheumatoid Phase 1 Completed - United States, California ... More >> Los Angeles, California, United States, 90048 Palo Alto, California, United States, 94304 United States, New York Lake Success, New York, United States, 11042 Rochester, New York, United States, 14642 United States, North Carolina Charlotte, North Carolina, United States, 28208 United States, Ohio Columbus, Ohio, United States, 43210 Canada, British Columbia Vancouver, British Columbia, Canada, V5Z 1M9 Canada, Ontario Mississauga, Ontario, Canada, L4W 1N2 Canada, Quebec Montreal, Quebec, Canada, H3P 3P1 Less <<
NCT00440726 Acute Lymphoblastic Leukemia Phase 1 Phase 2 Completed - United States, California ... More >> City of Hope Duarte, California, United States, 91010 Childrens Hospital Los Angeles Los Angeles, California, United States, 90027 Stanford University Medical Center Palo Alto, California, United States, 94304-1812 UCSF School of Medicine San Francisco, California, United States, 94143-0106 United States, Florida University of Miami Cancer Center Miami, Florida, United States, 33136 United States, Michigan C.S. Mott Children's Hospital Ann Arbor, Michigan, United States, 48109-0914 United States, Minnesota Childrens Hospital & Clinics of Minnesota Minneapolis, Minnesota, United States, 55404-4597 United States, New York New York University Medical Center New York, New York, United States, 10016 Children's Hospital New York-Presbyterian New York, New York, United States, 10032 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT00331708 Malaria Not Applicable Terminated(Lack of suitable pa... More >>rticipants) Less << - Mozambique ... More >> Ndlavela Health Centre Ndlavela, Maputo, Mozambique Less <<
NCT00443430 Juvenile Chronic Polyarthritis... More >> Juvenile Idiopathic Arthritis Juvenile Rheumatoid Arthritis Less << Phase 4 Completed - United States, California ... More >> Stanford University Medical Center Palo Alto, California, United States, 94305 Rady Children's Hospital San Diego, California, United States, 92123-4282 University of California San Francisco Medical Center San Francisco, California, United States, 94143 United States, Massachusetts Children's Hospital of Boston Boston, Massachusetts, United States, 02115 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Children's Hospital at Montefiore Bronx, New York, United States, 10467 Schneider Children's Hospital New Hyde Park, New York, United States, 11040 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Children's Hospital of Columbus Columbus, Ohio, United States, 43205 United States, Oklahoma Oklahoma University Health Science Center Oklahoma City, Oklahoma, United States, 73104 United States, Texas Texas Scottish Rite Hospital Dallas, Texas, United States, 75219 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 United States, Washington Seattle Children's Hospital and Regional Medical Center Seattle, Washington, United States, 98105 Less <<
NCT00441961 Fasciitis Not Applicable Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500 HB Less <<
NCT00443430 - Completed - -
NCT02394795 Colorectal Cancer Phase 3 Active, not recruiting March 1, 2020 -
NCT02394834 Colorectal Cancer Phase 3 Active, not recruiting May 31, 2020 -
NCT02109614 Aortic Stenosis and Lipoprotei... More >>n(a) Levels Less << Early Phase 1 Unknown September 2017 Canada, Quebec ... More >> MUHC - Montreal General Hospital Recruiting Montreal, Quebec, Canada, H3A 1A1 Contact: Kimberley V Kotar, BSc    5149341934 ext 35661    kimberley.kotar@muhc.mcgill.ca    Principal Investigator: George Thanassoulis, MD MSc FRCPC          MUHC - Royal Victoria Hospital Recruiting Montreal, Quebec, Canada, H3A 1A1 Contact: Kimberley V Kotar, B.Sc    514934-1934 ext 35166    kimberley.kotar@muhc.mcgill.ca    Contact: George Thanassoulis, MD    514-934-1934 ext 35465    george.thanassoulis@mcgill.ca    Principal Investigator: George Thanassoulis, MD          Jewish General Hospital Not yet recruiting Montreal, Quebec, Canada, H3T 1E2 Contact: Kimberley V Kotar, B.Sc    514-934-1934 ext 35661    kimberley.kotar@muhc.mcgill.ca    Contact: Mark Eisenberg, MD    514-340-8222    mark.eisenberg@mcgill.ca    Principal Investigator: Mark Eisenberg, md Less <<
NCT01618253 Hepatocellular Carcinoma ... More >> Hepatocellular Cancer Hepatoma Liver Cancer Less << Phase 1 Withdrawn(Closed due to poor a... More >>ccrual.) Less << June 2016 United States, Wisconsin ... More >> Froedtert Memorial Lutheran Hospital Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01613846 Renal Cell Carcinoma Phase 3 Completed - -
NCT01624285 Adult Primary Hepatocellular C... More >>arcinoma Localized Resectable Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer Less << Phase 2 Active, not recruiting July 2020 -
NCT01634893 Refractory or Relapsed Solid T... More >>umors Less << Phase 1 Completed - United States, Texas ... More >> Cancer Therapy and Research Center at UTHSCSA San Antonio, Texas, United States, 78229 Less <<
NCT02413853 Colorectal Adenocarcinoma ... More >> Stage IVA Colorectal Cancer Stage IVB Colorectal Cancer Less << Phase 2 Withdrawn(Study drug supply is... More >>sues) Less << November 2018 United States, California ... More >> USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT01009593 Hepatocellular Carcinoma Non-r... More >>esectable Hepatocellular Carcinoma Recurrent Carcinoma, Hepatocellular Liver Diseases Neoplasms by Histologic Type Digestive System Neoplasms Carcinoma Liver Neoplasms Neoplasms Neoplasms by Site Digestive System Diseases Adenocarcinoma Neoplasms, Glandular and Epithelial Less << Phase 3 Terminated(See termination rea... More >>son in detailed description) Less << - -
NCT00439296 Recurrent Pediatric ALL ... More >> Relapsed Pediatric ALL Acute Lymphoblastic Leukemia Refractory Pediatric ALL Less << Phase 1 Terminated(The study was stopp... More >>ed due to poor accrual and lack of funding.) Less << - United States, California ... More >> City of Hope Duarte, California, United States, 91010 Childrens Hospital Los Angeles Los Angeles, California, United States, 90027 Stanford University Medical Center Palo Alto, California, United States, 94304-1812 UCSF School of Medicine San Francisco, California, United States, 94143-0106 United States, Florida University of Miami Cancer Center Miami, Florida, United States, 33136 United States, Michigan C.S. Mott Children's Hospital Ann Arbor, Michigan, United States, 48109-0914 United States, Minnesota Childrens Hospital & Clinics of Minnesota Minneapolis, Minnesota, United States, 55404-4597 United States, New York New York University Medical Center New York, New York, United States, 10016 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT01666756 Adult Primary Hepatocellular C... More >>arcinoma Advanced Adult Primary Liver Cancer Advanced Adult Hepatocellular Carcinoma BCLC Stage B Adult Hepatocellular Carcinoma BCLC Stage C Adult Hepatocellular Carcinoma Less << Phase 1 Active, not recruiting January 2020 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT02440958 Pancreatic Ductal Adenocarcino... More >>ma Less << Phase 2 Unknown February 2017 -
NCT01683149 Solid Tumor Phase 1 Completed - United States, California ... More >> Childrens Hospital Los Angeles Los Angeles, California, United States, 90027 United States, Connecticut Connecticut Childrens Medical Center Hartford, Connecticut, United States, 06106 United States, Delaware Nemours/Alfred I. duPont Hospital for Children, Delaware Wilmington, Delaware, United States, 19803 United States, Florida University of Florida, Gainesville Gainesville, Florida, United States, 32610 Nemours Children's Clinic, Jacksonville Jacksonville, Florida, United States, 32207 University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 All Children's Hospital, St. Petersburg St. Petersburg, Florida, United States, 33701 United States, New York Montefiore Medical Center, Children's Hospital at Montefiore Bronx, New York, United States, 10467 United States, Utah Primary Children's Medical Center/Utah Salt Lake City, Utah, United States, 84113 Less <<
NCT02483000 Burkitt Lymphoma ... More >> CD20-Positive Neoplastic Cells Present Diffuse Large B-Cell Lymphoma Indolent Non-Hodgkin Lymphoma Mantle Cell Lymphoma Recurrent B-Cell Non-Hodgkin Lymphoma Refractory Mature B-Cell Non-Hodgkin Lymphoma Less << Phase 1 Recruiting March 1, 2025 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Ajay K. Gopal    206-288-2037    agopal@u.washington.edu    Principal Investigator: Ajay K. Gopal Less <<
NCT01696448 Metabolic Syndrome Not Applicable Completed - United States, Georgia ... More >> Atlanta Vascular Research Foundation Atlanta, Georgia, United States, 30342 Less <<
NCT00302341 Pneumonia, Interstitial Plasma... More >> Cell Pneumocystis Carinii Pneumonia Pneumonia, Pneumocystis Carinii HIV Infections Less << Phase 3 Terminated(FDA Clinical Hold a... More >>s of 12/21/07 due to safety concerns) Less << - United States, California ... More >> University of California San Francisco, California, United States, 94110 United States, Illinois The University of Chicago Chicago, Illinois, United States, 60637 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, New York NYU School of Medicine New York, New York, United States, 10016 United States, North Carolina UNC AIDS Clinical Trials Chapel Hill, North Carolina, United States, 27599-7030 United States, Ohio University of Cincinnati Cincinnati, Ohio, United States, 45267-0405 United States, South Carolina Medical University of SC Charleston, South Carolina, United States, 29425 Less <<
NCT02497157 Metastatic Colorectal Cancer Phase 2 Active, not recruiting September 2018 Japan ... More >> Matsuyama Red Cross Hospital Matsuyama-city, Ehime-prefecture, Japan, 790-8524 Kagawa University Hospital Kita-gun, Miki-cho, Kagawa-prefecture, Japan, 761-0793 Kawasaki Medical School Hospital Kurashiki-city, Okayama-prefecture, Japan, 701-0192 Okayama Saiseikai General Hospital Okayama-city, Okayama-prefecture, Japan, 700-8511 Okayama University Hospital Okayama-city, Okayama-prefecture, Japan, 700-8558 Okayama Rosai Hospital Okayama-city, Okayama-prefecture, Japan, 702-8055 Tokushima Red Cross Hospital Komatsushima-city, Tokushima-prefecture, Japan, 773-8502 Less <<
NCT02153879 Type 2 Diabetes Mellitus ... More >> Dyslipidemia Less << Phase 4 Completed - Spain ... More >> Hospital Universitari Sant Joan Reus, Tarragona, Spain, 43204 Less <<
NCT01054768 Anemia, Sickle Cell Phase 2 Completed - United States, California ... More >> Children's Hospital & Research Center Oakland Oakland, California, United States, 94609 Less <<
NCT01053000 - Completed - -
NCT02532816 Stunting Not Applicable Unknown July 2016 Indonesia ... More >> in the community (Woja,Manggelewa, Kempo subdistrict) Dompu, West Nusa Tenggara, Indonesia Less <<
NCT01687673 Hepatocellular Carcinoma Phase 2 Active, not recruiting September 2017 United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 United States, Illinois Robert H Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 Less <<
NCT01724606 Breast Cancer ... More >> Brain Metastases Less << Phase 1 Recruiting November 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Recruiting Basking Ridge, New Jersey, United States Contact: Andrew Seidman, MD    646-888-5445       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Andrew Seidman, MD    646-888-5445       United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting Commack, New York, United States, 11725 Contact: Andrew Seidman, MD    646-422-4333       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Andrew Seidman, MD    646-888-5445       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Andrew Seidman, MD    646-888-5445       Contact: Kathryn Beal, MD    212-639-5159       Principal Investigator: Andrew Seidman, MD          Memorial Sloan Kettering at Mercy Medical Center Recruiting Rockville Centre, New York, United States Contact: Andrew Seidman, MD    646-888-5445 Less <<
NCT01053000 ACTINIC KERATOSES Not Applicable Completed - United States, Florida ... More >> Roger Stewart MD PA Fort Lauderdale, Florida, United States, 33308 Less <<
NCT02254252 - Completed - -
NCT02254252 Slow Coronary Flow ... More >> Normal, or Near Normal Coronary Angiography Stable Angina Less << Phase 4 Completed - -
NCT01714609 - Completed - -
NCT01728948 - Completed - China ... More >> Many Locations, China Less <<
NCT01730937 Adult Primary Hepatocellular C... More >>arcinoma Advanced Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer Less << Phase 3 Recruiting June 2025 -
NCT01736878 Medullary Thyroid Carcinoma Phase 2 Withdrawn(Study was withdrawn ... More >>due to unanticipated hassle in patient recruitment.) Less << - Germany ... More >> University Hospital Ulm, Clinic for Nuclear Medicine Ulm, Baden-Wuerttemberg, Germany, D-89081 Less <<
NCT02576509 Hepatocellular Carcinoma Phase 3 Active, not recruiting July 14, 2020 -
NCT02578368 Gastric Cancer Phase 3 Recruiting December 2021 Germany ... More >> Krankenhaus Nordwest Recruiting Frankfurt am Main, Germany, 60488 Contact: Salah-Eddin Al-Batran, MD    +496976014420    albatran@aol.com    Contact: Claudia Pauligk, PhD    +496976013906    pauligk.claudia@khnw.de    Principal Investigator: Salah-Eddin Al-Batran, MD Less <<
NCT02573220 Stage IVA Colorectal Cancer ... More >> Stage IVB Colorectal Cancer Less << Phase 1 Withdrawn(Study terminated by ... More >>PI due to inability to accrue.) Less << - Italy ... More >> Centro di Riferimento Oncologico Aviano, Italy, 33081 Less <<
NCT01761266 Hepatocellular Carcinoma (HCC) Phase 3 Active, not recruiting March 2019 -
NCT01103336 Chronic Renal Failure Phase 4 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT02300311 Low Back Pain Phase 3 Completed - Russian Federation ... More >> 69.53.53201 Boehringer Ingelheim Investigational Site Kyiv, Russian Federation 69.53.53102 Boehringer Ingelheim Investigational Site St. Petersburg, Russian Federation 69.53.53103 Boehringer Ingelheim Investigational Site St. Petersburg, Russian Federation 69.53.53105 Boehringer Ingelheim Investigational Site St. Petersburg, Russian Federation 69.53.53106 Boehringer Ingelheim Investigational Site St. Petersburg, Russian Federation 69.53.53107 Boehringer Ingelheim Investigational Site St. Petersburg, Russian Federation Ukraine 69.53.53202 Boehringer Ingelheim Investigational Site Kyiv, Ukraine 69.53.53203 Boehringer Ingelheim Investigational Site Kyiv, Ukraine Less <<
NCT01761266 - Active, not recruiting - -
NCT02300311 - Completed - -
NCT02598622 Vincristine Induced Neuropathy Phase 2 Terminated(Drug availability) - -
NCT02590367 Peripheral Neuropathy Phase 2 Phase 3 Unknown October 2017 China, Jiangsu ... More >> Jiangsu Province Hospital of Integrated Chinese and Western Medicine Recruiting Nanjing, Jiangsu, China, 210028 Contact: Huo Jie Ge, M.D.    +86 02585637121    hjg16688@126.com Less <<
NCT02598622 - Terminated(Drug availability) - -
NCT01780974 Treated Hypertension Phase 1 Phase 2 Completed - United States, Oregon ... More >> Lynne Shinto, ND, MPH Portland, Oregon, United States, 97239 Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT01714609 Clinically Significant Portal ... More >>Hypertension Less << Phase 2 Completed - United States, Connecticut ... More >> Yale Cancer Center New Haven, Connecticut, United States, 06520 VA Medical Center West Haven West Haven, Connecticut, United States, 06516 United States, Massachusetts Brigham & Womens Boston, Massachusetts, United States, 02115 United States, New York New York University Langone Medical Center New York, New York, United States, 10016 United States, Pennsylvania University of Pennsylvania School of Medicine Philadelphia, Pennsylvania, United States, 19104 United States, Texas The University of Texas Health Science Center at Houston Houston, Texas, United States, 77030 Less <<
NCT01780974 - Completed - -
NCT02322203 Cardiovascular Disease Phase 2 Recruiting July 3, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT02589145 Lymphoma Phase 1 Phase 2 Active, not recruiting June 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02630485 Polycystic Ovary Syndrome ... More >> Infertility Less << Not Applicable Unknown August 2018 -
NCT02601898 Subchorionic Hematoma in the F... More >>irst Trimester Pregnancy Miscarriage Less << Phase 4 Completed - Italy ... More >> Azienda USL Ferrara Ferrara, Italy Less <<
NCT01801163 Hepatocellular Carcinoma Phase 1 Withdrawn(Trial had no patient... More >>s accrued while open) Less << - United States, Indiana ... More >> Indiana University Indianapolis, Indiana, United States, 46202 Less <<
NCT02641873 Metastatic Colorectal Cancer Phase 1 Completed - Japan ... More >> National Cancer Center Hospital East Kashiwa, Chiba, Japan Aichi Cancer Center Hospital Nagoya, Aichi, Japan Less <<
NCT02642159 Dyslipidemia Phase 4 Completed - -
NCT01829035 Advanced Adult Hepatocellular ... More >>Carcinoma Less << Phase 3 Completed - Korea, Republic of ... More >> National Cancer Center, Korea Seoul, Korea, Republic of Less <<
NCT01817751 Glioblastoma ... More >>Recurrent Adult Brain Neoplasm Malignant Glioma WHO Grade III Glioma Less << Phase 2 Recruiting March 31, 2019 United States, Virginia ... More >> Virginia Commonwealth University/Massey Cancer Center Recruiting Richmond, Virginia, United States, 23298 Contact: Alison A Ryan, NP    804-628-1936    masseysiit@vcu.edu    Principal Investigator: Mark G Malkin, MD Less <<
NCT02672488 Hepatocellular Carcinoma Phase 2 Unknown December 2018 China ... More >> Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, China, 300060 Contact: TI ZHANG, MD    +862223340123 ext 3092    zhangti@tjmuch.com    Contact: Huikai Li, MD    +862223340123 ext 3091    lihuikai@tjmuch.com Less <<
NCT01839630 - Completed - China ... More >> Multiple Locations, China Less <<
NCT01844947 Urothelial Carcinoma ... More >> Bladder Cancer Renal Pelvis Cancer Ureter Cancer Urethra Cancer Less << Phase 1 Completed - Denmark ... More >> Department of Oncology, Aarhus University Hospital Aarhus, Denmark, DK-8200 Department of Oncology, Rigshospitalet Copenhagen, Denmark, DK-2100 Sweden Department of Oncology, Karolinska University Hospital Stockholm, Sweden, SE-171 76 Less <<
NCT01849588 - Terminated(Slow Accrual) - -
NCT01851408 Melanoma Recu... More >>rrent Melanoma Stage III Melanoma Stage IV Melanoma Less << Phase 2 Withdrawn(No progression of Ph... More >>ase 1 trial to Phase 2.) Less << - -
NCT02642159 - Completed - -
NCT01833299 Hepatocellular Carcinoma ... More >> Face Cancer Less << Phase 4 Unknown December 2014 China ... More >> Cancer Centre of Sun Yat-Sen University Recruiting Guangzhou, China, 510060 Contact: min-shan chen, M.D.,Ph.D.    87343117    Chminsh@mail.sysu.edu.cn    Principal Investigator: min-shan chen, M.D.,Ph.D. Less <<
NCT02696512 Brain Injury Phase 1 Phase 2 Unknown April 2017 United States, New Jersey ... More >> International Brain Research Foundation Recruiting Edison, New Jersey, United States, 08837 Contact: Philip Defina, PhD    732-494-7600    pdefina@ibrfinc.org    Principal Investigator: Philip Defina, PhD Less <<
NCT01185015 Angina Pectoris Phase 4 Withdrawn - -
NCT00393770 Type 2 Diabetes Mellitus Phase 2 Completed - Italy ... More >> Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 Less <<
NCT02697058 Metastatic Pancreatic Cancer Phase 2 Completed - Japan ... More >> Hirosaki University School of Medicine & Hospital Hirosaki-shi, Aomori-Ken, Japan, 036-8563 Chiba Cancer Center Chiba-shi, Chiba-Ken, Japan, 260-8717 National Cancer Center Hospital East Kashiwa-shi, Chiba-Ken, Japan, 277-8577 NHO Shikoku Cancer Center Matsuyama-shi, Ehime-Ken, Japan, 791-0280 NHO Kyushu Cancer Center Fukuoka-shi, Fukuoka-Ken, Japan, 811-1395 Kyushu University Hospital Fukuoka-shi, Fukuoka-Ken, Japan, 812-8582 Hokkaido University Hospital Sapporo-shi, Hokkaido, Japan, 060-8648 Kanagawa Cancer Center Yokohama, Kanagawa -ku, Japan, 241-8515 Yokohama City University Medical Center Yokohama-shi, Kanagawa-Ken, Japan, 232-0024 Kyoto University Hospital Kyoto-shi, Kyoto-Fu, Japan, 606-8507 NHO Osaka National Hospital Osaka-shi, Osaka-Fu, Japan, 540-0006 Osaka International Cancer Institute Osaka-shi, Osaka-Fu, Japan, 541-8567 Saitama Cancer Center Kitaadachi-gun, Saitama-Ken, Japan, 362-0806 Cancer Institute Hospital of JFCR Koto-ku, Tokyo-To, Japan, 135-8550 Kyorin University Hospital Mitaka-shi, Tokyo-To, Japan, 181-8611 National Cancer Center Hospital Chuo Ku, Tokyo, Japan, 104-0045 Less <<
NCT02701673 Lymphoma Phase 1 Phase 2 Withdrawn - -
NCT01849588 Hepatocellular Cancer Phase 4 Terminated(Slow Accrual) - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02214 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT02716766 Carcinoma, Hepatocellular ... More >> Secondary Less << Phase 2 Active, not recruiting December 2020 Hong Kong ... More >> Queen Mary Hospital Hong Kong, Hong Kong Less <<
NCT01861314 Acute Myeloid Leukemia ... More >> Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Active, not recruiting - United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT02720068 Advanced Cancer Phase 1 Recruiting July 2, 2021 United States, Arizona ... More >> Call for Information (Investigational Site 0021) Recruiting Phoenix, Arizona, United States, 85054 United States, California Call for Information (Investigational Site 0008) Recruiting Encinitas, California, United States, 92024 Call for Information (Investigational Site 0009) Recruiting Fresno, California, United States, 93720 United States, Colorado Call for Information (Investigational Site 0019) Recruiting Denver, Colorado, United States, 80218 United States, Florida Call for Information (Investigational Site 0022) Recruiting Jacksonville, Florida, United States, 32224 United States, Michigan Call for Information (Investigational Site 0012) Recruiting Detroit, Michigan, United States, 48201 Call for Information (Investigational Site 0003) Recruiting Grand Rapids, Michigan, United States, 49503 United States, Minnesota Call for Information (Investigational Site 0020) Recruiting Rochester, Minnesota, United States, 55905 United States, Tennessee Call for Information (Investigational Site 0002) Recruiting Nashville, Tennessee, United States, 37203 United States, Texas Call for Information (Investigational Site 0017) Recruiting Houston, Texas, United States, 77030 Call for Information (Investigational Site 0001) Recruiting San Antonio, Texas, United States, 78229 Canada, Quebec Merck Canada Recruiting Kirkland, Quebec, Canada, H9H 4M7 Contact: Medical Information Centre Centre d'information medicale Merck Canada Inc.    514-428-8600 / 1-800-567-2594       Germany MSD Sharp & Dohme GmbH Recruiting Haar, Germany Contact: German Medical Information Center    49 800 673 673 673       Israel Merck Sharp & Dohme Co. Ltd. Recruiting Hod Hasharon, Israel Contact: Dan Goldstaub    972-9-9533326       Korea, Republic of MSD Korea LTD Recruiting Seoul, Korea, Republic of, 4130 Contact: TaeYoun Jo    8223312313       Poland MSD Polska Sp. Z o.o. Recruiting Warsaw, Poland Contact: Thomas J. Johansson    48224784324       Spain Merck Sharp and Dohme de Espana S.A. Recruiting Madrid, Spain Contact: Lourdes Lopez-Bravo    (0034) 913210654 Less <<
NCT02721173 Acne Vulgaris Phase 4 Completed - India ... More >> AIIMS, Bhubaneswar Bhubaneswar, Odisha, India, 751019 Less <<
NCT01877590 Type 2 Diabetes ... More >> Coronary Artery Disease Left Ventricular Mass Less << Phase 4 Completed - China, Hubei ... More >> Wuhan General Hospital Wuhan, Hubei, China, 430070 Less <<
NCT01872351 - Withdrawn(PI left the institut... More >>ion) Less << - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT01888861 Oxidative Stress ... More >> Inflammation Malnutrition Less << Phase 3 Unknown September 2013 Iran, Islamic Republic of ... More >> Shiraz University of Medical Sciences, Department of Nutrition Recruiting Shiraz, Fars, Iran, Islamic Republic of, 7157617516 Contact: Najmeh Hejazi, PhD       n20hejazi@yahoo.com    Principal Investigator: Najmeh Hejazi, PhD Less <<
NCT02747537 Pediatric Solid Tumors Phase 2 Recruiting February 29, 2020 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Alok Kothari, M.D.    314-454-6018    alok@wustl.edu    Principal Investigator: Alok Kothari, M.D. Less <<
NCT02748304 Hepatocellular Carcinoma Not Applicable Recruiting June 2021 China ... More >> Huashan hospital Recruiting Shanghai, China, 200040 Contact: Lu Lu, MD    862152887175    lulu@huashan.org.cn Less <<
NCT01895621 Entrapment Neuropathy, Carpal ... More >>Tunnel Compression Neuropathy, Carpal Tunnel Median Neuropathy, Carpal Tunnel Less << Phase 4 Completed - Italy ... More >> Istituto Ortopedico Rizzoli Bologna, Italy, 40136 Less <<
NCT01895699 Contrast Agent ... More >> Endothelial Function Cytokines Apoptosis of Endothelial Progenitor Cell Free Radical Alpha-lipoic Acid Less << Phase 4 Completed - China, Hubei ... More >> Wuhan General Hospital Wuhan, Hubei, China, 430070 Less <<
NCT01880372 Moderate Non-proliferative Dia... More >>betic Retinopathy Less << Phase 1 Phase 2 Suspended(Low number of patien... More >>ts enrolled) Less << January 2017 United States, Michigan ... More >> Ferris State University Big Rapids, Michigan, United States, 49307 Retina Specialists of Michigan Grand Rapids, Michigan, United States, 49525 Less <<
NCT01897038 Carcinoma, Hepatocellular Phase 1 Completed - United States, Florida ... More >> Sarasota, Florida, United States, 34232 United States, Maryland Baltimore, Maryland, United States, 21231 United States, New York New York, New York, United States, 10065 United States, Tennessee Nashville, Tennessee, United States, 37203 United States, Texas Houston, Texas, United States, 77030 Hong Kong Pokfulam, Hong Kong Singapore Singapore, Singapore, 119228 Singapore, Singapore, 169610 Taiwan Tainan, Taiwan, 00704 Taipei, Taiwan, 100 Less <<
NCT02458924 Schizophrenia Phase 2 Phase 3 Completed - -
NCT01900002 Liver Cancer Phase 2 Active, not recruiting September 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01901692 Hepatocellular Carcinoma Phase 2 Phase 3 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 05505 Less <<
NCT02705300 Colorectal Cancer Phase 2 Recruiting March 2025 Denmark ... More >> Department of Oncology, Vejle Hospital Recruiting Vejle, Denmark, DK-7100 Contact: Lars H Jensen, PhD       lars.henrik.jensen@rsyd.dk    Principal Investigator: Louise R Larsen, MD Less <<
NCT01903694 Child-Pugh A Hepatocellular Ca... More >>rcinoma Less << Phase 3 Completed - France ... More >> CHU de Dijon Dijon, France, 21079 Less <<
NCT02774187 Hepatocellular Carcinoma Phase 3 Active, not recruiting August 2018 China, Guangdong ... More >> Dongguan People 's Hospital Dongguan, Guangdong, China, 523059 Cancer Center Sun Yat-sen University Guangzhou, Guangdong, China, 510060 The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Guangzhou Twelfth People 's Hospita Guangzhou, Guangdong, China, 510620 The Kaiping Center's Hospital Kaiping, Guangdong, China, 529300 China, Hunan First Affiliated Hospital of University Of South China Hengyang, Hunan, China, 421001 China, Shanxi First Affiliated Hospital Of Xi'an Jiaotong University Xi'an, Shanxi, China, 710061 Less <<
NCT01906216 Hepatocellular Carcinoma Phase 2 Phase 3 Recruiting December 2018 China, Shaanxi ... More >> Xijing Hospital of Digestive Disease Recruiting Xi`an, Shaanxi, China, 710032 Contact: Wei Bai, MD    +8615991771343       Contact: Yan Zhao, MD    +8613571884093 Less <<
NCT02774226 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 2 Recruiting September 2018 United States, Georgia ... More >> Georgia Prevention Institute Recruiting Augusta, Georgia, United States, 30912 Contact: Ryan Harris, Ph.D.    706-721-5998    ryharris@augusta.edu    Contact: Nichole Seigler, BA    706-721-5998    maseigler@augusta.edu Less <<
NCT02772926 Type 2 Diabetes Mellitus Not Applicable Completed - Mexico ... More >> Department of Medical Sciences, University of Guanajuato, León Mexico León, Guanajuato, Mexico, 37320 Less <<
NCT01932385 Liver Cancer Phase 2 Phase 3 Completed - China, Shandong ... More >> Qingdao Central Hospital, Qingdao Cancer Hospital Qingdao, Shandong, China, 266042 Less <<
NCT02785146 Colorectal Cancer Phase 3 Unknown June 2018 China, Guangdong ... More >> Sixth Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Xiaojian Wu, Ph.D.    +86-13760608396    wuxjian@mail.sysu.edu.cn Less <<
NCT01893099 Ocular Melanoma Phase 1 Completed - Switzerland ... More >> Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland Less <<
NCT01915602 Carcinoma, Hepatocellular Phase 2 Completed - -
NCT02845908 Malignant Neoplasm of Stomach ... More >>Stage IV Less << Phase 2 Enrolling by invitation March 2020 China, Fujian ... More >> Rongbo Lin Fuzhou, Fujian, China, 350014 Less <<
NCT01934829 Hepatocellular Carcinoma Phase 2 Completed - China, Beijing ... More >> 301 Military Hospital, Beijing, China Beijing, Beijing, China, 100039 302 Military Hospital, Beijing, China Beijing, Beijing, China, 100039 China, Fujian Union Hospital of Fujian Medical University, Fujian, China Fuzhou, Fujian, China, 350001 China, Guangdong Guangdong Provincial People's Hospital, Guangdong, China Guangzhou, Guangdong, China, 510080 The Third Affiliated Hospital of Sun Yat-sen University, Guangdong, China Guangzhou, Guangdong, China, 510630 China, Heilongjiang Heilongjiang Provincial Cancer Hospital, Heilongjiang, China Haerbin, Heilongjiang, China, 150081 China, Jiangsu The 81 Hospital of the Chinese People's Liberation Army, Nanjing, China Nanjing, Jiangsu, China, 210002 China, Jilin Jilin Provincial Tumor Hospital, Jilin, China Changchun, Jilin, China, 130012 China, Shanghai Zhongshan Hospital, Fudan University, Shanghai Shanghai, Shanghai, China, 200032 Eastern Hepatobiliary Surgery Hospital of the Second Military Medical University, Shanghai, China Shanghai, Shanghai, China, 200438 China, Tianjin Tianjin Cancer Hospital, Tianjin, China Tianjin, Tianjin, China, 300060 Less <<
NCT00489086 Neoplastic Syndrome Phase 2 Completed - United States, California ... More >> Children's Hospital and Research Center Oakland Oakland, California, United States, 94609 United States, New York Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT02870036 Advanced Solid Tumor ... More >> Advanced/Metastatic Colorectal Cancer Less << Phase 1 Recruiting December 2020 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijin, Beijing, China, 100000 Contact: Lin Shen, M.D.    8610-88196561    lin100@medmail.com.cn    Principal Investigator: Lin Shen, M.D.          China, Heilongjiang Harbin Medical University Cancer Hospital Not yet recruiting Harbin, Heilongjiang, China Contact: Bai Yu Xian    13945095085    bai_yuxian@126.com    China, Hubei Tongji Hospital of Tongji Medical College,Huazhong University of Science and Technology Not yet recruiting Wuhan, Hubei, China, 430030 Contact: Xianglin Yuan, M.D.    8627-83662299    yxl@medmail.com.cn    Principal Investigator: Xianglin Yuan, M.D.          China, Hunan Hunan Cancer Hospital Not yet recruiting Changsha, Hunan, China, 410013 Contact: Nong Yang, M.D.    13055193557    yangnong0217@163.com    Principal Investigator: Nong Yang, M.D.          China, Jiangsu Jiangsu Cancer Hospital Not yet recruiting Nanjing, Jiangsu, China Contact: Feng Ji Feng, M.D    13901581264       China, Liaoning The first hospital of China Medical University Not yet recruiting Shenyang, Liaoning, China, 110001 Contact: Yunpeng Liu, M.D.    13898865122    cmu_trial@163.com    Principal Investigator: Yunpeng Liu, M.D.          China, Shanghai Fudan University Shanghai Cancer Center Not yet recruiting Shanghai, Shanghai, China, 200000 Contact: Junning Cao, M.D.    13651680209    cao_junning@126.com    Principal Investigator: Junning Cao, M.D.          China, Tianjin Tianjin Cancer Hospital Not yet recruiting Tianjin, Tianjin, China, 300060 Contact: Yi Ba, M.D.    13752157916    bayi@tjmuch.com    Principal Investigator: Yi Ba, M.D.          China, Zhejiang The Second Affiliated hospital of Zhejiang University School of Medicine Not yet recruiting Hangzhou, Zhejiang, China, 50011 Contact: Yuan Ying, M.D.    13858193601    yuanying1999@zju.edu.cn    Principal Investigator: Yuan Ying, M.D. Less <<
NCT01294176 Optic Neuritis Phase 1 Unknown October 2015 United States, Oregon ... More >> Oregon Health & Science University Recruiting Portland, Oregon, United States, 97239 Principal Investigator: Vijayshree Yadav, MBBS, MCR Less <<
NCT01978405 Acute Kidney Injury ... More >> The Changes of Plasma Creatinine The Changes of Plasma Free Radicals The Changes of Endothelium-dependent Arterial Dilation Less << Phase 4 Unknown June 2014 China, Hubei ... More >> Wuhan General Hospital Recruiting Wuhan, Hubei, China, 430070 Contact: Xiang Guangda, MD    +8602768878410 Less <<
NCT01988493 Carcinoma, Hepatocellular Phase 1 Phase 2 Active, not recruiting October 18, 2018 -
NCT02890992 Hypercholesterolaemia Phase 2 Active, not recruiting February 22, 2019 United States, Missouri ... More >> Investigational Site Number 8400002 Saint Louis, Missouri, United States, 63110 United States, North Carolina Investigational Site Number 8400005 Charlotte, North Carolina, United States, 28204 United States, Ohio Investigational Site Number 8400001 Cincinnati, Ohio, United States, 45229 Canada Investigational Site Number 1240001 Quebec, Canada, G1V 4W2 Czechia Investigational Site Number 2030001 Brno, Czechia, 62500 Investigational Site Number 2030003 Praha 5 - Motol, Czechia, 15006 Investigational Site Number 2030002 Zlin, Czechia, 76275 France Investigational Site Number 2500001 Bron Cedex, France, 69677 Netherlands Investigational Site Number 5280001 Amsterdam, Netherlands, 1105 AZ Norway Investigational Site Number 5780001 Oslo, Norway, 0373 Russian Federation Investigational Site Number 6430001 Kemerovo, Russian Federation, 650002 Investigational Site Number 6430004 Saint-Petersburg, Russian Federation, 194100 South Africa Investigational Site Number 7100001 Parow, South Africa, 7500 Spain Investigational Site Number 7240004 A Coruna, Spain, 15001 Investigational Site Number 7240001 Madrid, Spain, 28009 Sweden Investigational Site Number 7520001 Stockholm, Sweden, 171 76 Less <<
NCT01982097 - Completed - Russian Federation ... More >> Multiple Locations, Russian Federation Less <<
NCT02908295 Misoprostol, Blood Loss, Myome... More >>ctomy Less << Phase 4 Unknown April 2018 -
NCT02016495 Pregnancy Phase 4 Completed - Italy ... More >> Clinica Villa delle Querce Naples, Italy Less <<
NCT00489086 - Completed - -
NCT02021929 Hepatopulmonary Syndrome Phase 2 Terminated - United States, Arizona ... More >> Mayo Clinic Arizona Phoenix, Arizona, United States, 85054 United States, Illinois Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 United States, Minnesota Mayo Clinic - Rochester Rochester, Minnesota, United States, 55905 United States, New York Columbia University-NewYork-Presbyterian Hospital New York, New York, United States, 10032 United States, Pennsylvania University of Pennsylvania - Perelman Center Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29424 United States, Texas University of Texas Health Science Center at Houston Medical School Houston, Texas, United States, 77030 Less <<
NCT02904031 Elderly Metastatic Colorectal ... More >>Cancer Patients Less << Phase 2 Recruiting March 2019 Italy ... More >> Istituto Oncologico Veneto IRCCS Recruiting Padua, Italy, 35128 Contact: Federica Buggin       federica.buggin@iov.veneto.it    Principal Investigator: Sara Lonardi, MD          Principal Investigator: Fotios Loupakis, MD Less <<
NCT01933945 - Completed - -
NCT02024087 Advanced Adult Hepatocellular ... More >>Carcinoma Less << Phase 1 Phase 2 Completed - United States, Illinois ... More >> The University of Chicago Medical Center Chicago, Illinois, United States United States, Kansas University of Kansas Medical Center (KUMC) Westwood, Kansas, United States United States, Massachusetts Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States University of Rochester Rochester, New York, United States United States, Ohio University of Cincinnati Cancer Institute Cincinnati, Ohio, United States Less <<
NCT02941562 Rectal Cancer, Radiotherapy Phase 2 Not yet recruiting - -
NCT02961816 Lymphoma Phase 2 Withdrawn(Lack of funding) June 2021 -
NCT02961829 Chronic Infection ... More >> HIV Less << Not Applicable Active, not recruiting March 2020 Brazil ... More >> CCDI Sao Paulo, SP, Brazil, 04040002 Less <<
NCT02934464 Stomach Neoplasms Phase 3 Recruiting October 2019 Italy ... More >> Maria Di Bartolomeo Recruiting Milan, Italy, 20133 Contact: MARIA DI BARTOLOMEO, MD    +390223902882    maria.dibartolomeo@istitutotumori.mi.it    Contact: SILVIA LAZZATI    +3923903835    trialcenter@istitutotumori.mi.it Less <<
NCT00445770 Arthritis, Rheumatoid Phase 3 Completed - Japan ... More >> Pfizer Investigational Site Nagoya, Aichi, Japan, 460-0001 Pfizer Investigational Site Nagoya, Aichi, Japan, 4678602 Pfizer Investigational Site Goshogawara, Aomori, Japan, 037-0053 Pfizer Investigational Site Asahi, Chiba, Japan, 289-2511 Pfizer Investigational Site Matsuyama, Ehime, Japan, 790-8524 Pfizer Investigational Site Iizuka, Fukuoka, Japan, 820-8505 Pfizer Investigational Site Kurume, Fukuoka, Japan, 830-8543 Pfizer Investigational Site Kurume, Fukuoka, Japan, 8390863 Pfizer Investigational Site Munakata, Fukuoka, Japan, 8113431 Pfizer Investigational Site Takasaki, Gunma, Japan, 370-0053 Pfizer Investigational Site Asahikawa, Hokkaido, Japan, 078-8243 Pfizer Investigational Site Sapporo, Hokkaido, Japan, 060-0001 Pfizer Investigational Site Kakogawa, Hyogo, Japan, 6750009 Pfizer Investigational Site Katoh, Hyougo, Japan, 673-1462 Pfizer Investigational Site Yuki, Ibaraki, Japan, 307-0001 Pfizer Investigational Site Komatsu, Ishikawa, Japan, 923-8560 Pfizer Investigational Site Kawasaki, Kanagawa, Japan, 2120014 Pfizer Investigational Site Sagamihara, Kanagawa, Japan, 228-8522 Pfizer Investigational Site Yokohama, Kanagawa, Japan, 2310045 Pfizer Investigational Site Sendai, Miyagi, Japan, 9820032 Pfizer Investigational Site Hyuga, Miyazaki, Japan, 8830043 Pfizer Investigational Site Sasebo, Nagasaki, Japan, 857-1195 Pfizer Investigational Site Ikoma, Nara, Japan, 630-0293 Pfizer Investigational Site Kawagoe, Saitama, Japan, 350-8550 Pfizer Investigational Site Tokorozawa, Saitama, Japan, 359-1111 Pfizer Investigational Site Bunkyo-ku, Tokyo, Japan, 113-8549 Pfizer Investigational Site Ota, Tokyo, Japan, 1438541 Pfizer Investigational Site Sumida-ku, Tokyo, Japan, 130-0013 Pfizer Investigational Site Fukui, Japan, 9108561 Pfizer Investigational Site Fukuoka, Japan, 814-0002 Pfizer Investigational Site Fukuoka, Japan, 815-8588 Pfizer Investigational Site Fukuoka, Japan, 8150063 Pfizer Investigational Site Hiroshima, Japan, 7300031 Pfizer Investigational Site Kagoshima, Japan, 8900067 Pfizer Investigational Site Kagoshima, Japan, 891-0133 Pfizer Investigational Site Kato city Fujita letter Higashiyama, Japan, 944-25 Pfizer Investigational Site Kumamoto, Japan, 862-0976 Pfizer Investigational Site Kumamoto, Japan, 8620965 Pfizer Investigational Site Miyagi, Japan, 9810112 Pfizer Investigational Site Miyazaki, Japan, 8800122 Pfizer Investigational Site Toyama, Japan, 9338525 Less <<
NCT00445744 Adult Acute Myeloid Leukemia i... More >>n Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Childhood Acute Myeloid Leukemia in Remission Childhood Myelodysplastic Syndromes de Novo Myelodysplastic Syndromes Essential Thrombocythemia Myelodysplastic Syndrome With Isolated Del(5q) Polycythemia Vera Previously Treated Myelodysplastic Syndromes Primary Myelofibrosis Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Secondary Myelofibrosis Untreated Adult Acute Myeloid Leukemia Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Not Applicable Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00448201 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT00445770 - Completed - -
NCT00445744 - Completed - -
NCT00448201 - Completed - -
NCT00450983 - Terminated - -
NCT00484900 Plasmodium Falciparum Malaria Phase 3 Completed - Cameroon ... More >> Cameroon Baptist Convention Clinic of Biyem-Assi Yaounde, Cameroon Mali Health centres of Samako, Kolle and Bancoumane Bamako, Mali Rwanda Health centres Rwamagana and Muhima Kigali, Rwanda Sudan Alhara Alola Health centre New Halfa, Sudan Less <<
NCT00446784 Arthritis, Rheumatoid Phase 1 Completed - United States, Florida ... More >> Pfizer Investigational Site Miami, Florida, United States, 33169 Pfizer Investigational Site Ocala, Florida, United States, 34471 Pfizer Investigational Site Ocala, Florida, United States, 34474 United States, Michigan Pfizer Investigational Site Kalamazoo, Michigan, United States, 49007 United States, Pennsylvania Pfizer Investigational Site Ducansville, Pennsylvania, United States, 16635 Less <<
NCT00486694 Malaria, Vivax Phase 2 Completed - -
NCT00454649 Neoplasms Phase 1 Completed - United States, Georgia ... More >> Pfizer Investigational Site Augusta, Georgia, United States, 30909 Pfizer Investigational Site Augusta, Georgia, United States, 30912 United States, Illinois Pfizer Investigational Site Harvey, Illinois, United States, 60426-4265 Pfizer Investigational Site Harvey, Illinois, United States, 60426 Pfizer Investigational Site Tinley Park, Illinois, United States, 60477 United States, Indiana Pfizer Investigational Site Hobart, Indiana, United States, 46342 Pfizer Investigational Site Munster, Indiana, United States, 46321 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111 United States, Texas Pfizer Investigational Site Houston, Texas, United States, 77030-4009 United States, Washington Pfizer Investigational Site Kennewick, Washington, United States, 99336 Poland Pfizer Investigational Site Warszawa, Poland, 02-781 Spain Pfizer Investigational Site Barcelona, Spain, 08003 Pfizer Investigational Site Madrid, Spain, 28046 Less <<
NCT00455286 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Unknown November 2011 Taiwan ... More >> Changhua Christian Hospital Recruiting Changhua, Taiwan Contact: Cheng-Shyong Chang, M.D.    886-4-7238595    15120@cch.org.tw    China Medical University Hospital Recruiting Taichung, Taiwan Contact: Chang-Fang Chiu Chiu, M.D.    886-4-22052121    d5686@www.cmuh.org.tw    National Cheng Kung University Hospital Recruiting TaiNan, Taiwan Contact: Wu-Chou Su, M.D.    886-6-2353535    sunnysu@mail.ncku.edu.tw    Mackay Memorial Hospital Recruiting Taipei, Taiwan Contact: Ming-Chih Chang, M.D.    886-2-25433535 ext 3454    mmhdonald@yahoo.com.tw    Contact: Ming-Jer Huang Less <<
NCT00456261 - Completed - -
NCT01941173 Recurrent Colon Cancer ... More >> Recurrent Rectal Cancer Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer Less << Not Applicable Withdrawn(Lack of accrual) - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 City of Hope Antelope Valley Lancaster, California, United States, 93534 City of Hope- South Pasadena Cancer Center South Pasadena, California, United States, 91030 Less <<
NCT01261143 Diabetic Neuropathies Phase 3 Completed - Korea, Republic of ... More >> Kyung soo Ko Seoul, Korea, Republic of Less <<
NCT00450983 Graft Versus Host Disease ... More >> Leukemia Myelodysplastic Syndromes Less << Phase 2 Terminated - United States, Washington ... More >> Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT02047175 Hypertension ... More >>Hyperlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> The catholic university of Korea, seoul ST.Mary's hospital Seoul, Gangnam-gu, Korea, Republic of Less <<
NCT01264705 Hepatocellular Carcinoma ... More >> Liver Cancer Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT01262482 Advanced or Metastatic Gastric... More >> or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment) Less << Phase 2 Completed - Spain ... More >> Hospital Clinic de Barcelona Barcelona, Spain Hospital Sant Pau Barcelona, Spain H. Josep Trueta Girona, Spain Centro Oncológico M.D. Anderson Spain Madrid, Spain Hospital de Fuenlabrada Madrid, Spain Hospital La Paz Madrid, Spain Hospital Althaia Manresa, Spain Clínica Universitaria de Navarra Pamplona, Spain Hospital Parc Taulí Sabadell, Spain Hospital General de Valencia Valencia, Spain Less <<
NCT01708915 - Completed - -
NCT00454649 - Completed - -
NCT00456261 Lung Cancer Phase 2 Completed - United States, Alabama ... More >> Northeast Alabama Regional Medical Center Anniston, Alabama, United States, 36207 United States, Arkansas NEA Baptist Clinic Jonesboro, Arkansas, United States, 72401 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States, 33805 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Indiana Providence Medical Group Terre Haute, Indiana, United States, 47802 United States, Kentucky Graves-Gilbert Clinic Bowling Green, Kentucky, United States, 42101 Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Maine Mercy Hospital Portland, Maine, United States, 04101 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, North Carolina Cancer Care of Western North Carolina Asheville, North Carolina, United States, 28801 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Associates in Hematology Oncology Chattanooga, Tennessee, United States, 37404 Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT01708915 Acute Low Back Pain Phase 3 Completed - Germany ... More >> 69.52.49007 Boehringer Ingelheim Investigational Site Bad Lippspringe, Germany 69.52.49003 Boehringer Ingelheim Investigational Site Berlin, Germany 69.52.49004 Boehringer Ingelheim Investigational Site Berlin, Germany 69.52.49026 Boehringer Ingelheim Investigational Site Berlin, Germany 69.52.49032 Boehringer Ingelheim Investigational Site Berlin, Germany 69.52.49033 Boehringer Ingelheim Investigational Site Berlin, Germany 69.52.49041 Boehringer Ingelheim Investigational Site Berlin, Germany 69.52.49002 Boehringer Ingelheim Investigational Site Einbeck, Germany 69.52.49024 Boehringer Ingelheim Investigational Site Essen, Germany 69.52.49031 Boehringer Ingelheim Investigational Site Essen, Germany 69.52.49036 Boehringer Ingelheim Investigational Site Essen, Germany 69.52.49005 Boehringer Ingelheim Investigational Site Everswinkel, Germany 69.52.49039 Boehringer Ingelheim Investigational Site Fürth, Germany 69.52.49018 Boehringer Ingelheim Investigational Site Goch, Germany 69.52.49025 Boehringer Ingelheim Investigational Site Großheirath-Rossach, Germany 69.52.49022 Boehringer Ingelheim Investigational Site Haag, Germany 69.52.49009 Boehringer Ingelheim Investigational Site Hamburg, Germany 69.52.49019 Boehringer Ingelheim Investigational Site Hamburg, Germany 69.52.49015 Boehringer Ingelheim Investigational Site Kaarst, Germany 69.52.49042 Boehringer Ingelheim Investigational Site Karlsruhe-Rüppurr, Germany 69.52.49027 Boehringer Ingelheim Investigational Site Köln, Germany 69.52.49035 Boehringer Ingelheim Investigational Site Köln, Germany 69.52.49040 Boehringer Ingelheim Investigational Site Köln, Germany 69.52.49013 Boehringer Ingelheim Investigational Site Köthen, Germany 69.52.49014 Boehringer Ingelheim Investigational Site Künzing, Germany 69.52.49034 Boehringer Ingelheim Investigational Site Ludwigshafen, Germany 69.52.49028 Boehringer Ingelheim Investigational Site Meßkirch, Germany 69.52.49030 Boehringer Ingelheim Investigational Site Meßkirch, Germany 69.52.49029 Boehringer Ingelheim Investigational Site Münster, Germany 69.52.49012 Boehringer Ingelheim Investigational Site Neunkirchen, Germany 69.52.49020 Boehringer Ingelheim Investigational Site Rodgau, Germany 69.52.49037 Boehringer Ingelheim Investigational Site Siegen, Germany 69.52.49016 Boehringer Ingelheim Investigational Site Stockach, Germany 69.52.49010 Boehringer Ingelheim Investigational Site Straßkirchen, Germany 69.52.49021 Boehringer Ingelheim Investigational Site Villingen-Schwenningen, Germany 69.52.49023 Boehringer Ingelheim Investigational Site Wangen, Germany 69.52.49011 Boehringer Ingelheim Investigational Site Weilburg, Germany Less <<
NCT01265576 HCC Phase 2 Unknown April 2016 United States, California ... More >> Vicus Clinical Site Berkeley, California, United States, 94704 United States, Georgia Vicus Clinical Site Atlanta, Georgia, United States, 30318 United States, New Jersey Vicus Clinical Site New Brunswick, New Jersey, United States Vicus Clinical Site Newark, New Jersey, United States, 07103 Vicus Clinical Site Paterson, New Jersey, United States, 07503 United States, New York Vicus Clinical Site Buffalo, New York, United States, 14263 Vicus Clinical Site New York, New York, United States, 10016 United States, Pennsylvania Vicus Clinical Site Philadelphia, Pennsylvania, United States United States, Texas Vicus Clinical Site Houston, Texas, United States, 77024 Vicus Clinical Site Houston, Texas, United States, 77030 Less <<
NCT01276210 Tumors Metastatic to Brain Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT01271504 Hepatocellular Carcinoma Phase 1 Phase 2 Completed - United States, Arizona ... More >> Tucson, Arizona, United States, 85715 United States, Florida Fort Myers, Florida, United States, 33905 Saint Petersburg, Florida, United States, 33705 United States, North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Ohio Cincinnati, Ohio, United States, 45267 Toledo, Ohio, United States, 43623 United States, Tennessee Nashville, Tennessee, United States, 37203 Belgium Brussels, Belgium, 1070 Bruxelles, Belgium, 1200 Leuven, Belgium, 3000 Italy Rozzano, Milano, Italy, 20089 Modena, Italy, 40124 Pavia, Italy, 27100 Spain Madrid, Spain, 28007 Madrid, Spain, 28034 Madrid, Spain, 28046 Madrid, Spain, 28050 Ukraine Dnipropetrovsk, Ukraine, 49102 Donetsk, Ukraine, 83092 Kharkiv, Ukraine, 61037 Lviv, Ukraine, 79031 United Kingdom London, Greater London, United Kingdom, WC1E 6BT Manchester, Greater Manchester, United Kingdom, M20 4BX Glasgow, Strathclyde, United Kingdom, G12 OYN Less <<
NCT01959139 Metastatic Pancreatic Adenocar... More >>cinoma Less << Phase 1 Phase 2 Active, not recruiting October 2020 -
NCT01983735 Hypertension Phase 3 Unknown August 2014 Korea, Republic of ... More >> The catholic university of Korea Seoul St. Mary's hospital Not yet recruiting Seoul, Korea, Republic of Contact: Ho-Joong Yoon, Ph.D    82-2-2258-6029    younhj@catholic.ac.kr    Principal Investigator: Ho-Joong Yoon, Ph.D Less <<
NCT01983969 Advanced Cancers ... More >> Lymphoma Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01303341 Advanced Malignant Solid Neopl... More >>asm Recurrent Melanoma Refractory Malignant Solid Neoplasm Stage III Cutaneous Melanoma AJCC v7 Stage IIIA Cutaneous Melanoma AJCC v7 Stage IIIB Cutaneous Melanoma AJCC v7 Stage IIIC Cutaneous Melanoma AJCC v7 Stage IV Cutaneous Melanoma AJCC v6 and v7 Less << Phase 1 Active, not recruiting - United States, New Jersey ... More >> Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Less <<
NCT01754987 - Completed - -
NCT02013089 Gastrointestinal Cancers Not Applicable Unknown December 2017 China, Guangdong ... More >> Gastrointestinal Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Yanghong Deng, PhD    008613925106525    13925106525@163.com    Principal Investigator: Yanhong Deng, PhD Less <<
NCT01306058 - Completed - -
NCT01306058 Hepatoma Live... More >>r Neoplasms Adenoma, Liver Cell Carcinoma, Hepatocellular Liver Neoplasms, Experimental Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01328223 - Unknown December 2012 Taiwan ... More >> Shang-Wen Chen Recruiting Taichung, Taiwan, 404 Contact: Shang-Wen Chen, MD    886-4-22052121 ext 7450    vincent1680616@yahoo.com.tw    Sub-Investigator: Yu-Cheng Kuo          Sub-Investigator: Ji-An Liang, MD          Li-Ching Lin Recruiting Tainan, Taiwan, 700 Contact: Li-Ching Lin, MD       liching51@yahoo.com.tw    Jeng-Fong Chiou Recruiting Taipei, Taiwan, 100 Contact: Jeng-Fong Chiou, MD;PhD       sjfchiou@xuite.net Less <<
NCT01984567 Oxidative Stress Not Applicable Unknown January 2014 Netherlands ... More >> Maastricht University Medical Centre Maastricht, Limburg, Netherlands, 6229 ER Less <<
NCT01334710 Liver Cancer Phase 2 Terminated(safety issue observ... More >>ed on another hepatocellular study using OSI906) Less << - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT01319942 - Unknown June 2013 Taiwan ... More >> Chi-Mei Hospital Recruiting Tainan, Taiwan, 600 Contact: Li-Ching Lin, MD    886-6-2812811 ext 53501    liching51@yahoo.com.tw    Principal Investigator: Li-Ching Lin, MD          Taipei Medical University Hospital Recruiting Taipei, Taiwan, 100 Contact: Jeng-Fong Chiou, MD;PhD    886-2-27372181 ext 2130    sjfchiou@xuite.net    Principal Investigator: Jen-Fong Chiou, MD;PhD Less <<
NCT02015728 Recurrent Childhood Brain Tumo... More >>r Less << Not Applicable Unknown December 2017 United States, Washington ... More >> Seattle Children's Seattle, Washington, United States, 98105 Less <<
NCT01754987 Metastatic Hepatocellular Carc... More >>inoma Advanced Liver Cancer Less << Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01334710 - Terminated(safety issue observ... More >>ed on another hepatocellular study using OSI906) Less << - -
NCT02035527 Metastatic Squamous Neck Cance... More >>r With Occult Primary Squamous Cell Carcinoma Recurrent Metastatic Squamous Neck Cancer With Occult Primary Recurrent Salivary Gland Cancer Recurrent Squamous Cell Carcinoma of the Hypopharynx Recurrent Squamous Cell Carcinoma of the Larynx Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcinoma of the Nasopharynx Recurrent Squamous Cell Carcinoma of the Oropharynx Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Recurrent Verrucous Carcinoma of the Larynx Recurrent Verrucous Carcinoma of the Oral Cavity Salivary Gland Squamous Cell Carcinoma Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IVA Salivary Gland Cancer Stage IVA Squamous Cell Carcinoma of the Larynx Stage IVA Oral Cavity Squamous Cell Carcinoma Stage IVA Squamous Cell Carcinoma of the Oropharynx Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVA Verrucous Carcinoma of the Larynx Stage IVA Verrucous Carcinoma of the Oral Cavity Stage IVB Salivary Gland Cancer Stage IVB Squamous Cell Carcinoma of the Larynx Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVB Squamous Cell Carcinoma of the Oropharynx Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVB Verrucous Carcinoma of the Larynx Stage IVB Verrucous Carcinoma of the Oral Cavity Stage IVC Salivary Gland Cancer Stage IVC Squamous Cell Carcinoma of the Larynx Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVC Squamous Cell Carcinoma of the Oropharynx Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVC Verrucous Carcinoma of the Larynx Stage IVC Verrucous Carcinoma of the Oral Cavity Tongue Cancer Untreated Metastatic Squamous Neck Cancer With Occult Primary Less << Phase 1 Completed - United States, Ohio ... More >> Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT02041481 Recurrent Colon Cancer ... More >> Recurrent Rectal Cancer Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer Less << Phase 1 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT01335074 Hepatocellular Carcinoma Phase 1 Phase 2 Withdrawn - Germany ... More >> University Hospital Giessen and Marburg Marburg, Germany, 35043 Less <<
NCT01338857 - Terminated(Sorafenib ineffecti... More >>ve for tx of recurrent or progressive PLGA) Less << - -
NCT02045901 Morning Sickness Phase 4 Active, not recruiting September 2017 United States, Arizona ... More >> Watching Over Mothers and Babies Tucson, Arizona, United States, 85712 United States, California Clinica Del Socorro Medical Group, Inc. Los Angeles, California, United States, 90011 Futura Research Norwalk, California, United States, 90650 United States, Florida Empire Clinical Research, LLC Miami Lakes, Florida, United States, 33016 Medical Professional CR Center Miami, Florida, United States, 33165 United States, Michigan Western Michigan University Homer Stryker M.D. School of Medicine Kalamazoo, Michigan, United States, 49008 United States, New Jersey Jersey Shore University Medical Center Neptune, New Jersey, United States, 07753 United States, Ohio Complete Healthcare for Women Columbus, Ohio, United States, 43213 Less <<
NCT02054299 Drug Metabolism ... More >> Membrane Transport Less << Phase 1 Completed - Germany ... More >> Department of Clinical Pharmacology, University Medical Center Goettingen Goettingen, Germany, 37075 Less <<
NCT01809301 Healthy Phase 1 Completed - Canada, Ontario ... More >> Bio Pharma Services Inc. (BPSI) Toronto, Ontario, Canada, M9L 3A2 Less <<
NCT01338857 neurofibromatosis1 (NF1) ... More >> Recurrent or Progressive Optic Pathway Gliomas (OPG) Recurrent or Progressive Low-grade Glioma Less << Phase 2 Terminated(Sorafenib ineffecti... More >>ve for tx of recurrent or progressive PLGA) Less << - United States, New York ... More >> New York University Stephen D. Hassenfeld Children's Center for Cancer & Blood Disorders New York, New York, United States, 10016 Less <<
NCT01357486 Hepatocellular Carcinoma ... More >> CHILD B Less << Phase 2 Completed - France ... More >> CH d'Abbeville Abbeville, France, 80142 CH Pays d'Aix Aix-en-provence, France, 13616 CH d'Auxerre Auxerre, France, 89011 CH de la Côte Basque Bayonne, France, 64109 AP-HP- Hôpital Jean-Verdier Bondy, France, 93143 CHU de Bordeaux Bordeaux, France, 33075 CH Duchenne Boulogne Sur Mer, France, 62321 CH de Béziers Béziers, France, 34525 AP-HP Hôpital Henri Mondor Creteil, France, 94010 CHU Le Bocage Dijon, France, 21079 CH Départemental Vendée La Roche-sur-yon, France, 85925 CH Le Mans Le Mans, France, 72037 CH de Bretagne Sud Lorient, France, 56100 Hôpital privé Jean Mermoz Lyon, France, 69008 AP-HM Hôpital de la Timone Marseille, France, 13385 CH de Meaux Meaux, France, 77104 CH Mont de Marsan Mont-de-marsan, France, 40024 CHU de Nancy Hôpital Brabois Nancy, France, 54511 CHU de Nantes Hôpital de l'Hotel Dieu Nantes, France, 44093 CHU Nîmes Nimes, France, 30029 CHR d'Orléans - Hôpital La Source Orleans, France, 45067 Groupe Hospitalier Paris Saint Joseph Paris, France, 75014 CH Perpignan Perpignan, France, 66046 CHU de Bordeaux, Hôpital du Haut Lévèque Pessac, France, 33604 CH de la Région d'Annecy Pringy, France, 74374 Centre Eugène Marquis Rennes, France, 35042 Clinique Mathilde Rouen, France, 76000 Clinique Armoricaine de Radiologie Saint Brieuc, France, 22015 CH Saint-Malo Saint Malo, France, 35400 Centre René Gauducheau CLCC Nantes Atlantique Saint-herblain, France, 44805 CH Gaston Ramon Sens, France, 89100 Centre Régional de Lutte contre le Cancer Centre Paul Strauss Strasbourg, France, 67065 Hôpitaux Universitaires de Strasbourg Hôpital civil Strasbourg, France, 67091 Hôpitaux Universitaires de Strasbourg, Hôpital Hautepierre Strasbourg, France, 67098 CHRU de Tours Tours, France, 37044 Less <<
NCT01342627 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Terminated(low enrollment rate... More >>) Less << - Italy ... More >> Centro di Riferimento Oncologico Aviano, Pordenone, Italy, 33081 Less <<
NCT01371981 Acute Myeloid Leukemia ... More >> Leukemia Cutis Myeloid Neoplasm Myeloid Sarcoma Untreated Adult Acute Myeloid Leukemia Untreated Childhood Myeloid Neoplasm Less << Phase 3 Active, not recruiting - -
NCT02097342 Type 2 Diabetes Mellitus ... More >> Insulin Sensitivity/Resistance Less << Phase 4 Unknown January 2015 India ... More >> Postgraduate Institute of Medical Education & Research Recruiting Chandigarh, India, 160012 Contact: Anil Bhansali, MD DM       anilbhansaliendocrine@gmail.com Less <<
NCT02081287 Bipolar Disorder ... More >> Manic Depression Less << Phase 1 Completed - United States, California ... More >> VA San Diego Healthcare System San Diego, California, United States, 92161 Less <<
NCT02115724 Cardiovascular Disease Not Applicable Recruiting April 2020 United States, Georgia ... More >> Georgia Prevention Institute , Georgia Regents University Recruiting Augusta, Georgia, United States, 30912 Contact: Ryan Harris, PhD    706-721-5998    ryharris@gru.edu    Contact: Jacob Looney, BS    706 721-5483    jlooney@gru.edu    Principal Investigator: Ryan Harris, PhD Less <<
NCT01377025 Uveal Melanoma Phase 2 Unknown June 2017 Germany ... More >> Universitätsmedizin Berlin, Charité Campus Benjamin Franklin Berlin, Germany, 12203 Universitätsklinikum Erlangen Erlangen, Germany, 91052 Univesitätsklinikum Essen Essen, Germany, 45147 Less <<
NCT01355952 Obesity Weigh... More >>t Loss Schizophrenia Less << Not Applicable Completed - United States, Connecticut ... More >> Connecticut Mental Health Center New Haven, Connecticut, United States, 06519 Less <<
NCT01396733 Thyroid Cance... More >>r Less << Phase 2 Unknown December 2013 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Tae Yong Kim, MD, PhD    82-2-3010-3249    tykim@amc.seoul.kr    Principal Investigator: Won Bae Kim, MD, PhD Less <<
NCT02128243 Unresectable, Locally Advanced... More >> or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction Gastric Neoplasm Gastroesophageal Junction Adenocarcinoma Esophageal Adenocarcinoma Gastric Adenocarcinoma Esophageal Neoplasms Less << Phase 2 Recruiting September 2018 Germany ... More >> NCT-Med. Onkologie Recruiting Heidelberg, Baden-Württemberg, Germany, 69120 Contact: Georg Martin Haag, Dr.    +49-6221 ext 5637630    GeorgMartin.Haag@med.uni-heidelberg.de Less <<
NCT01405573 Advanced Adult Hepatocellular ... More >>Carcinoma Less << Phase 3 Terminated(lack of enrolment) - Italy ... More >> Azienda Ospedaliera G. Rummo Benevento, BN, Italy Policlinico Giaccone Palermo, PA, Italy, 90127 S. Orsola-Malpighi Bologna, Italy Ospedale Ramazzini di Carpi Carpi, Italy Osp. Civile Infermi Faenza, Italy Azienda Ospedaliera Careggi Firenze, Italy IRCCS-Azienda Ospedaliera Universitaria San Martino-IST Genova, Italy AO C. Poma Mantova, Italy Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Meldola, Italy A.O.U. G.Martino- Policlinico Universita di Messina Messina, Italy Istituto Nazionale Tumori Milano, Italy A.O.U. Federico II Napoli, Italy AOU II Università di Napoli Napoli, Italy Istituto Nazionale dei Tumori Napoli, Italy Ospedale Cardarelli Napoli, Italy Azienda Ospedaliera Universitaria di Padova Padova, Italy Istituto Oncologico Veneto Padova, Italy A.O. Ospedali Riuniti Villa Sofia-Cervello Palermo, Italy Azienda Ospedaliero Universitaria di Parma Parma, Italy Ospedale Guglielmo da Saliceto Piacenza, Italy, Italy AO S. Carlo Potenza, Italy Policlinico Universitario Tor Vergata Roma, Italy Oncologia IRCCS - Casa Sollilevo Sofferenza S. Giovanni Rotondo, Italy Azienda Ospedaliera Universitaria Arcispedal, U.O. di Oncologia Clinica Sant'Anna di Ferrara, Italy A.O. Trevigilio - Caravaggio Trevigilio, Italy Less <<
NCT02114502 Myeloma Phase 2 Withdrawn - -
NCT01409499 Hepatectomy H... More >>epatocellular Carcinoma Sorafenib Less << Phase 4 Completed - China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT01398501 Acute Myeloid Leukemia Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02214 Less <<
NCT01411436 - Completed - Japan ... More >> Many locations, Japan Less <<
NCT02143726 Refractory Hurthle Cell Thyroi... More >>d Cancer Less << Phase 2 Recruiting - United States, Florida ... More >> Mayo Clinic in Florida Suspended Jacksonville, Florida, United States, 32224-9980 United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Site Public Contact    312-695-1301    cancer@northwestern.edu    Principal Investigator: Maria Matsangou          United States, Iowa Siouxland Regional Cancer Center Recruiting Sioux City, Iowa, United States, 51101 Contact: Site Public Contact    712-252-0088       Principal Investigator: Donald B. Wender          United States, Michigan University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Site Public Contact    800-865-1125       Principal Investigator: Francis P. Worden          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Site Public Contact    855-776-0015       Principal Investigator: Ashish V. Chintakuntlawar          United States, Nebraska Nebraska Methodist Hospital Recruiting Omaha, Nebraska, United States, 68114 Contact: Site Public Contact    402-354-5144       Principal Investigator: Yungpo B. Su          United States, New Jersey Memorial Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Sleepy Hollow Suspended Sleepy Hollow, New York, United States, 10591 United States, North Carolina Southeastern Medical Oncology Center-Clinton Recruiting Clinton, North Carolina, United States, 28328 Contact: Site Public Contact    919-587-9077    ecooke@cancersmoc.com    Principal Investigator: James N. Atkins          Southeastern Medical Oncology Center-Goldsboro Recruiting Goldsboro, North Carolina, United States, 27534 Contact: Site Public Contact    919-587-9077    ecooke@cancersmoc.com    Principal Investigator: James N. Atkins          Wayne Memorial Hospital Recruiting Goldsboro, North Carolina, United States, 27534 Contact: Site Public Contact    919-731-6687    ecooke@cancersmoc.com    Principal Investigator: James N. Atkins          Southeastern Medical Oncology Center-Jacksonville Recruiting Jacksonville, North Carolina, United States, 28546 Contact: Site Public Contact    910-353-0824    ecooke@cancersmoc.com    Principal Investigator: James N. Atkins          Southeastern Medical Oncology Center-Wilson Suspended Wilson, North Carolina, United States, 27893 United States, Ohio Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Site Public Contact    800-293-5066    Jamesline@osumc.edu    Principal Investigator: Bhavana Konda          United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Site Public Contact    215-728-4790       Principal Investigator: Jessica R. Bauman          United States, Wisconsin Mercy Health System Recruiting Janesville, Wisconsin, United States, 53547 Contact: Site Public Contact    800-928-1103       Principal Investigator: Emily G. Robinson Less <<
NCT01412671 - Completed - Japan ... More >> Multiple Locations, Japan Less <<
NCT02161653 Severe Alcoholic Hepatitis Phase 4 Completed - Mexico ... More >> Hospital General de Mexico Mexico City, D.f., Mexico, 06726 Less <<
NCT01425216 Keloids Phase 2 Terminated(IND application was... More >> not approved by the US FDA - Project was never started) Less << - United States, New York ... More >> Michael H. Tirgan, MD New York, New York, United States, 10023 Less <<
NCT01411423 - Completed - Japan ... More >> Multiple Locations, Japan Less <<
NCT02169882 Tuberculosis, Meningeal Phase 2 Phase 3 Completed - Indonesia ... More >> Hasan Sadikin General Hospital Bandung, Jawa Barat, Indonesia, 40161 Less <<
NCT02162563 Colorectal Cancer ... More >> Liver Metastases Less << Phase 3 Recruiting July 2025 -
NCT01444807 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Recruiting September 2019 Italy ... More >> Istituto Tumori Milano Recruiting Milan, Mi, Italy, 20156 Contact: Giuseppe Procopio, MD    +390223902557    Giuseppe.Procopio@istitutotumori.mi.it    Contact: Elena Verzoni, MD    +390223902557    elena.verzoni@istitutotumori.mi.it    Principal Investigator: Giuseppe Procopio, MD          Cinzia Ortega Recruiting Alba, Italy Alessandra Bearz Recruiting Aviano, Italy Alfredo Berruti Recruiting Brescia, Italy Saverio Cinieri Recruiting Brindisi, Italy Francesco Atzori Recruiting Cagliari, Italy Rodolfo Passalaqua Recruiting Cremona, Italy Francesco Di Costanzo Recruiting Firenze, Italy Vincenzo Emanuele Chiuri Recruiting Lecce, Italy Alessandra Mosca Recruiting Novara, Italy Vittorio Gebbia Recruiting Palermo, Italy Enrico Cortesi Recruiting Roma, Italy Francesco Cognetti Recruiting Roma, Italy Contact: Michele Milella          Franco Morelli Recruiting San Giovanni Rotondo, Italy Less <<
NCT01418729 Advanced Hepatocarcinoma Phase 2 Completed - Spain ... More >> Hospital Donostia, Instituto Biodonostia San Sebastian, Gipuzkoa, Spain, 20014 Less <<
NCT00848562 Acute Myocardial Infarction ... More >> Congestive Heart Failure Less << Not Applicable Completed - Japan ... More >> Toujinkai Hospital Kyoto, Japan, 612-8026 Less <<
NCT01470495 HCC Radiofreq... More >>uency Ablation Sorafenib Less << Not Applicable Recruiting December 2018 China, Chongqing ... More >> Institute of hepatobiliary surgery,southwest hospital Recruiting Chongqing, Chongqing, China, 400038 Contact: feng xiaobin, MD    +86-23-13228683243    fengxiaobin200708@yahoo.com.cn    Principal Investigator: feng xiaobin, MD Less <<
NCT01909557 Quality of Life ... More >> Daily Activity Fatigue Less << Phase 3 Completed - Italy ... More >> University of Catania, Cannizzaro Hospital Catania, Italy, 95125 Less <<
NCT01942291 Hypoalphalipoproteinemia Phase 4 Completed - Brazil ... More >> University of Campinas Campinas, SP, Brazil, 13083-887 Less <<
NCT01481870 Metastatic Renal Cell Carcinom... More >>a Less << Phase 3 Unknown December 2015 Japan ... More >> Yamagata University Faculty of Medicine Yamagata, Japan, 990-9585 Less <<
NCT01921010 Cardiovascular Outcomes Phase 4 Completed - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Less <<
NCT01482442 Liver Carcinoma Phase 3 Completed - France ... More >> CHU Amiens #2 Amiens, France, 80054 CHU Angers #3 Angers, France, 49933 CHRU Besançon Hôpital Jean Minjoz #21 Besançon, France, 25030 Hôpital Jean Verdier #25 Bondy, France, 93140 Hôpital Côte de Nacre #4 Caen, France, 14033 Hôpital Antoine Béclère #29 Clamart, France, 92140 Hopital beaujon #1 Clichy, France, 92110 Henri Mondor #24 Créteil, France, 94000 CHU Dijon Hôpital Bocage #22 Dijon, France, 21000 CHU Grenoble #5 Grenoble, France, 38043 Hôpital Edouard Herriot #6 Lyon, France, 69003 Lyon La croix Rousse #27 Lyon, France, 69004 Institut Paoli Calmettes #7 Marseille, France, 13009 CHU Marseille Hôpital La Timone #23 Marseille, France, 13385 Hôpital Saint Eloi #8 Montpellier, France, 34295 Hôpital de Brabois #9 Nancy, France, 54511 Hotel Dieu #10 Nantes, France, 44093 Hôpital de L'Archet #11 Nice, France, 06002 Hôpital Européen Georges Pompidou #13 Paris, France, 75908 Hôpital Haut Leveque #14 Pessac, France, 33604 CHU Poitiers La Milétrie Poitiers, France, 86021 CHU Robert Debré #28 Reims, France, 51100 CHU Saint Etienne Hôpital Nord #17 Saint-Priest en Jarez, France, 42270 Hôpital de Hautepierre #18 Strasbourg, France, 67098 Paul Brousse #19 Villejuif, France, 94275 Institut Gustave Roussy #20 Villejuif, France, 94805 Less <<
NCT01480817 Hepatocellular Carcinoma Phase 2 Terminated(Difficulty of parti... More >>cipant enrollment.) Less << - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT02250833 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Kyungpook National University Hospital Daegu, samdeok-dong, 2-ga 50, samdeok-dong, 2-ga 50 Jung-gu, Korea, Republic of, 700-721 Less <<
NCT02244632 Colorectal Neoplasm Phase 1 Phase 2 Recruiting June 2019 Denmark ... More >> Odense University Hospital Recruiting Odense, Denmark Greece 251 General Airforce Hospital Recruiting Athens, Greece IASO General Hospital Recruiting Athens, Greece Medical School University of Athens, Aretaieio Hospital Recruiting Athens, Greece University Genral Hospital Attikon Recruiting Athens, Greece University General Hospital of Heraklion Recruiting Iráklion, Greece Norway Oslo University Hospital Completed Oslo, Norway Sweden Sahlgrenska University Hospital Recruiting Göteborg, Sweden, 461 85 Contact: Göran Carlsson, MD          Principal Investigator: Göran Carlsson, MD          Skaraborg hospital Recruiting Skövde, Sweden Less <<
NCT01498952 Unresectable or Metastatic Hep... More >>atocellular Carcinoma (HCC) Less << Phase 1 Completed - United States, California ... More >> Research Site Oxnard, California, United States United States, Colorado Research Site Golden Springs, Colorado, United States United States, Nevada Research Site Las Vegas, Nevada, United States Less <<
NCT02251977 Colorectal Cancer ... More >> Chemotherapy-induced Neutropenia Less << Phase 3 Recruiting August 2018 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Yuhong Li, MD       liyh@sysucc.org.cn    Principal Investigator: Yuhong Li, MD Less <<
NCT02235324 Mucinous Adenocarcinoma of the... More >> Colon Mucinous Adenocarcinoma of the Rectum Recurrent Colon Cancer Recurrent Rectal Cancer Signet Ring Adenocarcinoma of the Colon Signet Ring Adenocarcinoma of the Rectum Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer Less << Phase 2 Withdrawn(Lack of funding) March 2018 United States, California ... More >> USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90089 Less <<
NCT01497444 Kidney Cancer ... More >> Liver Cancer Less << Phase 1 Active, not recruiting - United States, Arizona ... More >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259-5499 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT02259647 Hepatocellular Carcinoma Not Applicable Unknown June 2016 India ... More >> Institute of Liver & Biliary Sciences Recruiting New Delhi, Delhi, India, 110070 Contact: Dr Devraj R, MD    011-46300000    drdevurgowda@gmail.com    Principal Investigator: Dr Devraja R, MD Less <<
NCT01507064 Hepatocellular Carcinoma Phase 2 Completed - Italy ... More >> UOSC Epatologia - Cardarelli Hospital Napoli, Italy, 80131 Less <<
NCT02167321 Locally Advanced Rectal Cancer Phase 3 Recruiting May 2021 Korea, Republic of ... More >> Severance Hospital Recruiting Seoul, Korea, Republic of Contact: Joong Bae Ahn, M.D., Ph.D.       vvswm513@yuhs.ac    Principal Investigator: Joong Bae Ahn, M.D., Ph.D. Less <<
NCT01502410 - Completed - -
NCT01984073 Dyslipidemia Phase 1 Recruiting October 2018 United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Laura J Pollan, MPH    215-615-4740    pollan@mail.med.upenn.edu    Principal Investigator: Richard L Dunbar, MD          Sub-Investigator: Daniel J Rader, MD          Presbyterian Hospital Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Laura J Pollan, MPH    215-615-4740    pollan@mail.med.upenn.edu    Principal Investigator: Richard L Dunbar, MD          Sub-Investigator: Daniel J Rader, MD Less <<
NCT01502410 Childhood Hepatocellular Carci... More >>noma Papillary Thyroid Cancer Previously Treated Childhood Rhabdomyosarcoma Recurrent Childhood Liver Cancer Recurrent Childhood Rhabdomyosarcoma Recurrent Thyroid Cancer Recurrent Wilms Tumor and Other Childhood Kidney Tumors Less << Phase 2 Completed - -
NCT01510756 - Terminated(slow enrollment) - -
NCT02276989 Compliance Ch... More >>ronic Pain Less << Phase 2 Withdrawn(poor recruitment) - United States, District of Col... More >>umbia Georgetown University Washington, District of Columbia, United States, 20007 Less <<
NCT02270606 Mucinous Adenocarcinoma of the... More >> Rectum Recurrent Rectal Cancer Signet Ring Adenocarcinoma of the Rectum Rectal Adenocarcinoma Stage IIA Rectal Cancer Stage IIB Rectal Cancer Stage IIC Rectal Cancer Stage IIIA Rectal Cancer Stage IIIB Rectal Cancer Stage IIIC Rectal Cancer Less << Phase 1 Active, not recruiting May 14, 2023 United States, Virginia ... More >> Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23219 Less <<
NCT01993927 - Completed - Japan ... More >> Osaka, Japan Less <<
NCT01515839 Traumatic Brain Injury Not Applicable Completed - United States, California ... More >> Amen Clinics, Inc. Newport Beach, California, United States, 92660 Less <<
NCT02003638 Coronary Artery Disease ... More >> Carotid Artery Disease Peripheral Artery Disease Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01524861 Apical Ballooning Syndrome ... More >> Nervous System Diseases, Sympathetic Less << Phase 4 Completed - Italy ... More >> Dept Geriatric and Metabolic diseases SUN Naples, Italy Less <<
NCT01510756 Chronic Lymphocytic Leukemia Phase 2 Terminated(slow enrollment) - United States, California ... More >> UCSD Medical Center La Jolla, California, United States, 92093 Less <<
NCT02003638 - Completed - -
NCT02292238 Alzheimer's Disease Phase 2 Recruiting November 2019 United States, New York ... More >> Burke Recruiting White Plains, New York, United States, 10605 Contact: Liz Magier, MPA    914-368-3159    burkegrants@med.cornell.edu Less <<
NCT02298348 Neuroblastoma Phase 1 Active, not recruiting May 2019 United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Colorado Children Hospital of Colorado Aurora, Colorado, United States, 80045 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 United States, Illinois University of Chicago, Comer Children's Hospital Chicago, Illinois, United States, 60637 United States, Massachusetts Childrens Hospital Boston, Dana-Farber Cancer Institute. Boston, Massachusetts, United States, 02115 United States, Michigan C.S Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Texas Cook Children's Healthcare System Fort Worth, Texas, United States, 76104 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT01534260 Acute Myeloid Leukemia Phase 1 Phase 2 Completed - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT01537549 Progressive Supranuclear Palsy Phase 1 Phase 2 Completed - United States, New York ... More >> Weill Cornell Medical College New York, New York, United States, 10021 Less <<
NCT01993927 - Completed - -
NCT01539018 Advanced Hepatocellular Carcin... More >>oma Less << Phase 2 Terminated(After interim resul... More >>ts data showed no evidence of a difference between both groups) Less << - Egypt ... More >> Ain shams university Cairo, Egypt Cairo University Hospitals Cairo, Egypt National cancer institute Cairo, Egypt NHTMRI Cairo, Egypt National Liver Institute Monofeiya, Egypt Less <<
NCT01539681 - Completed - Italy ... More >> Many Locations, Italy Less <<
NCT01556815 PHENYTOIN/SORAFENIB [VA Drug I... More >>nteraction] Liver Neoplasms Carcinoma, Hepatocellular Digestive System Neoplasms Neoplasms by Site Liver Diseases Adenocarcinoma Carcinoma Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type DOXORUBICIN/TRASTUZUMAB [VA Drug Interaction] HBV Less << Phase 2 Unknown May 2015 China, Shandong ... More >> Shandong Cancer Hospital and Institute Not yet recruiting Jinan, Shandong, China, 250117 Contact: Wenbo Shao, MD, Ph D    +8653167626412    shaowenbomd@gmail.com    Principal Investigator: Jinlong Song, MD          Sub-Investigator: Wenbo Shao, MD, Ph D Less <<
NCT01537549 - Completed - -
NCT01561833 T Cell Lymphoma Phase 1 Completed - United States, Connecticut ... More >> Yale Cancer Center New Haven, Connecticut, United States, 06510 Less <<
NCT01534260 - Completed - -
NCT02333188 Adenocarcinoma of Unknown Prim... More >>ary Adult Cholangiocarcinoma Gallbladder Carcinoma Gastric Adenocarcinoma Malignant Gastrointestinal Neoplasm Metastatic Pancreatic Adenocarcinoma Pancreatic Adenocarcinoma Stage III Ampulla of Vater Cancer Stage III Pancreatic Cancer Stage IIIA Gallbladder Cancer Stage IIIA Gastric Cancer Stage IIIB Gallbladder Cancer Stage IIIB Gastric Cancer Stage IV Ampulla of Vater Cancer Stage IV Gallbladder Cancer Stage IV Gastric Cancer Stage IV Pancreatic Cancer Less << Phase 1 Phase 2 Completed - United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 Decatur Memorial Hospital Decatur, Illinois, United States, 62526 NorthShore University Health System Evanston, Illinois, United States, 60201 Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 United States, Indiana Fort Wayne Medical Oncology/Hematology Fort Wayne, Indiana, United States, 46845 Indiana University Medical Center Indianapolis, Indiana, United States, 46202 United States, Michigan The University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Washington Virginia Mason Seattle, Washington, United States, 98101 Less <<
NCT02330783 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Recruiting December 2018 China, Guangdong ... More >> Sun Yat-sen university cancer center Not yet recruiting Guangzhou, Guangdong, China, 510060 Contact: Fangjian Zhou, MD    0086-20-87343088    zhoufj@sysucc.org.cn    Principal Investigator: Fangjian Zhou, MD          China Peking University First Hospital Recruiting Beijing, China, 100034 Contact: Zhisong He, MD    0086-10-83572211    wyj7074@sohu.com    Principal Investigator: Zhisong He, MD          Beijing Cancer Hospital Recruiting Beijing, China, 100142 Contact: Xinan Sheng, MD    0086-10-88196951    doctor_sheng@126.com    Principal Investigator: Jun Guo, MD,PHD          Sub-Investigator: Xinan Sheng, MD          Cancer Hospital, Fudan University Not yet recruiting Shanghai, China, 200032 Contact: Dingwei Ye, MD    0086-21-64175590    dwye@163.com    Principal Investigator: Dingwei Ye, MD Less <<
NCT02344810 Adenocarcinoma of the Esophagu... More >>s Adenocarcinoma of the Gastroesophageal Junction Diffuse Adenocarcinoma of the Stomach Gastrointestinal Cancer Intestinal Adenocarcinoma of the Stomach Mixed Adenocarcinoma of the Stomach Stage IIIA Esophageal Cancer Stage IIIA Gastric Cancer Stage IIIB Esophageal Cancer Stage IIIB Gastric Cancer Stage IIIC Esophageal Cancer Stage IIIC Gastric Cancer Stage IV Esophageal Cancer Stage IV Gastric Cancer Less << Phase 1 Phase 2 Withdrawn(The study did not op... More >>en to accrual. No start date and no completion dates.) Less << March 6, 2020 United States, Pennsylvania ... More >> ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT01531361 Advanced Malignant Neoplasm ... More >> BRAF Gene Mutation Metastatic Malignant Neoplasm Recurrent Malignant Neoplasm Refractory Malignant Neoplasm Less << Phase 1 Active, not recruiting February 28, 2020 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02345460 Pancreatic Adenocarcinoma ... More >> Poorly Differentiated Malignant Neoplasm Resectable Pancreatic Cancer Stage IA Pancreatic Cancer Stage IB Pancreatic Cancer Stage IIA Pancreatic Cancer Stage IIB Pancreatic Cancer Stage III Pancreatic Cancer Undifferentiated Pancreatic Carcinoma Less << Phase 2 Terminated(Competing studies) - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT02049814 Type 2 Diabetes Mellitus Phase 4 Completed - China, Anhui ... More >> Hefei, Anhui, China Maanshan, Anhui, China China, Beijing Beijing, Beijing, China China, Guangdong Guangzhou, Guangdong, China Shenzhen, Guangdong, China Taishan, Guangdong, China China, Hunan Zhuzhou, Hunan, China China, Jiangsu Nanjing, Jiangsu, China Xuzhou, Jiangsu, China China, Jilin Changchun, Jilin, China Jilin, Jilin, China China, Liaoning Shenyang, Liaoning, China China, Shandong Qingdao, Shandong, China China, Shanghai Shanghai, Shanghai, China China, Shanxi Yan An, Shanxi, China Yanan, Shanxi, China China, Tianjin Tianjin, Tianjin, China China, Zhejiang Wenzhou, Zhejiang, China Less <<
NCT02345460 - Terminated(Competing studies) - -
NCT02349867 Pancreatic Adenocarcinoma ... More >> Stage IA Pancreatic Cancer Stage IB Pancreatic Cancer Stage IIA Pancreatic Cancer Stage IIB Pancreatic Cancer Stage III Pancreatic Cancer Recurrent Pancreatic Carcinoma Less << Phase 1 Recruiting May 31, 2022 United States, Virginia ... More >> Virginia Commonwealth University/Massey Cancer Center Recruiting Richmond, Virginia, United States, 23298 Contact: Andrew Poklepovic, MD    804-628-2321    andrew.poklepovic@vcuhealth.org    Contact: Katherine Thompson, CRN    804-628-0960    masseysiit@vcu.edu    Principal Investigator: Andrew Poklepovic, MD Less <<
NCT02358824 Hypertension Phase 1 Completed - Korea, Republic of ... More >> Kyungpook National University Hospital Daegu, samdeok-dong, 2-ga 50, samdeok-dong, 2-ga 50 Jung-gu, Korea, Republic of, 700-721 Less <<
NCT02337946 Colorectal Carcinoma Phase 2 Completed - -
NCT01585870 Neoplasms Phase 1 Completed - France ... More >> Toulouse, France, 31052 Germany Freiburg, Baden-Württemberg, Germany, 79106 Heidelberg, Baden-Württemberg, Germany, 69120 Berlin, Germany, 10117 Less <<
NCT02366819 Esophageal Adenocarcinoma ... More >> Gastric Adenocarcinoma Stage IIB Gastric Cancer Stage IIIA Esophageal Adenocarcinoma Stage IIIA Gastric Cancer Stage IIIB Esophageal Adenocarcinoma Stage IIIB Gastric Cancer Stage IIIC Esophageal Adenocarcinoma Stage IIIC Gastric Cancer Less << Phase 4 Recruiting January 2019 United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Recruiting Chicago, Illinois, United States, 60637 Contact: Daniel V. Catenacci    773-702-7596    dcatenac@medicine.bsd.uchicago.edu    Principal Investigator: Daniel V. Catenacci          Kellogg Cancer Center - Evanston Hospital Recruiting Evanston, Illinois, United States, 60201 Contact: Robert d. Marsh    847-570-2112    rmarsh@northshore.org    Principal Investigator: Robert d. Marsh          NorthShore University HealthSystem Recruiting Evanston, Illinois, United States, 60201 Contact: Mark S. Talamonti    847-570-2560    mtalamonti@northshore.org    Principal Investigator: Mark S. Talamonti Less <<
NCT00458250 Leukemia, Myeloid, Acute ... More >> Leukemia, Lymphoblastic, Acute Less << Phase 1 Completed - Iran, Islamic Republic of ... More >> Hematology-Oncology & BMT Research Center Tehran, Iran, Islamic Republic of, 14114 Less <<
NCT01608139 Advanced Cancers Phase 1 Withdrawn - -
NCT01578109 Acute Myeloid Leukemia in Remi... More >>ssion Acute Myeloid Leukemia With FLT3/ITD Mutation Less << Not Applicable Active, not recruiting - United States, Maryland ... More >> University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 Less <<
NCT00497471 Malaria Anemi... More >>a Less << Not Applicable Terminated(Follow-up end in 19... More >>99) Less << - Tanzania ... More >> Ifakara Centre Ifakara, Tanzania Less <<
NCT00463008 Brain and Central Nervous Syst... More >>em Tumors Less << Not Applicable Completed - -
NCT00464997 - Unknown - -
NCT01605734 PHENYTOIN/SORAFENIB [VA Drug I... More >>nteraction] Carcinoma, Hepatocellular Less << Phase 2 Unknown December 2015 China, Shandong ... More >> Shandong Medical Imaging Research Institute Not yet recruiting Jinan, Shandong, China, 250021 Contact: Jun Tang, MD    +8613964031909    tangjun7925032@163.com    Principal Investigator: Jun Tang, MD          Qilu Hospital of Shandong University Not yet recruiting Jinan, Shandong, China, 250114 Contact: Caixia Li, MD    +8613505312972    Lilyshanda88@hotmail.com    Principal Investigator: Caixia Li, MD          Shandong Cancer Hospital and Institute Jinan, Shandong, China, 250117 the Affiliated Hospital of Medical College Qingdao University Not yet recruiting Qingdao, Shandong, China, 266003 Contact: Zixiang Li, MD    +8618669739263    zixiangli@yahoo.com.cn    Principal Investigator: Zixiang Li, MD          Yantai Yuhuangding Hospital Not yet recruiting Yantai, Shandong, China, 264000 Contact: Yanbo Zheng, MD    +8613805356068    13805356068@163.com    Principal Investigator: Yanbo Zheng Less <<
NCT00458848 Leukemia Phase 2 Completed - -
NCT00468546 - Completed - -
NCT00245037 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Precancerous Condition Less << Phase 1 Phase 2 Completed - United States, Oregon ... More >> Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239-3098 Less <<
NCT00468546 Rheumatoid Arthritis Phase 3 Completed - -
NCT00470548 - Terminated(Practice patterns w... More >>ith pemetrexed have evolved.) Less << - -
NCT00245037 - Completed - -
NCT00476190 Acute Lymphoblastic Leukemia Phase 2 Active, not recruiting December 2018 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Children's Hospital of Boston Boston, Massachusetts, United States, 02115 Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Utah LDS Hospital Salt Lake City, Utah, United States, 84143 Canada, British Columbia Vancouver Cancer Center Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba Cancer Care Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick The Moncton Hospital Moncton, New Brunswick, Canada Canada, Nova Scotia QEII, Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Quebec Hopital Charles LeMoyne Greenfield Park, Quebec, Canada, J4V 2H1 Hopital Maisonneuve Rosemont Montreal, Quebec, Canada, H1T 2M4 Hopital Notre-Dame Montreal, Quebec, Canada McGill University Department of Oncology Montreal, Quebec, Canada Less <<
NCT00476996 Rheumatoid Arthritis Phase 3 Completed - -
NCT00371735 Malaria, Falciparum Phase 3 Completed - Burkina Faso ... More >> GSK Investigational Site Ouagadougou, Burkina Faso Ghana GSK Investigational Site Kumasi, Ghana Mali GSK Investigational Site Bamako, Mali Nigeria GSK Investigational Site Ile-Ife, Nigeria GSK Investigational Site Jos, Nigeria GSK Investigational Site Lagos, Nigeria GSK Investigational Site Maiduguri, Nigeria Less <<
NCT00470548 Breast Cancer ... More >> Lung Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Phase 2 Terminated(Practice patterns w... More >>ith pemetrexed have evolved.) Less << - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT00480272 Rheumatoid Arthritis Phase 4 Completed - Italy ... More >> IRCCS S. Matteo Hospital Pavia, Italy, 27100 Less <<
NCT00487669 Advanced Non-small Cell Lung C... More >>ancer Less << Phase 2 Completed - United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT00481559 - - - -
NCT01835041 Acinar Cell Adenocarcinoma of ... More >>the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer Less << Phase 1 Active, not recruiting January 2019 United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00485589 Rheumatoid Arthritis Phase 3 Terminated(Based on analysis o... More >>f results and consideration of available treatments, the overall benefit to risk profile of ocrelizumab was not favorable in RA.) Less << - -
NCT00984425 Solid Tumors Phase 1 Completed - Italy ... More >> Istituto Clinco Humanitas Rozzano, Milano, Italy, 20089 Less <<
NCT00984282 - Completed - -
NCT01406704 NASH (Non-alcoholic Steato-hep... More >>atitis) Less << Phase 4 Terminated(because of withdraw... More >>al of Avandia sale due to its risks outweigh its benefits) Less << December 2013 -
NCT00984282 Thyroid Neoplasms Phase 3 Completed - -
NCT01616186 Locally Metastatic Malignant N... More >>eoplasm Less << Phase 2 Withdrawn April 2016 -
NCT00994513 Obesity Cardi... More >>ovascular Disease Type 2 Diabetes Less << Phase 2 Phase 3 Completed - China, Xinjiang ... More >> Xinjiang Medical University Urumqi, Xinjiang, China, 830054 Less <<
NCT01622543 Colorectal Cancer Phase 2 Active, not recruiting June 2018 Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Canada, British Columbia BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston Kingston, Ontario, Canada, K7L 5P9 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 Odette Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Less <<
NCT01634295 Hypertension Phase 3 Completed - Korea, Republic of ... More >> Seoul national university Bundang Hospital Bundang-gu, Gyeonggi-do, Korea, Republic of, 463-707 Less <<
NCT01414166 Dyslipidemia Phase 3 Terminated(In HPS2-THRIVE, MK-... More >>0524A did not meet the primary efficacy objective and there was a significant increase in incidence of some types of non-fatal SAEs) Less << - -
NCT01414166 - Terminated(In HPS2-THRIVE, MK-... More >>0524A did not meet the primary efficacy objective and there was a significant increase in incidence of some types of non-fatal SAEs) Less << - -
NCT00427349 Gastrointestinal Carcinoid Tum... More >>or Islet Cell Tumor Neoplastic Syndrome Less << Phase 2 Completed - -
NCT00997438 Multiple Sclerosis Phase 1 Completed - United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97239 Portland VA Medical Center Portland, Oregon, United States, 97239 Less <<
NCT00427349 - Completed - -
NCT00997022 Hepatocellular Cancer Phase 1 Completed - United States, California ... More >> University of Southern California Los Angeles, California, United States, 90089 University of California, Los Angeles Los Angeles, California, United States, 90095 United States, New York Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00997438 - Completed - -
NCT01640665 Metastatic Breast Cancer ... More >> Gastrointestinal Tumors Less << Phase 1 Completed - United States, Connecticut ... More >> Yale Cancer Center New Haven, Connecticut, United States, 06519 Less <<
NCT01643499 Acinar Cell Adenocarcinoma of ... More >>the Pancreas Adenocarcinoma of the Gallbladder Adenocarcinoma of Unknown Primary Adult Primary Cholangiocellular Carcinoma Advanced Adult Primary Liver Cancer Cholangiocarcinoma of the Extrahepatic Bile Duct Cholangiocarcinoma of the Gallbladder Diffuse Adenocarcinoma of the Stomach Duct Cell Adenocarcinoma of the Pancreas Intestinal Adenocarcinoma of the Stomach Localized Unresectable Adult Primary Liver Cancer Metastatic Carcinoma of Unknown Primary Metastatic Extrahepatic Bile Duct Cancer Mixed Adenocarcinoma of the Stomach Mucinous Adenocarcinoma of the Colon Mucinous Adenocarcinoma of the Rectum Newly Diagnosed Carcinoma of Unknown Primary Signet Ring Adenocarcinoma of the Colon Signet Ring Adenocarcinoma of the Rectum Stage III Pancreatic Cancer Stage IIIA Colon Cancer Stage IIIA Gallbladder Cancer Stage IIIA Gastric Cancer Stage IIIA Rectal Cancer Stage IIIB Colon Cancer Stage IIIB Gallbladder Cancer Stage IIIB Gastric Cancer Stage IIIB Rectal Cancer Stage IIIC Colon Cancer Stage IIIC Gastric Cancer Stage IIIC Rectal Cancer Stage IV Gastric Cancer Stage IV Pancreatic Cancer Stage IVA Colon Cancer Stage IVA Gallbladder Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Gallbladder Cancer Stage IVB Rectal Cancer Unresectable Extrahepatic Bile Duct Cancer Less << Phase 1 Active, not recruiting August 2020 United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Evanston CCOP-NorthShore University HealthSystem Evanston, Illinois, United States, 60201 Less <<
NCT01650181 Liver Disease Phase 4 Completed - Mexico ... More >> Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City, Mexico, 14000 Less <<
NCT01004003 Carcinoma, Hepatocellular Phase 2 Completed - Austria ... More >> 1199.37.43001 Boehringer Ingelheim Investigational Site Wien, Austria 1199.37.43002 Boehringer Ingelheim Investigational Site Wien, Austria France 1199.37.33001 Boehringer Ingelheim Investigational Site Paris, France 1199.37.33002 Boehringer Ingelheim Investigational Site Paris, France Germany 1199.37.49008 Boehringer Ingelheim Investigational Site Berlin, Germany 1199.37.49009 Boehringer Ingelheim Investigational Site Erlangen, Germany 1199.37.49002 Boehringer Ingelheim Investigational Site Freiburg, Germany 1199.37.49001 Boehringer Ingelheim Investigational Site Hannover, Germany 1199.37.49010 Boehringer Ingelheim Investigational Site Heidelberg, Germany 1199.37.49005 Boehringer Ingelheim Investigational Site Jena, Germany 1199.37.49004 Boehringer Ingelheim Investigational Site Magdeburg, Germany 1199.37.49003 Boehringer Ingelheim Investigational Site München, Germany 1199.37.49006 Boehringer Ingelheim Investigational Site Tübingen, Germany Hungary 1199.37.36001 Boehringer Ingelheim Investigational Site Debrecen, Hungary Netherlands 1199.37.31002 Boehringer Ingelheim Investigational Site Leiden, Netherlands 1199.37.31001 Boehringer Ingelheim Investigational Site Utrecht, Netherlands Poland 1199.37.48002 Boehringer Ingelheim Investigational Site Olsztyn, Poland 1199.37.48003 Boehringer Ingelheim Investigational Site Warsaw, Poland 1199.37.48001 Boehringer Ingelheim Investigational Site Warszawa, Poland Romania 1199.37.40002 Boehringer Ingelheim Investigational Site Bucharest, Romania 1199.37.40003 Boehringer Ingelheim Investigational Site Cluj-Napoca, Romania United Kingdom 1199.37.44001 Boehringer Ingelheim Investigational Site Edgbaston, Birmingham, United Kingdom 1199.37.44005 Boehringer Ingelheim Investigational Site Glasgow, United Kingdom 1199.37.44008 Boehringer Ingelheim Investigational Site Liverpool, United Kingdom 1199.37.44002 Boehringer Ingelheim Investigational Site London, United Kingdom 1199.37.44003 Boehringer Ingelheim Investigational Site London, United Kingdom 1199.37.44006 Boehringer Ingelheim Investigational Site Manchester, United Kingdom 1199.37.44004 Boehringer Ingelheim Investigational Site Nottingham, United Kingdom Less <<
NCT01005797 Renal Cancer ... More >>Non Small Cell Lung Cancer (NSCLC) Soft Tissue Sarcoma Less << Phase 1 Completed - United States, South Carolina ... More >> Medical University of South Carolina Hollings Cancer Center Charleston, South Carolina, United States, 29425 Less <<
NCT01005875 Hepatocellular Carcinoma ... More >> Liver Cancer Less << Not Applicable Terminated(Sponsor(Bayer)did n... More >>ot wish to continue with study due to slow accrual. Therefore, there is insufficient data and will not be any study results/outcomes.) Less << - United States, Alabama ... More >> UAB Birmingham, Alabama, United States, 35294 Less <<
NCT01005875 - Terminated(Sponsor(Bayer)did n... More >>ot wish to continue with study due to slow accrual. Therefore, there is insufficient data and will not be any study results/outcomes.) Less << - -
NCT01008917 Hepatocellular Carcinoma Phase 1 Completed - United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94143 United States, Illinois Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT00436579 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Terminated - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01658878 Hepatocellular Carcinoma Phase 1 Phase 2 Active, not recruiting December 26, 2019 -
NCT01664182 Stage III Renal Cell Cancer AJ... More >>CC v7 Stage IV Renal Cell Cancer AJCC v7 Less << Phase 2 Active, not recruiting - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 City of Hope South Pasadena South Pasadena, California, United States, 91030 United States, Michigan Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Metro Minnesota Community Oncology Research Consortium Saint Louis Park, Minnesota, United States, 55416 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Virginia VCU Massey Cancer Center at Hanover Medical Park Mechanicsville, Virginia, United States, 23116 Less <<
NCT01668069 Vomiting of Pregnancy Not Applicable Completed - United States, California ... More >> Naval Medical Center, San Diego San Diego, California, United States, 92134 Less <<
NCT01025453 Thyroid Cancer Phase 2 Completed - United States, New Jersey ... More >> Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT01666730 Acinar Cell Adenocarcinoma of ... More >>the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer Less << Phase 2 Active, not recruiting November 2018 United States, Ohio ... More >> University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT01025453 - Completed - -
NCT01675999 Colon Cancer ... More >>Locally Advanced Malignant Neoplasm Less << Phase 2 Recruiting February 2021 France ... More >> Hopital Henri Mondor Recruiting Paris, France, 94010 Contact: Mehdi KAROUI, PH    +33 (0) 1 42 17 56 11    mehdi.karoui@gmail.com Less <<
NCT01029418 Hepatocellular Carcinoma Phase 1 Phase 2 Terminated(The phase II portio... More >>n was not conducted due to funding issue.) Less << - Singapore ... More >> National University Hospital Singapore Singapore, Singapore, 119074 National Cancer Centre Singapore Singapore, Singapore, 169610 Less <<
NCT01030783 Advanced Renal Cell Carcinoma Phase 3 Completed - -
NCT01679327 Colorectal Cancer Phase 2 Unknown September 2014 China ... More >> Cancer Institute&Hospital Chinese Academy of Medical Sciences Recruiting Beijing, China Contact: Yihebali Chi, MD    8610-87788145    Yihebalichi@yahoo.com Less <<
NCT00999843 Hepatocellular Carcinoma Phase 1 Phase 2 Unknown October 2012 China, Shanghai ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Less <<
NCT01041482 Renal Cell Carcinoma Phase 2 Unknown November 2013 China, Beijing ... More >> Jianhui Ma Recruiting Beijing, Beijing, China, 100730 Contact: Jianhui Ma Jianhui Ma Jianhui Ma, Doctor    01086108878 Less <<
NCT00466752 Adenocarcinoma of the Prostate... More >> Stage II Prostate Cancer Stage III Prostate Cancer Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01469065 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> Pfizer Investigational Site Chula Vista, California, United States, 91911 United States, Florida Pfizer Investigational Site Miami, Florida, United States, 33169 Japan Pfizer Investigational Site Hachioji-shi, Tokyo, Japan Less <<
NCT01033240 Advanced Hepatocellular Carcin... More >>oma Liver Cancer Hepatic Cancer Liver Neoplasms Less << Phase 2 Completed - United States, California ... More >> Kenmar Research Group Los Angeles, California, United States, 90057 United States, District of Columbia Georgetown-Lombardi Cancer Center Washington DC, District of Columbia, United States, 20007 United States, New York The Mount Sinai Medical Center New York, New York, United States, 10029 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Japan Kurume University Hospital Kurume-shi, Fukuoka, Japan, 830-0011 Hiroshima University Hiroshima-city, Hiroshima, Japan Kanazawa University Kanazawa, Ishikawa, Japan Kinki University Hospital Osaka, Osaka-sayama, Japan, 589-8511 Osaka Med Center Cancer and Cardiovascular Disease Higashinari-ku, Osaka, Japan, 537-8511 Yamaguchi University Hospital Ube, Yamaguchi, Japan Chiba University Hospital Chiba, Japan, 260-8677 Okayama University Hospital Okayama, Japan, 700-8558 Musashino Red-Cross Hospital Tokyo, Japan, 180-8610 Korea, Republic of Samsung Medical Center Gangnam-gu, Seoul, Korea, Republic of, 135-710 Keimyung University Dongsan Hospital Daegu, Korea, Republic of, 700-712 Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Severance Hospital Seoul, Korea, Republic of, 120-752 Korea University Anam Hospital Seoul, Korea, Republic of, 136-705 Catholic Univ. of Korea, Seoul St. Mary's Hospital Seoul, Korea, Republic of, 137-701 Asan Medical Center Seoul, Korea, Republic of, 138-736 Taiwan Chang Gung Memorial Hospital Putz, Chiayi, Taiwan Kaohiung Chang Gung Hospital Kaohsiung, Niaosung Hsiang, Taiwan Chi-Mei Medical Center Liouying, Tainan County, Taiwan, 736 Changhua Christian Hospital Changhua, Taiwan, 500 Kaohslung Medical University Hospital Kaohsiung, Taiwan, 807 National Cheng-Kung University Hospital Tainan city, Taiwan, 704 National Taiwan University Hospital Taipei, Taiwan Chang Gung Medical Foundation-Linkuo Taoyuan, Taiwan, 33305 Less <<
NCT01469481 Healthy Phase 1 Completed - United States, Washington ... More >> Pfizer Investigational Site Tacoma, Washington, United States, 98418 Less <<
NCT01704196 Cocaine Dependence Phase 2 Completed - United States, California ... More >> Matrix Institute on Addictions Los Angeles, California, United States, 90016 VA San Diego Healthcare System San Diego, California, United States, 92161 United States, Colorado VA Medical Center - Denver, CO Denver, Colorado, United States, 80220 United States, Maryland Mountain Manor Treatment Center at Baltimore Baltimore, Maryland, United States, 21229 United States, New Mexico Pacific Institute for Research and Evaluation Albuquerque, New Mexico, United States, 87102 United States, New York Columbia University Medical Center New York, New York, United States, 10019 United States, Ohio Cincinnati Addiction Research Center Cincinnati, Ohio, United States, 45220 United States, Pennsylvania University of Pennsylvania - Treatment Research Center Philadelphia, Pennsylvania, United States, 19104 United States, Texas Michael E. DeBakey VA Medical Center Houston, Texas, United States, 77030 United States, Utah George E. Wahlen VA Medical Center Salt Lake City, Utah, United States, 84148 Less <<
NCT01469065 - Completed - -
NCT01704196 - Completed - -
NCT01047891 Ovarian Cancer Phase 2 Completed - Germany ... More >> Charité Campus Virchow-Klinikum Berlin, Germany, 13355 Less <<
NCT01004003 - Completed - -
NCT01058941 Alzheimer's Disease Phase 1 Phase 2 Completed - United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT01715441 Metastatic Colorectal Cancer P... More >>atients With KRAS Mutated Tumors Less << Phase 2 Unknown September 2015 France ... More >> Hôpital AVICENNE Recruiting Bobigny, France, 93009 Contact: Thomas APARICIO, MD       Thomas.aparicio@avc.aphp.fr    Principal Investigator: Thomas APARICIO, MD          Centre François Baclesse Recruiting Caen, France, 14076 Contact: Marie-Pierre GALAIS, MD          Principal Investigator: Marie-Pierre GALAIS, MD          Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Antoine ADENIS, MD       a-adenis@o-lambret.fr    Principal Investigator: Antoine ADENIS, MD          Centre Léon Bérard Recruiting Lyon, France, 69373 Contact: Françoise DESSEIGNE, MD          Principal Investigator: Françoise DESSEIGNE, MD          Hôpital LA TIMONE Recruiting Marseille, France, 13365 Contact: Jean-François SEITZ, MD       Jean-françois.seitz@ap-hm.fr    Principal Investigator: Jean-François SEITZ, MD          CRLC Val d'Aurelle-Paul Lamarque Recruiting Montpellier, France, 34298 Contact: Emmanuelle SAMALIN, MD          Principal Investigator: Emmanuelle SAMALIN, MD          C.H.U. de REIMS Recruiting Reims, France, 51092 Contact: Olivier BOUCHE, MD       Obouche@chu-reims.fr    Principal Investigator: Olivier BOUCHE, MD          CHU Charles Nicolle Recruiting Rouen, France, 76038 Contact: Frédéric Di FIORE, MD    33 2.32.88.81.01    Frederic.Di-Fiore@chu-rouen.fr    Principal Investigator: Frédéric Di FIORE, MD          Institut de Cancérologie de l'Ouest - René Gauducheau Recruiting St. Herblain, France, 44805 Contact: Jaafa BENNOUNA, MD       Jaafa.bennouna@ico.unicancer.fr    Principal Investigator: Jaafa BENNOUNA, MD Less <<
NCT01720095 Psychosis Phase 3 Completed - Canada, Nova Scotia ... More >> NS Early Psychosis Program Halifax, Nova Scotia, Canada, B3H 2E2 Less <<
NCT01058941 - Completed - -
NCT00466752 - Completed - -
NCT01075555 Liver Cancer Phase 3 Completed - France ... More >> Hopital Du Bocage Dijon, France, 21000 Less <<
NCT01076010 Advanced Renal Cell Carcinoma Phase 3 Completed - -
NCT01730313 Nodding Syndrome Phase 2 Unknown September 2013 Uganda ... More >> Kitgum Nodding Syndrome Treatment Center, Kitgum General Hospital Not yet recruiting Kitgum, Uganda Contact: RICHARD IDRO, MD    +256-774274173    ridro1@gmail.com    Contact: SUDHIR BUNGA, MD    678-314-1380    sbunga@cdc.gov    Principal Investigator: SUDHIR BUNGA, MD          Principal Investigator: RICHARD IDRO, MD Less <<
NCT01078961 Melanoma Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01091207 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135710 Less <<
NCT01751087 Abortion, Induced Not Applicable Completed - United States, California ... More >> San Francisco General Hospital San Francisco, California, United States, 94110 United States, Illinois Family Planning Associates Chicago, Illinois, United States, 60630 United States, Massachusetts Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Boston Medical Center Boston, Massachusetts, United States, 02118 United States, New York Planned Parenthood of New York City New York, New York, United States, 10012 United States, Oregon Lovejoy Surgical Center Portland, Oregon, United States, 97210 United States, Pennsylvania Magee Women's Hospital Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01093222 Extrahepatic Bile Duct Adenoca... More >>rcinoma Gallbladder Adenocarcinoma Gallbladder Adenocarcinoma With Squamous Metaplasia Hilar Cholangiocarcinoma Recurrent Extrahepatic Bile Duct Carcinoma Recurrent Gallbladder Carcinoma Undifferentiated Gallbladder Carcinoma Unresectable Extrahepatic Bile Duct Carcinoma Unresectable Gallbladder Carcinoma Less << Phase 2 Completed - -
NCT01093222 - Completed - -
NCT01098760 Hepatocellular Carcinoma Phase 4 Completed - Taiwan ... More >> Chia Yi, Taiwan, 613 Hualien county, Taiwan, 970 Kaohsiung City, Taiwan, 807 Kaohsiung City, Taiwan, 8330 Taichung City, Taiwan Taipei City,, Taiwan Taoyuan, Taiwan, 33305 Less <<
NCT01762150 Renal Cell Carcinoma Phase 2 Completed - China, Beijing ... More >> Beijing Cancer Hospital Beijing, Beijing, China, 100142 China, Guangdong Sun Yat-sen university cancer center Guangzhou, Guangdong, China, 510060 China, Liaoning Shenyang general hospital of Shenyang military command Shenyang, Liaoning, China, 110016 China, Shanxi Xijing Hospital Xi'an, Shanxi, China, 710032 China, Sichuan West China Hospital Chengdu, Sichuan, China, 610041 Less <<
NCT01100242 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Terminated(Low accrual) - United States, New Mexico ... More >> University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 The Cancer Center at Presbyterian Albuquerque, New Mexico, United States, 87110 Memorial Medical Center- Cancer Center Las Cruces, New Mexico, United States, 88011 Less <<
NCT01100242 - Terminated(Low accrual) - -
NCT01763424 Psoriasis Phase 2 Phase 3 Completed - Iran, Islamic Republic of ... More >> Skin Diseases and Leishmaniasis Research Center Isfahan, Iran, Islamic Republic of Less <<
NCT01771146 Pancreas Cancer ... More >> Localized Pancreas Cancer Non-metastatic Pancreas Cancer Less << Not Applicable Active, not recruiting September 2020 United States, Texas ... More >> Baylor University Medical Center - Texas Oncology Dallas, Texas, United States, 75246 Less <<
NCT01075113 Liver Cancer Phase 1 Active, not recruiting January 31, 2023 United States, Virginia ... More >> Hunter Holmes McGuire VA Medical Center Richmond, Virginia, United States, 23249 Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT01786538 Metastatic Colorectal Cancer Phase 3 Withdrawn May 2017 Korea, Republic of ... More >> Asan Medical Center Seoul, Songpa-gu, Korea, Republic of, 138736 Less <<
NCT01792934 Multi-organ Metastatic Colorec... More >>tal Cancer Less << Not Applicable Recruiting December 2020 Netherlands ... More >> Noordwest Ziekenhuis Groep Recruiting Alkmaar, Netherlands Contact: MP Hendriks, Dr          Principal Investigator: MP Hendriks, Dr          Ziekenhuisgroep Twente Recruiting Almelo, Netherlands Contact: R Hoekstra, R          Principal Investigator: R Hoekstra, R          Meander Medisch Centrum Recruiting Amersfoort, Netherlands Contact: HJ Bloemendal, HJ          Principal Investigator: HJ Bloemendal, Dr          Amstelveen Ziekenhuis Recruiting Amstelveen, Netherlands Contact: AA van Zweeden, Drs          Principal Investigator: AA van Zweeden, Drs          VU Medical Center Recruiting Amsterdam, Netherlands, NL-1081 HV Contact: H.M.W. Verheul, MD, PhD    0031-20-4444321    h.verheul@vumc.nl    Principal Investigator: H.M.W. Verheul, MD, PhD          Academisch Medisch Centrum Recruiting Amsterdam, Netherlands Contact: PJ Tanis, Dr          Principal Investigator: PJ Tanis, Dr          Onze Lieve Vrouwe Gasthuis Not yet recruiting Amsterdam, Netherlands Contact: JM Meerum Terwogt, Dr          Principal Investigator: JM Meerum Terwogt, Dr          Amphia Ziekenhuis Recruiting Breda, Netherlands Contact: A Ten Tije, Dr          Principal Investigator: A Ten Tije, Dr          Medisch Centrum Haaglanden Recruiting Den Haag, Netherlands Contact: HH Helgason, Dr          Principal Investigator: HH Helgason, Dr          Deventer Ziekenhuis Recruiting Deventer, Netherlands Contact: H Torrenga, Dr          Principal Investigator: H Torrenga, Dr          Albert Schweizer ziekenhuis Recruiting Dordrecht, Netherlands Contact: M Trajkovic, MD          Principal Investigator: M Trajkovic, MD          Maxima Medisch Centrum Recruiting Eindhoven, Netherlands Contact: G Vreugdenhil, Dr          Principal Investigator: G Vreugdenhil, Dr          Universitair Medisch Centrum Groningen Recruiting Groningen, Netherlands Contact: GAP Hospers, Prof Dr          Principal Investigator: GAP Hospers, Dr          Spaarne ziekenhuis Recruiting Hoofddorp, Netherlands Contact: A Beeker, Drs.          Principal Investigator: A Beeker, Drs          Medisch Centrum Leeuwarden Recruiting Leeuwarden, Netherlands Contact: M Polee, Dr          Principal Investigator: M Polee, Dr          Academisch ziekenhuis Maastricht Recruiting Maastricht, Netherlands Contact: RLH Jansen, Dr          Principal Investigator: RLH Jansen, Dr          Sint Antonius Ziekenhuis Recruiting Nieuwegein, Netherlands Contact: M Los, Dr          Principal Investigator: M Los, Dr          UMC Sint Radboud Recruiting Nijmegen, Netherlands Contact: SA Radema, Dr          Principal Investigator: SA Radema, Dr          Bravis ziekenhuis Recruiting Roosendaal, Netherlands Contact: Troost          Principal Investigator: Troost          Erasmus University Medical Center Recruiting Rotterdam, Netherlands, NL-3075 EA Contact: C. Verhoef, MD PhD    0031 (0)10 7040704    c.verhoef@erasmusmc.nl    Principal Investigator: C. Verhoef, MD PhD          Franciscus Gasthuis Recruiting Rotterdam, Netherlands Contact: P Hamberg, Dr          Principal Investigator: P Hamberg, Dr          IJsselland ziekenhuis Recruiting Rotterdam, Netherlands Contact: Vermaas          Principal Investigator: Vermaas          Maasstadziekenhuis Recruiting Rotterdam, Netherlands Contact: TC Kok, Dr          Principal Investigator: TC Kok, Dr          Elisabeth Tweesteden Ziekenhuis Recruiting Tilburg, Netherlands Contact: L Beerepoot, Dr          Principal Investigator: L Beerepoot, Dr          Diakonessenhuis Utrecht Recruiting Utrecht, Netherlands Contact: D Ten Bokkel Huinink, Dr          Principal Investigator: D Ten Bokkel Huinink, Dr          Universitait Medisch Centrum Utrecht Not yet recruiting Utrecht, Netherlands Contact: IHM Borel Rinkes, Prof Dr          Principal Investigator: IHM Rinkes, IHM          Admiraal de Ruyter Hospital Recruiting Vlissingen, Netherlands Contact: van Halteren          Principal Investigator: van Halteren          Jeroen Bosch Ziekenhuis Not yet recruiting Zaltbommel, Netherlands Contact: JFM Pruijt, Dr          Principal Investigator: JFM Pruijt, Dr          Isala Klinieken Recruiting Zwolle, Netherlands Contact: JWB de Groot, Dr          Principal Investigator: JWB de Groot, Dr Less <<
NCT01128998 Advanced Solid Tumors Phase 1 Completed - Taiwan ... More >> National Cheng-Kung University Hospital Tainan City, Taiwan, 704 Less <<
NCT01751087 - Completed - -
NCT01804374 Metastatic Osteosarcoma ... More >> Relapsed Osteosarcoma Less << Phase 2 Completed - Italy ... More >> Fondazione del Piemonte per l'Oncologia IRCC Candiolo Candiolo, Torino, Italy, 10060 Less <<
NCT01126645 Hepatocellular Carcinoma Phase 2 Unknown March 2018 Germany ... More >> University of Magdeburg Magdeburg, Germany, 39120 Less <<
NCT01138774 Obesity Body ... More >>Fat Insulin Resistance Less << Not Applicable Completed - Spain ... More >> Department of Nutrition, Food Science, Physiology and Toxicology. University of Navarra Pamplona, Navarra, Spain, 31008 Less <<
NCT01785186 Tuberculosis, Pulmonary Phase 2 Completed - South Africa ... More >> TASK Applied Science Bellville, South Africa, 7530 University of Cape Town, Centre for Tuberculosis Research Innovation Cape Town, South Africa, 7700 Wits Health Consortium Johannesburg, South Africa, 2092 The Aurum Institute for Health Research Johannesburg, South Africa, 2193 Tanzania Ifakara Health Institute Bagamoyo, Tanzania, P.O.Box 74 NIMR - Mbeya Medical Research Programme Mbeya, Tanzania, P.O. Box 2410 Kilimanjaro Christian Medical Centre (KCMC) / Kilimanjaro Clinical Research Institute (KCRI) (with affiliated field sites such as Kibong'oto National Tuberculosis Hospital Same, Mererani, Chekereni and Mawenzi Regional Hospital) Moshi, Tanzania, 2236 Less <<
NCT01785186 - Completed - -
NCT01141478 Carcinoma, Hepatocellular Not Applicable Unknown June 2018 United States, California ... More >> Loma Linda University Medical Center Recruiting Loma Linda, California, United States, 92354 Less <<
NCT01131689 Hepatocellular Carcinoma Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT01583647 - Terminated(In HPS2-THRIVE, MK-... More >>0524A did not meet the primary efficacy objective and there was a significant increase in incidence of some types of non-fatal SAEs.) Less << - -
NCT01583647 Hypercholesterolemia, Familial... More >> Heterozygous Familial Hypercholesterolemia Less << Phase 1 Terminated(In HPS2-THRIVE, MK-... More >>0524A did not meet the primary efficacy objective and there was a significant increase in incidence of some types of non-fatal SAEs.) Less << - -
NCT01135056 Hepatocellular Carcinoma Phase 3 Active, not recruiting July 31, 2018 -
NCT01808300 Healthy Phase 1 Completed - -
NCT01158287 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - Ireland ... More >> Bon Secours Hospital Cork, Ireland Cork University Hospital Cork, Ireland Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital Dublin, Ireland, 24 Mater Misericordiae University Hospital Dublin, Ireland, 7 St. James's Hospital Dublin, Ireland, 8 Beaumont Hospital Dublin, Ireland, 9 University College Hospital Galway, Ireland Waterford Regional Hospital Waterford, Ireland Less <<
NCT01170104 Hepatocellular Carcinoma Phase 2 Unknown June 2013 Korea, Republic of ... More >> Chung-Ang University Hospital Recruiting Dongjak, Seoul, Korea, Republic of, 156-755 Contact: Joung-Soon Jang, M.D.    82-2-6299-1427    alsaba@daum.net    Contact: In Gyu Hwang, M.D.    82-2-748-9786    higyu72@yahoo.co.kr    Principal Investigator: Joung-Soon Jang, M.D.          Sub-Investigator: Hyung Joon Kim, M.D.          Sub-Investigator: Hyun Woong Lee, M.D.          Sub-Investigator: In Gyu Hwang, M.D. Less <<
NCT01159327 Small Cell Lung Cancer Phase 2 Terminated(low enrolling parti... More >>cipants) Less << - Korea, Republic of ... More >> National Cancer Center, Korea Goyang-si, Gyeonggi-do, Korea, Republic of Less <<
NCT01159301 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Blastic Phase Chronic Myelogenous Leukemia Recurrent Adult Acute Myeloid Leukemia Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Terminated - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT01840592 Hepatocellular Carcinoma Phase 2 Active, not recruiting April 2019 United States, New Jersey ... More >> Memorial Sloan Kettering Cancer Center at Basking Ridge Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering West Harrison Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT01828437 Infantile Spasms Phase 3 Unknown March 2014 India ... More >> Lady Hardinge Medical College Recruiting New Delhi, India Contact: Suvasini Sharma, MD       sharma.suvasini@gmail.com Less <<
NCT01177189 Aging Not Applicable Terminated(Inadequate effect s... More >>ize.) Less << - -
NCT01853280 Attention Deficit Hyperactivit... More >>y Disorder Less << Phase 2 Phase 3 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01842230 Essential Hypertension ... More >> Hyperlipidemia Less << Phase 1 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of Less <<
NCT01182272 Liver Cancer Phase 2 Unknown - France ... More >> Hopital Beaujon Recruiting Clichy, France, 92110 Contact: Contact Person    33-1-4087-5614    sandrine.faivre@bjn.aphp.fr Less <<
NCT01188811 Multiple Sclerosis, Chronic Pr... More >>ogressive Less << Phase 2 Phase 3 Completed - United States, Oregon ... More >> VA Portland Health Care System, Portland, OR Portland, Oregon, United States, 97239 Less <<
NCT01189370 Renal Cell Cancer Phase 2 Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT01189370 - Completed - -
NCT01868191 Diabetic Neuropathies Phase 3 Unknown December 2014 Germany ... More >> Diabetes Schwerpunktpraxis Not yet recruiting Essen, NRW, Germany, 45136 Contact: Helga Zeller-Stefan, MD    +492011788892    helga.zeller@gmx.de    Principal Investigator: Alin O Stirban, MD, PhD          Sub-Investigator: Helga Zeller-Stefan, MD, PhD Less <<
NCT01853280 - Completed - -
NCT01871571 Mucinous Adenocarcinoma of the... More >> Rectum Signet Ring Adenocarcinoma of the Rectum Stage IIA Rectal Cancer Stage IIB Rectal Cancer Stage IIC Rectal Cancer Stage IIIA Rectal Cancer Stage IIIB Rectal Cancer Stage IIIC Rectal Cancer Less << Phase 2 Active, not recruiting August 2, 2020 United States, California ... More >> USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT01203787 Hepatocellular Carcinoma Phase 4 Completed - United States, Florida ... More >> University of Florida Hepatology Gainesville, Florida, United States, 32610-0277 Mayo Clinic Jacksonville, Florida, United States, 32224 Florida Hospital Transplant Center Orlando, Florida, United States, 32804 Tampa General Hospital Tampa, Florida, United States, 33606 United States, Illinois Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Pennsylvania Drexel University College of Medicine Philadelphia, Pennsylvania, United States, 19107 United States, Texas University of Texas Health Science Center Houston Houston, Texas, United States, 77030 Brooke Army Medical Center San Antonio, Texas, United States, 78234 Less <<
NCT01171651 Carcinoma, Hepatocellular Phase 2 Completed - Korea, Republic of ... More >> Pusan National University Hospital Busan, Korea, Republic of Pusan National University Yangsan Hospital Yangsan, Korea, Republic of Less <<
NCT01208948 Diabetes Mellitus ... More >> Macular Edema Less << Phase 3 Completed - Germany ... More >> Department of Ophthalmology Munich, Germany, 80336 Less <<
NCT01203787 - Completed - -
NCT01215266 Bladder Cancer Phase 2 Terminated(Slow recruitment) - -
NCT01188811 - Completed - -
NCT01217034 Hepatocellular Carcinoma ... More >> Unresectable Hepatocellular Carcinoma Carcinoma, Hepatocellular Liver Neoplasm Less << Phase 2 Active, not recruiting March 2018 Japan ... More >> Kinki University Hospital Osaka-Sayama, Osaka, Japan, 589-8511 Less <<
NCT01900717 Metastatic Colorectal Adenocar... More >>cinoma Less << Phase 2 Completed - France ... More >> CHU de Dijon Dijon, France, 21079 Less <<
NCT01891747 Malignant Glioma Phase 1 Active, not recruiting March 2020 United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT01221350 - Completed - -
NCT01221350 Asthma Allerg... More >>ic Rhinitis Less << Not Applicable Completed - Mexico ... More >> Hospital Civil de Guadalajara "Juan I. Menchaca" Guadalajara, Jalisco, Mexico, 44340 Departamento de Fisiología, CUCS, UdeG Guadalajara, Jalisco, Mexico, 44348 Less <<
NCT01224353 Diabetics Phase 2 Phase 3 Unknown July 2011 China, Jiangsu ... More >> Jiangsu Provincial People's Hospital Not yet recruiting Nanjing, Jiangsu, China, 210029 Contact: Qi Wan    86 13770316989    qi_wan@126.com    Sub-Investigator: Jie Gong          Sub-Investigator: Wei Wang          Principal Investigator: Qi Wan          Sub-Investigator: Ping Gu          Affiliated Hospital of Nantong University Not yet recruiting Nantong, Jiangsu, China, 226001 Contact: Kaifu Ke    0513-85052569    kekaifu_nt@126.com    Sub-Investigator: Maohong Cao          Principal Investigator: Kaifu Ke          Sub-Investigator: Aihong Li          The Second Affiliated Hospital of Soochow University Not yet recruiting Suzhou, Jiangsu, China, 215004 Contact: Heqing Zhao    86 13004571960    zhao_heqing@163.com    Principal Investigator: Heqing Zhao          Sub-Investigator: Xia Zhang          Sub-Investigator: Weidong Hu          The First Affiliated Hospital of Soochow University Not yet recruiting Suzhou, Jiangsu, China, 215006 Contact: Wanli Dong    86 512 65223637 ext 8317    dwlsz@163.com    Principal Investigator: Wanli Dong          Sub-Investigator: Shouru Xue          Sub-Investigator: Xiaowei Hu          Sub-Investigator: Hongxia Wang          Wuxi No.2 People's Hospital Not yet recruiting Wuxi, Jiangsu, China, 214002 Contact: Yuenan Kong    86 051267727501 ext 3503    kkyynn2008@yahoo.cn    Principal Investigator: Yuenan Kong          Sub-Investigator: Wenzhuo Dai          Sub-Investigator: Tao Ma Less <<
NCT01223027 - Completed - -
NCT01223027 Metastatic Renal Cell Carcinom... More >>a Less << Phase 3 Completed - -
NCT01204177 Carcinoma, Hepatocellular Phase 2 Completed - Hong Kong ... More >> Shatin, New Territories, Hong Kong Hong Kong, Hong Kong Korea, Republic of Jung-gu, Daegu Gwang''yeogsi, Korea, Republic of, 700-721 Goyang-si, Gyeonggido, Korea, Republic of, 410-769 Busan, Korea, Republic of, 602-739 Seoul, Korea, Republic of, 110-744 Seoul, Korea, Republic of, 120-752 Seoul, Korea, Republic of, 135-710 Seoul, Korea, Republic of, 138-736 Singapore Singapore, Singapore, 228510 Singapore, Singapore, 258499 Taiwan Kaohsiung, Taiwan, 833 Tainan, Taiwan, 736 Tainan, Taiwan Taipei, Taiwan, 100 Less <<
NCT01921374 Other Diseases or Conditions Not Applicable Completed - Brazil ... More >> University Federal of São Paulo São Paulo, Brazil, 04024001 Less <<
NCT01246986 Carcinoma, Hepatocellular Phase 2 Active, not recruiting December 3, 2018 -
NCT01232296 - Completed - -
NCT01932177 Metastatic or Locally Advanced... More >> Solid Tumors Less << Phase 1 Unknown October 2015 France ... More >> Hospices Civils de Lyon Recruiting Lyon, France, 69002 Less <<
NCT01683656 HIV Atheroscl... More >>erosis Less << Phase 4 Terminated(Withdrawal of IMP f... More >>rom the market. Data on risk-benefit ratio pending.) Less << July 2014 Switzerland ... More >> University Hospital Berne Inselspital Berne, BE, Switzerland, 3010 University Hospital Basel Basel, BS, Switzerland, 4031 University Hospitals Genève Geneva, GE, Switzerland, 1211 Kantonsspital St Gallen St Gallen, SG, Switzerland, 9007 EOC Ente Ospedaliero Cantonale, civico Lugano, TI, Switzerland, 6903 CHUV Cantonal University Hospital Vaud Lausanne, VD, Switzerland, 1011 University Hospital Zurich Zurich, ZH, Switzerland Less <<
NCT01253070 Acute Myeloid Leukemia ... More >> Acute Myeloid Leukemia (Megakaryoblastic) With t(1;22)(p13.3;q13.1); RBM15-MKL1 Acute Myeloid Leukemia With a Variant RARA Translocation Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP214 Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-KMT2A Acute Myeloid Leukemia With Variant MLL Translocations Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Active, not recruiting - -
NCT01232296 Hepatocellular Carcinoma Phase 2 Completed - China, Jiangsu ... More >> Novartis Investigative Site Nanjing, Jiangsu, China, 210002 China, Shanxi Novartis Investigative Site Xi'an, Shanxi, China, 710032 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310016 China Novartis Investigative Site Beijing, China, 100039 Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Novartis Investigative Site Shatin, New Territories, Hong Kong Japan Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 232-0024 Novartis Investigative Site OsakaSayama, Osaka, Japan, 589-8511 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03722 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Novartis Investigative Site Seoul, Korea, Republic of, 136-705 Singapore Novartis Investigative Site Singapore, Singapore, 308433 Taiwan Novartis Investigative Site Taipei, Taiwan, ROC, Taiwan, 112 Novartis Investigative Site Kuei-Shan Chiang, Taoyuan/ Taiwan ROC, Taiwan, 33305 Novartis Investigative Site Taichung, Taiwan, 40705 Novartis Investigative Site Taipei, Taiwan, 10048 Thailand Novartis Investigative Site Bangkok, Thailand, 10330 Novartis Investigative Site Bangkok, Thailand, 10700 Novartis Investigative Site Chiang Mai, Thailand, 50200 Novartis Investigative Site Khon Kaen, Thailand, 40002 Novartis Investigative Site Songkla, Thailand, 90110 Less <<
NCT01254890 Leukemia Phase 1 Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01258608 Carcinoma, Hepatocellular Phase 2 Completed - -
NCT01254890 - Completed - -
NCT01253070 - Active, not recruiting - -
NCT01259193 Hepatocellular Carcinoma Phase 2 Unknown July 2012 China, Shanghai ... More >> Liver Cancer Institute Recruiting Shanghai, Shanghai, China, 200032 Contact: Zheng-Gang Ren, Ph.D    0086-021-64041990 ext 2137    ren.zhenggang@zs-hospital.sh.cn    Contact: Lan Zhang, Master    0086-021-64041990 ext 2171    zhang.lan@zs-hospital.sh.cn    Principal Investigator: Zheng-Gang Ren, Ph.D          Sub-Investigator: Jubo Zhang, PhD Less <<
NCT01672710 Gulf War Illness Phase 2 Completed - United States, Maryland ... More >> Severna Park Health and Wellness Center Annapolis, Maryland, United States, 21401 Less <<
NCT00487825 Rheumatoid Arthritis Phase 2 Completed - -
NCT00488605 Leukemia Phase 3 Completed - United States, New Mexico ... More >> University of New Mexico Albuquerque, New Mexico, United States, 87131 Less <<
NCT00487669 - Completed - -
NCT00489203 Hematopoietic/Lymphoid Cancer ... More >> Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Atypical Chronic Myeloid Leukemia Blastic Phase Chronic Myelogenous Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Chronic Myelogenous Leukemia Childhood Myelodysplastic Syndromes Chronic Eosinophilic Leukemia Chronic Myelomonocytic Leukemia Chronic Neutrophilic Leukemia Chronic Phase Chronic Myelogenous Leukemia Contiguous Stage II Adult Burkitt Lymphoma Contiguous Stage II Adult Diffuse Large Cell Lymphoma Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Contiguous Stage II Adult Lymphoblastic Lymphoma Contiguous Stage II Grade 1 Follicular Lymphoma Contiguous Stage II Grade 2 Follicular Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma Contiguous Stage II Marginal Zone Lymphoma Contiguous Stage II Small Lymphocytic Lymphoma de Novo Myelodysplastic Syndromes Essential Thrombocythemia Extramedullary Plasmacytoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Graft Versus Host Disease Isolated Plasmacytoma of Bone Juvenile Myelomonocytic Leukemia Meningeal Chronic Myelogenous Leukemia Myelodysplastic/Myeloproliferative Disease, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Burkitt Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Noncontiguous Stage II Grade 1 Follicular Lymphoma Noncontiguous Stage II Grade 2 Follicular Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Noncontiguous Stage II Marginal Zone Lymphoma Noncontiguous Stage II Small Lymphocytic Lymphoma Previously Treated Myelodysplastic Syndromes Primary Myelofibrosis Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Relapsing Chronic Myelogenous Leukemia Secondary Myelodysplastic Syndromes Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Diffuse Small Cleaved Cell Lymphoma Stage I Adult Hodgkin Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Adult T-cell Leukemia/Lymphoma Stage I Childhood Hodgkin Lymphoma Stage I Chronic Lymphocytic Leukemia Stage I Cutaneous T-cell Non-Hodgkin Lymphoma Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage I Marginal Zone Lymphoma Stage I Multiple Myeloma Stage I Mycosis Fungoides/Sezary Syndrome Stage I Small Lymphocytic Lymphoma Stage II Adult Hodgkin Lymphoma Stage II Adult T-cell Leukemia/Lymphoma Stage II Chronic Lymphocytic Leukemia Stage II Cutaneous T-cell Non-Hodgkin Lymphoma Stage II Multiple Myeloma Stage II Mycosis Fungoides/Sezary Syndrome Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Hodgkin Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Adult T-cell Leukemia/Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Multiple Myeloma Stage III Mycosis Fungoides/Sezary Syndrome Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult T-cell Leukemia/Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Mycosis Fungoides/Sezary Syndrome Stage IV Small Lymphocytic Lymphoma Less << Phase 2 Completed - United States, New Jersey ... More >> Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00489983 Non-Small Cell Lung Cancer Phase 2 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, United Kingdom Less <<
NCT00487825 - Completed - -
NCT01059773 Psoriasis Phase 4 Completed - -
NCT01059773 - Completed - -
NCT00527800 Malaria HIV I... More >>nfections Less << Phase 3 Completed - Uganda ... More >> Tororo District Hospital Tororo, Uganda Less <<
NCT01063283 Advanced Non-squamous Non-Smal... More >>l Cell Lung Cancer Less << Not Applicable Completed - United States, Illinois ... More >> The University of Chicago Medical Center Chicago, Illinois, United States, 60637 North Shore University Health System Evanston, Illinois, United States, 60201 Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Less <<
NCT01063062 Rheumatoid Arthritis Phase 3 Completed - Egypt ... More >> Alexandria University Hospital; Rheumatology Alexandria, Egypt Alexandria University Alexandria, Egypt Banha Educational Hospital; Rheumatology Banha, Egypt Kasr El Ainy Hospital; Rheumatology Cairo, Egypt, 11562 Ain Shams University Hospital; Rheumatology Cairo, Egypt Bab El Sheereya Hospital; Rheumatology Cairo, Egypt El Hussein University Hospital; Rheumatology Cairo, Egypt Kasr El Ainy Hospital Cairo, Egypt Manial Specialized Hospital; Rheumatology Cairo, Egypt Less <<
NCT01068405 Polyarthritis Phase 3 Unknown March 2012 France ... More >> Nice University Hospital, Rheumatology Department Recruiting Nice, France, 06000 Contact: Christian H ROUX, PhD    0492035491    roux.cr@chu-nice.fr Less <<
NCT01063062 - Completed - -
NCT01064466 Small Cell Lung Cancer Phase 3 Active, not recruiting August 2020 United States, Maryland ... More >> Medicine Invention Design Incorporation (MIDI) - IORG0007849 Bethesda, Maryland, United States, 20852 MIDI Clinical Trial Site Type 1 -c/o- Dr. Han Xu - Physicians assigned by CRO / IRB / IORG Bethesda, Maryland, United States, 20852 MIDI Clinical Trial Site Type 2 -c/o- Dr. Han Xu - Investigators assigned by CRO / IRB / IORG Bethesda, Maryland, United States, 20852 MIDI Clinical Trial Site Type 3 -c/o- Dr. Han Xu - Laboratories assigned by CRO / IRB / IORG Bethesda, Maryland, United States, 20852 Less <<
NCT00919503 Hematopoietic Cell Transplanta... More >>tion Recipient Non-Malignant Less << Phase 2 Recruiting - United States, Colorado ... More >> Children's Hospital Colorado Active, not recruiting Aurora, Colorado, United States, 80045 United States, Oregon Oregon Health and Science University Completed Portland, Oregon, United States, 97239 United States, Tennessee Vanderbilt University/Ingram Cancer Center Active, not recruiting Nashville, Tennessee, United States, 37232 United States, Washington Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 Contact: Lauri M. Burroughs    206-667-2396    lburroug@fhcrc.org    Principal Investigator: Lauri M. Burroughs          Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Lauri M. Burroughs    206-667-2396    lburroug@fhcrc.org    Principal Investigator: Lauri M. Burroughs          United States, Wisconsin Children's Hospital of Wisconsin Suspended Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01079988 - Completed - -
NCT00928018 - Completed - -
NCT01383707 Colorectal Cancer Phase 2 Completed - Italy ... More >> IRCCS Istituto Nazionale Tumori Fondazione Pascale; Oncologia Medica A Napoli, Campania, Italy, 80131 Azienda Ospedaliero-Universitaria S.Orsola-Malpighi; Unità Operativa Oncologia Medica Bologna, Emilia-Romagna, Italy, 40138 A.O. Universitaria Policlinico Di Modena; Ematologia Modena, Emilia-Romagna, Italy, 41100 Azienda Ospedaliera Sant' Antonio Abate; Divisione di Oncologia Gallarate, Lombardia, Italy, 21013 Irccs Ospedale San Raffaele;Oncologia Medica Milano, Lombardia, Italy, 20132 Irccs Istituto Europeo Di Oncologia (IEO); Oncologia Medica Milano, Lombardia, Italy, 20141 Asst Grande Ospedale Metropolitano Niguarda; Dipartimento Di Ematologia Ed Oncologia Milano, Lombardia, Italy, 20162 Fondazione IRCCS Policlinico San Matteo Pavia, Lombardia, Italy, 27100 Ospedali Riuniti Di Ancona; Oncology Ancona, Marche, Italy, 60121 Az Ospedaliera Nuovo Garibaldi Quartiere Nesima; Oncologia Medica Catania, Sicilia, Italy, 95122 Centro Catanese Di Oncologia; Oncologia Medica Catania, Sicilia, Italy, 95126 Less <<
NCT01079988 Psoriasis Phase 4 Completed - -
NCT01378377 Advanced Solid Tumor Phase 1 Terminated(The trial was stopp... More >>ed due to the toxicities observed with the combination of pimasertib and temsirolimus.) Less << - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States United States, Massachusetts For Recruiting Locations in the US contact US Medical Information in Rockland, Massachusetts, United States United States, Texas The University of Texas MD Anderson Cancer Center Houston, Texas, United States Less <<
NCT00928018 Non-hodgkin Lymphoma ... More >> Hodgkin Lymphoma Less << Phase 3 Completed - United States, Georgia ... More >> Emory University Hospital Atlanta, Georgia, United States, 30322 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55454 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00764270 Atherosclerosis Phase 2 Phase 3 Active, not recruiting December 2018 United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97201 Less <<
NCT00764972 Metastatic Breast Cancer Phase 1 Phase 2 Unknown December 2011 Canada, Quebec ... More >> Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T 1E2 Contact: Lawrence Panasci    514-340-8248    lpanasci@hotmail.com    Contact: Cristiano Ferrario    514-340-8248    cristianoferrario@gmail.com    Principal Investigator: Lawrence Panasci Less <<
NCT00765310 Atherosclerosis Phase 2 Phase 3 Active, not recruiting December 2018 United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97201 Less <<
NCT01383707 - Completed - -
NCT01378377 - Terminated(The trial was stopp... More >>ed due to the toxicities observed with the combination of pimasertib and temsirolimus.) Less << - -
NCT00767468 Liver Cancer Phase 1 Terminated(Funding unavailable... More >>) Less << - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT01390818 Locally Advanced Solid Tumor ... More >> Metastatic Solid Tumor Breast Cancer Non Small Cell Lung Cancer Melanoma Colorectal Cancer Less << Phase 1 Completed - United States, Arizona ... More >> Pinnacle Oncology Hematology Scottsdale, Arizona, United States, 85258 United States, California Cedars Sinai Medical Center Los Angeles, California, United States, 90048 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37205 United States, Texas Cancer Therapy and Research Center San Antonio, Texas, United States, 78229 Italy Merck Serono Research Site Milan, Italy Spain Merck Serono Research Site Madrid, Spain Less <<
NCT00759928 Refractory Solid Tumors Phase 1 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33916 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT00771147 - Completed - Belgium ... More >> Many Locations, Belgium Less <<
NCT00768937 Hepatocellular Carcinoma Phase 1 Phase 2 Completed - Austria ... More >> Abteilung Gastroenterologie und Hepatologie, Medizinische Universität und AKH Wien Vienna, Austria, 1090 Less <<
NCT00772694 Testicular Cancer Phase 2 Unknown December 2011 Poland ... More >> Chemotherapy Unit, Dept of Urology, Instituite of Oncology Recruiting Warsaw, Poland, 02781 Principal Investigator: Iwona A Skoneczna, MD          Sub-Investigator: Agnieszka Chaladaj-Kujawska, MD Less <<
NCT01398423 Hypertension ... More >>Diabetes Mellitus, Type 2 Less << Phase 2 Completed - United States, California ... More >> Garden Grove, California, United States, 92844 La Mesa, California, United States, 91942 Northridge, California, United States, 91324 Riverside, California, United States, 92505 Tustin, California, United States, 92780 United States, Florida Kissimmee, Florida, United States, 34741 Miami, Florida, United States, 33015 United States, Georgia Macon, Georgia, United States, 31217 Tucker, Georgia, United States, 30084 United States, Maryland Reisterstown, Maryland, United States, 21136 United States, Minnesota Brooklyn Center, Minnesota, United States, 55430 United States, North Carolina Cary, North Carolina, United States, 27511 Greenville, North Carolina, United States, 27834 New Bern, North Carolina, United States, 28562 Raleigh, North Carolina, United States, 27610 United States, South Carolina Aiken, South Carolina, United States, 29801 United States, Texas San Antonio, Texas, United States, 78215 San Antonio, Texas, United States, 78228 United States, Virginia Norfolk, Virginia, United States, 23507 Less <<
NCT01398943 Pulmonary Disease, Chronic Obs... More >>tructive Less << Not Applicable Completed - United States, Georgia ... More >> Augusta University Augusta, Georgia, United States, 30912 Less <<
NCT00785226 Advanced Cancer Phase 1 Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center and LAC/USC Medical Center Los Angeles, California, United States, 90033 United States, Nevada Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89169 United States, New York New York Oncology Hematology, PC Albany, New York, United States, 12206 Roswell Park Cancer Institute Buffalo, New York, United States, 14263 James P. Wilmot Cancer Center Rochester, New York, United States, 14642 United States, Pennsylvania UPenn Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Greenville Hospital System University Medical Center, (ITOR) Greenville, South Carolina, United States, 29605 United States, Texas Texas Oncology - Baylor Charles A. Simmons Cancer Center Dallas, Texas, United States, 75246 Texas Oncology-Tyler Tyler, Texas, United States, 75702 Canada, Ontario Toronto General Hospital Toronto, Ontario, Canada, M5G 2N2 Less <<
NCT01200160 - Completed - Colombia ... More >> Site Reference ID/Investigator# 48183 Cali, Colombia, 101-102 Site Reference ID/Investigator# 48182 Cali, Colombia Mexico Site Reference ID/Investigator# 42108 Aguascalientes, Mexico, 20129 Site Reference ID/Investigator# 42110 Aguascalientes, Mexico, 20234 Site Reference ID/Investigator# 42103 Guadalajara, Jalisco, Mexico, 44657 Site Reference ID/Investigator# 42105 Metepec, Estado de Mexico, Mexico, 52140 Site Reference ID/Investigator# 42102 Mexico City DF, Mexico, 03920 Site Reference ID/Investigator# 42107 Mexico City DF, Mexico, 06359 Site Reference ID/Investigator# 42109 Mexico City DF, Mexico, 11560 Site Reference ID/Investigator# 42106 Mexico City DF, Mexico, 11850 Site Reference ID/Investigator# 26348 Mexico D.F., Mexico, C.P. 11650 Site Reference ID/Investigator# 42104 Tijuana, Baja California Norte, Mexico, 11650 Site Reference ID/Investigator# 42112 Tijuana, Baja California Norte, Mexico, 22420 Site Reference ID/Investigator# 42111 Tuxtla Gutierrez, Chiapas, Mexico, 29000 Site Reference ID/Investigator# 42114 Tuxtla Gutierrez, Chiapas, Mexico, 29030 Site Reference ID/Investigator# 42113 Zacatecas, Mexico, 98608 Site Reference ID/Investigator# 42115 Zapopan, Jalisco, Mexico, 45200 Venezuela Site Reference ID/Investigator# 44202 Bolivar, Venezuela, 8050 Site Reference ID/Investigator# 26350 Caracas, Venezuela, 1010 Site Reference ID/Investigator# 44206 Caracas, Venezuela, 1010 Site Reference ID/Investigator# 44203 Caracas, Venezuela, 1060 Site Reference ID/Investigator# 44204 Estado Carabobo, Venezuela, 2001 Less <<
NCT00791778 - Completed - -
NCT01200160 - Completed - -
NCT00791778 Ovarian Neoplasms Phase 2 Completed - -
NCT01390818 - Completed - -
NCT01397994 Chronic Stable Angina Phase 4 Unknown January 2012 Pakistan ... More >> National Institute of Cardiovascular Diseases Recruiting Karachi, Sind, Pakistan, 75850 Contact: Tariq Ashraf, MBBS, FCPS, FACC, FSCAI    092-03222999914    tariqashraf2009@hotmail.com    Contact: Hamid Tirmizey, MBBS, BSC, DIP. CARD    092-03212215383    alafzal1@yahoo.com    Principal Investigator: Tariq Ashraf, MBBS, FCPS, FACC, FSCAI Less <<
NCT00795262 Diabetes Hype... More >>rtension Less << Not Applicable Completed - United States, Georgia ... More >> Atlanta Vascular Research Foundation Tucker, Georgia, United States, 30084 Less <<
NCT01426438 HIV-1 Infection Phase 2 Completed - United States, Alabama ... More >> Alabama Therapeutics CRS (5801) Birmingham, Alabama, United States, 35294 United States, California University of Southern California (1201) Los Angeles, California, United States, 90033-1079 UCLA CARE Center CRS (601) Los Angeles, California, United States, 90095 Harbor-UCLA Med. Ctr. CRS (603) Torrance, California, United States, 90502 United States, Colorado University of Colorado Hospital CRS (6101) Aurora, Colorado, United States, 80045 United States, Illinois Northwestern University CRS (2701) Chicago, Illinois, United States, 60611 United States, New Jersey New Jersey Medical School-Adult Clinical Research Ctr. CRS (31477) Newark, New Jersey, United States, 07103 United States, New York NY Univ. HIV/AIDS CRS (401) New York, New York, United States, 10016 United States, North Carolina Unc Aids Crs (3201) Chapel Hill, North Carolina, United States, 27516 Duke Univ. Med. Ctr. Adult CRS (1601) Durham, North Carolina, United States, 27710 Moses H. Cone Memorial Hospital CRS (3203) Greensboro, North Carolina, United States, 27401 United States, Ohio Univ. of Cincinnati CRS (2401) Cincinnati, Ohio, United States, 45267 Case CRS (2501) Cleveland, Ohio, United States, 44106 United States, Washington University of Washington AIDS CRS (1401) Seattle, Washington, United States, 98104 Less <<
NCT01216956 Insulin Sensitivity ... More >> Lipoproteins Metabolism Non Esterified Fatty Acid Kinetics Lipid Profile Less << Not Applicable Completed - France ... More >> Centre de Recherche en Nutrition Humaine Nantes, France Less <<
NCT01417494 Colorectal Cancer Phase 2 Completed - France ... More >> Hôpital Avicenne Bobigny, France, 93000 Less <<
NCT00794235 Melanoma Stage III or IV ... More >> No Prior Chemotherapy Less << Phase 2 Completed - Switzerland ... More >> Department of Dermatology, University Hospital Zurich Zurich, Switzerland, 8091 Less <<
NCT00810394 - Completed - -
NCT00810394 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 2 Completed - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT01426438 - Completed - -
NCT01221402 Aortocoronary Saphenous Vein B... More >>ypass Graft Atherosclerosis Intermediate Saphenous Vein Graft Lesions Less << Phase 2 Completed - United States, Texas ... More >> VA North Texas Healthcare System Dallas, Texas, United States, 75216 Less <<
NCT01434602 Brain Tumor G... More >>lioblastoma Anaplastic Glioma Less << Phase 1 Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT01398943 - Completed - -
NCT00812175 - Completed - -
NCT01228019 - Terminated(In HPS2-THRIVE, MK-... More >>0524A did not meet the primary efficacy objective and there was a significant increase in incidence of some types of non-fatal SAEs) Less << - -
NCT00813293 Hepatocellular Cancer Phase 2 Active, not recruiting December 2017 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00815295 - Completed - -
NCT01440621 Cancer Related Fatigue ... More >> Quality of Life Less << Phase 3 Completed - India ... More >> Regional Cancer Centre Shimla, Himachal Pradesh, India, 171001 Less <<
NCT00815295 Squamous Cell Cancer Phase 1 Phase 2 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT01239004 Dyslipidemia ... More >>Hyperlipidemia Hyperglycemia Less << Phase 4 Completed - United States, Illinois ... More >> Radiant Research Chicago, Illinois, United States United States, Kansas Kansas City, Kansas, United States United States, Minnesota Minneapolis, Minnesota, United States United States, Missouri St Louis, Missouri, United States Less <<
NCT00822848 Sarcoma Phase 1 Completed - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT01239992 - Terminated(negative endpoint s... More >>tudy resulting in withdrawal of study drug) Less << - -
NCT00825734 - Completed - -
NCT01228019 - Terminated(In HPS2-THRIVE, MK-... More >>0524A did not meet the primary efficacy objective and there was a significant increase in incidence of some types of non-fatal SAEs) Less << - -
NCT01239992 Hyperlipoproteinemia ... More >> Metabolic Syndrome Less << Phase 4 Terminated(negative endpoint s... More >>tudy resulting in withdrawal of study drug) Less << - Germany ... More >> Medizinische Klinik II, Klinikum der Universitaet Muenchen, Grosshadern Munich, Germany, 81377 Less <<
NCT00827177 Advanced Solid Tumors Phase 1 Completed - United States, Massachusetts ... More >> Boston, Massachusetts, United States, 02111 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Tennessee Nashville, Tennessee, United States, 37232 Italy Rozzano, Italy, 20089 Less <<
NCT00828074 Breast Cancer Phase 1 Phase 2 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 South Pasadena Cancer Center Pasadena, California, United States, 91030 Less <<
NCT00828074 - Completed - -
NCT00825734 Metastatic Breast Cancer Phase 1 Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Ft. Myers, Florida, United States, 33916 United States, Indiana Providence Medical Group Terre Haute, Indiana, United States, 47802 RHHP/ Hope Cancer Center Terre Haute, Indiana, United States, 47802 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 United States, Louisiana Hematology Oncology Clinic, LLP Baton Rouge, Louisiana, United States, 70806 United States, Maine Mercy Hospital Portland, Maine, United States, 04101 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63044 United States, New Hampshire Portsmouth Regional Hospital Portsmouth, New Hampshire, United States, 03801 United States, New Jersey Hematology-Oncology Associates of Northern NJ Morristown, New Jersey, United States, 07962 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates Columbia, South Carolina, United States, 29210 Spartanburg Regional Medical Center Spartanburg, South Carolina, United States United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00828594 Hepatocellular Carcinoma Phase 1 Terminated - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 UCLA Department of Medicine Los Angeles, California, United States, 90005 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 Korea, Republic of Novartis Investigative Site Seoul, Korea, Republic of Netherlands Novartis Investigative Site Amsterdam, Netherlands Spain Novartis Investigative Site Barcelona, Spain Novartis Invstigative Site Madrid, Spain Taiwan Novartis Investigative Site Tainan, Taiwan Less <<
NCT00823290 Hepatocellular Carcinoma Phase 1 Unknown December 2010 Germany ... More >> Department of Medicine 1, University Hospital Erlangen Recruiting Erlangen, Germany, 91054 Contact: Matthias Ocker, MD    +49-6421-58 ext 68931    Matthias.Ocker@staff.uni-marburg.de    Contact: Susanne Gahr, MD    +49-9131-85 ext 35000    susanne.gahr@uk-erlangen.de    Principal Investigator: Deike Strobel, MD Less <<
NCT01250990 - Completed - -
NCT01250990 Dyslipidemias Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00837148 Sarcoma Synov... More >>ial Sarcoma Leiomyosarcoma Malignant Peripheral Nerve Sheath Tumor Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00837876 Pancreatic Cancer Phase 2 Completed - United States, Kentucky ... More >> Purchase Cancer Group - Paducah Paducah, Kentucky, United States, 42002 United States, Tennessee Erlanger Cancer Center at Erlanger Hospital - Baroness Chattanooga, Tennessee, United States, 37403 Baptist Regional Cancer Center at Baptist Riverside Knoxville, Tennessee, United States, 37901 Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00837876 - Completed - -
NCT00837148 - Completed - -
NCT00844168 Adult Primary Hepatocellular C... More >>arcinoma Advanced Adult Primary Liver Cancer Localized Resectable Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer Less << Phase 1 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00846131 Hepatocellular Carcinoma Phase 1 Completed - United States, Illinois ... More >> Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 Less <<
NCT00829231 Liver Disease Phase 1 Completed - United States, Florida ... More >> Miami, Florida, United States, 33014 Orlando, Florida, United States, 32809 United States, Tennessee Knoxville, Tennessee, United States, 37920 Less <<
NCT00848640 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Completed - Egypt ... More >> Egyptian Foundation For Cancer Research Cairo, Egypt, 11553 Less <<
NCT01471353 Colorectal Cancer Metastatic Phase 2 Completed - United States, Florida ... More >> UF Health Cancer Center Gainesville, Florida, United States, 32610 Less <<
NCT00845156 Insulin Resistance Not Applicable Completed - United States, California ... More >> University of California at San Francisco San Francisco, California, United States, 94143 Less <<
NCT01473303 Pancreatic Cancer Phase 1 Phase 2 Withdrawn(CALGB 81003 closed a... More >>bout a week after it was activated because of withdrawal of support. No patients were registered on this study.) Less << - -
NCT00854620 Carcinoma, Renal Cell ... More >> Kidney Disease Kidney Cancer Less << Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00854620 - Completed - -
NCT01267604 Infertility Phase 4 Unknown - Italy ... More >> University of Modena and Reggio Emilia Recruiting Reggio Emilia, Italy, 42100 Contact: Giovanni Battista La Sala, MD    +39 0522 296464    giovanni.lasala@asmn.re.it    Principal Investigator: Giovanni Battista La Sala, MD          Research Center for Reproductive Medicine Villa Mafalda Recruiting Roma, Italy, 00199 Contact: Franco Lisi, MD    +39 06 86094776    flisi@tin.it    Principal Investigator: Franco Lisi, MD Less <<
NCT00862082 Hepatocellular Carcinoma Phase 1 Phase 2 Terminated(PR104 plus sorafeni... More >>b was poorly tolerated in patients with advanced HCC) Less << - United States, Arizona ... More >> University of Arizona Tucson, Arizona, United States, 85724 United States, California Moores UCSD Cancer Center La Jolla, California, United States, 92093 University of California, Irvine Orange, California, United States, 92868 Sharp Clinical Oncology Research San Diego, California, United States, 92123 Pacific Oncology/Hematology San Francisco, California, United States, 94115 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Indiana Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Maryland Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Baltimore, Maryland, United States, 21231 United States, New York Columbia University Medical Center New York, New York, United States, 10032 Hong Kong Prince of Wales Hospital Shatin, New Territories, Hong Kong Singapore Singapore General Hospital Singapore, Singapore Taiwan Chang Gung Memorial Hospital Kaohsiung, Taiwan Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung, Taiwan Chi Mei Medical Center, Liouying T'ai-nan, Taiwan China Medical University Hospital Taichung City, Taiwan Cathay General Hospital Taipei City, Taiwan, 10630 National Taiwan University Hospital Taipei, Taiwan Less <<
NCT01471353 - Completed - -
NCT01274559 Primary Hypercholesterolemia ... More >> Mixed Dyslipidemia Less << Phase 3 Terminated(In HPS2-THRIVE, MK-... More >>0524A did not meet the primary efficacy objective and there was a significant increase in incidence of some types of non-fatal SAEs) Less << - -
NCT01274559 - Terminated(In HPS2-THRIVE, MK-... More >>0524A did not meet the primary efficacy objective and there was a significant increase in incidence of some types of non-fatal SAEs) Less << - -
NCT00862082 - Terminated(PR104 plus sorafeni... More >>b was poorly tolerated in patients with advanced HCC) Less << - -
NCT00865709 Metastatic Colorectal Cancer Phase 2 Completed - -
NCT00863746 - Completed - -
NCT01495260 Adrenomyeloneuropathy Phase 2 Completed - Spain ... More >> Hospital Universitari de Bellvitge L'Hospitalet de LLobregat, Barcelona, Spain, 08907 Less <<
NCT00870532 Non-Small Cell Lung Cancer Phase 1 Completed - Singapore ... More >> National Cancer Centre, Singapore Singapore, Singapore, 169610 Less <<
NCT00872014 Advanced Hepatocellular Carcin... More >>oma Inoperable Hepatocellular Carcinoma Less << Phase 2 Completed - -
NCT01498289 Adenocarcinoma of the Gastroes... More >>ophageal Junction Esophageal Cancer Gastric Cancer Less << Phase 2 Active, not recruiting March 2019 -
NCT00863746 Carcinoma Non... More >>-Small-Cell Lung Less << Phase 3 Completed - -
NCT00875615 - Completed - -
NCT00873002 Liver Cancer Phase 1 Terminated(Dose Limiting Toxic... More >>ity) Less << - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00865709 - Completed - -
NCT00875745 Leukemia, Myeloid, Acute ... More >> Leukemia, Promyelocytic, Acute Myelodysplastic Syndromes Less << Phase 1 Completed - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00857376 Metabolic Syndrome Phase 2 Completed - -
NCT00875615 Liver Cancer Phase 2 Completed - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 Less <<
NCT01501253 Hypertension Phase 3 Completed - Korea, Republic of ... More >> Seoul St. Mary's hospital, The catholic university of Korea Seoul, Korea, Republic of Less <<
NCT01504256 Gastric Adenocarcinoma With Pe... More >>ritoneal Carcinomatosis Siewert Type II Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis Siewert Type III Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis Less << Phase 2 Completed - Germany ... More >> Prof. Dr. F. Lordick Leipzig, Germany, 04103 Less <<
NCT00880542 - Terminated(The study lost fund... More >>ing.) Less << - -
NCT00884416 Glioblastoma ... More >>Gliosarcoma Anaplastic Astrocytoma Anaplastic Oligoastrocytoma Anaplastic Oligodendroglioma Less << Phase 1 Completed - Switzerland ... More >> Geneva University Hospital (Hopitaux Universitaires de Geneve), Department of Oncology Geneva, GE, Switzerland, 1211 Less <<
NCT01511822 PCOS Polycyst... More >>ic Ovary Syndrome Less << Phase 4 Completed - Italy ... More >> Istituto di Patologia Ostetrica e Ginecologica Catania, Italy Less <<
NCT00880542 Sarcoma Phase 2 Terminated(The study lost fund... More >>ing.) Less << - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT01518413 Rhabdomyosarcoma and Other Sof... More >>t Tissue Sarcomas Ewing's Sarcoma Family of Tumors Osteosarcoma Neuroblastoma Brain Tumors Less << Phase 1 Completed - United States, District of Col... More >>umbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Maryland National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Massachusetts Children's Hospital Boston/Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Pennsylvania The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00882869 Advanced Hepatocellular Carcin... More >>oma Less << Phase 1 Phase 2 Completed - China, New Territories, Hong K... More >>ong Tuen Mun Hospital Tuen Mun, New Territories, Hong Kong, China China Queen Elizabeth Hospital Hong Kong, China Queen Mary Hospital Hong Kong, China Less <<
NCT00892424 Liver Metastasis ... More >> Cancer Less << Phase 1 Phase 2 Active, not recruiting November 2019 Canada, Ontario ... More >> University Health Network Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00892658 Hepatocellular Carcinoma Phase 1 Active, not recruiting December 2019 Canada, Ontario ... More >> University Health Network Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00889057 Osteosarcoma Phase 2 Completed - Italy ... More >> I.R.C.C. - Unit of Medical Oncology Candiolo, Torino, Italy, 10060 Istituti Ortopedici Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors Bologna, Italy, 40136 Istituto Nazionale Tumori - Unit of Medical Oncology Milano, Italy, 20133 Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology Torino, Italy, 10126 Less <<
NCT00893373 Acute Myeloid Leukemia (AML) Phase 2 Completed - Germany ... More >> Sozialstiftung Bamberg Klinikum am Bruderwald Bamberg, Germany, 96049 Klinikum Bayreuth Bayreuth, Germany, 95445 Charite Campus Benjamin Franklin Berlin, Germany Ev. Diakonie-Krankenhaus gGmbH Bremen Bremen, Germany, 28239 University Hospital Dresden Dresden, Germany, 01307 Klinikum Frankfurt (Oder) GmbH Frankfurt (Oder), Germany, 15236 Westpfalz-Klinikum GmbH Kaiserslautern, Germany, 67655 Agaplesion Diakoniekrankenhaus Rotenburg Rotenburg, Germany, 27356 Robert-Bosch-Krankenhaus Stuttgart, Germany, 70376 Less <<
NCT01308203 Coronary Artery Disease ... More >> Dyslipidemias Less << Phase 4 Terminated(Merck has decided t... More >>o discontinue all studies with extended-release niacin/laropiprant.because the HPS2-THRIVE did not meet its primary endpoint) Less << - Argentina ... More >> Hospital Italiano de Buenos Aires Buenos Aires, Argentina, C1181ACH Less <<
NCT00887107 Thyroid Cancer Phase 2 Completed - Netherlands ... More >> Leiden University Medical Center Leiden, Netherlands, 2300 RC Less <<
NCT00901901 Carcinoma, Hepatocellular Phase 3 Completed - -
NCT01533220 Flu Cold ... More >> Allergic Disorder of Respiratory System Less << Phase 3 Unknown December 2013 Brazil ... More >> Instituto Paranaense de Otorrinolaringologia Curitiba, Parana, Brazil, 80620010 Less <<
NCT01321034 Hypercholesterolemia Phase 4 Completed - Spain ... More >> Hospital San Jorge Huesca, Spain Hospital Universitario Miguel Servet Zaragoza, Spain, 50009 Hospital Royo Villanova Zaragoza, Spain Less <<
NCT01524094 Colorectal Peritoneal Carcinom... More >>atosis Less << Phase 3 Completed - Sweden ... More >> Akademiska Sjukhuset (Uppsala University Hospital) Uppsala, Sweden, SE-751 85 Less <<
NCT01324297 - Terminated(Unable to secure fu... More >>nding for second phase of study (i.e., niacin skin flush test in early psychosis patients).) Less << - Canada, Nova Scotia ... More >> Nova Scotia First Episode Psychosis Program; QEII health Sciences Centre; Capital District Health Authority Halifax, Nova Scotia, Canada, B3H 2E2 Less <<
NCT01325389 Perimenopause Not Applicable Unknown - Italy ... More >> AGUNCO Recruiting Rome, Italy, 00155 Contact: Gianfranco Carlomagno, Ph.D.       gianfranco.carlomagno@gmail.com    Principal Investigator: Gianfranco Carlomagno, Ph.D          Principal Investigator: Vittorio Unfer, M.D. Less <<
NCT00924807 Prostate Cancer Phase 1 Phase 2 Terminated(Sponsor closed the ... More >>trial) Less << - United States, New York ... More >> St.Luke's-Roosevelt Hospital Center New York, New York, United States, 10019 Less <<
NCT00901901 - Completed - -
NCT00922584 Non-Small Cell Lung Cancer Phase 2 Completed - China, Guangdong ... More >> WuYiLong Guangzhou, Guangdong, China, 510080 Less <<
NCT00924807 - Terminated(Sponsor closed the ... More >>trial) Less << - -
NCT00917462 Esophageal Cancer ... More >> Gastroesophageal Junction Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00908167 Acute Myeloid Leukemia ... More >> Infantile Leukemia (Both AML and ALL) Myelodysplastic Syndrome Myelodysplastic/Myeloproliferative Neoplasms Biphenotypic Leukemia Less << Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00943449 Hepatocellular Carcinoma Phase 2 Completed - Germany ... More >> ONKOPLUS Beratung und Hilfe für Menschen mit Krebs Berlin, Germany, 14195 Universitätsklinikum Essen (Innere Klinik/Tumorforschung und Zentrum für Innere Medizin) Essen, Germany, 45147 Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg (Klinik und Poliklinik für Innere Medizin I) Halle, Germany, 06120 Universitätsklinikum Hamburg-Eppendorf (I. Medizinische Klinik und Poliklinik) Hamburg, Germany, 20246 Universitätsklinikum Heidelberg (Medizinische Universitätsklinik/Innere Medizin IV/Nationales Centrum für Tumorerkrankungen) Heidelberg, Germany, 69120 Johannes Gutenberg-Universität Mainz (I. Medizinische Klinik und Poliklinik) Mainz, Germany, 55131 Klinikum rechts der Isar der Technischen Universität München (Medizinische Klinik und Poliklinik II/Gastroenterologie) Munich, Germany, 81675 Universitätsklinikum Tübingen (Medizinische Klinik/Innere Medizin I) Tübingen, Germany, 72076 Italy l'Azienda Ospedaliero-Universitaria di Bologna-Policlinico S. Orsola Malpighi Bologna, Italy, 40138 l'Università degli Studi di Genova (Dipartimento di Medicina Interna e Specialità Mediche) Genova, Italy, 16132 Istituto Europea di Oncologia EIO Milano, Italy, 20141 A.O.R.N. Monaldi-Cotugno-CTO Napoli, Italy, 80131 l'Azienda Ospedaliera di Padova and l'Istituto Oncologico Veneto IOV Padova, Italy l'Ente "Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone" Palermo, Italy, 12990127 L'Istituto Clinico Humanitas-Humanitas Mirasole S.p.A. Rozzano-Milano, Italy, 20089 Less <<
NCT01574313 Vertigo Menie... More >>re Disease Less << Phase 4 Completed - Taiwan ... More >> i Mei Medical Center Tainan, Taiwan, Taiwan Tainan, Taiwan, 70014 Less <<
NCT00943943 Acute Myelogenous Leukemia ... More >> Leukemia Less << Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00954278 Carcinoma, Non Small Cell Lung Phase 1 Active, not recruiting December 2018 United States, Wisconsin ... More >> University of Wisconsin - Madison Madison, Wisconsin, United States, 53792 Less <<
NCT00942682 Neuroendocrine Tumor ... More >> Carcinoid Tumor Pancreatic Neuroendocrine Tumor Less << Phase 1 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01369277 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Less << Phase 1 Completed - United States, Connecticut ... More >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Less <<
NCT01601626 HIV Infection ... More >> Tuberculosis Less << Phase 2 Terminated(The study was stopp... More >>ed early due to feasibility concerns.) Less << - Brazil ... More >> Hospital Nossa Senhora da Conceicao CRS (12201) Porto Alegre, RS, Brazil, 9043010 Instituto de Pesquisa Clinica Evandro Chagas (12101) Rio de Janeiro, Brazil, 21045 Haiti GHESKIO Institute of Infectious Diseases and Reproductive Health (GHESKIO - IMIS) CRS (31730) Port Au Prince, Haiti Les Centres GHESKIO CRS (30022) Port-au-Prince, Haiti, HT-6110 Kenya Moi University Clinical Research Center CRS (12601) Eldoret, Kenya, 30100 Peru Investigaciones Medicas en Salud (INMENSA) (11302) San Isidro, Lima, Peru Asociacion Civil Impacta Salud y Educacion - Miraf CRS (11301) Lima, Peru, 18 PE South Africa Wits HIV CRS (11101) Johannesburg, Gauteng, South Africa Durban Adult HIV CRS (11201) Durban, South Africa, 4013 SF Less <<
NCT01369602 Type 2 Diabetes Mellitus ... More >> Healthy Less << Phase 1 Completed - United States, California ... More >> Pfizer Investigational Site Anaheim, California, United States, 92801 United States, Florida Pfizer Investigational Site DeLand, Florida, United States, 32720 Less <<
NCT00964743 - Terminated(Low Accrual) - -
NCT01388829 Healthy Phase 1 Completed - United States, Connecticut ... More >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Less <<
NCT00962429 CIDP Chronic ... More >>Inflammatory Demyelinating Polyneuropathy Less << Phase 2 Completed - United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT01613469 Rectal Neoplasms Phase 2 Terminated(Re-eval of patient ... More >>population) Less << - United States, Pennsylvania ... More >> Lankenau Medical Center Wynnewood, Pennsylvania, United States, 19096 Less <<
NCT01601626 - Terminated(The study was stopp... More >>ed early due to feasibility concerns.) Less << - -
NCT00971126 Hepatocellular Carcinoma Phase 1 Phase 2 Terminated(Two patients in the... More >> first dose level be counted as reaching DLT. DSMB recommend terminated early this trial.) Less << - Taiwan ... More >> Ghang-Gung Memorial Hospital at Chia-Yi Chia-Yi, Taiwan, 613 Less <<
NCT00977483 Diabetic Polyneuropathy Phase 3 Completed - -
NCT01391377 Peripheral Arterial Disease Not Applicable Terminated(Tredaptive has been... More >> suspended worldwide) Less << December 2014 Australia, Victoria ... More >> Baker IDI Heart and diabetes research institute Melbourne, Victoria, Australia, 3004 Less <<
NCT00964743 Neoplastic Meningitis Not Applicable Terminated(Low Accrual) - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01083342 CNS Lymphoma Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT01129206 Adenocarcinoma of the Esophagu... More >>s Adenocarcinomas of the Gastroesophageal Junction Recurrent Esophageal Cancer Squamous Cell Carcinoma of the Esophagus Stage IV Esophageal Cancer Less << Phase 2 Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT01085617 Leukemia Muco... More >>sitis Oral Complications Less << Phase 3 Recruiting July 2023 United Kingdom ... More >> UCL Cancer Institute Recruiting London, England, United Kingdom, WC1E 6DD Contact: Contact Person    44-207-830-2833 Less <<
NCT01136850 Malaria in Pregnancy ... More >> Sexually Transmitted Infections Anaemia Less << Phase 3 Completed - Papua New Guinea ... More >> Papua New Guinea Institute of Medical Research Madang, Madang Province, Papua New Guinea Less <<
NCT00529620 Malaria Phase 3 Completed - Senegal ... More >> Departement de Parasitologie et Mycologie, Universite Cheikh Anta Diop Dakar, Senegal Less <<
NCT01104025 Hemophagocytic Lymphohistiocyt... More >>osis Less << Phase 2 Completed - United States, Arizona ... More >> Phoenix Children's Hospital Phoenix, Arizona, United States, 85254 United States, California University of California, San Francisco Department of Pediatrics San Francisco, California, United States, 94143 Stanford University Stanford, California, United States, 94305 United States, Colorado University of Colorado Aurora, Colorado, United States, 80045 United States, Delaware Nemours Wilmington, Delaware, United States, 19803 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Florida Nemours Jacksonville, Florida, United States, 32827 Florida All Children's Hospital St. Petersburg, Florida, United States, 33701 United States, Louisiana Tulane University Medical Center New Orleans, Louisiana, United States, 70118 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 21703 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19145 United States, Texas Texas Children's Cancer Center/Baylor College of Medicine Houston, Texas, United States, 77030 Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada Less <<
NCT01129206 - Completed - -
NCT01109615 Metastatic Colorectal Cancer Phase 2 Terminated(Lacking effect of t... More >>reatment) Less << - Denmark ... More >> Vejle Hospital Vejle, Denmark, DK-7100 Less <<
NCT01087398 Osteopetrosis Phase 2 Phase 3 Unknown December 2012 Iran, Islamic Republic of ... More >> Hematology-Oncology & SCT Research Center Recruiting Tehran, Iran, Islamic Republic of, 14114 Contact: Amir Ali Hamidieh, MD    84902645 ext +98-21    aahamidieh@sina.tums.ac.ir    Sub-Investigator: Ardeshir Ghavamzadeh, MD          Sub-Investigator: Mahdi Jalili, MD Less <<
NCT01107626 Lung Cancer Phase 3 Active, not recruiting May 8, 2020 -
NCT01140516 Hydronephrosis ... More >> Urinary Tract Infection Less << Not Applicable Active, not recruiting September 2018 Canada, Ontario ... More >> McMaster Children's Hospital Hamitlon, Ontario, Canada, L8N 3Z5 Sick Kids Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT00547521 Rheumatoid Arthritis (RA) Phase 3 Completed - -
NCT01116219 Lung Cancer Phase 2 Completed - Switzerland ... More >> Kantonsspital Aarau Aarau, Switzerland, CH-5001 Kantonsspital Baden Baden, Switzerland, 5404 Saint Claraspital AG Basel, Switzerland, CH-4016 Clinical Cancer Research Center at University Hospital Basel Basel, Switzerland, CH-4031 Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland, CH-6500 Inselspital Bern Bern, Switzerland, CH-3010 Spitalzentrum Biel Biel, Switzerland, CH-2501 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Kantonsspital Freiburg Freiburg, Switzerland, 1700 Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Centre Pluridisciplinaire d' Oncologie Lausanne, Switzerland, 1011 Kantonsspital Liestal Liestal, Switzerland, CH-4410 Kantonsspital Luzern Luzerne, Switzerland, CH-6000 Kantonsspital Olten Olten, Switzerland, 4600 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Regionalspital Thun, Switzerland, 3600 Spital Uster Uster, Switzerland, 8610 Kantonsspital Winterthur Winterthur, Switzerland, CH-8401 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8044 City Hospital Triemli Zurich, Switzerland, CH-8063 Onkozentrum Hirslanden Zürich, Switzerland, 8008 Less <<
NCT01167452 Obesity Pharm... More >>acokinetics MRSA Tuberculosis PCP Less << Phase 4 Completed - United States, Texas ... More >> University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT01117129 Rheumatoid Arthritis Phase 4 Terminated(This study was prem... More >>aturely terminated as 2 patients were recruited and both of them withdrawn from the study before reaching the primary end point.) Less << - Spain ... More >> Barcelona, Spain, 08003 Less <<
NCT01167452 - Completed - -
NCT01123265 - Completed - United States, New York ... More >> University of Rochester Rochester, New York, United States, 14642 Less <<
NCT00986986 HIV Infections ... More >> Dyslipidemia Endothelial Dysfunction Less << Not Applicable Completed - United States, Hawaii ... More >> University of Hawaii - Hawaii Center for AIDS Honolulu, Hawaii, United States, 96816 Less <<
NCT00573755 Breast Cancer Phase 2 Terminated(lack of participant... More >> accrual) Less << - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 55259 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01120366 Rheumatoid Arthritis Phase 4 Completed - Japan ... More >> Hokkaido Medical Center for Rheumatic Diseases Hospital Sapporo, Hokkaido, Japan Utazu Hama Clinic Ayautagun, Japan Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University Bunkyo-ku, Japan Fukushima Red-Cross Hospital Fukushima, Japan Higashihiroshima Memorial Hospital Higashihiroshima, Japan Tokyo Dental College Ichikawa General Hospital Ichikawa, Japan Itabashi Medical Center Itabashi-ku, Japan Shimane University Faculty of Medicine Izumo, Japan Saitama Medical Center, Saitama Medical University Kawagoe, Japan Kagawa University Kida-gun, Japan University of Occupational and Environmental Health Hospital Kitakyusyu, Japan Kurashiki Sweet Hospital Kurashiki, Japan Kyoto University Graduate School of Medicine Kyoto, Japan Marunouchi Hospital Matsumoto, Japan Dogo Spa Hospital Matsuyama, Japan Zenjinkai Shimin-no-mori Hospital Miyazaki, Japan Nagasaki University Graduate School of Biomedical Sciences Nagasaki, Japan National Hospital Organization Nagoya Medical Center Nagoya, Japan Niigata University Graduate School of Medical and Dental Sciences Niigata, Japan Department of Internal Medicine, Hyogo College of Medicine Nishinomiya, Japan Oribe Rheumatism and Internal Medicine Clinic Oita, Japan Hokkaido University Graduate School of Medicine Sapporo, Japan Sasebo Chuo Hospital Sasebo, Japan Niigata Rheumatic Center Shibata, Japan Osaka University Hospital Suita, Japan Institute of Rheumatology, Tokyo Women's Medical University Tokyo, Japan Keio University Hospital Tokyo, Japan The University of Tokyo Graduate School of Medicine Tokyo, Japan Tomishiro Chuo Hospital Tomishiro, Japan Yokohama Minami Kyousai Hospital Yokohama, Japan Less <<
NCT00547521 - Completed - -
NCT01117441 Leukemia Phase 3 Active, not recruiting December 2021 -
NCT01194869 Breast Cancer Phase 2 Terminated(Slow accrual, avail... More >>ability of other clinical options) Less << - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT01194869 - Terminated(Slow accrual, avail... More >>ability of other clinical options) Less << - -
NCT00986986 - Completed - -
NCT00576056 Carcinoma, Hepatocellular Phase 2 Terminated(Bayer Healthcare is... More >> no supplying the study drug) Less << - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00576056 - Terminated(Bayer Healthcare is... More >> no supplying the study drug) Less << - -
NCT01198548 Stage IV Colon Cancer ... More >> Stage IV Rectal Cancer Less << Phase 2 Terminated(Lack of funding) - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT01198548 - Terminated(Lack of funding) - -
NCT01205022 Recurrent Colon Cancer ... More >> Recurrent Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Less << Phase 1 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT00586105 Carcinoma, Renal Cell Phase 3 Completed - China, Jiangsu ... More >> Nanjing, Jiangsu, China, 210003 China Beijing, China, 100021 Shanghai, China, 200032 Shanghai, China, 200127 Taiwan Tainan, Taiwan, 70428 Taipei, Taiwan, 10002 Taipei, Taiwan, 112 Taoyuan, Taiwan, 333 Less <<
NCT00586105 - Completed - -
NCT00573755 - Terminated(lack of participant... More >> accrual) Less << - -
NCT00586495 - Completed - -
NCT00595985 Gastric Cancer Phase 2 Terminated(low response rate, ... More >>no evidence of PFS or OS improved.) Less << January 2009 China, Shanghai ... More >> Fudan University Cancer Hospital ShangHai, Shanghai, China, 200032 Less <<
NCT01212822 Adenocarcinoma of the Esophagu... More >>s Adenocarcinoma of the Gastroesophageal Junction Diffuse Adenocarcinoma of the Stomach Intestinal Adenocarcinoma of the Stomach Mixed Adenocarcinoma of the Stomach Squamous Cell Carcinoma of the Esophagus Stage IA Esophageal Cancer Stage IA Gastric Cancer Stage IB Esophageal Cancer Stage IB Gastric Cancer Stage IIA Esophageal Cancer Stage IIA Gastric Cancer Stage IIB Esophageal Cancer Stage IIB Gastric Cancer Stage IIIA Esophageal Cancer Stage IIIA Gastric Cancer Stage IIIB Esophageal Cancer Stage IIIB Gastric Cancer Stage IIIC Esophageal Cancer Stage IIIC Gastric Cancer Less << Phase 2 Completed - United States, Ohio ... More >> Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00586495 Carcinoma, Renal Cell Phase 2 Completed - Japan ... More >> Asahi, Chiba, Japan, 289-2511 Matsuyama, Ehime, Japan, 791-0280 Kurume, Fukuoka, Japan, 830-0011 Isesaki, Gunma, Japan, 372-0817 Maebashi, Gunma, Japan, 371-8511 Sapporo, Hokkaido, Japan, 003-0804 Sapporo, Hokkaido, Japan, 060-8543 Sapporo, Hokkaido, Japan, 060-8648 Sunagawa, Hokkaido, Japan, 073-0196 Tsukuba, Ibaraki, Japan, 305-8576 Morioka, Iwate, Japan, 020-8505 Tsu, Mie, Japan, 514-8507 Natori, Miyagi, Japan, 981-1293 Kashihara, Nara, Japan, 634-8522 Kurashiki, Okayama, Japan, 710-8602 Osakasayama, Osaka, Japan, 589-8511 Suita, Osaka, Japan, 565-0871 Hidaka, Saitama, Japan, 350-1298 Irima-gun, Saitama, Japan, 350-0495 Tokorozawa, Saitama, Japan, 359-8513 Hamamatsu, Shizuoka, Japan, 431-3192 Sunto, Shizuoka, Japan, 411-8777 Utsunomiya, Tochigi, Japan, 320-0834 Arakawa-ku, Tokyo, Japan, 116-8567 Bunkyo-ku, Tokyo, Japan, 113-8655 Chuo-ku, Tokyo, Japan, 104-0045 Itabashi-ku, Tokyo, Japan, 173-0003 Shinjuku-ku, Tokyo, Japan, 162-8666 Ube, Yamaguchi, Japan, 755-8505 Akita, Japan, 010-8543 Chiba, Japan, 260-8677 Chiba, Japan, 260-8717 Fukuoka, Japan, 812-0033 Fukuoka, Japan, 812-8582 Kagoshima, Japan, 890-8520 Kyoto, Japan, 602-8566 Kyoto, Japan, 606-8507 Okayama, Japan, 700-8558 Osaka, Japan, 537-8511 Tokushima, Japan, 770-8503 Yamagata, Japan, 990-9585 Less <<
NCT00597493 - Completed - -
NCT00597493 Recurrent Glioblastoma Multifo... More >>rme Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT00600015 - Completed - -
NCT01222676 Bladder Cancer Phase 2 Unknown - Italy ... More >> Fondazione Istituto Nazionale dei Tumori Recruiting Milan, Italy, 20133 Contact: Contact Person    39-2-2390-2359    roberto.salvioni@istitutotumori.mi.it Less <<
NCT01214343 Advanced Hepatocellular Carcin... More >>oma Carcinoma Carcinoma, Hepatocellular Liver Neoplasms Neoplasms Less << Phase 3 Unknown September 2013 Japan ... More >> National Cancer Center Hospital East Recruiting Kashiwa, Chiba, Japan, 277-8577 Contact: Masafumi Ikeda, Dr.          Principal Investigator: Masafumi Ikeda, Dr.          Kurume University Medical Center Recruiting Kurume, Fukuoka, Japan, 839-0863 Contact: Masatoshi Tanaka, Professor          Principal Investigator: Masatoshi Tanaka, Professor          Ogaki Municipal Hospital Recruiting Ogaki, Gifu, Japan, 503-8502 Contact: Takashi Kumada, Dr          Principal Investigator: Takashi Kumada, Dr.          Sapporo Medical University Recruiting Sapporo, Hokkaido, Japan, 060-8556 Contact: Junji Kato, Dr.          Principal Investigator: Junji Kato, Dr.          Sapporo-Kosei General Hospital Recruiting Sapporo, Hokkaido, Japan, 060-8556 Contact: Takumi Ohmura, Dr.          Principal Investigator: Takumi Ohmura, Dr.          Japanese Red Cross Takamatsu Hospital Recruiting Takamatsu, Kagawa, Japan, 760-0017 Contact: Chikara Ogawa, Dr.          Principal Investigator: Chikara Ogawa, Dr.          Mie University Hospital Recruiting Tsu, Mie, Japan, 514-8507 Contact: Katsuya Shiraki, Dr.          Principal Investigator: Katsuya Shiraki, Dr.          National Hospital Organization Nagasaki Medical Center Recruiting Ohmura, Nagasaki, Japan, 856-8562 Contact: Hiromi Ishibashi, Dr.          Principal Investigator: Hiromi Ishibashi, Dr.          Kawasaki Medical School Hospital Recruiting Kurashiki, Okayama, Japan, 701-0192 Contact: Keisuke Hino, Dr.          Principal Investigator: Keisuke Hino, Dr.          Ikeda Municipal Hospital Recruiting Ikeda, Osaka, Japan, 563-8510 Contact: Yasuharu Imai, Dr.          Principal Investigator: Yasuharu Imai, Dr.          Kinki University Hospital Recruiting Osaka-Sayama, Osaka, Japan, 589-8511 Contact: Masatoshi Kudo, Professor    +81-72-366-0221 ext 3149    m-kudo@med.kindai.ac.jp    Contact: Kazuomi Ueshima, Dr.    +81-72-366-0221 ext 3525    kaz-ues@med.kindai.ac.jp    Principal Investigator: Masatoshi Kudo, Professor          Sub-Investigator: Kazuomi Ueshima, Dr.          Principal Investigator: Kazuto Nishio, Professor          Osaka University Hospital Recruiting Suita, Osaka, Japan, 565-0871 Contact: Hiroaki Nagano, Professor          Principal Investigator: Hiroaki Nagano, Professor          Kyorin University Hospital Recruiting Mitaka, Tokyo, Japan, 181-8611 Contact: Junji Furuse, Professor          Principal Investigator: Junji Furuse, Professor          Musashino Red Cross Hospital Recruiting Musashino, Tokyo, Japan, 180-8610 Contact: Namiki Izumi, Dr.          Principal Investigator: Namiki Izumi, Dr.          Juntendo University Nerima Hospital Recruiting Nerima, Tokyo, Japan, 177-0033 Contact: Shigehiro Kokubu, Dr.          Principal Investigator: Shigehiro Kokubu, Dr.          Yamaguchi University Hospital Recruiting Ube, Yamaguchi, Japan, 755-8505 Contact: Isao Sakaida, Prof          Principal Investigator: Isao Sakaida, Professor          Chiba University Hospital Recruiting Chiba, Japan, 260-8677 Contact: Fumihiko Kanai, Dr.          Principal Investigator: Fumihiko Kanai, Dr.          Gifu Municipal Hospital Recruiting Gifu, Japan, 500-8513 Contact: Eiichi Tomita, Dr.          Principal Investigator: Eiichi Tomita, Dr.          Hiroshima City Hospital Recruiting Hiroshima, Japan, 730-8518 Contact: Yoshiyuki Kobayashi, Dr.          Principal Investigator: Yoshiyuki Kobayashi, Dr.          Hiroshima University Hospital Recruiting Hiroshima, Japan, 734-8551 Contact: Hiroshi Aikata, Dr.          Principal Investigator: Hiroshi Aikata, Dr.          Kumamoto University Hospital Recruiting Kumamoto, Japan, 860-8556 Contact: Yutaka Sasaki, Professor          Principal Investigator: Yutaka Sasaki, Professor          Kyoto University Hospital Recruiting Kyoto, Japan, 606-8507 Contact: Etsuro Hatano, Professor          Principal Investigator: Etsuro Hatano, Professor          Center for Gastroenterological and Hepatological Diseases Recruiting Miyazaki, Japan, 880-0003 Contact: Hidemori Sakamoto, Dr.          Principal Investigator: Hidemori Sakamoto, Dr.          Saiseikai Niigata Dai-ni Hospital Recruiting Niigata, Japan, 950-1104 Contact: Toru Ishikawa, Dr.          Principal Investigator: Toru Ishikawa, Dr.          Niigata University Medical and Dental Hospital Recruiting Niigata, Japan, 951-8520 Contact: Kouhei Akazawa          Principal Investigator: Kouhei Akazawa          Okayama University Hospital Recruiting Okayama, Japan, 700-8558 Contact: Kazuhide Yamamoto, Professor          Principal Investigator: Kazuhide Yamamoto, Professor          Osaka Red Cross Hospital Recruiting Osaka, Japan, 543-8555 Contact: Ikuo Osaki, Dr.          Principal Investigator: Ikuo Osaki, Dr.          The University of Tokushima Faculty of Medicine Recruiting Tokushima, Japan, 770-8503 Contact: Tetsuji Takayama, Dr.          Principal Investigator: Tetsuji Takayama, Dr.          Kyoundo Hospital Recruiting Tokyo, Japan, 101-0062 Contact: Shuntaro Obi, Dr.          Principal Investigator: Shuntaro Obi, Dr.          National Cancer Center Hospital Recruiting Tokyo, Japan, 104-0045 Contact: Takushi Okusaka, Dr.          Principal Investigator: Takushi Okusaka, Dr. Less <<
NCT01226056 Advanced Solid Tumors Phase 1 Phase 2 Suspended(toxicity (protocol a... More >>mendment under approval)) Less << December 2012 Italy ... More >> Istituto Europeo di Oncologia, Milano, Italy, 20141 Less <<
NCT01228175 Smoking Addiction Phase 4 Completed - United States, New Mexico ... More >> The Mind Research Network Albuquerque, New Mexico, United States, 87106 Less <<
NCT01228175 - Completed - -
NCT00602576 Melanoma (Skin) Phase 2 Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT01229111 Adult Primary Cholangiocellula... More >>r Carcinoma Advanced Adult Primary Liver Cancer Cholangiocarcinoma of the Extrahepatic Bile Duct Cholangiocarcinoma of the Gallbladder Localized Unresectable Adult Primary Liver Cancer Periampullary Adenocarcinoma Recurrent Adult Primary Liver Cancer Recurrent Extrahepatic Bile Duct Cancer Recurrent Gallbladder Cancer Unresectable Extrahepatic Bile Duct Cancer Unresectable Gallbladder Cancer Less << Phase 2 Terminated(Lack of Drug Supply... More >>) Less << - United States, Ohio ... More >> Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Ireland Cancer Center Landerbrook Health Center Mayfield Heights, Ohio, United States, 44124 Lake University Ireland Cancer Center Mentor, Ohio, United States, 44060 UHHS-Chagrin Highlands Medical Center Orange Village, Ohio, United States, 44122 UH-Seidman Cancer Center at Saint John Medical Center Westlake, Ohio, United States, 44145 Less <<
NCT00606866 Metastatic Renal Cell Carcinom... More >>a Less << Phase 3 Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00609401 Metastatic Disease ... More >> Renal Cell Carcinoma Less << Phase 2 Completed - Italy ... More >> Istituto Tumori Milano, Italy Less <<
NCT00609804 Non-Small Cell Lung Cancer Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Indiana Providence Medical Group Terre Haute, Indiana, United States, 47802 United States, Kentucky Norton Cancer Institute Louisville, Kentucky, United States, 40207 United States, Louisiana Hematology Oncology Clinic, LLP Baton Rouge, Louisiana, United States, 70806 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, Mississippi Jackson Oncology Associates Jackson, Mississippi, United States, 39202 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 Research Medical Center Kansas City, Missouri, United States, 64132 United States, Nebraska Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, New Jersey Hematology-Oncology Associates of Northern NJ Morristown, New Jersey, United States, 07960 United States, Tennessee Associates in Hematology Oncology Chattanooga, Tennessee, United States, 37404 Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00610246 Cancer Phase 1 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00600015 Non-Small Cell Lung Cancer Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Kansas Kansas City Cancer Centers Overland Park, Kansas, United States, 66210 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, North Carolina Cancer Care of Western North Carolina Asheville, North Carolina, United States, 28801 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 Mid Ohio Oncology/Hematology, Inc./ The Mark H. Zangmeister Center Columbus, Ohio, United States, 43219 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Family Cancer Center Collierville, Tennessee, United States, 38017 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Texas Coastal Bend Cancer Center Corpus Christi, Texas, United States, 78463 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT00609934 Renal Cell Carcinoma Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hosptial Toronto, Ontario, Canada, M5G2M9 Less <<
NCT01231399 Adenocarcinoma of the Esophagu... More >>s Adenocarcinoma of the Gastroesophageal Junction Diffuse Adenocarcinoma of the Stomach Intestinal Adenocarcinoma of the Stomach Mixed Adenocarcinoma of the Stomach Recurrent Esophageal Cancer Recurrent Gastric Cancer Stage IV Esophageal Cancer Stage IV Gastric Cancer Less << Phase 1 Phase 2 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 South Pasadena Cancer Center South Pasadena, California, United States, 91030 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01229111 - Terminated(Lack of Drug Supply... More >>) Less << - -
NCT01231399 - Completed - -
NCT00609804 - Completed - -
NCT01235416 Histologically or Cytologicall... More >>y Documented Solid Tumors Less << Phase 1 Completed - -
NCT01230697 - Unknown September 2011 Italy ... More >> Alfredo Berruti Recruiting Orbassano (To), Turin, Italy, 10043 Contact: Elisa Bellini, MD    (+39) 011 9026 ext 526    elisa.bellini3@tin.it    Principal Investigator: Alfredo Berruti, PHD          Sub-Investigator: Isabella Chiappino, MD          Sub-Investigator: Cinzia Ortega, MD          Sub-Investigator: Mario Pirisi, PHD          Sub-Investigator: Antonino Picciotto, PHD          Sub-Investigator: Camillo Porta, MD          Sub-Investigator: Anna Pia, MD          Sub-Investigator: Elena Bianco, MD Less <<
NCT00618982 Carcinoma, Renal Cell Phase 2 Completed - France ... More >> Bordeaux, France, 33000 La Roche Sur Yon, France, 85925 Marseille, France, 13385 Nantes, France, 44805 Paris Cedex 10, France, 75475 Tours, France, 37044 Germany Tübingen, Baden-Württemberg, Germany, 72076 Marburg, Hessen, Germany, 35043 Hannover, Niedersachsen, Germany, 30625 Mainz, Rheinland-Pfalz, Germany, 55131 Jena, Thüringen, Germany, 07740 Italy Aviano, Pordenone, Italy, 33081 Milano, Italy, 20133 Pavia, Italy, 27100 Poland Olsztyn, Poland, 10-226 Warszawa, Poland, 02-781 Warszawa, Poland, 04-141 Wroclaw, Poland, 50 - 556 United Kingdom Greater Manchester, Manchester, United Kingdom, M20 4BX Cardiff, South Glamorgan, United Kingdom, CF14 7TB Glasgow, United Kingdom, G12 0YN London, United Kingdom, SW3 6JJ Less <<
NCT01234337 - Completed - -
NCT01237041 Obesity Short... More >> Stature Growth Hormone Deficiency Less << Phase 1 Phase 2 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00618384 Hepatocellular Carcinoma Phase 2 Terminated - Germany ... More >> Universitätsklinikum Tübingen Innere Medizin I Tübingen, BW, Germany, 72076 Medizinische Universitätsklinik Ulm Innere Medizin I Ulm, BW, Germany, 89081 Klinikum der Universität Großhardern Muenchen, BY, Germany, 81377 Klinikum der Johann-Goethe-Universität Frankfurt, HE, Germany, 60590 Universitätsklinikum Hamburg-Eppendorf Zentrum für Innere Medizin Hamburg, HH, Germany, 20246 Johannes-Gutenberg-Universität Medizinische Klinik Mainz, RP, Germany, 55131 Less <<
NCT00619242 Esophageal Cancer Not Applicable Terminated(Low accrual) - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00618982 - Completed - -
NCT01238965 Recurrent Colon Cancer ... More >> Recurrent Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Less << Phase 1 Terminated(Adverse Events) - United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT00622479 Carcinoma, Renal Cell Phase 1 Terminated - United States, Arizona ... More >> Scottsdale, Arizona, United States, 85259 United States, Florida Jacksonville, Florida, United States, 32224 United States, Illinois Maywood, Illinois, United States, 60153 United States, Michigan Detroit, Michigan, United States, 48201 United States, Minnesota Rochester, Minnesota, United States, 55905 United States, New Jersey Hackensack, New Jersey, United States, 07601 United States, New York Stony Brook, New York, United States, 11794-944 Less <<
NCT01234337 Breast Cancer Phase 3 Completed - -
NCT00619242 - Terminated(Low accrual) - -
NCT00625378 Neoplasms Phase 3 Active, not recruiting June 30, 2020 -
NCT01245582 Hepatic Neoplasm Malignant Phase 3 Withdrawn August 2015 -
NCT00627835 Locally Advanced Squamous Cell... More >> Carcinomas of the Head and Neck (SCCHN) Less << Phase 1 Withdrawn(Site decided not to ... More >>open this study) Less << - Canada, British Columbia ... More >> BC Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 Less <<
NCT01253187 Contraception Phase 1 Completed - Netherlands ... More >> Dinox B.V. Groningen, Netherlands, 9713GZ Less <<
NCT01253174 Contraception Phase 1 Completed - Germany ... More >> Scope International Hamburg, Germany, 22525 Less <<
NCT01052311 Coronary Artery Disease ... More >> Dyslipidemia Less << Phase 4 Terminated(The sponsor decided... More >> to withdraw study drug from market) Less << - Israel ... More >> Leviev Heart Center, Sheba Medical Center Tel Hashomer, Israel, 52621 Less <<
NCT01253187 - Completed - -
NCT01263483 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT01263483 - Completed - -
NCT01253174 - Completed - -
NCT01263509 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT01056497 Type 2 Diabetes ... More >> Prediabetes Less << Phase 4 Completed - Canada, Ontario ... More >> Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT00635791 Malignant Solid Tumour ... More >> Renal Cell Carcinoma Non Small Cell Lung Carcinoma Less << Phase 1 Completed - United States, Colorado ... More >> University of Colorado Cancer Center Aurora, Colorado, United States, 80045 Less <<
NCT01263951 Differentiated Thyroid Cancer Phase 2 Active, not recruiting - United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00639262 Brain Metastases ... More >> Primary Brain Tumors Less << Phase 1 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01266187 Liver Metastasis Not Applicable Terminated(Recruitment difficu... More >>lities) Less << - Germany ... More >> Department of Surgery, University Hospital Aachen Aachen, NRW, Germany, 52074 Less <<
NCT01270438 Adenocarcinoma of the Colon ... More >> Adenocarcinoma of the Rectum Recurrent Colon Cancer Recurrent Rectal Cancer Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer Less << Phase 2 Withdrawn - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00661180 Chronic Myelogenous Leukemia Phase 2 Completed - United States, Oregon ... More >> Portland, Oregon, United States, 97239 France Lyon Cedex, France, 69437 Paris, France, 75010 Poitiers Cedex, France, 86021 Less <<
NCT01272557 Liver Carcinoma Phase 2 Unknown December 2014 Germany ... More >> Medizinische Klinik und Poliklinik, Heinrich-Heine-Universität Düsseldorf, Germany, 40225 Martin-Luther-University Halle-Wittenberg Halle (Saale), Germany, D-06099 Universitätsklinikum des Saarlande Homburg/Saar, Germany, 66421 Ortenau Klinikum Lahr-Ettenheim Lahr, Germany, 77933 Universitätsklinikum Leipzig Leipzig, Germany, 04013 Klinikum Ludwigsburg Ludwigsburg, Germany, 71640 Less <<
NCT01275300 Healthy Volunteer Phase 4 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Hospital Phila., Pennsylvania, United States, 19104 Less <<
NCT00663741 Gastric Cancer Phase 1 Completed - Japan ... More >> Kashiwa, Chiba, Japan, 277-8577 Kobe, Hyogo, Japan, 650-0017 Chuo-ku, Tokyo, Japan, 104-0045 Less <<
NCT01263509 - Completed - -
NCT01071291 Dyslipidemia Phase 1 Completed - -
NCT00661375 Carcinoma, Renal Cell Phase 2 Completed - -
NCT01071525 Hypercholesterolemia Phase 3 Unknown October 2010 Israel ... More >> Rambam Health Care Campus Not yet recruiting Haifa, Israel, 31096 Contact: Shadi    +972-523591876    s_hamoud@rambam.health.gov.il    Contact: Tony Hayek, Prof    +972-523782009    t_hayek@rambam.health.gov.il    Sub-Investigator: Tony Hayek, Prof Less <<
NCT01286818 Colorectal Carcinoma Phase 1 Completed - Japan ... More >> ImClone Investigational Site Chiba, Japan, 277-8577 ImClone Investigational Site Osaka, Japan, 569-8686 ImClone Investigational Site Shizuoka, Japan, 411-8777 Less <<
NCT00657254 Neoplasm Meta... More >>stasis Less << Phase 2 Completed - United States, Massachusetts ... More >> Boston, Massachusetts, United States, 02115-6084 Belgium Bruxelles - Brussel, Belgium, 1000 Canada, Ontario Hamilton, Ontario, Canada, L8V 5C2 Toronto, Ontario, Canada, M5G 2M9 Germany Essen, Nordrhein-Westfalen, Germany, 45147 Herne, Nordrhein-Westfalen, Germany, 44625 Less <<
NCT01287221 - Terminated(DSMB recommended st... More >>opping the study after an interim analysis of the primary endpoint revealed that futility criteria were met.) Less << - -
NCT01290926 Colorectal Cancer Phase 2 Completed - Belgium ... More >> Cliniques Universitaires Saint Luc Woluwe Saint Lambert, Bruxelles, Belgium, 1200 Universiteit Ziekenhuis Antwerpen Antwerpen, Belgium Institut Jules Bordet Brussels, Belgium, 1000 Hopital Erasme Brussels, Belgium, 1070 Entité Jolimontoise La Louviere, Belgium Hopitaux St Joseph Liege, Belgium, 4000 CHU Ambroise Paré Mons, Belgium, 7000 Less <<
NCT01294683 Primary Hypercholesterolemia ... More >> Dyslipidemia Less << Phase 3 Terminated - -
NCT00676156 Multiple Sclerosis Phase 1 Completed - United States, Oregon ... More >> Oregon Health and Science University Multiple Sclerosis Dept. Portland, Oregon, United States, 97239 Less <<
NCT01295450 Lack of Appetite ... More >> Anorexia Less << Phase 3 Unknown August 2011 Brazil ... More >> ABC School of Medicine Not yet recruiting Sao Paulo, Brazil, 09060-650 Contact: Adriana P Albuquerque, Coordenator    55 (11) 4438-3558    adrianaalbuquerque@fmabc.br    Principal Investigator: Anete S Grumach, Physician Less <<
NCT01286818 - Completed - -
NCT00692770 Carcinoma, Hepatocellular Phase 3 Completed - -
NCT01309698 Type 2 Diabetes Phase 4 Completed - Japan ... More >> Novartis Investigative Site Tokyo, Japan Less <<
NCT01287221 Multiple System Atrophy Phase 3 Terminated(DSMB recommended st... More >>opping the study after an interim analysis of the primary endpoint revealed that futility criteria were met.) Less << - United States, California ... More >> UCLA Medical Center Los Angeles, California, United States, 90095 University of California, San Diego San Diego, California, United States, 92103 United States, Florida Mayo Clinic Jacksonville, Florida, United States, 32224 University of South Florida Tampa, Florida, United States, 33606 United States, Massachusetts Harvard Medical School Boston, Massachusetts, United States, 02215 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New York New York University New York, New York, United States, 10016 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT00157729 Diabetes Mellitus Type 2 ... More >> Hypertension Metabolic Syndrome Less << Phase 2 Completed - Canada, Quebec ... More >> Centre Hospitalier Université Laval Sainte-Foy, Quebec, Canada, G1V 4G2 Less <<
NCT01294683 - Terminated - -
NCT01288339 Metastatic Colorectal Cancer Phase 2 Completed - Spain ... More >> Hospital General Universitario de Elche Elche, Alicante, Spain, 03203 Hosptial General de l'Hospitalet de Barcelona Hospitalet de Llobregat, Barcelona, Spain, 08906 Corporació Sanitaria Parc Taulí de Barcelona Sabadell, Barcelona, Spain, 08208 Hospital de l'Esperit Sant Santa Coloma De Gramenet, Barcelona, Spain, 08923 Consorcio Hospitalario Provincial de Castellon Castellón De La Plana, Castellon, Spain, 12002 Hospital Son Espases de Mallorca Palma De Mallorca, Illes Balears, Spain, 07010 Hosptial Son Llatzer de Mallorca Palma De Mallorca, Illes Balears, Spain, 07198 Hosptial de Logroño Logroño, La Rioja, Spain, 26006 Hospital Universitario La Paz de Madrid Madrid, Madrdi, Spain, 28046 Clínica Universitaria de Navarra Pamplona, Navarra, Spain, 31008 Hospital de Navarra Pamplona, Navarra, Spain, 31008 Hospital Xeral Cies de Vigo Vigo, Pontevedra, Spain, 36204 Hospital Clínic i Provincial de Barcelona Barcelona, Spain, 08036 Hospital de la Santa Creu i Sant Pau de Barcelona Barcelona, Spain, 08041 Complejo Asitencia de Burgos. Hospital General Yague Burgos, Spain, 09005 Hospital General de Ciudad Real Ciudad Real, Spain, 13005 Institut Català d'Oncologia (ICO) de Girona Girona, Spain, 17007 Centro Oncológico de Galícia La Coruña, Spain, 15009 Hosptial Dr. Negrin de Las Palmas de Gran Canaria Las Palmas de Gran Canaria, Spain, 35010 Hospital Arnau de Vilanova de Lleida Lleida, Spain, 25198 Hospital Infanta Sofía de Madrid Madrid, Spain, 28072 Hospital Universitario Puerta de Hierro de Madrid Madrid, Spain, 28222 Hospital de Fuenlabrada de Madrid Madrid, Spain, 28942 Hospital Morales Meseguer Murcia, Spain, 30008 Hosptial de Sant Pau i Santa Tecla de Tarragona Tarragona, Spain, 43003 Hospital La Fe de Valencia Valencia, Spain, 46009 Instituto Valenciano de Oncología de Valencia Valencia, Spain, 46009 Hospital General de Valencia Valencia, Spain, 46014 Hospital Dr. Peset de Valencia Valencia, Spain, 46017 Hospital Miguel Servet de Zaragoza Zaragoza, Spain, 50009 Less <<
NCT01313117 - Completed - -
NCT01104519 Dyslipidemia Phase 1 Completed - -
NCT01102673 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Less << Phase 1 Completed - United States, Connecticut ... More >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Less <<
NCT00692770 - Completed - -
NCT01313117 Peripheral Neuropathy Phase 1 Phase 2 Completed - United States, Illinois ... More >> Northwestern Medical Faculty Foundation Chicago, Illinois, United States, 60611 Less <<
NCT00699374 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01320111 Metastatic Breast Cancer Phase 2 Completed - Germany ... More >> Germany Multiple Sites All Over Germany Recruiting Multiple Sites, Germany Contact: iOMEDICO AG Freiburg, Germany, 79108 Less <<
NCT00212030 Acute Myocardial Infarction Not Applicable Completed - Japan ... More >> National Cardiovascular Center Suita, Osaka, Japan, 565-8565 Less <<
NCT00699374 Carcinoma, Hepatocellular Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00703989 Type 1 Diabetes Not Applicable Completed - United States, New York ... More >> GCRC, Albert Einstein College of Medicine Bronx, New York, United States, 10461 Less <<
NCT01320683 Liver Metastases ... More >> Recurrent Colon Cancer Recurrent Rectal Cancer Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer Less << Phase 2 Terminated(Slow accrual.) - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT00712790 Hepatocellular Carcinoma Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seoul, Korea, Republic of Malaysia Selayang Hospital Selangor, Malaysia Myanmar Yangon GI & Liver Centre Yangon, Myanmar Singapore Singapore General Hospital Singapore, Singapore, 169608 National Cancer Centre Singapore, Singapore, 169610 Less <<
NCT01324076 Liver Cancer Phase 3 Unknown - United Kingdom ... More >> Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Recruiting Birmingham, England, United Kingdom, B15 2TH Contact: Contact Person    44-121-472-1311       Bristol Royal Infirmary Recruiting Bristol, England, United Kingdom, BS2 8HW Contact: Contact Person    44-117-923-0000       Aintree University Hospital Recruiting Liverpool, England, United Kingdom, L9 7AL Contact: Contact Person    44-151-525-5980       Royal Free Hospital Recruiting London, England, United Kingdom, NW3 2QG Contact: Contact Person    44-20-7794-0500       King's College Hospital Recruiting London, England, United Kingdom, SE5 9RS Contact: Contact Person    44-20-3299-9000       Royal Marsden - London Recruiting London, England, United Kingdom, SW3 6JJ Contact: Contact Person    44-20-7352-8171       Queen's Medical Centre Recruiting Nottingham, England, United Kingdom, NG7 2UH Contact: Contact Person    44-115-924-9924       Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Contact Person    44-23-8079-8751 Less <<
NCT00712855 Hepatocellular Carcinoma Phase 1 Completed - United States, California ... More >> Cedars-Sinai Health System Los Angeles, California, United States, 90048 United States, Colorado University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, Florida University of Florida Gainesville, Florida, United States, 32610 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania University of Pennsylvania- Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01331902 Coronary Artery Disease ... More >> Myocardial Ischemia Less << Phase 4 Unknown September 2011 Korea, Republic of ... More >> Cardiovascular Center, Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Ho-Jun Jang, MD    82-2-2072-3757    wingal@naver.com    Contact: Bon-Kwon Koo, MD.PhD    82-2-2072-2062    bkkoo@snu.ac.kr Less <<
NCT01320683 - Terminated(Slow accrual.) - -
NCT01115127 Pre-menopausal Irregular Cycle... More >>s and Bleedings Less << Phase 2 Phase 3 Completed - Italy ... More >> University Hospital Messina, Italy, 98100 Less <<
NCT01331655 Contraception Phase 3 Withdrawn November 2014 -
NCT01122355 Hypertriglyceridemia With Low ... More >>HDL-cholesterol Less << Phase 4 Completed - -
NCT01335997 Primary Hypercholesterolemia ... More >> Mixed Dyslipidemia Less << Phase 3 Terminated(Business Reasons) - -
NCT01333033 Adenocarcinoma of the Gastroes... More >>ophageal Junction Esophageal Cancer Less << Phase 2 Active, not recruiting - -
NCT01336738 Diabetes, Type 2 Phase 2 Completed - -
NCT01335997 - Terminated(Business Reasons) - -
NCT01338870 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00719706 Bipolar Depression Phase 2 Completed - United States, Massachusetts ... More >> McLean Hospital Belmont, Massachusetts, United States, 02478 Less <<
NCT01336738 - Completed - -
NCT00722072 - Terminated(Sponsor pulled fund... More >>ing and low accrual) Less << - -
NCT01338870 - Completed - -
NCT00722072 Breast Cancer Phase 2 Terminated(Sponsor pulled fund... More >>ing and low accrual) Less << - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT00726986 Lung Cancer Phase 2 Terminated(Extreme toxicity) - United States, New York ... More >> Columbia Presbyterian New York, New York, United States, 10032 United States, Ohio Lake/University Ireland Cancer Center Cleveland, Ohio, United States, 44060 Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 MetroHealth Medical Center Cleveland, Ohio, United States, 44109 CCF-Fairview Hospital Cleveland, Ohio, United States, 44111 UHHS Chagrin Highlands Medical Center Cleveland, Ohio, United States, 44122 Southwest General Health Center Cleveland, Ohio, United States, 44130 UHHS Westlake Medical Center Cleveland, Ohio, United States, 44145 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 UH-Monarch Mayfield Heights, Ohio, United States, 44124 UH-Firelands Sandusky, Ohio, United States, 44870 Less <<
NCT00719706 - Completed - -
NCT01129258 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Less << Phase 1 Completed - United States, California ... More >> Pfizer Investigational Site Chula Vista, California, United States, 91911 Pfizer Investigational Site Fountain Valley, California, United States, 92708 United States, Florida Pfizer Investigational Site Miami, Florida, United States, 33169 United States, Texas Pfizer Investigational Site San Antonio, Texas, United States, 78229 Less <<
NCT00722969 Non-Small Cell Lung Cancer Phase 2 Unknown April 2009 Netherlands ... More >> VU university medical center Amsterdam, Netherlands, 1007 MB Netherlands Cancer Institute Amsterdam, Netherlands University Medical Center Groningen Groningen, Netherlands University Hospital Maastricht Maastricht, Netherlands Less <<
NCT01348503 Hepatocellular Carcinoma Phase 1 Terminated(Treatment was ineff... More >>ective) Less << - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00726986 - Terminated(Extreme toxicity) - -
NCT00732914 Renal Cell Carcinoma Phase 3 Completed - Germany ... More >> Urologische Klinik Mannheim, Baden-Wuerttemberg, Germany, 68167 Less <<
NCT00734526 Glioblastoma ... More >>Gliosarcoma Less << Phase 1 Terminated - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01356043 Healthy Male Volunteers Phase 1 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT01364376 Stomach Neoplasms Not Applicable Completed - China, Shandong ... More >> Qilu Hospital of Shandong University Jinan, Shandong, China Shandong Provincial Hospital Jinan, Shandong, China China, Zhejiang Sir Run Run Shaw Hospital Hangzhou, Zhejiang, China The First Affiliated Hospital of Medical School of Zhejiang University Hangzhou, Zhejiang, China The Second Affiliated Hospital of Medical School of Zhejiang University Hangzhou, Zhejiang, China Jiaxing First Hospital Jiaxing, Zhejiang, China Ningbo Medical Treatment Center Lihuili Hospital Ningbo, Zhejiang, China The second affiliated hospital of Wenzhou medical college Wenzhou, Zhejiang, China Less <<
NCT00727532 Hereditary Clear Cell Renal Ce... More >>ll Carcinoma Kidney Cancer Less << Not Applicable Terminated(Low Accrual) June 2015 United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT01159054 Dialysis Card... More >>iovascular Disease Atherosclerosis Inflammation Less << Not Applicable Terminated(The funding source ... More >>is not going to fund this anymore. Only two subjects completed the study therefore meaningful analysis not possible.) Less << - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 BWH/FH/DCI Outpatient Dialysis Unit Boston, Massachusetts, United States, 02130 DCI Dialysis Unit-Somerville Somerville, Massachusetts, United States Less <<
NCT01368328 Type 2 Diabetes Phase 3 Unknown September 2011 Brazil ... More >> Goiania Municipal Health Departament Goiânia, Goiás, Brazil, 74000000 Less <<
NCT01370343 Healthy Drug ... More >>Interaction Less << Phase 1 Completed - Belgium ... More >> Pfizer Investigational Site Bruxelles, Belgium, B-1070 Less <<
NCT00754923 - Terminated - -
NCT01376453 Rectal Cancer Phase 1 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01159054 - Terminated(The funding source ... More >>is not going to fund this anymore. Only two subjects completed the study therefore meaningful analysis not possible.) Less << - -
NCT01143337 Rheumatoid Arthritis Phase 2 Completed - Japan ... More >> Investigational site Osaka, Japan Less <<
NCT01143337 - Completed - -
NCT00754923 Lung Cancer Phase 2 Terminated - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210-1240 Less <<
NCT00972660 Graft Versus Host Disease Phase 2 Unknown December 2017 China, Guangdong ... More >> Guangdong General Hospital Guangzhou, Guangdong, China, 510080 Less <<
NCT01158885 Minimal Residual Disease ... More >> Leukemia, Lymphoblastic, Acute Leukemia, Myelogenous, Acute Less << Phase 2 Terminated(Study terminated fo... More >>r lack of accrual.) Less << - -
NCT01162421 Rheumatoid Arthritis Phase 4 Completed - -
NCT01160744 - Completed - -
NCT01163747 Rheumatoid Arthritis Phase 4 Completed - -
NCT01160744 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - -
NCT01162551 Cancer Leukem... More >>ia Lymphoma Less << Phase 2 Completed - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01163747 - Completed - -
NCT01156883 Leukemia Not Applicable Completed - Italy ... More >> Complesso Ospedaliero S. Giovanni Addolorata Roma, (rm), Italy, 00184 Azienda Ospedaliera - Nuovo Ospedale "Torrette" Ancona, Italy USL 8 - Ospedale S.Donato Arezzo, Italy Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni" Ascoli, Italy Az.Ospedaliera S.G.Moscati Avellino, Italy UO Ematologia con trapianto- AOU Policlinico Consorziale di Bari Bari, Italy Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy Divisione di Ematologia Ospedale A. Perrino Brindisi, Italy Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Catania, Italy Azienda Ospedaliera Pugliese Ciaccio - Presidio Ospedaliero A.Pugliese - Unità Operativa di Ematologia Catanzaro, Italy Sezione di Ematologia e Fisiopatologia delle Emostasi - Azienda Ospedaliera - Arcispedale S. Anna Ferrara, Italy Divisione Ematologia 1 - Azienda Ospedaliera Universitaria "San Martino" Genova, Italy ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE Lecce, Italy Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte" Messina, Italy Ospedale Niguarda " Ca Granda" Milano, Italy Centro Oncologico Modenese - Dipartimento di Oncoematologia Modena, Italy Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli" Napoli, Italy UOSC di Ematologia Oncologica - Istituto Nazionale Tumori "Fondazione Senatore Giovanni Pascale" Napoli, Italy zienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia Napoli, Italy Inferiore U.O. Medicina Interna Ematologia ed Oncologia P.O. Umberto I Nocera Inferiore, Italy S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro Novara, Italy Divisione di Ematologia con trapianto di midollo - A.U. Policlinico "Paolo Giaccone" Palermo, Italy Ospedali Riuniti "Villa Sofia-Cervello" Palermo, Italy Cattedra di Ematologia CTMO Università degli Studi di Parma Parma, Italy S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo Pavia, Italy U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy Università di Pisa - Azienda Ospedaliera Pisana - Dipartimento di Oncologia, dei Trapianti e delle nuove Tecnologie in Medicina - Divisione di Ematologia Pisa, Italy Dipartimento Oncologico - Ospedale S.Maria delle Croci Ravenna, Italy Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli" Reggio Calabria, Italy Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova Reggio Emilia, Italy Az. Ospedaliera "Sant' Andrea"-Università la Sapienza Seconda Facoltà di Medicina e Chirurgia Roma, Italy Divisione di Ematologia - Ospedale S. Camillo Divisione di Ematologia - Ospedale S. Camillo Roma, Italy Divisione Ematologia - Università Campus Bio-Medico Roma, Italy S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena Roma, Italy U.O.C. Ematologia - Ospedale S.Eugenio Roma, Italy Università Cattolica del Sacro Cuore - Policlinico A. Gemelli Roma, Italy Università degli Studi - Policlinico di Tor Vergata Roma, Italy Universita Degli Studi "La Sapeinza" Rome, Italy, 00161 Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza S. G. Rotondo, Italy Serv. di Ematologia Ist. di Ematologia ed Endocrinologia Sassari, Italy Struttura Complessa Ematologia - Azienda Sanitaria Locale BAT1- Presidio Ospedaliero Bisceglie-Trani Trani, Italy Clinica Ematologica - Policlinico Universitario Udine, Italy Università degli Studi di Verona - A. O. - Istituti Ospitalieri di Verona- Div. di Ematologia - Policlinico G.B. Rossi Verona, Italy Less <<
NCT01172470 Head and Neck Cancer Phase 2 Completed - United States, Illinois ... More >> The University of Chicago Medical Center Chicago, Illinois, United States, 60653 Less <<
NCT01172639 Rheumatoid Arthritis Phase 4 Completed - Belgium ... More >> ASZ Aalst, Belgium, 9300 OLV Ziekenhuis Aalst, Belgium, 9300 Imelda Ziekenhuis Bonheiden, Belgium, 2820 AZ St Lucas Brugge, Belgium, 8310 Reuma praktijk Genk, Belgium, 3600 Reumacentrum Genk, Belgium, 3600 UZ Gent, dept. of Rheumatology Gent, Belgium, 9000 Reuma instituut Hasselt Hasselt, Belgium, 3500 Reumapraktijk Hasselt, Belgium, 3500 Jan Yperman Ziekenhuis Ieper, Belgium, 8900 AZ groeninge Kortrijk, Belgium, 8500 HHart Ziekenhuis Leuven, Belgium, 3000 MCH Leuven, Belgium, 3000 Universitaire Ziekenhuizen Leuven Leuven, Belgium, 3000 AZ St maarten Mechelen, Belgium, 2800 ZNA Jan Palfijn Merksem, Belgium, 2170 Henri Serruys ziekenhuis Oostende, Belgium, 8400 Less <<
NCT01164579 Rheumatoid Arthritis Phase 2 Completed - -
NCT01162421 - Completed - -
NCT01164579 - Completed - -
NCT01172028 Breast Cancer ... More >> Esophageal Cancer Gastric Cancer Head and Neck Cancer Lung Cancer Ovarian Cancer Prostate Cancer Less << Phase 1 Completed - United States, Arizona ... More >> Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724-5024 Less <<
NCT01175772 Ovarian Carcinoma Phase 2 Terminated(Due to change in th... More >>e national policy of medications) Less << - Israel ... More >> HaEmek Medical Center Afula, Israel, 18101 Less <<
NCT01172639 - Completed - -
NCT01177371 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With T(15;17)(q22;q12) Adult Acute Myeloid Leukemia With T(16;16)(p13;q22) Adult Acute Myeloid Leukemia With T(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Acute Promyelocytic Leukemia (M3) Adult Erythroleukemia (M6a) Adult Nasal Type Extranodal NK/T-cell Lymphoma Adult Pure Erythroid Leukemia (M6b) Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Burkitt Lymphoma Childhood Acute Erythroleukemia (M6) Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myeloid Leukemia in Remission Childhood Acute Myelomonocytic Leukemia (M4) Childhood Acute Promyelocytic Leukemia (M3) Childhood Chronic Myelogenous Leukemia Childhood Myelodysplastic Syndromes Chronic Phase Chronic Myelogenous Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma De Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Peripheral T-Cell Lymphoma Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult Non-Hodgkin Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Secondary Myelodysplastic Syndromes Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Testicular Lymphoma Waldenstrom Macroglobulinemia Less << Phase 2 Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Less <<
NCT01229761 HIV Infections ... More >> Neutropenia Anemia Less << Phase 2 Active, not recruiting October 2018 Botswana ... More >> Princess Marina Hospital Gaborone, Botswana Athlone Hospital Lobatse, Botswana Scottish Livingstone Hospital Molepolole, Botswana Less <<
NCT01181271 Diffuse, Large B-Cell, Lymphom... More >>a Lymphoma, Low-Grade T-Cell Lymphoma Mantle-Cell Lymphoma Hodgkin's Lymphoma Chronic Lymphocytic Leukemia Lymphoma, Small Lymphocytic Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01231334 Acne Vulgaris Phase 4 Completed - United States, Florida ... More >> Miramar, Florida, United States Less <<
NCT01185288 Rheumatoid Arthritis Phase 4 Completed - -
NCT01231334 - Completed - -
NCT01176981 Osteosarcoma Phase 3 Completed - Canada, Ontario ... More >> The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT00526799 Ovarian Cancer Phase 1 Phase 2 Terminated(Study closed to acc... More >>rual due unfavorable interim analysis) Less << - United States, Illinois ... More >> Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 St. Vincent Hospital Cynecologic Oncology Indianapolis, Indiana, United States, 46260 Arnett Cancer Care Lafayette, Indiana, United States, 47904 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 United States, New York Schwartz Gynecologic Oncology, PLLC Brightwaters, New York, United States, 11718 Less <<
NCT01185301 Early Rheumatoid Arthritis Phase 3 Completed - -
NCT01181271 - Completed - -
NCT00942266 - Completed - -
NCT00941863 - Completed - -
NCT00942266 Adenocarcinoma of the Colon ... More >> Adenocarcinoma of the Rectum Recurrent Colon Cancer Recurrent Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Less << Phase 2 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT01185288 - Completed - -
NCT00941967 Liver Cancer Phase 2 Unknown - France ... More >> Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Recruiting Montpellier, France, 34295 Contact: Eric Assenat, MD    33-4-6761-2593 Less <<
NCT00743366 Marijuana Smoking Phase 2 Completed - United States, New York ... More >> New York State Psychiatric Institute New York, New York, United States, 10032 Less <<
NCT00743366 - Completed - -
NCT00943124 Dyslipidemia Phase 1 Completed - -
NCT00949182 Liver Cancer Phase 2 Completed - United States, New Jersey ... More >> Rutgers University Hospital Newark, New Jersey, United States, 07101 Less <<
NCT00955721 Cholangiocarcinoma ... More >> Biliary Tract Cancer Gallbladder Cancer Less << Phase 1 Phase 2 Terminated(Lack of Funding) - United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 Less <<
NCT00955721 - Terminated(Lack of Funding) - -
NCT00941863 Carcinoma Phase 1 Completed - United States, Pennsylvania ... More >> Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Nashville, Tennessee, United States, 37232 United States, Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT00943124 - Completed - -
NCT00398892 Diabetes Mellitus, Type 2 Phase 2 Unknown January 2011 United Kingdom ... More >> Diabetes Department, St John's Hospital Recruiting Livingston, Scotland, United Kingdom, EH54 6PP Principal Investigator: James D Walker, MD Less <<
NCT00954135 Breast Cancer Phase 2 Unknown December 2010 Italy ... More >> Breast Unit Azienda Ospedaliera Istituti Ospitalieri Cremona, Italy Azienda Ospedaliera S.Luigi Orbassano Orbassano, Italy Less <<
NCT00398814 Renal Cancer ... More >>Tumors Less << Phase 1 Completed - -
NCT00713609 Acne Vulgaris Phase 2 Completed - United States, Arkansas ... More >> Dermatology Research of Arkansas Little Rock, Arkansas, United States, 72205 United States, California Center for Dermatology Cosmetic and Laser Surgery Fremont, California, United States, 94538 Center for Dermatology and Laser Surgery Sacramento, California, United States, 95819 United States, Colorado Boulder Medical Center, P.C. Boulder, Colorado, United States, 80304 United States, Florida Dermatology Associates Research Coral Gables, Florida, United States, 33134 United States, Georgia MedaPhase, Inc. Newnan, Georgia, United States, 30263 United States, Maryland Callender Center for Clinical Research Mitchellville, Maryland, United States, 20721 United States, Michigan Grekin Skin Institute Warren, Michigan, United States, 48088 United States, North Carolina University of North Carolina Chapel Hill Chapel Hill, North Carolina, United States, 27599 Dermatology Consulting Services High Point, North Carolina, United States, 27262 United States, Pennsylvania MS Hershey Medical Center Hershey, Pennsylvania, United States, 17033 United States, Tennessee Rivergate Dermatology & Skin Care Center Goodlettsville, Tennessee, United States, 37072 The Skin Wellness Center, PC Knoxville, Tennessee, United States, 37922 United States, Texas Dermatology Treatment & Research Center Dallas, Texas, United States, 75230 Suzanne Bruce and Associates, PA Houston, Texas, United States, 77056 Dermatology Clinical Research Center of San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT00956436 Hepatocellular Carcinoma Phase 1 Completed - United States, Colorado ... More >> Resesarch Site Denver, Colorado, United States United States, Florida Resesarch Site Ocoee, Florida, United States United States, Indiana Resesarch Site Indianapolis, Indiana, United States United States, Massachusetts Resesarch Site Boston, Massachusetts, United States United States, New York Resesarch Site New York, New York, United States United States, Virginia Resesarch Site Norfolk, Virginia, United States Singapore Resesarch Site Singapore, Singapore Taiwan Resesarch Site Tainan, Taiwan Resesarch Site Taipei, Taiwan Resesarch Site Tao-Yuan, Taiwan United Kingdom Resesarch Site Edgbaston, Birmingham, United Kingdom Less <<
NCT00714948 Bladder Cancer ... More >> URINARY BLADDER Less << Phase 2 Terminated(Lack of accrual) - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00714948 - Terminated(Lack of accrual) - -
NCT00715273 Coronary Artery Disease ... More >> Carotid Artery Diseases Atherosclerosis Less << Phase 4 Active, not recruiting February 2019 United States, California ... More >> University of Southern California Los Angeles, California, United States, 90089 United States, Idaho St. Luke's Idaho Cardiology Boise, Idaho, United States, 83712 United States, Washington University of Washington Coronary Atherosclerosis Research Lab Seattle, Washington, United States, 98104 Yakima Heart Center Yakima, Washington, United States, 98902 Less <<
NCT00238121 - Completed - -
NCT00238212 Adenocarcinoma of the Extrahep... More >>atic Bile Duct Adenocarcinoma of the Gallbladder Adenocarcinoma With Squamous Metaplasia of the Gallbladder Cholangiocarcinoma of the Extrahepatic Bile Duct Cholangiocarcinoma of the Gallbladder Recurrent Extrahepatic Bile Duct Cancer Recurrent Gallbladder Cancer Squamous Cell Carcinoma of the Gallbladder Unresectable Extrahepatic Bile Duct Cancer Unresectable Gallbladder Cancer Less << Phase 2 Completed - United States, Texas ... More >> Southwest Oncology Group San Antonio, Texas, United States, 78245 Less <<
NCT00713609 - Completed - -
NCT00238121 Recurrent Uterine Sarcoma ... More >> Stage III Uterine Sarcoma Stage IV Uterine Sarcoma Uterine Carcinosarcoma Less << Phase 2 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 University of Southern California Los Angeles, California, United States, 90033-0804 United States, Illinois Decatur Memorial Hospital Decatur, Illinois, United States, 62526 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 60702 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston General Hospital Kingston, Ontario, Canada, K7L 5P9 University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00719797 Colorectal Cancer Phase 3 Completed - Italy ... More >> Ospedale Civile Ss. Antonio E Biagio Di Alessandria - Alessandria (Al) Oncologia Medica Alessandria, Italy, 15100 A.O. Universitaria Ospedali Riuniti - Ospedale Umberto I Di Ancona - Ancona (An) Oncologia Medica Ancona, Italy, 60100 P.O. Zona Aretina - Ospedale S. Donato Di Arezzo - Arezzo (Ar) Oncologia Medica Arezzo, Italy, 52100 Irccs Centro Di Riferimento Oncologico (Cro) - Aviano (Pn) Oncologia Medica Aviano, Italy, 33081 Ospedale S. Orsola F.B.F. - Brescia - Brescia (Bs) Oncologia Medica Brescia, Italy, 25122 Istituto Ospedaliero Fondazione Poliambulanza Di Brescia - Brescia (Bs) Oncologia Medica Brescia, Italy, 25124 Stabilimento "Perrino" - Brindisi - Brindisi (Br) Oncologia Medica Brindisi, Italy, 72100 Azienda Ospedaliera S. Elia - Caltanissetta (Cl) Oncologia Medica Caltanissetta, Italy, 93100 Ausl 1 Di Massa E Carrara - Carrara (Ms) Oncologia Medica Carrara, Italy, 54033 Ospedale Cecina - Cecina (Li) Oncologia Medica Cecina, Italy, 57023 Istituti Ospitalieri - Cremona - Cremona (Cr) Oncologia Medica Cremona, Italy, 26100 Azienda Ospedaliera S. Croce E Carle Di Cuneo - Cuneo (Cn) Oncoematologia Cuneo, Italy, 12100 Ausl 11 Di Empoli (Fi) - Empoli (Fi) Oncologia Medica Empoli, Italy, 50053 U.S.L.N.6 -Ospedale Civile 'E.Profili'-F - Fabriano (An) Oncologia Medica Fabriano, Italy, 60044 Ausl 10 Di Firenze - Firenze (Fi) Oncologia Medica Firenze, Italy, 50122 Irccs Istituto Nazionale Per La Ricerca Sul Cancro (Ist) - Genova (Ge) Oncologia Medica Genova, Italy, 16132 Ausl Le Di Lecce - Lecce (Le) Oncologia Medica Lecce, Italy, 73100 Aulss 21 Di Legnago (Vr) - Legnago (Vr) Oncologia Medica Legnano, Italy, 37045 Ausl 12 Di Viareggio (Lu) - Lido Di Camaiore (Lu) Oncologia Medica Lido di Camaiore, Italy, 55053 Ospedale Livorno - Livorno (Li), Oncologia Medica Livorno, Italy, 57100 Presidio Ospedaliero Piana Di Lucca - Lucca (Lu) Oncologia Medica Lucca, Italy, 25124 Irccs Fondazione Centro S. Raffaele Del Monte Tabor - Milano (Mi) Oncologia Medica Milano, Italy, 20132 Ospedale Ca` Granda-Niguarda - Milano - Milano (Mi) Oncologia Medica Milano, Italy, 20162 S.Gerardo - Monza - Monza (Mi) Oncologia Medica Monza, Italy, 20052 A.O. Universitaria Federico Ii Di Napoli Oncologia Medica Napoli, Italy, 80131 A.O. Universitaria Maggiore Della Carita' Di Novara Oncologia Medica Novara, Italy, 28100 A.O. Universitaria Di Parma Oncologia Medica Parma, Italy, 43100 Asl 1 Di Citta' Di Castello (Pg) - Citta' Di Castello (Pg) Oncologia Medica Perugia, Italy, 06012 A.O. Di Perugia - Ospedale S. Maria Della Misericordia (Ex Silvestrini) - Perugia (Pg) Oncologia Medica Perugia, Italy, 06156 Azienda Ospedaliera San Salvatore - Pesaro (Pu) Oncologia Medica Pesaro, Italy, 61100 Ospedale Della Valdinievole - Pescia (Pt) Oncologia Medica Pescia, Italy, 51017 Ospedale Piombino - Piombino (Li) Oncologia Medica Piombino, Italy, 57100 A.O. Universitaria Pisana Oncologia Medica Pisa, Italy, 56100 Ausl 5 Di Pisa - Pisa (Pi) Oncologia Medica Pisa, Italy, 56100 Alfredo Falcone A.O. Universitaria Pisana - Pisa (Pi) Oncologia Medica Pisa, Italy, 56126 Ausl 3 Di Pistoia - Pistoia (Pt) Oncologia Medica Pistoia, Italy, 51100 Ausl 4 Di Prato - Prato (Po) Oncologia Medica Prato, Italy, 59100 Ospedale Di S. Maria Nuova - Reggio Nell`Emilia (Re) Oncologia Medica Reggio Emilia, Italy, 42100 Policlinico Universitario Campus Bio-Medico Di Roma Oncologia Medica Rome, Italy, 00155 Policlinico Umberto I Di Roma Oncologia Medica Rome, Italy, 00161 Policlinico Universitario Gemelli Di Roma Oncologia Medica Rome, Italy, 00168 A.O. Universitaria Senese Oncologia Medica Siena, Italy, 53100 Ospedale Civile - Sondrio - Sondrio (So) Oncologia Medica Sondrio, Italy, 23100 A.O. Universitaria S. Giovanni Battista-Molinette Di Torino Oncologia Medica Torino, Italy, 10134 Less <<
NCT00724503 Colorectal Cancer ... More >> Colorectal Carcinoma Liver Metastases Less << Not Applicable Completed - -
NCT00712049 Dyslipidemia ... More >>Atherosclerosis Less << Phase 4 Unknown - Austria ... More >> Medical University Vienna Recruiting Vienna, Austria, 1090 Contact: Renate Koppensteiner, Prof. Dr.    00431404004671    renate.koppensteiner@meduniwien.ac.at    Sub-Investigator: Martin Schillinger, Prof. Dr.          Sub-Investigator: Jasmin Amighi, Dr.          Sub-Investigator: Schila Sabeti, Dr. Less <<
NCT00245102 Adult Angiosarcoma ... More >> Adult Epithelioid Sarcoma Adult Leiomyosarcoma Adult Malignant Fibrous Histiocytoma Adult Neurofibrosarcoma Adult Synovial Sarcoma Ovarian Sarcoma Recurrent Adult Soft Tissue Sarcoma Recurrent Uterine Sarcoma Stage III Adult Soft Tissue Sarcoma Stage III Uterine Sarcoma Stage IV Adult Soft Tissue Sarcoma Stage IV Uterine Sarcoma Uterine Carcinosarcoma Uterine Leiomyosarcoma Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00720512 Colorectal Cancer Phase 3 Terminated - Italy ... More >> Universita Politecnica Delle Marche Ancona, Italy, 60100 Azienda Usl 8 Arezzo Arezzo, Italy, 52100 Ospedale degli Infermi - ASL 12 Biella, Italy, 13900 A. Perrino Hospital Brindisi, Italy, 72100 Azienda Ospedaliera S. Elia Caltanissetta, Italy, 93100 Ospedale Santa Croce Cuneo, Italy, 12100 Ospedale San Giuseppe Empoli, Italy, 50053 Ospedale E. Profili Fabriano, Italy, 60044 Ospedale Civile S. Croce Fano, Italy, 61032 Azienda Ospedaliera di Firenze Florence, Italy, 50011 Azienda Ospedaliero Careggi Florence, Italy, 50139 Istituto Nazionale per la Ricerca sul Cancro Genoa, Italy, 16132 Ospendale S. Andrea EST La Spezia, Italy, 19100 Azienda Ospedaliera Vito Fazzi Lecce, Italy, 73100 Azienda USL12 Versilia Lido di Camaiore, Italy, 55043 Ospedale Campo Di Marte Lucca Lucca, Italy, 55100 Azienda Ospedaliera Maggiore Della Carita Novara, Italy, 28100 Azienda Ospedaliera Pisana Pisa, Italy, 56126 Arcispedale S. Maria Nuova Reggio Emilia, Italy, 42100 Azienda Ospedaliera Universitaria Senese Siena, Italy, 53100 Dipartimento Oncologico Siena, Italy, 53100 Less <<
NCT00245102 - Completed - -
NCT00728910 Dyslipidemia Phase 2 Completed - United States, Pennsylvania ... More >> CTRC (Clinical Translational Research Center) Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00533611 Flushing Phase 3 Completed - -
NCT00244972 Advanced Malignant Neoplasm Phase 1 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00533312 Hypercholesterolemia Phase 2 Completed - -
NCT00536510 Hypercholesterolemia ... More >> Hyperlipidemia Less << Phase 3 Completed - -
NCT00536237 Flushing Phase 2 Completed - -
NCT00536510 - Completed - -
NCT00253578 Refractory Multiple Myeloma Phase 2 Completed - United States, Texas ... More >> Southwest Oncology Group San Antonio, Texas, United States, 78245 Less <<
NCT00254267 Advanced Gastrointestinal Stro... More >>mal Tumor Less << Phase 2 Completed - -
NCT00255658 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Texas ... More >> Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT00259129 Neoplasms Phase 1 Completed - United States, Massachusetts ... More >> Boston, Massachusetts, United States, 02115 United States, Texas San Antonio, Texas, United States, 78229 Less <<
NCT00727922 Neurotoxic Disorders ... More >> Cancer Less << Phase 2 Completed - France ... More >> Cochin Paris, France, 75014 Less <<
NCT00752063 Advanced Hepatocellular Carcin... More >>oma Metastatic Hepatocellular Carcinoma Less << Phase 2 Unknown December 2008 China ... More >> Queen Mary Hospital Recruiting Hong Kong, China Contact: Ida Choi, MPhil    (852)28553635    cychoia@hkucc.hku.hk    Principal Investigator: Ronnie Poon, MD Less <<
NCT00265798 Gastrointestinal Stromal Tumor Phase 2 Active, not recruiting - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 Decatur Memorial Hospital Decatur, Illinois, United States, 62526 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 62702 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00265798 - Active, not recruiting - -
NCT00751205 Prostate Cancer ... More >> Ovarian Cancer Less << Phase 2 Completed - Belgium ... More >> Bruxelles - Brussel, Belgium, 1200 France Caen, France, 14076 Montpellier Cedex, France, 34298 Nantes, France, 44805 Paris, France, 75012 Villejuif, France, 94805 Germany Tübingen, Baden-Württemberg, Germany, 72076 Rostock, Mecklenburg-Vorpommern, Germany, 18059 Bonn, Nordrhein-Westfalen, Germany, 53105 Essen, Nordrhein-Westfalen, Germany, 45122 Essen, Nordrhein-Westfalen, Germany, 45147 Magdeburg, Sachsen-Anhalt, Germany, 38108 Italy Meldola, Forlì, Italy, 47014 Bologna, Italy, 40138 Rimini, Italy, 47900 Roma, Italy, 00189 Netherlands Amsterdam, Netherlands, 1066 CX Amsterdam, Netherlands, 1081 HV Leiden, Netherlands, 2333 ZA Maastricht, Netherlands, 6229 HX United Kingdom Leicester, Leicestershire, United Kingdom, LE1 5WW Northwood, Middlesex, United Kingdom, HA6 2RN Less <<
NCT00758381 Locally Advanced Pancreatic Ca... More >>ncer Less << Phase 2 Unknown August 2009 Italy ... More >> A.O. Treviglio-Caravaggio, P.le Ospedale n1 Recruiting Treviglio, Bergamo, Italy, 24047 Sub-Investigator: sandro Barni, MD          Ospedale S.Orsola Fatebenefratelli Active, not recruiting Brescia, BS, Italy, 15100 A.O. Ospedale S.Martino Recruiting Genova, GE, Italy, 16132 Sub-Investigator: Alberto Sobrero, MD          A.O. san Paolo Recruiting Milano, MI, Italy, 20100 Sub-Investigator: Paolo Foa, MD          Casa di Cura Igea Not yet recruiting Milano, MI, Italy, 20100 Sub-Investigator: Gianfranco Pancera, MD          Ospedale S.Carlo Borromeo Not yet recruiting Milano, MI, Italy, 20123 Sub-Investigator: Donata Tabiadon, MD          A.O. S.Gerardo Recruiting Monza, MI, Italy, 20052 Sub-Investigator: Paolo Bidoli, MD          A.O. Universitaria Ospedali Riuniti Umberto I Recruiting Ancona, Italy, 60020 Principal Investigator: Stefano Cascinu, M.Pr          Ospedali Riuniti, Largo Barozzi, 1 Recruiting Bergamo, Italy, 24128 Principal Investigator: Roberto Labianca, MD          A.O.Policlinico S.Orsola Malpighi Active, not recruiting Bologna, Italy, 40138 A.O. Careggi-Università, Viale Pieraccini, 17 Recruiting Firenze, Italy, 50139 Sub-Investigator: Francesco Di Costanzo, MD          Ospedale Galliera Active, not recruiting Genova, Italy, 16132 A.O. Carlo Poma - Via Albertoni, 1 Recruiting Mantova, Italy, 46100 Sub-Investigator: Enrico Aitini, MD          A.O. Cà Granda, Piazza Ospedale Maggiore, 3 Recruiting Milano, Italy, 20162 Sub-Investigator: Salvatore Siena, MPr          Policlinico di modena Active, not recruiting Modena, Italy, 41100 Università Campus Biomedico, Via Emilio Longoni, 83 Active, not recruiting Roma, Italy, 00155 A.O. S.Giovanni Calabita Fatebenefratelli Active, not recruiting Roma, Italy, 00186 Less <<
NCT00747799 Nasopharyngeal Neoplasms Phase 2 Completed - China, Guangdong ... More >> Cancer Center of Sun-Yat Sen University Guangzhou, Guangdong, China, 510000 Less <<
NCT00769405 Colorectal Cancer ... More >> Primary Peritoneal Cavity Cancer Less << Phase 3 Completed - France ... More >> Centre Paul Papin Angers, France, 49036 Hôpital Antoine Béclère Clamart, France, 92141 CHU Estaing Clermont Ferrand, France, 63003 Louis Mourier Hospital Colombes Cedex, France, 92701 Hopital Du Bocage Dijon, France, 21034 CHU de Grenoble - Hopital de la Tronche Grenoble, France, 38043 Centre Leon Berard Lyon, France, 69373 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Hopital de l'Archet CHU de Nice Nice, France, F-06202 Institut Curie Paris, France, 75005 Hopital Lariboisiere Paris, France, 75010 Hôpital Lariboisière Paris, France, 75010 Hopital Tenon Paris, France, 75970 Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Institut Jean Godinot Reims, France, 51056 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Centre Hospitalier Regional de Purpan Toulouse, France, 31059 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00287495 Kaposi's Sarcoma ... More >> HHV-8 KSHV Less << Phase 1 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00728910 - Completed - -
NCT00281957 - Completed - -
NCT00786110 Adrenocortical Carcinoma Phase 2 Unknown October 2010 Italy ... More >> Department of Clinical and Biological Sciences, University of Turin Recruiting Orbassano, Italy Contact: Paola Perotti    : +390119026 ext Ext. 017       Principal Investigator: Alfredo Berruti          Azienda Ospedaliera di Padova Not yet recruiting Padova, Italy Contact: Franco Mantero          Sub-Investigator: Franco Mantero          Azienda Ospedaliera Università di Palermo Not yet recruiting Palermo, Italy Sub-Investigator: Vittorio Gebbia          Policlinico Universitario Campus Biomedico- Roma Not yet recruiting Roma, Italy Contact: Daniele Santini          Sub-Investigator: Daniele Santini          Ist. Clin.Humanitas Not yet recruiting Rozzano, Italy Contact: Carlo Carnaghi          Sub-Investigator: Carlo Carnaghi Less <<
NCT00788099 Advanced Solid Tumors ... More >> Lymphomas Less << Phase 1 Completed - United States, New Jersey ... More >> The Cancer Institute of New Jersey (CINJ) New Brunswick, New Jersey, United States, 08901 France Institut Gustave Roussy Villejuif, France, 94800 Less <<
NCT00278382 Anaplastic Large Cell Lymphoma... More >> Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Mantle Cell Lymphoma Less << Phase 2 Completed - United States, Maryland ... More >> University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201-1595 Less <<
NCT00281957 Recurrent Melanoma ... More >> Stage IV Melanoma Less << Phase 2 Completed - -
NCT00789763 Pancreatic Cancer Phase 1 Completed - Spain ... More >> Hospital de La Santa Creu I Sant Pau Barcelona, Spain, 08025 Hospital Clinic I Provincial Barcelona, Spain, 08036 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Universitario La Fe Valencia, Spain, 46009 Less <<
NCT00289354 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT00797485 Colorectal Cancer Phase 3 Unknown - Italy ... More >> Southern Italy Cooperative Oncology Group Recruiting Naples, Italy, 80131 Contact: Pasquale Comella, MD    39-81-590-3227    pasqualecomella@libero.it Less <<
NCT00791544 Liver Carcinoma Phase 1 Phase 2 Terminated(Company decision to... More >> discontinue the AVE1642 development program, not due to any safety or efficacy concerns) Less << - France ... More >> Sanofi-Aventis Administrative Office Paris, France Less <<
NCT00296036 - Completed - -
NCT00801801 Non Squamous Cell Lung Cancer ... More >> Non Small Cell Lung Cancer Less << Phase 2 Terminated(Sponsors withdrew f... More >>unding; preliminary efficacy data was not encouraging.) Less << - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 - 0104 Less <<
NCT00804843 Carotid Atherosclerosis Phase 2 Completed - -
NCT00804843 - Completed - -
NCT00590629 Coronary Artery Disease Phase 4 Completed - United States, California ... More >> CSMC Los Angeles, California, United States, 90048 Less <<
NCT00801801 - Terminated(Sponsors withdrew f... More >>unding; preliminary efficacy data was not encouraging.) Less << - -
NCT00301847 Kidney Cancer ... More >> Metastatic Cancer Less << Phase 2 Completed - United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States, 62526 Evanston Northwestern Health Care - Evanston Hospital Evanston, Illinois, United States, 60201-1781 Ingalls Cancer Care Center at Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois, United States, 60153 Oncology Hematology Associates of Central Illinois, PC - Peoria Peoria, Illinois, United States, 61615-7828 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 62701 United States, Indiana Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States, 46885-5099 CCOP - Northern Indiana CR Consortium South Bend, Indiana, United States, 46601 United States, Michigan Oncology Care Associates, PLLC Saint Joseph, Michigan, United States, 49085 United States, Missouri David C. Pratt Cancer Center at St. John's Mercy Saint Louis, Missouri, United States, 63141 United States, Wisconsin Medical College of Wisconsin Cancer Center Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00303797 Refractory Chronic Lymphocytic... More >> Leukemia Refractory Multiple Myeloma Stage III Multiple Myeloma Stage IV Chronic Lymphocytic Leukemia Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00303966 - Terminated(Slow accrual) - -
NCT00296036 Breast Cancer ... More >> Drug/Agent Toxicity by Tissue/Organ Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 3 Completed - -
NCT00303966 Refractory Chronic Lymphocytic... More >> Leukemia Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia Less << Phase 2 Terminated(Slow accrual) - United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT00308451 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Illinois ... More >> Radiant Research Chicago Chicago, Illinois, United States, 60610 Less <<
NCT00308971 Chronic Kidney Disease Phase 2 Completed - United States, Maine ... More >> Maine Medical Center Portland, Maine, United States, 04102 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00618995 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT00808145 Hepatocellular Carcinoma Phase 2 Withdrawn(Lack of enrollment, ... More >>many screen failures and non eligible study participants) Less << - United States, Massachusetts ... More >> Lahey Clinic Burlington, Massachusetts, United States, 01805 Less <<
NCT00619060 - Completed - -
NCT00619060 Healthy Phase 1 Completed - United States, Arizona ... More >> Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724-5024 Less <<
NCT00826540 Recurrent Colon Cancer ... More >> Recurrent Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Less << Phase 2 Completed - -
NCT00829049 Acne Vulgaris Phase 4 Terminated(Study enrollment wa... More >>s terminated due to company decision before the target enrollment of 220 patients was reached.) Less << - United States, California ... More >> Fremont, California, United States Less <<
NCT00065624 Hypercholesterolemia Phase 2 Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00826540 - Completed - -
NCT00618995 - Completed - -
NCT00837577 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 3 Completed - -
NCT00633698 Elevated Lipoprotein(a) Levels Phase 3 Unknown March 2010 Germany ... More >> Institute of Social Medicine, Epidemiology and Health Economics Berlin, Germany, 10098 Less <<
NCT00837577 - Completed - -
NCT00839111 Colorectal Neoplasms Phase 2 Unknown November 2010 China, Shanghai ... More >> Cancer Hospital,Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Yanfei Liu, Master    +862164175590 ext 1107 Less <<
NCT00841386 Keratoconus Phase 2 Phase 3 Unknown December 2011 United States, New York ... More >> Fichte,Endl, & Elmer EyeCare Recruiting Amherst, New York, United States, 14228 Contact: Linda Grant, C.O.M.T.    716-564-2020    linda.grant@fichte.com    Contact: Michael Endl, M.D.    716-564-2020    mpderme@aol.com    Principal Investigator: Michael Endl, M.D.          Sub-Investigator: Thomas R Elmer, M.D.          The Ira G. Ross Eye Institute Recruiting Buffalo, New York, United States, 14209 Contact: James J Reidy, M.D.    716-881-7920    jreidymd@mac.com    Principal Investigator: James J Reidy, M.D.          Sub-Investigator: Sandra L Everett, M.D. Less <<
NCT00829049 - Terminated(Study enrollment wa... More >>s terminated due to company decision before the target enrollment of 220 patients was reached.) Less << - -
NCT00844688 Hepatocellular Carcinoma Phase 2 Unknown December 2009 Pakistan ... More >> Combined Military Hospital Recruiting Rawalpindi, Punjab, Pakistan, 46000 Principal Investigator: Naeem Naqi, MBBS,FCPS Less <<
NCT00608699 Healthy Subjects ... More >> Dyslipidaemias Less << Phase 1 Completed - United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Less <<
NCT00326495 Metastatic Colorectal Cancer Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00844883 - Completed - -
NCT00844883 Hepatocellular Carcinoma ... More >> Hepatoma Less << Phase 2 Completed - United States, Maryland ... More >> The Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 Less <<
NCT00326898 Stage I Renal Cell Cancer ... More >> Stage II Renal Cell Cancer Stage III Renal Cell Cancer Less << Phase 3 Completed - -
NCT00851045 Colorectal Cancer (CRC) Phase 2 Completed - United States, Arizona ... More >> Acrc/Arizona Clinical Research Center, Inc. Tucson, Arizona, United States, 85715 United States, California Compassionate Cancer Care Medical Group Inc Fountain Valley, California, United States, 92708 Compassionate Cancer Care Medical Group, Inc Riverside, California, United States, 92501 Sharp Memorial Hospital San Diego, California, United States, 92123 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33916 United States, Illinois Midwest Center For Hematology/Oncology Joliet, Illinois, United States, 60432 United States, Kansas Cancer Center Of Kansas Wichita, Kansas, United States, 67214 United States, Louisiana Gurtler, Jayne Metairie, Louisiana, United States, 70006 United States, Pennsylvania Guthrie Clinic, Ltd Sayre, Pennsylvania, United States, 18840 United States, Rhode Island Pharma Resource East Providence, Rhode Island, United States, 02915 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas University Of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Argentina Local Institution Bahia Blanca, Buenos Aires, Argentina, 8000 Local Institution Capital Federal, Buenos Aires, Argentina, 1426 Italy Local Institution Terni, Italy, 05100 Less <<
NCT00329719 - Completed - -
NCT00326495 - Completed - -
NCT00329719 Adult Glioblastoma ... More >> Adult Gliosarcoma Recurrent Adult Brain Neoplasm Less << Phase 1 Phase 2 Completed - -
NCT00326898 - Completed - -
NCT00330421 - Completed - -
NCT00855218 Carcinoma, Hepatocellular Phase 2 Completed - -
NCT00330421 Metastatic Ewing Sarcoma/Perip... More >>heral Primitive Neuroectodermal Tumor Metastatic Osteosarcoma Recurrent Adult Soft Tissue Sarcoma Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Recurrent Osteosarcoma Stage I Adult Soft Tissue Sarcoma Stage II Adult Soft Tissue Sarcoma Stage III Adult Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00328601 Diabetic Polyneuropathy Phase 3 Completed - Israel ... More >> Wolfson Medical Center, Diabetes Unit Holon, Israel, 58100 Haddassah Medical Center Ein Kerem, Diabetes Unit Jerusalem, Israel, 91120 Russian Federation Chair of Nervous Diseases of IM Sechenov Moscow Medical Academy at City Clinical Hospital Moscow, Russian Federation, 119048 Chair of Endocrinology and Diabetology of Russian Medical Academy of Postgraduate Education at Central Clinical Hospital of Ministry of Communication RF Moscow, Russian Federation, 125315 Federal Centre of Medical Social Expertise and Rehabilitation of Invalids, Centre Diabetic Food Moscow, Russian Federation, 127486 Less <<
NCT00855218 - Completed - -
NCT00663884 Diabetes Mellitus, Type 2 Phase 4 Completed - Korea, Republic of ... More >> The Catholic Univ. of Korea, Kangnam ST. Mary's Hospital Seoul, Korea, Republic of, 137-701 Less <<
NCT00866320 Kidney Cancer Phase 2 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 United States, Texas Baylor Sammons Cancer Center Dallas, Texas, United States, 75246 Less <<
NCT00664287 Dyslipidemia Phase 3 Withdrawn - -
NCT00335764 - Completed - -
NCT00861419 Advanced Solid Tumors Phase 1 Completed - -
NCT00866320 - Completed - -
NCT00335764 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor Less << Phase 1 Phase 2 Completed - United States, California ... More >> University of California at Los Angeles Los Angeles, California, United States, 90095 University of California San Francisco San Francisco, California, United States, 94115 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00866944 Liver Metastases ... More >> Colorectal Cancer Less << Phase 2 Completed - France ... More >> Centre Paul Strauss Strasbourg, France, 67065 Germany Zentralklinikum Augsburg Augsburg, Germany, 86156 Klinikum am Bruderwald, Sozialstiftung Bamberg Bamberg, Germany, 96049 Charité Campus Virchow Klinikum Berlin, Germany, 13353 Klinikum der Heinrich-Heine Universität Düsseldorf, Germany, 40489 J.W. Goethe-Universität Frankfurt, Germany, 60590 Martin-Luther Universität Halle, Germany, 06120 Medizinische Hochschule Hannover Hannover, Germany, 30625 Universitätsklinikum Leipzig Leipzig, Germany, 04103 Klinikum Magdeburg gGmbH Magdeburg, Germany, 39130 Klinikum der Johannes-Gutenberg Universität Mainz, Germany, 55131 Klinikum Mannheim GmbH Universitätsklinikum Mannheim, Germany, 68167 Universitätsklinikum der LMU Grosshadern München, Germany, 81377 Städtisches Klinikum Neuperlach München, Germany, 81737 Klinikum Oldenburg gGmbH Oldenburg, Germany, 26133 Klinikum der Universität Regensburg Regensburg, Germany, 93053 Less <<
NCT00867321 Liver Cancer Phase 1 Phase 2 Completed - -
NCT00868569 Liver Metastasis ... More >> Colorectal Cancer Less << Phase 4 Unknown December 2010 China, Shanghai ... More >> Zhongshan Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: jianmin xu, MD, PHD    008613501984869    xujmin@yahoo.com.cn    Principal Investigator: jianmin xu, MD, PHD Less <<
NCT00867321 - Completed - -
NCT00869271 Unresectable Liver Metastasis ... More >>of Colorectal Cancer Less << Phase 4 Completed - China, Shanghai ... More >> Zhongshan Hospital, Fudan University Shanghai, Shanghai, China, 200032 Less <<
NCT00870311 Bipolar Disorder Phase 4 Completed - United States, Michigan ... More >> Wayne State University School of Medicine Detroit, Michigan, United States, 48201 Less <<
NCT00874406 Colorectal Cancer Phase 4 Unknown December 2009 China, Shanghai ... More >> Zhongshan Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: jianmin xu, MD, PHD    008613501984869    xujmin@yahoo.com.cn    Principal Investigator: jianmin xu, MD, PHD Less <<
NCT00873275 Colorectal Cancer Phase 1 Active, not recruiting September 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 Less <<
NCT00671996 Chemotherapy ... More >>Colon Cancer Less << Phase 2 Completed - Sweden ... More >> Onkologkliniken, Länssjukhuset Ryhov Jönköping, Sweden, SE-551 85 Less <<
NCT00869570 Colorectal Cancer Phase 1 Phase 2 Completed - Hungary ... More >> Szent Laszlo Korhaz Budapest, Hungary, 1097 Switzerland Saint Claraspital AG Basel, Switzerland, CH-4016 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland, 6500 Inselspital, Bern Bern, Switzerland, CH-3010 Spitalzentrum Biel Biel, Switzerland, CH-2501 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Hopital Cantonal Universitaire de Geneva HUG Geneva, Switzerland, CH-1211 Kantonsspital Luzern Luzern, Switzerland, 6000 OnkoZentrum Luzern at Klinik St. Anna Luzern, Switzerland, 6006 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 SpitalSTS AG Simmental-Thun-Saanenland Thun, Switzerland, 3600 Kantonsspital Winterthur Winterthur, Switzerland, CH-8400 Onkozentrum - Klinik im Park Zurich, Switzerland, 8002 Onkozentrum Hirslanden Zurich, Switzerland, CH-8008 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Stadtspital Triemli Zürich, Switzerland, 8063 Less <<
NCT00880178 - Completed - -
NCT00881751 Liver Cancer Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90033-0804 California Pacific Medical Center San Francisco, California, United States, 94115 United States, New York Columbia University/ New York Presbyterian Hospital New York, New York, United States, 10032 United States, South Carolina Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Tennessee Tennessee Oncology, PLLCat Sarah Cannon Cancer Center Nashville, Tennessee, United States, 37203 United States, Virginia UVA Cancer Center Charlottesville, Virginia, United States, 22908 Less <<
NCT00881751 - Completed - -
NCT00889343 Colorectal Neoplasms Phase 2 Terminated - -
NCT00890305 Metastatic Colorectal Cancer Phase 2 Completed - -
NCT00895193 Hypercholesterolemia ... More >> Flushing Less << Not Applicable Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT00349206 Melanoma Recu... More >>rrent Melanoma Stage III Melanoma Stage IV Melanoma Less << Phase 1 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00373373 Acute Myeloid Leukemia Phase 2 Completed - Germany ... More >> Charité Campus Benjamin Franklin, Med. Klinik III Berlin, Germany, 12203 Klinikum Chemnitz GmbH, Klinik für Innere Medizin III Chemnitz, Germany, 09113 Universitätsklinikum Carl Gustav Carus der TU Dresden, Medizinische Klinik I Dresden, Germany, 01307 St. Johannes Hospital, Medizinische Klinik II Duisburg, Germany, 47166 Universitätsklinikum Essen, Zentrum für Innere Medizin, Medizinische Klinik und Poliklinik für Hämatologie Essen, Germany, 45147 Klinikum der J. W. Goethe-Universität Frankfurt am Main, Medizinische Klinik II Frankfurt / Main, Germany, 60590 Allgemeines Krankenhaus St. Georg, Hämatologische Abteilung Hamburg, Germany, 20099 Universitätsklinikum Heidelberg, Med. Klinik V Heidelberg, Germany, D-69120 Klinikum der Universität zu Köln, Klinik I für Innere Medizin Köln, Germany, 50937 Klinikum der Johannes Gutenberg Universität, 3. Medizinische Klinik und Poliklinik Mainz, Germany, 55101 Philipps Universität, Abteilung für Hämatologie, Onkologie und Immunologie Marburg, Germany, 35043 Klinik für Hämatologie und Onkologie Klinikum Minden Minden, Germany, 32423 TU München, Medizinische Klinik III München, Germany, 81675 Universitätsklinikum Münster, Medizinische Klinik A Münster, Germany, 48149 Klinikum Nürnberg, 5. Medizinische Klinik Einheit für Knochenmarktransplantation Nürnberg, Germany, 90419 Universität Regensburg, Abteilung für Hämatologie und Internistische Onkologie Regensburg, Germany, 93042 Robert-Bosch Krankenhaus Stuttgart Stuttgart, Germany, 70376 Julius-Maximilians-Universität Würzburg, Medizinische Klinik und Poliklinik II Würzburg, Germany, 97979 Less <<
NCT00895193 - Completed - -
NCT00919061 Extrahepatic Bile Duct Cancer ... More >> Gallbladder Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00930839 - Completed - United States, Virginia ... More >> Eastern Virgnia Medical School, Strelitz Diabetes Center Norfolk, Virginia, United States, 23510f Less <<
NCT00919061 - Completed - -
NCT00933777 Unspecified Adult Solid Tumor,... More >> Protocol Specific Non-Small Cell Lung Cancer Less << Phase 1 Completed - Germany ... More >> Center for Integrated Oncology, Dep.I of Internal Medicine, University Hospital Cologne Cologne, Germany Less <<
NCT00932438 Colon Cancer With Metastases t... More >>o the Liver Less << Phase 1 Phase 2 Completed - United States, Alabama ... More >> Clearview Cancer Center Huntsville, Alabama, United States, 35805 United States, California Radiology Associates of Sacramento/Sutter Cancer Center Sacramento, California, United States, 95816 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 Northside Hospital/GA Cancer Specialists Atlanta, Georgia, United States, 30342 United States, Kentucky University of Louisville Louisville, Kentucky, United States, 40202 United States, Mississippi Hematology and Oncology Assoc. at Bridgeport Tupelo, Mississippi, United States, 38801 United States, Missouri Washington University/Alvin J. Siteman Cancer Center St. Louis, Missouri, United States, 63110 United States, Oregon Providence Portland Medical Center/Providence Cancer Center Portland, Oregon, United States, 97213 United States, Wisconsin Froedtert Memorial Lutheran Hospital Milwaukee, Wisconsin, United States, 53226 Argentina Hospital Italiano de Buenos Aires Buenos Aires, Argentina Less <<
NCT00933816 Hepatocellular Carcinoma Phase 1 Phase 2 Completed - Japan ... More >> Kurume University Medical Center Kurume, Fukuoka, Japan, 839-0863 Ogaki Municipal Hospital Oogaki, Gifu, Japan, 503-8502 Kinki University School of Medicine Osaka-Sayama, Osaka, Japan, 589-8511 Less <<
NCT00384969 Renal Cell Carcinoma Phase 1 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94115 Less <<
NCT00387543 - Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00939627 Metastatic Squamous Neck Cance... More >>r With Occult Primary Squamous Cell Carcinoma Recurrent Metastatic Squamous Neck Cancer With Occult Primary Recurrent Salivary Gland Cancer Recurrent Squamous Cell Carcinoma of the Hypopharynx Recurrent Squamous Cell Carcinoma of the Larynx Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcinoma of the Nasopharynx Recurrent Squamous Cell Carcinoma of the Oropharynx Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Recurrent Verrucous Carcinoma of the Larynx Recurrent Verrucous Carcinoma of the Oral Cavity Salivary Gland Squamous Cell Carcinoma Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IVA Salivary Gland Cancer Stage IVA Squamous Cell Carcinoma of the Larynx Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVA Squamous Cell Carcinoma of the Oropharynx Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVA Verrucous Carcinoma of the Larynx Stage IVA Verrucous Carcinoma of the Oral Cavity Stage IVB Salivary Gland Cancer Stage IVB Squamous Cell Carcinoma of the Larynx Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVB Squamous Cell Carcinoma of the Oropharynx Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVB Verrucous Carcinoma of the Larynx Stage IVB Verrucous Carcinoma of the Oral Cavity Stage IVC Salivary Gland Cancer Stage IVC Squamous Cell Carcinoma of the Larynx Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVC Squamous Cell Carcinoma of the Oropharynx Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVC Verrucous Carcinoma of the Larynx Stage IVC Verrucous Carcinoma of the Oral Cavity Tongue Cancer Untreated Metastatic Squamous Neck Cancer With Occult Primary Less << Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 Suburban Hospital Bethesda, Maryland, United States, 20814 United States, Montana Billings Clinic Billings, Montana, United States, 59107-7000 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467-2490 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT00941057 Pharmacology, Clinical Phase 1 Completed - Germany ... More >> Neu-Ulm, Bayern, Germany, 89231 Less <<
NCT00939627 - Completed - -
NCT00941499 Advanced Cancers Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00390325 Multiple Endocrine Neoplasia ... More >> Recurrent Thyroid Gland Carcinoma Thyroid Gland Medullary Carcinoma Less << Phase 2 Active, not recruiting - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT00405366 Kidney Cancer Early Phase 1 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT00893724 Neovascular Age-related Macula... More >>r Degeneration Diabetic Macular Edema Less << Not Applicable Unknown September 2011 United States, West Virginia ... More >> Mid-Atlantic Retina Consultations, Inc. Morgantown, West Virginia, United States, 26505 Less <<
NCT00765284 - Completed - United States, Texas ... More >> Diabetes and Glandular Research Associates San Antonio, Texas, United States, 78229 Less <<
NCT00389285 Carcinoma, Renal Cell Phase 1 Phase 2 Completed - United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35294 United States, Arizona Premiere Oncology of Arizona Scottsdale, Arizona, United States, 85260 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT00873756 Metastatic Colorectal Cancer Phase 1 Completed - United States, California ... More >> Los Angeles, California, United States, 90095 San Francisco, California, United States, 94115 United States, Colorado Aurora, Colorado, United States, 80045 Fort Collins, Colorado, United States, 80528 United States, Illinois Harvey, Illinois, United States, 60426 United States, New Mexico Albuquerque, New Mexico, United States, 87131 United States, North Carolina Chapel HIll, North Carolina, United States, 27599 Less <<
NCT00769132 Hypercholesterolemia Phase 1 Completed - -
NCT00406601 Sarcoma, Soft Tissue Phase 2 Completed - Italy ... More >> Istituto Clinico Humanitas Rozzano, Milan, Italy, 20089 Less <<
NCT00411671 Lung Cancer Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00769132 - Completed - -
NCT00414388 Prostate Cancer Phase 1 Phase 2 Completed - United States, Illinois ... More >> Onocology Specialists, S.C Niles, Illinois, United States, 60714 Oncology Specialists, S.C Park Ridge, Illinois, United States, 60068 Less <<
NCT00411671 - Completed - -
NCT00982592 Adenocarcinoma of the Gastroes... More >>ophageal Junction Adenocarcinoma of the Stomach Recurrent Gastric Cancer Stage IIIA Gastric Cancer Stage IIIB Gastric Cancer Stage IIIC Gastric Cancer Stage IV Gastric Cancer Less << Phase 2 Completed - United States, California ... More >> University of California at Davis Cancer Center Sacramento, California, United States, 95817 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 Cancer Care Center of Decatur Decatur, Illinois, United States, 62526 Decatur Memorial Hospital Decatur, Illinois, United States, 62526 Crossroads Cancer Center Effingham, Illinois, United States, 62401 NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States, 60201 Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Loyola University Medical Center Maywood, Illinois, United States, 60153 Illinois CancerCare-Peoria Peoria, Illinois, United States, 61615 Illinois Oncology Research Association CCOP Peoria, Illinois, United States, 61615 Memorial Medical Center Springfield, Illinois, United States, 62781-0001 United States, Indiana Fort Wayne Medical Oncology and Hematology Inc-Parkview Fort Wayne, Indiana, United States, 46845 Indiana University Medical Center Indianapolis, Indiana, United States, 46202 United States, Michigan University of Michigan University Hospital Ann Arbor, Michigan, United States, 48109 University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Missouri Saint John's Mercy Medical Center Saint Louis, Missouri, United States, 63141 United States, New York New York Cancer Consortium Bronx;, New York, United States, 10461 Albert Einstein College of Medicine Bronx, New York, United States, 10461 Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467-2490 Beth Israel Medical Center New York, New York, United States, 10003 New York University Langone Medical Center New York, New York, United States, 10016 Saint Luke's Roosevelt Hospital Center - Saint Luke's Division New York, New York, United States, 10025 Columbia University Medical Center New York, New York, United States, 10032 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Weill Medical College of Cornell University New York, New York, United States, 10065 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT00958737 Colorectal Cancer Phase 3 Active, not recruiting September 2017 France ... More >> GERCOR Groupe Cooperateur Multidisciplinaire en Oncologie Paris, France, 75011 Less <<
NCT00982592 - Completed - -
NCT00981162 Acinar Cell Adenocarcinoma of ... More >>the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Colorado ... More >> University of Colorado at Denver Health Sciences Center Aurora, Colorado, United States, 80045 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT00417248 Non-Small Cell Lung Cancer Phase 1 Phase 2 Terminated(Negative sorafenib ... More >>results from ESCAPE trial and safety concerns of regimen) Less << - United States, Illinois ... More >> Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Center for Cancer Care at Goshen Health System Goshen, Indiana, United States, 46527 Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Horizon Oncology Center Lafayette, Indiana, United States, 47905 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 United States, Ohio Oncology Partners Network Cincinnati, Ohio, United States, 45247 Less <<
NCT00417248 - Terminated(Negative sorafenib ... More >>results from ESCAPE trial and safety concerns of regimen) Less << - -
NCT00493064 Retinal Vein Occlusion Phase 2 Phase 3 Completed - United States, California ... More >> Palo Alto Medical Foundation Department of Ophthalmology Palo Alto, California, United States, 94301 Less <<
NCT00346970 Metabolic Syndrome Phase 4 Completed - Germany ... More >> Hannover Medical School Hannover, Germany, 30625 Less <<
NCT00414388 - Completed - -
NCT00492999 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Active, not recruiting May 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital Sleepy Hollow, New York, United States Less <<
NCT00345657 Hyperlipidemia ... More >> Mixed Hyperlipidemia Dyslipidemia Less << Phase 4 Completed - United States, Oklahoma ... More >> Family Medical Care of Tulsa Tulsa, Oklahoma, United States, 74136 Less <<
NCT00494182 Metastatic Head and Neck Squam... More >>ous Cell Carcinoma Metastatic Squamous Cell Carcinoma of the Hypopharynx Metastatic Squamous Cell Carcinoma of the Larynx Metastatic Squamous Cell Carcinoma of the Oral Cavity Metastatic Squamous Cell Carcinoma of the Oropharynx Recurrent Head and Neck Squamous Cell Carcinoma Recurrent Hypopharyngeal Squamous Cell Carcinoma Recurrent Laryngeal Squamous Cell Carcinoma Recurrent Oral Cavity Squamous Cell Carcinoma Recurrent Oropharyngeal Squamous Cell Carcinoma Less << Phase 2 Active, not recruiting April 30, 2019 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00493636 - Completed - -
NCT00494221 Metastatic Colorectal Cancer Phase 1 Phase 2 Completed - Japan ... More >> Research Site Osaka, Japan Research Site Saitama, Japan Less <<
NCT00494221 - Completed - -
NCT00493636 Breast Cancer Phase 2 Completed - -
NCT00093626 Primary Peritoneal Carcinoma ... More >> Recurrent Ovarian Carcinoma Less << Phase 2 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00093613 Adult Anaplastic Astrocytoma ... More >> Adult Anaplastic Oligodendroglioma Adult Giant Cell Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor Less << Phase 1 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland Adult Brain Tumor Consortium Baltimore, Maryland, United States, 21231-1000 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00515736 Critically Ill Patients ... More >> Cardiac Surgery Trauma Subarachnoid Hemorrhage Less << Phase 3 Terminated(enrollment was comp... More >>leted) Less << - Switzerland ... More >> Dpt of Adult Intensive Care - CHUV Lausanne, VD, Switzerland, 1011 Less <<
NCT00096512 Metastatic Squamous Neck Cance... More >>r With Occult Primary Squamous Cell Carcinoma Recurrent Metastatic Squamous Neck Cancer With Occult Primary Recurrent Salivary Gland Cancer Recurrent Squamous Cell Carcinoma of the Hypopharynx Recurrent Squamous Cell Carcinoma of the Larynx Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcinoma of the Nasopharynx Recurrent Squamous Cell Carcinoma of the Oropharynx Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Recurrent Verrucous Carcinoma of the Larynx Recurrent Verrucous Carcinoma of the Oral Cavity Salivary Gland Squamous Cell Carcinoma Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IVA Salivary Gland Cancer Stage IVA Squamous Cell Carcinoma of the Larynx Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVA Squamous Cell Carcinoma of the Oropharynx Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVA Verrucous Carcinoma of the Larynx Stage IVA Verrucous Carcinoma of the Oral Cavity Stage IVB Salivary Gland Cancer Stage IVB Squamous Cell Carcinoma of the Larynx Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVB Squamous Cell Carcinoma of the Oropharynx Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVB Verrucous Carcinoma of the Larynx Stage IVB Verrucous Carcinoma of the Oral Cavity Stage IVC Salivary Gland Cancer Stage IVC Squamous Cell Carcinoma of the Larynx Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVC Squamous Cell Carcinoma of the Oropharynx Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVC Verrucous Carcinoma of the Larynx Stage IVC Verrucous Carcinoma of the Oral Cavity Tongue Cancer Untreated Metastatic Squamous Neck Cancer With Occult Primary Less << Phase 2 Completed - United States, Texas ... More >> Southwest Oncology Group (SWOG) Research Base San Antonio, Texas, United States, 78245 Less <<
NCT00496301 Carcinoma, Renal Cell Phase 2 Completed - Spain ... More >> Hospital del Mar Barcelona, Spain, 08003 Hospital Vall d´Hebron Barcelona, Spain, 08035 Hospital de Basurto Bilbao, Spain, 48013 Hospital Santiago de Compostela Coruña, Spain, 15706 Hospital Josep Trueta Gerona, Spain, 17007 Hospital Juan Ramón Jiménez Huelva, Spain, 21005 Hospital Clínico Virgen de la Victoria Málaga, Spain, 29010 Clínica Universitaria de Navarra Pamplona, Spain, 31008 Hospital Virgen Macarena Sevilla, Spain, 41009 Hospital Xeral Cies Vigo, Spain, 36204 Less <<
NCT00378833 Hypercholesterolemia ... More >> Hyperlipidemia Less << Phase 3 Completed - -
NCT00376584 Hypercholesteremia ... More >> Hyperlipidemia Less << Phase 3 Completed - -
NCT00098254 - Completed - -
NCT00098254 Non-Small-Cell Lung Carcinoma Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00384293 Hypercholesterolemia, Familial Phase 3 Terminated - -
NCT00098540 Recurrent Non-small Cell Lung ... More >>Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 2 Completed - United States, Minnesota ... More >> North Central Cancer Treatment Group Rochester, Minnesota, United States, 55905 Less <<
NCT00384293 - Terminated - -
NCT00533585 Lung Cancer Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00544167 - Completed - -
NCT00544167 Breast Cancer Not Applicable Completed - United States, Florida ... More >> Integrated Community Oncology Network Jacksonville, Florida, United States, 32256 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Less <<
NCT00543504 Advanced Cancer Phase 1 Active, not recruiting October 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00101400 - Completed - -
NCT00101413 Cancer Carcin... More >>oma, Non-Small Cell Lung Less << Phase 2 Completed - United States, Texas ... More >> Houston, Texas, United States, 77030 Germany Großhansdorf, Schleswig-Holstein, Germany, 22927 Less <<
NCT00499525 Breast Cancer Phase 2 Active, not recruiting December 2021 -
NCT00558636 Carcinoma, Non-Small-Cell Lung Phase 3 Terminated(Terminated early wh... More >>en the results from Study NCT00300885 showed an overall lack of efficacy in NSCLC and increased mortality in subjects with squamous subtype.) Less << - China, Guangdong ... More >> Guangzhou, Guangdong, China, 510060 Guangzhou, Guangdong, China, 510515 China, Hong Kong Shatin, Hong Kong, China China, Jiangsu Nanjing, Jiangsu, China, 210003 China, Zhejiang Hangzhou, Zhejiang, China, (310022), Hangzhou, Zhejiang, China, 310016 China Beijing, China, 100021 Beijing, China, 100142 Beijing, China, 100730 Chongqing, China, 400038 Shanghai, China, 200032 Shanghai, China, 200433 India Mumbai, Maharashtra, India, 400012 New- Delhi, India, 110008 Korea, Republic of Gyeonggi-do, Korea, Republic of, 410-769 Seoul, Korea, Republic of, 136-705 Singapore Singapore, Singapore, 119228 Singapore, Singapore, 169610 Taiwan Changhua, Taiwan, 500 Taipei, Taiwan, 100 Thailand Bangkok, Thailand, 10330 Bangkok, Thailand Less <<
NCT00547443 Lung Cancer Phase 1 Phase 2 Terminated(Withdrawn as the sp... More >>onsor has stopped the drug for NSCLC population) Less << - United States, Texas ... More >> Arlington Cancer Center - Arlington Arlington, Texas, United States, 76012-2510 Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 Less <<
NCT00101413 - Completed - -
NCT00562523 Neoplasms Phase 1 Completed - United States, Florida ... More >> Tampa, Florida, United States, 33612 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19111-2497 Less <<
NCT00565370 Advanced Gastric Cancer Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00095693 Anaplastic Thyroid Cancer ... More >> Insular Thyroid Cancer Recurrent Thyroid Cancer Stage III Follicular Thyroid Cancer Stage III Papillary Thyroid Cancer Stage IV Follicular Thyroid Cancer Stage IV Papillary Thyroid Cancer Less << Phase 2 Terminated - United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00565370 - Completed - -
NCT00572078 SOLID TUMORS Phase 1 Completed - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00101400 Breast Neoplasms ... More >> Breast Cancer Less << Phase 2 Completed - Germany ... More >> Stuttgart, Baden-Württemberg, Germany, 70199 München, Bayern, Germany, 80637 Frankfurt, Hessen, Germany, 60590 Italy Bologna, Italy, 40138 Milano, Italy, 20133 Milano, Italy, 20162 Parma, Italy, 43100 Less <<
NCT00558636 - Terminated(Terminated early wh... More >>en the results from Study NCT00300885 showed an overall lack of efficacy in NSCLC and increased mortality in subjects with squamous subtype.) Less << - -
NCT00562913 Cancer Phase 1 Completed - Canada, Alberta ... More >> Edmonton, Alberta, Canada, T6G 1Z2 Canada, Quebec Montreal, Quebec, Canada, H3T 1E2 Less <<
NCT00581919 Multiple Myeloma Phase 2 Completed - United States, Wisconsin ... More >> Mercy Health Systems Janesville, Wisconsin, United States Gundersen Lutheran LaCrosse, Wisconsin, United States University of Wisconsin Cancer Center Madison, Wisconsin, United States, 53792 Regional Cancer Center Waukesha/Oconomowoc, Wisconsin, United States Aspirus Wausau Hospital, Aspirus Regional Cancer Center Wausau, Wisconsin, United States Less <<
NCT00571740 Colorectal Cancer Phase 2 Withdrawn(The study was not ac... More >>tivated) Less << - -
NCT00581919 - Completed - -
NCT00105443 Carcinoma, Hepatocellular Phase 3 Completed - -
NCT00589550 Kidney Cancer Phase 1 Terminated(low accrual) - United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT00105443 - Completed - -
NCT00107432 Epithelial Mesothelioma ... More >> Recurrent Malignant Mesothelioma Sarcomatous Mesothelioma Stage IA Malignant Mesothelioma Stage IB Malignant Mesothelioma Stage II Malignant Mesothelioma Stage III Malignant Mesothelioma Stage IV Malignant Mesothelioma Less << Phase 2 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00589550 - Terminated(low accrual) - -
NCT00599924 Colorectal Neoplasms ... More >> Neoplasms Less << Phase 1 Completed - United States, Colorado ... More >> Pfizer Investigational Site Aurora, Colorado, United States, 80045 United States, Tennessee Pfizer Investigational Site Nashville, Tennessee, United States, 37232 United States, Texas Pfizer Investigational Site Dallas, Texas, United States, 75246 Less <<
NCT00591045 Stomach Neoplasms ... More >> Gastric Cancer Less << Phase 2 Unknown December 2012 China, Beijing ... More >> Peking University School of Oncology Not yet recruiting Beijing, Beijing, China, 100036 Contact: Jiafu Ji, M.D.    86-10-88196048    jiafuj@hotmail.com    Principal Investigator: Jiafu Ji, M.D. Less <<
NCT00605566 Neuroendocrine Tumors Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00602329 Colorectal Cancer Phase 2 Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104-4283 Contact: Clinical Trials Office - Abramson Cancer Center of the Univers    800-474-9892 Less <<
NCT00602862 Clear Cell Renal Cell Carcinom... More >>a Less << Not Applicable Completed - Netherlands ... More >> Radboud University Nijmegen Medical Center Nijmegen, Gelderland, Netherlands, 6500 HB Less <<
NCT00606125 Neoplasms Phase 1 Completed - United States, Connecticut ... More >> New Haven, Connecticut, United States, 06511-5991 United States, Texas San Antonio, Texas, United States, 78229-3307 Less <<
NCT00610948 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT00615056 Colorectal Neoplasms Phase 2 Completed - -
NCT00619996 Prostate Cancer Phase 2 Completed - Italy ... More >> Dipartimento di Oncologia, dei Trapianti e delle Nuove Tecnologie in Medicina ... Indirizzo: via Roma, 55 - 56100 Pisa Tel. 050-2218690 - Fax. 050-2218685 Pisa, Italy, 56100 Less <<
NCT00607438 Breast Cancer Phase 2 Terminated(Low accrual) - United States, Ohio ... More >> Veeda Oncology Columbus, Ohio, United States, 43215 Less <<
NCT00621686 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - -
NCT00615056 - Completed - -
NCT00599924 - Completed - -
NCT00621686 - Completed - -
NCT00110994 Cancer Melano... More >>ma Less << Phase 2 Completed - United States, Arizona ... More >> Tucson, Arizona, United States, 85724 United States, Colorado Aurora, Colorado, United States, 80045 United States, Florida Lakeland, Florida, United States, 33805 United States, Illinois Park Ridge, Illinois, United States, 60068 United States, Massachusetts Boston, Massachusetts, United States, 02114 Boston, Massachusetts, United States, 02115-6084 Boston, Massachusetts, United States, 02215 United States, Missouri St. Louis, Missouri, United States, 63110-1093 United States, Nebraska Omaha, Nebraska, United States, 68114 United States, North Carolina Charlotte, North Carolina, United States, 28203 United States, Pennsylvania Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Hilton Head Island, South Carolina, United States, 29926-2739 United States, Tennessee Nashville, Tennessee, United States, 37232-6307 United States, Texas San Antonio, Texas, United States, 78229 Less <<
NCT00613145 Refractory Malignancy Phase 1 Completed - United States, Tennessee ... More >> Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00619541 Hepatocellular Carcinoma Phase 2 Completed - Italy ... More >> Dipartimento di Oncologia, dei Trapianti e delle Nuove Tecnologie in Medicina ... Indirizzo: via Roma, 55 - 56100 Pisa Tel. 050-2218690 - Fax. 050-2218685 Pisa, Italy, 56100 Less <<
NCT00111020 Carcinoma, Renal Cell Phase 3 Completed - -
NCT00622466 Breast Cancer Phase 2 Unknown December 2015 United States, Texas ... More >> University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT00626392 Dyslipidemia Phase 3 Completed - United States, Alabama ... More >> Huntsville, Alabama, United States, 35801 United States, Arizona Scottsdale, Arizona, United States, 85251 Tucson, Arizona, United States, 85710 Tucson, Arizona, United States, 85712 United States, California Anaheim, California, United States, 92801 Los Angeles, California, United States, 90057 Newport Beach, California, United States, 92660 Stockton, California, United States, 95204 Vista, California, United States, 90057 Westlake Village, California, United States, 91361 United States, Florida Coral Gables, Florida, United States, 33134 Jacksonville, Florida, United States, 32259 Miami, Florida, United States, 33186 Pembroke Pines, Florida, United States, 33027 West Palm Beach, Florida, United States, 33407 United States, Massachusetts N. Dartmouth, Massachusetts, United States, 02747 United States, New York Rochester, New York, United States, 14609 United States, North Carolina Charlotte, North Carolina, United States, 28262 Winston-Salem, North Carolina, United States, 27103 United States, Pennsylvania Penndel, Pennsylvania, United States, 19047 United States, Rhode Island Johnston, Rhode Island, United States, 02919 United States, South Carolina Mt. Pleasant, South Carolina, United States, 29464 Simpsonville, South Carolina, United States, 29681 United States, Texas Colleyville, Texas, United States, 76034 Houston, Texas, United States, 77074 San Antonio, Texas, United States, 78229 Less <<
NCT00632541 Metastatic Breast Cancer Phase 2 Terminated(Significant Toxicit... More >>ies Experienced) Less << - United States, Illinois ... More >> Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 Quality Cancer Center (MCGOP) Indianapolis, Indiana, United States, 46202 Arnett Cancer Care Lafayette, Indiana, United States, 47904 Horizon Oncology Center Lafayette, Indiana, United States, 47905 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 United States, Ohio Ireland Cancer Center - University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 Less <<
NCT00110994 - Completed - -
NCT00630877 - Completed - -
NCT00112671 Metastatic Transitional Cell C... More >>ancer of the Renal Pelvis and Ureter Recurrent Bladder Cancer Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter Regional Transitional Cell Cancer of the Renal Pelvis and Ureter Stage III Bladder Cancer Stage IV Bladder Cancer Transitional Cell Carcinoma of the Bladder Less << Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00632541 - Terminated(Significant Toxicit... More >>ies Experienced) Less << - -
NCT00623402 Melanoma Phase 2 Completed - Germany ... More >> Dpt. of Dermatology, Humboldt University Berlin, Germany, 10117 Dept. of Dermatology, Elbe Klinikum Buxtehude, Germany, 21614 Dpt. of Dermatology, University of Hannover Hannover, Germany, 30449 Dpt. of Dermatology, University of Homburg/Saar Homburg/Saar, Germany, 66421 Dpt. of Dermatology; UK-SH Campus Kiel, Germany Kiel, Germany, D-24105 Dpt. of Dermatology, University of Cologne Koeln, Germany, D-50937 Dpt. of Dermatology, University of Mannheim Mannheim, Germany, 68163 Dpt. of Dermatology, Ludwig-Maximilian-University München, Germany, 80337 Dpt. of Dermatology, University of Tübingen Tübingen, Germany, 72076 Dpt. of Dermatology, University of Würzburg Würzburg, Germany, 97080 Less <<
NCT00112671 - Completed - -
NCT00630877 Dyslipidemia Phase 3 Completed - -
NCT00626392 - Completed - -
NCT00112996 Neurotoxicity ... More >> Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 3 Completed - United States, Arkansas ... More >> Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States, 72913 United States, Indiana Horizon Oncology Center Lafayette, Indiana, United States, 47905 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Louisiana Cabrini Center for Cancer Care at Christus St. Frances Cabrini Hospital Alexandria, Louisiana, United States, 71301 United States, Michigan CCOP - Kalamazoo Kalamazoo, Michigan, United States, 49007-3731 United States, Minnesota CCOP - Metro-Minnesota St. Louis Park, Minnesota, United States, 55416 United States, Missouri Cancer Research for the Ozarks Springfield, Missouri, United States, 65804 United States, Oregon CCOP - Columbia River Oncology Program Portland, Oregon, United States, 97225 United States, Pennsylvania CCOP - Main Line Health Wynnewood, Pennsylvania, United States, 19096 United States, South Carolina CCOP - Greenville Greenville, South Carolina, United States, 29615 United States, Texas University of Texas M.D. Anderson CCOP Research Base Houston, Texas, United States, 77030-4009 CCOP - Scott and White Hospital Temple, Texas, United States, 76508 United States, Wisconsin Marshfield Clinic - Marshfield Center Marshfield, Wisconsin, United States, 54449 Less <<
NCT00112905 Adenocarcinoma of the Bladder ... More >> Distal Urethral Cancer Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter Proximal Urethral Cancer Recurrent Bladder Cancer Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter Recurrent Urethral Cancer Regional Transitional Cell Cancer of the Renal Pelvis and Ureter Squamous Cell Carcinoma of the Bladder Stage III Bladder Cancer Stage IV Bladder Cancer Transitional Cell Carcinoma of the Bladder Urethral Cancer Associated With Invasive Bladder Cancer Less << Phase 2 Terminated - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT00634634 Metastatic Breast Cancer Phase 1 Phase 2 Active, not recruiting May 2019 United States, District of Col... More >>umbia Georgetown University Hospital Washington, District of Columbia, United States, 20007 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 Cooper Hospital/University Medical Center Voorhees, New Jersey, United States, 08690 Less <<
NCT00634751 Pancreatic Neoplasms ... More >> Bile Duct Neoplasms Less << Phase 1 Phase 2 Completed - United States, Wisconsin ... More >> University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT00112905 - Terminated - -
NCT00646607 Colon Cancer Phase 3 Completed - -
NCT00654069 Pain Phase 3 Completed - -
NCT00652431 Hypercholesterolemia ... More >> Hyperlipidemia Less << Phase 1 Completed - -
NCT00634751 - Completed - -
NCT00647426 Non-Small Cell Lung Cancer Phase 2 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center of University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00654381 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> 1218.23.05 Boehringer Ingelheim Investigational Site Asahi, Chiba, Japan 1218.23.06 Boehringer Ingelheim Investigational Site Funabashi, Chiba, Japan 1218.23.21 Boehringer Ingelheim Investigational Site Hitachinaka, Ibaraki, Japan 1218.23.44 Boehringer Ingelheim Investigational Site Hitachiota, Ibaraki, Japan 1218.23.09 Boehringer Ingelheim Investigational Site Imizu, Toyama, Japan 1218.23.45 Boehringer Ingelheim Investigational Site Inashiki-gun, Ibaraki, Japan 1218.23.13 Boehringer Ingelheim Investigational Site Izumisano, Osaka, Japan 1218.23.27 Boehringer Ingelheim Investigational Site Kariya, Aichi, Japan 1218.23.47 Boehringer Ingelheim Investigational Site Kitakatsushika-gun, Saitama, Japan 1218.23.39 Boehringer Ingelheim Investigational Site Kitakyuushuu, Fukuoka, Japan 1218.23.02 Boehringer Ingelheim Investigational Site Koriyama, Fukushima, Japan 1218.23.03 Boehringer Ingelheim Investigational Site Koriyama, Fukushima, Japan 1218.23.10 Boehringer Ingelheim Investigational Site Kyoto, Kyoto, Japan 1218.23.37 Boehringer Ingelheim Investigational Site Marugame, Kagawa, Japan 1218.23.38 Boehringer Ingelheim Investigational Site Marugame, Kagawa, Japan 1218.23.23 Boehringer Ingelheim Investigational Site Matsumoto, Nagano, Japan 1218.23.07 Boehringer Ingelheim Investigational Site Meguro-ku, Tokyo, Japan 1218.23.25 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1218.23.26 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1218.23.28 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1218.23.29 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1218.23.30 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1218.23.04 Boehringer Ingelheim Investigational Site Naka, Ibaraki, Japan 1218.23.15 Boehringer Ingelheim Investigational Site Nishi-ku, Hiroshima, Hiroshima, Japan 1218.23.34 Boehringer Ingelheim Investigational Site Nishi-ku, Sakai, Osaka, Japan 1218.23.22 Boehringer Ingelheim Investigational Site Nishishinjyuku, Shinjyuku-ku, Tokyo, Japan 1218.23.16 Boehringer Ingelheim Investigational Site Oita, Oita, Japan 1218.23.40 Boehringer Ingelheim Investigational Site Oita, Oita, Japan 1218.23.36 Boehringer Ingelheim Investigational Site Okayama, Okayama, Japan 1218.23.11 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1218.23.12 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1218.23.32 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1218.23.33 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1218.23.35 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1218.23.17 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1218.23.18 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1218.23.19 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1218.23.41 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1218.23.42 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1218.23.43 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1218.23.01 Boehringer Ingelheim Investigational Site Sendai, Miyagi, Japan 1218.23.20 Boehringer Ingelheim Investigational Site Sendai, Miyagi, Japan 1218.23.46 Boehringer Ingelheim Investigational Site Shinjuku-ku, Tokyo, Japan 1218.23.08 Boehringer Ingelheim Investigational Site Shinjyuku-ku,Tokyo, Japan 1218.23.14 Boehringer Ingelheim Investigational Site Suita, Osaka, Japan 1218.23.31 Boehringer Ingelheim Investigational Site Takatsuki, Osaka, Japan 1218.23.48 Boehringer Ingelheim Investigational Site Yokohama, Kanagawa, Japan Less <<
NCT00118170 Extranodal Marginal Zone B-cel... More >>l Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Multiple Myeloma Splenic Marginal Zone Lymphoma Stage II Multiple Myeloma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Multiple Myeloma Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Waldenstr?m Macroglobulinemia Less << Phase 1 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B (CALGB) Research Base Chicago, Illinois, United States, 60604-1104 Less <<
NCT00660894 Colorectal Cancer Phase 3 Completed - Japan ... More >> Tokyo Medical and Dental University Tokyo, Japan, 113-8519 Less <<
NCT00654381 - Completed - -
NCT00661830 Adenocarcinoma Phase 2 Completed - Germany ... More >> Klinikum der Johannes Gutenberg-Universität Mainz, I. Med. Klinik Mainz, Rheinland-Pfalz, Germany, 55131 Universitätsklinikum Jena, Klinik für Innere Medizin, Innere Medizin II D-07740 Jena, Germany Universitätsklinikum Hamburg-Eppendorf, I. Med. Klinik, Zentrum für Innere Medizin, Martinistr. 3 D-20248 Hamburg, Germany Klinikum Fulda gAG, Tumorklinik, Pacelliallee 4 D-36043 Fulda, Germany Klinikum der Johann-Wolfgang Goethe-Universität, Innere Medizin I, Theodor-Stern-Kai 7 D-60590 Frankfurt, Germany Universitätsklinikum des Saarlandes, Klinik für Innere Medizin II, Kirrberger Str., Gebäude 41 D-66421 Homburg/Saar, Germany Klinikum der Universität München, Medizinische Klinik II, Marchioninistr. 15 D-81377 München, Germany Klinikum rechts der Isar, TU München, II. Medizinische Klinik und Poliklinik, Ismaningerstr. 22 D-81675 München, Germany II. Med. Klinik, Leopoldina-Krankenhaus der Stadt Schweinfurt, Gustav-Adolf-Str. 8 D-97422 Schweinfurt, Germany Klinikum Esslingen Esslingen, Germany, 73730 Universitätsklinikum Halle, Innere Medizin I Halle, Germany, 06120 Less <<
NCT00654069 - Completed - -
NCT00661830 - Completed - -
NCT00477607 - Completed - -
NCT00665990 Refractory Solid Tumors ... More >> Leukemia Less << Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00119249 Stage III Melanoma ... More >> Stage IV Melanoma Less << Phase 2 Completed - United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10467-2490 Less <<
NCT00667589 Hand-foot Skin Reaction ... More >> Rash Less << Phase 2 Terminated(Study was halted du... More >>e to poor subject accrual.) Less << - United States, Illinois ... More >> Northwestern University Feinberg School of Medicine, Department of Dermatology Chicago, Illinois, United States, 60611 Less <<
NCT00121264 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT00119639 Kidney Diseases Phase 1 Completed - -
NCT00668863 Unresectable or Metastatic Col... More >>orectal Cancer Less << Phase 2 Completed - Japan ... More >> Pfizer Investigational Site Nagoya, Aichi, Japan Pfizer Investigational Site Chiba-shi, Chiba-ken, Japan Pfizer Investigational Site Matsuyama-shi, Ehime, Japan Pfizer Investigational Site Sapporo-shi, Hokkaido, Japan Pfizer Investigational Site Sapporo, Hokkaido, Japan Pfizer Investigational Site Kochi-shi, Kochi, Japan Pfizer Investigational Site Saku, Nagano, Japan Pfizer Investigational Site Osakasayama-shi, Osaka, Japan Pfizer Investigational Site Takatsuki, Osaka, Japan Pfizer Investigational Site Shimotsuke-shi, Tochigi, Japan Pfizer Investigational Site Minoh/Osaka, Japan Less <<
NCT00668863 - Completed - -
NCT00477607 Ototoxicity U... More >>nspecified Adult Solid Tumor Less << Phase 2 Phase 3 Completed - United States, Oregon ... More >> VA Medical Center, Portland Portland, Oregon, United States, 97201 Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT00126568 Anaplastic Thyroid Cancer ... More >> Recurrent Thyroid Cancer Less << Phase 2 Terminated - United States, Ohio ... More >> Case Western Reserve University Cleveland, Ohio, United States, 44106 Less <<
NCT00667589 - Terminated(Study was halted du... More >>e to poor subject accrual.) Less << - -
NCT00126568 - Terminated - -
NCT00485758 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT00126659 - Terminated - -
NCT00126620 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - Canada, Ontario ... More >> Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00678288 Carcinoma, Renal Cell Phase 2 Terminated - Austria ... More >> Salzburg, Austria, 5020 Wien, Austria, 1090 France Avignon, France, 84000 Bayonne, France, 64100 Bordeaux, France, 33000 Marseille, France, 13015 Marseille, France, 13385 Nantes, France, 44020 Paris, France, 75014 Paris, France, 75651 Reims, France, 51100 Strasbourg, France, 67000 Toulouse, France, 31052 Vandoeuvre Les Nancy, France, 54000 Ireland Cork, Ireland Dublin, Ireland, 24 Italy Aviano, Pordenone, Italy, 33081 Legnago, Verona, Italy, 37045 Napoli, Italy, 80131 Pavia, Italy, 27100 Perugia, Italy, 06156 Reggio Emilia, Italy, 42100 Poland Gdansk, Poland, 80-219 Lublin, Poland, 20-090 Warszawa, Poland, 04-141 Wroclaw, Poland, 50 - 556 Spain Barcelona, Spain, 08035 Madrid, Spain, 28041 Madrid, Spain, 28046 Oviedo, Spain, 33006 Pamplona, Spain, 31008 Valencia, Spain, 46009 United Kingdom Northwood, Middlesex, United Kingdom, HA6 2RN Newcastle Upon Tyne, Tyne and Wear, United Kingdom, NE4 6BE London, United Kingdom, SW3 6JJ Less <<
NCT00485758 - Completed - -
NCT00126659 Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Cancer Stage IV Renal Cell Cancer Less << Phase 2 Terminated - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00131911 Gastrinoma Gl... More >>ucagonoma Insulinoma Metastatic Gastrointestinal Carcinoid Tumor Neuroendocrine Tumor Pancreatic Polypeptide Tumor Recurrent Gastrointestinal Carcinoid Tumor Recurrent Islet Cell Carcinoma Somatostatinoma WDHA Syndrome Less << Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00680121 - Completed - -
NCT00680121 Alcoholism Phase 4 Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT00131937 Anaplastic Large Cell Lymphoma... More >> Angioimmunoblastic T-cell Lymphoma Hepatosplenic T-cell Lymphoma Peripheral T-cell Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Less << Phase 2 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT00687076 Peripheral Arterial Disease Phase 4 Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00131911 - Completed - -
NCT00687076 - Completed - -
NCT00678288 - Terminated - -
NCT00131989 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 Less <<
NCT00687674 - Terminated(Due to study design... More >> (and toxicity), this trial closed to accrual prior to opening the phase II portion.) Less << - -
NCT00687674 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 1 Phase 2 Terminated(Due to study design... More >> (and toxicity), this trial closed to accrual prior to opening the phase II portion.) Less << - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00500045 Central Retinal Vein Occlusion... More >> Branch Retinal Vein Occlusion Less << Phase 2 Phase 3 Completed - United States, California ... More >> Palo Alto Medical Foundation Department of Ophthalmology Palo Alto, California, United States, 94301 Less <<
NCT00131937 - Completed - -
NCT00694291 Prostate Cancer Phase 2 Withdrawn - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00691210 Hodgkin's Disease ... More >> Non-Hodgkin's Lymphoma Less << Phase 1 Completed - United States, New York ... More >> Columbia University Medical Center NY, New York, United States, 10022 Less <<
NCT00696696 Pancreatic Cancer Phase 2 Completed - United States, California ... More >> Desert Regional Medical Center Palm Springs, California, United States, 92262 United States, New York Bellevue Hospital New York, New York, United States, 10016 New York University Cancer Center New York, New York, United States, 10016 Less <<
NCT00696696 - Completed - -
NCT00145106 Acne Vulgaris Phase 4 Completed - United States, Pennsylvania ... More >> KGL, Inc Broomall, Pennsylvania, United States, 19008 Less <<
NCT00699010 Opioid Abuse Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins Medical Center Baltimore, Maryland, United States, 21224 Less <<
NCT00699010 - Completed - -
NCT00703365 Carcinoma, Hepatocellular Phase 2 Completed - Thailand ... More >> Department of Medicine, Siriraj Hospital Bangkoknoi, Bangkok, Thailand, 10700 Medical Oncology Unit, Chulalongkorn Hospital Patumwan, Bangkok, Thailand, 10330 Horizon Regional Cancer Center, Bamrungrad Hospital Sukhumvit 3, Bangkok, Thailand, 10110 Less <<
NCT00187564 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, California ... More >> UCSF Division of Pediatric Endocrinology San Francisco, California, United States, 94143-0434 Less <<
NCT00217399 - Completed - -
NCT00508989 Sickle Cell Disease Phase 2 Completed - United States, District of Col... More >>umbia Howard University Hospital Washington, District of Columbia, United States, 20060 United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00217620 - Completed - -
NCT00217399 Recurrent Breast Cancer ... More >> Stage IV Breast Cancer Less << Phase 1 Phase 2 Completed - United States, District of Col... More >>umbia Lombardi Comprehensive Cancer Center at Georgetown University Washington, District of Columbia, United States, 20057 Less <<
NCT00182689 - Completed - -
NCT00217620 Sarcoma Phase 2 Completed - -
NCT00691210 - Completed - -
NCT00707174 Cancer Lentig... More >>o Maligna Less << Not Applicable Completed - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT00217646 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Adult Acute Monocytic Leukemia Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With Maturation Adult Acute Myeloid Leukemia With Minimal Differentiation Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL Adult Acute Myeloid Leukemia Without Maturation Adult Acute Myelomonocytic Leukemia Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA Adult Erythroleukemia Adult Pure Erythroid Leukemia Alkylating Agent-Related Acute Myeloid Leukemia Blastic Phase de Novo Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndrome Less << Phase 1 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00182689 Extensive Stage Small Cell Lun... More >>g Cancer Recurrent Small Cell Lung Cancer Less << Phase 2 Completed - United States, Oregon ... More >> SWOG Portland, Oregon, United States, 97239 Less <<
NCT00707174 - Completed - -
NCT00989469 Metastatic Colorectal Cancer Phase 1 Phase 2 Completed - France ... More >> Centre Oscar Lambret Lille, France Hopital Saint Eloi Montpellier, France Centre Rene Gauducheau Nantes, France Centre Antoine Lacassagne Nice, France CHU Robert Debre Reims, France Less <<
NCT00984750 Diabetes Type 2 ... More >> Hypertension Less << Phase 3 Completed - Italy ... More >> Hospital "Azienda Ospedaliera di Treviglio e Caravaggio" Ambulatory of Diabetology Ponte San Pietro, Bergamo, Italy, 24036 Clinical Research Center for Rare Diseases "Aldo and Cele Daccò" Ranica, Bergamo, Italy, 24020 Hospital "Azienda Ospedaliera di Treviglio-Caravaggio"Unit of Diabetology and Metabolic Diseases Romano di Lombardia, Bergamo, Italy Hospital "Azienda Ospedaliera di Treviglio-Caravaggio" Unit of Diabetology and Metabolic Disease Treviglio, Bergamo, Italy Hospital "Azienda Ospedaliera Ospedali Riunitidi Bergamo" Unit of Diabetology Bergamo, Italy, 24100 Less <<
NCT00424385 Prostate Cancer Phase 1 Completed - United States, Illinois ... More >> Oncology Specialists, S.C Niles, Illinois, United States, 60714 Oncology Specialists, S.C Park Ridge, Illinois, United States, 60068 Less <<
NCT00988715 Chronic Myelomonocytic Leukemi... More >>a Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts Refractory Cytopenia With Multilineage Dysplasia Refractory Cytopenia With Multilineage Dysplasia and Ringed Sideroblasts Secondary Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00796887 Ischemic Stroke Phase 2 Completed - United States, Michigan ... More >> Henry Ford Hospital Detroit, Michigan, United States, 48202 Less <<
NCT01004978 Hepatocellular Carcinoma ... More >> Unresectable Hepatocellular Carcinoma Less << Phase 3 Active, not recruiting - -
NCT00418496 Renal Cancer ... More >>Melanoma Less << Phase 1 Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00424385 - Completed - -
NCT01008566 Adult Hepatocellular Carcinoma... More >> Advanced Adult Hepatocellular Carcinoma Localized Non-Resectable Adult Liver Carcinoma Recurrent Adult Liver Carcinoma Less << Phase 1 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Pennsylvania Penn State Hershey Cancer Institute-Clinical Trials Office Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01005199 Liver Cancer Phase 2 Completed - Austria ... More >> Medizinische Universität Wien Wien, Austria, 1090 Hungary Szent Laszlo Korhaz Budapest, Hungary, 1097 Switzerland Saint Claraspital AG Basel, Switzerland, CH-4016 Clinical Cancer Research Center at University Hospital Basel Basel, Switzerland, CH-4031 Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland, 6500 Inselspital Bern Bern, Switzerland, CH-3010 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital Liestal Liestal, Switzerland, CH-4410 CHCVS - Hôpital de Sion Sion, Switzerland, 1950 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Regionalspital Thun, Switzerland, 3600 City Hospital Triemli Zurich, Switzerland, CH-8063 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT01011010 Liver Cancer Phase 1 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT01010516 Dyslipidemia Phase 4 Unknown - Greece ... More >> University of Ioannina Medical School Recruiting Ioannina, Greece, 45 110 Contact: M S Elisaf, MD    +302651007509    egepi@cc.uoi.gr    Principal Investigator: Moses S Elisaf, MD          Sub-Investigator: Evangelos N Liberopoulos, MD          Sub-Investigator: Anastazia Kei, MD Less <<
NCT01012219 - Completed - -
NCT01015833 Advanced Adult Hepatocellular ... More >>Carcinoma Recurrent Hepatocellular Carcinoma Stage III Hepatocellular Carcinoma AJCC v7 Stage IIIA Hepatocellular Carcinoma AJCC v7 Stage IIIB Hepatocellular Carcinoma AJCC v7 Stage IIIC Hepatocellular Carcinoma AJCC v7 Stage IV Hepatocellular Carcinoma AJCC v7 Stage IVA Hepatocellular Carcinoma AJCC v7 Stage IVB Hepatocellular Carcinoma AJCC v7 Unresectable Hepatocellular Carcinoma Less << Phase 3 Active, not recruiting - -
NCT01016977 Acne Vulgaris Phase 4 Completed - -
NCT01015833 - Active, not recruiting - -
NCT01011699 Chronic Renal Failure ... More >> Hemodialysis Less << Phase 3 Terminated(Financial problem) - France ... More >> Centre Hospitalier Général Soissons, Aisne, France, 02009 Centre Hospitalier Lisieux, Calvados, France, 14100 ALURAD Limoges, Limousin, France, 87042 Centre Hospitalier Universitaire Reims, Marne, France, 51092 Association Régionale Promotion Dialyse à domicile (ARPDD) Reims, Marne, France Association pour le Développement de l'Hémodialyse Hénin-Beaumont, Nord-Pas de Calais, France, 62110 Polyclinique de la Louvière Lille, Nord, France, 59000 CHRU Lille, Nord, France, 59037 Hôpital Victor Provo Roubaix, Nord, France, 59056 Centre Hospitalier Général Valenciennes, Nord, France, 59322 Centre Hospitalier Général Beauvais, Oise, France, 60000 Clinique Saint Côme Compiegne, Oise, France, 60200 Centre Hospitalier Général Creil, Oise, France, 60100 Clinique du Bois Bernard Bois Bernard, Pas de calais, France, 62320 Centre Hospitalier Boulogne sur mer, Pas de calais, France, 62200 Centre Hospital-Universitaire d'Amiens Amiens, Picardie, France, 80054 Clinique de l'Europe Rouen, Seine maritime, France, 76040 Centre Hospitalier Cambrai, France, 59407 Less <<
NCT00445042 Carcinoma, Renal Cell Phase 2 Completed - United States, Texas ... More >> Methodist Hospital - Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT01016483 Pancreatic Adenocarcinoma Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> For Recruiting Locations in the United States, please Contact U.S. Medical Information Rockland, Massachusetts, United States Germany For Recruiting Locations outside the United States, Please contact the Merck KGaA Communication Center Darmstadt, Germany Less <<
NCT01012219 Primary Hypercholesterolemia ... More >> Mixed Hyperlipidemia Less << Phase 1 Completed - -
NCT00090545 Prostate Cancer Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00090545 - Completed - -
NCT00071266 Intermittent Claudication ... More >> Peripheral Vascular Disease Less << Phase 3 Completed - -
NCT00095459 Neoplasms Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01016977 - Completed - -
NCT01016483 - Completed - -
NCT00095966 Adenocarcinoma of the Pancreas... More >> Recurrent Pancreatic Cancer Stage II Pancreatic Cancer Stage III Pancreatic Cancer Stage IV Pancreatic Cancer Less << Phase 2 Completed - United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT00096200 Recurrent Fallopian Tube Carci... More >>noma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Less << Phase 2 Completed - United States, Florida ... More >> Moffitt Cancer Center at Tampa General Hospital Tampa, Florida, United States, 33612 Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Lake University Ireland Cancer Center Mentor, Ohio, United States, 44060 United States, Virginia Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT00096278 Adenocarcinoma of the Colon ... More >> Stage IIA Colon Cancer Stage IIB Colon Cancer Stage IIC Colon Cancer Stage IIIA Colon Cancer Stage IIIB Colon Cancer Stage IIIC Colon Cancer Less << Phase 3 Completed - United States, Pennsylvania ... More >> National Surgical Adjuvant Breast and Bowel Project Pittsburgh, Pennsylvania, United States, 15212-5234 Less <<
NCT00096200 - Completed - -
NCT00096278 - Completed - -
NCT00098618 Clear Cell Renal Cell Carcinom... More >>a Papillary Renal Cell Carcinoma Recurrent Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer Less << Phase 2 Terminated - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00100841 Adenocarcinoma of the Rectum ... More >> Mucinous Adenocarcinoma of the Colon Recurrent Colon Cancer Recurrent Rectal Cancer Signet Ring Adenocarcinoma of the Colon Stage IV Colon Cancer Stage IV Rectal Cancer Less << Phase 2 Completed - United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10467-2490 Less <<
NCT00101114 Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer Less << Phase 2 Completed - United States, Texas ... More >> Southwest Oncology Group San Antonio, Texas, United States, 78245 Less <<
NCT00033176 Acquired Immunodeficiency Synd... More >>rome HIV Infections Less << Phase 2 Completed - United States, California ... More >> Quest Clinical Research San Francisco, California, United States, 94115 Eye Clinic, Santa Clara Valley Medical Center San Jose, California, United States, 95128 Less <<
NCT00101907 - Terminated(Study terminated pe... More >>r recommendation of Data Review Team) Less << - -
NCT00100841 - Completed - -
NCT00110019 Mucosal Melanoma ... More >> Recurrent Melanoma Stage IIIA Skin Melanoma Stage IIIB Skin Melanoma Stage IIIC Skin Melanoma Stage IV Skin Melanoma Less << Phase 3 Completed - -
NCT00108953 - Completed - -
NCT00101907 Lung Cancer P... More >>ancreatic Cancer Esophageal Cancer Less << Phase 1 Terminated(Study terminated pe... More >>r recommendation of Data Review Team) Less << - -
NCT00111007 Melanoma Phase 3 Completed - -
NCT00110019 - Completed - -
NCT00096395 Recurrent Ovarian Epithelial C... More >>ancer Recurrent Primary Peritoneal Cavity Cancer Less << Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00114244 Stage IV Pancreatic Cancer Phase 2 Completed - United States, California ... More >> City of Hope Duarte, California, United States, 91010 Less <<
NCT00108953 Carcinoma, Hepatocellular Phase 2 Completed - -
NCT00116207 Diabetic Autonomic Neuropathy Phase 3 Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT00044512 - Completed - -
NCT00111007 - Completed - -
NCT00117026 Diabetes Mellitus, Type 1 Phase 1 Phase 2 Completed - Norway ... More >> Aker University Hospital Oslo, Norway, 0514 Less <<
NCT00114244 - Completed - -
NCT00116207 - Completed - -
NCT00118261 Colorectal Cancer Phase 1 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 MetroHealth Cancer Care Center at MetroHealth Medical Center Cleveland, Ohio, United States, 44109 UHHS Chagrin Highlands Medical Center Cleveland, Ohio, United States, 44122 Less <<
NCT00044512 Carcinoma, Hepatocellular Phase 2 Completed - United States, California ... More >> Los Angeles, California, United States, 90057 United States, New York New York, New York, United States, 10021-6007 Belgium Bruxelles - Brussel, Belgium, 1000 Bruxelles - Brussel, Belgium, 1070 Bruxelles - Brussel, Belgium, 1090 Gent, Belgium, 9000 Leuven, Belgium, 3000 France Lille Cedex, France, 59020 Marseille, France, 13005 Paris, France, 75020 Rennes Cedex, France, 35062 Saint Herblain, France, 44805 Israel Haifa, Israel, 31096 Jerusalem, Israel, 91120 Petach Tikva, Israel, 49100 Rehovot, Israel, 76100 Tel Aviv, Israel, 64239 Tel Hashomer, Israel, 52621 Italy Rozzano, Milano, Italy, 20089 Forlì, Italy, 47100 Milano, Italy, 20122 Pisa, Italy, 56126 Verona, Italy, 37126 Less <<
NCT00117637 Carcinoma, Renal Cell Phase 2 Completed - -
NCT00120289 Cardiovascular Diseases ... More >> Heart Diseases Cerebrovascular Accident Coronary Disease Atherosclerosis Myocardial Infarction Less << Phase 3 Terminated(AIM-HIGH was stoppe... More >>d on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.) Less << - -
NCT00121251 Recurrent Renal Cell Carcinoma... More >> Stage III Renal Cell Cancer AJCC v7 Stage IV Renal Cell Cancer AJCC v7 Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467 Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, New York, United States, 10016 Mount Sinai Hospital New York, New York, United States, 10029 Weill Medical College of Cornell University New York, New York, United States, 10065 Less <<
NCT00122447 Impaired Glucose Tolerance ... More >> Prediabetic State Less << Not Applicable Completed - United States, Georgia ... More >> Grady Health System Atlanta, Georgia, United States, 30303 Emory University Hospital Atlanta, Georgia, United States, 30322 Less <<
NCT00126503 Chromophobe Renal Cell Carcino... More >>ma Clear Cell Renal Cell Carcinoma Papillary Renal Cell Carcinoma Recurrent Renal Cell Carcinoma Sarcomatoid Renal Cell Carcinoma Stage IV Renal Cell Cancer Less << Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Pennsylvania University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT00126503 - Completed - -
NCT00120289 - Terminated(AIM-HIGH was stoppe... More >>d on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.) Less << - -
NCT00127218 Atherosclerosis ... More >> Cardiovascular Disease Less << Phase 3 Completed - United States, Maryland ... More >> Johns Hopkins Unversity School of Medicine Baltimore, Maryland, United States, 21218 Less <<
NCT00126594 - Completed - -
NCT00117637 - Completed - -
NCT00126594 Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Carcinoma Stage IV Renal Cell Cancer Less << Phase 2 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00134069 Recurrent Colon Cancer ... More >> Recurrent Rectal Cancer Stage III Colon Cancer Stage III Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Less << Phase 1 Completed - United States, Colorado ... More >> University of Colorado at Denver Health Sciences Center Aurora, Colorado, United States, 80045 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 Less <<
NCT00127218 - Completed - -
NCT00143702 Acidosis, Lactic Phase 2 Phase 3 Completed - Canada, British Columbia ... More >> St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Ontario Positive Care Clinic Toronto, Ontario, Canada Less <<
NCT00152893 HIV Infections Phase 2 Completed - Canada, Ontario ... More >> University Health Network - Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT00138177 Recurrent Colon Cancer ... More >> Recurrent Rectal Cancer Stage III Colon Cancer Stage III Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT00194402 Dyslipidemia Phase 4 Completed - United States, Washington ... More >> Northwest Lipid Research Clinic, University of Washington Seattle, Washington, United States, 98104 Less <<
NCT00203476 Hyperlipidemia ... More >> Hypercholesterolemia Less << Phase 4 Completed - United States, Alabama ... More >> Tuscaloosa Research & Education Advancement Corporation Tuscaloosa, Alabama, United States, 35404 Less <<
NCT00208260 Colorectal Cancer ... More >> Liver Metastases Chemotherapy Less << Phase 2 Phase 3 Completed - France ... More >> CRLC Val d'Aurelle Montpellier, France, 34298 Less <<
NCT00122447 - Completed - -
NCT00245050 - Completed - -
NCT00253370 - Completed - -
NCT00253370 Adenocarcinoma of the Gastroes... More >>ophageal Junction Metastatic Gastric Cancer Advanced Unresectable Gastric Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT00203476 - Completed - -
NCT00262964 - Completed - -
NCT00245050 Breast Cancer ... More >> Drug/Agent Toxicity by Tissue/Organ Endometrial Cancer Fallopian Tube Cancer Ovarian Cancer Peritoneal Cavity Cancer Less << Phase 3 Completed - United States, Ohio ... More >> Geauga Regional Hospital Cleveland, Ohio, United States, 44024 Lake/University Ireland Cancer Center Cleveland, Ohio, United States, 44060 Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Southwest General Health Center Cleveland, Ohio, United States, 44130 University Suburban Health Center Cleveland, Ohio, United States, 44143 UHHS Westlake Medical Center Cleveland, Ohio, United States, 44145 Mercy Cancer Center at Mercy Medical Center Cleveland, Ohio, United States, 44708 UHHS Chagrin Highlands Medical Center Cleveland, Ohio, United States, 44708 Less <<
NCT00252564 Colorectal Cancer Metastatic Phase 3 Completed - -
NCT00262964 Non-alcoholic Fatty Liver Dise... More >>ase Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00265811 Colorectal Cancer Phase 3 Completed - France ... More >> Hopital Duffaut Avignon, France, 84902 CHU de Caen Caen, France, 14033 Hopital Robert Boulin Libourne, France, 33500 Hopital Bichat - Claude Bernard Paris, France, 75018 CHU Pitie-Salpetriere Paris, France, 75651 Hopital Tenon Paris, France, 75970 Centre Hospitalier Yves Le Foll Saint Brieuc Cedex 1, France, BP 2367 Nouvelle Clinique Generale Valence, France, 26000 Less <<
NCT00269217 Primary Hypercholesterolemia ... More >> Mixed Hyperlipidemia Less << Phase 3 Completed - -
NCT00271817 Hypercholesterolemia Phase 3 Completed - -
NCT00252564 - Completed - -
NCT00271817 - Completed - -
NCT00300365 Metabolic Syndrome Phase 2 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00281944 Childhood Central Nervous Syst... More >>em Choriocarcinoma Childhood Central Nervous System Embryonal Tumor Childhood Central Nervous System Germ Cell Tumor Childhood Central Nervous System Germinoma Childhood Central Nervous System Mixed Germ Cell Tumor Childhood Central Nervous System Teratoma Childhood Central Nervous System Yolk Sac Tumor Recurrent Childhood Brain Stem Glioma Recurrent Childhood Central Nervous System Embryonal Tumor Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00293644 Hyperemesis Gravidarum ... More >> Pregnancy Less << Phase 3 Completed - Canada, Ontario ... More >> The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT00300365 - Completed - -
NCT00300885 Carcinoma, Non-Small Cell Lung Phase 3 Terminated(Based on the result... More >>s of the interim analysis, it was determined that the study would not meet its primary efficacy endpoint and the study was terminated early.) Less << - -
NCT00286234 Metabolic Syndrome ... More >> Hypertriglyceridemia Less << Phase 4 Completed - United States, South Dakota ... More >> Sanford Clinic Clinical Research Services Sioux Falls, South Dakota, United States, 57105 Less <<
NCT00300885 - Terminated(Based on the result... More >>s of the interim analysis, it was determined that the study would not meet its primary efficacy endpoint and the study was terminated early.) Less << - -
NCT00303771 Colorectal Cancer Phase 3 Completed - -
NCT00303628 Adenocarcinoma of the Rectum ... More >> Stage II Rectal Cancer Stage III Rectal Cancer Less << Phase 3 Terminated(The study was termi... More >>nated before reaching its accrual goal due to slow accrual.) Less << April 2019 -
NCT00303628 - Terminated(The study was termi... More >>nated before reaching its accrual goal due to slow accrual.) Less << - -
NCT00304993 Metabolic Syndrome X ... More >> Insulin Resistance Less << Phase 4 Completed - United States, Florida ... More >> Foundation Research St. Petersburg, Florida, United States, 33705 Less <<
NCT00307307 Established Carotid Atheroscle... More >>rosis Less << Phase 4 Completed - -
NCT00111891 Dyslipidemia Phase 2 Completed - -
NCT00108485 - Terminated(Unable to recruit s... More >>ufficient study subjects) Less << - -
NCT00064350 - Completed - -
NCT00108485 Diabetes Mellitus, Type 2 ... More >> Kidney Failure, Chronic Hyperlipidemia Less << Phase 3 Terminated(Unable to recruit s... More >>ufficient study subjects) Less << - United States, Florida ... More >> Univesity of Miami/Diabetes Research Institute Miami, Florida, United States, 33136 Less <<
NCT00329641 Ciliary Body and Choroid Melan... More >>oma, Medium/Large Size Extraocular Extension Melanoma Iris Melanoma Metastatic Intraocular Melanoma Recurrent Intraocular Melanoma Less << Phase 2 Completed - United States, Texas ... More >> Southwest Oncology Group San Antonio, Texas, United States, 78245 Less <<
NCT00329641 - Completed - -
NCT00064350 Lung Cancer Phase 2 Completed - -
NCT00352859 Carcinoma, Renal Cell Phase 4 Terminated - United States, Missouri ... More >> Kansas City, Missouri, United States Less <<
NCT00337389 Metastatic Colorectal Cancer ... More >> Colon Cancer Rectal Cancer Less << Phase 3 Unknown - -
NCT00359281 Healthy Phase 2 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00322400 Locally Recurrent and Metastat... More >>ic Breast Cancer Less << Phase 1 Completed - -
NCT00359281 - Completed - -
NCT00356681 Breast Neoplasms ... More >> Breast Tumors Breast Cancer Locally Recurrent and Metastatic Breast Cancer Less << Phase 2 Terminated(Sponsor decision to... More >> close study) Less << - -
NCT00369070 Advanced Non-squamous NSCLC Phase 2 Terminated - -
NCT00073307 - Completed - -
NCT00073307 Carcinoma, Renal Cell Phase 3 Completed - -
NCT00378703 Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Carcinoma Stage IV Renal Cell Cancer AJCC v7 Less << Phase 2 Completed - -
NCT00232531 Atherosclerosis Not Applicable Unknown - United Kingdom ... More >> Oxford University Oxford, United Kingdom Less <<
NCT00335816 Colorectal Cancer Phase 2 Active, not recruiting December 2019 United States, California ... More >> Cancer Care Center at John Muir Health - Concord Campus Concord, California, United States, 94524-4110 City of Hope Medical Center Duarte, California, United States, 91010-3000 St. Joseph Hospital Regional Cancer Center - Orange Orange, California, United States, 92868-3849 Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange, California, United States, 92868 UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, District of Columbia Washington Cancer Institute at Washington Hospital Center Washington, District of Columbia, United States, 20010 United States, Florida H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 United States, Minnesota Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, Nebraska Colon and Rectal Surgery, Incorporated Omaha, Nebraska, United States, 68114 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Oregon Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239-3098 United States, Vermont Vermont Cancer Center at University of Vermont Burlington, Vermont, United States, 05405-0110 Canada, Alberta Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada, T2N 4N2 Less <<
NCT00384176 Colorectal Cancer Phase 2 Phase 3 Completed - -
NCT00375310 Pancreatic Cancer ... More >> Adenocarcinoma of the Pancreas Less << Phase 1 Completed - United States, Indiana ... More >> Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00384176 - Completed - -
NCT00385970 Colorectal Cancer Phase 3 Unknown April 2015 Japan ... More >> Osaka University Hospital Suita, Osaka, Japan, 565-0871 Less <<
NCT00387413 Hyperalgesia Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Less <<
NCT00387751 Recurrent Melanoma ... More >> Stage III Skin Melanoma Stage IV Skin Melanoma Less << Phase 2 Completed - United States, Texas ... More >> Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT00378703 - Completed - -
NCT00387751 - Completed - -
NCT00390611 - Completed - -
NCT00246376 - Completed - -
NCT00392821 Kidney Cancer Phase 1 Phase 2 Completed - United States, Florida ... More >> Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 Norton Cancer Institute Louisville, Kentucky, United States, 40207 United States, Missouri Research Medical Center Kansas City, Missouri, United States, 64132 United States, New Jersey Hematology Oncology Associates of Northern NJ Morristown, New Jersey, United States, 07960 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00390611 Ovarian Cancer Phase 2 Completed - United States, Arkansas ... More >> Northeast Arkansas Clinic Jonesboro, Arkansas, United States, 72401 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Holy Cross Hospital Ft. Lauderdale, Florida, United States, 33308 Gulfcoast Oncology Associates St. Petersburg, Florida, United States, 33705 United States, Georgia Medical College of Georgia Cancer Specialists Augusta, Georgia, United States, 30912 United States, Indiana Providence Medical Group Terre Haute, Indiana, United States, 47802 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, Michigan St. Joseph Mercy Hospital Ann Arbor, Michigan, United States, 48106 Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Oklahoma University of Oklahoma Oklahoma City, Oklahoma, United States, 73104 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Tennessee Valley Clinical Research Chattanooga, Tennessee, United States, 37411 Family Cancer Center Collierville, Tennessee, United States, 38017 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Peninsula Cancer Center Newport News, Virginia, United States, 23601 Less <<
NCT00392821 - Completed - -
NCT00397657 Atherosclerosis Phase 4 Terminated(Independent steerin... More >>g committee has stopped the trial based on results of a prespecified, blinded interim analysis. It was not stopped due to safety concerns.) Less << October 2009 United States, District of Col... More >>umbia Walter Reed Army Medical Center Washington, District of Columbia, United States, 20307 United States, Maryland Washington Adventist Hospital Takoma Park, Maryland, United States, 20912 Less <<
NCT00246376 Cardiovascular Diseases ... More >> Heart Diseases HIV Infections Hyperlipidemia Hypertriglyceridemia Insulin Resistance Atherosclerosis Less << Not Applicable Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77098 Less <<
NCT00269204 Primary Hypercholesterolaemia ... More >> Mixed Hyperlipidaemia Less << Phase 3 Completed - -
NCT00399035 - Completed - -
NCT00411554 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 3 Completed - -
NCT00399035 Metastatic Colorectal Cancer Phase 3 Completed - -
NCT00079612 Carcinoma, Renal Cell Phase 2 Completed - United States, Illinois ... More >> Chicago, Illinois, United States, 60637 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas Houston, Texas, United States, 77030 San Antonio, Texas, United States, 78229 United Kingdom London, Greater London, United Kingdom, SW3 6JJ Glasgow, Strathclyde, United Kingdom, G11 6NT Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT00411554 - Completed - -
NCT00079807 HIV Periphera... More >>l Neuropathy Less << Phase 1 Phase 2 Completed - United States, North Carolina ... More >> University of North Carolina Chapel Hill Chapel Hill, North Carolina, United States, 27599-7025 Less <<
NCT00423696 Colorectal Cancer Phase 2 Unknown - France ... More >> C.H.U. de Brest Brest, France, 29200 Centre Regional Francois Baclesse Caen, France, 14076 Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Oscar Lambret Lille, France, 59020 Polyclinique des Quatre Pavillons Lormont, France, 33310 Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Antoine Lacassagne Nice, France, 06189 Institut Curie Hopital Paris, France, 75248 Polyclinique Francheville Perigueux, France, 24004 Institut Jean Godinot Reims, France, 51056 Centre Eugene Marquis Rennes, France, 35062 Centre Rene Huguenin Saint Cloud, France, 92210 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00416767 Gastrointestinal Carcinoid Tum... More >>or Islet Cell Tumor Neoplastic Syndrome Less << Phase 2 Completed - -
NCT00424801 Microvascular Angina ... More >> Hypertension Less << Not Applicable Terminated(Due to recent findi... More >>ngs relating MRI contrast to nephrogenic systemic fibrosis) Less << December 2008 Denmark ... More >> Aarhus Hospital Aarhus, Denmark, 8000 Less <<
NCT00434369 Breast Cancer Phase 2 Unknown - Argentina ... More >> Clinical Research Site in Buenos Aires, Argentina Mexico Clinical Investigative Site Acapulco, Mexico Peru Clinical Investigative Site Lima, Peru Russian Federation Clinical Research Site in Kazan, Russian Federation Clinical Investigative Site St.Petersburg, Russian Federation Spain Clinical Investigative Site Valencia, Spain Less <<
NCT00436215 Ovarian Neoplasm ... More >> Fallopian Tube Cancer Primary Peritoneal Cancer Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00298909 Coronary Disease ... More >> Hypolipoproteinemia Less << Phase 4 Completed - Germany ... More >> University of Leipzig Heart Center Leipzig, Germany, 04289 Less <<
NCT00448149 Carcinoma, Renal Cell Phase 1 Phase 2 Completed - United States, Texas ... More >> The Methodist Hospital Research Institute Houston, Texas, United States, 77030 Less <<
NCT00436215 - Completed - -
NCT00449033 Carcinoma, Non-Small-Cell Lung Phase 3 Completed - -
NCT00431145 Coronary Artery Disease Phase 2 Unknown - Germany ... More >> University of Munich Recruiting Munich, Germany, 80333 Less <<
NCT00408551 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Unknown - United States, Indiana ... More >> Center for Cancer Care at Goshen General Hospital Recruiting Goshen, Indiana, United States, 46526 Contact: Clinical Trials Office - Center for Cancer Care at Goshen Gene    574-535-2858 Less <<
NCT00449033 - Completed - -
NCT00457691 Metastatic Colorectal Cancer Phase 3 Completed - -
NCT00452387 Metastatic Prostate Cancer Phase 2 Terminated(Early stopping rule... More >>) Less << - United States, California ... More >> Wilshire Oncology Medical Group, Inc. La Verne, California, United States, 91750 United States, Georgia Peachtree Hematology Oncology Consultants Atlanta, Georgia, United States, 30309 Central Georgia Cancer Care Macon, Georgia, United States, 31201 Northwest Georgia Oncology Centers Marietta, Georgia, United States, 30060 United States, Montana Hematology Oncology Centers of the Northern Rockies, PC Billings, Montana, United States, 59101 United States, Ohio Mid-Ohio Oncology/Hematology, Inc. Columbus, Ohio, United States, 43213 United States, Pennsylvania Lancaster Cancer Center Lancaster, Pennsylvania, United States, 17605 Pennsylvania Oncology Hematmology Associates Philadelphia, Pennsylvania, United States, 19106 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 United States, Virginia Cancer Specialists of Tidewater Chesapeake, Virginia, United States, 23320 Less <<
NCT00457691 - Completed - -
NCT00430235 Adenocarcinoma of the Prostate Phase 2 Completed - Canada, British Columbia ... More >> BC Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 Less <<
NCT00461851 Bladder Cancer Phase 2 Completed - United States, Connecticut ... More >> Yale University, Comprehensive Cancer Center New Haven, Connecticut, United States, 06520 Less <<
NCT00461630 Cardiovascular Disease ... More >> Peripheral Arterial Disease Diabetes Mellitus Coronary Heart Disease Less << Phase 3 Completed - United Kingdom ... More >> Clinical Trial Service Unit, University of Oxford Oxford, United Kingdom, OX3 7LF Less <<
NCT00461851 - Completed - -
NCT00461630 - Completed - -
NCT00469755 Acne Vulgaris Phase 4 Completed - United States, California ... More >> Therapeutics Clinical Research San Diego, California, United States, 92123 United States, Michigan Henry Ford Medical Center-Dept. of Dermatology Detroit, Michigan, United States, 48202 United States, Minnesota Minnesota Clinical Study Center Fridley, Minnesota, United States, 55432 United States, New York State University of New York Downstate Medical Center-Dept. of Dermatology Brooklyn, New York, United States, 11203 United States, Ohio Dermatology Research Associates Cincinnati, Ohio, United States, 45230 United States, Oregon Phoebe Rich, MD & Associates Portland, Oregon, United States, 97210 United States, Pennsylvania Milton S. Hershey Medical Center Center-Div. of Dermatology Hershey, Pennsylvania, United States, 17033-0850 United States, Texas DermResearch, Inc. Austin, Texas, United States, 78759 J & S Studies, Inc. Bryan, Texas, United States, 77802 Stephens & Associates Carrollton, Texas, United States, 75006 United States, Utah Dermatology Research Center Salt Lake City, Utah, United States, 84124 United States, Virginia Virginia Clinical Research, Inc. Norfolk, Virginia, United States, 23507 Less <<
NCT00474929 Lymphoma Mult... More >>iple Myeloma and Plasma Cell Neoplasm Less << Phase 1 Phase 2 Active, not recruiting January 2019 United States, Iowa ... More >> Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242-1002 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT00452387 - Terminated(Early stopping rule... More >>) Less << - -
NCT00465088 - Completed - -
NCT00474929 - Active, not recruiting - -
NCT00458055 Coronary Arteriosclerosis ... More >> Hypoalphalipoproteinemias Genetic Diseases, Inborn Less << Not Applicable Completed - Canada, Quebec ... More >> MUHC-Royal Victoria Hospital Montreal, Quebec, Canada, H3A 1A1 Less <<
NCT00465088 Hyperlipidemia ... More >> Mixed Dyslipidemia Less << Phase 3 Completed - -
NCT00479388 Primary Hypercholesterolemia ... More >> Mixed Dyslipidemia Less << Phase 3 Completed - -
NCT00478374 Hepatocellular Carcinoma Phase 1 Completed - Switzerland ... More >> Inselspital Bern, Switzerland, 3010 Less <<
NCT00479388 - Completed - -
NCT00446147 Hand-foot Syndrome Phase 3 Completed - -
NCT00449280 Advanced Solid Tumor Phase 1 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00090402 - Completed - -
NCT00446147 - Completed - -
NCT00445588 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor Less << Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01030406 Opioid Abuse Phase 2 Completed - United States, Utah ... More >> Lifetree Clinical Research Salt Lake City, Utah, United States, 84106 Less <<
NCT00090402 Alzheimer's Disease ... More >> Oxidative Stress Dementia Hyperlipidemia Inflammation Less << Phase 1 Phase 2 Completed - United States, Oregon ... More >> Oregon Health and Science University Portland, Oregon, United States, 97239 Less <<
NCT00445588 - Completed - -
NCT01031355 Contraception ... More >> Ovulation Inhibition Less << Phase 1 Completed - Germany ... More >> Neu-Ulm, Bayern, Germany, 89231 Less <<
NCT01030406 - Completed - -
NCT01032850 Hepatocellular Carcinoma Phase 2 Terminated(Low accrual rate) - United States, New Mexico ... More >> University of New Mexico Cancer Center @ Lovelace Medical Center Albuquerque, New Mexico, United States, 87102 University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 Cancer Center at Presbyterian Hospital Albuquerque, New Mexico, United States, 87110 Less <<
NCT01042041 Hepatocellular Carcinoma ... More >> Liver Cancer Localized Unresectable Liver Cancer Less << Phase 1 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00852969 Chronic Kidney Disease Phase 4 Completed - United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 Less <<
NCT00466232 Small Cell Carcinoma ... More >> Lung Cancer Less << Phase 1 Completed - United States, Minnesota ... More >> Park Nicollet Institute St. Louis Park, Minnesota, United States, 55416 Less <<
NCT01032850 - Terminated(Low accrual rate) - -
NCT01928420 Alzheimer's Disease ... More >> Dementia Less << Phase 2 Completed - United States, New York ... More >> James J Peters Veterans Affairs Medical Center Bronx, New York, United States, 10468 Less <<
NCT02079935 Bulimia Nervosa ... More >> Binge Eating Disorder Less << Not Applicable Active, not recruiting December 2018 Norway ... More >> Norwegian School of Sports Sciences Oslo, Norway, 0806 Less <<
NCT00852969 - Completed - -
NCT01050426 Pancreatic Cancer Phase 2 Terminated(Data from other tri... More >>als failed to demonstrate meaningful survival advantage) Less << - United Kingdom ... More >> Kent Oncology Centre Tunbridge Wells, Maidstone, United Kingdom, ME16 9QQ Royal Surrey County Hospital NHS Trust Guildford, Surrey, United Kingdom, GU2 7XX The Royal Marsden NHS Trust Sutton, Surrey, United Kingdom, SM2 5PT Aberdeen Royal Infirmary Aberdeen, United Kingdom, AB25 2ZN The Royal Bournemouth Hospital Bournemouth, United Kingdom Christie Hospital NHS Foundation Trust Manchester, United Kingdom, M20 4BX Poole Hospital NHS Trust Poole, United Kingdom, BH15 2JB Clatterbridge Centre for Oncology NHS Foundation Trust Wirral, United Kingdom, CH63 4JY Less <<
NCT01712074 Alzheimer's Disease Phase 2 Terminated(The study was termi... More >>nated October 23, 2015 as pre-specified, interim analysis futility criteria were met. The termination was not due to safety concerns.) Less << - -
NCT01712074 - Terminated(The study was termi... More >>nated October 23, 2015 as pre-specified, interim analysis futility criteria were met. The termination was not due to safety concerns.) Less << - -
NCT03480464 Obesity Baria... More >>tric Surgery Exercise Quality of Life Eating Behavior Body Fat Distribution Body Weight Changes Less << Not Applicable Recruiting December 31, 2019 Sweden ... More >> Vrinnevi Hospital Recruiting Norrköping, Sweden, 603 79 Contact: Ellen Andersson, MD, PhD    0046706037549    ellen.andersson@regionostergotland.se Less <<
NCT00004758 Spasms, Infantile ... More >> Epilepsy Less << Phase 2 Completed - -
NCT00010842 Multiple Sclerosis Phase 1 Phase 2 Completed - United States, Oregon ... More >> Oregon Health Sciences University Portland, Oregon, United States, 97207 Less <<
NCT00474786 Renal Cell Carcinoma Phase 3 Completed - -
NCT00012558 Bipolar Disorder Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305-5723 United States, Colorado University of Colorado, Colorado Psychiatric Health Clinical Investigation Center Denver, Colorado, United States, 80220 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 University of Massachusetts Medical Center Worcester, Massachusetts, United States, 01655 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Oklahoma University of Oklahoma Health Sciences Center Tulsa, Oklahoma, United States, 74135 United States, Oregon Portland Veteran's Administration Medical Center Portland, Oregon, United States, 97201 United States, Pennsylvania University of Pennsylvania Medical Center Philadelphia, Pennsylvania, United States, 19104-2649 University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229-3900 Less <<
NCT00000778 HIV Infections ... More >> Tuberculosis Less << Phase 1 Completed - United States, Alabama ... More >> Univ of Alabama at Birmingham Birmingham, Alabama, United States, 352336505 United States, California UCLA Med Ctr Los Angeles, California, United States, 900951793 Harbor - UCLA Med Ctr Torrance, California, United States, 90502 United States, Florida Broward Gen Med Ctr Fort Lauderdale, Florida, United States, 33316 Univ of Miami / Jackson Memorial Hosp Miami, Florida, United States, 33136 United States, Illinois Univ of Illinois Chicago, Illinois, United States, 60622 United States, Louisiana Tulane Univ Med School New Orleans, Louisiana, United States, 701122699 United States, Texas Univ of Texas Southwestern Med Ctr of Dallas Dallas, Texas, United States, 75235 Univ TX Galveston Galveston, Texas, United States, 77550 Baylor College of Medicine / Houston Veterans Adm Med Ctr Houston, Texas, United States, 77030 Less <<
NCT02034266 Type 1 Diabetes Phase 2 Completed - Canada, Ontario ... More >> University Health Network, Division of Neurology, Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT00000636 HIV Infections ... More >> Tuberculosis Less << Not Applicable Completed - -
NCT00000950 HIV Infections ... More >> Tuberculosis Less << Not Applicable Completed - United States, California ... More >> Univ of Southern California / LA County USC Med Ctr Los Angeles, California, United States, 900331079 Harbor UCLA Med Ctr Torrance, California, United States, 90502 United States, Florida University of Miami (Pediatric) Miami, Florida, United States, 33136 United States, Georgia Emory Univ Atlanta, Georgia, United States, 30308 United States, Hawaii Queens Med Ctr Honolulu, Hawaii, United States, 96816 Univ of Hawaii Honolulu, Hawaii, United States, 96816 United States, Louisiana Tulane Univ School of Medicine New Orleans, Louisiana, United States, 70112 United States, New York SUNY / Health Sciences Ctr at Brooklyn Brooklyn, New York, United States, 112032098 Beth Israel Med Ctr New York, New York, United States, 10003 St Vincent's Hosp / Mem Sloan-Kettering Cancer Ctr New York, New York, United States, 10021 Mount Sinai Med Ctr New York, New York, United States, 10029 United States, Ohio MetroHealth Med Ctr Cleveland, Ohio, United States, 441091998 United States, Pennsylvania Univ of Pennsylvania at Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00001033 HIV Infections ... More >> Tuberculosis Less << Phase 3 Completed - United States, California ... More >> USC CRS Los Angeles, California, United States, 90033 United States, District of Columbia Howard University Hosp., Div. of Infectious Diseases, ACTU Washington, District of Columbia, United States, 20059 United States, Florida Univ. of Miami AIDS CRS Miami, Florida, United States, 33136 United States, Hawaii Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu, Hawaii, United States, 96816 United States, Illinois Cook County Hosp. CORE Ctr. Chicago, Illinois, United States, 60612 United States, Maryland Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States, 21287 United States, New York SUNY - Buffalo, Erie County Medical Ctr Buffalo, New York, United States, 14215 NY Univ. HIV/AIDS CRS New York, New York, United States, 10016 Cornell University A2201 New York, New York, United States, 10021 Beth Israel Med. Ctr. (Mt. Sinai) New York, New York, United States, 10029 United States, Ohio Univ. of Cincinnati CRS Cincinnati, Ohio, United States, 45267 United States, Pennsylvania Hosp. of the Univ. of Pennsylvania CRS Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00000512 Cardiovascular Diseases ... More >> Coronary Arteriosclerosis Coronary Disease Heart Diseases Myocardial Ischemia Less << Phase 3 Completed - -
NCT00000796 HIV Infections ... More >> Tuberculosis Less << Not Applicable Completed - United States, Illinois ... More >> Cook County Hosp Chicago, Illinois, United States, 60612 United States, Michigan Henry Ford Hosp Detroit, Michigan, United States, 48202 United States, New York Bronx Lebanon Hosp Ctr Bronx, New York, United States, 10456 Bronx Municipal Hosp Ctr/Jacobi Med Ctr Bronx, New York, United States, 10461 Comprehensive Health Care Ctr / Bronx Municipal Hosp Bronx, New York, United States, 10461 Montefiore Drug Treatment Ctr / Bronx Municipal Hosp Bronx, New York, United States, 10461 Montefiore Family Health Ctr / Bronx Municipal Hosp Bronx, New York, United States, 10461 Samaritan Village Inc / Bronx Municipal Hosp Bronx, New York, United States, 10461 Jack Weiler Hosp / Bronx Municipal Hosp Bronx, New York, United States, 10465 Montefiore Med Ctr / Bronx Municipal Hosp Bronx, New York, United States, 10467 North Central Bronx Hosp / Bronx Municipal Hosp Bronx, New York, United States, 10467 Interfaith Med Ctr Brooklyn, New York, United States, 112032098 SUNY / Health Sciences Ctr at Brooklyn Brooklyn, New York, United States, 112032098 Beth Israel Med Ctr New York, New York, United States, 10003 Clinical Directors Network of Region II New York, New York, United States, 10011 Bellevue Hosp / New York Univ Med Ctr New York, New York, United States, 10016 Saint Clare's Hosp and Health Ctr New York, New York, United States, 10019 Cornell Univ Med Ctr New York, New York, United States, 10021 Mount Sinai Med Ctr New York, New York, United States, 10029 Columbia Presbyterian Med Ctr New York, New York, United States, 100323784 Harlem AIDS Treatment Group / Harlem Hosp Ctr New York, New York, United States, 10037 Less <<
NCT00002716 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 3 Completed - United States, Iowa ... More >> CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 John Stoddard Cancer Center at Iowa Methodist Medical Center Des Moines, Iowa, United States, 50309 Mercy Cancer Center at Mercy Medical Center-Des Moines Des Moines, Iowa, United States, 50314 Iowa Lutheran Hospital Des Moines, Iowa, United States, 50316-2301 United States, Nebraska Midlands Cancer Center at Midlands Community Hospital Papillion, Nebraska, United States, 68128-4157 United States, New Mexico MBCCOP - University of New Mexico HSC Albuquerque, New Mexico, United States, 87131 United States, Ohio MetroHealth Medical Center Cleveland, Ohio, United States, 44109 United States, Pennsylvania Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 United States, Wisconsin CCOP - St. Vincent Hospital Cancer Center, Green Bay Green Bay, Wisconsin, United States, 54307-3453 Australia, New South Wales Westmead Hospital Westmead, New South Wales, Australia, 2145 Peru Instituto de Enfermedades Neoplasicas Lima, Peru, 34 Puerto Rico San Juan City Hospital San Juan, Puerto Rico, 00936-7344 Less <<
NCT00003799 Adenocarcinoma of the Rectum ... More >> Mucinous Adenocarcinoma of the Rectum Signet Ring Adenocarcinoma of the Rectum Stage IIA Rectal Cancer Stage IIB Rectal Cancer Stage IIC Rectal Cancer Stage IIIA Rectal Cancer Stage IIIB Rectal Cancer Stage IIIC Rectal Cancer Less << Phase 1 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT00001428 Colorectal Neoplasms Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00001449 Neoplasms Phase 1 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00000959 HIV Infections ... More >> Tuberculosis Less << Not Applicable Completed - United States, California ... More >> UCLA Med Ctr Los Angeles, California, United States, 90095 Community Consortium of San Francisco San Francisco, California, United States, 94110 United States, Colorado Denver CPCRA / Denver Public Hlth Denver, Colorado, United States, 80204 United States, Connecticut Hill Health Corp New Haven, Connecticut, United States, 06519 United States, Delaware Wilmington Hosp / Med Ctr of Delaware Wilmington, Delaware, United States, 19899 United States, District of Columbia Veterans Administration Med Ctr / Regional AIDS Program Washington, District of Columbia, United States, 20422 United States, Georgia AIDS Research Consortium of Atlanta Atlanta, Georgia, United States, 30308 United States, Louisiana Louisiana Comm AIDS Rsch Prog / Tulane Univ Med New Orleans, Louisiana, United States, 70112 United States, Michigan Comprehensive AIDS Alliance of Detroit Detroit, Michigan, United States, 48201 United States, New Jersey North Jersey Community Research Initiative Newark, New Jersey, United States, 07103 United States, New York Bronx Lebanon Hosp Ctr Bronx, New York, United States, 10456 Addiction Research and Treatment Corp Brooklyn, New York, United States, 11201 Clinical Directors Network of Region II New York, New York, United States, 10011 Harlem AIDS Treatment Group / Harlem Hosp Ctr New York, New York, United States, 10037 Less <<
NCT00000638 HIV Infections ... More >> Tuberculosis Less << Not Applicable Completed - -
NCT00016952 Colorectal Cancer Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Florida Mayo Clinic Jacksonville, Florida, United States, 32224 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68106 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57104 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Less <<
NCT00005036 Mucinous Adenocarcinoma of the... More >> Colon Mucinous Adenocarcinoma of the Rectum Recurrent Colon Cancer Recurrent Rectal Cancer Signet Ring Adenocarcinoma of the Colon Signet Ring Adenocarcinoma of the Rectum Stage IIIA Colon Cancer Stage IIIA Rectal Cancer Stage IIIB Colon Cancer Stage IIIB Rectal Cancer Stage IIIC Colon Cancer Stage IIIC Rectal Cancer Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer Less << Phase 3 Completed - United States, Minnesota ... More >> North Central Cancer Treatment Group Rochester, Minnesota, United States, 55905 Less <<
NCT00023751 Colorectal Cancer Phase 2 Completed - -
NCT00025337 Adenocarcinoma of the Colon ... More >> Adenocarcinoma of the Rectum Recurrent Colon Cancer Recurrent Rectal Cancer Stage III Colon Cancer Stage III Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Less << Phase 3 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT00052910 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 3 Completed - -
NCT00042874 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00052585 Adenocarcinoma of the Colon ... More >> Adenocarcinoma of the Rectum Mucinous Adenocarcinoma of the Colon Mucinous Adenocarcinoma of the Rectum Recurrent Colon Cancer Recurrent Rectal Cancer Signet Ring Adenocarcinoma of the Colon Signet Ring Adenocarcinoma of the Rectum Stage IV Colon Cancer Stage IV Rectal Cancer Less << Phase 2 Terminated(Administratively co... More >>mplete.) Less << - United States, Pennsylvania ... More >> Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00056030 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Completed - -
NCT00043121 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Wisconsin ... More >> University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00052910 - Completed - -
NCT00060411 Mucinous Adenocarcinoma of the... More >> Colon Mucinous Adenocarcinoma of the Rectum Recurrent Colon Cancer Recurrent Rectal Cancer Signet Ring Adenocarcinoma of the Colon Signet Ring Adenocarcinoma of the Rectum Stage IIIA Colon Cancer Stage IIIA Rectal Cancer Stage IIIB Colon Cancer Stage IIIB Rectal Cancer Stage IIIC Colon Cancer Stage IIIC Rectal Cancer Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer Less << Phase 1 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 Less <<
NCT00026364 Colorectal Cancer Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00004931 Stage II Colon Cancer ... More >> Stage III Colon Cancer Less << Phase 3 Completed - United States, Pennsylvania ... More >> National Surgical Adjuvant Breast and Bowel Project Pittsburgh, Pennsylvania, United States, 15212-5234 Less <<
NCT00037063 HIV Infections Not Applicable Withdrawn - United States, Colorado ... More >> Univ of Colorado Health Sciences Ctr Denver, Colorado, United States, 80262 United States, Ohio Case Western Reserve Univ Cleveland, Ohio, United States, 44106 MetroHealth Med Ctr Cleveland, Ohio, United States, 441091998 United States, Pennsylvania Univ of Pennsylvania, Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00006103 Colorectal Cancer Phase 3 Completed - -
NCT00058201 Pancreatic Cancer Phase 3 Completed - -
NCT00069095 Colorectal Cancer Phase 3 Completed - -
NCT00046267 HIV Infections ... More >> Hypercholesterolemia Hypertriglyceridemia Diabetes Mellitus Less << Not Applicable Completed - United States, California ... More >> UCLA School of Medicine Los Angeles, California, United States, 90095 Univ of California, San Diego Antirviral Research San Diego, California, United States, 92103 San Mateo County AIDS Program Stanford, California, United States, 94305 Stanford Univ Stanford, California, United States, 94305 Willow Clinic Stanford, California, United States, 94305 United States, Colorado Univ of Colorado Health Sciences Ctr, Denver Denver, Colorado, United States, 80262-3706 United States, Florida Univ of Miami School of Medicine Miami, Florida, United States, 33136-1013 United States, Indiana Indiana University Hospital Indianapolis, Indiana, United States, 46202 Methodist Hosp of Indiana Indianapolis, Indiana, United States, 46202 Wishard Hospital Indianapolis, Indiana, United States, 46202 United States, Minnesota Univ of Minnesota Minneapolis, Minnesota, United States, 55455-0392 United States, Missouri St. Louis Connect Care St. Louis, Missouri, United States, 63108 Washington Univ (St. Louis) St. Louis, Missouri, United States, 63108 United States, Ohio Univ of Cincinnati Cincinnati, Ohio, United States, 45267-0405 Case Western Reserve Univ Cleveland, Ohio, United States, 44106 United States, Pennsylvania Univ of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213-2582 Less <<
NCT00070434 Colorectal Cancer Phase 2 Withdrawn(poor accrual) - -
NCT00070122 Adenocarcinoma of the Colon ... More >> Adenocarcinoma of the Rectum Recurrent Colon Cancer Recurrent Rectal Cancer Stage III Colon Cancer Stage III Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Less << Phase 3 Terminated(Administratively co... More >>mplete.) Less << - United States, Texas ... More >> Southwest Oncology Group San Antonio, Texas, United States, 78245 Less <<
NCT00006050 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Unknown - France ... More >> Institut J. Paoli and I. Calmettes Marseille, France, 13273 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00009893 Extrahepatic Bile Duct Cancer ... More >> Gallbladder Cancer Liver Cancer Less << Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Florida Mayo Clinic Jacksonville Jacksonville, Florida, United States, 32224 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Clinic Saint Cloud, Minnesota, United States, 56303 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, North Dakota Medcenter One Health System Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 United States, Ohio CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57104 Less <<
NCT00003594 Colorectal Cancer Phase 3 Completed - -
NCT00007878 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, California ... More >> University of Southern California Los Angeles, California, United States, 90033-0804 Less <<
NCT00079274 Adenocarcinoma of the Colon ... More >> Stage III Colon Cancer Less << Phase 3 Completed - -
NCT00079638 Dyslipidemia ... More >>Coronary Heart Disease Atherosclerosis Stroke Diabetes Less << Phase 4 Completed - -
NCT00080275 Hypercholesterolemia Phase 3 Completed - -
NCT00069095 - Completed - -
NCT00004770 Mitochondrial Myopathy Not Applicable Completed - -
NCT00080951 Colorectal Cancer Phase 2 Completed - -
NCT00016978 Colorectal Cancer Phase 2 Completed - -
NCT00079274 - Completed - -
NCT00080990 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00003834 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Louisiana CCOP - Ochsner New Orleans, Louisiana, United States, 70121 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Clinic Saint Cloud, Minnesota, United States, 56303 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, North Dakota Medcenter One Health System Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania CCOP - Geisinger Clinic and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Less <<
NCT00003018 Pancreatic Cancer Phase 2 Completed - -
NCT00003835 Adenocarcinoma of the Colon ... More >> Stage III Colon Cancer Less << Phase 3 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Less <<
NCT00082251 Hypercholesterolemia Phase 3 Completed - -
NCT00002154 Cognitive Disorders ... More >> HIV Infections Less << Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins Hosp Baltimore, Maryland, United States, 212876965 United States, New York Columbia Univ New York, New York, United States, 10032 Univ of Rochester Med Ctr Rochester, New York, United States, 14642 Less <<
NCT00002551 Colorectal Cancer Phase 3 Completed - -
NCT00062556 Intermittent Claudication ... More >> Peripheral Vascular Disease Less << Phase 3 Completed - -
NCT01069328 Carcinoma, Non-Small-Cell Lung... More >> Lung Cancer Less << Phase 1 Completed - United States, Minnesota ... More >> Rochester, Minnesota, United States, 55905 United States, Texas Houston, Texas, United States, 77030 Less <<
NCT01068327 Adenocarcinoma of the Pancreas... More >> Stage III Pancreatic Cancer Less << Phase 1 Active, not recruiting April 2019 United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 Less <<
NCT00474786 - Completed - -
NCT00483301 Malignant Melanoma Phase 2 Completed - United States, California ... More >> Dr. Steven O'Day Los Angeles, California, United States, 90025 United States, Florida Mt. Sinai Medical Center Miami Beach, Florida, United States, 33140 Less <<
NCT00480389 Renal Cell Carcinoma ... More >> Metastatic Disease Less << Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital, University Health Network Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00478114 Renal Cell Carcinoma Phase 3 Completed - Thailand ... More >> Siriraj Hospital, Department of Medicine Bangkoknoi, Bangkok, Thailand, 10700 Less <<
NCT00490867 Type 2 Diabetes Phase 2 Completed - -
NCT00490685 Carcinoma, Hepatocellular Phase 2 Completed - Italy ... More >> Istituto Clinico Humanitas Rozzano, Milan, Italy, 20089 Less <<
NCT00492297 Melanoma Phase 2 Completed - France ... More >> Bordeaux, France, 33000 Lyon Cedex, France, 39373 Toulouse, France, 31052 Villejuif, France, 94805 United Kingdom Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Southampton, Hampshire, United Kingdom, SO16 6YD Northwood, Middlesex, United Kingdom, HA6 2RN Sutton, Surrey, United Kingdom, SM2 5PT London, United Kingdom, NW3 2QG London, United Kingdom, SE1 7EH London, United Kingdom, SW3 6JJ Manchester, United Kingdom, M20 4BX Less <<
NCT00492297 - Completed - -
NCT00486213 Dermatologic Complications ... More >> Palmar-plantar Erythrodysesthesia Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 3 Terminated(Slow accrual) - Singapore ... More >> National Cancer Centre - Singapore Singapore, Singapore, 169610 Less <<
NCT00494299 - Completed - -
NCT00494299 Carcinoma, Hepatocellular Phase 3 Completed - -
NCT00492752 Carcinoma, Hepatocellular Phase 3 Completed - China, Anhui ... More >> Hefei, Anhui, China, 230022 China, Guangdong Guangzhou, Guangdong, China, 510060 Guangzhou, Guangdong, China, 510515 China, Hubei Wuhan, Hubei, China, 430030 China, Jiangsu Nanjing, Jiangsu, China, 210003 Nanjing, Jiangsu, China, 210009 China, Liaoning Dalian, Liaoning, China, 116011 Dalian, Liaoning, China, 116027 China, Zhejiang Hangzhou, Zhejiang, China, 310016 China Beijing, China, 100021 Beijing, China, 100039 Chongqing, China, 400038 Shanghai, China, 200003 Shanghai, China, 200032 Tianjin, China Korea, Republic of Seoul, Seoul Teugbyeolsi, Korea, Republic of, 152-703 Daegu, Korea, Republic of, 702-701 Seoul, Korea, Republic of, 138-736 Taiwan Changhua, Taiwan, 500 Tainan, Taiwan, 736 Taipei, Taiwan, 10016 Taipei, Taiwan, 251 Taoyuan, Taiwan, 333 Less <<
NCT00496756 Kidney Cancer Phase 2 Terminated(Low accrual rate.) - United States, Nebraska ... More >> UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6805 Less <<
NCT01092481 Colon Cancer Phase 3 Recruiting December 2019 Korea, Republic of ... More >> Hallym University Medical Center Recruiting Anyang, Gyeonggi, Korea, Republic of, 431-070 Contact: Dae Young Zang, M.D., Ph.D    82-31-380-3871    fhdzang@hallym.or.kr    Principal Investigator: Dae Young Zang, M.D., Ph.D          Soon Chun Hyang University Hospital Bucheon Recruiting Bucheon, Gyeonggi, Korea, Republic of, 420-767 Contact: Dae Sik Hong, M.D., Ph.D    82-32-621-5104    dshong@schbc.ac.kr    Principal Investigator: Dae Sik Hong, M.D., Ph.D          National Cancer Center Recruiting Goyang, Gyeonggi, Korea, Republic of, 410-768 Contact: Sun Young Kim, M.D., Ph.D    82-31-920-1661    cathykimmd@gmail.com    Principal Investigator: Sun Young Kim, M.D., Ph.D          School of Medicine, CHA University Recruiting Seongnam, Gyeonggi, Korea, Republic of, 463-712 Contact: Doyeun Oh, M.D., Ph.D    82-31-780-5217    doh@cha.ac.kr    Principal Investigator: Doyeun Oh, M.D., Ph.D          Sungkyunkwan University Masan Samsung Hospital Recruiting Masan, Gyeongsangnam, Korea, Republic of, 630-522 Contact: Kyung Tae Park, M.D., Ph.D    82-55-290-6007    pkt@unitel.co.kr    Principal Investigator: Kyung Tae Park, M.D., Ph.D          Pusan National University Yangsan Hospital Recruiting Yangsan, Gyeongsangnam, Korea, Republic of, 626-770 Contact: Seong - Geun Kim, M.D., Ph.D    82-55-360-1424    patheny@nate.com    Principal Investigator: Seong - Geun Kim, M.D., Ph.D          Chonnam National University Hwasun Hospital Recruiting Hwasun, Jeollanam, Korea, Republic of, 519-809 Contact: Ik Joo Chung, M.D., Ph.D    82-61-379-7632    ijchung@jnu.ac.kr    Principal Investigator: Ik Joo Chung, M.D., Ph.D          Kosin Medical Center Recruiting Busan, Korea, Republic of, 602-702 Contact: Seong-Hoon Shin, M.D., Ph.D    82-51-990-6107    ssh1533@hanmail.net    Principal Investigator: Seong-Hoon Shin, M.D., Ph.D          Dong-A University Medical Center Recruiting Busan, Korea, Republic of, 602-715 Contact: Hyuk-Chan Kwon, M.D., Ph.D    82-51-240-2887    hckwon@dau.ac.kr    Principal Investigator: Hyuk-Chan Kwon, M.D., Ph.D          Gachon University Gil Hospital Recruiting Incheon, Korea, Republic of, 405-760 Contact: Dong Bok Shin, M.D., Ph.D    82-32-460-2187    dbs@ghil.com    Principal Investigator: Dong Bok Shin, M.D., Ph.D          Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 120-752 Contact: Joong Bae Ahn, M.D., Ph.D    82-2-2228-8134    vvswm513@yuhs.ac    Principal Investigator: Joong Bae Ahn, M.D., Ph.D          Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Young Suk Park, M.D.,Ph.D.    82-2-3410-3459    pys27hmo@skku.edu    Sub-Investigator: Ho-Kyung Chun, M.D., Ph.D          Sub-Investigator: Woo Yong Lee, M.D., Ph.D          Sub-Investigator: Seong Hyeon Yun, M.D., Ph.D          Sub-Investigator: Hee Cheol Kim, M.D., Ph.D          Sub-Investigator: Yong Beom Cho, M.D.          Sub-Investigator: Haeran Yun, M.D.          Sub-Investigator: Won Ki Kang, M.D., Ph.D          Sub-Investigator: Ho Yeong Lim, M.D., Ph.D          Sub-Investigator: Joon Oh Park, M.D., Ph.D          Sub-Investigator: Se Hoon Park, M.D., Ph.D          Sub-Investigator: Jeeyun Lee, M.D., Ph.D          Seoul St. Mary's hospital, Catholic Univerisity Recruiting Seoul, Korea, Republic of, 137-701 Contact: Myung Ah Lee, M.D., Ph.D    82-2-2258-6044    angelamd@catholic.ac.kr    Principal Investigator: Myung Ah Lee, M.D., Ph.D          Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Tae Won Kim, M.D., Ph.D    82-2-3010-3210    twkimmd@amc.seoul.kr    Principal Investigator: Tae Won Kim, M.D., Ph.D          Soonchunhyang University Hospital Recruiting Seoul, Korea, Republic of, 140-210 Contact: Nam Su Lee, M.D., Ph.D    82-2-709-9287    mdnslee@hosp.sch.ac.kr    Principal Investigator: Nam Su Lee, M.D., Ph.D          SMG-SNU Boramae Medical Center Recruiting Seoul, Korea, Republic of, 156-707 Contact: In Sil Choi, M.D., Ph.D    82-2-870-2231    hmoischoi@hanmail.net    Principal Investigator: In Sil In Sil, M.D., Ph.D          Chung-Ang University College of Medicine Recruiting Seoul, Korea, Republic of, 156-755 Contact: Joung Soon Jang, M.D., Ph.D    82-2-6299-1427    alsaba@hanmail.net    Principal Investigator: Joung Soon Jang, M.D., Ph.D Less <<
NCT00492986 Carcinoma, Renal Cell Phase 3 Completed - -
NCT00498836 Malignant Melanoma Phase 2 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas Cancer Therapy and Research Center, Institute for Drug Development San Antonio, Texas, United States, 78229 Norway The Norwegian Radium Hospital Oslo, Norway, NO-0310 Sweden Lund University Hospital Lund, Sweden, SE-221 85 Umeå University Hospital Umeå, Sweden Uppsala University Hospital Uppsala, Sweden, SE-751 85 Less <<
NCT00497107 Colorectal Cancer Phase 3 Unknown May 2013 Japan ... More >> Iwate Medical University Hospital Recruiting Morioka, Iwate, Japan, 020-8505 Contact: Koki Otsuka, MD    +81-19-651-5111 ext 3627    kokiotsu@iwate-med.ac.jp    Principal Investigator: Go Wakabayashi, MD, PhD          Sub-Investigator: Koki Otsuka, MD Less <<
NCT00510250 Cancer of the Cervix Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00505427 Insulin Resistance ... More >> Oxidative Stress Less << Phase 1 Completed - United States, California ... More >> University of California at San Francisco San Francisco, California, United States, 94143 Less <<
NCT00510289 - Terminated(Early closure of st... More >>udy due to poor response) Less << - -
NCT00903617 - Completed - -
NCT00492752 - Completed - -
NCT01126073 Coronary Heart Disease Phase 4 Completed - Slovenia ... More >> UMC Ljubljana Ljubljana, Slovenia, 1000 Less <<
NCT00903617 Dyslipidaemias Phase 2 Completed - United States, Florida ... More >> GSK Investigational Site Pembroke Pines, Florida, United States, 33026 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46260 United States, Kentucky GSK Investigational Site Louisville, Kentucky, United States, 40213 United States, Maine GSK Investigational Site Auburn, Maine, United States, 04210 United States, Minnesota GSK Investigational Site Brooklyn Center, Minnesota, United States, 55430 United States, North Carolina GSK Investigational Site Statesville, North Carolina, United States, 28677 United States, Ohio GSK Investigational Site Cincinnati, Ohio, United States, 45246 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78205 United States, Virginia GSK Investigational Site Richmond, Virginia, United States, 23294 United States, Washington GSK Investigational Site Olympia, Washington, United States, 98502 GSK Investigational Site Seattle, Washington, United States, 98104 Less <<
NCT00913081 - Completed - -
NCT00913081 Flushing Phase 4 Completed - United States, Pennsylvania ... More >> CTRC Univ. of Penn - Andrew Mutch Bldg., 4th floor Phila, Pennsylvania, United States, 19104 University of Pennsylvania Phila, Pennsylvania, United States, 19104 Less <<
NCT00522301 - Terminated - -
NCT01128322 Hypertension Phase 2 Completed - Korea, Republic of ... More >> Hallym University Sacred Heart Hospital Anyang, Korea, Republic of Soonchunhyang University Hospital in Bucheon Bucheon, Korea, Republic of Kosin University Gospel Hospital Busan, Korea, Republic of Chungbuk National Uiversity Hospital Cheongju, Korea, Republic of Daegu Catholic University Medical Center Daegu, Korea, Republic of Keimyung University Dongsan Medical Center Daegu, Korea, Republic of DonGuk University International Hospital Goyang, Korea, Republic of National Health Insurance Corporation Ilsan Hospital Goyang, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of Gachon University Gil Medical Center Inchon, Korea, Republic of Chonbuk National University Hospital Jeonju, Korea, Republic of Pusan National University Hospital Pusan, Korea, Republic of Seoul National University Bundang Hospital Seongnam, Korea, Republic of Ewha Womans University Hospital Seoul, Korea, Republic of Gangnam Severance Hospital Seoul, Korea, Republic of Kandong Sacred Heart Hospital Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Kyung Hee University Medical Center Seoul, Korea, Republic of Seoul St. Mary's Hospital, The catholic University of Korea Seoul, Korea, Republic of Severance Hospital Seoul, Korea, Republic of SMG-SNU Boramae Medical Center Seoul, Korea, Republic of Soon Chun Hyang University Hospital Seoul, Korea, Republic of St. Paul's Hospital, The catholic University of Korea Seoul, Korea, Republic of Ajou University Hospital Suwon, Korea, Republic of Uijeongbu St. Mary's Hospital, The catholic University of Korea Uijeongbu, Korea, Republic of Wonju Christian Hospital Wonju, Korea, Republic of Less <<
NCT01131546 Essential Hypertension Phase 4 Completed - China ... More >> Peking University People's Hospital Beijing, China Less <<
NCT00525161 Breast Cancer Phase 2 Terminated(Slow accrual and lo... More >>ss of funding) Less << - United States, Kentucky ... More >> University of Kentucky Lexington, Kentucky, United States, 40536 Less <<
NCT00510289 Myelodysplastic Syndromes ... More >> Leukemia, Myelomonocytic, Chronic Less << Phase 2 Terminated(Early closure of st... More >>udy due to poor response) Less << - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00522301 Fallopian Tube Cancer ... More >> Ovarian Cancer Primary Peritoneal Cavity Cancer Less << Phase 2 Terminated - United States, New York ... More >> Memorial Sloan - Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00532025 Carcinoma, Non-Small-Cell Lung Phase 2 Terminated - Germany ... More >> SIRN investigational trial site Essen, Germany SIRN investigational trial site Halle (Saale), Germany SIRN investigational trial site Loewenstein, Germany SIRN investigational trial site Johannes Gutenberg Universität Mainz, Germany SIRN investigational trial site Katholisches Klinikum Mainz, Germany SIRN investigational trial site Rotenburg (Wuemme), Germany Less <<
NCT00526799 - Terminated(Study closed to acc... More >>rual due unfavorable interim analysis) Less << - -
NCT01141309 Thyroid Cancer Phase 2 Active, not recruiting June 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00525161 - Terminated(Slow accrual and lo... More >>ss of funding) Less << - -
NCT00944645 - Completed - -
NCT01147289 Lumbar Sciatic Pain Phase 3 Completed - Brazil ... More >> CEDOES Vitoria, Espirito Santo, Brazil, 29055-450 Sociedade Beneficente São Camilo Campinas, São Paulo, Brazil, 05022-001 Instituto De Pesquisa Clínica De Campinas IPECC Campinas, São Paulo, Brazil, 13073-350 Instituto de Pesquisa Clínica e Medicina Avançada Ltda IMA São paulo, Brazil, 05437-010 Hospital Santa Marcelina São Paulo, Brazil, 08270-070 Faculdade de Medicina ABC São Paulo, Brazil, 0960-650 Less <<
NCT00536575 Multiple Myeloma Phase 1 Phase 2 Completed - United States, Maryland ... More >> Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00541840 Soft Tissue Sarcoma Phase 1 Phase 2 Unknown April 2010 Spain ... More >> Grupo Geis Recruiting Madrid, Spain, 28001 Contact: Xavier Garcia del Muro, MD    915775281    info@grupogeis.org    Principal Investigator: Xavier Garcia del Muro, MD Less <<
NCT00944645 Dyslipidemia Phase 1 Completed - -
NCT00542971 AML Acute Mye... More >>loid Leukemia Myelodysplastic Disorders Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00542971 - Completed - -
NCT00544609 Bladder Cancer Phase 1 Completed - Spain ... More >> Hospital Clínic i Provincial de Barcelona Barcelona, Spain Hospital de la Santa Creu i Sant Pau Barcelona, Spain Institut Català d' Oncología Barcelona, Spain Less <<
NCT00536575 - Completed - -
NCT00544817 - Completed - -
NCT00543335 Lung Cancer Phase 1 Terminated(Lack of Accrual.) - United States, Texas ... More >> UT MD . Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00957359 Cancer Phase 1 Phase 2 Active, not recruiting June 2019 United States, New York ... More >> NYU College of Dentistry Bluestone Center for Clinical Research New York, New York, United States, 10010 Less <<
NCT00953667 - Completed - -
NCT00548899 Breast Cancer Phase 2 Completed - Germany ... More >> St. Gertrauden Krankenhaus Berlin, Germany, 10713 Klinikum der J. W. Goethe Universität Frankfurt am Main, Germany, 60590 Henriettenstiftung Hannover, Germany, 30559 Elisabeth Krankenhaus Kassel, Germany, 34177 Universitätsklinikum Schleswig-Holstein Campus Kiel Kiel, Germany, 24105 Klinikum der Universität zu Köln Köln, Germany, 50924 Klinikum Offenbach Offenbach, Germany, 63069 Klinikum Südstadt Rostock, Germany, 18059 Dr.-Horst-Schmidt-Kliniken GmbH Wiesbaden, Germany, 65199 Less <<
NCT00544817 Glioblastoma Multiforme Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas South Texas Oncology and Hematology San Antonio, Texas, United States, 78258 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT00961636 - Completed - -
NCT00961636 Dyslipidemia Phase 3 Completed - -
NCT01167725 Colorectal Cancer Phase 3 Unknown - United States, Maryland ... More >> St. Agnes Hospital Cancer Center Baltimore, Maryland, United States, 21229 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT01171482 Carcinoma, Hepatocellular Phase 2 Terminated(There were problems... More >> with national reimbursement policies.) Less << - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT00557830 Renal Cell Carcinoma Phase 2 Terminated(The study was close... More >>d to enrollment when it became clear that enrollment was too slow to complete the full enrollment target within the time frame allowed.) Less << - United States, Arkansas ... More >> Clopton Clinic Jonesboro, Arkansas, United States, 72401 United States, California Wilshire Oncology Medical Group, Inc. La Verne, California, United States, 91750 United States, Florida Advanced Medical Specialties Miami, Florida, United States, 33176 United States, Georgia Northeast Georgia Cancer Care Athens, Georgia, United States, 30607 Peachtree Hematology Oncology Consultants Atlanta, Georgia, United States, 30309 Central Georgia Cancer Care Macon, Georgia, United States, 31201 Northwest Georgia Oncology Centers Marietta, Georgia, United States, 30060 United States, Illinois Mid-Illinois Hematology and Oncology Associates, Ltd. Normal, Illinois, United States, 61761 United States, Montana Hematology Oncology Centers of the Northern Rockies Billings, Montana, United States, 59101 United States, North Carolina Gaston Hematology and Oncology Gastonia, North Carolina, United States, 28054 United States, Oregon Pacific Oncology, PC Beaverton, Oregon, United States, 97006 United States, Pennsylvania The Lancaster Cancer Center, Ltd Lancaster, Pennsylvania, United States, 17605 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 Less <<
NCT00953667 Healthy Volunteers Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00559858 Breast Cancer ... More >> Colorectal Cancer Palmar-plantar Erythrodysesthesia Less << Phase 3 Unknown - United Kingdom ... More >> Basildon University Hospital Basildon, England, United Kingdom, SS16 5NL Primrose Oncology Unit Bedford, England, United Kingdom, MK42 9DJ West Suffolk Hospital Bury St. Edmunds, England, United Kingdom, IP33 2QZ Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Kent and Canterbury Hospital Canterbury, England, United Kingdom, CT2 7NR Derbyshire Royal Infirmary Derby, England, United Kingdom, DE1 2QY Royal Devon and Exeter Hospital Exeter, England, United Kingdom, EX2 5DW Queen Elizabeth Hospital King's Lynn, England, United Kingdom, PE30 4ET Royal Albert Edward Infirmary Lancanshire, England, United Kingdom, WN1 2NN Mid Kent Oncology Centre at Maidstone Hospital Maidstone, England, United Kingdom, ME16 9QQ Peterborough Hospitals Trust Peterborough, England, United Kingdom, PE3 6DA Derriford Hospital Plymouth, England, United Kingdom, PL6 8DH Great Western Hospital Swindon, England, United Kingdom, SN3 6BB Kent and Sussex Hospital Tunbridge Wells, England, United Kingdom, TN4 8AT Walsall Manor Hospital Walsall, England, United Kingdom, WS2 9PS Southend University Hospital NHS Foundation Trust Westcliff-On-Sea, England, United Kingdom, SS0 0RY Less <<
NCT01183663 Advanced Cancers Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00966563 Myocardial Infarction Phase 2 Completed - Sweden ... More >> Department of Internal Medicine, County Hospital Ryhov Jönköping, Sweden, 551 85 Less <<
NCT00565968 Melanoma (Skin) Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01187199 Advanced Cancer Phase 1 Active, not recruiting August 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01178320 - Completed - United States, Arizona ... More >> Cardiovascular Consultants Phoenix, Arizona, United States, 85032 United States, California Long Beach VA Medical Center Long Beach, California, United States, 90822 University of Southern California Los Angeles, California, United States, 90033 United States, Maryland University of Maryland Baltimore, Maryland, United States, 21201 Johns Hopkins University Baltimore, Maryland, United States, 21205 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 Wake Forest University Winston-Salem, North Carolina, United States, 27157 United States, Pennsylvania Philadelphia VA Medical Center Philadelphia, Pennsylvania, United States, 19104 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Kelsey Research Foundation Houston, Texas, United States, 77030 Methodist Hospital Houston, Texas, United States, 77030 United States, Washington Harborview Medical Center Seattle, Washington, United States, 98104 University of Washington Seattle, Washington, United States, 98105 Puget Sound VA Medical Center, Seattle Campus Seattle, Washington, United States, 98108 Canada, Alberta Heart Health Institute Calgary, Alberta, Canada, T2E-7C5 University of Calgary Calgary, Alberta, Canada, T2N-2T9 Canada, British Columbia Vancouver General Hospital Vancouver, British Columbia, Canada, V5Z-1M9 Canada, Ontario University of Western Ontario London, Ontario, Canada, N6A-5A5 Less <<
NCT01054651 Schistosoma Mansoni Phase 3 Completed - Kenya ... More >> KEMRI Centre for Global Health Research Kisumu, Kenya Less <<
NCT01185301 - Completed - -
NCT01224418 Rheumatoid Arthritis Phase 4 Completed - Korea, Republic of ... More >> Gyeonggido, Korea, Republic of Seoul, Korea, Republic of Less <<
NCT01225393 Rheumatoid Arthritis Phase 2 Completed - -
NCT00557830 - Terminated(The study was close... More >>d to enrollment when it became clear that enrollment was too slow to complete the full enrollment target within the time frame allowed.) Less << - -
NCT01227408 Breast Cancer Phase 2 Withdrawn(Sponsor withdrew due... More >> to funding issues) Less << February 2011 United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT01225874 Leukemia Not Applicable Completed - -
NCT01224041 Rheumatoid Arthritis Phase 4 Completed - Korea, Republic of ... More >> Busan, Korea, Republic of Daegu, Korea, Republic of Gwangju, Korea, Republic of Jeonju, Korea, Republic of Jinju, Korea, Republic of Less <<
NCT01228331 Leukemia Phase 2 Phase 3 Recruiting September 2021 Germany ... More >> Krankenanstalten Gilead gCmbH Neurochirurgische Klinik Recruiting Bielefeld, Germany, 33617 Contact: Contact Person    49-521-144-2728       Klinikum Bremen-Mitte Recruiting Bremen, Germany, D-28205 Contact: Contact Person    49-421-497-5413       Universitaetsklinikum Duesseldorf Recruiting Duesseldorf, Germany, D-40225 Contact: Contact Person    49-211-81-17662       Klinik und Poliklinik Fuer Kinder-und Jugendmedizin - Universitaetsklinikum Greifswald Recruiting Greifswald, Germany, 17487 Contact: Contact Person    49-3834-86-6321       University Medical Center Hamburg - Eppendorf Recruiting Hamburg, Germany, D-20246 Contact: Contact Person    49-407-4105-2580    horstmann@uke.uni-hamburg.de    Clinic for Bone Marrow Transplantation and Hematology and Oncology Recruiting Idar-Oberstein, Germany, D-55743 Contact: Contact Person    49-6781-66-1582       Klinikum Krefeld GmbH Recruiting Krefeld, Germany, D-47805 Contact: Contact Person    49-2151-322-375       Universitaets - Kinderklinik Recruiting Leipzig, Germany, D-04317 Contact: Contact Person    49-341-9726-113       Johannes Gutenberg University Recruiting Mainz, Germany, D-55101 Contact: Contact Person    49-6131-17-2642       Dr. von Haunersches Kinderspital der Universitaet Muenchen Recruiting Munich, Germany, D-80337 Contact: Contact Person    49-89-5160-2843       Staedtisches Krankenhaus Muenchen - Harlaching Recruiting Munich, Germany, D-81545 Contact: Contact Person    49-89-6210-2720       Klinik St. Hedwig-Kinderklinik Recruiting Regensburg, Germany, 93049 Contact: Contact Person    49-941-2080-493       Dr. Horst-Schmidt-Kliniken Recruiting Wiesbaden, Germany, D-65199 Contact: Contact Person    49-611-43-2564       Helios Kliniken Wuppertal University Hospital Recruiting Wuppertal, Germany, D-42283 Contact: Contact Person    49-202-896-2444 Less <<
NCT01230827 Juvenile Idiopathic Arthritis Phase 3 Terminated(Trial has failed to... More >> meet primary - and major secondary endpoints) Less << - -
NCT01187212 Malignant Neoplasm of Stomach ... More >> Effects of Chemotherapy Less << Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Songpa-gu, Seoul, Korea, Republic of, 138-736 Less <<
NCT01230827 - Terminated(Trial has failed to... More >> meet primary - and major secondary endpoints) Less << - -
NCT01240850 Idiopathic Retroperitoneal Fib... More >>rosis Perianeurysmal Retroperitoneal Fibrosis Chronic Periaortitis Less << Phase 3 Unknown December 2013 Italy ... More >> Nephrology Unit, University Hospital of Parma Recruiting Parma, Italy, 43126 Contact: Augusto Vaglio, MD PhD    +39 0521 702345    augusto.vaglio@virgilio.it    Principal Investigator: Augusto Vaglio, MD PhD Less <<
NCT01235507 - Completed - -
NCT01245452 Rheumatoid Arthritis Not Applicable Completed - Belgium ... More >> Université Catholique de Louvain Bruxelles, Belgium, 1200 Less <<
NCT01242488 Rheumatoid Arthritis Phase 2 Completed - -
NCT01248780 - Completed - -
NCT01251614 Plaque Psoriasis Phase 3 Completed - -
NCT01248780 Rheumatoid Arthritis Phase 3 Completed - China ... More >> Beijing, China Chengdu, China Hefei, China Jinan, China Nanjing, China Shanghai, China Suzhou, China Wuhan, China Xi'An, China Less <<
NCT01242917 Rheumatoid Arthritis Phase 2 Completed - -
NCT00146718 Malaria Phase 2 Phase 3 Completed - -
NCT00144352 Malaria HIV ... More >> AIDS Less << Phase 4 Completed - Kenya ... More >> CDC KEMRI Research Institute Kisumu, Kenya Less <<
NCT01251614 - Completed - -
NCT00609739 Leukemia Phase 1 Phase 2 Terminated(Low accrual) - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00609739 - Terminated(Low accrual) - -
NCT00679744 G(M2) Ganglioside ... More >> Tay-Sachs Disease Ganglioside Sandhoff Disease Ganglioside Less << Phase 1 Withdrawn(Due to lack of fundi... More >>ng) Less << - United States, New York ... More >> New York University, School of Medicine, Department of Neurology New York, New York, United States, 10016 United States, Ohio University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 Canada, Ontario Division of Clinical & Metabolic Genetics, Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT01118013 Leukemia Lymp... More >>homa Lymphoproliferative Disorder Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Terminated - United States, Delaware ... More >> Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 United States, Florida Florida Hospital Cancer Institute at Florida Hospital Orlando Orlando, Florida, United States, 32803-1273 United States, Maryland Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States, 21201 Union Hospital of Cecil County Elkton MD, Maryland, United States, 21921 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, New Jersey Cancer Institute of New Jersey at Cooper - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York New York Weill Cornell Cancer Center at Cornell University New York, New York, United States, 10021 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 Less <<
NCT01313728 - Completed - -
NCT01101412 Chronic Myeloproliferative Dis... More >>orders Infection Leukemia Lymphoma Lymphoproliferative Disorder Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Phase 2 Withdrawn(Study was not opened... More >>.) Less << - -
NCT01235507 Rheumatoid Arthritis Phase 3 Completed - Bosnia and Herzegovina ... More >> Banja Luka, Bosnia and Herzegovina, 78 000 Sarajevo, Bosnia and Herzegovina, 71000 Tuzla, Bosnia and Herzegovina, 75000 Less <<
NCT01313728 Acne Vulgaris Phase 4 Completed - United States, Pennsylvania ... More >> Skin Study Center Broomall, Pennsylvania, United States, 19008 Less <<
NCT01118013 - Terminated - -
NCT01115439 - Completed - Afghanistan ... More >> Provincial Malaria Control Centers (MRC) Maimana, Faryab, Afghanistan Provincial Malaria Control Centers (MRC) Asadabad, Kunar, Afghanistan Provincial Malaria Control Centers (MRC) Jalalabad, Nangarhar, Afghanistan Provincial Malaria Control Centers (MRC) Taloqan, Afghanistan Less <<
NCT01168219 Acute Myeloid Leukemia ... More >> Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Adult Acute Monocytic Leukemia Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With Maturation Adult Acute Myeloid Leukemia With Minimal Differentiation Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A Adult Acute Myeloid Leukemia Without Maturation Adult Acute Myelomonocytic Leukemia Adult Erythroleukemia Adult Pure Erythroid Leukemia Alkylating Agent-Related Acute Myeloid Leukemia de Novo Myelodysplastic Syndrome Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Secondary Myelodysplastic Syndrome Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Active, not recruiting November 15, 2018 United States, Delaware ... More >> Beebe Medical Center Lewes, Delaware, United States, 19958 Christiana Care Health System-Christiana Hospital Newark, Delaware, United States, 19718 United States, Florida Florida Hospital Orlando Orlando, Florida, United States, 32803 United States, Iowa University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Union Hospital of Cecil County Elkton, Maryland, United States, 21921 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Hampshire Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, New Jersey Cooper Hospital University Medical Center Camden, New Jersey, United States, 08103 United States, New York Northwell Health NCORP Lake Success, New York, United States, 11042 Mount Sinai Hospital New York, New York, United States, 10029 Weill Medical College of Cornell University New York, New York, United States, 10065 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT00711906 Malaria in Pregnancy Phase 3 Terminated(Malaria prev. fell ... More >>in the study area, so we cannot evaluate the primary endpoint) Less << - Zambia ... More >> Choma hospital Choma, Zambia Shampande Clinic Shampande, Zambia Less <<
NCT01281696 Breast Neoplasms ... More >> Leptomeningeal Metastasis Brain Metastases Less << Phase 2 Completed - Taiwan ... More >> Department of Oncology, National Taiwan University Hospital Taipei City, Taiwan, 100 Less <<
NCT01168219 - Active, not recruiting - -
NCT01283399 - Completed - Lebanon ... More >> Beirut, Lebanon, 11-236 Beirut, Lebanon, 99999 Beirut, Lebanon Jbeil, Lebanon, 1401 Tripoli, Lebanon, 371 Tripoli Less <<
NCT00712374 Malaria Phase 4 Unknown July 2012 -
NCT01282151 Carcinoma, Non Small Cell Lung Phase 3 Terminated(Difficulty in recru... More >>itment due to approval of maintenance pemetrexed treatment) Less << - Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Hwasun, Jeonnam, Korea, Republic of, 519-709 Kyungpook National University Medical Center Daegu, Kyungpook, Korea, Republic of Hallym University Medical Center Anyang, Korea, Republic of Dankook University Hospital Cheonan, Korea, Republic of, 330-715 Keimyung University Dongsan Center Daegu, Korea, Republic of, 700-712 Yeungnam Univeristy Hospital Daegu, Korea, Republic of Chosun University Hospital Gwangju, Korea, Republic of Wonkwang University Hospital Iksan, Korea, Republic of Inha University Hospital Incheon, Korea, Republic of Pusan National University Hospital Pusan, Korea, Republic of, 602-739 Kosin University Gospel Hospital Pusan, Korea, Republic of Konkuk university medical center Seoul, Korea, Republic of, 143-729 Korea Cancer Center Hospital Seoul, Korea, Republic of Korea University Medical Center Seoul, Korea, Republic of Wonju Christian Hospital Wonju, Korea, Republic of Less <<
NCT00882206 Leukemia Lymp... More >>homa Less << Phase 2 Terminated(Slow accrual) - United States, Minnesota ... More >> University of Minnesota Amplatz Children's Hospital Minneapolis, Minnesota, United States, 55455 Less <<
NCT00882206 - Terminated(Slow accrual) - -
NCT01299545 - Terminated(Recruitment difficu... More >>lties) Less << - -
NCT01285817 Solid Tumours. Phase 2 Unknown March 2016 France ... More >> Assistance Publique Hopitaux de Marseille Recruiting Marseille, France, 13354 Contact: arnaud verschuur       arnaud.verschuur@ap-hm.fr Less <<
NCT01349738 - Unknown May 2013 United States, California ... More >> Scripps Green Hospital La Jolla, California, United States, 92037 Less <<
NCT01301716 Solid Cancers Phase 1 Completed - United States, California ... More >> Los Angeles, California, United States, 90025 United States, Florida Tampa, Florida, United States, 33612 United States, Massachusetts Boston, Massachusetts, United States, 02114 Boston, Massachusetts, United States, 02215 Spain Madrid, Spain, 28050 Less <<
NCT01303874 Rheumatoid Arthritis ... More >> Arthritis Less << Phase 4 Unknown March 2011 United Kingdom ... More >> Leeds Teaching Hospital HNS Trust Leeds, West Yorkshire, United Kingdom, LS7 4SA Less <<
NCT01303926 Non-squamous Nonsmall Cell Neo... More >>plasm of Lung Less << Phase 3 Unknown June 2012 Italy ... More >> "Giovanni Paolo II" Oncology Institute Bari, BA, Italy, 70124 "San Paolo Hospital" Oncology Service Bari, BA, Italy Division of Medical Oncology, "Fatebenefratelli" Hospital Benevento, BN, Italy Division of Medical Oncology, "Sen. Perrino" Hospital, Brindisi, Italy Brindisi, BR, Italy, 72100 7 Division of Medical Oncology, "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, FG, Italy Medical Oncology Division "Vito Fazzi" Hospital Lecce, Le, Italy Division of Medical Oncology, "Buccheri-La Ferla" Hospital Palermo, PA, Italy Division of Medical Oncology, "La Maddalena" Hospital Palermo, PA, Italy Division of Medical Oncology, Castellaneta Hospital Castellaneta, TA, Italy Division of Medical Oncology "San Giuseppe Moscati Hospital" Taranto, TA, Italy Clinical Trials Office, Department of Medical Sciences, Azienda ULSS 13 Mirano, VE, Italy National Cancer Institute "G. Pascale" Thoracic Dept. Napoli, Italy Less <<
NCT01296568 Advanced Cancer Phase 1 Completed - Switzerland ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bruderholz, Switzerland, 4101 Less <<
NCT01305655 - Completed - -
NCT00738946 Malaria Not Applicable Completed - Burkina Faso ... More >> Centre National de Recherche et de Formation sur le Paludisme Ouagadougou, Kadiogo, Burkina Faso, BP 2208 Mali Malaria Research and Training Centre Bamako, Mali Less <<
NCT01313858 - Completed - -
NCT01305655 Acute Lymphoblastic Leukemia (... More >>ALL) Less << Phase 3 Completed - Denmark ... More >> Department of Pediatrics, Rigshospitalet Copenhagen, Denmark, DK-2100 Finland Helsinki University Hospital Helsinki, Finland Iceland University of Reykjavik Reykjavik, Iceland Norway University Hospital of Trondheim Trondheim, Norway Sweden Department of Pediatrics, Drottning Sylvias Pediatric Hospital Goteborg, Sweden Less <<
NCT01306474 - Completed - China, Shaanxi ... More >> Department of Ophthalmology, Xijing Hosptial Xi'an, Shaanxi, China, 710032 Less <<
NCT01067989 Chemotherapy ... More >>Breast Cancer, Metastatic Less << Phase 2 Terminated(No satisfactory acr... More >>ual) Less << - Israel ... More >> Oncology unit Afula, Israel, 18101 Less <<
NCT01313858 - Completed - -
NCT00165503 Pleural Mesothelioma ... More >> Malignant Pleural Mesothelioma Less << Phase 2 Terminated(lack of acurral) - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01319591 - Unknown September 1, 2018 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT01296568 - Completed - -
NCT01128244 Vitamin B6 Deficiency Phase 2 Phase 3 Completed - United States, Florida ... More >> University of Florida Clinical Research Center Gainesville, Florida, United States, 32610 Less <<
NCT01319981 Leukemia Phase 2 Active, not recruiting December 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01128244 - Completed - -
NCT01323920 Leukemia Lymp... More >>homa Myelodysplastic Syndrome Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT00766662 Malaria Not Applicable Completed - Mali ... More >> Malaria Research & Training Center; Faculty of Medicine, Pharmacy and Dentistry, University of Bamako Bamako, Mali, 0000 Less <<
NCT01105390 Advanced Malignant Mesotheliom... More >>a Epithelial Mesothelioma Recurrent Malignant Mesothelioma Sarcomatous Mesothelioma Less << Phase 2 Withdrawn(withdrawn) - -
NCT01329991 Rheumatoid Arthritis Phase 1 Completed - United States, Alabama ... More >> Pinnacle Research Group Anniston, Alabama, United States, 36207 United States, Michigan Medical Practice of Justus Fiechtner, MD Lansing, Michigan, United States, 48910 United States, Pennsylvania Altoona Center for Clinical research Duncansville, Pennsylvania, United States, 16635 United States, Texas Metroplex Clinical Research Center Dallas, Texas, United States, 75231 Less <<
NCT01336543 Stage III Non-small Cell Lung ... More >>Cancer Less << Phase 2 Withdrawn(Low accrual, small p... More >>atient population at center.) Less << - United States, Louisiana ... More >> LSU Health Sciences Center, 1501 Kings Highway Shreveport, Louisiana, United States, 71103 Less <<
NCT01338987 Myelodysplastic Syndrome RAEB ... More >>2 Acute Lymphocytic Leukemia Acute Myelogenous Leukemia Myelodysplastic Syndrome RAEB 1 Less << Phase 2 Active, not recruiting November 19, 2020 United States, District of Col... More >>umbia Childrens National Medical Center Washington, District of Columbia, United States United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Oklahoma University of Oklahoma Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT01392430 HIV Infection Not Applicable Completed - Thailand ... More >> Maharaj Nakorn Chiang Mai Hospital, Department of Medicine, Chiang Mai University Muang, Chiang Mai, Thailand, 50130 Less <<
NCT00165503 - Terminated(lack of acurral) - -
NCT01323920 - Completed - -
NCT01344824 Lung Cancer Phase 2 Completed - United States, North Carolina ... More >> Mission Hospital Asheville, North Carolina, United States, 28801 Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 CCHC New Bern Cancer Care New Bern, North Carolina, United States, 28562 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01345682 Head and Neck Neoplasms ... More >> Carcinoma, Squamous Cell Less << Phase 3 Completed - -
NCT01347983 Rheumatoid Arthritis Phase 3 Completed - Taiwan ... More >> Buddhist Dalin Tzu Chi General Hospital Chiayi, Taiwan Chang Gung Memorial Hospital -Kaohsiung Kaohsiung, Taiwan Kaohsiung Medical University Hospital Kaohsiung, Taiwan Kaohsiung Veterans General Hospital Kaohsiung, Taiwan Chung Shan Medical University Hospital Taichung, Taiwan Taichung Veterans General Hospital Taichung, Taiwan National Cheng Kung University Hospital Tainan, Taiwan Cathay General Hospital Taipei, Taiwan National Taiwan University Hospital Taipei, Taiwan Taipei Veterans General Hospital Taipei, Taiwan Tri-Service General Hospital Taipei, Taiwan Chang Gung Memorial Hospital - Linkou Taoyuan, Taiwan Less <<
NCT01344824 - Completed - -
NCT01349192 Cystic Fibrosis ... More >> Methicillin-resistant Staphylococcus Aureus Less << Phase 2 Terminated(Interim review show... More >>ed a statistically significant treatment effect and the DMC recommended that the study be stopped with ongoing follow-up of enrolled subjects) Less << - United States, Alabama ... More >> The Children's Hospital-University of Birmingham Birmingham, Alabama, United States, 35233 United States, Colorado The Children's Hospital Aurora, Colorado, United States, 80045 United States, Florida University of Florida Gainesville, Florida, United States, 32611 United States, Michigan University of Michigan Health System Ann Arbor, Michigan, United States, 48109-5212 United States, Minnesota Children's Hospitals and Clinics of Minnesota Minneapolis Minneapolis, Minnesota, United States, 55404 United States, Missouri St. Louis Children's Hospital St. Louis, Missouri, United States, 63110 United States, North Carolina N.C Memorial Hospital and N.C Children's Hospital Chapel Hill, North Carolina, United States, 27599 United States, Ohio CFF Care Center & Pediatric Program Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3026 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Cook Children's Medical Center Fort Worth, Texas, United States, 76104 Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Seattle Children's Seattle, Washington, United States, 98145-9807 University of Washington Medical Center Seattle, Washington, United States, 98195 Less <<
NCT01351415 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 3 Completed - -
NCT01353859 - Completed - -
NCT01358253 Acute Lymphoblastic Leukemia Phase 4 Completed - China, Shanghai ... More >> Ruijin Hospital Shanghai, Shanghai, China, 200025 Less <<
NCT01345682 - Completed - -
NCT01358201 Acute Lymphoblastic Leukemia Phase 4 Recruiting December 2020 -
NCT01353859 Rheumatoid Arthritis Phase 3 Completed - Indonesia ... More >> Bandung, Indonesia, 40161 Central Jakarta, Indonesia, 10430 East Java, Indonesia Malang, Indonesia, 65111 Yogyakarta, Indonesia, 55284 Less <<
NCT01358968 Cancer Phase 1 Completed - United States, Tennessee ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States, 38120 Less <<
NCT01358968 - Completed - -
NCT01351415 - Completed - -
NCT01359150 - Completed - -
NCT01360970 Response to Hepatitis A Vaccin... More >>e Less << Phase 2 Completed - Finland ... More >> Dept infectious diseases Helsingfors, Finland, 00029 Sweden Dept infectious diseases Eskilstuna, Sweden, 631 88 Dept infectious diseases Karlstad, Sweden, 651 85 Department of infectious diseases Stockholm, Sweden, 17176 Less <<
NCT01359943 - Completed - -
NCT01349192 - Terminated(Interim review show... More >>ed a statistically significant treatment effect and the DMC recommended that the study be stopped with ongoing follow-up of enrolled subjects) Less << - -
NCT01359150 Rheumatoid Arthritis Phase 2 Completed - -
NCT01366898 Acute Lymphoblastic Leukemia Phase 4 Recruiting December 2019 Spain ... More >> Hospital Germans Trias i Pujol and all Hospital Pethema Recruiting Badalona, Barcelona, Spain Contact: José Mª Ribera, Dr       jribera@iconcologia.net Less <<
NCT01359943 Rheumatoid Arthritis Phase 2 Completed - -
NCT00482833 Leukemia Phase 3 Active, not recruiting December 2018 -
NCT01371630 Acute Lymphoblastic Leukemia ... More >> B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Recruiting August 31, 2019 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Elias Jabbour    713-792-7026       Principal Investigator: Elias Jabbour Less <<
NCT01363128 Leukemia Phase 2 Active, not recruiting July 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01376310 Cancer Phase 2 Completed - -
NCT01425320 Acne Vulgaris Phase 1 Withdrawn(Study was never init... More >>iated due to company decision. No study subjects were ever enrolled or dosed.) Less << June 2013 -
NCT01425073 HIV Infections ... More >> Acquired Immunodeficiency Syndrome Disease Progression Immune System Diseases Malaria Parasitic Diseases Pneumonia Diarrhea Infectious Disorder of Immune System Less << Not Applicable Completed - Kenya ... More >> Homa Bay District Hospital Homa Bay, Nyanza Pronvince, Kenya Kombewa District Hospital Kombewa, Nyanza, Kenya Less <<
NCT01382940 Rheumatoid Arthritis Phase 4 Completed - -
NCT01383148 Non-Small-Cell Lung Carcinoma Phase 2 Phase 3 Terminated - -
NCT01373151 Rheumatoid Arthritis Phase 2 Completed - -
NCT01384461 - Completed - Hungary ... More >> Budapest, Hungary, 1023 Budapest, Hungary, 1027 Budapest, Hungary, 1062 Debrecen, Hungary, 4032 Debrecen, Hungary, 4043 Eger, Hungary, 3300 Esztergom, Hungary, 2500 Gyula, Hungary, 5700 Győr, Hungary, 9023 Heviz, Hungary, 8380 Kecskemet, Hungary, 6000 Kistarcsa, Hungary, 2143 Miskolc, Hungary, 3529 Nyiregyhaza, Hungary, 4400 Pécs, Hungary, 7632 Szeged, Hungary, 6724 Szekesfehervar, Hungary, 8000 Szolnok, Hungary, 5000 Szombathely, Hungary, 9700 Veszprem, Hungary, 8200 Less <<
NCT00811421 Pregnancy Mal... More >>aria HIV Infections Less << Not Applicable Completed - Benin ... More >> Faculté des Sciences de la Santé (FSS), Université d'Abomey Calavi Allada, Benin Gabon Medical Rsearch Unit (MRU), Albert Schweitzer Hospital Lambaréné, Gabon Kenya Kenya Medical Research Institute (KEMRI)/ CDC Kisumu, Kenya Mozambique Centro de Investigaçao em Saúde da Manhiça (CISM) Manhiça, Maputo, Mozambique Tanzania Ifakara Health Institute (IHI) Dodoma, Tanzania Less <<
NCT01389076 Follicular Lymphoma Phase 2 Terminated(Bexxar isn't being ... More >>produced by the manufacturer as of Feb. 2014) Less << - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT01382940 - Completed - -
NCT01384422 Rheumatoid Arthritis Phase 2 Completed - Moldova, Republic of ... More >> Innophar MO S.R.L. Chisinau, Moldova, Republic of, MD-2025 Less <<
NCT01389076 - Terminated(Bexxar isn't being ... More >>produced by the manufacturer as of Feb. 2014) Less << - -
NCT01390402 - Completed - -
NCT01376427 Acute Lymphoblastic Leukemia P... More >>h Positive Less << Not Applicable Recruiting December 2019 Spain ... More >> Hospital Germans Trias i Pujol and all Hospital Pethema Recruiting Badalona, Barcelona, Spain Contact: Jose Mª Ribera, Dr       jribera@iconcologia.net Less <<
NCT01443130 Malaria Phase 3 Completed - Malawi ... More >> Blantyre Malaria Project - Queen Elizabeth Central Hospital Blantryre, Blantyre, Malawi Less <<
NCT01390441 Rheumatoid Arthritis Phase 1 Terminated(The study was termi... More >>nated early by the Sponsor for business reasons.) Less << - -
NCT01390402 Leukemia Chro... More >>nic Myelogenous Leukemia Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01399281 - Recruiting December 2021 Italy ... More >> IRCCS G. Gaslini Recruiting Genoa, Italy, 16147 Principal Investigator: Nicola Ruperto, MD, MPH Less <<
NCT01395758 - Completed - -
NCT01443130 - Completed - -
NCT01390441 - Terminated(The study was termi... More >>nated early by the Sponsor for business reasons.) Less << - -
NCT01399372 Chemotherapeutic Agent Toxicit... More >>y Cognitive/Functional Effects Lymphoma Neurotoxicity Radiation Toxicity Less << Phase 2 Active, not recruiting September 2026 -
NCT01399697 Rheumatoid Arthritis Phase 4 Completed - -
NCT01395758 Metastatic Non-Small Cell Lung... More >> Cancer Less << Phase 2 Completed - United States, California ... More >> Stanford, California, United States, 94305 United States, District of Columbia Washington, District of Columbia, United States, 20057 United States, Florida Weston, Florida, United States, 33331 United States, Georgia Atlanta, Georgia, United States, 30341 United States, Illinois Chicago, Illinois, United States, 60611 United States, Kansas Kansas City, Kansas, United States, 66160 United States, Maryland Baltimore, Maryland, United States, 21205 United States, Massachusetts Boston, Massachusetts, United States, 02114 Burlington, Massachusetts, United States, 01805 United States, New York New York, New York, United States, 10016 United States, Pennsylvania Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Dallas, Texas, United States, 75390 Less <<
NCT01995201 Rheumatoid Arthritis Phase 3 Completed - -
NCT01399697 - Completed - -
NCT01999192 - Terminated(Lack of efficacy) - -
NCT01995201 - Completed - -
NCT02001168 Non-small Cell Lung Cancer Phase 3 Active, not recruiting October 2022 China, Xinjiang ... More >> Cancer Hospital of Xinjiang Medical University Urumqi, Xinjiang, China, 830011 Less <<
NCT01999192 Rheumatoid Arthritis Phase 2 Terminated(Lack of efficacy) - -
NCT02006706 Rheumatoid Arthritis Phase 3 Completed - Serbia ... More >> Belgrade, Serbia, 11000 Niska Banja, Serbia, 18250 Nova Sad, Serbia, 21000 Less <<
NCT02003222 Acute Lymphoblastic Leukemia ... More >> B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative BCR/ABL1 Fusion Protein Negative Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 3 Recruiting - -
NCT02006706 - Completed - -
NCT02001987 - Completed - -
NCT02072317 Advanced Gastric Cancer Phase 2 Unknown March 2016 China, Shanghai ... More >> Cancer hospital Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: GUO WEI JIAN, doctor    13816066360    guoweijian1@hotmail.com Less <<
NCT02017964 Untreated Childhood Medullobla... More >>stoma Less << Phase 2 Completed - -
NCT02013453 Cancer of Head and Neck Phase 2 Withdrawn(Lack of funding) - United States, Michigan ... More >> University of Michigan Hospital Ann Arbor, Michigan, United States, 48109 Less <<
NCT02020161 APL Phase 4 Recruiting December 2019 Spain ... More >> Hospital La Fe Recruiting Valencia, Spain Contact: Pau Montesinos, Dr       montesinos_pau@gva.es Less <<
NCT02001987 Rheumatoid Arthritis Phase 3 Completed - France ... More >> Amiens, France, 80054 Bordeaux, France, 33076 Brest, France, 29609 Caen, France, 14033 Cahors, France, 46005 Clermont-ferrand, France, 63003 Echirolles, France, 38434 La Source, France, 45100 Le Mans, France, 72037 Lille, France, 59037 Limoges, France, 87042 Lomme, France, 59462 Lyon cedex 3, France, 69437 Marseille, France, 13274 Marseille, France, 13285 Metz Tessy, France, 74370 Monaco, France, 98012 Montpellier, France, 34295 Mulhouse, France, 68070 Paris, France, 75475 Paris, France, 75571 Paris, France, 75651 Paris, France, 75679 Paris, France, 75877 Rennes, France, 35033 Rouen, France, 76031 St Mande, France, 94163 St Priest En Jarez, France, 42277 Strasbourg, France, 67098 Thonon Les Bains, France, 74203 Toulouse, France, 31059 Vandoeuvre-les-nancy, France, 54511 Less <<
NCT02096159 Hypospadias Not Applicable Active, not recruiting June 2023 United States, Illinois ... More >> Ann & Robert H Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60611 Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT02029599 Rheumatoid Arthritis Phase 2 Completed - China, Hubei ... More >> Hubei provincial hospital of tcm Wuhan, Hubei, China China, Liaoning Hospital of Liaoning University of Traditional Chinese Medicine Shenyang, Liaoning, China China, Shanghai LONGHUA Hospital Shanghai University of TCM Shanghai, Shanghai, China China, Tianjin First Teaching hospital of Tianjin University of Traditional Chinese Medicine Tianjin, Tianjin, China Second affiliated hospital of Tianjin university of tcm Tianjin, Tianjin, China Less <<
NCT02011022 Methotrexate Adverse Reaction Not Applicable Completed - China, Zhejiang ... More >> The Children's Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China, 310006 Less <<
NCT02028676 Human Immunodeficiency Virus Phase 4 Completed - Uganda ... More >> MRC /UVRI Uganda Research Unit on AIDS Entebbe, Uganda Joint Clinical Research Centre Kampala, Uganda Baylor College of Medicine Children's Foundation Mulago, Uganda Zimbabwe University of Zimbabwe Medical School Harare, Zimbabwe Less <<
NCT02037737 - Completed - -
NCT02037997 Non Small Cell Lung Cancer Phase 2 Unknown December 2017 China, Shanghai ... More >> Cancer hospital Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Chang J hua, PD    13916619284    changjianhua@163.com Less <<
NCT02037191 ALOPECIA AREATA Phase 3 Completed - France ... More >> Head Dermatology Department Rouen, Haute Normandie, France, 76031 CHU de Rouen - Hôpitaux de Rouen Rouen, Seine Maritime, France, 76031 Less <<
NCT02031601 Non-Small-Cell Lung Cancer Phase 4 Unknown December 2017 China, Shandong ... More >> Yu Li Recruiting Jinan, Shandong, China, 250012 Contact: Yu Li Less <<
NCT02039674 Non-small Cell Lung Carcinoma Phase 1 Phase 2 Active, not recruiting October 18, 2021 United States, California ... More >> Call for Information (Investigational Site 0018) La Jolla, California, United States, 92037 Call for Information (Investigational Site 0010) San Francisco, California, United States, 94115 United States, Indiana Call for Information (Investigational Site 0019) Indianapolis, Indiana, United States, 46202 United States, Massachusetts Call for Information (Investigational Site 0017) Boston, Massachusetts, United States, 02114 Call for Information (Investigational Site 0002) Boston, Massachusetts, United States, 02215 Call for Information (Investigational Site 0016) Boston, Massachusetts, United States, 02215 United States, Nebraska Call for Information (Investigational Site 0023) Omaha, Nebraska, United States, 68130 United States, New Jersey Call for Information (Investigational Site 0055) Hackensack, New Jersey, United States, 07601 United States, New York Call for Information (Investigational Site 0056) Lake Success, New York, United States, 11042 United States, Pennsylvania Call for Information (Investigational Site 0009) Philadelphia, Pennsylvania, United States, 19104 Call for Information (Investigational Site 0015) Philadelphia, Pennsylvania, United States, 19104 Call for Information (Investigational Site 0004) Philadelphia, Pennsylvania, United States, 19111 United States, Texas Call for Information (Investigational Site 0007) Houston, Texas, United States, 77030 Call for Information (Investigational Site 0003) San Antonio, Texas, United States, 78229 Taiwan Merck Sharp & Dohme (I.A.) Corp. Taipei, Taiwan Less <<
NCT02042690 Acute Lymphoblastic Leukemia Phase 3 Unknown December 2018 China, Beijing ... More >> Aerospace Center Hospital Beijing, Beijing, China, 100044 Peking University First Hospital Beijing, Beijing, China, 100044 Less <<
NCT02028676 - Completed - -
NCT02041533 - Active, not recruiting - -
NCT02043587 Acute Lymphocytic Leukemia ... More >> Adult Lymphoblastic Lymphoma Less << Phase 2 Active, not recruiting January 2020 United States, California ... More >> UCSD, Division of Blood and Marrow Transplantation, Moores Cancer Center La Jolla, California, United States, 92093 Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA Los Angeles, California, United States, 90095 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0324 Less <<
NCT02041533 Stage IV or Recurrent Non-Smal... More >>l Cell Lung Cancer Less << Phase 3 Active, not recruiting October 1, 2018 -
NCT02039674 - Active, not recruiting - -
NCT02045368 Breast Cancer ... More >> Brain Cancer Gastrointestinal Cancers Genitourinary Cancers Gynecologic Cancers Head and Neck Cancers Melanoma Thoracic Cancers Less << Phase 1 Completed - United States, Illinois ... More >> University of Illinois at Chicago Chicago, Illinois, United States, 60612 Less <<
NCT02046603 Rheumatoid Arthritis Phase 3 Completed - United Kingdom ... More >> Aberdeen Royal Infirmary Aberdeen, United Kingdom, AB25 2ZN Christchurch Hospital; Rheumatology Bournemouth, United Kingdom, BH23 2JX Royal Sussex County Hospital; Clinical Investigation Research Unit Brighton, United Kingdom, BN2 5BE Queens Hospital Burton on Trent, United Kingdom, DE13 0RB West Suffolk Hospital Bury Saint Edmonds, United Kingdom, IP33 2QZ Addenbrooke'S Hospital; Rheumatology Research Unit Cambridge, United Kingdom, CB2 2QQ Cannock Chase Hospital; Rheumatology Cannock, United Kingdom, WS11 5XY University Hospital of Wales; Dept of Rhematology Cardiff, United Kingdom, CF14 4XW Broomfield Hospital Chelmsford, United Kingdom, CM1 7ET Countess of Chester Hospital; Dept of Rheumatology Chester, United Kingdom, CH2 1UL Dewsbury & District Hospital; Dept of Rheumatology Dewsbury, United Kingdom, WF13 4HS Russells Hall Hospital; Rheumatology Department Dudley, United Kingdom, DY1 2HQ Ninewells Hospital Dundee, United Kingdom, DD12 9SY Eastbourne District General Hospital; Dept of Rheumatology Eastbourne, United Kingdom, BN21 2UD Western General Hospital; Pharmacy Department Edinburgh, United Kingdom, EH4 2XU Gartnavel General Hospital; Rheumatology Glasgow, United Kingdom, G12 0YN Diana Princess of Wales Hosp. Grimsby, United Kingdom, DN33 2BA Princess Alexandra Hospital Harlow, United Kingdom, CM20 1QX Northwick Park Hospital Harrow, United Kingdom, HA1 3UJ Hemel Hempstead General Hospital; Rheumatology Dept Hemel Hempstead, United Kingdom, HP2 4AD Hull Royal Infirmary; Rheumatology Department Hull, United Kingdom, HU3 3JZ Llandudno General Hospital Llandudno, United Kingdom, LL30 1LB Whipps Cross Hospital; Rheumatology Dept London, United Kingdom, E11 1NR Royal Free Hospital; Department of Rheumatology London, United Kingdom, NW3 2QG Maidstone Hospital; Dept of Rheumatology Maidstone, United Kingdom, ME16 9QQ Wythenshawe Hospital Manchester, United Kingdom, M23 9QZ Freeman Hospital; Dept of Rheumatology Newcastle Upon Tyne, United Kingdom, NE7 7DN North Tyneside General Hospital North Shields, United Kingdom, NE29 8NH Norfolk & Norwich Hospital; Rheumatology Norwich, United Kingdom, NR4 7UY Integrated Care Centre Oldham, United Kingdom, OL1 1NL Solihull Hospital Solihull, United Kingdom, B91 2JL Haywood Hospital; Staffordshire Rheumatology Centre Stoke-on-trent, United Kingdom, ST6 7AG Great Western Hospital; Dept of Rheumatology Swindon, United Kingdom, SN3 6BB Torbay Hospital; Dept of Rhematology Torquay, United Kingdom, TQ2 7AA Royal Cornwall Hospital; Rhuematololgy Dept Truro, United Kingdom, TR1 3LJ Warrington Hospital Warrington, United Kingdom, WA5 1QG Wrightington Hospital; Rheumatology Wigan, United Kingdom, WN6 9EW Wishaw General Hospital Wishaw, United Kingdom, ML2 0DP Less <<
NCT02046616 Rheumatoid Arthritis Phase 3 Completed - Denmark ... More >> Aalborg Universitetshospital Nord, Reumatologisk Afdeling Alborg, Denmark, 9000 Glostrup Hospital, Reumatologisk Afdeling, Ambulatoriet Glostrup, Denmark, 2600 Gentofte Hospital, Medicinsk Afd. C, Klinik for Gigt- og Rygsygdomme Hellerup, Denmark, 2900 Holbæk Sygehus, Medicinsk Afd., Reumatologisk Amb.15-2 Holbæk, Denmark, 4300 Sjællands Universitetshospital, Køge; Reumatologisk Afdeling Køge, Denmark, 4600 Odense Universitetshospital, Reumatologisk Afdeling C, Ambulatoriet Odense, Denmark, 5000 Svendborg Sygehus, Reumatologisk Ambulatorium Svendborg, Denmark, 5700 Finland Helsinki University Central Hospital; Rheumatology Clinic Helsinki, Finland, 00290 Kiljavan Lääketutkimus Oy Hyvinkää, Finland, 05800 Central Hospital of Pohjois-Karjala; Outpatient Clinic of Rheumatology Joensuu, Finland, 80210 Keski-Suomen Keskussairaala; Sisätautien Klinikka Jyväskylä, Finland, 40620 Lappeenranta Central Hospital; Outpatient Clinic of Internal Medicine Lappeenranta, Finland, 53130 Oulu University Hospital; Rheumatology Oulu, Finland, 90220 Norway Haukeland Universitetssykehus; Revmatologisk Avdeling Bergen, Norway, 5053 Drammen sykehus Vestre Viken HF, Revmatologisk avd. Drammen, Norway, 3004 Diakonhjemmet; Reumatolgisk Avdeling Oslo, Norway, 0370 St. Olavs Hospital; Revmatologisk avdeling Trondheim, Norway, 7030 Ålesund Sykehus; Revmatologisk Avdeling Ålesund, Norway, 6017 Sweden Länssjukhuset Ryhov; Ortoped- och Reumatolog kliniken Jönköping, Sweden, 551 85 Uni Hospital Linkoeping; Dept. of Rheumatology Linkoeping, Sweden, 58185 Skånes Universitetssjukhus Lund; Reumatologkliniken Lund, Sweden, 221 85 Skånes Universitetssjukhus Malmö; Reumatologkliniken Malmo, Sweden, 205 02 Örebro Uni Hospital; Rheumatology Oerebro, Sweden, 70185 Simrishamns Sjukhus Simrishamn, Sweden, 272 81 Karolinska Sjukhuset; Reumatologkliniken D2-1 Stockholm, Sweden, 171 76 Akademiska sjukhuset, Reumatologkliniken Uppsala, Sweden, 75185 Västmanlands sjukhus Västerås, Reumatologkliniken Västerås, Sweden, 72189 Less <<
NCT02046616 - Completed - -
NCT02046603 - Completed - -
NCT02046694 Acute Lymphoblastic Leukemia (... More >>ALL) Less << Early Phase 1 Recruiting September 2021 United States, Maryland ... More >> Johns Hopkins Hospital Recruiting Baltimore, Maryland, United States, 21287 Principal Investigator: Colleen Annesley, MD          Sub-Investigator: Patrick A Brown, MD          United States, Texas Texas Children's Cancer and Hematology Centers Recruiting Houston, Texas, United States, 77030 Contact: Julie Brackett, MD    832-822-4242       Sub-Investigator: Edward Sisson, MD          Principal Investigator: Julie Brackett, MD          United States, Washington Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 Contact: Colleen Annesley, MD          Principal Investigator: Colleen Annesley, MD Less <<
NCT02052167 Juvenile Idiopathic Arthritis Early Phase 1 Completed - United States, Missouri ... More >> Children's Mercy Hospital & Clinics Kansas City, Missouri, United States, 64108 Less <<
NCT02054442 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 1 Phase 2 Recruiting February 2018 Netherlands ... More >> Medical Centre Haaglanden Suspended Den Haag, Netherlands Medisch Spectrum Twente Not yet recruiting Enschede, Netherlands Contact: A. Wymenga, MD, PhD          Principal Investigator: A. Wymenga, MD, PhD          Medical Centre Leeuwarden Suspended Leeuwarden, Netherlands Leiden University Medical Center Suspended Leiden, Netherlands Academisch Ziekenhuis Maastricht Suspended Maastricht, Netherlands Radboud university medical center Recruiting Nijmegen, Netherlands Contact: Olga P Huber, MSc    +31 (0)24 361 47 94    trialbureauhematologie-onco@radboudumc.nl    Principal Investigator: C M van Herpen, MD, PhD          Erasmus Medical Center Suspended Rotterdam, Netherlands St. Elisabeth Ziekenhuis Suspended Tilburg, Netherlands Less <<
NCT02057250 RA Phase 3 Completed - -
NCT02057250 - Completed - -
NCT00732992 - Completed - -
NCT02065713 Psoriatic Arthritis Phase 3 Completed - Portugal ... More >> Centro Académico de Medicina de Lisboa Lisbon, Portugal Less <<
NCT02052375 Rheumatoid Arthritis ... More >> Pharmacokinetics of ASP2408 Less << Phase 1 Completed - United States, Alabama ... More >> Pinnacle Research Group, LLC Anniston, Alabama, United States, 36207 United States, Pennsylvania Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 United States, Texas Metroplex Clinical Research Center, LLC Dallas, Texas, United States, 75231 Less <<
NCT00738582 Malignant Pleural Mesothelioma Phase 2 Completed - -
NCT02074319 Schizophrenia ... More >> Schizoaffective Disorder Schizophreniform Disorder Less << Phase 1 Completed - Pakistan ... More >> Abasi Shaheed Hospital Karachi, Sindh, Pakistan, 72000 Civil hospital Karachi Karachi, Sindh, Pakistan, 72000 Institute of Behavioural Sciences Karachi, Sindh, Pakistan, 72000 Karwn e Hayat Karachi, Sindh, Pakistan, 72000 Less <<
NCT00732992 Neoplasm, Malignant Phase 1 Completed - Japan ... More >> Pfizer Investigational Site Osakasayama-shi, Osaka, Japan Less <<
NCT02076477 Oligo-metastatic Stage IV Non-... More >>small Cell Lung Cancer Less << Phase 3 Unknown - China, Sichuan ... More >> Sichuan Cancer Hospital & Institute Recruiting Chengdu, Sichuan, China, 610041 Contact: TAO LI, MD, PhD    86-18908178818    litaoxmf@163.com    Principal Investigator: TAO LI, MD, PhD          Sub-Investigator: XIAOHU WANG, MD, PhD          Sub-Investigator: XIAOBO DU, MD, PhD          Sub-Investigator: BING LU, MD, PhD Less <<
NCT02076997 Cancer Not Applicable Active, not recruiting June 2019 United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT02066389 Rheumatoid Arthritis Phase 2 Completed - -
NCT02145338 Urinary Tract Infections, Recu... More >>rrent Less << Phase 4 Completed - United Kingdom ... More >> Institute of Cellular Medicine, Newcastle University Newcastle upon Tyne, United Kingdom, NE2 4HH Less <<
NCT02083679 Carcinoma, Non-Small-Cell Lung Phase 1 Terminated(Sponsor the return ... More >>rights of the compound to the collaboration partner for further clinical development) Less << - United States, Massachusetts ... More >> Please Contact U.S. Medical Information Located in Rockland, Massachusetts, United States Germany Please contact the Merck KGaA Communication Center located in Darmstadt, Germany Less <<
NCT02083679 - Terminated(Sponsor the return ... More >>rights of the compound to the collaboration partner for further clinical development) Less << - -
NCT02079636 Carcinoma, Non-small Cell Lung Phase 1 Active, not recruiting July 2, 2020 United States, Arkansas ... More >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, California UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States, 90095 University of California, Davis - Health Systems Sacramento, California, United States, 95817 United States, Indiana Indiana Cancer Pavilion Indianapolis, Indiana, United States, 46202 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New Mexico University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87102 United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States, 28204 United States, Tennessee The West Clinic Germantown, Tennessee, United States, 38138 Spain Hospital Universitario Ramon y Cajal Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Majadahonda, Spain, 28222 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sevilla, Spain, 41013 Less <<
NCT02085655 Extranodal NK-T-Cell Lymphoma,... More >> Nasal and Nasal-Type Less << Phase 3 Unknown December 2018 China, Guangdong ... More >> Department of Medical Oncology, Sun Yat-sen University Cancer Center, Recruiting Guangzhou, Guangdong, China, 510060 Contact: HuiQiang Huang    86-020-87343350    huanghq@sysucc.org.cn Less <<
NCT05296369 Lung Cancer UNKNOWN 2025-05-23 The Affiliated Cancer Hospital... More >> of Guizhou Medical University, Guiyang, Guizhou, 550025, China Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.27mL

0.45mL

0.23mL

11.33mL

2.27mL

1.13mL

22.66mL

4.53mL

2.27mL
Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

[1]Price RJ, Lillycrop KA, Burdge GC. Folic acid supplementation in vitro induces cell type-specific changes in BRCA1 and BRCA 2 mRNA expression, but does not alter DNA methylation of their promoters or DNA repair. Nutr Res. 2015 Jun;35(6):532-44.

[2]Shin JH, Shiota K. Folic acid supplementation of pregnant mice suppresses heat-induced neural tube defects in the offspring. J Nutr. 1999 Nov;129(11):2070-3.

[3]Pietrzik K, Bailey L, Shane B. Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2010 Aug;49(8):535-48

[4]van Gool JD, Hirche H, Lax H, De Schaepdrijver L. Folic acid and primary prevention of neural tube defects: A review. Reprod Toxicol. 2018 Sep;80:73-84

[5]Adi AC, Christanto C, Rachmawati H, Adlia A. Vitamin E-based Folic Acid Nanoemulsion: Formulation and Physical Evaluation for Oral Administration. Pharm Nanotechnol. 2019;7(4):304-313

[6]Paul RT, McDonnell AP, Kelly CB. Folic acid: neurochemistry, metabolism and relationship to depression. Hum Psychopharmacol. 2004 Oct;19(7):477-88

 

Historical Records

Categories

Inhibitors/Agonists
Cell Cycle
DNA/RNA Synthesis
Inhibitors/Agonists
DNA Damage
DNA/RNA Synthesis
Inhibitors/Agonists
Other Inhibitors/Agonists
Vitamin

Tags: Folic acid | Vitamin B9 | Vitamin M | Vitamin B 9 | Vitamin B-9 | DNA/RNA Synthesis | Endogenous Metabolite | nutrient | ntidepressant-like | neural tube defects | folic deficiency | 59-30-3